[
  {
    "id": 2,
    "user_query": "Is the protein Papilin secreted?",
    "yulan-chat-2-13b-fp16_response": "Papilin is a protein that is found in the salivary glands of certain insects, such as the caterpillars of the family Pyralidae. It is not secreted by the salivary glands, but is produced by specialized cells called myoepithelial cells. These cells secrete papilin into the salivary glands, where it is stored in granules until it is needed. When the caterpillar feeds on a host plant, the papilin is released from the salivary glands and mixed with saliva to form a sticky substance that helps the caterpillar to adhere to the plant and feed on its leaves.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Papilin is a protein found in the salivary glands of certain caterpillars of the family Pyralidae.\n2. Papilin is produced by specialized cells called myoepithelial cells.\n3. Myoepithelial cells secrete papilin into the salivary glands.\n4. Papilin is stored in granules within the salivary glands until needed.\n5. When a caterpillar feeds, papilin is released from the salivary glands and mixed with saliva to help the caterpillar adhere to plants.",
    "yulan-chat-2-13b-fp16_fact": [
      "Papilin is a protein found in the salivary glands of certain caterpillars of the family Pyralidae.",
      "Papilin is produced by specialized cells called myoepithelial cells.",
      "Myoepithelial cells secrete papilin into the salivary glands.",
      "Papilin is stored in granules within the salivary glands until needed.",
      "When a caterpillar feeds, papilin is released from the salivary glands and mixed with saliva to help the caterpillar adhere to plants."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Myoepithelial cells are specialized cells often found in glands, but they are not known to produce papilin, which is a proteoglycan and not typically associated with myoepithelial cells.\n3. FALSE [correction]: If statement 2 is false and myoepithelial cells are not the producers of papilin, then they would not secrete it into the salivary glands.\n4. UNKNOWN\n5. UNKNOWN\n\nThe context does not provide enough information to confirm whether papilin functions as stated in statements 1, 4, and 5, especially since papilin's function varies across different organisms, and there's limited information on its specific role in caterpillars of the family Pyralidae.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 8,
    "user_query": "Has Denosumab (Prolia) been approved by FDA?",
    "yulan-chat-2-13b-fp16_response": "Yes, Denosumab (Prolia) has been approved by the US Food and Drug Administration (FDA) for the treatment of osteoporosis in postmenopausal women and men, and for the treatment of glucocorticoid-induced osteoporosis in women and men. It was also approved for the treatment of bone loss in people with multiple myeloma and for the reduction of fracture risk in women with a history of osteoporotic fracture.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Denosumab (Prolia) has been approved by the US Food and Drug Administration (FDA).\n2. The FDA approved Denosumab (Prolia) for the treatment of osteoporosis in postmenopausal women.\n3. The FDA approved Denosumab (Prolia) for the treatment of osteoporosis in men.\n4. Denosumab (Prolia) has been approved by the FDA for treating glucocorticoid-induced osteoporosis in women and men.\n5. The FDA approved Denosumab (Prolia) for the treatment of bone loss in people with multiple myeloma and for the reduction of fracture risk in women with a history of osteoporotic fracture.",
    "yulan-chat-2-13b-fp16_fact": [
      "Denosumab (Prolia) has been approved by the US Food and Drug Administration (FDA).",
      "The FDA approved Denosumab (Prolia) for the treatment of osteoporosis in postmenopausal women.",
      "The FDA approved Denosumab (Prolia) for the treatment of osteoporosis in men.",
      "Denosumab (Prolia) has been approved by the FDA for treating glucocorticoid-induced osteoporosis in women and men.",
      "The FDA approved Denosumab (Prolia) for the treatment of bone loss in people with multiple myeloma and for the reduction of fracture risk in women with a history of osteoporotic fracture."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The FDA approved Denosumab (Prolia) for the treatment of bone loss in men with prostate cancer undergoing hormone ablation and women with breast cancer undergoing aromatase inhibitor therapy. It is also used for the treatment of glucocorticoid-induced osteoporosis. Denosumab (Xgeva), another formulation of the same medication, is used for the prevention of skeletal-related events in patients with multiple myeloma and bone metastases from solid tumors.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "yulan-chat-2-13b-fp16_response": "Acrokeratosis paraneoplastica is also known as Bazex's acrokeratosis or Bazex's syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Acrokeratosis paraneoplastica is also known as Bazex's acrokeratosis.\n2. Acrokeratosis paraneoplastica is referred to as Bazex's syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Acrokeratosis paraneoplastica is also known as Bazex's acrokeratosis.",
      "Acrokeratosis paraneoplastica is referred to as Bazex's syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 11,
    "user_query": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?",
    "yulan-chat-2-13b-fp16_response": "The Vaughan-Williams classification is a method of categorizing anti-arrhythmic drugs based on their mechanism of action and their potential to cause proarrhythmic effects. The classification system divides anti-arrhythmic drugs into nine classes:\n1. Ia: Sodium channel blockers (e.g. quinidine, procainamide)\n2. Ib: Potassium channel blockers (e.g. flecainide, moricizine)\n3. Ic: Calcium channel blockers (e.g. verapamil, diltiazem)\n4. II: Beta-blockers (e.g. metoprolol, atenolol)\n5. III: Alpha-blockers (e.g. doxazosin, prazosin)\n6. IV: Benzodiazepine receptor agonists (e.g. lorazepam, midazolam)\n7. V: Anti-glutamate drugs (e.g. topiramate, zonisamide)\n8. Vi: Alpha-2 adrenergic agonists (e.g. clonidine, tizanidine)\n9. IX: Other drugs (e.g. amiodarone, sotalol)\nIt's important to note that this classification system is not used anymore, as it has been replaced by a newer one called the \"Mechanisms of Action\" classification, which is based on the specific molecular targets of the drugs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Vaughan-Williams classification categorizes anti-arrhythmic drugs into nine classes.\n2. Class Ia according to the Vaughan-Williams classification includes sodium channel blockers such as quinidine and procainamide.\n3. Class Ic in the Vaughan-Williams classification includes calcium channel blockers such as verapamil and diltiazem.\n4. Class II of the Vaughan-Williams classification comprises beta-blockers like metoprolol and atenolol.\n5. The Vaughan-Williams classification system is no longer used and has been replaced by the \"Mechanisms of Action\" classification.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Vaughan-Williams classification categorizes anti-arrhythmic drugs into nine classes.",
      "Class Ia according to the Vaughan-Williams classification includes sodium channel blockers such as quinidine and procainamide.",
      "Class Ic in the Vaughan-Williams classification includes calcium channel blockers such as verapamil and diltiazem.",
      "Class II of the Vaughan-Williams classification comprises beta-blockers like metoprolol and atenolol.",
      "The Vaughan-Williams classification system is no longer used and has been replaced by the \"Mechanisms of Action\" classification."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Vaughan-Williams classification categorizes anti-arrhythmic drugs into four classes, not nine.\n2. TRUE\n3. FALSE [correction]: Class Ic in the Vaughan-Williams classification includes sodium channel blockers such as flecainide and propafenone, not calcium channel blockers.\n4. TRUE\n5. FALSE [correction]: The Vaughan-Williams classification system is still used, although alternative or supplementing classification schemes, like the \"Mechanisms of Action\" classification, may also be utilized in clinical practice.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 12,
    "user_query": "Which are the different isoforms of the mammalian Notch receptor?",
    "yulan-chat-2-13b-fp16_response": "In mammals, there are five known isoforms of the Notch receptor: Notch1-5. These isoforms are produced by alternative splicing of the Notch1-5 genes and have distinct expression patterns and functions.\nNotch1 is involved in development of the nervous system and is also expressed in some tumors. Notch2 is mainly expressed in the hematopoietic system and plays a role in the development of blood cells. Notch3 is involved in the development of the lung and esophagus, and is also expressed in some tumors. Notch4 is mainly expressed in the skin and is involved in the development of the hair follicle. Notch5 is mainly expressed in the gut and is involved in the development of the intestinal epithelium.\nIn addition to these five isoforms, there are also several other Notch receptors that have been identified in non-mammalian species, such as Notch6 and Notch7 in birds and Notch8 in insects.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There are five known isoforms of the Notch receptor in mammals, known as Notch1-5.\n2. The Notch1 isoform plays a role in the development of the nervous system.\n3. The Notch2 isoform is primarily expressed in the hematopoietic system and is involved in blood cell development.\n4. Notch3 is associated with the development of the lung and esophagus.\n5. Notch4 is mainly expressed in the skin and is involved in the development of the hair follicle.",
    "yulan-chat-2-13b-fp16_fact": [
      "There are five known isoforms of the Notch receptor in mammals, known as Notch1-5.",
      "The Notch1 isoform plays a role in the development of the nervous system.",
      "The Notch2 isoform is primarily expressed in the hematopoietic system and is involved in blood cell development.",
      "Notch3 is associated with the development of the lung and esophagus.",
      "Notch4 is mainly expressed in the skin and is involved in the development of the hair follicle."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: There are four known isoforms of the Notch receptor in mammals, known as Notch1-4.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Notch3 is associated with vascular smooth muscle development and is linked to the disease known as CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy).\n5. FALSE [correction]: Notch4 is mainly expressed in the endothelium and is involved in angiogenesis rather than the development of the skin and hair follicle.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 15,
    "user_query": "Is the monoclonal antibody Trastuzumab (Herceptin) of potential use in the treatment of prostate cancer?",
    "yulan-chat-2-13b-fp16_response": "Trastuzumab (Herceptin) is a monoclonal antibody that is primarily used to treat breast cancer and gastroesophageal cancer. It works by binding to a protein called HER2, which is overexpressed in certain types of cancer cells.\nProstate cancer cells do not typically overexpress the HER2 protein, so the use of Trastuzumab for the treatment of prostate cancer is not currently recommended. However, there is ongoing research exploring the use of other monoclonal antibodies for the treatment of prostate cancer, so it is possible that a similar drug could be developed in the future.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Trastuzumab (Herceptin) is primarily used to treat breast cancer and gastroesophageal cancer.\n2. Trastuzumab works by binding to the HER2 protein.\n3. The HER2 protein is overexpressed in certain types of cancer cells.\n4. Prostate cancer cells do not typically overexpress the HER2 protein.\n5. The use of Trastuzumab for the treatment of prostate cancer is not currently recommended.",
    "yulan-chat-2-13b-fp16_fact": [
      "Trastuzumab (Herceptin) is primarily used to treat breast cancer and gastroesophageal cancer.",
      "Trastuzumab works by binding to the HER2 protein.",
      "The HER2 protein is overexpressed in certain types of cancer cells.",
      "Prostate cancer cells do not typically overexpress the HER2 protein.",
      "The use of Trastuzumab for the treatment of prostate cancer is not currently recommended."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 22,
    "user_query": "Are transcription and splicing connected?",
    "yulan-chat-2-13b-fp16_response": "Transcription and splicing are two different processes that occur in the process of gene expression in eukaryotic cells. Transcription is the process by which the information stored in a gene's DNA is used to synthesize a complementary strand of RNA, which is then used to direct the synthesis of a protein. Splicing, on the other hand, is the process by which introns, the non-coding regions of DNA, are removed from a pre-mRNA molecule and the remaining exons are joined together to form a mature mRNA molecule that can be translated into protein.\nWhile transcription and splicing occur in the same cell and are both part of the process of gene expression, they are distinct processes that occur in different locations within the cell and are carried out by different enzymes. Transcription occurs in the nucleus of the cell, while splicing occurs in the cytoplasm. Additionally, transcription is the process by which the information in the DNA is used to make RNA, while splicing is the process by which the RNA is modified to remove non-coding regions and join together the coding regions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Transcription is the process where a gene's DNA information is synthesized into a complementary strand of RNA.\n2. Transcription occurs in the nucleus of eukaryotic cells.\n3. Splicing is the process in which introns are removed from pre-mRNA and the exons are joined to form mature mRNA.\n4. Splicing takes place after transcription and is part of the process of gene expression.\n5. The processes of transcription and splicing are carried out by different enzymes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Transcription is the process where a gene's DNA information is synthesized into a complementary strand of RNA.",
      "Transcription occurs in the nucleus of eukaryotic cells.",
      "Splicing is the process in which introns are removed from pre-mRNA and the exons are joined to form mature mRNA.",
      "Splicing takes place after transcription and is part of the process of gene expression.",
      "The processes of transcription and splicing are carried out by different enzymes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 23,
    "user_query": "What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?",
    "yulan-chat-2-13b-fp16_response": "Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder that is caused by a defect in a gene called DUX4. This gene is located on the short (or \"p\" or \"paternal\") arm of chromosome 4 at position 11.2. The mode of inheritance of FSHD is autosomal dominant, which means that a person only needs to inherit one copy of the mutated gene from one parent in order to develop the disease. The mutated gene causes the production of a protein called DUX4, which is involved in the development and maintenance of muscle tissue. When the DUX4 protein is not functioning properly, it can lead to the progressive weakening and wasting of muscles, eventually resulting in the characteristic symptoms of FSHD, such as muscle weakness and wasting in the face, shoulders, and arms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Facioscapulohumeral muscular dystrophy (FSHD) is caused by a defect in the DUX4 gene.\n2. The DUX4 gene is located on the short arm of chromosome 4 at position 11.2.\n3. The mode of inheritance for FSHD is autosomal dominant.\n4. A person only needs to inherit one copy of the mutated gene from one parent to develop FSHD.\n5. The mutated DUX4 gene leads to the production of a dysfunctional DUX4 protein involved in muscle development and maintenance.",
    "yulan-chat-2-13b-fp16_fact": [
      "Facioscapulohumeral muscular dystrophy (FSHD) is caused by a defect in the DUX4 gene.",
      "The DUX4 gene is located on the short arm of chromosome 4 at position 11.2.",
      "The mode of inheritance for FSHD is autosomal dominant.",
      "A person only needs to inherit one copy of the mutated gene from one parent to develop FSHD.",
      "The mutated DUX4 gene leads to the production of a dysfunctional DUX4 protein involved in muscle development and maintenance."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The mutation linked to FSHD typically results in the toxic expression of the DUX4 gene in muscles, where it is not usually active, rather than the production of a dysfunctional protein. Normally, the DUX4 gene is silent in adult tissues, and FSHD is associated with relaxation of this silencing, leading to inappropriate expression of the DUX4 protein that can be harmful to muscle cells.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 25,
    "user_query": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?",
    "yulan-chat-2-13b-fp16_response": "The ryanodine receptor forms a quaternary macromolecular complex with several proteins, including:\n1. Calcium handling proteins such as calmodulin and troponin C, which regulate the activity of the receptor.\n2. Ryanodine binding proteins, which bind to the ryanodine receptor and modulate its activity.\n3. Proteins of the endoplasmic reticulum, such as synaptotagmin, which interact with the ryanodine receptor and play a role in regulated secretion.\n4. Proteins of the mitochondrial outer membrane, such as cyclophilin D, which interact with the ryanodine receptor and regulate its activity.\nThese proteins work together to regulate the activity of the ryanodine receptor and control calcium release from the endoplasmic reticulum in response to various signals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Calmodulin is a protein that regulates the activity of the ryanodine receptor.\n2. Troponin C is involved in the regulation of the ryanodine receptor.\n3. Ryanodine binding proteins modulate the activity of the ryanodine receptor.\n4. Synaptotagmin is a protein of the endoplasmic reticulum that interacts with the ryanodine receptor.\n5. Cyclophilin D, a protein of the mitochondrial outer membrane, regulates the activity of the ryanodine receptor.",
    "yulan-chat-2-13b-fp16_fact": [
      "Calmodulin is a protein that regulates the activity of the ryanodine receptor.",
      "Troponin C is involved in the regulation of the ryanodine receptor.",
      "Ryanodine binding proteins modulate the activity of the ryanodine receptor.",
      "Synaptotagmin is a protein of the endoplasmic reticulum that interacts with the ryanodine receptor.",
      "Cyclophilin D, a protein of the mitochondrial outer membrane, regulates the activity of the ryanodine receptor."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Troponin C is involved in the regulation of muscle contraction by binding calcium, but it is not primarily known for regulating the ryanodine receptor. It is the troponin complex on the actin filaments of muscle cells that interacts with calcium to regulate muscle contraction.\n3. TRUE\n4. FALSE [correction]: Synaptotagmin is a protein that acts as a calcium sensor and is involved in the regulation of neurotransmitter release at the synaptic cleft, not directly with the ryanodine receptor. \n5. FALSE [correction]: Cyclophilin D is a protein located in the mitochondrial inner membrane (not the outer membrane) that is involved in the formation of the mitochondrial permeability transition pore (mPTP), which is a different molecular complex from the ryanodine receptor.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 26,
    "user_query": "What kind of chromatography is HILIC?",
    "yulan-chat-2-13b-fp16_response": "HILIC stands for hydrophilic interaction liquid chromatography. It is a type of liquid chromatography that separates analytes based on their hydrophobicity and hydrophilicity. In HILIC, a hydrophobic stationary phase is used, and the mobile phase consists of a mixture of a polar protic solvent and a hydrophobic solvent. The polar protic solvent interacts with the hydrophobic stationary phase, while the hydrophobic solvent interacts with the analytes, leading to separation based on their hydrophobicity and hydrophilicity. HILIC is commonly used for the separation of polar and ionic compounds, as well as peptides and proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. HILIC stands for hydrophilic interaction liquid chromatography.\n2. HILIC separates analytes based on their hydrophobicity and hydrophilicity.\n3. In HILIC, a hydrophobic stationary phase is utilized.\n4. The mobile phase in HILIC consists of a mixture of a polar protic solvent and a hydrophobic solvent.\n5. HILIC is commonly used for the separation of polar and ionic compounds, as well as peptides and proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "HILIC stands for hydrophilic interaction liquid chromatography.",
      "HILIC separates analytes based on their hydrophobicity and hydrophilicity.",
      "In HILIC, a hydrophobic stationary phase is utilized.",
      "The mobile phase in HILIC consists of a mixture of a polar protic solvent and a hydrophobic solvent.",
      "HILIC is commonly used for the separation of polar and ionic compounds, as well as peptides and proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In HILIC, a hydrophilic stationary phase is utilized.\n4. FALSE [correction]: The mobile phase in HILIC usually consists of a mixture of water with a significant proportion of organic solvents such as acetonitrile, which may or may not be protic.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 27,
    "user_query": "What is the effect of TRH on myocardial contractility?",
    "yulan-chat-2-13b-fp16_response": "Thyrotropin-releasing hormone (TRH) is a hormone produced by the hypothalamus that stimulates the release of thyrotropin (TSH) from the pituitary gland, which in turn stimulates the production of thyroid hormones. TRH does not have a direct effect on myocardial contractility, which is the ability of the heart muscle to contract and pump blood.\nHowever, TRH may indirectly affect myocardial contractility through its effects on the thyroid hormones. Thyroid hormones, particularly triiodothyronine (T3), have important roles in regulating cardiac function and contractility. T3 increases the contractility of the heart muscle by increasing the concentration of sarcomeres, the basic units of muscle fibers in the heart. It also increases the rate of calcium uptake by the sarcoplasmic reticulum, which is important for the release of calcium ions that trigger muscle contraction.\nTherefore, if TRH stimulates the production of thyroid hormones, it may indirectly enhance myocardial contractility. However, the exact mechanism by which TRH affects myocardial contractility is not fully understood and may depend on various factors, such as the individual's overall health status and the presence of any underlying medical conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyrotropin-releasing hormone (TRH) is produced by the hypothalamus.\n2. TRH stimulates the release of thyrotropin (TSH) from the pituitary gland.\n3. Thyrotropin (TSH) in turn stimulates the production of thyroid hormones.\n4. Triiodothyronine (T3), a thyroid hormone, increases the contractility of the heart muscle by increasing the concentration of sarcomeres.\n5. Triiodothyronine (T3) enhances the rate of calcium uptake by the sarcoplasmic reticulum, which is crucial for muscle contraction.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyrotropin-releasing hormone (TRH) is produced by the hypothalamus.",
      "TRH stimulates the release of thyrotropin (TSH) from the pituitary gland.",
      "Thyrotropin (TSH) in turn stimulates the production of thyroid hormones.",
      "Triiodothyronine (T3), a thyroid hormone, increases the contractility of the heart muscle by increasing the concentration of sarcomeres.",
      "Triiodothyronine (T3) enhances the rate of calcium uptake by the sarcoplasmic reticulum, which is crucial for muscle contraction."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Triiodothyronine (T3) increases the contractility of the heart muscle, but not by increasing the concentration of sarcomeres. It does so through genomic and non-genomic effects that increase cardiac output and enhance the efficiency of muscular contraction.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 28,
    "user_query": "Proteomic analyses need prior knowledge of the organism complete genome. Is the complete genome of the bacteria of the genus Arthrobacter available?",
    "yulan-chat-2-13b-fp16_response": "Yes, the complete genome of several species within the bacterial genus Arthrobacter is available. The GenBank database, maintained by the National Institutes of Health (NIH), provides access to genome sequences and related information for a wide range of organisms, including bacteria. As of my knowledge cutoff in September 2021, there were several Arthrobacter species whose genomes were available on GenBank, including Arthrobacter cryohalophilus, Arthrobacter luteus, Arthrobacter plebeius, and Arthrobacter ureafaciens. These genomes can be accessed through the GenBank website or via various bioinformatics tools and databases that utilize GenBank data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The complete genome of several species within the bacterial genus Arthrobacter is available.\n2. The GenBank database provides access to genome sequences for a wide range of organisms, including bacteria.\n3. As of September 2021, the genomes of Arthrobacter species such as Arthrobacter cryohalophilus, Arthrobacter luteus, Arthrobacter plebeius, and Arthrobacter ureafaciens were available on GenBank.\n4. The GenBank database is maintained by the National Institutes of Health (NIH).",
    "yulan-chat-2-13b-fp16_fact": [
      "The complete genome of several species within the bacterial genus Arthrobacter is available.",
      "The GenBank database provides access to genome sequences for a wide range of organisms, including bacteria.",
      "As of September 2021, the genomes of Arthrobacter species such as Arthrobacter cryohalophilus, Arthrobacter luteus, Arthrobacter plebeius, and Arthrobacter ureafaciens were available on GenBank.",
      "The GenBank database is maintained by the National Institutes of Health (NIH)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The GenBank database is maintained by the National Center for Biotechnology Information (NCBI), which is part of the National Institutes of Health (NIH).",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 29,
    "user_query": "What is the structural fold of bromodomain proteins?",
    "yulan-chat-2-13b-fp16_response": "Bromodomain proteins are characterized by a specific structural fold known as the \"bromodomain\". This fold is composed of two alpha-helical domains, which are connected by a flexible linker region. The bromodomain fold is named after the bromodomain protein, which was the first protein to be identified with this structural motif. Bromodomain proteins are involved in a variety of biological processes, including transcriptional regulation, chromatin remodeling, and protein-protein interactions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bromodomain proteins have a structural fold known as the \"bromodomain\".\n2. The bromodomain fold consists of two alpha-helical domains.\n3. These alpha-helical domains are connected by a flexible linker region.\n4. The term \"bromodomain\" comes from the first identified protein with this structural motif.\n5. Bromodomain proteins play roles in transcriptional regulation, chromatin remodeling, and protein-protein interactions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Bromodomain proteins have a structural fold known as the \"bromodomain\".",
      "The bromodomain fold consists of two alpha-helical domains.",
      "These alpha-helical domains are connected by a flexible linker region.",
      "The term \"bromodomain\" comes from the first identified protein with this structural motif.",
      "Bromodomain proteins play roles in transcriptional regulation, chromatin remodeling, and protein-protein interactions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The bromodomain fold typically consists of four alpha-helices.\n3. TRUE\n4. FALSE [correction]: The term \"bromodomain\" is derived from the word \"bromine\" as the domain can recognize acetylated lysine residues, where \"bromo\" refers to a recognition feature for certain brominated compounds.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 32,
    "user_query": "Which MAP kinase phosphorylates the transcription factor c-jun?",
    "yulan-chat-2-13b-fp16_response": "The MAP kinase that phosphorylates the transcription factor c-jun is MAP kinase 1 (MAPK1), also known as mitogen-activated protein kinase 1 (Mitogen-activated protein kinase 1). MAPK1 is a serine/threonine kinase that is activated by a variety of extracellular signals, including growth factors, cytokines, and neurotransmitters. Once activated, MAPK1 can phosphorylate and activate c-jun, which then binds to other transcription factors to regulate the expression of target genes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MAP kinase 1 (MAPK1) phosphorylates the transcription factor c-jun.\n2. MAPK1 is also known as mitogen-activated protein kinase 1.\n3. MAPK1 is a serine/threonine kinase.\n4. MAPK1 is activated by extracellular signals such as growth factors, cytokines, and neurotransmitters.\n5. Once activated, MAPK1 can phosphorylate c-jun, enabling it to bind to other transcription factors and regulate gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "MAP kinase 1 (MAPK1) phosphorylates the transcription factor c-jun.",
      "MAPK1 is also known as mitogen-activated protein kinase 1.",
      "MAPK1 is a serine/threonine kinase.",
      "MAPK1 is activated by extracellular signals such as growth factors, cytokines, and neurotransmitters.",
      "Once activated, MAPK1 can phosphorylate c-jun, enabling it to bind to other transcription factors and regulate gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Once activated, MAPK1 can phosphorylate c-jun, which enables it to bind to DNA and regulate gene expression. C-jun does not necessarily bind to other transcription factors; it binds to DNA as part of the Activator Protein-1 (AP-1) transcription factor complex.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 36,
    "user_query": "Which fusion protein is involved in the development of Ewing sarcoma?",
    "yulan-chat-2-13b-fp16_response": "Ewing sarcoma is a type of cancer that typically affects children and young adults. It is caused by the EWS-FLI1 fusion protein, which is formed by a translocation event between the EWS (Ewing sarcoma) gene and the FLI1 (E1A binding protein p48) gene. The EWS-FLI1 fusion protein is a transcription factor that regulates the expression of genes involved in cell growth and division, and is thought to contribute to the development and progression of Ewing sarcoma.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ewing sarcoma is a type of cancer that typically affects children and young adults.\n2. The EWS-FLI1 fusion protein is involved in the development of Ewing sarcoma.\n3. The EWS-FLI1 fusion protein is formed by a translocation event between the EWS gene and the FLI1 gene.\n4. The EWS gene is also known as the Ewing sarcoma gene.\n5. The FLI1 gene is also known as the E1A binding protein p48 gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ewing sarcoma is a type of cancer that typically affects children and young adults.",
      "The EWS-FLI1 fusion protein is involved in the development of Ewing sarcoma.",
      "The EWS-FLI1 fusion protein is formed by a translocation event between the EWS gene and the FLI1 gene.",
      "The EWS gene is also known as the Ewing sarcoma gene.",
      "The FLI1 gene is also known as the E1A binding protein p48 gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The EWS gene is also known as EWSR1 (Ewing sarcoma breakpoint region 1), not specifically the \"Ewing sarcoma gene\".\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 40,
    "user_query": "Treatment of which disease was investigated in the MR CLEAN study?",
    "yulan-chat-2-13b-fp16_response": "The MR CLEAN study investigated the treatment of COVID-19, which is caused by the SARS-CoV-2 virus.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 44,
    "user_query": "Does BNP increase after intensive exercise in athletes?",
    "yulan-chat-2-13b-fp16_response": "BNP, or brain natriuretic peptide, is a hormone that is released by the heart in response to increased pressure and volume. It plays a role in regulating blood flow and blood pressure.\nIntensive exercise can cause an increase in BNP levels in athletes, as the heart works harder to supply oxygen and nutrients to the muscles during exercise. This increase in BNP is typically temporary and returns to normal levels after exercise.\nIt's worth noting that BNP levels are not the only factor that can affect blood pressure and heart function during exercise. Other hormones, such as adrenaline and noradrenaline, are also released during exercise and can have an impact on blood pressure and heart rate.\nOverall, while BNP levels may increase after intensive exercise in athletes, this is just one of many factors that contribute to the complex physiological responses to exercise.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Brain natriuretic peptide (BNP) is released by the heart in response to increased pressure and volume.\n2. Intensive exercise can cause an increase in BNP levels in athletes.\n3. The increase in BNP levels due to intensive exercise is typically temporary.\n4. BNP levels generally return to normal after exercise.\n5. Hormones like adrenaline and noradrenaline are also released during exercise and can impact blood pressure and heart rate.",
    "yulan-chat-2-13b-fp16_fact": [
      "Brain natriuretic peptide (BNP) is released by the heart in response to increased pressure and volume.",
      "Intensive exercise can cause an increase in BNP levels in athletes.",
      "The increase in BNP levels due to intensive exercise is typically temporary.",
      "BNP levels generally return to normal after exercise.",
      "Hormones like adrenaline and noradrenaline are also released during exercise and can impact blood pressure and heart rate."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "yulan-chat-2-13b-fp16_response": "Weaver syndrome and Sotos syndrome are both rare genetic disorders that are characterized by overgrowth and developmental delays. However, they are caused by different genetic mutations and are not considered to be similar in terms of their underlying biology.\nWeaver syndrome, also known as Weaver-Riedel aneurysmalia, is a rare genetic disorder that is caused by mutations in the TGFBR2 gene. It is characterized by a distinctive facial appearance, including a broad forehead, prominent eyes, and a short, upturned nose. People with Weaver syndrome also typically have overgrowth of the extremities and other parts of the body, as well as developmental delays and intellectual disability.\nSotos syndrome, also known as craniofacial hyperostosis, is a rare genetic disorder that is caused by mutations in the NSD1 gene. It is characterized by a distinctive facial appearance, including a broad forehead, prominent eyes, and a broad, flat nose. People with Sotos syndrome also typically have overgrowth of the extremities and other parts of the body, as well as developmental delays and intellectual disability.\nWhile both Weaver syndrome and Sotos syndrome are characterized by overgrowth and developmental delays, they are caused by different genetic mutations and are not considered to be similar in terms of their underlying biology.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Weaver syndrome and Sotos syndrome are both rare genetic disorders characterized by overgrowth and developmental delays.\n2. Weaver syndrome is caused by mutations in the TGFBR2 gene.\n3. Characteristics of Weaver syndrome include a distinctive facial appearance with a broad forehead, prominent eyes, and a short, upturned nose.\n4. Sotos syndrome is caused by mutations in the NSD1 gene.\n5. Characteristics of Sotos syndrome include a distinctive facial appearance with a broad forehead, prominent eyes, and a broad, flat nose.",
    "yulan-chat-2-13b-fp16_fact": [
      "Weaver syndrome and Sotos syndrome are both rare genetic disorders characterized by overgrowth and developmental delays.",
      "Weaver syndrome is caused by mutations in the TGFBR2 gene.",
      "Characteristics of Weaver syndrome include a distinctive facial appearance with a broad forehead, prominent eyes, and a short, upturned nose.",
      "Sotos syndrome is caused by mutations in the NSD1 gene.",
      "Characteristics of Sotos syndrome include a distinctive facial appearance with a broad forehead, prominent eyes, and a broad, flat nose."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Weaver syndrome is most commonly caused by mutations in the EZH2 gene, not the TGFBR2 gene.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 49,
    "user_query": "Are ultraconserved elements often transcribed?",
    "yulan-chat-2-13b-fp16_response": "Yes, ultraconserved elements (UCEs) are often transcribed. In fact, many UCEs have been shown to be highly expressed in a variety of tissues and under different developmental stages, suggesting that they play important biological roles.\nUCEs are defined as DNA sequences that are conserved across multiple species and are also conserved within the genome of a single species, suggesting that they are functionally important. Because they are conserved across multiple species, UCEs are often located in non-coding regions of the genome, where they may regulate gene expression by interacting with regulatory proteins or by serving as binding sites for transcription factors.\nAlthough UCEs are often located in non-coding regions of the genome, recent studies have shown that some UCEs are also associated with coding genes and may be involved in regulating their expression. In addition, some UCEs have been shown to be involved in the regulation of gene expression by serving as enhancer or silencer elements.\nOverall, while UCEs are often located in non-coding regions of the genome, they are not \"junk DNA\" and are likely to play important roles in regulating gene expression and other biological processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ultraconserved elements (UCEs) are often transcribed.\n2. Many UCEs are highly expressed in a variety of tissues and under different developmental stages.\n3. UCEs are conserved across multiple species and within the genome of a single species.\n4. UCEs are often located in non-coding regions of the genome, where they may act as regulatory elements.\n5. Some UCEs are associated with coding genes and may be involved in regulating their expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ultraconserved elements (UCEs) are often transcribed.",
      "Many UCEs are highly expressed in a variety of tissues and under different developmental stages.",
      "UCEs are conserved across multiple species and within the genome of a single species.",
      "UCEs are often located in non-coding regions of the genome, where they may act as regulatory elements.",
      "Some UCEs are associated with coding genes and may be involved in regulating their expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 54,
    "user_query": "Which DNA sequences are more prone for the formation of R-loops?",
    "yulan-chat-2-13b-fp16_response": "R-loops are a type of DNA structure that can form when a single-stranded RNA molecule becomes paired with a double-stranded DNA molecule, resulting in a loop structure. R-loops are thought to be formed when there is a mismatch between the RNA and DNA strands, and they can have a number of negative effects on cellular function, including promoting genomic instability and contributing to the development of certain diseases.\nIt is not clear which specific DNA sequences are more prone to the formation of R-loops, as this can depend on a variety of factors, including the length and structure of the RNA molecule, the presence of other proteins or nucleic acids in the cell, and the overall cellular environment. However, it is generally thought that R-loops are more likely to form in regions of the genome that are highly transcribed or expressed, as these regions tend to have a higher concentration of single-stranded DNA that can form base pairs with the RNA molecule. Additionally, R-loops have been shown to form more readily in cells that are under stress or experiencing other forms of cellular dysfunction, such as during viral infection or in cancer cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 55,
    "user_query": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?",
    "yulan-chat-2-13b-fp16_response": "The gene that is commonly mutated in familial isolated pituitary adenoma (FIPA) is the MEN1 gene. This gene is involved in the regulation of several physiological processes, including the development and growth of the pituitary gland. Mutations in the MEN1 gene are associated with an increased risk of developing pituitary adenomas, which are non-cancerous tumors that develop in the pituitary gland. FIPA is a rare inherited disorder that is characterized by a predisposition to developing pituitary adenomas, and it is typically inherited in an autosomal dominant pattern.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The MEN1 gene is commonly mutated in familial isolated pituitary adenoma (FIPA).\n2. Mutations in the MEN1 gene are associated with an increased risk of developing pituitary adenomas.\n3. Pituitary adenomas are non-cancerous tumors that develop in the pituitary gland.\n4. Familial isolated pituitary adenoma (FIPA) is a rare inherited disorder.\n5. Familial isolated pituitary adenoma (FIPA) is typically inherited in an autosomal dominant pattern.",
    "yulan-chat-2-13b-fp16_fact": [
      "The MEN1 gene is commonly mutated in familial isolated pituitary adenoma (FIPA).",
      "Mutations in the MEN1 gene are associated with an increased risk of developing pituitary adenomas.",
      "Pituitary adenomas are non-cancerous tumors that develop in the pituitary gland.",
      "Familial isolated pituitary adenoma (FIPA) is a rare inherited disorder.",
      "Familial isolated pituitary adenoma (FIPA) is typically inherited in an autosomal dominant pattern."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The AIP gene, not the MEN1 gene, is commonly mutated in familial isolated pituitary adenoma (FIPA).\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 56,
    "user_query": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?",
    "yulan-chat-2-13b-fp16_response": "Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by mutations in several genes, including the troponin C (TNC) gene. Mutations in the TNC gene that have been found to cause HCM include:\n1. R1448X mutation: This is a missense mutation that results in the substitution of arginine for glutamine at position 1448 of the TNC gene. This mutation has been found to cause HCM in a significant number of cases.\n2. R948X mutation: This is another missense mutation that results in the substitution of arginine for glutamine at position 948 of the TNC gene. This mutation has also been found to cause HCM in a significant number of cases.\n3. R1448W mutation: This is another missense mutation that results in the substitution of arginine for tryptophan at position 1448 of the TNC gene. This mutation has been found to cause HCM in some cases.\n4. R948C mutation: This is a missense mutation that results in the substitution of arginine for cysteine at position 948 of the TNC gene. This mutation has been found to cause HCM in some cases.\nIt's important to note that not all mutations in the TNC gene cause HCM, and not all cases of HCM are caused by mutations in the TNC gene. Genetic testing and genetic counseling can help determine the specific cause of HCM in an individual.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The R1448X mutation in the troponin C (TNC) gene causes hypertrophic cardiomyopathy (HCM).\n2. The R948X mutation in the TNC gene has been found to cause HCM.\n3. The R1448W mutation in the TNC gene has been associated with causing HCM.\n4. The R948C mutation in the TNC gene has been found to cause HCM.\n5. Not all mutations in the TNC gene cause hypertrophic cardiomyopathy.",
    "yulan-chat-2-13b-fp16_fact": [
      "The R1448X mutation in the troponin C (TNC) gene causes hypertrophic cardiomyopathy (HCM).",
      "The R948X mutation in the TNC gene has been found to cause HCM.",
      "The R1448W mutation in the TNC gene has been associated with causing HCM.",
      "The R948C mutation in the TNC gene has been found to cause HCM.",
      "Not all mutations in the TNC gene cause hypertrophic cardiomyopathy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nIt is known that not all mutations in a given gene will cause a specific disease or condition, including a gene like TNC which is related to hypertrophic cardiomyopathy (HCM). This is because some genetic variations may be benign or have an unclear significance. However, without specific scientific references or a detailed passage providing explicit information about each named mutation (R1448X, R948X, R1448W, R948C) and their association with HCM, we cannot determine the accuracy of statements 1-4. They may very well be true, false, or inaccurately represented, but without context or a reputable source, their status as true or false cannot be determined.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 58,
    "user_query": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?",
    "yulan-chat-2-13b-fp16_response": "Constitutive heterochromatin is characterized by several post-translational histone modifications, including:\n1. Hypoacetylation: Histones in constitutive heterochromatin have reduced levels of acetylation, which leads to tight packing of chromatin and reduced transcriptional activity.\n2. Methylation of histone H3 at lysine 27 (H3K27me3): This modification is carried out by the EZH2 histone methyltransferase and is a hallmark of constitutive heterochromatin. H3K27me3 is associated with gene silencing and is found at the promoter regions of genes in constitutive heterochromatin.\n3. Methylation of histone H3 at lysine 9 (H3K9me3): This modification is carried out by the G9a histone methyltransferase and is also associated with gene silencing.\n4. Methylation of histone H4 at lysine 20 (H4K20me3): This modification is carried out by the SETDB1 histone methyltransferase and is also associated with gene silencing.\n5. Ubiquitination of histone H2A: Ubiquitination of histone H2A is carried out by the PHD2 ubiquitin ligase and is associated with gene silencing.\nThese modifications work together to form a compact, inactive chromatin structure that is characteristic of constitutive heterochromatin.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histones in constitutive heterochromatin have reduced levels of acetylation, known as hypoacetylation, which leads to tight packing of chromatin.\n2. Methylation of histone H3 at lysine 27 (H3K27me3) is a post-translational modification that is carried out by the EZH2 histone methyltransferase.\n3. Methylation of histone H3 at lysine 9 (H3K9me3) is a post-translational modification that is carried out by the G9a histone methyltransferase.\n4. Methylation of histone H4 at lysine 20 (H4K20me3) is a post-translational modification that is carried out by the SETDB1 histone methyltransferase.\n5. Ubiquitination of histone H2A is a post-translational modification that is carried out by the PHD2 ubiquitin ligase.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histones in constitutive heterochromatin have reduced levels of acetylation, known as hypoacetylation, which leads to tight packing of chromatin.",
      "Methylation of histone H3 at lysine 27 (H3K27me3) is a post-translational modification that is carried out by the EZH2 histone methyltransferase.",
      "Methylation of histone H3 at lysine 9 (H3K9me3) is a post-translational modification that is carried out by the G9a histone methyltransferase.",
      "Methylation of histone H4 at lysine 20 (H4K20me3) is a post-translational modification that is carried out by the SETDB1 histone methyltransferase.",
      "Ubiquitination of histone H2A is a post-translational modification that is carried out by the PHD2 ubiquitin ligase."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Methylation of histone H4 at lysine 20 (H4K20me3) is a post-translational modification, but it is primarily carried out by the SUV420H1 and SUV420H2 histone methyltransferases, not SETDB1.\n5. FALSE [correction]: Ubiquitination of histone H2A is a post-translational modification that is typically carried out by the RING1 and RING2 ubiquitin ligases as part of the Polycomb repressive complex 1 (PRC1), not by the PHD2 ubiquitin ligase.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 63,
    "user_query": "Are long non coding RNAs as conserved in sequence as protein coding genes?",
    "yulan-chat-2-13b-fp16_response": "Long non-coding RNAs (lncRNAs) are generally less conserved in sequence compared to protein-coding genes. While some lncRNAs have been found to be highly conserved across different species, others show a high degree of variation both within and between species. This variation in sequence conservation likely reflects the diverse functions of lncRNAs, which can include regulatory roles in gene expression, post-transcriptional processing, and other cellular processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Long non-coding RNAs (lncRNAs) are generally less conserved in sequence than protein-coding genes.\n2. Some long non-coding RNAs have been found to be highly conserved across different species.\n3. Long non-coding RNAs can have regulatory roles in gene expression and post-transcriptional processing.\n4. There is a high degree of variation in the sequence conservation of long non-coding RNAs both within and between species.",
    "yulan-chat-2-13b-fp16_fact": [
      "Long non-coding RNAs (lncRNAs) are generally less conserved in sequence than protein-coding genes.",
      "Some long non-coding RNAs have been found to be highly conserved across different species.",
      "Long non-coding RNAs can have regulatory roles in gene expression and post-transcriptional processing.",
      "There is a high degree of variation in the sequence conservation of long non-coding RNAs both within and between species."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 65,
    "user_query": "What is clathrin?",
    "yulan-chat-2-13b-fp16_response": "Clathrin is a protein that plays a key role in the formation of vesicles and the internal organization of cells. It is a large protein molecule that forms a lattice-like structure called a clathrin coat, which surrounds and encloses the membrane-bound vesicles that transport materials within the cell. Clathrin is involved in the process of endocytosis, which is the process by which cells take in material from their environment, and in the process of exocytosis, which is the process by which cells release material to their environment. It is also involved in the formation of the cytoskeleton, which is the network of proteins that provides structure and organization to the cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Clathrin is a protein that plays a significant role in vesicle formation and cellular internal organization.\n2. Clathrin forms a lattice-like structure known as a clathrin coat.\n3. The clathrin coat surrounds and encloses membrane-bound vesicles involved in cellular transport.\n4. Clathrin is involved in the process of endocytosis, where cells take in material from their environment.\n5. Clathrin participates in the process of exocytosis, where cells release material to their environment.",
    "yulan-chat-2-13b-fp16_fact": [
      "Clathrin is a protein that plays a significant role in vesicle formation and cellular internal organization.",
      "Clathrin forms a lattice-like structure known as a clathrin coat.",
      "The clathrin coat surrounds and encloses membrane-bound vesicles involved in cellular transport.",
      "Clathrin is involved in the process of endocytosis, where cells take in material from their environment.",
      "Clathrin participates in the process of exocytosis, where cells release material to their environment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Clathrin is primarily involved in endocytosis, not exocytosis. During exocytosis, vesicles fuse with the cell membrane to release contents outside the cell, which is not directly facilitated by clathrin. Clathrin-mediated transport is typically associated with the formation of vesicles for endocytosis.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 66,
    "user_query": "What are the main results of PRKAR1A Knockdown?",
    "yulan-chat-2-13b-fp16_response": "PRKAR1A is a gene that encodes for the protein AMP-activated protein kinase (AMPK), which plays a key role in regulating cellular energy homeostasis. PRKAR1A knockdown refers to the reduction of AMPK levels in cells by targeting the PRKAR1A gene.\nThe consequences of PRKAR1A knockdown can vary depending on the cell type and context. However, some of the main results of PRKAR1A knockdown include:\n1. Increased oxidative stress: AMPK is known to regulate oxidative stress by activating antioxidant enzymes and reducing ROS production. PRKAR1A knockdown can lead to decreased AMPK levels, which can result in increased oxidative stress and cellular damage.\n2. Impaired glucose metabolism: AMPK is a key regulator of glucose metabolism, and PRKAR1A knockdown can lead to decreased AMPK levels, which can result in impaired glucose uptake and utilization in cells.\n3. Increased inflammation: AMPK has been shown to regulate inflammation by inhibiting pro-inflammatory signaling pathways. PRKAR1A knockdown can lead to decreased AMPK levels, which can result in increased inflammation.\n4. Reduced cell proliferation: AMPK has been shown to regulate cell proliferation by inhibiting the mTOR pathway. PRKAR1A knockdown can lead to decreased AMPK levels, which can result in increased cell proliferation.\n5. Altered cell differentiation: AMPK has been shown to regulate cell differentiation by inhibiting the mTOR pathway. PRKAR1A knockdown can lead to decreased AMPK levels, which can result in altered cell differentiation.\nOverall, PRKAR1A knockdown can have significant consequences on cellular metabolism, stress response, inflammation, and proliferation, highlighting the importance of AMPK in maintaining cellular homeostasis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PRKAR1A is a gene that encodes for the protein AMP-activated protein kinase (AMPK).\n2. PRKAR1A knockdown can lead to increased oxidative stress due to decreased AMPK levels, which may cause cellular damage.\n3. Decreased AMPK levels from PRKAR1A knockdown can impair glucose uptake and utilization in cells.\n4. PRKAR1A knockdown can lead to increased inflammation as a result of decreased AMPK levels.\n5. Decreased AMPK levels due to PRKAR1A knockdown can result in altered cell differentiation.",
    "yulan-chat-2-13b-fp16_fact": [
      "PRKAR1A is a gene that encodes for the protein AMP-activated protein kinase (AMPK).",
      "PRKAR1A knockdown can lead to increased oxidative stress due to decreased AMPK levels, which may cause cellular damage.",
      "Decreased AMPK levels from PRKAR1A knockdown can impair glucose uptake and utilization in cells.",
      "PRKAR1A knockdown can lead to increased inflammation as a result of decreased AMPK levels.",
      "Decreased AMPK levels due to PRKAR1A knockdown can result in altered cell differentiation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: PRKAR1A is a gene that encodes for the regulatory subunit type I-alpha of protein kinase A (PKA), not AMP-activated protein kinase (AMPK).\n2. UNKNOWN (Although PRKAR1A knockdown affecting oxidative stress may be plausible, without specific context or source data, the direct impact on oxidative stress levels due to decreased AMPK levels from this specific knockdown cannot be confirmed as true or false).\n3. UNKNOWN (While it is known that AMPK plays a role in glucose uptake and utilization, the statement relates PRKAR1A knockdown to AMPK. Because PRKAR1A is related to PKA and not AMPK, the impacts of its knockdown on glucose uptake and utilization via AMPK are not directly correlated and thus cannot be confirmed as true or false without additional information).\n4. UNKNOWN (Similar to the above statements, without specific context or source data, it is difficult to determine the exact impact of PRKAR1A knockdown on inflammation, especially since the statement incorrectly associates PRKAR1A with AMPK).\n5. UNKNOWN (As with the other statements, the effects of decreased AMPK levels on cell differentiation due to PRKAR1A knockdown are not directly correlated, so the statement's accuracy is unclear without further context).",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 72,
    "user_query": "Are transcribed ultraconserved regions involved in cancer?",
    "yulan-chat-2-13b-fp16_response": "Transcribed ultraconserved regions (TUCs) are genomic regions that are highly conserved across species and are actively transcribed in multiple tissues. While TUCs are not directly involved in cancer, they may play a role in cancer progression by regulating the expression of oncogenes and tumor suppressor genes.\nTUCs are often located in gene regulatory regions, such as promoters and enhancers, and are thought to play a role in maintaining the stability and function of the genome. Some studies have suggested that TUCs may act as tumor suppressors by regulating the expression of genes involved in cell proliferation, differentiation, and apoptosis.\nHowever, other studies have suggested that TUCs may also be involved in cancer progression by regulating the expression of oncogenes and promoting tumor growth. For example, some TUCs have been shown to be upregulated in certain types of cancer, such as breast and lung cancer, and may contribute to tumor development by activating oncogenic signaling pathways.\nOverall, the role of TUCs in cancer is complex and may depend on the specific context and type of cancer. Further research is needed to fully understand the mechanisms by which TUCs contribute to cancer progression and potential therapeutic targets.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Transcribed ultraconserved regions (TUCs) are genomic regions that are highly conserved across species.\n2. TUCs are actively transcribed in multiple tissues.\n3. TUCs are often located in gene regulatory regions, such as promoters and enhancers.\n4. Some studies have suggested that TUCs may act as tumor suppressors by regulating genes involved in cell proliferation, differentiation, and apoptosis.\n5. Certain TUCs have been shown to be upregulated in types of cancer such as breast and lung cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Transcribed ultraconserved regions (TUCs) are genomic regions that are highly conserved across species.",
      "TUCs are actively transcribed in multiple tissues.",
      "TUCs are often located in gene regulatory regions, such as promoters and enhancers.",
      "Some studies have suggested that TUCs may act as tumor suppressors by regulating genes involved in cell proliferation, differentiation, and apoptosis.",
      "Certain TUCs have been shown to be upregulated in types of cancer such as breast and lung cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Certain TUCs have been shown to be downregulated in types of cancer such as breast and lung cancer, which may indicate their role in tumor suppression.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 75,
    "user_query": "List side effects of SGLT2 inhibitors?",
    "yulan-chat-2-13b-fp16_response": "SGLT2 inhibitors are a class of medications used to treat type 2 diabetes. Some potential side effects of SGLT2 inhibitors include:\n1. Genital yeast infections: SGLT2 inhibitors can increase the risk of genital yeast infections, which may cause symptoms such as itching, burning, and discharge.\n2. Urinary tract infections: SGLT2 inhibitors can increase the risk of urinary tract infections, which may cause symptoms such as burning during urination, frequent urination, and cloudy or strong-smelling urine.\n3. Diabetic ketoacidosis: In rare cases, SGLT2 inhibitors can cause diabetic ketoacidosis, a potentially life-threatening condition that occurs when the body produces high levels of ketones. Symptoms of diabetic ketoacidosis include nausea, vomiting, abdominal pain, and confusion.\n4. Hypoglycemia: SGLT2 inhibitors can increase the risk of hypoglycemia, or low blood sugar, especially if they are taken with other diabetes medications that lower blood sugar. Symptoms of hypoglycemia include dizziness, weakness, and hunger.\n5. Dehydration: SGLT2 inhibitors can cause dehydration by increasing the amount of glucose in the urine. This can lead to a lack of fluids in the body, which can cause symptoms such as dry mouth, dizziness, and fatigue.\n6. Increased risk of amputation: SGLT2 inhibitors can increase the risk of amputation, particularly in patients with peripheral vascular disease or history of foot ulcers.\nIt is important to discuss any concerns or potential side effects with your healthcare provider before starting any new medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SGLT2 inhibitors can increase the risk of genital yeast infections.\n2. SGLT2 inhibitors can increase the risk of urinary tract infections.\n3. In rare cases, SGLT2 inhibitors can cause diabetic ketoacidosis.\n4. SGLT2 inhibitors can increase the risk of hypoglycemia when taken with other diabetes medications.\n5. SGLT2 inhibitors can cause dehydration by increasing the amount of glucose in the urine.",
    "yulan-chat-2-13b-fp16_fact": [
      "SGLT2 inhibitors can increase the risk of genital yeast infections.",
      "SGLT2 inhibitors can increase the risk of urinary tract infections.",
      "In rare cases, SGLT2 inhibitors can cause diabetic ketoacidosis.",
      "SGLT2 inhibitors can increase the risk of hypoglycemia when taken with other diabetes medications.",
      "SGLT2 inhibitors can cause dehydration by increasing the amount of glucose in the urine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: While it was initially thought that SGLT2 inhibitors could increase the risk of urinary tract infections (UTIs), subsequent research has shown that the risk of developing UTIs with SGLT2 inhibitors is not significantly higher than with other diabetes medications.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "yulan-chat-2-13b-fp16_response": "JASPAR is a database of protein-binding interactions, which is regularly updated with new data. Here are the most recent releases of JASPAR as of my knowledge cutoff date of September 2021:\n* JASPAR 2021: This is the latest release of JASPAR, which was published in January 2021. It contains over 2 million protein-binding interactions, including both experimentally validated and predicted interactions.\n* JASPAR 2020: This release was published in January 2020 and contains over 1.9 million protein-binding interactions.\n* JASPAR 2019: This release was published in January 2019 and contains over 1.8 million protein-binding interactions.\n* JASPAR 2018: This release was published in January 2018 and contains over 1.7 million protein-binding interactions.\n* JASPAR 2017: This release was published in January 2017 and contains over 1.6 million protein-binding interactions.\nNote that there may have been additional releases of JASPAR since my knowledge cutoff date of September 2021, so it is always a good idea to check the JASPAR website for the most up-to-date information.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. JASPAR database is a database of protein-binding interactions that is updated regularly.\n2. The JASPAR 2021 release was published in January 2021 and contains over 2 million protein-binding interactions.\n3. JASPAR 2020 was released in January 2020 with over 1.9 million protein-binding interactions.\n4. The JASPAR 2019 release, containing over 1.8 million interactions, was published in January 2019.\n5. JASPAR 2018 and JASPAR 2017 releases were published in January 2018 and January 2017, respectively, with the 2018 release having over 1.7 million interactions and the 2017 release containing over 1.6 million interactions.",
    "yulan-chat-2-13b-fp16_fact": [
      "JASPAR database is a database of protein-binding interactions that is updated regularly.",
      "The JASPAR 2021 release was published in January 2021 and contains over 2 million protein-binding interactions.",
      "JASPAR 2020 was released in January 2020 with over 1.9 million protein-binding interactions.",
      "The JASPAR 2019 release, containing over 1.8 million interactions, was published in January 2019.",
      "JASPAR 2018 and JASPAR 2017 releases were published in January 2018 and January 2017, respectively, with the 2018 release having over 1.7 million interactions and the 2017 release containing over 1.6 million interactions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The JASPAR 2021 release was published in 2021, but it does not contain over 2 million protein-binding interactions. JASPAR databases typically contain profiles of DNA-binding motifs, not counts of interactions.\n3. FALSE [correction]: The JASPAR 2020 release was indeed released in 2020, but the number of protein-binding interactions is not accurately stated here. The database focuses on transcription factor binding profiles, not on the number of interactions.\n4. FALSE [correction]: The JASPAR 2019 release was published in 2019, but similar to the others, it would not contain a count of interactions but rather updated sets of transcription factor binding profiles.\n5. FALSE [correction]: JASPAR releases for 2017 and 2018 were indeed published annually, but the details on the number of interactions are incorrect. They include new and updated profiles of transcription factor DNA-binding preferences, not tallies of interactions.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 83,
    "user_query": "Which gene is required for the efficient function of clopidogrel?",
    "yulan-chat-2-13b-fp16_response": "Clopidogrel is a drug that is used to prevent blood clots. It works by inhibiting the activity of a protein called cyclooxygenase-1 (COX-1), which is involved in the production of thromboxane, a substance that promotes blood clotting.\nThe efficiency of clopidogrel's action is dependent on the presence of a specific gene in the body. This gene is called CYP2C19, and it encodes for an enzyme called cytochrome P450 2C19. This enzyme is involved in the metabolism of clopidogrel to its active metabolite, which is responsible for its anti-clotting effects.\nIndividuals who have two functional copies of the CYP2C19 gene (i.e., they are homozygous for the wild-type allele) are more likely to metabolize clopidogrel efficiently and therefore have a greater response to the drug. On the other hand, individuals who have one or two non-functional copies of the CYP2C19 gene (i.e., they are heterozygous or homozygous for a functional allele and a non-functional allele, respectively) are more likely to metabolize clopidogrel poorly and may not respond as well to the drug.\nTherefore, the efficiency of clopidogrel's action is dependent on the presence and function of the CYP2C19 gene and its encoded enzyme.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Clopidogrel is used to prevent blood clots by inhibiting the activity of cyclooxygenase-1 (COX-1).\n2. The gene CYP2C19 encodes for an enzyme called cytochrome P450 2C19, which is involved in the metabolism of clopidogrel.\n3. The CYP2C19 gene is required for the conversion of clopidogrel into its active metabolite.\n4. Individuals with two functional copies of the CYP2C19 gene are likely to have a greater response to clopidogrel.\n5. People with one or two non-functional copies of the CYP2C19 gene may metabolize clopidogrel poorly and respond less effectively to the drug.",
    "yulan-chat-2-13b-fp16_fact": [
      "Clopidogrel is used to prevent blood clots by inhibiting the activity of cyclooxygenase-1 (COX-1).",
      "The gene CYP2C19 encodes for an enzyme called cytochrome P450 2C19, which is involved in the metabolism of clopidogrel.",
      "The CYP2C19 gene is required for the conversion of clopidogrel into its active metabolite.",
      "Individuals with two functional copies of the CYP2C19 gene are likely to have a greater response to clopidogrel.",
      "People with one or two non-functional copies of the CYP2C19 gene may metabolize clopidogrel poorly and respond less effectively to the drug."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Clopidogrel is used to prevent blood clots by inhibiting the activity of adenosine diphosphate (ADP) receptors on platelet cells, not cyclooxygenase-1 (COX-1).\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 86,
    "user_query": "Which antibiotics target peptidoglycan biosynthesis?",
    "yulan-chat-2-13b-fp16_response": "Peptidoglycan is a key component of the bacterial cell wall, and inhibitors of peptidoglycan biosynthesis are a class of antibiotics that target this pathway. Some antibiotics that target peptidoglycan biosynthesis include:\n1. Penicillins: These are among the first antibiotics discovered and are still widely used today. They inhibit the transpeptidase activity of the penicillin-binding proteins, which are essential for peptidoglycan synthesis.\n2. Cephalosporins: These are structurally related to penicillins and also inhibit peptidoglycan synthesis by targeting the transpeptidase activity of penicillin-binding proteins.\n3. Carbapenems: These are a newer class of antibiotics that are more effective against many strains of resistant bacteria. They inhibit the synthesis of peptidoglycan by binding to the muramyl-lysine-peptidoglycan synthase enzyme.\n4. Aminoglycosides: These antibiotics target the bacterial ribosome, interfering with protein synthesis, but they also have some effects on peptidoglycan synthesis.\n5. Glycopeptides: These antibiotics, such as vancomycin, target the synthesis of peptidoglycan by inhibiting the formation of the glycopeptide intermediate.\nIt's important to note that while these antibiotics target peptidoglycan biosynthesis, they may have off-target effects on other cellular processes, and resistance to these antibiotics can develop over time.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Penicillins inhibit the transpeptidase activity of penicillin-binding proteins, which are essential for peptidoglycan synthesis.\n2. Cephalosporins inhibit peptidoglycan synthesis by targeting the transpeptidase activity of penicillin-binding proteins.\n3. Carbapenems inhibit the synthesis of peptidoglycan by binding to the muramyl-lysine-peptidoglycan synthase enzyme.\n4. Aminoglycosides interfere with protein synthesis and have some effects on peptidoglycan synthesis.\n5. Glycopeptides, such as vancomycin, inhibit the formation of the glycopeptide intermediate in peptidoglycan biosynthesis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Penicillins inhibit the transpeptidase activity of penicillin-binding proteins, which are essential for peptidoglycan synthesis.",
      "Cephalosporins inhibit peptidoglycan synthesis by targeting the transpeptidase activity of penicillin-binding proteins.",
      "Carbapenems inhibit the synthesis of peptidoglycan by binding to the muramyl-lysine-peptidoglycan synthase enzyme.",
      "Aminoglycosides interfere with protein synthesis and have some effects on peptidoglycan synthesis.",
      "Glycopeptides, such as vancomycin, inhibit the formation of the glycopeptide intermediate in peptidoglycan biosynthesis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Carbapenems inhibit peptidoglycan synthesis by binding to penicillin-binding proteins, not specifically to the muramyl-lysine-peptidoglycan synthase enzyme.\n4. TRUE (although the statement might be a bit misleading since the primary action of aminoglycosides is the inhibition of bacterial protein synthesis by binding to the ribosomal 30S subunit; their effect on peptidoglycan synthesis is not their main mechanism of action)\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 92,
    "user_query": "What is the mode of action of everolimus?",
    "yulan-chat-2-13b-fp16_response": "Everolimus is a kinase inhibitor that acts by inhibiting the activity of the mTOR (mammalian target of rapamycin) pathway. The mTOR pathway is involved in cell growth, proliferation, and survival, and is a key regulator of cell metabolism. By inhibiting the activity of mTOR, everolimus can slow down cell growth and proliferation, and can also induce cell death in certain types of cells.\nEverolimus is used to treat a variety of conditions, including renal cell carcinoma, breast cancer, and other types of solid tumors. It is also used to prevent organ rejection in patients who have received a kidney transplant. In these applications, everolimus works by inhibiting the growth and proliferation of cancer cells or by preventing the immune system from attacking the transplanted organ.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Everolimus is a kinase inhibitor.\n2. The mode of action of everolimus involves inhibiting the mTOR pathway.\n3. The mTOR pathway is implicated in cell growth, proliferation, and survival.\n4. Everolimus is used in the treatment of renal cell carcinoma and breast cancer.\n5. Everolimus is used to prevent organ rejection in kidney transplant patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Everolimus is a kinase inhibitor.",
      "The mode of action of everolimus involves inhibiting the mTOR pathway.",
      "The mTOR pathway is implicated in cell growth, proliferation, and survival.",
      "Everolimus is used in the treatment of renal cell carcinoma and breast cancer.",
      "Everolimus is used to prevent organ rejection in kidney transplant patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Everolimus is not a kinase inhibitor; it is an mTOR inhibitor.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 97,
    "user_query": "Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?",
    "yulan-chat-2-13b-fp16_response": "Hypertrophic cardiomyopathy (HCM) is a genetic disorder that causes the heart muscle to become thickened and stiffened, making it difficult for the heart to pump blood effectively. It is one of the most common genetic heart diseases, affecting approximately one in 500 people. HCM can lead to a range of symptoms, including shortness of breath, fatigue, swelling in the legs, and chest pain or discomfort. In severe cases, it can lead to heart failure or sudden death. HCM is typically diagnosed through an echocardiogram, a non-invasive test that uses sound waves to create images of the heart. Treatment options for HCM may include medications, such as beta blockers or ACE inhibitors, to help manage symptoms and improve heart function. In some cases, surgery may be necessary to remove excess heart tissue or repair any structural abnormalities in the heart.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hypertrophic cardiomyopathy (HCM) is a genetic disorder that results in the thickening and stiffening of the heart muscle.\n2. HCM affects approximately one in 500 people.\n3. Symptoms of HCM can include shortness of breath, fatigue, swelling in the legs, and chest pain or discomfort.\n4. An echocardiogram, which creates images of the heart using sound waves, is typically used to diagnose HCM.\n5. Treatments for HCM may include medications like beta blockers or ACE inhibitors, and in some cases, surgery.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hypertrophic cardiomyopathy (HCM) is a genetic disorder that results in the thickening and stiffening of the heart muscle.",
      "HCM affects approximately one in 500 people.",
      "Symptoms of HCM can include shortness of breath, fatigue, swelling in the legs, and chest pain or discomfort.",
      "An echocardiogram, which creates images of the heart using sound waves, is typically used to diagnose HCM.",
      "Treatments for HCM may include medications like beta blockers or ACE inhibitors, and in some cases, surgery."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "yulan-chat-2-13b-fp16_response": "The KP4 protein is a viral protein that is encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV). It is also known as vFLIP (viral FLICE-like inhibitory protein) or vIAP (viral inhibitor of apoptosis protein).\nThe function of the KP4 protein is to inhibit apoptosis, which is a process of programmed cell death that plays a critical role in maintaining tissue homeostasis and eliminating damaged or infected cells. By inhibiting apoptosis, the KP4 protein helps to protect infected cells from undergoing apoptosis and allows the virus to continue to replicate and spread.\nThe KP4 protein achieves this function by interacting with and inhibiting the activity of caspases, which are enzymes that play a key role in the execution of apoptosis. By binding to and inhibiting caspases, the KP4 protein prevents them from activating the apoptotic pathway and triggering cell death.\nIn addition to its role in inhibiting apoptosis, the KP4 protein has also been shown to have other functions, such as promoting cell survival, inhibiting inflammation, and modulating the immune response.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The KP4 protein is encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV).\n2. KP4 is also known as vFLIP (viral FLICE-like inhibitory protein) or vIAP (viral inhibitor of apoptosis protein).\n3. The function of the KP4 protein is to inhibit apoptosis, a process of programmed cell death.\n4. The KP4 protein interacts with and inhibits the activity of caspases, enzymes involved in the execution of apoptosis.\n5. Aside from inhibiting apoptosis, the KP4 protein is involved in promoting cell survival, inhibiting inflammation, and modulating the immune response.",
    "yulan-chat-2-13b-fp16_fact": [
      "The KP4 protein is encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV).",
      "KP4 is also known as vFLIP (viral FLICE-like inhibitory protein) or vIAP (viral inhibitor of apoptosis protein).",
      "The function of the KP4 protein is to inhibit apoptosis, a process of programmed cell death.",
      "The KP4 protein interacts with and inhibits the activity of caspases, enzymes involved in the execution of apoptosis.",
      "Aside from inhibiting apoptosis, the KP4 protein is involved in promoting cell survival, inhibiting inflammation, and modulating the immune response."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The protein encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) that inhibits apoptosis is known as vFLIP (viral FLICE-like inhibitory protein) or sometimes K13, not KP4.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 101,
    "user_query": "What is the principle of the PAR-CLIP methodology?",
    "yulan-chat-2-13b-fp16_response": "PAR-CLIP (Partially Augmented Reality for Clip Interaction and Placement) is a methodology for augmenting real-world objects with digital information and interactions. The principle of the PAR-CLIP methodology is to overlay digital information and interactions onto real-world objects in a way that enhances the user's understanding and interaction with those objects. This is achieved by using a combination of computer vision, machine learning, and augmented reality technologies to recognize and track real-world objects, and to display relevant digital information and interactions on top of those objects. The goal of PAR-CLIP is to provide users with a more immersive and interactive experience when interacting with real-world objects, and to make those interactions more efficient and effective.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PAR-CLIP stands for Partially Augmented Reality for Clip Interaction and Placement.\n2. The principle of PAR-CLIP is to overlay digital information and interactions onto real-world objects.\n3. PAR-CLIP aims to enhance the user's understanding and interaction with real-world objects.\n4. PAR-CLIP uses a combination of computer vision, machine learning, and augmented reality technologies.\n5. The goal of PAR-CLIP is to provide a more immersive and interactive experience with real-world objects and to improve the efficiency and effectiveness of those interactions.",
    "yulan-chat-2-13b-fp16_fact": [
      "PAR-CLIP stands for Partially Augmented Reality for Clip Interaction and Placement.",
      "The principle of PAR-CLIP is to overlay digital information and interactions onto real-world objects.",
      "PAR-CLIP aims to enhance the user's understanding and interaction with real-world objects.",
      "PAR-CLIP uses a combination of computer vision, machine learning, and augmented reality technologies.",
      "The goal of PAR-CLIP is to provide a more immersive and interactive experience with real-world objects and to improve the efficiency and effectiveness of those interactions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: PAR-CLIP stands for Photoactivatable Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation.\n2. FALSE [correction]: The principle of PAR-CLIP is a method used to identify the binding sites of cellular RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) within a cellular environment.\n3. FALSE [correction]: PAR-CLIP aims to enhance the understanding of RNA-RBP interactions and post-transcriptional regulatory networks, not to interact with real-world objects.\n4. FALSE [correction]: PAR-CLIP uses photoactivatable ribonucleosides and ultraviolet light to induce crosslinking between RNA molecules and RBPs, rather than computer vision, machine learning, and augmented reality technologies.\n5. FALSE [correction]: The goal of PAR-CLIP is to provide insights into the RNA targets of RBPs and miRNPs and to study post-transcriptional gene regulation. It is not about providing an immersive and interactive experience with real-world objects.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 106,
    "user_query": "Which package is available for analysing genomic interactions in R/Bioconductor?",
    "yulan-chat-2-13b-fp16_response": "There are several packages available for analyzing genomic interactions in R/Bioconductor, including:\n1. WGCNA: Weighted Gene Co-expression Network Analysis\n2. CCAST: Canonical Correlation Analysis of Gene Co-expression Networks\n3. limma: Linear Models for Microarray Data\n4. edgeR: Differential Edge Analysis via Randomization\n5. DESeq2: Differential Expression Analysis of RNA-Seq Data\n6. DESeq2Seq: Differential Expression Analysis of RNA-Seq Data with Sequence Data Integration\n7. sva: Analysis of Variance in RNA-Seq Data\n8. edgeRqpcr: edgeR-based Quantification of RNA-Seq Data\n9. SCAN: Statistical Analysis of ChIP-Seq Data\n10. ChIPSeq: ChIP-Seq Data Analysis in R/Bioconductor\nThese packages provide a range of tools for analyzing gene expression data, identifying co-regulated genes, detecting differentially expressed genes, and analyzing genomic interactions. The specific package(s) used will depend on the research question and the type of data being analyzed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. WGCNA is a package in R/Bioconductor for Weighted Gene Co-expression Network Analysis.\n2. CCAST stands for Canonical Correlation Analysis of Gene Co-expression Networks in R/Bioconductor.\n3. limma is a package in R/Bioconductor used for Linear Models for Microarray Data.\n4. edgeR is a package in R/Bioconductor for Differential Edge Analysis via Randomization.\n5. DESeq2 is a package available in R/Bioconductor for Differential Expression Analysis of RNA-Seq Data.",
    "yulan-chat-2-13b-fp16_fact": [
      "WGCNA is a package in R/Bioconductor for Weighted Gene Co-expression Network Analysis.",
      "CCAST stands for Canonical Correlation Analysis of Gene Co-expression Networks in R/Bioconductor.",
      "limma is a package in R/Bioconductor used for Linear Models for Microarray Data.",
      "edgeR is a package in R/Bioconductor for Differential Edge Analysis via Randomization.",
      "DESeq2 is a package available in R/Bioconductor for Differential Expression Analysis of RNA-Seq Data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: CCAST does not stand for Canonical Correlation Analysis of Gene Co-expression Networks in R/Bioconductor. CCAST likely refers to \"Computational Clusters for Accurate Sequence Typing,\" which is not the same as Canonical Correlation Analysis.\n3. TRUE\n4. FALSE [correction]: edgeR is a package in R/Bioconductor for analyzing differential expression of RNA-seq data, not for Differential Edge Analysis via Randomization.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 107,
    "user_query": "How many clinical trials for off-label drugs in neonates are cited in the literature.",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have access to the most recent literature and I don't have information on the exact number of clinical trials for off-label drugs in neonates that have been cited in the literature. However, off-label drug use in neonates is a topic of interest and research, and there have been studies and reviews published on the subject. It is important to note that off-label drug use in neonates should be carefully considered and based on sound medical evidence and clinical judgment.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 112,
    "user_query": "What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?",
    "yulan-chat-2-13b-fp16_response": "Affinity purification is a technique used to isolate specific proteins or protein complexes from a mixture based on their interactions with a specific ligand or antibody. In order to isolate soluble lysosomal proteins, a type of affinity purification that could be used is immunoprecipitation using an antibody that recognizes a specific lysosomal protein or a protein that is known to be present in lysosomes. This antibody can be coupled to a bead or a magnetic particle, and the lysosomal proteins can be captured by incubating the mixture with the antibody-bead or antibody-magnetic particle mixture. The captured proteins can then be eluted and analyzed by techniques such as mass spectrometry or western blotting. Another option could be to use a lysosomal protein-specific ligand as a bait in a protein-protein interaction assay such as a yeast two-hybrid system to capture the lysosomal proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Affinity purification is used to isolate proteins or protein complexes based on interactions with a specific ligand or antibody.\n2. Immunoprecipitation can be used to isolate soluble lysosomal proteins using an antibody that recognizes a specific lysosomal protein.\n3. The antibody used for immunoprecipitation can be coupled to a bead or magnetic particle.\n4. Captured lysosomal proteins can be eluted and analyzed by mass spectrometry or western blotting.\n5. A lysosomal protein-specific ligand can be used as bait in a protein-protein interaction assay to capture lysosomal proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "Affinity purification is used to isolate proteins or protein complexes based on interactions with a specific ligand or antibody.",
      "Immunoprecipitation can be used to isolate soluble lysosomal proteins using an antibody that recognizes a specific lysosomal protein.",
      "The antibody used for immunoprecipitation can be coupled to a bead or magnetic particle.",
      "Captured lysosomal proteins can be eluted and analyzed by mass spectrometry or western blotting.",
      "A lysosomal protein-specific ligand can be used as bait in a protein-protein interaction assay to capture lysosomal proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Typically, ligands would be used to capture proteins that interact with them, rather than being protein-specific. A specific ligand in the context of lysosomal proteins would imply a molecule that binds to lysosomal proteins due to a biochemical interaction. However, the term \"lysosomal protein-specific ligand\" is not common and is likely to be misinterpreted. Instead, antibodies are commonly used as bait in protein-protein interaction assays to capture specific proteins, not ligands.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 113,
    "user_query": "Which are the genes thought to be regulated by EWS/FLI?",
    "yulan-chat-2-13b-fp16_response": "EWS/FLI is a transcription factor that regulates the expression of numerous genes, particularly those involved in cell growth, differentiation, and survival. Some of the genes that are known to be regulated by EWS/FLI include:\n* Cyclin D1: a protein that is involved in the regulation of the cell cycle\n* Bcl-2: a protein that promotes cell survival and inhibits apoptosis (programmed cell death)\n* Survivin: a protein that is involved in the regulation of the cell cycle and is associated with cancer progression\n* VEGF: a protein that promotes angiogenesis (the formation of new blood vessels)\n* TGF-beta: a protein that regulates cell growth and differentiation\n* Myc: a transcription factor that is involved in the regulation of cell growth and differentiation\nThese are just a few examples of the many genes that are regulated by EWS/FLI. The exact genes that are regulated by EWS/FLI can vary depending on the cell type and the specific context in which the transcription factor is expressed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. EWS/FLI is a transcription factor that regulates the expression of numerous genes.\n2. Cyclin D1, which is involved in the regulation of the cell cycle, is known to be regulated by EWS/FLI.\n3. Bcl-2, a protein that promotes cell survival and inhibits programmed cell death, is regulated by EWS/FLI.\n4. Survivin, associated with cancer progression and involved in cell cycle regulation, is regulated by EWS/FLI.\n5. EWS/FLI regulates VEGF, a protein that promotes the formation of new blood vessels (angiogenesis).",
    "yulan-chat-2-13b-fp16_fact": [
      "EWS/FLI is a transcription factor that regulates the expression of numerous genes.",
      "Cyclin D1, which is involved in the regulation of the cell cycle, is known to be regulated by EWS/FLI.",
      "Bcl-2, a protein that promotes cell survival and inhibits programmed cell death, is regulated by EWS/FLI.",
      "Survivin, associated with cancer progression and involved in cell cycle regulation, is regulated by EWS/FLI.",
      "EWS/FLI regulates VEGF, a protein that promotes the formation of new blood vessels (angiogenesis)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: EWS/FLI is indeed a transcription factor that arises from a chromosomal translocation and regulates the expression of numerous genes, particularly in the context of Ewing sarcoma.\n2. UNKNOWN: While EWS/FLI regulates a variety of genes, the specific regulation of Cyclin D1 by EWS/FLI is not common knowledge and would require specific evidence from a scientific study to confirm or refute.\n3. UNKNOWN: Similar to the case of Cyclin D1, the regulation of Bcl-2 by EWS/FLI is not commonly known and requires specific scientific evidence to validate such a statement.\n4. UNKNOWN: Survivin is associated with cancer progression and involved in inhibiting apoptosis, and while EWS/FLI is implicated in oncogenic processes, a direct regulatory relationship would require specific evidence from scientific research.\n5. UNKNOWN: EWS/FLI has been shown to influence various aspects of tumorigenesis, including possibly angiogenesis. However, a direct regulatory role in VEGF expression would require validation from a scientific research study.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 115,
    "user_query": "Which pathological conditions are caused by mutations in the CYLD gene?",
    "yulan-chat-2-13b-fp16_response": "Mutations in the CYLD gene have been associated with several pathological conditions, including:\n1. Hereditary papillary renal cell carcinoma (HPRCC): CYLD mutations are the most common genetic alterations found in HPRCC, a subtype of renal cell carcinoma (RCC) that is characterized by the formation of papillary structures in the kidney.\n2. Familial adenomatous polyposis (FAP): CYLD mutations have been identified in some cases of FAP, a hereditary disorder characterized by the development of numerous adenomatous polyps in the colon and other organs.\n3. Cowden disease: CYLD mutations have been implicated in Cowden disease, a rare autosomal dominant disorder characterized by the development of non-cancerous growths on the skin, eyes, and other organs.\n4. Other cancers: CYLD mutations have been found in other types of cancer, including breast cancer, ovarian cancer, and gastric cancer. However, the clinical significance of these mutations in these contexts is still being studied.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CYLD gene mutations are associated with hereditary papillary renal cell carcinoma.\n2. Mutations in the CYLD gene are the most common genetic alterations found in HPRCC.\n3. Some cases of familial adenomatous polyposis have been identified to involve CYLD gene mutations.\n4. Cowden disease has been implicated with mutations in the CYLD gene.\n5. CYLD mutations have been found in various other cancers such as breast cancer, ovarian cancer, and gastric cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "CYLD gene mutations are associated with hereditary papillary renal cell carcinoma.",
      "Mutations in the CYLD gene are the most common genetic alterations found in HPRCC.",
      "Some cases of familial adenomatous polyposis have been identified to involve CYLD gene mutations.",
      "Cowden disease has been implicated with mutations in the CYLD gene.",
      "CYLD mutations have been found in various other cancers such as breast cancer, ovarian cancer, and gastric cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: CYLD gene mutations are associated with a genetic disorder called cylindromatosis, not hereditary papillary renal cell carcinoma (HPRCC).\n2. FALSE [correction]: Mutations in the MET gene, not the CYLD gene, are the most common genetic alterations found in HPRCC.\n3. FALSE [correction]: Familial adenomatous polyposis is commonly associated with mutations in the APC gene, not the CYLD gene.\n4. FALSE [correction]: Cowden disease is associated with mutations in the PTEN gene, not the CYLD gene.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 121,
    "user_query": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A).",
    "yulan-chat-2-13b-fp16_response": "Charcot-Marie-Tooth disease type 1A (CMT1A) is a heritable neuropathy caused by mutations in the peripheral myelin protein 22 (PMP22) gene. Mutations in the PMP22 gene result in the production of an abnormal form of the protein, which leads to the degeneration of the peripheral nerves.\nThe following is a list of some of the genes that have been found mutated in CMT1A:\n* PMP22\n* EGR1\n* KCNS1\n* NGF\n* NTRK1\n* NTRK3\n* RAPGEF5\n* SPTAN1\n* TRIM34\n* ZEB2\nIt's important to note that this is not an exhaustive list, and new genes may be identified as research in this area continues. Additionally, not all cases of CMT1A are caused by mutations in these genes, as some cases may be caused by mutations in other genes or by environmental factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Charcot-Marie-Tooth disease type 1A (CMT1A) is caused by mutations in the peripheral myelin protein 22 (PMP22) gene.\n2. Mutations in the PMP22 gene can result in the production of an abnormal form of the protein.\n3. Mutated genes associated with CMT1A include EGR1, KCNS1, and NGF.\n4. NTRK1, NTRK3, and RAPGEF5 are some of the genes found mutated in CMT1A.\n5. SPTAN1, TRIM34, and ZEB2 are also among the genes that have been identified as mutated in CMT1A.",
    "yulan-chat-2-13b-fp16_fact": [
      "Charcot-Marie-Tooth disease type 1A (CMT1A) is caused by mutations in the peripheral myelin protein 22 (PMP22) gene.",
      "Mutations in the PMP22 gene can result in the production of an abnormal form of the protein.",
      "Mutated genes associated with CMT1A include EGR1, KCNS1, and NGF.",
      "NTRK1, NTRK3, and RAPGEF5 are some of the genes found mutated in CMT1A.",
      "SPTAN1, TRIM34, and ZEB2 are also among the genes that have been identified as mutated in CMT1A."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The commonly known mutated gene associated with CMT1A is the PMP22 gene, not EGR1, KCNS1, or NGF. Other genetic causes are related to different types of Charcot-Marie-Tooth disease.\n4. FALSE [correction]: NTRK1 and NTRK3 mutations are associated with different forms of CMT (e.g., CMT4D with NTRK1 mutations) but not specifically CMT1A.\n5. FALSE [correction]: The SPTAN1, TRIM34, and ZEB2 genes are not commonly associated with CMT1A. CMT1A is primarily caused by a duplication of the PMP22 gene or, less commonly, by point mutations in the same gene.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 123,
    "user_query": "Which genes have been associated with Cerebral Cavernous Malformation?",
    "yulan-chat-2-13b-fp16_response": "Cerebral cavernous malformations (CCMs) are vascular malformations that occur in the brain and are characterized by the presence of cavernous structures that are filled with blood. CCMs can cause a variety of neurological symptoms, including seizures, headaches, and hemorrhages.\nSeveral genes have been associated with CCMs, including:\n1. CCM1: This gene encodes a protein that is involved in the regulation of blood vessel growth and maintenance. Mutations in this gene have been linked to the development of CCMs.\n2. CCM2: This gene encodes a protein that is involved in the regulation of cell division and differentiation. Mutations in this gene have also been linked to the development of CCMs.\n3. KRIT1: This gene encodes a protein that is involved in the regulation of blood vessel growth and maintenance. Mutations in this gene have been linked to the development of CCMs.\n4. CNTNAP2: This gene encodes a protein that is involved in the regulation of cell adhesion and migration. Mutations in this gene have been linked to the development of CCMs.\nIt is important to note that not all CCMs are caused by genetic mutations, and some may occur spontaneously or be caused by other factors. If you are concerned about your risk for CCMs, it is important to speak with a healthcare professional for further evaluation and advice.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the CCM1 gene have been linked to the development of Cerebral Cavernous Malformations (CCMs).\n2. The CCM2 gene is associated with CCMs and encodes a protein that regulates cell division and differentiation.\n3. The KRIT1 gene is implicated in the development of CCMs and is involved in the regulation of blood vessel growth and maintenance.\n4. Mutations in the CNTNAP2 gene have been associated with the development of CCMs.\n5. Not all Cerebral Cavernous Malformations are caused by genetic mutations; some may occur spontaneously or be caused by other factors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the CCM1 gene have been linked to the development of Cerebral Cavernous Malformations (CCMs).",
      "The CCM2 gene is associated with CCMs and encodes a protein that regulates cell division and differentiation.",
      "The KRIT1 gene is implicated in the development of CCMs and is involved in the regulation of blood vessel growth and maintenance.",
      "Mutations in the CNTNAP2 gene have been associated with the development of CCMs.",
      "Not all Cerebral Cavernous Malformations are caused by genetic mutations; some may occur spontaneously or be caused by other factors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE - The KRIT1 gene is another name for CCM1, and mutations in this gene have indeed been implicated in the development of CCMs and are involved in the regulation of blood vessel growth and maintenance.\n4. FALSE [correction]: Mutations in the CNTNAP2 gene have not been primarily associated with the development of CCMs. CNTNAP2 gene mutations are more commonly associated with neurological disorders such as autism spectrum disorders and epilepsy.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "yulan-chat-2-13b-fp16_response": "DITPA (3,5-diiodothyropropacetic acid) is a synthetic compound that has been studied as a potential thyroid hormone analog. It is structurally related to the natural thyroid hormone thyroxine (T4), and has been shown to have some of the same effects on the body as T4, such as increasing metabolism and heart rate. However, DITPA is not a naturally occurring thyroid hormone and has not been approved for clinical use. It has been primarily studied in experimental models and has not been extensively studied in humans.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DITPA stands for 3,5-diiodothyropropionic acid.\n2. DITPA is a synthetic compound that is structurally related to thyroxine (T4).\n3. DITPA has been shown to have effects such as increasing metabolism and heart rate.\n4. DITPA is not a naturally occurring thyroid hormone.\n5. DITPA has not been approved for clinical use and has been primarily studied in experimental models.",
    "yulan-chat-2-13b-fp16_fact": [
      "DITPA stands for 3,5-diiodothyropropionic acid.",
      "DITPA is a synthetic compound that is structurally related to thyroxine (T4).",
      "DITPA has been shown to have effects such as increasing metabolism and heart rate.",
      "DITPA is not a naturally occurring thyroid hormone.",
      "DITPA has not been approved for clinical use and has been primarily studied in experimental models."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 130,
    "user_query": "What is needed for MMP proteins to be functional?",
    "yulan-chat-2-13b-fp16_response": "MMP (matrix metalloproteinase) proteins are a family of enzymes that are involved in the breakdown of extracellular matrix (ECM) proteins. In order for MMP proteins to be functional, they require several factors:\n1. Activation: MMPs are pro-enzymes that need to be activated before they can function. This activation can occur through proteolytic cleavage by other proteases or through autocatalytic cleavage.\n2. Zinc ions: MMPs require zinc ions for their activity. Zinc ions bind to the active site of the enzyme and are essential for the catalytic activity of MMPs.\n3. ECM components: MMPs require ECM components as substrates to cleave. The ECM is a complex network of proteins that provides structural support to cells and tissues. MMPs cleave these proteins into smaller peptides and amino acids, which can then be taken up by cells and used for various cellular processes.\n4. Nuclear factor kappa B (NF-B) activation: NF-B is a transcription factor that regulates the expression of MMP genes. NF-B activation is necessary for the expression of MMPs and their subsequent activation.\n5. Other regulatory proteins: MMPs are also regulated by a variety of other proteins, including tissue inhibitors of metalloproteinases (TIMPs), endostatin, and batimastatins. These proteins can inhibit MMP activity and help to maintain the integrity of the ECM.\nIn summary, MMP proteins require activation, zinc ions, ECM components, NF-B activation, and other regulatory proteins to be functional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MMP (matrix metalloproteinase) proteins require activation through proteolytic cleavage for functionality.\n2. Zinc ions are essential for the catalytic activity of MMP proteins.\n3. MMP proteins cleave extracellular matrix (ECM) components, which are necessary substrates for their activity.\n4. Nuclear factor kappa B (NF-B) activation regulates the expression of MMP genes.\n5. Tissue inhibitors of metalloproteinases (TIMPs), endostatin, and batimastatins can inhibit MMP activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "MMP (matrix metalloproteinase) proteins require activation through proteolytic cleavage for functionality.",
      "Zinc ions are essential for the catalytic activity of MMP proteins.",
      "MMP proteins cleave extracellular matrix (ECM) components, which are necessary substrates for their activity.",
      "Nuclear factor kappa B (NF-B) activation regulates the expression of MMP genes.",
      "Tissue inhibitors of metalloproteinases (TIMPs), endostatin, and batimastatins can inhibit MMP activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Tissue inhibitors of metalloproteinases (TIMPs), endostatin, and batimastat can inhibit MMP activity. (The word \"batimastatins\" seems to be a typographical error; \"batimastat\" is the correct term for the synthetic inhibitor of MMPs).",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 133,
    "user_query": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?",
    "yulan-chat-2-13b-fp16_response": "The most known bacterium responsible for botulism is Clostridium botulinum. It is a gram-positive, anaerobic bacterium that produces potent neurotoxins, including botulinum toxin, which is commonly used in cosmetic treatments to temporarily reduce the appearance of fine lines and wrinkles. However, the toxin can also cause a serious and potentially fatal form of food poisoning known as botulism. C. botulinum can grow in a wide range of environments, including soil, water, and the intestinal tracts of animals, and it can survive in these environments for long periods of time. It is important to take precautions to prevent the growth and spread of C. botulinum, especially when handling and preparing food.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Clostridium botulinum is the most known bacterium responsible for botulism.\n2. It is a gram-positive, anaerobic bacterium.\n3. Clostridium botulinum produces botulinum toxin.\n4. Botulinum toxin is used in cosmetic treatments to reduce the appearance of fine lines and wrinkles.\n5. The bacterium can grow in environments such as soil, water, and the intestinal tracts of animals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Clostridium botulinum is the most known bacterium responsible for botulism.",
      "It is a gram-positive, anaerobic bacterium.",
      "Clostridium botulinum produces botulinum toxin.",
      "Botulinum toxin is used in cosmetic treatments to reduce the appearance of fine lines and wrinkles.",
      "The bacterium can grow in environments such as soil, water, and the intestinal tracts of animals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 138,
    "user_query": "Which are the plant DNA (cytosine-5) methyltransferase families?",
    "yulan-chat-2-13b-fp16_response": "There are several families of plant DNA (cytosine-5) methyltransferases, including:\n1. DNMT1 family: This family includes the enzyme DNA methyltransferase 1 (DNMT1), which is responsible for maintaining DNA methylation patterns in plants.\n2. DNMT3 family: This family includes three members, DNMT3A, DNMT3B, and DNMT3L1, which are involved in de novo methylation and maintenance of DNA methylation patterns.\n3. CMT3 family: This family includes three members, CMT3A, CMT3B, and CMT3L1, which are involved in de novo methylation and maintenance of DNA methylation patterns.\n4. H3K4me3 family: This family includes the enzyme histone H3 lysine 4 trimethyltransferase (H3K4me3), which is involved in the regulation of gene expression by modifying histones.\n5. H3K27me3 family: This family includes the enzyme histone H3 lysine 27 trimethyltransferase (H3K27me3), which is involved in the regulation of gene expression by modifying histones.\n6. Dot1 family: This family includes the enzyme histone H3 lysine 79 methyltransferase (Dot1), which is involved in the regulation of gene expression by modifying histones.\n7. EZH2 family: This family includes the enzyme EZH2, which is involved in the regulation of gene expression by modifying histones.\n8. SUV39H1 family: This family includes the enzyme SUV39H1, which is involved in the regulation of gene expression by modifying histones.\n9. SUV39H2 family: This family includes the enzyme SUV39H2, which is involved in the regulation of gene expression by modifying histones.\n10. SETD1A family: This family includes the enzyme SETD1A, which is involved in the regulation of gene expression by modifying histones.\n11. SETD2 family: This family includes the enzym",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The DNMT1 family includes DNA methyltransferase 1 (DNMT1), responsible for maintaining DNA methylation patterns in plants.\n2. The DNMT3 family contains DNMT3A, DNMT3B, and DNMT3L1, which are involved in de novo methylation and maintenance of DNA methylation patterns.\n3. The CMT3 family consists of CMT3A, CMT3B, and CMT3L1, which also play a role in de novo methylation and maintenance of DNA methylation patterns in plants.\n4. The H3K27me3 family includes the enzyme histone H3 lysine 27 trimethyltransferase, which is involved in gene expression regulation by modifying histones.\n5. The SUV39H1 family involves the enzyme SUV39H1, which regulates gene expression by modifying histones.",
    "yulan-chat-2-13b-fp16_fact": [
      "The DNMT1 family includes DNA methyltransferase 1 (DNMT1), responsible for maintaining DNA methylation patterns in plants.",
      "The DNMT3 family contains DNMT3A, DNMT3B, and DNMT3L1, which are involved in de novo methylation and maintenance of DNA methylation patterns.",
      "The CMT3 family consists of CMT3A, CMT3B, and CMT3L1, which also play a role in de novo methylation and maintenance of DNA methylation patterns in plants.",
      "The H3K27me3 family includes the enzyme histone H3 lysine 27 trimethyltransferase, which is involved in gene expression regulation by modifying histones.",
      "The SUV39H1 family involves the enzyme SUV39H1, which regulates gene expression by modifying histones."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: DNMT1 is responsible for maintaining DNA methylation patterns, but it is typically not referred to as a family and is not specifically associated with plants, as it is a conserved enzyme in mammals as well.\n2. TRUE\n3. FALSE [correction]: The CMT3 family refers to chromomethylase 3 (CMT3) and related proteins that are plant-specific and are involved in maintaining DNA methylation, particularly at CHG sites (where H is any base except G). There are no enzymes specifically named CMT3A, CMT3B, or CMT3L1 in the CMT3 family.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 139,
    "user_query": "Where is the histone variant CENPA preferentially localized?",
    "yulan-chat-2-13b-fp16_response": "Histone variant CENPA (histone H3.1) is preferentially localized to the centromere region of chromosomes. The centromere is a specialized DNA sequence that plays a crucial role in the proper segregation of chromosomes during cell division. CENPA is essential for the formation and maintenance of the centromere, and its presence is necessary for the normal function of the centromere. CENPA is also found in other regions of the genome, but its concentration at the centromere is particularly high.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histone variant CENPA is preferentially localized to the centromere region of chromosomes.\n2. The centromere is a specialized DNA sequence important for the proper segregation of chromosomes during cell division.\n3. CENPA is essential for the formation and maintenance of the centromere.\n4. The presence of CENPA is necessary for the normal function of the centromere.\n5. Although CENPA is found in other regions of the genome, its concentration is particularly high at the centromere.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histone variant CENPA is preferentially localized to the centromere region of chromosomes.",
      "The centromere is a specialized DNA sequence important for the proper segregation of chromosomes during cell division.",
      "CENPA is essential for the formation and maintenance of the centromere.",
      "The presence of CENPA is necessary for the normal function of the centromere.",
      "Although CENPA is found in other regions of the genome, its concentration is particularly high at the centromere."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: CENPA is specifically localized to the centromere region of chromosomes and is not typically found in other regions of the genome in significant concentrations. Its high concentration is characteristic of centromeres.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 140,
    "user_query": "In which proteins is the chromodomain present?",
    "yulan-chat-2-13b-fp16_response": "The chromodomain is a protein structural motif that is found in a variety of proteins involved in chromatin-related functions, including histone proteins, chromatin remodeling complexes, and transcription factors. Histones are the primary proteins that make up the nucleosome, the basic unit of chromatin, and the chromodomain is present in several histone proteins, including histone H3 and histone H2A. The chromodomain is also found in other proteins that interact with histones, such as chromatin remodeling complexes and transcription factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The chromodomain is a protein structural motif.\n2. The chromodomain is present in proteins involved in chromatin-related functions.\n3. Histone proteins, which contain the chromodomain, are a primary component of nucleosomes.\n4. Histone H3 and histone H2A are examples of histone proteins that contain the chromodomain.\n5. Proteins that interact with histones, like chromatin remodeling complexes and transcription factors, can also contain the chromodomain.",
    "yulan-chat-2-13b-fp16_fact": [
      "The chromodomain is a protein structural motif.",
      "The chromodomain is present in proteins involved in chromatin-related functions.",
      "Histone proteins, which contain the chromodomain, are a primary component of nucleosomes.",
      "Histone H3 and histone H2A are examples of histone proteins that contain the chromodomain.",
      "Proteins that interact with histones, like chromatin remodeling complexes and transcription factors, can also contain the chromodomain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Histone proteins do not contain the chromodomain. Chromodomains are found in other proteins that interact with histones or chromatin, like HP1 or Polycomb.\n4. FALSE [correction]: Neither histone H3 nor histone H2A contain chromodomains. Chromodomains are not found in the core histone proteins.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 142,
    "user_query": "Is amiodarone a class I anti-arrhythmic drug?",
    "yulan-chat-2-13b-fp16_response": "Yes, amiodarone is a class I anti-arrhythmic drug. It is a medication that is used to treat abnormal heart rhythms, including ventricular tachycardia and ventricular fibrillation. It works by slowing the heart rate and reducing the likelihood of life-threatening arrhythmias. Amiodarone is available in oral tablet form and is usually taken by mouth. It is important to follow the dosage and administration instructions provided by your healthcare provider when taking this medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Amiodarone is used to treat abnormal heart rhythms.\n2. Amiodarone can treat conditions such as ventricular tachycardia and ventricular fibrillation.\n3. The drug works by slowing the heart rate.\n4. Amiodarone is available in oral tablet form.\n5. Amiodarone is usually taken by mouth.",
    "yulan-chat-2-13b-fp16_fact": [
      "Amiodarone is used to treat abnormal heart rhythms.",
      "Amiodarone can treat conditions such as ventricular tachycardia and ventricular fibrillation.",
      "The drug works by slowing the heart rate.",
      "Amiodarone is available in oral tablet form.",
      "Amiodarone is usually taken by mouth."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE (Although amiodarone can slow the heart rate, its primary function is to restore normal heart rhythm, but the statement itself isn't false.)\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "yulan-chat-2-13b-fp16_response": "COUGER is a software tool for simulating and analyzing the behavior of complex systems. It is used in a variety of fields, including engineering, physics, and computer science, to model and simulate the behavior of systems that are difficult or impossible to study experimentally. COUGER can be used to simulate the behavior of systems over time, and it can also be used to analyze the behavior of systems and identify patterns and trends. It is often used to study the behavior of systems that are subject to random or stochastic processes, such as systems that are influenced by noise or other forms of uncertainty.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. COUGER is a software tool designed for simulating and analyzing the behavior of complex systems.\n2. COUGER is utilized in various fields, including engineering, physics, and computer science.\n3. The tool allows users to model and simulate systems that are difficult or impossible to study experimentally.\n4. COUGER can simulate the behavior of systems over time.\n5. The tool is often used to study systems that are subject to random or stochastic processes.",
    "yulan-chat-2-13b-fp16_fact": [
      "COUGER is a software tool designed for simulating and analyzing the behavior of complex systems.",
      "COUGER is utilized in various fields, including engineering, physics, and computer science.",
      "The tool allows users to model and simulate systems that are difficult or impossible to study experimentally.",
      "COUGER can simulate the behavior of systems over time.",
      "The tool is often used to study systems that are subject to random or stochastic processes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or a reliable source of information about COUGER, it's not possible to confirm whether these statements are true or false. The name \"COUGER\" doesn't correspond to a widely recognized software tool in the context provided.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are drugs that can be used to treat Tick-borne Encephalitis (TBE). However, the most effective treatment is prevention, which includes avoiding tick bites and taking precautions to reduce exposure to ticks.\nIf a person is infected with TBE, the treatment options may include:\n1. Antiviral medications: These medications, such as ribavirin and favipiravir, can help reduce the severity of the disease and shorten the duration of illness.\n2. Supportive care: This includes providing fluids, oxygen, and other medical interventions to support the body's response to the infection.\n3. Immune globulin: This is a preparation of antibodies that can be administered to people who have been infected with TBE. It can help reduce the severity of the disease and shorten the duration of illness.\nIt is important to note that the effectiveness of these treatments can vary depending on the severity of the infection and the individual patient's response. If you have any concerns about TBE or any other tick-borne illness, it is always best to consult with a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Drugs can be used to treat Tick-borne Encephalitis (TBE).\n2. Antiviral medications such as ribavirin and favipiravir can be used to reduce the severity of TBE and shorten the duration of illness.\n3. Providing supportive care is a treatment option for TBE.\n4. Immune globulin, a preparation of antibodies, can be administered to people infected with TBE.\n5. The effectiveness of treatments for TBE can vary depending on the severity of the infection and the individual patient's response.",
    "yulan-chat-2-13b-fp16_fact": [
      "Drugs can be used to treat Tick-borne Encephalitis (TBE).",
      "Antiviral medications such as ribavirin and favipiravir can be used to reduce the severity of TBE and shorten the duration of illness.",
      "Providing supportive care is a treatment option for TBE.",
      "Immune globulin, a preparation of antibodies, can be administered to people infected with TBE.",
      "The effectiveness of treatments for TBE can vary depending on the severity of the infection and the individual patient's response."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: While there is no specific cure for Tick-borne Encephalitis, certain medications may be used to alleviate symptoms associated with the infection.\n2. FALSE [correction]: There are no specific antiviral medications proven to be effective against Tick-borne Encephalitis. Ribavirin and favipiravir are not standard treatments for TBE.\n3. TRUE: Providing supportive care, including hospitalization, monitoring, and supportive therapy, is the main treatment approach for Tick-borne Encephalitis.\n4. FALSE [correction]: Immune globulin treatment is used for prophylaxis (preventative treatment) before or soon after potential exposure to TBE, but it is not a treatment for an ongoing TBE infection.\n5. TRUE: The effectiveness of supportive treatments for Tick-borne Encephalitis can indeed vary depending on factors such as the severity of the infection and the individual characteristics of the patient.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 146,
    "user_query": "Is SLC22A3 expressed in the brain?",
    "yulan-chat-2-13b-fp16_response": "SLC22A3, also known as organic cation transporter 3 (OCT3), is a protein that is involved in the transport of organic cations across cell membranes. It is primarily expressed in the liver, kidneys, and intestines, and is involved in the uptake and transport of various substances, including drugs and neurotransmitters.\nWhile SLC22A3 is not highly expressed in the brain, it has been detected in certain brain regions, including the hippocampus and cerebellum. It is not yet clear what role SLC22A3 may play in the brain, but it is possible that it may be involved in the transport of certain neurotransmitters or other substances across the blood-brain barrier.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SLC22A3 is also known as organic cation transporter 3 (OCT3).\n2. SLC22A3 is involved in the transport of organic cations across cell membranes.\n3. SLC22A3 is primarily expressed in the liver, kidneys, and intestines.\n4. SLC22A3 has been detected in certain brain regions, including the hippocampus and cerebellum.\n5. The role of SLC22A3 in the brain is not yet clear.",
    "yulan-chat-2-13b-fp16_fact": [
      "SLC22A3 is also known as organic cation transporter 3 (OCT3).",
      "SLC22A3 is involved in the transport of organic cations across cell membranes.",
      "SLC22A3 is primarily expressed in the liver, kidneys, and intestines.",
      "SLC22A3 has been detected in certain brain regions, including the hippocampus and cerebellum.",
      "The role of SLC22A3 in the brain is not yet clear."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nSLC22A3, commonly known as organic cation transporter 3 (OCT3), is indeed involved in the transport of organic cations across cell membranes. It has a broad expression profile, including liver, kidneys, and intestines, as well as certain brain regions such as the hippocampus and cerebellum. The role of SLC22A3 in the brain and its potential implications in various physiological or pathological processes are areas of ongoing research, making the final statement true to the best knowledge available.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "yulan-chat-2-13b-fp16_response": "There are several genome browser databases available for DNA shape annotations, including:\n1. UCSC Genome Browser: The UCSC Genome Browser is a web-based tool that allows users to visualize and explore genome data. It includes a variety of annotations, including DNA shape annotations.\n2. Ensembl Genome Browser: The Ensembl Genome Browser is a web-based tool that provides a visual representation of genome data, including DNA shape annotations.\n3. NCBI Genome Browser: The NCBI Genome Browser is a web-based tool that allows users to view and analyze genome data, including DNA shape annotations.\n4. Genome Data Viewer (GDV): GDV is a web-based tool that allows users to visualize and analyze genome data, including DNA shape annotations.\n5. Integrated Genomics and Bioinformatics Network (IGV): IGV is a web-based tool that allows users to visualize and analyze genome data, including DNA shape annotations.\nThese databases provide a variety of tools and features for exploring DNA shape annotations, including the ability to view and manipulate genome data, search for specific sequences, and compare different genomes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The UCSC Genome Browser includes DNA shape annotations as part of its genome data visualization tools.\n2. The Ensembl Genome Browser is a web-based tool that provides DNA shape annotations in its visual representation of genome data.\n3. The NCBI Genome Browser allows for visualization and analysis of genome data, including DNA shape annotations.\n4. Genome Data Viewer (GDV) is a web tool designed for visualizing and analyzing genome data with features for DNA shape annotations.\n5. The Integrated Genomics and Bioinformatics Network (IGV) is a web-based tool that supports visualization and analysis of genome data, including DNA shape annotations.",
    "yulan-chat-2-13b-fp16_fact": [
      "The UCSC Genome Browser includes DNA shape annotations as part of its genome data visualization tools.",
      "The Ensembl Genome Browser is a web-based tool that provides DNA shape annotations in its visual representation of genome data.",
      "The NCBI Genome Browser allows for visualization and analysis of genome data, including DNA shape annotations.",
      "Genome Data Viewer (GDV) is a web tool designed for visualizing and analyzing genome data with features for DNA shape annotations.",
      "The Integrated Genomics and Bioinformatics Network (IGV) is a web-based tool that supports visualization and analysis of genome data, including DNA shape annotations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe provided statements revolve around the functionality and features of various genome browsers and visualization tools like UCSC Genome Browser, Ensembl Genome Browser, NCBI Genome Browser, Genome Data Viewer (GDV), and the Integrated Genomics and Bioinformatics Network (IGV). Each tool may or may not include DNA shape annotations as a feature, but without current, specific knowledge about the features of these tools, I cannot definitively state the truthfulness of these claims. Users interested in these features should refer to the latest updates or documentation related to each of these genome browsers for accurate information.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 153,
    "user_query": "What is the relationship between TailorX and Oncotype?",
    "yulan-chat-2-13b-fp16_response": "TailorX and Oncotype are both companies that develop and market cancer treatment solutions. However, they are not directly related to each other.\nTailorX is a company that develops personalized cancer treatment plans based on a patient's individual characteristics and medical history. Their approach is to use machine learning algorithms to analyze large amounts of data and generate treatment plans that are tailored to each patient's unique needs.\nOncotype, on the other hand, is a company that develops and markets a range of cancer diagnostic tests, including the Oncotype DX test. This test is used to determine the likelihood of cancer recurrence in certain types of breast, colon, and prostate cancer. The test analyzes the gene expression of cancer cells to provide information that can help guide treatment decisions.\nWhile TailorX and Oncotype are both focused on cancer treatment, they approach the problem from different angles. TailorX is focused on developing personalized treatment plans, while Oncotype is focused on developing diagnostic tests to help guide treatment decisions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TailorX develops personalized cancer treatment plans using machine learning algorithms.\n2. Oncotype develops and markets cancer diagnostic tests, including the Oncotype DX test.\n3. The Oncotype DX test is used to determine the likelihood of cancer recurrence in certain types of breast, colon, and prostate cancer.\n4. TailorX and Oncotype are both companies that develop and market cancer treatment solutions.\n5. The companies TailorX and Oncotype are not directly related to each other.",
    "yulan-chat-2-13b-fp16_fact": [
      "TailorX develops personalized cancer treatment plans using machine learning algorithms.",
      "Oncotype develops and markets cancer diagnostic tests, including the Oncotype DX test.",
      "The Oncotype DX test is used to determine the likelihood of cancer recurrence in certain types of breast, colon, and prostate cancer.",
      "TailorX and Oncotype are both companies that develop and market cancer treatment solutions.",
      "The companies TailorX and Oncotype are not directly related to each other."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: TailorX is not a company but a clinical trial, named the Trial Assigning IndividuaLized Options for Treatment (Rx), which utilizes genetic information to make decisions about the treatment of breast cancer. Oncotype, on the other hand, refers to tests developed by Genomic Health Inc., notably the Oncotype DX test which helps in the treatment of various cancers.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 154,
    "user_query": "Does strenuous physical activity affect thyroid hormone metabolism?",
    "yulan-chat-2-13b-fp16_response": "Strenuous physical activity can affect thyroid hormone metabolism in several ways. Exercise can increase the metabolic rate, which can lead to an increase in the production of thyroid hormones by the thyroid gland. This increase in thyroid hormone production can lead to an increase in metabolic rate, which can help the body to cope with the increased demands of exercise.\nHowever, strenuous physical activity can also lead to an increase in the breakdown of thyroid hormones by the body. This can occur because exercise can cause an increase in the production of certain enzymes that break down thyroid hormones. Additionally, strenuous physical activity can lead to an increase in the production of stress hormones, such as cortisol, which can also lead to an increase in the breakdown of thyroid hormones.\nOverall, the effects of strenuous physical activity on thyroid hormone metabolism are complex and can vary depending on a number of factors, including the intensity and duration of the exercise, the individual's overall health and fitness level, and the presence of any underlying medical conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Strenuous physical activity can increase the metabolic rate.\n2. Increased metabolic rate from exercise can lead to an increase in the production of thyroid hormones by the thyroid gland.\n3. Exercise can cause an increase in the production of enzymes that break down thyroid hormones.\n4. Strenuous physical activity can increase the production of stress hormones like cortisol.\n5. The production of cortisol can lead to an increase in the breakdown of thyroid hormones.",
    "yulan-chat-2-13b-fp16_fact": [
      "Strenuous physical activity can increase the metabolic rate.",
      "Increased metabolic rate from exercise can lead to an increase in the production of thyroid hormones by the thyroid gland.",
      "Exercise can cause an increase in the production of enzymes that break down thyroid hormones.",
      "Strenuous physical activity can increase the production of stress hormones like cortisol.",
      "The production of cortisol can lead to an increase in the breakdown of thyroid hormones."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 155,
    "user_query": "Which is the main function of \"RNA sponges\"?",
    "yulan-chat-2-13b-fp16_response": "RNA sponges are small RNA molecules that can bind to and inhibit the function of other RNA molecules, such as messenger RNA (mRNA) or microRNA (miRNA). The main function of RNA sponges is to regulate gene expression by blocking the translation of mRNA into protein or by destabilizing miRNA, which can also regulate gene expression. RNA sponges can also act as decoys for other RNA molecules, allowing them to be degraded or inhibiting their interaction with other proteins. In this way, RNA sponges play an important role in regulating various cellular processes, including development, differentiation, and disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNA sponges are small RNA molecules that bind to and inhibit the function of other RNA molecules.\n2. RNA sponges' main function is to regulate gene expression.\n3. RNA sponges can block the translation of mRNA into protein.\n4. RNA sponges can destabilize microRNA (miRNA).\n5. RNA sponges can act as decoys that lead to the degradation of other RNA molecules or inhibit their interaction with proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "RNA sponges are small RNA molecules that bind to and inhibit the function of other RNA molecules.",
      "RNA sponges' main function is to regulate gene expression.",
      "RNA sponges can block the translation of mRNA into protein.",
      "RNA sponges can destabilize microRNA (miRNA).",
      "RNA sponges can act as decoys that lead to the degradation of other RNA molecules or inhibit their interaction with proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: RNA sponges are typically not small RNA molecules; instead, they are often long non-coding RNAs or artificial constructs that have multiple binding sites for microRNA (miRNA) or other types of RNA.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 157,
    "user_query": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?",
    "yulan-chat-2-13b-fp16_response": "Phospholamban (PLN) is a protein that regulates cardiac contractility by interacting with cardiac troponin C and calcium. Mutations in the PLN gene have been associated with cardiomyopathy, a disease characterized by heart muscle weakness.\nSeveral mutations in the PLN gene have been identified in patients with cardiomyopathy. Some of the most common mutations include:\n1. R14C: This mutation results in a substitution of arginine for cysteine at position 14 in the PLN protein. This mutation has been associated with dilated cardiomyopathy.\n2. R14W: This mutation results in a substitution of arginine for tryptophan at position 14 in the PLN protein. This mutation has been associated with hypertrophic cardiomyopathy.\n3. R14H: This mutation results in a substitution of arginine for histidine at position 14 in the PLN protein. This mutation has been associated with dilated cardiomyopathy.\n4. R14S: This mutation results in a substitution of arginine for serine at position 14 in the PLN protein. This mutation has been associated with dilated cardiomyopathy.\n5. R14L: This mutation results in a substitution of arginine for leucine at position 14 in the PLN protein. This mutation has been associated with dilated cardiomyopathy.\nIt's important to note that not all mutations in the PLN gene cause cardiomyopathy, and the clinical presentation of the disease can vary widely depending on the specific mutation and other genetic and environmental factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phospholamban (PLN) is a protein that regulates cardiac contractility.\n2. Mutations in the PLN gene have been associated with cardiomyopathy.\n3. The R14C mutation in the PLN protein is associated with dilated cardiomyopathy.\n4. The R14W mutation in the PLN protein is associated with hypertrophic cardiomyopathy.\n5. Not all mutations in the PLN gene cause cardiomyopathy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phospholamban (PLN) is a protein that regulates cardiac contractility.",
      "Mutations in the PLN gene have been associated with cardiomyopathy.",
      "The R14C mutation in the PLN protein is associated with dilated cardiomyopathy.",
      "The R14W mutation in the PLN protein is associated with hypertrophic cardiomyopathy.",
      "Not all mutations in the PLN gene cause cardiomyopathy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The R14Del mutation in the PLN protein is associated with hypertrophic cardiomyopathy, not the R14W mutation.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 160,
    "user_query": "Is there any software for automated analysis of FISH images?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are several software programs available for automated analysis of FISH (Fluorescence In Situ Hybridization) images. These programs typically use image analysis algorithms to automatically detect and quantify specific molecular markers in the FISH images. Some examples of software programs that can be used for automated FISH image analysis include:\n1. Aperio eSlide Manager: This is a web-based software that allows for the analysis of FISH images and other types of histopathology images. It includes tools for automated marker detection and quantification.\n2. FISHquant: This is a software program specifically designed for the analysis of FISH images. It includes algorithms for automated marker detection and quantification, as well as tools for image segmentation and object recognition.\n3. Imagene: This is a software program that includes tools for automated marker detection and quantification in FISH images, as well as other types of microscopy images.\n4. Inova FISHanalyzer: This is a software program that includes algorithms for automated marker detection and quantification in FISH images, as well as tools for image analysis and statistical analysis.\nIt's important to note that the specific features and capabilities of these software programs may vary, and it's important to carefully evaluate the different options available to determine which one is the best fit for your specific needs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aperio eSlide Manager is a web-based software used for the analysis of FISH images.\n2. FISHquant is a software program designed specifically for the analysis of FISH images.\n3. Imagene software includes tools for automated marker detection and quantification in FISH images.\n4. Inova FISHanalyzer is a software program that provides algorithms and tools for analyzing FISH images.\n",
    "yulan-chat-2-13b-fp16_fact": [
      "Aperio eSlide Manager is a web-based software used for the analysis of FISH images.",
      "FISHquant is a software program designed specifically for the analysis of FISH images.",
      "Imagene software includes tools for automated marker detection and quantification in FISH images.",
      "Inova FISHanalyzer is a software program that provides algorithms and tools for analyzing FISH images."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Aperio eSlide Manager is a web-based software used for managing and viewing digital slides and images in pathology, not specifically for the analysis of FISH images.\n2. TRUE\n3. UNKNOWN (While Imagene is a software that could potentially include such tools, without specific information about a software named \"Imagene,\" and its features or capabilities, it is not possible to determine the accuracy of this statement.)\n4. UNKNOWN (There is no well-known software by the name of Inova FISHanalyzer; thus, it is not possible to confirm the features of the software without further information.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 165,
    "user_query": "List markers for autophagy.",
    "yulan-chat-2-13b-fp16_response": "Autophagy is a cellular process of degrading and recycling cellular components, such as organelles and proteins, in lysosomes. Some markers that indicate the presence of autophagy include:\n1. Lysosomal acid lipase (Lamp) enzymes, such as acid lipase, alpha/beta-mannosidase, and cathepsin D, which are enzymes that are found in lysosomes and are released into the circulation during autophagy.\n2. Microtubule-associated protein 1 light chain 3 (LC3) proteins, which are involved in the formation of autophagosomes and are cleaved into LC3-II during autophagy.\n3. p62/SQSTM1 protein, which is a protein that binds to ubiquitinated proteins and is degraded by autophagy.\n4. Chaperone-mediated autophagy (CMA) markers, such as heat shock protein 70 (HSP70) and heat shock protein 27 (HSP27), which are involved in the degradation of misfolded proteins by autophagy.\n5. Autophagy-related protein 7 (ATG7) and ATG12, which are involved in the formation of autophagosomes and are cleaved during autophagy.\nThese markers can be detected in the blood or in tissue samples, and their levels can be used to assess the extent of autophagy in a particular tissue or organ.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lysosomal acid lipase (Lamp) enzymes such as acid lipase, alpha/beta-mannosidase, and cathepsin D are released into the circulation during autophagy.\n2. Microtubule-associated protein 1 light chain 3 (LC3) proteins are involved in the formation of autophagosomes and are cleaved into LC3-II during autophagy.\n3. The p62/SQSTM1 protein binds to ubiquitinated proteins and is degraded by autophagy.\n4. Chaperone-mediated autophagy (CMA) involves heat shock protein 70 (HSP70) and heat shock protein 27 (HSP27) in the degradation of misfolded proteins.\n5. Autophagy-related protein 7 (ATG7) and ATG12 are involved in the formation of autophagosomes and are cleaved during autophagy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lysosomal acid lipase (Lamp) enzymes such as acid lipase, alpha/beta-mannosidase, and cathepsin D are released into the circulation during autophagy.",
      "Microtubule-associated protein 1 light chain 3 (LC3) proteins are involved in the formation of autophagosomes and are cleaved into LC3-II during autophagy.",
      "The p62/SQSTM1 protein binds to ubiquitinated proteins and is degraded by autophagy.",
      "Chaperone-mediated autophagy (CMA) involves heat shock protein 70 (HSP70) and heat shock protein 27 (HSP27) in the degradation of misfolded proteins.",
      "Autophagy-related protein 7 (ATG7) and ATG12 are involved in the formation of autophagosomes and are cleaved during autophagy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Lysosomal acid lipase (LAL) is indeed a lysosomal enzyme, but it's not referred to as Lamp (which often refers to Lysosome-associated membrane protein), and such lysosomal enzymes are not typically released into the circulation during autophagy; they function within the lysosome to degrade materials delivered by the autophagic process.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Chaperone-mediated autophagy (CMA) relies notably on heat shock protein 70 (HSP70), but not on heat shock protein 27 (HSP27) for the degradation of misfolded proteins.\n5. FALSE [correction]: Autophagy-related protein 7 (ATG7) and ATG12 are indeed involved in the autophagosome formation process, but they are not cleaved during autophagy. ATG12 is conjugated to ATG5 in a process that is facilitated by ATG7, and none of these proteins are cleaved in the sense that LC3 is.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 169,
    "user_query": "Are there any specific antidotes for rivaroxaban?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are specific antidotes for rivaroxaban, which is a type of blood thinner medication.\nProthrombin complex concentrate (PCC) is an antidote for rivaroxaban that can be used in cases of bleeding or major bleeding events. PCC contains vitamin K and other clotting factors, which help to reverse the effects of rivaroxaban by increasing the clotting ability of the blood.\nActivated charcoal and sodium bicarbonate may also be used as supportive measures in cases of rivaroxaban overdose, as they can help to reduce the absorption of the drug and prevent further toxicity.\nIt is important to note that the use of these antidotes should be determined by a healthcare professional based on the specific situation and the severity of the bleeding event.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Rivaroxaban is a type of blood thinner medication.\n2. Prothrombin complex concentrate (PCC) can be used as an antidote for rivaroxaban in cases of bleeding or major bleeding events.\n3. PCC contains vitamin K and other clotting factors.\n4. Activated charcoal and sodium bicarbonate may be used to reduce the absorption of rivaroxaban in cases of overdose.\n5. The use of antidotes for rivaroxaban toxicity should be determined by a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact": [
      "Rivaroxaban is a type of blood thinner medication.",
      "Prothrombin complex concentrate (PCC) can be used as an antidote for rivaroxaban in cases of bleeding or major bleeding events.",
      "PCC contains vitamin K and other clotting factors.",
      "Activated charcoal and sodium bicarbonate may be used to reduce the absorption of rivaroxaban in cases of overdose.",
      "The use of antidotes for rivaroxaban toxicity should be determined by a healthcare professional."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Prothrombin complex concentrate (PCC) does not contain vitamin K but does include other clotting factors.\n4. TRUE (However, the effectiveness of activated charcoal is dependent on how recently the overdose occurred, typically within a few hours of ingestion.)\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 171,
    "user_query": "What is the function of 6SRNA in bacteria?",
    "yulan-chat-2-13b-fp16_response": "6S RNA is a type of RNA molecule found in bacteria that plays a role in the process of ribosome biogenesis. Ribosomes are large complexes of RNA and protein that are responsible for the synthesis of proteins in the cells of all living organisms. In bacteria, ribosomes are composed of a small subunit (16S rRNA) and a large subunit (5S rRNA and 23S rRNA), and the 6S RNA molecule is a component of the large subunit.\nThe function of 6S RNA is not fully understood, but it is thought to play a role in the folding and assembly of the large ribosomal subunit. It may also interact with other ribosomal proteins and RNA molecules to help form the complete ribosome complex.\nOverall, ribosome biogenesis is a complex process that is essential for the survival of bacteria, and the various RNA and protein components of ribosomes play important roles in this process.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 172,
    "user_query": "Is cytisine superior to nicotine replacement therapy for smoking cessation?",
    "yulan-chat-2-13b-fp16_response": "Cytisine and nicotine replacement therapy (NRT) are both effective aids for smoking cessation, but they have different mechanisms of action and may have different advantages and disadvantages depending on the individual.\nCytisine is a natural alkaloid found in the seeds of the Cytisus vernus plant, and it has been used for many years in Russia and some Eastern European countries as an aid for smoking cessation. It works by blocking the receptors in the brain that are normally activated by nicotine, which reduces the craving for cigarettes and the withdrawal symptoms that occur when a person tries to quit smoking.\nNRT, on the other hand, is a synthetic form of nicotine that is available in a variety of forms, including gum, patches, lozenges, and inhalers. It works by providing a steady stream of nicotine to the body, which reduces the craving for cigarettes and eases the withdrawal symptoms.\nStudies have shown that both cytisine and NRT are effective aids for smoking cessation, with success rates ranging from 20% to 30% depending on the product and the individual. However, some studies have suggested that cytisine may be slightly more effective than NRT, with higher quit rates and lower rates of relapse.\nOne advantage of cytisine is that it is a natural substance and has a longer half-life than nicotine, which means it may have a longer-lasting effect on reducing the craving for cigarettes. It is also generally less expensive than NRT and is available in some countries as an over-the-counter product.\nHowever, NRT may be more suitable for some people, particularly those who are heavily dependent on nicotine and need a higher dose of nicotine to help them quit. NRT is also available in a variety of forms, which may be more convenient for some people.\nUltimately, the choice between cytisine and NRT will depend on the individual's preferences, budget, and the availability of the products in their country. It is important to consult with a healthcare professional to determine the best option for quitting smoking.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cytisine is a natural alkaloid found in the seeds of the Cytisus vernus plant.\n2. Cytisine has been used in Russia and some Eastern European countries as an aid for smoking cessation.\n3. Nicotine replacement therapy (NRT) is a synthetic form of nicotine that comes in gum, patches, lozenges, and inhalers.\n4. Studies have indicated that the success rates of cytisine and NRT for smoking cessation range from 20% to 30%.\n5. Cytisine generally has a longer half-life than nicotine and may have a longer-lasting effect on reducing the craving for cigarettes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cytisine is a natural alkaloid found in the seeds of the Cytisus vernus plant.",
      "Cytisine has been used in Russia and some Eastern European countries as an aid for smoking cessation.",
      "Nicotine replacement therapy (NRT) is a synthetic form of nicotine that comes in gum, patches, lozenges, and inhalers.",
      "Studies have indicated that the success rates of cytisine and NRT for smoking cessation range from 20% to 30%.",
      "Cytisine generally has a longer half-life than nicotine and may have a longer-lasting effect on reducing the craving for cigarettes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Cytisine is a natural alkaloid found in the seeds of the Laburnum anagyroides plant, also known as the golden rain tree, not in the seeds of the Cytisus vernus plant.\n2. TRUE\n3. TRUE\n4. UNKNOWN: Without specific studies referenced, the success rates provided cannot be verified as accurate or inaccurate.\n5. FALSE [correction]: Cytisine generally has a shorter half-life than nicotine. It is the stronger binding to nicotinic acetylcholine receptors than nicotine that may contribute to the effect on reducing the craving for cigarettes, not the half-life.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 173,
    "user_query": "Which amino acid residue appears mutated in most of the cases reported with  cadasil syndrome?",
    "yulan-chat-2-13b-fp16_response": "Cadasil syndrome is caused by mutations in the CDSN (cadherin-specificity-related protein) gene, which encodes a protein called cadherin-related organizer of the cytoskeleton (CORC). The majority of mutations reported in Cadasil syndrome involve the amino acid residue Arg301Cys in the CORC protein. This mutation results in the replacement of a positively charged arginine residue with a negatively charged cysteine residue, which disrupts the structure and function of the CORC protein, leading to the development of Cadasil syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cadasil syndrome is caused by mutations in the CDSN gene.\n2. The protein encoded by the CDSN gene is called cadherin-related organizer of the cytoskeleton (CORC).\n3. The majority of mutations reported in Cadasil syndrome involve the amino acid residue Arg301Cys in the CORC protein.\n4. The Arg301Cys mutation results in the replacement of a positively charged arginine residue with a negatively charged cysteine residue.\n5. The Arg301Cys mutation disrupts the structure and function of the CORC protein, leading to the development of Cadasil syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cadasil syndrome is caused by mutations in the CDSN gene.",
      "The protein encoded by the CDSN gene is called cadherin-related organizer of the cytoskeleton (CORC).",
      "The majority of mutations reported in Cadasil syndrome involve the amino acid residue Arg301Cys in the CORC protein.",
      "The Arg301Cys mutation results in the replacement of a positively charged arginine residue with a negatively charged cysteine residue.",
      "The Arg301Cys mutation disrupts the structure and function of the CORC protein, leading to the development of Cadasil syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Cadasil syndrome is caused by mutations in the NOTCH3 gene, not the CDSN gene.\n2. FALSE [correction]: The protein encoded by the NOTCH3 gene is called Notch 3 receptor protein, not cadherin-related organizer of the cytoskeleton (CORC).\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: While the Arg301Cys mutation does result in the replacement of a positively charged arginine residue with a negatively charged cysteine residue, the mutation affects the Notch 3 receptor protein, not a protein called CORC, since the CORC protein is not associated with Cadasil syndrome. The dysfunction of the Notch 3 receptor protein leads to the development of Cadasil syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "yulan-chat-2-13b-fp16_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Clouston Syndrome: A rare genetic disorder characterized by the development of multiple non-cancerous growths on the skin, nails, and bones.\n2. Ataxia-Telangiectasia: A group of genetic disorders characterized by poor coordination, balance problems, and a higher risk of infections.\n3. Sotos Syndrome: A rare genetic disorder characterized by tall stature, large head size, and intellectual disability.\n4. Beckwith-Wiedemann Syndrome: A rare genetic disorder characterized by a wide range of symptoms, including epilepsy, learning difficulties, and an increased risk of developing certain cancers.\n5. Angelman Syndrome: A rare genetic disorder characterized by developmental delay, intellectual disability, and a distinctive facial appearance.\nIt's important to note that mutations in the EZH2 gene can also lead to various types of cancer, including lymphoma, breast cancer, and colon cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Clouston Syndrome is genetically related to mutations in the EZH2 gene.\n2. Ataxia-Telangiectasia is associated with mutations in the EZH2 gene.\n3. Sotos Syndrome is linked to mutations in the EZH2 gene.\n4. Beckwith-Wiedemann Syndrome is connected to mutations in the EZH2 gene.\n5. Angelman Syndrome has an association with mutations in the EZH2 gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "Clouston Syndrome is genetically related to mutations in the EZH2 gene.",
      "Ataxia-Telangiectasia is associated with mutations in the EZH2 gene.",
      "Sotos Syndrome is linked to mutations in the EZH2 gene.",
      "Beckwith-Wiedemann Syndrome is connected to mutations in the EZH2 gene.",
      "Angelman Syndrome has an association with mutations in the EZH2 gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Ataxia-Telangiectasia is associated with mutations in the ATM gene.\n3. FALSE [correction]: Sotos Syndrome is linked to mutations in the NSD1 gene.\n4. UNKNOWN\n5. FALSE [correction]: Angelman Syndrome has an association with mutations in the UBE3A gene.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 175,
    "user_query": "Which databases exist for experimentally determined topologies of -helical transmembrane proteins ?",
    "yulan-chat-2-13b-fp16_response": "There are several databases that contain experimentally determined topologies of -helical transmembrane proteins. Some examples include:\n1. Transmembrane Protein Database (TMDB): This database contains annotated transmembrane protein sequences and structures, including information on the topology of -helical transmembrane proteins.\n2. membrane proteins database (MPD): This database contains annotated membrane protein sequences and structures, including information on the topology of -helical transmembrane proteins.\n3. Protein Data Bank (PDB): The PDB contains a large collection of protein structures, including many transmembrane proteins. Users can search the database for structures of -helical transmembrane proteins using the \"search\" function and filtering by protein type and membrane orientation.\n4. TCDB (Transmembrane protein database): This database provides a comprehensive collection of annotated transmembrane protein sequences and structures, including information on the topology of -helical transmembrane proteins.\n5. Pfam: This is a database of protein families and domains, it includes annotations of transmembrane helices and their topology.\n6. SWISS-MODEL: This is a modeling tool that can be used to build models of transmembrane proteins, including -helical transmembrane proteins, based on known structures of related proteins.\nIt's worth noting that these databases are constantly updated, so the information provided may change over time.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Transmembrane Protein Database (TMDB) contains annotated transmembrane protein sequences and structures, including -helical transmembrane proteins.\n2. The Membrane Proteins Database (MPD) includes annotated sequences and structures of membrane proteins with information on -helical transmembrane protein topology.\n3. The Protein Data Bank (PDB) has a large collection of protein structures, which allows users to search for -helical transmembrane protein structures.\n4. TCDB provides a comprehensive collection of annotated transmembrane protein sequences and structures, including those of -helical transmembrane proteins.\n5. Pfam is a database of protein families and domains that includes annotations of transmembrane helices and their topology.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Transmembrane Protein Database (TMDB) contains annotated transmembrane protein sequences and structures, including -helical transmembrane proteins.",
      "The Membrane Proteins Database (MPD) includes annotated sequences and structures of membrane proteins with information on -helical transmembrane protein topology.",
      "The Protein Data Bank (PDB) has a large collection of protein structures, which allows users to search for -helical transmembrane protein structures.",
      "TCDB provides a comprehensive collection of annotated transmembrane protein sequences and structures, including those of -helical transmembrane proteins.",
      "Pfam is a database of protein families and domains that includes annotations of transmembrane helices and their topology."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The Transporter Classification Database (TCDB) is focused on the classification of transporter proteins based on their structure and function rather than providing a comprehensive collection of annotated transmembrane protein sequences and structures.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 178,
    "user_query": "How is oprozomib administered?",
    "yulan-chat-2-13b-fp16_response": "Oprozomib is an oral proteasome inhibitor that is used to treat multiple myeloma. It is typically administered in a 28-day cycle, with each cycle consisting of four weeks of treatment.\nDuring each week of treatment, the patient takes oprozomib for three days in a row (known as the \"weekly dosing schedule\"). The dosing schedule is designed to allow the drug to be effective against the cancer cells while minimizing the potential side effects.\nOprozomib is usually taken with dexamethasone, a type of steroid that can help reduce inflammation and swelling in the body. The dosage and schedule of oprozomib and dexamethasone may vary depending on the individual patient and their response to treatment.\nIt is important to follow the dosing schedule provided by your healthcare provider and to take the medication as directed to ensure the best possible outcome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Oprozomib is an oral proteasome inhibitor.\n2. Oprozomib is utilized in the treatment of multiple myeloma.\n3. The administration of oprozomib typically follows a 28-day cycle.\n4. The patient takes oprozomib on three consecutive days each week, also referred to as the \"weekly dosing schedule.\"\n5. Oprozomib is commonly taken in combination with dexamethasone, a steroid used to reduce inflammation and swelling.",
    "yulan-chat-2-13b-fp16_fact": [
      "Oprozomib is an oral proteasome inhibitor.",
      "Oprozomib is utilized in the treatment of multiple myeloma.",
      "The administration of oprozomib typically follows a 28-day cycle.",
      "The patient takes oprozomib on three consecutive days each week, also referred to as the \"weekly dosing schedule.\"",
      "Oprozomib is commonly taken in combination with dexamethasone, a steroid used to reduce inflammation and swelling."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 182,
    "user_query": "Does thyroid hormone regulate calcium transient in the myocardium?",
    "yulan-chat-2-13b-fp16_response": "Yes, thyroid hormone does play a role in regulating calcium transients in the myocardium, which is the muscle tissue of the heart. Thyroid hormone is known to increase the contractility of the heart muscle, and it does so by increasing the sensitivity of the myocardium to calcium.\nWhen thyroid hormone binds to its receptors in the myocardium, it activates a signaling pathway that leads to an increase in the number and sensitivity of calcium channels in the muscle cells. This results in an increased influx of calcium ions during each heartbeat, which in turn leads to greater contraction of the muscle fibers.\nIn addition to its direct effects on calcium transients, thyroid hormone also has indirect effects on the heart muscle by regulating other factors that influence myocardial contractility, such as the expression of contractile proteins and the activity of energy-producing enzymes.\nOverall, thyroid hormone plays an important role in maintaining the proper functioning of the myocardium and ensuring that the heart can pump blood efficiently.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyroid hormone helps regulate calcium transients in the myocardium, the muscle tissue of the heart.\n2. Increased sensitivity of the myocardium to calcium is an effect of thyroid hormone on heart contractility.\n3. Thyroid hormone increases the number and sensitivity of calcium channels in myocardial cells.\n4. This increase in calcium channels leads to an increased influx of calcium ions during each heartbeat.\n5. Thyroid hormone influences myocardial contractility by affecting the expression of contractile proteins and the activity of energy-producing enzymes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyroid hormone helps regulate calcium transients in the myocardium, the muscle tissue of the heart.",
      "Increased sensitivity of the myocardium to calcium is an effect of thyroid hormone on heart contractility.",
      "Thyroid hormone increases the number and sensitivity of calcium channels in myocardial cells.",
      "This increase in calcium channels leads to an increased influx of calcium ions during each heartbeat.",
      "Thyroid hormone influences myocardial contractility by affecting the expression of contractile proteins and the activity of energy-producing enzymes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Thyroid hormone plays a role in regulating calcium transients in the myocardium, which is crucial for cardiac muscle contraction.\n2. TRUE: Thyroid hormone can increase the sensitivity of the myocardium to calcium, thus affecting heart contractility.\n3. TRUE: Thyroid hormone increases the number and sensitivity of calcium channels in myocardial cells, contributing to its effects on heart function.\n4. TRUE: The increase in calcium channels due to thyroid hormone leads to an increased influx of calcium ions during each heartbeat, contributing to stronger heart contractions.\n5. TRUE: Thyroid hormone does influence myocardial contractility by affecting the expression of contractile proteins and the activity of enzymes involved in energy production, thus impacting the strength and efficiency of heart muscle contractions.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 185,
    "user_query": "The protein NONO forms heterodimers. With which proteins?",
    "yulan-chat-2-13b-fp16_response": "NONO (Nucleolar complex protein 66 homolog, Nop10 homolog, Oza1-related factor, and Nucleic acid-binding protein 1) is a protein that is involved in various cellular processes, including DNA repair, telomere maintenance, and transcription regulation. NONO is known to form heterodimers with several proteins, including:\n1. PIC1 (Protein IC1): PIC1 is a protein that interacts with NONO and is involved in the regulation of telomerase activity.\n2. HDAC1 (Histone deacetylase 1): HDAC1 is a protein that interacts with NONO and is involved in the regulation of transcription and chromatin structure.\n3. TIN2 (Transformation/transcription domain-associated protein 2): TIN2 is a protein that interacts with NONO and is involved in the regulation of telomere length and stability.\n4. NHP2 (Non-histone protein H2A/H2B-like 2): NHP2 is a protein that interacts with NONO and is involved in the regulation of telomere length and stability.\nThese interactions between NONO and other proteins are important for the regulation of various cellular processes and suggest that NONO plays a key role in maintaining the stability and integrity of the genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NONO forms heterodimers with the protein PIC1, which is involved in the regulation of telomerase activity.\n2. NONO forms heterodimers with HDAC1, which is involved in the regulation of transcription and chromatin structure.\n3. NONO forms heterodimers with TIN2, which is involved in the regulation of telomere length and stability.\n4. NONO forms heterodimers with NHP2, which is involved in the regulation of telomere length and stability.",
    "yulan-chat-2-13b-fp16_fact": [
      "NONO forms heterodimers with the protein PIC1, which is involved in the regulation of telomerase activity.",
      "NONO forms heterodimers with HDAC1, which is involved in the regulation of transcription and chromatin structure.",
      "NONO forms heterodimers with TIN2, which is involved in the regulation of telomere length and stability.",
      "NONO forms heterodimers with NHP2, which is involved in the regulation of telomere length and stability."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: Without specific scientific literature or source material, the role of NONO protein in forming heterodimers with PIC1 and its involvement in the regulation of telomerase activity cannot be confirmed or denied.\n2. TRUE: NONO, also known as Non-POU domain-containing octamer-binding protein, is known to interact with various proteins, including HDAC1 (Histone Deacetylase 1). They do play a role in the regulation of transcription and chromatin structure.\n3. UNKNOWN: The interaction between NONO and TIN2 (TRF1-interacting nuclear factor 2), particularly in the context of forming heterodimers and the regulation of telomere length and stability, would require specific references to confirm or refute.\n4. UNKNOWN: The role of NONO in forming heterodimers with NHP2, especially concerning telomere length and stability regulation, requires scientific evidence to support or correct the statement.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 188,
    "user_query": "Is there any link between CTF4 and CTF18 during sister chromatid cohesion?",
    "yulan-chat-2-13b-fp16_response": "Cohesin complex proteins CTF4 and CTF18 play important roles in sister chromatid cohesion, which is the process by which sister chromatids are held together during mitosis and meiosis. CTF4 and CTF18 are part of the cohesin complex, which is a large protein complex that forms a ring around sister chromatids and holds them together.\nCTF4 and CTF18 are both part of the core cohesin complex, which consists of four proteins: Smc2, Smc3, Ctf4, and Ctf18. The core cohesin complex is responsible for establishing and maintaining sister chromatid cohesion.\nDuring mitosis, the cohesin complex is recruited to the centromere region of the chromosome, where it helps to separate the sister chromatids during the process of cell division. In meiosis, the cohesin complex is responsible for holding sister chromatids together until they are ready to be separated by the spindle fibers.\nOverall, the cohesin complex, including CTF4 and CTF18, is essential for maintaining the integrity of sister chromatids during mitosis and meiosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The cohesin complex proteins CTF4 and CTF18 are involved in sister chromatid cohesion.\n2. Sister chromatid cohesion is the process by which sister chromatids are held together during mitosis and meiosis.\n3. The cohesin complex forms a ring around sister chromatids to hold them together.\n4. The core cohesin complex includes the proteins Smc2, Smc3, Ctf4, and Ctf18.\n5. The cohesin complex aids in the separation of sister chromatids during cell division in mitosis and holds them together until they separate in meiosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "The cohesin complex proteins CTF4 and CTF18 are involved in sister chromatid cohesion.",
      "Sister chromatid cohesion is the process by which sister chromatids are held together during mitosis and meiosis.",
      "The cohesin complex forms a ring around sister chromatids to hold them together.",
      "The core cohesin complex includes the proteins Smc2, Smc3, Ctf4, and Ctf18.",
      "The cohesin complex aids in the separation of sister chromatids during cell division in mitosis and holds them together until they separate in meiosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The cohesin complex proteins CTF4 and CTF18 are not directly involved in sister chromatid cohesion. CTF18 is related to a complex involved in DNA replication, while CTF4 is associated with DNA replication and the maintenance of genome stability, rather than the cohesin complex.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The core cohesin complex includes the proteins Smc1, Smc3, Scc1 (also known as Rad21), and Scc3. Ctf4 and Ctf18 are not part of the core cohesin complex.\n5. FALSE [correction]: The cohesin complex aids in keeping sister chromatids together and ensures their proper separation during mitosis. During meiosis, cohesin holds sister chromatids together until they separate in Anaphase II, not during the entire process of cell division.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "yulan-chat-2-13b-fp16_response": "There are several human proteins that undergo a dimer-to-tetramer transition, including:\n1. Hemoglobin: Hemoglobin is a tetramer composed of four subunits, each of which is a heme group that can bind to an oxygen molecule. In the presence of low oxygen pressure, hemoglobin can dissociate into two dimers, each composed of two subunits.\n2. Insulin: Insulin is a hormone that regulates glucose metabolism. It is a dimer composed of two peptide chains, A and B, that are linked by two disulfide bonds. In the presence of certain chemicals or conditions, insulin can form a tetramer composed of two A and two B chains.\n3. Transforming growth factor beta (TGF-): TGF- is a cytokine that regulates cell growth and differentiation. It is a dimer composed of two identical subunits that are linked by two disulfide bonds. In the presence of certain proteases, TGF- can be cleaved to form two active monomers that can then form a tetramer.\n4. Immunoglobulin E (IgE): IgE is an antibody that plays a role in allergic reactions. It is a tetramer composed of four subunits, each of which is a heavy chain and a light chain that are linked by disulfide bonds. In the presence of certain proteases, IgE can be cleaved to form two active dimers.\n5. Interleukin-2 (IL-2): IL-2 is a cytokine that regulates immune cell proliferation and differentiation. It is a dimer composed of two identical subunits that are linked by two disulfide bonds. In the presence of certain proteases, IL-2 can be cleaved to form two active monomers that can then form a tetramer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hemoglobin can undergo a dimer-to-tetramer transition.\n2. Insulin exists as a dimer and can form a tetramer under certain conditions.\n3. Transforming growth factor beta (TGF-) is normally a dimer and can be cleaved to form monomers, which can then form a tetramer.\n4. Immunoglobulin E (IgE) is typically a tetramer that can be cleaved to form active dimers.\n5. Interleukin-2 (IL-2) can transition from a dimer to a tetramer in the presence of certain proteases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hemoglobin can undergo a dimer-to-tetramer transition.",
      "Insulin exists as a dimer and can form a tetramer under certain conditions.",
      "Transforming growth factor beta (TGF-) is normally a dimer and can be cleaved to form monomers, which can then form a tetramer.",
      "Immunoglobulin E (IgE) is typically a tetramer that can be cleaved to form active dimers.",
      "Interleukin-2 (IL-2) can transition from a dimer to a tetramer in the presence of certain proteases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Hemoglobin normally exists as a tetramer, not as a dimer transitioning to a tetramer.\n2. TRUE\n3. FALSE [correction]: Transforming growth factor-beta (TGF-) is typically secreted as an inactive, latency-associated peptide-bound small latent complex that requires activation; the active form is generally a dimer, not a monomer or tetramer.\n4. FALSE [correction]: Immunoglobulin E (IgE) is typically a monomer rather than a tetramer, and it does not cleave into active dimers.\n5. FALSE [correction]: Interleukin-2 (IL-2) is a cytokine that typically exists as a monomer, not a dimer that can transition to a tetramer in the presence of certain proteases.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 197,
    "user_query": "Which gene strand is targeted by transcription-coupled repair (TCR)?",
    "yulan-chat-2-13b-fp16_response": "Transcription-coupled repair (TCR) targets both strands of DNA, the coding strand and the non-coding strand. TCR is a DNA repair mechanism that occurs during transcription, and it helps to repair DNA damage that occurs during the synthesis of new DNA strands. This repair process is important for maintaining the integrity of the genome and preventing mutations that could lead to diseases such as cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Transcription-coupled repair (TCR) targets both the coding strand and the non-coding strand of DNA.\n2. TCR is a DNA repair mechanism that occurs during transcription.\n3. TCR helps to repair DNA damage that occurs during the synthesis of new DNA strands.\n4. The repair process of TCR is important for maintaining the integrity of the genome.\n5. TCR helps in preventing mutations that could lead to diseases such as cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Transcription-coupled repair (TCR) targets both the coding strand and the non-coding strand of DNA.",
      "TCR is a DNA repair mechanism that occurs during transcription.",
      "TCR helps to repair DNA damage that occurs during the synthesis of new DNA strands.",
      "The repair process of TCR is important for maintaining the integrity of the genome.",
      "TCR helps in preventing mutations that could lead to diseases such as cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Transcription-coupled repair (TCR) preferentially targets the coding strand, which is being transcribed, as opposed to the non-coding strand which is not typically being transcribed.\n2. TRUE\n3. FALSE [correction]: TCR helps to repair DNA damage that blocks transcription, not damage that occurs during the synthesis of new DNA strands, which is typically addressed by replication-associated repair mechanisms.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 199,
    "user_query": "Which is the branch site consensus sequence in U12-dependent introns?",
    "yulan-chat-2-13b-fp16_response": "The branch site consensus sequence in U12-dependent introns is usually defined as a 5' end sequence of the intron, which is recognized by the U12 spliceosomal RNA and its associated proteins during splicing. The consensus sequence is typically defined as a 10-12 nucleotide sequence that is present in the 5' end of most U12-dependent introns. The consensus sequence is important for the recognition and binding of the U12 spliceosome to the intron, and it plays a key role in the splicing process. The exact sequence of the branch site consensus sequence can vary between different introns, but it typically contains a number of conserved nucleotides that are important for spliceosome binding and splicing.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The branch site consensus sequence in U12-dependent introns is typically a 10-12 nucleotide sequence.\n2. This sequence is located at the 5' end of most U12-dependent introns.\n3. The U12 spliceosomal RNA and its associated proteins recognize the branch site consensus sequence during splicing.\n4. The branch site consensus sequence is important for the recognition and binding of the U12 spliceosome to the intron.\n5. The sequence plays a key role in the splicing process.",
    "yulan-chat-2-13b-fp16_fact": [
      "The branch site consensus sequence in U12-dependent introns is typically a 10-12 nucleotide sequence.",
      "This sequence is located at the 5' end of most U12-dependent introns.",
      "The U12 spliceosomal RNA and its associated proteins recognize the branch site consensus sequence during splicing.",
      "The branch site consensus sequence is important for the recognition and binding of the U12 spliceosome to the intron.",
      "The sequence plays a key role in the splicing process."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The branch site consensus sequence in U12-dependent introns is typically a 6-8 nucleotide sequence.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 201,
    "user_query": "What is the suggested therapy for Mycobacterium avium infection?",
    "yulan-chat-2-13b-fp16_response": "Mycobacterium avium is a type of bacteria that can cause infections in humans. The suggested therapy for Mycobacterium avium infection typically involves a combination of antibiotics, such as clarithromycin, ethambutol, and rifabutin. These medications are usually taken for an extended period of time, often several months, to ensure that the infection is fully treated. In some cases, other antibiotics may be used instead or in addition to these medications. It is important to follow the treatment plan prescribed by a healthcare provider and to take all of the medication as directed to ensure that the infection is fully treated and does not become resistant to the antibiotics.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mycobacterium avium is a type of bacteria that can cause infections in humans.\n2. The therapy for Mycobacterium avium infection typically involves a combination of antibiotics.\n3. Clarithromycin, ethambutol, and rifabutin are antibiotics used in the treatment of Mycobacterium avium infection.\n4. The medications for Mycobacterium avium infection are usually taken for an extended period of time, often several months.\n5. It is important to take all of the medication as directed to prevent the infection from becoming resistant to the antibiotics.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mycobacterium avium is a type of bacteria that can cause infections in humans.",
      "The therapy for Mycobacterium avium infection typically involves a combination of antibiotics.",
      "Clarithromycin, ethambutol, and rifabutin are antibiotics used in the treatment of Mycobacterium avium infection.",
      "The medications for Mycobacterium avium infection are usually taken for an extended period of time, often several months.",
      "It is important to take all of the medication as directed to prevent the infection from becoming resistant to the antibiotics."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "yulan-chat-2-13b-fp16_response": "One protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is B-cell lymphoma-2 (Bcl-2). Bcl-2 is a protein that plays a crucial role in regulating programmed cell death or apoptosis. It prevents the release of cytochrome c from mitochondria, which is a key event in the initiation of apoptosis. Phospholamban has been shown to interact with Bcl-2 and enhance its anti-apoptotic activity, thereby protecting cells from apoptosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. B-cell lymphoma-2 (Bcl-2) interacts with phospholamban (PLN).\n2. B-cell lymphoma-2 (Bcl-2) is an anti-apoptotic protein.\n3. Bcl-2 plays a role in regulating programmed cell death, also known as apoptosis.\n4. Bcl-2 prevents the release of cytochrome c from mitochondria.\n5. The interaction between phospholamban and Bcl-2 enhances the anti-apoptotic activity of Bcl-2.",
    "yulan-chat-2-13b-fp16_fact": [
      "B-cell lymphoma-2 (Bcl-2) interacts with phospholamban (PLN).",
      "B-cell lymphoma-2 (Bcl-2) is an anti-apoptotic protein.",
      "Bcl-2 plays a role in regulating programmed cell death, also known as apoptosis.",
      "Bcl-2 prevents the release of cytochrome c from mitochondria.",
      "The interaction between phospholamban and Bcl-2 enhances the anti-apoptotic activity of Bcl-2."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: The statement is specific and requires knowledge of the molecular interactions between proteins. Without specific scientific evidence or a supporting study reference, the truth of this statement cannot be determined.\n2. TRUE: B-cell lymphoma-2 (Bcl-2) is indeed known as an anti-apoptotic protein that inhibits cell death.\n3. TRUE: Bcl-2 does have a role in regulating apoptosis, which is programmed cell death.\n4. TRUE: One of the mechanisms through which Bcl-2 exerts its anti-apoptotic effect is by preventing the release of cytochrome c from the mitochondria, which is a step in the apoptosis pathway.\n5. UNKNOWN: As with the first statement, without specific scientific literature or evidence, the truth of the statement about the interaction enhancing the anti-apoptotic activity cannot be determined.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 213,
    "user_query": "Is protein M3/6 a dual specificity phosphatase?",
    "yulan-chat-2-13b-fp16_response": "Protein M3/6 is a dual-specificity phosphatase. Dual-specificity phosphatases are enzymes that can hydrolyze both orthophosphate groups from inorganic pyrophosphate, as well as from organic phosphate esters in proteins and other molecules. They play important roles in various cellular processes, including signal transduction, metabolism, and transcriptional regulation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Protein M3/6 is a dual-specificity phosphatase.\n2. Dual-specificity phosphatases can hydrolyze orthophosphate groups from inorganic pyrophosphate.\n3. Dual-specificity phosphatases can hydrolyze phosphate esters in proteins and other molecules.\n4. Dual-specificity phosphatases are involved in cellular processes such as signal transduction.\n5. Dual-specificity phosphatases play roles in metabolism and transcriptional regulation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Protein M3/6 is a dual-specificity phosphatase.",
      "Dual-specificity phosphatases can hydrolyze orthophosphate groups from inorganic pyrophosphate.",
      "Dual-specificity phosphatases can hydrolyze phosphate esters in proteins and other molecules.",
      "Dual-specificity phosphatases are involved in cellular processes such as signal transduction.",
      "Dual-specificity phosphatases play roles in metabolism and transcriptional regulation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Dual-specificity phosphatases can hydrolyze phosphomonoester bonds within proteins and other molecules, not from inorganic pyrophosphate.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "yulan-chat-2-13b-fp16_response": "Yes, several clinical trials have suggested that vitamin D supplementation may reduce the incidence of falls in older people.\nA meta-analysis of 26 randomized controlled trials involving a total of 20,105 participants, published in the Journal of Clinical Endocrinology and Metabolism in 2017, found that vitamin D supplementation was associated with a 22% reduction in the risk of falls compared to placebo.\nAnother meta-analysis of 10 randomized controlled trials involving a total of 44,642 participants, published in the Journal of the American Medical Association in 2018, found that vitamin D supplementation was associated with a 19% reduction in the risk of falls compared to placebo.\nHowever, it's worth noting that the evidence is not consistent, and some studies have found no significant effect of vitamin D supplementation on falls. Additionally, the optimal dose and duration of vitamin D supplementation to reduce falls is still not clear, and more research is needed to confirm the findings.\nOverall, while vitamin D supplementation may have a role in reducing falls in older people, it's important to discuss this with a healthcare professional before starting any supplements, as there may be potential risks and side effects.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Clinical trials have suggested that vitamin D supplementation may reduce the incidence of falls in older people.\n2. A meta-analysis published in the Journal of Clinical Endocrinology and Metabolism in 2017 analyzed 26 randomized controlled trials with 20,105 participants.\n3. The 2017 meta-analysis found a 22% reduction in the risk of falls with vitamin D supplementation compared to placebo.\n4. A meta-analysis in the Journal of the American Medical Association in 2018 included 10 randomized controlled trials with 44,642 participants.\n5. The 2018 meta-analysis reported a 19% reduction in the risk of falls with vitamin D supplementation compared to placebo.",
    "yulan-chat-2-13b-fp16_fact": [
      "Clinical trials have suggested that vitamin D supplementation may reduce the incidence of falls in older people.",
      "A meta-analysis published in the Journal of Clinical Endocrinology and Metabolism in 2017 analyzed 26 randomized controlled trials with 20,105 participants.",
      "The 2017 meta-analysis found a 22% reduction in the risk of falls with vitamin D supplementation compared to placebo.",
      "A meta-analysis in the Journal of the American Medical Association in 2018 included 10 randomized controlled trials with 44,642 participants.",
      "The 2018 meta-analysis reported a 19% reduction in the risk of falls with vitamin D supplementation compared to placebo."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: The 2017 meta-analysis found a 14% reduction, not a 22% reduction, in the risk of falls with vitamin D supplementation compared to placebo.\n4. UNKNOWN\n5. FALSE [correction]: The 2018 meta-analysis reported no significant reduction in the risk of falls with vitamin D supplementation compared to placebo.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 221,
    "user_query": "What is the generic name of Gliolan?",
    "yulan-chat-2-13b-fp16_response": "Gliolan is a type of extracellular matrix protein that is involved in the formation and maintenance of the extracellular matrix in various tissues, including the brain, heart, and skin. The generic name for Gliolan is \"glycosaminoglycan\" or \"GAG\".",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells. Jarid2 is a histone demethylase that regulates the differentiation of T helper 17 (Th17) cells, and miR-155 is a microRNA that has been shown to be involved in the regulation of Th17 cell differentiation. Studies have shown that Jarid2 regulates the expression of miR-155 in Th17 cells, and that miR-155 in turn regulates the expression of key transcription factors that are involved in Th17 cell differentiation, such as RORgt and IL-17A. Therefore, the association between Jarid2 and miR-155 in Th17 cells plays an important role in the regulation of Th17 cell differentiation and function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Jarid2 is a histone demethylase that plays a role in the differentiation of T helper 17 (Th17) cells.\n2. miR-155 is a microRNA that is involved in the regulation of Th17 cell differentiation.\n3. Jarid2 regulates the expression of miR-155 in Th17 cells.\n4. miR-155 affects the expression of key transcription factors involved in Th17 cell differentiation, including RORgt and IL-17A.",
    "yulan-chat-2-13b-fp16_fact": [
      "Jarid2 is a histone demethylase that plays a role in the differentiation of T helper 17 (Th17) cells.",
      "miR-155 is a microRNA that is involved in the regulation of Th17 cell differentiation.",
      "Jarid2 regulates the expression of miR-155 in Th17 cells.",
      "miR-155 affects the expression of key transcription factors involved in Th17 cell differentiation, including RORgt and IL-17A."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Jarid2 is a component of the Polycomb Repressor Complex 2 (PRC2) and does not have histone demethylase activity itself; it is involved in the regulation of gene expression, including roles in the differentiation of T helper 17 (Th17) cells.\n2. TRUE\n3. UNKNOWN: Without specific information from the passage indicating that Jarid2 regulates miR-155 in Th17 cells, we cannot conclusively determine the veracity of this statement.\n4. TRUE: miR-155 has been shown to affect the expression of various genes including those encoding key transcription factors involved in the differentiation of Th17 cells, such as RORt (RORc) and IL-17A.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "yulan-chat-2-13b-fp16_response": "The human HoxD cluster contains 10 genes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The human HoxD cluster contains 10 genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The human HoxD cluster contains 10 genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The human HoxD cluster contains 9 genes.",
    "yulan-chat-2-13b-fp16_judge": [
      "false"
    ]
  },
  {
    "id": 229,
    "user_query": "Which are the human glutamate transporters?",
    "yulan-chat-2-13b-fp16_response": "Human glutamate transporters are a family of proteins that are responsible for transporting the neurotransmitter glutamate out of the synapse and into the extracellular space. There are three main types of glutamate transporters in humans:\n1. Solute carrier family 12 member 2 (SLC12A2): Also known as the excitatory amino acid transporter 2 (EAAT2), this transporter is found primarily in the brain and is responsible for transporting glutamate into astrocytes, which are supportive cells in the brain.\n2. Solute carrier family 12 member 3 (SLC12A3): Also known as the excitatory amino acid transporter 3 (EAAT3), this transporter is found primarily in the brain and is responsible for transporting glutamate into astrocytes.\n3. Solute carrier family 12 member 5 (SLC12A5): Also known as the excitatory amino acid transporter 5 (EAAT5), this transporter is found primarily in the brain and is responsible for transporting glutamate into astrocytes.\nThese transporters play a crucial role in regulating the levels of glutamate in the brain, which is important for maintaining proper neurotransmission and preventing neurotoxicity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Human glutamate transporters transport the neurotransmitter glutamate out of the synapse and into the extracellular space.\n2. There are three main types of glutamate transporters in humans: SLC12A2 (EAAT2), SLC12A3 (EAAT3), and SLC12A5 (EAAT5).\n3. The SLC12A2 (EAAT2) transporter is primarily found in the brain and transports glutamate into astrocytes.\n4. The SLC12A3 (EAAT3) transporter is also predominantly located in the brain and is involved in the transportation of glutamate into astrocytes.\n5. The SLC12A5 (EAAT5) transporter is primarily found in the brain and facilitates the transport of glutamate into astrocytes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Human glutamate transporters transport the neurotransmitter glutamate out of the synapse and into the extracellular space.",
      "There are three main types of glutamate transporters in humans: SLC12A2 (EAAT2), SLC12A3 (EAAT3), and SLC12A5 (EAAT5).",
      "The SLC12A2 (EAAT2) transporter is primarily found in the brain and transports glutamate into astrocytes.",
      "The SLC12A3 (EAAT3) transporter is also predominantly located in the brain and is involved in the transportation of glutamate into astrocytes.",
      "The SLC12A5 (EAAT5) transporter is primarily found in the brain and facilitates the transport of glutamate into astrocytes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Human glutamate transporters transport the neurotransmitter glutamate out of the extracellular space and into neurons and glial cells, not out of the synapse into the extracellular space.\n2. FALSE [correction]: The correct gene names for the three main types of glutamate transporters in humans are SLC1A2 (EAAT2), SLC1A3 (EAAT3), and SLC1A6 (EAAT4), not SLC12A2, SLC12A3, and SLC12A5. Additionally, there are five types of EAATs, not three, which are EAAT1 (GLAST/SLC1A3), EAAT2 (GLT-1/SLC1A2), EAAT3 (EAAC1/SLC1A1), EAAT4 (SLC1A6), and EAAT5 (SLC1A7).\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The SLC1A7 (EAAT5) transporter is primarily found in the retina, not the brain, and is involved in the transportation of glutamate into retinal cells.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 235,
    "user_query": "What is the causative agent of the \"Panama disease\" affecting bananas?",
    "yulan-chat-2-13b-fp16_response": "The causative agent of Panama disease, which is a fungal disease that affects bananas, is Fusarium oxysporum f.sp. cubense. This fungus attacks the roots of banana plants, causing them to rot and eventually die. Panama disease is one of the most devastating banana diseases in the world and has had a significant impact on banana production and trade.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Panama disease is a fungal disease that affects banana plants.\n2. The causative agent of Panama disease is Fusarium oxysporum f.sp. cubense.\n3. Fusarium oxysporum f.sp. cubense attacks the roots of banana plants, leading to rot.\n4. Panama disease has had a significant impact on banana production and trade.",
    "yulan-chat-2-13b-fp16_fact": [
      "Panama disease is a fungal disease that affects banana plants.",
      "The causative agent of Panama disease is Fusarium oxysporum f.sp. cubense.",
      "Fusarium oxysporum f.sp. cubense attacks the roots of banana plants, leading to rot.",
      "Panama disease has had a significant impact on banana production and trade."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 237,
    "user_query": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with the term \"Mercedes Benz syndrome\" in the context of synostosis of cranial structures. Synostosis is a congenital anomaly in which two or more bones in the skull are fused together, but it is not specific to any particular medical condition or syndrome. It can occur in a variety of different conditions, including craniosynostosis, which is a type of congenital abnormality in which the bones of the skull are fused prematurely, affecting the shape of the head and potentially causing other symptoms such as developmental delays and vision problems. If you have more specific information about the Mercedes Benz syndrome, I may be able to provide more information.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Synostosis is a congenital anomaly in which two or more bones in the skull are fused together.\n2. Synostosis is not specific to any particular medical condition or syndrome.\n3. Craniosynostosis is a type of congenital abnormality where skull bones fuse prematurely.\n4. Craniosynostosis affects the shape of the head.\n5. Craniosynostosis can potentially cause developmental delays and vision problems.",
    "yulan-chat-2-13b-fp16_fact": [
      "Synostosis is a congenital anomaly in which two or more bones in the skull are fused together.",
      "Synostosis is not specific to any particular medical condition or syndrome.",
      "Craniosynostosis is a type of congenital abnormality where skull bones fuse prematurely.",
      "Craniosynostosis affects the shape of the head.",
      "Craniosynostosis can potentially cause developmental delays and vision problems."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Synostosis can be associated with specific medical conditions or syndromes, such as craniosynostosis syndromes.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 242,
    "user_query": "What is a mitochondrial nucleoid?",
    "yulan-chat-2-13b-fp16_response": "A mitochondrial nucleoid is a structure within the mitochondria of eukaryotic cells that serves as a storage site for the mitochondrial DNA (mtDNA). The nucleoid is composed of a matrix of proteins and DNA, and is the site where the mtDNA is replicated and transcribed. The mitochondrial nucleoid is similar in structure and function to the nucleus of a cell, which contains the cell's DNA and is the site of DNA replication and transcription. However, the mitochondrial nucleoid is much smaller and less complex than the nucleus, and is located within the mitochondria rather than in the cell nucleus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A mitochondrial nucleoid is a structure within mitochondria that stores mitochondrial DNA (mtDNA).\n2. The mitochondrial nucleoid consists of a matrix of proteins and DNA.\n3. Mitochondrial DNA replication and transcription occur at the mitochondrial nucleoid.\n4. In eukaryotic cells, the mitochondrial nucleoid is similar in function to the cell nucleus, where DNA replication and transcription take place.\n5. The mitochondrial nucleoid is smaller and less complex than the cell nucleus and is located within the mitochondria.",
    "yulan-chat-2-13b-fp16_fact": [
      "A mitochondrial nucleoid is a structure within mitochondria that stores mitochondrial DNA (mtDNA).",
      "The mitochondrial nucleoid consists of a matrix of proteins and DNA.",
      "Mitochondrial DNA replication and transcription occur at the mitochondrial nucleoid.",
      "In eukaryotic cells, the mitochondrial nucleoid is similar in function to the cell nucleus, where DNA replication and transcription take place.",
      "The mitochondrial nucleoid is smaller and less complex than the cell nucleus and is located within the mitochondria."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE [clarification]: While the mitochondrial nucleoid and the cell nucleus both are sites where DNA replication and transcription occur, they are quite distinct in their functions, structure, and evolutionary origins. The cell nucleus houses the majority of a eukaryotic cell's genetic material and is involved in regulating numerous cell functions and the cell cycle. The mitochondrial nucleoid serves a more specialized role in mitochondrial DNA maintenance and gene expression within the mitochondrion. \n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 247,
    "user_query": "What is the effect of ivabradine in heart failure with preserved ejection fraction?",
    "yulan-chat-2-13b-fp16_response": "Ivabradine is a medication that is used to treat heart failure with reduced ejection fraction. It works by slowing down the heart rate, which can help to reduce the workload on the heart and improve symptoms of heart failure. In patients with heart failure and preserved ejection fraction, ivabradine may also be effective in improving symptoms and quality of life. However, more research is needed to fully understand its effects in this population. It is important to note that ivabradine should only be used under the supervision of a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ivabradine is used to treat heart failure with reduced ejection fraction.\n2. Ivabradine works by slowing down the heart rate.\n3. Ivabradine may help reduce the workload on the heart.\n4. Ivabradine may improve symptoms and quality of life in patients with heart failure and preserved ejection fraction.\n5. Ivabradine should only be used under the supervision of a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ivabradine is used to treat heart failure with reduced ejection fraction.",
      "Ivabradine works by slowing down the heart rate.",
      "Ivabradine may help reduce the workload on the heart.",
      "Ivabradine may improve symptoms and quality of life in patients with heart failure and preserved ejection fraction.",
      "Ivabradine should only be used under the supervision of a healthcare professional."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Ivabradine has not been proven to improve symptoms and quality of life in patients with heart failure with preserved ejection fraction (HFpEF); its benefits have been primarily demonstrated in patients with heart failure with reduced ejection fraction (HFrEF).\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 248,
    "user_query": "Is low T3 syndrome a prognostic marker in patients with renal insufficiency?",
    "yulan-chat-2-13b-fp16_response": "Low T3 syndrome, also known as T3 syndrome, is a condition characterized by low levels of triiodothyronine (T3), a thyroid hormone, in the blood. It is not a prognostic marker in patients with renal insufficiency, meaning that it does not predict the outcome or progression of the disease. However, low T3 levels may be a symptom of underlying thyroid dysfunction, which can have an impact on overall health and well-being. It is important for individuals with low T3 syndrome to work with their healthcare provider to address any underlying thyroid issues and manage their symptoms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Low T3 syndrome is characterized by low levels of triiodothyronine (T3) in the blood.\n2. Low T3 syndrome is not a prognostic marker in patients with renal insufficiency.\n3. Low T3 levels can be a symptom of underlying thyroid dysfunction.",
    "yulan-chat-2-13b-fp16_fact": [
      "Low T3 syndrome is characterized by low levels of triiodothyronine (T3) in the blood.",
      "Low T3 syndrome is not a prognostic marker in patients with renal insufficiency.",
      "Low T3 levels can be a symptom of underlying thyroid dysfunction."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Low T3 syndrome can be a prognostic marker in patients with renal insufficiency.\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 254,
    "user_query": "Which is the relation between sweating and anaerobic threshold?",
    "yulan-chat-2-13b-fp16_response": "Sweating and anaerobic threshold are related in that sweating is one of the physiological responses that occurs during exercise when an individual approaches or exceeds their anaerobic threshold.\nThe anaerobic threshold is the point during exercise beyond which the body is unable to produce enough energy through aerobic metabolism and begins to rely on anaerobic metabolism. Anaerobic metabolism produces energy more quickly, but it is less efficient and results in the accumulation of metabolic waste products, such as lactic acid, which can lead to fatigue and discomfort.\nAs an individual approaches their anaerobic threshold, their body temperature increases, and they may begin to sweat in an attempt to regulate their body temperature. Sweating helps to cool the body by promoting the evaporation of sweat from the skin, which reduces the body's core temperature.\nIn addition to sweating, other physiological responses that occur during exercise when an individual approaches their anaerobic threshold include an increase in heart rate, breathing rate, and blood pressure. These responses are part of the body's natural adaptation to the increased demand for oxygen and energy during exercise.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Sweating is a physiological response that occurs during exercise when an individual approaches or exceeds their anaerobic threshold.\n2. The anaerobic threshold is the point during exercise beyond which the body begins to rely on anaerobic metabolism.\n3. Anaerobic metabolism leads to the accumulation of metabolic waste products, such as lactic acid.\n4. Sweating helps to cool the body by promoting the evaporation of sweat from the skin.\n5. Approaching the anaerobic threshold can also lead to an increase in heart rate, breathing rate, and blood pressure.",
    "yulan-chat-2-13b-fp16_fact": [
      "Sweating is a physiological response that occurs during exercise when an individual approaches or exceeds their anaerobic threshold.",
      "The anaerobic threshold is the point during exercise beyond which the body begins to rely on anaerobic metabolism.",
      "Anaerobic metabolism leads to the accumulation of metabolic waste products, such as lactic acid.",
      "Sweating helps to cool the body by promoting the evaporation of sweat from the skin.",
      "Approaching the anaerobic threshold can also lead to an increase in heart rate, breathing rate, and blood pressure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 256,
    "user_query": "What is the mode of action of bedaquiline?",
    "yulan-chat-2-13b-fp16_response": "Bedaquiline is an antibiotic that is used to treat tuberculosis (TB). It works by interfering with the ability of the bacteria that cause TB to produce a component of their cell walls, which is necessary for their growth and survival. By inhibiting this process, bedaquiline can help to kill the bacteria and reduce the severity of the infection. It is usually used in combination with other TB drugs to ensure that the bacteria are eliminated completely.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bedaquiline is an antibiotic used to treat tuberculosis (TB).\n2. It interferes with the ability of the TB-causing bacteria to produce a component of their cell walls.\n3. The interference with cell wall production is necessary for the bacteria's growth and survival.\n4. Bedaquiline works by inhibiting a process to help kill the bacteria.\n5. Bedaquiline is usually used in combination with other TB drugs.",
    "yulan-chat-2-13b-fp16_fact": [
      "Bedaquiline is an antibiotic used to treat tuberculosis (TB).",
      "It interferes with the ability of the TB-causing bacteria to produce a component of their cell walls.",
      "The interference with cell wall production is necessary for the bacteria's growth and survival.",
      "Bedaquiline works by inhibiting a process to help kill the bacteria.",
      "Bedaquiline is usually used in combination with other TB drugs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 259,
    "user_query": "Is oxidative stress affected by FOXO expression?",
    "yulan-chat-2-13b-fp16_response": "Yes, oxidative stress can be affected by FOXO (Forkhead box O) expression. FOXO transcription factors play a role in regulating cellular processes related to stress response, including oxidative stress.\nFOXO proteins can activate genes involved in antioxidant defense and DNA repair, which can help to protect cells against oxidative damage. Additionally, FOXO proteins can also inhibit the expression of pro-oxidant genes, further reducing oxidative stress.\nStudies have shown that alterations in FOXO expression can affect oxidative stress levels in cells. For example, decreased FOXO expression has been associated with increased oxidative stress and cellular damage in various diseases, including cancer and neurodegenerative disorders.\nOverall, FOXO expression is an important factor in regulating oxidative stress and cellular responses to stress.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FOXO (Forkhead box O) transcription factors regulate cellular processes related to stress response, including oxidative stress.\n2. FOXO proteins can activate genes that are involved in antioxidant defense and DNA repair.\n3. FOXO proteins can inhibit the expression of pro-oxidant genes.\n4. Alterations in FOXO expression can affect oxidative stress levels in cells.\n5. Decreased FOXO expression has been associated with increased oxidative stress and cellular damage in various diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "FOXO (Forkhead box O) transcription factors regulate cellular processes related to stress response, including oxidative stress.",
      "FOXO proteins can activate genes that are involved in antioxidant defense and DNA repair.",
      "FOXO proteins can inhibit the expression of pro-oxidant genes.",
      "Alterations in FOXO expression can affect oxidative stress levels in cells.",
      "Decreased FOXO expression has been associated with increased oxidative stress and cellular damage in various diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 260,
    "user_query": "Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.",
    "yulan-chat-2-13b-fp16_response": "The LINX system is a minimally invasive surgical treatment option for gastroesophageal reflux disease (GERD). The system consists of a series of small magnetic beads that are placed around the lower esophageal sphincter (LES), which is the muscle that separates the esophagus from the stomach.\nThe mechanism of action of the LINX system is based on the principle of magnetic sphincteraugmentation. The magnetic beads are attached to each other and to the LES, creating a magnetic field that strengthens the muscle and helps to prevent acid reflux. The beads are made of a biocompatible material that is designed to be permanently implanted in the body.\nDuring the procedure, a surgeon places the beads around the LES using a laparoscope, which is a thin tube with a camera and light on the end. The beads are placed in a circular pattern, with the magnetic fields oriented towards the center of the LES. This creates a barrier that helps to prevent acid from flowing back up into the esophagus.\nThe LINX system is designed to be a less invasive alternative to traditional surgical treatments for GERD, such as Nissen fundoplication. It is typically recommended for patients who have not responded to medication or lifestyle changes, or who are unable to take medication due to side effects. The procedure is generally well-tolerated, with most patients able to return to their normal activities within a few days.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The LINX system is a minimally invasive surgical treatment for gastroesophageal reflux disease (GERD).\n2. The system consists of a series of small magnetic beads placed around the lower esophageal sphincter (LES).\n3. The LINX system's mechanism is based on magnetic sphincter augmentation, which strengthens the LES to prevent acid reflux.\n4. The magnetic beads used in the LINX system are made of a biocompatible material designed to be permanently implanted in the body.\n5. The LINX system is typically recommended for GERD patients who haven't responded to medication or lifestyle changes, or cannot take medication due to side effects.",
    "yulan-chat-2-13b-fp16_fact": [
      "The LINX system is a minimally invasive surgical treatment for gastroesophageal reflux disease (GERD).",
      "The system consists of a series of small magnetic beads placed around the lower esophageal sphincter (LES).",
      "The LINX system's mechanism is based on magnetic sphincter augmentation, which strengthens the LES to prevent acid reflux.",
      "The magnetic beads used in the LINX system are made of a biocompatible material designed to be permanently implanted in the body.",
      "The LINX system is typically recommended for GERD patients who haven't responded to medication or lifestyle changes, or cannot take medication due to side effects."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 262,
    "user_query": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.",
    "yulan-chat-2-13b-fp16_response": "Dyke-Davidoff-Masson (DDM) syndrome is a rare genetic disorder that is characterized by a combination of symptoms including intellectual disability, epilepsy, and a distinctive facial appearance. People with DDM syndrome typically have a broad, flat nasal bridge, a low-placed nasal tip, and a prominent upper lip. They may also have a wide space between their eyes (frontal prominence) and a downward slanting palpebral fissures (the spaces between the eyelids and the eyes). DDM syndrome is caused by mutations in the CDKL5 gene, which is involved in the development and function of brain cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dyke-Davidoff-Masson (DDM) syndrome is a rare genetic disorder.\n2. DDM syndrome is characterized by symptoms including intellectual disability and epilepsy.\n3. Individuals with DDM syndrome often have a distinctive facial appearance with features like a broad, flat nasal bridge and a prominent upper lip.\n4. The facial characteristics of someone with DDM syndrome may include a wide space between the eyes and downward slanting palpebral fissures.\n5. Mutations in the CDKL5 gene cause Dyke-Davidoff-Masson syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dyke-Davidoff-Masson (DDM) syndrome is a rare genetic disorder.",
      "DDM syndrome is characterized by symptoms including intellectual disability and epilepsy.",
      "Individuals with DDM syndrome often have a distinctive facial appearance with features like a broad, flat nasal bridge and a prominent upper lip.",
      "The facial characteristics of someone with DDM syndrome may include a wide space between the eyes and downward slanting palpebral fissures.",
      "Mutations in the CDKL5 gene cause Dyke-Davidoff-Masson syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Dyke-Davidoff-Masson syndrome is not primarily known as a genetic disorder; it is typically associated with cerebral hemiatrophy, and the cause is often attributed to factors such as injury or issues during brain development rather than genetics.\n2. TRUE\n3. FALSE [correction]: The statement inaccurately describes DDM syndrome. DDM syndrome does not typically include distinctive facial features as part of its presentation, as it is more related to cerebral hemiatrophy and the resulting neurological impairments.\n4. FALSE [correction]: Similarly, the described facial characteristics are not typically associated with DDM syndrome. The syndrome is primarily neurological and does not typically involve specific facial dysmorphisms.\n5. FALSE [correction]: Dyke-Davidoff-Masson syndrome is not caused by mutations in the CDKL5 gene. CDKL5 gene mutations are associated with a different rare genetic disorder called CDKL5 deficiency disorder (CDD), which can cause seizures, developmental delays, and other neurological problems.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 263,
    "user_query": "Which gene is involved in the development of Barth syndrome?",
    "yulan-chat-2-13b-fp16_response": "Barth syndrome is caused by mutations in the TAF1 gene, which is located on the long (q) arm of the chromosome at position 22.131. This gene encodes a protein called TATA-binding protein associated factor 1 (TBP1), which is a key component of the transcriptional machinery that controls gene expression in cells. Mutations in the TAF1 gene lead to a deficiency in TBP1, which disrupts normal gene expression and causes the characteristic features of Barth syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Barth syndrome is caused by mutations in the TAF1 gene.\n2. The TAF1 gene is located on the long (q) arm of the chromosome at position 22.131.\n3. The TAF1 gene encodes a protein known as TATA-binding protein associated factor 1 (TBP1).\n4. TBP1 is a component of the transcriptional machinery that controls gene expression in cells.\n5. A deficiency in TBP1 due to mutations in the TAF1 gene leads to the characteristic features of Barth syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Barth syndrome is caused by mutations in the TAF1 gene.",
      "The TAF1 gene is located on the long (q) arm of the chromosome at position 22.131.",
      "The TAF1 gene encodes a protein known as TATA-binding protein associated factor 1 (TBP1).",
      "TBP1 is a component of the transcriptional machinery that controls gene expression in cells.",
      "A deficiency in TBP1 due to mutations in the TAF1 gene leads to the characteristic features of Barth syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Barth syndrome is caused by mutations in the TAZ (also known as G4.5) gene, not the TAF1 gene.\n2. FALSE [correction]: While this statement is about the TAF1 gene location, since Barth syndrome is associated with the TAZ gene, the location should reference TAZ. The TAZ gene is located on the X chromosome at position Xq28.\n3. FALSE [correction]: The TAF1 gene encodes a protein known as TATA-binding protein associated factor 1, but it's abbreviated as TAF1, not TBP1.\n4. TRUE: TAF1, like other TATA-binding protein associated factors, is indeed a component of the transcriptional machinery that controls gene expression in cells.\n5. FALSE [correction]: A deficiency in the TAZ protein, which is encoded by the TAZ gene and not TBP1, leads to the characteristic features of Barth syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "yulan-chat-2-13b-fp16_response": "Casein Kinase 1 (CK1) is a protein kinase that phosphorylates a wide variety of substrates, including proteins, lipids, and nucleic acids. CK1 has two isoforms in mammals, CK1 and CK1, which have different substrate specificities and cellular localizations.\nThe consensus motifs for CK1 phosphorylation are as follows:\n1. S/TxxPx: This motif is the most commonly recognized by CK1 and is present in many proteins. It consists of a serine or threonine residue followed by two proline residues.\n2. SxxS/T: This motif is present in some proteins and consists of a serine or threonine residue followed by another serine or threonine residue.\n3. TxxT/S: This motif is present in some proteins and consists of a threonine or serine residue followed by another threonine or serine residue.\n4. S/TxPx: This motif is present in some proteins and consists of a serine or threonine residue followed by any two proline residues.\n5. S/TxPxP: This motif is present in some proteins and consists of a serine or threonine residue followed by any two proline residues and a third proline residue.\nIt's worth noting that CK1 can also phosphorylate other motifs, including S/TxxPxP, S/TxxPxS, and S/TxxPxT, but these motifs are less common than the ones listed above.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Casein Kinase 1 (CK1) is a protein kinase that phosphorylates a wide variety of substrates, including proteins, lipids, and nucleic acids.\n2. CK1 has two isoforms in mammals: CK1 and CK1.\n3. CK1 and CK1 have different substrate specificities and cellular localizations.\n4. The consensus motif S/TxxPx is commonly recognized by CK1 for phosphorylation and is present in many proteins.\n5. CK1 also phosphorylates other motifs, including but not limited to S/TxxPxP, S/TxxPxS, and S/TxxPxT.",
    "yulan-chat-2-13b-fp16_fact": [
      "Casein Kinase 1 (CK1) is a protein kinase that phosphorylates a wide variety of substrates, including proteins, lipids, and nucleic acids.",
      "CK1 has two isoforms in mammals: CK1 and CK1.",
      "CK1 and CK1 have different substrate specificities and cellular localizations.",
      "The consensus motif S/TxxPx is commonly recognized by CK1 for phosphorylation and is present in many proteins.",
      "CK1 also phosphorylates other motifs, including but not limited to S/TxxPxP, S/TxxPxS, and S/TxxPxT."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Casein Kinase 1 (CK1) is indeed a protein kinase that phosphorylates a wide variety of substrates, which may include proteins, lipids, and nucleic acids, although its main substrates are typically proteins.\n2. FALSE [correction]: CK1 has multiple isoforms in mammals, not just two. These include CK1, CK1, CK1, and others.\n3. UNKNOWN: The specifics about the substrate specificities and cellular localizations of CK1 and CK1 are not common knowledge and would require specialized biochemical knowledge or literature to confirm.\n4. TRUE: The consensus sequence S/TxxPx (Serine or Threonine followed by any two amino acids, then Proline, another amino acid) is indeed a motif commonly recognized by CK1 enzymes for phosphorylation.\n5. TRUE: CK1 is known to phosphorylate a variety of motifs that are similar to S/TxxPx, including modifications such as S/TxxPxP, S/TxxPxS, and S/TxxPxT.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 273,
    "user_query": "What is the Barr body?",
    "yulan-chat-2-13b-fp16_response": "The Barr body is a term used to describe the inactivation of one of the two X chromosomes in female mammals. This occurs during embryonic development when one of the two X chromosomes is randomly inactivated in each cell of the developing embryo. This process is called \"X-chromosome inactivation\" and it is necessary to ensure that females have only one functional X chromosome, while still having enough genetic material to develop normally.\nThe Barr body is named after the Scottish geneticist Mary F.A. Barr, who first described the phenomenon in 1961. The Barr body is visible under a microscope as a brightly stained, condensed region on one of the two X chromosomes in the nucleus of a female cell.\nX-chromosome inactivation is a random process, which means that in each cell of a female embryo, one of the two X chromosomes is randomly inactivated. This is why some cells in a female body have two X chromosomes that are both active, while others have only one active X chromosome. This is also why females have a higher incidence of certain genetic disorders that are linked to the X chromosome, such as hemophilia and Rett syndrome, compared to males.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Barr body is associated with the inactivation of one X chromosome in female mammals.\n2. X-chromosome inactivation occurs during embryonic development.\n3. The Barr body is named after Scottish geneticist Mary F.A. Barr, who described the phenomenon in 1961.\n4. The Barr body can be observed under a microscope as a condensed region in the nucleus of a female cell.\n5. X-chromosome inactivation is a random process that takes place in female embryos.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Barr body is associated with the inactivation of one X chromosome in female mammals.",
      "X-chromosome inactivation occurs during embryonic development.",
      "The Barr body is named after Scottish geneticist Mary F.A. Barr, who described the phenomenon in 1961.",
      "The Barr body can be observed under a microscope as a condensed region in the nucleus of a female cell.",
      "X-chromosome inactivation is a random process that takes place in female embryos."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Barr body is named after Canadian geneticist Murray L. Barr, who first described the phenomenon in 1949.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 275,
    "user_query": "Is shotgun lipidomics the direct infusion of a lipid sample into a mass spectrometer?",
    "yulan-chat-2-13b-fp16_response": "Shotgun lipidomics is a technique used to identify and quantify lipids in a sample. It involves the direct infusion of a lipid sample into a mass spectrometer, which allows for the detection and identification of lipids based on their mass-to-charge ratio. The term \"shotgun\" refers to the fact that the technique generates a large amount of data, as it analyzes all the lipids in a sample simultaneously.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Shotgun lipidomics is used to identify and quantify lipids in a sample.\n2. It involves the direct infusion of a lipid sample into a mass spectrometer.\n3. Lipids are detected and identified based on their mass-to-charge ratio in shotgun lipidomics.\n4. The term \"shotgun\" in shotgun lipidomics refers to the generation of a large amount of data from analyzing all the lipids in a sample simultaneously.",
    "yulan-chat-2-13b-fp16_fact": [
      "Shotgun lipidomics is used to identify and quantify lipids in a sample.",
      "It involves the direct infusion of a lipid sample into a mass spectrometer.",
      "Lipids are detected and identified based on their mass-to-charge ratio in shotgun lipidomics.",
      "The term \"shotgun\" in shotgun lipidomics refers to the generation of a large amount of data from analyzing all the lipids in a sample simultaneously."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 283,
    "user_query": "List functions that are evaluated with the Full Outline of Unresponsiveness score?",
    "yulan-chat-2-13b-fp16_response": "The Full Outline of Unresponsiveness (FOUR) score is a tool used to evaluate the level of unresponsiveness in a patient. It is typically used in emergency medicine to assess the severity of a patient's condition and guide treatment decisions. The FOUR score includes the following functions:\n1. Age: The patient's age is taken into account, as older patients may have different medical needs and be more susceptible to certain conditions.\n2. Medical history: The patient's past medical history is reviewed to identify any underlying medical conditions that may affect their current condition.\n3. Vital signs: The patient's vital signs, including heart rate, blood pressure, respiratory rate, and temperature, are measured and evaluated.\n4. Neurological status: The patient's neurological status is assessed, including their level of consciousness, ability to respond to stimuli, and any signs of neurological deficits.\n5. Physical exam findings: A thorough physical exam is performed to evaluate the patient's overall condition, including any signs of injury or illness.\n6. Laboratory results: Laboratory tests, such as blood tests or urinalysis, may be ordered to further evaluate the patient's condition.\n7. Treatment: The patient's treatment is evaluated based on their condition and any interventions that have been implemented.\nThe FOUR score is typically used to assign a severity score to the patient's condition, with higher scores indicating a more severe level of unresponsiveness. This score can help guide treatment decisions and determine whether the patient needs to be admitted to the hospital or can be treated on an outpatient basis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Full Outline of Unresponsiveness (FOUR) score is used to evaluate the level of unresponsiveness in a patient.\n2. The FOUR score is typically used in emergency medicine to assess the severity of a patient's condition.\n3. The FOUR score takes the patient's age into account.\n4. The FOUR score involves a review of the patient's past medical history.\n5. Vital signs measured and evaluated in the FOUR score include heart rate, blood pressure, respiratory rate, and temperature.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Full Outline of Unresponsiveness (FOUR) score is used to evaluate the level of unresponsiveness in a patient.",
      "The FOUR score is typically used in emergency medicine to assess the severity of a patient's condition.",
      "The FOUR score takes the patient's age into account.",
      "The FOUR score involves a review of the patient's past medical history.",
      "Vital signs measured and evaluated in the FOUR score include heart rate, blood pressure, respiratory rate, and temperature."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The FOUR score does not take the patient's age into account; it is based on four components: eye response, motor response, brainstem reflexes, and respiration.\n4. FALSE [correction]: The FOUR score does not involve a review of the patient's past medical history; it is an assessment of the patient's current level of consciousness and brain function.\n5. FALSE [correction]: Vital signs such as heart rate, blood pressure, respiratory rate, and temperature are not part of the FOUR score. The FOUR score evaluates eye response, motor response, brainstem reflexes, and respiration patterns.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 285,
    "user_query": "Is ospemifene effective for treatment of dyspareunia?",
    "yulan-chat-2-13b-fp16_response": "Ospemifene is a drug that is used to treat dyspareunia, which is a condition characterized by painful sexual intercourse. It works by relaxing the muscles in the vagina, which can help to reduce pain and discomfort during sexual activity.\nStudies have shown that ospemifene can be effective in reducing the symptoms of dyspareunia. In clinical trials, women who took ospemifene reported significant improvement in their symptoms compared to those who took a placebo.\nHowever, it is important to note that ospemifene may not work for everyone, and the extent to which it reduces symptoms can vary from person to person. It is also important to talk to your doctor about the potential risks and benefits of this medication before starting treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ospemifene is used to treat dyspareunia, a condition characterized by painful sexual intercourse.\n2. Ospemifene works by relaxing the muscles in the vagina.\n3. Studies have indicated that ospemifene can reduce the symptoms of dyspareunia.\n4. Clinical trials have shown that women taking ospemifene reported significant improvement in their symptoms compared to those who took a placebo.\n5. The effectiveness of ospemifene in reducing symptoms of dyspareunia can vary from person to person.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ospemifene is used to treat dyspareunia, a condition characterized by painful sexual intercourse.",
      "Ospemifene works by relaxing the muscles in the vagina.",
      "Studies have indicated that ospemifene can reduce the symptoms of dyspareunia.",
      "Clinical trials have shown that women taking ospemifene reported significant improvement in their symptoms compared to those who took a placebo.",
      "The effectiveness of ospemifene in reducing symptoms of dyspareunia can vary from person to person."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Ospemifene works by acting as a selective estrogen receptor modulator (SERM), which has estrogenic effects on the vaginal tissues that help improve symptoms of dyspareunia.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 287,
    "user_query": "What is the biological role of expansins in fungi?",
    "yulan-chat-2-13b-fp16_response": "Expansins are a type of cellulose-degrading enzyme produced by certain fungi, particularly those in the phallus section of the genus Phallus. These enzymes play a key role in the breakdown of cellulose, a complex carbohydrate found in plant cell walls, and are thought to be important for the fungal digestion of plant material.\nExpansins are unique in that they are able to hydrolyze cellulose in a manner that is dependent on the presence of water. This is in contrast to other cellulose-degrading enzymes, which require the presence of a metal ion, such as calcium or magnesium, to function. Expansins are also able to dissolve cellulose in water, which allows them to break down the tough plant material that makes up the cell walls.\nIn addition to their role in the breakdown of cellulose, expansins have also been shown to have other biological functions. For example, they have been found to be involved in the formation of fungal hyphae, which are the long, branching structures that fungi use to absorb nutrients from their environment. Expansins may also play a role in the formation of mycelium, which is the vegetative growth form of certain fungi.\nOverall, the biological role of expansins in fungi is to aid in the breakdown of plant material and to facilitate the uptake of nutrients by the fungus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Expansins are enzymes produced by certain fungi, particularly in the phallus section of the genus Phallus.\n2. Expansins are involved in the breakdown of cellulose, which is a complex carbohydrate found in plant cell walls.\n3. These enzymes are important for the fungal digestion of plant material.\n4. Expansins hydrolyze cellulose in a manner that is dependent on the presence of water, unlike other cellulose-degrading enzymes which require a metal ion.\n5. Expansins have been found to be involved in the formation of fungal hyphae and may also play a role in the formation of mycelium.",
    "yulan-chat-2-13b-fp16_fact": [
      "Expansins are enzymes produced by certain fungi, particularly in the phallus section of the genus Phallus.",
      "Expansins are involved in the breakdown of cellulose, which is a complex carbohydrate found in plant cell walls.",
      "These enzymes are important for the fungal digestion of plant material.",
      "Expansins hydrolyze cellulose in a manner that is dependent on the presence of water, unlike other cellulose-degrading enzymes which require a metal ion.",
      "Expansins have been found to be involved in the formation of fungal hyphae and may also play a role in the formation of mycelium."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Expansins are not enzymes and they are not produced by fungi. They are proteins produced by plants that are involved in the modification of cell walls by non-enzymatic mechanisms.\n2. FALSE [correction]: Expansins do not break down cellulose. They act by loosening the plant cell walls, facilitating growth and other processes.\n3. FALSE [correction]: Since expansins are not produced by fungi and do not break down cellulose, they are not involved in fungal digestion of plant material.\n4. FALSE [correction]: The statement is incorrect because expansins are not cellulose-degrading enzymes. They do not hydrolyze cellulose but rather modulate the extensibility of plant cell walls in a non-enzymatic manner which involves the disruption of non-covalent bonding between cellulose microfibrils and matrix polysaccharides.\n5. FALSE [correction]: Expansins are associated with plant cell wall loosening processes such as cell growth and fruit ripening, not with the formation of fungal structures such as hyphae or mycelium.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 301,
    "user_query": "Which oncogenes are able to induce cellular senescence?",
    "yulan-chat-2-13b-fp16_response": "Oncogenes are genes that have the potential to cause cancer when they are activated or overexpressed. While some oncogenes can promote cell proliferation and survival, others have been shown to induce cellular senescence, a state of cell cycle arrest characterized by the accumulation of senescence-associated beta-galactosidase (SA--gal) and the presence of senescence-associated secretory phenotype (SASP) factors.\nSome examples of oncogenes that have been shown to induce cellular senescence include:\n1. p53: The tumor suppressor gene p53 is one of the most well-known oncogenes. When it is functioning normally, p53 can induce cellular senescence as a response to DNA damage or other stressors. Mutations in p53 can lead to its loss of function and the ability to induce senescence, which can contribute to tumor formation.\n2. Ras: The Ras oncogene is a key regulator of cell proliferation and differentiation. Overactivation of Ras can lead to cellular senescence as well as cell proliferation.\n3. Myc: The Myc oncogene is a transcription factor that regulates cell growth and differentiation. Overexpression of Myc can induce cellular senescence in some contexts.\n4. E2F: The E2F transcription factors are involved in the regulation of the cell cycle. Overexpression of E2F can induce cellular senescence in some contexts.\nIt's important to note that the ability of oncogenes to induce cellular senescence can depend on the cell type, context, and other factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The oncogene p53 can induce cellular senescence in response to DNA damage or other stressors.\n2. Mutations in p53 can lead to loss of function and the inability to induce senescence, contributing to tumor formation.\n3. Overactivation of the Ras oncogene can lead to cellular senescence as well as cell proliferation.\n4. The Myc oncogene, when overexpressed, can induce cellular senescence in some contexts.\n5. Overexpression of E2F transcription factors can induce cellular senescence in some contexts.",
    "yulan-chat-2-13b-fp16_fact": [
      "The oncogene p53 can induce cellular senescence in response to DNA damage or other stressors.",
      "Mutations in p53 can lead to loss of function and the inability to induce senescence, contributing to tumor formation.",
      "Overactivation of the Ras oncogene can lead to cellular senescence as well as cell proliferation.",
      "The Myc oncogene, when overexpressed, can induce cellular senescence in some contexts.",
      "Overexpression of E2F transcription factors can induce cellular senescence in some contexts."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The tumor suppressor p53 can induce cellular senescence in response to DNA damage or other stressors, not the oncogene p53.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "yulan-chat-2-13b-fp16_response": "The ASPH gene in humans encodes for two isoforms: aspartate beta-hydroxylase (ASPH) and aspartyl (beta-hydroxy) protease (ASPH2). ASPH is a homodimeric enzyme that catalyzes the hydroxylation of aspartate residues in asparagine endopeptidases, while ASPH2 is a monomeric enzyme that is involved in the degradation of asparagine-linked glycoproteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The human ASPH gene encodes for the aspartate beta-hydroxylase (ASPH) isoform.\n2. The human ASPH gene also encodes for the aspartyl (beta-hydroxy) protease (ASPH2) isoform.\n3. Aspartate beta-hydroxylase (ASPH) is a homodimeric enzyme.\n4. ASPH catalyzes the hydroxylation of aspartate residues in asparagine endopeptidases.\n5. Aspartyl (beta-hydroxy) protease (ASPH2) is a monomeric enzyme involved in the degradation of asparagine-linked glycoproteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "The human ASPH gene encodes for the aspartate beta-hydroxylase (ASPH) isoform.",
      "The human ASPH gene also encodes for the aspartyl (beta-hydroxy) protease (ASPH2) isoform.",
      "Aspartate beta-hydroxylase (ASPH) is a homodimeric enzyme.",
      "ASPH catalyzes the hydroxylation of aspartate residues in asparagine endopeptidases.",
      "Aspartyl (beta-hydroxy) protease (ASPH2) is a monomeric enzyme involved in the degradation of asparagine-linked glycoproteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The ASPH gene does not encode an isoform known as aspartyl (beta-hydroxy) protease (ASPH2). The gene is known for encoding aspartate beta-hydroxylase.\n3. UNKNOWN: Without specific scientific literature or data about the oligomeric state of aspartate beta-hydroxylase (ASPH), it is difficult to confirm if it is homodimeric.\n4. FALSE [correction]: ASPH catalyzes the hydroxylation of aspartate residues in epidermal growth factor-like domains of certain proteins, not in asparagine endopeptidases.\n5. UNKNOWN: There is no widely recognized enzyme named \"aspartyl (beta-hydroxy) protease\" (ASPH2) associated with the ASPH gene, and the specific function stated does not correspond to known activities of the protein products of the ASPH gene.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 310,
    "user_query": "Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\"",
    "yulan-chat-2-13b-fp16_response": "The most common measure of differences between dinucleotide relative abundance, or genomic signatures, is the TPM (Transcript Per Million) value. TPM is a normalized value that represents the number of transcripts per million transcripts in a sample. It takes into account the total number of transcripts in the sample and the number of transcripts from each gene, allowing for a direct comparison of gene expression levels across different samples and experimental conditions. Other measures, such as FPKM (Fragments Per Kilogram Million) and RPKM (Reads Per Kilogram Million), are also used but less commonly than TPM.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 312,
    "user_query": "Why do we use \"N-terminal proteomics\"?",
    "yulan-chat-2-13b-fp16_response": "N-terminal proteomics is a method used to identify and quantify proteins based on their N-terminal amino acid sequences. This method is used because the N-terminal amino acid sequence is unique to each protein and can be used to identify and distinguish between different proteins. It is also a useful tool for studying post-translational modifications, such as phosphorylation and glycosylation, that occur on the N-terminal end of a protein. Additionally, N-terminal proteomics can be used to study protein-protein interactions and protein complexes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. N-terminal proteomics identifies and quantifies proteins based on their N-terminal amino acid sequences.\n2. The N-terminal amino acid sequence is unique to each protein.\n3. This method can distinguish between different proteins.\n4. N-terminal proteomics can be used for studying post-translational modifications at the protein's N-terminal end.\n5. N-terminal proteomics can be utilized to study protein-protein interactions and protein complexes.",
    "yulan-chat-2-13b-fp16_fact": [
      "N-terminal proteomics identifies and quantifies proteins based on their N-terminal amino acid sequences.",
      "The N-terminal amino acid sequence is unique to each protein.",
      "This method can distinguish between different proteins.",
      "N-terminal proteomics can be used for studying post-translational modifications at the protein's N-terminal end.",
      "N-terminal proteomics can be utilized to study protein-protein interactions and protein complexes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: While the N-terminal amino acid sequence is a part of what makes each protein unique, proteins can share similar or identical N-terminal sequences. The entire amino acid sequence and the three-dimensional structure ultimately determine each protein's uniqueness.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: N-terminal proteomics primarily focuses on the analysis of the N-terminal amino acid sequences of proteins. Techniques for studying protein-protein interactions and protein complexes include methods such as co-immunoprecipitation, cross-linking mass spectrometry, and yeast two-hybrid, among others, which are not necessarily part of N-terminal proteomics.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 317,
    "user_query": "Have mutations in the Polycomb group been found in human diseases?",
    "yulan-chat-2-13b-fp16_response": "Yes, mutations in the Polycomb group (PcG) genes have been associated with various human diseases. PcG genes play a crucial role in regulating gene expression and maintaining the stability of the genome. Mutations in these genes can lead to aberrant gene expression and contribute to the development of various diseases.\nFor example, mutations in the PcG gene EZH2 have been linked to various cancers, including breast cancer, lymphoma, and bladder cancer. Mutations in the PcG gene CBX8 have been associated with developmental disorders, such as nail-patella syndrome and thrombocytopenia with developmental delay.\nOther PcG genes, such as EED, SUZ12, and JARID2, have also been implicated in various human diseases, including cancer, neurodevelopmental disorders, and immune disorders.\nOverall, mutations in the PcG genes can have significant consequences for human health, and further research is needed to understand the mechanisms underlying these associations and to develop targeted therapies for PcG-related diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the Polycomb group (PcG) genes are associated with various human diseases.\n2. PcG genes are essential for regulating gene expression and maintaining genome stability.\n3. Mutations in the PcG gene EZH2 have been linked to breast cancer, lymphoma, and bladder cancer.\n4. Mutations in the PcG gene CBX8 have been associated with developmental disorders, including nail-patella syndrome and thrombocytopenia with developmental delay.\n5. PcG genes EED, SUZ12, and JARID2 have been implicated in diseases such as cancer, neurodevelopmental disorders, and immune disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the Polycomb group (PcG) genes are associated with various human diseases.",
      "PcG genes are essential for regulating gene expression and maintaining genome stability.",
      "Mutations in the PcG gene EZH2 have been linked to breast cancer, lymphoma, and bladder cancer.",
      "Mutations in the PcG gene CBX8 have been associated with developmental disorders, including nail-patella syndrome and thrombocytopenia with developmental delay.",
      "PcG genes EED, SUZ12, and JARID2 have been implicated in diseases such as cancer, neurodevelopmental disorders, and immune disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Mutations in the Polycomb group (PcG) gene CBX8 have not been associated with nail-patella syndrome. Nail-patella syndrome is associated with mutations in the LMX1B gene. However, as of my knowledge cutoff in 2023, CBX8 has been linked to cancer development. Thrombocytopenia with developmental delay has not been specifically linked to CBX8 mutations.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 318,
    "user_query": "Describe the mechanism of action of drisapersen",
    "yulan-chat-2-13b-fp16_response": "Drisapersen is an investigational drug being developed for the treatment of various types of cancer, including prostate cancer. It works by targeting the androgen receptor, which is a protein that plays a key role in the growth and survival of prostate cancer cells.\nDrisapersen is a small molecule that binds to the androgen receptor with high affinity and selectivity, inhibiting its activity. By blocking the androgen receptor, drisapersen can prevent prostate cancer cells from growing and dividing, leading to cell death.\nIn addition to its direct effect on the androgen receptor, drisapersen may also have indirect effects on the tumor microenvironment, including the inhibition of angiogenesis and the modulation of immune responses.\nDrisapersen is currently being studied in clinical trials to evaluate its safety and efficacy as a potential treatment for prostate cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Drisapersen is an investigational drug being developed for the treatment of various types of cancer, including prostate cancer.\n2. It functions by targeting the androgen receptor.\n3. The androgen receptor is instrumental in the growth and survival of prostate cancer cells.\n4. Drisapersen binds to the androgen receptor with high affinity and selectivity, inhibiting its activity.\n5. Drisapersen is currently being studied in clinical trials for its safety and efficacy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Drisapersen is an investigational drug being developed for the treatment of various types of cancer, including prostate cancer.",
      "It functions by targeting the androgen receptor.",
      "The androgen receptor is instrumental in the growth and survival of prostate cancer cells.",
      "Drisapersen binds to the androgen receptor with high affinity and selectivity, inhibiting its activity.",
      "Drisapersen is currently being studied in clinical trials for its safety and efficacy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Drisapersen is not an investigational drug for the treatment of various types of cancer, including prostate cancer. Drisapersen is an investigational drug that was being developed for the treatment of Duchenne Muscular Dystrophy (DMD).\n2. FALSE [correction]: Drisapersen does not function by targeting the androgen receptor. It was designed to induce exon skipping in the dystrophin gene.\n3. TRUE: The androgen receptor is instrumental in the growth and survival of prostate cancer cells, although this is unrelated to the action of drisapersen.\n4. FALSE [correction]: Drisapersen does not bind to the androgen receptor as it is not intended for the treatment of prostate cancer or related to the androgen receptor's function. Drisapersen targets specific RNA sequences to modify splicing in the dystrophin gene.\n5. FALSE [correction]: Drisapersen was previously studied in clinical trials for safety and efficacy in the treatment of Duchenne Muscular Dystrophy, not in the context of cancer. However, it did not receive regulatory approval and its development was discontinued.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 325,
    "user_query": "How does ranolazine affect calcium handling in the heart",
    "yulan-chat-2-13b-fp16_response": "Ranolazine is a medication that is used to treat angina (chest pain) and heart attacks. It works by blocking the late sodium channels in the heart, which can help to reduce the amount of oxygen needed by the heart.\nRanolazine may also affect calcium handling in the heart. Calcium is an important ion that plays a key role in the contraction of heart muscle. When calcium ions flow into the heart muscle cells, they cause the muscle to contract.\nRanolazine may decrease the amount of calcium that is available for the heart muscle to contract. This can lead to a decrease in the strength of the heart muscle and may make it more difficult for the heart to pump blood.\nIt is important to note that ranolazine should only be used under the supervision of a healthcare provider. It can have serious side effects, including low blood pressure, dizziness, and fainting. It is important to talk to your healthcare provider about any concerns you may have about the use of ranolazine.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ranolazine is used to treat angina and heart attacks.\n2. Ranolazine works by blocking the late sodium channels in the heart.\n3. Blocking these channels can reduce the amount of oxygen needed by the heart.\n4. Ranolazine may decrease the amount of calcium available for heart muscle contraction.\n5. Serious side effects of ranolazine can include low blood pressure, dizziness, and fainting.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ranolazine is used to treat angina and heart attacks.",
      "Ranolazine works by blocking the late sodium channels in the heart.",
      "Blocking these channels can reduce the amount of oxygen needed by the heart.",
      "Ranolazine may decrease the amount of calcium available for heart muscle contraction.",
      "Serious side effects of ranolazine can include low blood pressure, dizziness, and fainting."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Ranolazine is used to treat chronic angina but is not specifically indicated for the treatment of heart attacks.\n2. TRUE\n3. TRUE\n4. UNKNOWN: While it's known that ranolazine affects sodium and calcium channels in the heart, the specific statement about decreasing the amount of calcium available for heart muscle contraction is not clearly established without a reference to specific scientific evidence or guidelines.\n5. TRUE: Serious side effects of ranolazine can include hypotension (low blood pressure), dizziness, and syncope (fainting), amongst others.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 326,
    "user_query": "Which is the primary distinction between the Reverse Warburg effect and the conventional Warburg effect?",
    "yulan-chat-2-13b-fp16_response": "The primary distinction between the Reverse Warburg effect and the conventional Warburg effect is the direction of electron flow during cellular respiration. In the conventional Warburg effect, which is observed in most cancer cells, the majority of the electron flow occurs in the mitochondria, resulting in the production of ATP through oxidative phosphorylation. In contrast, the Reverse Warburg effect involves the majority of electron flow occurring outside of the mitochondria, leading to the production of ATP through glycolysis. This means that the Reverse Warburg effect is characterized by a shift towards anaerobic metabolism, which is less efficient in terms of ATP production but can provide a quick source of energy for cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Reverse Warburg effect and the conventional Warburg effect differ in the direction of electron flow during cellular respiration.\n2. In the conventional Warburg effect, the majority of the electron flow occurs in the mitochondria.\n3. The production of ATP in the conventional Warburg effect happens through oxidative phosphorylation.\n4. In the Reverse Warburg effect, the majority of electron flow occurs outside of the mitochondria.\n5. The Reverse Warburg effect leads to the production of ATP through glycolysis.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Reverse Warburg effect and the conventional Warburg effect differ in the direction of electron flow during cellular respiration.",
      "In the conventional Warburg effect, the majority of the electron flow occurs in the mitochondria.",
      "The production of ATP in the conventional Warburg effect happens through oxidative phosphorylation.",
      "In the Reverse Warburg effect, the majority of electron flow occurs outside of the mitochondria.",
      "The Reverse Warburg effect leads to the production of ATP through glycolysis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE - The Reverse Warburg effect is characterized by alterations in cancer metabolism different from those of the conventional Warburg effect, including differences in the flow of electrons during cellular respiration.\n2. FALSE [correction]: In the conventional Warburg effect, the majority of the electron flow does not primarily occur in the mitochondria. Instead, cancer cells favor glycolysis for energy production, even in the presence of oxygen, which limits the amount of electron flow through the mitochondrial electron transport chain.\n3. FALSE [correction]: Although oxidative phosphorylation can still occur, the production of ATP in the conventional Warburg effect predominantly happens through glycolysis, despite the presence of oxygen.\n4. UNKNOWN - The Reverse Warburg effect is a metabolic process observed in some cancer-associated fibroblasts, but the exact patterns of electron flow with respect to the mitochondria are complex and may not be generalized as occurring \"outside\" in all cases.\n5. TRUE - The Reverse Warburg effect involves the production of energy through aerobic glycolysis in the stromal cells, which indeed leads to the production of ATP through glycolysis.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 327,
    "user_query": "What is the role of per genes in circadian rhythm control?",
    "yulan-chat-2-13b-fp16_response": "The per genes play a crucial role in the control of circadian rhythms. These genes encode for transcription factors that form a complex with other proteins to create a transcriptional activator that drives the expression of clock-associated genes. The per genes are regulated by a negative feedback loop, where the protein products inhibit their own transcription, creating a 24-hour cycle of expression. This cycle is coordinated with other genes involved in the circadian clock, such as the cry genes, to regulate various physiological processes, including sleep-wake cycles, hormone secretion, and metabolism. Mutations in the per genes can disrupt the normal functioning of the circadian clock and lead to various disorders, such as circadian rhythm sleep disorders and metabolic disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The per genes are involved in the control of circadian rhythms.\n2. The per genes encode for transcription factors that form a complex with other proteins to regulate the expression of clock-associated genes.\n3. There is a negative feedback loop regulating per genes where their protein products inhibit their own transcription.\n4. The 24-hour cycle of per gene expression is coordinated with other genes like the cry genes.\n5. Mutations in the per genes can lead to disorders related to the circadian clock, including circadian rhythm sleep disorders and metabolic disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "The per genes are involved in the control of circadian rhythms.",
      "The per genes encode for transcription factors that form a complex with other proteins to regulate the expression of clock-associated genes.",
      "There is a negative feedback loop regulating per genes where their protein products inhibit their own transcription.",
      "The 24-hour cycle of per gene expression is coordinated with other genes like the cry genes.",
      "Mutations in the per genes can lead to disorders related to the circadian clock, including circadian rhythm sleep disorders and metabolic disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "yulan-chat-2-13b-fp16_response": "Empagliflozin is a medication used to treat type 2 diabetes. It was approved by the US Food and Drug Administration (FDA) in 2011. It is marketed under the brand name Jardiance by Boehringer Ingelheim.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Empagliflozin is used to treat type 2 diabetes.\n2. The US Food and Drug Administration (FDA) approved empagliflozin in 2011.\n3. Empagliflozin is marketed under the brand name Jardiance.\n4. Boehringer Ingelheim markets Jardiance.",
    "yulan-chat-2-13b-fp16_fact": [
      "Empagliflozin is used to treat type 2 diabetes.",
      "The US Food and Drug Administration (FDA) approved empagliflozin in 2011.",
      "Empagliflozin is marketed under the brand name Jardiance.",
      "Boehringer Ingelheim markets Jardiance."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The US Food and Drug Administration (FDA) approved empagliflozin in 2014.\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 331,
    "user_query": "Which R/bioconductor package is used for integrative genomics visualizations?",
    "yulan-chat-2-13b-fp16_response": "The R/bioconductor package that is commonly used for integrative genomics visualizations is called \"complexheatmap\". This package allows for the visualization of complex heatmaps, which are used to display patterns of gene expression or other types of molecular data across multiple samples or conditions. Other packages that may be used for integrative genomics visualizations include \"ggplot2\" and \"pvclust\".",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The package \"complexheatmap\" is used for integrative genomics visualizations within R/bioconductor.\n2. \"complexheatmap\" is designed to visualize complex heatmaps.\n3. Complex heatmaps can display patterns of gene expression or other types of molecular data.\n4. \"ggplot2\" is another package that may be used for integrative genomics visualizations.\n5. \"pvclust\" is also a package used for integrative genomics visualizations.",
    "yulan-chat-2-13b-fp16_fact": [
      "The package \"complexheatmap\" is used for integrative genomics visualizations within R/bioconductor.",
      "\"complexheatmap\" is designed to visualize complex heatmaps.",
      "Complex heatmaps can display patterns of gene expression or other types of molecular data.",
      "\"ggplot2\" is another package that may be used for integrative genomics visualizations.",
      "\"pvclust\" is also a package used for integrative genomics visualizations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\n- While \"pvclust\" is a package in R for assessing the uncertainty in hierarchical cluster analysis, without additional context, it's unclear if it is specifically designed for integrative genomics visualizations or not, though it can be related to the field.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 333,
    "user_query": "How many genes are imprinted in the human genome?",
    "yulan-chat-2-13b-fp16_response": "It is estimated that there are approximately 100-200 imprinted genes in the human genome. Imprinted genes are genes that are expressed from only one parent's copy of a gene, either the maternal or paternal copy, and are regulated by epigenetic marks such as DNA methylation. These genes play important roles in development and have been implicated in a variety of diseases, including cancer and neurological disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The human genome contains approximately 100-200 imprinted genes.\n2. Imprinted genes are expressed from only one parent's copy of a gene.\n3. The regulation of imprinted genes involves epigenetic marks such as DNA methylation.\n4. Imprinted genes have significant roles in human development.\n5. Imprinted genes have been implicated in diseases such as cancer and neurological disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "The human genome contains approximately 100-200 imprinted genes.",
      "Imprinted genes are expressed from only one parent's copy of a gene.",
      "The regulation of imprinted genes involves epigenetic marks such as DNA methylation.",
      "Imprinted genes have significant roles in human development.",
      "Imprinted genes have been implicated in diseases such as cancer and neurological disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 336,
    "user_query": "In which cells are A-type lamins expressed?",
    "yulan-chat-2-13b-fp16_response": "A-type lamins are expressed in a variety of cell types, including:\n* Epithelial cells: A-type lamins are important for maintaining the structural integrity of epithelial cells, which line the surfaces of organs and organs and form the outermost layer of skin.\n* Fibroblasts: A-type lamins are also expressed in fibroblasts, which are cells that synthesize and secrete the extracellular matrix (a network of proteins and other molecules that provides structural support to tissues).\n* Muscle cells: A-type lamins are expressed in muscle cells, where they help to maintain the organization of the contractile apparatus and other cellular structures.\n* Neural cells: A-type lamins are expressed in neural cells, where they play a role in the development and maintenance of the cellular membrane and other structures.\n* Other cell types: A-type lamins are also expressed in a variety of other cell types, including adipocytes (fat cells), endothelial cells (cells that line the blood vessels), and smooth muscle cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A-type lamins are expressed in epithelial cells and contribute to maintaining their structural integrity.\n2. A-type lamins are expressed in fibroblasts, which are responsible for synthesizing and secreting the extracellular matrix.\n3. Muscle cells express A-type lamins, which help maintain the organization of the contractile apparatus.\n4. Neural cells express A-type lamins, playing a role in the development and maintenance of the cellular membrane.\n5. A-type lamins are expressed in other cell types, including adipocytes, endothelial cells, and smooth muscle cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "A-type lamins are expressed in epithelial cells and contribute to maintaining their structural integrity.",
      "A-type lamins are expressed in fibroblasts, which are responsible for synthesizing and secreting the extracellular matrix.",
      "Muscle cells express A-type lamins, which help maintain the organization of the contractile apparatus.",
      "Neural cells express A-type lamins, playing a role in the development and maintenance of the cellular membrane.",
      "A-type lamins are expressed in other cell types, including adipocytes, endothelial cells, and smooth muscle cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Neural cells express A-type lamins, playing a role in the development and maintenance of the nuclear envelope, not specifically the cellular membrane.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 338,
    "user_query": "Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms. What is the name of the analogous process in prokaryotic organisms?",
    "yulan-chat-2-13b-fp16_response": "The analogous process in prokaryotic organisms is called RNA chaperoning.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 339,
    "user_query": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?",
    "yulan-chat-2-13b-fp16_response": "Directional mutation pressure can introduce mutational biases between different types of DNA bases. For example, if a mutation occurs in a region of the genome that is under strong positive selection, the mutation is more likely to be a transversion (a mutation that changes a purine for a pyrimidine or vice versa) than a transversion. This is because transversions are more likely to be beneficial than transversions, which are more likely to be neutral or deleterious. Similarly, if a mutation occurs in a region of the genome that is under strong negative selection, the mutation is more likely to be a transversion than a transversion. This is because transversions are more likely to be deleterious than transversions, which are more likely to be neutral.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 340,
    "user_query": "Is it feasible to determine the complete proteome of yeast?",
    "yulan-chat-2-13b-fp16_response": "Yes, it is feasible to determine the complete proteome of yeast. In fact, several groups have already published comprehensive proteomic analyses of yeast, including the model organism Saccharomyces cerevisiae. These studies have identified thousands of proteins and have provided a detailed understanding of the proteomic dynamics of yeast cells under different conditions.\nTo determine the complete proteome of yeast, researchers typically use a combination of techniques, including mass spectrometry-based proteomics, two-dimensional gel electrophoresis, and other protein separation and identification methods. These approaches allow for the identification and quantification of all proteins in yeast cells, including those that are expressed at low levels or have unconventional post-translational modifications.\nHowever, it is important to note that determining the complete proteome of yeast is an ongoing effort, and there is still much to be learned about the proteins and proteomic networks that underlie yeast biology. Ongoing research and advances in proteomic technologies will continue to improve our understanding of the yeast proteome and its role in cellular processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. It is feasible to determine the complete proteome of yeast.\n2. Comprehensive proteomic analyses of Saccharomyces cerevisiae have been published by several groups.\n3. These studies have identified thousands of proteins.\n4. Researchers use techniques such as mass spectrometry-based proteomics and two-dimensional gel electrophoresis to identify yeast proteins.\n5. Determining the complete proteome of yeast is an ongoing effort with continuous research.",
    "yulan-chat-2-13b-fp16_fact": [
      "It is feasible to determine the complete proteome of yeast.",
      "Comprehensive proteomic analyses of Saccharomyces cerevisiae have been published by several groups.",
      "These studies have identified thousands of proteins.",
      "Researchers use techniques such as mass spectrometry-based proteomics and two-dimensional gel electrophoresis to identify yeast proteins.",
      "Determining the complete proteome of yeast is an ongoing effort with continuous research."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 346,
    "user_query": "Which is the most common cause of sudden cardiac death in young athletes?",
    "yulan-chat-2-13b-fp16_response": "The most common cause of sudden cardiac death in young athletes is hypertrophic cardiomyopathy (HCM), a genetic disorder that affects the heart muscle and makes it thicken. HCM can cause the heart to thicken and become stiff, making it difficult for the heart to pump blood effectively and leading to sudden cardiac death during physical activity. Other causes of sudden cardiac death in young athletes include coronary artery disease, arrhythmias, and myocarditis. It is important for young athletes to undergo regular physical exams and heart screenings to identify any underlying heart conditions that may increase their risk of sudden cardiac death.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young athletes.\n2. Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle.\n3. HCM can lead to the thickening and stiffening of the heart muscle.\n4. Other causes of sudden cardiac death in young athletes include coronary artery disease, arrhythmias, and myocarditis.\n5. Regular physical exams and heart screenings can help identify underlying heart conditions in young athletes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young athletes.",
      "Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle.",
      "HCM can lead to the thickening and stiffening of the heart muscle.",
      "Other causes of sudden cardiac death in young athletes include coronary artery disease, arrhythmias, and myocarditis.",
      "Regular physical exams and heart screenings can help identify underlying heart conditions in young athletes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 347,
    "user_query": "Could the Menzerath-Altmann law be proved mathematically trivial in genomes?",
    "yulan-chat-2-13b-fp16_response": "The Menzerath-Altmann law is a statistical law that describes the relationship between the number of genes and the number of regulatory elements in a genome. It states that the ratio of the number of regulatory elements to the number of genes in a genome increases with the logarithm of the genome size.\nWhile the Menzerath-Altmann law has been observed in many genomes and is generally considered to be a robust statistical phenomenon, it is not mathematically trivial to prove. In fact, proving the Menzerath-Altmann law for a specific genome would require a detailed analysis of the genome's structure and organization, which is a complex and challenging task.\nThat being said, there have been some mathematical models that attempt to explain the Menzerath-Altmann law, such as the \"regulatory landscape\" model, which suggests that the distribution of regulatory elements in a genome is shaped by a balance between the rate of gene evolution and the cost of regulatory element duplication. However, these models are still subject to ongoing research and refinement.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Menzerath-Altmann law describes the relationship between the number of genes and the number of regulatory elements in a genome.\n2. The Menzerath-Altmann law states the ratio of the number of regulatory elements to the number of genes in a genome increases with the logarithm of the genome size.\n3. Proving the Menzerath-Altmann law requires a detailed analysis of a genome's structure and organization.\n4. The \"regulatory landscape\" model attempts to explain the Menzerath-Altmann law.\n5. The \"regulatory landscape\" model suggests a balance between the rate of gene evolution and the cost of regulatory element duplication shapes the distribution of regulatory elements in a genome.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Menzerath-Altmann law describes the relationship between the number of genes and the number of regulatory elements in a genome.",
      "The Menzerath-Altmann law states the ratio of the number of regulatory elements to the number of genes in a genome increases with the logarithm of the genome size.",
      "Proving the Menzerath-Altmann law requires a detailed analysis of a genome's structure and organization.",
      "The \"regulatory landscape\" model attempts to explain the Menzerath-Altmann law.",
      "The \"regulatory landscape\" model suggests a balance between the rate of gene evolution and the cost of regulatory element duplication shapes the distribution of regulatory elements in a genome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Menzerath-Altmann law describes a linguistic phenomenon of the relationship between the size of linguistic constructs (like sentences) and the length (such as the number of syllables) of the constructs within them.\n2. UNKNOWN\n3. UNKNOWN: While detailed analysis of a genome's structure and organization might be involved in testing or exploring biological laws analogous to the Menzerath-Altmann law applied to linguistics, without the exact biological context or a clear statement describing a biological version of the law, it's not possible to determine the truth of this statement.\n4. UNKNOWN\n5. UNKNOWN: Without more context, it's not possible to verify whether this model suggests such a balance or even if the \"regulatory landscape\" model relates to genomics or another field entirely.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "yulan-chat-2-13b-fp16_response": "Lon1 is a protein that plays a role in regulating the aging process in plants. In Arabidopsis, a model plant species for research, loss of the Lon1 protein has been shown to result in several phenotypic changes.\nOne of the most notable effects of loss of Lon1 is an increase in lifespan. Arabidopsis plants lacking Lon1 have been found to live longer than wild-type plants, indicating that Lon1 plays a role in regulating the aging process.\nIn addition to an extended lifespan, loss of Lon1 has also been shown to result in increased stress tolerance. Arabidopsis plants lacking Lon1 are better able to tolerate various types of stress, such as drought, salt, and cold stress.\nOther changes observed in Lon1-deficient plants include alterations in root growth, reduced fertility, and changes in the expression of genes involved in various metabolic pathways.\nOverall, the loss of Lon1 in Arabidopsis has been shown to result in a range of phenotypic changes, including an extended lifespan and increased stress tolerance.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lon1 protein plays a role in regulating the aging process in Arabidopsis plants.\n2. Arabidopsis plants lacking Lon1 have a longer lifespan compared to wild-type plants.\n3. Loss of Lon1 in Arabidopsis results in increased stress tolerance, particularly to drought, salt, and cold stress.\n4. Arabidopsis plants with a deficiency of the Lon1 protein exhibit alterations in root growth.\n5. Lon1-deficient Arabidopsis plants demonstrate reduced fertility.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lon1 protein plays a role in regulating the aging process in Arabidopsis plants.",
      "Arabidopsis plants lacking Lon1 have a longer lifespan compared to wild-type plants.",
      "Loss of Lon1 in Arabidopsis results in increased stress tolerance, particularly to drought, salt, and cold stress.",
      "Arabidopsis plants with a deficiency of the Lon1 protein exhibit alterations in root growth.",
      "Lon1-deficient Arabidopsis plants demonstrate reduced fertility."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: The Lon1 protein has been implicated in playing a role in the aging process of various organisms, including plants like Arabidopsis.\n2. FALSE [correction]: Arabidopsis plants lacking Lon1 typically have a shorter lifespan compared to wild-type plants, as Lon1 is involved in the removal of damaged proteins and maintaining mitochondrial function which are processes that can affect aging.\n3. TRUE: The loss of Lon1 in Arabidopsis has been associated with increased stress tolerance, including responses to drought, salt, and cold stress, as stress response mechanisms may be upregulated in the absence of Lon1.\n4. TRUE: Deficiencies in proteins that are involved in mitochondrial function, such as Lon1, can result in various developmental and physiological changes in plants, including alterations in root growth.\n5. UNKNOWN: Without specific information on how Lon1 deficiency affects the fertility of Arabidopsis plants, the effect on fertility cannot be determined. Additional research would be needed to confirm this statement.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 352,
    "user_query": "Are there studies representing the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's and Prion's disease, and cadasil syndrome?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are studies that suggest a role for Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's disease, and cadasil syndrome.\nDown syndrome is a genetic disorder caused by the presence of an extra copy of chromosome 21. Studies have shown that the Notch1 gene is one of the genes that is upregulated in the brains of individuals with Down syndrome, and that this upregulation may contribute to the development of certain features of the condition, such as cognitive impairment and Alzheimer's disease-like pathology.\nPick's disease is a rare neurodegenerative disorder that is characterized by the accumulation of abnormal protein aggregates in the brain. Some studies have suggested that mutations in the Notch1 gene may be involved in the development of Pick's disease, although the evidence is not yet conclusive.\nCadasil syndrome is a rare genetic disorder that is caused by mutations in the Notch2 gene. The condition is characterized by the accumulation of abnormal protein aggregates in the brain, as well as other features such as cognitive impairment, seizures, and peripheral neuropathy.\nPrion disease is a rare and fatal neurodegenerative disorder that is caused by the accumulation of abnormal protein aggregates in the brain. While there is currently no evidence to suggest that mutations in the Notch gene are involved in the development of prion disease, some studies have suggested that Notch signaling may play a role in the progression of the disease.\nOverall, while the evidence is still emerging, there is growing evidence to suggest that Notch mutations may play a role in the development of certain neurodegenerative diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Notch mutations have been suggested to play a role in neurodegenerative diseases such as Down syndrome, Pick's disease, and cadasil syndrome.\n2. The Notch1 gene is upregulated in the brains of individuals with Down syndrome, which may contribute to cognitive impairment and Alzheimer's disease-like pathology.\n3. Studies have shown that mutations in the Notch1 gene may be involved in the development of Pick's disease.\n4. Cadasil syndrome is caused by mutations in the Notch2 gene and is characterized by cognitive impairment, seizures, and peripheral neuropathy.\n5. No evidence currently suggests that mutations in the Notch gene are involved in the development of prion disease, though Notch signaling may play a role in the disease's progression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Notch mutations have been suggested to play a role in neurodegenerative diseases such as Down syndrome, Pick's disease, and cadasil syndrome.",
      "The Notch1 gene is upregulated in the brains of individuals with Down syndrome, which may contribute to cognitive impairment and Alzheimer's disease-like pathology.",
      "Studies have shown that mutations in the Notch1 gene may be involved in the development of Pick's disease.",
      "Cadasil syndrome is caused by mutations in the Notch2 gene and is characterized by cognitive impairment, seizures, and peripheral neuropathy.",
      "No evidence currently suggests that mutations in the Notch gene are involved in the development of prion disease, though Notch signaling may play a role in the disease's progression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Notch mutations have indeed been associated with various neurodegenerative conditions, including the ones listed.\n2. TRUE: There is evidence that in individuals with Down syndrome, the Notch1 gene is upregulated, which might contribute to the disease's pathology.\n3. UNKNOWN: While Notch signaling pathways have been implicated in various neurodegenerative diseases, whether specific mutations in the Notch1 gene are directly involved in the development of Pick's disease is not definitively established and would require current and more detailed research to confirm.\n4. FALSE [correction]: Cadasil syndrome is actually caused by mutations in the NOTCH3 gene, not Notch2. It is characterized by migraine with aura, mood disturbances, recurrent strokes, and dementia, not typically including seizures or peripheral neuropathy as primary features.\n5. UNKNOWN: Since the involvement of Notch mutations in prion diseases is still a topic of research and the statement does not commit to a definitive position, its accuracy is difficult to determine without more specific information.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 353,
    "user_query": "Are there any functional differences between Mfd and its human Cocaine syndrome protein B (CSB) homolog?",
    "yulan-chat-2-13b-fp16_response": "Mfd (Mitochondrial Dna-encoded heavy-chain assembly factor) and Cocaine-induced CSB (Cocaine-regulated serine protease) are two distinct proteins that have different functions.\nMfd is a protein that plays a role in the assembly of mitochondrial DNA-encoded heavy-chain proteins. It is involved in the transfer of proteins from the mitochondrial matrix to the intermembrane space, where they can be further processed and imported into the mitochondria.\nCocaine-induced CSB, on the other hand, is a serine protease that is upregulated in response to cocaine exposure. It has been implicated in the regulation of cocaine-induced changes in gene expression and may play a role in the development of cocaine addiction.\nTherefore, there are no functional differences between Mfd and its human CSB homolog, as they have distinct and unrelated functions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mfd (Mitochondrial Dna-encoded heavy-chain assembly factor) is involved in the assembly of mitochondrial DNA-encoded heavy-chain proteins.\n2. Mfd assists in the transfer of proteins from the mitochondrial matrix to the intermembrane space.\n3. Cocaine-induced CSB (Cocaine-regulated serine protease) is upregulated in response to cocaine exposure.\n4. Cocaine-induced CSB is implicated in the regulation of gene expression changes due to cocaine and may be involved in the development of cocaine addiction.\n5. Mfd and Cocaine-induced CSB have distinct and unrelated functions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mfd (Mitochondrial Dna-encoded heavy-chain assembly factor) is involved in the assembly of mitochondrial DNA-encoded heavy-chain proteins.",
      "Mfd assists in the transfer of proteins from the mitochondrial matrix to the intermembrane space.",
      "Cocaine-induced CSB (Cocaine-regulated serine protease) is upregulated in response to cocaine exposure.",
      "Cocaine-induced CSB is implicated in the regulation of gene expression changes due to cocaine and may be involved in the development of cocaine addiction.",
      "Mfd and Cocaine-induced CSB have distinct and unrelated functions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Mfd is thought to be involved in the maintenance of mitochondrial DNA rather than in the transfer of proteins from the mitochondrial matrix to the intermembrane space.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE (Based on the given statements, Mfd is related to mitochondrial DNA while Cocaine-induced CSB is related to cocaine response, which are separate biological processes. However, without further context, it's difficult to definitively determine the relationship between the two.)",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 354,
    "user_query": "What is membrane scission?",
    "yulan-chat-2-13b-fp16_response": "Membrane scission is the process of cleaving or splitting a lipid bilayer, which is the main component of cell membranes. This process involves the separation of two layers of lipids, resulting in the formation of two separate lipid layers.\nMembrane scission can occur through various mechanisms, including:\n1. Exocytosis: This is the process of moving a cell membrane inward, allowing the cell to take in material from the outside. During exocytosis, the cell membrane fuses with the cell membrane of the target cell, and the contents of the vesicle are released into the target cell.\n2. Endocytosis: This is the process of moving a cell membrane outward, allowing the cell to take in material from the inside. During endocytosis, the cell membrane forms a pocket around the material, and the pocket is then engulfed by the cell.\n3. Hemolysis: This is the process of breaking down red blood cells, which are composed of a lipid bilayer and a protein called hemoglobin. Hemolysis occurs when the red blood cells are damaged or destroyed, and the lipid bilayer is separated.\nMembrane scission is an important process in many biological processes, including cell signaling, cell division, and the transport of molecules across cell membranes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Membrane scission is the process of cleaving or splitting a lipid bilayer, which is the main component of cell membranes.\n2. The process of membrane scission results in the formation of two separate lipid layers.\n3. Exocytosis is a mechanism of membrane scission where cell membrane moves inward, and the contents of the vesicle are released into the target cell.\n4. Endocytosis is a mechanism of membrane scission where cell membrane moves outward, forming a pocket around material which is then engulfed by the cell.\n5. Hemolysis, a form of membrane scission, involves breaking down red blood cells, separating the lipid bilayer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Membrane scission is the process of cleaving or splitting a lipid bilayer, which is the main component of cell membranes.",
      "The process of membrane scission results in the formation of two separate lipid layers.",
      "Exocytosis is a mechanism of membrane scission where cell membrane moves inward, and the contents of the vesicle are released into the target cell.",
      "Endocytosis is a mechanism of membrane scission where cell membrane moves outward, forming a pocket around material which is then engulfed by the cell.",
      "Hemolysis, a form of membrane scission, involves breaking down red blood cells, separating the lipid bilayer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The process of membrane scission results in the separation of a vesicle from a lipid bilayer, not necessarily the formation of two separate lipid layers.\n3. FALSE [correction]: Exocytosis is a mechanism where cell membrane moves outward, and the contents of the vesicle are released outside of the cell, not into a target cell.\n4. FALSE [correction]: Endocytosis is a mechanism where cell membrane moves inward, forming a pocket around material which is then engulfed by the cell, and it does not involve membrane scission but rather membrane invagination followed by vesicle formation.\n5. FALSE [correction]: Hemolysis refers to the destruction or lysis of red blood cells, resulting in the release of hemoglobin; it is not a form of membrane scission in the context of cellular transport processes like endocytosis or exocytosis.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 356,
    "user_query": "Is the yeast ac1 transcription factor induced upon copper deficiency?",
    "yulan-chat-2-13b-fp16_response": "Yes, the yeast transcription factor MAP1 (Mac1) is induced upon copper deficiency. MAP1 is a key regulator of copper homeostasis in yeast and is involved in the transcriptional control of genes involved in copper uptake, transport, and utilization.\nCopper deficiency in yeast leads to a decrease in copper levels, which triggers the induction of MAP1. The induced MAP1 then binds to the promoter regions of target genes involved in copper uptake and utilization, such as the CTR1 and CTR2 genes, and activates their transcription. This results in increased expression of these genes and ultimately leads to increased copper uptake and utilization in the cell.\nOverall, the induction of MAP1 upon copper deficiency is an important mechanism for regulating copper homeostasis in yeast and ensuring that the cell has access to sufficient copper for its biological functions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The yeast transcription factor MAP1 (Mac1) is induced upon copper deficiency.\n2. MAP1 regulates copper homeostasis in yeast.\n3. MAP1 is involved in the transcriptional control of genes related to copper uptake, transport, and utilization.\n4. Copper deficiency triggers the induction of MAP1, which then binds to the promoter regions of target genes.\n5. The target genes for MAP1 include the CTR1 and CTR2 genes that are involved in copper uptake and utilization.",
    "yulan-chat-2-13b-fp16_fact": [
      "The yeast transcription factor MAP1 (Mac1) is induced upon copper deficiency.",
      "MAP1 regulates copper homeostasis in yeast.",
      "MAP1 is involved in the transcriptional control of genes related to copper uptake, transport, and utilization.",
      "Copper deficiency triggers the induction of MAP1, which then binds to the promoter regions of target genes.",
      "The target genes for MAP1 include the CTR1 and CTR2 genes that are involved in copper uptake and utilization."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The target genes for Mac1 include the CTR1 and CTR3 genes that are involved in copper uptake. CTR2 is involved in copper transport but is not directly regulated by Mac1.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 357,
    "user_query": "What is the mechanism of DNA replication termination in vertebrates?",
    "yulan-chat-2-13b-fp16_response": "In vertebrates, DNA replication termination is a highly regulated process that involves the coordination of multiple proteins to ensure the accurate and timely completion of DNA synthesis. The process of DNA replication termination can be divided into three main stages: pre-replication, replication, and post-replication.\nDuring the pre-replication stage, a complex called the Cdc45-GINS (CDK-associated factor 45 and the minichromosome maintenance complex) helicase is loaded onto the DNA. This complex unwinds the DNA and primes the replication fork for the entry of the replication machinery.\nDuring the replication stage, the DNA polymerase delta (Pol ) enzyme is recruited to the replication fork and initiates the synthesis of new strands of DNA. Pol  synthesizes DNA in a 5' to 3' direction and is able to proofread newly synthesized DNA to ensure its accuracy.\nAt the end of the replication stage, the process of DNA replication termination is initiated. This involves the recruitment of several proteins, including the Cdc20 and Cdc45 phosphatases, which activate the Mcm helicase. The Mcm helicase then unwinds the DNA at the replication fork, allowing the replication machinery to move past the end of the DNA strand.\nFinally, during the post-replication stage, the DNA is processed to ensure its proper function. This involves the removal of the replication fork and the ligation of the DNA strands.\nOverall, the process of DNA replication termination in vertebrates is a highly regulated process that involves the coordination of multiple proteins to ensure the accurate and timely completion of DNA synthesis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DNA replication termination in vertebrates is a regulated process that involves multiple proteins.\n2. The pre-replication stage of DNA replication termination includes the loading of the Cdc45-GINS helicase complex onto DNA.\n3. DNA polymerase delta (Pol ) is recruited during the replication stage and has a proofreading function to ensure accuracy.\n4. Proteins such as Cdc20 and Cdc45 phosphatases are recruited for the initiation of DNA replication termination.\n5. The Mcm helicase unwinds the DNA at the replication fork to permit the replication machinery to progress past the end of the DNA strand during termination.",
    "yulan-chat-2-13b-fp16_fact": [
      "DNA replication termination in vertebrates is a regulated process that involves multiple proteins.",
      "The pre-replication stage of DNA replication termination includes the loading of the Cdc45-GINS helicase complex onto DNA.",
      "DNA polymerase delta (Pol ) is recruited during the replication stage and has a proofreading function to ensure accuracy.",
      "Proteins such as Cdc20 and Cdc45 phosphatases are recruited for the initiation of DNA replication termination.",
      "The Mcm helicase unwinds the DNA at the replication fork to permit the replication machinery to progress past the end of the DNA strand during termination."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The pre-replication stage of DNA replication involves the loading of the Cdc45-GINS helicase complex onto DNA, but this occurs during initiation, not termination.\n3. TRUE\n4. FALSE [correction]: Cdc20 is not a phosphatase and is not recruited for the initiation of DNA replication termination. Instead, Cdc20 is an activator of the anaphase-promoting complex (APC) during mitosis. Cdc45 is involved in the initiation of DNA replication, not termination, and it is not a phosphatase.\n5. FALSE [correction]: The Mcm helicase unwinds the DNA at the replication fork to permit the replication machinery to progress, but this activity occurs during the elongation phase of DNA replication, not specifically during termination.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 360,
    "user_query": "Have thyronamines  effects on fat tissue?",
    "yulan-chat-2-13b-fp16_response": "Thyronamines are compounds that are structurally similar to thyroid hormones and can interact with thyroid receptors. Some studies have suggested that thyronamines may have effects on fat tissue, including increasing lipolysis (the breakdown of fat) and reducing fat mass. However, more research is needed to fully understand the potential effects of thyronamines on fat tissue and their clinical relevance.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyronamines are structurally similar to thyroid hormones.\n2. Thyronamines can interact with thyroid receptors.\n3. Some studies suggest that thyronamines may increase lipolysis.\n4. It has been suggested that thyronamines may reduce fat mass.\n5. More research is needed to fully understand the potential effects of thyronamines on fat tissue.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyronamines are structurally similar to thyroid hormones.",
      "Thyronamines can interact with thyroid receptors.",
      "Some studies suggest that thyronamines may increase lipolysis.",
      "It has been suggested that thyronamines may reduce fat mass.",
      "More research is needed to fully understand the potential effects of thyronamines on fat tissue."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Thyronamines do not bind to thyroid hormone receptors but rather to a distinct set of receptors, such as trace amine-associated receptors (TAARs).\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 361,
    "user_query": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?",
    "yulan-chat-2-13b-fp16_response": "The name of the anti-CD52 monoclonal antibody used for the treatment of multiple sclerosis patients is Alemtuzumab.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alemtuzumab is an anti-CD52 monoclonal antibody used for the treatment of multiple sclerosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alemtuzumab is an anti-CD52 monoclonal antibody used for the treatment of multiple sclerosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 369,
    "user_query": "At which kind of individuals is pharmacological treatment of subclinical hypothyroidism effective in reducing cardiovascular events?",
    "yulan-chat-2-13b-fp16_response": "Pharmacological treatment of subclinical hypothyroidism may be effective in reducing cardiovascular events in individuals with symptoms of cardiovascular disease, such as high blood pressure, cholesterol levels, or a history of heart attack or stroke. However, the evidence is not conclusive and more research is needed to determine the benefits of treating subclinical hypothyroidism in individuals without symptoms of cardiovascular disease. It is important to note that subclinical hypothyroidism is often asymptomatic and may not cause any harm if left untreated. Therefore, the decision to treat subclinical hypothyroidism should be made on a case-by-case basis, taking into account the individual's overall health and risk factors for cardiovascular disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pharmacological treatment of subclinical hypothyroidism may be effective in reducing cardiovascular events in individuals with symptoms of cardiovascular disease.\n2. Individuals with symptoms of cardiovascular disease may include those with high blood pressure, cholesterol levels, or a history of heart attack or stroke.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pharmacological treatment of subclinical hypothyroidism may be effective in reducing cardiovascular events in individuals with symptoms of cardiovascular disease.",
      "Individuals with symptoms of cardiovascular disease may include those with high blood pressure, cholesterol levels, or a history of heart attack or stroke."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN (Without specific evidence from clinical studies or guidelines, the effectiveness of pharmacological treatment of subclinical hypothyroidism in reducing cardiovascular events cannot be determined as a general statement.)\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 372,
    "user_query": "What is known about the association between the use of selective serotonin reuptake inhibitors during pregnancy and risk for autism in offspring?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may increase the risk of autism spectrum disorder (ASD) in offspring. However, the evidence is not definitive and more research is needed to confirm the association.\nStudies have shown that SSRIs can cross the placenta and reach the developing fetus. Some research suggests that exposure to SSRIs during pregnancy may increase the risk of ASD in offspring, although the exact mechanism is not fully understood.\nHowever, it is important to note that the overall risk of ASD in offspring is still relatively low, and the decision to use SSRIs during pregnancy should be made on a case-by-case basis with the advice of a healthcare provider. Women who are taking SSRIs and are pregnant or planning to become pregnant should discuss the potential risks and benefits with their healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may increase the risk of autism spectrum disorder (ASD) in offspring.\n2. SSRIs can cross the placenta and reach the developing fetus.\n3. Studies suggest an increased risk of ASD associated with exposure to SSRIs during pregnancy, though the exact mechanism is unclear.\n4. The overall risk of ASD in offspring due to SSRI usage during pregnancy is considered relatively low.\n5. Decisions regarding the use of SSRIs during pregnancy should be made with the advice of a healthcare provider.",
    "yulan-chat-2-13b-fp16_fact": [
      "The use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may increase the risk of autism spectrum disorder (ASD) in offspring.",
      "SSRIs can cross the placenta and reach the developing fetus.",
      "Studies suggest an increased risk of ASD associated with exposure to SSRIs during pregnancy, though the exact mechanism is unclear.",
      "The overall risk of ASD in offspring due to SSRI usage during pregnancy is considered relatively low.",
      "Decisions regarding the use of SSRIs during pregnancy should be made with the advice of a healthcare provider."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Some studies have suggested that the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may be associated with an increased risk of autism spectrum disorder (ASD) in offspring, but there is still debate and ongoing research to understand this relationship fully.\n2. TRUE: SSRIs can cross the placenta, which means they have the potential to reach the developing fetus.\n3. TRUE: There is a suggested increase in risk of ASD associated with exposure to SSRIs during pregnancy, as per some studies. However, the mechanism by which SSRIs may contribute to this increased risk is not fully understood.\n4. TRUE: While there is an observed association in some studies between SSRI exposure during pregnancy and an increased risk of ASD, it is generally considered that the absolute risk increase is relatively low.\n5. TRUE: Decisions about the use of SSRIs during pregnancy should be individualized and made in consultation with a healthcare provider, considering both the benefits and risks to the mother and the developing fetus.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 374,
    "user_query": "Is desmin an intermediate filament protein involved in Dilated Cardiomyopathy (DCM)?",
    "yulan-chat-2-13b-fp16_response": "Desmin is an intermediate filament protein that is involved in the structure and function of cardiac muscle cells. Dilated cardiomyopathy (DCM) is a type of heart muscle disease that can cause the heart to become enlarged and weakened, leading to difficulty pumping blood. Desmin is one of the intermediate filament proteins that is found in the heart muscle cells of the myocardium, and it plays a role in maintaining the structure and function of these cells.\nResearch has shown that mutations in the desmin gene can cause DCM, and that the presence of abnormal desmin protein in the heart muscle cells of patients with DCM is a marker of the disease. However, it is important to note that desmin is not the only intermediate filament protein that is involved in DCM, and that other factors, such as genetic mutations and environmental factors, can also contribute to the development of the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Desmin is an intermediate filament protein involved in the structure and function of cardiac muscle cells.\n2. Dilated cardiomyopathy (DCM) can cause the heart to become enlarged and weakened.\n3. Desmin is found in the heart muscle cells of the myocardium.\n4. Mutations in the desmin gene can cause DCM.\n5. Abnormal desmin protein in heart muscle cells is a marker of DCM.",
    "yulan-chat-2-13b-fp16_fact": [
      "Desmin is an intermediate filament protein involved in the structure and function of cardiac muscle cells.",
      "Dilated cardiomyopathy (DCM) can cause the heart to become enlarged and weakened.",
      "Desmin is found in the heart muscle cells of the myocardium.",
      "Mutations in the desmin gene can cause DCM.",
      "Abnormal desmin protein in heart muscle cells is a marker of DCM."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Abnormal desmin protein in heart muscle cells is associated with desmin-related myopathies including DCM, but it is not exclusively a marker of DCM. Other conditions can also cause abnormal desmin protein accumulations.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 376,
    "user_query": "List human diseases involving genomic imprinting.",
    "yulan-chat-2-13b-fp16_response": "Genomic imprinting is a process in which the expression of certain genes is controlled by the parent of origin, with the paternal allele being expressed in the offspring of a male, and the maternal allele being expressed in the offspring of a female. Genomic imprinting plays an important role in the development of certain tissues and organs, and it is also involved in the regulation of various physiological processes.\nThere are several human diseases that involve genomic imprinting, including:\n1. Angelman syndrome: This is a rare genetic disorder that affects the development of the brain and nervous system. It is caused by a deletion or mutation of the maternally inherited UBE3A gene, which is imprinted in the brain.\n2. Prader-Willi syndrome: This is a genetic disorder that affects the development of the brain and nervous system, as well as the endocrine system. It is caused by a deletion or mutation of the paternally inherited genes on chromosome 15, which are imprinted in the brain.\n3. Beckwith-Wiedemann syndrome: This is a genetic disorder that affects the development of the brain and nervous system, as well as the limbs and other body structures. It is caused by a deletion or mutation of the paternally inherited genes on chromosome 11p15.5, which are imprinted in the brain.\n4. Rett syndrome: This is a rare genetic disorder that affects the development of the brain and nervous system. It is caused by a mutation of the MECP2 gene, which is imprinted in the brain.\n5. Silver-Russell syndrome: This is a genetic disorder that affects the development of the body, causing a wide range of physical features and health problems. It is caused by a deletion or mutation of the paternally inherited genes on chromosome 11p15.5, which are imprinted in the body.\nThese are just a few examples of human diseases that involve genomic imprinting. There are many other diseases that are also thought to be related to genomic imprinting, and research in this area is ongoing.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Angelman syndrome is caused by a deletion or mutation of the maternally inherited UBE3A gene.\n2. Prader-Willi syndrome is caused by a deletion or mutation of the paternally inherited genes on chromosome 15.\n3. Beckwith-Wiedemann syndrome is caused by a deletion or mutation of the paternally inherited genes on chromosome 11p15.5.\n4. Rett syndrome is caused by a mutation of the MECP2 gene.\n5. Silver-Russell syndrome is caused by a deletion or mutation of the paternally inherited genes on chromosome 11p15.5.",
    "yulan-chat-2-13b-fp16_fact": [
      "Angelman syndrome is caused by a deletion or mutation of the maternally inherited UBE3A gene.",
      "Prader-Willi syndrome is caused by a deletion or mutation of the paternally inherited genes on chromosome 15.",
      "Beckwith-Wiedemann syndrome is caused by a deletion or mutation of the paternally inherited genes on chromosome 11p15.5.",
      "Rett syndrome is caused by a mutation of the MECP2 gene.",
      "Silver-Russell syndrome is caused by a deletion or mutation of the paternally inherited genes on chromosome 11p15.5."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Silver-Russell syndrome is primarily associated with dysregulation of imprinted genes on chromosome 7 and 11p15.5. There are instances where the maternally inherited genes, not the paternally inherited genes, are affected on chromosome 11p15.5.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 378,
    "user_query": "Which deficiency is the cause of restless leg syndrome?",
    "yulan-chat-2-13b-fp16_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an overwhelming urge to move the legs, often accompanied by uncomfortable sensations such as creeping, crawling, or throbbing. While the exact cause of RLS is not fully understood, it is believed to be related to a deficiency in iron.\nIron is essential for the production of hemoglobin, a protein in red blood cells that carries oxygen from the lungs to the body's tissues. When iron levels are low, the body may not be able to supply enough oxygen to the nerves, leading to the uncomfortable sensations and urge to move that are characteristic of RLS.\nOther potential causes of RLS include nerve damage, kidney disease, diabetes, and certain medications. However, the most common cause of RLS is iron deficiency. Treatment for RLS often involves addressing the underlying cause, such as iron supplements for those with iron deficiency.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Restless leg syndrome (RLS) is a neurological disorder characterized by an overwhelming urge to move the legs.\n2. The exact cause of Restless leg syndrome is not fully understood.\n3. A deficiency in iron is believed to be related to Restless leg syndrome.\n4. Treatment for RLS often involves iron supplements for those with iron deficiency.\n5. Iron is essential for the production of hemoglobin, which carries oxygen from the lungs to the body's tissues.",
    "yulan-chat-2-13b-fp16_fact": [
      "Restless leg syndrome (RLS) is a neurological disorder characterized by an overwhelming urge to move the legs.",
      "The exact cause of Restless leg syndrome is not fully understood.",
      "A deficiency in iron is believed to be related to Restless leg syndrome.",
      "Treatment for RLS often involves iron supplements for those with iron deficiency.",
      "Iron is essential for the production of hemoglobin, which carries oxygen from the lungs to the body's tissues."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 379,
    "user_query": "What histone modification is recognized by the bromodomain?",
    "yulan-chat-2-13b-fp16_response": "The bromodomain recognizes the acetylation modification on histone proteins. Acetylation of histones is a reversible modification that can be added or removed by enzymes, and it plays a key role in regulating gene expression. The bromodomain is a protein domain found in several transcription factors and chromatin remodeling complexes, and it binds specifically to acetylated lysine residues on histone proteins. This binding can recruit other proteins that can alter chromatin structure and accessibility, ultimately affecting gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The bromodomain recognizes the acetylation modification on histone proteins.\n2. Acetylation of histones is a reversible modification.\n3. Acetylation of histones is added or removed by enzymes.\n4. The bromodomain is found in several transcription factors and chromatin remodeling complexes.\n5. The bromodomain binds specifically to acetylated lysine residues on histone proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "The bromodomain recognizes the acetylation modification on histone proteins.",
      "Acetylation of histones is a reversible modification.",
      "Acetylation of histones is added or removed by enzymes.",
      "The bromodomain is found in several transcription factors and chromatin remodeling complexes.",
      "The bromodomain binds specifically to acetylated lysine residues on histone proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 387,
    "user_query": "What is the methodological principle of ChIA-PET?",
    "yulan-chat-2-13b-fp16_response": "ChIA-PET (Chromatin Interaction Analysis by Paired-End Tagging) is a method for studying the three-dimensional organization of chromosomes in cells. The methodological principle of ChIA-PET is to use paired-end sequencing to identify the locations where chromosomal regions interact with each other. This is done by analyzing the patterns of DNA interactions that occur between chromosomes during the process of mitosis, when chromosomes are being separated and distributed to the two daughter cells. By analyzing these interactions, researchers can gain insights into the spatial organization of chromosomes and how they are organized within the nucleus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ChIA-PET stands for Chromatin Interaction Analysis by Paired-End Tagging.\n2. ChIA-PET is utilized for studying the three-dimensional organization of chromosomes in cells.\n3. The method involves paired-end sequencing to identify where chromosomal regions interact.\n4. ChIA-PET analysis is conducted by examining DNA interaction patterns during mitosis.\n5. The technique provides insights into spatial chromosome organization and nuclear arrangement.",
    "yulan-chat-2-13b-fp16_fact": [
      "ChIA-PET stands for Chromatin Interaction Analysis by Paired-End Tagging.",
      "ChIA-PET is utilized for studying the three-dimensional organization of chromosomes in cells.",
      "The method involves paired-end sequencing to identify where chromosomal regions interact.",
      "ChIA-PET analysis is conducted by examining DNA interaction patterns during mitosis.",
      "The technique provides insights into spatial chromosome organization and nuclear arrangement."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: ChIA-PET analysis is typically conducted to examine DNA interaction patterns at a specific snapshot in time, which could be during interphase or other stages of the cell cycle, not just limited to mitosis.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 390,
    "user_query": "Does PU.1 (SPI1) affect NF-kB binding?",
    "yulan-chat-2-13b-fp16_response": "Yes, PU.1 (SPI1) can affect NF-kB binding. PU.1 is a transcription factor that plays a key role in the development and maintenance of hematopoietic stem cells and is involved in the regulation of many genes, including those involved in the immune response. NF-kB is a transcription factor that regulates the expression of genes involved in inflammation and immune function. PU.1 can interact with NF-kB and modulate its activity, either enhancing or inhibiting NF-kB-mediated transcription. The exact mechanisms by which PU.1 affects NF-kB binding are not fully understood, but it is thought to involve direct interactions between the two transcription factors and alterations in the chromatin structure around NF-kB target genes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PU.1 (SPI1) is a transcription factor important for the development and maintenance of hematopoietic stem cells.\n2. PU.1 is involved in the regulation of genes associated with the immune response.\n3. NF-kB is a transcription factor that regulates gene expression related to inflammation and immune function.\n4. PU.1 can interact with NF-kB and influence its transcriptional activity.\n5. The interaction between PU.1 and NF-kB may involve altering the chromatin structure around NF-kB target genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "PU.1 (SPI1) is a transcription factor important for the development and maintenance of hematopoietic stem cells.",
      "PU.1 is involved in the regulation of genes associated with the immune response.",
      "NF-kB is a transcription factor that regulates gene expression related to inflammation and immune function.",
      "PU.1 can interact with NF-kB and influence its transcriptional activity.",
      "The interaction between PU.1 and NF-kB may involve altering the chromatin structure around NF-kB target genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nPU.1 is known for its role in immune system development and function, NF-B is a key regulator of inflammatory and immune responses, and there are indeed studies suggesting that PU.1 can interact with NF-B to regulate gene expression, sometimes involving changes in chromatin structure.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 391,
    "user_query": "Does the majority of the mitochondrial genomes abide to the second parity rule (PR2)?",
    "yulan-chat-2-13b-fp16_response": "The second parity rule (PR2) is a rule in molecular biology that states that the majority of the mitochondrial genome should be oriented in a specific direction. Specifically, it states that the majority of the mitochondrial genome should be oriented in the same direction as the majority of the nuclear genome.\nHowever, it is important to note that the majority of the mitochondrial genome does not necessarily abide by the second parity rule (PR2). In fact, many organisms have mitochondrial genomes that are oriented in a different direction than the majority of their nuclear genome. This is because the orientation of the mitochondrial genome is determined by a variety of factors, including the replication machinery of the mitochondria and the presence of rearrangements within the genome.\nTherefore, while the second parity rule (PR2) is a useful rule of thumb for predicting the orientation of the mitochondrial genome, it is not a hard and fast rule that applies to all organisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The second parity rule (PR2) is a rule in molecular biology that pertains to the orientation of the mitochondrial genome.\n2. The second parity rule (PR2) suggests that the majority of the mitochondrial genome should be oriented in the same direction as the majority of the nuclear genome.\n3. Many organisms have mitochondrial genomes that are oriented differently than the majority of their nuclear genome.\n4. Factors such as the replication machinery of the mitochondria and the presence of rearrangements can determine the orientation of the mitochondrial genome.",
    "yulan-chat-2-13b-fp16_fact": [
      "The second parity rule (PR2) is a rule in molecular biology that pertains to the orientation of the mitochondrial genome.",
      "The second parity rule (PR2) suggests that the majority of the mitochondrial genome should be oriented in the same direction as the majority of the nuclear genome.",
      "Many organisms have mitochondrial genomes that are oriented differently than the majority of their nuclear genome.",
      "Factors such as the replication machinery of the mitochondria and the presence of rearrangements can determine the orientation of the mitochondrial genome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The second parity rule (PR2) is not specifically about the orientation of the mitochondrial or any other genome, but it states that each of the four DNA bases (adenine [A], thymine [T], cytosine [C], and guanine [G]) should be present in a genome at roughly equal proportions of 1:1, meaning AT and CG.\n2. FALSE [correction]: The second parity rule (PR2) refers to the observation that on a single DNA strand the percentages of adenine and thymine are roughly equal, as are the percentages of cytosine and guanine; it does not suggest anything about the orientation of the mitochondrial genome in relation to the nuclear genome.\n3. UNKNOWN\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 396,
    "user_query": "Which hormone abnormalities are common in Williams syndrome ?",
    "yulan-chat-2-13b-fp16_response": "Williams syndrome is a genetic disorder caused by a deletion of a segment of chromosome 7, which includes several genes. One of the characteristic features of Williams syndrome is the presence of abnormalities in the levels and activity of several hormones in the body.\nSome of the hormone abnormalities that are commonly seen in individuals with Williams syndrome include:\n1. Low levels of platelet-derived growth factor (PDGF): This hormone is important for the growth and development of cells in the body, and low levels of PDGF can lead to slow growth and developmental delays in children with Williams syndrome.\n2. High levels of dopamine: Dopamine is a neurotransmitter that plays a role in regulating movement, mood, and cognition. High levels of dopamine are associated with hyperactivity, impulsivity, and behavioral problems in individuals with Williams syndrome.\n3. Low levels of vasopressin: Vasopressin is a hormone that regulates blood pressure and fluid balance in the body. Low levels of vasopressin can lead to low blood pressure and increased thirst in individuals with Williams syndrome.\n4. Low levels of thyroid hormone: Thyroid hormone is important for regulating metabolism in the body. Low levels of thyroid hormone can lead to slow growth and development, as well as fatigue and weight gain.\n5. Abnormal levels of sex hormones: Individuals with Williams syndrome may have abnormal levels of sex hormones, including low levels of testosterone in males and high levels of estrogen in females. This can lead to delayed puberty and other reproductive problems.\nIt's important to note that not all individuals with Williams syndrome will have all of these hormone abnormalities, and the severity of the abnormalities can vary widely depending on the individual.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Williams syndrome is caused by a deletion of a segment of chromosome 7.\n2. Individuals with Williams syndrome commonly have low levels of platelet-derived growth factor (PDGF).\n3. Those with Williams syndrome often exhibit high levels of dopamine.\n4. Low levels of vasopressin are a common abnormality in individuals with Williams syndrome.\n5. Abnormal levels of thyroid hormone are commonly seen in those with Williams syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Williams syndrome is caused by a deletion of a segment of chromosome 7.",
      "Individuals with Williams syndrome commonly have low levels of platelet-derived growth factor (PDGF).",
      "Those with Williams syndrome often exhibit high levels of dopamine.",
      "Low levels of vasopressin are a common abnormality in individuals with Williams syndrome.",
      "Abnormal levels of thyroid hormone are commonly seen in those with Williams syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: Abnormal levels of calcium are commonly seen in those with Williams syndrome, particularly during infancy. There is no widespread evidence to suggest that abnormal levels of thyroid hormone are a common feature of Williams syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 398,
    "user_query": "Albumin depletion is a common first step for proteomic analysis of CSF fluid. What is the advantage and disadvantage of this procedure?",
    "yulan-chat-2-13b-fp16_response": "Albumin depletion is a common technique used in proteomic analysis of CSF (cerebrospinal fluid) to enrich the analysis for low molecular weight proteins. The main advantage of this procedure is that it allows for the detection of proteins that are often overshadowed by the high abundance of albumin in CSF. By removing albumin, the low molecular weight proteins can be more easily detected and quantified.\nHowever, there are also some disadvantages to this procedure. First, albumin depletion can lead to a loss of important proteins that are bound to albumin, which may affect the accuracy of the results. Additionally, the depletion process can be time-consuming and may require multiple steps, which can increase the complexity and cost of the analysis.\nOverall, the advantages of albumin depletion in proteomic analysis of CSF outweigh the disadvantages, and it remains a commonly used technique in the field. However, it is important to carefully consider the potential limitations of the procedure and to validate the results with other methods whenever possible.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Albumin depletion is used in proteomic analysis to enrich the analysis for low molecular weight proteins in CSF (cerebrospinal fluid).\n2. The main advantage of albumin depletion is it allows for the detection of low molecular weight proteins that are usually overshadowed by the abundance of albumin in CSF.\n3. One disadvantage is that important proteins bound to albumin may be lost during albumin depletion.\n4. The albumin depletion process can be time-consuming and may increase the complexity and cost of the analysis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Albumin depletion is used in proteomic analysis to enrich the analysis for low molecular weight proteins in CSF (cerebrospinal fluid).",
      "The main advantage of albumin depletion is it allows for the detection of low molecular weight proteins that are usually overshadowed by the abundance of albumin in CSF.",
      "One disadvantage is that important proteins bound to albumin may be lost during albumin depletion.",
      "The albumin depletion process can be time-consuming and may increase the complexity and cost of the analysis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nThese statements are generally true based on current knowledge of proteomics and albumin depletion methods used to enrich samples for lower-abundance proteins. Albumin depletion is a common technique used to decrease the concentration of albumin, which is a high-abundance protein in biological fluids such as CSF. This helps in detecting lower-abundance proteins that are otherwise difficult to identify due to the masking effect of albumin. Albumin depletion can indeed lead to the loss of proteins that bind to albumin and also potentially add steps to the process, thus increasing time, complexity, and cost.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 401,
    "user_query": "Which residue of alpha-synuclein was found to be phosphorylated in Lewy bodies?",
    "yulan-chat-2-13b-fp16_response": "The residue of alpha-synuclein that is found to be phosphorylated in Lewy bodies is serine 129.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alpha-synuclein has a residue that is found to be phosphorylated in Lewy bodies.\n2. The specific residue of alpha-synuclein phosphorylated in Lewy bodies is serine 129.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alpha-synuclein has a residue that is found to be phosphorylated in Lewy bodies.",
      "The specific residue of alpha-synuclein phosphorylated in Lewy bodies is serine 129."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 403,
    "user_query": "What is known about thalidomide therapy and survival of glioblastoma patients?",
    "yulan-chat-2-13b-fp16_response": "Thalidomide is an immunomodulatory drug that has been used in the treatment of various cancers, including glioblastoma. It works by inhibiting the production of certain proteins that are involved in the growth and survival of cancer cells.\nSeveral clinical trials have investigated the use of thalidomide in the treatment of glioblastoma. One phase II trial found that thalidomide given in combination with standard chemotherapy was effective in extending the survival of patients with newly diagnosed glioblastoma. Another phase II trial found that thalidomide given as a single agent was also effective in extending survival in patients with recurrent glioblastoma.\nHowever, it is important to note that thalidomide can have serious side effects, including birth defects if taken by pregnant women. It is also not recommended for use in women who are pregnant or planning to become pregnant, as well as in men who are trying to father a child, due to the risk of birth defects.\nOverall, thalidomide appears to be a promising treatment option for glioblastoma patients, but further research is needed to fully understand its efficacy and safety.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thalidomide is an immunomodulatory drug used in treating various cancers, including glioblastoma.\n2. Thalidomide inhibits the production of proteins involved in the growth and survival of cancer cells.\n3. A phase II clinical trial indicated that thalidomide combined with standard chemotherapy extended survival for patients with newly diagnosed glioblastoma.\n4. According to another phase II trial, thalidomide as a single agent was effective in extending survival for patients with recurrent glioblastoma.\n5. Thalidomide can cause serious side effects such as birth defects if taken by pregnant women.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thalidomide is an immunomodulatory drug used in treating various cancers, including glioblastoma.",
      "Thalidomide inhibits the production of proteins involved in the growth and survival of cancer cells.",
      "A phase II clinical trial indicated that thalidomide combined with standard chemotherapy extended survival for patients with newly diagnosed glioblastoma.",
      "According to another phase II trial, thalidomide as a single agent was effective in extending survival for patients with recurrent glioblastoma.",
      "Thalidomide can cause serious side effects such as birth defects if taken by pregnant women."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Thalidomide as a single agent was not significantly effective in extending survival for patients with recurrent glioblastoma, according to available literature.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 404,
    "user_query": "Is endostatin a proangiogenic factor?",
    "yulan-chat-2-13b-fp16_response": "Endostatin is a naturally occurring protein that is found in the cell walls of endothelial cells, which are the cells that line the blood vessels. It has been shown to have proangiogenic effects, meaning that it promotes the growth of new blood vessels.\nEndostatin works by inhibiting the activity of matrix metalloproteinases (MMPs), which are enzymes that break down extracellular matrix proteins. By inhibiting the activity of MMPs, endostatin helps to maintain the integrity of the extracellular matrix, which is important for the formation of new blood vessels.\nIn addition to its proangiogenic effects, endostatin has also been shown to have anti-tumor effects, as it can inhibit the growth and spread of cancer cells. As a result, it is being investigated as a potential therapeutic agent for the treatment of various types of cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Endostatin is a naturally occurring protein found in the cell walls of endothelial cells.\n2. Endostatin promotes the growth of new blood vessels, exhibiting proangiogenic effects.\n3. Endostatin inhibits the activity of matrix metalloproteinases (MMPs).\n4. The inhibition of MMPs by endostatin helps to maintain the integrity of the extracellular matrix.\n5. Endostatin has been shown to have anti-tumor effects and is being investigated as a potential therapeutic agent for cancer treatment.",
    "yulan-chat-2-13b-fp16_fact": [
      "Endostatin is a naturally occurring protein found in the cell walls of endothelial cells.",
      "Endostatin promotes the growth of new blood vessels, exhibiting proangiogenic effects.",
      "Endostatin inhibits the activity of matrix metalloproteinases (MMPs).",
      "The inhibition of MMPs by endostatin helps to maintain the integrity of the extracellular matrix.",
      "Endostatin has been shown to have anti-tumor effects and is being investigated as a potential therapeutic agent for cancer treatment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Endostatin is a naturally occurring protein found in blood vessels, but it is not part of the cell walls of endothelial cells; rather, it is a component of the extracellular matrix and cleaved from a larger protein, collagen XVIII.\n2. FALSE [correction]: Endostatin inhibits the growth of new blood vessels, exhibiting antiangiogenic effects.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 407,
    "user_query": "List the off-label use of SSRIs",
    "yulan-chat-2-13b-fp16_response": "SSRIs (selective serotonin reuptake inhibitors) are a class of antidepressant medications that are commonly prescribed to treat depression, anxiety, and other mental health conditions. However, they can also be used for off-label purposes, which means they are not approved by the FDA for that specific use but are sometimes prescribed by doctors anyway. Some common off-label uses of SSRIs include:\n1. Treating obsessive-compulsive disorder (OCD)\n2. Treating post-traumatic stress disorder (PTSD)\n3. Treating social anxiety disorder\n4. Treating panic disorder\n5. Treating eating disorders, such as bulimia nervosa and anorexia nervosa\n6. Treating chronic pain\n7. Treating premature ejaculation\n8. Treating hot flashes associated with menopause\n9. Treating certain types of headaches, such as migraines\n10. Treating certain types of sexual dysfunction, such as erectile dysfunction.\nIt's important to note that while SSRIs can be effective for these off-label uses, they may not work for everyone and may have potential side effects. It's always best to talk to your doctor about the risks and benefits of using SSRIs for any purpose.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SSRIs are commonly prescribed to treat depression, anxiety, and other mental health conditions.\n2. Treating obsessive-compulsive disorder (OCD) is a common off-label use of SSRIs.\n3. SSRIs are used off-label to treat post-traumatic stress disorder (PTSD).\n4. Doctors sometimes prescribe SSRIs off-label for treating social anxiety disorder.\n5. SSRIs are sometimes used off-label for treating chronic pain.",
    "yulan-chat-2-13b-fp16_fact": [
      "SSRIs are commonly prescribed to treat depression, anxiety, and other mental health conditions.",
      "Treating obsessive-compulsive disorder (OCD) is a common off-label use of SSRIs.",
      "SSRIs are used off-label to treat post-traumatic stress disorder (PTSD).",
      "Doctors sometimes prescribe SSRIs off-label for treating social anxiety disorder.",
      "SSRIs are sometimes used off-label for treating chronic pain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Treating obsessive-compulsive disorder (OCD) is a common and approved use of SSRIs, not off-label.\n3. FALSE [correction]: SSRIs are often prescribed and approved for the treatment of post-traumatic stress disorder (PTSD), not just off-label.\n4. FALSE [correction]: SSRIs are commonly prescribed and approved for treating social anxiety disorder, not just off-label.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 408,
    "user_query": "Which is the definition of pyknons in DNA?",
    "yulan-chat-2-13b-fp16_response": "Pyknons are not a defined term in DNA or genetics. It is possible that you may be referring to \"punctuated non-random evolution\" (PNRE), which is a theory that suggests that evolution occurs in bursts or rapid changes, rather than through gradual, continuous changes. However, this theory is not widely accepted and is still a topic of debate among scientists.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "yulan-chat-2-13b-fp16_response": "Yes, a linker histone exists in the yeast genome. In yeast, the linker histone is called Ctf19 (also known as H2A.Z), which is a type of histone that is found in the nucleosome and plays a role in regulating gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A linker histone exists in the yeast genome.\n2. The linker histone in yeast is called Ctf19.\n3. Ctf19 is also known as H2A.Z.\n4. Ctf19 is found in the nucleosome.\n5. Ctf19 plays a role in regulating gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "A linker histone exists in the yeast genome.",
      "The linker histone in yeast is called Ctf19.",
      "Ctf19 is also known as H2A.Z.",
      "Ctf19 is found in the nucleosome.",
      "Ctf19 plays a role in regulating gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Yeast genomes typically do not have a canonical linker histone. However, some yeast species may have histone-like proteins that can perform similar functions.\n2. FALSE [correction]: Ctf19 is not a linker histone but a component of the kinetochore complex in yeast.\n3. FALSE [correction]: H2A.Z is a variant of the histone H2A, not related to Ctf19.\n4. FALSE [correction]: Since Ctf19 is not a histone but part of the kinetochore complex, it is not found in the nucleosome.\n5. TRUE (Although the statement doesn't specify which yeast species or provide the context that Ctf19 isn't a histone, Ctf19 does play a role in regulating gene expression by being part of the kinetochore complex involved in chromosome segregation during cell division.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 410,
    "user_query": "What is the role of deadenylases in the cell?",
    "yulan-chat-2-13b-fp16_response": "Deadenylases are enzymes that remove the poly(A) tail from pre-mRNA, mRNA, and other RNA molecules. This process, known as deadenylation, is important for several reasons:\n1. Gene expression regulation: Dadenylases can regulate gene expression by controlling the stability and translation of mRNA molecules. By removing the poly(A) tail, deadenylases can destabilize mRNA and promote its degradation, thus reducing the amount of protein produced from that mRNA.\n2. mRNA sorting: Dadenylases can also play a role in sorting mRNA molecules for transport out of the nucleus. By removing the poly(A) tail, deadenylases can help to distinguish mRNA molecules that are destined for the cytoplasm from those that are destined for the endoplasmic reticulum.\n3. RNA interference: Dadenylases can also be involved in RNA interference (RNAi) pathways, which are used to silence gene expression. By deadenylating small RNA molecules called siRNAs, deadenylases can help to promote their degradation and prevent them from effectively silencing target genes.\nOverall, deadenylases play an important role in regulating gene expression and controlling the fate of RNA molecules in the cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Deadenylases are enzymes that remove the poly(A) tail from RNA molecules, including pre-mRNA and mRNA.\n2. The process of removing the poly(A) tail by deadenylases is known as deadenylation.\n3. Deadenylation by deadenylases can regulate gene expression by affecting the stability and translation of mRNA molecules.\n4. Deadenylases support the sorting of mRNA molecules for transport out of the nucleus.\n5. Deadenylases participate in RNA interference pathways by deadenylating small RNA molecules such as siRNAs.",
    "yulan-chat-2-13b-fp16_fact": [
      "Deadenylases are enzymes that remove the poly(A) tail from RNA molecules, including pre-mRNA and mRNA.",
      "The process of removing the poly(A) tail by deadenylases is known as deadenylation.",
      "Deadenylation by deadenylases can regulate gene expression by affecting the stability and translation of mRNA molecules.",
      "Deadenylases support the sorting of mRNA molecules for transport out of the nucleus.",
      "Deadenylases participate in RNA interference pathways by deadenylating small RNA molecules such as siRNAs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Deadenylases primarily function in the cytoplasm by affecting the stability and translation of mRNA molecules, not in the sorting of mRNA for nuclear export. The poly(A) tail has roles in the export of mature mRNA from the nucleus, but deadenylation typically occurs in the cytoplasm and is associated with mRNA decay.\n5. FALSE [correction]: RNA interference pathways typically involve small RNA molecules such as siRNAs and miRNAs, but these molecules do not have poly(A) tails. Deadenylases do not deadenylate these types of RNA molecules; instead, they are involved in the deadenylation of mRNA molecules.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 412,
    "user_query": "How long, in kb (kilobases),  is a \"Long interspersed nuclear element\"?",
    "yulan-chat-2-13b-fp16_response": "A Long Interspersed Nuclear Element (LINE) is a type of transposable element, which is a DNA sequence that can move from one location in a genome to another. LINEs are characterized by their ability to insert into genes and disrupt their function, which can lead to genetic diseases. LINEs are also known for their ability to insert into the genome in a non-random manner, which has been used as a tool for studying the organization of the genome.\nThe length of a LINE can vary, but on average, it is around 6,000 base pairs (bp) long, which is equivalent to 6 kb. However, some LINEs can be much longer or shorter than this average.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LINEs (Long Interspersed Nuclear Elements) are a type of transposable element.\n2. LINEs can move from one location in a genome to another.\n3. LINEs can disrupt gene function and potentially lead to genetic diseases.\n4. The average length of a LINE is around 6,000 base pairs (bp), which is equivalent to 6 kilobases (kb).\n5. LINEs have varying lengths and can be longer or shorter than the average.",
    "yulan-chat-2-13b-fp16_fact": [
      "LINEs (Long Interspersed Nuclear Elements) are a type of transposable element.",
      "LINEs can move from one location in a genome to another.",
      "LINEs can disrupt gene function and potentially lead to genetic diseases.",
      "The average length of a LINE is around 6,000 base pairs (bp), which is equivalent to 6 kilobases (kb).",
      "LINEs have varying lengths and can be longer or shorter than the average."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 414,
    "user_query": "List receptors of the drug Cilengitide",
    "yulan-chat-2-13b-fp16_response": "Cilengitide is a medication that is being developed for the treatment of various types of cancer, including glioblastoma, pancreatic cancer, and ovarian cancer. It works by targeting a protein called alpha-vbeta-6 integrin, which is expressed on the surface of cancer cells.\nAlpha-vbeta-6 integrin is a receptor for several growth factors, including fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). By binding to alpha-vbeta-6 integrin, cilengitide can inhibit the activity of these growth factors and slow down the growth and spread of cancer cells.\nIn addition to its direct effect on alpha-vbeta-6 integrin, cilengitide may also have other effects on cancer cells, such as inducing apoptosis (cell death) and inhibiting angiogenesis (the formation of new blood vessels).\nCilengitide has been shown to be effective in preclinical studies and is currently being tested in clinical trials for the treatment of various types of cancer. However, more research is needed to fully understand its mechanism of action and to determine its potential as a cancer therapy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cilengitide targets the protein alpha-vbeta-6 integrin.\n2. Alpha-vbeta-6 integrin is expressed on the surface of cancer cells.\n3. Cilengitide inhibits the activity of growth factors such as fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF).\n4. Cilengitide may induce apoptosis in cancer cells.\n5. Cilengitide is being tested in clinical trials for the treatment of various types of cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cilengitide targets the protein alpha-vbeta-6 integrin.",
      "Alpha-vbeta-6 integrin is expressed on the surface of cancer cells.",
      "Cilengitide inhibits the activity of growth factors such as fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF).",
      "Cilengitide may induce apoptosis in cancer cells.",
      "Cilengitide is being tested in clinical trials for the treatment of various types of cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Cilengitide targets the proteins alpha-v beta-3 and alpha-v beta-5 integrins.\n2. TRUE\n3. FALSE [correction]: Cilengitide does not directly inhibit the activity of growth factors; it inhibits angiogenesis by blocking the integrins alpha-v beta-3 and alpha-v beta-5 on the surface of endothelial cells, thereby indirectly affecting growth factor signaling.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 415,
    "user_query": "Can protein coding exons originate from ALU sequences?",
    "yulan-chat-2-13b-fp16_response": "It is possible for protein coding exons to originate from ALU sequences, although this is relatively rare. ALU sequences are short, highly repetitive DNA elements that are found in the genome of many organisms, including humans. They are often found in non-coding regions of the genome, such as introns and intergenic regions, and are thought to have originated from mobile elements that were able to insert themselves into the genome.\nIn some cases, ALU sequences can be inserted into coding regions of the genome, including exons. When this happens, the ALU sequence can be spliced out of the pre-mRNA and can potentially contribute to the protein coding sequence. However, this is not a common occurrence and is generally thought to be rare.\nIt is important to note that the vast majority of protein coding exons are not derived from ALU sequences. Instead, they are derived from sequences that are specifically designed to code for proteins, such as exons that are derived from other coding genes or that are created de novo through gene duplication and divergence.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Protein coding exons can originate from ALU sequences, although this is relatively rare.\n2. ALU sequences are short, highly repetitive DNA elements found in the genome of many organisms, including humans.\n3. ALU sequences are often located in non-coding regions of the genome, such as introns and intergenic regions.\n4. ALU sequences may have originated from mobile elements that inserted themselves into the genome.\n5. The majority of protein coding exons are not derived from ALU sequences, but are instead derived from sequences that are designed to code for proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "Protein coding exons can originate from ALU sequences, although this is relatively rare.",
      "ALU sequences are short, highly repetitive DNA elements found in the genome of many organisms, including humans.",
      "ALU sequences are often located in non-coding regions of the genome, such as introns and intergenic regions.",
      "ALU sequences may have originated from mobile elements that inserted themselves into the genome.",
      "The majority of protein coding exons are not derived from ALU sequences, but are instead derived from sequences that are designed to code for proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that tomato juice may help lower cholesterol levels. Studies have found that the lycopene, a carotenoid pigment found in tomatoes, may help reduce cholesterol levels by inhibiting the absorption of cholesterol in the gut.\nHowever, it is important to note that the evidence is not conclusive and more research is needed to fully understand the effects of tomato juice on cholesterol levels. Additionally, tomato juice may not be effective for everyone and should not be used as a sole treatment for high cholesterol.\nIt is always best to speak with a healthcare professional before making any changes to your diet or treatment plan. They can provide personalized advice based on your individual needs and health status.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Studies have found that lycopene, a pigment found in tomatoes, may help reduce cholesterol levels.\n2. Lycopene may inhibit the absorption of cholesterol in the gut.",
    "yulan-chat-2-13b-fp16_fact": [
      "Studies have found that lycopene, a pigment found in tomatoes, may help reduce cholesterol levels.",
      "Lycopene may inhibit the absorption of cholesterol in the gut."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown"
    ]
  },
  {
    "id": 423,
    "user_query": "What is the mode of inheritance of nemaline myopathy?",
    "yulan-chat-2-13b-fp16_response": "Nemaline myopathy is a rare genetic disorder that is characterized by muscle weakness and wasting. It is caused by mutations in the NEML gene, which encodes a protein called nebulin.\nThe mode of inheritance of nemaline myopathy is autosomal recessive, which means that a person must inherit two copies of the mutated NEML gene (one from each parent) in order to develop the disorder. If both parents are carriers of a mutated NEML gene, there is a 25% chance that their child will inherit two copies of the mutated gene and develop nemaline myopathy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nemaline myopathy is a rare genetic disorder characterized by muscle weakness and wasting.\n2. Nemaline myopathy is caused by mutations in the NEML gene.\n3. The NEML gene encodes a protein called nebulin.\n4. The mode of inheritance for nemaline myopathy is autosomal recessive.\n5. If both parents are carriers of a mutated NEML gene, there is a 25% chance that their child will inherit two copies of the mutated gene and develop nemaline myopathy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nemaline myopathy is a rare genetic disorder characterized by muscle weakness and wasting.",
      "Nemaline myopathy is caused by mutations in the NEML gene.",
      "The NEML gene encodes a protein called nebulin.",
      "The mode of inheritance for nemaline myopathy is autosomal recessive.",
      "If both parents are carriers of a mutated NEML gene, there is a 25% chance that their child will inherit two copies of the mutated gene and develop nemaline myopathy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Nemaline myopathy is not caused by mutations in a gene named NEML; it is caused by mutations in various genes, such as ACTA1, NEB, TPM2, TPM3, and others, but not one specifically called NEML.\n3. TRUE (assuming NEML is a typographical error for NEB): The NEB gene encodes the protein nebulin, which is associated with nemaline myopathy when mutated.\n4. TRUE: Nemaline myopathy has an autosomal recessive mode of inheritance in most cases.\n5. TRUE: If both parents are carriers of a mutated gene that can cause nemaline myopathy, there is a 25% chance with each pregnancy that they will have a child who inherits two copies of the mutated gene, which would result in the child having the condition.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 432,
    "user_query": "Is it possible to detect survivin protein expression in normal human adult tissues?",
    "yulan-chat-2-13b-fp16_response": "Yes, it is possible to detect survivin protein expression in normal human adult tissues. Survivin is a member of the inhibitor of apoptosis protein (IAP) family, which plays a role in cell survival and apoptosis. It is expressed in a variety of normal adult tissues, including the heart, liver, kidneys, and brain.\nHowever, the expression levels of survivin can vary among different tissues and cell types. In some tissues, such as the gut epithelium, survivin is expressed at high levels, while in others, such as skeletal muscle, it is expressed at lower levels.\nIt is important to note that while survivin is expressed in normal adult tissues, its expression can also be upregulated in cancer cells, making it an attractive target for cancer therapy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Survivin protein expression can be detected in normal human adult tissues.\n2. Survivin is a member of the inhibitor of apoptosis protein (IAP) family.\n3. Survivin plays a role in cell survival and apoptosis.\n4. Survivin is expressed in adult tissues including the heart, liver, kidneys, and brain.\n5. The expression levels of survivin can vary among different tissues and cell types.",
    "yulan-chat-2-13b-fp16_fact": [
      "Survivin protein expression can be detected in normal human adult tissues.",
      "Survivin is a member of the inhibitor of apoptosis protein (IAP) family.",
      "Survivin plays a role in cell survival and apoptosis.",
      "Survivin is expressed in adult tissues including the heart, liver, kidneys, and brain.",
      "The expression levels of survivin can vary among different tissues and cell types."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Survivin protein expression is generally not detected in most normal human adult tissues; it is typically found in fetal tissues, cancer cells, and rapidly dividing cells.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Survivin is generally not detected in most adult tissues but is found in fetal tissues, cancer cells, and other rapidly dividing cells.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 433,
    "user_query": "List symptoms of Meigs' Syndrome.",
    "yulan-chat-2-13b-fp16_response": "Meigs' Syndrome is a rare condition that is characterized by the presence of a large tumor in the abdomen, which can cause a variety of symptoms. Some of the most common symptoms of Meigs' Syndrome include:\n* Abdominal pain or discomfort\n* Abdominal swelling or distention\n* Nausea or vomiting\n* Difficulty eating or digesting food\n* Fatigue or weakness\n* Weight loss\n* Fever or night sweats\n* Yellowing of the skin or eyes (jaundice)\n* Blood in the stool or vomit\nIt is important to note that not all people with Meigs' Syndrome will experience all of these symptoms, and some may have few or no symptoms at all. If you are experiencing any of these symptoms, it is important to speak with a healthcare provider for proper diagnosis and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Meigs' Syndrome is characterized by the presence of a large tumor in the abdomen.\n2. Common symptoms of Meigs' Syndrome include abdominal pain or discomfort.\n3. Additional symptoms of Meigs' Syndrome include abdominal swelling or distention.\n4. Patients with Meigs' Syndrome may experience nausea or vomiting.\n5. Symptoms of Meigs' Syndrome can also include difficulty eating or digesting food.",
    "yulan-chat-2-13b-fp16_fact": [
      "Meigs' Syndrome is characterized by the presence of a large tumor in the abdomen.",
      "Common symptoms of Meigs' Syndrome include abdominal pain or discomfort.",
      "Additional symptoms of Meigs' Syndrome include abdominal swelling or distention.",
      "Patients with Meigs' Syndrome may experience nausea or vomiting.",
      "Symptoms of Meigs' Syndrome can also include difficulty eating or digesting food."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 435,
    "user_query": "What is the molecular function of psoralen photobinding on DNA?",
    "yulan-chat-2-13b-fp16_response": "Psoralen is a natural compound that is known to interact with DNA through a process called photobinding. Photobinding is the process by which psoralen is activated by ultraviolet light and forms a covalent bond with DNA.\nThe molecular function of psoralen photobinding on DNA is to induce structural changes in the DNA molecule. Specifically, psoralen can cause the formation of pyrimidine dimers, which are covalent bonds between adjacent pyrimidine bases in the DNA molecule. This can lead to mutations in the DNA sequence and can also cause damage to the DNA structure.\nPsoralen photobinding is a process that is thought to play a role in the development of skin cancer, as it can cause mutations in the DNA of skin cells. It is also used in some medical treatments, such as phototherapy for vitiligo, a skin condition characterized by the loss of pigment in patches.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Psoralen interacts with DNA through a process called photobinding.\n2. Photobinding is activated by ultraviolet light and results in Psoralen forming a covalent bond with DNA.\n3. Psoralen photobinding can induce the formation of pyrimidine dimers in DNA.\n4. Psoralen photobinding can lead to mutations in the DNA sequence.\n5. Psoralen photobinding is used in phototherapy for vitiligo.",
    "yulan-chat-2-13b-fp16_fact": [
      "Psoralen interacts with DNA through a process called photobinding.",
      "Photobinding is activated by ultraviolet light and results in Psoralen forming a covalent bond with DNA.",
      "Psoralen photobinding can induce the formation of pyrimidine dimers in DNA.",
      "Psoralen photobinding can lead to mutations in the DNA sequence.",
      "Psoralen photobinding is used in phototherapy for vitiligo."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Psoralen, when activated by ultraviolet light, forms covalent bonds with pyrimidine bases in DNA, but it does not induce the formation of pyrimidine dimers. Instead, it forms monoadducts and cross-links with thymine bases in DNA.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 440,
    "user_query": "Which are the main causes of fetal echogenic bowel?",
    "yulan-chat-2-13b-fp16_response": "Fetal echogenic bowel is a condition in which the bowel appears bright and reflective on ultrasound imaging during pregnancy. There are several potential causes of fetal echogenic bowel, including:\n1. Meconium: Meconium is the first stool that a baby passes after birth. In some cases, meconium can accumulate in the bowel during fetal development, leading to increased echogenicity.\n2. Intestinal obstruction: An obstruction in the bowel can cause the bowel to become distended and filled with fluid, which can increase echogenicity.\n3. Intestinal perforation: A perforation or hole in the bowel can allow fluid to accumulate in the abdominal cavity, which can also increase echogenicity.\n4. Intestinal malrotation: In some cases, the bowel does not properly rotate during fetal development, which can lead to a blockage or obstruction. This can cause the bowel to become distended and increase in echogenicity.\n5. Intestinal atresia: Atresia is a condition in which a portion of the bowel is absent or closed off, leading to obstruction and distention. This can also increase echogenicity.\nIt is important to note that fetal echogenic bowel may be a benign condition, or it may be a sign of a more serious underlying problem. Your healthcare provider will be able to provide more information and guidance based on the specific details of your case.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fetal echogenic bowel is a condition where the bowel appears bright on ultrasound imaging during pregnancy.\n2. Accumulation of meconium in the bowel during fetal development can lead to increased echogenicity.\n3. An intestinal obstruction can cause the bowel to become distended and filled with fluid, increasing echogenicity.\n4. Intestinal perforation can lead to fluid accumulation in the abdominal cavity, which can increase echogenicity.\n5. Intestinal malrotation during fetal development can lead to blockage or obstruction, causing the bowel to become distended and increase in echogenicity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fetal echogenic bowel is a condition where the bowel appears bright on ultrasound imaging during pregnancy.",
      "Accumulation of meconium in the bowel during fetal development can lead to increased echogenicity.",
      "An intestinal obstruction can cause the bowel to become distended and filled with fluid, increasing echogenicity.",
      "Intestinal perforation can lead to fluid accumulation in the abdominal cavity, which can increase echogenicity.",
      "Intestinal malrotation during fetal development can lead to blockage or obstruction, causing the bowel to become distended and increase in echogenicity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 442,
    "user_query": "Which is the enzymatic activity of the myotubularin family of proteins?",
    "yulan-chat-2-13b-fp16_response": "The myotubularin family of proteins is involved in regulating various cellular processes, including autophagy, lipid metabolism, and cell signaling. The enzymatic activity of myotubularin proteins is phosphoinositide phosphatase activity, which involves the hydrolysis of phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P3) to produce phosphatidylinositol (3,4)bisphosphate (PI(3,4)P2) and inositol trisphosphate (IP3). This enzymatic activity is important for regulating various signaling pathways and for controlling cellular processes such as cell growth, differentiation, and survival.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The myotubularin family of proteins is involved in regulating autophagy, lipid metabolism, and cell signaling.\n2. The enzymatic activity of myotubularin proteins is phosphoinositide phosphatase activity.\n3. Myotubularin proteins hydrolyze phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P3) to produce phosphatidylinositol (3,4)bisphosphate (PI(3,4)P2).\n4. The enzymatic activity of myotubularin proteins also produces inositol trisphosphate (IP3).\n5. The phosphoinositide phosphatase activity of myotubularin proteins is important for regulating signaling pathways and controlling processes such as cell growth, differentiation, and survival.",
    "yulan-chat-2-13b-fp16_fact": [
      "The myotubularin family of proteins is involved in regulating autophagy, lipid metabolism, and cell signaling.",
      "The enzymatic activity of myotubularin proteins is phosphoinositide phosphatase activity.",
      "Myotubularin proteins hydrolyze phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P3) to produce phosphatidylinositol (3,4)bisphosphate (PI(3,4)P2).",
      "The enzymatic activity of myotubularin proteins also produces inositol trisphosphate (IP3).",
      "The phosphoinositide phosphatase activity of myotubularin proteins is important for regulating signaling pathways and controlling processes such as cell growth, differentiation, and survival."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The enzymatic activity of myotubularin proteins does not produce inositol trisphosphate (IP3). Myotubularins specifically act on phosphoinositides, not on inositol phosphates like IP3.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 445,
    "user_query": "Is there any relationship between histone ubiquitylation and splicing?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is a relationship between histone ubiquitylation and splicing. Histone ubiquitylation is a post-translational modification in which ubiquitin molecules are covalently attached to lysine residues on histone proteins. This modification can affect the structure and function of histones, and in turn, affect the regulation of gene expression.\nSplicing is the process by which introns are removed from pre-mRNA molecules to generate mature mRNA molecules. The splicing process is tightly regulated and can be influenced by various factors, including histone modifications.\nRecent studies have shown that histone ubiquitylation can affect splicing by modulating the recruitment of splicing factors to the pre-mRNA molecule. For example, ubiquitylation of histone H3 at specific genomic regions has been shown to promote the recruitment of splicing factors, leading to increased splicing efficiency at those regions.\nConversely, histone deubiquitylation has also been shown to affect splicing. Deubiquitylation of histone H3 at specific genomic regions has been shown to decrease splicing efficiency at those regions.\nOverall, histone ubiquitylation is an important regulator of gene expression and splicing, and its dysregulation has been implicated in various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histone ubiquitylation is a post-translational modification where ubiquitin molecules attach covalently to lysine residues on histone proteins.\n2. Histone ubiquitylation can have an impact on the structure and function of histones, subsequently affecting gene expression regulation.\n3. The process of splicing involves the removal of introns from pre-mRNA molecules to produce mature mRNA molecules.\n4. Histone ubiquitylation can influence the recruitment of splicing factors to pre-mRNA, impacting splicing efficiency.\n5. Dysregulation of histone ubiquitylation has been implicated in various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histone ubiquitylation is a post-translational modification where ubiquitin molecules attach covalently to lysine residues on histone proteins.",
      "Histone ubiquitylation can have an impact on the structure and function of histones, subsequently affecting gene expression regulation.",
      "The process of splicing involves the removal of introns from pre-mRNA molecules to produce mature mRNA molecules.",
      "Histone ubiquitylation can influence the recruitment of splicing factors to pre-mRNA, impacting splicing efficiency.",
      "Dysregulation of histone ubiquitylation has been implicated in various diseases, including cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nHistone ubiquitylation indeed involves the covalent attachment of ubiquitin molecules to lysine residues on histone proteins. This modification affects the structure and function of histones and can regulate gene expression. Splicing is the process by which introns are removed from pre-mRNA molecules to produce mature mRNA. Histone ubiquitylation can impact the recruitment of splicing factors to pre-mRNA, which in turn affects splicing efficiency. The dysregulation of histone ubiquitylation has been associated with various diseases, including cancer, as current scientific research suggests.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 448,
    "user_query": "What are the advantages of the top down mass spectrometric analysis of histones?",
    "yulan-chat-2-13b-fp16_response": "Top-down mass spectrometry is a technique that allows for the analysis of large, complex molecules such as histones. It has several advantages over other methods of mass spectrometry, including:\n1. It allows for the identification and quantification of all the different forms of a protein, including post-translational modifications and isoforms.\n2. It can provide information on the stoichiometry of protein complexes, including the number of subunits and the relative abundance of each subunit.\n3. It can be used to study the dynamics of protein complexes, including the binding and unbinding of subunits.\n4. It can be used to study the stability of protein complexes and the effects of different environmental conditions on their stability.\n5. It can be used to study the interactions between proteins and other molecules, such as ligands or inhibitors.\n6. It can be used to study the effects of mutations or other genetic alterations on protein structure and function.\n7. It can be used to study the effects of post-translational modifications on protein structure and function.\n8. It can be used to study the effects of different post-translational modifications on protein-protein interactions.\n9. It can be used to study the effects of different post-translational modifications on protein-DNA interactions.\n10. It can be used to study the effects of different post-translational modifications on chromatin structure and function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Top-down mass spectrometry allows for the identification and quantification of all forms of a protein, including post-translational modifications and isoforms.\n2. This technique can provide information on the stoichiometry of protein complexes, including the number of subunits and the relative abundance of each subunit.\n3. Top-down mass spectrometry can be used to study the dynamics of protein complexes, including the binding and unbinding of subunits.\n4. It can be utilized to analyze the stability of protein complexes and the influence of different environmental conditions on that stability.\n5. The technique can be employed to understand the interactions between proteins and other molecules, such as ligands or inhibitors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Top-down mass spectrometry allows for the identification and quantification of all forms of a protein, including post-translational modifications and isoforms.",
      "This technique can provide information on the stoichiometry of protein complexes, including the number of subunits and the relative abundance of each subunit.",
      "Top-down mass spectrometry can be used to study the dynamics of protein complexes, including the binding and unbinding of subunits.",
      "It can be utilized to analyze the stability of protein complexes and the influence of different environmental conditions on that stability.",
      "The technique can be employed to understand the interactions between proteins and other molecules, such as ligands or inhibitors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nTop-down mass spectrometry is a powerful analytical technique that enables the analysis of intact proteins and their complexes. It can indeed provide detailed information on the proteoforms, including post-translational modifications and isoform diversity (statement 1), information on the stoichiometry and composition of protein complexes (statement 2), and insights into the dynamics of these complexes under various conditions (statement 3 and 4). Additionally, it can be applied to study protein interactions with various molecules, which include ligands or inhibitors (statement 5).",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 451,
    "user_query": "What is the indication of Daonil (Glibenclamide)?",
    "yulan-chat-2-13b-fp16_response": "Daonil is a medication that contains glibenclamide, which is a type of medication called an oral hypoglycemic agent. It is used to treat type 2 diabetes, a condition in which the body does not produce or use insulin properly. Insulin is a hormone that helps regulate blood sugar levels, and type 2 diabetes is characterized by high blood sugar levels.\nGlibenclamide works by helping the body to produce more insulin and by making the body more sensitive to insulin. This helps to lower blood sugar levels and improve glycemic control. It is usually taken in combination with diet and exercise to manage type 2 diabetes.\nIt is important to note that Daonil should only be used under the supervision of a healthcare professional, as it can cause serious side effects if it is not used correctly. It is also important to follow the dosage instructions carefully and to monitor blood sugar levels regularly to ensure that the medication is working effectively.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Daonil contains glibenclamide, which is classified as an oral hypoglycemic agent.\n2. Daonil is used to treat type 2 diabetes.\n3. Type 2 diabetes is characterized by the body not producing or using insulin properly.\n4. Glibenclamide functions by stimulating the body to produce more insulin and increasing the body's sensitivity to insulin.\n5. Daonil is intended to be used in combination with diet and exercise to manage type 2 diabetes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Daonil contains glibenclamide, which is classified as an oral hypoglycemic agent.",
      "Daonil is used to treat type 2 diabetes.",
      "Type 2 diabetes is characterized by the body not producing or using insulin properly.",
      "Glibenclamide functions by stimulating the body to produce more insulin and increasing the body's sensitivity to insulin.",
      "Daonil is intended to be used in combination with diet and exercise to manage type 2 diabetes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Glibenclamide functions by stimulating the pancreas to produce more insulin but does not increase the body's sensitivity to insulin.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 452,
    "user_query": "Which is the most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus?",
    "yulan-chat-2-13b-fp16_response": "The most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is a sequence containing a dipeptide motif that is recognized by the retrieval receptor, receptor-mediated endoplasmic reticulum-to-Golgi transport protein 1 (Rab1). This motif is known as the KDEL sequence, which stands for lysine-based dileucine motif. The KDEL sequence is recognized by the KDEL receptor, which mediates the retrieval of ER lumenal proteins from the Golgi apparatus and their return to the ER.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The typical peptide sequence responsible for retrieval of endoplasmic reticulum lumenal proteins from the Golgi apparatus contains a dipeptide motif.\n2. The retrieval receptor involved in this process is receptor-mediated endoplasmic reticulum-to-Golgi transport protein 1 (Rab1).\n3. The KDEL sequence, which stands for lysine-based dileucine motif, is the specific motif recognized for retrieval.\n4. The KDEL receptor mediates the retrieval of ER lumenal proteins from the Golgi apparatus back to the ER.",
    "yulan-chat-2-13b-fp16_fact": [
      "The typical peptide sequence responsible for retrieval of endoplasmic reticulum lumenal proteins from the Golgi apparatus contains a dipeptide motif.",
      "The retrieval receptor involved in this process is receptor-mediated endoplasmic reticulum-to-Golgi transport protein 1 (Rab1).",
      "The KDEL sequence, which stands for lysine-based dileucine motif, is the specific motif recognized for retrieval.",
      "The KDEL receptor mediates the retrieval of ER lumenal proteins from the Golgi apparatus back to the ER."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus does not contain a dipeptide motif but rather a tetrapeptide motif, commonly known as the KDEL sequence or an equivalent sequence that functions similarly in retrieval.\n2. FALSE [correction]: The retrieval receptor involved in this process is not Rab1, which is a small GTPase involved in vesicle transport; instead, the retrieval is mediated by proteins known as KDEL receptors.\n3. FALSE [correction]: The KDEL sequence stands for a tetrapeptide motif consisting of the amino acids Lys-Asp-Glu-Leu, not a lysine-based dileucine motif.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 454,
    "user_query": "List the main proteases used for sample digestion in proteomics.",
    "yulan-chat-2-13b-fp16_response": "The main proteases used for sample digestion in proteomics are:\n1. Trypsin\n2. Chymotrypsin\n3. Papain\n4. Protease K\n5. Pepsin\n6. Lys-C\n7. Arg-C\n8. N-terminal protease (Nt-alpha)\n9. C-terminal protease (C-beta)\n10. Carboxypeptidase E\n11. Carboxypeptidase D\n12. Endopeptidase Lys-C\n13. Endopeptidase Arg-C\n14. Endopeptidase Glu-C\n15. Endopeptidase Ile-C\n16. Endopeptidase Leu-C\n17. Endopeptidase Lys-C/Phe-C\n18. Endopeptidase Pro-C\n19. Endopeptidase Ser-C\n20. Endopeptidase Thr-C.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Trypsin is used for sample digestion in proteomics.\n2. Chymotrypsin is used for sample digestion in proteomics.\n3. Protease K is used for sample digestion in proteomics.\n4. Pepsin is used for sample digestion in proteomics.\n5. Carboxypeptidase E is used for sample digestion in proteomics.",
    "yulan-chat-2-13b-fp16_fact": [
      "Trypsin is used for sample digestion in proteomics.",
      "Chymotrypsin is used for sample digestion in proteomics.",
      "Protease K is used for sample digestion in proteomics.",
      "Pepsin is used for sample digestion in proteomics.",
      "Carboxypeptidase E is used for sample digestion in proteomics."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Carboxypeptidase E is not commonly used for sample digestion in proteomics. It is an exopeptidase that cleaves amino acids from the C-terminal end of proteins and peptides, and it is typically involved in processing neuropeptides and peptide hormones, not in the initial proteomic digestion process which usually requires endopeptidases like trypsin, which cleave at specific internal peptide bonds.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 456,
    "user_query": "What is the association between Generalized anxiety disorder and mortality risk?",
    "yulan-chat-2-13b-fp16_response": "Generalized anxiety disorder (GAD) has been associated with an increased mortality risk. Several studies have shown that individuals with GAD have a higher risk of dying from cardiovascular disease, cancer, and other causes compared to the general population.\nOne study published in the Journal of Clinical Psychiatry found that individuals with GAD had a 2-fold increased risk of mortality compared to those without the disorder. The study also found that the risk of mortality was highest among individuals with comorbid conditions such as cardiovascular disease, diabetes, and respiratory disease.\nAnother study published in the Journal of Anxiety Disorders found that individuals with GAD had a higher risk of mortality due to cardiovascular disease, cancer, and other causes. The study also found that the risk of mortality was higher in individuals with more severe symptoms of GAD.\nThe exact mechanism behind the association between GAD and mortality risk is not fully understood. However, it is believed that chronic stress and inflammation associated with GAD may contribute to the increased risk of mortality.\nOverall, these findings suggest that individuals with GAD may benefit from early intervention and treatment to reduce the risk of mortality.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Generalized anxiety disorder (GAD) is associated with an increased mortality risk.\n2. Studies have indicated that individuals with GAD have a higher risk of dying from cardiovascular disease, cancer, and other causes compared to the general population.\n3. A study published in the Journal of Clinical Psychiatry reported a 2-fold increased risk of mortality for individuals with GAD versus those without the disorder.\n4. According to the Journal of Clinical Psychiatry study, the risk of mortality is highest among GAD patients with comorbid conditions, including cardiovascular disease, diabetes, and respiratory disease.\n5. A study published in the Journal of Anxiety Disorders found that the mortality risk is higher in individuals with more severe symptoms of GAD.",
    "yulan-chat-2-13b-fp16_fact": [
      "Generalized anxiety disorder (GAD) is associated with an increased mortality risk.",
      "Studies have indicated that individuals with GAD have a higher risk of dying from cardiovascular disease, cancer, and other causes compared to the general population.",
      "A study published in the Journal of Clinical Psychiatry reported a 2-fold increased risk of mortality for individuals with GAD versus those without the disorder.",
      "According to the Journal of Clinical Psychiatry study, the risk of mortality is highest among GAD patients with comorbid conditions, including cardiovascular disease, diabetes, and respiratory disease.",
      "A study published in the Journal of Anxiety Disorders found that the mortality risk is higher in individuals with more severe symptoms of GAD."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Generalized anxiety disorder (GAD) is associated with a variety of health concerns, but there is no direct evidence to suggest that it is associated with an increased overall mortality risk.\n2. FALSE [correction]: While individuals with GAD may have a higher risk for certain physical health conditions, such as heart disease, it's not accurate to say that they have a universally higher risk of dying from cardiovascular disease, cancer, and other causes compared to the general population without additional context or specifics.\n3. UNKNOWN: Without access to the specific study from the Journal of Clinical Psychiatry, the accuracy of the claim about a 2-fold increased risk of mortality cannot be verified.\n4. UNKNOWN: Similarly, without the specific details from the Journal of Clinical Psychiatry study, it cannot be confirmed whether the study reported that the risk of mortality is highest among GAD patients with comorbid conditions.\n5. UNKNOWN: Again, without access to the exact study from the Journal of Anxiety Disorders, the claim regarding the association between the severity of GAD symptoms and mortality risk cannot be confirmed.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 457,
    "user_query": "Which molecule is targeted by a monoclonal antibody Mepolizumab?",
    "yulan-chat-2-13b-fp16_response": "Mepolizumab is a monoclonal antibody that targets a molecule called interleukin-5 (IL-5). IL-5 is a cytokine that plays a role in the development and activation of eosinophils, a type of white blood cell that is involved in the immune response to certain parasites and cancer cells. Mepolizumab is used to treat asthma and other eosinophilic disorders by reducing the number of eosinophils in the blood and airways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mepolizumab is a monoclonal antibody that targets interleukin-5 (IL-5).\n2. Interleukin-5 is a cytokine involved in the development and activation of eosinophils.\n3. Eosinophils are a type of white blood cell involved in the immune response to certain parasites and cancer cells.\n4. Mepolizumab is used to treat asthma and other eosinophilic disorders.\n5. Mepolizumab works by reducing the number of eosinophils in the blood and airways.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mepolizumab is a monoclonal antibody that targets interleukin-5 (IL-5).",
      "Interleukin-5 is a cytokine involved in the development and activation of eosinophils.",
      "Eosinophils are a type of white blood cell involved in the immune response to certain parasites and cancer cells.",
      "Mepolizumab is used to treat asthma and other eosinophilic disorders.",
      "Mepolizumab works by reducing the number of eosinophils in the blood and airways."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE (although eosinophils are primarily associated with allergic responses and parasitic infections, they can also have roles related to cancer)\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 461,
    "user_query": "Which genes are affected in ROMANO-WARD syndrome?",
    "yulan-chat-2-13b-fp16_response": "ROMANO-WARD syndrome is a rare genetic disorder caused by mutations in the COL7A1 and COL17A1 genes. These genes provide instructions for making proteins that are essential for the structure and function of the skin, hair, and nails. Mutations in these genes can lead to a range of symptoms, including skin blistering, hair loss, and nail abnormalities. It is important to note that ROMANO-WARD syndrome is also known as epidermolysis bullosa simplex with pyloric atresia, and it is classified as a subtype of epidermolysis bullosa simplex (EBSS).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ROMANO-WARD syndrome is a rare genetic disorder.\n2. Mutations in the COL7A1 and COL17A1 genes cause ROMANO-WARD syndrome.\n3. The COL7A1 and COL17A1 genes are involved in the production of proteins for the skin, hair, and nails.\n4. Symptoms of ROMANO-WARD syndrome include skin blistering, hair loss, and nail abnormalities.\n5. ROMANO-WARD syndrome is also known as epidermolysis bullosa simplex with pyloric atresia.",
    "yulan-chat-2-13b-fp16_fact": [
      "ROMANO-WARD syndrome is a rare genetic disorder.",
      "Mutations in the COL7A1 and COL17A1 genes cause ROMANO-WARD syndrome.",
      "The COL7A1 and COL17A1 genes are involved in the production of proteins for the skin, hair, and nails.",
      "Symptoms of ROMANO-WARD syndrome include skin blistering, hair loss, and nail abnormalities.",
      "ROMANO-WARD syndrome is also known as epidermolysis bullosa simplex with pyloric atresia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutations in the KCNQ1, KCNH2, SCN5A, KCNE1, or KCNE2 genes cause Romano-Ward syndrome, which is associated with a heart condition called long QT syndrome.\n3. FALSE [correction]: The COL7A1 and COL17A1 genes are associated with different conditions related to the skin, not Romano-Ward syndrome. They are involved in the production of type VII and type XVII collagen, respectively.\n4. FALSE [correction]: Symptoms of Romano-Ward syndrome do not include skin blistering, hair loss, and nail abnormalities. Instead, they are associated with a risk of cardiac arrhythmia, fainting, and possible sudden death due to long QT syndrome.\n5. FALSE [correction]: Romano-Ward syndrome is not the same as epidermolysis bullosa simplex with pyloric atresia. Romano-Ward syndrome is an inherited condition that affects the heart's rhythm, while epidermolysis bullosa simplex with pyloric atresia is a skin condition.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 462,
    "user_query": "Does melanoma  occur in people of African origin ?",
    "yulan-chat-2-13b-fp16_response": "Yes, melanoma can occur in people of African origin. Melanoma is a type of skin cancer that develops from the melanocytes, which are the cells that produce the pigment melanin in the skin. It is generally believed that people with darker skin have a lower risk of developing melanoma than people with lighter skin, but it can still occur in people of all skin types.\nHowever, it is important to note that the incidence of melanoma in people of African origin is lower than in people of European or Asian origin. This is likely due to the fact that people of African origin have more melanin in their skin, which provides some protection against UV radiation and can help reduce the risk of skin cancer.\nIt is also important to note that while the incidence of melanoma may be lower in people of African origin, it is still a serious disease that can be life-threatening if not detected and treated early. It is important for all individuals, regardless of their skin type or ethnicity, to protect their skin from the sun and to be aware of the signs and symptoms of melanoma.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Melanoma can occur in people of African origin.\n2. Melanoma is a type of skin cancer that develops from melanocytes, the cells that produce melanin in the skin.\n3. Individuals with darker skin, such as those of African origin, have a lower risk of developing melanoma compared to people with lighter skin.\n4. The incidence of melanoma in people of African origin is lower than in people of European or Asian origin.\n5. Increased melanin in the skin of people of African origin provides some protection against UV radiation and can help reduce the risk of skin cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Melanoma can occur in people of African origin.",
      "Melanoma is a type of skin cancer that develops from melanocytes, the cells that produce melanin in the skin.",
      "Individuals with darker skin, such as those of African origin, have a lower risk of developing melanoma compared to people with lighter skin.",
      "The incidence of melanoma in people of African origin is lower than in people of European or Asian origin.",
      "Increased melanin in the skin of people of African origin provides some protection against UV radiation and can help reduce the risk of skin cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 463,
    "user_query": "What is the effect of resveratrol on mTOR activity?",
    "yulan-chat-2-13b-fp16_response": "Resveratrol is a polyphenol compound found in various plant-based foods, such as grapes, berries, and peanuts. It has been shown to have various biological effects, including anti-inflammatory, antioxidant, and cardioprotective properties.\nRegarding its effect on mTOR (mammalian target of rapamycin) activity, resveratrol has been found to inhibit mTOR signaling in some studies, while in others it has been shown to activate it. The conflicting results may be due to the different concentrations and duration of resveratrol treatment used in the studies, as well as the cell types and experimental models employed.\nHowever, it is generally believed that resveratrol may have a dual effect on mTOR activity, depending on the context and dose. At low doses, it may inhibit mTOR signaling, which can lead to a decrease in protein synthesis and an increase in autophagy (a process of cellular recycling). At higher doses, resveratrol may activate mTOR signaling, leading to an increase in protein synthesis and cell growth.\nOverall, the effect of resveratrol on mTOR activity is still an area of active research, and more studies are needed to fully understand its mechanisms and potential therapeutic implications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Resveratrol is found in plant-based foods such as grapes, berries, and peanuts.\n2. Resveratrol has been found to inhibit mTOR signaling in some studies.\n3. In other studies, resveratrol has been shown to activate mTOR signaling.\n4. Low doses of resveratrol may inhibit mTOR signaling, potentially leading to decreased protein synthesis and increased autophagy.\n5. Higher doses of resveratrol may activate mTOR signaling, potentially leading to an increase in protein synthesis and cell growth.",
    "yulan-chat-2-13b-fp16_fact": [
      "Resveratrol is found in plant-based foods such as grapes, berries, and peanuts.",
      "Resveratrol has been found to inhibit mTOR signaling in some studies.",
      "In other studies, resveratrol has been shown to activate mTOR signaling.",
      "Low doses of resveratrol may inhibit mTOR signaling, potentially leading to decreased protein synthesis and increased autophagy.",
      "Higher doses of resveratrol may activate mTOR signaling, potentially leading to an increase in protein synthesis and cell growth."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nResearch has indicated that resveratrol can have different effects on mTOR signaling depending on the dosage and context. However, without specifying the particular studies or the contexts in which these effects were observed, these statements should be generally accepted as true based on what is known about the compound's biological activity.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 464,
    "user_query": "Are people with blood group O protected against severe Malaria?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that people with blood group O may have a slightly lower risk of developing severe malaria compared to those with other blood groups. This is thought to be due to the presence of certain antibodies in the blood of people with blood group O that may provide some protection against the disease. However, it is important to note that having blood group O does not completely protect against malaria and other factors, such as access to proper medical care, also play a role in determining the severity of the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. People with blood group O may have a slightly lower risk of developing severe malaria.\n2. The lower risk of severe malaria in individuals with blood group O may be due to certain antibodies present in their blood.\n3. Having blood group O does not completely protect against malaria.",
    "yulan-chat-2-13b-fp16_fact": [
      "People with blood group O may have a slightly lower risk of developing severe malaria.",
      "The lower risk of severe malaria in individuals with blood group O may be due to certain antibodies present in their blood.",
      "Having blood group O does not completely protect against malaria."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The lower risk of severe malaria in individuals with blood group O is believed to be related to the fact that their red blood cells are less likely to have severe changes in shape during a malaria infection.\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 467,
    "user_query": "What is the mechanism of action of solanezumab?",
    "yulan-chat-2-13b-fp16_response": "Solanezumab is a monoclonal antibody that is being developed for the treatment of Alzheimer's disease. It works by binding to amyloid-beta (A) protein, which is a key component of the amyloid plaques that accumulate in the brains of people with Alzheimer's disease. By binding to A protein, solanezumab is thought to prevent the formation of new amyloid plaques and to facilitate the clearance of existing plaques from the brain. This may help to slow the progression of Alzheimer's disease and improve cognitive function in affected individuals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Solanezumab is a monoclonal antibody developed for the treatment of Alzheimer's disease.\n2. It works by binding to amyloid-beta (A) protein in the brain.\n3. Amyloid-beta protein is a component of the amyloid plaques associated with Alzheimer's disease.\n4. Solanezumab is posited to prevent the formation of new amyloid plaques in the brain.\n5. Solanezumab may facilitate the clearance of existing amyloid plaques from the brain.",
    "yulan-chat-2-13b-fp16_fact": [
      "Solanezumab is a monoclonal antibody developed for the treatment of Alzheimer's disease.",
      "It works by binding to amyloid-beta (A) protein in the brain.",
      "Amyloid-beta protein is a component of the amyloid plaques associated with Alzheimer's disease.",
      "Solanezumab is posited to prevent the formation of new amyloid plaques in the brain.",
      "Solanezumab may facilitate the clearance of existing amyloid plaques from the brain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\n[Explanation for answer 5: While the exact mechanism of solanezumab is complex and still not fully understood, one of the hypothesized benefits of the drug, based on its targeted action on amyloid-beta, is that it might help in the clearance of existing amyloid plaques. However, clinical trials have had mixed results, and it's important to note that this therapeutic strategy has not been unequivocally proven to be effective in altering the disease course in Alzheimer's patients as of my knowledge cutoff date in early 2023.]",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 469,
    "user_query": "What is the treatment of neuropathic pain in children?",
    "yulan-chat-2-13b-fp16_response": "Neuropathic pain in children can be treated with a combination of medication and non-pharmacological therapies. The choice of treatment depends on the underlying cause of the neuropathic pain, the severity of the pain, and the age and health status of the child.\nMedications commonly used to treat neuropathic pain in children include:\n1. Anticonvulsants: These medications, such as gabapentin and pregabalin, can help to reduce pain by blocking pain signals in the brain.\n2. Opioids: Strong opioids, such as morphine, may be used to treat severe neuropathic pain in children. However, these medications carry a risk of addiction and overdose, so they are usually used with caution in children.\n3. Anti-inflammatory drugs: Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may be used to reduce inflammation and pain in children with neuropathic pain caused by inflammatory conditions.\nNon-pharmacological therapies that may be used to treat neuropathic pain in children include:\n1. Physical therapy: Exercise and physical therapy can help to reduce pain and improve function in children with neuropathic pain.\n2. Pain management techniques: Techniques such as relaxation, distraction, and biofeedback can help children to manage their pain and reduce the intensity of their symptoms.\n3. Cognitive-behavioral therapy: This type of therapy can help children to manage the emotional and psychological aspects of their pain, and can be particularly helpful for children with neuropathic pain caused by conditions such as diabetes or HIV.\nIt is important to work with a healthcare professional to develop a treatment plan that is tailored to the individual needs of the child.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neuropathic pain in children can be treated with both medication and non-pharmacological therapies.\n2. Anticonvulsants like gabapentin and pregabalin are used to treat neuropathic pain in children by blocking pain signals in the brain.\n3. Strong opioids such as morphine may be used to treat severe neuropathic pain in children, with caution due to the risk of addiction and overdose.\n4. Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may be employed to address inflammation and pain in neuropathic conditions in children.\n5. Cognitive-behavioral therapy can assist children in managing the emotional and psychological aspects of neuropathic pain.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neuropathic pain in children can be treated with both medication and non-pharmacological therapies.",
      "Anticonvulsants like gabapentin and pregabalin are used to treat neuropathic pain in children by blocking pain signals in the brain.",
      "Strong opioids such as morphine may be used to treat severe neuropathic pain in children, with caution due to the risk of addiction and overdose.",
      "Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may be employed to address inflammation and pain in neuropathic conditions in children.",
      "Cognitive-behavioral therapy can assist children in managing the emotional and psychological aspects of neuropathic pain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Nonsteroidal anti-inflammatory drugs (NSAIDs) are typically not effective for neuropathic pain as it does not usually involve the inflammatory pathways that NSAIDs target; however, corticosteroids may sometimes be employed if there's a significant inflammatory component to the neuropathic condition.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 470,
    "user_query": "Which phenomenon is known as the \"calcium paradox\" in the isolated perfused heart?",
    "yulan-chat-2-13b-fp16_response": "The \"calcium paradox\" in the isolated perfused heart refers to the observation that, in the absence of external sources of calcium, the heart muscle cells continue to maintain a normal level of intracellular calcium. This occurs because the heart cells have a high affinity for calcium, and can actively transport it into the cell even in the absence of external sources. This allows the cells to maintain the necessary calcium levels for normal function, and is an example of the cells' adaptive capacity.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "yulan-chat-2-13b-fp16_response": "Heat shock proteins (Hsp) 70 and 110 are chaperones that play a role in maintaining protein stability and preventing aggregation. However, they also have a role in regulating mRNA stability.\nHsp70 and Hsp110 can interact with mRNA by binding to the poly(A) tail of the mRNA molecule. This binding can protect mRNA from degradation by exonucleases, which are enzymes that break down mRNA. Additionally, Hsp70 and Hsp110 can also help to stabilize mRNA by preventing the binding of other proteins that can cause degradation, such as the poly(ADP-ribose) polymerase (PARP) enzyme.\nOverall, the interaction of Hsp70 and Hsp110 with mRNA can help to regulate mRNA stability and prevent degradation, thereby contributing to the overall regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Heat shock proteins 70 and 110 are chaperones that help in maintaining protein stability and preventing aggregation.\n2. Hsp70 and Hsp110 are involved in regulating mRNA stability.\n3. Hsp70 and Hsp110 can bind to the poly(A) tail of mRNA molecules.\n4. The binding of Hsp70 and Hsp110 to mRNA can protect it from exonuclease-induced degradation.\n5. Hsp70 and Hsp110 can prevent the binding of other proteins like poly(ADP-ribose) polymerase (PARP) that can cause mRNA degradation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Heat shock proteins 70 and 110 are chaperones that help in maintaining protein stability and preventing aggregation.",
      "Hsp70 and Hsp110 are involved in regulating mRNA stability.",
      "Hsp70 and Hsp110 can bind to the poly(A) tail of mRNA molecules.",
      "The binding of Hsp70 and Hsp110 to mRNA can protect it from exonuclease-induced degradation.",
      "Hsp70 and Hsp110 can prevent the binding of other proteins like poly(ADP-ribose) polymerase (PARP) that can cause mRNA degradation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Hsp70 is involved in regulating protein stability, not typically mRNA stability. While some HSPs might be involved in mRNA related processes, this is not their primary known function.\n3. UNKNOWN: While some heat shock proteins have been implicated in interactions with mRNA, the specific binding of Hsp70 and Hsp110 to the poly(A) tail of mRNA molecules is not widely established and would require specific evidence.\n4. UNKNOWN: The protection of mRNA from exonuclease-induced degradation by Hsp70 and Hsp110 is not a well-established function and would require specific evidence from molecular biology studies.\n5. UNKNOWN: The interaction between Hsp70 and Hsp110 with proteins such as poly(ADP-ribose) polymerase (PARP) concerning mRNA degradation is very specific and would require evidence from studies showing this interaction and its effects on mRNA stability.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 477,
    "user_query": "What is FINDbase?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I am not familiar with the term \"FINDbase.\" Could you provide more context or information about what you are referring to?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "yulan-chat-2-13b-fp16_response": "There are three main types of deiodinases (D1, D2, and D3) that are present in various tissues throughout the body, including skeletal muscle.\nDeiodinase 1 (D1) is the major deiodinase in skeletal muscle and is responsible for the conversion of thyroxine (T4) to triiodothyronine (T3) in peripheral tissues. D1 is also involved in the regulation of energy metabolism and glucose homeostasis.\nDeiodinase 2 (D2) is present in skeletal muscle, but its function is not well understood. It is thought to play a role in the regulation of thyroid hormone metabolism and may be involved in the control of bone growth and development.\nDeiodinase 3 (D3) is also present in skeletal muscle, and its main function is to convert T4 to the inactive metabolite reverse T3 (rT3). D3 is expressed in various tissues, including skeletal muscle, and is involved in the regulation of thyroid hormone metabolism.\nOverall, the deiodinases play an important role in regulating thyroid hormone metabolism and function in skeletal muscle and other tissues throughout the body.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Three types of deiodinases (D1, D2, and D3) are present in skeletal muscle.\n2. Deiodinase 1 (D1) in skeletal muscle is responsible for converting thyroxine (T4) to triiodothyronine (T3).\n3. Deiodinase 2 (D2) is present in skeletal muscle and may play a role in thyroid hormone metabolism and bone growth and development.\n4. Deiodinase 3 (D3) in skeletal muscle converts T4 to the inactive metabolite reverse T3 (rT3).\n5. Deiodinase 3 (D3) is expressed in various tissues, including skeletal muscle, and is involved in the regulation of thyroid hormone metabolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "Three types of deiodinases (D1, D2, and D3) are present in skeletal muscle.",
      "Deiodinase 1 (D1) in skeletal muscle is responsible for converting thyroxine (T4) to triiodothyronine (T3).",
      "Deiodinase 2 (D2) is present in skeletal muscle and may play a role in thyroid hormone metabolism and bone growth and development.",
      "Deiodinase 3 (D3) in skeletal muscle converts T4 to the inactive metabolite reverse T3 (rT3).",
      "Deiodinase 3 (D3) is expressed in various tissues, including skeletal muscle, and is involved in the regulation of thyroid hormone metabolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: While Deiodinase 1 (D1) does convert thyroxine (T4) to triiodothyronine (T3), it is primarily present in the liver and kidneys, not predominantly in skeletal muscle.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 483,
    "user_query": "Which is the molecular weight of the protein angiogenin?",
    "yulan-chat-2-13b-fp16_response": "The molecular weight of the protein angiogenin can vary depending on the species of origin and the specific isoform. In general, the molecular weight of angiogenin is in the range of 35-45 kDa (kilodaltons).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The molecular weight of the protein angiogenin generally ranges from 35 to 45 kilodaltons (kDa).",
    "yulan-chat-2-13b-fp16_fact": [
      "The molecular weight of the protein angiogenin generally ranges from 35 to 45 kilodaltons (kDa)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 484,
    "user_query": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.",
    "yulan-chat-2-13b-fp16_response": "There are several SGLT2 inhibitors that have been approved by the FDA for the treatment of type 2 diabetes mellitus:\n1. Canagliflozin (Invokana, Invokamet, Invokamet XR)\n2. Dapagliflozin (Farxiga, Xigduo XR)\n3. Empagliflozin (Jardiance, Glyxambi, Synjardy, Synjardy XR)\n4. Ertugliflozin (Steglatro, Segluris)\n5. Sotagliflozin (Qtern, Qternmet, Qtern T20)\nIt's important to note that while these medications can be effective in managing blood sugar levels, they may also have potential side effects and risks, and should only be used under the guidance of a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Canagliflozin has been approved by the FDA for the treatment of type 2 diabetes mellitus and is available under brand names such as Invokana, Invokamet, and Invokamet XR.\n2. Dapagliflozin is an FDA-approved SGLT2 inhibitor for treating type 2 diabetes mellitus and is marketed as Farxiga and Xigduo XR.\n3. Empagliflozin has received FDA approval for use in the treatment of type 2 diabetes mellitus and is sold under the brands Jardiance, Glyxambi, Synjardy, and Synjardy XR.\n4. The FDA has approved ertugliflozin as a treatment for type 2 diabetes mellitus, and it is known by the brand names Steglatro and Segluromet.\n5. Sotagliflozin is an FDA-approved drug for type 2 diabetes mellitus treatment with brand names including Qtern and Qternmet XR.",
    "yulan-chat-2-13b-fp16_fact": [
      "Canagliflozin has been approved by the FDA for the treatment of type 2 diabetes mellitus and is available under brand names such as Invokana, Invokamet, and Invokamet XR.",
      "Dapagliflozin is an FDA-approved SGLT2 inhibitor for treating type 2 diabetes mellitus and is marketed as Farxiga and Xigduo XR.",
      "Empagliflozin has received FDA approval for use in the treatment of type 2 diabetes mellitus and is sold under the brands Jardiance, Glyxambi, Synjardy, and Synjardy XR.",
      "The FDA has approved ertugliflozin as a treatment for type 2 diabetes mellitus, and it is known by the brand names Steglatro and Segluromet.",
      "Sotagliflozin is an FDA-approved drug for type 2 diabetes mellitus treatment with brand names including Qtern and Qternmet XR."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Sotagliflozin is not approved by the FDA for the treatment of type 2 diabetes mellitus. The brand names Qtern and Qternmet XR are associated with dapagliflozin and saxagliptin combination products. Sotagliflozin is associated with brand names Zynquista, but its approval by the FDA for type 2 diabetes has been declined.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 486,
    "user_query": "Why does the prodrug amifostine (ethyol) create hypoxia?",
    "yulan-chat-2-13b-fp16_response": "Amifostine (ethyol) is a prodrug that is converted in the body to its active form, which is called WR-2723. WR-2723 is a potent antioxidant that can scavenge a variety of reactive oxygen species (ROS), including superoxide, hydroxyl radical, and peroxynitrite.\nOne of the mechanisms by which WR-2723 can create hypoxia is by reducing the levels of superoxide and hydroxyl radical in the body. These ROS can react with nitric oxide (NO) to form peroxynitrite, which can cause endothelial dysfunction and impair blood flow. By scavenging these ROS, WR-2723 can reduce the formation of peroxynitrite and improve endothelial function, leading to increased blood flow and tissue oxygenation.\nIn addition to its antioxidant properties, WR-2723 can also increase the levels of HIF-1alpha, a transcription factor that is involved in the response to hypoxia. This can lead to the upregulation of genes that are involved in angiogenesis and glucose metabolism, further contributing to the creation of hypoxia.\nOverall, the hypoxic effects of amifostine (ethyol) are likely due to its ability to scavenge ROS and increase HIF-1alpha levels, leading to improved blood flow and tissue oxygenation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Amifostine (ethyol) is converted in the body to its active form, WR-2723.\n2. WR-2723 is a potent antioxidant that can scavenge reactive oxygen species (ROS) including superoxide, hydroxyl radical, and peroxynitrite.\n3. By reducing levels of superoxide and hydroxyl radical, WR-2723 can reduce the formation of peroxynitrite.\n4. Reduction in peroxynitrite formation by WR-2723 can improve endothelial function, leading to increased blood flow and tissue oxygenation.\n5. WR-2723 can also increase levels of HIF-1alpha, a transcription factor involved in the response to hypoxia.",
    "yulan-chat-2-13b-fp16_fact": [
      "Amifostine (ethyol) is converted in the body to its active form, WR-2723.",
      "WR-2723 is a potent antioxidant that can scavenge reactive oxygen species (ROS) including superoxide, hydroxyl radical, and peroxynitrite.",
      "By reducing levels of superoxide and hydroxyl radical, WR-2723 can reduce the formation of peroxynitrite.",
      "Reduction in peroxynitrite formation by WR-2723 can improve endothelial function, leading to increased blood flow and tissue oxygenation.",
      "WR-2723 can also increase levels of HIF-1alpha, a transcription factor involved in the response to hypoxia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE  WR-2721 (active form of amifostine), once converted to its active form, acts as a potent antioxidant and scavenges reactive oxygen species (ROS).\n3. TRUE  By scavenging superoxide and hydroxyl radicals, the compound would reduce the substrates available for the formation of peroxynitrite.\n4. TRUE  If WR-2723 reduces peroxynitrite formation, this can indirectly improve endothelial function because peroxynitrite can impair endothelial function. Improved endothelial function can lead to increased blood flow and better tissue oxygenation.\n5. UNKNOWN  While WR-2723 has antioxidant properties and can reduce oxidative stress, there is not enough specific information provided in this context to confirm whether it increases levels of HIF-1alpha. The effects on HIF-1alpha would depend on specific cellular responses and regulatory mechanisms which are not detailed here.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 493,
    "user_query": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?",
    "yulan-chat-2-13b-fp16_response": "The Goldberg-Shprintzen syndrome is a rare genetic disorder that is characterized by a combination of features including intellectual disability, autism, and a distinctive facial appearance. It is also known as 22q131 deletion syndrome, and is caused by a deletion of a segment of chromosome 22 that includes the genes COMT and DBT.\nThere is no additional disease that is typically included with the Goldberg-Shprintzen syndrome. However, some individuals with the syndrome may have additional health problems or medical conditions that are not directly related to the genetic deletion. These may include seizures, heart defects, and gastrointestinal issues, among others.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Goldberg-Shprintzen syndrome is a rare genetic disorder.\n2. The syndrome is characterized by intellectual disability, autism, and a distinctive facial appearance.\n3. Goldberg-Shprintzen syndrome is also known as 22q13.1 deletion syndrome.\n4. The syndrome is caused by a deletion of a segment of chromosome 22 that includes the genes COMT and DBT.\n5. Individuals with Goldberg-Shprintzen syndrome may have additional health problems such as seizures, heart defects, and gastrointestinal issues.",
    "yulan-chat-2-13b-fp16_fact": [
      "Goldberg-Shprintzen syndrome is a rare genetic disorder.",
      "The syndrome is characterized by intellectual disability, autism, and a distinctive facial appearance.",
      "Goldberg-Shprintzen syndrome is also known as 22q13.1 deletion syndrome.",
      "The syndrome is caused by a deletion of a segment of chromosome 22 that includes the genes COMT and DBT.",
      "Individuals with Goldberg-Shprintzen syndrome may have additional health problems such as seizures, heart defects, and gastrointestinal issues."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Goldberg-Shprintzen syndrome is not known as 22q13.1 deletion syndrome. 22q13.1 deletion syndrome is a different condition also known as Phelan-McDermid syndrome.\n4. FALSE [correction]: Goldberg-Shprintzen syndrome is not specifically caused by a deletion of the genes COMT and DBT on chromosome 22. It is associated with mutations in the gene KIAA1279.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 496,
    "user_query": "Which disease of the central nervous system is characterized by the presence of Lewy bodies?",
    "yulan-chat-2-13b-fp16_response": "The disease of the central nervous system characterized by the presence of Lewy bodies is Parkinson's disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Parkinson's disease is characterized by the presence of Lewy bodies in the central nervous system.",
    "yulan-chat-2-13b-fp16_fact": [
      "Parkinson's disease is characterized by the presence of Lewy bodies in the central nervous system."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 501,
    "user_query": "Is Kanzaki disease associated with deficiency in alpha-N-acetylgalactosaminidase?",
    "yulan-chat-2-13b-fp16_response": "Yes, Kanzaki disease is associated with deficiency in alpha-N-acetylgalactosaminidase. Alpha-N-acetylgalactosaminidase is an enzyme that is involved in the metabolism of glycosphingolipids, which are a type of lipid found in cell membranes. Deficiency in this enzyme can lead to the accumulation of glycosphingolipids in the body, which can cause a range of symptoms including neurological problems, kidney damage, and skin rashes. Kanzaki disease is a rare genetic disorder that is caused by mutations in the GALNS gene, which codes for alpha-N-acetylgalactosaminidase.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Kanzaki disease is associated with a deficiency in alpha-N-acetylgalactosaminidase.\n2. Alpha-N-acetylgalactosaminidase is an enzyme involved in the metabolism of glycosphingolipids.\n3. Deficiency in alpha-N-acetylgalactosaminidase can lead to the accumulation of glycosphingolipids in the body.\n4. Symptoms of Kanzaki disease may include neurological problems, kidney damage, and skin rashes.\n5. Kanzaki disease is caused by mutations in the GALNS gene that codes for the enzyme alpha-N-acetylgalactosaminidase.",
    "yulan-chat-2-13b-fp16_fact": [
      "Kanzaki disease is associated with a deficiency in alpha-N-acetylgalactosaminidase.",
      "Alpha-N-acetylgalactosaminidase is an enzyme involved in the metabolism of glycosphingolipids.",
      "Deficiency in alpha-N-acetylgalactosaminidase can lead to the accumulation of glycosphingolipids in the body.",
      "Symptoms of Kanzaki disease may include neurological problems, kidney damage, and skin rashes.",
      "Kanzaki disease is caused by mutations in the GALNS gene that codes for the enzyme alpha-N-acetylgalactosaminidase."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Kanzaki disease, also known as Schindler disease type I, is caused by mutations in the NAGA gene, not the GALNS gene. The GALNS gene mutations cause a different lysosomal storage disorder known as Morquio syndrome type A.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 512,
    "user_query": "Is vemurafenib effective for hairy-cell leukemia?",
    "yulan-chat-2-13b-fp16_response": "Vemurafenib is not typically used to treat hairy-cell leukemia. It is a drug that is used to treat a specific type of skin cancer called melanoma, and it works by blocking a specific protein called BRAF that is involved in the growth and division of cells. Hairy-cell leukemia is a type of blood cancer that affects the bone marrow and is typically treated with chemotherapy, targeted therapy, or stem cell transplantation. The most effective treatment for hairy-cell leukemia depends on the individual patient and the specific characteristics of their cancer. It is important to consult with a healthcare professional for personalized treatment recommendations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vemurafenib is used to treat a specific type of skin cancer called melanoma.\n2. Vemurafenib works by blocking a protein called BRAF, which is involved in cell growth and division.\n3. Hairy-cell leukemia is a type of blood cancer that affects the bone marrow.\n4. Hairy-cell leukemia is typically treated with chemotherapy, targeted therapy, or stem cell transplantation.\n5. Treatment for hairy-cell leukemia depends on the individual patient and specific characteristics of their cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vemurafenib is used to treat a specific type of skin cancer called melanoma.",
      "Vemurafenib works by blocking a protein called BRAF, which is involved in cell growth and division.",
      "Hairy-cell leukemia is a type of blood cancer that affects the bone marrow.",
      "Hairy-cell leukemia is typically treated with chemotherapy, targeted therapy, or stem cell transplantation.",
      "Treatment for hairy-cell leukemia depends on the individual patient and specific characteristics of their cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 513,
    "user_query": "Which are the inhibitors of histone methyltransferases?",
    "yulan-chat-2-13b-fp16_response": "Histone methyltransferases (HMTs) are enzymes that add a methyl group to the lysine residues of histone proteins, which plays a crucial role in regulating gene expression. Inhibitors of HMTs can be used to study the role of histone methylation in various biological processes and may have potential therapeutic applications.\nSome of the known inhibitors of HMTs include:\n1. 5,10-dihydro-5,10-dioxo-1-naphthacene (5,10-dihydro-5,10-dioxonaphthacene-1,3-disulfonate, DHN)\n2. 3,4-dihydro-5,6-dimethyl-4-[2-(3-hydroxy-4-nitro-5-oxo-1,4-benzodiazepin-2-ylidene)cyclohexyl]-1H-imidazole (DBN)\n3. 3,4-dihydro-5,6-dimethyl-4-[2-(4-methyl-3-nitro-5-oxo-1,4-benzodiazepin-2-ylidene)cyclohexyl]-1H-imidazole (DBN-MC)\n4. 3,4-dihydro-5,6-dimethyl-4-[2-(4-nitro-3-methyl-5-oxo-1,4-benzodiazepin-2-ylidene)cyclohexyl]-1H-imidazole (DBN-INM)\n5. 3,4-dihydro-5,6-dimethyl-4-[2-(4-nitro-3-methyl-5-oxo-1,4-benzodiazepin-2-ylidene)cyclohexyl]-1H-imidazole (DBN-INM)\n6. 3,4-dihydro-5,6-dimethyl-4-[2-(4-nitro-3-methyl-5-ox",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histone methyltransferases (HMTs) are enzymes that add a methyl group to the lysine residues of histone proteins.\n2. Inhibitors of HMTs can be used to study the role of histone methylation in various biological processes.\n3. Inhibitors of HMTs may have potential therapeutic applications.\n4. 5,10-dihydro-5,10-dioxo-1-naphthacene is known as an inhibitor of HMTs. \n\nThe rest of the list of inhibitors presented in the answer contains items that are either repeated or incorrectly presented as separate inhibitors (specifically the last presented inhibitor is cut off and potentially a duplicate of a previous item), thus only one compound is listed as verifiable.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histone methyltransferases (HMTs) are enzymes that add a methyl group to the lysine residues of histone proteins.",
      "Inhibitors of HMTs can be used to study the role of histone methylation in various biological processes.",
      "Inhibitors of HMTs may have potential therapeutic applications.",
      "5,10-dihydro-5,10-dioxo-1-naphthacene is known as an inhibitor of HMTs.",
      "e rest of the list of inhibitors presented in the answer contains items that are either repeated or incorrectly presented as separate inhibitors (specifically the last presented inhibitor is cut off and potentially a duplicate of a previous item), thus only one compound is listed as verifiable."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nExplanation:\n- Statements 1 to 3 are true based on common scientific knowledge about histone methyltransferases and their inhibitors.\n- Statement 4 mentions a specific chemical compound, 5,10-dihydro-5,10-dioxo-1-naphthacene. Without specific literature or database references, it's difficult to verify whether this compound is an HMT inhibitor, hence the response is UNKNOWN.\n- Statement 5 references content or a list that was not provided, making it impossible to assess its accuracy. Therefore, the answer is UNKNOWN.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 517,
    "user_query": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?",
    "yulan-chat-2-13b-fp16_response": "Baricitinib is a JAK inhibitor that is currently being developed for the treatment of rheumatoid arthritis. It has been shown to be effective in reducing inflammation and improving symptoms in patients with the condition. However, it is important to note that baricitinib has not yet been approved by regulatory authorities and is still undergoing clinical trials.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Baricitinib is a JAK inhibitor being developed for the treatment of rheumatoid arthritis.\n2. Baricitinib has been shown to reduce inflammation and improve symptoms in patients with rheumatoid arthritis.\n3. Baricitinib has not yet been approved by regulatory authorities.\n4. Baricitinib is still undergoing clinical trials.",
    "yulan-chat-2-13b-fp16_fact": [
      "Baricitinib is a JAK inhibitor being developed for the treatment of rheumatoid arthritis.",
      "Baricitinib has been shown to reduce inflammation and improve symptoms in patients with rheumatoid arthritis.",
      "Baricitinib has not yet been approved by regulatory authorities.",
      "Baricitinib is still undergoing clinical trials."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Baricitinib has been approved by regulatory authorities for the treatment of rheumatoid arthritis. As of my knowledge cutoff in 2023, baricitinib has been approved by several regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).\n4. TRUE [clarification]: While Baricitinib has been approved for the treatment of rheumatoid arthritis, it may still be undergoing clinical trials for other indications or to gather more data.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 519,
    "user_query": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?",
    "yulan-chat-2-13b-fp16_response": "I am not aware of any newly identified DNA nucleases that have been specifically identified for the treatment of thalassemia. Thalassemia is a genetic disorder caused by a deficiency of hemoglobin production, and while there is currently no cure for thalassemia, treatment options are available to manage the condition and minimize its effects.\nHowever, there is ongoing research in the field of gene therapy for the treatment of genetic disorders, including thalassemia. Gene therapy involves the use of genetic material, such as DNA or RNA, to treat or prevent disease, and it has the potential to provide a cure for some genetic disorders.\nIn the case of thalassemia, gene therapy approaches may involve the introduction of functional hemoglobin genes into the affected cells, or the use of gene editing technologies to correct the underlying genetic mutations that cause the disorder. While these approaches are still in the experimental stages, they hold promise for the treatment of thalassemia and other genetic disorders in the future.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 524,
    "user_query": "Is the protein 1-integrin recycled?",
    "yulan-chat-2-13b-fp16_response": "Yes, 1-integrin can be recycled. Integrins are a family of heterodimeric integral membrane proteins that play a critical role in cell adhesion, migration, and signaling. They are composed of an alpha chain and a beta chain, and the beta chain in 1-integrin is recycled.\nDuring integrin endocytosis, the beta chain is released from the alpha chain and is recycled back to the plasma membrane, where it can be reused for new integrin formation. This process is regulated by various signaling pathways and is important for maintaining the turnover and function of integrins.\nRecycling of 1-integrin can also be modulated by various factors, such as the presence of ligands, growth factors, and cytokines, which can affect the stability and turnover of integrins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. 1-integrin is a protein that can be recycled.\n2. Integrins are composed of an alpha chain and a beta chain.\n3. During integrin endocytosis, the beta chain is recycled back to the plasma membrane.\n4. The process of 1-integrin recycling is regulated by various signaling pathways.\n5. Recycling of 1-integrin can be affected by factors like ligands, growth factors, and cytokines.",
    "yulan-chat-2-13b-fp16_fact": [
      "1-integrin is a protein that can be recycled.",
      "Integrins are composed of an alpha chain and a beta chain.",
      "During integrin endocytosis, the beta chain is recycled back to the plasma membrane.",
      "The process of 1-integrin recycling is regulated by various signaling pathways.",
      "Recycling of 1-integrin can be affected by factors like ligands, growth factors, and cytokines."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 526,
    "user_query": "Which signaling pathway is activating the dishevelled proteins?",
    "yulan-chat-2-13b-fp16_response": "The activation of dishevelled proteins typically occurs through the Wnt signaling pathway. Wnt proteins bind to receptors on the cell surface, leading to the activation of dishevelled proteins and subsequent downstream signaling events. However, dishevelled proteins can also be activated by other signaling pathways, such as the Notch and BMP pathways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dishevelled proteins are typically activated through the Wnt signaling pathway.\n2. Wnt proteins bind to receptors on the cell surface to activate dishevelled proteins.\n3. Activation of dishevelled proteins leads to subsequent downstream signaling events.\n4. Dishevelled proteins can also be activated by signaling pathways other than Wnt, like the Notch and BMP pathways.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dishevelled proteins are typically activated through the Wnt signaling pathway.",
      "Wnt proteins bind to receptors on the cell surface to activate dishevelled proteins.",
      "Activation of dishevelled proteins leads to subsequent downstream signaling events.",
      "Dishevelled proteins can also be activated by signaling pathways other than Wnt, like the Notch and BMP pathways."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Dishevelled proteins are specifically associated with the Wnt signaling pathway and not directly activated by the Notch or BMP pathways. However, there can be cross-talk between these pathways at various points in the signaling networks.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 533,
    "user_query": "Can a peptide aptamer be used as protein inhibitor?",
    "yulan-chat-2-13b-fp16_response": "Yes, peptide aptamers can be used as protein inhibitors. Peptide aptamers are short peptides that can bind to specific target proteins with high affinity and specificity, and they have been developed as potential therapeutic agents for a variety of diseases.\nInhibition of protein-protein interactions (PPIs) is an important therapeutic strategy for many diseases, and peptide aptamers can be used to inhibit PPIs by binding to the interface of two interacting proteins and disrupting their interaction. Peptide aptamers can also be used to inhibit enzyme activity by binding to the active site of the enzyme and preventing substrate binding or catalysis.\nThere are several advantages to using peptide aptamers as protein inhibitors. First, peptide aptamers are generally smaller and more stable than full-length proteins, which can make them easier to deliver and less likely to induce an immune response. Second, peptide aptamers can be designed to have high affinity and specificity for their target proteins, which can make them more effective inhibitors. Finally, peptide aptamers can be modified to improve their stability, pharmacokinetic properties, and efficacy, which can enhance their therapeutic potential.\nOverall, peptide aptamers are a promising class of molecules for use as protein inhibitors, and there is ongoing research to develop and optimize these compounds for use in the treatment of various diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Peptide aptamers can be used as protein inhibitors.\n2. Peptide aptamers are short peptides that bind to specific target proteins with high affinity and specificity.\n3. Peptide aptamers have been developed as potential therapeutic agents for a variety of diseases.\n4. Peptide aptamers can inhibit protein-protein interactions by binding to the interface of two interacting proteins and disrupting their interaction.\n5. Peptide aptamers can be designed to have high affinity and specificity for their target proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "Peptide aptamers can be used as protein inhibitors.",
      "Peptide aptamers are short peptides that bind to specific target proteins with high affinity and specificity.",
      "Peptide aptamers have been developed as potential therapeutic agents for a variety of diseases.",
      "Peptide aptamers can inhibit protein-protein interactions by binding to the interface of two interacting proteins and disrupting their interaction.",
      "Peptide aptamers can be designed to have high affinity and specificity for their target proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "yulan-chat-2-13b-fp16_response": "Caspases are a family of proteolytic enzymes that play a critical role in programmed cell death, or apoptosis. They are synthesized as inactive pro-caspases, which are activated by proteolytic cleavage in a cascade that ultimately leads to cell death. Some caspases are also involved in inflammation, where they play a role in the regulation of the inflammatory response. Here are some examples of inflammatory caspase proteins:\n1. Caspase-1: This enzyme is activated in response to bacterial and fungal infections and plays a key role in the formation of the inflammasome, a multiprotein complex that senses microbial infections and triggers the release of proinflammatory cytokines.\n2. Caspase-3: This enzyme is involved in the execution phase of apoptosis and is also activated in response to inflammatory stimuli. It has been implicated in the pathogenesis of various inflammatory diseases, including sepsis and neurodegenerative disorders.\n3. Caspase-4: This enzyme is primarily expressed in immune cells and is activated in response to bacterial and viral infections. It has been implicated in the pathogenesis of autoimmune diseases and cancer.\n4. Caspase-5: This enzyme is activated in response to bacterial and viral infections and has been implicated in the pathogenesis of sepsis and other inflammatory diseases.\n5. Caspase-8: This enzyme is involved in the regulation of the immune response and is activated in response to viral infections. It has been implicated in the pathogenesis of autoimmune diseases and cancer.\n6. Caspase-9: This enzyme is involved in the regulation of the immune response and is activated in response to bacterial and viral infections. It has been implicated in the pathogenesis of sepsis and other inflammatory diseases.\nIt's important to note that while some caspases are involved in inflammation, others play a role in the regulation of the imm",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Caspase-1 is activated in response to bacterial and fungal infections and is key in the formation of the inflammasome.\n2. Caspase-3 is involved in the execution phase of apoptosis and can be activated by inflammatory stimuli.\n3. Caspase-4 is primarily expressed in immune cells and is activated in response to bacterial and viral infections.\n4. Caspase-5 is activated in response to bacterial and viral infections and implicated in the pathogenesis of sepsis.\n5. Caspase-8 is involved in the regulation of the immune response and activated in response to viral infections.",
    "yulan-chat-2-13b-fp16_fact": [
      "Caspase-1 is activated in response to bacterial and fungal infections and is key in the formation of the inflammasome.",
      "Caspase-3 is involved in the execution phase of apoptosis and can be activated by inflammatory stimuli.",
      "Caspase-4 is primarily expressed in immune cells and is activated in response to bacterial and viral infections.",
      "Caspase-5 is activated in response to bacterial and viral infections and implicated in the pathogenesis of sepsis.",
      "Caspase-8 is involved in the regulation of the immune response and activated in response to viral infections."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE \n2. TRUE \n3. FALSE [correction]: Caspase-4 is primarily expressed in immune cells and is activated in response to bacterial infections, not viral.\n4. UNKNOWN \n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 538,
    "user_query": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma",
    "yulan-chat-2-13b-fp16_response": "Two chemotherapeutic agents that are commonly used for the treatment of Subependymal Giant Cell Astrocytoma (SEGA) are:\n1. Irinotecan: It is a topoisomerase inhibitor that is used to treat various types of cancers, including brain tumors. Irinotecan has been shown to be effective in treating SEGA in some cases.\n2. Temozolomide: It is an alkylating agent that is commonly used to treat brain tumors, including SEGA. Temozolomide is often used in combination with radiation therapy to improve outcomes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Irinotecan is used to treat Subependymal Giant Cell Astrocytoma (SEGA) and is a topoisomerase inhibitor.\n2. Temozolomide is used to treat SEGA and is an alkylating agent.\n3. Temozolomide is commonly used in combination with radiation therapy to treat brain tumors, including SEGA.",
    "yulan-chat-2-13b-fp16_fact": [
      "Irinotecan is used to treat Subependymal Giant Cell Astrocytoma (SEGA) and is a topoisomerase inhibitor.",
      "Temozolomide is used to treat SEGA and is an alkylating agent.",
      "Temozolomide is commonly used in combination with radiation therapy to treat brain tumors, including SEGA."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Irinotecan is not typically used to treat Subependymal Giant Cell Astrocytoma (SEGA); it is a topoisomerase inhibitor used to treat other types of cancer, such as colorectal cancer.\n2. FALSE [correction]: Temozolomide is not used to treat SEGA specifically; it is an alkylating agent used to treat certain brain tumors, such as glioblastomas.\n3. TRUE (with reservations) [clarification]: Temozolomide is commonly used in combination with radiation therapy to treat certain types of brain tumors, though its specific use for SEGA is not well-established and might depend on professional medical judgment and the specific context of the condition. ",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 541,
    "user_query": "List available databases containing information about conserved noncoding elements.",
    "yulan-chat-2-13b-fp16_response": "There are several databases available that contain information about conserved noncoding elements. Here are some of the most popular ones:\n1. UCSC Genome Browser: This database provides a comprehensive view of genomic sequences, including both coding and noncoding regions. It includes information on conserved noncoding elements such as enhancers, promoters, and other regulatory elements.\n2. NCBI GenBank: GenBank is a publicly available database of DNA sequences, including both coding and noncoding regions. It provides information on conserved noncoding elements such as introns, regulatory regions, and other noncoding DNA sequences.\n3. Ensembl: Ensembl is a genome annotation database that provides information on both coding and noncoding regions of genomic sequences. It includes information on conserved noncoding elements such as enhancers, promoters, and other regulatory elements.\n4. RefSeq: RefSeq is a curated non-redundant database of protein sequences and related information. It includes information on conserved noncoding elements such as introns, regulatory regions, and other noncoding DNA sequences.\n5. UCSC Table Browser: This database provides a comprehensive view of genomic sequences, including both coding and noncoding regions. It includes information on conserved noncoding elements such as enhancers, promoters, and other regulatory elements.\n6. NCBI BLAST: BLAST is a bioinformatics tool that allows users to compare DNA or protein sequences against a database of known sequences. It can be used to identify conserved noncoding elements such as enhancers, promoters, and other regulatory elements.\n7. Ensembl Regulatory Build: This database provides a comprehensive view of regulatory elements in the genome, including both coding and noncoding regions. It includes information on conserved noncoding elements such as enhancers, promoters, and other regulatory elements.\n8. Genomics Integrated Omics Explorer (GIO): GIO is a web-based platform that integrates genomic, transcriptomic, and epigenomic data. It includes information on conserved noncoding elements such as enhancers, promoters, and other regulatory elements.\nThese databases are just a few examples of the many resources available for identifying",
    "yulan-chat-2-13b-fp16_fact_raw": "1. UCSC Genome Browser provides information on conserved noncoding elements such as enhancers, promoters, and other regulatory elements.\n2. NCBI GenBank is a public database of DNA sequences that includes information on conserved noncoding elements like introns and regulatory regions.\n3. Ensembl is a genome annotation database that offers information on both coding and noncoding regions, including conserved noncoding elements.\n4. RefSeq includes information on conserved noncoding elements and is a curated non-redundant database of protein sequences.\n5. NCBI BLAST is a bioinformatics tool that can identify conserved noncoding elements by comparing DNA or protein sequences against a known sequence database.",
    "yulan-chat-2-13b-fp16_fact": [
      "UCSC Genome Browser provides information on conserved noncoding elements such as enhancers, promoters, and other regulatory elements.",
      "NCBI GenBank is a public database of DNA sequences that includes information on conserved noncoding elements like introns and regulatory regions.",
      "Ensembl is a genome annotation database that offers information on both coding and noncoding regions, including conserved noncoding elements.",
      "RefSeq includes information on conserved noncoding elements and is a curated non-redundant database of protein sequences.",
      "NCBI BLAST is a bioinformatics tool that can identify conserved noncoding elements by comparing DNA or protein sequences against a known sequence database."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: RefSeq is a curated non-redundant database of nucleotide sequences, which includes genomic, transcript, and protein sequences.\n5. TRUE, but with clarification: NCBI BLAST is a bioinformatics tool that can be used to compare DNA or protein sequences against a sequence database which may include known conserved noncoding elements; however, its primary purpose is to find regions of local similarity rather than specifically identifying conserved noncoding elements.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 546,
    "user_query": "What disease in Loxapine prominently used for?",
    "yulan-chat-2-13b-fp16_response": "Loxapine is a typical antipsychotic medication that is primarily used to treat symptoms of schizophrenia. It can also be used to treat other mental health conditions such as bipolar disorder and acute psychotic episodes. Loxapine works by blocking dopamine receptors in the brain, which can help to reduce the symptoms of psychosis such as hallucinations, delusions, and disorganized thinking. It is important to note that loxapine should only be used under the supervision of a qualified healthcare provider, as it can have serious side effects and may not be appropriate for everyone.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Loxapine is used to treat symptoms of schizophrenia.\n2. Loxapine can be used to treat bipolar disorder.\n3. Loxapine is also used to treat acute psychotic episodes.\n4. Loxapine works by blocking dopamine receptors in the brain.\n5. Loxapine should only be used under the supervision of a qualified healthcare provider.",
    "yulan-chat-2-13b-fp16_fact": [
      "Loxapine is used to treat symptoms of schizophrenia.",
      "Loxapine can be used to treat bipolar disorder.",
      "Loxapine is also used to treat acute psychotic episodes.",
      "Loxapine works by blocking dopamine receptors in the brain.",
      "Loxapine should only be used under the supervision of a qualified healthcare provider."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 548,
    "user_query": "Which antibodies cause Riedel thyroiditis?",
    "yulan-chat-2-13b-fp16_response": "Riedel thyroiditis is a rare autoimmune disorder that affects the thyroid gland. It is caused by the production of certain antibodies, specifically anti-thyroid peroxidase (anti-TPO) antibodies and anti-thyroglobulin (anti-Tg) antibodies. These antibodies are produced by the immune system and attack the thyroid gland, leading to inflammation and damage to the thyroid tissue. Riedel thyroiditis can cause symptoms such as a swollen thyroid gland, difficulty swallowing, and an enlarged lymph node in the neck. Treatment typically involves the use of corticosteroids to reduce inflammation and manage symptoms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Riedel thyroiditis is an autoimmune disorder that targets the thyroid gland.\n2. Anti-thyroid peroxidase (anti-TPO) antibodies are associated with Riedel thyroiditis.\n3. Anti-thyroglobulin (anti-Tg) antibodies are also associated with Riedel thyroiditis.\n4. Symptoms of Riedel thyroiditis can include a swollen thyroid gland and difficulty swallowing.\n5. Corticosteroids are typically used to treat the inflammation caused by Riedel thyroiditis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Riedel thyroiditis is an autoimmune disorder that targets the thyroid gland.",
      "Anti-thyroid peroxidase (anti-TPO) antibodies are associated with Riedel thyroiditis.",
      "Anti-thyroglobulin (anti-Tg) antibodies are also associated with Riedel thyroiditis.",
      "Symptoms of Riedel thyroiditis can include a swollen thyroid gland and difficulty swallowing.",
      "Corticosteroids are typically used to treat the inflammation caused by Riedel thyroiditis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Riedel thyroiditis is not primarily an autoimmune disorder; it is a rare form of chronic thyroiditis characterized by extensive fibrosis of the thyroid gland.\n2. FALSE [correction]: Anti-thyroid peroxidase (anti-TPO) antibodies are typically associated with autoimmune thyroid diseases like Hashimoto's thyroiditis, not Riedel thyroiditis.\n3. FALSE [correction]: Anti-thyroglobulin (anti-Tg) antibodies are commonly associated with autoimmune thyroid conditions, but their association with Riedel thyroiditis is not well-established or characteristic.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 551,
    "user_query": "Which receptors are bound by Tasimelteon?",
    "yulan-chat-2-13b-fp16_response": "Tasimelteon is a melatonin receptor agonist that binds to the MT1 and MT2 melatonin receptors. These receptors are G protein-coupled receptors that are expressed in various tissues throughout the body, including the brain, pineal gland, and other organs. Melatonin receptors play a role in regulating circadian rhythms, sleep-wake cycles, and other physiological processes. Tasimelteon is thought to modulate the activity of these receptors, leading to its therapeutic effects.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tasimelteon is a melatonin receptor agonist.\n2. Tasimelteon binds to the MT1 and MT2 melatonin receptors.\n3. MT1 and MT2 receptors are G protein-coupled receptors.\n4. Melatonin receptors are expressed in the brain, pineal gland, and other organs.\n5. Melatonin receptors are involved in regulating circadian rhythms and sleep-wake cycles.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tasimelteon is a melatonin receptor agonist.",
      "Tasimelteon binds to the MT1 and MT2 melatonin receptors.",
      "MT1 and MT2 receptors are G protein-coupled receptors.",
      "Melatonin receptors are expressed in the brain, pineal gland, and other organs.",
      "Melatonin receptors are involved in regulating circadian rhythms and sleep-wake cycles."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 552,
    "user_query": "Is zyxin a focal adhesion protein?",
    "yulan-chat-2-13b-fp16_response": "Zyxin is a protein that is involved in the regulation of cell adhesion and migration. It is a member of the zyxin family of proteins, which are characterized by a unique sequence of amino acids called the zyxin motif. Zyxin is primarily localized to the focal adhesion complex, which is a structure that forms between cells and is involved in the transmission of mechanical stress.\nFocal adhesion proteins are a group of proteins that are involved in the formation and maintenance of the focal adhesion complex. In addition to zyxin, other focal adhesion proteins include integrins, fibronectin, and paxillin. These proteins work together to regulate cell adhesion, migration, and signaling.\nOverall, while zyxin is not a classical focal adhesion protein, it is closely associated with the focal adhesion complex and plays a key role in regulating cell adhesion and migration.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Zyxin is involved in the regulation of cell adhesion and migration.\n2. Zyxin is a member of the zyxin family of proteins.\n3. The zyxin family of proteins is characterized by a sequence called the zyxin motif.\n4. Zyxin primarily localizes to the focal adhesion complex.\n5. The focal adhesion complex is involved in the transmission of mechanical stress between cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Zyxin is involved in the regulation of cell adhesion and migration.",
      "Zyxin is a member of the zyxin family of proteins.",
      "The zyxin family of proteins is characterized by a sequence called the zyxin motif.",
      "Zyxin primarily localizes to the focal adhesion complex.",
      "The focal adhesion complex is involved in the transmission of mechanical stress between cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The zyxin family of proteins is characterized by sequences called LIM domains, not a \"zyxin motif.\"\n4. TRUE\n5. FALSE [correction]: The focal adhesion complex is involved in the transmission of mechanical stress between cells and the extracellular matrix, not between cells themselves.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 556,
    "user_query": "Which RNA polymerase is used for the replication of viroids?",
    "yulan-chat-2-13b-fp16_response": "Viroids are the smallest known agents of biological inheritance. They are RNA molecules that can replicate and cause disease in plants. The replication of viroids is thought to be carried out by a host cell's RNA-dependent RNA polymerase (RdRp). This enzyme is responsible for synthesizing new RNA molecules from a template RNA molecule. It is not clear which specific RdRp is used by the host cell to replicate viroids, as this can vary depending on the plant species and the viroid in question. However, it is known that some plant RdRps can replicate certain viroids, and that the replication of viroids can be blocked by inhibitors of RdRp activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Viroids are RNA molecules that replicate and can cause disease in plants.\n2. The replication of viroids is carried out by a host cell's RNA-dependent RNA polymerase (RdRp).\n3. RNA-dependent RNA polymerase synthesizes new RNA molecules from a template RNA molecule.\n4. It is not clear which specific RNA-dependent RNA polymerase is used by host cells to replicate viroids, as this can vary.\n5. The replication of viroids can be inhibited by chemicals that block RdRp activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Viroids are RNA molecules that replicate and can cause disease in plants.",
      "The replication of viroids is carried out by a host cell's RNA-dependent RNA polymerase (RdRp).",
      "RNA-dependent RNA polymerase synthesizes new RNA molecules from a template RNA molecule.",
      "It is not clear which specific RNA-dependent RNA polymerase is used by host cells to replicate viroids, as this can vary.",
      "The replication of viroids can be inhibited by chemicals that block RdRp activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 559,
    "user_query": "What is known about Vancomycin dosing in neonates?",
    "yulan-chat-2-13b-fp16_response": "Vancomycin is an antibiotic commonly used to treat serious infections caused by susceptible bacteria, including those that can affect neonates. Dosing in neonates is based on body weight and age, as well as the severity of the infection being treated.\nIn general, vancomycin dosing in neonates follows the same guidelines as in adults, with adjustments made for the patient's age and weight. The recommended initial dose for neonates is 15 mg/kg/day, given in two equal doses separated by 12 hours. This dose may be adjusted based on the patient's response to treatment and the results of frequent renal function tests.\nIt is important to note that vancomycin dosing in neonates can be complex and requires careful monitoring. Serum levels of the drug should be measured periodically to ensure that the dosing regimen is appropriate and that the drug is not accumulating in the body to toxic levels. Additionally, neonates are at increased risk of developing nephrotoxicity (kidney damage) from vancomycin, so close monitoring of renal function is necessary.\nOverall, vancomycin dosing in neonates should be individualized based on the patient's clinical condition, age, weight, and renal function, and should be closely monitored to ensure safe and effective treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vancomycin is used to treat serious infections caused by susceptible bacteria in neonates.\n2. Vancomycin dosing in neonates is determined by body weight, age, and the severity of the infection.\n3. The recommended initial dose of vancomycin for neonates is 15 mg/kg/day, administered in two equal doses separated by 12 hours.\n4. Serum levels of vancomycin should be measured periodically in neonates to ensure appropriate dosing and to avoid toxic accumulation.\n5. Neonates are at increased risk of nephrotoxicity from vancomycin, necessitating close monitoring of renal function.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vancomycin is used to treat serious infections caused by susceptible bacteria in neonates.",
      "Vancomycin dosing in neonates is determined by body weight, age, and the severity of the infection.",
      "The recommended initial dose of vancomycin for neonates is 15 mg/kg/day, administered in two equal doses separated by 12 hours.",
      "Serum levels of vancomycin should be measured periodically in neonates to ensure appropriate dosing and to avoid toxic accumulation.",
      "Neonates are at increased risk of nephrotoxicity from vancomycin, necessitating close monitoring of renal function."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The recommended initial dose of vancomycin for neonates is typically higher than 15 mg/kg/day, and dosing frequency may vary depending on age and weight. A common dosing regimen for neonates may start at 15-20 mg/kg/dose every 8-12 hours, not in two equal doses separated by 12 hours.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 562,
    "user_query": "Which antiepileptic drug is most strongly associated with spina bifida?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I cannot provide an answer to your question as it is not accurate or appropriate. Spina bifida is a congenital birth defect that occurs when the spine and spinal cord do not develop properly during fetal development. It is not associated with any specific antiepileptic drug. While some antiepileptic drugs may have the potential to cause birth defects, including spina bifida, if taken during pregnancy, the risk of these defects is generally low and the benefits of seizure control often outweigh the risks. It is important to discuss any medication use with a healthcare provider, particularly if you are pregnant or planning to become pregnant.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Spina bifida is a congenital birth defect.\n2. Spina bifida occurs when the spine and spinal cord do not develop properly during fetal development.\n3. Some antiepileptic drugs may have the potential to cause birth defects, including spina bifida, if taken during pregnancy.\n4. The risk of birth defects from antiepileptic drugs is generally low.\n5. The benefits of seizure control often outweigh the risks of taking antiepileptic drugs during pregnancy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Spina bifida is a congenital birth defect.",
      "Spina bifida occurs when the spine and spinal cord do not develop properly during fetal development.",
      "Some antiepileptic drugs may have the potential to cause birth defects, including spina bifida, if taken during pregnancy.",
      "The risk of birth defects from antiepileptic drugs is generally low.",
      "The benefits of seizure control often outweigh the risks of taking antiepileptic drugs during pregnancy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN (while some studies may suggest a lower or higher risk, without specific data or references, it is not possible to determine the accuracy of this statement)\n5. TRUE (although this is a complex medical determination that must take into account individual circumstances, in general, healthcare professionals balance the benefits of seizure control against the potential risks of taking medication during pregnancy)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 564,
    "user_query": "The drug JTV519 is derivative of which group of chemical compounds?",
    "yulan-chat-2-13b-fp16_response": "JTV519 is a derivative of a group of chemical compounds called imidazoquinones.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. JTV519 is a derivative of chemical compounds.\n2. JTV519 belongs to the group of compounds called imidazoquinones.",
    "yulan-chat-2-13b-fp16_fact": [
      "JTV519 is a derivative of chemical compounds.",
      "JTV519 belongs to the group of compounds called imidazoquinones."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: JTV519 (also known as K201) is not an imidazoquinone; it belongs to the group of compounds called benzothiazepines.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 566,
    "user_query": "Oxantel is used for periodontitis treatment. How does it work?",
    "yulan-chat-2-13b-fp16_response": "Oxantel is not typically used for the treatment of periodontitis. Oxantel is an anthelminthic drug, which means it is used to treat parasitic infections. It is primarily used to treat infections caused by roundworms and hookworms in animals.\nPeriodontitis is a serious gum infection that can lead to tooth loss if left untreated. Treatment for periodontitis typically involves a combination of professional cleaning, medications, and lifestyle changes.\nThere are several medications that may be used to treat periodontitis, including antibiotics, antimicrobial mouthwashes, and topical gels. These medications work by killing or inhibiting the growth of the bacteria that cause periodontitis.\nIf you have been diagnosed with periodontitis, it is important to follow your dentist or periodontist's recommended treatment plan to help manage and prevent further damage to your teeth and gums.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Oxantel is primarily used to treat infections caused by roundworms and hookworms in animals.\n2. Periodontitis is a serious gum infection that can lead to tooth loss if left untreated.\n3. Treatment for periodontitis usually involves professional cleaning, medications, and lifestyle changes.\n4. Antibiotics, antimicrobial mouthwashes, and topical gels are among the medications that may be used to treat periodontitis.\n5. These medications for periodontitis work by killing or inhibiting the growth of bacteria that cause the condition.",
    "yulan-chat-2-13b-fp16_fact": [
      "Oxantel is primarily used to treat infections caused by roundworms and hookworms in animals.",
      "Periodontitis is a serious gum infection that can lead to tooth loss if left untreated.",
      "Treatment for periodontitis usually involves professional cleaning, medications, and lifestyle changes.",
      "Antibiotics, antimicrobial mouthwashes, and topical gels are among the medications that may be used to treat periodontitis.",
      "These medications for periodontitis work by killing or inhibiting the growth of bacteria that cause the condition."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 568,
    "user_query": "What is the function of the protein encoded by the gene PABPC4?",
    "yulan-chat-2-13b-fp16_response": "The protein encoded by the gene PABPC4 is known as poly(A) binding protein 4, or PABPC4. PABPC4 is a key regulator of mRNA stability and translation, and plays a critical role in the process of mRNA maturation and degradation. Specifically, PABPC4 binds to the poly(A) tail of mRNA molecules and helps to recruit other proteins that either stabilize or degrade the mRNA. In addition to its role in mRNA stability and degradation, PABPC4 has also been implicated in other aspects of mRNA metabolism, including alternative splicing and microRNA regulation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The gene PABPC4 encodes for the protein known as poly(A) binding protein 4.\n2. PABPC4 is a regulator of mRNA stability and translation.\n3. PABPC4 plays a role in mRNA maturation and degradation.\n4. PABPC4 binds to the poly(A) tail of mRNA molecules.\n5. PABPC4 is involved in processes beyond mRNA stability and degradation, including alternative splicing and microRNA regulation.",
    "yulan-chat-2-13b-fp16_fact": [
      "The gene PABPC4 encodes for the protein known as poly(A) binding protein 4.",
      "PABPC4 is a regulator of mRNA stability and translation.",
      "PABPC4 plays a role in mRNA maturation and degradation.",
      "PABPC4 binds to the poly(A) tail of mRNA molecules.",
      "PABPC4 is involved in processes beyond mRNA stability and degradation, including alternative splicing and microRNA regulation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 570,
    "user_query": "What is the mode of inheritance of Romano Ward long QT syndrome?",
    "yulan-chat-2-13b-fp16_response": "Romano-Ward long QT syndrome is a genetic disorder that is inherited in an autosomal recessive pattern. This means that a person must inherit two copies of the mutated gene (one from each parent) in order to develop the condition. If both parents are carriers of the mutated gene, there is a 25% chance with each pregnancy that the child will inherit two copies of the mutated gene and develop the condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Romano-Ward long QT syndrome is a genetic disorder.\n2. It is inherited in an autosomal recessive pattern.\n3. A person must inherit two copies of the mutated gene to develop the condition, one from each parent.\n4. If both parents are carriers of the mutated gene, there is a 25% chance that their child will inherit two copies of the mutated gene and develop the condition with each pregnancy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Romano-Ward long QT syndrome is a genetic disorder.",
      "It is inherited in an autosomal recessive pattern.",
      "A person must inherit two copies of the mutated gene to develop the condition, one from each parent.",
      "If both parents are carriers of the mutated gene, there is a 25% chance that their child will inherit two copies of the mutated gene and develop the condition with each pregnancy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Romano-Ward long QT syndrome is inherited in an autosomal dominant pattern.\n3. FALSE [correction]: A person can develop the condition by inheriting only one copy of the mutated gene.\n4. FALSE [correction]: Since Romano-Ward long QT syndrome is autosomal dominant, if both parents are carriers (meaning they each have one copy of the mutated gene), there is a 50% chance that their child will inherit one mutated gene and develop the condition with each pregnancy.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 571,
    "user_query": "Which histone modifications have been associated to alternative splicing?",
    "yulan-chat-2-13b-fp16_response": "Several histone modifications have been associated with alternative splicing, including:\n1. Acetylation: Histone acetylation has been shown to promote exon inclusion by increasing the accessibility of the DNA to transcription factors.\n2. Methylation: Histone methylation, particularly at H3K4me3, has been associated with exon skipping and silencing.\n3. Phosphorylation: Histone phosphorylation has been shown to regulate alternative splicing by modulating the interaction between splicing factors and chromatin.\n4. Ubiquitination: Histone ubiquitination has been associated with exon skipping and silencing.\n5. Sumoylation: Histone sumoylation has been shown to regulate alternative splicing by modulating the interaction between splicing factors and chromatin.\nIt's important to note that the relationship between histone modifications and alternative splicing is complex and context-dependent, and different modifications can have different effects depending on the specific gene and cell type.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histone acetylation has been associated with promoting exon inclusion in alternative splicing.\n2. Histone methylation at H3K4me3 has been associated with exon skipping and silencing in the context of alternative splicing.\n3. Histone phosphorylation has been shown to influence alternative splicing by affecting the interaction of splicing factors with chromatin.\n4. Histone ubiquitination has been linked to exon skipping and silencing in alternative splicing.\n5. Histone sumoylation has been reported to regulate alternative splicing by modulating chromatin and splicing factor interactions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histone acetylation has been associated with promoting exon inclusion in alternative splicing.",
      "Histone methylation at H3K4me3 has been associated with exon skipping and silencing in the context of alternative splicing.",
      "Histone phosphorylation has been shown to influence alternative splicing by affecting the interaction of splicing factors with chromatin.",
      "Histone ubiquitination has been linked to exon skipping and silencing in alternative splicing.",
      "Histone sumoylation has been reported to regulate alternative splicing by modulating chromatin and splicing factor interactions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Histone methylation at H3K4me3 is generally associated with active transcription and has been linked to promoting exon inclusion, not exon skipping and silencing.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 575,
    "user_query": "What is the mechanism of action of decitabine?",
    "yulan-chat-2-13b-fp16_response": "Decitabine is a nucleoside analogue that is used as a potential cancer therapy. It works by inhibiting DNA methylation, which is an important epigenetic modification that plays a role in the regulation of gene expression.\nDNA methylation involves the addition of a methyl group to the cytosine base of a DNA molecule. This modification can lead to the silencing of genes, which can contribute to the development and progression of cancer. Decitabine is converted to 5-azacytidine, which is a nucleotide analogue that can be incorporated into DNA during replication. This leads to the inhibition of DNA methylation, which can result in the reactivation of silenced genes and the inhibition of cancer cell growth.\nIn addition to its effects on DNA methylation, decitabine has also been shown to have other mechanisms of action, including the inhibition of histone deacetylase activity and the modulation of miRNA expression. These effects may also contribute to its potential anticancer activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Decitabine is a nucleoside analogue used as a potential cancer therapy.\n2. Decitabine works by inhibiting DNA methylation, a process that contributes to the regulation of gene expression.\n3. DNA methylation involves the addition of a methyl group to the cytosine base of a DNA molecule.\n4. Decitabine is converted to 5-azacytidine, which can be incorporated into DNA during replication.\n5. Decitabine has been shown to inhibit histone deacetylase activity and modulate miRNA expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Decitabine is a nucleoside analogue used as a potential cancer therapy.",
      "Decitabine works by inhibiting DNA methylation, a process that contributes to the regulation of gene expression.",
      "DNA methylation involves the addition of a methyl group to the cytosine base of a DNA molecule.",
      "Decitabine is converted to 5-azacytidine, which can be incorporated into DNA during replication.",
      "Decitabine has been shown to inhibit histone deacetylase activity and modulate miRNA expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Decitabine is not converted to 5-azacytidine. Decitabine and 5-azacytidine (also known as azacitidine) are distinct compounds, although both are nucleoside analogues that can be incorporated into DNA.\n5. TRUE (with a caveat): While it is true that decitabine can have effects on histone modifications and miRNA expression, its primary known mechanism is through the inhibition of DNA methyltransferase, leading to reductions in DNA methylation. Direct inhibition of histone deacetylase is not a primary action of decitabine, but changes in histone acetylation may occur as downstream effects of DNA methylation changes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 576,
    "user_query": "Which gene is associated with the Mitchell-Riley syndrome?",
    "yulan-chat-2-13b-fp16_response": "The Mitchell-Riley syndrome is also known as Wiedemann-Rautio syndrome, which is a rare genetic disorder caused by mutations in the LEMD2 gene. This gene is located on the long (q) arm of chromosome 2 at position 21.31 and spans approximately 30 kilobases. The LEMD2 gene encodes a protein called Lim domain-containing protein 2 (LDB2), which is a component of the dystrophin-glycoprotein complex (DGC) that helps to maintain the integrity of the muscle cell membrane. Mutations in the LEMD2 gene result in the loss of LDB2 function, leading to muscle weakness, atrophy, and other features of the Mitchell-Riley syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mitchell-Riley syndrome is caused by mutations in the LEMD2 gene.\n2. The LEMD2 gene is located on the long (q) arm of chromosome 2 at position 21.31.\n3. The LEMD2 gene spans approximately 30 kilobases.\n4. The protein encoded by the LEMD2 gene is called Lim domain-containing protein 2 (LDB2).\n5. Mutations in the LEMD2 gene can result in muscle weakness, atrophy, and other features of the Mitchell-Riley syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mitchell-Riley syndrome is caused by mutations in the LEMD2 gene.",
      "The LEMD2 gene is located on the long (q) arm of chromosome 2 at position 21.31.",
      "The LEMD2 gene spans approximately 30 kilobases.",
      "The protein encoded by the LEMD2 gene is called Lim domain-containing protein 2 (LDB2).",
      "Mutations in the LEMD2 gene can result in muscle weakness, atrophy, and other features of the Mitchell-Riley syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The LEMD2 gene is located on the long (q) arm of chromosome 1 at position 24.3.\n3. UNKNOWN\n4. FALSE [correction]: The protein encoded by the LEMD2 gene is called LEM domain containing 2.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is a link between the aurora B kinase and the polycomb protein ring1B (RING1B). Aurora B kinase is a protein that plays a key role in regulating cell division by controlling the progression of the cell cycle. RING1B is a component of the polycomb group (PcG) of proteins, which play important roles in regulating gene expression and maintaining the stability of chromosomes.\nResearch has shown that the aurora B kinase can interact with RING1B, and this interaction may play a role in regulating the activity of the PcG complex. Specifically, it has been suggested that aurora B kinase may phosphorylate RING1B, which could affect its ability to function as part of the PcG complex.\nIn addition, mutations in the aurora B kinase gene have been linked to abnormalities in chromosome segregation during cell division, which could potentially affect the function of the PcG complex. Overall, the relationship between aurora B kinase and RING1B is complex and likely involves multiple interactions and regulatory mechanisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aurora B kinase is involved in regulating cell division by controlling the progression of the cell cycle.\n2. RING1B is a component of the polycomb group (PcG) of proteins and is involved in regulating gene expression and chromosome stability.\n3. Aurora B kinase can interact with RING1B, suggesting a link between the two proteins.\n4. Aurora B kinase may phosphorylate RING1B, potentially impacting the PcG complex's function.\n5. Mutations in the aurora B kinase gene have been associated with abnormalities in chromosome segregation during cell division.",
    "yulan-chat-2-13b-fp16_fact": [
      "Aurora B kinase is involved in regulating cell division by controlling the progression of the cell cycle.",
      "RING1B is a component of the polycomb group (PcG) of proteins and is involved in regulating gene expression and chromosome stability.",
      "Aurora B kinase can interact with RING1B, suggesting a link between the two proteins.",
      "Aurora B kinase may phosphorylate RING1B, potentially impacting the PcG complex's function.",
      "Mutations in the aurora B kinase gene have been associated with abnormalities in chromosome segregation during cell division."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Aurora B kinase is indeed involved in regulating cell division by ensuring proper progression of the cell cycle, particularly during mitosis.\n2. TRUE: RING1B is part of the polycomb group (PcG) of proteins and plays a role in epigenetic regulation of gene expression and maintaining chromosome stability.\n3. UNKNOWN: Without specific context or reference to a study showing an interaction between Aurora B kinase and RING1B, it's not possible to confirm this statement.\n4. UNKNOWN: Similarly, whether Aurora B kinase may phosphorylate RING1B and affect the polycomb group (PcG) complex's function would require specific experimental evidence, which is not provided here.\n5. TRUE: Mutations in the gene encoding Aurora B kinase have been linked to defects in chromosome segregation, which is consistent with its role in regulating cell division.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 582,
    "user_query": "Name five programs for transcript quantification from RNASeq experiments",
    "yulan-chat-2-13b-fp16_response": "1. featureCounts\n2. Subread\n3. HTSeq\n4. Picard\n5. STAR",
    "yulan-chat-2-13b-fp16_fact_raw": "1. featureCounts is a program used for transcript quantification from RNASeq experiments.\n2. Subread is a program used for transcript quantification from RNASeq experiments.\n3. HTSeq is a program used for transcript quantification from RNASeq experiments.\n4. Picard is a program used for transcript quantification from RNASeq experiments.\n5. STAR is a program used for transcript quantification from RNASeq experiments.",
    "yulan-chat-2-13b-fp16_fact": [
      "featureCounts is a program used for transcript quantification from RNASeq experiments.",
      "Subread is a program used for transcript quantification from RNASeq experiments.",
      "HTSeq is a program used for transcript quantification from RNASeq experiments.",
      "Picard is a program used for transcript quantification from RNASeq experiments.",
      "STAR is a program used for transcript quantification from RNASeq experiments."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: featureCounts is a program used for counting reads mapping to genomic features such as genes, exons, promoters, and genomic bins, not directly for transcript quantification.\n2. FALSE [correction]: Subread is the package that includes featureCounts and is mainly used for read alignment, not direct transcript quantification.\n3. TRUE\n4. FALSE [correction]: Picard is a set of Java-based command-line utilities that manipulate high-throughput sequencing (HTS) data and formats, such as SAM/BAM files, not specifically for transcript quantification.\n5. FALSE [correction]: STAR (Spliced Transcripts Alignment to a Reference) is a program primarily used for aligning RNA-Seq reads to a reference genome, not directly for transcript quantification, although it can facilitate this process by providing aligned read files that can be used by quantification software.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 587,
    "user_query": "List variants of the MC1R gene.",
    "yulan-chat-2-13b-fp16_response": "The MC1R gene is a gene that provides instructions for making a protein called melanocortin-1 receptor type 1 (MC1R). This protein plays a role in the production of melanin, a pigment that determines the color of hair, eyes, and skin in animals.\nThere are several variants of the MC1R gene that have been identified in different animal species. Some of these variants are associated with changes in coat color and pattern, while others may have no apparent effect on coat color. Here are a few examples:\n* In dogs, the MC1R gene has two alleles (versions): the \"A\" allele, which is associated with black or dark brown coat color, and the \"B\" allele, which is associated with red or golden coat color. Heterozygous dogs (carrying one \"A\" and one \"B\" allele) may have a mix of black and red hair, while homozygous dogs (carrying two of the same allele) will have a coat color that is dominant to the other allele.\n* In horses, the MC1R gene has several alleles that are associated with different coat colors, including black, chestnut, and bay. Some of these alleles are also associated with other traits, such as the presence of a dorsal stripe or a mane.\n* In cattle, the MC1R gene has several alleles that are associated with different coat colors, including black, brown, and red. Some of these alleles are also associated with other traits, such as the presence of a belt or a dorsal stripe.\nOverall, the MC1R gene and its variants play an important role in determining the coat color and pattern of many different animal species.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The MC1R gene provides instructions for making the protein called melanocortin-1 receptor type 1.\n2. Variants of the MC1R gene are associated with changes in coat color and pattern in different animal species.\n3. In dogs, the \"A\" allele of the MC1R gene is associated with black or dark brown coat color, and the \"B\" allele is associated with red or golden coat color.\n4. In horses, there are several alleles of the MC1R gene that dictate different coat colors, such as black, chestnut, and bay.\n5. In cattle, the MC1R gene has several alleles that determine different coat colors, including black, brown, and red.",
    "yulan-chat-2-13b-fp16_fact": [
      "The MC1R gene provides instructions for making the protein called melanocortin-1 receptor type 1.",
      "Variants of the MC1R gene are associated with changes in coat color and pattern in different animal species.",
      "In dogs, the \"A\" allele of the MC1R gene is associated with black or dark brown coat color, and the \"B\" allele is associated with red or golden coat color.",
      "In horses, there are several alleles of the MC1R gene that dictate different coat colors, such as black, chestnut, and bay.",
      "In cattle, the MC1R gene has several alleles that determine different coat colors, including black, brown, and red."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In dogs, the \"E\" allele of the MC1R gene is associated with black or dark brown coat color, not the \"A\" allele. The \"e\" allele often results in red or yellow coat color.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 589,
    "user_query": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?",
    "yulan-chat-2-13b-fp16_response": "Heterozygous mutations of the BSCL2 gene have been associated with various phenotypes, including:\n1. Thrombophilia: Heterozygous mutations of the BSCL2 gene have been linked to an increased risk of thrombosis, which is the formation of blood clots in the blood vessels.\n2. Coronary artery disease: Heterozygous mutations of the BSCL2 gene have been associated with an increased risk of coronary artery disease, which is the buildup of plaque in the arteries that supply blood to the heart.\n3. Venous thrombosis: Heterozygous mutations of the BSCL2 gene have been linked to an increased risk of venous thrombosis, which is the formation of blood clots in the veins.\n4. Deep vein thrombosis: Heterozygous mutations of the BSCL2 gene have been associated with an increased risk of deep vein thrombosis, which is the formation of blood clots in the deep veins of the legs or arms.\n5. Pulmonary embolism: Heterozygous mutations of the BSCL2 gene have been linked to an increased risk of pulmonary embolism, which is the blocking of blood vessels in the lungs by blood clots.\nOverall, heterozygous mutations of the BSCL2 gene have been associated with an increased risk of blood clots and related conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Heterozygous mutations of the BSCL2 gene have been linked to an increased risk of thrombosis.\n2. Heterozygous mutations of the BSCL2 gene have been associated with an increased risk of coronary artery disease.\n3. Heterozygous mutations of the BSCL2 gene have been connected to an increased risk of venous thrombosis.\n4. Heterozygous mutations of the BSCL2 gene have been associated with an increased risk of deep vein thrombosis.\n5. Heterozygous mutations of the BSCL2 gene have been related to an increased risk of pulmonary embolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "Heterozygous mutations of the BSCL2 gene have been linked to an increased risk of thrombosis.",
      "Heterozygous mutations of the BSCL2 gene have been associated with an increased risk of coronary artery disease.",
      "Heterozygous mutations of the BSCL2 gene have been connected to an increased risk of venous thrombosis.",
      "Heterozygous mutations of the BSCL2 gene have been associated with an increased risk of deep vein thrombosis.",
      "Heterozygous mutations of the BSCL2 gene have been related to an increased risk of pulmonary embolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided relate to the genetic and medical field, specifically associations between the BSCL2 gene and various health conditions. Without specific scientific references or context that confirms these associations, it is not possible to determine the truthfulness of these claims. More information from credible medical sources or research studies would be required to assess these statements accurately.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 592,
    "user_query": "What is the genomic structure of the FAA (FANCA) gene?",
    "yulan-chat-2-13b-fp16_response": "The FANCA gene is located on the long (q) arm of chromosome 16 at position 22.1 and spans approximately 100 kb. The gene consists of 27 exons, with the first 25 exons encoding for the FANCA protein and the last 2 exons being non-coding regions. The FANCA gene produces a protein of 2344 amino acids, which is a component of the Fanconia anemia group of proteins, also known as the FA core complex. The FANCA gene is highly expressed in many tissues, including bone marrow, lymphoid tissue, and testis, and is essential for the maintenance of genome stability. Mutations in the FANCA gene are associated with Fanconia anemia, a genetic disorder characterized by increased susceptibility to cancer and congenital abnormalities.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The FANCA gene is located on the long (q) arm of chromosome 16 at position 22.1.\n2. The FANCA gene spans approximately 100 kilobases (kb).\n3. The gene consists of 27 exons.\n4. The FANCA protein is comprised of 2344 amino acids.\n5. Mutations in the FANCA gene are associated with Fanconi anemia.",
    "yulan-chat-2-13b-fp16_fact": [
      "The FANCA gene is located on the long (q) arm of chromosome 16 at position 22.1.",
      "The FANCA gene spans approximately 100 kilobases (kb).",
      "The gene consists of 27 exons.",
      "The FANCA protein is comprised of 2344 amino acids.",
      "Mutations in the FANCA gene are associated with Fanconi anemia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The FANCA gene spans approximately 80 to 85 kilobases (kb).\n3. FALSE [correction]: The gene consists of 43 exons.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 593,
    "user_query": "What is Snord116?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I am not familiar with the term \"Snord116.\" It is possible that it refers to a specific product or concept that is not widely known or documented. Can you provide more context or information about what you are referring to?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 594,
    "user_query": "What is the functional role of the protein Drp1?",
    "yulan-chat-2-13b-fp16_response": "Drp1 (Dynamin-related protein 1) is a protein that plays a key role in the process of mitochondrial fission, which is the division of mitochondria in cells. During mitochondrial fission, Drp1 forms a ring around the mitochondrial outer membrane and then constricts the ring, pinching the membrane inward and dividing the mitochondrion into two daughter cells. This process is important for several reasons:\n1. Maintenance of mitochondrial function: Mitochondria are constantly undergoing changes in volume and shape, and mitochondrial fission helps to ensure that the organelles remain small and functional.\n2. Apoptosis: Mitochondrial fission is also involved in the process of apoptosis (programmed cell death), which is a necessary process for the removal of damaged or infected cells.\n3. Cellular signaling: The process of mitochondrial fission can also signal to the rest of the cell that there is a need for increased stress or energy production.\nOverall, Drp1 is an important protein that plays a critical role in the process of mitochondrial fission, which is essential for maintaining the health and function of cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Drp1 is involved in the process of mitochondrial fission, the division of mitochondria in cells.\n2. During mitochondrial fission, Drp1 forms a ring around the mitochondrial outer membrane.\n3. Drp1 constricts this ring to divide the mitochondrion into two parts.\n4. Mitochondrial fission contributes to the maintenance of mitochondrial function by ensuring organelles remain small and functional.\n5. Mitochondrial fission, involving Drp1, is part of the process of apoptosis (programmed cell death).",
    "yulan-chat-2-13b-fp16_fact": [
      "Drp1 is involved in the process of mitochondrial fission, the division of mitochondria in cells.",
      "During mitochondrial fission, Drp1 forms a ring around the mitochondrial outer membrane.",
      "Drp1 constricts this ring to divide the mitochondrion into two parts.",
      "Mitochondrial fission contributes to the maintenance of mitochondrial function by ensuring organelles remain small and functional.",
      "Mitochondrial fission, involving Drp1, is part of the process of apoptosis (programmed cell death)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 595,
    "user_query": "Which is the genetic cause for the development of Fanconi anemia complementation group D1?",
    "yulan-chat-2-13b-fp16_response": "Fanconi anemia complementation group D1 (FANCD1) is caused by mutations in the FANCD1 gene. This gene provides instructions for making a protein that is involved in a process called the DNA damage response. The protein helps to repair damaged DNA and prevent the accumulation of errors that can lead to cancer. Mutations in the FANCD1 gene can lead to a deficiency in the FANCD1 protein, which can increase the risk of developing cancer and other health problems.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fanconi anemia complementation group D1 (FANCD1) is caused by mutations in the FANCD1 gene.\n2. The FANCD1 gene provides instructions for making a protein involved in the DNA damage response.\n3. The protein produced by the FANCD1 gene helps to repair damaged DNA.\n4. Mutations in the FANCD1 gene can lead to a deficiency in the FANCD1 protein.\n5. A deficiency in the FANCD1 protein can increase the risk of developing cancer and other health problems.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fanconi anemia complementation group D1 (FANCD1) is caused by mutations in the FANCD1 gene.",
      "The FANCD1 gene provides instructions for making a protein involved in the DNA damage response.",
      "The protein produced by the FANCD1 gene helps to repair damaged DNA.",
      "Mutations in the FANCD1 gene can lead to a deficiency in the FANCD1 protein.",
      "A deficiency in the FANCD1 protein can increase the risk of developing cancer and other health problems."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Fanconi anemia complementation group D1 (FANCD1) is caused by mutations in the BRCA2 gene, not a gene with the name FANCD1.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 596,
    "user_query": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?",
    "yulan-chat-2-13b-fp16_response": "Mutations in the Calsequestrin 2 (CASQ2) gene have been associated with several diseases, including:\n1. Inherited thrombophilia: This is a condition characterized by an increased risk of blood clots forming in the veins or arteries.\n2. Familial dilated cardiomyopathy: This is a type of heart muscle disease that causes the heart to become enlarged and weakened, leading to heart failure.\n3. Arrhythmic right ventricular cardiomyopathy: This is a type of heart muscle disease that affects the right ventricle of the heart and can cause abnormal heart rhythms.\n4. Neuromuscular disorders: Mutations in the CASQ2 gene have also been associated with certain neuromuscular disorders, such as myopathy and neuropathy.\nIt's important to note that not all mutations in the CASQ2 gene are associated with disease, and the relationship between genetic mutations and disease is complex and not fully understood.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the Calsequestrin 2 (CASQ2) gene can increase the risk of inherited thrombophilia.\n2. Mutations in the Calsequestrin 2 (CASQ2) gene can be associated with familial dilated cardiomyopathy.\n3. Mutations in the Calsequestrin 2 (CASQ2) gene can lead to arrhythmic right ventricular cardiomyopathy.\n4. Mutations in the CASQ2 gene have been linked to certain neuromuscular disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the Calsequestrin 2 (CASQ2) gene can increase the risk of inherited thrombophilia.",
      "Mutations in the Calsequestrin 2 (CASQ2) gene can be associated with familial dilated cardiomyopathy.",
      "Mutations in the Calsequestrin 2 (CASQ2) gene can lead to arrhythmic right ventricular cardiomyopathy.",
      "Mutations in the CASQ2 gene have been linked to certain neuromuscular disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Mutations in the Calsequestrin 2 (CASQ2) gene are associated with a condition called catecholaminergic polymorphic ventricular tachycardia, not inherited thrombophilia.\n2. TRUE\n3. FALSE [correction]: Mutations in the Calsequestrin 2 (CASQ2) gene are linked to catecholaminergic polymorphic ventricular tachycardia, not arrhythmic right ventricular cardiomyopathy.\n4. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "yulan-chat-2-13b-fp16_response": "In vertebrates, the most frequent non-canonical sequence motifs at the donor and acceptor splice sites are the consensus sequences (also known as the spliceosome recognition site or splice site consensus sequence) which are defined by the presence of the nucleotides GCU/GUC at the donor site and AG/UGA at the acceptor site. However, there are also other non-canonical motifs that can be found at these sites, such as polypyrimidine tracts, stem-loop structures, and various other RNA secondary structures. These motifs can affect splicing efficiency and accuracy, and their presence can lead to alternative splicing patterns.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The most frequent non-canonical sequence motifs at the donor splice site in vertebrates are defined by the presence of the nucleotides GCU/GUC.\n2. The most frequent non-canonical sequence motifs at the acceptor splice site in vertebrates are defined by the presence of the nucleotides AG/UGA.\n3. Polypyrimidine tracts are among the non-canonical motifs found at the splice sites.\n4. Stem-loop structures are one type of non-canonical motif that can be found at splice sites.\n5. Various RNA secondary structures can be non-canonical motifs at donor and acceptor splice sites in vertebrates.",
    "yulan-chat-2-13b-fp16_fact": [
      "The most frequent non-canonical sequence motifs at the donor splice site in vertebrates are defined by the presence of the nucleotides GCU/GUC.",
      "The most frequent non-canonical sequence motifs at the acceptor splice site in vertebrates are defined by the presence of the nucleotides AG/UGA.",
      "Polypyrimidine tracts are among the non-canonical motifs found at the splice sites.",
      "Stem-loop structures are one type of non-canonical motif that can be found at splice sites.",
      "Various RNA secondary structures can be non-canonical motifs at donor and acceptor splice sites in vertebrates."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The most frequent canonical sequence motifs at the donor splice site in vertebrates are defined by the presence of the nucleotides GT at the exon-intron boundary (GT/AG rule).\n2. FALSE [correction]: The most frequent canonical sequence motifs at the acceptor splice site in vertebrates are defined by the presence of the nucleotides AG at the intron-exon boundary (GT/AG rule).\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 602,
    "user_query": "Which are the Atg8 homologs in human?",
    "yulan-chat-2-13b-fp16_response": "In humans, the Atg8 homolog is called Autophagy-related protein 16 (ATG16L1). It plays a key role in the process of autophagy, which is a cellular process of degrading and recycling cellular components.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 606,
    "user_query": "Which is the molecular mechanism underlying K-ras alterations in carcinomas?",
    "yulan-chat-2-13b-fp16_response": "K-ras is a protein that is involved in several cellular signaling pathways, including those that control cell growth and differentiation. Mutations in the K-ras gene are commonly found in many types of cancer, including carcinomas.\nThe molecular mechanism underlying K-ras alterations in carcinomas involves a process called point mutation. This occurs when a single nucleotide in the K-ras gene is changed, resulting in a change in the amino acid sequence of the K-ras protein. This can lead to the activation of the K-ras protein, which can promote cell growth and division, leading to the development of cancer.\nIn addition to point mutations, K-ras alterations can also occur through other mechanisms, such as gene duplication or amplification, or through changes in the regulatory elements of the K-ras gene. These alterations can also lead to the activation of the K-ras protein and the development of cancer.\nOverall, the molecular mechanism underlying K-ras alterations in carcinomas involves changes in the K-ras gene that lead to the activation of the K-ras protein, which can promote cancer cell growth and survival.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. K-ras is a protein involved in cellular signaling pathways that control cell growth and differentiation.\n2. Mutations in the K-ras gene are commonly found in many types of cancer, including carcinomas.\n3. Point mutations in the K-ras gene involve a change of a single nucleotide, resulting in a different amino acid sequence of the K-ras protein.\n4. The activation of the K-ras protein due to point mutations can promote cell growth and division, leading to cancer development.\n5. K-ras alterations can also occur through gene duplication, amplification, or changes in regulatory elements, leading to protein activation and potential cancer development.",
    "yulan-chat-2-13b-fp16_fact": [
      "K-ras is a protein involved in cellular signaling pathways that control cell growth and differentiation.",
      "Mutations in the K-ras gene are commonly found in many types of cancer, including carcinomas.",
      "Point mutations in the K-ras gene involve a change of a single nucleotide, resulting in a different amino acid sequence of the K-ras protein.",
      "The activation of the K-ras protein due to point mutations can promote cell growth and division, leading to cancer development.",
      "K-ras alterations can also occur through gene duplication, amplification, or changes in regulatory elements, leading to protein activation and potential cancer development."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 607,
    "user_query": "Is microRNA(miRNA) 30 involved in post-ischemic cardiac remodeling?",
    "yulan-chat-2-13b-fp16_response": "MicroRNA (miRNA) 30 has been implicated in post-ischemic cardiac remodeling, although the exact role it plays in this process is still not fully understood.\nStudies have shown that miRNA 30 can be upregulated in the heart after ischemia-reperfusion injury, which is a common complication in patients with heart attacks. This upregulation is thought to contribute to the development of cardiac fibrosis, which is a key feature of post-ischemic cardiac remodeling.\nCardiac fibrosis is the formation of excess connective tissue in the heart, which can lead to stiffening of the heart muscle and impair its ability to pump blood effectively. MiRNA 30 is thought to contribute to this process by regulating the expression of genes involved in the development of fibrosis, including those involved in the activation of fibroblasts and the production of extracellular matrix components.\nHowever, more research is needed to fully understand the role of miRNA 30 in post-ischemic cardiac remodeling and to determine its potential as a therapeutic target for the treatment of heart disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MicroRNA (miRNA) 30 has been implicated in post-ischemic cardiac remodeling.\n2. miRNA 30 can be upregulated in the heart after ischemia-reperfusion injury.\n3. Ischemia-reperfusion injury is a common complication in patients with heart attacks.\n4. Cardiac fibrosis involves the formation of excess connective tissue in the heart.\n5. miRNA 30 is thought to regulate the expression of genes involved in the development of cardiac fibrosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "MicroRNA (miRNA) 30 has been implicated in post-ischemic cardiac remodeling.",
      "miRNA 30 can be upregulated in the heart after ischemia-reperfusion injury.",
      "Ischemia-reperfusion injury is a common complication in patients with heart attacks.",
      "Cardiac fibrosis involves the formation of excess connective tissue in the heart.",
      "miRNA 30 is thought to regulate the expression of genes involved in the development of cardiac fibrosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEach statement pertains to general knowledge in the field of molecular biology and cardiology as of my knowledge cutoff date. However, for a more precise verification, it would require referencing specific scientific studies or consensus in medical literature, which might be beyond the scope of general knowledge.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 613,
    "user_query": "How is myotonic dystrophy inherited?",
    "yulan-chat-2-13b-fp16_response": "Myotonic dystrophy is a genetic disorder that is inherited in an autosomal dominant pattern. This means that a person only needs to inherit one copy of the mutated gene from one parent in order to develop the condition. The mutated gene responsible for myotonic dystrophy is located on the long (q) arm of chromosome 19 at position 13.11.11.11-13.12 and it encodes a protein called myotonic dystrophy protein (MDP). The MDP protein plays a role in regulating the stability of RNA molecules, and the mutation in the gene leads to an expansion of a repeated segment in the MDP gene, which causes the protein to be abnormally long and stable. This leads to the characteristic symptoms of myotonic dystrophy, including muscle weakness and wasting, cataracts, and heart muscle disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Myotonic dystrophy is inherited in an autosomal dominant pattern.\n2. A person with myotonic dystrophy only needs one copy of the mutated gene from one parent to develop the condition.\n3. The mutated gene responsible for myotonic dystrophy is located on the long (q) arm of chromosome 19 at position 13.11.11.11-13.12.\n4. The protein encoded by the mutated gene in myotonic dystrophy is called myotonic dystrophy protein (MDP).\n5. The mutation in the gene for myotonic dystrophy leads to an expansion of a repeated segment in the MDP gene, resulting in an abnormally long and stable protein.",
    "yulan-chat-2-13b-fp16_fact": [
      "Myotonic dystrophy is inherited in an autosomal dominant pattern.",
      "A person with myotonic dystrophy only needs one copy of the mutated gene from one parent to develop the condition.",
      "The mutated gene responsible for myotonic dystrophy is located on the long (q) arm of chromosome 19 at position 13.11.11.11-13.12.",
      "The protein encoded by the mutated gene in myotonic dystrophy is called myotonic dystrophy protein (MDP).",
      "The mutation in the gene for myotonic dystrophy leads to an expansion of a repeated segment in the MDP gene, resulting in an abnormally long and stable protein."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The known mutations for myotonic dystrophy are located on chromosome 19 at position q13.3 (known as DM1 and caused by a mutation in the DMPK gene) or on chromosome 3 at position q21.3 (known as DM2 and caused by a mutation in the CNBP gene), not at the position 13.11.11.11-13.12.\n4. FALSE [correction]: The protein encoded by the DMPK gene in myotonic dystrophy is known as myotonic dystrophy protein kinase (DMPK), not myotonic dystrophy protein (MDP).\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 615,
    "user_query": "Which are the mammalian orthologs of Drosophila Yki?",
    "yulan-chat-2-13b-fp16_response": "Yki is a transcriptional co-activator in Drosophila that plays a key role in regulating gene expression during development and in response to environmental cues. While there is no direct one-to-one ortholog of Yki in mammals, there are several proteins that share some functional similarities.\nOne of the most well-known Yki orthologs in mammals is the transcription factor SRY (Sex-determing factor in the Y chromosome), which is involved in the development of male sex characteristics. SRY contains a similar DNA-binding domain as Yki and is also involved in regulating gene expression.\nAnother Yki ortholog in mammals is the protein STAT3 (Signal transducer and activator of transcription 3), which is involved in regulating immune responses, cell differentiation, and proliferation. STAT3 contains a similar structure as Yki and functions as a transcriptional co-activator.\nOther proteins that share some functional similarities with Yki in mammals include the transcription factors C/EBP (CCAAT/enhancer-binding protein), PPAR (Peroxisome proliferator-activated receptor gamma), and HIF (Hypoxia-inducible factor). These proteins are involved in regulating gene expression in response to various stimuli, such as nutrient availability, oxygen levels, and stress.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Yki is a transcriptional co-activator in Drosophila that plays a role in gene expression regulation during development and in response to environmental cues.\n2. The transcription factor SRY is considered a mammalian ortholog of Yki that is involved in male sex characteristics development.\n3. SRY contains a similar DNA-binding domain as Yki and also regulates gene expression.\n4. The protein STAT3 is a mammalian ortholog of Yki involved in immune responses, cell differentiation, and proliferation.\n5. STAT3 functions as a transcriptional co-activator and shares a similar structure with Yki.",
    "yulan-chat-2-13b-fp16_fact": [
      "Yki is a transcriptional co-activator in Drosophila that plays a role in gene expression regulation during development and in response to environmental cues.",
      "The transcription factor SRY is considered a mammalian ortholog of Yki that is involved in male sex characteristics development.",
      "SRY contains a similar DNA-binding domain as Yki and also regulates gene expression.",
      "The protein STAT3 is a mammalian ortholog of Yki involved in immune responses, cell differentiation, and proliferation.",
      "STAT3 functions as a transcriptional co-activator and shares a similar structure with Yki."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The transcription factor SRY is not considered a mammalian ortholog of Yki. SRY is specifically involved in male sex determination in mammals and is not directly related to Yki.\n3. FALSE [correction]: While SRY does regulate gene expression and is involved in male sex determination, it does not contain a similar DNA-binding domain to Yki.\n4. FALSE [correction]: The protein STAT3 is not a mammalian ortholog of Yki; instead, it is a signal transducer and activator of transcription that is part of a different signaling pathway than Yki.\n5. FALSE [correction]: Although STAT3 functions as a transcriptional co-activator and is involved in a variety of cellular processes, it does not share a similar structure with Yki. Yki is part of the Hippo signaling pathway, which is distinct from the JAK-STAT signaling pathway that involves STAT3.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 618,
    "user_query": "Does molindone affect body weight?",
    "yulan-chat-2-13b-fp16_response": "Yes, molindone can affect body weight. It is a typical antipsychotic drug that has been associated with weight gain in some patients. However, the extent of weight gain can vary depending on the individual and the dosage of the medication. Some people may experience significant weight gain, while others may not notice any changes in their weight. It is important to discuss any concerns about weight gain or other side effects with your doctor when taking molindone or any other medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Molindone is a typical antipsychotic drug.\n2. Molindone has been associated with weight gain in some patients.\n3. The extent of weight gain from molindone can vary depending on the individual and the dosage.\n4. Some people may not notice any changes in their weight when taking molindone.",
    "yulan-chat-2-13b-fp16_fact": [
      "Molindone is a typical antipsychotic drug.",
      "Molindone has been associated with weight gain in some patients.",
      "The extent of weight gain from molindone can vary depending on the individual and the dosage.",
      "Some people may not notice any changes in their weight when taking molindone."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 622,
    "user_query": "Neurostimulation of which nucleus is used for treatment of dystonia?",
    "yulan-chat-2-13b-fp16_response": "Dystonia is a movement disorder characterized by involuntary muscle contractions and spasms, which can cause twisting and repetitive movements or abnormal postures. One type of dystonia, called cervical dystonia, affects the neck and head muscles.\nThere are several treatments for dystonia, including medications, surgery, and neurostimulation. One type of neurostimulation that has been used to treat dystonia is deep brain stimulation (DBS) of the internal globus pallidus (GPi) or the subthalamic nucleus (STN).\nDBS involves implanting electrodes into specific areas of the brain that are responsible for the dystonia. The electrodes deliver electrical impulses to these areas, which can help regulate abnormal brain activity and reduce symptoms. DBS has been shown to be an effective treatment for dystonia, particularly for patients who do not respond to medications or who experience significant side effects from medications.\nIt is important to note that DBS is a complex procedure and requires careful evaluation by a team of specialists, including a neurologist, a neurosurgeon, and a psychologist. Patients considering DBS should carefully weigh the potential benefits and risks and discuss their options with their healthcare providers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dystonia is a movement disorder characterized by involuntary muscle contractions and spasms.\n2. Deep brain stimulation (DBS) of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) has been used to treat dystonia.\n3. DBS involves implanting electrodes into specific areas of the brain responsible for dystonia.\n4. DBS has been shown to be an effective treatment for patients with dystonia who do not respond to medications or experience significant side effects from medications.\n5. Deep brain stimulation is a complex procedure that requires the evaluation by a team of specialists including a neurologist, a neurosurgeon, and a psychologist.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dystonia is a movement disorder characterized by involuntary muscle contractions and spasms.",
      "Deep brain stimulation (DBS) of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) has been used to treat dystonia.",
      "DBS involves implanting electrodes into specific areas of the brain responsible for dystonia.",
      "DBS has been shown to be an effective treatment for patients with dystonia who do not respond to medications or experience significant side effects from medications.",
      "Deep brain stimulation is a complex procedure that requires the evaluation by a team of specialists including a neurologist, a neurosurgeon, and a psychologist."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 625,
    "user_query": "Where is the angiogenin binding element  located?",
    "yulan-chat-2-13b-fp16_response": "Angiogenin is a protein that is involved in angiogenesis, the process of new blood vessel formation. The binding element for angiogenin is typically located within the promoter region of the gene that encodes for this protein. The promoter region is a specific sequence of DNA that is recognized by transcription factors and other regulatory proteins, which bind to it and initiate the transcription of the gene. The exact location of the binding element for angiogenin may vary depending on the species and the specific context in which it is being studied.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Angiogenin is a protein involved in angiogenesis, which is the process of new blood vessel formation.\n2. The binding element for angiogenin is usually located within the promoter region of the gene that encodes for this protein.\n3. The promoter region is a sequence of DNA recognized by transcription factors and regulatory proteins.\n4. These transcription factors and regulatory proteins bind to the promoter region to initiate gene transcription.\n5. The exact location of the angiogenin binding element may vary depending on the species.",
    "yulan-chat-2-13b-fp16_fact": [
      "Angiogenin is a protein involved in angiogenesis, which is the process of new blood vessel formation.",
      "The binding element for angiogenin is usually located within the promoter region of the gene that encodes for this protein.",
      "The promoter region is a sequence of DNA recognized by transcription factors and regulatory proteins.",
      "These transcription factors and regulatory proteins bind to the promoter region to initiate gene transcription.",
      "The exact location of the angiogenin binding element may vary depending on the species."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The statement seems to conflate the function of angiogenin with elements that regulate its expression. Angiogenin itself does not bind within the promoter region of its own gene but rather is a protein that acts elsewhere in the body to promote angiogenesis. The binding element for a protein usually refers to a sequence within the DNA or another molecule that the protein binds to exert its function, not to the regulatory regions of its own gene.\n3. TRUE\n4. TRUE\n5. UNKNOWN (The statement is vague as it does not specify what is meant by the \"angiogenin binding element.\" Typically, binding elements for transcription factors and regulatory proteins can vary across species, but without specific context, it's unclear whether this statement refers to the regulatory region of the angiogenin gene or some functional region where angiogenin binds.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 626,
    "user_query": "Which proteins cause cytoplasmic sequestration of NF-kB?",
    "yulan-chat-2-13b-fp16_response": "Cytoplasmic sequestration of NF-kB (nuclear factor kappa B) is a process that involves the translocation of NF-kB from the nucleus to the cytoplasm, where it is sequestered and inhibited. This process is mediated by a group of proteins known as IB (inhibitor of NF-kB) and their kinases, which phosphorylate and degradate IB, leading to the release of NF-kB and its translocation to the nucleus.\nThe IB proteins are composed of two subunits: p65 and p50. p65 is a transcription factor that binds to the DNA and regulates the expression of target genes, while p50 acts as a negative regulator of NF-kB activity. The kinases that phosphorylate and degradate IB include IB kinase (IKK), which is composed of three subunits (IKK, IKK, and IKK), and the protein kinase C- (PKC-).\nTherefore, the proteins that cause cytoplasmic sequestration of NF-kB are the IB proteins and their kinases, particularly IKK and PKC-.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cytoplasmic sequestration of NF-kB is mediated by a group of proteins known as IB and their kinases.\n2. Phosphorylation and degradation of IB lead to the release of NF-kB, allowing its translocation to the nucleus.\n3. IB proteins are composed of two subunits, p65 and p50, where p65 is a transcription factor and p50 acts as a negative regulator of NF-kB activity.\n4. IB kinase (IKK) is involved in the phosphorylation and degradation of IB and is composed of three subunits: IKK, IKK, and IKK.\n5. Protein kinase C- (PKC-) is also a kinase that mediates phosphorylation and degradation of IB.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cytoplasmic sequestration of NF-kB is mediated by a group of proteins known as IB and their kinases.",
      "Phosphorylation and degradation of IB lead to the release of NF-kB, allowing its translocation to the nucleus.",
      "IB proteins are composed of two subunits, p65 and p50, where p65 is a transcription factor and p50 acts as a negative regulator of NF-kB activity.",
      "IB kinase (IKK) is involved in the phosphorylation and degradation of IB and is composed of three subunits: IKK, IKK, and IKK.",
      "Protein kinase C- (PKC-) is also a kinase that mediates phosphorylation and degradation of IB."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: IB proteins are inhibitors that bind to NF-kB preventing its translocation to the nucleus. The p65 and p50 are subunits of the NF-kB complex itself, not IB. p65 is often referred to as RelA and is a transcriptional activator, while p50 can modulate NF-kB activity, but is not an IB protein.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 627,
    "user_query": "What is the mode of inheritance of Marchesani syndrome?",
    "yulan-chat-2-13b-fp16_response": "Marchesani syndrome is a rare genetic disorder that is caused by mutations in the COL7A1 gene. This gene provides instructions for making a protein called type VII collagen, which is a key component of the extracellular matrix. The extracellular matrix is a complex network of proteins and other molecules that provides structural support to cells and tissues.\nMarchesani syndrome is inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated COL7A1 gene (one from each parent) in order to develop the condition. Most cases of Marchesani syndrome are caused by mutations that result in the production of an abnormal form of type VII collagen that is unstable and prone to aggregation. These mutations lead to the degeneration of cartilage and other connective tissues, which can cause a range of symptoms including joint pain, stiffness, and deformities.\nIt is important to note that Marchesani syndrome is a rare disorder, and it is not yet clear how common autosomal recessive inheritance is in cases of this condition. Some cases of Marchesani syndrome may be caused by mutations in other genes, and the mode of inheritance may vary depending on the underlying genetic cause.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Marchesani syndrome is caused by mutations in the COL7A1 gene.\n2. The COL7A1 gene provides instructions for making a protein called type VII collagen.\n3. Type VII collagen is a component of the extracellular matrix, which provides structural support to cells and tissues.\n4. Marchesani syndrome is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene for the condition to develop.\n5. Mutations in the COL7A1 gene can lead to the production of an abnormal form of type VII collagen.",
    "yulan-chat-2-13b-fp16_fact": [
      "Marchesani syndrome is caused by mutations in the COL7A1 gene.",
      "The COL7A1 gene provides instructions for making a protein called type VII collagen.",
      "Type VII collagen is a component of the extracellular matrix, which provides structural support to cells and tissues.",
      "Marchesani syndrome is inherited in an autosomal recessive pattern, requiring two copies of the mutated gene for the condition to develop.",
      "Mutations in the COL7A1 gene can lead to the production of an abnormal form of type VII collagen."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Marchesani syndrome is caused by mutations in the ADAMTS10 gene, not the COL7A1 gene.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Marchesani syndrome is inherited in an autosomal dominant pattern, not an autosomal recessive pattern.\n5. FALSE [correction]: Mutations in the COL7A1 gene can lead to the production of an abnormal form of type VII collagen, but this is associated with a condition called dystrophic epidermolysis bullosa, not Marchesani syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "yulan-chat-2-13b-fp16_response": "The activation of the protein kinase B (AKT) pathway results in the acetylation of S6K1. Specifically, the phosphorylation of S6K1 at threonine 389 by AKT-PKB leads to its recruitment to the ribosome and subsequent acetylation by the co-activator p300.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The activation of the protein kinase B (AKT) pathway results in the acetylation of S6K1.\n2. Phosphorylation of S6K1 at threonine 389 by AKT-PKB leads to its recruitment to the ribosome.\n3. The co-activator p300 is responsible for the acetylation of S6K1 following its recruitment to the ribosome.",
    "yulan-chat-2-13b-fp16_fact": [
      "The activation of the protein kinase B (AKT) pathway results in the acetylation of S6K1.",
      "Phosphorylation of S6K1 at threonine 389 by AKT-PKB leads to its recruitment to the ribosome.",
      "The co-activator p300 is responsible for the acetylation of S6K1 following its recruitment to the ribosome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n\nThe activation and mechanisms of the AKT pathway and its downstream effects on S6K1 (also known as p70S6 kinase) are well-defined in molecular biology. However, acetylation and the specific enzymes responsible for such post-translational modifications can be highly context-dependent and are not standard textbook knowledge. Without access to the specific passage or current literature, the statement linking AKT activation directly to S6K1 acetylation (Statement 1) and the specific role of p300 in S6K1 acetylation (Statement 3) cannot be verified. The process of phosphorylation of S6K1 at threonine 389 by AKT is a well-documented step in the mTOR signaling pathway (Statement 2).",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 630,
    "user_query": "List angiocrine factors",
    "yulan-chat-2-13b-fp16_response": "Angiocrine factors are a group of signaling molecules that are secreted by cells and can have a direct impact on the behavior of neighboring cells, particularly in the context of blood vessels. Some examples of angiocrine factors include:\n1. Vascular endothelial growth factor (VEGF)\n2. Angiopoietin-1\n3. Platelet-derived growth factor (PDGF)\n4. Fibroblast growth factor (FGF)\n5. Transforming growth factor-beta (TGF-)\n6. Hepatocyte growth factor (HGF)\n7. Midkine\n8. Angiogenin\n9. Thrombopoietin (TPO)\n10. Stromal cell-derived factor 1 (SDF-1)\nThese factors play a critical role in regulating angiogenesis, the process of new blood vessel formation, and in maintaining the integrity and function of existing blood vessels. They can also have other effects on cell behavior, such as promoting cell proliferation, survival, and migration.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vascular endothelial growth factor (VEGF) is an angiocrine factor.\n2. Angiopoietin-1 is an angiocrine factor.\n3. Platelet-derived growth factor (PDGF) is an angiocrine factor.\n4. Fibroblast growth factor (FGF) is an angiocrine factor.\n5. Transforming growth factor-beta (TGF-) is an angiocrine factor.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vascular endothelial growth factor (VEGF) is an angiocrine factor.",
      "Angiopoietin-1 is an angiocrine factor.",
      "Platelet-derived growth factor (PDGF) is an angiocrine factor.",
      "Fibroblast growth factor (FGF) is an angiocrine factor.",
      "Transforming growth factor-beta (TGF-) is an angiocrine factor."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Platelet-derived growth factor (PDGF) is generally considered a growth factor acting in a paracrine manner rather than specifically an angiocrine factor.\n4. FALSE [correction]: Fibroblast growth factor (FGF) is generally considered a growth factor, involved in various processes including angiogenesis, but not specifically classified as an angiocrine factor.\n5. FALSE [correction]: Transforming growth factor-beta (TGF-) while involved in angiogenesis, is not typically referred to as an angiocrine factor. It has broader roles, including regulation of cell growth and differentiation in both normal and diseased tissues, often acting in a paracrine or autocrine manner.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 631,
    "user_query": "What is protein carbamylation?",
    "yulan-chat-2-13b-fp16_response": "Protein carbamylation is a chemical modification in which a carbamyl group (-CONH-) is added to the amino group of a lysine residue in a protein. This modification is catalyzed by the enzyme carbamyltransferase and is reversible. Protein carbamylation has been implicated in various cellular processes, including the regulation of gene expression, protein degradation, and cell signaling. It has also been linked to various diseases, including cancer and diabetes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Protein carbamylation involves the addition of a carbamyl group (-CONH2) to the amino group of a lysine residue in a protein.\n2. The enzyme carbamyltransferase catalyzes the protein carbamylation process.\n3. Protein carbamylation is a reversible chemical modification.\n4. Protein carbamylation has been implicated in the regulation of gene expression, protein degradation, and cell signaling.\n5. Protein carbamylation has been linked to various diseases, including cancer and diabetes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Protein carbamylation involves the addition of a carbamyl group (-CONH2) to the amino group of a lysine residue in a protein.",
      "The enzyme carbamyltransferase catalyzes the protein carbamylation process.",
      "Protein carbamylation is a reversible chemical modification.",
      "Protein carbamylation has been implicated in the regulation of gene expression, protein degradation, and cell signaling.",
      "Protein carbamylation has been linked to various diseases, including cancer and diabetes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Carbamylation is a non-enzymatic process that does not involve carbamyltransferase. It occurs when isocyanic acid reacts with the amino groups of proteins.\n3. FALSE [correction]: Protein carbamylation is generally considered an irreversible modification.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "yulan-chat-2-13b-fp16_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder caused by mutations in the KCNA6 gene. This gene provides instructions for making a protein called potassium channel tetrodotoxin-sensitive subunit alpha-6, which is an important component of a type of ion channel found in nerve cells. Mutations in the KCNA6 gene can lead to abnormal ion channel function, which disrupts the normal electrical activity of nerve cells and causes episodes of ataxia, a condition characterized by loss of coordination and balance. These episodes can be triggered by certain triggers, such as stress, exercise, or alcohol consumption, and can last for several minutes to several hours. In addition to ataxia, EA6 can also cause other neurological symptoms, such as tremors, dizziness, and headaches.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Episodic ataxia type 6 (EA6) is caused by mutations in the KCNA6 gene.\n2. The KCNA6 gene is responsible for making a protein called potassium channel tetrodotoxin-sensitive subunit alpha-6.\n3. Potassium channel tetrodotoxin-sensitive subunit alpha-6 is a component of an ion channel found in nerve cells.\n4. Mutations in the KCNA6 gene lead to abnormal ion channel function, which disrupts the normal electrical activity of nerve cells.\n5. Episodes of ataxia in EA6 can be triggered by stress, exercise, or alcohol consumption.",
    "yulan-chat-2-13b-fp16_fact": [
      "Episodic ataxia type 6 (EA6) is caused by mutations in the KCNA6 gene.",
      "The KCNA6 gene is responsible for making a protein called potassium channel tetrodotoxin-sensitive subunit alpha-6.",
      "Potassium channel tetrodotoxin-sensitive subunit alpha-6 is a component of an ion channel found in nerve cells.",
      "Mutations in the KCNA6 gene lead to abnormal ion channel function, which disrupts the normal electrical activity of nerve cells.",
      "Episodes of ataxia in EA6 can be triggered by stress, exercise, or alcohol consumption."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Episodic ataxia type 6 (EA6) is caused by mutations in the SLC1A3 gene, not the KCNA6 gene.\n2. UNKNOWN: The statement about the KCNA6 gene's responsibility for a specific protein cannot be confirmed as true or false without the correct context for the gene's function.\n3. TRUE: Generally, potassium channel subunits (though not specifically tetrodotoxin-sensitive subunit alpha-6 without proper context) are components of ion channels found in nerve cells.\n4. TRUE: Mutations in genes responsible for ion channel function, such as the KCNA6 gene, can lead to abnormal ion channel function, which disrupts the normal electrical activity of nerve cells.\n5. TRUE: Episodes of ataxia in different types of episodic ataxia can indeed be triggered by factors such as stress, exercise, or alcohol consumption. However, without specific reference to EA6, this statement should be regarded with caution for this subtype.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 633,
    "user_query": "What is the main role of Ctf4 in dna replication?",
    "yulan-chat-2-13b-fp16_response": "Ctf4 (also known as Cdc4) is a protein that plays a key role in the process of DNA replication in eukaryotic cells. The main role of Ctf4 is to help coordinate the unwinding of the double-stranded DNA molecule by recruiting other proteins to form a helicase complex that separates the DNA strands. This allows the replication machinery to access the DNA and synthesize new strands. Ctf4 also helps to ensure that the DNA is replicated accurately by interacting with other proteins that monitor and repair DNA damage.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ctf4 is a protein that plays a key role in DNA replication in eukaryotic cells.\n2. The main role of Ctf4 is to coordinate the unwinding of the double-stranded DNA.\n3. Ctf4 recruits other proteins to form a helicase complex that separates the DNA strands.\n4. Ctf4 interacts with other proteins that monitor and repair DNA damage to ensure accurate DNA replication.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ctf4 is a protein that plays a key role in DNA replication in eukaryotic cells.",
      "The main role of Ctf4 is to coordinate the unwinding of the double-stranded DNA.",
      "Ctf4 recruits other proteins to form a helicase complex that separates the DNA strands.",
      "Ctf4 interacts with other proteins that monitor and repair DNA damage to ensure accurate DNA replication."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The main role of Ctf4 is not to coordinate the unwinding of the double-stranded DNA; rather, it acts as a bridge that connects the replicative DNA polymerase with the helicase and other proteins associated with the replication fork.\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 634,
    "user_query": "Could Arimidex (anastrozole) cause hot flashes?",
    "yulan-chat-2-13b-fp16_response": "Yes, Arimidex (anastrozole) can cause hot flashes as a side effect. Hot flashes are a common symptom of menopause and are caused by changes in hormone levels. Anastrozole works by reducing the amount of estrogen produced by the body, and this reduction in estrogen levels can lead to hot flashes.\nOther possible side effects of anastrozole include:\n* Joint pain\n* Nausea\n* Headache\n* Fatigue\n* Insomnia\n* Vaginal dryness\n* Decreased bone density\n* Increased risk of fractures\n* Swelling of the hands and feet\n* Rash or itching\nIt's important to talk to your doctor if you experience any side effects while taking anastrozole. Your doctor may be able to adjust your dosage or recommend alternative treatments to help manage your symptoms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Arimidex (anastrozole) can cause hot flashes as a side effect.\n2. Anastrozole reduces the amount of estrogen produced by the body.\n3. Decreased bone density is a possible side effect of anastrozole.\n4. An increased risk of fractures can be a side effect of taking anastrozole.\n5. Swelling of the hands and feet is a potential side effect of anastrozole.",
    "yulan-chat-2-13b-fp16_fact": [
      "Arimidex (anastrozole) can cause hot flashes as a side effect.",
      "Anastrozole reduces the amount of estrogen produced by the body.",
      "Decreased bone density is a possible side effect of anastrozole.",
      "An increased risk of fractures can be a side effect of taking anastrozole.",
      "Swelling of the hands and feet is a potential side effect of anastrozole."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 635,
    "user_query": "What is the role of Inn1 in cytokinesis?",
    "yulan-chat-2-13b-fp16_response": "Inn1 is a protein that plays a key role in cytokinesis, which is the process of dividing the cytoplasm and organelles of a cell to form two daughter cells. In eukaryotic cells, cytokinesis is typically carried out by the contractile ring, which is a structure composed of actin and myosin filaments that constricts to pinch the cell membrane inward and divide the cell.\nInn1 is a member of the septin family of proteins, which are involved in various aspects of cell division and organization. Inn1 is localized to the contractile ring during cytokinesis, where it helps to recruit other septin proteins and to regulate the timing and coordination of the contractile ring's contraction.\nIn particular, Inn1 is thought to help stabilize the contractile ring and promote its formation by interacting with other proteins that are involved in the regulation of the contractile ring's assembly and function. Inn1 may also play a role in the regulation of the cell cycle and in the coordination of other aspects of cell division, such as the separation of chromosomes and the formation of the spindle.\nOverall, Inn1 is an important protein that plays a critical role in the process of cytokinesis, helping to ensure that cells divide correctly and efficiently.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Inn1 is a protein that plays a key role in cytokinesis.\n2. Cytokinesis is the process of dividing the cytoplasm and organelles of a cell to form two daughter cells.\n3. The contractile ring, composed of actin and myosin filaments, carries out cytokinesis in eukaryotic cells.\n4. Inn1 is a member of the septin family of proteins which are involved in cell division and organization.\n5. Inn1 localizes to the contractile ring during cytokinesis to recruit other septin proteins and regulate the contractile ring's contraction.",
    "yulan-chat-2-13b-fp16_fact": [
      "Inn1 is a protein that plays a key role in cytokinesis.",
      "Cytokinesis is the process of dividing the cytoplasm and organelles of a cell to form two daughter cells.",
      "The contractile ring, composed of actin and myosin filaments, carries out cytokinesis in eukaryotic cells.",
      "Inn1 is a member of the septin family of proteins which are involved in cell division and organization.",
      "Inn1 localizes to the contractile ring during cytokinesis to recruit other septin proteins and regulate the contractile ring's contraction."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Inn1 (Iqg1/Cyk2-interacting network component 1) cooperates with other proteins during cytokinesis, but it is not typically described as playing a \"key role\" like proteins such as actin and myosin do.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Inn1 is not a member of the septin family of proteins. It interacts with proteins essential for cytokinesis but is not classified as a septin itself.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 636,
    "user_query": "Which hormone deficiency is implicated in the Costello syndrome ?",
    "yulan-chat-2-13b-fp16_response": "Costello syndrome is a rare genetic disorder caused by mutations in the HRAS gene, which encodes the protein ras homologue A. Ras homologue A plays a key role in signal transduction pathways that regulate cell growth and differentiation. Mutations in the HRAS gene lead to abnormal signaling and uncontrolled cell growth, which can result in a range of physical characteristics and medical problems associated with Costello syndrome.\nThere is no specific hormone deficiency that is implicated in Costello syndrome. However, some individuals with the condition may have hormonal imbalances or abnormalities due to the effects of the mutated HRAS protein on various endocrine systems. For example, some people with Costello syndrome may have low levels of growth hormone, which can result in short stature. Others may have abnormalities in the thyroid gland, leading to problems with thyroid hormone production and regulation. Overall, the hormonal abnormalities associated with Costello syndrome are variable and depend on the specific effects of the mutated HRAS protein on different endocrine systems.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Costello syndrome is a rare genetic disorder caused by mutations in the HRAS gene.\n2. The HRAS gene is responsible for encoding the protein ras homologue A.\n3. Ras homologue A is important in signal transduction pathways that control cell growth and differentiation.\n4. Mutations in the HRAS gene can cause abnormal signaling and uncontrolled cell growth.\n5. Some individuals with Costello syndrome may have low levels of growth hormone or abnormalities in thyroid hormone production and regulation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Costello syndrome is a rare genetic disorder caused by mutations in the HRAS gene.",
      "The HRAS gene is responsible for encoding the protein ras homologue A.",
      "Ras homologue A is important in signal transduction pathways that control cell growth and differentiation.",
      "Mutations in the HRAS gene can cause abnormal signaling and uncontrolled cell growth.",
      "Some individuals with Costello syndrome may have low levels of growth hormone or abnormalities in thyroid hormone production and regulation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 640,
    "user_query": "Which is the most common CFTR mutation in Caucasians?",
    "yulan-chat-2-13b-fp16_response": "The most common CFTR mutation in Caucasians is the deltaF508 mutation, which is responsible for about 70% of cases of cystic fibrosis in this population. This mutation results in the production of a misfolded and non-functional CFTR protein, leading to the accumulation of thick, sticky mucus in the lungs and other organs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The most common CFTR mutation in Caucasians is the deltaF508 mutation.\n2. The deltaF508 mutation is responsible for about 70% of cases of cystic fibrosis in Caucasians.\n3. This mutation leads to the production of a misfolded and non-functional CFTR protein.\n4. The result of the deltaF508 mutation is the accumulation of thick, sticky mucus in the lungs and other organs.",
    "yulan-chat-2-13b-fp16_fact": [
      "The most common CFTR mutation in Caucasians is the deltaF508 mutation.",
      "The deltaF508 mutation is responsible for about 70% of cases of cystic fibrosis in Caucasians.",
      "This mutation leads to the production of a misfolded and non-functional CFTR protein.",
      "The result of the deltaF508 mutation is the accumulation of thick, sticky mucus in the lungs and other organs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 641,
    "user_query": "Which CDK targets control cytokinesis?",
    "yulan-chat-2-13b-fp16_response": "Cytokinesis is the process of dividing the cytoplasm and organelles of a cell to form two daughter cells. In eukaryotic cells, cytokinesis is typically carried out by the contractile ring, which is a structure composed of actin and myosin filaments that constricts to pinch off the cell membrane and divide the cell.\nThe contractile ring is regulated by several key proteins, including the Rho family of GTPases, which are small GTP-binding proteins that play a key role in the regulation of the cytoskeleton. RhoA is often activated during cytokinesis, and it promotes the formation of the contractile ring by stimulating the assembly of actin filaments.\nOther proteins that are involved in the regulation of cytokinesis include centralspindlin, which helps to align the microtubules and organize the contractile ring, and the separase complex, which separates the sister chromatids during mitosis.\nOverall, the regulation of cytokinesis is a complex process that involves the coordination of multiple proteins and signaling pathways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cytokinesis is the process in which the cytoplasm and organelles of a cell divide to form two daughter cells.\n2. In eukaryotic cells, the contractile ring, composed of actin and myosin filaments, plays a central role in cytokinesis by constricting to divide the cell.\n3. The Rho family of GTPases, especially RhoA, is involved in the regulation of the cytoskeleton during cytokinesis.\n4. RhoA promotes the formation of the contractile ring by stimulating the assembly of actin filaments during cytokinesis.\n5. The centralspindlin complex is involved in aligning microtubules and organizing the contractile ring during cytokinesis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cytokinesis is the process in which the cytoplasm and organelles of a cell divide to form two daughter cells.",
      "In eukaryotic cells, the contractile ring, composed of actin and myosin filaments, plays a central role in cytokinesis by constricting to divide the cell.",
      "The Rho family of GTPases, especially RhoA, is involved in the regulation of the cytoskeleton during cytokinesis.",
      "RhoA promotes the formation of the contractile ring by stimulating the assembly of actin filaments during cytokinesis.",
      "The centralspindlin complex is involved in aligning microtubules and organizing the contractile ring during cytokinesis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The centralspindlin complex is involved in microtubule bundling and in the recruitment of proteins that regulate the assembly of the contractile ring during cytokinesis, but it is not primarily responsible for aligning microtubules. The microtubules are generally aligned by motor proteins and other microtubule-associated proteins.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 643,
    "user_query": "In what type(s) of plant organelles we can detect prolamellar bodies?",
    "yulan-chat-2-13b-fp16_response": "Prolamellar bodies are found in the endoplasmic reticulum (ER) of plant cells. The ER is a network of membranous tubules and flattened sacs that are interconnected and extend throughout the cell. Prolamellar bodies are formed by the accumulation of proline-rich proteins in the ER, and they play a role in the regulation of cell growth and differentiation. They are also involved in the formation of other organelles, such as the nucleus and mitochondria.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "yulan-chat-2-13b-fp16_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that catalyze the transfer of a methyl group from one molecule to another, including DNA. In animals, these enzymes play important roles in regulating gene expression and maintaining the integrity of the genome.\nOne example of a chromomethylase in animals is the DNA methyltransferase enzyme. This enzyme adds a methyl group to the DNA molecule, typically at cytosine residues that precede guanine bases. This process, known as DNA methylation, is a common epigenetic modification that can influence gene expression by silencing genes or preventing their transcription into RNA.\nOther types of chromomethylases in animals include histone methyltransferases, which add methyl groups to histone proteins, and chromomethyl-binding domain proteins, which recognize and bind to methylated DNA sequences. These enzymes and proteins play important roles in regulating gene expression, maintaining genome stability, and responding to environmental cues.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chromomethylases are present in animal genomes.\n2. Chromomethylases catalyze the transfer of a methyl group from one molecule to another, including DNA.\n3. DNA methyltransferase is an enzyme in animals that adds a methyl group to DNA, typically at cytosine residues preceding guanine bases.\n4. DNA methylation is an epigenetic modification that can influence gene expression by silencing genes or preventing their transcription into RNA.\n5. Histone methyltransferases and chromomethyl-binding domain proteins are examples of chromomethylases in animals that regulate gene expression and maintain genome stability.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chromomethylases are present in animal genomes.",
      "Chromomethylases catalyze the transfer of a methyl group from one molecule to another, including DNA.",
      "DNA methyltransferase is an enzyme in animals that adds a methyl group to DNA, typically at cytosine residues preceding guanine bases.",
      "DNA methylation is an epigenetic modification that can influence gene expression by silencing genes or preventing their transcription into RNA.",
      "Histone methyltransferases and chromomethyl-binding domain proteins are examples of chromomethylases in animals that regulate gene expression and maintain genome stability."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Chromomethylases are not present in animal genomes. They are typically found in plants where they function in DNA methylation.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Histone methyltransferases and proteins with chromodomains are involved in the regulation of gene expression and maintenance of genome stability in animals, but they are distinct from chromomethylases. Chromomethylases are specifically plant enzymes related to DNA methylation, not proteins that bind methylated histones or chromatin.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 647,
    "user_query": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?",
    "yulan-chat-2-13b-fp16_response": "Autosomal dominant Charcot-Marie-Tooth disease (CMT1A) is caused by mutations in the PMP22 gene, which is located on chromosome 17. The PMP22 gene provides instructions for making a protein called peripheral myelin protein 22, which is a component of the myelin sheath that surrounds nerve cells. Mutations in the PMP22 gene lead to the production of an abnormal form of the protein, which disrupts the structure and function of the myelin sheath, causing nerve damage and resulting in the symptoms of CMT1A.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Autosomal dominant Charcot-Marie-Tooth disease (CMT1A) is caused by mutations in the PMP22 gene.\n2. The PMP22 gene is located on chromosome 17.\n3. The PMP22 gene provides instructions for making a protein called peripheral myelin protein 22.\n4. Peripheral myelin protein 22 is a component of the myelin sheath that surrounds nerve cells.\n5. Mutations in the PMP22 gene can lead to the production of an abnormal form of the protein, which disrupts the myelin sheath's structure and function, causing nerve damage.",
    "yulan-chat-2-13b-fp16_fact": [
      "Autosomal dominant Charcot-Marie-Tooth disease (CMT1A) is caused by mutations in the PMP22 gene.",
      "The PMP22 gene is located on chromosome 17.",
      "The PMP22 gene provides instructions for making a protein called peripheral myelin protein 22.",
      "Peripheral myelin protein 22 is a component of the myelin sheath that surrounds nerve cells.",
      "Mutations in the PMP22 gene can lead to the production of an abnormal form of the protein, which disrupts the myelin sheath's structure and function, causing nerve damage."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 648,
    "user_query": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?",
    "yulan-chat-2-13b-fp16_response": "The interferon-beta (IFN-b) enhanceosome is a group of transcription factors (TFs) that regulate the expression of IFN-b, a cytokine that plays a critical role in the immune response to viral infections. The IFN-b enhanceosome includes several TFs, including:\n1. Interferon regulatory factor 1 (IRF-1)\n2. Interferon consensus sequence-binding protein (ICSBP)\n3. Pseudogene 1 of the interferon regulatory factor (IRF-1)\n4. Nuclear factor kappa B (NF-B)\n5. Activator protein 1 (AP-1)\n6. STAT1 and STAT2\nThese TFs work together to activate the IFN-b gene by binding to specific sequences in the promoter and enhancer regions of the gene. The IFN-b enhanceosome is activated in response to viral infections, and the resulting increase in IFN-b production helps to protect the host from viral infection.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Interferon regulatory factor 1 (IRF-1) is a transcription factor that participates in the formation of the interferon-beta (IFN-b) enhanceosome.\n2. Interferon consensus sequence-binding protein (ICSBP) is a part of the interferon-beta (IFN-b) enhanceosome.\n3. Nuclear factor kappa B (NF-B) is involved in the enhanceosome formation for interferon-beta (IFN-b).\n4. Activator protein 1 (AP-1) is a transcription factor in the interferon-beta (IFN-b) enhanceosome.\n5. STAT1 and STAT2 are involved in the activation of the IFN-b gene through the interferon-beta (IFN-b) enhanceosome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Interferon regulatory factor 1 (IRF-1) is a transcription factor that participates in the formation of the interferon-beta (IFN-b) enhanceosome.",
      "Interferon consensus sequence-binding protein (ICSBP) is a part of the interferon-beta (IFN-b) enhanceosome.",
      "Nuclear factor kappa B (NF-B) is involved in the enhanceosome formation for interferon-beta (IFN-b).",
      "Activator protein 1 (AP-1) is a transcription factor in the interferon-beta (IFN-b) enhanceosome.",
      "STAT1 and STAT2 are involved in the activation of the IFN-b gene through the interferon-beta (IFN-b) enhanceosome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE (though the name interferon consensus sequence-binding protein is more commonly referred to as IRF-8, it is indeed a part of the interferon-beta [IFN-b] enhanceosome)\n3. FALSE [correction]: Nuclear factor kappa B (NF-B) is not typically involved in the formation of the interferon-beta (IFN-b) enhanceosome. It is involved in the response to other types of stimuli, like pro-inflammatory cytokines.\n4. FALSE [correction]: Activator protein 1 (AP-1) is not a part of the interferon-beta (IFN-b) enhanceosome. The enhanceosome mainly includes IRF and STAT family members.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "yulan-chat-2-13b-fp16_response": "There are several packages available in R/Bioconductor for analyzing transcription factor binding sites (TFBS). Here are some of the popular ones:\n1. ChIPseeker: This package provides tools for the analysis of ChIP-seq data and the identification of TFBS. It includes functions for peak calling, motif analysis, and the identification of genomic regions with enriched TFBS.\n2. HOMFLY: This package provides a method for identifying TFBS based on the distribution of nucleotides in the DNA sequence. It uses a statistical model to calculate the probability of a TFBS occurring at a particular location in the genome.\n3. MEME Suite: This package provides a suite of tools for the discovery and analysis of motifs in DNA and protein sequences. It includes functions for motif discovery, alignment, and comparison, as well as tools for visualizing and annotating TFBS.\n4. TFBS-ID: This package provides a method for identifying TFBS based on the presence of specific DNA sequences that are known to be recognized by particular transcription factors. It includes functions for searching for TFBS in DNA sequences and for predicting the binding affinity of transcription factors to specific sequences.\n5. TRANSFAC: This package provides a database of transcription factor binding sites and a tool for searching for TFBS in DNA sequences. It includes functions for predicting the binding of transcription factors to specific sequences and for analyzing the regulation of gene expression by transcription factors.\nThese packages provide a range of tools for analyzing TFBS and can be used to identify potential regulatory elements in DNA sequences and predict the binding of transcription factors to specific sequences.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ChIPseeker is an R/Bioconductor package for analyzing ChIP-seq data and identifying transcription factor binding sites (TFBS).\n2. HOMFLY is an R/Bioconductor package that identifies TFBS based on the distribution of nucleotides using a statistical model.\n3. MEME Suite is an R/Bioconductor package providing tools for the discovery and analysis of motifs in DNA and protein sequences.\n4. TFBS-ID is an R/Bioconductor package that identifies TFBS based on the presence of specific DNA sequences known to be recognized by transcription factors.\n5. TRANSFAC is an R/Bioconductor package that includes a database of transcription factor binding sites and tools for searching TFBS in DNA sequences.",
    "yulan-chat-2-13b-fp16_fact": [
      "ChIPseeker is an R/Bioconductor package for analyzing ChIP-seq data and identifying transcription factor binding sites (TFBS).",
      "HOMFLY is an R/Bioconductor package that identifies TFBS based on the distribution of nucleotides using a statistical model.",
      "MEME Suite is an R/Bioconductor package providing tools for the discovery and analysis of motifs in DNA and protein sequences.",
      "TFBS-ID is an R/Bioconductor package that identifies TFBS based on the presence of specific DNA sequences known to be recognized by transcription factors.",
      "TRANSFAC is an R/Bioconductor package that includes a database of transcription factor binding sites and tools for searching TFBS in DNA sequences."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: HOMFLY is not an R/Bioconductor package; it is a polynomial invariant of knots and links in topology. There is no evidence of an R/Bioconductor package by this name for identifying TFBS.\n3. FALSE [correction]: MEME Suite is not an R/Bioconductor package; it is a standalone suite of tools for motif discovery that can be accessed through a web interface or installed locally.\n4. UNKNOWN\n5. FALSE [correction]: TRANSFAC is not an R/Bioconductor package; it is a database of eukaryotic transcription factors, their genomic binding sites, and DNA-binding profiles. There are, however, packages that might interface with the TRANSFAC database or use its data.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 651,
    "user_query": "Simpson grading is used to describe resection of which brain tumor?",
    "yulan-chat-2-13b-fp16_response": "Simpson grade is used to describe the classification of astrocytoma, a type of brain tumor that is derived from astrocytes, a type of supportive cell in the brain. The Simpson grade system is used to classify astrocytomas based on their histological features, with grades ranging from grade I (lowest grade) to grade IV (highest grade). The grading system was developed by Dr. James E. Simpson in the 1960s and is still widely used today.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Simpson grading is used to describe the resection of astrocytomas.\n2. Astrocytomas are brain tumors derived from astrocytes.\n3. The Simpson grade system ranges from grade I (lowest grade) to grade IV (highest grade).\n4. Dr. James E. Simpson developed the Simpson grading system in the 1960s.\n5. The grading system is based on the histological features of astrocytomas.",
    "yulan-chat-2-13b-fp16_fact": [
      "Simpson grading is used to describe the resection of astrocytomas.",
      "Astrocytomas are brain tumors derived from astrocytes.",
      "The Simpson grade system ranges from grade I (lowest grade) to grade IV (highest grade).",
      "Dr. James E. Simpson developed the Simpson grading system in the 1960s.",
      "The grading system is based on the histological features of astrocytomas."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Simpson grading system ranges from grade I (most complete resection) to grade V (least complete resection).\n4. FALSE [correction]: The Simpson grading system was developed by Dr. Donald Simpson in the 1950s.\n5. FALSE [correction]: The grading system is based on the extent of tumor removal during surgery, not the histological features.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 653,
    "user_query": "Is delayed enhancement documented in patients with non-ischemic dilated cardiomyopathy?",
    "yulan-chat-2-13b-fp16_response": "Delayed enhancement (DE) is a type of cardiac magnetic resonance imaging (MRI) technique that can be used to diagnose and evaluate various cardiac conditions, including non-ischemic dilated cardiomyopathy (NICM).\nNICM is a type of heart muscle disease that is characterized by the dilatation (enlargement) of the heart chambers, which can lead to heart failure. It is typically caused by a variety of factors, including genetic predisposition, high blood pressure, and viral infections.\nStudies have shown that DE can be detected in patients with NICM, and it can provide valuable information about the extent and severity of the disease. For example, DE can help identify areas of the heart muscle that are damaged or scarred, which can help guide treatment decisions.\nHowever, it is important to note that DE is not a definitive diagnostic test for NICM, and it should be used in conjunction with other clinical and laboratory findings. Additionally, the interpretation of DE images can be complex and may require expertise in cardiac MRI.\nOverall, DE is a useful tool for evaluating patients with NICM, but it should be used as part of a comprehensive diagnostic workup and in consultation with a qualified healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Delayed enhancement (DE) is a cardiac magnetic resonance imaging (MRI) technique.\n2. Non-ischemic dilated cardiomyopathy (NICM) is characterized by the enlargement of the heart chambers.\n3. NICM can be caused by genetic predisposition, high blood pressure, and viral infections.\n4. DE can be detected in patients with NICM and provides information about the extent and severity of the disease.\n5. DE is not a definitive diagnostic test for NICM on its own.",
    "yulan-chat-2-13b-fp16_fact": [
      "Delayed enhancement (DE) is a cardiac magnetic resonance imaging (MRI) technique.",
      "Non-ischemic dilated cardiomyopathy (NICM) is characterized by the enlargement of the heart chambers.",
      "NICM can be caused by genetic predisposition, high blood pressure, and viral infections.",
      "DE can be detected in patients with NICM and provides information about the extent and severity of the disease.",
      "DE is not a definitive diagnostic test for NICM on its own."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 654,
    "user_query": "Which enzyme is inhibited by Varespladib?",
    "yulan-chat-2-13b-fp16_response": "Varespladib is an inhibitor of the enzyme acid ceramidase.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 660,
    "user_query": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?",
    "yulan-chat-2-13b-fp16_response": "The KFERQ motif of cytosolic proteins triggers the autophagy pathway known as the \"starvation-induced\" or \"nutrient deprivation\" autophagy pathway. This pathway is also referred to as \"autophagy type II\" or \"receptor-independent autophagy.\"\nThe KFERQ motif is a sequence of amino acids that is present in certain cytosolic proteins, such as Atg8, which plays a key role in the initiation of autophagy. When cells are subjected to nutrient deprivation or other stress conditions, the KFERQ motif in cytosolic proteins is recognized by the autophagy receptor, which then initiates the process of autophagy.\nIn this pathway, the cytosolic proteins with the KFERQ motif are targeted by the autophagy receptor and degraded by the lysosome, which helps to recycle nutrients and other cellular components. This process is important for maintaining cellular homeostasis and survival during periods of nutrient deprivation or other stress conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The KFERQ motif of cytosolic proteins triggers the starvation-induced or nutrient deprivation autophagy pathway.\n2. The autophagy pathway initiated by the KFERQ motif is also referred to as autophagy type II or receptor-independent autophagy.\n3. Atg8 is an example of a cytosolic protein that contains the KFERQ motif and is involved in the initiation of autophagy.\n4. When cells experience nutrient deprivation or stress, the KFERQ motif is recognized by the autophagy receptor, initiating autophagy.\n5. Proteins with the KFERQ motif are targeted for degradation by the lysosome during this autophagy pathway.",
    "yulan-chat-2-13b-fp16_fact": [
      "The KFERQ motif of cytosolic proteins triggers the starvation-induced or nutrient deprivation autophagy pathway.",
      "The autophagy pathway initiated by the KFERQ motif is also referred to as autophagy type II or receptor-independent autophagy.",
      "Atg8 is an example of a cytosolic protein that contains the KFERQ motif and is involved in the initiation of autophagy.",
      "When cells experience nutrient deprivation or stress, the KFERQ motif is recognized by the autophagy receptor, initiating autophagy.",
      "Proteins with the KFERQ motif are targeted for degradation by the lysosome during this autophagy pathway."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The autophagy pathway initiated by the KFERQ motif is commonly referred to as chaperone-mediated autophagy (CMA), not autophagy type II or receptor-independent autophagy.\n3. UNKNOWN\n4. FALSE [correction]: When cells experience nutrient deprivation or stress, the KFERQ motif is recognized not by a traditional autophagy receptor but by chaperone proteins such as hsc70, which guide the targeted proteins to the lysosome for degradation.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 665,
    "user_query": "Has overexpression of sirtuins been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae)?",
    "yulan-chat-2-13b-fp16_response": "Yes, overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae). In fact, several studies have shown that increasing the levels of sirtuins in yeast can extend the lifespan of the cells.\nFor example, a study published in the journal Aging Cell in 2010 found that overexpression of the SIR2 gene, which encodes for a sirtuin protein, increased the lifespan of yeast cells by about 30%. The researchers also found that the overexpression of SIR2 led to increased resistance to oxidative stress and improved the function of mitochondria, which are important for cellular energy production and survival.\nAnother study published in the journal PLoS Genetics in 2012 found that overexpression of the SIR4 gene, which encodes for a different sirtuin protein, also increased the lifespan of yeast cells. The researchers found that the overexpression of SIR4 led to increased resistance to various stressors, including heat shock, and improved the function of the cellular stress response pathways.\nOverall, these studies suggest that sirtuins play an important role in regulating lifespan and stress resistance in yeast, and that increasing the levels of sirtuins can extend the lifespan of yeast cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Overexpression of sirtuins has been reported to increase lifespan in Saccharomyces cerevisiae.\n2. A study published in Aging Cell in 2010 found that overexpression of the SIR2 gene increased the lifespan of yeast cells by about 30%.\n3. The study in Aging Cell reported that overexpression of SIR2 in yeast led to increased resistance to oxidative stress.\n4. The same study mentioned improved mitochondrial function associated with SIR2 overexpression in yeast cells.\n5. A study published in PLoS Genetics in 2012 reported that overexpression of the SIR4 gene also increased the lifespan of yeast cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Overexpression of sirtuins has been reported to increase lifespan in Saccharomyces cerevisiae.",
      "A study published in Aging Cell in 2010 found that overexpression of the SIR2 gene increased the lifespan of yeast cells by about 30%.",
      "The study in Aging Cell reported that overexpression of SIR2 in yeast led to increased resistance to oxidative stress.",
      "The same study mentioned improved mitochondrial function associated with SIR2 overexpression in yeast cells.",
      "A study published in PLoS Genetics in 2012 reported that overexpression of the SIR4 gene also increased the lifespan of yeast cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nIt is known that overexpression of certain sirtuins can extend the lifespan of yeast and this has been a topic of various studies. However, without specific details regarding a publication in PLoS Genetics in 2012 and its findings about SIR4, the statement about the overexpression of the SIR4 gene cannot be verified as true or false.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 669,
    "user_query": "How does phospholamban affect the biological activity of the calcium ATPase SERCA?",
    "yulan-chat-2-13b-fp16_response": "Phospholamban (PLB) is a protein that regulates the biological activity of the calcium ATPase SERCA (sarco/endoplasmic reticulum calcium ATPase) in several ways. \nFirstly, PLB binds to the C-terminal region of SERCA and enhances its ATPase activity, which means that it increases the rate at which SERCA pumps calcium ions against their concentration gradient. This enhancement of ATPase activity is due to the interaction between PLB and SERCA, which stabilizes the open state of the ATPase and promotes the release of calcium ions from the SERCA pore.\nSecondly, PLB also regulates the calcium sensitivity of SERCA. PLB binds to SERCA in a calcium-dependent manner, which means that the presence of calcium ions enhances the binding of PLB to SERCA. This enhances the ATPase activity of SERCA in the presence of calcium ions, which means that SERCA pumps calcium ions more efficiently in the presence of PLB and calcium ions.\nFinally, PLB also regulates the trafficking of SERCA to the plasma membrane. PLB is localized to the endoplasmic reticulum (ER) and binds to SERCA in the ER lumen. When PLB is phosphorylated by protein kinase C (PKC), it is released from the ER and transports to the plasma membrane, where it enhances the activity of SERCA.\nOverall, PLB plays a crucial role in regulating the biological activity of SERCA and calcium homeostasis in cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phospholamban (PLB) binds to the C-terminal region of SERCA (sarco/endoplasmic reticulum calcium ATPase) and enhances its ATPase activity.\n2. The interaction between PLB and SERCA stabilizes the open state of the ATPase and promotes the release of calcium ions from the SERCA pore.\n3. PLB regulates the calcium sensitivity of SERCA and enhances its ATPase activity in the presence of calcium ions.\n4. PLB is localized to the endoplasmic reticulum (ER) and binds to SERCA in the ER lumen.\n5. Phosphorylation of PLB by protein kinase C (PKC) can cause it to be released from the ER and transported to the plasma membrane, where it enhances the activity of SERCA.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phospholamban (PLB) binds to the C-terminal region of SERCA (sarco/endoplasmic reticulum calcium ATPase) and enhances its ATPase activity.",
      "The interaction between PLB and SERCA stabilizes the open state of the ATPase and promotes the release of calcium ions from the SERCA pore.",
      "PLB regulates the calcium sensitivity of SERCA and enhances its ATPase activity in the presence of calcium ions.",
      "PLB is localized to the endoplasmic reticulum (ER) and binds to SERCA in the ER lumen.",
      "Phosphorylation of PLB by protein kinase C (PKC) can cause it to be released from the ER and transported to the plasma membrane, where it enhances the activity of SERCA."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Phospholamban (PLB) binds to the C-terminal region of SERCA (sarco/endoplasmic reticulum calcium ATPase) and inhibits its ATPase activity.\n2. FALSE [correction]: The interaction between PLB and SERCA stabilizes the E2 state of the ATPase, which is associated with a lower affinity for calcium and inhibits the release of calcium ions from the SERCA pore.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Phosphorylation of PLB by protein kinase A (PKA) can cause conformational changes in PLB that reduce its inhibitory effect on SERCA, thus enhancing SERCA's activity. However, phosphorylation does not cause PLB to be released from the ER and transported to the plasma membrane.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 670,
    "user_query": "List the components of mTOR Complex 2 (mTORC2).",
    "yulan-chat-2-13b-fp16_response": "The components of mTOR Complex 2 (mTORC2) are:\n1. mTOR (mammalian target of rapamycin) - a serine/threonine kinase that is the catalytic component of the complex.\n2. Raptor (regulatory associated protein of mTOR) - a protein that binds to mTOR and serves as a scaffold for the assembly of the complex.\n3. mLST8 (mTOR-interacting lysine deacetylase 8) - a deacetylase that is part of the complex and helps to regulate its activity.\n4. PRAS40 (protein rich in serine 40) - a protein that binds to mTOR and helps to regulate its activity.\n5. DEPTOR (dual-specificity mTORC2-interacting recombinant protein) - a protein that binds to mTOR and inhibits its activity.\n6. SIN1 (sch9 in non-malignant) - a protein that is part of the complex and helps to regulate its activity.\n7. MLK2 (mitogen-activated protein kinase-interacting kinase 2) - a protein that is part of the complex and helps to regulate its activity.\n8. TSC1/2 (tuberous sclerosis complex 1/2) - proteins that are part of the complex and help to regulate its activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. mTOR (mammalian target of rapamycin) is the catalytic component of mTOR Complex 2 (mTORC2).\n2. Raptor is a protein that binds to mTOR and serves as a scaffold for the assembly of mTORC2.\n3. mLST8 is a part of mTORC2 and helps to regulate its activity.\n4. DEPTOR binds to mTOR and inhibits its activity within mTORC2.\n5. SIN1 is a protein that is a component of mTORC2 and helps to regulate its activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "mTOR (mammalian target of rapamycin) is the catalytic component of mTOR Complex 2 (mTORC2).",
      "Raptor is a protein that binds to mTOR and serves as a scaffold for the assembly of mTORC2.",
      "mLST8 is a part of mTORC2 and helps to regulate its activity.",
      "DEPTOR binds to mTOR and inhibits its activity within mTORC2.",
      "SIN1 is a protein that is a component of mTORC2 and helps to regulate its activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Raptor is a protein that binds to mTOR and serves as a scaffold for the assembly of mTOR Complex 1 (mTORC1), not mTORC2.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 675,
    "user_query": "Which multiple kinase inhibitors are used in cancer therapy?",
    "yulan-chat-2-13b-fp16_response": "There are several multiple kinase inhibitors that are used in cancer therapy, including:\n1. Imatinib (Gleevec): It inhibits the tyrosine kinases, such as BCR-ABL, KIT, and PDGFR.\n2. Sunitinib (Sutent): It inhibits multiple receptor tyrosine kinases, such as VEGFR, PDGFR, and c-Kit.\n3. Dasatinib (Sprycel): It inhibits the tyrosine kinases, such as BCR-ABL, KIT, and PDGFR.\n4. Bosutinib (Bosulif): It inhibits the Src kinase and Abl kinase.\n5. Crizotinib (Xalkori): It inhibits the anaplastic lymphoma kinase (ALK) and c-Met.\n6. Ceritinib (Zykadia): It inhibits the anaplastic lymphoma kinase (ALK).\n7. Alectinib (Alecensa): It inhibits the anaplastic lymphoma kinase (ALK).\n8. Brigatinib (Alunbrig): It inhibits the anaplastic lymphoma kinase (ALK).\n9. Midostaurin (Midostaurin): It inhibits the FLT3 and KIT kinases.\n10. Pinometostat (Plexxikon DMD): It inhibits the Delta-like kinase 1 (DLK1) and VEGFR-3.\nThese drugs work by blocking specific kinases that are involved in the growth and spread of cancer cells. By inhibiting these kinases, they can slow down or stop the growth of cancer cells, and in some cases, even cause them to die.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Imatinib (Gleevec) inhibits tyrosine kinases such as BCR-ABL, KIT, and PDGFR.\n2. Sunitinib (Sutent) inhibits multiple receptor tyrosine kinases including VEGFR, PDGFR, and c-Kit.\n3. Dasatinib (Sprycel) inhibits tyrosine kinases such as BCR-ABL, KIT, and PDGFR.\n4. Bosutinib (Bosulif) inhibits the Src kinase and Abl kinase.\n5. Crizotinib (Xalkori) inhibits the anaplastic lymphoma kinase (ALK) and c-Met.",
    "yulan-chat-2-13b-fp16_fact": [
      "Imatinib (Gleevec) inhibits tyrosine kinases such as BCR-ABL, KIT, and PDGFR.",
      "Sunitinib (Sutent) inhibits multiple receptor tyrosine kinases including VEGFR, PDGFR, and c-Kit.",
      "Dasatinib (Sprycel) inhibits tyrosine kinases such as BCR-ABL, KIT, and PDGFR.",
      "Bosutinib (Bosulif) inhibits the Src kinase and Abl kinase.",
      "Crizotinib (Xalkori) inhibits the anaplastic lymphoma kinase (ALK) and c-Met."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEach statement is true as it correctly identifies the targets inhibited by the respective tyrosine kinase inhibitors mentioned.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 678,
    "user_query": "List types of avoided words in bacterial genomes",
    "yulan-chat-2-13b-fp16_response": "There are several types of words that are typically avoided when analyzing bacterial genomes. These include:\n1. Technical jargon: Bacterial genomics is a highly specialized field, and as such, it is important to use technical terms and jargon appropriately. Avoid using terms that may be unfamiliar to the general scientific community or to non-experts in the field.\n2. Ambiguous terms: Some terms may have multiple meanings or may be ambiguous in the context of bacterial genomics. For example, the term \"gene\" can refer to a specific DNA sequence that encodes a protein, or it can refer to a functional unit of heredity. To avoid confusion, it is important to use precise and unambiguous language.\n3. Colloquialisms: Colloquialisms are informal expressions or slang that are not widely understood or accepted in the scientific community. Avoid using colloquialisms in your analysis of bacterial genomes, as they can lead to confusion and misunderstandings.\n4. Non-specific terms: Some terms may be too general to be useful in the context of bacterial genomics. For example, the term \"protein\" refers to a large class of molecules that have many different functions. To avoid confusion, it is important to use more specific terms that accurately reflect the function of the protein in question.\n5. Redundant terms: Avoid using redundant terms that convey the same information. For example, \"bacterial genome\" and \"bacterial DNA\" both refer to the same thing, and it is unnecessary to use both terms in the same sentence.\nOverall, it is important to use clear and precise language when analyzing bacterial genomes to ensure that your findings are accurately understood and interpreted by others.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 681,
    "user_query": "Which is the physiological target for LeuRS translational quality control?",
    "yulan-chat-2-13b-fp16_response": "LeuRS (Leu-tRNA synthetase) is involved in translational quality control, specifically for the recognition and rejection of leucine tRNAs that have a mismatched anticodon. The physiological target for LeuRS in this process is the accuracy of leucine incorporation during protein synthesis. LeuRS helps to ensure that leucine is only incorporated into proteins when it is paired with the correct leucine tRNA, which has a correctly matched anticodon. If a mismatched leucine tRNA is used, LeuRS recognizes the mismatch and signals the ribosome to stop translation, preventing the incorporation of an incorrect amino acid into the protein.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LeuRS (Leu-tRNA synthetase) is involved in translational quality control.\n2. LeuRS recognizes and rejects leucine tRNAs that have a mismatched anticodon.\n3. The physiological target for LeuRS is the accuracy of leucine incorporation during protein synthesis.\n4. LeuRS ensures that leucine is incorporated into proteins only when paired with the correct leucine tRNA.\n5. LeuRS can signal the ribosome to stop translation if a mismatched leucine tRNA is used.",
    "yulan-chat-2-13b-fp16_fact": [
      "LeuRS (Leu-tRNA synthetase) is involved in translational quality control.",
      "LeuRS recognizes and rejects leucine tRNAs that have a mismatched anticodon.",
      "The physiological target for LeuRS is the accuracy of leucine incorporation during protein synthesis.",
      "LeuRS ensures that leucine is incorporated into proteins only when paired with the correct leucine tRNA.",
      "LeuRS can signal the ribosome to stop translation if a mismatched leucine tRNA is used."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Leucyl-tRNA synthetase (LeuRS) is involved in translational quality control as it is responsible for the charging of tRNAs with their respective amino acids, in this case, leucine.\n2. FALSE [correction]: LeuRS does not recognize and reject leucine tRNAs based on anticodon mismatch. Rather, it ensures the correct amino acid (leucine) is attached to the tRNA specific for leucine. Anticodon recognition and mismatch prevention is the role of the ribosome during translation.\n3. TRUE: The physiological target for LeuRS is indeed the accuracy of leucine incorporation during protein synthesis, as it specifically catalyzes the attachment of leucine to its corresponding tRNA.\n4. TRUE: LeuRS ensures that leucine is correctly incorporated into proteins by charging the correct tRNA with leucine, which will pair with the mRNA codon for leucine during translation.\n5. UNKNOWN: It is unclear from the statement whether LeuRS has a direct role in signaling the ribosome to stop translation in the case of a mismatched tRNA. Typically, the fidelity of tRNA selection is a function of the ribosome, and factors involved in translation termination are distinct from tRNA synthetases. Therefore, without specific context or evidence, it's uncertain whether LeuRS has this capability.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 685,
    "user_query": "Which is the target of the drug Denosumab?",
    "yulan-chat-2-13b-fp16_response": "Denosumab is a monoclonal antibody drug that targets a protein called RANKL (receptor activator of nuclear factor kappa-B ligand). RANKL is a key regulator of bone resorption, which is the process by which bone tissue is broken down and dissolved.\nDenosumab works by binding to RANKL and inhibiting its activity, thereby reducing bone resorption and preserving bone density. The drug is used to treat osteoporosis, a condition in which bones become weak and fragile due to a loss of bone density, as well as other conditions that involve bone resorption, such as bone metastases and multiple myeloma.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Denosumab is a drug that is classified as a monoclonal antibody.\n2. The target of Denosumab is a protein known as RANKL.\n3. RANKL plays a role as a key regulator of the process of bone resorption.\n4. Denosumab functions by inhibiting the activity of RANKL.\n5. Denosumab is used in the treatment of osteoporosis and conditions involving bone resorption such as bone metastases and multiple myeloma.",
    "yulan-chat-2-13b-fp16_fact": [
      "Denosumab is a drug that is classified as a monoclonal antibody.",
      "The target of Denosumab is a protein known as RANKL.",
      "RANKL plays a role as a key regulator of the process of bone resorption.",
      "Denosumab functions by inhibiting the activity of RANKL.",
      "Denosumab is used in the treatment of osteoporosis and conditions involving bone resorption such as bone metastases and multiple myeloma."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 693,
    "user_query": "Which gene test can be used for the X-linked myotubular myopathy?",
    "yulan-chat-2-13b-fp16_response": "X-linked myotubular myopathy (XLMM) is caused by mutations in the MYOTB gene, which is located on the X chromosome. Therefore, a gene test that can be used to diagnose XLMM is a genetic test for mutations in the MYOTB gene. This test can detect mutations in the gene that cause XLMM and confirm the diagnosis. The test can be performed on a blood sample or a sample of muscle tissue. It is important to note that genetic testing is not always necessary to diagnose XLMM, as the condition can often be diagnosed based on the symptoms and a physical examination by a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. X-linked myotubular myopathy is caused by mutations in the MYOTB gene.\n2. The MYOTB gene is located on the X chromosome.\n3. A genetic test for mutations in the MYOTB gene can be used to diagnose X-linked myotubular myopathy.\n4. This genetic test for MYOTB gene mutations can be performed on a blood sample or a muscle tissue sample.\n5. X-linked myotubular myopathy can often be diagnosed based on symptoms and physical examination without genetic testing.",
    "yulan-chat-2-13b-fp16_fact": [
      "X-linked myotubular myopathy is caused by mutations in the MYOTB gene.",
      "The MYOTB gene is located on the X chromosome.",
      "A genetic test for mutations in the MYOTB gene can be used to diagnose X-linked myotubular myopathy.",
      "This genetic test for MYOTB gene mutations can be performed on a blood sample or a muscle tissue sample.",
      "X-linked myotubular myopathy can often be diagnosed based on symptoms and physical examination without genetic testing."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: X-linked myotubular myopathy is caused by mutations in the MTM1 gene.\n2. TRUE\n3. FALSE [correction]: A genetic test for mutations in the MTM1 gene can be used to diagnose X-linked myotubular myopathy.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 695,
    "user_query": "What is the association between adiponectin and migraine?",
    "yulan-chat-2-13b-fp16_response": "Adiponectin is a protein hormone secreted by adipose tissue that plays a role in regulating glucose and lipid metabolism. Several studies have investigated the association between adiponectin levels and migraine, with mixed results.\nSome studies have found that lower levels of adiponectin are associated with an increased risk of migraine. For example, a study published in the journal Cephalalgia found that women with migraine had lower levels of adiponectin compared to women without migraine. Another study published in the journal Neurology found that lower levels of adiponectin were associated with a higher frequency of migraine attacks.\nOther studies have found no association between adiponectin levels and migraine. For example, a study published in the journal Headache found no significant difference in adiponectin levels between women with migraine and women without migraine.\nOverall, the evidence suggests that there may be a link between adiponectin levels and migraine, but more research is needed to confirm this association and to understand the underlying mechanisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Adiponectin is a protein hormone secreted by adipose tissue involved in glucose and lipid metabolism regulation.\n2. Some studies indicate that lower levels of adiponectin are associated with an increased risk of migraine.\n3. A study published in the journal Cephalalgia found that women with migraine had lower adiponectin levels compared to women without migraine.\n4. Another study in the journal Neurology associated lower adiponectin levels with a higher frequency of migraine attacks.\n5. A study published in the journal Headache found no significant difference in adiponectin levels between women with migraine and those without.",
    "yulan-chat-2-13b-fp16_fact": [
      "Adiponectin is a protein hormone secreted by adipose tissue involved in glucose and lipid metabolism regulation.",
      "Some studies indicate that lower levels of adiponectin are associated with an increased risk of migraine.",
      "A study published in the journal Cephalalgia found that women with migraine had lower adiponectin levels compared to women without migraine.",
      "Another study in the journal Neurology associated lower adiponectin levels with a higher frequency of migraine attacks.",
      "A study published in the journal Headache found no significant difference in adiponectin levels between women with migraine and those without."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 703,
    "user_query": "Is there an association between FGFR3 mutation and plagiocephaly?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is an association between FGFR3 mutation and plagiocephaly. FGFR3 is a gene that encodes a receptor for fibroblast growth factor, a protein that plays a role in the development and growth of bones and other tissues. Mutations in FGFR3 have been linked to a condition called craniosynostosis, which is a type of plagiocephaly that occurs when the bones in a baby's skull fuse together too early, causing the skull to be misshapen. Craniosynostosis is a relatively rare condition, but it is one of the most common types of plagiocephaly. It is estimated to affect about 1 in 2,000 live births.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FGFR3 is a gene that encodes a receptor for fibroblast growth factor.\n2. Mutations in FGFR3 have been linked to craniosynostosis, a type of plagiocephaly.\n3. Craniosynostosis occurs when the bones in a baby's skull fuse together too early.\n4. Craniosynostosis causes the skull to be misshapen.\n5. Craniosynostosis is estimated to affect about 1 in 2,000 live births.",
    "yulan-chat-2-13b-fp16_fact": [
      "FGFR3 is a gene that encodes a receptor for fibroblast growth factor.",
      "Mutations in FGFR3 have been linked to craniosynostosis, a type of plagiocephaly.",
      "Craniosynostosis occurs when the bones in a baby's skull fuse together too early.",
      "Craniosynostosis causes the skull to be misshapen.",
      "Craniosynostosis is estimated to affect about 1 in 2,000 live births."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutations in FGFR3 have been linked to a variety of skeletal disorders, including achondroplasia, but not specifically to craniosynostosis. However, mutations in FGFR1, FGFR2, and FGFR3 genes have been associated with certain types of syndromic craniosynostosis.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 708,
    "user_query": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?",
    "yulan-chat-2-13b-fp16_response": "The enzymes involved in the addition of 7-methylguanosine (m7G) in mRNA are called methyltransferases. There are several different types of methyltransferases that add m7G to specific locations in mRNA, including:\n1. Methyltransferase 7 (MT7): This enzyme adds a single m7G to the 7th position of guanosine (G) in mRNA.\n2. Methyltransferase 8 (MT8): This enzyme adds a single m7G to the 8th position of guanosine (G) in mRNA.\n3. Methyltransferase 9 (MT9): This enzyme adds two m7Gs to the 28th position of guanosine (G) in mRNA.\n4. Methyltransferase 10 (MT10): This enzyme adds two m7Gs to the 32nd position of guanosine (G) in mRNA.\nThese enzymes play important roles in the regulation of gene expression by modifying the mRNA molecule after its synthesis.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 709,
    "user_query": "What is HOCOMOCO?",
    "yulan-chat-2-13b-fp16_response": "HOCOMOCO is a database of RNA secondary structures, including hairpins, loops, and junctions. It is a comprehensive resource for studying RNA folding and designing RNA molecules with specific structures and functions. HOCOMOCO stands for \"Hierarchical Classification of RNA Secondary Structures\" and is maintained by the European Bioinformatics Institute (EBI).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. HOCOMOCO is a database of RNA secondary structures.\n2. The database includes features such as hairpins, loops, and junctions.\n3. HOCOMOCO is used for studying RNA folding and designing RNA molecules with specific structures and functions.\n4. HOCOMOCO stands for \"Hierarchical Classification of RNA Secondary Structures.\"\n5. The European Bioinformatics Institute (EBI) maintains HOCOMOCO.",
    "yulan-chat-2-13b-fp16_fact": [
      "HOCOMOCO is a database of RNA secondary structures.",
      "The database includes features such as hairpins, loops, and junctions.",
      "HOCOMOCO is used for studying RNA folding and designing RNA molecules with specific structures and functions.",
      "HOCOMOCO stands for \"Hierarchical Classification of RNA Secondary Structures.\"",
      "The European Bioinformatics Institute (EBI) maintains HOCOMOCO."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: HOCOMOCO is a database of transcription factor binding models (motifs), not RNA secondary structures.\n2. FALSE [correction]: Since HOCOMOCO is not a database of RNA secondary structures, it would not include features such as hairpins, loops, and junctions which are attributed to RNA.\n3. FALSE [correction]: HOCOMOCO is used for understanding transcription factor binding sites and motifs, not for studying RNA folding and design.\n4. FALSE [correction]: HOCOMOCO stands for \"Handbook of Transcription Factor Binding Sites Models in Human and Mouse.\"\n5. FALSE [correction]: HOCOMOCO is maintained by the Vavilov Institute of General Genetics, not the European Bioinformatics Institute (EBI).",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 713,
    "user_query": "What is the typical alteration of the thyroid profile metabolism early after coronary artery bypass graft surgery?",
    "yulan-chat-2-13b-fp16_response": "After coronary artery bypass graft surgery, there may be changes in thyroid hormone metabolism. These changes can occur due to the effects of surgery and anesthesia, as well as the stress response to surgery.\nOne study found that thyroid hormone levels, specifically thyroxine (T4) and triiodothyronine (T3), were lower in patients immediately after coronary artery bypass graft surgery compared to healthy controls. However, these levels returned to normal within a few days to a week after surgery.\nAnother study found that thyroid hormone levels were not significantly different between patients who underwent coronary artery bypass graft surgery and healthy controls. However, this study did find that patients who had more severe coronary artery disease had lower thyroid hormone levels.\nIt is important to note that these studies were small and more research is needed to fully understand the alterations in thyroid hormone metabolism after coronary artery bypass graft surgery. It is also important to discuss any concerns about thyroid function with a healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyroid hormone metabolism may change after coronary artery bypass graft surgery.\n2. Thyroxine (T4) and triiodothyronine (T3) levels were found to be lower in patients immediately after coronary artery bypass graft surgery in one study.\n3. In one study, T4 and T3 levels returned to normal within several days to a week after surgery.\n4. Another study reported that thyroid hormone levels were not significantly different between patients who underwent coronary artery bypass graft surgery and healthy controls.\n5. More severe coronary artery disease was associated with lower thyroid hormone levels according to one study.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyroid hormone metabolism may change after coronary artery bypass graft surgery.",
      "Thyroxine (T4) and triiodothyronine (T3) levels were found to be lower in patients immediately after coronary artery bypass graft surgery in one study.",
      "In one study, T4 and T3 levels returned to normal within several days to a week after surgery.",
      "Another study reported that thyroid hormone levels were not significantly different between patients who underwent coronary artery bypass graft surgery and healthy controls.",
      "More severe coronary artery disease was associated with lower thyroid hormone levels according to one study."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 715,
    "user_query": "What does the SAGA complex acronym stands for?",
    "yulan-chat-2-13b-fp16_response": "The SAGA complex acronym stands for \"Spt-Adducin-Globus-Adapter\" complex.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 716,
    "user_query": "What is the result of the interaction between TSC1 and PLK1?",
    "yulan-chat-2-13b-fp16_response": "The interaction between TSC1 and PLK1 has important implications for cell growth and division. TSC1 and TSC2 (also known as TSC1/2) form a complex that acts as a tumor suppressor by regulating cell growth and autophagy. PLK1 (also known as Polo-like kinase 1) is a key regulator of cell division that promotes mitotic entry by phosphorylating and activating various proteins involved in the process.\nThe interaction between TSC1 and PLK1 is complex and context-dependent. In some cases, TSC1/2 can inhibit PLK1 activity, leading to a decrease in mitotic entry and cell proliferation. This can occur through direct binding and inhibition of PLK1 activity, or through the activation of PLK1 inhibitors such as LATS1/2.\nHowever, in some contexts, TSC1/2 can also activate PLK1 activity, leading to increased mitotic entry and cell proliferation. This can occur through the activation of PLK1 downstream targets such as Cdk1 and Cyclin B, which are necessary for mitotic entry.\nOverall, the interaction between TSC1 and PLK1 is a critical regulatory pathway that controls cell growth and division, and dysregulation of this pathway can lead to various diseases including cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TSC1 and TSC2 form a complex that acts as a tumor suppressor by regulating cell growth and autophagy.\n2. Polo-like kinase 1 (PLK1) is a key regulator of cell division.\n3. In some cases, the TSC1/2 complex can inhibit PLK1 activity, leading to a decreased mitotic entry and cell proliferation.\n4. The TSC1/2 complex can sometimes activate PLK1 activity, which leads to increased mitotic entry and cell proliferation.\n5. Dysregulation of the interaction between TSC1 and PLK1 can lead to various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "TSC1 and TSC2 form a complex that acts as a tumor suppressor by regulating cell growth and autophagy.",
      "Polo-like kinase 1 (PLK1) is a key regulator of cell division.",
      "In some cases, the TSC1/2 complex can inhibit PLK1 activity, leading to a decreased mitotic entry and cell proliferation.",
      "The TSC1/2 complex can sometimes activate PLK1 activity, which leads to increased mitotic entry and cell proliferation.",
      "Dysregulation of the interaction between TSC1 and PLK1 can lead to various diseases, including cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The TSC1/2 complex generally does not activate PLK1 activity; it inhibits it. Activation of PLK1 by the TSC1/2 complex leading to increased mitotic entry and cell proliferation is inconsistent with the role of TSC1/2 as a tumor suppressor.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 717,
    "user_query": "What are the characteristics of the \"Universal Proteomics Standard 2\" (UPS2)?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I am not aware of any specific technology or standard called \"Universal Proteomics Standard 2\" (UPS2). Could you provide more context or information about where you heard about this term?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 719,
    "user_query": "Which are the smallest known subviral pathogens of plants?",
    "yulan-chat-2-13b-fp16_response": "Subviral pathogens of plants are microorganisms that are smaller than viruses and can cause disease in plants. Some of the smallest known subviral pathogens of plants include:\n1. Bacterial microsporidia: These are highly resistant spores produced by some bacteria that can infect plants and cause disease.\n2. Chloroplasts: Although not strictly subviral pathogens, chloroplasts are small organelles found in some plant cells that can cause disease when they are infected with certain bacteria or viruses.\n3. Mycoplasmas: These are the smallest known bacteria and can cause disease in plants.\n4. Nanoarchaea: These are a group of microorganisms that are related to bacteria but have unique properties, including the ability to cause disease in plants.\nIt's worth noting that the size of subviral pathogens can vary depending on the specific organism and the conditions under which it is studied.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bacterial microsporidia can infect plants and cause disease.\n2. Chloroplasts can cause disease in plants when infected with certain bacteria or viruses.\n3. Mycoplasmas are considered the smallest known bacteria that can cause disease in plants.\n4. Nanoarchaea are capable of causing disease in plants.",
    "yulan-chat-2-13b-fp16_fact": [
      "Bacterial microsporidia can infect plants and cause disease.",
      "Chloroplasts can cause disease in plants when infected with certain bacteria or viruses.",
      "Mycoplasmas are considered the smallest known bacteria that can cause disease in plants.",
      "Nanoarchaea are capable of causing disease in plants."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Bacterial microsporidia are not bacteria; they are a group of spore-forming unicellular parasites. They mainly infect animals and are not known to cause disease in plants.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Nanoarchaea are a group of archaea, which are single-celled organisms distinct from bacteria. They are not known to cause diseases in plants.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 720,
    "user_query": "What causes Katayama Fever?",
    "yulan-chat-2-13b-fp16_response": "Katayama fever is a type of rickettsial infection caused by the bacterium Rickettsia japonica. It is primarily transmitted to humans through the bite of an infected tick, particularly the Dermacentor vector.\nThe infection typically presents with fever, headache, muscle pain, and a rash, which usually appears on the wrists and ankles. Other symptoms may include nausea, vomiting, and lethargy. In some cases, the infection can spread to other parts of the body, such as the brain, heart, and lungs, leading to more severe complications.\nThe tick that transmits Katayama fever is commonly found in wooded areas and brushy habitats in Japan, Korea, and China. The infection can be diagnosed through blood tests, and treatment typically involves antibiotics such as doxycycline.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Katayama fever is caused by the bacterium Rickettsia japonica.\n2. It is transmitted to humans through the bite of an infected tick.\n3. Symptoms of Katayama fever include fever, headache, muscle pain, and a rash typically on the wrists and ankles.\n4. The tick that transmits Katayama fever is commonly found in Japan, Korea, and China.\n5. Treatment for Katayama fever usually involves antibiotics such as doxycycline.",
    "yulan-chat-2-13b-fp16_fact": [
      "Katayama fever is caused by the bacterium Rickettsia japonica.",
      "It is transmitted to humans through the bite of an infected tick.",
      "Symptoms of Katayama fever include fever, headache, muscle pain, and a rash typically on the wrists and ankles.",
      "The tick that transmits Katayama fever is commonly found in Japan, Korea, and China.",
      "Treatment for Katayama fever usually involves antibiotics such as doxycycline."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Katayama fever is caused by a parasitic infection from Schistosoma larvae, not the bacterium Rickettsia japonica.\n2. FALSE [correction]: Katayama fever is transmitted to humans through freshwater contaminated with Schistosoma larvae, not through the bite of an infected tick.\n3. FALSE [correction]: Symptoms of Katayama fever usually include fever, chills, cough, and gastrointestinal symptoms; it is not characterized by a rash on the wrists and ankles, which is more typical of rickettsial infections.\n4. UNKNOWN: The statement refers to the tick and its geographical distribution, but as Katayama fever is not transmitted by ticks, the relevance of the tick's distribution is unclear without additional context.\n5. FALSE [correction]: Treatment for Katayama fever involves antiparasitic medications such as praziquantel, not the antibiotic doxycycline, which is used for rickettsial and bacterial infections.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "yulan-chat-2-13b-fp16_response": "As of my knowledge cutoff date in September 2021, there were several ongoing and completed clinical trials investigating interventions for the prevention of sarcopenia. Here are some examples:\n1. Sarcopenia Prevention through Agriculture and Lifestyle Intervention (SPARK) Trial: This is an ongoing randomized controlled trial aimed at preventing sarcopenia in older adults through a combination of dietary and physical activity interventions. The trial is being conducted at the University of California, Los Angeles, and is expected to be completed in September 2023.\n2. Resistance Exercise and Sarcopenia in Older Adults (RESA) Trial: This is a completed randomized controlled trial that investigated the effectiveness of resistance exercise training in preventing sarcopenia in older adults. The trial was conducted at the University of Texas at Dallas and was completed in 2019.\n3. Sarcopenia Prevention through Multidisciplinary Geriatric Health Management (SPM-GHM) Trial: This is an ongoing randomized controlled trial aimed at preventing sarcopenia in older adults through a multidisciplinary intervention that includes exercise, nutrition, and other lifestyle modifications. The trial is being conducted at the National Center for Geriatrics and Gerontology in Japan and is expected to be completed in March 2023.\n4. Sarcopenia Prevention with Vitamin D and Physical Activity (SPV-PA) Trial: This is an ongoing randomized controlled trial that aims to investigate the effectiveness of vitamin D supplementation and physical activity in preventing sarcopenia in older adults. The trial is being conducted at the University of Sao Paulo in Brazil and is expected to be completed in December 2023.\nThese are just a few examples of the clinical trials that have been conducted or are ongoing for the prevention of sarcopenia. It is important to note that new trials may have been initiated since my knowledge cutoff date in September 2021.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The SPARK Trial is a randomized controlled trial aiming to prevent sarcopenia at the University of California, Los Angeles, expected to complete in September 2023.\n2. The RESA Trial was a completed randomized controlled trial that studied the effectiveness of resistance exercise in preventing sarcopenia at the University of Texas at Dallas, completed in 2019.\n3. The SPM-GHM Trial is an ongoing trial at the National Center for Geriatrics and Gerontology in Japan expected to be completed in March 2023.\n4. The SPV-PA Trial aims to study the effectiveness of vitamin D supplementation and physical activity in preventing sarcopenia at the University of Sao Paulo in Brazil, with expected completion in December 2023.\n5. The knowledge cutoff date for the information provided about these clinical trials is September 2021.",
    "yulan-chat-2-13b-fp16_fact": [
      "The SPARK Trial is a randomized controlled trial aiming to prevent sarcopenia at the University of California, Los Angeles, expected to complete in September 2023.",
      "The RESA Trial was a completed randomized controlled trial that studied the effectiveness of resistance exercise in preventing sarcopenia at the University of Texas at Dallas, completed in 2019.",
      "The SPM-GHM Trial is an ongoing trial at the National Center for Geriatrics and Gerontology in Japan expected to be completed in March 2023.",
      "The SPV-PA Trial aims to study the effectiveness of vitamin D supplementation and physical activity in preventing sarcopenia at the University of Sao Paulo in Brazil, with expected completion in December 2023.",
      "The knowledge cutoff date for the information provided about these clinical trials is September 2021."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: The statement about the SPARK Trial at the University of California, Los Angeles, and its expected completion date of September 2023 cannot be confirmed as true or false without access to current clinical trial registries or databases.\n2. UNKNOWN: The statement about the RESA Trial at the University of Texas at Dallas and its completion in 2019 also requires validation through clinical trial databases or records.\n3. UNKNOWN: Information regarding the SPM-GHM Trial at the National Center for Geriatrics and Gerontology in Japan and its expected completion in March 2023 would also need to be verified.\n4. UNKNOWN: Details about the SPV-PA Trial at the University of Sao Paulo in Brazil, including the study aims and expected completion date of December 2023, require verification through clinical trial registries or the institution's records.\n5. TRUE: The statement about the knowledge cutoff date being in September 2021 is something that can be confirmed based on the context of this task and how it is being presented.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "yulan-chat-2-13b-fp16_response": "The database of molecular recognition features in membrane proteins is called the Protein Data Bank (PDB). The PDB is a public database that contains information about the three-dimensional structures of proteins and other biomolecules. It is maintained by the Research Collaboratory for Structural Bioinformatics (RCSB) and is accessible online at <https://www.rcsb.org/>. The PDB includes information about the structures of membrane proteins, as well as other types of proteins. It is a valuable resource for researchers who are interested in understanding the structure and function of proteins, including those that are involved in membrane transport, signaling, and other processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Protein Data Bank (PDB) is the database of molecular recognition features in membrane proteins.\n2. The PDB is a public database.\n3. The PDB contains information about the three-dimensional structures of proteins and other biomolecules.\n4. The Research Collaboratory for Structural Bioinformatics (RCSB) maintains the PDB.\n5. The PDB database is accessible online at <https://www.rcsb.org/>.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Protein Data Bank (PDB) is the database of molecular recognition features in membrane proteins.",
      "The PDB is a public database.",
      "The PDB contains information about the three-dimensional structures of proteins and other biomolecules.",
      "The Research Collaboratory for Structural Bioinformatics (RCSB) maintains the PDB.",
      "The PDB database is accessible online at <https://www.rcsb.org/>."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Protein Data Bank (PDB) is a database of three-dimensional structural data of large biomolecules such as proteins and nucleic acids, not specifically \"molecular recognition features in membrane proteins.\"\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 731,
    "user_query": "What kind of bonds are connecting keratin molecules?",
    "yulan-chat-2-13b-fp16_response": "Keratin is a fibrous protein that is found in the skin, hair, nails, and feathers of animals. It is made up of pairs of long, coiled molecules called alpha helices, which are connected by weak, hydrogen bonds. These bonds help to hold the molecules together and give keratin its characteristic strength and flexibility. In addition to hydrogen bonds, keratin molecules are also held together by other types of chemical bonds, such as disulfide bonds, which are stronger and help to give keratin its unique structure.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Keratin is a fibrous protein found in the skin, hair, nails, and feathers of animals.\n2. Keratin molecules are made up of long, coiled structures called alpha helices.\n3. Alpha helices in keratin are connected by weak hydrogen bonds.\n4. Hydrogen bonds contribute to the strength and flexibility of keratin.\n5. Disulfide bonds are another type of chemical bond present in keratin, providing additional strength and structure.",
    "yulan-chat-2-13b-fp16_fact": [
      "Keratin is a fibrous protein found in the skin, hair, nails, and feathers of animals.",
      "Keratin molecules are made up of long, coiled structures called alpha helices.",
      "Alpha helices in keratin are connected by weak hydrogen bonds.",
      "Hydrogen bonds contribute to the strength and flexibility of keratin.",
      "Disulfide bonds are another type of chemical bond present in keratin, providing additional strength and structure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 734,
    "user_query": "What is the risk of developing acute myelogenous leukemia in Fanconi anemia?",
    "yulan-chat-2-13b-fp16_response": "Fanconi anemia is a rare genetic disorder that affects the bone marrow, which produces blood cells. One of the complications of Fanconi anemia is an increased risk of developing acute myelogenous leukemia (AML), a type of cancer that affects the blood and bone marrow.\nThe risk of developing AML in Fanconi anemia is higher than in the general population. Studies have shown that up to 20% of people with Fanconi anemia may develop AML at some point in their lives, usually in childhood or early adulthood.\nThe exact mechanism by which Fanconi anemia increases the risk of AML is not fully understood, but it is thought to be related to the defect in the DNA repair mechanism that is present in Fanconi anemia. This defect can lead to the accumulation of genetic mutations in blood cells, which can increase the risk of developing AML.\nIt is important for people with Fanconi anemia to be monitored closely for the development of AML, as early detection and treatment can improve outcomes. Treatment options for AML in people with Fanconi anemia may include chemotherapy, radiation therapy, bone marrow transplantation, or a combination of these approaches.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fanconi anemia is a rare genetic disorder that affects the bone marrow and its production of blood cells.\n2. Individuals with Fanconi anemia have an increased risk of developing acute myelogenous leukemia (AML).\n3. Studies suggest that up to 20% of people with Fanconi anemia may develop AML, typically in childhood or early adulthood.\n4. The increased risk of AML in Fanconi anemia patients is thought to be related to a defect in the DNA repair mechanism.\n5. Treatment options for AML in individuals with Fanconi anemia include chemotherapy, radiation therapy, and bone marrow transplantation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fanconi anemia is a rare genetic disorder that affects the bone marrow and its production of blood cells.",
      "Individuals with Fanconi anemia have an increased risk of developing acute myelogenous leukemia (AML).",
      "Studies suggest that up to 20% of people with Fanconi anemia may develop AML, typically in childhood or early adulthood.",
      "The increased risk of AML in Fanconi anemia patients is thought to be related to a defect in the DNA repair mechanism.",
      "Treatment options for AML in individuals with Fanconi anemia include chemotherapy, radiation therapy, and bone marrow transplantation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: It is difficult to provide an exact percentage without a specific reference, but various studies suggest that individuals with Fanconi anemia have an increased risk of developing leukemia, including AML. However, saying \"up to 20%\" may not be accurate without context. It is known that the risk is higher compared to the general population.\n4. TRUE\n5. FALSE [correction]: Due to the underlying DNA repair defect in Fanconi anemia, standard doses of chemotherapy and radiation therapy are often not suitable due to increased toxicity. Treatment options do include bone marrow transplantation, and any use of chemotherapy or radiation would typically be at much lower doses specifically tailored to the tolerance levels of individuals with Fanconi anemia.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 735,
    "user_query": "How many different mutations have been associated with Muenke syndrome?",
    "yulan-chat-2-13b-fp16_response": "Muenke syndrome is a rare genetic disorder that is caused by mutations in the FGFR2 gene. The exact number of mutations that have been associated with Muenke syndrome is not clear, as new mutations are continually being discovered. However, it is estimated that there are over 400 different mutations that have been identified in individuals with Muenke syndrome. These mutations can occur in different regions of the FGFR2 gene and can result in a wide range of symptoms and severity of the disorder.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Muenke syndrome is a rare genetic disorder.\n2. The FGFR2 gene mutations cause Muenke syndrome.\n3. It is estimated that there are over 400 different mutations associated with Muenke syndrome.\n4. Mutations related to Muenke syndrome can occur in different regions of the FGFR2 gene.\n5. The symptoms and severity of Muenke syndrome can vary due to different mutations.",
    "yulan-chat-2-13b-fp16_fact": [
      "Muenke syndrome is a rare genetic disorder.",
      "The FGFR2 gene mutations cause Muenke syndrome.",
      "It is estimated that there are over 400 different mutations associated with Muenke syndrome.",
      "Mutations related to Muenke syndrome can occur in different regions of the FGFR2 gene.",
      "The symptoms and severity of Muenke syndrome can vary due to different mutations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Muenke syndrome is caused by mutations in the FGFR3 gene, not the FGFR2 gene.\n3. FALSE [correction]: Muenke syndrome is typically associated with a single specific mutation in the FGFR3 gene (Pro250Arg), not over 400 different mutations.\n4. FALSE [correction]: Since Muenke syndrome is typically associated with a specific mutation in the FGFR3 gene, the statement about different regions of the FGFR2 gene is incorrect.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 737,
    "user_query": "Which genes have been proposed as potential candidates for gene therapy of heart failure?",
    "yulan-chat-2-13b-fp16_response": "Several genes have been proposed as potential candidates for gene therapy of heart failure, including:\n1. Beta-myosin heavy chain (BMHC): Gene therapy targeting BMHC has been shown to improve cardiac function in animal models of heart failure.\n2. Angiotensin-converting enzyme (ACE): Overexpression of ACE in the heart has been shown to increase cardiac contractility and improve heart failure in animal models.\n3. Heat shock protein 27 (HSP27): HSP27 gene therapy has been shown to improve cardiac function and survival in animal models of heart failure.\n4. Brain natriuretic peptide (BNP): BNP gene therapy has been shown to improve cardiac function and survival in animal models of heart failure.\n5. Vascular endothelial growth factor (VEGF): VEGF gene therapy has been shown to improve cardiac function and survival in animal models of heart failure by promoting angiogenesis and myocardial ischemia.\nIt is important to note that while these genes have shown promise in preclinical studies, further research is needed to determine their safety and efficacy in human clinical trials.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Beta-myosin heavy chain has been proposed as a candidate for gene therapy of heart failure.\n2. Gene therapy targeting Angiotensin-converting enzyme has been studied for improving heart failure in animal models.\n3. Heat shock protein 27 is among the genes proposed for gene therapy to improve cardiac function and survival in heart failure.\n4. Brain natriuretic peptide gene therapy has been proposed to improve cardiac function in animal models of heart failure.\n5. Vascular endothelial growth factor gene therapy has been shown to promote angiogenesis and improve cardiac function in heart failure in animal studies.",
    "yulan-chat-2-13b-fp16_fact": [
      "Beta-myosin heavy chain has been proposed as a candidate for gene therapy of heart failure.",
      "Gene therapy targeting Angiotensin-converting enzyme has been studied for improving heart failure in animal models.",
      "Heat shock protein 27 is among the genes proposed for gene therapy to improve cardiac function and survival in heart failure.",
      "Brain natriuretic peptide gene therapy has been proposed to improve cardiac function in animal models of heart failure.",
      "Vascular endothelial growth factor gene therapy has been shown to promote angiogenesis and improve cardiac function in heart failure in animal studies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Beta-myosin heavy chain has indeed been proposed as a candidate for gene therapy of heart failure due to its role in cardiac muscle contraction.\n\n2. TRUE: Gene therapy targeting Angiotensin-converting enzyme (ACE) has been studied for heart failure treatment since ACE plays a role in blood pressure regulation and fluid balance.\n\n3. TRUE: Heat shock protein 27 is among the genes that have been proposed for gene therapy to potentially improve cardiac function and survival in heart failure due to its role in protein folding and protection against stress.\n\n4. TRUE: Brain natriuretic peptide (BNP) gene therapy has been proposed and studied for its potential to improve cardiac function in animal models of heart failure. BNP is involved in reducing vascular resistance and venous pressure, and has diuretic effects.\n\n5. TRUE: VEGF (Vascular Endothelial Growth Factor) gene therapy has indeed been shown to promote angiogenesis and has been studied for its potential to improve cardiac function in heart failure within animal studies.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 738,
    "user_query": "DX-88 is investigational name of which drug?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information about a drug with the investigational name DX-88. It's possible that this name is not widely recognized or has been changed or updated since my knowledge cutoff date of September 2021. If you have any additional information about this drug, please provide it and I'll do my best to help you.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 740,
    "user_query": "Which genes have been found to be associated with restless leg syndrome",
    "yulan-chat-2-13b-fp16_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an overwhelming urge to move the legs, often accompanied by uncomfortable sensations such as crawling, tingling, or throbbing. While the exact cause of RLS is not fully understood, research has identified several genes that may be associated with the condition.\nOne of the most well-known genes associated with RLS is the iron regulatory gene (IRS1), which has been linked to increased iron levels in the brain. Iron accumulation in the brain has been implicated in the development of RLS.\nOther genes that have been identified as potential risk factors for RLS include:\n* The dopamine receptor D4 gene (DRD4), which has been linked to increased risk of RLS in some studies.\n* The dopamine transporter gene (DAT), which has been associated with increased risk of RLS in some populations.\n* The mu-opioid receptor gene (OPRM1), which has been linked to increased risk of RLS in some studies.\n* The serotonin transporter gene (5-HTTLPR), which has been associated with increased risk of RLS in some populations.\nIt's important to note that while these genes have been linked to RLS in some studies, the relationship between genetics and RLS is still not fully understood, and more research is needed to confirm these findings. Additionally, RLS is a complex condition that is likely influenced by a combination of genetic, environmental, and lifestyle factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The iron regulatory gene (IRS1) has been linked to increased iron levels in the brain and associated with restless leg syndrome.\n2. The dopamine receptor D4 gene (DRD4) has been linked to an increased risk of restless leg syndrome in some studies.\n3. The dopamine transporter gene (DAT) has been associated with an increased risk of restless leg syndrome in some populations.\n4. The mu-opioid receptor gene (OPRM1) has been linked to an increased risk of restless leg syndrome in some studies.\n5. The serotonin transporter gene (5-HTTLPR) has been associated with an increased risk of restless leg syndrome in some populations.",
    "yulan-chat-2-13b-fp16_fact": [
      "The iron regulatory gene (IRS1) has been linked to increased iron levels in the brain and associated with restless leg syndrome.",
      "The dopamine receptor D4 gene (DRD4) has been linked to an increased risk of restless leg syndrome in some studies.",
      "The dopamine transporter gene (DAT) has been associated with an increased risk of restless leg syndrome in some populations.",
      "The mu-opioid receptor gene (OPRM1) has been linked to an increased risk of restless leg syndrome in some studies.",
      "The serotonin transporter gene (5-HTTLPR) has been associated with an increased risk of restless leg syndrome in some populations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The correct gene associated with increased iron levels in the brain and restless leg syndrome is BTBD9, not IRS1.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nIt's important to note that although DRD4 and DAT have been studied in relation to restless leg syndrome, the degree of association and causation can vary across different studies. As for OPRM1 and 5-HTTLPR, while they are involved in neurotransmission systems that could theoretically be related to restless leg syndrome, without specific evidence or studies to support the claim, their association with restless leg syndrome remains unknown.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 743,
    "user_query": "Do the Sleeping Beauty or the piggyBac transposons have higher transposition efficiency?",
    "yulan-chat-2-13b-fp16_response": "The transposition efficiency of the Sleeping Beauty and piggyBac transposons can vary depending on the specific genetic context and the experimental conditions used. In general, both transposons are capable of efficient transposition in a wide range of organisms, including mammals.\nThe Sleeping Beauty transposon is known for its high transposition efficiency in mammalian cells, with reported rates ranging from a few percent to over 100%. It has been used extensively as a genetic tool for gene insertion and gene expression studies, as well as for the development of gene therapies.\nThe piggyBac transposon is also known for its high transposition efficiency in mammalian cells, with reported rates ranging from a few percent to over 50%. It has been used for similar applications as the Sleeping Beauty transposon, including gene insertion and gene expression studies, as well as for the development of gene therapies.\nOverall, both the Sleeping Beauty and piggyBac transposons have high transposition efficiencies, and the choice of which one to use may depend on the specific requirements of a given experiment or application.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The transposition efficiency of the Sleeping Beauty and piggyBac transposons can vary based on the genetic context and experimental conditions.\n2. The Sleeping Beauty transposon can achieve high transposition efficiency in mammalian cells, with reported rates ranging from a few percent to over 100%.\n3. The Sleeping Beauty transposon has been used as a genetic tool for gene insertion and gene expression studies, as well as for gene therapy development.\n4. The piggyBac transposon can achieve high transposition efficiency in mammalian cells, with reported rates ranging from a few percent to over 50%.\n5. The piggyBac transposon has been utilized for similar applications as the Sleeping Beauty transposon, including gene insertion and gene expression studies and gene therapy development.",
    "yulan-chat-2-13b-fp16_fact": [
      "The transposition efficiency of the Sleeping Beauty and piggyBac transposons can vary based on the genetic context and experimental conditions.",
      "The Sleeping Beauty transposon can achieve high transposition efficiency in mammalian cells, with reported rates ranging from a few percent to over 100%.",
      "The Sleeping Beauty transposon has been used as a genetic tool for gene insertion and gene expression studies, as well as for gene therapy development.",
      "The piggyBac transposon can achieve high transposition efficiency in mammalian cells, with reported rates ranging from a few percent to over 50%.",
      "The piggyBac transposon has been utilized for similar applications as the Sleeping Beauty transposon, including gene insertion and gene expression studies and gene therapy development."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The Sleeping Beauty transposon can achieve high transposition efficiency in mammalian cells, but the reported rates typically do not exceed 100% as this would imply more transposition events than available target sites in the genome.\n3. TRUE\n4. TRUE  though the exact efficiency rates can vary and typically do not exceed 100%, the statement is generally accurate in stating that the transposition efficiency can range from a few percent to over 50%.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 744,
    "user_query": "Where does TORC1 sequester during heat stress?",
    "yulan-chat-2-13b-fp16_response": "TORC1 (Target of Rapamycin Complex 1) is a key regulator of cell growth and metabolism that is involved in many biological processes, including autophagy, transcription, and protein synthesis. During heat stress, TORC1 is sequestered in the cytoplasm, away from its normal location in the nucleus. This sequestration is thought to be a protective mechanism that helps to prevent heat-induced damage to the cell. It is also believed that TORC1 sequestration may play a role in the activation of heat shock proteins, which are molecular chaperones that help to protect cells from heat stress.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TORC1 stands for Target of Rapamycin Complex 1.\n2. TORC1 is a regulator of cell growth and metabolism.\n3. During heat stress, TORC1 is sequestered in the cytoplasm.\n4. The normal location of TORC1 is in the nucleus.\n5. The sequestration of TORC1 may play a role in the activation of heat shock proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "TORC1 stands for Target of Rapamycin Complex 1.",
      "TORC1 is a regulator of cell growth and metabolism.",
      "During heat stress, TORC1 is sequestered in the cytoplasm.",
      "The normal location of TORC1 is in the nucleus.",
      "The sequestration of TORC1 may play a role in the activation of heat shock proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The normal location of TORC1 is not in the nucleus; TORC1 is generally found in the cytoplasm and associated with cellular membranes, such as the lysosomal or endosomal membranes.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "yulan-chat-2-13b-fp16_response": "Rivaroxaban is a medication that is used to prevent blood clots. It is a type of medication called a direct factor Xa inhibitor, which means that it works by blocking the activity of a protein called factor Xa.\nRivaroxaban is not metabolized by the kidneys. It is eliminated from the body primarily through the liver, where it is converted into other compounds that are then excreted in the feces. The kidneys play a role in the elimination of rivaroxaban by helping to remove it from the blood, but they do not metabolize the medication itself.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Rivaroxaban is a medication used to prevent blood clots.\n2. Rivaroxaban is classified as a direct factor Xa inhibitor.\n3. Rivaroxaban works by blocking the activity of the protein factor Xa.\n4. Rivaroxaban is not metabolized by the kidneys.\n5. Rivaroxaban is primarily eliminated through the liver and excreted in the feces.",
    "yulan-chat-2-13b-fp16_fact": [
      "Rivaroxaban is a medication used to prevent blood clots.",
      "Rivaroxaban is classified as a direct factor Xa inhibitor.",
      "Rivaroxaban works by blocking the activity of the protein factor Xa.",
      "Rivaroxaban is not metabolized by the kidneys.",
      "Rivaroxaban is primarily eliminated through the liver and excreted in the feces."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Rivaroxaban is partially metabolized by the kidneys; renal excretion accounts for approximately one-third of the elimination of the drug.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 746,
    "user_query": "What are the side effects of Nalmefene?",
    "yulan-chat-2-13b-fp16_response": "Nalmefene is a medication that is used to reverse the effects of opioid overdose. It is typically administered in the form of an injection and works by blocking the effects of opioids on the brain.\nAs with any medication, there can be side effects associated with the use of nalmefene. Some of the most common side effects of nalmefene include:\n* Dizziness or lightheadedness\n* Nausea or vomiting\n* Sleepiness or fatigue\n* Headache\n* Muscle pain or weakness\n* Rapid heartbeat\n* Agitation or anxiety\n* Chest pain or discomfort\n* Allergic reactions, such as hives, itching, or difficulty breathing\nIt is important to note that these side effects are generally mild and temporary, and they should go away on their own as the medication wears off. However, if you experience any serious or persistent side effects, or if you have any concerns about your health or the use of this medication, you should speak to your doctor or other healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nalmefene is used to reverse the effects of opioid overdose.\n2. Nalmefene is typically administered in the form of an injection.\n3. Nalmefene works by blocking the effects of opioids on the brain.\n4. Common side effects of nalmefene include dizziness, nausea, sleepiness, headache, muscle pain or weakness, rapid heartbeat, agitation, chest pain, and allergic reactions.\n5. The side effects of nalmefene are generally mild and temporary.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nalmefene is used to reverse the effects of opioid overdose.",
      "Nalmefene is typically administered in the form of an injection.",
      "Nalmefene works by blocking the effects of opioids on the brain.",
      "Common side effects of nalmefene include dizziness, nausea, sleepiness, headache, muscle pain or weakness, rapid heartbeat, agitation, chest pain, and allergic reactions.",
      "The side effects of nalmefene are generally mild and temporary."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Naloxone, not nalmefene, is commonly used to reverse the effects of opioid overdose. Nalmefene can be used to reduce alcohol consumption.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 756,
    "user_query": "Which is the E3 ubiquitin ligase of Hsp90?",
    "yulan-chat-2-13b-fp16_response": "The E3 ubiquitin ligase of Hsp90 is called Hsp90-associated protein E3 ubiquitin ligase 1 (HERU1). It is also known as E6-AP, which stands for E6 apolipoprotein-mediated ubiquitination. HERU1 is a member of the E6-AP protein family, which is involved in regulating various cellular processes, including protein turnover, cell cycle progression, and apoptosis. HERU1 interacts with Hsp90 and facilitates the ubiquitination of client proteins that bind to Hsp90.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hsp90-associated protein E3 ubiquitin ligase 1 (HERU1) is the E3 ubiquitin ligase of Hsp90.\n2. HERU1 is also known as E6-AP, which stands for E6 apolipoprotein-mediated ubiquitination.\n3. HERU1 is a member of the E6-AP protein family.\n4. The E6-AP protein family is involved in regulating various cellular processes such as protein turnover, cell cycle progression, and apoptosis.\n5. HERU1 interacts with Hsp90 to facilitate the ubiquitination of client proteins that bind to Hsp90.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hsp90-associated protein E3 ubiquitin ligase 1 (HERU1) is the E3 ubiquitin ligase of Hsp90.",
      "HERU1 is also known as E6-AP, which stands for E6 apolipoprotein-mediated ubiquitination.",
      "HERU1 is a member of the E6-AP protein family.",
      "The E6-AP protein family is involved in regulating various cellular processes such as protein turnover, cell cycle progression, and apoptosis.",
      "HERU1 interacts with Hsp90 to facilitate the ubiquitination of client proteins that bind to Hsp90."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: Without additional information or a scientific reference, the existence and functions of a protein named \"Hsp90-associated protein E3 ubiquitin ligase 1 (HERU1)\" cannot be verified.\n2. FALSE [correction]: E6-AP actually stands for E6-Associated Protein, which is involved in the ubiquitin-proteasome pathway, and it is not typically known as HERU1. \n3. UNKNOWN: The name \"HERU1\" is not well-recognized in scientific literature related to E6-AP, and therefore, it is not possible to confirm without further context whether HERU1 is a member of the E6-AP protein family.\n4. TRUE: The E6-AP protein family or more generally, E3 ubiquitin ligases, are indeed involved in regulating cellular processes such as protein turnover, cell cycle progression, and apoptosis through the ubiquitination of proteins.\n5. UNKNOWN: The interaction of HERU1 with Hsp90 for the ubiquitination of client proteins cannot be confirmed without specific scientific evidence pertaining to the existence and functions of a protein named \"HERU1\".",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 757,
    "user_query": "Which are the major phycobiliproteins present in cyanobacteria?",
    "yulan-chat-2-13b-fp16_response": "Phycobiliproteins are a group of water-soluble pigments found in cyanobacteria and some algae. They are responsible for the red, blue, and green colors observed in these organisms. The major phycobiliproteins present in cyanobacteria are phycoerythrins, phycocyanins, and allophycocyanins. These pigments are involved in photosynthesis and play a key role in the absorption of light by the cyanobacterial cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phycobiliproteins are water-soluble pigments found in cyanobacteria and some algae.\n2. Phycobiliproteins are responsible for the red, blue, and green colors observed in cyanobacteria and some algae.\n3. The major phycobiliproteins present in cyanobacteria are phycoerythrins, phycocyanins, and allophycocyanins.\n4. These pigments are involved in the process of photosynthesis in cyanobacteria. \n5. Phycobiliproteins play a key role in the absorption of light by the cyanobacterial cell.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phycobiliproteins are water-soluble pigments found in cyanobacteria and some algae.",
      "Phycobiliproteins are responsible for the red, blue, and green colors observed in cyanobacteria and some algae.",
      "The major phycobiliproteins present in cyanobacteria are phycoerythrins, phycocyanins, and allophycocyanins.",
      "These pigments are involved in the process of photosynthesis in cyanobacteria.",
      "Phycobiliproteins play a key role in the absorption of light by the cyanobacterial cell."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Phycobiliproteins are responsible for the red and blue colors observed in cyanobacteria and some algae, not green.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 759,
    "user_query": "In which kingdom do microsporidia belong, according to their current classification scheme?",
    "yulan-chat-2-13b-fp16_response": "Microsporidia belong to the kingdom Fungi according to their current classification scheme.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Microsporidia are classified under the kingdom Fungi.",
    "yulan-chat-2-13b-fp16_fact": [
      "Microsporidia are classified under the kingdom Fungi."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "yulan-chat-2-13b-fp16_response": "TRalpha2 (thyroid hormone receptor alpha 2) is a transcription factor that plays a role in regulating gene expression in the heart. It is involved in the development and maintenance of the cardiovascular system, and regulates the expression of genes that are involved in various aspects of heart function, including contractility, hypertrophy, and heart rate.\nSome of the genes that are known to be regulated by TRalpha2 in the heart include:\n* Myosin heavy chain (MHC) genes: These genes are involved in the production of the contractile proteins in the heart muscle. TRalpha2 regulates the expression of different MHC isoforms, which can affect the strength and endurance of the heart muscle.\n* Beta-adrenergic receptor (ADRB2) gene: This gene encodes a receptor for the hormone epinephrine, which plays a role in regulating heart rate and contractility. TRalpha2 regulates the expression of ADRB2 in the heart, which can affect the responsiveness of the heart to epinephrine.\n* Calcium handling genes: TRalpha2 regulates the expression of genes that are involved in the regulation of calcium in the heart, which is essential for muscle contraction.\n* Angiotensin-converting enzyme (ACE) gene: This gene is involved in the regulation of blood pressure, and TRalpha2 regulates its expression in the heart.\nOverall, TRalpha2 plays a complex role in regulating gene expression in the heart, and its activity can have significant effects on heart function and physiology.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TRalpha2 is a transcription factor that regulates gene expression in the heart.\n2. TRalpha2 is involved in the development and maintenance of the cardiovascular system.\n3. Myosin heavy chain (MHC) genes, which are involved in the production of contractile proteins in the heart muscle, are regulated by TRalpha2.\n4. TRalpha2 regulates the expression of the Beta-adrenergic receptor (ADRB2) gene in the heart.\n5. Angiotensin-converting enzyme (ACE) gene, which is involved in the regulation of blood pressure, is regulated by TRalpha2 in the heart.",
    "yulan-chat-2-13b-fp16_fact": [
      "TRalpha2 is a transcription factor that regulates gene expression in the heart.",
      "TRalpha2 is involved in the development and maintenance of the cardiovascular system.",
      "Myosin heavy chain (MHC) genes, which are involved in the production of contractile proteins in the heart muscle, are regulated by TRalpha2.",
      "TRalpha2 regulates the expression of the Beta-adrenergic receptor (ADRB2) gene in the heart.",
      "Angiotensin-converting enzyme (ACE) gene, which is involved in the regulation of blood pressure, is regulated by TRalpha2 in the heart."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: TRalpha2 is not a transcription factor; Thyroid hormone receptor alpha (TR1) is the isoform that is involved in gene regulation.\n2. UNKNOWN\n3. UNKNOWN - While MHC genes are crucial for the production of contractile proteins in the heart muscle, the specific regulation by TRalpha2 cannot be confirmed without additional context.\n4. UNKNOWN - It's not clear from the statement whether TRalpha2 regulates ADRB2 without specific scientific evidence.\n5. UNKNOWN - The regulation of the ACE gene by TRalpha2 isn't clearly established without further scientific context.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 767,
    "user_query": "Is tubulin acetylation involved in cell motility?",
    "yulan-chat-2-13b-fp16_response": "Yes, tubulin acetylation is involved in cell motility. Tubulin acetylation is a post-translational modification that affects the stability and dynamics of microtubules, which are important for cell motility. Studies have shown that acetylated tubulin promotes the stability of microtubules, which in turn promotes cell motility. Additionally, microtubule-dependent processes such as cell division and intracellular transport also require tubulin acetylation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tubulin acetylation is a post-translational modification that affects microtubules.\n2. Microtubules are important for cell motility.\n3. Acetylated tubulin promotes the stability of microtubules.\n4. The stability of microtubules is linked to the promotion of cell motility.\n5. Tubulin acetylation is required for microtubule-dependent processes such as cell division and intracellular transport.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tubulin acetylation is a post-translational modification that affects microtubules.",
      "Microtubules are important for cell motility.",
      "Acetylated tubulin promotes the stability of microtubules.",
      "The stability of microtubules is linked to the promotion of cell motility.",
      "Tubulin acetylation is required for microtubule-dependent processes such as cell division and intracellular transport."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Tubulin acetylation is not strictly required for microtubule-dependent processes such as cell division and intracellular transport, but it can enhance the performance and regulation of these processes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 768,
    "user_query": "List available genetic multicolor cell labeling techiniques in Drosophila",
    "yulan-chat-2-13b-fp16_response": "There are several genetic multicolor cell labeling techniques available for Drosophila melanogaster, including:\n1. Fluorescent proteins: Drosophila melanogaster expresses endogenous fluorescent proteins, such as GFP (green fluorescent protein) and RFP (red fluorescent protein), which can be used for cell labeling.\n2. GFP+/+ and RFP+/+ flies: These flies express GFP and RFP, respectively, in all cells, and can be used to label cells in Drosophila.\n3. Gal4/UAS system: The Gal4/UAS system is a genetic tool that allows for the expression of specific genes in specific cells. By using Gal4-driven expression of fluorescent proteins, cells can be labeled in a multicolor fashion.\n4. LexA/LEX system: The LexA/LEX system is another genetic tool that allows for the expression of specific genes in specific cells. By using LexA-driven expression of fluorescent proteins, cells can be labeled in a multicolor fashion.\n5. FLP/FRT system: The FLP/FRT system is a genetic tool that allows for the site-specific recombination of DNA sequences. By using FLP-driven expression of fluorescent proteins, cells can be labeled in a multicolor fashion.\n6. MAR system: The MAR (mosaic analysis with a repressible cell marker) system is a genetic tool that allows for the labeling of specific cells in Drosophila. By using MAR-driven expression of fluorescent proteins, cells can be labeled in a multicolor fashion.\nThese techniques can be used to label cells in different ways, such as by expressing fluorescent proteins in specific cells, by expressing fluorescent proteins in specific developmental stages, or by expressing fluorescent proteins in specific tissues.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Drosophila melanogaster can express endogenous fluorescent proteins like GFP (green fluorescent protein) and RFP (red fluorescent protein) for cell labeling.\n2. GFP+/+ and RFP+/+ are types of Drosophila melanogaster that express GFP and RFP, respectively, in all cells.\n3. The Gal4/UAS system is used in Drosophila melanogaster to drive expression of specific genes in specific cells, including the expression of fluorescent proteins for cell labeling.\n4. The LexA/LEX system is a genetic tool used for expressing genes in specific cells of Drosophila, such as fluorescent proteins for cell labeling.\n5. The FLP/FRT genetic system allows for site-specific DNA recombination in Drosophila and can be used for cell labeling with fluorescent proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "Drosophila melanogaster can express endogenous fluorescent proteins like GFP (green fluorescent protein) and RFP (red fluorescent protein) for cell labeling.",
      "GFP+/+ and RFP+/+ are types of Drosophila melanogaster that express GFP and RFP, respectively, in all cells.",
      "The Gal4/UAS system is used in Drosophila melanogaster to drive expression of specific genes in specific cells, including the expression of fluorescent proteins for cell labeling.",
      "The LexA/LEX system is a genetic tool used for expressing genes in specific cells of Drosophila, such as fluorescent proteins for cell labeling.",
      "The FLP/FRT genetic system allows for site-specific DNA recombination in Drosophila and can be used for cell labeling with fluorescent proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Drosophila melanogaster does not naturally express endogenous fluorescent proteins like GFP or RFP; these proteins are derived from other organisms and must be artificially introduced into Drosophila for cell labeling.\n2. FALSE [correction]: The description GFP+/+ and RFP+/+ implies homozygous expression, but without genetic engineering, Drosophila melanogaster would not express GFP or RFP in any cells. These designations could be used for genetically engineered flies that carry these markers on both alleles of a certain gene locus.\n3. TRUE\n4. TRUE (assuming familiarity with Drosophila genetic engineering methodologies, LexA/LEXAOp system is analogous to the Gal4/UAS but uses a different set of proteins for gene expression; LEX system should likely read LexA/lexAop for clarity).\n5. TRUE (FLP/FRT system is indeed used for site-specific recombination in genetics including in Drosophila, which can be a part of cell labeling strategies, although the system itself is not inherently about fluorescent labeling without additional genetic constructs).",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 769,
    "user_query": "Which growth factors are known to be involved in the induction of EMT?",
    "yulan-chat-2-13b-fp16_response": "Several growth factors have been implicated in the induction of epithelial-mesenchymal transition (EMT), including:\n1. Transforming growth factor-beta (TGF-) - TGF- is a cytokine that promotes the development of mesenchymal cells and inhibits the growth of epithelial cells. It is involved in the regulation of cell growth, differentiation, and apoptosis.\n2. Fibroblast growth factor 2 (FGF2) - FGF2 is a growth factor that promotes the proliferation and migration of mesenchymal cells. It is involved in the regulation of embryonic development, wound healing, and tissue repair.\n3. Wnt signaling pathway - The Wnt signaling pathway is involved in the regulation of cell growth, differentiation, and polarity. It promotes the development of epithelial cells and inhibits the development of mesenchymal cells.\n4. Sonic hedgehog (SHH) - SHH is a signaling molecule that promotes the development of mesenchymal cells and inhibits the development of epithelial cells. It is involved in the regulation of embryonic development, tissue patterning, and cell differentiation.\n5. Hepatocyte growth factor (HGF) - HGF is a growth factor that promotes the proliferation and migration of mesenchymal cells. It is involved in the regulation of embryonic development, wound healing, and tissue repair.\nThese growth factors can act as signaling molecules to induce EMT by promoting the loss of epithelial characteristics and the acquisition of mesenchymal characteristics.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Transforming growth factor-beta (TGF-) is a cytokine that promotes the development of mesenchymal cells and inhibits the growth of epithelial cells.\n2. Fibroblast growth factor 2 (FGF2) is a growth factor involved in the proliferation and migration of mesenchymal cells, embryonic development, wound healing, and tissue repair.\n3. The Wnt signaling pathway is involved in regulating cell growth, differentiation, and polarity, and promotes the development of epithelial cells.\n4. Sonic hedgehog (SHH) is a signaling molecule that promotes the development of mesenchymal cells and is involved in embryonic development, tissue patterning, and cell differentiation.\n5. Hepatocyte growth factor (HGF) promotes the proliferation and migration of mesenchymal cells and is involved in embryonic development, wound healing, and tissue repair.",
    "yulan-chat-2-13b-fp16_fact": [
      "Transforming growth factor-beta (TGF-) is a cytokine that promotes the development of mesenchymal cells and inhibits the growth of epithelial cells.",
      "Fibroblast growth factor 2 (FGF2) is a growth factor involved in the proliferation and migration of mesenchymal cells, embryonic development, wound healing, and tissue repair.",
      "The Wnt signaling pathway is involved in regulating cell growth, differentiation, and polarity, and promotes the development of epithelial cells.",
      "Sonic hedgehog (SHH) is a signaling molecule that promotes the development of mesenchymal cells and is involved in embryonic development, tissue patterning, and cell differentiation.",
      "Hepatocyte growth factor (HGF) promotes the proliferation and migration of mesenchymal cells and is involved in embryonic development, wound healing, and tissue repair."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Sonic hedgehog (SHH) is a signaling molecule that is primarily known for its role in regulating the patterning of the embryonic neural tube, the anterior-posterior patterning of limbs, and the growth of digits. While SHH is involved in embryonic development, tissue patterning, and cell differentiation, it is more specifically associated with the patterning of neural elements rather than promoting the development of mesenchymal cells.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 774,
    "user_query": "Which histone modification discriminates between active and poised enhancers?",
    "yulan-chat-2-13b-fp16_response": "Histone modifications are an important mechanism for regulating gene expression, and they can be used to distinguish between active and poised enhancers. One of the most commonly studied histone modifications that is used to distinguish between active and poised enhancers is H3K4me3, which is a trimethylation of lysine 4 on the histone H3 protein. This modification is often found at active enhancers, where it is associated with high levels of gene expression. In contrast, H3K27ac, which is an acetylation of lysine 27 on histone H3, is often found at poised enhancers, where it is associated with lower levels of gene expression. Other histone modifications, such as H3K27me3 and H3K9me3, can also be used to distinguish between active and poised enhancers, but they are less well studied than H3K4me3 and H3K27ac.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. H3K4me3, which is the trimethylation of lysine 4 on histone H3, is associated with active enhancers.\n2. H3K27ac, the acetylation of lysine 27 on histone H3, is often found at poised enhancers.\n3. H3K4me3 is often associated with high levels of gene expression.\n4. H3K27ac is associated with lower levels of gene expression.\n5. H3K27me3 and H3K9me3 are other histone modifications that can be used to distinguish between active and poised enhancers.",
    "yulan-chat-2-13b-fp16_fact": [
      "H3K4me3, which is the trimethylation of lysine 4 on histone H3, is associated with active enhancers.",
      "H3K27ac, the acetylation of lysine 27 on histone H3, is often found at poised enhancers.",
      "H3K4me3 is often associated with high levels of gene expression.",
      "H3K27ac is associated with lower levels of gene expression.",
      "H3K27me3 and H3K9me3 are other histone modifications that can be used to distinguish between active and poised enhancers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: H3K4me3, the trimethylation of lysine 4 on histone H3, is associated with active promoters, not necessarily enhancers.\n2. FALSE [correction]: H3K27ac, the acetylation of lysine 27 on histone H3, is often found at active enhancers, not poised ones.\n3. TRUE\n4. FALSE [correction]: H3K27ac is associated with higher levels of gene expression, often marking active enhancers and promoters.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 776,
    "user_query": "What is the inheritance pattern of LiFraumeni syndrome?",
    "yulan-chat-2-13b-fp16_response": "LiFUMNeni syndrome is an inherited genetic disorder that is caused by mutations in the TP53 gene, which is a tumor suppressor gene. The inheritance pattern of LiFUMNeni syndrome is autosomal dominant, which means that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition.\nIn autosomal dominant inheritance, there is a 50% chance with each pregnancy that the child will inherit the mutated gene and therefore inherit the disorder. This means that if one parent has LiFUMNeni syndrome, each of their children has a 50% chance of inheriting the condition.\nIt is important to note that not all individuals who inherit a mutated TP53 gene will develop LiFUMNeni syndrome. Some people may have a higher risk of developing certain types of cancer, but they may not experience any symptoms or health problems related to the condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LiFraumeni syndrome is an inherited genetic disorder caused by mutations in the TP53 gene.\n2. The TP53 gene is a tumor suppressor gene.\n3. The inheritance pattern of LiFraumeni syndrome is autosomal dominant.\n4. A person only needs to inherit one copy of the mutated gene from one parent to develop the condition.\n5. Each child of a parent with LiFraumeni syndrome has a 50% chance of inheriting the disorder.",
    "yulan-chat-2-13b-fp16_fact": [
      "LiFraumeni syndrome is an inherited genetic disorder caused by mutations in the TP53 gene.",
      "The TP53 gene is a tumor suppressor gene.",
      "The inheritance pattern of LiFraumeni syndrome is autosomal dominant.",
      "A person only needs to inherit one copy of the mutated gene from one parent to develop the condition.",
      "Each child of a parent with LiFraumeni syndrome has a 50% chance of inheriting the disorder."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 781,
    "user_query": "Which are the synonyms of prostate-specific antigen?",
    "yulan-chat-2-13b-fp16_response": "Prostate-specific antigen (PSA) is a protein produced by the prostate gland in men. It is used as a marker for the presence of prostate cancer, and elevated levels of PSA in the blood can indicate the presence of the disease. There are no true synonyms for PSA, as it is a specific protein produced by the prostate gland. However, there are other proteins and markers that are related to PSA and may be used in conjunction with it to diagnose and monitor prostate cancer. These include:\n* Prostate-specific acid phosphatase (PSAP): an enzyme produced by the prostate gland that is used as a marker for prostate cancer.\n* Prostate-specific membrane antigen (PSMA): a protein produced by the prostate gland that is used as a marker for prostate cancer.\n* Free PSA: a fraction of the total PSA that is not bound to other proteins in the blood. It is used as a marker for the presence of prostate cancer and may be used to help determine the risk of the disease.\n* Total PSA: the total amount of PSA in the blood, including both free and bound PSA. It is used as a marker for the presence of prostate cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prostate-specific antigen (PSA) is produced by the prostate gland in men.\n2. Elevated levels of PSA in the blood can indicate the presence of prostate cancer.\n3. Prostate-specific acid phosphatase (PSAP) is an enzyme produced by the prostate gland and is used as a marker for prostate cancer.\n4. Prostate-specific membrane antigen (PSMA) is a protein produced by the prostate gland and is used as a marker for prostate cancer.\n5. Free PSA is used as a marker to help determine the risk of prostate cancer and is a fraction not bound to other proteins in the blood.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prostate-specific antigen (PSA) is produced by the prostate gland in men.",
      "Elevated levels of PSA in the blood can indicate the presence of prostate cancer.",
      "Prostate-specific acid phosphatase (PSAP) is an enzyme produced by the prostate gland and is used as a marker for prostate cancer.",
      "Prostate-specific membrane antigen (PSMA) is a protein produced by the prostate gland and is used as a marker for prostate cancer.",
      "Free PSA is used as a marker to help determine the risk of prostate cancer and is a fraction not bound to other proteins in the blood."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 783,
    "user_query": "What is the function of circular RNA?",
    "yulan-chat-2-13b-fp16_response": "Circular RNA (circRNA) is a type of RNA molecule that forms a covalently closed loop, without a 5' or 3' end. Unlike linear RNA molecules, which are typically processed from pre-mRNA by RNA polymerase to generate mature mRNA, circRNA is thought to be directly transcribed from the genome.\nThe function of circRNA is still not fully understood, but emerging evidence suggests that it plays a role in various biological processes, including gene regulation, post-transcriptional modification, and protein synthesis. CircRNA may also act as a sponge for microRNAs, preventing them from binding to their target mRNAs, and thus regulating gene expression at the post-transcriptional level.\nAdditionally, some studies have suggested that circRNA may be involved in the regulation of cell differentiation, development, and disease. However, further research is needed to fully understand the function and potential clinical implications of circRNA.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Circular RNA (circRNA) forms a covalently closed loop without a 5' or 3' end.\n2. Unlike linear RNA, circRNA is thought to be directly transcribed from the genome rather than processed from pre-mRNA.\n3. CircRNA is believed to play a role in gene regulation.\n4. CircRNA may act as a sponge for microRNAs to regulate gene expression at the post-transcriptional level.\n5. Research has suggested that circRNA might be involved in the regulation of cell differentiation, development, and disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Circular RNA (circRNA) forms a covalently closed loop without a 5' or 3' end.",
      "Unlike linear RNA, circRNA is thought to be directly transcribed from the genome rather than processed from pre-mRNA.",
      "CircRNA is believed to play a role in gene regulation.",
      "CircRNA may act as a sponge for microRNAs to regulate gene expression at the post-transcriptional level.",
      "Research has suggested that circRNA might be involved in the regulation of cell differentiation, development, and disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Unlike linear RNA, circRNA is typically formed by back-splicing, a process where a downstream splice donor site is joined to an upstream splice acceptor site, allowing it to be processed from pre-mRNA.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "yulan-chat-2-13b-fp16_response": "There are several biomedical question answering systems available, including:\n1. BioASQ: A system that provides answers to biomedical questions using natural language processing and machine learning techniques.\n2. IBM Watson: A system that uses artificial intelligence to answer biomedical questions and provide insights from large amounts of data.\n3. MedCog: A system that uses natural language processing and machine learning to answer biomedical questions and extract information from medical texts.\n4. SIFT-FS: A system that uses machine learning to predict the effects of genetic variants on human health.\n5. TRIPOD: A system that uses natural language processing and machine learning to extract information from biomedical texts and answer questions.\n6. YODA: A system that uses natural language processing and machine learning to answer biomedical questions and extract information from electronic health records.\n7. BioPortal: A system that provides access to biomedical knowledge and data through a web portal and APIs.\n8. OpenBiomed: An open-source platform for biomedical data integration and analysis.\n9. Clinical Genomics Annotation Tool (CGAT): A system that uses machine learning to annotate genomic variants and predict their effects on human health.\n10. DrugBank: A database of drug information that can be accessed through a web portal or API.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. BioASQ is a biomedical question answering system utilizing natural language processing and machine learning techniques.\n2. IBM Watson is capable of answering biomedical questions and can provide insights by analyzing large amounts of data.\n3. MedCog is a system using natural language processing and machine learning to answer biomedical questions.\n4. SIFT-FS is a system that applies machine learning to predict the impact of genetic variants on human health.\n5. DrugBank is a database providing drug information accessible via a web portal or API.",
    "yulan-chat-2-13b-fp16_fact": [
      "BioASQ is a biomedical question answering system utilizing natural language processing and machine learning techniques.",
      "IBM Watson is capable of answering biomedical questions and can provide insights by analyzing large amounts of data.",
      "MedCog is a system using natural language processing and machine learning to answer biomedical questions.",
      "SIFT-FS is a system that applies machine learning to predict the impact of genetic variants on human health.",
      "DrugBank is a database providing drug information accessible via a web portal or API."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "yulan-chat-2-13b-fp16_response": "The betalain pigment pathway in plants is activated by a group of transcription factors known as the \"BETALAIN REGULATORY FACTORS\" (BRFs). These transcription factors are responsible for the regulation of the genes involved in the biosynthesis of betalains, which are pigments that give red, purple, and yellow colors to certain plant tissues. The BRFs are a family of proteins that bind to specific DNA sequences and activate or repress the expression of target genes. In the betalain pathway, the BRFs activate the expression of genes encoding enzymes involved in the biosynthesis of betalains, leading to the production of pigments in plant tissues.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The betalain pigment pathway in plants is activated by transcription factors known as \"BETALAIN REGULATORY FACTORS\" (BRFs).\n2. Betalains are pigments that give red, purple, and yellow colors to certain plant tissues.\n3. BRFs are responsible for the regulation of genes involved in the biosynthesis of betalains.\n4. The BRFs bind to specific DNA sequences and activate or repress the expression of target genes.\n5. In the betalain pathway, the BRFs specifically activate the expression of genes encoding enzymes involved in the biosynthesis of betalains.",
    "yulan-chat-2-13b-fp16_fact": [
      "The betalain pigment pathway in plants is activated by transcription factors known as \"BETALAIN REGULATORY FACTORS\" (BRFs).",
      "Betalains are pigments that give red, purple, and yellow colors to certain plant tissues.",
      "BRFs are responsible for the regulation of genes involved in the biosynthesis of betalains.",
      "The BRFs bind to specific DNA sequences and activate or repress the expression of target genes.",
      "In the betalain pathway, the BRFs specifically activate the expression of genes encoding enzymes involved in the biosynthesis of betalains."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN \n2. TRUE \n3. TRUE \n4. TRUE \n5. TRUE\n\nPlease note that while statements 2, 3, 4, and 5 are true based on general knowledge about transcription factors and the typical patterns of plant pigment biosynthesis, the specific naming of \"BETALAIN REGULATORY FACTORS\" (BRFs) may not be standard terminology or could be fictional for this scenario. As such, the validity of statement 1 and the claim that this specific term is used to describe transcription factors relevant to the betalain pigment pathway cannot be confirmed without specific literature or scientific references.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 796,
    "user_query": "Which is the most well-accepted method for Down syndrome non-invasive prenatal diagnosis?",
    "yulan-chat-2-13b-fp16_response": "The most well-accepted method for non-invasive prenatal diagnosis (NIPD) of Down syndrome is cell-free DNA (cfDNA) analysis. This involves analyzing the DNA present in the mother's blood to detect any chromosomal abnormalities in the fetus. The test can be performed as early as 10 weeks gestation and is considered highly accurate. It is important to note that NIPD is not a definitive diagnosis and confirmatory testing with chorionic villus sampling (CVS) or amniocentesis may be necessary.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cell-free DNA (cfDNA) analysis is the most well-accepted method for non-invasive prenatal diagnosis of Down syndrome.\n2. cfDNA analysis involves analyzing DNA in the mother's blood to detect fetal chromosomal abnormalities.\n3. The cfDNA test for Down syndrome can be performed as early as 10 weeks gestation.\n4. The cfDNA test is considered highly accurate for detecting Down syndrome.\n5. Confirmatory testing with chorionic villus sampling (CVS) or amniocentesis may be necessary after a cfDNA test.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cell-free DNA (cfDNA) analysis is the most well-accepted method for non-invasive prenatal diagnosis of Down syndrome.",
      "cfDNA analysis involves analyzing DNA in the mother's blood to detect fetal chromosomal abnormalities.",
      "The cfDNA test for Down syndrome can be performed as early as 10 weeks gestation.",
      "The cfDNA test is considered highly accurate for detecting Down syndrome.",
      "Confirmatory testing with chorionic villus sampling (CVS) or amniocentesis may be necessary after a cfDNA test."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Cell-free DNA (cfDNA) analysis is indeed a well-accepted method for non-invasive prenatal diagnosis of Down syndrome, though not necessarily \"the most\" well-accepted as this is subjective and there may be other competing methodologies or opinions in the medical community.\n2. TRUE: cfDNA analysis does involve analyzing DNA found in the mother's blood to determine fetal chromosomal abnormalities, including trisomies such as Down syndrome.\n3. TRUE: The cfDNA test for Down syndrome can indeed be performed as early as 10 weeks of gestation.\n4. TRUE: The cfDNA test is considered highly accurate for detecting Down syndrome, though no test is 100% accurate.\n5. TRUE: Confirmatory testing with chorionic villus sampling (CVS) or amniocentesis is recommended after a positive cfDNA test result to confirm the diagnosis, as cfDNA tests are not diagnostic.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 799,
    "user_query": "What is the average diameter of intermediate filaments?",
    "yulan-chat-2-13b-fp16_response": "Intermediate filaments are a type of protein fiber that make up the cytoskeleton of cells. They are found in a variety of cell types, including keratinocytes (skin cells), muscle cells, and neurons. The diameter of intermediate filaments can vary depending on the cell type and the specific protein that makes up the filaments. In general, intermediate filaments are larger than microtubules and actin filaments, but smaller than the nuclear lamina. The average diameter of intermediate filaments is typically around 7-8 nanometers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Intermediate filaments are a type of protein fiber that makes up the cytoskeleton of cells.\n2. Intermediate filaments are found in a variety of cell types, including keratinocytes, muscle cells, and neurons.\n3. Intermediate filaments are generally larger than microtubules and actin filaments.\n4. Intermediate filaments are smaller than the nuclear lamina.\n5. The average diameter of intermediate filaments is typically around 7-8 nanometers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Intermediate filaments are a type of protein fiber that makes up the cytoskeleton of cells.",
      "Intermediate filaments are found in a variety of cell types, including keratinocytes, muscle cells, and neurons.",
      "Intermediate filaments are generally larger than microtubules and actin filaments.",
      "Intermediate filaments are smaller than the nuclear lamina.",
      "The average diameter of intermediate filaments is typically around 7-8 nanometers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Intermediate filaments are generally smaller than microtubules but larger than actin filaments.\n4. FALSE [correction]: The nuclear lamina is composed of a type of intermediate filament, so intermediate filaments are not smaller but are actually a part of the structure of the nuclear lamina.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 805,
    "user_query": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?",
    "yulan-chat-2-13b-fp16_response": "One intermediate filament protein that can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone is NeuN (neuronal nuclei). NeuN is a neuronal-specific protein that is expressed in most neuronal cell types, including neuronal precursor cells of the subventricular zone. It can be used as a pan-neuronal marker to identify and isolate neuronal precursor cells from other cell types in the brain. However, it should be noted that NeuN alone cannot be used to definitively identify all neuronal precursor cells, as some subpopulations of these cells may not express NeuN.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NeuN (neuronal nuclei) is an intermediate filament protein that can be used as a marker of neuronal precursor cells.\n2. NeuN is expressed in most neuronal cell types.\n3. NeuN is a pan-neuronal marker utilized to identify and isolate neuronal precursor cells from other brain cell types.\n4. Some subpopulations of neuronal precursor cells may not express NeuN.",
    "yulan-chat-2-13b-fp16_fact": [
      "NeuN (neuronal nuclei) is an intermediate filament protein that can be used as a marker of neuronal precursor cells.",
      "NeuN is expressed in most neuronal cell types.",
      "NeuN is a pan-neuronal marker utilized to identify and isolate neuronal precursor cells from other brain cell types.",
      "Some subpopulations of neuronal precursor cells may not express NeuN."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: NeuN (neuronal nuclei) is not an intermediate filament protein; it is a protein that is believed to be involved in neuronal DNA organization or RNA splicing.\n2. TRUE\n3. FALSE [correction]: NeuN is a pan-neuronal marker utilized to identify neurons, but not specifically for isolating neuronal precursor cells, as it is not expressed by undifferentiated neural precursors.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 806,
    "user_query": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?",
    "yulan-chat-2-13b-fp16_response": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is called DNA methyltransferase.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DNA methyltransferase is the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation.",
    "yulan-chat-2-13b-fp16_fact": [
      "DNA methyltransferase is the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 807,
    "user_query": "Is transcapillary  albumin escape altered in diabetic patients?",
    "yulan-chat-2-13b-fp16_response": "Transcapillary albumin escape refers to the passage of albumin, a type of protein, from the bloodstream into the urine, which can occur in diabetic patients. In diabetes, high blood sugar levels can damage the blood vessels and nerves that control the flow of fluids in the body, leading to increased permeability of the capillary walls and allowing albumin to leak into the urine. This can be a sign of diabetic nephropathy, a complication of diabetes that can lead to kidney damage and failure. However, the exact extent and mechanisms of transcapillary albumin escape in diabetic patients are still being studied and may vary depending on the individual's disease severity and other factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Transcapillary albumin escape refers to the passage of albumin from the bloodstream into the urine.\n2. Diabetic patients may experience transcapillary albumin escape.\n3. High blood sugar levels in diabetics can damage blood vessels and nerves controlling fluid flow in the body.\n4. This damage can lead to increased permeability of the capillary walls.\n5. Transcapillary albumin escape is a sign of diabetic nephropathy, which can lead to kidney damage and failure.",
    "yulan-chat-2-13b-fp16_fact": [
      "Transcapillary albumin escape refers to the passage of albumin from the bloodstream into the urine.",
      "Diabetic patients may experience transcapillary albumin escape.",
      "High blood sugar levels in diabetics can damage blood vessels and nerves controlling fluid flow in the body.",
      "This damage can lead to increased permeability of the capillary walls.",
      "Transcapillary albumin escape is a sign of diabetic nephropathy, which can lead to kidney damage and failure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Transcapillary albumin escape refers to the passage of albumin from the bloodstream across the capillary walls into the interstitial space, not specifically into the urine.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 812,
    "user_query": "Which cell type has the protein Chromogranin A as marker?",
    "yulan-chat-2-13b-fp16_response": "Chromogranin A (CGA) is a protein that is expressed in several different types of cells, including:\n1. Neuroendocrine cells: These cells are found in the pancreas, gastrointestinal tract, and lung, and they produce hormones and neurotransmitters.\n2. Enteroendocrine cells: These cells are found in the gastrointestinal tract and produce hormones and peptides that regulate digestive functions.\n3. Neurons: CGA is also expressed in some neurons, particularly those that are involved in the regulation of hormone secretion.\nIn summary, CGA is a marker for neuroendocrine and enteroendocrine cells, as well as some neurons.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chromogranin A is expressed in neuroendocrine cells.\n2. Neuroendocrine cells that express Chromogranin A are found in the pancreas, gastrointestinal tract, and lung.\n3. Enteroendocrine cells, which produce hormones and peptides that regulate digestive functions, express Chromogranin A.\n4. Chromogranin A is a marker for enteroendocrine cells located in the gastrointestinal tract.\n5. Some neurons, especially those involved in hormone secretion regulation, express Chromogranin A.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chromogranin A is expressed in neuroendocrine cells.",
      "Neuroendocrine cells that express Chromogranin A are found in the pancreas, gastrointestinal tract, and lung.",
      "Enteroendocrine cells, which produce hormones and peptides that regulate digestive functions, express Chromogranin A.",
      "Chromogranin A is a marker for enteroendocrine cells located in the gastrointestinal tract.",
      "Some neurons, especially those involved in hormone secretion regulation, express Chromogranin A."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nChromogranin A is indeed expressed in neuroendocrine cells, which are found in various body systems including the pancreas, gastrointestinal tract, and lung. Enteroendocrine cells are a type of neuroendocrine cell located in the gastrointestinal tract that produce hormones and peptides, and they express Chromogranin A, which acts as a marker for these cells. Additionally, certain neurons that are involved in the regulation of hormone secretion also express Chromogranin A.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 813,
    "user_query": "Does a selective sweep increase genetic variation?",
    "yulan-chat-2-13b-fp16_response": "A selective sweep is a process in which a particular allele or a group of alleles becomes fixed in a population due to natural selection, leading to a decrease in genetic variation in the region of the genome associated with the selected allele(s). This is because individuals with the selected allele(s) have a reproductive advantage and are more likely to pass on their alleles to the next generation, leading to an increase in the frequency of the selected allele(s) and a decrease in the frequency of other alleles in the region.\nTherefore, a selective sweep does not necessarily increase genetic variation, but rather can lead to a decrease in genetic variation in the region of the genome associated with the selected allele(s). However, it is important to note that selective sweeps can occur in different contexts and under different selection pressures, and their effects on genetic variation can vary depending on the specifics of the situation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A selective sweep leads to a particular allele or group of alleles becoming fixed in a population.\n2. The fixation occurs due to natural selection.\n3. A selective sweep leads to a decrease in genetic variation in the region of the genome associated with the selected allele(s).\n4. Individuals with the selected allele(s) have a reproductive advantage, allowing them to pass on their alleles more frequently.\n5. A selective sweep does not increase genetic variation; it can decrease it in certain genomic regions.",
    "yulan-chat-2-13b-fp16_fact": [
      "A selective sweep leads to a particular allele or group of alleles becoming fixed in a population.",
      "The fixation occurs due to natural selection.",
      "A selective sweep leads to a decrease in genetic variation in the region of the genome associated with the selected allele(s).",
      "Individuals with the selected allele(s) have a reproductive advantage, allowing them to pass on their alleles more frequently.",
      "A selective sweep does not increase genetic variation; it can decrease it in certain genomic regions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 814,
    "user_query": "Which disease phenotypes are associated to PRPS1 mutations?",
    "yulan-chat-2-13b-fp16_response": "PRPS1 mutations are associated with a group of rare genetic disorders known as hereditary spastic paraplegia (HSP). HSP is a neurological disorder characterized by progressive spasticity (stiffness and difficulty moving) in the lower limbs, which eventually spreads to the upper limbs and can result in difficulty walking, balance problems, and bladder and bowel dysfunction.\nThere are several different types of HSP, which are classified based on the underlying genetic cause. PRPS1 mutations are associated with a specific type of HSP known as HSP type 1, which is also sometimes called \"spastic paraplegia type 1.\"\nIn addition to spasticity, individuals with PRPS1 mutations may also experience other neurological symptoms, such as muscle weakness, ataxia (lack of coordination), and dysarthria (difficulty with speech). Some individuals with PRPS1 mutations may also develop other neurological conditions, such as dementia or epilepsy.\nIt is important to note that HSP is a complex disorder, and the specific symptoms and disease progression can vary widely among individuals with the same genetic cause. If you have questions about HSP or PRPS1 mutations, it is best to speak with a healthcare professional who can provide more information and guidance.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PRPS1 mutations are associated with a group of rare genetic disorders known as hereditary spastic paraplegia (HSP).\n2. HSP is characterized by progressive spasticity in the lower limbs.\n3. PRPS1 mutations lead to a specific type of HSP known as HSP type 1 or spastic paraplegia type 1.\n4. Individuals with PRPS1 mutations may experience symptoms such as muscle weakness, ataxia, and dysarthria.\n5. Some individuals with PRPS1 mutations can develop other neurological conditions, such as dementia or epilepsy.",
    "yulan-chat-2-13b-fp16_fact": [
      "PRPS1 mutations are associated with a group of rare genetic disorders known as hereditary spastic paraplegia (HSP).",
      "HSP is characterized by progressive spasticity in the lower limbs.",
      "PRPS1 mutations lead to a specific type of HSP known as HSP type 1 or spastic paraplegia type 1.",
      "Individuals with PRPS1 mutations may experience symptoms such as muscle weakness, ataxia, and dysarthria.",
      "Some individuals with PRPS1 mutations can develop other neurological conditions, such as dementia or epilepsy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: PRPS1 mutations are associated with a variety of disorders, including Arts syndrome, Charcot-Marie-Tooth disease, and nonsyndromic sensorineural deafness, but not specifically hereditary spastic paraplegia (HSP).\n2. TRUE\n3. FALSE [correction]: PRPS1 mutations are not specifically linked to HSP type 1 but to several X-linked disorders with some features that might overlap with spastic paraplegia.\n4. TRUE - Muscle weakness and ataxia can be symptoms associated with PRPS1 mutations, though ataxia is more related to the cerebellar function, and PRPS1-related disorders can affect various parts of the nervous system. Dysarthria can also result from these disorders.\n5. TRUE - Some individuals with mutations in the PRPS1 gene can present neurological conditions such as intellectual disability, which might encompass symptoms similar to dementia, and sensory deficits, with some patients also experiencing seizures.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 815,
    "user_query": "Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that antioxidant supplements may have a protective effect against the development of coronary artery disease (CAD). However, the evidence is not definitive and more research is needed to fully understand the potential benefits and risks of antioxidant supplementation in this population.\nSome studies have suggested that antioxidants, such as vitamins C and E, may help to reduce the risk of CAD by protecting against the damage caused by free radicals, which are unstable molecules that can damage cells and contribute to the development of chronic diseases.\nHowever, other studies have found that antioxidant supplementation may not have a significant effect on the risk of CAD, or may even increase the risk in some cases. For example, a large randomized trial known as the Antioxidants and Coronary Artery Disease (ORACLE) study found that vitamin E supplementation did not significantly reduce the risk of CAD in patients with heart disease.\nOverall, the evidence on the use of antioxidant supplements in patients at risk for CAD is mixed, and more research is needed to fully understand their potential benefits and risks. It is important to speak with a healthcare provider before starting any new supplement regimen, as they can help to determine whether antioxidant supplements are appropriate for an individual's specific health needs and risks.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Some studies have suggested that antioxidants, such as vitamins C and E, may help to reduce the risk of coronary artery disease (CAD) by protecting against damage caused by free radicals.\n2. The evidence regarding the protective effect of antioxidant supplements against the development of CAD is not definitive.\n3. A large randomized trial named the Antioxidants and Coronary Artery Disease (ORACLE) study found that vitamin E supplementation did not significantly reduce the risk of CAD in patients with heart disease.\n4. The overall evidence on the use of antioxidant supplements in patients at risk for CAD is mixed.\n5. It is recommended to speak with a healthcare provider before starting any new supplement regimen.",
    "yulan-chat-2-13b-fp16_fact": [
      "Some studies have suggested that antioxidants, such as vitamins C and E, may help to reduce the risk of coronary artery disease (CAD) by protecting against damage caused by free radicals.",
      "The evidence regarding the protective effect of antioxidant supplements against the development of CAD is not definitive.",
      "A large randomized trial named the Antioxidants and Coronary Artery Disease (ORACLE) study found that vitamin E supplementation did not significantly reduce the risk of CAD in patients with heart disease.",
      "The overall evidence on the use of antioxidant supplements in patients at risk for CAD is mixed.",
      "It is recommended to speak with a healthcare provider before starting any new supplement regimen."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN (The statement refers to a specific trial named ORACLE, but without additional context it is not possible to verify the results of this trial. Also, the name of the study might be fictional or incorrect.)\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 821,
    "user_query": "Is K-63 linked protein ubiquitination related to proteasomal degradation?",
    "yulan-chat-2-13b-fp16_response": "Yes, K-63 linked protein ubiquitination is related to proteasomal degradation. Ubiquitination is a post-translational modification in which a ubiquitin protein is covalently attached to a lysine residue of a target protein. This modification marks the target protein for degradation by the proteasome, a large protein complex that functions as a waste disposal system in cells.\nK-63 linked ubiquitination is a specific type of ubiquitination in which a lysine residue at position 63 of the target protein is ubiquitinated. This type of ubiquitination is commonly used to target proteins for degradation by the proteasome. Once a protein is ubiquitinated, it is transported to the proteasome, where it is broken down into smaller peptides that are then degraded further by the proteasome or other proteolytic systems in the cell.\nTherefore, K-63 linked protein ubiquitination is an important mechanism for regulating protein turnover and maintaining cellular homeostasis by targeting proteins for degradation by the proteasome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. K-63 linked protein ubiquitination is related to proteasomal degradation.\n2. Ubiquitination involves a ubiquitin protein being covalently attached to a lysine residue of a target protein.\n3. This post-translational modification marks proteins for degradation by the proteasome.\n4. K-63 linked ubiquitination specifically targets a lysine residue at position 63 on the target protein.\n5. The proteasome functions as a waste disposal system in cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "K-63 linked protein ubiquitination is related to proteasomal degradation.",
      "Ubiquitination involves a ubiquitin protein being covalently attached to a lysine residue of a target protein.",
      "This post-translational modification marks proteins for degradation by the proteasome.",
      "K-63 linked ubiquitination specifically targets a lysine residue at position 63 on the target protein.",
      "The proteasome functions as a waste disposal system in cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: K-63 linked protein ubiquitination is typically associated with non-degradative processes such as DNA repair, signaling pathways, and endocytosis, not primarily proteasomal degradation, which is usually associated with K-48 ubiquitination.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 822,
    "user_query": "Could transcription factors act as cell-cell signalling molecules?",
    "yulan-chat-2-13b-fp16_response": "Transcription factors are proteins that regulate the expression of genes by binding to specific DNA sequences. While transcription factors do not typically function as traditional cell-cell signaling molecules, they can play a role in cell-cell communication by regulating the expression of genes involved in signaling pathways.\nFor example, transcription factors can bind to the promoter regions of genes involved in signaling pathways and control their expression. This can ultimately affect the ability of cells to receive and respond to signals from other cells. Additionally, transcription factors can also regulate the expression of genes involved in the formation and maintenance of cell-cell junctions, which are important for cell-cell communication.\nIn summary, while transcription factors are not typically thought of as cell-cell signaling molecules, they can play a role in regulating the expression of genes involved in signaling pathways and cell-cell communication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences.\n2. Transcription factors traditionally do not function as cell-cell signaling molecules.\n3. They can influence cell-cell communication by regulating genes involved in signaling pathways.\n4. Transcription factors can bind to promoter regions of genes to control their expression.\n5. They can regulate the expression of genes related to the formation and maintenance of cell-cell junctions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences.",
      "Transcription factors traditionally do not function as cell-cell signaling molecules.",
      "They can influence cell-cell communication by regulating genes involved in signaling pathways.",
      "Transcription factors can bind to promoter regions of genes to control their expression.",
      "They can regulate the expression of genes related to the formation and maintenance of cell-cell junctions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 828,
    "user_query": "Is muscle lim protein (MLP) involved in cardiomyopathies?",
    "yulan-chat-2-13b-fp16_response": "Muscle lim protein (MLP) is a protein that is involved in the regulation of muscle growth and development. It has been suggested that MLP may be involved in the development of certain types of cardiomyopathy, which are diseases that affect the heart muscle. However, more research is needed to fully understand the role of MLP in cardiomyopathy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Muscle lim protein (MLP) is involved in the regulation of muscle growth and development.\n2. MLP may be involved in the development of certain types of cardiomyopathy.\n3. Cardiomyopathy refers to diseases that affect the heart muscle.\n4. There is a need for more research to understand the role of MLP in cardiomyopathy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Muscle lim protein (MLP) is involved in the regulation of muscle growth and development.",
      "MLP may be involved in the development of certain types of cardiomyopathy.",
      "Cardiomyopathy refers to diseases that affect the heart muscle.",
      "There is a need for more research to understand the role of MLP in cardiomyopathy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 834,
    "user_query": "What is Tn-seq?",
    "yulan-chat-2-13b-fp16_response": "Tn-seq (also known as targeted nucleotide sequencing) is a type of DNA sequencing technology that is used to analyze specific regions of the genome. It is a targeted sequencing approach that focuses on specific genomic regions of interest, rather than sequencing the entire genome.\nTn-seq typically involves hybridizing a specific DNA probe to the region of interest in the genome, followed by nucleotide sequencing of the bound DNA. This allows for the identification of specific DNA sequences within the targeted region, as well as the detection of genetic variations such as single nucleotide polymorphisms (SNPs) and copy number variations (CNVs).\nTn-seq has a number of potential applications, including the identification of genetic variants associated with disease, the analysis of gene expression, and the study of epigenetic modifications. It can also be used to study specific genomic regions in more detail than is possible with whole-genome sequencing, allowing for a more focused analysis of specific genes or regulatory regions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tn-seq is a type of DNA sequencing technology used to analyze specific regions of the genome.\n2. It is a targeted sequencing approach that focuses on specific genomic regions of interest.\n3. Tn-seq involves hybridizing a specific DNA probe to the region of interest in the genome.\n4. Tn-seq allows for the identification of specific DNA sequences within the targeted region and the detection of genetic variations such as SNPs and CNVs.\n5. Tn-seq can be used for identifying genetic variants associated with disease, analyzing gene expression, and studying epigenetic modifications.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tn-seq is a type of DNA sequencing technology used to analyze specific regions of the genome.",
      "It is a targeted sequencing approach that focuses on specific genomic regions of interest.",
      "Tn-seq involves hybridizing a specific DNA probe to the region of interest in the genome.",
      "Tn-seq allows for the identification of specific DNA sequences within the targeted region and the detection of genetic variations such as SNPs and CNVs.",
      "Tn-seq can be used for identifying genetic variants associated with disease, analyzing gene expression, and studying epigenetic modifications."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Tn-seq is not a type of DNA sequencing technology used to analyze specific regions of the genome; it is a technique used to study gene function and essentiality by transposon insertion mutagenesis.\n2. FALSE [correction]: Tn-seq is not a targeted sequencing approach that focuses on specific genomic regions of interest; it is a genome-wide mutagenesis approach used to identify genes that are essential for the survival or fitness of an organism under certain conditions.\n3. FALSE [correction]: Tn-seq does not involve hybridizing a specific DNA probe to the region of interest in the genome; it involves inserting transposons randomly into the genome and sequencing the junctions between the transposons and the host genome to identify which genes have been disrupted.\n4. FALSE [correction]: Tn-seq does not allow for the identification of specific DNA sequences within the targeted region like SNPs and CNVs; it is used to determine the importance of genes based on the survival and fitness of mutants in a population after transposon insertions.\n5. FALSE [correction]: Tn-seq is mainly used for identifying essential genes and studying functional genomics in bacteria; while it can contribute to understanding genetic factors that affect fitness and survival, it is not typically used for identifying genetic variants associated with disease, analyzing gene expression, or studying epigenetic modifications in the context described.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 836,
    "user_query": "Is there any functional association during viral replication between flaviviridae viral RNA depended RNA polymerase and viral helicase?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is a functional association between the flaviviridae viral RNA-dependent RNA polymerase (RdRp) and the viral helicase during viral replication. The helicase, which is a viral protein, helps the RdRp to unwind the viral RNA genome and to initiate replication by synthesizing new copies of the viral RNA. The RdRp then uses these new copies as templates to produce more viral RNA and proteins, which are required for viral replication and virion assembly. The helicase and RdRp work together to ensure that the viral RNA genome is replicated accurately and efficiently, which is essential for the successful replication of the virus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Flaviviridae viral RNA-dependent RNA polymerase (RdRp) has a functional association with viral helicase during viral replication.\n2. The viral helicase helps the RdRp to unwind the viral RNA genome.\n3. Viral RNA replication is initiated by the synthesis of new copies of viral RNA by the RdRp.\n4. The RdRp uses the new copies of viral RNA as templates to produce more viral RNA and proteins.\n5. The helicase and RdRp work together to replicate the viral RNA genome accurately and efficiently.",
    "yulan-chat-2-13b-fp16_fact": [
      "Flaviviridae viral RNA-dependent RNA polymerase (RdRp) has a functional association with viral helicase during viral replication.",
      "The viral helicase helps the RdRp to unwind the viral RNA genome.",
      "Viral RNA replication is initiated by the synthesis of new copies of viral RNA by the RdRp.",
      "The RdRp uses the new copies of viral RNA as templates to produce more viral RNA and proteins.",
      "The helicase and RdRp work together to replicate the viral RNA genome accurately and efficiently."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Flaviviridae viral RNA-dependent RNA polymerase (RdRp) does have a functional association with viral helicase during viral replication, which is a characteristic mechanism in viruses of this family.\n2. TRUE: The viral helicase indeed helps the RNA-dependent RNA polymerase to unwind the viral RNA genome, which is an essential step in viral replication.\n3. TRUE: Viral RNA replication is initiated by the synthesis of new copies of viral RNA by the RdRp, starting with negative-strand RNA synthesis which is then used as a template for new positive-strand genomes.\n4. TRUE: The RdRp indeed uses these new copies of viral RNA as templates to produce more viral RNA, which will be packaged into new virions, as well as mRNA for viral protein production.\n5. TRUE: The helicase and RdRp work together to replicate the viral RNA genome, and their interactions are important for accurate and efficient replication of the viral genome.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 838,
    "user_query": "Which is the prevalence of cystic fibrosis in the human population?",
    "yulan-chat-2-13b-fp16_response": "Cystic fibrosis (CF) is a genetic disorder that affects the respiratory, digestive, and reproductive systems. It is caused by mutations in the CFTR gene, which codes for a protein that regulates the movement of salt and water in and out of cells.\nThe prevalence of cystic fibrosis in the human population varies depending on the population being studied. In the United States, for example, it is estimated that one in every 3,000 to 3,500 people has cystic fibrosis. This means that about 70,000 people in the United States have the condition.\nCystic fibrosis is more common in people of European ancestry, with the highest prevalence rates found in people of Northern European descent. However, it can also affect people of other racial and ethnic backgrounds.\nOverall, cystic fibrosis is a relatively rare condition, but it is a serious and life-threatening one that requires ongoing medical care and management.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cystic fibrosis (CF) is a genetic disorder that affects the respiratory, digestive, and reproductive systems.\n2. It is caused by mutations in the CFTR gene.\n3. The estimated prevalence of cystic fibrosis in the United States is one in every 3,000 to 3,500 people.\n4. It is estimated that about 70,000 people in the United States have cystic fibrosis.\n5. Cystic fibrosis is more common in people of European ancestry, particularly in those of Northern European descent.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cystic fibrosis (CF) is a genetic disorder that affects the respiratory, digestive, and reproductive systems.",
      "It is caused by mutations in the CFTR gene.",
      "The estimated prevalence of cystic fibrosis in the United States is one in every 3,000 to 3,500 people.",
      "It is estimated that about 70,000 people in the United States have cystic fibrosis.",
      "Cystic fibrosis is more common in people of European ancestry, particularly in those of Northern European descent."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The estimated prevalence of cystic fibrosis in the United States is approximately one in every 2,500 to 3,500 Caucasian newborns, but this can vary among different populations.\n4. FALSE [correction]: As of the knowledge cutoff in 2023, it's estimated that about 30,000 people in the United States have cystic fibrosis, though this number can fluctuate with new diagnoses and treatments.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 844,
    "user_query": "Is there a genome-wide technique for the detection of R-loop formation?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are genome-wide techniques for the detection of R-loop formation. One such technique is called RNA immunoprecipitation sequencing (RIP-seq), which is used to identify RNA-protein interactions, including those involving R-loop formation. RIP-seq involves immunoprecipitating RNA using an antibody specific to a particular RNA-binding protein, followed by sequencing of the associated RNA fragments. This can reveal RNA-binding protein binding sites, including those at R-loop formation sites. Other techniques that can be used to detect R-loop formation include DNA methylation analysis, chromatin immunoprecipitation sequencing (ChIP-seq), and single-stranded DNA sequencing.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNA immunoprecipitation sequencing (RIP-seq) is a technique used to identify RNA-protein interactions, including R-loop formation.\n2. RIP-seq includes using an antibody specific to a particular RNA-binding protein followed by sequencing of associated RNA fragments.\n3. RIP-seq can reveal RNA-binding protein binding sites at R-loop formation sites.\n4. DNA methylation analysis is a technique that can be used to detect R-loop formation.\n5. Chromatin immunoprecipitation sequencing (ChIP-seq) can be used to detect R-loop formation.",
    "yulan-chat-2-13b-fp16_fact": [
      "RNA immunoprecipitation sequencing (RIP-seq) is a technique used to identify RNA-protein interactions, including R-loop formation.",
      "RIP-seq includes using an antibody specific to a particular RNA-binding protein followed by sequencing of associated RNA fragments.",
      "RIP-seq can reveal RNA-binding protein binding sites at R-loop formation sites.",
      "DNA methylation analysis is a technique that can be used to detect R-loop formation.",
      "Chromatin immunoprecipitation sequencing (ChIP-seq) can be used to detect R-loop formation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: DNA methylation analysis is a technique that can be used to study modifications of DNA, not directly to detect R-loop formation.\n5. FALSE [correction]: Chromatin immunoprecipitation sequencing (ChIP-seq) is used to investigate protein-DNA interactions, not directly to detect R-loop formation. However, there are modified versions of ChIP, like DNA-RNA immunoprecipitation (DRIP), which can be used to detect R-loops.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 847,
    "user_query": "Is transcription-associated mutagenesis (TAM) related to gene expression levels?",
    "yulan-chat-2-13b-fp16_response": "Transcription-associated mutagenesis (TAM) is a process by which mutations occur in the DNA sequence of a gene during transcription. These mutations can be caused by errors in DNA replication or by the action of transcription-associated repair mechanisms.\nThere is some evidence to suggest that TAM can affect gene expression levels. For example, mutations that occur in the promoter region of a gene can affect the binding of transcription factors and alter the rate of transcription of the gene. Similarly, mutations that occur in the coding region of a gene can affect the protein sequence or stability of the resulting protein, which can in turn affect the activity of the protein and the overall expression of the gene.\nHowever, the relationship between TAM and gene expression is complex and can depend on a variety of factors, including the location and type of mutation, the presence of other genetic or epigenetic modifications, and the cellular context in which the mutation occurs. Therefore, it is difficult to make generalizations about the effects of TAM on gene expression levels.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Transcription-associated mutagenesis (TAM) occurs when mutations happen in the DNA sequence of a gene during transcription.\n2. TAM can be caused by errors in DNA replication.\n3. TAM can also be caused by the action of transcription-associated repair mechanisms.\n4. Mutations in the promoter region of a gene can affect the binding of transcription factors and alter the rate of transcription.\n5. Mutations in the coding region of a gene can affect the protein sequence or stability of the resulting protein.",
    "yulan-chat-2-13b-fp16_fact": [
      "Transcription-associated mutagenesis (TAM) occurs when mutations happen in the DNA sequence of a gene during transcription.",
      "TAM can be caused by errors in DNA replication.",
      "TAM can also be caused by the action of transcription-associated repair mechanisms.",
      "Mutations in the promoter region of a gene can affect the binding of transcription factors and alter the rate of transcription.",
      "Mutations in the coding region of a gene can affect the protein sequence or stability of the resulting protein."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Transcription-associated mutagenesis (TAM) is linked to the process of transcription, not replication. Replication-associated mutations occur during DNA replication.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 848,
    "user_query": "Is there a pharmacogenetic test for trastuzumab?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is a pharmacogenetic test for trastuzumab. Trastuzumab is a monoclonal antibody drug used to treat certain types of breast cancer, and it works by targeting a protein called HER2 that is overexpressed in some cancer cells.\nThe pharmacogenetic test for trastuzumab looks for variations in the HER2 gene that may affect how the drug works in an individual patient. Specifically, the test looks for mutations or variations in the HER2 gene that may lead to increased or decreased expression of the HER2 protein.\nPatients who have been diagnosed with HER2-positive breast cancer may benefit from trastuzumab therapy, but the effectiveness of the drug can vary depending on the patient's HER2 gene expression levels. By performing a pharmacogenetic test for trastuzumab, doctors can determine whether a patient is likely to benefit from the drug and adjust the dosage as needed to minimize the risk of side effects.\nIt's important to note that the use of pharmacogenetic testing for trastuzumab is still evolving, and there is ongoing research to better understand how to use this type of testing to optimize treatment for breast cancer patients.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Trastuzumab is a monoclonal antibody drug used to treat certain types of breast cancer.\n2. The pharmacogenetic test for trastuzumab checks for variations in the HER2 gene that may impact the drug's effectiveness.\n3. Trastuzumab targets a protein called HER2 that is overexpressed in some cancer cells.\n4. Patients with HER2-positive breast cancer may benefit from trastuzumab therapy.\n5. The effectiveness of trastuzumab can vary based on the patient's HER2 gene expression levels.",
    "yulan-chat-2-13b-fp16_fact": [
      "Trastuzumab is a monoclonal antibody drug used to treat certain types of breast cancer.",
      "The pharmacogenetic test for trastuzumab checks for variations in the HER2 gene that may impact the drug's effectiveness.",
      "Trastuzumab targets a protein called HER2 that is overexpressed in some cancer cells.",
      "Patients with HER2-positive breast cancer may benefit from trastuzumab therapy.",
      "The effectiveness of trastuzumab can vary based on the patient's HER2 gene expression levels."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The pharmacogenetic test for trastuzumab checks for overexpression or amplification of the HER2 protein in the cancer cells, not variations in the HER2 gene.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 849,
    "user_query": "Which calcium channels does ethosuximide target?",
    "yulan-chat-2-13b-fp16_response": "Ethosuximide is a medication that is used to treat epilepsy. It works by blocking the activity of certain calcium channels in the brain. Specifically, ethosuximide targets the alpha-ethyl-beta-subunit of the calcium channel complex, which is found in the brain. This helps to reduce the frequency of seizures in people with epilepsy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ethosuximide is a medication used to treat epilepsy.\n2. Ethosuximide functions by blocking the activity of certain calcium channels in the brain.\n3. Ethosuximide specifically targets the alpha-ethyl-beta-subunit of the calcium channel complex in the brain.\n4. The use of ethosuximide can reduce the frequency of seizures in people with epilepsy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ethosuximide is a medication used to treat epilepsy.",
      "Ethosuximide functions by blocking the activity of certain calcium channels in the brain.",
      "Ethosuximide specifically targets the alpha-ethyl-beta-subunit of the calcium channel complex in the brain.",
      "The use of ethosuximide can reduce the frequency of seizures in people with epilepsy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ethosuximide does not specifically target an \"alpha-ethyl-beta-subunit\" of the calcium channel complex in the brain; it is known to block T-type calcium channels in thalamic neurons, which plays a role in controlling the rhythmic cortical discharge in absence seizures.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 850,
    "user_query": "What is the sedimentation coefficient of the mammalian mitoribosome?",
    "yulan-chat-2-13b-fp16_response": "The sedimentation coefficient of the mammalian mitoribosome is approximately 7S, which means it has a sedimentation coefficient of approximately 7 Svedberg units (Svu) when measured by ultracentrifugation. The mitoribosome is a large ribosomal particle that is responsible for the synthesis of mitochondrial proteins in mammalian cells. It is composed of a 28S mitochondrial ribosomal protein and a 32S mitochondrial ribosomal protein, and has a sedimentation coefficient that is slightly higher than that of the 70S ribosome found in the cytoplasm.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The sedimentation coefficient of the mammalian mitoribosome is approximately 7S.\n2. The sedimentation coefficient is measured in Svedberg units (Svu).\n3. The mammalian mitoribosome is involved in the synthesis of mitochondrial proteins.\n4. It is composed of a 28S mitochondrial ribosomal protein and a 32S mitochondrial ribosomal protein.\n5. The sedimentation coefficient of the mammalian mitoribosome is slightly higher than that of the 70S cytoplasmic ribosome.",
    "yulan-chat-2-13b-fp16_fact": [
      "The sedimentation coefficient of the mammalian mitoribosome is approximately 7S.",
      "The sedimentation coefficient is measured in Svedberg units (Svu).",
      "The mammalian mitoribosome is involved in the synthesis of mitochondrial proteins.",
      "It is composed of a 28S mitochondrial ribosomal protein and a 32S mitochondrial ribosomal protein.",
      "The sedimentation coefficient of the mammalian mitoribosome is slightly higher than that of the 70S cytoplasmic ribosome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The sedimentation coefficient of the mammalian mitoribosome is approximately 55S.\n2. FALSE [correction]: The sedimentation coefficient is measured in Svedberg units (S), not Svedberg units (Svu).\n3. TRUE\n4. FALSE [correction]: The mammalian mitoribosome is typically composed of a 39S large subunit and a 28S small subunit, not a 28S and a 32S mitochondrial ribosomal protein.\n5. FALSE [correction]: The sedimentation coefficient of the mammalian mitoribosome (55S) is not slightly higher, but actually significantly higher than that of the 70S cytoplasmic ribosomes typically found in bacteria.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 852,
    "user_query": "Which proteins act as histone-like molecules in prokaryotes?",
    "yulan-chat-2-13b-fp16_response": "In prokaryotes, histone-like proteins are known as HU proteins (histone-like proteins). These proteins play a similar role to histones in eukaryotes, which is to package DNA into a compact form called chromatin. HU proteins are responsible for organizing the DNA into a specific conformation, which allows for the regulation of gene expression. There are four main types of HU proteins in prokaryotes, which are HUA, HUB, HUC, and HUD. These proteins are highly conserved across different species of bacteria and archaea, and they play a critical role in maintaining the structure and function of the genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. HU proteins are known as histone-like proteins in prokaryotes.\n2. HU proteins are responsible for packaging DNA into a compact form in prokaryotes.\n3. There are four main types of HU proteins: HUA, HUB, HUC, and HUD.\n4. HU proteins are highly conserved across different species of bacteria and archaea.\n5. HU proteins play a role in the regulation of gene expression in prokaryotes.",
    "yulan-chat-2-13b-fp16_fact": [
      "HU proteins are known as histone-like proteins in prokaryotes.",
      "HU proteins are responsible for packaging DNA into a compact form in prokaryotes.",
      "There are four main types of HU proteins: HUA, HUB, HUC, and HUD.",
      "HU proteins are highly conserved across different species of bacteria and archaea.",
      "HU proteins play a role in the regulation of gene expression in prokaryotes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is not a widely recognized categorization of HU proteins into four main types (HUA, HUB, HUC, HUD) as described. Typically, HU proteins are referred to without such specific subclassification.\n4. TRUE  While variations can exist, HU proteins are generally conserved among bacteria and some archaeal species.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 860,
    "user_query": "Is hypersensitivity to DNA crosslinking agents a hallmark of Fanconi anemia?",
    "yulan-chat-2-13b-fp16_response": "Yes, hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia. This condition is characterized by a defect in the DNA repair mechanism, leading to increased sensitivity to DNA-damaging agents such as crosslinking agents. This can result in a range of symptoms, including bone marrow failure, increased risk of cancer, and developmental abnormalities. Fanconi anemia is inherited in an autosomal recessive manner and is caused by mutations in one of several genes that encode for proteins involved in the DNA repair process.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia.\n2. Fanconi anemia is characterized by a defect in the DNA repair mechanism.\n3. Individuals with Fanconi anemia have increased sensitivity to DNA-damaging agents such as crosslinking agents.\n4. Symptoms of Fanconi anemia include bone marrow failure, increased risk of cancer, and developmental abnormalities.\n5. Fanconi anemia is inherited in an autosomal recessive manner.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia.",
      "Fanconi anemia is characterized by a defect in the DNA repair mechanism.",
      "Individuals with Fanconi anemia have increased sensitivity to DNA-damaging agents such as crosslinking agents.",
      "Symptoms of Fanconi anemia include bone marrow failure, increased risk of cancer, and developmental abnormalities.",
      "Fanconi anemia is inherited in an autosomal recessive manner."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 869,
    "user_query": "What is the pyroptotic pathway?",
    "yulan-chat-2-13b-fp16_response": "The pyroptotic pathway is a type of programmed cell death (PCD) that is characterized by the formation of a pore in the outer membrane of the cell, leading to the release of cytoplasmic contents and the death of the cell. It is also known as type III PCD.\nThe pyroptotic pathway is activated in response to various stressors, such as infection with pathogens, and is mediated by a protein complex called the pyroptosome. The pyroptosome is composed of the proteins pyroptin and lysine-specific peptidase 1 (LSD1), which form a pore in the outer membrane of the cell.\nThe activation of the pyroptotic pathway leads to the recruitment of other proteins to the pore, including the protein aspartyl (or asparagine) protease , which cleaves and activates the caspase-1-like protease, Caspase-1. Caspase-1 then activates other caspases, leading to the cleavage and destruction of various proteins in the cell, ultimately leading to cell death.\nThe pyroptotic pathway is thought to play a role in the defense against pathogens, as it can be induced by the presence of pathogen-associated molecular patterns (PAMPs) and can help to eliminate infected cells and prevent the spread of infection. However, it can also be activated under normal conditions and may play a role in the pathogenesis of certain diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The pyroptotic pathway is a type of programmed cell death characterized by the formation of a pore in the outer membrane of the cell.\n2. Pyroptosis is also known as type III programmed cell death.\n3. The pyroptosome, which mediates the pyroptotic pathway, is composed of the proteins pyroptin and lysine-specific peptidase 1 (LSD1).\n4. Activation of the pyroptotic pathway leads to the cleavage and activation of the caspase-1-like protease, Caspase-1.\n5. The pyroptotic pathway can be induced by the presence of pathogen-associated molecular patterns (PAMPs).",
    "yulan-chat-2-13b-fp16_fact": [
      "The pyroptotic pathway is a type of programmed cell death characterized by the formation of a pore in the outer membrane of the cell.",
      "Pyroptosis is also known as type III programmed cell death.",
      "The pyroptosome, which mediates the pyroptotic pathway, is composed of the proteins pyroptin and lysine-specific peptidase 1 (LSD1).",
      "Activation of the pyroptotic pathway leads to the cleavage and activation of the caspase-1-like protease, Caspase-1.",
      "The pyroptotic pathway can be induced by the presence of pathogen-associated molecular patterns (PAMPs)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Pyroptosis is sometimes referred to as type of programmed cell death, but it is more commonly known as type I programmed cell death or inflammatory cell death, not type III.\n3. FALSE [correction]: The pyroptosome mediates the pyroptotic pathway but is composed of oligomerized ASC and activated caspase-1, not proteins named pyroptin and LSD1.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 871,
    "user_query": "What are the known families of deadenylases?",
    "yulan-chat-2-13b-fp16_response": "There are two known families of deadenylases: the CCR4-NOT complex and the Pat1 complex. The CCR4-NOT complex is a large protein complex that functions as an RNA deadenylase. It is composed of multiple subunits, including CCR4, NOT1, NOT2, and several other proteins. The Pat1 complex is a smaller protein complex that also functions as an RNA deadenylase. It is composed of three subunits: Pat1, Pat2, and Pat3. Both of these complexes are involved in the regulation of gene expression by catalyzing the removal of the poly(A) tail from mRNA molecules.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There are two known families of deadenylases: the CCR4-NOT complex and the Pat1 complex.\n2. The CCR4-NOT complex functions as an RNA deadenylase.\n3. The CCR4-NOT complex is composed of multiple subunits, including CCR4, NOT1, NOT2, and several other proteins.\n4. The Pat1 complex functions as an RNA deadenylase.\n5. The Pat1 complex is composed of three subunits: Pat1, Pat2, and Pat3.",
    "yulan-chat-2-13b-fp16_fact": [
      "There are two known families of deadenylases: the CCR4-NOT complex and the Pat1 complex.",
      "The CCR4-NOT complex functions as an RNA deadenylase.",
      "The CCR4-NOT complex is composed of multiple subunits, including CCR4, NOT1, NOT2, and several other proteins.",
      "The Pat1 complex functions as an RNA deadenylase.",
      "The Pat1 complex is composed of three subunits: Pat1, Pat2, and Pat3."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Pat1 complex is not composed of subunits named Pat2 or Pat3. The main components of the Pat1 complex include Pat1, Lsm17 complex, and other associated factors. Pat1 works closely with the Lsm17 complex to facilitate mRNA decapping and deadenylation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 872,
    "user_query": "Which translocation is harbored in the Askin tumor cells?",
    "yulan-chat-2-13b-fp16_response": "The Askin tumor cells harbor a translocation between chromosomes 11 and 19, specifically t(11;19)(q24;q13), which results in the fusion of the EWSR1 gene on chromosome 11 with the FLI1 gene on chromosome 19. This translocation is unique to the development of the Askin tumor and is not found in other types of sarcomas. The fusion protein EWS-FLI1 created by this translocation plays a key role in the development and progression of the Askin tumor.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Askin tumor cells contain a translocation between chromosomes 11 and 19.\n2. The specific translocation in Askin tumor cells is t(11;19)(q24;q13).\n3. This translocation results in the fusion of the EWSR1 gene on chromosome 11 with the FLI1 gene on chromosome 19.\n4. The fusion protein created by this translocation is called EWS-FLI1.\n5. The EWS-FLI1 fusion protein is significant in the development and progression of the Askin tumor.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Askin tumor cells contain a translocation between chromosomes 11 and 19.",
      "The specific translocation in Askin tumor cells is t(11;19)(q24;q13).",
      "This translocation results in the fusion of the EWSR1 gene on chromosome 11 with the FLI1 gene on chromosome 19.",
      "The fusion protein created by this translocation is called EWS-FLI1.",
      "The EWS-FLI1 fusion protein is significant in the development and progression of the Askin tumor."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Askin tumor cells contain a translocation between chromosomes 22 and 11, not chromosomes 11 and 19.\n2. FALSE [correction]: The specific translocation often found in Askin tumor cells is t(11;22)(q24;q12).\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 875,
    "user_query": "Which R/bioconductor package utilizes the Hilbert curve in order to visualize genomic data?",
    "yulan-chat-2-13b-fp16_response": "The R/bioconductor package that utilizes the Hilbert curve in order to visualize genomic data is called \"HilbertR\".",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 876,
    "user_query": "Can fetal aneuploidy be detected with non-invasive prenatal testing?",
    "yulan-chat-2-13b-fp16_response": "Yes, fetal aneuploidy can be detected with non-invasive prenatal testing (NIPT), also known as cell-free DNA (cfDNA) testing. NIPT is a screening test that analyzes fetal DNA that is present in the mother's bloodstream. The test can detect certain chromosomal abnormalities, including aneuploidies, such as Down syndrome, trisomy 18, and trisomy 13.\nNIPT is typically offered to pregnant women who are at higher risk of having a child with a chromosomal abnormality, such as women who are over 35 years old or who have a family history of chromosomal abnormalities. The test is usually performed between 10 and 20 weeks of pregnancy.\nIt's important to note that while NIPT can detect certain chromosomal abnormalities, it is not a diagnostic test. If the test results are positive, a follow-up diagnostic test, such as amniocentesis or chorionic villus sampling (CVS), may be necessary to confirm the diagnosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Non-invasive prenatal testing (NIPT) can detect fetal aneuploidy.\n2. NIPT analyzes fetal DNA present in the mother's bloodstream.\n3. NIPT can detect chromosomal abnormalities such as Down syndrome, trisomy 18, and trisomy 13.\n4. NIPT is typically offered to pregnant women who are at a higher risk of having a child with a chromosomal abnormality.\n5. NIPT is usually performed between 10 and 20 weeks of pregnancy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Non-invasive prenatal testing (NIPT) can detect fetal aneuploidy.",
      "NIPT analyzes fetal DNA present in the mother's bloodstream.",
      "NIPT can detect chromosomal abnormalities such as Down syndrome, trisomy 18, and trisomy 13.",
      "NIPT is typically offered to pregnant women who are at a higher risk of having a child with a chromosomal abnormality.",
      "NIPT is usually performed between 10 and 20 weeks of pregnancy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 877,
    "user_query": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?",
    "yulan-chat-2-13b-fp16_response": "There are several packages in the bioconductor project that can be used for performing overlap analysis of genomic regions in R. Some of the commonly used packages are:\n1. `seqinr`: This package provides functions for reading and writing sequence data in various file formats, including BED, BAM, and SAM. It also includes functions for performing overlap analysis between genomic regions.\n2. `bedtools`: This package provides a set of tools for working with genomic data in BED format. It includes functions for performing overlap analysis between genomic regions.\n3. `GenomicRanges`: This package provides functions for working with genomic regions, including functions for performing overlap analysis between regions.\n4. `overlap`: This package provides functions for performing overlap analysis between genomic regions, including both exact and fuzzy overlap analysis.\n5. `seqboot`: This package provides functions for performing statistical analysis on genomic data, including overlap analysis between regions.\nThese packages can be used to perform a variety of overlap analysis tasks, including identifying overlapping genomic regions, calculating the percentage of overlap between regions, and performing statistical tests to determine the significance of overlap between regions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The `seqinr` package in bioconductor provides functions for reading and writing sequence data in various file formats and for performing overlap analysis between genomic regions.\n2. The `bedtools` package includes tools for working with genomic data in BED format and for performing overlap analysis.\n3. `GenomicRanges` is a package that provides functions for working with genomic regions, including overlap analysis.\n4. The `overlap` package offers functions for both exact and fuzzy overlap analysis between genomic regions.\n5. `seqboot` is a package that includes functions for statistical analysis on genomic data, such as overlap analysis.",
    "yulan-chat-2-13b-fp16_fact": [
      "The `seqinr` package in bioconductor provides functions for reading and writing sequence data in various file formats and for performing overlap analysis between genomic regions.",
      "The `bedtools` package includes tools for working with genomic data in BED format and for performing overlap analysis.",
      "`GenomicRanges` is a package that provides functions for working with genomic regions, including overlap analysis.",
      "The `overlap` package offers functions for both exact and fuzzy overlap analysis between genomic regions.",
      "`seqboot` is a package that includes functions for statistical analysis on genomic data, such as overlap analysis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The `seqinr` package is indeed for biological sequences, but it is part of the R project and not specifically \"bioconductor,\" which is a separate project that also distributes R packages for genomic data.\n2. TRUE\n3. TRUE\n4. UNKNOWN: Without a specific reference to a package named `overlap`, the truth of this statement is unclear. The term \"overlap\" is generic and could refer to functions available in a variety of packages, but without more context or a known package by that exact name, it is difficult to verify this statement.\n5. FALSE [correction]: The `seqboot` function from the `phangorn` or `ape` package in R is typically used for bootstrapping sequences, which is different from conducting overlap analysis on genomic data. It is not known as a package itself for statistical analysis on genomic data related to overlap analysis.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 878,
    "user_query": "Is dichlorphenamide effective for periodic paralysis?",
    "yulan-chat-2-13b-fp16_response": "Dichlorphenamide is a medication that is used to treat periodic paralysis, which is a condition characterized by episodes of muscle weakness or paralysis that occur at regular intervals. It works by blocking the action of potassium channels in nerve cells, which helps to reduce the frequency and severity of these episodes.\nStudies have shown that dichlorphenamide can be effective in treating periodic paralysis, particularly in people with a specific type of the condition called periodic paralysis associated with the SCN5A gene mutation. In these individuals, dichlorphenamide has been shown to reduce the frequency and severity of attacks, improve muscle strength, and improve quality of life.\nHowever, it is important to note that dichlorphenamide may not work for everyone with periodic paralysis, and it can have side effects. It is also important to talk to a healthcare provider about the risks and benefits of this medication, as well as other treatment options that may be available.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dichlorphenamide is used to treat periodic paralysis.\n2. Dichlorphenamide works by blocking the action of potassium channels in nerve cells.\n3. Studies indicate that dichlorphenamide can effectively treat periodic paralysis, especially in individuals with the SCN5A gene mutation.\n4. Dichlorphenamide has been shown to reduce the frequency and severity of attacks in patients with periodic paralysis.\n5. Dichlorphenamide may have side effects and may not work for everyone with periodic paralysis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dichlorphenamide is used to treat periodic paralysis.",
      "Dichlorphenamide works by blocking the action of potassium channels in nerve cells.",
      "Studies indicate that dichlorphenamide can effectively treat periodic paralysis, especially in individuals with the SCN5A gene mutation.",
      "Dichlorphenamide has been shown to reduce the frequency and severity of attacks in patients with periodic paralysis.",
      "Dichlorphenamide may have side effects and may not work for everyone with periodic paralysis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Dichlorphenamide works by inhibiting carbonic anhydrase, which in turn can help to normalize potassium levels in the body, but it does not directly block the action of potassium channels in nerve cells.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 881,
    "user_query": "Which pathway is activated by ficolin-3?",
    "yulan-chat-2-13b-fp16_response": "Ficolin-3 (also known as FCN3) is a collectin, a type of C-type lectin that plays a role in the innate immune system. Ficolins are involved in the recognition and clearance of microorganisms, as well as in the regulation of inflammation.\nFicolin-3 activates the complement pathway, specifically the classical pathway. When ficolin-3 binds to a microbial surface, it activates the complement component C1, which in turn activates the rest of the classical pathway. The activation of the complement pathway leads to the recruitment and activation of immune cells, such as neutrophils and monocytes, and the generation of opsonizing antibodies, which can help to eliminate the microorganism.\nIn addition to activating the classical pathway, ficolin-3 has also been shown to activate the lectin pathway of the complement system. This pathway is involved in the recognition and clearance of microorganisms, and is thought to play a role in the regulation of inflammation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ficolin-3 is a type of C-type lectin that is part of the innate immune system.\n2. Ficolin-3 is involved in the recognition and clearance of microorganisms.\n3. Ficolin-3 activates the complement pathway, specifically the classical pathway.\n4. Activation of the classical pathway by ficolin-3 starts with the activation of the complement component C1.\n5. Ficolin-3 has been shown to activate the lectin pathway of the complement system.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ficolin-3 is a type of C-type lectin that is part of the innate immune system.",
      "Ficolin-3 is involved in the recognition and clearance of microorganisms.",
      "Ficolin-3 activates the complement pathway, specifically the classical pathway.",
      "Activation of the classical pathway by ficolin-3 starts with the activation of the complement component C1.",
      "Ficolin-3 has been shown to activate the lectin pathway of the complement system."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ficolin-3 is known to activate the lectin pathway, not the classical pathway of the complement system.\n4. FALSE [correction]: Activation of the lectin pathway by ficolin-3 does not start with the activation of complement component C1, but rather with the activation of the MASP (MBL-associated serine protease) complex.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "yulan-chat-2-13b-fp16_response": "There are several preferred technologies for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses. Some of the commonly used technologies include:\n1. Immunoprecipitation (IP) followed by phosphopeptide enrichment: This method involves the use of specific antibodies that recognize phosphorylated peptides to capture them from the sample. The captured phosphopeptides are then enriched using metal ion affinity chromatography (MAC) or immobilized metal ion affinity chromatography (IMAC).\n2. Metal ion affinity chromatography (MAC): This method involves the separation of phosphopeptides based on their binding affinity to a metal ion. Phosphopeptides bind to the metal ion, which can then be eluted and collected for further analysis.\n3. Immunobilized metal ion affinity chromatography (IMAC): This method is similar to MAC, but the metal ion is immobilized on a solid support, such as a bead or a resin. The immobilized metal ion can then be used to capture phosphopeptides from the sample.\n4. Phospho-specific antibody beads: This method involves the use of beads that are coated with phospho-specific antibodies to capture phosphorylated peptides from the sample. The captured phosphopeptides can then be eluted and analyzed.\n5. TiO2 chromatography: This method involves the separation of phosphopeptides based on their interaction with TiO2 particles. Phosphopeptides bind to the TiO2 particles, which can then be eluted and analyzed.\nThese are some of the preferred technologies for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses. The choice of method may depend on the specific requirements of the experiment and the availability of resources.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Immunoprecipitation followed by phosphopeptide enrichment is a technology used in phosphoproteomic analyses.\n2. Metal ion affinity chromatography is a method used to separate phosphopeptides based on their binding affinity to a metal ion.\n3. Immobilized metal ion affinity chromatography involves a metal ion immobilized on a solid support to capture phosphopeptides from samples.\n4. Phospho-specific antibody beads are used to capture phosphorylated peptides from samples in phosphoproteomic analyses.\n5. TiO2 chromatography is a method for separating phosphopeptides based on their interaction with TiO2 particles.",
    "yulan-chat-2-13b-fp16_fact": [
      "Immunoprecipitation followed by phosphopeptide enrichment is a technology used in phosphoproteomic analyses.",
      "Metal ion affinity chromatography is a method used to separate phosphopeptides based on their binding affinity to a metal ion.",
      "Immobilized metal ion affinity chromatography involves a metal ion immobilized on a solid support to capture phosphopeptides from samples.",
      "Phospho-specific antibody beads are used to capture phosphorylated peptides from samples in phosphoproteomic analyses.",
      "TiO2 chromatography is a method for separating phosphopeptides based on their interaction with TiO2 particles."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 884,
    "user_query": "Which histone modifications are correlated with transcription elongation?",
    "yulan-chat-2-13b-fp16_response": "Histone modifications that are correlated with transcription elongation include:\n1. Acetylation of histone H3 and H4, which is associated with active gene expression and transcription elongation.\n2. Methylation of histone H3 lysine 47 (H3K47me3) and histone H3 lysine 79 (H3K79me3), which is associated with transcription elongation and gene expression.\n3. Phosphorylation of histone H3 serine 10 (H3S10ph) and histone H3 serine 28 (H3S28ph), which is associated with transcription elongation and gene expression.\n4. Ubiquitination of histone H2A, which is associated with transcription elongation and gene expression.\nIt's worth noting that different histone modifications can have different effects on transcription elongation, and that the effects of histone modifications can vary depending on the specific gene and cell type.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Acetylation of histone H3 and H4 is associated with active gene expression and transcription elongation.\n2. Methylation of histone H3 lysine 47 (H3K47me3) is associated with transcription elongation and gene expression.\n3. Methylation of histone H3 lysine 79 (H3K79me3) is associated with transcription elongation and gene expression.\n4. Phosphorylation of histone H3 serine 10 (H3S10ph) is associated with transcription elongation and gene expression.\n5. Ubiquitination of histone H2A is associated with transcription elongation and gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Acetylation of histone H3 and H4 is associated with active gene expression and transcription elongation.",
      "Methylation of histone H3 lysine 47 (H3K47me3) is associated with transcription elongation and gene expression.",
      "Methylation of histone H3 lysine 79 (H3K79me3) is associated with transcription elongation and gene expression.",
      "Phosphorylation of histone H3 serine 10 (H3S10ph) is associated with transcription elongation and gene expression.",
      "Ubiquitination of histone H2A is associated with transcription elongation and gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Histone H3 lysine 47 (H3K47) is not a well-documented site of methylation in relation to gene expression. Methylation can occur at sites such as H3 lysine 4 (H3K4), lysine 36 (H3K36), and lysine 79 (H3K79), among others, to modulate gene expression. Therefore, without further specific context, the statement about H3K47me3 is considered false.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 885,
    "user_query": "Does  thyroid hormone receptor beta1 affect insulin secretion?",
    "yulan-chat-2-13b-fp16_response": "Yes, thyroid hormone receptor beta1 (TR1) has been shown to play a role in regulating insulin secretion.\nStudies have suggested that TR1 is expressed in pancreatic beta cells and that it plays a role in the regulation of insulin secretion. Specifically, TR1 has been shown to regulate the expression of genes involved in glucose metabolism and insulin secretion, and it has been implicated in the regulation of insulin secretion in response to changes in glucose levels.\nIn addition, mutations in the TR1 gene have been associated with changes in insulin secretion and an increased risk of developing type 2 diabetes.\nOverall, while the exact mechanisms by which TR1 regulates insulin secretion are not fully understood, there is evidence to suggest that it plays an important role in this process.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyroid hormone receptor beta1 (TR1) is implicated in regulating insulin secretion.\n2. TR1 is expressed in pancreatic beta cells.\n3. TR1 helps to regulate the expression of genes involved in glucose metabolism and insulin secretion.\n4. TR1 plays a role in the regulation of insulin secretion in response to changes in glucose levels.\n5. Mutations in the TR1 gene have been linked with changes in insulin secretion and an increased risk of type 2 diabetes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyroid hormone receptor beta1 (TR1) is implicated in regulating insulin secretion.",
      "TR1 is expressed in pancreatic beta cells.",
      "TR1 helps to regulate the expression of genes involved in glucose metabolism and insulin secretion.",
      "TR1 plays a role in the regulation of insulin secretion in response to changes in glucose levels.",
      "Mutations in the TR1 gene have been linked with changes in insulin secretion and an increased risk of type 2 diabetes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThese statements are consistent with known functions of thyroid hormone receptors and their implications in metabolic processes including insulin secretion and glucose metabolism. Thyroid hormone receptors, including TR1, have been linked to the regulation of genes involved in these pathways. Mutations in TR1 have indeed been associated with metabolic disorders, including diabetes. However, as this is a summary without specific sources, the validation of each statement would rely on the accuracy of the passage from which these statements were extracted.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 893,
    "user_query": "What is commotio cordis?",
    "yulan-chat-2-13b-fp16_response": "Commotio cordis is a rare and potentially life-threatening condition that occurs when a blow to the chest causes the heart to stop or to beat erratically. This can happen when a person is struck in the chest by a blunt object, such as a baseball bat or a fist, while the heart is in a particular phase of its contraction cycle. Commotio cordis is most commonly seen in young athletes who are struck in the chest while playing sports, but it can also occur in other situations, such as in cases of domestic violence or accidents.\nThe condition is caused by a disruption of the normal electrical activity in the heart, which can lead to a disturbance in the heart's rhythm and a decrease in the blood flow to the heart and other organs. This can cause symptoms such as dizziness, loss of consciousness, and cardiac arrest. Treatment for commotio cordis typically involves the use of cardiopulmonary resuscitation (CPR) and other emergency medical interventions to restore normal heart function and prevent further complications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Commotio cordis is a condition where a blow to the chest can cause the heart to stop or beat erratically.\n2. It can occur when a person is struck by a blunt object like a baseball bat or a fist.\n3. The disruption of normal electrical activity in the heart can lead to a disturbance in the heart's rhythm.\n4. Symptoms of commotio cordis can include dizziness, loss of consciousness, and cardiac arrest.\n5. Treatment for commotio cordis typically involves cardiopulmonary resuscitation (CPR) and other emergency medical interventions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Commotio cordis is a condition where a blow to the chest can cause the heart to stop or beat erratically.",
      "It can occur when a person is struck by a blunt object like a baseball bat or a fist.",
      "The disruption of normal electrical activity in the heart can lead to a disturbance in the heart's rhythm.",
      "Symptoms of commotio cordis can include dizziness, loss of consciousness, and cardiac arrest.",
      "Treatment for commotio cordis typically involves cardiopulmonary resuscitation (CPR) and other emergency medical interventions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 894,
    "user_query": "What is the cause of Phthiriasis Palpebrarum?",
    "yulan-chat-2-13b-fp16_response": "Phthiriasis palpebrarum, also known as lice infestation of the eyelashes, is caused by the lice (Pthirus pubis) that live on the eyelashes. These lice are usually transmitted through close contact with an infected person or by sharing personal hygiene items such as towels, pillowcases, or makeup brushes.\nThe lice feed on the blood from the scalp and can cause irritation, itching, and redness of the eyelids. They can also cause a buildup of crust on the eyelashes, which can make the eyelashes appear stuck together or clumped.\nIn addition to affecting the eyelashes, lice can also infest the scalp and other parts of the body. Lice infestations are highly contagious and can spread quickly in schools, dormitories, and other settings where people live or work in close proximity to one another.\nTo prevent the spread of lice, it is important to practice good hygiene, such as washing your hair and brushing it regularly, using separate towels and pillowcases for each person in the household, and avoiding sharing personal hygiene items. If you suspect that you or someone you know has a lice infestation, it is important to seek treatment from a healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phthiriasis palpebrarum is caused by the lice species Pthirus pubis.\n2. These lice are usually transmitted through close contact with an infected person.\n3. Lice can be transmitted by sharing personal items such as towels, pillowcases, or makeup brushes.\n4. The symptoms of Phthiriasis palpebrarum include irritation, itching, and redness of the eyelids.\n5. Lice infestations can cause a buildup of crust on the eyelashes, leading them to appear stuck together or clumped.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phthiriasis palpebrarum is caused by the lice species Pthirus pubis.",
      "These lice are usually transmitted through close contact with an infected person.",
      "Lice can be transmitted by sharing personal items such as towels, pillowcases, or makeup brushes.",
      "The symptoms of Phthiriasis palpebrarum include irritation, itching, and redness of the eyelids.",
      "Lice infestations can cause a buildup of crust on the eyelashes, leading them to appear stuck together or clumped."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 896,
    "user_query": "How are CpG island shores defined?",
    "yulan-chat-2-13b-fp16_response": "CpG islands are defined as regions of a DNA sequence that are rich in CpG dinucleotides, which are sequences of the form CG(G/C) that are often found in the promoter regions of genes. CpG islands are typically defined as regions of at least 200 base pairs with a CpG content of at least 60%. These regions are often associated with gene regulation, as the presence or absence of methylation of the cytosine residues in CpG dinucleotides can affect the expression of nearby genes. CpG islands are often identified using computer algorithms that search for sequences with a high CpG content, and they can also be identified by their location near the transcription start site of a gene.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CpG islands are regions of a DNA sequence that are rich in CpG dinucleotides.\n2. CpG dinucleotides are sequences of the form CG(G/C) often found in the promoter regions of genes.\n3. A typical definition for CpG islands is regions of at least 200 base pairs with a CpG content of at least 60%.\n4. The presence or absence of methylation of the cytosine residues in CpG dinucleotides can affect the expression of nearby genes.\n5. CpG islands are often located near the transcription start site of a gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "CpG islands are regions of a DNA sequence that are rich in CpG dinucleotides.",
      "CpG dinucleotides are sequences of the form CG(G/C) often found in the promoter regions of genes.",
      "A typical definition for CpG islands is regions of at least 200 base pairs with a CpG content of at least 60%.",
      "The presence or absence of methylation of the cytosine residues in CpG dinucleotides can affect the expression of nearby genes.",
      "CpG islands are often located near the transcription start site of a gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: CpG dinucleotides are simply cytosine followed by guanine connected by a phosphate link (C-phosphate-G) and not the specific sequence CG(G/C).\n3. FALSE [correction]: A typical definition for CpG islands is regions of at least 200 base pairs with a high CpG content relative to the genomic average, where the observed to expected CpG ratio is greater than 60%.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 898,
    "user_query": "Which gene is mutated in a subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease?",
    "yulan-chat-2-13b-fp16_response": "The gene that is mutated in a subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease is called DES. The mutation is a deletion of the exons 5-8 of the DES gene, which encodes a protein called plakoglobulin-1. This mutation is thought to disrupt the structure and function of the desmosome complex, which is important for maintaining the integrity of the intercellular space in the heart and other tissues. Naxos disease is a rare autosomal recessive disorder that is characterized by heart failure, arrhythmias, and emphysema. It is caused by mutations in the DES gene, which is also mutated in other subtypes of arrhythmogenic right ventricular cardiomyopathy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease is caused by a mutation in the DES gene.\n2. The specific mutation associated with Naxos disease is the deletion of exons 5-8 of the DES gene.\n3. The DES gene encodes a protein called plakoglobulin-1.\n4. Naxos disease is an autosomal recessive disorder.\n5. Naxos disease is characterized by heart failure, arrhythmias, and emphysema.",
    "yulan-chat-2-13b-fp16_fact": [
      "A subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease is caused by a mutation in the DES gene.",
      "The specific mutation associated with Naxos disease is the deletion of exons 5-8 of the DES gene.",
      "The DES gene encodes a protein called plakoglobulin-1.",
      "Naxos disease is an autosomal recessive disorder.",
      "Naxos disease is characterized by heart failure, arrhythmias, and emphysema."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: A subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease is caused by a mutation in the JUP gene, not the DES gene.\n2. FALSE [correction]: The specific mutation associated with Naxos disease is not in the DES gene but in the JUP gene, and it involves a 2 base pair deletion in exon 2.\n3. FALSE [correction]: The DES gene encodes desmin, not plakoglobulin-1 (which is encoded by the JUP gene).\n4. TRUE\n5. FALSE [correction]: Naxos disease is characterized by woolly hair, palmoplantar keratosis, and arrhythmogenic right ventricular dysplasia/cardiomyopathy, not emphysema.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 899,
    "user_query": "What is the role of edaravone in traumatic brain injury?",
    "yulan-chat-2-13b-fp16_response": "Edaravone is a medication that has been studied for its potential role in the treatment of traumatic brain injury (TBI). TBI is a serious injury that can occur when the brain is damaged by a blow or bump to the head, or when an object penetrates the skull. TBI can cause a range of symptoms, including confusion, memory loss, difficulty with speech or vision, and difficulty with balance or coordination.\nEdaravone is a type of medication called a free radical scavenger, which means that it helps to protect cells from damage caused by molecules called free radicals. Free radicals are unstable molecules that can cause damage to cells and tissues by stealing electrons from them. This can lead to a chain reaction that can cause further damage to the body.\nStudies have suggested that edaravone may help to reduce the damage caused by TBI by protecting brain cells from free radicals. It may also help to improve cognitive function and reduce the severity of symptoms such as confusion and memory loss. However, more research is needed to fully understand the potential benefits of edaravone for TBI.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Edaravone has been studied for its potential use in treating traumatic brain injury (TBI).\n2. Traumatic brain injury can occur from a blow to the head or when an object penetrates the skull.\n3. Symptoms of TBI can include confusion, memory loss, and difficulty with speech or vision.\n4. Edaravone functions as a free radical scavenger, which helps protect cells from damage by free radicals.\n5. Research has suggested that edaravone may reduce damage caused by TBI and improve cognitive function.",
    "yulan-chat-2-13b-fp16_fact": [
      "Edaravone has been studied for its potential use in treating traumatic brain injury (TBI).",
      "Traumatic brain injury can occur from a blow to the head or when an object penetrates the skull.",
      "Symptoms of TBI can include confusion, memory loss, and difficulty with speech or vision.",
      "Edaravone functions as a free radical scavenger, which helps protect cells from damage by free radicals.",
      "Research has suggested that edaravone may reduce damage caused by TBI and improve cognitive function."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 900,
    "user_query": "Are there plasma membrane receptors for thyroid hormones?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are plasma membrane receptors for thyroid hormones. These receptors are called thyroid hormone receptors (TRs) and they are located in the cytoplasm of the cell. TRs are transcription factors, which means that they regulate gene expression by binding to specific DNA sequences and modifying the transcription of target genes.\nThere are two main types of TRs: TR and TR. TR is the predominant form in most tissues and is involved in regulating metabolism, development, and growth. TR is found mainly in the brain and plays a role in regulating thyroid hormone-dependent processes in the nervous system.\nWhen thyroid hormones bind to their receptors, it triggers a cascade of intracellular signaling events that ultimately lead to changes in gene expression and alterations in cellular metabolism. Therefore, thyroid hormone receptors are critical regulators of cellular function and play a vital role in the physiological responses to thyroid hormones.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyroid hormone receptors (TRs) are plasma membrane receptors for thyroid hormones.\n2. TR and TR are two main types of thyroid hormone receptors.\n3. TR is the predominant form in most tissues and is involved in regulating metabolism, development, and growth.\n4. TR is primarily found in the brain and regulates thyroid hormone-dependent processes in the nervous system.\n5. The activation of thyroid hormone receptors by thyroid hormones triggers a cascade of intracellular signaling events leading to changes in gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyroid hormone receptors (TRs) are plasma membrane receptors for thyroid hormones.",
      "TR and TR are two main types of thyroid hormone receptors.",
      "TR is the predominant form in most tissues and is involved in regulating metabolism, development, and growth.",
      "TR is primarily found in the brain and regulates thyroid hormone-dependent processes in the nervous system.",
      "The activation of thyroid hormone receptors by thyroid hormones triggers a cascade of intracellular signaling events leading to changes in gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Thyroid hormone receptors (TRs) are not plasma membrane receptors; they are located in the cell nucleus and sometimes in the cytoplasm.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: TR is not primarily found in the brain, it is also found in other tissues such as the liver and the retina. However, it does regulate thyroid hormone-dependent processes in various systems, not exclusively the nervous system.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "yulan-chat-2-13b-fp16_response": "Palmini classification is a system used to classify certain types of congenital heart defects (CHDs) based on the presence or absence of certain features. It is named after the Italian cardiologist Angelo Palmini, who developed the system in the 1970s.\nThe Palmini classification system includes the following categories:\n1. Type 1: Atrial septal defect (ASD)\n2. Type 2: Ventricular septal defect (VSD)\n3. Type 3: Tetralogy of Fallot (ToF)\n4. Type 4: Transposition of the great arteries (TGA)\n5. Type 5: D-transposition of the great arteries (d-TGA)\n6. Type 6: Hypoplastic left heart syndrome (HLHS)\n7. Type 7: Patent ductus arteriosus (PDA)\n8. Type 8: Coarctation of the aorta\n9. Type 9: Other complex CHDs\nIt is important to note that the Palmini classification system is not widely used in modern cardiology, as it has been largely replaced by more comprehensive classification systems such as the International Classification of Diseases, 10th Revision (ICD-10) and the European Society for Cardiology classification system.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Palmini classification is used to classify certain types of congenital heart defects.\n2. The Palmini classification system was developed in the 1970s.\n3. It is named after the Italian cardiologist Angelo Palmini.\n4. The Palmini classification includes a category for Tetralogy of Fallot (ToF).\n5. More comprehensive classification systems such as the ICD-10 have largely replaced the Palmini classification in modern cardiology.",
    "yulan-chat-2-13b-fp16_fact": [
      "Palmini classification is used to classify certain types of congenital heart defects.",
      "The Palmini classification system was developed in the 1970s.",
      "It is named after the Italian cardiologist Angelo Palmini.",
      "The Palmini classification includes a category for Tetralogy of Fallot (ToF).",
      "More comprehensive classification systems such as the ICD-10 have largely replaced the Palmini classification in modern cardiology."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Paneth classification, not Palmini, is used to classify the severity of congenital heart defects.\n2. TRUE\n3. FALSE [correction]: The Paneth classification was named after the Austrian-born British pediatrician and cardiologist Max Paneth.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 904,
    "user_query": "Are there any desmins present in plants?",
    "yulan-chat-2-13b-fp16_response": "Desmin is a protein that is found in animals, including humans. It is a type of filament protein that is involved in the structure and function of muscle tissue. Plants do not have muscles in the same way that animals do, so they do not produce desmin.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Desmin is a protein found in animals, including humans.\n2. Desmin is involved in the structure and function of muscle tissue.\n3. Plants do not produce desmin.",
    "yulan-chat-2-13b-fp16_fact": [
      "Desmin is a protein found in animals, including humans.",
      "Desmin is involved in the structure and function of muscle tissue.",
      "Plants do not produce desmin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "yulan-chat-2-13b-fp16_response": "Subacute thyroiditis is a condition that causes inflammation of the thyroid gland, which is located in the neck. It is characterized by a gradual onset of symptoms, including pain or discomfort in the neck, swelling of the thyroid gland, and changes in thyroid hormone levels.\nWhile there is no definitive cause of subacute thyroiditis, it is believed to be associated with a variety of factors, including viral infections. Some studies have suggested that a viral infection may trigger the immune system to attack the thyroid gland, leading to inflammation and thyroid hormone production problems.\nHowever, it is important to note that subacute thyroiditis is not considered to be contagious, and it is not caused by a direct infection with a virus. Rather, it is thought to be the result of an immune response triggered by an underlying infection or other factors.\nIn summary, while viruses may play a role in the development of subacute thyroiditis, they are not the primary cause of the condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Subacute thyroiditis is characterized by inflammation of the thyroid gland.\n2. Symptoms of subacute thyroiditis include pain or discomfort in the neck, swelling of the thyroid gland, and changes in thyroid hormone levels.\n3. Some studies have suggested a link between viral infections and the triggering of subacute thyroiditis.\n4. Subacute thyroiditis is not considered to be contagious.\n5. Subacute thyroiditis is thought to result from an immune response rather than from a direct viral infection.",
    "yulan-chat-2-13b-fp16_fact": [
      "Subacute thyroiditis is characterized by inflammation of the thyroid gland.",
      "Symptoms of subacute thyroiditis include pain or discomfort in the neck, swelling of the thyroid gland, and changes in thyroid hormone levels.",
      "Some studies have suggested a link between viral infections and the triggering of subacute thyroiditis.",
      "Subacute thyroiditis is not considered to be contagious.",
      "Subacute thyroiditis is thought to result from an immune response rather than from a direct viral infection."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 910,
    "user_query": "Which is the receptor for substrates of Chaperone Mediated Autophagy?",
    "yulan-chat-2-13b-fp16_response": "The receptor for substrates of Chaperone Mediated Autophagy (CMA) is a protein called p62/SQSTM1. p62/SQSTM1 is a ubiquitin-like protein that acts as a sensor for damaged or misfolded proteins in the cytosol. When p62/SQSTM1 binds to these substrates, it recruits other proteins to form a structure called an autophagosome, which is then engulfed by a lysosome for degradation. This process helps to clear damaged or misfolded proteins from the cell, preventing them from causing further damage.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 913,
    "user_query": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?",
    "yulan-chat-2-13b-fp16_response": "There have been several clinical trials that have directly compared microsurgical clipping with endovascular coiling for the treatment of ruptured brain aneurysms. Here are some of the notable ones:\n1. International Subarachnoid Aneurysm Trial (ISAT): This was a randomized controlled trial that compared the efficacy and safety of microsurgical clipping and endovascular coiling in patients with ruptured aneurysms. The trial involved 20,000 patients from 27 countries and found that both treatments were equally effective in preventing death and disability at 1 year. However, the rate of re-rupture was higher in the endovascular group.\n2. Cerebral Aneurysm Clipping vs. Coiling (CASC) Trial: This was a randomized controlled trial that compared the efficacy and safety of microsurgical clipping and endovascular coiling in patients with unruptured aneurysms. The trial involved 250 patients and found that both treatments were equally effective in preventing death and disability at 2 years. However, the rate of peri-procedural complications was higher in the microsurgical group.\n3. Endovascular Versus Microvascular Decompression for Unruptured Cerebral Aneurysms (EVT-MVD) Trial: This was a randomized controlled trial that compared the efficacy and safety of endovascular coiling and microsurgical clipping in patients with unruptured aneurysms. The trial involved 200 patients and found that both treatments were equally effective in preventing death and disability at 2 years. However, the rate of peri-procedural complications was higher in the microsurgical group.\n4. Clipping Versus Coiling in the Treatment of Unruptured Aneurysms (CEREBRO): This was a randomized controlled trial that compared the efficacy and safety of microsurgical clipping and endovascular coiling in patients with unruptured aneurysms. The trial involved 200 patients and found that both treatments were equally effective in preventing death and disability at 2 years. However, the rate of peri-procedural complications",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The International Subarachnoid Aneurysm Trial (ISAT) was a randomized controlled trial that compared microsurgical clipping and endovascular coiling for ruptured aneurysms.\n2. The ISAT involved 20,000 patients from 27 countries.\n3. The Cerebral Aneurysm Clipping vs. Coiling (CASC) Trial was a randomized controlled trial focusing on patients with unruptured aneurysms.\n4. The CASC Trial involved 250 patients.\n5. The Endovascular Versus Microvascular Decompression for Unruptured Cerebral Aneurysms (EVT-MVD) Trial was a randomized controlled trial with 200 participants.",
    "yulan-chat-2-13b-fp16_fact": [
      "The International Subarachnoid Aneurysm Trial (ISAT) was a randomized controlled trial that compared microsurgical clipping and endovascular coiling for ruptured aneurysms.",
      "The ISAT involved 20,000 patients from 27 countries.",
      "The Cerebral Aneurysm Clipping vs. Coiling (CASC) Trial was a randomized controlled trial focusing on patients with unruptured aneurysms.",
      "The CASC Trial involved 250 patients.",
      "The Endovascular Versus Microvascular Decompression for Unruptured Cerebral Aneurysms (EVT-MVD) Trial was a randomized controlled trial with 200 participants."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The ISAT involved around 2,143 patients from hospitals in the UK, Europe, Australia, Canada, and the United States, not 20,000 patients from 27 countries.\n3. UNKNOWN: Without further context or specific references to the CASC Trial, it's difficult to determine the accuracy of the statement.\n4. UNKNOWN: Without additional information regarding the actual number of participants in the CASC Trial, the accuracy of the number of participants stated cannot be confirmed.\n5. UNKNOWN: Without further detail, it's not possible to verify the specifics of the EVT-MVD Trial, including the number of participants.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 919,
    "user_query": "Which are the mutational hotspots of the human KRAS oncogene?",
    "yulan-chat-2-13b-fp16_response": "The human KRAS oncogene is a well-known oncogene that is frequently mutated in various types of human cancers. Mutations in KRAS are associated with increased cancer risk and poor prognosis. There are several mutational hotspots in the KRAS gene that are commonly mutated in human cancers.\nThe most frequently mutated residues in KRAS are G12, G13, and Q61. G12 and G13 are located in the switch region of KRAS, which regulates the activation of downstream signaling pathways. Mutations at these residues result in a constitutively active KRAS protein that promotes cell proliferation and survival. Q61 is located in the effector domain of KRAS and is involved in the regulation of cell adhesion and migration. Mutations at this residue also result in a constitutively active KRAS protein that promotes tumor growth and metastasis.\nOther hotspots of KRAS mutations include H12, H13, and H14, which are located in the same switch region as G12 and G13. Mutations at these residues also result in a constitutively active KRAS protein.\nOverall, the mutational hotspots of the human KRAS oncogene are associated with increased cancer risk and poor prognosis. Understanding the mechanisms of KRAS mutations and their downstream effects on cell signaling pathways is important for the development of new cancer therapies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in KRAS are associated with increased cancer risk and poor prognosis.\n2. The most frequently mutated residues in KRAS are G12, G13, and Q61.\n3. Mutations in G12 and G13, located in the switch region of KRAS, result in a constitutively active KRAS protein that promotes cell proliferation and survival.\n4. Mutation at Q61, located in the effector domain of KRAS, leads to a constitutively active KRAS protein that promotes tumor growth and metastasis.\n5. H12, H13, and H14 are additional hotspots of KRAS mutations resulting in a constitutively active KRAS protein.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in KRAS are associated with increased cancer risk and poor prognosis.",
      "The most frequently mutated residues in KRAS are G12, G13, and Q61.",
      "Mutations in G12 and G13, located in the switch region of KRAS, result in a constitutively active KRAS protein that promotes cell proliferation and survival.",
      "Mutation at Q61, located in the effector domain of KRAS, leads to a constitutively active KRAS protein that promotes tumor growth and metastasis.",
      "H12, H13, and H14 are additional hotspots of KRAS mutations resulting in a constitutively active KRAS protein."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The recognized hotspots of KRAS mutations that result in a constitutively active KRAS protein are G12, G13, and Q61. H12, H13, and H14 are not established as hotspots for KRAS mutations.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 921,
    "user_query": "What is the mechanism of action of ocrelizumab for treatment of multiple sclerosis?",
    "yulan-chat-2-13b-fp16_response": "Ocrelizumab is a monoclonal antibody that is used to treat multiple sclerosis (MS). It works by targeting a protein called CD20, which is found on the surface of certain immune cells called B cells. B cells play a role in the immune system by producing antibodies that help to fight infections. In MS, B cells are thought to contribute to the development of the disease by producing autoantibodies, which are antibodies that attack the body's own tissues.\nOcrelizumab works by binding to CD20 on B cells and triggering their destruction by the immune system. By reducing the number of B cells in the body, ocrelizumab can help to reduce the production of autoantibodies and slow the progression of MS.\nStudies have shown that ocrelizumab can reduce the number of relapses and the progression of disability in people with MS. It is approved for the treatment of relapsing and primary progressive MS in many countries.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ocrelizumab is a monoclonal antibody used to treat multiple sclerosis (MS).\n2. It targets a protein called CD20 found on the surface of B cells.\n3. Ocrelizumab works by binding to CD20 and triggering the destruction of B cells by the immune system.\n4. The drug helps to reduce the production of autoantibodies and slow the progression of MS.\n5. Ocrelizumab is approved for the treatment of relapsing and primary progressive MS in many countries.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ocrelizumab is a monoclonal antibody used to treat multiple sclerosis (MS).",
      "It targets a protein called CD20 found on the surface of B cells.",
      "Ocrelizumab works by binding to CD20 and triggering the destruction of B cells by the immune system.",
      "The drug helps to reduce the production of autoantibodies and slow the progression of MS.",
      "Ocrelizumab is approved for the treatment of relapsing and primary progressive MS in many countries."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 933,
    "user_query": "Are patients with marfan syndrome at increased risk of arrhythmias?",
    "yulan-chat-2-13b-fp16_response": "Patients with Marfan syndrome may be at increased risk of developing arrhythmias, which are irregular heartbeats. This is because Marfan syndrome can affect the heart and its electrical activity. However, the risk of developing arrhythmias in Marfan syndrome can vary depending on the severity of the condition and other factors, such as age and overall health. It is important for patients with Marfan syndrome to have regular check-ups with a healthcare provider to monitor their heart health and address any concerns.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Patients with Marfan syndrome may be at increased risk of developing arrhythmias.\n2. Marfan syndrome can affect the heart and its electrical activity.\n3. The risk of developing arrhythmias in Marfan syndrome varies depending on the severity of the condition.\n4. Age and overall health are factors that can affect the risk of developing arrhythmias in patients with Marfan syndrome.\n5. Regular check-ups with a healthcare provider are important for monitoring heart health in patients with Marfan syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Patients with Marfan syndrome may be at increased risk of developing arrhythmias.",
      "Marfan syndrome can affect the heart and its electrical activity.",
      "The risk of developing arrhythmias in Marfan syndrome varies depending on the severity of the condition.",
      "Age and overall health are factors that can affect the risk of developing arrhythmias in patients with Marfan syndrome.",
      "Regular check-ups with a healthcare provider are important for monitoring heart health in patients with Marfan syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 935,
    "user_query": "List Kartagener Syndrome Triad.",
    "yulan-chat-2-13b-fp16_response": "Kartagener syndrome is a rare genetic disorder that affects the autonomic nervous system, which controls involuntary functions such as heart rate, blood pressure, and digestion. The syndrome is characterized by a triad of symptoms, which include:\n1. Sinus bradycardia: A slow heart rate, usually less than 60 beats per minute.\n2. Gastric atony: Weakness or paralysis of the stomach muscles, which can lead to vomiting, difficulty swallowing, and malnutrition.\n3. Hypertensive hydrocephalus: Increased pressure on the brain caused by excess fluid, which can lead to headaches, vision problems, and cognitive impairment.\nThese symptoms can vary in severity and may not be present in all individuals with Kartagener syndrome. The disorder is caused by mutations in the genes that encode for the proteins that make up the cilia, which are microtubule-based structures found in many cells throughout the body.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 936,
    "user_query": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?",
    "yulan-chat-2-13b-fp16_response": "The ectopic expression of the protein encoded by the gene DUX4 is associated with a rare genetic disorder called Duchenne muscular dystrophy (DMD). DMD is a progressive muscle disorder that affects primarily boys and is caused by mutations in the dystrophin gene. DUX4 is a gene located on the X chromosome that is normally silenced in muscle cells. However, in DMD, a defective gene on the X chromosome can activate DUX4, leading to the production of the DUX4 protein, which interferes with muscle cell function and causes muscle degeneration.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The protein encoded by the gene DUX4, when ectopically expressed, is associated with Duchenne muscular dystrophy (DMD).\n2. Duchenne muscular dystrophy is a progressive muscle disorder.\n3. Duchenne muscular dystrophy primarily affects boys.\n4. Mutations in the dystrophin gene cause Duchenne muscular dystrophy.\n5. The gene DUX4 is normally silenced in muscle cells but can be activated by a defective gene on the X chromosome in DMD.",
    "yulan-chat-2-13b-fp16_fact": [
      "The protein encoded by the gene DUX4, when ectopically expressed, is associated with Duchenne muscular dystrophy (DMD).",
      "Duchenne muscular dystrophy is a progressive muscle disorder.",
      "Duchenne muscular dystrophy primarily affects boys.",
      "Mutations in the dystrophin gene cause Duchenne muscular dystrophy.",
      "The gene DUX4 is normally silenced in muscle cells but can be activated by a defective gene on the X chromosome in DMD."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The protein encoded by the gene DUX4, when ectopically expressed, is associated with facioscapulohumeral muscular dystrophy (FSHD), not Duchenne muscular dystrophy (DMD).\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: DUX4 is associated with facioscapulohumeral muscular dystrophy (FSHD), not Duchenne muscular dystrophy (DMD). For DMD, it is mutations in the dystrophin gene that are typically responsible for the disease. The gene DUX4 is normally silenced in most tissues but can become active in individuals with FSHD, not DMD.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 938,
    "user_query": "Which are the main functions of the APOBEC3 family of proteins?",
    "yulan-chat-2-13b-fp16_response": "The APOBEC3 family of proteins has several functions, including:\n1. Inhibition of HIV-1 and other retroviruses: APOBEC3 proteins can target and inhibit the replication of retroviruses, such as HIV-1, by deaminating cytosine to uracil in the viral DNA.\n2. Regulation of cell differentiation: APOBEC3 proteins have been shown to play a role in regulating cell differentiation and maintaining the stem cell-like properties of certain cell types.\n3. Control of immune response: APOBEC3 proteins have been implicated in the regulation of the immune response, particularly in the context of viral infections.\n4. Maintenance of genome stability: APOBEC3 proteins can also play a role in maintaining the stability of the genome by targeting and degrading single-stranded DNA.\n5. Regulation of cell proliferation: APOBEC3 proteins have been shown to play a role in regulating cell proliferation and cell cycle progression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. APOBEC3 proteins can inhibit the replication of retroviruses such as HIV-1 by deaminating cytosine to uracil in the viral DNA.\n2. APOBEC3 proteins play a role in regulating cell differentiation.\n3. APOBEC3 proteins have been implicated in the regulation of the immune response, especially in the context of viral infections.\n4. APOBEC3 proteins can play a role in maintaining the stability of the genome by targeting and degrading single-stranded DNA.\n5. APOBEC3 proteins are involved in regulating cell proliferation and cell cycle progression.",
    "yulan-chat-2-13b-fp16_fact": [
      "APOBEC3 proteins can inhibit the replication of retroviruses such as HIV-1 by deaminating cytosine to uracil in the viral DNA.",
      "APOBEC3 proteins play a role in regulating cell differentiation.",
      "APOBEC3 proteins have been implicated in the regulation of the immune response, especially in the context of viral infections.",
      "APOBEC3 proteins can play a role in maintaining the stability of the genome by targeting and degrading single-stranded DNA.",
      "APOBEC3 proteins are involved in regulating cell proliferation and cell cycle progression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no extensive evidence that directly links APOBEC3 proteins to the regulation of cell differentiation. APOBEC3 proteins are primarily involved in innate immune defense against viruses and endogenous retroelements.\n3. TRUE\n4. TRUE: While the APOBEC3 family of proteins is most well-known for their role in defense against viruses, some members can also target genomic DNA and contribute to mutagenesis, which can have effects on genome stability.\n5. UNKNOWN: The role of APOBEC3 proteins in regulating cell proliferation and cell cycle progression is not well-established and would require specific context to determine the truth of this statement. These proteins are known for their role in innate immunity and retroviral restriction, and while they may have implications in cellular processes like proliferation due to mutagenic activity or other mechanisms, this statement is too vague without further context.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 939,
    "user_query": "Which histone modifications are associated with constitutive heterochromatin?",
    "yulan-chat-2-13b-fp16_response": "Constitutive heterochromatin is characterized by tightly packaged DNA and reduced gene expression. Histone modifications associated with constitutive heterochromatin include:\n1. Histone-to-DNA interactions: Histones H1 and H3 are highly conserved in constitutive heterochromatin, and they interact with DNA to form a more compact chromatin structure.\n2. DNA methylation: Methylation of cytosine residues in CpG islands is a common modification in constitutive heterochromatin. Methylation of CpG islands is associated with gene silencing and is a hallmark of constitutive heterochromatin.\n3. Histone modifications: Histone H3 can be trimethylated at lysine 27 (H3K27me3) and histone H4 can be trimethylated at lysine 20 (H4K20me3) in constitutive heterochromatin. These modifications are associated with gene silencing and are thought to contribute to the formation of constitutive heterochromatin.\n4. Chromatin remodeling: Chromatin remodeling complexes, such as the ISWI complex, can also contribute to the formation of constitutive heterochromatin by altering the structure of chromatin and regulating gene expression.\nOverall, these modifications contribute to the formation of a compact, highly condensed chromatin structure that is associated with reduced gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histones H1 and H3 are highly conserved in constitutive heterochromatin and contribute to forming a more compact chromatin structure.\n2. Methylation of cytosine residues in CpG islands is a common modification in constitutive heterochromatin and is associated with gene silencing.\n3. Histone H3 can be trimethylated at lysine 27 (H3K27me3) in constitutive heterochromatin.\n4. Histone H4 can be trimethylated at lysine 20 (H4K20me3) in constitutive heterochromatin.\n5. Chromatin remodeling complexes, such as the ISWI complex, are involved in the formation of constitutive heterochromatin by altering chromatin structure and regulating gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histones H1 and H3 are highly conserved in constitutive heterochromatin and contribute to forming a more compact chromatin structure.",
      "Methylation of cytosine residues in CpG islands is a common modification in constitutive heterochromatin and is associated with gene silencing.",
      "Histone H3 can be trimethylated at lysine 27 (H3K27me3) in constitutive heterochromatin.",
      "Histone H4 can be trimethylated at lysine 20 (H4K20me3) in constitutive heterochromatin.",
      "Chromatin remodeling complexes, such as the ISWI complex, are involved in the formation of constitutive heterochromatin by altering chromatin structure and regulating gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Histone H1 is often associated with linker DNA between nucleosomes and contributes to the overall compaction of chromatin. Histone H3, while not exclusively present in constitutive heterochromatin, is subject to modifications that can lead to a more compact chromatin structure, which is characteristic of heterochromatin.\n\n2. TRUE: Methylation of cytosine residues in CpG islands is indeed a common modification that occurs in constitutive heterochromatin and is generally linked to the repression of gene expression.\n\n3. FALSE [correction]: Histone H3 trimethylated at lysine 27 (H3K27me3) is commonly associated with facultative heterochromatin, rather than constitutive heterochromatin. Constitutive heterochromatin is more typically associated with the trimethylation of Histone H3 at lysine 9 (H3K9me3).\n\n4. TRUE: Trimethylation of histone H4 at lysine 20 (H4K20me3) is indeed a modification that is associated with constitutive heterochromatin, and it contributes to the maintenance of its structure.\n\n5. TRUE: Chromatin remodeling complexes, such as the ISWI complex, do play roles in the formation of constitutive heterochromatin by altering chromatin structure and regulating gene expression. These complexes can reposition nucleosomes and contribute to the condensed state of heterochromatin.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 940,
    "user_query": "What is the main application of SWATH-MS in proteomics?",
    "yulan-chat-2-13b-fp16_response": "SWATH-MS (Synthetic Tandem Mass Spectrometry) is a mass spectrometry-based technique that has become increasingly popular in proteomics for the analysis of complex protein mixtures. The main application of SWATH-MS in proteomics is the identification and quantification of proteins in biological samples, such as blood, urine, or tissue extracts.\nSWATH-MS works by fragmenting peptides into tandem mass spectrometry (MS/MS) using a collision-induced dissociation (CID) event, followed by analysis of the resulting fragment ions. This approach allows for the identification of peptides derived from a large number of proteins in a sample, which can then be quantified using stable isotope labeling or other quantitative methods.\nOne of the key advantages of SWATH-MS is its ability to generate high-resolution and accurate-mass data for large numbers of peptides in a single analysis, which can be used for both discovery and targeted proteomics. This makes it particularly useful for the analysis of complex biological samples, such as those from clinical specimens or biological pathways, where the identification and quantification of multiple proteins is critical.\nOverall, SWATH-MS is a powerful tool in proteomics that has the potential to transform our understanding of complex biological systems and accelerate the development of new diagnostic and therapeutic approaches.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SWATH-MS is mainly used for the identification and quantification of proteins in biological samples such as blood, urine, or tissue extracts.\n2. SWATH-MS employs collision-induced dissociation (CID) for fragmenting peptides and analyzing the resulting fragment ions.\n3. The technique can identify peptides from a large number of proteins in a sample.\n4. SWATH-MS can be used for both discovery and targeted proteomics due to its high-resolution and accurate-mass data generation for large numbers of peptides.\n5. The utility of SWATH-MS extends to the analysis of complex biological samples relevant to clinical specimens or biological pathways.",
    "yulan-chat-2-13b-fp16_fact": [
      "SWATH-MS is mainly used for the identification and quantification of proteins in biological samples such as blood, urine, or tissue extracts.",
      "SWATH-MS employs collision-induced dissociation (CID) for fragmenting peptides and analyzing the resulting fragment ions.",
      "The technique can identify peptides from a large number of proteins in a sample.",
      "SWATH-MS can be used for both discovery and targeted proteomics due to its high-resolution and accurate-mass data generation for large numbers of peptides.",
      "The utility of SWATH-MS extends to the analysis of complex biological samples relevant to clinical specimens or biological pathways."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll of the statements are accurate descriptions of SWATH-MS (Sequential Window Acquisition of All Theoretical Mass Spectra) capabilities and applications in proteomics.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 949,
    "user_query": "Do R-loops tend to form at sites of DNA replication?",
    "yulan-chat-2-13b-fp16_response": "Yes, R-loops tend to form at sites of DNA replication. R-loops are a type of DNA structure that forms when RNA molecules form a loop between a DNA strand and its complementary strand, trapping the RNA in the loop. This structure can form at replication forks, which are the regions where DNA replication occurs. At these sites, the DNA double helix is unwound and each strand serves as a template for the synthesis of a new complementary strand. The RNA molecule can bind to the template DNA and form an R-loop. R-loops have been implicated in various genetic disorders and are also thought to play a role in the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. R-loops tend to form at sites of DNA replication.\n2. R-loops are structures where an RNA molecule forms a loop between a DNA strand and its complementary strand.\n3. R-loops can form at replication forks.\n4. Replication forks are regions where DNA replication occurs and involve unwinding of the DNA double helix.\n5. R-loops have been implicated in various genetic disorders and are thought to play a role in the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "R-loops tend to form at sites of DNA replication.",
      "R-loops are structures where an RNA molecule forms a loop between a DNA strand and its complementary strand.",
      "R-loops can form at replication forks.",
      "Replication forks are regions where DNA replication occurs and involve unwinding of the DNA double helix.",
      "R-loops have been implicated in various genetic disorders and are thought to play a role in the regulation of gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: R-loops tend to form at sites of transcription, not DNA replication.\n2. FALSE [correction]: R-loops are structures where an RNA molecule hybridizes to one strand of DNA, displacing the complementary DNA strand, which \"loops out.\"\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 951,
    "user_query": "What are the structures formed when keratin molecules come together?",
    "yulan-chat-2-13b-fp16_response": "Keratin is a fibrous protein that is found in the skin, hair, nails, feathers, hooves, and other structures in animals. When keratin molecules come together, they form a variety of structures depending on the specific type of keratin and the conditions under which it is found.\nIn hair, keratin molecules form a tightly packed, helical structure that gives hair its strength and flexibility. In nails, keratin molecules form a hard, protective shell that covers the finger or toe. In feathers, keratin molecules form a complex, branching structure that gives feathers their distinctive shapes and colors.\nKeratin can also form filaments, sheets, and other structures in the skin and other tissues. These structures help to provide strength, flexibility, and protection to the body's tissues.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Keratin is a fibrous protein found in the skin, hair, nails, feathers, hooves, and other structures in animals.\n2. In hair, keratin molecules form a tightly packed, helical structure.\n3. Keratin forms a hard, protective shell in nails.\n4. In feathers, keratin molecules form a complex, branching structure.\n5. Keratin can form filaments, sheets, and other structures in the skin and other tissues.",
    "yulan-chat-2-13b-fp16_fact": [
      "Keratin is a fibrous protein found in the skin, hair, nails, feathers, hooves, and other structures in animals.",
      "In hair, keratin molecules form a tightly packed, helical structure.",
      "Keratin forms a hard, protective shell in nails.",
      "In feathers, keratin molecules form a complex, branching structure.",
      "Keratin can form filaments, sheets, and other structures in the skin and other tissues."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: In hair, keratin molecules form intermediate filaments, which are then bundled together into a microfibril structure, rather than forming a tightly packed, helical structure.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 953,
    "user_query": "Which are the main features of CREST and other ALS-linked proteins?",
    "yulan-chat-2-13b-fp16_response": "CREST (Chromatin Remodeling Signature Tag) is a protein that is involved in the regulation of gene expression. It is a component of the ISWI (Immobilized SWItch) complex, which is a member of the ISWI-like family of chromatin remodeling complexes. The ISWI complex uses the energy of ATP hydrolysis to move along DNA and remodel chromatin structure.\nCREST and other ALS-linked proteins are characterized by a number of structural and functional features. Some of the main features of CREST and other ALS-linked proteins include:\n1. ATP-dependent chromatin remodeling: CREST and other ALS-linked proteins use the energy of ATP hydrolysis to move along DNA and remodel chromatin structure.\n2. Chromatin-associated factors: CREST and other ALS-linked proteins are associated with chromatin and play a role in the regulation of gene expression.\n3. Nucleosome-sliding activity: CREST and other ALS-linked proteins have the ability to slide nucleosomes along DNA, which can alter chromatin structure and affect gene expression.\n4. DNA-binding domains: CREST and other ALS-linked proteins have specific domains that allow them to bind to DNA and recruit other factors to the chromatin.\n5. Multisubunit structure: CREST and other ALS-linked proteins are typically multisubunit complexes, which allows them to carry out a range of functions related to chromatin remodeling and gene expression.\nOverall, CREST and other ALS-linked proteins are important regulators of gene expression and play a key role in the maintenance and function of chromatin structure.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CREST (Chromatin Remodeling Signature Tag) is involved in the regulation of gene expression.\n2. CREST is a component of the ISWI (Immobilized SWItch) complex, a member of the ISWI-like family of chromatin remodeling complexes.\n3. The ISWI complex uses the energy of ATP hydrolysis to move along DNA and remodel chromatin structure.\n4. CREST and other ALS-linked proteins have the ability to slide nucleosomes along DNA, which can alter chromatin structure and affect gene expression.\n5. CREST and other ALS-linked proteins typically have a multisubunit structure, conducting a range of functions related to chromatin remodeling and gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "CREST (Chromatin Remodeling Signature Tag) is involved in the regulation of gene expression.",
      "CREST is a component of the ISWI (Immobilized SWItch) complex, a member of the ISWI-like family of chromatin remodeling complexes.",
      "The ISWI complex uses the energy of ATP hydrolysis to move along DNA and remodel chromatin structure.",
      "CREST and other ALS-linked proteins have the ability to slide nucleosomes along DNA, which can alter chromatin structure and affect gene expression.",
      "CREST and other ALS-linked proteins typically have a multisubunit structure, conducting a range of functions related to chromatin remodeling and gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: CREST refers to \"Calcium Responsive Transactivator\", which is not typically associated with the ISWI complex; rather, the ISWI (Imitation SWItch) complex is a member of a different family of chromatin remodeling complexes.\n3. TRUE\n4. UNKNOWN (however, the statement seems to conflate CREST with the function of chromatin remodeling complexes like ISWI, which can slide nucleosomes; it is not clear if CREST itself has this ability)\n5. UNKNOWN (the statement combines CREST with \"other ALS-linked proteins\" which is too vague to assess without specific details on which proteins are being referred to and their structures and functions)",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 955,
    "user_query": "What is the relationship between nucleosomes and exons?",
    "yulan-chat-2-13b-fp16_response": "Nucleosomes and exons are related in that nucleosomes are the basic unit of chromatin, which is the complex of DNA and proteins that makes up the chromosomes in eukaryotic cells. Exons are the regions of DNA that code for proteins, while introns are the non-coding regions. Nucleosomes play a role in regulating gene expression by packaging the DNA and making it more difficult for transcription factors to access the DNA and initiate transcription of the genes. In this way, the presence or absence of nucleosomes can affect the expression of exons.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nucleosomes are the basic unit of chromatin in eukaryotic cells.\n2. Chromatin is the complex of DNA and proteins that makes up chromosomes.\n3. Exons are regions of DNA that code for proteins.\n4. Introns are the non-coding regions of DNA.\n5. The presence or absence of nucleosomes can affect the expression of exons by regulating gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nucleosomes are the basic unit of chromatin in eukaryotic cells.",
      "Chromatin is the complex of DNA and proteins that makes up chromosomes.",
      "Exons are regions of DNA that code for proteins.",
      "Introns are the non-coding regions of DNA.",
      "The presence or absence of nucleosomes can affect the expression of exons by regulating gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 956,
    "user_query": "List programs suitable for pharmacophore modelling",
    "yulan-chat-2-13b-fp16_response": "Pharmacophore modeling is a technique used in drug design and virtual screening to identify the molecular features of a drug that are important for its biological activity. Here are some programs that are suitable for pharmacophore modeling:\n1. AutoDock Vina: This is a popular program for docking small molecules to a target protein. It can also be used for pharmacophore generation and optimization.\n2. Schrodinger Suite: This is a comprehensive suite of programs for drug discovery and design, including tools for pharmacophore generation, virtual screening, and molecular dynamics simulations.\n3. PyMOL: This is a molecular visualization program that can be used for generating and manipulating pharmacophores.\n4. LigandScout: This is a program specifically designed for pharmacophore-based virtual screening and ligand-based drug design.\n5. PharmaMapper: This program is used for the identification of pharmacophores and the generation of 2D and 3D representations of drug-target interactions.\n6. RDKit: This is a Python-based open-source toolkit for molecular manipulation and analysis, which includes tools for pharmacophore generation and virtual screening.\n7. MOE: This is a molecular modeling and visualization software that can be used for pharmacophore-based virtual screening and ligand-based drug design.\n8. GOLD: This is a program that uses machine learning algorithms to generate pharmacophores and predict the activity of new compounds.\nThese are just a few examples of programs that can be used for pharmacophore modeling. The choice of program will depend on the specific needs and requirements of the project.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. AutoDock Vina is used for docking small molecules to a target protein and for pharmacophore generation and optimization.\n2. The Schrodinger Suite includes tools for pharmacophore generation, virtual screening, and molecular dynamics simulations as part of its drug discovery and design programs.\n3. PyMOL is a molecular visualization program that can be used for generating and manipulating pharmacophores.\n4. LigandScout is designed specifically for pharmacophore-based virtual screening and ligand-based drug design.\n5. PharmaMapper is used for identifying pharmacophores and generating both 2D and 3D representations of drug-target interactions.",
    "yulan-chat-2-13b-fp16_fact": [
      "AutoDock Vina is used for docking small molecules to a target protein and for pharmacophore generation and optimization.",
      "The Schrodinger Suite includes tools for pharmacophore generation, virtual screening, and molecular dynamics simulations as part of its drug discovery and design programs.",
      "PyMOL is a molecular visualization program that can be used for generating and manipulating pharmacophores.",
      "LigandScout is designed specifically for pharmacophore-based virtual screening and ligand-based drug design.",
      "PharmaMapper is used for identifying pharmacophores and generating both 2D and 3D representations of drug-target interactions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: AutoDock Vina is used for docking small molecules to a target protein but it is not typically used for pharmacophore generation and optimization.\n2. TRUE\n3. FALSE [correction]: PyMOL is primarily a molecular visualization program and does not generate or manipulate pharmacophores.\n4. TRUE\n5. FALSE [correction]: PharmaMapper is used for identifying potential drug targets, not for generating representations of drug-target interactions.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 959,
    "user_query": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?",
    "yulan-chat-2-13b-fp16_response": "Circulating tumor DNA (ctDNA) detection is a method of detecting cancer by analyzing DNA fragments that are circulating in the bloodstream. There are several methods for ctDNA detection, including:\n1. Next-generation sequencing (NGS): This method involves sequencing the entire genome or specific genes of ctDNA fragments to identify mutations and other genetic alterations that are indicative of cancer.\n2. Digital PCR (dPCR): This method involves dividing the DNA in the blood sample into thousands of small reactions, each of which is individually analyzed for the presence of ctDNA.\n3. Quantitative PCR (qPCR): This method involves amplifying specific DNA sequences in the blood sample and measuring the amount of ctDNA present.\n4. Circulating tumor DNA (ctDNA) liquid biopsy: This method involves analyzing a blood sample for the presence of circulating tumor DNA using a variety of technologies, including NGS, dPCR, and qPCR.\n5. Magnetic capture and detection: This method involves capturing ctDNA using magnetic beads and then detecting it using a variety of technologies, including NGS, dPCR, and qPCR.\nThese methods can be used to detect ctDNA in various types of cancer, including lung, breast, colon, and liver cancer. The choice of method depends on the specific type of cancer, the stage of the disease, and the patient's individual needs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Next-Generation Sequencing (NGS) is used to sequence the genome or specific genes of ctDNA fragments to identify cancer indicators.\n2. Digital PCR (dPCR) involves dividing DNA in the blood sample into many small reactions for ctDNA analysis.\n3. Quantitative PCR (qPCR) is a method that amplifies specific DNA sequences to measure the amount of ctDNA.\n4. ctDNA liquid biopsy refers to the analysis of a blood sample for circulating tumor DNA using technologies like NGS, dPCR, and qPCR.\n5. Magnetic capture and detection is a method that uses magnetic beads to capture ctDNA and includes technologies such as NGS, dPCR, and qPCR for detection.",
    "yulan-chat-2-13b-fp16_fact": [
      "Next-Generation Sequencing (NGS) is used to sequence the genome or specific genes of ctDNA fragments to identify cancer indicators.",
      "Digital PCR (dPCR) involves dividing DNA in the blood sample into many small reactions for ctDNA analysis.",
      "Quantitative PCR (qPCR) is a method that amplifies specific DNA sequences to measure the amount of ctDNA.",
      "ctDNA liquid biopsy refers to the analysis of a blood sample for circulating tumor DNA using technologies like NGS, dPCR, and qPCR.",
      "Magnetic capture and detection is a method that uses magnetic beads to capture ctDNA and includes technologies such as NGS, dPCR, and qPCR for detection."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Magnetic capture and detection is a method that uses magnetic beads to capture ctDNA, but it does not inherently include technologies such as NGS, dPCR, and qPCR for detection. These technologies may be used after magnetic capture for the analysis and detection of the captured ctDNA, but they are not a part of the magnetic capture process itself.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 960,
    "user_query": "Which gene is associated with Muenke syndrome?",
    "yulan-chat-2-13b-fp16_response": "Muenke syndrome is caused by a mutation in the FGFR3 gene, which is located on chromosome 8. This gene provides instructions for making a protein called the fibroblast growth factor receptor 3 (FGFR3), which plays a role in the development of bones in the skull and other parts of the body. A mutation in the FGFR3 gene leads to the overactivation of this protein, which causes the characteristic features of Muenke syndrome, such as the distinctive facial appearance, bone abnormalities, and delayed closure of the fontanels.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Muenke syndrome is caused by a mutation in the FGFR3 gene.\n2. The FGFR3 gene is located on chromosome 8.\n3. The FGFR3 gene provides instructions for making the fibroblast growth factor receptor 3 (FGFR3) protein.\n4. The FGFR3 protein is involved in the development of bones in the skull and other parts of the body.\n5. A mutation in the FGFR3 gene can lead to the overactivation of the FGFR3 protein, resulting in the symptoms of Muenke syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Muenke syndrome is caused by a mutation in the FGFR3 gene.",
      "The FGFR3 gene is located on chromosome 8.",
      "The FGFR3 gene provides instructions for making the fibroblast growth factor receptor 3 (FGFR3) protein.",
      "The FGFR3 protein is involved in the development of bones in the skull and other parts of the body.",
      "A mutation in the FGFR3 gene can lead to the overactivation of the FGFR3 protein, resulting in the symptoms of Muenke syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The FGFR3 gene is located on chromosome 4.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "yulan-chat-2-13b-fp16_response": "There is evidence to suggest that STAT3 (Signal Transducer and Activator of Transcription 3) is involved in the EIF2AK2 (Eukaryotic Initiation Factor 2A-activating Kinase 2)-dependent suppression of autophagy.\nAutophagy is a cellular process by which cells degrade and recycle their own components, such as damaged organelles and proteins, to maintain cellular homeostasis. EIF2AK2 is a key regulator of autophagy, as it activates the translation of autophagy-related genes through the phosphorylation of eIF2, which promotes the recruitment of autophagy machinery to the site of degradation.\nSTAT3 is a transcription factor that plays a role in regulating cellular processes such as inflammation, immune response, and cell survival. It has been shown to be involved in the regulation of autophagy, as it can activate or inhibit autophagy depending on the context.\nSeveral studies have suggested that STAT3 can inhibit EIF2AK2-dependent autophagy by suppressing the translation of autophagy-related genes. For example, it has been shown that STAT3 can inhibit the translation of the autophagy gene ATG5 in cancer cells, which can promote tumor growth.\nHowever, other studies have suggested that STAT3 can also promote autophagy by activating the translation of autophagy-related genes. For example, it has been shown that STAT3 can promote the translation of the autophagy gene ATG7 in immune cells, which can enhance the immune response to pathogens.\nOverall, the involvement of STAT3 in EIF2AK2-dependent suppression of autophagy is complex and context-dependent, and further research is needed to fully understand the mechanisms underlying this regulation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. STAT3 (Signal Transducer and Activator of Transcription 3) is implicated in EIF2AK2 (Eukaryotic Initiation Factor 2A-activating Kinase 2)-dependent suppression of autophagy.\n2. EIF2AK2 activates the translation of autophagy-related genes through the phosphorylation of eIF2.\n3. STAT3 is a transcription factor that can regulate the process of autophagy.\n4. Studies have shown that STAT3 can inhibit the translation of the autophagy gene ATG5 in cancer cells.\n5. Research has indicated that STAT3 can promote the translation of the autophagy gene ATG7 in immune cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "STAT3 (Signal Transducer and Activator of Transcription 3) is implicated in EIF2AK2 (Eukaryotic Initiation Factor 2A-activating Kinase 2)-dependent suppression of autophagy.",
      "EIF2AK2 activates the translation of autophagy-related genes through the phosphorylation of eIF2.",
      "STAT3 is a transcription factor that can regulate the process of autophagy.",
      "Studies have shown that STAT3 can inhibit the translation of the autophagy gene ATG5 in cancer cells.",
      "Research has indicated that STAT3 can promote the translation of the autophagy gene ATG7 in immune cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: Without the specific scientific context or findings regarding STAT3's role in EIF2AK2-dependent suppression of autophagy, a determination cannot be made.\n2. TRUE: EIF2AK2 (also known as PKR) is known to phosphorylate eIF2, which can influence the translation of autophagy-related genes among its various regulatory functions.\n3. TRUE: STAT3 is recognized as a transcription factor involved in multiple cellular processes, including autophagy regulation.\n4. UNKNOWN: Information on STAT3's impact on the translation of the autophagy gene ATG5 in cancer cells would need to come from specific studies, which are not provided here.\n5. UNKNOWN: As with statement 4, the effect of STAT3 on the translation of the autophagy gene ATG7 in immune cells would need to be verified by specific scientific research.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 965,
    "user_query": "What are the Topological Domains (TADs)?",
    "yulan-chat-2-13b-fp16_response": "Topological domains (TADs) are regions of space in a cell nucleus that are defined by the arrangement of chromatin, the complex of DNA and proteins that makes up the chromosomes. TADs are thought to play a role in regulating gene expression by controlling the accessibility of DNA to transcription factors and other regulatory proteins. They are also believed to be important for maintaining the stability of the genome and for the proper functioning of the cell. TADs are formed by the interaction of chromatin with the nuclear lamina, a network of proteins that helps to define the shape and organization of the nucleus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Topological domains (TADs) are regions in a cell nucleus defined by the arrangement of chromatin.\n2. TADs are thought to play a role in regulating gene expression by controlling DNA accessibility to transcription factors and regulatory proteins.\n3. TADs are believed to be important for maintaining genome stability.\n4. TADs are important for the proper functioning of the cell.\n5. TADs are formed by the interaction of chromatin with the nuclear lamina.",
    "yulan-chat-2-13b-fp16_fact": [
      "Topological domains (TADs) are regions in a cell nucleus defined by the arrangement of chromatin.",
      "TADs are thought to play a role in regulating gene expression by controlling DNA accessibility to transcription factors and regulatory proteins.",
      "TADs are believed to be important for maintaining genome stability.",
      "TADs are important for the proper functioning of the cell.",
      "TADs are formed by the interaction of chromatin with the nuclear lamina."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: TADs are formed by the folding of chromatin into distinct regions within the nucleus. While interactions with the nuclear lamina can play a role in organizing chromatin within the nucleus, TADs are not specifically formed by chromatin interaction with the nuclear lamina. They are established by chromatin looping interactions that are often mediated by proteins like CTCF and cohesin.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 966,
    "user_query": "What is the vibrational theory of olfaction?",
    "yulan-chat-2-13b-fp16_response": "The vibrational theory of olfaction proposes that odorants interact with specific receptors in the nose through intermolecular vibrations. According to this theory, odorants are able to excite the vibrational modes of the receptor proteins, which in turn triggers a signaling cascade that ultimately leads to the perception of a particular odor.\nThe vibrational theory was first proposed by Luca Turin and colleagues in the late 1990s, and it has since gained support from a number of experimental studies. The theory suggests that the specificity of odorant-receptor interactions is due to the fact that the vibrational frequencies of the odorants are able to selectively excite specific vibrational modes of the receptor proteins. This selectivity is thought to be responsible for the high specificity of olfactory receptors, which can distinguish between a vast array of different odorants.\nOverall, the vibrational theory of olfaction provides a mechanistic explanation for how odorants are able to activate olfactory receptors and trigger the perception of different smells. While there is still much to be learned about the complex processes involved in olfactory perception, the vibrational theory represents an important step forward in our understanding of how the sense of smell works.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The vibrational theory of olfaction proposes that odorants interact with olfactory receptors through intermolecular vibrations.\n2. The theory suggests that odorants excite the vibrational modes of receptor proteins, initiating a signaling cascade leading to odor perception.\n3. Luca Turin and colleagues first proposed the vibrational theory in the late 1990s.\n4. The theory has gained support from a number of experimental studies.\n5. The vibrational theory posits that olfactory receptors have a high specificity capable of distinguishing between many different odorants.",
    "yulan-chat-2-13b-fp16_fact": [
      "The vibrational theory of olfaction proposes that odorants interact with olfactory receptors through intermolecular vibrations.",
      "The theory suggests that odorants excite the vibrational modes of receptor proteins, initiating a signaling cascade leading to odor perception.",
      "Luca Turin and colleagues first proposed the vibrational theory in the late 1990s.",
      "The theory has gained support from a number of experimental studies.",
      "The vibrational theory posits that olfactory receptors have a high specificity capable of distinguishing between many different odorants."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE: Luca Turin is widely associated with the vibrational theory of olfaction, and he began to develop his ideas in the 1990s, with significant publications on the topic appearing towards the end of the decade.\n4. UNKNOWN: While there has been some experimental evidence that may support the vibrational theory of olfaction, it remains a contested theory with alternative explanations for olfactory perception, such as the shape theory of olfaction. Support may exist, but the degree of acceptance within the scientific community is not specified and can vary.\n5. TRUE: The vibrational theory does indeed suggest that olfactory receptors would need to be highly specific to differentiate between the vibrational frequencies of different odorant molecules, leading to the ability to distinguish many different smells.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 971,
    "user_query": "Which deiodinases are best known to be present in brain?",
    "yulan-chat-2-13b-fp16_response": "Deiodinases are enzymes that play a key role in regulating thyroid hormone metabolism in the body. There are three known types of deiodinases: deiodinase 1 (DIO1), deiodinase 2 (DIO2), and deiodinase 3 (DIO3).\nDIO1 is the major deiodinase in the brain and is responsible for the conversion of thyroxine (T4) to triiodothyronine (T3) in this tissue. DIO2 is also present in the brain, but to a lesser extent than DIO1. DIO3 is not known to be present in the brain.\nIn addition to the brain, DIO1 is also found in other tissues such as the kidney, liver, and skeletal muscle, where it plays a similar role in regulating thyroid hormone metabolism. DIO2 is primarily expressed in the thyroid gland, where it is involved in the production of T3 and T4 from thyroglobulin.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There are three known types of deiodinases: deiodinase 1 (DIO1), deiodinase 2 (DIO2), and deiodinase 3 (DIO3).\n2. Deiodinase 1 (DIO1) is the major deiodinase present in the brain.\n3. Deiodinase 1 (DIO1) in the brain is responsible for the conversion of thyroxine (T4) to triiodothyronine (T3).\n4. Deiodinase 2 (DIO2) is present in the brain, but to a lesser extent than DIO1.\n5. Deiodinase 1 (DIO1) is also found in other tissues such as the kidney, liver, and skeletal muscle.",
    "yulan-chat-2-13b-fp16_fact": [
      "There are three known types of deiodinases: deiodinase 1 (DIO1), deiodinase 2 (DIO2), and deiodinase 3 (DIO3).",
      "Deiodinase 1 (DIO1) is the major deiodinase present in the brain.",
      "Deiodinase 1 (DIO1) in the brain is responsible for the conversion of thyroxine (T4) to triiodothyronine (T3).",
      "Deiodinase 2 (DIO2) is present in the brain, but to a lesser extent than DIO1.",
      "Deiodinase 1 (DIO1) is also found in other tissues such as the kidney, liver, and skeletal muscle."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Deiodinase 2 (DIO2) is the major deiodinase present in the brain.\n3. FALSE [correction]: Deiodinase 2 (DIO2) in the brain is primarily responsible for the conversion of thyroxine (T4) to triiodothyronine (T3).\n4. FALSE [correction]: Deiodinase 2 (DIO2) is not present to a lesser extent than DIO1 in the brain; it is the predominant deiodinase in the central nervous system.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "yulan-chat-2-13b-fp16_response": "Theatre is a software tool used for genomic analysis that allows researchers to analyze and visualize large-scale genomic data sets. It is designed to help researchers identify patterns and relationships within genomic data, and to facilitate the interpretation of complex genomic data.\nTheatre software is used to analyze and visualize genomic data in a variety of ways. For example, it can be used to identify genetic markers associated with specific diseases or traits, to analyze the structure and function of genes and proteins, and to study the interactions between different genes and proteins.\nOne of the key features of Theatre is its ability to integrate data from multiple sources, including genomic sequencing data, gene expression data, and functional genomic data. This allows researchers to gain a more comprehensive understanding of the genetic basis of complex traits and diseases.\nOverall, Theatre is a powerful tool for genomic analysis that enables researchers to gain insights into the complex relationships between genes, proteins, and other molecular components of the genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Theatre is a software tool used for genomic analysis.\n2. Theatre allows researchers to analyze and visualize large-scale genomic data sets.\n3. The software can identify genetic markers associated with specific diseases or traits.\n4. Theatre can be used to analyze the structure and function of genes and proteins.\n5. Theatre integrates data from multiple sources, including genomic sequencing data, gene expression data, and functional genomic data.",
    "yulan-chat-2-13b-fp16_fact": [
      "Theatre is a software tool used for genomic analysis.",
      "Theatre allows researchers to analyze and visualize large-scale genomic data sets.",
      "The software can identify genetic markers associated with specific diseases or traits.",
      "Theatre can be used to analyze the structure and function of genes and proteins.",
      "Theatre integrates data from multiple sources, including genomic sequencing data, gene expression data, and functional genomic data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Theatre is not known as a software tool used for genomic analysis. It might be confused with other tools such as Galaxy, IGV, or GATK.\n2. UNKNOWN (Based on the response to statement 1, it's unclear whether this statement refers to the correct tool since \"Theatre\" isn't recognized as genomic software.)\n3. UNKNOWN (Same as above)\n4. UNKNOWN (Same as above)\n5. UNKNOWN (Same as above)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 974,
    "user_query": "How are CRM (cis-regulatory modules) defined?",
    "yulan-chat-2-13b-fp16_response": "CRM (cis-regulatory modules) are defined as the DNA sequences that control gene expression by binding to regulatory proteins and initiating or inhibiting transcription of the genes. These DNA sequences are located in the promoter region of a gene and contain specific binding sites for transcription factors, which are proteins that regulate gene expression by binding to specific DNA sequences. CRMs play a critical role in the regulation of gene expression and are essential for the proper development and function of organisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CRM (cis-regulatory modules) are DNA sequences that control gene expression.\n2. CRMs function by binding regulatory proteins to initiate or inhibit the transcription of genes.\n3. CRMs are located in the promoter region of a gene.\n4. CRMs contain specific binding sites for transcription factors.\n5. Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences.",
    "yulan-chat-2-13b-fp16_fact": [
      "CRM (cis-regulatory modules) are DNA sequences that control gene expression.",
      "CRMs function by binding regulatory proteins to initiate or inhibit the transcription of genes.",
      "CRMs are located in the promoter region of a gene.",
      "CRMs contain specific binding sites for transcription factors.",
      "Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CRMs can be located in various regions relative to their target genes, including promoters, enhancers, silencers, and insulators, not exclusively in the promoter region.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 978,
    "user_query": "Which factor interacts with Treslin/TICRR throughout the cell cycle of human cells?",
    "yulan-chat-2-13b-fp16_response": "Treslin (also known as TICRR, or TICAM-1) is a transmembrane protein that plays a role in regulating the cell cycle progression of human cells. Treslin interacts with various factors throughout the cell cycle, including:\n1. Cyclins: Treslin interacts with cyclin-dependent kinases (CDKs) and cyclins during the G1 phase of the cell cycle. This interaction is important for the activation of CDKs and the initiation of DNA synthesis during the S phase.\n2. p53: Treslin can also interact with the tumor suppressor protein p53 during the G2 phase of the cell cycle. This interaction is thought to play a role in the regulation of the cell cycle checkpoint and the response to DNA damage.\n3. Microtubules: Treslin interacts with microtubules during mitosis, which is the process of cell division. This interaction is important for the proper alignment and separation of chromosomes during cell division.\n4. Other cell cycle regulators: Treslin has been shown to interact with other cell cycle regulators, including Cdk4, Cdk6, and Cdk9, as well as various transcription factors and signaling proteins. These interactions are thought to play a role in the regulation of the cell cycle at various stages.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Treslin interacts with cyclin-dependent kinases (CDKs) and cyclins during the G1 phase of the cell cycle.\n2. The interaction between Treslin and CDKs/cyclins is important for the activation of CDKs and the initiation of DNA synthesis during the S phase.\n3. Treslin can interact with the tumor suppressor protein p53 during the G2 phase of the cell cycle.\n4. The interaction between Treslin and p53 is thought to play a role in the regulation of the cell cycle checkpoint and the response to DNA damage.\n5. Treslin interacts with microtubules during mitosis, which is important for the proper alignment and separation of chromosomes during cell division.",
    "yulan-chat-2-13b-fp16_fact": [
      "Treslin interacts with cyclin-dependent kinases (CDKs) and cyclins during the G1 phase of the cell cycle.",
      "The interaction between Treslin and CDKs/cyclins is important for the activation of CDKs and the initiation of DNA synthesis during the S phase.",
      "Treslin can interact with the tumor suppressor protein p53 during the G2 phase of the cell cycle.",
      "The interaction between Treslin and p53 is thought to play a role in the regulation of the cell cycle checkpoint and the response to DNA damage.",
      "Treslin interacts with microtubules during mitosis, which is important for the proper alignment and separation of chromosomes during cell division."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: Treslin is known to be involved in the initiation of DNA replication at the beginning of the S phase, not in interacting with microtubules during mitosis. It is the mitotic spindle that interacts with microtubules during mitosis to ensure proper chromosome alignment and separation.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 981,
    "user_query": "Which medication should be administered when managing patients with suspected acute opioid overdose?",
    "yulan-chat-2-13b-fp16_response": "When managing patients with suspected acute opioid overdose, the medication that should be administered is naloxone. Naloxone is a medication that can quickly reverse the effects of an opioid overdose by binding to opioid receptors and blocking the effects of opioids. It is important to note that naloxone should be administered as soon as possible, as delay in treatment can lead to severe respiratory depression and even death. Additionally, other supportive measures such as oxygen therapy, assisted ventilation, and cardiovascular support may also be necessary.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Naloxone is a medication used to reverse the effects of an opioid overdose.\n2. Naloxone works by binding to opioid receptors and blocking the effects of opioids.\n3. It is essential to administer naloxone as soon as possible when treating a suspected acute opioid overdose.\n4. Delay in treating an opioid overdose with naloxone can lead to severe respiratory depression.\n5. Alongside naloxone, supportive measures like oxygen therapy, assisted ventilation, and cardiovascular support may be necessary.",
    "yulan-chat-2-13b-fp16_fact": [
      "Naloxone is a medication used to reverse the effects of an opioid overdose.",
      "Naloxone works by binding to opioid receptors and blocking the effects of opioids.",
      "It is essential to administer naloxone as soon as possible when treating a suspected acute opioid overdose.",
      "Delay in treating an opioid overdose with naloxone can lead to severe respiratory depression.",
      "Alongside naloxone, supportive measures like oxygen therapy, assisted ventilation, and cardiovascular support may be necessary."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 982,
    "user_query": "In which nuclear compartments is heterochromatin located?",
    "yulan-chat-2-13b-fp16_response": "Heterochromatin is a type of chromatin that is characterized by the presence of highly condensed DNA and reduced levels of gene expression. It is found in several nuclear compartments, including the nucleus, the mitochondria, and the chloroplasts. In the nucleus, heterochromatin is typically found in the pericentromeric region, which is the region of the genome that is closest to the centromere. It can also be found in the telomeres, which are the regions of the genome that are associated with the ends of chromosomes. In the mitochondria and chloroplasts, heterochromatin is found in the intermembrane space, which is the space between the inner and outer membranes of the organelle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Heterochromatin is characterized by highly condensed DNA and reduced levels of gene expression.\n2. Heterochromatin is located in the pericentromeric region of the genome in the nucleus.\n3. Heterochromatin can be found at the telomeres, the ends of chromosomes.\n\nThe statements regarding heterochromatin being located in the mitochondria and chloroplasts, as well as in the intermembrane spaces of these organelles, are incorrect and cannot be verified as factual statements, since heterochromatin is generally understood to be a feature of the eukaryotic cell nucleus and does not occur within mitochondria or chloroplasts.",
    "yulan-chat-2-13b-fp16_fact": [
      "Heterochromatin is characterized by highly condensed DNA and reduced levels of gene expression.",
      "Heterochromatin is located in the pericentromeric region of the genome in the nucleus.",
      "Heterochromatin can be found at the telomeres, the ends of chromosomes.",
      "e statements regarding heterochromatin being located in the mitochondria and chloroplasts, as well as in the intermembrane spaces of these organelles, are incorrect and cannot be verified as factual statements, since heterochromatin is generally understood to be a feature of the eukaryotic cell nucleus and does not occur within mitochondria or chloroplasts."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 984,
    "user_query": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?",
    "yulan-chat-2-13b-fp16_response": "In bacteria, global genome nucleotide excision repair (GG-NER) is mediated by a set of enzymes that work together to remove damaged nucleotides from the DNA. The main enzymes involved in GG-NER in bacteria are:\n1. DNA photolyase: This enzyme is responsible for the photoreaction that initiates the GG-NER pathway. It uses light energy to form a cyclobutane ring structure in the DNA, which serves as a signal for the recruitment of other GG-NER enzymes.\n2. DNA glycosylase: This enzyme recognizes and removes the damaged nucleotide from the DNA. It cleaves the N-glycosidic bond between the damaged nucleotide and the adjacent undamaged nucleotide, creating a apurinic or apyrimidinic site.\n3. Endonuclease: This enzyme cleaves the DNA strand at the site of the damaged nucleotide, creating a double-stranded break.\n4. Ligase: This enzyme re-synthesizes the broken DNA strand by joining the two ends of the double-stranded break together.\n5. DNA polymerase: This enzyme synthesizes a new DNA strand to replace the damaged one.\nTogether, these enzymes work to remove damaged nucleotides from the DNA and restore the genome to its original state.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DNA photolyase is an enzyme that initiates the GG-NER pathway in bacteria by forming a cyclobutane ring structure in the DNA.\n2. DNA glycosylase in bacteria recognizes and removes damaged nucleotides from the DNA by cleaving the N-glycosidic bond.\n3. An endonuclease in bacteria cleaves the DNA strand at the site of the damaged nucleotide, creating a double-stranded break.\n4. Ligase is an enzyme that re-synthesizes the broken DNA strand by joining the ends of a double-stranded break in bacteria.\n5. DNA polymerase synthesizes a new DNA strand to replace the damaged one in bacterial GG-NER.",
    "yulan-chat-2-13b-fp16_fact": [
      "DNA photolyase is an enzyme that initiates the GG-NER pathway in bacteria by forming a cyclobutane ring structure in the DNA.",
      "DNA glycosylase in bacteria recognizes and removes damaged nucleotides from the DNA by cleaving the N-glycosidic bond.",
      "An endonuclease in bacteria cleaves the DNA strand at the site of the damaged nucleotide, creating a double-stranded break.",
      "Ligase is an enzyme that re-synthesizes the broken DNA strand by joining the ends of a double-stranded break in bacteria.",
      "DNA polymerase synthesizes a new DNA strand to replace the damaged one in bacterial GG-NER."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: DNA photolyase is an enzyme that repairs UV-induced thymine dimers in DNA by using light energy to cleave the cyclobutane ring structure of the dimers, not by forming it. It is not directly involved in the GG-NER (Global Genome Nucleotide Excision Repair) pathway.\n2. TRUE\n3. FALSE [correction]: An endonuclease in bacteria cleaves the DNA strand at the site of the damaged nucleotide, but typically this cleavage is within a few nucleotides at either side of the lesion, creating a single-stranded break rather than a double-stranded break, which is then filled in and repaired.\n4. FALSE [correction]: Ligase is an enzyme that joins the ends of a single-stranded break (not a double-stranded break) in DNA after the gap has been filled by DNA polymerase. Ligase creates a phosphodiester bond to seal nicks in double-stranded DNA molecules, thereby completing the repair process.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 988,
    "user_query": "In which genomic regions are Alu enriched?",
    "yulan-chat-2-13b-fp16_response": "Alu elements are found throughout the human genome, but they are particularly abundant in some regions. Alu elements are enriched in the non-coding regions of the genome, such as introns and intergenic regions, as well as in the 5' and 3' untranslated regions (UTRs) of genes. They are also found in the regulatory regions of genes, such as promoters and enhancers. Alu elements are not found in the coding regions of genes, which are the regions that code for proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alu elements are found throughout the human genome.\n2. Alu elements are enriched in the non-coding regions of the genome.\n3. Alu elements are particularly abundant in introns and intergenic regions.\n4. Alu elements are found in the 5' and 3' untranslated regions (UTRs) of genes.\n5. Alu elements are located in the regulatory regions of genes, such as promoters and enhancers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alu elements are found throughout the human genome.",
      "Alu elements are enriched in the non-coding regions of the genome.",
      "Alu elements are particularly abundant in introns and intergenic regions.",
      "Alu elements are found in the 5' and 3' untranslated regions (UTRs) of genes.",
      "Alu elements are located in the regulatory regions of genes, such as promoters and enhancers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAlu elements are indeed short stretches of DNA originally characterized by the action of the Alu restriction endonuclease, and they are plentiful throughout the human genome. They are particularly common in non-coding regions such as introns and intergenic areas but can occasionally be found in untranslated regions (UTRs) and regulatory regions of genes. They have been implicated in various aspects of gene regulation and genome evolution.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 993,
    "user_query": "Are there clinical trials using stem cells for the treatment of cardiac disease?",
    "yulan-chat-2-13b-fp16_response": "Yes, there have been several clinical trials using stem cells for the treatment of cardiac disease. These trials have investigated the use of various types of stem cells, including bone marrow-derived mesenchymal stem cells, induced pluripotent stem cells, and cardiac-derived stem cells, to repair damaged heart tissue and improve cardiac function.\nSome of the promising results from these trials include improved heart function, reduced scar tissue formation, and decreased inflammation. However, more research is needed to fully understand the potential benefits and risks of stem cell therapy for cardiac disease, and to determine the optimal delivery methods and dosages for different patient populations.\nIt is important to note that while some clinical trials have shown promise, others have had negative results or safety concerns, highlighting the need for careful regulation and oversight of stem cell therapies. As with any medical treatment, patients should consult with their healthcare provider to determine if stem cell therapy is appropriate for their specific condition and individual needs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There have been several clinical trials using stem cells to treat cardiac disease.\n2. Types of stem cells used in these trials include bone marrow-derived mesenchymal stem cells, induced pluripotent stem cells, and cardiac-derived stem cells.\n3. Some clinical trials have reported improved heart function as a result of stem cell therapy for cardiac disease.\n4. Other clinical trials have reported reduced scar tissue formation and decreased inflammation in the context of stem cell therapy for cardiac disease.\n5. Various clinical trials have had differing outcomes, with some showing negative results or safety concerns.",
    "yulan-chat-2-13b-fp16_fact": [
      "There have been several clinical trials using stem cells to treat cardiac disease.",
      "Types of stem cells used in these trials include bone marrow-derived mesenchymal stem cells, induced pluripotent stem cells, and cardiac-derived stem cells.",
      "Some clinical trials have reported improved heart function as a result of stem cell therapy for cardiac disease.",
      "Other clinical trials have reported reduced scar tissue formation and decreased inflammation in the context of stem cell therapy for cardiac disease.",
      "Various clinical trials have had differing outcomes, with some showing negative results or safety concerns."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 996,
    "user_query": "Has Revlimid been approved by the US Food and Drug Administration?",
    "yulan-chat-2-13b-fp16_response": "Yes, Revlimid has been approved by the US Food and Drug Administration (FDA) for the treatment of multiple myeloma and other conditions. It was first approved in 2005 for the treatment of relapsed or refractory multiple myeloma, and has since been approved for other uses, including the treatment of certain types of anemia and certain types of cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Revlimid has been approved by the US Food and Drug Administration.\n2. Revlimid was first approved by the FDA in 2005.\n3. Revlimid is approved for the treatment of multiple myeloma.\n4. Revlimid is approved for the treatment of certain types of anemia.\n5. Revlimid is approved for the treatment of certain types of cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Revlimid has been approved by the US Food and Drug Administration.",
      "Revlimid was first approved by the FDA in 2005.",
      "Revlimid is approved for the treatment of multiple myeloma.",
      "Revlimid is approved for the treatment of certain types of anemia.",
      "Revlimid is approved for the treatment of certain types of cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Revlimid was first approved by the FDA in 2005 for the treatment of multiple myeloma in combination with dexamethasone, and later for other indications.\n3. TRUE\n4. TRUE [correction]: Revlimid is approved for the treatment of anemia in patients with myelodysplastic syndromes (MDS) with a deletion 5q cytogenetic abnormality, among other indications.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "yulan-chat-2-13b-fp16_response": "The Smith-Waterman algorithm is a dynamic programming algorithm that is used to find the best alignment of two sequences. The execution time (complexity) of the Smith-Waterman algorithm depends on the length of the sequences being aligned and the number of matches between the sequences.\nIn the worst case, the execution time of the Smith-Waterman algorithm is O(mn), where m and n are the lengths of the two sequences being aligned. This is because the algorithm needs to compare every element of the first sequence with every element of the second sequence, which takes O(m\\*n) time.\nHowever, the Smith-Waterman algorithm can be optimized using several techniques to reduce its execution time. For example, the algorithm can use heuristics to prune the search space and avoid comparing elements that are unlikely to match. Additionally, the algorithm can use techniques such as memoization and parallelization to further reduce its execution time.\nOverall, the Smith-Waterman algorithm is a computationally intensive algorithm, but its execution time can be significantly reduced through the use of optimization techniques.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Smith-Waterman algorithm is a dynamic programming algorithm designed for sequence alignment.\n2. The worst-case execution time (complexity) of the Smith-Waterman algorithm is O(mn), where m and n are the lengths of the two sequences.\n3. The execution time of the Smith-Waterman algorithm depends on the length of the sequences being aligned and the number of matches between them.\n4. The Smith-Waterman algorithm's execution time can be optimized using heuristics to prune the search space.\n5. Techniques such as memoization and parallelization can be used to reduce the execution time of the Smith-Waterman algorithm.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Smith-Waterman algorithm is a dynamic programming algorithm designed for sequence alignment.",
      "The worst-case execution time (complexity) of the Smith-Waterman algorithm is O(mn), where m and n are the lengths of the two sequences.",
      "The execution time of the Smith-Waterman algorithm depends on the length of the sequences being aligned and the number of matches between them.",
      "The Smith-Waterman algorithm's execution time can be optimized using heuristics to prune the search space.",
      "Techniques such as memoization and parallelization can be used to reduce the execution time of the Smith-Waterman algorithm."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The execution time of the Smith-Waterman algorithm mainly depends on the lengths of the sequences being aligned (m and n), not directly on the number of matches between them.\n4. FALSE [correction]: The Smith-Waterman algorithm itself does not employ heuristics to prune the search space. Optimization techniques such as the use of SIMD instructions or specialized hardware may be used, but those are not considered heuristics.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1003,
    "user_query": "What is Piebaldism?",
    "yulan-chat-2-13b-fp16_response": "Piebaldism is a rare genetic disorder characterized by a pattern of pigmentation on the skin that is white with irregularly shaped patches of dark-colored pigment. It is caused by a mutation in the SLC24A5 gene, which is involved in the production of a protein that transports melanin, the pigment that determines skin color, to the skin's surface. Piebaldism is usually inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Piebaldism is a rare genetic disorder characterized by a pattern of unpigmented (white) and pigmented skin.\n2. The condition is caused by a mutation in the SLC24A5 gene.\n3. The SLC24A5 gene is involved in the production of a protein that transports melanin to the skin's surface.\n4. The presence of dark-colored patches on the skin is a feature of Piebaldism.\n5. Piebaldism is usually inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to develop the condition.",
    "yulan-chat-2-13b-fp16_fact": [
      "Piebaldism is a rare genetic disorder characterized by a pattern of unpigmented (white) and pigmented skin.",
      "The condition is caused by a mutation in the SLC24A5 gene.",
      "The SLC24A5 gene is involved in the production of a protein that transports melanin to the skin's surface.",
      "The presence of dark-colored patches on the skin is a feature of Piebaldism.",
      "Piebaldism is usually inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to develop the condition."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The condition is typically caused by a mutation in the KIT gene, not the SLC24A5 gene.\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: Piebaldism is usually inherited in an autosomal dominant pattern, in which only one copy of the mutated gene is required to develop the condition.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "yulan-chat-2-13b-fp16_response": "FLVCR1 is a member of the SLC22A1 family of solute carrier proteins (SLCs).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FLVCR1 is a member of the SLC family of solute carrier proteins.\n2. FLVCR1 belongs to the SLC22A1 family specifically.",
    "yulan-chat-2-13b-fp16_fact": [
      "FLVCR1 is a member of the SLC family of solute carrier proteins.",
      "FLVCR1 belongs to the SLC22A1 family specifically."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: FLVCR1 is not a member of the SLC (solute carrier) family of proteins. Instead, it belongs to the Major Facilitator Superfamily (MFS).\n2. FALSE [correction]: FLVCR1 does not belong to the SLC22A1 family. SLC22A1 refers to a specific member of the solute carrier protein family, which is different from FLVCR1. FLVCR1 is a heme transporter protein.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false"
    ]
  },
  {
    "id": 1008,
    "user_query": "Which inherited disorder is known to be caused by mutations in the NEMO gene?",
    "yulan-chat-2-13b-fp16_response": "The inherited disorder known to be caused by mutations in the NEMO gene is periodic fever, also known as familial Mediterranean fever (FMF).",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1009,
    "user_query": "What is ISMARA?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have any information on an organization or concept called \"ISMARA.\" Could you provide more context or clarify what you are asking?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1014,
    "user_query": "What histone variants play a role in the DNA damage reponse?",
    "yulan-chat-2-13b-fp16_response": "Histone variants that play a role in the DNA damage response include:\n1. Histone H3.3 - a variant of histone H3 that is enriched in the nucleus and plays a role in the regulation of gene expression.\n2. Histone H2A.Z - a variant of histone H2A that is involved in the regulation of gene expression and chromatin organization.\n3. Histone H2B.Z - a variant of histone H2B that is involved in the regulation of gene expression and chromatin organization.\n4. Histone H1 - a protein that plays a role in the organization of chromatin and the regulation of gene expression.\n5. Histone H4 - a protein that plays a role in the regulation of gene expression and chromatin organization.\nThese histone variants can be modified by various post-translational modifications, such as acetylation, methylation, and phosphorylation, which can affect their function in the DNA damage response.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histone H3.3 is a variant of histone H3 that participates in the regulation of gene expression.\n2. Histone H2A.Z is a variant of histone H2A involved in gene expression regulation and chromatin organization.\n3. Histone H2B.Z is a variant of histone H2B also involved in gene expression regulation and chromatin organization.\n4. Histone H1 plays a role in the organization of chromatin and the regulation of gene expression.\n5. Histone H4 is involved in the regulation of gene expression and chromatin organization.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histone H3.3 is a variant of histone H3 that participates in the regulation of gene expression.",
      "Histone H2A.Z is a variant of histone H2A involved in gene expression regulation and chromatin organization.",
      "Histone H2B.Z is a variant of histone H2B also involved in gene expression regulation and chromatin organization.",
      "Histone H1 plays a role in the organization of chromatin and the regulation of gene expression.",
      "Histone H4 is involved in the regulation of gene expression and chromatin organization."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There isn't a recognized histone variant known as \"Histone H2B.Z\". Histone H2B does have variants, but they are not typically named in this manner.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1019,
    "user_query": "Which disease has been associated to a disruptive ALX1 protein?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information on a specific disease that has been associated with a disruptive ALX1 protein. Could you provide more context or information about ALX1 and its potential role in disease?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1022,
    "user_query": "In which yeast chromosome does the rDNA cluster reside?",
    "yulan-chat-2-13b-fp16_response": "The rDNA (ribosomal DNA) cluster resides on the left arm of the yeast chromosome III.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The rDNA cluster is located in yeast chromosome III.\n2. The rDNA cluster resides on the left arm of chromosome III.",
    "yulan-chat-2-13b-fp16_fact": [
      "The rDNA cluster is located in yeast chromosome III.",
      "The rDNA cluster resides on the left arm of chromosome III."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The rDNA cluster resides on the right arm of chromosome III.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 1023,
    "user_query": "Which is the underlying mechanism for exon skipping used to treat Duchenne muscular dystrophy?",
    "yulan-chat-2-13b-fp16_response": "Exon skipping is a technique used to treat Duchenne muscular dystrophy (DMD) by allowing the production of functional dystrophin protein, which is missing or defective in individuals with DMD. The underlying mechanism of exon skipping is the use of antisense oligonucleotides (ASOs) to target and bind to specific pre-mRNA sequences in the dystrophin gene.\nThe ASOs are designed to hybridize with the pre-mRNA sequences, causing the splicing machinery to skip over the exon containing the DMD-causing mutation. This results in the production of a truncated but functional dystrophin protein that can help stabilize the muscle cells and improve their function.\nExon skipping is a promising therapy for DMD, as it can potentially restore dystrophin production in individuals with the disease, even those with severe mutations. However, it is important to note that exon skipping is not a cure for DMD, but rather a treatment that can help manage the symptoms and improve the quality of life for those affected by the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Exon skipping is a technique used to treat Duchenne muscular dystrophy (DMD) by allowing the production of functional dystrophin protein.\n2. The underlying mechanism of exon skipping involves the use of antisense oligonucleotides (ASOs) to bind to specific pre-mRNA sequences in the dystrophin gene.\n3. Antisense oligonucleotides cause the splicing machinery to skip over the exon containing the mutation responsible for DMD.\n4. The result of exon skipping is the production of a truncated but functional dystrophin protein.\n5. While exon skipping can help manage symptoms and improve quality of life, it is not a cure for Duchenne muscular dystrophy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Exon skipping is a technique used to treat Duchenne muscular dystrophy (DMD) by allowing the production of functional dystrophin protein.",
      "The underlying mechanism of exon skipping involves the use of antisense oligonucleotides (ASOs) to bind to specific pre-mRNA sequences in the dystrophin gene.",
      "Antisense oligonucleotides cause the splicing machinery to skip over the exon containing the mutation responsible for DMD.",
      "The result of exon skipping is the production of a truncated but functional dystrophin protein.",
      "While exon skipping can help manage symptoms and improve quality of life, it is not a cure for Duchenne muscular dystrophy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1028,
    "user_query": "What is the link between Dax1 and Esrrb?",
    "yulan-chat-2-13b-fp16_response": "Dax1 and Esrrb are two transcription factors that play important roles in regulating gene expression in the Drosophila melanogaster fruit fly. Dax1 is a member of the Hox-related family of transcription factors, while Esrrb is a member of the Ets family of transcription factors.\nThe link between Dax1 and Esrrb lies in their ability to regulate the expression of genes involved in the development and maintenance of the Drosophila nervous system. Specifically, Dax1 and Esrrb work together to activate the expression of genes that are required for the development and function of neurons in the Drosophila brain.\nDax1 and Esrrb interact with each other through a process known as co-activation, where they form a complex with other transcriptional co-activators and co-repressors to regulate the expression of target genes. This complex is thought to be important for the proper development and function of the Drosophila nervous system.\nOverall, the interaction between Dax1 and Esrrb is a key regulatory mechanism that controls the expression of genes involved in the development and function of the Drosophila nervous system.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dax1 is a member of the Hox-related family of transcription factors.\n2. Esrrb is a member of the Ets family of transcription factors.\n3. Dax1 and Esrrb regulate gene expression involved in the development and maintenance of the Drosophila melanogaster fruit fly's nervous system.\n4. Dax1 and Esrrb work together to activate the expression of genes required for neuron development and function in the Drosophila brain.\n5. Dax1 and Esrrb interact through co-activation, forming a complex to regulate the expression of target genes in Drosophila.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dax1 is a member of the Hox-related family of transcription factors.",
      "Esrrb is a member of the Ets family of transcription factors.",
      "Dax1 and Esrrb regulate gene expression involved in the development and maintenance of the Drosophila melanogaster fruit fly's nervous system.",
      "Dax1 and Esrrb work together to activate the expression of genes required for neuron development and function in the Drosophila brain.",
      "Dax1 and Esrrb interact through co-activation, forming a complex to regulate the expression of target genes in Drosophila."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Esrrb is a member of the Nuclear Receptor family of transcription factors, not the Ets family.\n3. FALSE [correction]: Dax1 and Esrrb regulate gene expression involved in the development and maintenance of stem cells in mammals, not specifically in the Drosophila melanogaster fruit fly's nervous system.\n4. UNKNOWN: Without specific context or evidence, it is uncertain if Dax1 and Esrrb work together in the manner described specifically in the Drosophila brain.\n5. UNKNOWN: Whether Dax1 and Esrrb interact through co-activation in Drosophila to regulate gene expression is not clearly stated in the given statements, thus making the statement difficult to confirm without further context.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1030,
    "user_query": "Are DNA helicases involved in progeroid syndromes?",
    "yulan-chat-2-13b-fp16_response": "Yes, DNA helicases have been implicated in progeroid syndromes. Progeroid syndromes are a group of rare genetic disorders characterized by premature aging and accelerated cellular senescence. One such syndrome is progeria, which is caused by mutations in the LMNA gene that encodes the major nuclear lamina proteins.\nThe LMNA gene also encodes the protein EIF2B4, which is a component of the eIF2B complex, a key regulator of protein synthesis. EIF2B4 has also been shown to interact with DNA helicases, including the helicase-like protein HLRNP1.\nMutations in HLRNP1 have been associated with several progeroid syndromes, including Cranio-facial-skeletal dysplasia-1 (CFSKD1) and Cranio-facial-skeletal dysplasia-2 (CFSKD2). These mutations have been shown to disrupt the function of HLRNP1 in DNA repair and replication, leading to genomic instability and accelerated cellular senescence.\nOverall, these findings suggest that DNA helicases play a role in the pathogenesis of progeroid syndromes, and that disruption of their function can lead to premature aging and accelerated cellular senescence.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DNA helicases have been implicated in progeroid syndromes, which are characterized by premature aging and accelerated cellular senescence.\n2. Progeria, a type of progeroid syndrome, is caused by mutations in the LMNA gene.\n3. The LMNA gene encodes the protein EIF2B4, a component of the eIF2B complex, which is a key regulator of protein synthesis.\n4. EIF2B4 interacts with DNA helicases, including the helicase-like protein HLRNP1.\n5. Mutations in HLRNP1 have been associated with several progeroid syndromes, including Cranio-facial-skeletal dysplasia-1 (CFSKD1) and Cranio-facial-skeletal dysplasia-2 (CFSKD2).",
    "yulan-chat-2-13b-fp16_fact": [
      "DNA helicases have been implicated in progeroid syndromes, which are characterized by premature aging and accelerated cellular senescence.",
      "Progeria, a type of progeroid syndrome, is caused by mutations in the LMNA gene.",
      "The LMNA gene encodes the protein EIF2B4, a component of the eIF2B complex, which is a key regulator of protein synthesis.",
      "EIF2B4 interacts with DNA helicases, including the helicase-like protein HLRNP1.",
      "Mutations in HLRNP1 have been associated with several progeroid syndromes, including Cranio-facial-skeletal dysplasia-1 (CFSKD1) and Cranio-facial-skeletal dysplasia-2 (CFSKD2)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The LMNA gene encodes lamin A and lamin C, which are structural proteins of the nuclear envelope, not EIF2B4.\n4. UNKNOWN (About EIF2B4 interacting with DNA helicases; the statement is accurate if referring to lamin A/C rather than EIF2B4, yet the specific interaction with DNA helicase HLRNP1 is not well-established in widely recognized scientific literature.)\n5. UNKNOWN (While mutations in genes can be associated with syndromes like CFSKD1 and CFSKD2, there is likely an error in the gene name HLRNP1; it may be referring to a different gene, and these specific associations are not widely recognized in scientific literature. The standard nomenclature for human genes uses symbols like \"HNRNPA1\" for heterogeneous nuclear ribonucleoprotein A1, which could be confused with HLRNP1. Without a correct gene symbol, it's difficult to confirm the associated syndromes.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1034,
    "user_query": "Which heat shock protein is found to be upregulated during Hsp90 inhibition?",
    "yulan-chat-2-13b-fp16_response": "Hsp90 is a heat shock protein that plays a role in the folding and stabilization of other proteins. When Hsp90 is inhibited, it can lead to the upregulation of other heat shock proteins, including Hsp70 and Hsp27. These proteins can help to stabilize the cellular proteome and prevent the accumulation of misfolded proteins, which can be toxic to cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hsp90 is a heat shock protein involved in the folding and stabilization of other proteins.\n2. Inhibition of Hsp90 can lead to the upregulation of Hsp70.\n3. Inhibition of Hsp90 can also lead to the upregulation of Hsp27.\n4. Hsp70 and Hsp27 help stabilize the cellular proteome.\n5. Hsp70 and Hsp27 help prevent the accumulation of misfolded proteins which can be toxic to cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hsp90 is a heat shock protein involved in the folding and stabilization of other proteins.",
      "Inhibition of Hsp90 can lead to the upregulation of Hsp70.",
      "Inhibition of Hsp90 can also lead to the upregulation of Hsp27.",
      "Hsp70 and Hsp27 help stabilize the cellular proteome.",
      "Hsp70 and Hsp27 help prevent the accumulation of misfolded proteins which can be toxic to cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1036,
    "user_query": "What is the name for anorexia in gymnasts?",
    "yulan-chat-2-13b-fp16_response": "Anorexia nervosa, commonly referred to as anorexia, is an eating disorder characterized by a distorted body image and an intense fear of gaining weight. It is not specific to gymnasts and can affect individuals from all walks of life. While it is true that gymnastics, like other sports, may place a high premium on weight and body shape, it is important to remember that anorexia is a complex mental illness that cannot be solely attributed to any one factor or activity. If you or someone you know is struggling with anorexia or any other eating disorder, it is important to seek professional help as soon as possible.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Anorexia nervosa is an eating disorder characterized by a distorted body image and an intense fear of gaining weight.\n2. Anorexia can affect individuals from all walks of life, not just gymnasts.\n3. Anorexia is a complex mental illness.\n4. Professional help should be sought if someone is struggling with anorexia or any other eating disorder.",
    "yulan-chat-2-13b-fp16_fact": [
      "Anorexia nervosa is an eating disorder characterized by a distorted body image and an intense fear of gaining weight.",
      "Anorexia can affect individuals from all walks of life, not just gymnasts.",
      "Anorexia is a complex mental illness.",
      "Professional help should be sought if someone is struggling with anorexia or any other eating disorder."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1038,
    "user_query": "What are the indications for alteplase?",
    "yulan-chat-2-13b-fp16_response": "Alteplase, also known by the brand name Activase, is a medication and thrombolytic agent used to treat acute myocardial infarction (AMI), also known as a heart attack. It is administered intravenously and works by breaking down blood clots that have formed in the blood vessels supplying the heart muscle.\nThe primary indication for using alteplase is the treatment of AMI, which occurs when a blood clot blocks the blood supply to the heart muscle, leading to damage or death of the heart muscle. Alteplase is used to dissolve the clot and improve blood flow to the heart muscle, which can help to reduce the extent of damage and improve outcomes.\nIn addition to its use in treating AMI, alteplase may also be used in the treatment of other conditions characterized by abnormal blood clotting, such as pulmonary embolism and thrombosis. However, its use in these conditions is generally less common and is typically reserved for situations where other treatments have been unsuccessful or are not available.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alteplase is used to treat acute myocardial infarction (AMI), also known as a heart attack.\n2. Alteplase works by breaking down blood clots in blood vessels.\n3. It is administered intravenously.\n4. The primary indication for alteplase is to dissolve blood clots that block blood supply to the heart muscle.\n5. Alteplase may also be used to treat conditions like pulmonary embolism and thrombosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alteplase is used to treat acute myocardial infarction (AMI), also known as a heart attack.",
      "Alteplase works by breaking down blood clots in blood vessels.",
      "It is administered intravenously.",
      "The primary indication for alteplase is to dissolve blood clots that block blood supply to the heart muscle.",
      "Alteplase may also be used to treat conditions like pulmonary embolism and thrombosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1039,
    "user_query": "List scaffold proteins of the ERK signaling pathway.",
    "yulan-chat-2-13b-fp16_response": "The ERK (Extracellular Signal-Regulated Kinase) signaling pathway is a well-studied pathway that is involved in various cellular processes, including cell growth, differentiation, and survival. Scaffold proteins are proteins that provide a platform for the assembly of signaling complexes and help to coordinate the activity of multiple signaling molecules. Here are some of the scaffold proteins that are involved in the ERK signaling pathway:\n1. PDZ-binding proteins: These proteins have a PDZ (polyglutamine tract-mediated protein-protein interaction) domain, which can bind to PDZ-binding motifs on other proteins. Examples of PDZ-binding proteins that are involved in the ERK signaling pathway include PDZ-1 (Disabled-1), which interacts with the scaffolding protein DLG1 (Discs large homolog 1), and PDZ-2 (S-sculptor), which interacts with the scaffolding protein PDLIM1 (PDZ and LIM domain-containing protein 1).\n2. Scaffolding proteins: These proteins provide a platform for the assembly of signaling complexes and help to coordinate the activity of multiple signaling molecules. Examples of scaffolding proteins that are involved in the ERK signaling pathway include SOS (Son of Sevenless), which is a guanine nucleotide exchange factor (GEF) for Ras, and Grb2 (Growth factor receptor-bound protein 2), which is a scaffolding protein that interacts with the receptor tyrosine kinase (RTK) and activates the ERK pathway.\n3. Proteins with SH3 (Src homology 3) domains: These proteins have SH3 domains, which can bind to PxxP motifs on other proteins. Examples of proteins with SH3 domains that are involved in the ERK signaling pathway include SH3-GAP (Src homology 3 GTPase-activating protein), which regulates the activity of GTPases, and SH3-domain-containing proteins such as Nck and Hck, which interact with the scaffolding protein Grb2",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PDZ-binding protein Disabled-1 (Dab1) interacts with the scaffolding protein DLG1 in the ERK signaling pathway.\n2. PDZ-binding protein S-sculptor interacts with the scaffolding protein PDLIM1 in the ERK signaling pathway.\n3. SOS is a guanine nucleotide exchange factor that acts as a scaffold protein in the ERK signaling pathway.\n4. Growth factor receptor-bound protein 2 (Grb2) is a scaffolding protein that activates the ERK pathway by interacting with receptor tyrosine kinase.\n5. SH3-domain-containing proteins such as Nck and Hck interact with the scaffolding protein Grb2 in the ERK signaling pathway.",
    "yulan-chat-2-13b-fp16_fact": [
      "PDZ-binding protein Disabled-1 (Dab1) interacts with the scaffolding protein DLG1 in the ERK signaling pathway.",
      "PDZ-binding protein S-sculptor interacts with the scaffolding protein PDLIM1 in the ERK signaling pathway.",
      "SOS is a guanine nucleotide exchange factor that acts as a scaffold protein in the ERK signaling pathway.",
      "Growth factor receptor-bound protein 2 (Grb2) is a scaffolding protein that activates the ERK pathway by interacting with receptor tyrosine kinase.",
      "SH3-domain-containing proteins such as Nck and Hck interact with the scaffolding protein Grb2 in the ERK signaling pathway."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. FALSE [correction]: SOS (Son of Sevenless) is a guanine nucleotide exchange factor that facilitates the activation of Ras but is not typically described as a scaffold protein in the ERK signaling pathway.\n4. TRUE\n5. FALSE [correction]: SH3-domain-containing proteins, such as Nck and Hck, do interact with proline-rich sequences but not necessarily with Grb2 in the ERK signaling pathway. Grb2 mainly binds to phosphorylated tyrosine residues on activated receptor tyrosine kinases using its SH2 domain and recruits SOS to the membrane to activate Ras, leading to ERK pathway activation.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1041,
    "user_query": "Which classes of endogenous retroelements are known to date?",
    "yulan-chat-2-13b-fp16_response": "There are several classes of endogenous retroelements known to date, including:\n1. Long terminal repeat (LTR) retroelements: These are the most common type of endogenous retroelements and include the retroviruses and retrotransposons.\n2. Non-LTR retroelements: These include the soloists, SINEs (short interspersed elements), and LINEs (long interspersed elements).\n3. Pseudogenes: These are inactive, non-functional copies of genes that have been inserted into the genome by retroelements.\n4. DNA transposons: These are mobile genetic elements that can move within a genome and include the hATs (human accelerated regions) and pATs (primate accelerated regions).\nEndogenous retroelements play important roles in genome evolution and can have significant impacts on gene expression and regulation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Long terminal repeat (LTR) retroelements are a common type of endogenous retroelements, which include retroviruses and retrotransposons.\n2. Non-LTR retroelements include soloists, SINEs (short interspersed elements), and LINEs (long interspersed elements).\n3. Pseudogenes, considered a class of endogenous retroelements, are non-functional copies of genes inserted into the genome by retroelements.\n4. DNA transposons are mobile genetic elements that can move within a genome, including the hATs (human accelerated regions) and pATs (primate accelerated regions).\n5. Endogenous retroelements are known to play significant roles in genome evolution and can impact gene expression and regulation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Long terminal repeat (LTR) retroelements are a common type of endogenous retroelements, which include retroviruses and retrotransposons.",
      "Non-LTR retroelements include soloists, SINEs (short interspersed elements), and LINEs (long interspersed elements).",
      "Pseudogenes, considered a class of endogenous retroelements, are non-functional copies of genes inserted into the genome by retroelements.",
      "DNA transposons are mobile genetic elements that can move within a genome, including the hATs (human accelerated regions) and pATs (primate accelerated regions).",
      "Endogenous retroelements are known to play significant roles in genome evolution and can impact gene expression and regulation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Pseudogenes are indeed non-functional copies of genes, but they are not considered a class of endogenous retroelements. They can be created through processes such as gene duplication or retrotransposition but are not necessarily inserted into the genome by retroelements.\n4. FALSE [correction]: DNA transposons are indeed mobile genetic elements that can move within a genome, but hATs (hobo/Activator/Tam3) and pATs (piggyBac) are different classes of transposons and should not be confused with regions like HARs (human accelerated regions) which refer to regions of the genome that show significant differences between humans and closely related species.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "yulan-chat-2-13b-fp16_response": "GATA-1 is a transcription factor that plays a crucial role in regulating gene expression in various cell types, including immune cells. The biotinylation tagging approach is a technique used to identify protein-protein interactions by labeling proteins with biotin and isolating them using streptavidin beads.\nSeveral studies have used the biotinylation tagging approach to identify GATA-1 interacting partners. Here are some of the GATA-1 interacting partners that have been discovered using this approach:\n1. STAT1: STAT1 is a transcription factor that plays a role in the immune response to viral infections. GATA-1 and STAT1 have been shown to interact and regulate the expression of genes involved in the immune response.\n2. NF-B: NF-B is a transcription factor that regulates the expression of genes involved in inflammation and immune response. GATA-1 and NF-B have been shown to interact and regulate the expression of genes involved in the immune response.\n3. AP-1: AP-1 is a transcription factor that regulates the expression of genes involved in cell proliferation and differentiation. GATA-1 and AP-1 have been shown to interact and regulate the expression of genes involved in the immune response.\n4. p300: p300 is a coactivator protein that plays a role in the regulation of gene expression. GATA-1 and p300 have been shown to interact and regulate the expression of genes involved in the immune response.\n5. HDAC1: HDAC1 is a histone deacetylase protein that plays a role in the regulation of gene expression. GATA-1 and HDAC1 have been shown to interact and regulate the expression of genes involved in the immune response.\n6. C/EBP: C/EBP is a transcription factor that plays a role in the regulation of cell differentiation and immune response. GATA-1 and C/EBP have been shown to interact and regulate the expression of genes involved in the immune response.\n7. HIF-1: HIF-1 is a transcription factor that",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GATA-1 and STAT1 interact, affecting gene expression involved in the immune response.\n2. GATA-1 and NF-B interact to regulate gene expression related to inflammation and the immune response.\n3. GATA-1 and AP-1 have been shown to interact and influence gene expression regarding cell proliferation and differentiation.\n4. p300 interacts with GATA-1 to regulate gene expression pertinent to the immune response.\n5. GATA-1 and HDAC1 interaction influences the regulation of gene expression related to the immune response.",
    "yulan-chat-2-13b-fp16_fact": [
      "GATA-1 and STAT1 interact, affecting gene expression involved in the immune response.",
      "GATA-1 and NF-B interact to regulate gene expression related to inflammation and the immune response.",
      "GATA-1 and AP-1 have been shown to interact and influence gene expression regarding cell proliferation and differentiation.",
      "p300 interacts with GATA-1 to regulate gene expression pertinent to the immune response.",
      "GATA-1 and HDAC1 interaction influences the regulation of gene expression related to the immune response."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements are specific claims about interactions between proteins and their roles in regulating gene expression related to the immune system and other cellular processes. Without the specific scientific context or research findings that support these claims, it's not possible to accurately determine their truthfulness. These statements would require reference to specific scientific studies or data to be verified.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1053,
    "user_query": "Which proteins are the different members of the NF-kappaB family of transcription factors?",
    "yulan-chat-2-13b-fp16_response": "The NF-kappaB family of transcription factors includes:\n1. NF-kappaB1 (p105/p50)\n2. NF-kappaB2 (p100/p52)\n3. NF-kappaB3 (p50/p105)\n4. NF-kappaB4 (p65/RelA)\n5. NF-kappaB5 (p52/p100)\n6. NF-kappaB6 (p50/p105)\n7. NF-kappaB7 (p52/p100)\n8. NF-kappaB8 (p65/RelA)\n9. NF-kappaB9 (p50/p105)\n10. NF-kappaB10 (p52/p100)\nNote: NF-kappaB1, NF-kappaB2, NF-kappaB3, NF-kappaB4, NF-kappaB5, NF-kappaB6, NF-kappaB7, NF-kappaB8, and NF-kappaB9 are commonly referred to as \"classical\" NF-kappaB proteins, while NF-kappaB10 is a recently discovered member of the family.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NF-kappaB1 is also known as p105/p50.\n2. NF-kappaB2 is also known as p100/p52.\n3. NF-kappaB4 is also known as p65/RelA.\n4. NF-kappaB5 is also known as p52/p100.\n5. NF-kappaB1, NF-kappaB2, NF-kappaB3, NF-kappaB4, NF-kappaB5, NF-kappaB6, NF-kappaB7, NF-kappaB8, and NF-kappaB9 are referred to as \"classical\" NF-kappaB proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "NF-kappaB1 is also known as p105/p50.",
      "NF-kappaB2 is also known as p100/p52.",
      "NF-kappaB4 is also known as p65/RelA.",
      "NF-kappaB5 is also known as p52/p100.",
      "NF-kappaB1, NF-kappaB2, NF-kappaB3, NF-kappaB4, NF-kappaB5, NF-kappaB6, NF-kappaB7, NF-kappaB8, and NF-kappaB9 are referred to as \"classical\" NF-kappaB proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: NF-kappaB3 is not known as p65/RelA; p65/RelA is another name for the RELA gene, which is part of the NF-kappaB complex, but not termed NF-kappaB4 or NF-kappaB3.\n4. FALSE [correction]: NF-kappaB5 is not accurately termed p52/p100. NF-kappaB2 is the protein that can be processed from p100 to p52.\n5. FALSE [correction]: The classical NF-kappaB pathway typically involves NF-kappaB1 (p50) and NF-kappaB2 (p52) along with RelA (p65), c-Rel, and RelB. There are not NF-kappaB6 to NF-kappaB9 proteins as part of the classical NF-kappaB nomenclature.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1061,
    "user_query": "Which proteins have been identified as RET ligands?",
    "yulan-chat-2-13b-fp16_response": "Several proteins have been identified as retinal ligands, including:\n1. Allatostatin A\n2. Cocaine\n3. Deltorphin I\n4. Deltorphin II\n5. Deltorphin III\n6. Deltorphin IV\n7. Deltorphin V\n8. Deltorphin VI\n9. Deltorphin VII\n10. Deltorphin VIII\n11. Deltorphin IX\n12. Deltorphin X\n13. Deltorphin XI\n14. Deltorphin XII\n15. Deltorphin XIII\n16. Deltorphin XIV\n17. Deltorphin XV\n18. Deltorphin XVI\n19. Deltorphin XVII\n20. Deltorphin XVIII\n21. Deltorphin XIX\n22. Deltorphin XX\n23. Deltorphin XXI\n24. Deltorphin XXII\n25. Deltorphin XXIII\n26. Deltorphin XXIV\n27. Deltorphin XXV\n28. Deltorphin XXVI\n29. Deltorphin XXVII\n30. Deltorphin XXVIII\n31. Deltorphin XXIX\n32. Deltorphin XXX\n33. Deltorphin XXXI\n34. Deltorphin XXXII\n35. Deltorphin XXXIII\n36. Deltorphin XXXIV\n37. Deltorphin XXXV\n38. Deltorphin XXXVI\n39. Deltorphin XXXVII\n40. Deltorphin XXXVIII\n41. Deltorphin XXXIX\n42. Deltorphin XL\n43. Deltorphin XLI\n44. Deltorphin XLII\n45. Deltorphin XLIII\n46. Deltorphin XLIV\n47. Deltorphin XLV\n48. Deltorphin XLVI\n49. Deltorphin XLVII\n50. Deltorphin XLVIII\n51. Deltorphin XLIX\n52. Deltorph",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1066,
    "user_query": "List all articles on network meta-analysis for smoking cessation",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, I am not able to provide you with a list of all articles on network meta-analysis for smoking cessation. However, I can provide you with some tips on how to find such articles.\n1. Start by searching for articles on network meta-analysis in general, and then narrow down your search to those that focus on smoking cessation.\n2. Use a search engine such as Google Scholar and enter keywords such as \"network meta-analysis\" and \"smoking cessation\" in the search bar.\n3. Look for articles in peer-reviewed journals that specialize in the field of smoking cessation, such as Addiction, Tobacco Control, and Nicotine & Tobacco Research.\n4. Check the references of articles that you find to see if they cite any other relevant articles on network meta-analysis for smoking cessation.\n5. Consider using a citation management tool such as Zotero or EndNote to help you organize and keep track of the articles you find.\nI hope these tips are helpful in your search for articles on network meta-analysis for smoking cessation.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1068,
    "user_query": "Which clotting factor is inhibited by betrixaban?",
    "yulan-chat-2-13b-fp16_response": "Betrixaban is an inhibitor of factor Xa, which is a key component of the blood clotting cascade. Factor Xa is an enzyme that plays a critical role in the formation of blood clots by catalyzing the conversion of prothrombin to thrombin. By inhibiting factor Xa, betrixaban prevents the formation of blood clots and is used to treat conditions such as deep vein thrombosis and pulmonary embolism.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Betrixaban inhibits factor Xa.\n2. Factor Xa is a component of the blood clotting cascade.\n3. Factor Xa enzyme catalyzes the conversion of prothrombin to thrombin.\n4. Betrixaban is used to treat deep vein thrombosis.\n5. Betrixaban is used to treat pulmonary embolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "Betrixaban inhibits factor Xa.",
      "Factor Xa is a component of the blood clotting cascade.",
      "Factor Xa enzyme catalyzes the conversion of prothrombin to thrombin.",
      "Betrixaban is used to treat deep vein thrombosis.",
      "Betrixaban is used to treat pulmonary embolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Betrixaban is not used to treat deep vein thrombosis (DVT); it is used for the prophylaxis of venous thromboembolism (VTE) in adults hospitalized for an acute medical illness and at risk for thromboembolic complications.\n5. FALSE [correction]: Betrixaban is not used to treat pulmonary embolism (PE); it is used to prevent VTE in specific patient populations, as mentioned above.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1071,
    "user_query": "Are there any specific antidotes for dabigatran?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are specific antidotes for dabigatran, which is a type of blood thinner medication. Dabigatran works by inhibiting the activity of a protein called thrombin, which is involved in blood clotting.\nThe antidotes for dabigatran are:\n1. Idarucizumab: This is a specific antidote for dabigatran that works by binding to dabigatran in the bloodstream and inactivating it. Idarucizumab can reverse the effects of dabigatran and restore the body's ability to form blood clots. It is given as an injection and is most effective when given within 24 hours of taking the last dose of dabigatran.\n2. Prothrombin complex concentrate (PCC): This is another antidote for dabigatran that works by replacing the clotting factors that dabigatran inhibits. PCC contains a mix of clotting factors, including factor II, VII, IX, and X, which help to restore the body's ability to form blood clots. PCC is given intravenously and is most effective when given within 8 hours of taking the last dose of dabigatran.\nIt is important to note that both idarucizumab and PCC have potential risks and side effects, and they should only be used in specific circumstances where there is a clear need to reverse the effects of dabigatran. Your doctor will decide whether these antidotes are appropriate for you based on your medical condition and the reason you are taking dabigatran.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dabigatran is a medication that inhibits the activity of the protein thrombin, which is involved in blood clotting.\n2. Idarucizumab is an antidote for dabigatran that works by binding to and inactivating it.\n3. Idarucizumab can reverse the effects of dabigatran and is given as an injection.\n4. Prothrombin complex concentrate (PCC) is another antidote for dabigatran that works by replacing clotting factors.\n5. PCC contains clotting factors II, VII, IX, and X, and is administered intravenously.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dabigatran is a medication that inhibits the activity of the protein thrombin, which is involved in blood clotting.",
      "Idarucizumab is an antidote for dabigatran that works by binding to and inactivating it.",
      "Idarucizumab can reverse the effects of dabigatran and is given as an injection.",
      "Prothrombin complex concentrate (PCC) is another antidote for dabigatran that works by replacing clotting factors.",
      "PCC contains clotting factors II, VII, IX, and X, and is administered intravenously."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Prothrombin complex concentrate (PCC) is not a specific antidote for dabigatran. It is used off-label to reverse the effects of dabigatran, but idarucizumab is the specific antidote for dabigatran.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "yulan-chat-2-13b-fp16_response": "TAF10 is a protein that interacts with the GATA1 transcription factor, which is a key regulator of gene expression in cells. The interaction between TAF10 and GATA1 is important for the recruitment of the TFIID complex to GATA1-bound promoters, which is necessary for the transcriptional activation of target genes.\nThe exact outcome of TAF10 interacting with GATA1 can vary depending on the specific context and cell type. However, in general, the interaction between TAF10 and GATA1 is thought to enhance the transcriptional activity of GATA1 by promoting the recruitment of additional transcriptional coactivators and by stabilizing the GATA1-DNA complex.\nIn addition to its role in regulating gene expression, TAF10 has also been implicated in a number of other cellular processes, including DNA repair, cell cycle progression, and apoptosis. Overall, the interaction between TAF10 and GATA1 is an important regulatory mechanism that helps to ensure proper gene expression and cellular function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TAF10 is a protein that interacts with the GATA1 transcription factor.\n2. The interaction between TAF10 and GATA1 is important for recruiting the TFIID complex to GATA1-bound promoters.\n3. This recruitment is necessary for the transcriptional activation of target genes.\n4. The interaction between TAF10 and GATA1 generally enhances the transcriptional activity of GATA1.\n5. TAF10 is involved in other cellular processes, such as DNA repair, cell cycle progression, and apoptosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "TAF10 is a protein that interacts with the GATA1 transcription factor.",
      "The interaction between TAF10 and GATA1 is important for recruiting the TFIID complex to GATA1-bound promoters.",
      "This recruitment is necessary for the transcriptional activation of target genes.",
      "The interaction between TAF10 and GATA1 generally enhances the transcriptional activity of GATA1.",
      "TAF10 is involved in other cellular processes, such as DNA repair, cell cycle progression, and apoptosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe provided statements appear to be technically accurate descriptions of the roles of TAF10 and GATA1, and their involvement in transcriptional regulation and possibly other cellular processes. TAF10 is indeed a component of the TFIID complex and interacts with various transcription factors, including GATA1. These interactions are central to transcriptional activation of target genes. TAF10 is also known to be involved in other cellular processes, consistent with what is known about the multifunctionality of many transcription cofactors. Without specific contradictory evidence from the given context, these statements would generally be considered true based on current knowledge in molecular biology.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1073,
    "user_query": "How does TNF affect thyroid hormone receptors?",
    "yulan-chat-2-13b-fp16_response": "TNF (Tumor Necrosis Factor) is a cytokine that plays a role in the regulation of immune function and inflammation. It has been shown to have an impact on thyroid hormone receptors, which are proteins that bind to and regulate the activity of thyroid hormones in the body.\nStudies have suggested that TNF can downregulate the expression of thyroid hormone receptors, meaning that it can decrease the amount of these receptors on cells. This can lead to decreased sensitivity to thyroid hormones, which can result in a variety of symptoms, including fatigue, weight gain, and decreased metabolism.\nIt is thought that TNF may also play a role in the development of autoimmune thyroid diseases, such as Graves' disease and Hashimoto's thyroiditis, which are characterized by an overactive or underactive thyroid gland. In these conditions, the immune system produces antibodies that target the thyroid gland, leading to dysfunction and symptoms such as hyperthyroidism or hypothyroidism.\nOverall, while the exact mechanisms by which TNF affects thyroid hormone receptors are not fully understood, it is clear that this cytokine can have significant impacts on thyroid function and metabolism.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TNF (Tumor Necrosis Factor) is a cytokine involved in immune function regulation and inflammation.\n2. TNF can downregulate the expression of thyroid hormone receptors.\n3. A decrease in thyroid hormone receptors can lead to symptoms such as fatigue, weight gain, and decreased metabolism.\n4. TNF may play a role in the development of autoimmune thyroid diseases like Graves' disease and Hashimoto's thyroiditis.\n5. Autoimmune thyroid diseases can result in symptoms of hyperthyroidism or hypothyroidism.",
    "yulan-chat-2-13b-fp16_fact": [
      "TNF (Tumor Necrosis Factor) is a cytokine involved in immune function regulation and inflammation.",
      "TNF can downregulate the expression of thyroid hormone receptors.",
      "A decrease in thyroid hormone receptors can lead to symptoms such as fatigue, weight gain, and decreased metabolism.",
      "TNF may play a role in the development of autoimmune thyroid diseases like Graves' disease and Hashimoto's thyroiditis.",
      "Autoimmune thyroid diseases can result in symptoms of hyperthyroidism or hypothyroidism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1078,
    "user_query": "What is the action of molindone?",
    "yulan-chat-2-13b-fp16_response": "Molindone is a antipsychotic drug that is used to treat symptoms of psychosis such as hallucinations, delusions, and thought disorders. It is also sometimes used to treat other conditions such as anxiety and depression. The exact mechanism of action of molindone is not fully understood, but it is thought to work by blocking the action of dopamine in the brain. Dopamine is a neurotransmitter that is involved in regulating mood, motivation, and cognitive function. By blocking the action of dopamine, molindone can help to reduce the symptoms of psychosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Molindone is an antipsychotic drug.\n2. Molindone is used to treat symptoms of psychosis, including hallucinations, delusions, and thought disorders.\n3. It is sometimes used to treat conditions other than psychosis, such as anxiety and depression.\n4. The mechanism of action of molindone involves blocking the action of dopamine in the brain.\n5. Dopamine is a neurotransmitter that is involved in regulating mood, motivation, and cognitive function.",
    "yulan-chat-2-13b-fp16_fact": [
      "Molindone is an antipsychotic drug.",
      "Molindone is used to treat symptoms of psychosis, including hallucinations, delusions, and thought disorders.",
      "It is sometimes used to treat conditions other than psychosis, such as anxiety and depression.",
      "The mechanism of action of molindone involves blocking the action of dopamine in the brain.",
      "Dopamine is a neurotransmitter that is involved in regulating mood, motivation, and cognitive function."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Molindone is primarily used to treat symptoms of schizophrenia (a type of psychosis); it is not commonly used to treat anxiety and depression.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are decision support systems available for chronic pain management. These systems are designed to assist healthcare professionals in making informed decisions about the best treatment options for patients with chronic pain. They may use a variety of data sources, such as patient medical records, clinical guidelines, and patient-reported outcomes, to provide personalized recommendations for pain management. Some examples of decision support systems for chronic pain management include the Chronic Pain Management Decision Support System and the Pain Management Decision Aid.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Decision support systems exist for chronic pain management.\n2. These systems help healthcare professionals make informed decisions for treating chronic pain patients.\n3. Decision support systems for chronic pain management may utilize patient medical records, clinical guidelines, and patient-reported outcomes.\n4. The Chronic Pain Management Decision Support System is an example of such a system.\n5. The Pain Management Decision Aid is another example of a decision support system for chronic pain management.",
    "yulan-chat-2-13b-fp16_fact": [
      "Decision support systems exist for chronic pain management.",
      "These systems help healthcare professionals make informed decisions for treating chronic pain patients.",
      "Decision support systems for chronic pain management may utilize patient medical records, clinical guidelines, and patient-reported outcomes.",
      "The Chronic Pain Management Decision Support System is an example of such a system.",
      "The Pain Management Decision Aid is another example of a decision support system for chronic pain management."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1084,
    "user_query": "Which is the methyl donor of histone methyltransferases?",
    "yulan-chat-2-13b-fp16_response": "The methyl donor for histone methyltransferases is typically S-adenosylmethionine (SAM), which is converted to S-adenosylhomocysteine (SAH) during the reaction. SAM is a molecule that contains an adenosine molecule and a molecule of S-adenosylmethionine, which is a molecule that contains a methyl group attached to a cysteine residue. When a histone methyltransferase catalyzes the transfer of a methyl group from SAM to a histone protein, it forms SAH and the modified histone protein.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. S-adenosylmethionine (SAM) is the methyl donor for histone methyltransferases.\n2. During the methylation reaction, S-adenosylmethionine (SAM) is converted to S-adenosylhomocysteine (SAH).\n3. A histone methyltransferase catalyzes the transfer of a methyl group from SAM to a histone protein.\n4. The methylation reaction results in the formation of S-adenosylhomocysteine (SAH) and a modified histone protein.",
    "yulan-chat-2-13b-fp16_fact": [
      "S-adenosylmethionine (SAM) is the methyl donor for histone methyltransferases.",
      "During the methylation reaction, S-adenosylmethionine (SAM) is converted to S-adenosylhomocysteine (SAH).",
      "A histone methyltransferase catalyzes the transfer of a methyl group from SAM to a histone protein.",
      "The methylation reaction results in the formation of S-adenosylhomocysteine (SAH) and a modified histone protein."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1085,
    "user_query": "How are human accelerated regions (HAR) defined?",
    "yulan-chat-2-13b-fp16_response": "Human accelerated regions (HARs) are stretches of DNA in the human genome that are highly conserved across many different species, but have undergone rapid evolution in humans compared to other species. They are thought to be important for the unique features of the human lineage, such as the development of larger brains and the ability to walk upright on two legs. HARs are identified by comparing the DNA sequences of humans and other species and looking for regions where the human sequence is significantly different from the sequences of other species, but still highly conserved within the human genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Human accelerated regions (HARs) are parts of the DNA in the human genome that are highly conserved across various species.\n2. HARs have undergone rapid evolution specifically in humans compared to other species.\n3. HARs are associated with distinct characteristics of the human lineage, like larger brain development and bipedalism.\n4. The identification of HARs involves comparing human DNA sequences with those of other species to find regions with significant differences.\n5. Despite the evolutionary changes, HARs remain highly conserved within the human genome itself.",
    "yulan-chat-2-13b-fp16_fact": [
      "Human accelerated regions (HARs) are parts of the DNA in the human genome that are highly conserved across various species.",
      "HARs have undergone rapid evolution specifically in humans compared to other species.",
      "HARs are associated with distinct characteristics of the human lineage, like larger brain development and bipedalism.",
      "The identification of HARs involves comparing human DNA sequences with those of other species to find regions with significant differences.",
      "Despite the evolutionary changes, HARs remain highly conserved within the human genome itself."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Human accelerated regions (HARs) are parts of the DNA in the human genome that have undergone rapid evolution in humans compared to other species, they are not highly conserved across various species.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1091,
    "user_query": "In which genomic positions is the histone variant macroH2A enriched?",
    "yulan-chat-2-13b-fp16_response": "MacroH2A is a histone variant that is enriched in the genomic positions where it is involved in the formation of heterochromatin, which is a type of chromatin that is characterized by the tight packaging of DNA and reduced gene expression. MacroH2A is particularly enriched in the pericentromeric regions of the genome, which are the regions of DNA that are closest to the centromere, and in the telomeres, which are the regions of DNA at the ends of chromosomes. MacroH2A is also enriched in other regions of the genome that are involved in the regulation of gene expression, such as promoters and enhancers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MacroH2A is a histone variant that is involved in the formation of heterochromatin.\n2. Heterochromatin is characterized by the tight packaging of DNA and reduced gene expression.\n3. MacroH2A is particularly enriched in the pericentromeric regions of the genome.\n4. MacroH2A is enriched in the telomeres, which are the regions of DNA at the ends of chromosomes.\n5. MacroH2A is also enriched in genomic regions involved in the regulation of gene expression, such as promoters and enhancers.",
    "yulan-chat-2-13b-fp16_fact": [
      "MacroH2A is a histone variant that is involved in the formation of heterochromatin.",
      "Heterochromatin is characterized by the tight packaging of DNA and reduced gene expression.",
      "MacroH2A is particularly enriched in the pericentromeric regions of the genome.",
      "MacroH2A is enriched in the telomeres, which are the regions of DNA at the ends of chromosomes.",
      "MacroH2A is also enriched in genomic regions involved in the regulation of gene expression, such as promoters and enhancers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: MacroH2A is typically not enriched in telomeres; instead, it is often found in regions of the genome involved in inactivation, such as the inactive X chromosome in females.\n5. FALSE [correction]: MacroH2A enrichment is generally associated with repressed genomic regions, such as the inactive X chromosome, and not typically with active promoters and enhancers involved in the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1093,
    "user_query": "From which sequence does the Alu repeat originate from?",
    "yulan-chat-2-13b-fp16_response": "The Alu repeat is a short sequence of DNA that is found in the genome of many animals, including humans. It is named after the Alu element, which is a type of transposable element that is found in the DNA of many mammals. Transposable elements are segments of DNA that can move from one location in the genome to another, and the Alu element is able to do this through a process called transposition.\nThe Alu element is about 300 base pairs long, and it is characterized by the presence of a short sequence of DNA that is repeated multiple times within the element. This sequence is known as the Alu repeat, and it is thought to play a role in the regulation of gene expression. The Alu repeat is found in the DNA of many mammals, and it is believed to have originated from a transposable element that was present in the genome of a common ancestor of mammals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Alu repeat is a short sequence of DNA found in the genomes of many animals, including humans.\n2. The Alu element, from which the Alu repeat originates, is a type of transposable element found in the DNA of many mammals.\n3. The Alu element can move within the genome through a process called transposition.\n4. The Alu element is approximately 300 base pairs long.\n5. The Alu repeat is believed to have originated from a transposable element in the genome of a common ancestor of mammals.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Alu repeat is a short sequence of DNA found in the genomes of many animals, including humans.",
      "The Alu element, from which the Alu repeat originates, is a type of transposable element found in the DNA of many mammals.",
      "The Alu element can move within the genome through a process called transposition.",
      "The Alu element is approximately 300 base pairs long.",
      "The Alu repeat is believed to have originated from a transposable element in the genome of a common ancestor of mammals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1099,
    "user_query": "Are there any HCV replication inhibitors available?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are several HCV replication inhibitors available for the treatment of chronic hepatitis C virus (HCV) infection. These drugs work by targeting different stages of the HCV replication cycle and blocking the production of new virus particles. Some of the commonly used HCV replication inhibitors include:\n1. NS5 inhibitors: These drugs target the NS5 protein, which is involved in the replication and assembly of the HCV virus particle. Examples of NS5 inhibitors include sofosbuvir, velpatasvir, and voxilaprevir.\n2. NS3/4A inhibitors: These drugs target the NS3 and NS4A proteins, which are involved in the replication and processing of the HCV genome. Examples of NS3/4A inhibitors include daclatasvir, asunaprevir, and simeprevir.\n3. NS5A inhibitors: These drugs target the NS5A protein, which is involved in the formation of the HCV virus particle. Examples of NS5A inhibitors include ledipasvir, ombitasvir, and dasabuvir.\nCombination therapy with two or more HCV replication inhibitors is often used to achieve sustained virological response and cure HCV infection. The choice of drugs and the duration of treatment depend on various factors, including the genotype of HCV, the patient's medical history, and potential drug interactions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. HCV replication inhibitors are available for the treatment of chronic HCV infection.\n2. These drugs target different stages of the HCV replication cycle to block the production of new virus particles.\n3. NS5 inhibitors, such as sofosbuvir, velpatasvir, and voxilaprevir, target the NS5 protein of the HCV virus.\n4. NS3/4A inhibitors, including daclatasvir, asunaprevir, and simeprevir, target the NS3 and NS4A proteins of HCV.\n5. NS5A inhibitors, like ledipasvir, ombitasvir, and dasabuvir, target the NS5A protein of HCV.",
    "yulan-chat-2-13b-fp16_fact": [
      "HCV replication inhibitors are available for the treatment of chronic HCV infection.",
      "These drugs target different stages of the HCV replication cycle to block the production of new virus particles.",
      "NS5 inhibitors, such as sofosbuvir, velpatasvir, and voxilaprevir, target the NS5 protein of the HCV virus.",
      "NS3/4A inhibitors, including daclatasvir, asunaprevir, and simeprevir, target the NS3 and NS4A proteins of HCV.",
      "NS5A inhibitors, like ledipasvir, ombitasvir, and dasabuvir, target the NS5A protein of HCV."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: NS5A inhibitors, like ledipasvir and ombitasvir, target the NS5A protein of HCV. Dasabuvir is a non-nucleoside NS5B polymerase inhibitor.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1108,
    "user_query": "Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?",
    "yulan-chat-2-13b-fp16_response": "PLK2 (Polarisome complex protein 1 kinase 2) is a serine/threonine kinase that has been implicated in the phosphorylation of alpha-synuclein (-syn) in Parkinson's disease (PD). However, the exact role of PLK2 in PD pathogenesis is still a matter of debate.\nStudies have shown that PLK2 can phosphorylate -syn at serine residues 129 and 214, which are known to be involved in the formation of pathological -syn aggregates in PD. PLK2-mediated phosphorylation of -syn has been shown to promote its aggregation and toxicity in cell culture models of PD.\nHowever, other studies have suggested that PLK2 may play a protective role in PD by regulating -syn expression and degradation. For example, PLK2 has been shown to promote the degradation of -syn by regulating the activity of the protein degradation pathway, the ubiquitin-proteasome system.\nOverall, while PLK2 has been implicated in -syn phosphorylation in PD, the exact role of PLK2 in PD pathogenesis is still not fully understood and is an area of active research.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PLK2 (Polarisome complex protein 1 kinase 2) is a serine/threonine kinase.\n2. PLK2 has been implicated in the phosphorylation of alpha-synuclein in Parkinson's disease.\n3. PLK2 can phosphorylate alpha-synuclein at serine residues 129 and 214.\n4. Phosphorylation of alpha-synuclein by PLK2 is associated with the formation of pathological aggregates in Parkinson's disease.\n5. Some studies suggest that PLK2 may have a protective role in Parkinson's disease by promoting the degradation of alpha-synuclein through the ubiquitin-proteasome system.",
    "yulan-chat-2-13b-fp16_fact": [
      "PLK2 (Polarisome complex protein 1 kinase 2) is a serine/threonine kinase.",
      "PLK2 has been implicated in the phosphorylation of alpha-synuclein in Parkinson's disease.",
      "PLK2 can phosphorylate alpha-synuclein at serine residues 129 and 214.",
      "Phosphorylation of alpha-synuclein by PLK2 is associated with the formation of pathological aggregates in Parkinson's disease.",
      "Some studies suggest that PLK2 may have a protective role in Parkinson's disease by promoting the degradation of alpha-synuclein through the ubiquitin-proteasome system."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: PLK2 can phosphorylate alpha-synuclein at serine residue 129, but there is no well-established evidence that it phosphorylates at serine residue 214.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1111,
    "user_query": "Name five popular  computer  programs used to identify genes in genomic sequences",
    "yulan-chat-2-13b-fp16_response": "1. BLAST (Basic Local Alignment Search Tool)\n2. FASTA (Fast All)\n3. Clustal Omega\n4. MEGA (Molecular Evolutionary Genetics Analysis)\n5. Geneious",
    "yulan-chat-2-13b-fp16_fact_raw": "1. BLAST stands for Basic Local Alignment Search Tool.\n2. FASTA is a program used to identify genes in genomic sequences.\n3. Clustal Omega is a computer program used for gene identification in genomic sequences.\n4. MEGA stands for Molecular Evolutionary Genetics Analysis.\n5. Geneious is a software program used to identify genes in genomic sequences.",
    "yulan-chat-2-13b-fp16_fact": [
      "BLAST stands for Basic Local Alignment Search Tool.",
      "FASTA is a program used to identify genes in genomic sequences.",
      "Clustal Omega is a computer program used for gene identification in genomic sequences.",
      "MEGA stands for Molecular Evolutionary Genetics Analysis.",
      "Geneious is a software program used to identify genes in genomic sequences."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: FASTA is a sequence alignment program that can be used to search sequence databases and compare sequences, not specifically to identify genes in genomic sequences.\n3. FALSE [correction]: Clustal Omega is a computer program used for multiple sequence alignment, not specifically for gene identification in genomic sequences.\n4. TRUE\n5. FALSE [correction]: Geneious is a bioinformatics software platform for molecular biology and sequence analysis, which includes a range of tools such as sequence alignment and assembly, not limited to gene identification.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1112,
    "user_query": "Which are the major transcription factors regulating glycolysis in mammals?",
    "yulan-chat-2-13b-fp16_response": "There are several major transcription factors that regulate glycolysis in mammals, including:\n1. Hypoxia-inducible factor 1 (HIF-1): HIF-1 is a transcription factor that is activated in response to low oxygen levels (hypoxia). It regulates the expression of genes involved in glucose metabolism, including glycolytic enzymes and glucose transporters.\n2. Glucocorticoid receptor (GR): GR is a transcription factor that regulates the expression of genes involved in glucose metabolism in response to changes in glucocorticoid hormone levels. It can activate or repress the expression of genes involved in glycolysis, depending on the context.\n3. Insulin receptor substrate 1 (IRS-1): IRS-1 is a transcription factor that regulates the expression of genes involved in glucose metabolism in response to insulin signaling. It can activate the expression of genes involved in glycolysis and glucose uptake.\n4. cAMP-response element binding protein (CREB): CREB is a transcription factor that regulates the expression of genes involved in glucose metabolism in response to changes in intracellular signaling pathways. It can activate the expression of genes involved in glycolysis and glucose uptake.\n5. Nuclear factor kappa B (NF-B): NF-B is a transcription factor that regulates the expression of genes involved in inflammation and immune response. It can also regulate the expression of genes involved in glucose metabolism, including glycolytic enzymes and glucose transporters.\nThese transcription factors work together to regulate the expression of genes involved in glycolysis in response to changes in the cellular environment, hormone levels, and other signaling pathways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hypoxia-inducible factor 1 (HIF-1) is activated in response to low oxygen levels and regulates the expression of genes involved in glucose metabolism.\n2. Glucocorticoid receptor (GR) regulates genes involved in glucose metabolism in response to glucocorticoid hormone levels.\n3. Insulin receptor substrate 1 (IRS-1) regulates gene expression related to glucose metabolism in response to insulin signaling.\n4. cAMP-response element binding protein (CREB) regulates the expression of genes involved in glucose metabolism in response to changes in intracellular signaling pathways.\n5. Nuclear factor kappa B (NF-B) can influence the expression of genes involved in glucose metabolism and inflammation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hypoxia-inducible factor 1 (HIF-1) is activated in response to low oxygen levels and regulates the expression of genes involved in glucose metabolism.",
      "Glucocorticoid receptor (GR) regulates genes involved in glucose metabolism in response to glucocorticoid hormone levels.",
      "Insulin receptor substrate 1 (IRS-1) regulates gene expression related to glucose metabolism in response to insulin signaling.",
      "cAMP-response element binding protein (CREB) regulates the expression of genes involved in glucose metabolism in response to changes in intracellular signaling pathways.",
      "Nuclear factor kappa B (NF-B) can influence the expression of genes involved in glucose metabolism and inflammation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Insulin receptor substrate 1 (IRS-1) does not regulate gene expression directly. It is a cytoplasmic signaling molecule that transmits signals from the insulin and insulin-like growth factor receptors to intracellular pathways, affecting various processes including glucose metabolism.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1113,
    "user_query": "Mutations in which gene determine response to both erlotinib and gefitinib?",
    "yulan-chat-2-13b-fp16_response": "The mutations in the EGFR gene (Epidermal Growth Factor Receptor) determine response to both erlotinib and gefitinib. These drugs are targeted therapies that work by blocking the activity of the EGFR protein, which is overactive in certain types of cancer cells. Mutations in the EGFR gene can lead to overactivity of the EGFR protein, and these drugs can help to inhibit this activity and slow or stop the growth of the cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the EGFR gene (Epidermal Growth Factor Receptor) influence the response to both erlotinib and gefitinib.\n2. Erlotinib and gefitinib are targeted therapies designed to block the activity of the EGFR protein.\n3. Overactivity of the EGFR protein can be present in certain types of cancer cells.\n4. Drugs such as erlotinib and gefitinib can inhibit overactive EGFR protein activity.\n5. Inhibiting EGFR protein activity can slow or stop the growth of cancer that exhibits such overactivity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the EGFR gene (Epidermal Growth Factor Receptor) influence the response to both erlotinib and gefitinib.",
      "Erlotinib and gefitinib are targeted therapies designed to block the activity of the EGFR protein.",
      "Overactivity of the EGFR protein can be present in certain types of cancer cells.",
      "Drugs such as erlotinib and gefitinib can inhibit overactive EGFR protein activity.",
      "Inhibiting EGFR protein activity can slow or stop the growth of cancer that exhibits such overactivity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1114,
    "user_query": "Which protein complexes contain mitofilin?",
    "yulan-chat-2-13b-fp16_response": "Mitochondrial filin (MIF) is a protein that is a component of several protein complexes in mitochondria, including:\n1. The mitochondrial inner membrane complex (MIC), which is involved in the formation and maintenance of the inner mitochondrial membrane.\n2. The mitochondrial annular complex (MAC), which is involved in the formation of the annular mitochondrial membrane.\n3. The mitochondrial contact site and cristae complex (MCC), which is involved in the organization and regulation of the mitochondrial cristae and the formation of the mitochondrial contact site.\n4. The mitochondrial protein-processing complex (MPPC), which is involved in the processing and degradation of mitochondrial proteins.\nMIF plays a critical role in the formation and maintenance of the inner mitochondrial membrane and is also involved in the regulation of mitochondrial dynamics and the maintenance of mitochondrial function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mitofilin is a protein component of the mitochondrial inner membrane complex (MIC).\n2. Mitofilin is involved in the formation and maintenance of the inner mitochondrial membrane.\n3. Mitofilin is a component of the mitochondrial contact site and cristae complex (MCC).\n4. Mitofilin plays a role in the organization and regulation of the mitochondrial cristae.\n5. Mitofilin is involved in the processing and degradation of mitochondrial proteins as part of the mitochondrial protein-processing complex (MPPC).",
    "yulan-chat-2-13b-fp16_fact": [
      "Mitofilin is a protein component of the mitochondrial inner membrane complex (MIC).",
      "Mitofilin is involved in the formation and maintenance of the inner mitochondrial membrane.",
      "Mitofilin is a component of the mitochondrial contact site and cristae complex (MCC).",
      "Mitofilin plays a role in the organization and regulation of the mitochondrial cristae.",
      "Mitofilin is involved in the processing and degradation of mitochondrial proteins as part of the mitochondrial protein-processing complex (MPPC)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mitofilin is not primarily involved in the processing and degradation of mitochondrial proteins as part of the mitochondrial protein-processing complex (MPPC). Mitofilin's main roles are associated with the structure and organization of mitochondrial cristae, which is a part of the mitochondrial contact site and cristae organizing system (MICOS), also known as the mitochondrial inner membrane organizing system. The MPPC, also known as the matrix processing peptidase or mitochondrial processing peptidase, is responsible for processing precursor proteins that are imported into the mitochondria, and it involves different components such as MPP and MPP.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1120,
    "user_query": "Which computational frameworks are available for predicting enhancers?",
    "yulan-chat-2-13b-fp16_response": "There are several computational frameworks available for predicting enhancers, including:\n1. ChIPseeker: This tool uses genomic features such as H3K4me3 and H3K27ac ChIP-seq data to identify putative enhancers.\n2. DNase I footprints: This method uses DNase I footprinting data to identify regions of the genome where open chromatin is associated with transcriptional activity.\n3. TRANSFAC: This tool uses transcription factor binding site analysis to predict putative enhancers.\n4. Enhancer Prediction: This tool uses a combination of genomic features such as H3K4me3, H3K27ac, and DNase I data to predict enhancers.\n5. EnhancerMap: This tool uses a machine learning approach to predict enhancers based on genomic features and epigenetic marks.\n6. ROSE: This tool uses a Bayesian network approach to predict enhancers based on genomic features and epigenetic marks.\n7. SPICE: This tool uses a machine learning approach to predict enhancers based on genomic features and epigenetic marks.\nThese tools can be used to identify potential enhancers in the genome, which can then be further validated experimentally.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ChIPseeker is a computational tool used to identify putative enhancers using genomic features such as H3K4me3 and H3K27ac ChIP-seq data.\n2. DNase I footprinting data is used by a method to identify regions of open chromatin associated with transcriptional activity.\n3. TRANSFAC predicts putative enhancers through transcription factor binding site analysis.\n4. The \"Enhancer Prediction\" tool uses a combination of genomic features, including H3K4me3, H3K27ac, and DNase I data, to predict enhancers.\n5. EnhancerMap employs a machine learning approach to predict enhancers using genomic features and epigenetic marks.",
    "yulan-chat-2-13b-fp16_fact": [
      "ChIPseeker is a computational tool used to identify putative enhancers using genomic features such as H3K4me3 and H3K27ac ChIP-seq data.",
      "DNase I footprinting data is used by a method to identify regions of open chromatin associated with transcriptional activity.",
      "TRANSFAC predicts putative enhancers through transcription factor binding site analysis.",
      "The \"Enhancer Prediction\" tool uses a combination of genomic features, including H3K4me3, H3K27ac, and DNase I data, to predict enhancers.",
      "EnhancerMap employs a machine learning approach to predict enhancers using genomic features and epigenetic marks."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: ChIPseeker is a computational tool that annotates ChIP-seq data and provides visualization; it is not specifically designed to identify putative enhancers.\n2. TRUE\n3. FALSE [correction]: TRANSFAC is a database of transcription factor binding sites but does not itself predict putative enhancers.\n4. UNKNOWN: Without specific information about the \"Enhancer Prediction\" tool or its methodology, it is difficult to determine the truthfulness of this statement.\n5. UNKNOWN: Without specific information about EnhancerMap or its methodologies, it is difficult to determine the truthfulness of this statement. Moreover, \"EnhancerMap\" is a general term that could refer to different tools or approaches, and if it is a specific tool, it's not widely recognized under this name as of my knowledge cutoff date.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1123,
    "user_query": "What is GRO-seq?",
    "yulan-chat-2-13b-fp16_response": "GRO-seq (Genomic Run-On sequencing) is a technique used to study gene expression by measuring the amount of RNA produced by a gene in response to a specific stimulus or treatment. It is a method for measuring transcript dynamics, which is the change in the amount of RNA transcripts of a gene over time in response to a stimulus. GRO-seq can be used to study the effects of drugs, genetic mutations, or other treatments on gene expression in cells or organisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GRO-seq stands for Genomic Run-On sequencing.\n2. GRO-seq is used to study gene expression by measuring RNA amounts produced by a gene in response to specific stimuli or treatments.\n3. It allows for the measurement of transcript dynamics, indicating changes in RNA transcript levels over time in response to stimuli.\n4. GRO-seq can be applied to investigate the effects of drugs on gene expression.\n5. It can also be used to examine the impacts of genetic mutations or other treatments on gene expression in cells or organisms.",
    "yulan-chat-2-13b-fp16_fact": [
      "GRO-seq stands for Genomic Run-On sequencing.",
      "GRO-seq is used to study gene expression by measuring RNA amounts produced by a gene in response to specific stimuli or treatments.",
      "It allows for the measurement of transcript dynamics, indicating changes in RNA transcript levels over time in response to stimuli.",
      "GRO-seq can be applied to investigate the effects of drugs on gene expression.",
      "It can also be used to examine the impacts of genetic mutations or other treatments on gene expression in cells or organisms."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1134,
    "user_query": "Are Drosophila ultraconserved elements candidate ncRNAs?",
    "yulan-chat-2-13b-fp16_response": "Drosophila ultraconserved elements (UCEs) are regions of the genome that are highly conserved across different species, including humans. These elements have been shown to be associated with regulatory functions, such as gene expression and development. Some studies have suggested that UCEs may be candidate non-coding RNAs (ncRNAs), which are RNA molecules that do not code for proteins but have regulatory functions in the cell. However, the exact functions of UCEs and their potential role as ncRNAs are still being investigated and require further study.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Drosophila ultraconserved elements (UCEs) are highly conserved regions of the genome across different species.\n2. UCEs are associated with regulatory functions like gene expression and development.\n3. Some studies suggest that UCEs may be candidate non-coding RNAs (ncRNAs).\n4. Non-coding RNAs are RNA molecules that do not code for proteins but have regulatory functions in the cell.\n5. The exact functions of UCEs and their potential role as ncRNAs are still under investigation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Drosophila ultraconserved elements (UCEs) are highly conserved regions of the genome across different species.",
      "UCEs are associated with regulatory functions like gene expression and development.",
      "Some studies suggest that UCEs may be candidate non-coding RNAs (ncRNAs).",
      "Non-coding RNAs are RNA molecules that do not code for proteins but have regulatory functions in the cell.",
      "The exact functions of UCEs and their potential role as ncRNAs are still under investigation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1142,
    "user_query": "How are thyroid hormones involved in the development of diabetic cardiomyopathy?",
    "yulan-chat-2-13b-fp16_response": "Thyroid hormones play a crucial role in the development of diabetic cardiomyopathy, which is a type of heart disease that occurs in people with diabetes. These hormones help regulate the metabolism of cells in the body, including the heart muscle cells.\nIn diabetes, high levels of blood sugar can damage the heart muscle over time, leading to diabetic cardiomyopathy. Thyroid hormones can also be affected by diabetes, with low levels of thyroid hormones (hypothyroidism) being common in people with diabetes.\nHypothyroidism can contribute to the development of diabetic cardiomyopathy by reducing the ability of the heart muscle to contract effectively. This can lead to heart failure, a condition in which the heart is unable to pump blood effectively.\nIn addition, high levels of thyroid hormones (hyperthyroidism) can also contribute to the development of diabetic cardiomyopathy by causing the heart to beat too fast and weakly. This can also lead to heart failure.\nTherefore, maintaining optimal thyroid hormone levels is important for preventing and managing diabetic cardiomyopathy in people with diabetes. This can be achieved through regular monitoring of thyroid function and appropriate treatment, such as hormone replacement therapy or medication to control thyroid hormone levels.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyroid hormones regulate the metabolism of cells, including heart muscle cells.\n2. High levels of blood sugar can damage the heart muscle over time, which can lead to diabetic cardiomyopathy.\n3. Low levels of thyroid hormones (hypothyroidism) are common in people with diabetes.\n4. Hypothyroidism can reduce the ability of the heart muscle to contract effectively.\n5. High levels of thyroid hormones (hyperthyroidism) can cause the heart to beat too fast and weakly, contributing to potential heart failure.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyroid hormones regulate the metabolism of cells, including heart muscle cells.",
      "High levels of blood sugar can damage the heart muscle over time, which can lead to diabetic cardiomyopathy.",
      "Low levels of thyroid hormones (hypothyroidism) are common in people with diabetes.",
      "Hypothyroidism can reduce the ability of the heart muscle to contract effectively.",
      "High levels of thyroid hormones (hyperthyroidism) can cause the heart to beat too fast and weakly, contributing to potential heart failure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll statements provided relate to established connections between thyroid function, diabetes, and heart health. If there are errors in the details, more specific medical literature would need to be cited to correct them.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "yulan-chat-2-13b-fp16_response": "Angiogenin is a protein that is localized to the cytoplasm of cells. It is a member of the vascular endothelial growth factor (VEGF) family of proteins, which are involved in the regulation of angiogenesis (the formation of new blood vessels). Angiogenin is thought to play a role in the regulation of angiogenesis by promoting the growth and survival of endothelial cells (the cells that line the blood vessels).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Angiogenin is a protein that is localized to the cytoplasm of cells.\n2. Angiogenin is a member of the vascular endothelial growth factor (VEGF) family of proteins.\n3. The VEGF family of proteins is involved in the regulation of angiogenesis.\n4. Angiogenesis refers to the formation of new blood vessels.\n5. Angiogenin is thought to promote the growth and survival of endothelial cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Angiogenin is a protein that is localized to the cytoplasm of cells.",
      "Angiogenin is a member of the vascular endothelial growth factor (VEGF) family of proteins.",
      "The VEGF family of proteins is involved in the regulation of angiogenesis.",
      "Angiogenesis refers to the formation of new blood vessels.",
      "Angiogenin is thought to promote the growth and survival of endothelial cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Angiogenin is not a member of the vascular endothelial growth factor (VEGF) family of proteins. It is a ribonuclease which is a member of the RNase A superfamily.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1151,
    "user_query": "Which bone protein is used in archaelogy for dating and species identification?",
    "yulan-chat-2-13b-fp16_response": "The bone protein commonly used in archaeology for dating and species identification is collagen. Collagen is a fibrous protein that makes up a large portion of the organic matter in bones, and it is highly resistant to degradation. By analyzing the collagen from bone samples, scientists can determine the age of the sample and the species to which it belonged. This is done by comparing the amino acid sequence of the collagen to that of known species and by using radiocarbon dating to determine the age of the sample.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Collagen is a bone protein used in archaeology for dating and species identification.\n2. Collagen makes up a large portion of the organic matter in bones.\n3. Collagen is highly resistant to degradation.\n4. Scientists can determine the age of bone samples by analyzing their collagen.\n5. The identification of species from bone samples involves comparing the amino acid sequence of the sample's collagen to that of known species.",
    "yulan-chat-2-13b-fp16_fact": [
      "Collagen is a bone protein used in archaeology for dating and species identification.",
      "Collagen makes up a large portion of the organic matter in bones.",
      "Collagen is highly resistant to degradation.",
      "Scientists can determine the age of bone samples by analyzing their collagen.",
      "The identification of species from bone samples involves comparing the amino acid sequence of the sample's collagen to that of known species."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nCollagen is indeed a protein found in bones that is used in archaeology for dating and species identification through various methods such as collagen fingerprinting or peptide mass fingerprinting. It makes up a significant portion of the organic component of bones and is known for its durability over time, which is why it can be used to determine age, such as with radiocarbon dating, and species identification through the comparison of amino acid sequences.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1156,
    "user_query": "Is armodafinil used for treatment of insomnia?",
    "yulan-chat-2-13b-fp16_response": "Armodafinil is not typically used for the treatment of insomnia. It is a wakefulness-promoting agent that is used to improve wakefulness and alertness in individuals with excessive sleepiness associated with conditions such as narcolepsy, shift work sleep disorder, and obstructive sleep apnea/hypopnea syndrome. While it may have some effects on sleep patterns, its primary use is to improve wakefulness and cognitive function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Armodafinil is a wakefulness-promoting agent.\n2. It is used to treat excessive sleepiness in individuals with conditions such as narcolepsy, shift work sleep disorder, and obstructive sleep apnea/hypopnea syndrome.\n3. Armodafinil's primary use is to improve wakefulness and cognitive function.\n4. Armodafinil is not typically used for the treatment of insomnia.",
    "yulan-chat-2-13b-fp16_fact": [
      "Armodafinil is a wakefulness-promoting agent.",
      "It is used to treat excessive sleepiness in individuals with conditions such as narcolepsy, shift work sleep disorder, and obstructive sleep apnea/hypopnea syndrome.",
      "Armodafinil's primary use is to improve wakefulness and cognitive function.",
      "Armodafinil is not typically used for the treatment of insomnia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE - While armodafinil is primarily prescribed to promote wakefulness in individuals with sleep disorders, which is mentioned in statement 2, it has also been researched for its potential effects on cognitive function.\n4. TRUE - Armodafinil is a wakefulness-promoting agent, which means it's used to help people stay awake rather than to help people fall asleep. Thus, it is not typically used to treat insomnia, which is characterized by difficulty falling or staying asleep.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1159,
    "user_query": "What is Trypan blue used for?",
    "yulan-chat-2-13b-fp16_response": "Trypan blue is a dye that is commonly used in cell biology research to stain cells and measure their viability. It is often used to assess the health and function of cells, as well as to determine the efficacy of drugs or other treatments. Trypan blue is particularly useful because it is able to penetrate cells and bind to DNA, which allows it to be easily visualized under a microscope. Additionally, trypan blue is relatively inexpensive and easy to use, making it a popular choice for researchers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Trypan blue is used to stain cells in cell biology research.\n2. It is used to measure cell viability.\n3. Trypan blue can be used to assess the health and function of cells.\n4. The dye is used to determine the efficacy of drugs or other treatments.\n5. It penetrates cells and binds to DNA for visualization under a microscope.",
    "yulan-chat-2-13b-fp16_fact": [
      "Trypan blue is used to stain cells in cell biology research.",
      "It is used to measure cell viability.",
      "Trypan blue can be used to assess the health and function of cells.",
      "The dye is used to determine the efficacy of drugs or other treatments.",
      "It penetrates cells and binds to DNA for visualization under a microscope."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Trypan blue is a viability dye that allows researchers to distinguish between live and dead cells. It does not bind to DNA for visualization under a microscope. Live cells are not penetrated by the dye and remain unstained, while dead cells are permeable to the dye and appear blue.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "yulan-chat-2-13b-fp16_response": "Ranolazine is a pharmacological agent that is used to treat angina pectoris and acute myocardial infarction. It works by blocking the late sodium channels in the cardiac myocytes, which results in reduced late sodium current and decreased intracellular calcium concentration. This, in turn, reduces the amount of adenosine triphosphate (ATP) consumption by the myocardial cells, leading to less oxygen consumption and improved cardiac function.\nRanolazine has been shown to affect kinase signaling activation in the heart. Specifically, it has been found to activate the AMP-activated protein kinase (AMPK) pathway, which is involved in regulating energy metabolism and cellular stress. Activation of AMPK by ranolazine has been shown to reduce the activity of the mitochondrial proton motive force, leading to reduced oxygen consumption and improved cardiac function.\nIn addition, ranolazine has been found to inhibit the phosphatidylinositol-3-kinase (PI3K)/Akt pathway, which is involved in regulating cell survival and proliferation. Inhibition of this pathway by ranolazine may contribute to its cardioprotective effects by reducing the activity of the pro-survival factors, such as Bcl-2 and Bax, and promoting apoptosis in the myocardial cells.\nOverall, ranolazine's effects on kinase signaling activation in the heart are complex and multifaceted, and its precise mechanisms of action are still being studied. However, its ability to activate AMPK and inhibit the PI3K/Akt pathway suggest that it may have important implications for the treatment of cardiovascular disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ranolazine is used to treat angina pectoris and acute myocardial infarction.\n2. Ranolazine works by blocking the late sodium channels in cardiac myocytes, leading to a reduced late sodium current.\n3. The drug reduces intracellular calcium concentration and decreases ATP consumption in myocardial cells.\n4. Ranolazine has been found to activate the AMP-activated protein kinase (AMPK) pathway in the heart.\n5. Ranolazine inhibits the phosphatidylinositol-3-kinase (PI3K)/Akt pathway, which may contribute to its cardioprotective effects.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ranolazine is used to treat angina pectoris and acute myocardial infarction.",
      "Ranolazine works by blocking the late sodium channels in cardiac myocytes, leading to a reduced late sodium current.",
      "The drug reduces intracellular calcium concentration and decreases ATP consumption in myocardial cells.",
      "Ranolazine has been found to activate the AMP-activated protein kinase (AMPK) pathway in the heart.",
      "Ranolazine inhibits the phosphatidylinositol-3-kinase (PI3K)/Akt pathway, which may contribute to its cardioprotective effects."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Ranolazine is used to treat chronic angina pectoris, but it is not typically used for acute myocardial infarction as a primary treatment.\n2. TRUE\n3. TRUE: The reduction in intracellular calcium is an indirect effect due to the reduction in late sodium current, but it is correct that Ranolazine decreases ATP consumption in myocardial cells.\n4. UNKNOWN: The activation of the AMP-activated protein kinase (AMPK) pathway by Ranolazine is a subject of research, and definitive conclusions may not be widely accepted or may depend on specific conditions.\n5. UNKNOWN: The effect of Ranolazine on the phosphatidylinositol-3-kinase (PI3K)/Akt pathway is complex and may not be fully understood or universally agreed upon in the scientific literature.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1164,
    "user_query": "Pridopidine has been tested for treatment of which disorder?",
    "yulan-chat-2-13b-fp16_response": "Pridopidine has been tested for the treatment of Parkinson's disease. Parkinson's disease is a progressive neurological disorder that affects movement. It is characterized by the loss of dopamine-producing nerve cells in the brain, which leads to symptoms such as tremors, stiffness, and difficulty with movement. Pridopidine is a drug that acts on the dopamine system in the brain and has been shown to improve symptoms in people with Parkinson's disease. It is currently being studied in clinical trials as a potential treatment for this condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pridopidine has been tested for the treatment of Parkinson's disease.\n2. Parkinson's disease is a progressive neurological disorder that affects movement.\n3. Parkinson's disease involves the loss of dopamine-producing nerve cells in the brain.\n4. Symptoms of Parkinson's disease include tremors, stiffness, and difficulty with movement.\n5. Pridopidine acts on the dopamine system in the brain and has been shown to improve symptoms in people with Parkinson's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pridopidine has been tested for the treatment of Parkinson's disease.",
      "Parkinson's disease is a progressive neurological disorder that affects movement.",
      "Parkinson's disease involves the loss of dopamine-producing nerve cells in the brain.",
      "Symptoms of Parkinson's disease include tremors, stiffness, and difficulty with movement.",
      "Pridopidine acts on the dopamine system in the brain and has been shown to improve symptoms in people with Parkinson's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While pridopidine has been tested for the treatment of Parkinson's disease, as of my last update, there is no conclusive evidence that it improves symptoms in people with Parkinsons disease as its primary mechanism is thought to be related to the sigma-1 receptor, not directly targeting the dopamine system.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1166,
    "user_query": "Are CpG islands located close to housekeeping genes?",
    "yulan-chat-2-13b-fp16_response": "CpG islands are often located near housekeeping genes, but this is not always the case. CpG islands are regions of the genome that contain a high density of CpG sites, which are sites where cytosine and guanine are adjacent to each other in the DNA sequence. These regions are often found in the promoter regions of genes, where they play a role in regulating gene expression. Housekeeping genes are genes that are essential for the normal functioning of cells and are required for basic cellular processes such as metabolism, protein synthesis, and DNA replication. They are often found in the nucleus of cells and are expressed at relatively constant levels in different cell types and under different conditions. CpG islands are often found near housekeeping genes because these genes are often regulated by mechanisms that involve the binding of transcription factors to the promoter region of the gene, and CpG islands are often sites of binding for these transcription factors. However, CpG islands can also be found in other regions of the genome, such as in introns or in the coding regions of genes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CpG islands are regions of the genome with a high density of CpG sites, where cytosine and guanine are adjacent in the DNA sequence.\n2. CpG islands are often found in the promoter regions of genes and play a role in regulating gene expression.\n3. Housekeeping genes are essential for normal cell functioning and are involved in basic cellular processes like metabolism, protein synthesis, and DNA replication.\n4. Housekeeping genes are typically expressed at relatively constant levels across different cell types and under various conditions.\n5. CpG islands are often located near housekeeping genes due to their role in gene regulation by providing binding sites for transcription factors.",
    "yulan-chat-2-13b-fp16_fact": [
      "CpG islands are regions of the genome with a high density of CpG sites, where cytosine and guanine are adjacent in the DNA sequence.",
      "CpG islands are often found in the promoter regions of genes and play a role in regulating gene expression.",
      "Housekeeping genes are essential for normal cell functioning and are involved in basic cellular processes like metabolism, protein synthesis, and DNA replication.",
      "Housekeeping genes are typically expressed at relatively constant levels across different cell types and under various conditions.",
      "CpG islands are often located near housekeeping genes due to their role in gene regulation by providing binding sites for transcription factors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1168,
    "user_query": "Which is the target of bortezomib used in cancer therapy?",
    "yulan-chat-2-13b-fp16_response": "Bortezomib is a proteasome inhibitor that is used in the treatment of multiple myeloma and mantle cell lymphoma. It works by inhibiting the proteasome, which is a protein complex that is involved in the degradation of unwanted proteins in cells. By inhibiting the proteasome, bortezomib can accumulate toxic proteins in the cells, leading to cell death.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bortezomib is used in the treatment of multiple myeloma.\n2. Bortezomib is used in the treatment of mantle cell lymphoma.\n3. Bortezomib works by inhibiting the proteasome.\n4. The proteasome is a protein complex involved in the degradation of unwanted proteins in cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Bortezomib is used in the treatment of multiple myeloma.",
      "Bortezomib is used in the treatment of mantle cell lymphoma.",
      "Bortezomib works by inhibiting the proteasome.",
      "The proteasome is a protein complex involved in the degradation of unwanted proteins in cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1178,
    "user_query": "Idarucizumab is an antidote of which drug?",
    "yulan-chat-2-13b-fp16_response": "Idarucizumab is an antidote for dabigatran, a blood thinner medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Idarucizumab is an antidote for the medication dabigatran.\n2. Dabigatran is a blood thinner medication.",
    "yulan-chat-2-13b-fp16_fact": [
      "Idarucizumab is an antidote for the medication dabigatran.",
      "Dabigatran is a blood thinner medication."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1179,
    "user_query": "What are the main clinical characteristics of Pendred syndrome?",
    "yulan-chat-2-13b-fp16_response": "Pendred syndrome is a rare genetic disorder that affects the inner ear and is characterized by hearing loss, tinnitus, and balance problems. It is caused by mutations in the SLC26A4 gene, which encodes a protein involved in the development of the cochlea, the spiral-shaped organ in the inner ear that converts sound waves into electrical signals that are sent to the brain.\nThe main clinical characteristics of Pendred syndrome include:\n1. Hearing loss: Pendred syndrome typically causes progressive hearing loss that begins in childhood and progresses to severe or profound deafness in adulthood.\n2. Tinnitus: Many people with Pendred syndrome experience ringing in the ears (tinnitus).\n3. Balance problems: Pendred syndrome can cause problems with balance, which can lead to dizziness, vertigo, and difficulty with coordination and motor skills.\n4. Vestibular areflexia: This is a condition in which the vestibular system, which helps to control balance, does not function properly.\n5. Delayed language development: Children with Pendred syndrome may experience delayed language development due to hearing loss.\n6. Enlarged vestibular aqueduct: Pendred syndrome is characterized by an enlarged vestibular aqueduct, which is a passageway in the inner ear that connects the cochlea to the vestibular system.\nIt is important to note that not everyone with Pendred syndrome will experience all of these symptoms, and some people may have mild or no symptoms at all. If you are concerned that you or a loved one may have Pendred syndrome, it is important to speak with a healthcare provider for proper diagnosis and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pendred syndrome is a genetic disorder that affects the inner ear and leads to hearing loss, tinnitus, and balance problems.\n2. It is caused by mutations in the SLC26A4 gene.\n3. Pendred syndrome typically causes progressive hearing loss that begins in childhood.\n4. Many people with Pendred syndrome experience tinnitus, which is ringing in the ears.\n5. Pendred syndrome is associated with an enlarged vestibular aqueduct in the inner ear.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pendred syndrome is a genetic disorder that affects the inner ear and leads to hearing loss, tinnitus, and balance problems.",
      "It is caused by mutations in the SLC26A4 gene.",
      "Pendred syndrome typically causes progressive hearing loss that begins in childhood.",
      "Many people with Pendred syndrome experience tinnitus, which is ringing in the ears.",
      "Pendred syndrome is associated with an enlarged vestibular aqueduct in the inner ear."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1181,
    "user_query": "What is a popular mesaure of gene expression in RNA-seq experiments?",
    "yulan-chat-2-13b-fp16_response": "One popular measure of gene expression in RNA-seq experiments is the Fragments Per Kilobase of transcript sequence (FPKM) measure. This measure is calculated by dividing the number of RNA-seq reads that align to a particular gene by the length of the transcript in kilobases and then normalizing by the total number of mapped reads. This allows for a comparison of gene expression levels between samples and can be used to identify differentially expressed genes. Other measures of gene expression in RNA-seq experiments include reads per kilobase per million mapped reads (RPKM) and TPM (Transcripts Per Million).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fragments Per Kilobase of transcript sequence (FPKM) measure is used in RNA-seq experiments to determine gene expression.\n2. FPKM is calculated by dividing the number of RNA-seq reads that align to a gene by the transcript length in kilobases.\n3. FPKM is then normalized by the total number of mapped reads in the RNA-seq experiment.\n4. Reads per kilobase per million mapped reads (RPKM) are another measure of gene expression in RNA-seq experiments.\n5. Transcripts Per Million (TPM) is also a measure of gene expression used in RNA-seq experiments.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fragments Per Kilobase of transcript sequence (FPKM) measure is used in RNA-seq experiments to determine gene expression.",
      "FPKM is calculated by dividing the number of RNA-seq reads that align to a gene by the transcript length in kilobases.",
      "FPKM is then normalized by the total number of mapped reads in the RNA-seq experiment.",
      "Reads per kilobase per million mapped reads (RPKM) are another measure of gene expression in RNA-seq experiments.",
      "Transcripts Per Million (TPM) is also a measure of gene expression used in RNA-seq experiments."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll the statements listed are correct in regards to measures used to determine gene expression levels in RNA-seq experiments. FPKM and RPKM are earlier measures that were commonly used, while TPM is another comparable method that has become popular as it accounts for specific biases in the normalization of gene expression data.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1182,
    "user_query": "Is macroautophagy a selective degradation process?",
    "yulan-chat-2-13b-fp16_response": "Macroautophagy, also known as chaperone-mediated autophagy (CMA), is a selective degradation process in which cytoplasmic proteins and other cellular components are degraded by lysosomal enzymes. This process is selective in the sense that it targets specific proteins and other cellular components, rather than degrading all cellular components indiscriminately.\nCMA is mediated by a group of proteins known as chaperones, which bind to and facilitate the degradation of target proteins. These chaperones recognize and bind to specific protein substrates, which are then transported to the lysosome for degradation. This process is thought to play a role in the maintenance of protein quality control and the clearance of damaged or misfolded proteins from the cell.\nOverall, macroautophagy is a selective degradation process that targets specific cellular components for degradation by lysosomal enzymes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Macroautophagy, also known as chaperone-mediated autophagy (CMA), is a selective degradation process.\n2. This process targets specific proteins and other cellular components for degradation.\n3. The degradation in macroautophagy is conducted by lysosomal enzymes.\n4. Chaperones are proteins that mediate CMA by recognizing and binding to specific protein substrates.\n5. The proteins bound by chaperones are transported to the lysosome for degradation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Macroautophagy, also known as chaperone-mediated autophagy (CMA), is a selective degradation process.",
      "This process targets specific proteins and other cellular components for degradation.",
      "The degradation in macroautophagy is conducted by lysosomal enzymes.",
      "Chaperones are proteins that mediate CMA by recognizing and binding to specific protein substrates.",
      "The proteins bound by chaperones are transported to the lysosome for degradation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Macroautophagy is a type of autophagy, but it is not the same as chaperone-mediated autophagy (CMA). Both are distinct processes of degradation in cells.\n2. TRUE: The statement correctly describes autophagy as it targets specific proteins and cellular components for degradation.\n3. TRUE: In macroautophagy, the degradation of cellular components occurs through lysosomal enzymes.\n4. TRUE: Chaperones are indeed proteins that mediate chaperone-mediated autophagy (CMA) by recognizing and binding to specific protein substrates.\n5. TRUE: In the context of chaperone-mediated autophagy, proteins bound by chaperones are indeed transported to the lysosome for degradation.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1188,
    "user_query": "Which protein is affected by dusp8 activation?",
    "yulan-chat-2-13b-fp16_response": "Dusp8 is a dual-specificity protein phosphatase that is involved in regulating various signaling pathways in cells. One of the proteins that can be affected by Dusp8 activation is the mitogen-activated protein kinase (MAPK) pathway. Dusp8 can dephosphorylate and inhibit the activity of MAPK, which is a key regulator of cell growth and proliferation. By inhibiting MAPK activity, Dusp8 can help prevent uncontrolled cell growth and promote cellular homeostasis. Other proteins that can be affected by Dusp8 activation include cyclin-dependent kinases and transcription factors, among others.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dusp8 is a dual-specificity protein phosphatase.\n2. Dusp8 is involved in regulating various signaling pathways in cells.\n3. The mitogen-activated protein kinase (MAPK) pathway can be affected by Dusp8 activation.\n4. Dusp8 can dephosphorylate and inhibit the activity of MAPK.\n5. MAPK is a key regulator of cell growth and proliferation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dusp8 is a dual-specificity protein phosphatase.",
      "Dusp8 is involved in regulating various signaling pathways in cells.",
      "The mitogen-activated protein kinase (MAPK) pathway can be affected by Dusp8 activation.",
      "Dusp8 can dephosphorylate and inhibit the activity of MAPK.",
      "MAPK is a key regulator of cell growth and proliferation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1191,
    "user_query": "Which drugs are utilized to treat eosinophilic esophagitis?",
    "yulan-chat-2-13b-fp16_response": "Eosinophilic esophagitis is a chronic immune system disease that affects the esophagus, the tube that connects the throat to the stomach. The primary goal of treatment for eosinophilic esophagitis is to reduce the number of eosinophils in the esophagus and alleviate symptoms such as difficulty swallowing, chest pain, and food getting stuck in the esophagus.\nThe following drugs are commonly used to treat eosinophilic esophagitis:\n1. Corticosteroids: Steroids such as prednisone are often used to reduce inflammation and swelling in the esophagus. They can be taken orally or through an inhaler.\n2. Leukotriene receptor antagonists: These medications, such as montelukast and zafirlukast, block the action of leukotrienes, which are chemicals released during an allergic reaction. They can help reduce inflammation in the esophagus.\n3. Immunomodulatory drugs: These medications, such as omalizumab, target specific immune system cells or proteins that contribute to eosinophilic esophagitis. They can help reduce the number of eosinophils in the esophagus.\n4. Antihistamines: These medications, such as cetirizine and fexofenadine, can help relieve symptoms such as itching and hives that may be associated with eosinophilic esophagitis.\n5. Proton pump inhibitors: These medications, such as omeprazole and esomeprazole, can help reduce acid reflux, which can exacerbate eosinophilic esophagitis.\nIt is important to note that the most effective treatment for eosinophilic esophagitis may vary depending on the severity of the condition and the individual patient. Treatment plans are typically developed in consultation with a healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eosinophilic esophagitis is a chronic immune system disease.\n2. The primary goal of treatment for eosinophilic esophagitis is to reduce the number of eosinophils in the esophagus.\n3. Corticosteroids such as prednisone are used to reduce inflammation and swelling in the esophagus.\n4. Leukotriene receptor antagonists, like montelukast and zafirlukast, block the action of leukotrienes to reduce inflammation.\n5. Proton pump inhibitors, such as omeprazole and esomeprazole, are used to reduce acid reflux associated with eosinophilic esophagitis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eosinophilic esophagitis is a chronic immune system disease.",
      "The primary goal of treatment for eosinophilic esophagitis is to reduce the number of eosinophils in the esophagus.",
      "Corticosteroids such as prednisone are used to reduce inflammation and swelling in the esophagus.",
      "Leukotriene receptor antagonists, like montelukast and zafirlukast, block the action of leukotrienes to reduce inflammation.",
      "Proton pump inhibitors, such as omeprazole and esomeprazole, are used to reduce acid reflux associated with eosinophilic esophagitis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While leukotriene receptor antagonists like montelukast and zafirlukast block the action of leukotrienes and can reduce inflammation, they are not typically used to treat eosinophilic esophagitis; their use is more common in conditions like asthma.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1194,
    "user_query": "What is the Her2 status in Li-Fraumeni syndrome?",
    "yulan-chat-2-13b-fp16_response": "Li-FUMNeni syndrome is a rare genetic disorder that is associated with an increased risk of various types of cancer, including breast cancer. One of the genes that is often altered in Li-FUMNeni syndrome is the HER2 gene, which encodes a protein called human epidermal growth factor receptor 2 (HER2).\nIn some cases of Li-FUMNeni syndrome, the HER2 gene is amplified or overexpressed, leading to the production of excess HER2 protein. This can stimulate the growth of cancer cells and contribute to the development of breast cancer in people with Li-FUMNeni syndrome.\nHowever, not all people with Li-FUMNeni syndrome have HER2 gene amplification or overexpression, and the HER2 status can vary widely even among individuals with the same diagnosis. Therefore, it is important for people with Li-FUMNeni syndrome to be closely monitored for the development of breast cancer and to receive appropriate screening and treatment based on their individual circumstances.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Li-Fraumeni syndrome is a rare genetic disorder associated with an increased risk of various types of cancer.\n2. The HER2 gene, which encodes the human epidermal growth factor receptor 2 (HER2), can be altered in Li-Fraumeni syndrome.\n3. In some cases of Li-Fraumeni syndrome, the HER2 gene is amplified or overexpressed.\n4. Overproduction of HER2 protein can stimulate the growth of cancer cells in Li-Fraumeni syndrome.\n5. The HER2 status in individuals with Li-Fraumeni syndrome can vary and is not uniform among those with the diagnosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Li-Fraumeni syndrome is a rare genetic disorder associated with an increased risk of various types of cancer.",
      "The HER2 gene, which encodes the human epidermal growth factor receptor 2 (HER2), can be altered in Li-Fraumeni syndrome.",
      "In some cases of Li-Fraumeni syndrome, the HER2 gene is amplified or overexpressed.",
      "Overproduction of HER2 protein can stimulate the growth of cancer cells in Li-Fraumeni syndrome.",
      "The HER2 status in individuals with Li-Fraumeni syndrome can vary and is not uniform among those with the diagnosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The TP53 gene, which encodes the tumor protein p53, can be altered in Li-Fraumeni syndrome.\n3. FALSE [correction]: Alterations in the TP53 gene, not the HER2 gene, are typically seen in cases of Li-Fraumeni syndrome.\n4. FALSE [correction]: Overproduction of the p53 protein due to TP53 gene mutations, rather than HER2, can lead to the development of cancer cells in Li-Fraumeni syndrome.\n5. TRUE (with the clarification that it should be referring to p53 status, not HER2 status). If referring to HER2, the statement would be considered UNKNOWN without further context as the HER2 status is not typically associated with Li-Fraumeni syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1197,
    "user_query": "Why can't humans synthesize Neu5Gc (N-Glycolylneuraminic acid)?",
    "yulan-chat-2-13b-fp16_response": "Neu5Gc is a type of sialic acid, which is a type of carbohydrate molecule that is found on the surface of many types of cells in the human body. It is an important component of the protective coating on the surface of cells called the glycocalyx.\nHumans are able to synthesize some types of sialic acid, but not Neu5Gc. This is because humans have lost the ability to produce Neu5Gc due to a genetic mutation that occurred at some point in human evolution. This mutation is thought to have occurred around 10,000 years ago, and it is believed to have been caused by a genetic change that affected the gene responsible for producing Neu5Gc.\nAs a result of this mutation, humans are unable to produce Neu5Gc on their own and must obtain it from their diet. Neu5Gc is found in small amounts in some foods, such as red meat and certain types of seafood. However, it is not essential for human health, and it is possible for humans to survive without consuming Neu5Gc.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neu5Gc is a type of sialic acid found on the surface of many types of cells in the human body.\n2. Humans cannot synthesize Neu5Gc due to a genetic mutation that affected the gene responsible for producing it.\n3. The genetic mutation that prevents human production of Neu5Gc is thought to have occurred around 10,000 years ago.\n4. Neu5Gc is found in small amounts in foods such as red meat and certain types of seafood.\n5. Neu5Gc is not essential for human health, and humans can survive without consuming it.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neu5Gc is a type of sialic acid found on the surface of many types of cells in the human body.",
      "Humans cannot synthesize Neu5Gc due to a genetic mutation that affected the gene responsible for producing it.",
      "The genetic mutation that prevents human production of Neu5Gc is thought to have occurred around 10,000 years ago.",
      "Neu5Gc is found in small amounts in foods such as red meat and certain types of seafood.",
      "Neu5Gc is not essential for human health, and humans can survive without consuming it."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Neu5Gc is a type of sialic acid that is not typically found on the surface of cells in the human body, as humans lack the ability to synthesize it.\n2. TRUE\n3. FALSE [correction]: The mutation that prevents human production of Neu5Gc is thought to have occurred 2 to 3 million years ago, not around 10,000 years ago.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1198,
    "user_query": "Which enzyme is inhibited by Orteronel?",
    "yulan-chat-2-13b-fp16_response": "Orteronel is an inhibitor of the enzyme 5-reductase, which is involved in the conversion of testosterone to dihydrotestosterone (DHT) in the body. DHT is a potent androgen that plays a role in the development and maintenance of male characteristics, such as facial hair, deep voice, and muscle mass. Inhibition of 5-reductase by orteronel can reduce the production of DHT, which may be useful in the treatment of conditions such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Orteronel inhibits the enzyme 5-reductase.\n2. 5-reductase is involved in the conversion of testosterone to dihydrotestosterone (DHT).\n3. Dihydrotestosterone (DHT) is a potent androgen involved in the development of male characteristics.\n4. Inhibition of 5-reductase can reduce the production of DHT.\n5. Orteronel may be useful in the treatment of benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness).",
    "yulan-chat-2-13b-fp16_fact": [
      "Orteronel inhibits the enzyme 5-reductase.",
      "5-reductase is involved in the conversion of testosterone to dihydrotestosterone (DHT).",
      "Dihydrotestosterone (DHT) is a potent androgen involved in the development of male characteristics.",
      "Inhibition of 5-reductase can reduce the production of DHT.",
      "Orteronel may be useful in the treatment of benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Orteronel inhibits the enzyme CYP17A1, not 5-reductase.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Since Orteronel does not inhibit 5-reductase, it is not typically used in the treatment of benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness). These conditions are often treated with actual 5-reductase inhibitors such as finasteride or dutasteride.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1202,
    "user_query": "Elaborate on the TREAT-NMD initiative for DMD patients",
    "yulan-chat-2-13b-fp16_response": "TREAT-NMD is an international initiative aimed at improving the diagnosis, care, and treatment of muscular dystrophies (MDs) and related neuromuscular disorders (NMDs). The initiative was launched in 2007 by the European Neuromuscular Society (ENMS) and the European Neurological Society (ENS), with the support of other professional societies and patient organizations.\nThe main goal of TREAT-NMD is to promote the development and implementation of best practice guidelines for the diagnosis and management of MDs and NMDs. These guidelines are based on the latest scientific research and clinical experience, and are intended to help healthcare professionals provide the best possible care for patients with these conditions.\nIn addition to developing guidelines, TREAT-NMD also works to raise awareness of NMDs among healthcare professionals, policymakers, and the general public. The initiative also aims to promote research into the causes and treatments of NMDs, and to facilitate collaboration and knowledge sharing among researchers and clinicians working in this field.\nFor patients with Duchenne muscular dystrophy (DMD), a specific sub-initiative called TREAT-NMD DMD is focused on addressing the unique needs and challenges faced by this patient population. This sub-initiative aims to promote the development and implementation of evidence-based care pathways for DMD, as well as to support research into new treatments for this condition.\nOverall, the TREAT-NMD initiative plays an important role in improving the lives of people with NMDs, including DMD, by promoting best practice guidelines, raising awareness, and supporting research.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TREAT-NMD was launched in 2007 by the European Neuromuscular Society and the European Neurological Society.\n2. The initiative's main goal is to improve the diagnosis, care, and treatment of muscular dystrophies and related neuromuscular disorders.\n3. TREAT-NMD develops best practice guidelines for the diagnosis and management of muscular dystrophies and neuromuscular disorders.\n4. TREAT-NMD also works to raise awareness of neuromuscular disorders among healthcare professionals, policymakers, and the public.\n5. There is a sub-initiative called TREAT-NMD DMD that is specifically focused on addressing the needs and challenges of patients with Duchenne muscular dystrophy.",
    "yulan-chat-2-13b-fp16_fact": [
      "TREAT-NMD was launched in 2007 by the European Neuromuscular Society and the European Neurological Society.",
      "The initiative's main goal is to improve the diagnosis, care, and treatment of muscular dystrophies and related neuromuscular disorders.",
      "TREAT-NMD develops best practice guidelines for the diagnosis and management of muscular dystrophies and neuromuscular disorders.",
      "TREAT-NMD also works to raise awareness of neuromuscular disorders among healthcare professionals, policymakers, and the public.",
      "There is a sub-initiative called TREAT-NMD DMD that is specifically focused on addressing the needs and challenges of patients with Duchenne muscular dystrophy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: TREAT-NMD was launched in 2007 by a consortium of leading scientists and clinicians from across Europe, not specifically by the European Neuromuscular Society and the European Neurological Society.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1207,
    "user_query": "What is the physiological role of LKB1 involved in Peutz-Jeghers syndrome?",
    "yulan-chat-2-13b-fp16_response": "LKB1 (Lysophosphatidic Acid Receptor 1) is a G protein-coupled receptor that is involved in various physiological processes, including cell proliferation, differentiation, and survival. In Peutz-Jeghers syndrome, a hereditary autosomal dominant disorder, LKB1 has been implicated in the development of hamartomatous polyps in the gastrointestinal tract.\nStudies have shown that LKB1 is highly expressed in the cells of these polyps, and its activation promotes the proliferation and survival of the cells, leading to the formation and growth of the polyps. It is believed that mutations in the LKB1 gene may contribute to the development of Peutz-Jeghers syndrome by altering the normal function of LKB1 in the gut epithelial cells.\nFurthermore, LKB1 has also been implicated in the regulation of cell differentiation and migration, which may play a role in the formation of other features associated with Peutz-Jeghers syndrome, such as pigmented spots on the skin and mucocutaneous papillary hamartomas.\nOverall, while the exact role of LKB1 in Peutz-Jeghers syndrome is still being investigated, it is clear that its dysregulation plays a significant role in the development and progression of the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LKB1 is involved in cell proliferation, differentiation, and survival.\n2. Peutz-Jeghers syndrome is a hereditary autosomal dominant disorder.\n3. LKB1 has been implicated in the development of hamartomatous polyps in the gastrointestinal tract of individuals with Peutz-Jeghers syndrome.\n4. Mutations in the LKB1 gene may contribute to the development of Peutz-Jeghers syndrome.\n5. The dysregulation of LKB1 plays a role in the development and progression of Peutz-Jeghers syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "LKB1 is involved in cell proliferation, differentiation, and survival.",
      "Peutz-Jeghers syndrome is a hereditary autosomal dominant disorder.",
      "LKB1 has been implicated in the development of hamartomatous polyps in the gastrointestinal tract of individuals with Peutz-Jeghers syndrome.",
      "Mutations in the LKB1 gene may contribute to the development of Peutz-Jeghers syndrome.",
      "The dysregulation of LKB1 plays a role in the development and progression of Peutz-Jeghers syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nLKB1 is a well-known tumor suppressor gene involved in various cellular processes including cell proliferation, differentiation, and survival. Peutz-Jeghers syndrome is indeed an autosomal dominant disorder characterized by the development of distinctive hamartomatous polyps in the gastrointestinal tract and other symptoms. Mutations in the LKB1 gene (also known as STK11) have been directly implicated in the development of Peutz-Jeghers syndrome, and the dysregulation of LKB1 is significant in the pathogenesis of the syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1213,
    "user_query": "Which is the major function of sororin?",
    "yulan-chat-2-13b-fp16_response": "Sororin is a type of protein that is found in the blood of many animals, including humans. Its major function is to act as a transport protein for certain molecules, such as heme and biliverdin, in the bloodstream. Sororin helps to regulate the levels of these molecules in the blood and plays a role in maintaining the proper functioning of various organs and systems in the body.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1216,
    "user_query": "Can desvenlafaxine be used at a dose of 50mg/day?",
    "yulan-chat-2-13b-fp16_response": "Desvenlafaxine is a prescription medication that is used to treat depression and anxiety. It is a selective serotonin and norepinephrine reuptake inhibitor (SNRI), which means that it works by increasing the levels of certain chemicals in the brain, such as serotonin and norepinephrine.\nThe recommended starting dose of desvenlafaxine is 25 mg per day, and the maximum recommended dose is 50 mg per day. However, the appropriate dose for an individual patient will depend on a number of factors, including their age, weight, medical history, and the severity of their condition.\nIt is important to note that desvenlafaxine should only be used under the supervision of a healthcare provider, as the risk of side effects and drug interactions can increase at higher doses. If you are taking desvenlafaxine and are considering increasing your dose to 50 mg per day, it is important to discuss this with your doctor first to determine if this is the right course of treatment for you.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Desvenlafaxine is used to treat depression and anxiety.\n2. Desvenlafaxine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI).\n3. The recommended starting dose of desvenlafaxine is 25 mg per day.\n4. The maximum recommended dose of desvenlafaxine is 50 mg per day.\n5. Desvenlafaxine should be used under the supervision of a healthcare provider.",
    "yulan-chat-2-13b-fp16_fact": [
      "Desvenlafaxine is used to treat depression and anxiety.",
      "Desvenlafaxine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI).",
      "The recommended starting dose of desvenlafaxine is 25 mg per day.",
      "The maximum recommended dose of desvenlafaxine is 50 mg per day.",
      "Desvenlafaxine should be used under the supervision of a healthcare provider."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The recommended starting dose of desvenlafaxine is generally 50 mg per day. However, dosing may vary based on individual patient needs and the specific product formulation.\n4. FALSE [correction]: The maximum recommended dose of desvenlafaxine can be 100 mg per day depending on the individual's response and tolerability. Dosage recommendations can vary, so it's important to follow the prescribing information or a healthcare provider's instructions.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1219,
    "user_query": "Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?",
    "yulan-chat-2-13b-fp16_response": "Ferric carboxymaltose is a medication that is used to treat iron deficiency anemia. It is not specifically indicated for the treatment of anemia in inflammatory bowel disease (IBD) patients, but it may be used off-label for this purpose.\nAnemia is a common complication of IBD, particularly in patients with chronic inflammation and chronic blood loss. The most common cause of anemia in IBD is iron deficiency, which can be due to blood loss in the gastrointestinal tract, inadequate dietary intake, or increased iron requirements due to inflammation.\nFerric carboxymaltose is a form of iron that is administered intravenously. It is a complex of iron and carboxymaltose, a carbohydrate that helps to increase the absorption of iron in the gut. The medication works by increasing the amount of iron in the blood, which can help to alleviate symptoms of anemia such as fatigue, weakness, and shortness of breath.\nWhile ferric carboxymaltose may be used to treat anemia in IBD patients, it is important to note that the underlying cause of the anemia should be identified and treated. This may involve managing the inflammation and blood loss associated with IBD, as well as addressing any nutritional deficiencies. It is important to discuss the use of ferric carboxymaltose with a healthcare provider to determine if it is an appropriate treatment option for a specific patient.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ferric carboxymaltose is used to treat iron deficiency anemia.\n2. Anemia is a common complication in patients with inflammatory bowel disease (IBD).\n3. The most common cause of anemia in IBD patients is iron deficiency.\n4. Ferric carboxymaltose is administered intravenously.\n5. Ferric carboxymaltose is a complex of iron and carboxymaltose.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ferric carboxymaltose is used to treat iron deficiency anemia.",
      "Anemia is a common complication in patients with inflammatory bowel disease (IBD).",
      "The most common cause of anemia in IBD patients is iron deficiency.",
      "Ferric carboxymaltose is administered intravenously.",
      "Ferric carboxymaltose is a complex of iron and carboxymaltose."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1220,
    "user_query": "Which disease is treated with Eliglustat?",
    "yulan-chat-2-13b-fp16_response": "Eliglustat is a medication that is used to treat adults with a rare genetic disorder called Gaucher disease. Gaucher disease is a condition in which the body is unable to properly break down certain fatty substances, leading to the accumulation of these substances in certain organs and tissues. Eliglustat works by reducing the amount of a specific enzyme in the body that is involved in the breakdown of these fatty substances, which helps to reduce the symptoms of Gaucher disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eliglustat is used to treat Gaucher disease.\n2. Gaucher disease is a genetic disorder where the body cannot break down certain fatty substances.\n3. Gaucher disease causes accumulation of fatty substances in organs and tissues.\n4. Eliglustat works by reducing the amount of an enzyme involved in the breakdown of fatty substances.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eliglustat is used to treat Gaucher disease.",
      "Gaucher disease is a genetic disorder where the body cannot break down certain fatty substances.",
      "Gaucher disease causes accumulation of fatty substances in organs and tissues.",
      "Eliglustat works by reducing the amount of an enzyme involved in the breakdown of fatty substances."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Eliglustat works by inhibiting the enzyme glucosylceramide synthase, which is involved in the production of glucocerebroside, the fatty substance that accumulates in individuals with Gaucher disease, rather than reducing an enzyme involved in the breakdown of fatty substances.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "yulan-chat-2-13b-fp16_response": "The regulation of V endonuclease, an enzyme involved in the bacterial adaptive response to DNA damage, can vary depending on the growth phase of the bacteria. While some studies suggest that the expression of V endonuclease is growth phase-independent, others have reported differential regulation during different growth phases.\nFor example, one study found that the expression of V endonuclease in Escherichia coli was constitutively high and not affected by growth phase, while another study observed a growth phase-dependent regulation, with higher expression during the stationary phase. Similarly, some studies have reported that the transcription of the vsr endonuclease gene is regulated by specific transcriptional regulators, such as the FNR family of transcription factors, which can be influenced by growth phase-specific signals.\nOverall, while the regulation of V endonuclease may not be strictly dependent on the growth phase of bacteria, it is likely to be influenced by various factors, including the cellular response to DNA damage, metabolic state, and environmental conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vsr endonuclease is an enzyme involved in the bacterial adaptive response to DNA damage.\n2. Some studies suggest that the expression of Vsr endonuclease is growth phase-independent.\n3. Other studies have observed differential regulation of Vsr endonuclease expression during different growth phases in bacteria.\n4. A study found that the expression of Vsr endonuclease in Escherichia coli was constitutively high and not affected by the growth phase.\n5. The transcription of the vsr endonuclease gene can be regulated by specific transcriptional regulators, such as the FNR family of transcription factors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vsr endonuclease is an enzyme involved in the bacterial adaptive response to DNA damage.",
      "Some studies suggest that the expression of Vsr endonuclease is growth phase-independent.",
      "Other studies have observed differential regulation of Vsr endonuclease expression during different growth phases in bacteria.",
      "A study found that the expression of Vsr endonuclease in Escherichia coli was constitutively high and not affected by the growth phase.",
      "The transcription of the vsr endonuclease gene can be regulated by specific transcriptional regulators, such as the FNR family of transcription factors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Vsr endonuclease is involved in the repair of DNA mismatches, which is part of the bacterial response to DNA damage.\n2. UNKNOWN: The expression of Vsr endonuclease can vary, and without specific details from the studies, it is difficult to determine the growth phase dependency.\n3. TRUE: This is consistent with the complexity of bacterial gene expression and the statement that studies have observed differential regulation suggests that there are indeed variations in the expression of Vsr endonuclease during different growth phases.\n4. UNKNOWN: Again, without specific details from the study, it is difficult to verify this claim. The expression levels of enzymes can vary based on experimental conditions and genetic background.\n5. UNKNOWN: The transcription of the vsr endonuclease gene might be regulated by transcriptional regulators, but without specific information, it cannot be confirmed whether the FNR family of transcription factors plays a role in this regulation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1230,
    "user_query": "What is the life expectancy of professional athletes in respect to the general population?",
    "yulan-chat-2-13b-fp16_response": "It is difficult to determine the life expectancy of professional athletes as a whole, as it can vary greatly depending on the specific sport, the individual's health and lifestyle habits, and other factors. Additionally, the definition of a \"professional athlete\" can be subjective and can vary depending on the sport and the level of competition.\nThat being said, there is some evidence to suggest that professional athletes may have a slightly lower life expectancy than the general population. This may be due to a number of factors, including the physical demands of their sport, the risk of injury, and the potential for long-term health effects from repetitive strain injuries or other types of damage to the body.\nHowever, it is important to note that many professional athletes do live long and healthy lives, and there are many examples of athletes who have competed at a high level well into their 30s and beyond. Additionally, many professional athletes have access to top-notch medical care and other resources that can help them maintain their health and well-being.\nOverall, it is difficult to make broad generalizations about the life expectancy of professional athletes, and it is important to consider the specific factors and circumstances that can affect an individual's health and longevity.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1232,
    "user_query": "How does adrenergic signaling affect thyroid hormone receptors?",
    "yulan-chat-2-13b-fp16_response": "Adrenergic signaling can affect thyroid hormone receptors in several ways.\nFirstly, adrenergic signaling can increase the expression of thyroid hormone receptors in some tissues, such as in the heart and skeletal muscle. This can lead to increased sensitivity to thyroid hormone and increased metabolic activity.\nSecondly, adrenergic signaling can inhibit the binding of thyroid hormone to its receptors in some tissues, such as in the liver and kidneys. This can lead to decreased metabolic activity and decreased sensitivity to thyroid hormone.\nFinally, adrenergic signaling can also affect the activity of enzymes involved in thyroid hormone metabolism, such as the enzyme responsible for converting thyroxine (T4) to triiodothyronine (T3), which can alter the overall availability of active thyroid hormone.\nOverall, the effects of adrenergic signaling on thyroid hormone receptors are complex and can vary depending on the tissue and context.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "yulan-chat-2-13b-fp16_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Some of the commonly used tools are:\n1. HMMER (hidden Markov model): It is a powerful tool for the prediction of transmembrane proteins using hidden Markov models.\n2. TMHMM (transmembrane helix-spacing algorithm): It is a web-based tool that uses a statistical model to predict transmembrane proteins.\n3. MEME (multiple em for motif evaluation): It is a software package that can be used to detect and analyze transmembrane motifs in protein sequences.\n4. Transmembrane Prediction Server (TPS): It is a web-based tool that uses a combination of methods, including hidden Markov models and neural networks, to predict transmembrane proteins.\n5. Phylogenetic analysis: It is a method that uses the evolutionary history of proteins to predict the presence of transmembrane domains.\nThese tools can be used to predict the presence and location of beta-barrel transmembrane proteins in a given protein sequence. However, it is important to note that the accuracy of these predictions depends on the quality and completeness of the protein sequence data available.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. HMMER is a tool that uses hidden Markov models for the prediction of transmembrane proteins.\n2. TMHMM is a web-based tool that predicts transmembrane proteins using a statistical model.\n3. MEME is a software package designed to detect and analyze transmembrane motifs in protein sequences.\n4. The Transmembrane Prediction Server is a web-based tool that combines hidden Markov models and neural networks to predict transmembrane proteins.\n5. Phylogenetic analysis is used to predict the presence of transmembrane domains based on the evolutionary history of proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "HMMER is a tool that uses hidden Markov models for the prediction of transmembrane proteins.",
      "TMHMM is a web-based tool that predicts transmembrane proteins using a statistical model.",
      "MEME is a software package designed to detect and analyze transmembrane motifs in protein sequences.",
      "The Transmembrane Prediction Server is a web-based tool that combines hidden Markov models and neural networks to predict transmembrane proteins.",
      "Phylogenetic analysis is used to predict the presence of transmembrane domains based on the evolutionary history of proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: HMMER is a bioinformatics tool that uses hidden Markov models to perform sequence analysis, but it is not specifically for the prediction of transmembrane proteins.\n2. TRUE\n3. FALSE [correction]: MEME (Multiple EM for Motif Elicitation) is a tool to discover motifs in a group of related DNA or protein sequences, but it does not specifically analyze transmembrane motifs unless such motifs are provided as part of the input data.\n4. TRUE\n5. FALSE [correction]: Phylogenetic analysis is used to understand the evolutionary relationships between organisms or genes, but it is not typically used to predict transmembrane domains. Instead, the presence of transmembrane domains is usually predicted using specific algorithms and bioinformatics tools.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1236,
    "user_query": "Is there any cross-talk between the Wnt and the Akt pathways?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is cross-talk between the Wnt and Akt pathways. The Wnt and Akt pathways are two of the most well-known signaling pathways in cells, and they play important roles in regulating cell proliferation, differentiation, and survival.\nThe Wnt pathway is activated when a Wnt protein binds to a receptor on the cell surface, leading to the activation of downstream signaling proteins, including the beta-catenin protein. Beta-catenin then translocates to the nucleus, where it binds to T-cell factor (TCF) and activates the transcription of target genes that promote cell proliferation and survival.\nThe Akt pathway is activated when a phosphoinositide-dependent protein kinase (PI3K) catalyzes the phosphorylation of phosphatidylinositol-4,5-bisphosphate (PIP2) to produce phosphatidylinositol-3,4,5-trisphosphate (PIP3). This leads to the activation of the protein kinase B (AKT) protein, which then phosphorylates and activates downstream target proteins, including mTOR, that promote cell proliferation and survival.\nThere is cross-talk between the Wnt and Akt pathways in several ways. For example, the Wnt pathway can activate the Akt pathway by promoting the phosphorylation of AKT and its downstream targets. Conversely, the Akt pathway can also regulate the Wnt pathway by promoting the phosphorylation and degradation of beta-catenin, thereby inhibiting Wnt-mediated transcriptional activation.\nOverall, the cross-talk between the Wnt and Akt pathways allows for the coordinated regulation of cell proliferation and survival, and dysregulation of this cross-talk has been implicated in various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Wnt and Akt pathways play key roles in regulating cell proliferation, differentiation, and survival.\n2. Activation of the Wnt pathway occurs when a Wnt protein binds to a receptor on the cell surface, leading to downstream activation including the beta-catenin protein.\n3. Beta-catenin, when activated by the Wnt pathway, translocates to the nucleus and activates transcription of target genes that promote cell proliferation and survival.\n4. The Akt pathway is activated by the phosphorylation of phosphatidylinositol-4,5-bisphosphate (PIP2) by phosphoinositide-dependent protein kinase (PI3K) to create phosphatidylinositol-3,4,5-trisphosphate (PIP3).\n5. Dysregulation of the cross-talk between the Wnt and Akt pathways has been implicated in various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Wnt and Akt pathways play key roles in regulating cell proliferation, differentiation, and survival.",
      "Activation of the Wnt pathway occurs when a Wnt protein binds to a receptor on the cell surface, leading to downstream activation including the beta-catenin protein.",
      "Beta-catenin, when activated by the Wnt pathway, translocates to the nucleus and activates transcription of target genes that promote cell proliferation and survival.",
      "The Akt pathway is activated by the phosphorylation of phosphatidylinositol-4,5-bisphosphate (PIP2) by phosphoinositide-dependent protein kinase (PI3K) to create phosphatidylinositol-3,4,5-trisphosphate (PIP3).",
      "Dysregulation of the cross-talk between the Wnt and Akt pathways has been implicated in various diseases, including cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The Akt pathway is activated by the phosphorylation of phosphatidylinositol-4,5-bisphosphate (PIP2) by phosphoinositide 3-kinase (PI3K) to create phosphatidylinositol-3,4,5-trisphosphate (PIP3). Then, PIP3 recruits Akt to the membrane where it is further phosphorylated and activated by other kinases such as PDK1.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1238,
    "user_query": "Is the Snord116 cluster associated with the Prader-Willi syndrome?",
    "yulan-chat-2-13b-fp16_response": "The Snord116 cluster is a region on chromosome 11 that has been associated with the Prader-Willi syndrome (PWS). PWS is a rare genetic disorder that is characterized by a number of symptoms, including hyperphagia (excessive eating), obesity, and behavioral and cognitive problems.\nThe Snord116 cluster contains a number of genes that have been implicated in the development of PWS, including the SNORD116.2 gene. Mutations in this gene have been found in individuals with PWS, and it is thought to play a role in the regulation of gene expression and the development of the brain.\nHowever, it is important to note that not all individuals with PWS have mutations in the Snord116 cluster, and not all individuals with mutations in this region will develop PWS. Further research is needed to fully understand the genetic basis of PWS and how mutations in the Snord116 cluster contribute to the development of this condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Snord116 cluster is located on chromosome 11.\n2. The Snord116 cluster has been associated with Prader-Willi syndrome (PWS).\n3. Prader-Willi syndrome is characterized by symptoms such as hyperphagia, obesity, and behavioral and cognitive problems.\n4. The SNORD116.2 gene within the Snord116 cluster has been implicated in the development of Prader-Willi syndrome.\n5. Mutations in the Snord116 cluster are not present in all individuals with Prader-Willi syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Snord116 cluster is located on chromosome 11.",
      "The Snord116 cluster has been associated with Prader-Willi syndrome (PWS).",
      "Prader-Willi syndrome is characterized by symptoms such as hyperphagia, obesity, and behavioral and cognitive problems.",
      "The SNORD116.2 gene within the Snord116 cluster has been implicated in the development of Prader-Willi syndrome.",
      "Mutations in the Snord116 cluster are not present in all individuals with Prader-Willi syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: SNORD116 is not a gene, it refers to a small nucleolar RNA cluster (snoRNA); however SNORD116 deletions or loss of function are implicated in the development of Prader-Willi syndrome.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1242,
    "user_query": "Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?",
    "yulan-chat-2-13b-fp16_response": "Nimodipine is a calcium channel blocker that is commonly used to prevent and treat vasospasm in patients with aneurysmal subarachnoid hemorrhage (SAH). However, the use of nimodipine for this indication is still a matter of debate and its efficacy has not been definitively established.\nSome studies have suggested that nimodipine may be effective in preventing vasospasm in patients with SAH, while others have found no significant benefit. The evidence is not definitive and further research is needed to fully understand the role of nimodipine in the management of SAH.\nIt is important to note that the use of any medication for the prevention of vasospasm in SAH patients should be individualized and based on the patient's specific clinical characteristics and medical history. It is recommended that the decision to use nimodipine for this indication be made by a neurosurgeon or neurologist with experience in the management of SAH.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nimodipine is a calcium channel blocker used to prevent and treat vasospasm in patients with aneurysmal subarachnoid hemorrhage.\n2. The efficacy of nimodipine for preventing vasospasm in SAH patients has not been definitively established.\n3. Some studies suggest that nimodipine may be effective in preventing vasospasm in patients with SAH, but there is no consensus.\n4. The decision to use nimodipine for preventing vasospasm in SAH patients should be made by a neurosurgeon or neurologist with experience in managing SAH.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nimodipine is a calcium channel blocker used to prevent and treat vasospasm in patients with aneurysmal subarachnoid hemorrhage.",
      "The efficacy of nimodipine for preventing vasospasm in SAH patients has not been definitively established.",
      "Some studies suggest that nimodipine may be effective in preventing vasospasm in patients with SAH, but there is no consensus.",
      "The decision to use nimodipine for preventing vasospasm in SAH patients should be made by a neurosurgeon or neurologist with experience in managing SAH."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The efficacy of nimodipine for preventing vasospasm in patients with SAH has been established and it is recommended by guidelines for this purpose.\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1245,
    "user_query": "Where can we find the protein lacritin?",
    "yulan-chat-2-13b-fp16_response": "Lacritin is a protein that is found in the tears of mammals, including humans. It is a major component of the protein layer that coats the surface of the tear film and helps to keep the eyes moist and protected. Lacritin is also present in small amounts in other secretions, such as sweat and milk. It is a highly hydrophobic protein that is thought to play a role in the formation and maintenance of the lipid layer of the tear film.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lacritin is a protein found in the tears of mammals.\n2. It is present in human tears.\n3. Lacritin is a major component of the protein layer of the tear film.\n4. Small amounts of lacritin are also present in other secretions such as sweat and milk.\n5. Lacritin plays a role in the formation and maintenance of the lipid layer of the tear film.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lacritin is a protein found in the tears of mammals.",
      "It is present in human tears.",
      "Lacritin is a major component of the protein layer of the tear film.",
      "Small amounts of lacritin are also present in other secretions such as sweat and milk.",
      "Lacritin plays a role in the formation and maintenance of the lipid layer of the tear film."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Lacritin is not a major component of the protein layer of the tear film. While it is indeed present in the tear film, it is not one of the major proteins; major proteins include lysozyme, lactoferrin, lipocalin, and immunoglobulins among others.\n4. TRUE\n5. FALSE [correction]: Lacritin plays a role in tear film homeostasis and promotes corneal cell health, but it is not directly involved in the formation or maintenance of the lipid layer of the tear film. The lipid layer is primarily maintained by lipids secreted from the meibomian glands.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1247,
    "user_query": "What is the triple screening test performed during pregnancy measuring?",
    "yulan-chat-2-13b-fp16_response": "The triple screening test is a prenatal test that is performed during pregnancy to assess the risk of certain birth defects and genetic disorders in the developing fetus. The test measures the levels of three substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol.\nAFP is a protein produced by the developing fetus and is usually present in low levels in the mother's blood. High levels of AFP can indicate a neural tube defect, such as spina bifida, or other fetal abnormalities.\nhCG is a hormone produced by the placenta and is usually present in high levels in the mother's blood during early pregnancy. Low levels of hCG can indicate a problem with the pregnancy, such as a miscarriage or ectopic pregnancy.\nEstriol is a form of estrogen produced by the placenta and is usually present in high levels in the mother's blood during the second trimester of pregnancy. High levels of estriol can indicate a chromosomal abnormality, such as Down syndrome, or other fetal abnormalities.\nThe triple screening test is typically performed between 15 and 20 weeks of pregnancy. The results of the test can provide information about the risk of certain birth defects and genetic disorders, although they are not diagnostic. If the test results indicate an increased risk, further testing may be recommended.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The triple screening test measures the levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol in the mother's blood.\n2. High levels of alpha-fetoprotein (AFP) can indicate a neural tube defect or other fetal abnormalities.\n3. Low levels of human chorionic gonadotropin (hCG) can suggest a possible miscarriage or ectopic pregnancy.\n4. High levels of estriol may be associated with chromosomal abnormalities like Down syndrome.\n5. The triple screening test is typically conducted between 15 and 20 weeks of pregnancy.",
    "yulan-chat-2-13b-fp16_fact": [
      "The triple screening test measures the levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol in the mother's blood.",
      "High levels of alpha-fetoprotein (AFP) can indicate a neural tube defect or other fetal abnormalities.",
      "Low levels of human chorionic gonadotropin (hCG) can suggest a possible miscarriage or ectopic pregnancy.",
      "High levels of estriol may be associated with chromosomal abnormalities like Down syndrome.",
      "The triple screening test is typically conducted between 15 and 20 weeks of pregnancy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Low levels of estriol may be associated with chromosomal abnormalities like Down syndrome, whereas high levels can indicate multiple gestations or an overestimation of gestational age.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1249,
    "user_query": "Which protein interacts with the Ragulator-RAG GTPases to control mTOR activity?",
    "yulan-chat-2-13b-fp16_response": "The protein that interacts with the Ragulator-RAG GTPases to control mTOR activity is called S6 kinase (S6K). S6K is a key regulator of mTOR signaling, and it is activated by the Ragulator-RAG complex when amino acids are available for protein synthesis. S6K then phosphorylates and activates several downstream effectors, including S6 ribosomal protein, eIF4E binding protein (4EBP), and insulin receptor substrate 1 (IRS-1), which ultimately lead to increased protein synthesis and cell growth.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. S6 kinase (S6K) interacts with the Ragulator-RAG GTPases to control mTOR activity.\n2. S6K is activated by the Ragulator-RAG complex in the presence of amino acids.\n3. S6 kinase phosphorylates and activates downstream effectors such as S6 ribosomal protein, eIF4E binding protein (4EBP), and insulin receptor substrate 1 (IRS-1).\n4. The activation of these effectors by S6K leads to increased protein synthesis and cell growth.",
    "yulan-chat-2-13b-fp16_fact": [
      "S6 kinase (S6K) interacts with the Ragulator-RAG GTPases to control mTOR activity.",
      "S6K is activated by the Ragulator-RAG complex in the presence of amino acids.",
      "S6 kinase phosphorylates and activates downstream effectors such as S6 ribosomal protein, eIF4E binding protein (4EBP), and insulin receptor substrate 1 (IRS-1).",
      "The activation of these effectors by S6K leads to increased protein synthesis and cell growth."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: S6 kinase (S6K) is a downstream effector of mTOR (mechanistic target of rapamycin) and does not directly interact with the Ragulator-RAG GTPases to control mTOR activity. It is mTORC1 that interacts with the Ragulator-RAG complex.\n2. FALSE [correction]: S6K is not activated by the Ragulator-RAG complex; instead, S6K is downstream of mTORC1, which is activated by the Ragulator-RAG complex in the presence of amino acids.\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "yulan-chat-2-13b-fp16_response": "Galassi classification is not a classification system for a specific disorder, but rather a method for classifying the morphology of red blood cells (RBCs) in a blood smear. It is named after the Italian hematologist, Dr. Ernesto Galassi, who developed the system in the early 20th century.\nThe Galassi classification system assigns a number to each RBC based on its shape and size. The number indicates the degree of deviation from the normal, biconcave shape of RBCs. RBCs with a higher number are more irregularly shaped and may indicate an underlying disorder.\nThe Galassi classification system is often used in the diagnosis and monitoring of various hematological disorders, such as sickle cell disease, thalassemia, and hemoglobinopathies. However, it is not a diagnostic tool in itself, but rather a tool to aid in the analysis of blood films.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Galassi classification is a method for classifying the morphology of red blood cells in a blood smear.\n2. It was developed by Italian hematologist Dr. Ernesto Galassi in the early 20th century.\n3. The system assigns a number to each red blood cell based on its shape and size.\n4. Red blood cells with a higher number in the Galassi classification system are more irregularly shaped.\n5. The Galassi classification system is used in the diagnosis and monitoring of hematological disorders such as sickle cell disease, thalassemia, and hemoglobinopathies.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Galassi classification is a method for classifying the morphology of red blood cells in a blood smear.",
      "It was developed by Italian hematologist Dr. Ernesto Galassi in the early 20th century.",
      "The system assigns a number to each red blood cell based on its shape and size.",
      "Red blood cells with a higher number in the Galassi classification system are more irregularly shaped.",
      "The Galassi classification system is used in the diagnosis and monitoring of hematological disorders such as sickle cell disease, thalassemia, and hemoglobinopathies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Galassi classification is a grading system for middle ear effusions, not the morphology of red blood cells.\n2. UNKNOWN\n3. FALSE [correction]: Since the Galassi classification is not concerned with red blood cells, it does not assign numbers to them based on shape and size.\n4. FALSE [correction]: Given that the Galassi classification does not relate to red blood cells, it doesn't categorize their shapes with numbers.\n5. FALSE [correction]: The Galassi classification system is not used for diagnosing hematological disorders as it is not related to red blood cell morphology.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1258,
    "user_query": "List fluorescent reporter proteins.",
    "yulan-chat-2-13b-fp16_response": "Fluorescent reporter proteins are proteins that can be used to track the activity of specific genes in cells. They work by producing a fluorescent protein that can be visualized under a microscope, allowing researchers to monitor the expression of a particular gene in real-time. Some common fluorescent reporter proteins include:\n1. Green fluorescent protein (GFP)\n2. Red fluorescent protein (RFP)\n3. Blue fluorescent protein (BFP)\n4. Cyan fluorescent protein (CFP)\n5. Yellow fluorescent protein (YFP)\n6. Lifeact\n7. mCherry\n8. DsRed\n9. Kaede\n10. Nluc\nThese proteins can be used in a variety of applications, including gene expression analysis, cell tracking, and live-cell imaging.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Green fluorescent protein (GFP) is a fluorescent reporter protein used to track gene activity in cells.\n2. Red fluorescent protein (RFP) is another fluorescent reporter protein used for gene tracking.\n3. Blue fluorescent protein (BFP) is used as a fluorescent reporter for monitoring gene expression.\n4. Cyan fluorescent protein (CFP) is used to visualize gene activity under a microscope.\n5. Yellow fluorescent protein (YFP) is a fluorescent reporter protein used in various applications like live-cell imaging.",
    "yulan-chat-2-13b-fp16_fact": [
      "Green fluorescent protein (GFP) is a fluorescent reporter protein used to track gene activity in cells.",
      "Red fluorescent protein (RFP) is another fluorescent reporter protein used for gene tracking.",
      "Blue fluorescent protein (BFP) is used as a fluorescent reporter for monitoring gene expression.",
      "Cyan fluorescent protein (CFP) is used to visualize gene activity under a microscope.",
      "Yellow fluorescent protein (YFP) is a fluorescent reporter protein used in various applications like live-cell imaging."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1259,
    "user_query": "By which mechanism MutT proteins act against DNA lesions in bacteria?",
    "yulan-chat-2-13b-fp16_response": "MutT proteins in bacteria act against DNA lesions by catalyzing the hydrolysis of adenosine triphosphate (ATP) to adenosine monophosphate (AMP) and orthophosphate, which is a key step in the DNA repair process. MutT proteins are part of the DNA repair machinery in bacteria and are involved in the base excision repair (BER) pathway.\nIn the BER pathway, MutT proteins work together with other proteins to remove damaged bases from DNA and replace them with correct ones. When a DNA lesion is detected, the MutT protein is recruited to the site of the damage along with other repair proteins. The MutT protein then catalyzes the hydrolysis of ATP to AMP and orthophosphate, which provides the energy needed for the repair process.\nThe ATP hydrolysis catalyzed by MutT also activates other repair proteins, such as DNA polymerase, which is responsible for synthesizing new DNA strands. The activated DNA polymerase then repairs the damaged DNA by adding correct nucleotides to the damaged site.\nOverall, the MutT protein plays a critical role in the DNA repair process in bacteria by providing the energy needed for the repair machinery to function properly and efficiently.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MutT proteins catalyze the hydrolysis of adenosine triphosphate (ATP) to adenosine monophosphate (AMP) and orthophosphate in bacteria.\n2. MutT proteins are part of the DNA repair machinery in bacteria.\n3. The base excision repair (BER) pathway involves MutT proteins in the process of repairing DNA.\n4. MutT proteins help to activate other repair proteins, including DNA polymerase.\n5. DNA polymerase is responsible for synthesizing new DNA strands during the DNA repair process.",
    "yulan-chat-2-13b-fp16_fact": [
      "MutT proteins catalyze the hydrolysis of adenosine triphosphate (ATP) to adenosine monophosphate (AMP) and orthophosphate in bacteria.",
      "MutT proteins are part of the DNA repair machinery in bacteria.",
      "The base excision repair (BER) pathway involves MutT proteins in the process of repairing DNA.",
      "MutT proteins help to activate other repair proteins, including DNA polymerase.",
      "DNA polymerase is responsible for synthesizing new DNA strands during the DNA repair process."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: MutT proteins catalyze the hydrolysis of 8-oxo-dGTP (8-oxo-deoxyguanosine triphosphate) in the nucleotide pool to 8-oxo-dGMP (8-oxo-deoxyguanosine monophosphate), not ATP to AMP.\n2. TRUE\n3. TRUE: MutT proteins are indeed involved in the BER pathway, specifically in preventing the incorporation of oxidized nucleotides.\n4. UNKNOWN: The statement is vague because MutT proteins primarily prevent the incorporation of oxidized GTP into DNA rather than directly activating other repair proteins. However, they could be indirectly involved in the repair process.\n5. TRUE: DNA polymerase is indeed responsible for synthesizing new DNA strands, and part of this role includes DNA repair processes like BER.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1269,
    "user_query": "Which is the molecular function of the protein CCDC40?",
    "yulan-chat-2-13b-fp16_response": "The molecular function of the protein CCDC40 is not known. It is possible that CCDC40 is involved in a variety of cellular processes, but without more information it is difficult to say for certain. CCDC40 is a member of the Coiled-Coil Domain Containing Protein 40 (CCDC40) family of proteins, which are characterized by the presence of a coiled-coil domain. Coiled-coil domains are regions of a protein that are rich in amino acids with a helical shape, and they are often involved in protein-protein interactions. CCDC40 is expressed in many tissues throughout the body, and it is thought to play a role in the regulation of cell division and other cellular processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The protein CCDC40 is a member of the Coiled-Coil Domain Containing Protein 40 family.\n2. Proteins in the CCDC40 family are characterized by the presence of a coiled-coil domain.\n3. Coiled-coil domains are regions rich in amino acids that form a helical shape.\n4. CCDC40 is expressed in many tissues throughout the body.\n5. CCDC40 is thought to play a role in the regulation of cell division and other cellular processes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The protein CCDC40 is a member of the Coiled-Coil Domain Containing Protein 40 family.",
      "Proteins in the CCDC40 family are characterized by the presence of a coiled-coil domain.",
      "Coiled-coil domains are regions rich in amino acids that form a helical shape.",
      "CCDC40 is expressed in many tissues throughout the body.",
      "CCDC40 is thought to play a role in the regulation of cell division and other cellular processes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The protein CCDC40 is not a member of the Coiled-Coil Domain Containing Protein 40 family; CCDC40 stands for \"Coiled-Coil Domain Containing 40,\" indicating the name of the protein itself, not a family of proteins.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1273,
    "user_query": "What is Cerebral Cavernous Malformation?",
    "yulan-chat-2-13b-fp16_response": "Cerebral cavernous malformation (CCM) is a rare, genetic disorder characterized by the presence of abnormal blood vessels in the brain. These malformed vessels are prone to leaking and bleeding, which can cause a range of symptoms including seizures, headaches, cognitive impairment, and vision problems. CCM is caused by mutations in one of two genes, CCM1 or CCM2, which are responsible for the development and maintenance of the blood-brain barrier. There is currently no cure for CCM, but treatments such as surgery, radiation therapy, and medication can help manage symptoms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cerebral cavernous malformation (CCM) is a genetic disorder.\n2. CCM is characterized by the presence of abnormal blood vessels in the brain.\n3. These malformed vessels can lead to symptoms like seizures, headaches, cognitive impairment, and vision problems.\n4. Mutations in either the CCM1 or CCM2 gene cause CCM.\n5. There is no cure for CCM, but symptoms can be managed through surgery, radiation therapy, and medication.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cerebral cavernous malformation (CCM) is a genetic disorder.",
      "CCM is characterized by the presence of abnormal blood vessels in the brain.",
      "These malformed vessels can lead to symptoms like seizures, headaches, cognitive impairment, and vision problems.",
      "Mutations in either the CCM1 or CCM2 gene cause CCM.",
      "There is no cure for CCM, but symptoms can be managed through surgery, radiation therapy, and medication."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Mutations in the CCM1, CCM2, or CCM3 genes can cause CCM.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1275,
    "user_query": "Which protein pathway is regulating SGK1-mediated phosphorylation of FOXO3a to control cell proliferation?",
    "yulan-chat-2-13b-fp16_response": "The protein pathway that regulates SGK1-mediated phosphorylation of FOXO3a to control cell proliferation is the AKT/PKB pathway. AKT/PKB is a protein kinase that phosphorylates and activates SGK1, which in turn phosphorylates and inhibits FOXO3a. This inhibition of FOXO3a leads to increased cell proliferation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The AKT/PKB pathway regulates SGK1-mediated phosphorylation of FOXO3a.\n2. AKT/PKB phosphorylates and activates SGK1.\n3. SGK1 phosphorylates and inhibits FOXO3a.\n4. Inhibition of FOXO3a by SGK1 leads to increased cell proliferation.",
    "yulan-chat-2-13b-fp16_fact": [
      "The AKT/PKB pathway regulates SGK1-mediated phosphorylation of FOXO3a.",
      "AKT/PKB phosphorylates and activates SGK1.",
      "SGK1 phosphorylates and inhibits FOXO3a.",
      "Inhibition of FOXO3a by SGK1 leads to increased cell proliferation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: The AKT/PKB pathway does regulate SGK1-mediated phosphorylation of FOXO3a.\n2. UNKNOWN: Although AKT (also known as PKB) is upstream of SGK1 in related signaling pathways, direct phosphorylation and activation of SGK1 by AKT/PKB is not well-established and may depend on the specific cellular context or additional factors.\n3. TRUE: SGK1 is known to phosphorylate and inhibit FOXO3a, which is a transcription factor involved in various cellular processes.\n4. TRUE: Inhibition of FOXO3a by phosphorylation generally leads to decreased transcription of pro-apoptotic and cell cycle arresting genes, which can result in increased cell proliferation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1281,
    "user_query": "Is TNNI3K a cardiac-specific protein?",
    "yulan-chat-2-13b-fp16_response": "TNNI3K (Troponin I3K) is a cardiac-specific protein, specifically expressed in cardiac muscle. It is a variant of troponin I, a protein that plays a crucial role in the regulation of muscle contraction. In the heart, troponin I3K is involved in the regulation of cardiac contractility and is essential for the proper functioning of the heart muscle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TNNI3K (Troponin I3K) is a cardiac-specific protein.\n2. TNNI3K is specifically expressed in cardiac muscle.\n3. TNNI3K is a variant of troponin I.\n4. Troponin I plays a crucial role in the regulation of muscle contraction.\n5. TNNI3K is involved in the regulation of cardiac contractility.",
    "yulan-chat-2-13b-fp16_fact": [
      "TNNI3K (Troponin I3K) is a cardiac-specific protein.",
      "TNNI3K is specifically expressed in cardiac muscle.",
      "TNNI3K is a variant of troponin I.",
      "Troponin I plays a crucial role in the regulation of muscle contraction.",
      "TNNI3K is involved in the regulation of cardiac contractility."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: TNNI3K (Troponin I-interacting kinase) is not a cardiac-specific protein; it is expressed in various tissues including cardiac muscle.\n2. FALSE [correction]: While TNNI3K is expressed in cardiac muscle, it is not specifically expressed there as it is also found in other tissues.\n3. TRUE: TNNI3K is a kinase that interacts with troponin I, which is a component of the troponin complex in muscle fibers.\n4. TRUE: Troponin I is part of the troponin complex of the thin filaments of muscle tissue and plays a crucial role in the regulation of muscle contraction by participating in calcium binding and interaction with actin and tropomyosin.\n5. TRUE: TNNI3K is believed to be involved in the regulation of cardiac contractility through phosphorylation mechanisms that affect the troponin complex and other targets.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1287,
    "user_query": "Can the apoptosis regulator BAX trigger the release of cytochrome c?",
    "yulan-chat-2-13b-fp16_response": "Yes, BAX can trigger the release of cytochrome c. BAX is a pro-apoptotic protein that plays a key role in the regulation of apoptosis, or programmed cell death. When BAX is activated, it can form large oligomeric complexes in the outer membrane of the mitochondria. These complexes can then insert into the inner mitochondrial membrane and form pores that allow for the release of cytochrome c and other apoptotic proteins from the mitochondria into the cytosol. Cytochrome c is a protein that is normally located in the intermembrane space of the mitochondria, but its release is a key signal for the initiation of the apoptotic cascade. Once released, cytochrome c can bind to and activate the caspase proteases, which ultimately lead to the destruction of the cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The apoptosis regulator BAX can trigger the release of cytochrome c.\n2. BAX is a pro-apoptotic protein involved in the regulation of apoptosis.\n3. Activated BAX can form oligomeric complexes in the outer membrane of the mitochondria.\n4. The oligomeric complexes formed by BAX can make pores in the inner mitochondrial membrane to allow release of cytochrome c.\n5. The release of cytochrome c from mitochondria into the cytosol is a key signal for the initiation of the apoptotic cascade.",
    "yulan-chat-2-13b-fp16_fact": [
      "The apoptosis regulator BAX can trigger the release of cytochrome c.",
      "BAX is a pro-apoptotic protein involved in the regulation of apoptosis.",
      "Activated BAX can form oligomeric complexes in the outer membrane of the mitochondria.",
      "The oligomeric complexes formed by BAX can make pores in the inner mitochondrial membrane to allow release of cytochrome c.",
      "The release of cytochrome c from mitochondria into the cytosol is a key signal for the initiation of the apoptotic cascade."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The oligomeric complexes formed by BAX can make pores in the outer mitochondrial membrane to allow the release of cytochrome c, not the inner mitochondrial membrane.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1289,
    "user_query": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients",
    "yulan-chat-2-13b-fp16_response": "Here are some BRAF inhibitors that have been tested in clinical trials for the treatment of melanoma patients:\n1. Vemurafenib (Zelboraf)\n2. Dabrafenib (Tafinlar)\n3. Trametinib (Mekinist)\n4. Sorafenib (Nexavar)\n5. Sunitinib (Sutent)\n6. Peginterferon alfa-2b (Sylatron)\n7. Ipilimumab (Yervoy)\n8. Nivolumab (Opdivo)\n9. Pembrolizumab (Keytruda)\n10. Atezolizumab (Tecentriq)\nIt's important to note that not all of these drugs have been approved by regulatory agencies for the treatment of melanoma, and some may be in earlier stages of development. Additionally, the effectiveness of these drugs can vary depending on the individual patient and the specific characteristics of their cancer. It's always best to consult with a healthcare professional for the most up-to-date and personalized information.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vemurafenib (Zelboraf) has been tested in clinical trials for the treatment of melanoma patients.\n2. Dabrafenib (Tafinlar) has been tested in clinical trials for the treatment of melanoma patients.\n3. Trametinib (Mekinist) has been tested in clinical trials for the treatment of melanoma patients.\n4. Sorafenib (Nexavar) has been tested in clinical trials for the treatment of melanoma patients.\n5. Peginterferon alfa-2b (Sylatron) has been tested in clinical trials for the treatment of melanoma patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vemurafenib (Zelboraf) has been tested in clinical trials for the treatment of melanoma patients.",
      "Dabrafenib (Tafinlar) has been tested in clinical trials for the treatment of melanoma patients.",
      "Trametinib (Mekinist) has been tested in clinical trials for the treatment of melanoma patients.",
      "Sorafenib (Nexavar) has been tested in clinical trials for the treatment of melanoma patients.",
      "Peginterferon alfa-2b (Sylatron) has been tested in clinical trials for the treatment of melanoma patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll of the listed drugs have been involved in clinical trials for melanoma treatment. Vemurafenib, Dabrafenib, and Trametinib are targeted therapies for melanoma patients with certain mutations. Sorafenib is a kinase inhibitor that has been tested for multiple types of cancer, including melanoma. Peginterferon alfa-2b is an immunotherapy used for adjuvant treatment in melanoma.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1292,
    "user_query": "Which are the coactivators of the Yes-associated protein (yap)?",
    "yulan-chat-2-13b-fp16_response": "The Yes-associated protein (YAP) is a transcriptional coactivator that plays a key role in regulating gene expression and cellular growth. YAP acts as a molecular switch that is activated by various signaling pathways and promotes the transcription of target genes by binding to specific DNA sequences and recruiting transcriptional coactivators.\nSeveral coactivators have been identified that interact with YAP and enhance its transcriptional activity. Some of the key coactivators of YAP include:\n1. Src homology 2 (SH2) domain-containing protein 1 (SHP-1): SHP-1 is a phosphatase that regulates YAP activity by dephosphorylating and inhibiting its transcriptional activity.\n2. Src homology 3 (SH3) domain-binding protein 1 (SHBP1): SHBP1 is a transcriptional coactivator that interacts with YAP and enhances its transcriptional activity by promoting its recruitment to target genes.\n3. Src homology 2 (SH2) domain-containing protein 2 (SHP-2): SHP-2 is a phosphatase that regulates YAP activity by dephosphorylating and inhibiting its transcriptional activity.\n4. Src homology 3 (SH3) domain-binding protein 2 (SHBP2): SHBP2 is a transcriptional coactivator that interacts with YAP and enhances its transcriptional activity by promoting its recruitment to target genes.\n5. Src homology 2 (SH2) domain-containing protein 3 (SHP-3): SHP-3 is a phosphatase that regulates YAP activity by dephosphorylating and inhibiting its transcriptional activity.\nThese coactivators work together with YAP to regulate gene expression and cellular growth in response to various signaling pathways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Yes-associated protein (YAP) is a transcriptional coactivator that is involved in regulating gene expression and cellular growth.\n2. Src homology 2 (SH2) domain-containing protein 1 (SHP-1) is a coactivator of YAP that regulates its activity by dephosphorylation.\n3. Src homology 3 (SH3) domain-binding protein 1 (SHBP1) is a transcriptional coactivator that interacts with YAP to enhance its transcriptional activity.\n4. Src homology 2 (SH2) domain-containing protein 2 (SHP-2) is another phosphatase that regulates YAP activity by dephosphorylation.\n5. Src homology 2 (SH2) domain-containing protein 3 (SHP-3) is a coactivator of YAP and similarly regulates its activity by dephosphorylation.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Yes-associated protein (YAP) is a transcriptional coactivator that is involved in regulating gene expression and cellular growth.",
      "Src homology 2 (SH2) domain-containing protein 1 (SHP-1) is a coactivator of YAP that regulates its activity by dephosphorylation.",
      "Src homology 3 (SH3) domain-binding protein 1 (SHBP1) is a transcriptional coactivator that interacts with YAP to enhance its transcriptional activity.",
      "Src homology 2 (SH2) domain-containing protein 2 (SHP-2) is another phosphatase that regulates YAP activity by dephosphorylation.",
      "Src homology 2 (SH2) domain-containing protein 3 (SHP-3) is a coactivator of YAP and similarly regulates its activity by dephosphorylation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: SHP-1 is a protein tyrosine phosphatase, not a coactivator of YAP. It is involved in cell signaling pathways, but it does not act as a coactivator for YAP.\n3. FALSE [correction]: There is no protein known as Src homology 3 (SH3) domain-binding protein 1 (SHBP1) that is recognized to interact with YAP as a transcriptional coactivator. The statement appears to be a mix of different protein domain names and does not correspond to a known protein that interacts with YAP.\n4. TRUE: SHP-2 can indeed regulate YAP activity, though it is not solely responsible for the regulation of YAP. It is involved in various signaling pathways and can have an effect on YAP activity through dephosphorylation.\n5. FALSE [correction]: There is no known Src homology 2 (SH2) domain-containing protein 3 (SHP-3) that acts as a coactivator of YAP. SH2 domain-containing proteins typically act as parts of signal transduction pathways, not as transcriptional coactivators for YAP.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1296,
    "user_query": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?",
    "yulan-chat-2-13b-fp16_response": "During epithelial-mesenchymal transition (EMT), the loss of cell-cell adhesion is associated with the downregulation of tight junction proteins, such as occludin, ZO-1, and claudin-1, and the upregulation of matrix metalloproteinases (MMPs), which degrade the extracellular matrix and basement membrane. Some of the proteins that are related to the loss of cell-cell adhesion during EMT include:\n1. Zeb2: a transcription factor that promotes EMT by downregulating E-cadherin and upregulating MMPs.\n2. Snail: a transcription factor that represses E-cadherin and promotes MMP expression.\n3. Twist: a transcription factor that promotes EMT by repressing E-cadherin and activating MMPs.\n4. SNAI1: a member of the Snail family of transcription factors that promotes EMT by repressing E-cadherin and activating MMPs.\n5. N-cadherin: a cadherin protein that promotes cell migration and invasion by disrupting cell-cell adhesion.\n6. Vimentin: a intermediate filament protein that is involved in the loss of cell-cell adhesion during EMT.\n7. Fibronectin: a extracellular matrix protein that promotes cell adhesion and migration.\n8. MMPs: a group of enzymes that degrade extracellular matrix components and basement membrane, leading to loss of cell-cell adhesion.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The downregulation of tight junction proteins like occludin, ZO-1, and claudin-1 is associated with the loss of cell-cell adhesion during EMT.\n2. The upregulation of matrix metalloproteinases (MMPs) contributes to the degradation of the extracellular matrix and basement membrane during EMT.\n3. Zeb2 is a transcription factor that promotes EMT by downregulating E-cadherin and upregulating MMPs.\n4. Snail is a transcription factor that represses E-cadherin and promotes MMP expression during EMT.\n5. Twist is a transcription factor that promotes EMT by repressing E-cadherin and activating MMPs.",
    "yulan-chat-2-13b-fp16_fact": [
      "The downregulation of tight junction proteins like occludin, ZO-1, and claudin-1 is associated with the loss of cell-cell adhesion during EMT.",
      "The upregulation of matrix metalloproteinases (MMPs) contributes to the degradation of the extracellular matrix and basement membrane during EMT.",
      "Zeb2 is a transcription factor that promotes EMT by downregulating E-cadherin and upregulating MMPs.",
      "Snail is a transcription factor that represses E-cadherin and promotes MMP expression during EMT.",
      "Twist is a transcription factor that promotes EMT by repressing E-cadherin and activating MMPs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: The downregulation of tight junction proteins such as occludin, ZO-1, and claudin-1 is indeed associated with the loss of cell-cell adhesion during epithelial-mesenchymal transition (EMT).\n\n2. TRUE: The upregulation of matrix metalloproteinases (MMPs) does contribute to the degradation of the extracellular matrix and basement membrane, which is a characteristic of EMT.\n\n3. TRUE: Zeb2 (Zinc finger E-box-binding homeobox 2) is a transcription factor that can promote EMT. It is known to downregulate E-cadherin expression and can contribute to the upregulation of MMPs, which facilitates the EMT process.\n\n4. TRUE: Snail is a well-known transcription factor that represses the transcription of E-cadherin, and its activity is associated with the promotion of EMT, including the increase in MMP expression.\n\n5. TRUE: Twist is a transcription factor that promotes EMT by repressing E-cadherin and is implicated in the activation of mechanisms responsible for invasion and metastasis, including the activation of MMPs.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1300,
    "user_query": "What is known about diseases associated with mutations in the CHCHD10 gene?",
    "yulan-chat-2-13b-fp16_response": "Mutations in the CHCHD10 gene have been associated with several diseases, including:\n1. Congenital heart disease: Mutations in the CHCHD10 gene can cause various congenital heart defects, such as atrial septal defects, ventricular septal defects, and tetralogy of Fallot.\n2. Intellectual disability: Some individuals with CHCHD10 mutations have been reported to have intellectual disability or developmental delay.\n3. Short stature: Some individuals with CHCHD10 mutations have been reported to be short in stature.\n4. Other rare conditions: There have been some case reports of individuals with CHCHD10 mutations who have developed other rare conditions, such as renal dysplasia and pulmonary stenosis.\nIt is important to note that not all individuals with CHCHD10 mutations will necessarily develop these conditions, and the severity of symptoms can vary widely depending on the specific mutation and other genetic and environmental factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the CHCHD10 gene can cause various congenital heart defects.\n2. Atrial septal defects, ventricular septal defects, and tetralogy of Fallot can be caused by mutations in the CHCHD10 gene.\n3. Some individuals with CHCHD10 mutations have been reported to have intellectual disability or developmental delay.\n4. Some individuals with CHCHD10 mutations have been reported to be short in stature.\n5. Case reports exist of individuals with CHCHD10 mutations developing rare conditions such as renal dysplasia and pulmonary stenosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the CHCHD10 gene can cause various congenital heart defects.",
      "Atrial septal defects, ventricular septal defects, and tetralogy of Fallot can be caused by mutations in the CHCHD10 gene.",
      "Some individuals with CHCHD10 mutations have been reported to have intellectual disability or developmental delay.",
      "Some individuals with CHCHD10 mutations have been reported to be short in stature.",
      "Case reports exist of individuals with CHCHD10 mutations developing rare conditions such as renal dysplasia and pulmonary stenosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Mutations in the CHCHD10 gene are known to be associated with mitochondrial diseases and potentially other neurodegenerative diseases; they are not typically associated with congenital heart defects.\n2. FALSE [correction]: Atrial septal defects, ventricular septal defects, and tetralogy of Fallot are congenital heart defects, and there is no widely recognized evidence linking these conditions directly to mutations in the CHCHD10 gene.\n3. UNKNOWN: Without specific information linking CHCHD10 mutations to intellectual disabilities or developmental delay, this cannot be verified. However, as CHCHD10 is associated with mitochondrial function, it is possible for mutations to contribute to a broad spectrum of symptoms, including neurological ones.\n4. UNKNOWN: There is no clear consensus nor is it widely reported that individuals with CHCHD10 mutations are characteristically short in stature. This condition might be related to or independent of CHCHD10 mutations.\n5. UNKNOWN: While renal dysplasia and pulmonary stenosis are rare conditions, without specific evidence or research linking these to CHCHD10 mutations, it is not possible to confirm the accuracy of this statement.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "yulan-chat-2-13b-fp16_response": "Shapiro Syndrome is a rare genetic disorder that is characterized by a number of distinct features. Some of the most common features of Shapiro Syndrome include:\n1. Short stature: Most people with Shapiro Syndrome are short in stature and have a disproportionate appearance, with a large head and short limbs.\n2. Intellectual disability: Many people with Shapiro Syndrome have mild to moderate intellectual disability, although some may have normal intelligence.\n3. Delayed bone age: People with Shapiro Syndrome often have delayed bone age, which means that their bones may not develop at the same rate as other children their age.\n4. Skeletal abnormalities: People with Shapiro Syndrome may have a number of skeletal abnormalities, including shortened limbs, curved spine, and abnormalities in the chest and pelvis.\n5. Joint problems: Many people with Shapiro Syndrome have joint problems, including hypermobile joints, which can lead to instability and discomfort.\n6. Sleep apnea: Some people with Shapiro Syndrome may have sleep apnea, a condition in which a person stops breathing briefly during sleep.\n7. Heart defects: Some people with Shapiro Syndrome may have heart defects, which can range from mild to severe.\n8. Delayed puberty: People with Shapiro Syndrome may experience delayed puberty, which can lead to a number of other issues, including delayed growth and development.\n9. Hearing loss: Some people with Shapiro Syndrome may have hearing loss, which can range from mild to severe.\n10. Vision problems: People with Shapiro Syndrome may have vision problems, including cataracts, glaucoma, and other issues that can affect their ability to see clearly.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Most people with Shapiro Syndrome are short in stature with a disproportionate appearance.\n2. Many individuals with Shapiro Syndrome have mild to moderate intellectual disability.\n3. People with Shapiro Syndrome often have delayed bone age.\n4. Individuals with Shapiro Syndrome may have skeletal abnormalities such as shortened limbs and a curved spine.\n5. Some people with Shapiro Syndrome may experience sleep apnea.",
    "yulan-chat-2-13b-fp16_fact": [
      "Most people with Shapiro Syndrome are short in stature with a disproportionate appearance.",
      "Many individuals with Shapiro Syndrome have mild to moderate intellectual disability.",
      "People with Shapiro Syndrome often have delayed bone age.",
      "Individuals with Shapiro Syndrome may have skeletal abnormalities such as shortened limbs and a curved spine.",
      "Some people with Shapiro Syndrome may experience sleep apnea."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Shapiro Syndrome is characterized by the triad of episodic spontaneous hypothermia, hyperhidrosis (increased sweating), and agenesis of the corpus callosum (absence of a structure in the brain), not necessarily short stature with a disproportionate appearance.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nShapiro Syndrome is a rare disease, and there are limited data regarding its full spectrum of symptoms and characteristics. The statements provided do not align with the well-documented core features of the condition and without additional context regarding the associated features of the syndrome, it's difficult to definitively classify the other statements as true or false.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1309,
    "user_query": "What is the role of the histidine rich calcium binding protein (HRC) in cardiomyopathy?",
    "yulan-chat-2-13b-fp16_response": "Histidine-rich calcium binding protein (HRC) is a protein that is involved in various cellular processes, including calcium signaling and muscle contraction. In the context of cardiomyopathy, HRC has been implicated in the pathogenesis of the disease.\nCardiomyopathy is a group of diseases that affect the heart muscle and can lead to heart failure. HRC has been found to be involved in the development of dilated cardiomyopathy, which is a type of cardiomyopathy characterized by the enlargement of the heart and a decrease in its ability to pump blood.\nStudies have shown that HRC can interact with other proteins involved in calcium signaling and muscle contraction, and that mutations in the HRC gene can lead to abnormal calcium handling in the heart muscle. This can result in impaired muscle contraction and dilated cardiomyopathy.\nIn addition to its role in calcium signaling, HRC has also been implicated in the regulation of the cell cycle and in the process of apoptosis (programmed cell death). It is possible that dysregulation of these processes may also contribute to the development of cardiomyopathy.\nOverall, while the exact role of HRC in cardiomyopathy is not fully understood, it is clear that the protein plays a significant role in the pathogenesis of the disease. Further research is needed to fully elucidate the mechanisms by which HRC contributes to the development of cardiomyopathy and to identify potential therapeutic targets for the treatment of this disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histidine-rich calcium binding protein (HRC) is involved in calcium signaling and muscle contraction.\n2. HRC has been implicated in the pathogenesis of cardiomyopathy.\n3. Dilated cardiomyopathy, which involves the enlargement of the heart and decreased blood pumping ability, is associated with HRC involvement.\n4. Mutations in the HRC gene can lead to abnormal calcium handling in the heart muscle, resulting in impaired muscle contraction and potentially dilated cardiomyopathy.\n5. HRC has been implicated in the regulation of the cell cycle and in the process of apoptosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histidine-rich calcium binding protein (HRC) is involved in calcium signaling and muscle contraction.",
      "HRC has been implicated in the pathogenesis of cardiomyopathy.",
      "Dilated cardiomyopathy, which involves the enlargement of the heart and decreased blood pumping ability, is associated with HRC involvement.",
      "Mutations in the HRC gene can lead to abnormal calcium handling in the heart muscle, resulting in impaired muscle contraction and potentially dilated cardiomyopathy.",
      "HRC has been implicated in the regulation of the cell cycle and in the process of apoptosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Histidine-rich calcium binding protein (HRC) is indeed involved in calcium signaling and muscle contraction.\n2. TRUE: HRC has been implicated in the pathogenesis of various forms of cardiomyopathy, including dilated cardiomyopathy.\n3. TRUE: Dilated cardiomyopathy is characterized by the enlargement of the heart and decreased blood pumping ability, and HRC involvement has been studied in relation to this condition.\n4. TRUE: Mutations in the HRC gene can affect calcium handling, which is crucial for heart muscle contraction. These mutations can result in conditions like dilated cardiomyopathy due to impaired muscle contraction.\n5. UNKNOWN: The involvement of HRC in the regulation of the cell cycle and apoptosis is not a well-established or widely recognized function like its role in muscle contraction and cardiomyopathy. More context would be needed to confirm this statement.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1312,
    "user_query": "Which post-translational histone modifications are characteristic of facultative heterochromatin?",
    "yulan-chat-2-13b-fp16_response": "Facultative heterochromatin is a type of chromatin that can be either euchromatin or heterochromatin depending on the cellular context. Histone modifications that are characteristic of facultative heterochromatin include:\n1. Hypoacetylation: Hypoacetylation of histones is a hallmark of heterochromatin and is associated with the compaction of chromatin.\n2. Methylation of histone H3 at lysine 27 (H3K27me3): H3K27me3 is a marker of heterochromatin and is associated with the silencing of genes.\n3. Methylation of histone H3 at lysine 9 (H3K9me3): H3K9me3 is also associated with heterochromatin and is thought to play a role in the recruitment of chromatin-associated proteins that contribute to the formation of heterochromatin.\n4. Methylation of histone H4 at lysine 20 (H4K20me3): H4K20me3 is a marker of heterochromatin and is associated with the silencing of genes.\nIt is important to note that the presence or absence of these modifications does not definitively determine whether a region of chromatin is euchromatin or heterochromatin, but rather their levels and distribution within a given region of chromatin.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hypoacetylation of histones is associated with the compaction of chromatin and is a characteristic of facultative heterochromatin.\n2. Methylation of histone H3 at lysine 27 (H3K27me3) is a marker of heterochromatin and is related to gene silencing.\n3. Methylation of histone H3 at lysine 9 (H3K9me3) is associated with heterochromatin.\n4. Methylation of histone H4 at lysine 20 (H4K20me3) is a marker of heterochromatin and is related to gene silencing.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hypoacetylation of histones is associated with the compaction of chromatin and is a characteristic of facultative heterochromatin.",
      "Methylation of histone H3 at lysine 27 (H3K27me3) is a marker of heterochromatin and is related to gene silencing.",
      "Methylation of histone H3 at lysine 9 (H3K9me3) is associated with heterochromatin.",
      "Methylation of histone H4 at lysine 20 (H4K20me3) is a marker of heterochromatin and is related to gene silencing."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Methylation of histone H4 at lysine 20 (H4K20me3) is a marker of euchromatin, particularly during replication; however, the monomethylation of H4K20 (H4K20me1) has been associated with compacted heterochromatin and gene silencing.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1313,
    "user_query": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?",
    "yulan-chat-2-13b-fp16_response": "Aicardi-Goutieres syndrome (AGS) is a rare genetic disorder caused by mutations in the RELN gene, which is located on the X chromosome. The RELN gene provides instructions for making a protein called reelin, which is important for the development of the brain and the nervous system. Mutations in the RELN gene lead to a lack of reelin, which can cause the characteristic features of AGS, including severe intellectual disability, epilepsy, and abnormalities in the structure of the brain.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aicardi-Goutieres syndrome is a rare genetic disorder.\n2. The disorder is associated with mutations in the RELN gene.\n3. The RELN gene is located on the X chromosome.\n4. The RELN gene is responsible for providing instructions to make the protein reelin.\n5. A lack of reelin due to mutations in the RELN gene can lead to severe intellectual disability, epilepsy, and brain structure abnormalities characteristic of Aicardi-Goutieres syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Aicardi-Goutieres syndrome is a rare genetic disorder.",
      "The disorder is associated with mutations in the RELN gene.",
      "The RELN gene is located on the X chromosome.",
      "The RELN gene is responsible for providing instructions to make the protein reelin.",
      "A lack of reelin due to mutations in the RELN gene can lead to severe intellectual disability, epilepsy, and brain structure abnormalities characteristic of Aicardi-Goutieres syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Aicardi-Goutieres syndrome is associated with mutations in several genes, including TREX1, RNASEH2A, RNASEH2B, RNASEH2C, ADAR, and IFIH1, but not typically with mutations in the RELN gene.\n3. FALSE [correction]: The RELN gene is located on chromosome 7, not the X chromosome.\n4. TRUE\n5. FALSE [correction]: While the RELN gene does provide instructions to make the protein reelin, which is important for brain development, it is not typically associated with Aicardi-Goutieres syndrome. Aicardi-Goutieres syndrome is characterized by brain abnormalities, amongst other symptoms, but these are not due to the lack of reelin caused by mutations in the RELN gene.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1317,
    "user_query": "What is the mechanism of action of abiraterone?",
    "yulan-chat-2-13b-fp16_response": "Abiraterone is a drug that is used to treat prostate cancer. It works by blocking the production of androgens, which are hormones that can stimulate the growth of prostate cancer cells.\nAbiraterone inhibits the enzyme called 17-hydroxylase/17,20-lyase, which is involved in the production of androgens. By inhibiting this enzyme, abiraterone reduces the amount of androgens that are available to the prostate cancer cells, which can cause the cells to shrink or die.\nIn addition to blocking the production of androgens, abiraterone may also have other effects on the body that can help to treat prostate cancer. For example, it may help to reduce the risk of the cancer spreading to other parts of the body, and it may also help to improve symptoms such as bone pain.\nOverall, the mechanism of action of abiraterone is to block the production of androgens, which can help to slow the growth of prostate cancer cells and reduce the risk of the cancer spreading.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Abiraterone is used in the treatment of prostate cancer.\n2. Abiraterone works by blocking the production of androgens.\n3. Abiraterone inhibits the enzyme 17-hydroxylase/17,20-lyase, which is involved in androgen production.\n4. The reduction of androgens by abiraterone can lead to the shrinkage or death of prostate cancer cells.\n5. Abiraterone may help to reduce the risk of prostate cancer spreading to other parts of the body.",
    "yulan-chat-2-13b-fp16_fact": [
      "Abiraterone is used in the treatment of prostate cancer.",
      "Abiraterone works by blocking the production of androgens.",
      "Abiraterone inhibits the enzyme 17-hydroxylase/17,20-lyase, which is involved in androgen production.",
      "The reduction of androgens by abiraterone can lead to the shrinkage or death of prostate cancer cells.",
      "Abiraterone may help to reduce the risk of prostate cancer spreading to other parts of the body."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1318,
    "user_query": "The protein neprilysin  has an positive effect on Alzheimer disease, how can it be delivered to the brain?",
    "yulan-chat-2-13b-fp16_response": "Neprilysin is an enzyme that is involved in the regulation of blood pressure and has been shown to have a positive effect on Alzheimer's disease. Delivering neprilysin to the brain could potentially be beneficial in the treatment of Alzheimer's disease.\nOne way to deliver neprilysin to the brain is through the use of a drug delivery system, such as a nanoparticle or liposome. These delivery systems can be designed to target specific cells or regions of the brain, allowing for more precise delivery of the neprilysin enzyme.\nAnother approach could be to use gene therapy to increase the production of neprilysin in the brain. This could involve delivering a gene encoding the neprilysin enzyme to the brain using a viral vector, which would then express the enzyme in the brain.\nIt is important to note that the delivery of any therapeutic agent to the brain is a complex process and requires careful consideration of various factors, such as the blood-brain barrier and the potential toxicity of the agent. Further research is needed to determine the most effective and safe way to deliver neprilysin to the brain for the treatment of Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neprilysin is an enzyme involved in the regulation of blood pressure.\n2. Neprilysin has been shown to have a positive effect on Alzheimer's disease.\n3. Drug delivery systems such as nanoparticles or liposomes can be used to deliver neprilysin to the brain.\n4. Gene therapy can be used to increase the production of neprilysin in the brain by delivering a gene encoding the enzyme using a viral vector.\n5. The delivery of therapeutic agents to the brain must account for the blood-brain barrier and potential toxicity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neprilysin is an enzyme involved in the regulation of blood pressure.",
      "Neprilysin has been shown to have a positive effect on Alzheimer's disease.",
      "Drug delivery systems such as nanoparticles or liposomes can be used to deliver neprilysin to the brain.",
      "Gene therapy can be used to increase the production of neprilysin in the brain by delivering a gene encoding the enzyme using a viral vector.",
      "The delivery of therapeutic agents to the brain must account for the blood-brain barrier and potential toxicity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: While neprilysin is known to degrade beta-amyloid, a protein associated with Alzheimer's disease, saying it has a \"positive effect\" on Alzheimer's disease is misleading. Research is ongoing, and while increasing neprilysin levels could potentially be beneficial in Alzheimer's disease by reducing amyloid plaques, it's not established as a treatment or definitively shown to have a positive effect in clinical settings.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "yulan-chat-2-13b-fp16_response": "BRAG1 mutations are associated with a disease called familial Mediterranean fever (FMF). FMF is an autosomal recessive genetic disorder characterized by recurrent episodes of fever, abdominal pain, and skin rash. It is caused by mutations in the MEFV gene, which encodes a component of the inflammasome, a protein complex that plays a role in the immune response to cellular stress. BRAG1 is a paralog of MEFV, and mutations in BRAG1 can also cause FMF.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Familial Mediterranean fever (FMF) is linked to mutations within BRAG1.\n2. FMF is an autosomal recessive genetic disorder.\n3. FMF is characterized by recurrent episodes of fever, abdominal pain, and skin rash.\n4. The MEFV gene is associated with FMF and encodes a component of the inflammasome.\n5. BRAG1 is a paralog of the MEFV gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "Familial Mediterranean fever (FMF) is linked to mutations within BRAG1.",
      "FMF is an autosomal recessive genetic disorder.",
      "FMF is characterized by recurrent episodes of fever, abdominal pain, and skin rash.",
      "The MEFV gene is associated with FMF and encodes a component of the inflammasome.",
      "BRAG1 is a paralog of the MEFV gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Familial Mediterranean fever (FMF) is linked to mutations within the MEFV gene, not BRAG1.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1328,
    "user_query": "What is the effect induced by sympathetic nervous system on pupil size?",
    "yulan-chat-2-13b-fp16_response": "The sympathetic nervous system can cause the pupils to dilate (become larger). This is known as the \"fight or flight\" response, and it is an automatic response to stress or danger. When the sympathetic nervous system is activated, it causes the pupils to dilate in order to allow more light to enter the eyes and improve vision. This can help the body to better respond to the stressor or danger.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The sympathetic nervous system can cause the pupils to dilate.\n2. Pupil dilation is part of the \"fight or flight\" response.\n3. The dilation of pupils is an automatic response to stress or danger.\n4. When the pupils dilate, it allows more light to enter the eyes.\n5. The purpose of pupil dilation is to improve vision in response to stress or danger.",
    "yulan-chat-2-13b-fp16_fact": [
      "The sympathetic nervous system can cause the pupils to dilate.",
      "Pupil dilation is part of the \"fight or flight\" response.",
      "The dilation of pupils is an automatic response to stress or danger.",
      "When the pupils dilate, it allows more light to enter the eyes.",
      "The purpose of pupil dilation is to improve vision in response to stress or danger."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1329,
    "user_query": "Is p100 the precursor protein molecule of the NF-kappaB transcription factor subunit p50?",
    "yulan-chat-2-13b-fp16_response": "Yes, p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50. p100 is cleaved by proteolytic processing to generate p50 and p52, which are then further processed to generate mature p50 and p52 subunits, respectively. The p50 subunit is a key component of the NF-kappaB transcription factor complex, which plays a critical role in regulating gene expression in response to various stimuli, including cytokines, growth factors, and stress-related signals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50.\n2. p100 is cleaved to generate p50 and p52.\n3. The p50 subunit is part of the NF-kappaB transcription factor complex.\n4. The NF-kappaB transcription factor complex regulates gene expression in response to stimuli such as cytokines, growth factors, and stress-related signals.",
    "yulan-chat-2-13b-fp16_fact": [
      "p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50.",
      "p100 is cleaved to generate p50 and p52.",
      "The p50 subunit is part of the NF-kappaB transcription factor complex.",
      "The NF-kappaB transcription factor complex regulates gene expression in response to stimuli such as cytokines, growth factors, and stress-related signals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: p100 is cleaved to generate p52, not p50 and p52. It is the p105 precursor that is processed to generate p50.\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1331,
    "user_query": "Is there a difference in the rate between gene fusion and gene fission?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is a difference in the rate between gene fusion and gene fission. Gene fusion occurs when two or more genes combine to form a new gene, while gene fission occurs when a single gene splits into two or more genes. The rate of gene fusion and gene fission can vary depending on the organism and the specific genes involved. In general, gene fusion is thought to be a relatively rare event, while gene fission is more common. This is because the process of gene fusion requires the simultaneous mutation of multiple genes, while gene fission can occur through a single mutation that splits a gene into multiple parts. Additionally, gene fission can be driven by selective pressures that favor the evolution of smaller, more specialized genes, while gene fusion is more likely to occur by chance.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gene fusion refers to the process where two or more genes combine to form a new gene.\n2. Gene fission refers to the process where a single gene splits into two or more genes.\n3. The rate of gene fusion is generally rarer than gene fission.\n4. Gene fusion requires simultaneous mutation of multiple genes.\n5. Gene fission can be driven by selective pressures favoring smaller, more specialized genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gene fusion refers to the process where two or more genes combine to form a new gene.",
      "Gene fission refers to the process where a single gene splits into two or more genes.",
      "The rate of gene fusion is generally rarer than gene fission.",
      "Gene fusion requires simultaneous mutation of multiple genes.",
      "Gene fission can be driven by selective pressures favoring smaller, more specialized genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The rate of gene fusion is generally more common than gene fission.\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1344,
    "user_query": "Which genes were found to be methylated in bladder cancer cells?",
    "yulan-chat-2-13b-fp16_response": "There are several genes that have been found to be methylated in bladder cancer cells, including:\n1. TP53: Methylation of the TP53 gene is one of the most common epigenetic alterations in bladder cancer and is associated with poor prognosis.\n2. P16INK4a: Methylation of the P16INK4a gene is also a common event in bladder cancer and is associated with silencing of the tumor suppressor gene.\n3. HIC1: Methylation of the HIC1 gene has been reported to be associated with the development and progression of bladder cancer.\n4. CDKN2A: Methylation of the CDKN2A gene has been reported to be associated with the development and progression of bladder cancer.\n5. MLH1: Methylation of the MLH1 gene has been reported to be associated with the development and progression of bladder cancer.\n6. MGMT: Methylation of the MGMT gene has been reported to be associated with the development and progression of bladder cancer.\nThese are just a few examples, and there are likely many other genes that are methylated in bladder cancer cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Methylation of the TP53 gene is commonly found in bladder cancer cells.\n2. The methylation of the P16INK4a gene is a common event in bladder cancer.\n3. Methylation of the HIC1 gene is associated with the development and progression of bladder cancer.\n4. Methylation of the CDKN2A gene is reported to be associated with the development and progression of bladder cancer.\n5. Methylation of the MLH1 gene is associated with the development and progression of bladder cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Methylation of the TP53 gene is commonly found in bladder cancer cells.",
      "The methylation of the P16INK4a gene is a common event in bladder cancer.",
      "Methylation of the HIC1 gene is associated with the development and progression of bladder cancer.",
      "Methylation of the CDKN2A gene is reported to be associated with the development and progression of bladder cancer.",
      "Methylation of the MLH1 gene is associated with the development and progression of bladder cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: While TP53 mutations are common in bladder cancer, whether methylation of the TP53 gene is commonly found in bladder cancer cells would require specific scientific data that isn't provided here.\n2. TRUE: The methylation of the P16INK4a gene (also known as CDKN2A) is indeed a common event in bladder cancer and has been widely studied and reported in scientific literature.\n3. TRUE: Methylation of the HIC1 (Hypermethylated in Cancer 1) gene has been associated with the development and progression of various types of cancer, including bladder cancer.\n4. TRUE: Methylation of the CDKN2A gene (which encodes the p16INK4a protein) is reported to be associated with the development and progression of various cancers, including bladder cancer.\n5. UNKNOWN: Methylation of the MLH1 gene is most commonly associated with Lynch syndrome and colorectal cancers; however, its association with bladder cancer development and progression is less clear and would require specific scientific references to confirm.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1348,
    "user_query": "What is the characteristic domain of histone methyltransferases?",
    "yulan-chat-2-13b-fp16_response": "Histone methyltransferases are enzymes that add a methyl group to the lysine residues of histone proteins, which play a key role in regulating gene expression. The characteristic domain of histone methyltransferases is the SET domain, which stands for Su(var)3-9, Enhancer-of-zester, and Tudor domain. This domain is conserved across different species and is essential for the enzymatic activity of histone methyltransferases. The SET domain contains a catalytic core that binds the methyl group and transfers it to the lysine residue of the histone protein. Additionally, the SET domain also contains other structural elements that are important for the recognition and binding of histone proteins, as well as for the regulation of enzyme activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histone methyltransferases are enzymes that add a methyl group to the lysine residues of histone proteins.\n2. The SET domain is the characteristic domain of histone methyltransferases.\n3. SET stands for Su(var)3-9, Enhancer-of-zester, and Tudor domain.\n4. The SET domain is conserved across different species.\n5. The SET domain is essential for the enzymatic activity of histone methyltransferases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histone methyltransferases are enzymes that add a methyl group to the lysine residues of histone proteins.",
      "The SET domain is the characteristic domain of histone methyltransferases.",
      "SET stands for Su(var)3-9, Enhancer-of-zester, and Tudor domain.",
      "The SET domain is conserved across different species.",
      "The SET domain is essential for the enzymatic activity of histone methyltransferases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: SET stands for Su(var)3-9, Enhancer-of-zeste, and Trithorax.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1350,
    "user_query": "Which are the bioinformatics tools for gene structure prediction?",
    "yulan-chat-2-13b-fp16_response": "There are several bioinformatics tools available for predicting gene structures, including:\n1. FGENESH: This tool uses ab initio methods to predict gene structures from DNA sequences.\n2. GENSCAN: This tool uses statistical models to predict gene structures from DNA sequences.\n3. Glimmer: This tool uses a combination of ab initio and homology-based methods to predict gene structures from DNA sequences.\n4. Augustus: This tool uses a combination of ab initio and homology-based methods to predict gene structures from DNA sequences.\n5. PASA: This tool uses a combination of ab initio and homology-based methods to predict gene structures from DNA sequences.\n6. GeneMark: This tool uses a combination of ab initio and homology-based methods to predict gene structures from DNA sequences.\n7. MAKER: This tool uses a combination of ab initio and homology-based methods to predict gene structures from DNA sequences.\n8. Proovread: This tool uses a combination of ab initio and homology-based methods to predict gene structures from DNA sequences.\n9. NCBI Gene: This tool uses a combination of ab initio and homology-based methods to predict gene structures from DNA sequences.\nThese are some of the commonly used tools for gene structure prediction, but there are many others available as well. The choice of tool may depend on the specific needs and requirements of a particular project.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FGENESH is a bioinformatics tool used for predicting gene structures from DNA sequences using ab initio methods.\n2. GENSCAN is a bioinformatics tool that predicts gene structures using statistical models.\n3. Glimmer is a bioinformatics tool used for predicting gene structures through a combination of ab initio and homology-based methods.\n4. Augustus is a bioinformatics tool for gene structure prediction that combines ab initio and homology-based methods.\n5. GeneMark is a tool used in bioinformatics for predicting gene structures with a combination of ab initio and homology-based methods.",
    "yulan-chat-2-13b-fp16_fact": [
      "FGENESH is a bioinformatics tool used for predicting gene structures from DNA sequences using ab initio methods.",
      "GENSCAN is a bioinformatics tool that predicts gene structures using statistical models.",
      "Glimmer is a bioinformatics tool used for predicting gene structures through a combination of ab initio and homology-based methods.",
      "Augustus is a bioinformatics tool for gene structure prediction that combines ab initio and homology-based methods.",
      "GeneMark is a tool used in bioinformatics for predicting gene structures with a combination of ab initio and homology-based methods."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Glimmer is a bioinformatics tool used for predicting gene structures in microbial genomes using ab initio methods. It does not combine ab initio and homology-based methods.\n4. TRUE\n5. FALSE [correction]: GeneMark is a bioinformatics tool that typically uses ab initio methods for predicting gene structures, not a combination of ab initio and homology-based methods.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1352,
    "user_query": "What is the correlation between SPARC expression and growth inhibition in human cancer?",
    "yulan-chat-2-13b-fp16_response": "Studies have shown that increased expression of the gene encoding the protein SPARC (secreted protein acidic and rich in cysteine) is associated with growth inhibition in various human cancers, including breast cancer, ovarian cancer, and lung cancer. This suggests that SPARC may play a role in regulating cell growth and proliferation in these and possibly other types of cancer. However, more research is needed to fully understand the relationship between SPARC expression and growth inhibition in human cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Increased expression of SPARC is associated with growth inhibition in various human cancers.\n2. Human cancers where SPARC expression has been studied include breast cancer, ovarian cancer, and lung cancer.\n3. SPARC is a protein encoded by the gene with the same name (secreted protein acidic and rich in cysteine).\n4. SPARC may play a role in regulating cell growth and proliferation in cancer.\n5. Further research is necessary to fully understand the relationship between SPARC expression and growth inhibition in human cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Increased expression of SPARC is associated with growth inhibition in various human cancers.",
      "Human cancers where SPARC expression has been studied include breast cancer, ovarian cancer, and lung cancer.",
      "SPARC is a protein encoded by the gene with the same name (secreted protein acidic and rich in cysteine).",
      "SPARC may play a role in regulating cell growth and proliferation in cancer.",
      "Further research is necessary to fully understand the relationship between SPARC expression and growth inhibition in human cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1353,
    "user_query": "Which syndrome is associated with mutations in the LYST gene?",
    "yulan-chat-2-13b-fp16_response": "The syndrome associated with mutations in the LYST gene is called lysosomal storage disorder type 6B (LSD6B). It is also known as N-glycanase deficiency.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1354,
    "user_query": "Has the presence of delayed enhancement been documented in athletes performing strenuous exercise?",
    "yulan-chat-2-13b-fp16_response": "Yes, the presence of delayed enhancement has been documented in athletes performing strenuous exercise. Delayed enhancement refers to the phenomenon where muscle protein synthesis and muscle hypertrophy occur after a bout of exercise, even though the muscle tissue may not appear to have increased in size immediately after exercise.\nThis phenomenon has been observed in a variety of athletic populations, including resistance-trained individuals, endurance athletes, and even sedentary individuals who undergo a single bout of exercise. Delayed enhancement is thought to be related to the activation of signaling pathways that promote muscle protein synthesis and muscle growth, which can take time to fully manifest.\nWhile the exact mechanisms underlying delayed enhancement are not fully understood, it is clear that it plays an important role in muscle adaptation to exercise and may be a key factor in the long-term adaptations that underlie athletic performance.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Delayed enhancement has been documented in athletes performing strenuous exercise.\n2. Delayed enhancement refers to muscle protein synthesis and muscle hypertrophy occurring after exercise.\n3. This phenomenon has been observed in resistance-trained individuals, endurance athletes, and sedentary individuals who undergo a bout of exercise.\n4. Delayed enhancement is related to the activation of signaling pathways that promote muscle protein synthesis and growth.\n5. Delayed enhancement plays a role in muscle adaptation to exercise and may contribute to long-term athletic performance adaptations.",
    "yulan-chat-2-13b-fp16_fact": [
      "Delayed enhancement has been documented in athletes performing strenuous exercise.",
      "Delayed enhancement refers to muscle protein synthesis and muscle hypertrophy occurring after exercise.",
      "This phenomenon has been observed in resistance-trained individuals, endurance athletes, and sedentary individuals who undergo a bout of exercise.",
      "Delayed enhancement is related to the activation of signaling pathways that promote muscle protein synthesis and growth.",
      "Delayed enhancement plays a role in muscle adaptation to exercise and may contribute to long-term athletic performance adaptations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Delayed enhancement often refers to a term used in cardiac imaging related to the detection of scar tissue in the heart after a cardiac event such as a myocardial infarction; it is not typically used to describe muscle protein synthesis and muscle hypertrophy. The term often used for the latter is \"Delayed Onset Muscle Soreness (DOMS)\" or \"post-exercise muscle growth.\"\n3. UNKNOWN\n4. FALSE [correction]: While the activation of signaling pathways does promote muscle protein synthesis and growth after exercise, this is typically associated with the concept of muscle recovery and growth rather than \"delayed enhancement,\" which is more commonly related to cardiac imaging.\n5. FALSE [correction]: Similar to the previous statements, the term typically associated with muscle adaptation to exercise and athletic performance adaptations is not \"delayed enhancement,\" but concepts like \"muscle hypertrophy,\" \"training adaptation,\" or \"muscle recovery.\"",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 1356,
    "user_query": "Name the factors required for selenoprotein synthesis in eukaryotes",
    "yulan-chat-2-13b-fp16_response": "Selenoprotein synthesis in eukaryotes requires several factors, including:\n1. Selenium: Selenium is a trace element that is required for the synthesis of selenoproteins. It is incorporated into the active site of selenocysteine, the 21st amino acid in the genetic code.\n2. Selenocysteine tRNA: Selenocysteine is delivered to the ribosome by a specific tRNA, which is encoded by the SEPSECS3 gene in mammals.\n3. Selenoprotein P: Selenoprotein P is a plasma protein that binds to and transports selenite, the reduced form of selenium, to the liver, where it is incorporated into selenoproteins.\n4. Selenophosphate synthase: Selenophosphate synthase is an enzyme that catalyzes the conversion of selenite to selenophosphate, the precursor to selenoproteins.\n5. Selenoprotein K: Selenoprotein K is a selenoprotein that helps to activate selenophosphate synthase and also helps to incorporate selenocysteine into nascent peptide chains.\n6. Other selenoproteins: Several other selenoproteins are required for selenoprotein synthesis, including selenoprotein N, selenoprotein H, and selenoprotein I. These proteins help to transfer selenocysteine to the active site of other selenoproteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Selenium is a trace element required for the synthesis of selenoproteins in eukaryotes.\n2. Selenocysteine tRNA, encoded by the SEPSECS gene, delivers selenocysteine to the ribosome in mammals.\n3. Selenoprotein P binds to and transports selenite to the liver for incorporation into selenoproteins.\n4. Selenophosphate synthase is an enzyme that catalyzes the conversion of selenite to selenophosphate.\n5. Selenoprotein K activates selenophosphate synthase and helps incorporate selenocysteine into nascent peptide chains.",
    "yulan-chat-2-13b-fp16_fact": [
      "Selenium is a trace element required for the synthesis of selenoproteins in eukaryotes.",
      "Selenocysteine tRNA, encoded by the SEPSECS gene, delivers selenocysteine to the ribosome in mammals.",
      "Selenoprotein P binds to and transports selenite to the liver for incorporation into selenoproteins.",
      "Selenophosphate synthase is an enzyme that catalyzes the conversion of selenite to selenophosphate.",
      "Selenoprotein K activates selenophosphate synthase and helps incorporate selenocysteine into nascent peptide chains."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Selenoprotein P is known to bind selenium and transport it throughout the body, including to the liver, but not specifically in the form of selenite. It carries selenium mainly in the form of selenocysteine residues incorporated into its structure.\n4. TRUE\n5. FALSE [correction]: Selenoprotein K is involved in calcium flux in the endoplasmic reticulum and is associated with immune function, but it does not activate selenophosphate synthetase or help incorporate selenocysteine into nascent peptide chains. The process of incorporating selenocysteine involves the selenocysteine insertion sequence (SECIS) element, selenocysteine tRNA, and specific protein factors, but not selenoprotein K.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1359,
    "user_query": "What is the role of TRH in hypertension?",
    "yulan-chat-2-13b-fp16_response": "Thyrotropin-releasing hormone (TRH) is a hormone produced by the hypothalamus in the brain that plays a role in regulating the release of thyroid hormones from the thyroid gland.\nThere is some evidence to suggest that TRH may also have a role in the regulation of blood pressure. Studies have shown that TRH can stimulate the release of certain hormones, such as vasopressin and oxytocin, which can have an effect on blood pressure.\nHowever, the exact role of TRH in hypertension is not fully understood and more research is needed to determine its potential impact on blood pressure regulation. It is possible that TRH may play a role in the development of hypertension, but more studies are needed to confirm this.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyrotropin-releasing hormone (TRH) is produced by the hypothalamus in the brain.\n2. TRH regulates the release of thyroid hormones from the thyroid gland.\n3. TRH may play a role in the regulation of blood pressure.\n4. TRH can stimulate the release of hormones such as vasopressin and oxytocin.\n5. The exact role of TRH in hypertension is not fully understood, necessitating further research.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyrotropin-releasing hormone (TRH) is produced by the hypothalamus in the brain.",
      "TRH regulates the release of thyroid hormones from the thyroid gland.",
      "TRH may play a role in the regulation of blood pressure.",
      "TRH can stimulate the release of hormones such as vasopressin and oxytocin.",
      "The exact role of TRH in hypertension is not fully understood, necessitating further research."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: TRH does not directly stimulate the release of vasopressin and oxytocin. These hormones are released by the posterior pituitary, although their secretion can be influenced by the hypothalamus.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 1360,
    "user_query": "Is triadin involved in cardiac function?",
    "yulan-chat-2-13b-fp16_response": "Yes, triadin is involved in cardiac function. Triadin is a protein complex that is found in the inner membrane of the mitochondria, and it plays a key role in the production of ATP, the energy currency of the cell. ATP is essential for many cellular processes, including cardiac function. Triadin is also involved in the regulation of the mitochondrial membrane potential, which is important for the proper functioning of the mitochondria and the cell as a whole. In addition, triadin has been shown to play a role in the regulation of cell death, or apoptosis, which is an important process for maintaining tissue homeostasis and preventing the accumulation of damaged or dysfunctional cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Triadin is involved in cardiac function.\n2. Triadin is a protein complex found in the inner membrane of the mitochondria.\n3. Triadin plays a key role in the production of ATP.\n4. ATP is essential for many cellular processes, including cardiac function.\n5. Triadin is involved in the regulation of the mitochondrial membrane potential.",
    "yulan-chat-2-13b-fp16_fact": [
      "Triadin is involved in cardiac function.",
      "Triadin is a protein complex found in the inner membrane of the mitochondria.",
      "Triadin plays a key role in the production of ATP.",
      "ATP is essential for many cellular processes, including cardiac function.",
      "Triadin is involved in the regulation of the mitochondrial membrane potential."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Triadin is not found in the inner membrane of the mitochondria; it is associated with the sarcoplasmic reticulum of muscle cells.\n3. FALSE [correction]: Triadin plays a key role in calcium handling and signaling, not directly in the production of ATP.\n4. TRUE\n5. FALSE [correction]: Triadin is involved in the regulation of calcium release from the sarcoplasmic reticulum, not the mitochondrial membrane potential.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "yulan-chat-2-13b-fp16_response": "The main inhibitor of protein phosphatase 1 (PP1) is the protein calpain. Calpain is a calcium-dependent protease that can cleave PP1 into smaller fragments, rendering it inactive. Additionally, other proteins such as PP1-interacting proteins and PP1-regulatory proteins can also modulate PP1 activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Calpain is the main inhibitor of protein phosphatase 1 (PP1).\n2. Calpain is a calcium-dependent protease.\n3. Calpain can cleave PP1 into smaller fragments.\n4. Cleaving PP1 into smaller fragments renders it inactive.",
    "yulan-chat-2-13b-fp16_fact": [
      "Calpain is the main inhibitor of protein phosphatase 1 (PP1).",
      "Calpain is a calcium-dependent protease.",
      "Calpain can cleave PP1 into smaller fragments.",
      "Cleaving PP1 into smaller fragments renders it inactive."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Calpain is not the main inhibitor of protein phosphatase 1 (PP1); it is an enzyme that can proteolytically modify PP1, but the primary regulators of PP1 activity are regulatory proteins often termed as \"inhibitor proteins\" or \"regulatory subunits\".\n2. TRUE\n3. TRUE\n4. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1364,
    "user_query": "Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?",
    "yulan-chat-2-13b-fp16_response": "The protein required for Argonaute 2 recruitment to stress granules and P-bodies is GW182. GW182 is a RNA-binding protein that interacts with Argonaute 2 and helps recruit it to these structures.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GW182 is the protein required for Argonaute 2 recruitment to stress granules and P-bodies.\n2. GW182 is a RNA-binding protein.\n3. GW182 interacts with Argonaute 2.",
    "yulan-chat-2-13b-fp16_fact": [
      "GW182 is the protein required for Argonaute 2 recruitment to stress granules and P-bodies.",
      "GW182 is a RNA-binding protein.",
      "GW182 interacts with Argonaute 2."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1365,
    "user_query": "Is Mammaprint approved by the United States Food and Drug Administration?",
    "yulan-chat-2-13b-fp16_response": "I am not aware of any product called \"Mammaprint\" that is approved by the United States Food and Drug Administration (FDA). It is possible that \"Mammaprint\" is a product that is not yet approved by the FDA or that it is a product that is not marketed or sold in the United States.\nThe FDA is responsible for regulating the safety and effectiveness of medical devices, including diagnostic tests, that are marketed and sold in the United States. Before a medical device can be marketed and sold in the United States, it must undergo a rigorous review process by the FDA to ensure that it is safe and effective.\nIf you have questions about a specific medical device or test, it is always a good idea to consult with a healthcare professional or the manufacturer of the product for more information.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The United States Food and Drug Administration (FDA) is responsible for regulating the safety and effectiveness of medical devices in the United States.\n2. Diagnostic tests are among the medical devices regulated by the FDA.\n3. Before being marketed and sold in the United States, a medical device must undergo a review process by the FDA.\n4. The FDA's review process is established to ensure that medical devices are safe and effective.",
    "yulan-chat-2-13b-fp16_fact": [
      "The United States Food and Drug Administration (FDA) is responsible for regulating the safety and effectiveness of medical devices in the United States.",
      "Diagnostic tests are among the medical devices regulated by the FDA.",
      "Before being marketed and sold in the United States, a medical device must undergo a review process by the FDA.",
      "The FDA's review process is established to ensure that medical devices are safe and effective."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1368,
    "user_query": "Which pharmacogenetic test is available for abacavir?",
    "yulan-chat-2-13b-fp16_response": "The pharmacogenetic test that is available for abacavir is the HLA-B\\*57 test. This test is used to determine if a person has the HLA-B\\*57 genotype, which is associated with an increased risk of developing a hypersensitivity reaction to abacavir. If a person has this genotype, they should not take abacavir, as they are at a higher risk of developing a severe hypersensitivity reaction, which can be life-threatening. The HLA-B\\*57 test is typically performed before starting treatment with abacavir to determine if it is safe for the person to take the medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The pharmacogenetic test available for abacavir is the HLA-B*57 test.\n2. The HLA-B*57 genotype is associated with an increased risk of developing a hypersensitivity reaction to abacavir.\n3. Individuals with the HLA-B*57 genotype should not take abacavir due to the risk of a severe hypersensitivity reaction.\n4. The HLA-B*57 test is typically performed before starting treatment with abacavir.\n5. A hypersensitivity reaction to abacavir can be life-threatening.",
    "yulan-chat-2-13b-fp16_fact": [
      "The pharmacogenetic test available for abacavir is the HLA-B*57 test.",
      "The HLA-B*57 genotype is associated with an increased risk of developing a hypersensitivity reaction to abacavir.",
      "Individuals with the HLA-B*57 genotype should not take abacavir due to the risk of a severe hypersensitivity reaction.",
      "The HLA-B*57 test is typically performed before starting treatment with abacavir.",
      "A hypersensitivity reaction to abacavir can be life-threatening."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The pharmacogenetic test available for abacavir is the HLA-B*5701 test.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1370,
    "user_query": "Are nucleosomes positioned at DNA replication origins?",
    "yulan-chat-2-13b-fp16_response": "Nucleosomes are not typically positioned at DNA replication origins. DNA replication origins are specific regions of DNA where replication begins, and they are typically devoid of nucleosomes. Nucleosomes are structures made up of DNA wrapped around a core of histone proteins, and they are the basic unit of chromatin, the complex of DNA and proteins that makes up the chromosomes. Nucleosomes are found throughout the genome, except at replication origins, where the DNA is more accessible to the replication machinery.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DNA replication origins are specific regions of DNA where replication begins.\n2. DNA replication origins are typically devoid of nucleosomes.\n3. Nucleosomes consist of DNA wrapped around a core of histone proteins.\n4. Nucleosomes are the basic unit of chromatin.\n5. Nucleosomes are found throughout the genome, except at replication origins.",
    "yulan-chat-2-13b-fp16_fact": [
      "DNA replication origins are specific regions of DNA where replication begins.",
      "DNA replication origins are typically devoid of nucleosomes.",
      "Nucleosomes consist of DNA wrapped around a core of histone proteins.",
      "Nucleosomes are the basic unit of chromatin.",
      "Nucleosomes are found throughout the genome, except at replication origins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: DNA replication origins are not typically devoid of nucleosomes; nucleosomes can be found at replication origins but may be reorganized or temporarily removed during the initiation of replication.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Nucleosomes are found throughout the genome, including at replication origins, although their presence at origins might be dynamically regulated during the cell cycle.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1371,
    "user_query": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?",
    "yulan-chat-2-13b-fp16_response": "It is difficult to identify the most under-represented oligonucleotides in higher eukaryote genomes, as the representation of different oligonucleotides can vary greatly depending on the specific genome and sequence context. However, some studies have identified certain oligonucleotides as being under-represented in various eukaryotic genomes. For example, a study published in 2013 found that the dinucleotide CA was under-represented in the human genome, while the trinucleotide CGC was over-represented. Another study published in 2014 found that the tetranucleotide CGCA was under-represented in the mouse genome. These findings suggest that the representation of different oligonucleotides in eukaryotic genomes is complex and can vary depending on the specific genome and sequence context.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The representation of different oligonucleotides in higher eukaryote genomes can vary greatly.\n2. Some studies have identified specific oligonucleotides as being under-represented in various eukaryotic genomes.\n3. A 2013 study found that the dinucleotide CA was under-represented in the human genome.\n4. The same study found that the trinucleotide CGC was over-represented in the human genome.\n5. A 2014 study identified the tetranucleotide CGCA as under-represented in the mouse genome.",
    "yulan-chat-2-13b-fp16_fact": [
      "The representation of different oligonucleotides in higher eukaryote genomes can vary greatly.",
      "Some studies have identified specific oligonucleotides as being under-represented in various eukaryotic genomes.",
      "A 2013 study found that the dinucleotide CA was under-represented in the human genome.",
      "The same study found that the trinucleotide CGC was over-represented in the human genome.",
      "A 2014 study identified the tetranucleotide CGCA as under-represented in the mouse genome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: It is a known fact in genomics that the representation of different oligonucleotides can vary greatly in higher eukaryote genomes due to various biological processes and evolutionary factors.\n2. TRUE: Several studies have reported specific oligonucleotides as being over- or under-represented in various eukaryotic genomes.\n3. TRUE: Studies, including those before and around 2013, have indeed found certain dinucleotides, such as CG (and possibly CA by extension in certain contexts), to be under-represented in eukaryotic genomes, including humans, due to factors like methylation and mutational pressures.\n4. UNKNOWN: Without the specifics of the study, it is not possible to confirm or deny this result regarding the trinucleotide CGC, though CG dinucleotide under-representation is well-known.\n5. UNKNOWN: Without the specific details of the 2014 study, the statement about the tetranucleotide CGCA being under-represented in the mouse genome cannot be confirmed or denied. However, it is plausible as studies do find various oligonucleotide frequencies to be non-random in different genomes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "yulan-chat-2-13b-fp16_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a process by which bacteria such as Bacillus subtilis can acquire genetic mutations that enhance their ability to survive in changing environments. This process is thought to be mediated by a variety of mechanisms, including:\n1. Error-prone replication: During DNA replication, errors can occur that result in mutations. These errors are more likely to occur during stationary phase, when the cell is under stress and has a higher mutation rate.\n2. Homologous recombination: Homologous recombination is a process by which DNA sequences are exchanged between two homologous chromosomes. This process can result in the acquisition of new genetic information through the integration of foreign DNA.\n3. Transformation: Transformation is the process by which bacteria take up DNA from their environment. This can result in the acquisition of new genetic information that can enhance the bacterium's ability to survive in a changing environment.\n4. Spontaneous mutations: Spontaneous mutations can occur due to errors in DNA replication, repair, or other processes. These mutations can result in the acquisition of new genetic information that can enhance the bacterium's ability to survive in a changing environment.\nOverall, these mechanisms work together to generate genetic diversity in Bacillus subtilis and other bacteria, allowing them to adapt to changing environments and survive under a wide range of conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bacillus subtilis can acquire genetic mutations during stationary phase, which is a period of stress for the cell.\n2. Error-prone replication during DNA replication can result in mutations for Bacillus subtilis during stationary phase.\n3. Homologous recombination in Bacillus subtilis allows for the exchange of DNA sequences between homologous chromosomes.\n4. Transformation is a process where Bacillus subtilis can take up DNA from their environment.\n5. Spontaneous mutations in Bacillus subtilis can result from errors in DNA replication and repair.",
    "yulan-chat-2-13b-fp16_fact": [
      "Bacillus subtilis can acquire genetic mutations during stationary phase, which is a period of stress for the cell.",
      "Error-prone replication during DNA replication can result in mutations for Bacillus subtilis during stationary phase.",
      "Homologous recombination in Bacillus subtilis allows for the exchange of DNA sequences between homologous chromosomes.",
      "Transformation is a process where Bacillus subtilis can take up DNA from their environment.",
      "Spontaneous mutations in Bacillus subtilis can result from errors in DNA replication and repair."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1375,
    "user_query": "What personality traits can be evaluated with the Ten Item Personality Inventory.",
    "yulan-chat-2-13b-fp16_response": "The Ten Item Personality Inventory (TIPI) is a brief self-report measure of personality that assesses several key personality traits. The traits evaluated by TIPI include:\n1. Agreeableness: This trait refers to an individual's tendency to be cooperative, compassionate, and empathetic towards others.\n2. Conscientiousness: This trait refers to an individual's level of responsibility, organization, and dependability.\n3. Extraversion: This trait refers to an individual's tendency to seek out social interaction, excitement, and stimulation.\n4. Neuroticism: This trait refers to an individual's tendency to experience negative emotions such as anxiety, sadness, and anger.\n5. Openness: This trait refers to an individual's level of imagination, creativity, and openness to new experiences.\n6. Honesty-Humility: This trait refers to an individual's tendency to be honest and humble in their interactions with others.\n7. Emotional stability: This trait refers to an individual's ability to regulate their emotions and cope with stress.\n8. Warmth: This trait refers to an individual's level of friendliness, kindness, and warmth towards others.\n9. Self-discipline: This trait refers to an individual's ability to control their impulses and maintain focus and concentration.\n10. Self-esteem: This trait refers to an individual's level of self-confidence and self-worth.\nTIPI is a useful tool for evaluating these personality traits in a relatively brief and efficient manner, making it popular for research and clinical settings.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Ten Item Personality Inventory (TIPI) is a self-report measure of personality.\n2. TIPI assesses the trait of Agreeableness, related to cooperativeness and empathy.\n3. Conscientiousness, a trait indicating organization and dependability, is evaluated by TIPI.\n4. TIPI measures the trait of Extraversion, which is linked to social interaction and excitement seeking.\n5. Openness, encompassing imagination and receptiveness to new experiences, is a trait assessed by TIPI.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Ten Item Personality Inventory (TIPI) is a self-report measure of personality.",
      "TIPI assesses the trait of Agreeableness, related to cooperativeness and empathy.",
      "Conscientiousness, a trait indicating organization and dependability, is evaluated by TIPI.",
      "TIPI measures the trait of Extraversion, which is linked to social interaction and excitement seeking.",
      "Openness, encompassing imagination and receptiveness to new experiences, is a trait assessed by TIPI."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEach statement is correct with respect to the traits assessed by the Ten Item Personality Inventory (TIPI), which measures the five-factor model of personality traits, including Agreeableness, Conscientiousness, Extraversion, and Openness.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1376,
    "user_query": "Which are the enzymes involved in the control of tubulin acetylation?",
    "yulan-chat-2-13b-fp16_response": "Tubulin acetylation is controlled by a group of enzymes, including:\n1. Tubulin acetyltransferases: These enzymes add acetyl groups to tubulin proteins, promoting their stability and promoting microtubule assembly. Examples include TUBULIN ACETYLTRANSFEASE 1 (TAG1) and TUBULIN ACETYLTRANSFEASE 2 (TAG2) in mammals.\n2. Tubulin deacetylases: These enzymes remove acetyl groups from tubulin proteins, promoting microtubule disassembly. Examples include HDAC6 and SIRT2 in mammals.\n3. Tubulin tyrosine ligases: These enzymes add tyrosine residues to tubulin proteins, which can modulate microtubule dynamics. Examples include TUBULIN TYROSINE LIGASE (TYL) in mammals.\nOverall, the balance between these enzymes and their activities plays a critical role in regulating microtubule dynamics and cellular functions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tubulin acetyltransferases are enzymes that add acetyl groups to tubulin proteins.\n2. Tubulin acetyltransferases promote microtubule assembly.\n3. Tubulin deacetylases are enzymes that remove acetyl groups from tubulin proteins, leading to microtubule disassembly.\n4. HDAC6 and SIRT2 are examples of tubulin deacetylases in mammals.\n5. Tubulin tyrosine ligases add tyrosine residues to tubulin proteins and modulate microtubule dynamics.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tubulin acetyltransferases are enzymes that add acetyl groups to tubulin proteins.",
      "Tubulin acetyltransferases promote microtubule assembly.",
      "Tubulin deacetylases are enzymes that remove acetyl groups from tubulin proteins, leading to microtubule disassembly.",
      "HDAC6 and SIRT2 are examples of tubulin deacetylases in mammals.",
      "Tubulin tyrosine ligases add tyrosine residues to tubulin proteins and modulate microtubule dynamics."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Tubulin deacetylases are enzymes that remove acetyl groups from tubulin proteins, but this action does not necessarily lead to microtubule disassembly. It can affect microtubule stability and function in various ways.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1378,
    "user_query": "List all approved indications for Glivec",
    "yulan-chat-2-13b-fp16_response": "Glivec (imatinib) is a drug that is used to treat certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It is also sometimes used to treat other types of cancer.\nGlivec is approved for the following indications:\n* The treatment of adult patients with chronic myeloid leukemia (CML) in chronic phase, accelerated phase, or blast crisis phase.\n* The treatment of adult patients with acute lymphoblastic leukemia (ALL) with the Philadelphia chromosome positive.\n* The treatment of adult patients with myelodysplastic/myeloproliferative neoplasm (MDS/MPN) associated with the Philadelphia chromosome.\n* The treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib.\n* The treatment of adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the Philadelphia chromosome positive.\n* The treatment of pediatric patients with CML, Ph+ ALL, and Ph+ MDS/MPN.\nIt's important to note that the use of Glivec for these indications is not approved in all countries, and the drug may be available for use in certain countries for certain indications but not for others. It's always best to check with a doctor or a healthcare professional for the most up-to-date information.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Glivec (imatinib) is used to treat chronic myeloid leukemia (CML).\n2. Glivec is approved for treating gastrointestinal stromal tumors (GIST).\n3. Glivec is indicated for the treatment of adult patients with acute lymphoblastic leukemia (ALL) with the Philadelphia chromosome positive.\n4. Glivec is used for treating adult patients with myelodysplastic/myeloproliferative neoplasm (MDS/MPN) associated with the Philadelphia chromosome.\n5. Glivec is approved for treating pediatric patients with CML, Ph+ ALL, and Ph+ MDS/MPN.",
    "yulan-chat-2-13b-fp16_fact": [
      "Glivec (imatinib) is used to treat chronic myeloid leukemia (CML).",
      "Glivec is approved for treating gastrointestinal stromal tumors (GIST).",
      "Glivec is indicated for the treatment of adult patients with acute lymphoblastic leukemia (ALL) with the Philadelphia chromosome positive.",
      "Glivec is used for treating adult patients with myelodysplastic/myeloproliferative neoplasm (MDS/MPN) associated with the Philadelphia chromosome.",
      "Glivec is approved for treating pediatric patients with CML, Ph+ ALL, and Ph+ MDS/MPN."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Glivec (imatinib) is not specifically indicated for treating myelodysplastic/myeloproliferative neoplasms (MDS/MPN) associated with the Philadelphia chromosome. Imatinib is used to treat certain types of chronic myeloid leukemia and gastrointestinal stromal tumors, and some other conditions, but Philadelphia chromosome-positive MDS/MPN is typically not among them.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1379,
    "user_query": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?",
    "yulan-chat-2-13b-fp16_response": "LINE-1 and Alu retrotransposons are endogenous retroviral elements that can move around within the genome and cause various genetic disorders. The inhibition of these elements is important for maintaining genome stability. Several proteins have been identified that can induce inhibition of LINE-1 and Alu retrotransposition, including:\n1. APOBEC3 family proteins: The APOBEC3 family of proteins are cytosine deaminases that can target and inhibit LINE-1 and Alu retrotransposition by deaminating cytosine residues in the retrotransposon sequence.\n2. Restriction factors: Restriction factors are proteins that can recognize and bind to specific retroviral elements, including LINE-1 and Alu elements, and prevent their transcription and replication.\n3. p53: The tumor suppressor protein p53 can induce the expression of APOBEC3 family proteins and other factors that inhibit LINE-1 and Alu retrotransposition.\n4. DNA methylation: Methylation of the LINE-1 and Alu elements can also inhibit their transcription and replication.\nOverall, the inhibition of LINE-1 and Alu retrotransposition is a complex process that involves multiple mechanisms, including the action of various proteins and epigenetic modifications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. APOBEC3 family proteins inhibit LINE-1 and Alu retrotransposition by deaminating cytosine residues in the retrotransposon sequence.\n2. Restriction factors can inhibit LINE-1 and Alu retrotransposition by recognizing, binding to, and preventing their transcription and replication.\n3. The protein p53 can induce the expression of APOBEC3 proteins and other factors that inhibit LINE-1 and Alu retrotransposition.\n4. Methylation of LINE-1 and Alu retrotransposon sequences can inhibit their transcription and replication.\n5. LINE-1 and Alu elements are endogenous retroviral elements that can cause various genetic disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "APOBEC3 family proteins inhibit LINE-1 and Alu retrotransposition by deaminating cytosine residues in the retrotransposon sequence.",
      "Restriction factors can inhibit LINE-1 and Alu retrotransposition by recognizing, binding to, and preventing their transcription and replication.",
      "The protein p53 can induce the expression of APOBEC3 proteins and other factors that inhibit LINE-1 and Alu retrotransposition.",
      "Methylation of LINE-1 and Alu retrotransposon sequences can inhibit their transcription and replication.",
      "LINE-1 and Alu elements are endogenous retroviral elements that can cause various genetic disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE  The protein p53 is known to regulate the expression of numerous genes, including genes that can contribute to the inhibition of retrotransposition, although direct induction of specific APOBEC3 proteins may vary.\n4. TRUE  Methylation of DNA sequences, including those of retrotransposons like LINE-1 and Alu elements, can inhibit their expression and thus their ability to transpose.\n5. FALSE [correction]: LINE-1 (L1) and Alu elements are not endogenous retroviral elements; they are non-LTR retrotransposons. While they are not retroviruses, these elements can indeed cause genetic disorders through insertional mutagenesis.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1382,
    "user_query": "Describe the usefulness of Macrostomum lignano in ion channel and stem cell research",
    "yulan-chat-2-13b-fp16_response": "Macrostomum lignano is a freshwater planarian, a type of flatworm, that has gained attention in recent years for its potential as a model organism in biological research. Specifically, it has been found to be useful in ion channel and stem cell research.\nIon channels are important molecular targets for drug development, as they play a crucial role in the transmission of electrical signals in cells. Macrostomum lignano has been found to express a high diversity of ion channels, making it a useful model for studying ion channel function and drug interactions. The planarian's transparent body and relatively simple nervous system make it an ideal system for imaging and electrophysiological recordings of ion channels.\nIn stem cell research, Macrostomum lignano has been found to be capable of regenerating its entire body from a single cell, making it a promising model for studying stem cell biology and regeneration. The planarian's ability to rapidly regenerate its nervous system has also made it a useful model for studying the development and function of neural circuits.\nOverall, Macrostomum lignano's unique properties and capabilities make it a valuable model organism for ion channel and stem cell research, and could lead to important advances in our understanding of these important biological processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Macrostomum lignano is a freshwater planarian, a type of flatworm.\n2. It is used as a model organism in ion channel and stem cell research.\n3. Macrostomum lignano expresses a high diversity of ion channels.\n4. The planarian can regenerate its entire body from a single cell.\n5. Macrostomum lignano's transparent body and simple nervous system make it suitable for imaging and electrophysiological recordings.",
    "yulan-chat-2-13b-fp16_fact": [
      "Macrostomum lignano is a freshwater planarian, a type of flatworm.",
      "It is used as a model organism in ion channel and stem cell research.",
      "Macrostomum lignano expresses a high diversity of ion channels.",
      "The planarian can regenerate its entire body from a single cell.",
      "Macrostomum lignano's transparent body and simple nervous system make it suitable for imaging and electrophysiological recordings."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Macrostomum lignano is a marine flatworm, not a freshwater planarian.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Macrostomum lignano can regenerate its body from small pieces but not from a single cell.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1384,
    "user_query": "Which drug is benserazide usually co-administered with?",
    "yulan-chat-2-13b-fp16_response": "Benserazide is usually co-administered with an antipsychotic drug, such as risperidone or haloperidol, to enhance the effectiveness of the antipsychotic and reduce the risk of side effects.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1387,
    "user_query": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?",
    "yulan-chat-2-13b-fp16_response": "There are several biomedical text mining tools available for the detection of protein-protein interactions, including:\n1. STRING (Search Tool for the Retrieval of Interacting Genes/Proteins): This tool uses both experimental and predicted interactions to build a comprehensive network of protein-protein interactions.\n2. BioGRID (Biological General Reaction Matrix): This tool provides a comprehensive, manually curated database of protein-protein interactions, with a focus on interactions involved in molecular pathways.\n3. MINT (Molecular Interaction Network Analysis): This tool uses a combination of experimental and computational methods to predict protein-protein interactions and build molecular interaction networks.\n4. Cytoscape: This tool is a open-source software platform for network analysis and visualization, and can be used to analyze and visualize protein-protein interaction networks.\n5. Ingenuity Pathway Analysis: This tool uses a database of known biological interactions to identify and analyze molecular networks and pathways.\n6. STRING-Interactome: This tool is a web-based platform that allows users to search and visualize protein-protein interaction networks, and to identify enriched functional pathways and networks.\n7. DIP (Database of Interacting Proteins): This tool provides a comprehensive, manually curated database of protein-protein interactions, with a focus on interactions involving human proteins.\n8. InterologFinder: This tool uses comparative genomics to identify conserved protein-protein interactions across species, and can be used to predict novel interactions in humans.\nThese tools can be used to identify and analyze protein-protein interactions, and to understand the functional roles of proteins in biological processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. STRING is a text mining tool that builds a comprehensive network of protein-protein interactions using experimental and predicted interactions.\n2. BioGRID is a manually curated database of protein-protein interactions with a focus on interactions involved in molecular pathways.\n3. MINT combines experimental and computational methods to predict protein-protein interactions and build molecular interaction networks.\n4. Cytoscape is an open-source software platform for network analysis and visualization of protein-protein interaction networks.\n5. Ingenuity Pathway Analysis uses a database of known biological interactions to analyze molecular networks and pathways.",
    "yulan-chat-2-13b-fp16_fact": [
      "STRING is a text mining tool that builds a comprehensive network of protein-protein interactions using experimental and predicted interactions.",
      "BioGRID is a manually curated database of protein-protein interactions with a focus on interactions involved in molecular pathways.",
      "MINT combines experimental and computational methods to predict protein-protein interactions and build molecular interaction networks.",
      "Cytoscape is an open-source software platform for network analysis and visualization of protein-protein interaction networks.",
      "Ingenuity Pathway Analysis uses a database of known biological interactions to analyze molecular networks and pathways."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: MINT (the Molecular INTeraction database) is a public repository for protein-protein interactions, not specifically combining experimental and computational methods to predict protein-protein interactions but rather collecting experimentally verified interactions reported in peer-reviewed publications.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1391,
    "user_query": "Can RNASeq be used for the analysis of nascent transcripts?",
    "yulan-chat-2-13b-fp16_response": "Yes, RNA sequencing (RNA-Seq) can be used for the analysis of nascent transcripts. Nascent transcripts are the RNA transcripts that are being synthesized in real-time by active genes, but have not yet been processed into mature RNA molecules. RNA-Seq can be used to study the transcriptional landscape of cells, including the identification of nascent transcripts.\nRNA-Seq works by sequencing the RNA molecules that are present in a sample, which can include both mature and nascent transcripts. The resulting sequence data can then be analyzed to identify the genes that are being actively transcribed, as well as to characterize the structure and organization of the transcripts themselves.\nOne advantage of using RNA-Seq for the analysis of nascent transcripts is that it allows for the detection of alternative splicing events and other transcript modifications that occur post-transcriptionally. This can provide valuable insights into the regulation of gene expression and the diversity of transcripts produced from a given gene locus.\nOverall, RNA-Seq is a powerful tool for the study of transcription and can be used to analyze both mature and nascent transcripts.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNA sequencing (RNA-Seq) can be utilized to analyze nascent transcripts.\n2. Nascent transcripts are RNA transcripts currently in the process of being synthesized by active genes, but not yet processed into mature RNA molecules.\n3. RNA-Seq is capable of identifying genes that are actively transcribed.\n4. RNA-Seq allows for the detection of alternative splicing events and other post-transcriptional transcript modifications.\n5. RNA-Seq can be used to study the transcriptional landscape of cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "RNA sequencing (RNA-Seq) can be utilized to analyze nascent transcripts.",
      "Nascent transcripts are RNA transcripts currently in the process of being synthesized by active genes, but not yet processed into mature RNA molecules.",
      "RNA-Seq is capable of identifying genes that are actively transcribed.",
      "RNA-Seq allows for the detection of alternative splicing events and other post-transcriptional transcript modifications.",
      "RNA-Seq can be used to study the transcriptional landscape of cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1392,
    "user_query": "Do RNA:DNA hybrids preferentially form in high or low GC regions?",
    "yulan-chat-2-13b-fp16_response": "RNA:DNA hybrids can form in both high GC and low GC regions, but the formation of these hybrids is influenced by various factors, including the sequence composition and the overall structure of the DNA.\nIn high GC regions, the guanine-cytosine (GC) base pairs have a higher chance of forming a stable RNA:DNA duplex, as the GC base pairs have a stronger interaction than the other base pairs. This can lead to the formation of RNA:DNA hybrids in these regions.\nHowever, in low GC regions, the formation of RNA:DNA hybrids may be less favored due to the weaker interaction between the base pairs. Additionally, the overall structure of the DNA, including the presence of structural elements such as repetitive sequences or GC-rich regions, can also influence the formation of RNA:DNA hybrids.\nOverall, the formation of RNA:DNA hybrids is a complex process that is influenced by various factors, and it is difficult to make a general statement about whether these hybrids preferentially form in high or low GC regions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNA:DNA hybrids can form in both high GC and low GC regions.\n2. GC base pairs have a stronger interaction than other base pairs, which may influence the stability of RNA:DNA duplexes in high GC regions.\n3. RNA:DNA hybrid formation in low GC regions may be less likely due to weaker interactions between base pairs.\n4. The presence of structural elements like repetitive sequences can influence the formation of RNA:DNA hybrids.\n5. The formation of RNA:DNA hybrids is influenced by sequence composition and the overall structure of the DNA.",
    "yulan-chat-2-13b-fp16_fact": [
      "RNA:DNA hybrids can form in both high GC and low GC regions.",
      "GC base pairs have a stronger interaction than other base pairs, which may influence the stability of RNA:DNA duplexes in high GC regions.",
      "RNA:DNA hybrid formation in low GC regions may be less likely due to weaker interactions between base pairs.",
      "The presence of structural elements like repetitive sequences can influence the formation of RNA:DNA hybrids.",
      "The formation of RNA:DNA hybrids is influenced by sequence composition and the overall structure of the DNA."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nRNA:DNA hybrids can indeed form in both high GC and low GC regions, although the stability of these hybrids can vary based on GC content due to the strength of GC pairing. Additionally, structural elements within the DNA, such as repetitive sequences, and the overall sequence composition and structure can affect the formation and stability of RNA:DNA hybrids.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1397,
    "user_query": "Which drugs are included in TAS-102?",
    "yulan-chat-2-13b-fp16_response": "TAS-102 is a combination drug therapy that includes two drugs: voretigene neparvovec (intravitreal injection) and ranibizumab-eqwg (intravitreal injection).\nVoretigene neparvovec is an adeno-associated viral vector-based gene therapy that is designed to treat inherited retinal diseases caused by mutations in the RPE65 gene. It works by delivering a functional copy of the RPE65 gene to the retinal cells, which can help restore vision in patients with certain genetic forms of blindness.\nRanibizumab-eqwg is an anti-vascular endothelial growth factor (VEGF) drug that is used to treat wet age-related macular degeneration (AMD) and other retinal diseases. It works by blocking the growth of abnormal blood vessels in the eye that can cause vision loss.\nTAS-102 is being studied as a potential treatment for inherited retinal diseases, including Leber congenital amaurosis and other forms of retinal dystrophy. The combination of voretigene neparvovec and ranibizumab-eqwg may provide a more effective treatment by addressing both the genetic and inflammatory components of these diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TAS-102 is a combination drug therapy that includes the drugs voretigene neparvovec and ranibizumab-eqwg.\n2. Voretigene neparvovec is designed to treat inherited retinal diseases caused by mutations in the RPE65 gene.\n3. Voretigene neparvovec delivers a functional copy of the RPE65 gene to the retinal cells.\n4. Ranibizumab-eqwg is used to treat wet age-related macular degeneration (AMD) and other retinal diseases.\n5. Ranibizumab-eqwg is an anti-vascular endothelial growth factor (VEGF) drug that blocks the growth of abnormal blood vessels in the eye.",
    "yulan-chat-2-13b-fp16_fact": [
      "TAS-102 is a combination drug therapy that includes the drugs voretigene neparvovec and ranibizumab-eqwg.",
      "Voretigene neparvovec is designed to treat inherited retinal diseases caused by mutations in the RPE65 gene.",
      "Voretigene neparvovec delivers a functional copy of the RPE65 gene to the retinal cells.",
      "Ranibizumab-eqwg is used to treat wet age-related macular degeneration (AMD) and other retinal diseases.",
      "Ranibizumab-eqwg is an anti-vascular endothelial growth factor (VEGF) drug that blocks the growth of abnormal blood vessels in the eye."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: TAS-102 is a combination drug therapy that includes the drugs trifluridine and tipiracil, not voretigene neparvovec and ranibizumab-eqwg.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "yulan-chat-2-13b-fp16_response": "Euclidism is not a recognized medical term or condition. It is possible that you may have meant \"euphoria,\" which is a feeling of intense happiness or well-being.\nThere are many potential causes of euphoria, including:\n1. Endorphins: Endorphins are natural chemicals produced by the body that act as painkillers and mood elevators. Exercise, sex, and other activities can trigger the release of endorphins, leading to feelings of euphoria.\n2. Dopamine: Dopamine is a neurotransmitter that plays a role in reward, motivation, and pleasure. Activities such as eating, sex, and drug use can trigger the release of dopamine, leading to feelings of euphoria.\n3. Serotonin: Serotonin is a neurotransmitter that regulates mood, appetite, and sleep. Serotonin levels can be affected by diet, exercise, and other factors, and imbalances in serotonin levels can contribute to feelings of euphoria.\n4. Mental health conditions: Certain mental health conditions, such as bipolar disorder and schizophrenia, can cause episodes of euphoria as part of their symptoms.\n5. Medications: Some medications, such as antidepressants and stimulants, can cause euphoria as a side effect.\nIt is important to note that feelings of euphoria can be temporary and may not always be a positive experience. If you are experiencing persistent or intense feelings of euphoria that are interfering with your daily life, it is important to speak with a healthcare professional for guidance and support.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1400,
    "user_query": "How does Hst5 (histatin 5) affect infections by Candida glabrata?",
    "yulan-chat-2-13b-fp16_response": "Histatin 5 is an antimicrobial peptide that is produced by epithelial cells in the skin and mucous membranes. It has been shown to have antifungal activity against Candida glabrata, which is a species of fungus that can cause infections in humans.\nStudies have shown that histatin 5 can inhibit the growth and adhesion of Candida glabrata cells, and it can also induce apoptosis (cell death) in these cells. It is thought to work by disrupting the cell membrane of the fungus, leading to the leakage of cellular components and ultimately causing cell death.\nHistatin 5 has been shown to be effective against a variety of strains of Candida glabrata, and it has been suggested that it may be useful in the treatment of candida infections. However, further research is needed to fully understand its mechanism of action and to determine its potential as a therapeutic agent.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histatin 5 is an antimicrobial peptide produced by epithelial cells in the skin and mucous membranes.\n2. Histatin 5 has antifungal activity against Candida glabrata.\n3. Histatin 5 can inhibit the growth and adhesion of Candida glabrata cells.\n4. Histatin 5 can induce apoptosis in Candida glabrata cells.\n5. Histatin 5 disrupts the cell membrane of Candida glabrata, leading to leakage of cellular components and cell death.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histatin 5 is an antimicrobial peptide produced by epithelial cells in the skin and mucous membranes.",
      "Histatin 5 has antifungal activity against Candida glabrata.",
      "Histatin 5 can inhibit the growth and adhesion of Candida glabrata cells.",
      "Histatin 5 can induce apoptosis in Candida glabrata cells.",
      "Histatin 5 disrupts the cell membrane of Candida glabrata, leading to leakage of cellular components and cell death."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Histatin 5 is an antimicrobial peptide produced by salivary glands, not epithelial cells in the skin and mucous membranes.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1402,
    "user_query": "Are there Conserved Noncoding Elements (CNEs) in plant genomes?",
    "yulan-chat-2-13b-fp16_response": "Yes, conserved noncoding elements (CNEs) have been identified in plant genomes. CNEs are DNA sequences that are conserved across different species, indicating that they have important functional roles in the regulation of gene expression.\nCNEs can be classified into different types based on their sequence and structure, such as promoter-like elements, enhancer-like elements, and transcription factor binding sites. These elements can play important roles in regulating gene expression, including the initiation, regulation, and termination of transcription.\nStudies have identified CNEs in various plant species, including Arabidopsis thaliana, rice, maize, and soybean, among others. These elements have been shown to be involved in the regulation of key developmental processes, such as seed germination, flowering time control, and stress response.\nOverall, CNEs are an important class of noncoding DNA elements in plant genomes that play critical roles in gene regulation and may have important implications for crop improvement and agriculture.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Conserved noncoding elements (CNEs) have been identified in plant genomes.\n2. CNEs are conserved DNA sequences across different species.\n3. CNEs have important functional roles in the regulation of gene expression.\n4. Studies have identified CNEs in various plant species, including Arabidopsis thaliana, rice, maize, and soybean.\n5. CNEs are involved in the regulation of key developmental processes in plants, such as seed germination, flowering time control, and stress response.",
    "yulan-chat-2-13b-fp16_fact": [
      "Conserved noncoding elements (CNEs) have been identified in plant genomes.",
      "CNEs are conserved DNA sequences across different species.",
      "CNEs have important functional roles in the regulation of gene expression.",
      "Studies have identified CNEs in various plant species, including Arabidopsis thaliana, rice, maize, and soybean.",
      "CNEs are involved in the regulation of key developmental processes in plants, such as seed germination, flowering time control, and stress response."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1403,
    "user_query": "Which is the localization of the RIFIN family of proteins?",
    "yulan-chat-2-13b-fp16_response": "The RIFIN family of proteins is localized to the endoplasmic reticulum (ER) and the Golgi apparatus in eukaryotic cells. RIFIN proteins are involved in regulating the transport of proteins and lipids between these organelles and controlling their levels in the cell. They also play a role in the formation of the trans-Golgi network (TGN), a specialized compartment of the Golgi apparatus that is involved in the sorting and modification of proteins and lipids.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The RIFIN family of proteins is localized to the endoplasmic reticulum (ER) in eukaryotic cells.\n2. The RIFIN family of proteins is also localized to the Golgi apparatus in eukaryotic cells.\n3. RIFIN proteins regulate the transport of proteins and lipids between the endoplasmic reticulum and the Golgi apparatus.\n4. RIFIN proteins are involved in controlling the levels of proteins and lipids in the cell.\n5. They play a role in the formation of the trans-Golgi network (TGN), which is involved in sorting and modifying proteins and lipids.",
    "yulan-chat-2-13b-fp16_fact": [
      "The RIFIN family of proteins is localized to the endoplasmic reticulum (ER) in eukaryotic cells.",
      "The RIFIN family of proteins is also localized to the Golgi apparatus in eukaryotic cells.",
      "RIFIN proteins regulate the transport of proteins and lipids between the endoplasmic reticulum and the Golgi apparatus.",
      "RIFIN proteins are involved in controlling the levels of proteins and lipids in the cell.",
      "They play a role in the formation of the trans-Golgi network (TGN), which is involved in sorting and modifying proteins and lipids."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The RIFIN family of proteins is not known to be localized to the endoplasmic reticulum in eukaryotic cells. These proteins are predominantly studied in Plasmodium falciparum, the malaria-causing parasite, and are localized on the surface of infected erythrocytes.\n2. UNKNOWN: Without explicit evidence, it's unclear if RIFIN proteins are localized to the Golgi apparatus in eukaryotic cells. The known research primarily involves their function and localization related to Plasmodium falciparum-infected erythrocytes, not general eukaryotic cell biology.\n3. FALSE [correction]: RIFIN proteins are not known to regulate the transport of proteins and lipids between the endoplasmic reticulum and the Golgi apparatus. Their known functions relate to immune evasion and antigenic variation in the context of malaria.\n4. UNKNOWN: There is no definitive information provided regarding RIFIN proteins controlling the levels of proteins and lipids in cells. Their established functions are mostly related to the malaria parasite's interaction with the host.\n5. FALSE [correction]: There is no evidence to suggest that RIFIN proteins play a role in the formation of the trans-Golgi network (TGN). The statement does not align with the well-documented roles of RIFIN proteins in regards to malaria.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1406,
    "user_query": "Is there any genetic determinant of hair pigmentation that could be useful in forensic analyses?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are genetic determinants of hair pigmentation that could be useful in forensic analyses. The most important genes involved in hair pigmentation are the MC1R and ASIP genes. Mutations in these genes can result in changes in hair color and pattern, and can be used to identify individuals or to determine ancestry. For example, a person with red hair is likely to have a mutation in the MC1R gene, which can be used to identify them or to determine their ancestry. Additionally, the presence of certain variants of these genes can also be used to determine the likelihood of a person having a particular ancestry, which can be useful in forensic investigations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The MC1R and ASIP genes are involved in hair pigmentation.\n2. Mutations in the MC1R and ASIP genes can result in changes in hair color and pattern.\n3. A person with red hair is likely to have a mutation in the MC1R gene.\n4. These genetic mutations can be used to identify individuals or to determine ancestry.\n5. The presence of certain gene variants can be used to determine the likelihood of a person having a particular ancestry in forensic investigations.",
    "yulan-chat-2-13b-fp16_fact": [
      "The MC1R and ASIP genes are involved in hair pigmentation.",
      "Mutations in the MC1R and ASIP genes can result in changes in hair color and pattern.",
      "A person with red hair is likely to have a mutation in the MC1R gene.",
      "These genetic mutations can be used to identify individuals or to determine ancestry.",
      "The presence of certain gene variants can be used to determine the likelihood of a person having a particular ancestry in forensic investigations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1408,
    "user_query": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) cause sudden cardiac death?",
    "yulan-chat-2-13b-fp16_response": "Yes, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can cause sudden cardiac death. CPVT is a rare genetic disorder that affects the heart's electrical activity, and it can lead to life-threatening arrhythmias, including ventricular tachycardia or ventricular fibrillation, which can cause sudden cardiac death. It is important for individuals with CPVT to be closely monitored by a healthcare provider and to receive appropriate treatment to reduce the risk of sudden cardiac death.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can lead to life-threatening arrhythmias.\n2. CPVT is a rare genetic disorder that affects the heart's electrical activity.\n3. One of the arrhythmias caused by CPVT can be ventricular tachycardia.\n4. CPVT can also cause ventricular fibrillation.\n5. Individuals with CPVT are at risk of sudden cardiac death.",
    "yulan-chat-2-13b-fp16_fact": [
      "Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can lead to life-threatening arrhythmias.",
      "CPVT is a rare genetic disorder that affects the heart's electrical activity.",
      "One of the arrhythmias caused by CPVT can be ventricular tachycardia.",
      "CPVT can also cause ventricular fibrillation.",
      "Individuals with CPVT are at risk of sudden cardiac death."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1411,
    "user_query": "Is the ACE inhibitor indicated for lung cancer treatment?",
    "yulan-chat-2-13b-fp16_response": "ACE inhibitors are a class of medications that are primarily used to treat hypertension (high blood pressure) and heart disease. They work by blocking the action of a protein called angiotensin-converting enzyme (ACE), which helps to regulate blood pressure and fluid balance in the body.\nThere is no evidence to suggest that ACE inhibitors are effective for the treatment of lung cancer. In fact, ACE inhibitors are not typically used as a primary treatment for lung cancer.\nHowever, ACE inhibitors may be used in some cases to manage certain symptoms associated with lung cancer, such as fluid buildup (edema) in the lungs. They may also be used to treat high blood pressure or heart disease in patients with lung cancer.\nIt is important to note that the use of ACE inhibitors for lung cancer treatment is off-label, meaning that they are not approved by regulatory agencies for this specific use. As with any medication, the decision to use an ACE inhibitor for lung cancer treatment should be made by a healthcare provider on a case-by-case basis, taking into account the individual patient's medical history and needs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ACE inhibitors are primarily used to treat hypertension and heart disease.\n2. ACE inhibitors work by blocking the action of angiotensin-converting enzyme.\n3. There is no evidence suggesting that ACE inhibitors are effective for the treatment of lung cancer.\n4. ACE inhibitors are not typically used as a primary treatment for lung cancer.\n5. The use of ACE inhibitors for lung cancer treatment is considered off-label.",
    "yulan-chat-2-13b-fp16_fact": [
      "ACE inhibitors are primarily used to treat hypertension and heart disease.",
      "ACE inhibitors work by blocking the action of angiotensin-converting enzyme.",
      "There is no evidence suggesting that ACE inhibitors are effective for the treatment of lung cancer.",
      "ACE inhibitors are not typically used as a primary treatment for lung cancer.",
      "The use of ACE inhibitors for lung cancer treatment is considered off-label."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN (While there is no prominent evidence that ACE inhibitors are primarily used to treat lung cancer, a statement claiming \"no evidence suggesting they are effective\" cannot be confirmed without comprehensive, up-to-date medical research data. Some researchers investigate various existing drugs for new applications, so without current information, it's not possible to assert the complete absence of evidence.)\n4. TRUE\n5. TRUE (Given that ACE inhibitors are not commonly a primary treatment for lung cancer, their use for this condition would generally be considered off-label, which means they are not approved by regulatory agencies for this specific treatment but may be prescribed at the discretion of a healthcare provider.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "yulan-chat-2-13b-fp16_response": "Hydrochlorothiazide is a diuretic medication that is primarily used to treat high blood pressure (hypertension). It works by increasing the amount of salt and water that the body removes through urine, which helps to reduce the amount of fluid in the body and lower blood pressure.\nHydrochlorothiazide may also be used for other conditions, such as:\n* Edema (excess fluid accumulation in the body) caused by heart disease, liver disease, or kidney disease\n* Symptoms of menopause, such as hot flashes\n* Certain types of kidney stones\n* Certain types of lung disease, such as pulmonary edema\nIt is important to note that hydrochlorothiazide should only be used under the guidance of a healthcare provider, as it may not be appropriate for everyone. It is also important to follow the dosage and usage instructions provided by your healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hydrochlorothiazide is used to treat high blood pressure (hypertension).\n2. Hydrochlorothiazide is a diuretic that increases the amount of salt and water removed through urine.\n3. It is used to treat edema caused by heart disease, liver disease, or kidney disease.\n4. Hydrochlorothiazide can be used to alleviate symptoms of menopause such as hot flashes.\n5. Some types of kidney stones can be treated with hydrochlorothiazide.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hydrochlorothiazide is used to treat high blood pressure (hypertension).",
      "Hydrochlorothiazide is a diuretic that increases the amount of salt and water removed through urine.",
      "It is used to treat edema caused by heart disease, liver disease, or kidney disease.",
      "Hydrochlorothiazide can be used to alleviate symptoms of menopause such as hot flashes.",
      "Some types of kidney stones can be treated with hydrochlorothiazide."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Hydrochlorothiazide is not used to treat symptoms of menopause such as hot flashes; it is used for its diuretic properties and antihypertensive effects.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1418,
    "user_query": "Which genes are thought to be involved in medulloblastoma development?",
    "yulan-chat-2-13b-fp16_response": "Medulloblastoma is a type of brain cancer that primarily affects children. The development of medulloblastoma is thought to involve multiple genes, both oncogenes and tumor suppressor genes. Some of the key genes that have been implicated in medulloblastoma development include:\n1. Sonic hedgehog (SHH) pathway genes: Medulloblastoma is one of the cancers that is strongly associated with the activation of the Sonic hedgehog (SHH) signaling pathway. Mutations in the SHH pathway genes, such as PTCH1, PTCH2, and SMO, have been found in a significant proportion of medulloblastoma cases.\n2. TP53 tumor suppressor gene: TP53 is a tumor suppressor gene that is frequently mutated in various types of cancers, including medulloblastoma. Mutations in the TP53 gene have been found in about 20% of medulloblastoma cases, and are thought to contribute to the development and progression of the disease.\n3. CDKN2A tumor suppressor gene: CDKN2A is a tumor suppressor gene that encodes two proteins, p16INK4a and ARF. Mutations in CDKN2A have been found in about 20% of medulloblastoma cases, and are thought to play a role in the development of the disease.\n4. MYC oncogene: MYC is an oncogene that is frequently amplified or overexpressed in various types of cancers, including medulloblastoma. MYC amplification has been found in about 20% of medulloblastoma cases, and is thought to contribute to the development and progression of the disease.\n5. Other genes: In addition to the above genes, other genes that have been implicated in medulloblastoma development include genes involved in cell differentiation and proliferation, such as GLI1, GLI2, and NPPA.\nIt is important to note that the genetic changes that occur in medulloblastoma can vary widely between individuals, and can involve different combinations of genes. Understanding the specific genetic changes that occur in each case of med",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Medulloblastoma is a type of brain cancer that primarily affects children.\n2. Mutations in Sonic hedgehog (SHH) pathway genes, such as PTCH1, PTCH2, and SMO, have been found in a significant proportion of medulloblastoma cases.\n3. Mutations in the TP53 tumor suppressor gene have been found in about 20% of medulloblastoma cases.\n4. Mutations in the CDKN2A tumor suppressor gene have been found in about 20% of medulloblastoma cases.\n5. MYC amplification is present in about 20% of medulloblastoma cases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Medulloblastoma is a type of brain cancer that primarily affects children.",
      "Mutations in Sonic hedgehog (SHH) pathway genes, such as PTCH1, PTCH2, and SMO, have been found in a significant proportion of medulloblastoma cases.",
      "Mutations in the TP53 tumor suppressor gene have been found in about 20% of medulloblastoma cases.",
      "Mutations in the CDKN2A tumor suppressor gene have been found in about 20% of medulloblastoma cases.",
      "MYC amplification is present in about 20% of medulloblastoma cases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN: The percentage of medulloblastoma cases involving TP53 mutations can vary based on subtypes and different scientific studies, so without specific context, it is difficult to confirm this figure.\n4. FALSE [correction]: Mutations in the CDKN2A tumor suppressor gene are found in some medulloblastoma cases, but without specific context or references, giving an exact percentage such as 20% is not accurate and could be misleading. The exact prevalence can vary and should be confirmed with up-to-date scientific data.\n5. UNKNOWN: Like TP53 mutations, the prevalence of MYC amplification in medulloblastoma cases can vary, with significant variation across different subgroups and studies. Without additional context, this statement's accuracy is unclear.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1425,
    "user_query": "Which diseases can be treated with Afamelanotide?",
    "yulan-chat-2-13b-fp16_response": "Afamelanotide is a synthetic analog of a natural peptide hormone called alpha-melanocyte-stimulating hormone (alpha-MSH). It is being investigated as a potential treatment for several conditions, including:\n1. Acne: Afamelanotide has been shown to reduce the number of acne lesions in clinical trials.\n2. Cutaneous melanoma: Afamelanotide has been shown to reduce the size and number of moles in patients with cutaneous melanoma, a type of skin cancer.\n3. Pulmonary arterial hypertension: Afamelanotide has been shown to improve exercise capacity and reduce symptoms in patients with pulmonary arterial hypertension, a condition in which the blood vessels in the lungs become narrowed or blocked.\n4. Erectile dysfunction: Afamelanotide has been shown to improve erectile function in some men with erectile dysfunction.\nIt's important to note that while these potential uses of afamelanotide are being studied, it is not yet approved for any of these indications and more research is needed to fully understand its safety and effectiveness.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Afamelanotide is being investigated as a potential treatment for acne.\n2. Afamelanotide is being investigated as a potential treatment for cutaneous melanoma.\n3. Afamelanotide is being investigated as a potential treatment for pulmonary arterial hypertension.\n4. Afamelanotide is being investigated as a potential treatment for erectile dysfunction.\n5. Afamelanotide is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH).",
    "yulan-chat-2-13b-fp16_fact": [
      "Afamelanotide is being investigated as a potential treatment for acne.",
      "Afamelanotide is being investigated as a potential treatment for cutaneous melanoma.",
      "Afamelanotide is being investigated as a potential treatment for pulmonary arterial hypertension.",
      "Afamelanotide is being investigated as a potential treatment for erectile dysfunction.",
      "Afamelanotide is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Afamelanotide has not been primarily investigated as a treatment for acne. It is developed for skin disorders influenced by light exposure.\n2. TRUE: Afamelanotide has been investigated for use as a potential adjuvant treatment in cutaneous melanoma.\n3. FALSE [correction]: Afamelanotide has not been directly investigated as a treatment for pulmonary arterial hypertension. Instead, it has been researched for its effects on skin disorders.\n4. UNKNOWN: While afamelanotide affects melanocortin receptors, which are linked to various functions including sexual arousal, there is insufficient information to conclusively determine its investigation as a treatment for erectile dysfunction without more context.\n5. TRUE: Afamelanotide is indeed a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH).",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1429,
    "user_query": "Which is the main calcium binding protein of the sarcoplasmic reticulum?",
    "yulan-chat-2-13b-fp16_response": "The main calcium binding protein of the sarcoplasmic reticulum is called sarco/endoplasmic reticulum calcium ATPase (SERCA). It is an ATP-dependent calcium pump that actively transports calcium ions from the cytosol into the sarcoplasmic reticulum.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The main calcium binding protein of the sarcoplasmic reticulum is sarco/endoplasmic reticulum calcium ATPase (SERCA).\n2. SERCA is an ATP-dependent calcium pump.\n3. SERCA actively transports calcium ions from the cytosol into the sarcoplasmic reticulum.",
    "yulan-chat-2-13b-fp16_fact": [
      "The main calcium binding protein of the sarcoplasmic reticulum is sarco/endoplasmic reticulum calcium ATPase (SERCA).",
      "SERCA is an ATP-dependent calcium pump.",
      "SERCA actively transports calcium ions from the cytosol into the sarcoplasmic reticulum."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin.\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1430,
    "user_query": "Is the UGT1A1*28 polymorphism associated with irinotecan response in Caucasians?",
    "yulan-chat-2-13b-fp16_response": "The UGT1A1*28 polymorphism has been studied in relation to irinotecan response in Caucasians, but the results have been inconsistent. Some studies have suggested that the UGT1A1*28 polymorphism is associated with decreased metabolism of irinotecan and decreased efficacy of irinotecan-based chemotherapy, while other studies have found no association.\nOne study published in the Journal of Clinical Oncology in 2008 found that Caucasian patients with the UGT1A1*28 polymorphism had a significantly lower overall response rate to irinotecan-based chemotherapy compared to patients without the polymorphism. However, another study published in the same journal in 2011 found no association between the UGT1A1*28 polymorphism and irinotecan response in Caucasian patients with colon cancer.\nOverall, the evidence for an association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians is mixed and further research is needed to clarify the relationship.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The UGT1A1*28 polymorphism has been studied for its potential association with irinotecan response in Caucasians.\n2. There is inconsistency in study results regarding the association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians.\n3. Some studies suggest the UGT1A1*28 polymorphism is associated with decreased metabolism and efficacy of irinotecan-based chemotherapy in Caucasians.\n4. A study published in the Journal of Clinical Oncology in 2008 found a lower overall response rate to irinotecan-based chemotherapy in Caucasian patients with the UGT1A1*28 polymorphism.\n5. Another study published in the Journal of Clinical Oncology in 2011 found no association between the UGT1A1*28 polymorphism and irinotecan response in Caucasian patients with colon cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "The UGT1A1*28 polymorphism has been studied for its potential association with irinotecan response in Caucasians.",
      "There is inconsistency in study results regarding the association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians.",
      "Some studies suggest the UGT1A1*28 polymorphism is associated with decreased metabolism and efficacy of irinotecan-based chemotherapy in Caucasians.",
      "A study published in the Journal of Clinical Oncology in 2008 found a lower overall response rate to irinotecan-based chemotherapy in Caucasian patients with the UGT1A1*28 polymorphism.",
      "Another study published in the Journal of Clinical Oncology in 2011 found no association between the UGT1A1*28 polymorphism and irinotecan response in Caucasian patients with colon cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: The UGT1A1*28 polymorphism has been widely studied for its potential impact on irinotecan metabolism; variations in this gene affect how patients respond to the drug irinotecan, which is used in treating various cancers.\n2. TRUE: There is indeed inconsistency in the research findings regarding the influence of the UGT1A1*28 polymorphism on irinotecan response, with different studies yielding varying results.\n3. TRUE: Some studies have shown that the UGT1A1*28 polymorphism can be associated with a reduced metabolism of irinotecan, leading to higher drug levels and potentially increased toxicity, which may affect the drug's efficacy and patient outcomes.\n4. UNKNOWN: Without specific details on the study, such as the title or authors, the veracity of the statement can't be verified here. Therefore, the true or false status of this statement remains unknown.\n5. UNKNOWN: Similar to statement 4, without specific details on the study, its veracity cannot be verified, and the true or false status of this statement remains unknown.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1433,
    "user_query": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.",
    "yulan-chat-2-13b-fp16_response": "There are several anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for the treatment of Alzheimer's disease. Some of these include:\n1. Aducanumab (Biogen)\n2. Aducanumab-avwa (Biogen)\n3. Gantenerumab (Roche/Genentech)\n4. Crenezumab (Genentech)\n5. Solanezumab (Eli Lilly)\n6. Bapineuzumab (Elan/Wyeth)\n7. LY3076464 (Lilly)\n8. ALZ-801 (Alector)\n9. JNJ-752605 (Janssen)\n10. BAN2401 (Banner Health)\nIt's worth noting that some of these drugs are still in clinical trials and have not yet been approved by regulatory authorities.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aducanumab is an anti-amyloid-beta monoclonal antibody investigated in clinical trials for the treatment of Alzheimer's disease.\n2. Gantenerumab is an anti-amyloid-beta monoclonal antibody by Roche/Genentech investigated for the treatment of Alzheimer's disease.\n3. Crenezumab is an anti-amyloid-beta monoclonal antibody by Genentech investigated for the treatment of Alzheimer's disease.\n4. Solanezumab is an anti-amyloid-beta monoclonal antibody by Eli Lilly investigated for the treatment of Alzheimer's disease.\n5. Bapineuzumab is an anti-amyloid-beta monoclonal antibody by Elan/Wyeth investigated for the treatment of Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Aducanumab is an anti-amyloid-beta monoclonal antibody investigated in clinical trials for the treatment of Alzheimer's disease.",
      "Gantenerumab is an anti-amyloid-beta monoclonal antibody by Roche/Genentech investigated for the treatment of Alzheimer's disease.",
      "Crenezumab is an anti-amyloid-beta monoclonal antibody by Genentech investigated for the treatment of Alzheimer's disease.",
      "Solanezumab is an anti-amyloid-beta monoclonal antibody by Eli Lilly investigated for the treatment of Alzheimer's disease.",
      "Bapineuzumab is an anti-amyloid-beta monoclonal antibody by Elan/Wyeth investigated for the treatment of Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1434,
    "user_query": "Does MVIIA and MVIIC bind to the same calcium channel?",
    "yulan-chat-2-13b-fp16_response": "MVIIA and MVIIC are two different types of calcium channels that have different properties and functions. MVIIA (alpha-1H) and MVIIC (alpha-1I) are both members of the voltage-gated calcium channel (VGCC) family, which are ion channels that allow the flow of calcium ions (Ca2+) into cells in response to changes in membrane potential.\nHowever, they bind to different sites on the calcium channel. MVIIA binds to the N-terminal region of the calcium channel, while MVIIC binds to the C-terminal region. This means that they can activate different regions of the calcium channel and have different effects on its function.\nIn summary, MVIIA and MVIIC do not bind to the same calcium channel, but rather to different regions of the calcium channel.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MVIIA and MVIIC are both members of the voltage-gated calcium channel (VGCC) family.\n2. Voltage-gated calcium channels allow the flow of calcium ions into cells in response to changes in membrane potential.\n3. MVIIA binds to the N-terminal region of the calcium channel.\n4. MVIIC binds to the C-terminal region of the calcium channel.\n5. MVIIA and MVIIC do not bind to the same site on the calcium channel.",
    "yulan-chat-2-13b-fp16_fact": [
      "MVIIA and MVIIC are both members of the voltage-gated calcium channel (VGCC) family.",
      "Voltage-gated calcium channels allow the flow of calcium ions into cells in response to changes in membrane potential.",
      "MVIIA binds to the N-terminal region of the calcium channel.",
      "MVIIC binds to the C-terminal region of the calcium channel.",
      "MVIIA and MVIIC do not bind to the same site on the calcium channel."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1437,
    "user_query": "What is SHAPE-Seq?",
    "yulan-chat-2-13b-fp16_response": "SHAPE-Seq is a method for measuring the binding of RNA molecules to RNA-binding proteins (RBPs). It is an alternative to other methods such as RNA immunoprecipitation (RIP) and cross-linking immunoprecipitation (CLIP).",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1446,
    "user_query": "Describe Heyde syndrome.",
    "yulan-chat-2-13b-fp16_response": "Heyde syndrome, also known as primary hyperparathyroidism, is a medical condition in which one or more of the four parathyroid glands become overactive and produce too much parathyroid hormone (PTH). The parathyroid glands are small glands located in the neck that regulate the levels of calcium and phosphorus in the body.\nThe excess PTH causes the body to absorb too much calcium from the bones, which can lead to weakened bones and increased risk of fractures. It can also cause kidney stones, kidney damage, and abdominal pain. In addition, high levels of calcium in the blood can cause symptoms such as muscle weakness, fatigue, confusion, and heart arrhythmias.\nHeyde syndrome is usually diagnosed through blood tests that measure calcium and PTH levels. Imaging tests such as ultrasound or CT scan may also be used to locate any abnormal growths or tumors in the parathyroid glands.\nTreatment for Heyde syndrome typically involves surgery to remove the overactive parathyroid gland or glands. This can help to lower PTH levels and restore normal calcium levels in the blood. In some cases, medications may be used to control symptoms and lower PTH levels before surgery.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Heyde syndrome, also known as primary hyperparathyroidism, involves overactivity of one or more parathyroid glands.\n2. The parathyroid glands are located in the neck and regulate the levels of calcium and phosphorus in the body.\n3. Excess PTH from Heyde syndrome can lead to weakened bones, an increased risk of fractures, kidney stones, kidney damage, and abdominal pain.\n4. High levels of calcium in the blood due to Heyde syndrome can cause symptoms like muscle weakness, fatigue, confusion, and heart arrhythmias.\n5. Surgery to remove overactive parathyroid gland(s) is a typical treatment for Heyde syndrome to lower PTH levels and normalize calcium levels in the blood.",
    "yulan-chat-2-13b-fp16_fact": [
      "Heyde syndrome, also known as primary hyperparathyroidism, involves overactivity of one or more parathyroid glands.",
      "The parathyroid glands are located in the neck and regulate the levels of calcium and phosphorus in the body.",
      "Excess PTH from Heyde syndrome can lead to weakened bones, an increased risk of fractures, kidney stones, kidney damage, and abdominal pain.",
      "High levels of calcium in the blood due to Heyde syndrome can cause symptoms like muscle weakness, fatigue, confusion, and heart arrhythmias.",
      "Surgery to remove overactive parathyroid gland(s) is a typical treatment for Heyde syndrome to lower PTH levels and normalize calcium levels in the blood."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Heyde syndrome is characterized by the triad of aortic stenosis, acquired von Willebrand syndrome, and gastrointestinal bleeding from angiodysplasia, not primary hyperparathyroidism.\n2. TRUE\n3. FALSE [correction]: Excess PTH is a characteristic of primary hyperparathyroidism, not Heyde syndrome. However, primary hyperparathyroidism can lead to similar symptoms.\n4. FALSE [correction]: These are symptoms of hypercalcemia often associated with primary hyperparathyroidism, not specifically Heyde syndrome.\n5. FALSE [correction]: Surgery to remove the aortic valve is a treatment for alleviating the aortic stenosis component of Heyde syndrome. Surgery on parathyroid glands would be the treatment for primary hyperparathyroidism, not Heyde syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "yulan-chat-2-13b-fp16_response": "Yes, silicone has been used in the treatment of incontinence. Silicone incontinence devices, such as silicone rubber sheets and silicone urethral bulking agents, are commonly used to manage stress urinary incontinence (SUI) in women.\nSilicone rubber sheets are inserted into the vagina and placed against the urethra to provide support and prevent urine leakage during physical activity. These devices are designed to be comfortable and unobtrusive, and can be worn during exercise, sports, or other activities that may increase the risk of urine leakage.\nSilicone urethral bulking agents are injected into the urethra to increase the muscle tone of the bladder neck and urethral sphincter, which can help to reduce urine leakage. These agents are typically made of a silicone gel or a silicone-based polymer.\nWhile silicone incontinence devices have been shown to be effective in managing SUI, they are not suitable for everyone and may have some side effects, such as discomfort, pain, or infection. It is important to discuss the risks and benefits of these treatments with a healthcare provider before deciding whether they are right for you.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Silicone has been used in the treatment of incontinence.\n2. Silicone incontinence devices are commonly used to manage stress urinary incontinence (SUI) in women.\n3. Silicone rubber sheets are inserted into the vagina to support the urethra and prevent urine leakage during physical activity.\n4. Silicone urethral bulking agents are injected into the urethra to increase the muscle tone of the bladder neck and urethral sphincter.\n5. The side effects of silicone incontinence devices may include discomfort, pain, or infection.",
    "yulan-chat-2-13b-fp16_fact": [
      "Silicone has been used in the treatment of incontinence.",
      "Silicone incontinence devices are commonly used to manage stress urinary incontinence (SUI) in women.",
      "Silicone rubber sheets are inserted into the vagina to support the urethra and prevent urine leakage during physical activity.",
      "Silicone urethral bulking agents are injected into the urethra to increase the muscle tone of the bladder neck and urethral sphincter.",
      "The side effects of silicone incontinence devices may include discomfort, pain, or infection."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: It's not silicone rubber sheets that are inserted; pelvic floor muscle trainers or pessaries made of silicone can be inserted into the vagina to provide support.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1448,
    "user_query": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?",
    "yulan-chat-2-13b-fp16_response": "The error prevention GO (8-oxo-G) system in Pseudomonas putida is composed of several proteins, including:\n1. Goa1: a DNA glycosylase that recognizes and removes 8-oxo-G lesions from DNA.\n2. Goa2: a DNA lyase that removes 8-oxo-G lesions from DNA.\n3. Goa3: a protein that binds to 8-oxo-G lesions and facilitates their recognition by Goa1.\n4. Goa4: a protein that interacts with Goa1 and Goa3 to facilitate the repair of 8-oxo-G lesions.\n5. Goa5: a protein that binds to 8-oxo-G lesions and may play a role in preventing their propagation.\nTogether, these proteins work to prevent the accumulation of 8-oxo-G lesions in DNA and to repair them when they occur, thereby helping to maintain the accuracy and stability of the genetic material.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Goa1 is a DNA glycosylase involved in the error prevention GO system of Pseudomonas putida.\n2. Goa2 is identified as a DNA lyase that participates in the error prevention GO system of Pseudomonas putida.\n3. Goa3 is a protein that aids in the recognition of 8-oxo-G lesions in the error prevention GO system of Pseudomonas putida.\n4. Goa4 is a protein that assists in the repair of 8-oxo-G lesions within the error prevention GO system of Pseudomonas putida.\n5. Goa5 is a protein proposed to have a role in preventing the propagation of 8-oxo-G lesions in the error prevention GO system of Pseudomonas putida.",
    "yulan-chat-2-13b-fp16_fact": [
      "Goa1 is a DNA glycosylase involved in the error prevention GO system of Pseudomonas putida.",
      "Goa2 is identified as a DNA lyase that participates in the error prevention GO system of Pseudomonas putida.",
      "Goa3 is a protein that aids in the recognition of 8-oxo-G lesions in the error prevention GO system of Pseudomonas putida.",
      "Goa4 is a protein that assists in the repair of 8-oxo-G lesions within the error prevention GO system of Pseudomonas putida.",
      "Goa5 is a protein proposed to have a role in preventing the propagation of 8-oxo-G lesions in the error prevention GO system of Pseudomonas putida."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided are highly technical and specific to the molecular biology of Pseudomonas putida. Specific knowledge about the proteins named as Goa1, Goa2, Goa3, Goa4, and Goa5, and their roles in the GO system would be required to verify these statements. Without access to specific scientific literature or details regarding these proteins and their functions, it is not possible to determine the truthfulness of these statements. Therefore, all responses are marked as UNKNOWN.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1449,
    "user_query": "List five applications of machine learning algorithms in medical diagnosis.",
    "yulan-chat-2-13b-fp16_response": "1. Medical Imaging: Machine learning algorithms are used to analyze medical images such as X-rays, CT scans, and MRIs to detect abnormalities and assist in diagnosis.\n2. Disease Diagnosis: Machine learning algorithms can be trained to identify patterns in patient data to diagnose diseases such as cancer, diabetes, and heart disease.\n3. Drug Development: Machine learning algorithms can be used to analyze large datasets to identify potential drug candidates and predict their efficacy.\n4. Predictive Analytics: Machine learning algorithms can be used to analyze patient data to predict the likelihood of certain health outcomes, such as the risk of developing a particular disease or the likelihood of a patient being readmitted to the hospital.\n5. Personalized Medicine: Machine learning algorithms can be used to analyze patient data to develop personalized treatment plans based on individual patient characteristics and medical history.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Machine learning algorithms are used to analyze medical images like X-rays, CT scans, and MRIs.\n2. Machine learning algorithms help diagnose diseases such as cancer, diabetes, and heart disease by identifying patterns in patient data.\n3. In drug development, machine learning algorithms analyze large datasets to identify potential drug candidates and predict their efficacy.\n4. Machine learning algorithms are used in predictive analytics to forecast the likelihood of certain health outcomes, like disease risk or hospital readmission.\n5. Machine learning algorithms assist in creating personalized treatment plans using patient-specific data and medical histories.",
    "yulan-chat-2-13b-fp16_fact": [
      "Machine learning algorithms are used to analyze medical images like X-rays, CT scans, and MRIs.",
      "Machine learning algorithms help diagnose diseases such as cancer, diabetes, and heart disease by identifying patterns in patient data.",
      "In drug development, machine learning algorithms analyze large datasets to identify potential drug candidates and predict their efficacy.",
      "Machine learning algorithms are used in predictive analytics to forecast the likelihood of certain health outcomes, like disease risk or hospital readmission.",
      "Machine learning algorithms assist in creating personalized treatment plans using patient-specific data and medical histories."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1450,
    "user_query": "Does the 3D structure of  the genome remain stable during cell differentiation?",
    "yulan-chat-2-13b-fp16_response": "The 3D structure of the genome, also known as the chromatin structure, does not remain completely stable during cell differentiation. While there is a general organization of the genome that is maintained, there are also changes in the way that genes are packaged and regulated during differentiation.\nFor example, during cell differentiation, some genes that were previously inactive may become active, while others that were previously active may become inactive. This can lead to changes in the way that the genome is packaged and regulated, as well as changes in the way that genes are expressed.\nAdditionally, during cell differentiation, there may be changes in the way that chromatin structures are formed and maintained. For example, certain proteins that are involved in the formation and maintenance of chromatin structures may be expressed at different levels in different cell types, leading to changes in the way that the genome is organized.\nOverall, while there is a general organization of the genome that is maintained during cell differentiation, there are also changes in the way that genes are packaged and regulated, as well as changes in the way that chromatin structures are formed and maintained.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The 3D structure of the genome, also known as the chromatin structure, does not stay completely stable during cell differentiation.\n2. Genes that were previously inactive may become active during cell differentiation.\n3. Genes that were previously active may become inactive during the process of cell differentiation.\n4. Changes can occur in the way that chromatin structures are formed and maintained during cell differentiation.\n5. Proteins involved in the formation and maintenance of chromatin structures may be expressed at different levels in different cell types.",
    "yulan-chat-2-13b-fp16_fact": [
      "The 3D structure of the genome, also known as the chromatin structure, does not stay completely stable during cell differentiation.",
      "Genes that were previously inactive may become active during cell differentiation.",
      "Genes that were previously active may become inactive during the process of cell differentiation.",
      "Changes can occur in the way that chromatin structures are formed and maintained during cell differentiation.",
      "Proteins involved in the formation and maintenance of chromatin structures may be expressed at different levels in different cell types."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided all relate to the fundamental principles of cellular biology and epigenetics concerning cell differentiation and gene expression. All statements are consistent with the current understanding of these processes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1453,
    "user_query": "What is 2d 4d ratio in athletes.",
    "yulan-chat-2-13b-fp16_response": "The 2D:4D ratio, also known as the \"2D:4D ratio of the radius and ulna,\" is a measure of the relative lengths of the second and fourth metacarpal bones in the hand. This ratio has been proposed as a potential indicator of athletic performance, with some studies suggesting that athletes may have a lower 2D:4D ratio than non-athletes. However, the evidence for this is mixed and the validity of the 2D:4D ratio as a measure of athletic performance is still a matter of debate.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The 2D:4D ratio is a measure of the relative lengths of the second and fourth digits (fingers).\n2. It has been proposed as a potential indicator of athletic performance.\n3. Some studies suggest that athletes may have a lower 2D:4D ratio than non-athletes.\n4. The validity of the 2D:4D ratio as a measure of athletic performance is controversial and debated.",
    "yulan-chat-2-13b-fp16_fact": [
      "The 2D:4D ratio is a measure of the relative lengths of the second and fourth digits (fingers).",
      "It has been proposed as a potential indicator of athletic performance.",
      "Some studies suggest that athletes may have a lower 2D:4D ratio than non-athletes.",
      "The validity of the 2D:4D ratio as a measure of athletic performance is controversial and debated."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "yulan-chat-2-13b-fp16_response": "There is no established association between the moon cycle and the rupture risk of intracranial aneurysms. Intracranial aneurysms are weak spots in the walls of blood vessels that supply the brain, and they can rupture and cause life-threatening bleeding in the brain. The rupture risk of intracranial aneurysms is influenced by various factors, such as age, gender, blood pressure, smoking, and family history, but there is no evidence to suggest that the moon cycle has any effect on aneurysm rupture. While some studies have investigated the relationship between the moon cycle and aneurysm rupture, the results have been inconclusive and no consistent pattern has been observed. Therefore, it is important to focus on established risk factors and seek medical advice if you have any concerns about intracranial aneurysms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There is no established association between the moon cycle and the rupture risk of intracranial aneurysms.\n2. Intracranial aneurysms are weak spots in the walls of blood vessels that supply the brain.\n3. Intracranial aneurysm rupture can cause life-threatening bleeding in the brain.\n4. Factors such as age, gender, blood pressure, smoking, and family history influence the rupture risk of intracranial aneurysms.\n5. Studies investigating the relationship between the moon cycle and aneurysm rupture have been inconclusive with no consistent pattern observed.",
    "yulan-chat-2-13b-fp16_fact": [
      "There is no established association between the moon cycle and the rupture risk of intracranial aneurysms.",
      "Intracranial aneurysms are weak spots in the walls of blood vessels that supply the brain.",
      "Intracranial aneurysm rupture can cause life-threatening bleeding in the brain.",
      "Factors such as age, gender, blood pressure, smoking, and family history influence the rupture risk of intracranial aneurysms.",
      "Studies investigating the relationship between the moon cycle and aneurysm rupture have been inconclusive with no consistent pattern observed."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1461,
    "user_query": "List functional roles of the FtsZ protein.",
    "yulan-chat-2-13b-fp16_response": "The FtsZ protein is a bacterial homolog of the eukaryotic tubulin protein and plays a crucial role in the formation of the bacterial cytoskeleton. The functional roles of FtsZ include:\n1. Bacterial cytokinesis: FtsZ forms a ring structure that divides the bacterial cell during cytokinesis.\n2. Cell elongation: FtsZ forms a dynamic network that provides structural support and allows for cell elongation.\n3. Cell shape maintenance: FtsZ helps to maintain the shape of the bacterial cell by resisting the external forces.\n4. DNA segregation: FtsZ plays a role in the segregation of DNA during cell division.\n5. Stress response: FtsZ can help bacteria to survive under stress conditions, such as high salt concentrations or exposure to antibiotics.\n6. Cell motility: FtsZ can also be involved in cell motility by providing a track for the movement of proteins involved in flagellar assembly.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FtsZ forms a ring structure that is involved in bacterial cytokinesis.\n2. The protein helps in bacterial cell elongation by forming a dynamic network.\n3. FtsZ contributes to the maintenance of bacterial cell shape.\n4. It plays a role in the segregation of DNA during bacterial cell division.\n5. FtsZ can assist bacterial survival under stressful conditions.",
    "yulan-chat-2-13b-fp16_fact": [
      "FtsZ forms a ring structure that is involved in bacterial cytokinesis.",
      "The protein helps in bacterial cell elongation by forming a dynamic network.",
      "FtsZ contributes to the maintenance of bacterial cell shape.",
      "It plays a role in the segregation of DNA during bacterial cell division.",
      "FtsZ can assist bacterial survival under stressful conditions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The protein FtsZ doesn't help in bacterial cell elongation by forming a dynamic network. It helps in cell division by forming a contractile ring structure known as the Z ring, which pinches the cell in two during cytokinesis. MreB protein is typically responsible for cell elongation.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1463,
    "user_query": "Is there any evidence of dysregulated long non coding RNAs and Alzheimer's disease?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is evidence to suggest that dysregulated long non-coding RNAs (lncRNAs) may play a role in the development and progression of Alzheimer's disease (AD).\nStudies have shown that the expression levels of certain lncRNAs are altered in the brains of individuals with AD compared to healthy individuals. For example, some studies have found decreased expression of the lncRNA H19 in the brains of AD patients, while others have found increased expression of the lncRNA MALAT1.\nAdditionally, some lncRNAs have been implicated in the pathological processes associated with AD, such as amyloid-beta (A) plaque formation and tau protein aggregation. For example, the lncRNA Nrf1 has been shown to regulate the expression of genes involved in A production and clearance, and dysregulation of Nrf1 has been linked to increased A levels and AD pathology.\nOverall, while the role of lncRNAs in AD is still being investigated, there is growing evidence to suggest that dysregulated lncRNAs may contribute to the development and progression of this disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dysregulated long non-coding RNAs (lncRNAs) may be involved in the development and progression of Alzheimer's disease (AD).\n2. Expression levels of certain lncRNAs are different in the brains of individuals with AD compared to healthy individuals.\n3. There is a reported decreased expression of the lncRNA H19 in the brains of AD patients.\n4. Increased expression of the lncRNA MALAT1 has been found in the brains of AD patients.\n5. The lncRNA Nrf1 has been shown to regulate genes involved in amyloid-beta production and clearance, and its dysregulation has been linked to increased amyloid-beta levels and AD pathology.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dysregulated long non-coding RNAs (lncRNAs) may be involved in the development and progression of Alzheimer's disease (AD).",
      "Expression levels of certain lncRNAs are different in the brains of individuals with AD compared to healthy individuals.",
      "There is a reported decreased expression of the lncRNA H19 in the brains of AD patients.",
      "Increased expression of the lncRNA MALAT1 has been found in the brains of AD patients.",
      "The lncRNA Nrf1 has been shown to regulate genes involved in amyloid-beta production and clearance, and its dysregulation has been linked to increased amyloid-beta levels and AD pathology."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: The transcription factor Nrf1 (NFE2L1), not an lncRNA, is known to regulate genes involved in amyloid-beta production and clearance, and its dysregulation has been linked to increased amyloid-beta levels and AD pathology. There might be confusion with the NEAT1 lncRNA, which is involved in AD pathology.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1469,
    "user_query": "What is known about type D personality trait in cancer patients?",
    "yulan-chat-2-13b-fp16_response": "Type D personality is a relatively new concept in the field of psychology, which refers to a combination of negative emotionality (D1) and disinhibition (D2). It is characterized by the tendency to experience negative emotions such as anxiety and sadness, and to exhibit impulsive and self-centered behavior.\nThere is some evidence to suggest that individuals with type D personality traits may be at increased risk for a variety of negative health outcomes, including cardiovascular disease, depression, and cancer. Some studies have found that individuals with high levels of type D personality traits may be more likely to develop cancer, and that their cancer may be more advanced when it is diagnosed.\nIt is important to note that type D personality is just one of many factors that can influence a person's risk of developing cancer, and that it is not a definitive indicator of whether or not someone will develop cancer. Other factors, such as genetics, lifestyle, and environmental exposures, also play a role in cancer risk.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Type D personality refers to a combination of negative emotionality and disinhibition.\n2. Individuals with type D personality traits may experience negative emotions such as anxiety and sadness.\n3. Individuals with type D personality traits may exhibit impulsive and self-centered behavior.\n4. Individuals with type D personality traits may be at increased risk for cardiovascular disease, depression, and cancer.\n5. Studies suggest that individuals with high levels of type D personality traits could be more likely to develop cancer, and their cancer may be more advanced at diagnosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Type D personality refers to a combination of negative emotionality and disinhibition.",
      "Individuals with type D personality traits may experience negative emotions such as anxiety and sadness.",
      "Individuals with type D personality traits may exhibit impulsive and self-centered behavior.",
      "Individuals with type D personality traits may be at increased risk for cardiovascular disease, depression, and cancer.",
      "Studies suggest that individuals with high levels of type D personality traits could be more likely to develop cancer, and their cancer may be more advanced at diagnosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Type D personality refers to a combination of negative affectivity and social inhibition, not disinhibition.\n2. TRUE\n3. FALSE [correction]: Type D personality is characterized by high levels of social inhibition, not impulsivity or self-centered behavior.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1471,
    "user_query": "Which species may be used for the biotechnological production of itaconic acid?",
    "yulan-chat-2-13b-fp16_response": "Itaconic acid is a polyester monomer that can be produced through biotechnological processes using various microorganisms. Some of the microorganisms that have been used for the production of itaconic acid include:\n1. Myxococcus plumatopsis: This bacterium is one of the most commonly used microorganisms for the production of itaconic acid. It can produce high yields of itaconic acid under fermentation conditions.\n2. Pseudomonas oleracea: This bacterium is another microorganism that has been used for the production of itaconic acid. It can produce itaconic acid at high yields and has been shown to be a promising candidate for industrial-scale production.\n3. Rhodothermus heterothermus: This bacterium is a thermophilic species that can produce itaconic acid at high temperatures. It has been used for the production of itaconic acid at temperatures above 60C and has been shown to be a promising candidate for the production of itaconic acid under high-temperature conditions.\n4. Acinetobacter calcoaceticus: This bacterium is another thermophilic species that has been used for the production of itaconic acid. It can produce itaconic acid at high yields and has been shown to be a promising candidate for the production of itaconic acid under high-temperature conditions.\nOverall, the choice of microorganism for the biotechnological production of itaconic acid depends on various factors such as the production scale, cost-effectiveness, and the desired yield of itaconic acid.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Itaconic acid can be produced through biotechnological processes using various microorganisms.\n2. Myxococcus plumatopsis is a commonly used bacterium for the production of itaconic acid and can produce high yields under fermentation conditions.\n3. Pseudomonas oleracea is a bacterium that has been used for the production of itaconic acid, and is considered a promising candidate for industrial-scale production.\n4. Rhodothermus heterothermus is a thermophilic bacterium that can produce itaconic acid at temperatures above 60C.\n5. Acinetobacter calcoaceticus is a thermophilic bacterium that has been used to produce itaconic acid at high yields.",
    "yulan-chat-2-13b-fp16_fact": [
      "Itaconic acid can be produced through biotechnological processes using various microorganisms.",
      "Myxococcus plumatopsis is a commonly used bacterium for the production of itaconic acid and can produce high yields under fermentation conditions.",
      "Pseudomonas oleracea is a bacterium that has been used for the production of itaconic acid, and is considered a promising candidate for industrial-scale production.",
      "Rhodothermus heterothermus is a thermophilic bacterium that can produce itaconic acid at temperatures above 60C.",
      "Acinetobacter calcoaceticus is a thermophilic bacterium that has been used to produce itaconic acid at high yields."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Myxococcus xanthus is the bacterium known for the production of itaconic acid, not Myxococcus plumatopsis.\n3. FALSE [correction]: Pseudomonas oleovorans is a bacterium that has been used for the production of itaconic acid, not Pseudomonas oleracea.\n4. UNKNOWN\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1474,
    "user_query": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?",
    "yulan-chat-2-13b-fp16_response": "The proteins that constitute the methyl-directed mismatch repair system (MMR) in bacteria are:\n1. Methyltransferase: This enzyme adds a methyl group to the target DNA sequence.\n2. Mismatch repair endonuclease: This enzyme recognizes and cleaves the DNA strand at the site of the mismatch.\n3. Mismatch repair exonuclease: This enzyme removes the incorrect nucleotide from the DNA strand.\n4. DNA polymerase: This enzyme replaces the incorrect nucleotide with the correct one during replication.\nTogether, these proteins work to identify and repair mismatches that occur during DNA replication, thereby preventing the accumulation of mutations that could lead to genetic disorders or cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Methyltransferase is an enzyme that adds a methyl group to DNA.\n2. Mismatch repair endonuclease recognizes and cleaves the DNA strand where there is a mismatch.\n3. Mismatch repair exonuclease removes the incorrect nucleotide from the DNA strand.\n4. DNA polymerase replaces the incorrect nucleotide with the correct one during replication.\n5. The proteins involved in the methyl-directed mismatch repair system function to repair mismatches during DNA replication.",
    "yulan-chat-2-13b-fp16_fact": [
      "Methyltransferase is an enzyme that adds a methyl group to DNA.",
      "Mismatch repair endonuclease recognizes and cleaves the DNA strand where there is a mismatch.",
      "Mismatch repair exonuclease removes the incorrect nucleotide from the DNA strand.",
      "DNA polymerase replaces the incorrect nucleotide with the correct one during replication.",
      "The proteins involved in the methyl-directed mismatch repair system function to repair mismatches during DNA replication."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1476,
    "user_query": "Which is the vector of Louping ill virus?",
    "yulan-chat-2-13b-fp16_response": "The vector of Louping ill virus is the biting midge or no-see-um.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "yulan-chat-2-13b-fp16_response": "Yes, HuR protein is known to play a role in regulating the splicing process. HuR (Human Antigen R) is a protein that binds to and stabilizes the spliced mRNA molecules, thereby promoting their translation. It also interacts with various splicing factors and regulates alternative splicing by modulating the binding of splicing factors to the pre-mRNA.\nHuR protein is involved in the regulation of alternative splicing, which is the process by which a single gene can produce multiple mRNA transcripts with different protein-coding potentials. Alternative splicing is a crucial mechanism for generating diversity in the proteome and is implicated in various diseases, including cancer.\nOverall, HuR protein is an important regulator of the splicing process and plays a critical role in the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. HuR protein (Human Antigen R) plays a role in regulating the splicing process.\n2. HuR protein binds to and stabilizes spliced mRNA molecules, promoting their translation.\n3. HuR protein interacts with various splicing factors.\n4. HuR protein regulates alternative splicing by modulating the binding of splicing factors to pre-mRNA.\n5. Alternative splicing is a mechanism that allows a single gene to produce multiple mRNA transcripts with different protein-coding potentials.",
    "yulan-chat-2-13b-fp16_fact": [
      "HuR protein (Human Antigen R) plays a role in regulating the splicing process.",
      "HuR protein binds to and stabilizes spliced mRNA molecules, promoting their translation.",
      "HuR protein interacts with various splicing factors.",
      "HuR protein regulates alternative splicing by modulating the binding of splicing factors to pre-mRNA.",
      "Alternative splicing is a mechanism that allows a single gene to produce multiple mRNA transcripts with different protein-coding potentials."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: HuR protein (Human Antigen R) is primarily known for its role in regulating mRNA stability and translation, not the splicing process.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1478,
    "user_query": "Is Titin the largest single protein molecule found in Nature?",
    "yulan-chat-2-13b-fp16_response": "Yes, Titin is the largest single protein molecule found in nature. It is a protein that is found in muscle cells and is responsible for the elasticity and contraction of muscles. It is made up of approximately 30,000 amino acids and has a molecular weight of around 3 million Daltons.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Titin is the largest single protein molecule found in nature.\n2. Titin is found in muscle cells.\n3. Titin is responsible for the elasticity and contraction of muscles.\n4. Titin is made up of approximately 30,000 amino acids.\n5. Titin has a molecular weight of around 3 million Daltons.",
    "yulan-chat-2-13b-fp16_fact": [
      "Titin is the largest single protein molecule found in nature.",
      "Titin is found in muscle cells.",
      "Titin is responsible for the elasticity and contraction of muscles.",
      "Titin is made up of approximately 30,000 amino acids.",
      "Titin has a molecular weight of around 3 million Daltons."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Titin is made up of approximately 34,350 amino acids.\n5. FALSE [correction]: Titin has a molecular weight of almost 3,000 kDa (kiloDaltons), which is about 3 billion Daltons.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1481,
    "user_query": "What is the the Menzerath-Altmann law?",
    "yulan-chat-2-13b-fp16_response": "The Menzerath-Altmann law, also known as the Menzerath-Altmann phenomenon, is a phenomenon in the field of information theory that describes the relationship between the capacity of a communication channel and the number of messages that can be transmitted over that channel. The law states that the maximum capacity of a channel is proportional to the logarithm of the number of messages that can be transmitted over that channel.\nThe Menzerath-Altmann law was first proposed by Heinz Menzer and Wolfgang Altmann in 1945, and it has since become an important concept in the field of information theory. It is often used to analyze the efficiency of communication systems, and it has applications in a wide range of fields, including telecommunications, computer networks, and data compression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Menzerath-Altmann law is a phenomenon in the field of information theory.\n2. It describes the relationship between the capacity of a communication channel and the number of messages that can be transmitted over that channel.\n3. The law states that the maximum capacity of a channel is proportional to the logarithm of the number of messages that can be transmitted.\n4. The Menzerath-Altmann law was first proposed by Heinz Menzer and Wolfgang Altmann in 1945.\n5. It has applications in telecommunications, computer networks, and data compression.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Menzerath-Altmann law is a phenomenon in the field of information theory.",
      "It describes the relationship between the capacity of a communication channel and the number of messages that can be transmitted over that channel.",
      "The law states that the maximum capacity of a channel is proportional to the logarithm of the number of messages that can be transmitted.",
      "The Menzerath-Altmann law was first proposed by Heinz Menzer and Wolfgang Altmann in 1945.",
      "It has applications in telecommunications, computer networks, and data compression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The Menzerath-Altmann law describes the relationship between the size of linguistic constructs and the size of their constituents. It does not directly relate to the capacity of communication channels or to the number of messages that can be transmitted.\n3. FALSE [correction]: The Menzerath-Altmann law states that the longer a linguistic construct (like a sentence, clause, or phrase), the smaller its constituents (like syllables, words, or sounds) tend to be, on average. It does not concern the capacity of a channel or its relationship with logarithms of message numbers.\n4. FALSE [correction]: The Menzerath-Altmann law is named after Paul Menzerath and Gabriel Altmann, who were not named Heinz Menzer and Wolfgang Altmann. The year it was first proposed is also not specified in this statement. The law is associated with work in the mid-20th century but exact dates can vary.\n5. FALSE [correction]: While the Menzerath-Altmann law has relevance in the study of linguistics and psycholinguistics, it is not specifically applied to telecommunications, computer networks, or data compression in the way the statement suggests.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1482,
    "user_query": "Which receptor(s) recognize lysosomal hydrolases in trans-Golgi network (TGN)?",
    "yulan-chat-2-13b-fp16_response": "Lysosomal hydrolases are transported from the trans-Golgi network (TGN) to lysosomes via a process known as lysosomal targeting. The transport of lysosomal hydrolases from the TGN to lysosomes is mediated by a complex system of proteins, including chaperones, adaptors, and receptors.\nOne of the receptors that recognize lysosomal hydrolases in the TGN is the mannose 6-phosphate receptor (MPR). The MPR is a type I transmembrane protein that recognizes lysosomal hydrolases through its mannose 6-phosphate (M6P) moiety, a type of glycan structure that is found on the lysosomal enzymes. The MPR plays a crucial role in the sorting of lysosomal hydrolases in the TGN by mediating their attachment to lysosomal membranes.\nAnother receptor that recognizes lysosomal hydrolases in the TGN is the sorting receptor for the lysosomal enzymes (SORLA). SORLA is a transmembrane protein that recognizes lysosomal hydrolases through its extracellular domain, which contains a sequence of amino acids that is specific for the M6P moiety. SORLA plays a role in the sorting of lysosomal hydrolases by mediating their attachment to adaptor proteins, which then transport them to lysosomes.\nOverall, the transport of lysosomal hydrolases from the TGN to lysosomes is a complex process that involves the action of multiple proteins, including chaperones, adaptors, and receptors. The MPR and SORLA are two of the key receptors that recognize lysosomal hydrolases in the TGN and play important roles in their sorting and transport to lysosomes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lysosomal hydrolases are transported from the trans-Golgi network to lysosomes via lysosomal targeting.\n2. The mannose 6-phosphate receptor (MPR) is one receptor that recognizes lysosomal hydrolases in the TGN.\n3. The mannose 6-phosphate receptor (MPR) is a type I transmembrane protein.\n4. Sorting receptor for the lysosomal enzymes (SORLA) is another receptor that recognizes lysosomal hydrolases in the TGN.\n5. SORLA is a transmembrane protein with an extracellular domain specific for the mannose 6-phosphate moiety.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lysosomal hydrolases are transported from the trans-Golgi network to lysosomes via lysosomal targeting.",
      "The mannose 6-phosphate receptor (MPR) is one receptor that recognizes lysosomal hydrolases in the TGN.",
      "The mannose 6-phosphate receptor (MPR) is a type I transmembrane protein.",
      "Sorting receptor for the lysosomal enzymes (SORLA) is another receptor that recognizes lysosomal hydrolases in the TGN.",
      "SORLA is a transmembrane protein with an extracellular domain specific for the mannose 6-phosphate moiety."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: SORLA is a transmembrane protein involved in intracellular trafficking; however, it does not have an extracellular domain specific for the mannose 6-phosphate moiety. Rather, it is involved in the trafficking and processing of amyloid precursor protein and may not directly interact with mannose-6-phosphate on lysosomal hydrolases.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "yulan-chat-2-13b-fp16_response": "Prothymosin alpha (ProT alpha) is a protein that plays a role in the differentiation of hematopoietic stem cells into mature blood cells. The c-terminal peptide of ProT alpha has been shown to have several functions, including:\n1. Acting as a transcriptional co-activator: The c-terminal peptide of ProT alpha has been shown to interact with certain transcription factors, such as the glucocorticoid receptor, and enhance their transcriptional activity.\n2. Regulating cell differentiation: The c-terminal peptide of ProT alpha has been shown to play a role in the differentiation of hematopoietic stem cells into mature blood cells. It has been suggested that it may act as a negative regulator of this process.\n3. Regulating cell proliferation: The c-terminal peptide of ProT alpha has been shown to regulate cell proliferation in certain cell types, such as fibroblasts.\n4. Acting as a signaling molecule: The c-terminal peptide of ProT alpha has been shown to interact with certain signaling molecules, such as the protein kinase C beta chain, and regulate signaling pathways.\n5. Acting as a marker of cell differentiation: The c-terminal peptide of ProT alpha has been shown to be a marker of cell differentiation in certain cell types, such as osteoblasts.\n6. Acting as a regulator of the actin cytoskeleton: The c-terminal peptide of ProT alpha has been shown to interact with certain proteins that regulate the actin cytoskeleton, such as filamin-1, and regulate cell shape and migration.\nIt's important to note that the functions of the c-terminal peptide of ProT alpha may vary depending on the cell type and the specific context in which it is expressed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The c-terminal peptide of Prothymosin alpha acts as a transcriptional co-activator, enhancing the transcriptional activity of certain transcription factors like the glucocorticoid receptor.\n2. The c-terminal peptide of Prothymosin alpha plays a role in the negative regulation of the differentiation of hematopoietic stem cells into mature blood cells.\n3. The c-terminal peptide of Prothymosin alpha regulates cell proliferation in certain cell types, including fibroblasts.\n4. The c-terminal peptide of Prothymosin alpha interacts with signaling molecules like protein kinase C beta chain to regulate signaling pathways.\n5. The c-terminal peptide of Prothymosin alpha acts as a marker of cell differentiation in certain cell types such as osteoblasts.",
    "yulan-chat-2-13b-fp16_fact": [
      "The c-terminal peptide of Prothymosin alpha acts as a transcriptional co-activator, enhancing the transcriptional activity of certain transcription factors like the glucocorticoid receptor.",
      "The c-terminal peptide of Prothymosin alpha plays a role in the negative regulation of the differentiation of hematopoietic stem cells into mature blood cells.",
      "The c-terminal peptide of Prothymosin alpha regulates cell proliferation in certain cell types, including fibroblasts.",
      "The c-terminal peptide of Prothymosin alpha interacts with signaling molecules like protein kinase C beta chain to regulate signaling pathways.",
      "The c-terminal peptide of Prothymosin alpha acts as a marker of cell differentiation in certain cell types such as osteoblasts."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The c-terminal peptide of Prothymosin alpha is not known for the negative regulation of the differentiation of hematopoietic stem cells into mature blood cells; its role is more associated with cell proliferation and apoptosis regulation.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nIt is challenging to confirm or correct the specific roles of the c-terminal peptide of Prothymosin alpha for statements 4 and 5 without specific research references, as this protein can be involved in various cellular processes, and new research could provide additional insights not covered by the current knowledge base.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1494,
    "user_query": "What is the role of the Ada O6-alkylguanine alkyltransferase in bacteria?",
    "yulan-chat-2-13b-fp16_response": "The Ada O6-alkylguanine alkyltransferase is an enzyme that plays a critical role in the DNA repair process in bacteria. This enzyme is responsible for reversing the damage caused by alkylating agents, such as certain antibiotics and environmental pollutants, by transferring an alkyl group from the agent to a specific amino acid in the enzyme itself. This process helps to protect the bacterial cells from the harmful effects of these agents and ensures the integrity of their genetic material. Additionally, the Ada O6-alkylguanine alkyltransferase is also involved in the activation of certain antibiotics, making it an important target for the development of new antibacterial drugs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ada O^6-alkylguanine alkyltransferase is an enzyme involved in DNA repair in bacteria.\n2. The enzyme reverses damage caused by alkylating agents.\n3. Ada O^6-alkylguanine alkyltransferase transfers an alkyl group from the alkylating agent to a specific amino acid in the enzyme itself.\n4. The action of Ada O^6-alkylguanine alkyltransferase assists in protecting bacterial cells from the harmful effects of alkylating agents.\n5. Ada O^6-alkylguanine alkyltransferase is involved in the activation of certain antibiotics.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ada O^6-alkylguanine alkyltransferase is an enzyme involved in DNA repair in bacteria.",
      "The enzyme reverses damage caused by alkylating agents.",
      "Ada O^6-alkylguanine alkyltransferase transfers an alkyl group from the alkylating agent to a specific amino acid in the enzyme itself.",
      "The action of Ada O^6-alkylguanine alkyltransferase assists in protecting bacterial cells from the harmful effects of alkylating agents.",
      "Ada O^6-alkylguanine alkyltransferase is involved in the activation of certain antibiotics."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Ada O^6-alkylguanine alkyltransferase is not involved in the activation of antibiotics. Its primary function is to repair DNA by removing alkyl groups from the DNA molecule, not to activate antibiotics.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1503,
    "user_query": "Which is the clinical meaning of the presence of delayed enhancement in patients with hypertrophic cardiomyopathy?",
    "yulan-chat-2-13b-fp16_response": "Delayed enhancement in patients with hypertrophic cardiomyopathy (HCM) is a finding on cardiac magnetic resonance imaging (MRI) that indicates the presence of fibrosis in the heart muscle. HCM is a genetic disorder that causes the heart muscle to become thickened, which can lead to problems with the heart's ability to pump blood effectively. Delayed enhancement on MRI suggests that there is scarring in the heart muscle, which can contribute to the development of HCM and increase the risk of complications such as heart failure, arrhythmias, and sudden cardiac death.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Delayed enhancement on cardiac MRI indicates the presence of fibrosis in the heart muscle.\n2. Hypertrophic cardiomyopathy (HCM) is a genetic disorder.\n3. HCM causes the heart muscle to become thickened.\n4. The thickening of the heart muscle in HCM can affect the heart's ability to pump blood effectively.\n5. The presence of delayed enhancement on MRI can increase the risk of heart failure, arrhythmias, and sudden cardiac death in patients with HCM.",
    "yulan-chat-2-13b-fp16_fact": [
      "Delayed enhancement on cardiac MRI indicates the presence of fibrosis in the heart muscle.",
      "Hypertrophic cardiomyopathy (HCM) is a genetic disorder.",
      "HCM causes the heart muscle to become thickened.",
      "The thickening of the heart muscle in HCM can affect the heart's ability to pump blood effectively.",
      "The presence of delayed enhancement on MRI can increase the risk of heart failure, arrhythmias, and sudden cardiac death in patients with HCM."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1509,
    "user_query": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?",
    "yulan-chat-2-13b-fp16_response": "Alpha-spectrin and beta-spectrin subunits form parallel heterodimers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alpha-spectrin and beta-spectrin subunits form parallel heterodimers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alpha-spectrin and beta-spectrin subunits form parallel heterodimers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.",
    "yulan-chat-2-13b-fp16_judge": [
      "false"
    ]
  },
  {
    "id": 1510,
    "user_query": "Is gastro esophageal reflux related to burning mouth syndrome?",
    "yulan-chat-2-13b-fp16_response": "Gastroesophageal reflux disease (GERD) and burning mouth syndrome (BMS) are two distinct conditions that can present with similar symptoms. GERD is a condition in which the stomach acid flows back up into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing. BMS is a condition characterized by a persistent and often debilitating burning sensation in the mouth, often accompanied by other symptoms such as tingling, numbness, and changes in taste.\nWhile there is some overlap in symptoms between GERD and BMS, the two conditions are not directly related. GERD is typically caused by a weak or damaged lower esophageal sphincter (LES), which is the muscle that separates the esophagus from the stomach. This allows stomach acid to flow back up into the esophagus, causing symptoms.\nBMS, on the other hand, is a complex condition that is thought to be related to a variety of factors, including neuropathy (damage to the nerves in the mouth), psychological factors, and certain medications. While GERD can contribute to the development of BMS in some cases, it is not considered to be the primary cause of the condition.\nIf you are experiencing persistent symptoms of GERD or BMS, it is important to speak with a healthcare provider to determine the underlying cause and develop an appropriate treatment plan.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gastroesophageal reflux disease (GERD) is a condition in which stomach acid flows back up into the esophagus.\n2. Symptoms of GERD include heartburn, chest pain, and difficulty swallowing.\n3. Burning mouth syndrome (BMS) is characterized by a burning sensation in the mouth, along with possible tingling, numbness, and changes in taste.\n4. GERD is typically caused by a weak or damaged lower esophageal sphincter (LES).\n5. Factors thought to be related to the development of BMS include neuropathy, psychological factors, and certain medications.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gastroesophageal reflux disease (GERD) is a condition in which stomach acid flows back up into the esophagus.",
      "Symptoms of GERD include heartburn, chest pain, and difficulty swallowing.",
      "Burning mouth syndrome (BMS) is characterized by a burning sensation in the mouth, along with possible tingling, numbness, and changes in taste.",
      "GERD is typically caused by a weak or damaged lower esophageal sphincter (LES).",
      "Factors thought to be related to the development of BMS include neuropathy, psychological factors, and certain medications."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1511,
    "user_query": "Which is the protein (antigen) targeted by anti-Vel antibodies in the Vel blood group?",
    "yulan-chat-2-13b-fp16_response": "The protein targeted by anti-Vel antibodies in the Vel blood group is called \"Vel binding protein\" or \"Vel-related endothelial cell adhesion molecule\" (Vel-ECAM). This protein is a member of the immunoglobulin superfamily and is expressed on the surface of endothelial cells in the blood vessels. Anti-Vel antibodies bind to Vel-ECAM and can cause the formation of immune complexes, which can lead to the development of vasculitis (inflammation of the blood vessels) in some individuals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Vel binding protein or Vel-related endothelial cell adhesion molecule (Vel-ECAM) is targeted by anti-Vel antibodies in the Vel blood group.\n2. Vel-ECAM is a member of the immunoglobulin superfamily.\n3. Vel-ECAM is expressed on the surface of endothelial cells in the blood vessels.\n4. Anti-Vel antibodies can cause the formation of immune complexes.\n5. The formation of immune complexes by anti-Vel antibodies can lead to vasculitis in some individuals.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Vel binding protein or Vel-related endothelial cell adhesion molecule (Vel-ECAM) is targeted by anti-Vel antibodies in the Vel blood group.",
      "Vel-ECAM is a member of the immunoglobulin superfamily.",
      "Vel-ECAM is expressed on the surface of endothelial cells in the blood vessels.",
      "Anti-Vel antibodies can cause the formation of immune complexes.",
      "The formation of immune complexes by anti-Vel antibodies can lead to vasculitis in some individuals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Vel-ECAM is not a member of the immunoglobulin superfamily; it is a GPI-anchored cell surface protein.\n3. TRUE\n4. TRUE  Anti-Vel antibodies can indeed cause the formation of immune complexes typically when they bind to their target antigens on the surface of red blood cells. \n5. UNKNOWN  While the formation of immune complexes can lead to vasculitis, whether anti-Vel antibodies specifically cause vasculitis as a result of immune complex formation is not a well-established fact and requires specific medical references to confirm.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "yulan-chat-2-13b-fp16_response": "Cystatin C is a small protein that is widely expressed in many tissues and organs of the human body. It has been shown to play a pivotal role in the formation of amyloid fibrils, which are aggregates of proteins that can accumulate in tissues and cause damage.\nThere are several peptides that have been identified as playing a role in the formation of cystatin C fibrils, including the N-terminal region of the protein and a region known as the \"cystatin C domain.\" The exact mechanism of fibrillization is not fully understood, but it is thought to involve the formation of beta-sheet structures that then aggregate to form fibrils.\nOverall, the role of cystatin C in the formation of amyloid fibrils is an area of active research, and more studies are needed to fully understand the mechanisms involved.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cystatin C is a protein expressed in many tissues and organs of the human body.\n2. Cystatin C has a role in the formation of amyloid fibrils.\n3. Amyloid fibrils are aggregates of proteins that can accumulate in tissues and cause damage.\n4. The N-terminal region of cystatin C is one of the peptides that have been identified in the formation of its fibrils.\n5. The formation of cystatin C fibrils may involve the creation of beta-sheet structures.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cystatin C is a protein expressed in many tissues and organs of the human body.",
      "Cystatin C has a role in the formation of amyloid fibrils.",
      "Amyloid fibrils are aggregates of proteins that can accumulate in tissues and cause damage.",
      "The N-terminal region of cystatin C is one of the peptides that have been identified in the formation of its fibrils.",
      "The formation of cystatin C fibrils may involve the creation of beta-sheet structures."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Cystatin C is a known inhibitor of amyloid formation rather than having a role in the formation of amyloid fibrils.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1518,
    "user_query": "What is the use of MammaPrint and Oncotype DX?",
    "yulan-chat-2-13b-fp16_response": "MammaPrint and Oncotype DX are two different types of diagnostic tests that are used to help inform treatment decisions for women with breast cancer.\nMammaPrint is a gene expression test that analyzes the genetic material in a sample of breast cancer tissue to determine the likelihood of the cancer returning after surgery. The test is designed to help identify women who are at a high risk of recurrence, so that they can be offered more aggressive treatment options, such as chemotherapy, in order to reduce the risk of the cancer coming back.\nOncotype DX, on the other hand, is a gene expression test that is used to help predict the likelihood of breast cancer recurrence in women with early-stage disease. The test is designed to help identify women who are at a high risk of recurrence, so that they can be offered more aggressive treatment options, such as chemotherapy, in order to reduce the risk of the cancer coming back.\nBoth MammaPrint and Oncotype DX are considered to be useful tools for informing treatment decisions for women with breast cancer, and they are often used in combination with other diagnostic tests and clinical factors to help guide treatment decisions. However, it is important to note that these tests are not suitable for all women with breast cancer, and they should only be used in consultation with a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MammaPrint is a diagnostic test used to determine the likelihood of breast cancer recurrence after surgery by analyzing genetic material in a sample of breast cancer tissue.\n2. Oncotype DX is a diagnostic test used to predict the likelihood of breast cancer recurrence in early-stage disease by analyzing gene expression.\n3. Both MammaPrint and Oncotype DX are designed to help identify women at a high risk of breast cancer recurrence so that more aggressive treatment options may be considered.\n4. MammaPrint and Oncotype DX are tools used in informing treatment decisions for women with breast cancer.\n5. MammaPrint and Oncotype DX should be used in consultation with a healthcare professional and are not suitable for all women with breast cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "MammaPrint is a diagnostic test used to determine the likelihood of breast cancer recurrence after surgery by analyzing genetic material in a sample of breast cancer tissue.",
      "Oncotype DX is a diagnostic test used to predict the likelihood of breast cancer recurrence in early-stage disease by analyzing gene expression.",
      "Both MammaPrint and Oncotype DX are designed to help identify women at a high risk of breast cancer recurrence so that more aggressive treatment options may be considered.",
      "MammaPrint and Oncotype DX are tools used in informing treatment decisions for women with breast cancer.",
      "MammaPrint and Oncotype DX should be used in consultation with a healthcare professional and are not suitable for all women with breast cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1520,
    "user_query": "Is there any data to suggest that TRH (thyrotropin releasing hormone) administration can improve symptom severity of amyotrophic lateral sclerosis patients?",
    "yulan-chat-2-13b-fp16_response": "I am not aware of any studies or data that specifically suggest that TRH administration can improve symptom severity in amyotrophic lateral sclerosis (ALS) patients.\nALS is a progressive neurological disorder that affects motor neurons in the brain and spinal cord, leading to muscle weakness and eventual paralysis. While there is currently no cure for ALS, there are treatments available that can help manage symptoms and slow the progression of the disease.\nTRH is a hormone that stimulates the release of thyroid-stimulating hormone (TSH), which in turn stimulates the production of thyroid hormones by the thyroid gland. TRH has been studied as a potential treatment for a variety of conditions, including ALS, but there is limited evidence to support its use in this context.\nOne small study published in the Journal of Neurological Sciences in 2013 found that TRH administration improved survival and muscle strength in a mouse model of ALS. However, this study was conducted in animals and it is not clear if the results would translate to human patients.\nOverall, while TRH administration may have potential as a treatment for ALS, more research is needed to determine its effectiveness and safety in humans. If you are considering TRH treatment for ALS or any other condition, it is important to discuss the potential benefits and risks with a qualified healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder that affects motor neurons in the brain and spinal cord.\n2. ALS leads to muscle weakness and eventual paralysis.\n3. TRH stimulates the release of thyroid-stimulating hormone (TSH).\n4. A study published in the Journal of Neurological Sciences in 2013 found that TRH administration improved survival and muscle strength in a mouse model of ALS.\n5. The results of the study conducted on a mouse model of ALS may not necessarily translate to human patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder that affects motor neurons in the brain and spinal cord.",
      "ALS leads to muscle weakness and eventual paralysis.",
      "TRH stimulates the release of thyroid-stimulating hormone (TSH).",
      "A study published in the Journal of Neurological Sciences in 2013 found that TRH administration improved survival and muscle strength in a mouse model of ALS.",
      "The results of the study conducted on a mouse model of ALS may not necessarily translate to human patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1524,
    "user_query": "What is the gold standard treatment for Iatrogenic male incontinence?",
    "yulan-chat-2-13b-fp16_response": "Iatrogenic male incontinence refers to the unintended loss of urine that is caused by medical treatment or surgery. The gold standard treatment for iatrogenic male incontinence typically involves a combination of medical therapy and surgical interventions.\nMedical therapy may include medications such as alpha-adrenergic blockers, cholinergic agonists, and botulinum toxin injections. These medications work by relaxing the bladder muscle and increasing bladder capacity, respectively.\nSurgical interventions may include bulbocavernosus muscle suspension, which involves lifting and supporting the bladder neck with a ligament from the bulbocavernosus muscle. Another surgical option is the insertion of an artificial sphincter, which is a device that is placed around the urethra to control urine flow.\nThe specific treatment approach for iatrogenic male incontinence will depend on the underlying cause of the incontinence and the severity of the symptoms. It is important to consult with a urologist or other healthcare provider to determine the most appropriate treatment plan.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Iatrogenic male incontinence is the unintended loss of urine caused by medical treatment or surgery.\n2. The gold standard treatment for iatrogenic male incontinence involves a combination of medical therapy and surgical interventions.\n3. Alpha-adrenergic blockers and cholinergic agonists are medications used in the medical therapy for iatrogenic male incontinence.\n4. Bulbocavernosus muscle suspension is a surgical intervention for iatrogenic male incontinence, which involves lifting and supporting the bladder neck.\n5. Another surgical option for iatrogenic male incontinence is the insertion of an artificial sphincter around the urethra.",
    "yulan-chat-2-13b-fp16_fact": [
      "Iatrogenic male incontinence is the unintended loss of urine caused by medical treatment or surgery.",
      "The gold standard treatment for iatrogenic male incontinence involves a combination of medical therapy and surgical interventions.",
      "Alpha-adrenergic blockers and cholinergic agonists are medications used in the medical therapy for iatrogenic male incontinence.",
      "Bulbocavernosus muscle suspension is a surgical intervention for iatrogenic male incontinence, which involves lifting and supporting the bladder neck.",
      "Another surgical option for iatrogenic male incontinence is the insertion of an artificial sphincter around the urethra."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The gold standard treatment for iatrogenic male incontinence is usually the surgical implantation of an artificial urinary sphincter or a sling, not necessarily a combination of medical therapy and surgery.\n3. FALSE [correction]: Alpha-adrenergic blockers are typically used to treat symptoms of an enlarged prostate and urinary retention, not incontinence. Antimuscarinic agents, not cholinergic agonists, are often used for overactive bladder, which can include symptoms of incontinence.\n4. FALSE [correction]: Bulbocavernosus muscle suspension is not a recognized surgical intervention for iatrogenic male incontinence. The Remeex system or an advance sling procedure might be used to support the urethra, not typically the bladder neck.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1525,
    "user_query": "Which is the main CHEK2 genetic variant, thought to be involved in familial breast cancer?",
    "yulan-chat-2-13b-fp16_response": "The main CHEK2 genetic variant that is thought to be involved in familial breast cancer is the CHEK2 c.1100delC mutation. This mutation results in a frameshift mutation that leads to a premature stop codon and a truncated protein that is unable to perform its normal function. This mutation has been found to be associated with an increased risk of hereditary breast cancer, particularly in individuals of Eastern European Jewish descent.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The CHEK2 c.1100delC mutation is a genetic variant thought to be involved in familial breast cancer.\n2. The mutation causes a frameshift that leads to a premature stop codon.\n3. The resulting protein from the CHEK2 c.1100delC mutation is truncated and unable to perform its normal function.\n4. This mutation is associated with an increased risk of hereditary breast cancer.\n5. The CHEK2 c.1100delC mutation is particularly found in individuals of Eastern European Jewish descent.",
    "yulan-chat-2-13b-fp16_fact": [
      "The CHEK2 c.1100delC mutation is a genetic variant thought to be involved in familial breast cancer.",
      "The mutation causes a frameshift that leads to a premature stop codon.",
      "The resulting protein from the CHEK2 c.1100delC mutation is truncated and unable to perform its normal function.",
      "This mutation is associated with an increased risk of hereditary breast cancer.",
      "The CHEK2 c.1100delC mutation is particularly found in individuals of Eastern European Jewish descent."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The CHEK2 c.1100delC mutation is notably found in individuals of Northern and Eastern European descent, not specifically or exclusively in Eastern European Jewish individuals.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1535,
    "user_query": "Are immune cells affected in Amyotrophic Lateral Sclerosis?",
    "yulan-chat-2-13b-fp16_response": "Yes, immune cells are affected in Amyotrophic Lateral Sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects motor neurons, leading to muscle weakness and eventual paralysis. Immune cells, including microglia and astrocytes, play a role in the pathology of ALS.\nStudies have shown that in ALS, microglia become activated and release pro-inflammatory cytokines, which can contribute to neurodegeneration. Astrocytes, on the other hand, can promote inflammation and contribute to the progression of ALS by secreting factors that damage motor neurons.\nWhile the exact role of the immune system in ALS is still being studied, it is clear that immune cells play a significant role in the pathology of the disease. Understanding the interactions between the immune system and motor neurons in ALS may lead to the development of new treatments for the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons.\n2. In Amyotrophic Lateral Sclerosis, immune cells such as microglia and astrocytes are involved in the disease pathology.\n3. Microglia in ALS patients become activated and release pro-inflammatory cytokines.\n4. Astrocytes in ALS patients can promote inflammation and damage motor neurons by secreting harmful factors.\n5. There is ongoing research to understand the exact role of the immune system in ALS.",
    "yulan-chat-2-13b-fp16_fact": [
      "Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons.",
      "In Amyotrophic Lateral Sclerosis, immune cells such as microglia and astrocytes are involved in the disease pathology.",
      "Microglia in ALS patients become activated and release pro-inflammatory cytokines.",
      "Astrocytes in ALS patients can promote inflammation and damage motor neurons by secreting harmful factors.",
      "There is ongoing research to understand the exact role of the immune system in ALS."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1537,
    "user_query": "What is the mechanism of action of eprotirome?",
    "yulan-chat-2-13b-fp16_response": "Eprotirome is a drug that is being developed for the treatment of various types of cancer, including non-small cell lung cancer, pancreatic cancer, and ovarian cancer. It works by targeting a protein called CD133, which is expressed on the surface of certain types of cancer cells. CD133 is involved in the process of cell division and survival, and eprotirome works by binding to CD133 and blocking its function, leading to the death of cancer cells. In addition to its direct effect on cancer cells, eprotirome may also stimulate the immune system to attack cancer cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eprotirome is a drug being developed for the treatment of various types of cancer such as non-small cell lung cancer, pancreatic cancer, and ovarian cancer.\n2. The drug targets a protein called CD133 that is expressed on the surface of certain cancer cells.\n3. CD133 is involved in cell division and survival.\n4. Eprotirome functions by binding to CD133 and blocking its activity.\n5. One of the effects of eprotirome is to potentially stimulate the immune system to attack cancer cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eprotirome is a drug being developed for the treatment of various types of cancer such as non-small cell lung cancer, pancreatic cancer, and ovarian cancer.",
      "The drug targets a protein called CD133 that is expressed on the surface of certain cancer cells.",
      "CD133 is involved in cell division and survival.",
      "Eprotirome functions by binding to CD133 and blocking its activity.",
      "One of the effects of eprotirome is to potentially stimulate the immune system to attack cancer cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE  CD133 (prominin-1) is indeed a protein expressed on the surface of certain cancer cells, as well as other stem cells, and is believed to be involved in cell development, growth, and survival.\n4. FALSE [correction]: Eprotirome is actually a thyroid hormone analog developed for the treatment of high cholesterol; it does not target CD133 or cancer cells.\n5. FALSE [correction]: Since eprotirome is not a drug developed for cancer treatment, it does not have the effect of stimulating the immune system to attack cancer cells. Instead, it was investigated for lowering lipid levels in the blood.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1541,
    "user_query": "What is GDF10?",
    "yulan-chat-2-13b-fp16_response": "GDF10 is a protein that is involved in the regulation of bone growth and development. It is a member of the transforming growth factor beta superfamily of proteins, which are involved in a wide range of biological processes, including cell growth, differentiation, and death.\nGDF10 is primarily produced by bone cells and plays a key role in the regulation of bone mass and strength. It helps to stimulate the differentiation and mineralization of osteoblasts, which are cells that are responsible for the formation of new bone tissue. In addition to its role in bone development, GDF10 has also been shown to have other functions, including the regulation of cell proliferation and differentiation, and the modulation of immune responses.\nGDF10 has been the subject of research in recent years due to its potential therapeutic applications. For example, it has been suggested that GDF10 may be able to promote bone growth and repair in individuals with osteoporosis or other bone disorders. However, further research is needed to fully understand the potential benefits and risks of using GDF10 as a therapeutic agent.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GDF10 is a protein involved in the regulation of bone growth and development.\n2. GDF10 is a member of the transforming growth factor beta superfamily of proteins.\n3. GDF10 plays a key role in the regulation of bone mass and strength.\n4. It stimulates the differentiation and mineralization of osteoblasts, the cells responsible for forming new bone tissue.\n5. GDF10 has potential therapeutic applications for promoting bone growth and repair in individuals with osteoporosis or other bone disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "GDF10 is a protein involved in the regulation of bone growth and development.",
      "GDF10 is a member of the transforming growth factor beta superfamily of proteins.",
      "GDF10 plays a key role in the regulation of bone mass and strength.",
      "It stimulates the differentiation and mineralization of osteoblasts, the cells responsible for forming new bone tissue.",
      "GDF10 has potential therapeutic applications for promoting bone growth and repair in individuals with osteoporosis or other bone disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: GDF10 is a protein associated with brain recovery following a stroke. It is not directly involved in the regulation of bone growth and development.\n2. TRUE\n3. FALSE [correction]: GDF10, while a member of the TGF-beta superfamily, is known for its role in neurogenesis and stroke recovery, not specifically in the regulation of bone mass and strength.\n4. FALSE [correction]: GDF10 is not known to stimulate the differentiation and mineralization of osteoblasts, as it is more associated with brain tissue rather than bone tissue.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1552,
    "user_query": "Which genetic defects are observed in Prader-Willi syndrome?",
    "yulan-chat-2-13b-fp16_response": "Prader-Willi syndrome is a genetic disorder that is caused by the deletion of genes on chromosome 15. The deletion can occur in different locations on the chromosome, but the most common location is called the \"critical region.\" The critical region contains several genes that are important for normal development and function, including the genes for the Prader-Willi and Angleman-Ewing syndromes.\nThe deletion of these genes in Prader-Willi syndrome leads to a range of physical, intellectual, and behavioral problems. Some of the most common symptoms of the disorder include:\n* Delayed development of motor skills, such as sitting, crawling, and walking\n* Learning difficulties and intellectual disability\n* Behavioral problems, such as temper tantrums and aggression\n* Obesity and a strong desire to eat, which can lead to malnutrition and other health problems\n* Sexual development problems, such as delayed puberty or lack of sexual development\n* Sleep apnea and other breathing problems\nIn addition to these symptoms, people with Prader-Willi syndrome may also have other physical features, such as a narrow head, low-set ears, and a short, upturned nose.\nPrader-Willi syndrome is a rare disorder, affecting only about 1 in 10,000 people. It is usually diagnosed in childhood, and there is no cure for the disorder. However, treatment can help manage the symptoms and improve quality of life for people with the disorder.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prader-Willi syndrome is caused by the deletion of genes on chromosome 15.\n2. The most common location of gene deletion in Prader-Willi syndrome is the \"critical region\" on chromosome 15.\n3. Common symptoms of Prader-Willi syndrome include delayed development of motor skills, learning difficulties, behavioral problems, obesity, and sexual development issues.\n4. Prader-Willi syndrome affects approximately 1 in 10,000 people.\n5. Prader-Willi syndrome can lead to health problems such as sleep apnea and other breathing problems.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prader-Willi syndrome is caused by the deletion of genes on chromosome 15.",
      "The most common location of gene deletion in Prader-Willi syndrome is the \"critical region\" on chromosome 15.",
      "Common symptoms of Prader-Willi syndrome include delayed development of motor skills, learning difficulties, behavioral problems, obesity, and sexual development issues.",
      "Prader-Willi syndrome affects approximately 1 in 10,000 people.",
      "Prader-Willi syndrome can lead to health problems such as sleep apnea and other breathing problems."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE  Although the exact incidence can vary slightly in different sources, this is within the commonly stated range for Prader-Willi syndrome.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1555,
    "user_query": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?",
    "yulan-chat-2-13b-fp16_response": "There are several computational tools available for the prediction of gene fusion events, and the state-of-the-art tools are constantly evolving. Here are some of the most commonly used tools:\n1. FusionGen: This tool uses a de novo assembly approach to identify gene fusions from RNA-seq data. It can detect both novel and known fusions and is particularly useful for identifying fusions in cancer.\n2. FusionHunter: This tool uses a combination of de novo assembly and homology-based approaches to identify gene fusions from RNA-seq data. It can detect both known and novel fusions and is particularly useful for identifying fusions in cancer.\n3. FusionScore: This tool uses a homology-based approach to identify gene fusions from RNA-seq data. It can detect both known and novel fusions and is particularly useful for identifying fusions in cancer.\n4. FusionCatcher: This tool uses a de novo assembly approach to identify gene fusions from RNA-seq data. It can detect both known and novel fusions and is particularly useful for identifying fusions in cancer.\n5. FusionBuster: This tool uses a de novo assembly approach to identify gene fusions from RNA-seq data. It can detect both known and novel fusions and is particularly useful for identifying fusions in cancer.\n6. FusionDetector: This tool uses a de novo assembly approach to identify gene fusions from RNA-seq data. It can detect both known and novel fusions and is particularly useful for identifying fusions in cancer.\nThese tools are constantly evolving, and new tools are being developed, so it is important to stay up-to-date with the latest developments in this field.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FusionGen uses a de novo assembly approach to identify gene fusions from RNA-seq data.\n2. FusionHunter combines de novo assembly and homology-based approaches to identify gene fusions from RNA-seq data.\n3. FusionScore uses a homology-based approach to identify gene fusions from RNA-seq data.\n4. FusionCatcher employs a de novo assembly approach for detecting gene fusions from RNA-seq data.\n5. FusionBuster uses a de novo assembly approach to identify gene fusions from RNA-seq data.",
    "yulan-chat-2-13b-fp16_fact": [
      "FusionGen uses a de novo assembly approach to identify gene fusions from RNA-seq data.",
      "FusionHunter combines de novo assembly and homology-based approaches to identify gene fusions from RNA-seq data.",
      "FusionScore uses a homology-based approach to identify gene fusions from RNA-seq data.",
      "FusionCatcher employs a de novo assembly approach for detecting gene fusions from RNA-seq data.",
      "FusionBuster uses a de novo assembly approach to identify gene fusions from RNA-seq data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: Without specific information on a tool named \"FusionGen,\" it is not possible to determine if this statement is true or false.\n2. FALSE [correction]: FusionHunter uses a read-mapping and pair-end tag (PET) mapping approach, not a de novo assembly and homology-based approach, to identify gene fusions from RNA-seq data.\n3. UNKNOWN: There is no widely recognized tool named \"FusionScore\" known for gene fusion detection, and without further context, it is impossible to assess the validity of the statement.\n4. TRUE: FusionCatcher indeed employs various methods including de novo assembly for detecting gene fusions from RNA-seq data.\n5. UNKNOWN: As with \"FusionGen\" and \"FusionScore,\" without specific information on a tool named \"FusionBuster,\" the validity of this statement cannot be determined.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1559,
    "user_query": "Are the proteins Erbin (LAP2) and Merlin cooperating?",
    "yulan-chat-2-13b-fp16_response": "Erbin (LAP2) and Merlin are two proteins that play important roles in regulating chromosome stability and organization. While they have some similarities in their functions, they also have distinct roles and can have both cooperative and competitive interactions.\nErbin, also known as LAP2 (Locus Apical Protein 2), is a member of the LAP2/APC (ATP-dependent Chromatin Assembly Factor) family of proteins. It plays a key role in the recruitment of chromatin-modifying enzymes and other factors to the pericentromeric region of chromosomes, where it helps to regulate the formation and maintenance of cohesin complexes.\nMerlin, on the other hand, is a protein that is involved in the regulation of mitotic spindle assembly and chromosome segregation. It is also involved in the regulation of the cell cycle and apoptosis.\nWhile Erbin and Merlin have some overlap in their functions, they also have distinct roles and can have both cooperative and competitive interactions. For example, they can both interact with the cohesin complex and help to regulate chromosome organization, but they may also compete for the same binding sites on chromatin.\nOverall, the relationship between Erbin and Merlin is complex and can vary depending on the specific context and cell type. In some cases, they may cooperate to regulate chromosome stability and organization, while in other cases they may compete for the same binding sites or have distinct roles.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Erbin (LAP2) is involved in the recruitment of chromatin-modifying enzymes to the pericentromeric region of chromosomes.\n2. Erbin (LAP2) helps regulate the formation and maintenance of cohesin complexes.\n3. Merlin is involved in the regulation of mitotic spindle assembly and chromosome segregation.\n4. Merlin plays a role in the regulation of the cell cycle and apoptosis.\n5. Erbin (LAP2) and Merlin can have both cooperative and competitive interactions depending on the specific context and cell type.",
    "yulan-chat-2-13b-fp16_fact": [
      "Erbin (LAP2) is involved in the recruitment of chromatin-modifying enzymes to the pericentromeric region of chromosomes.",
      "Erbin (LAP2) helps regulate the formation and maintenance of cohesin complexes.",
      "Merlin is involved in the regulation of mitotic spindle assembly and chromosome segregation.",
      "Merlin plays a role in the regulation of the cell cycle and apoptosis.",
      "Erbin (LAP2) and Merlin can have both cooperative and competitive interactions depending on the specific context and cell type."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: Without specific scientific context or sources, the role of Erbin in the recruitment of chromatin-modifying enzymes to the pericentromeric region is not verifiable.\n2. UNKNOWN: Again, the detailed function of Erbin (LAP2) in cohesin complexes regulation cannot be confirmed without specific scientific literature or context.\n3. TRUE: Merlin, the protein product of the NF2 (neurofibromatosis type 2) gene, is known to be involved in the regulation of mitotic spindle assembly and chromosome segregation.\n4. TRUE: Merlin, indeed, plays a role in the regulation of the cell cycle and apoptosis.\n5. TRUE: Based on the typical behavior of proteins in cellular processes, Erbin and Merlin can have both cooperative and competitive interactions, although the specifics of these interactions would depend on context and cell type and would require scientific literature to elucidate.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1568,
    "user_query": "Which deficiency is the cause of restless leg syndrome",
    "yulan-chat-2-13b-fp16_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an overwhelming urge to move the legs, often accompanied by uncomfortable sensations such as creeping, crawling, or throbbing. While the exact cause of RLS is not fully understood, it is believed to be related to a deficiency in iron.\nIron is an essential mineral that plays a critical role in the production of hemoglobin, a protein in red blood cells that carries oxygen throughout the body. When iron levels are low, the body may not be able to supply enough oxygen to the brain and nervous system, leading to the uncomfortable sensations and urges associated with RLS.\nOther potential causes of RLS include nerve damage, kidney disease, diabetes, and certain medications. However, the most common cause of RLS is iron deficiency. Treatment for RLS often involves addressing the underlying deficiency, such as through iron supplements or changes to diet and lifestyle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Restless leg syndrome (RLS) is a neurological disorder associated with an urge to move the legs and sensations like creeping, crawling, or throbbing.\n2. A deficiency in iron is believed to be related to the cause of RLS.\n3. Iron plays a role in the production of hemoglobin, which is responsible for carrying oxygen in the blood.\n4. Common potential causes of RLS include nerve damage, kidney disease, diabetes, and certain medications.\n5. Treatment for RLS often involves addressing iron deficiency through supplements or dietary changes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Restless leg syndrome (RLS) is a neurological disorder associated with an urge to move the legs and sensations like creeping, crawling, or throbbing.",
      "A deficiency in iron is believed to be related to the cause of RLS.",
      "Iron plays a role in the production of hemoglobin, which is responsible for carrying oxygen in the blood.",
      "Common potential causes of RLS include nerve damage, kidney disease, diabetes, and certain medications.",
      "Treatment for RLS often involves addressing iron deficiency through supplements or dietary changes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1572,
    "user_query": "What is the role of eteplirsen in DMD patients?",
    "yulan-chat-2-13b-fp16_response": "Eteplirsen is an investigational drug being developed for the treatment of Duchenne muscular dystrophy (DMD) caused by a specific genetic mutation. It is an antisense oligonucleotide drug that works by selectively binding to and \"skipping\" a specific exon in the dystrophin pre-mRNA, which is missing in individuals with this particular genetic mutation. By skipping this exon, the drug aims to produce a functional dystrophin protein in the body, which is missing in individuals with this mutation and is thought to have a potential therapeutic benefit in DMD.\nEteplirsen has completed phase 2 clinical trials and is currently being evaluated in phase 3 clinical trials for the treatment of DMD caused by the specific genetic mutation. While the results of the phase 2 trial were promising, more research is needed to fully understand the safety and efficacy of eteplirsen in treating DMD.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eteplirsen is being developed for the treatment of Duchenne muscular dystrophy (DMD) caused by a specific genetic mutation.\n2. Eteplirsen is an antisense oligonucleotide drug.\n3. Eteplirsen works by selectively binding to and \"skipping\" a specific exon in the dystrophin pre-mRNA.\n4. The goal of eteplirsen is to produce a functional dystrophin protein in individuals with a specific genetic mutation associated with DMD.\n5. Eteplirsen has completed phase 2 clinical trials and is being evaluated in phase 3 clinical trials for treatment of DMD.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eteplirsen is being developed for the treatment of Duchenne muscular dystrophy (DMD) caused by a specific genetic mutation.",
      "Eteplirsen is an antisense oligonucleotide drug.",
      "Eteplirsen works by selectively binding to and \"skipping\" a specific exon in the dystrophin pre-mRNA.",
      "The goal of eteplirsen is to produce a functional dystrophin protein in individuals with a specific genetic mutation associated with DMD.",
      "Eteplirsen has completed phase 2 clinical trials and is being evaluated in phase 3 clinical trials for treatment of DMD."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: As of my knowledge cutoff date in 2023, eteplirsen has already been approved by the FDA and is not currently in phase 3 clinical trials. It was granted accelerated approval in September 2016.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1573,
    "user_query": "Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.",
    "yulan-chat-2-13b-fp16_response": "Guadeloupe syndrome, also known as Parkinsonism with dementia, is a rare neurological disorder characterized by the presence of Parkinsonian symptoms, such as tremors, rigidity, and bradykinesia, as well as dementia.\nThe clinical presentation of Guadeloupe syndrome typically includes the following symptoms:\n1. Parkinsonian symptoms: These include tremors, rigidity, bradykinesia (slowness of movement), and postural instability. These symptoms are similar to those seen in Parkinson's disease, but they tend to develop more rapidly and are more severe.\n2. Dementia: This is the most distinguishing feature of Guadeloupe syndrome, and it typically presents as a progressive decline in cognitive function, including memory loss, difficulty with problem-solving and decision-making, and impaired judgment.\n3. Autonomic dysfunction: This can include symptoms such as orthostatic hypotension (a drop in blood pressure upon standing), constipation, and urinary dysfunction.\n4. Psychiatric symptoms: Some people with Guadeloupe syndrome may experience psychiatric symptoms such as depression, anxiety, or psychosis.\nThe exact cause of Guadeloupe syndrome is unknown, but it is thought to be related to a combination of genetic and environmental factors. There is no cure for the disorder, but treatments such as levodopa and dopamine agonists can help manage symptoms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Guadeloupe syndrome is characterized by both Parkinsonian symptoms and dementia.\n2. Symptoms of Guadeloupe syndrome include tremors, rigidity, bradykinesia, and postural instability.\n3. Dementia in Guadeloupe syndrome presents as a progressive decline in cognitive function, including memory loss and difficulty with problem-solving and decision-making.\n4. Patients with Guadeloupe syndrome may experience autonomic dysfunction, including orthostatic hypotension, constipation, and urinary dysfunction.\n5. Psychiatric symptoms such as depression, anxiety, or psychosis can be associated with Guadeloupe syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Guadeloupe syndrome is characterized by both Parkinsonian symptoms and dementia.",
      "Symptoms of Guadeloupe syndrome include tremors, rigidity, bradykinesia, and postural instability.",
      "Dementia in Guadeloupe syndrome presents as a progressive decline in cognitive function, including memory loss and difficulty with problem-solving and decision-making.",
      "Patients with Guadeloupe syndrome may experience autonomic dysfunction, including orthostatic hypotension, constipation, and urinary dysfunction.",
      "Psychiatric symptoms such as depression, anxiety, or psychosis can be associated with Guadeloupe syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: Guadeloupe syndrome is not a widely recognized medical term or condition. It may refer to a cluster of symptoms observed in a specific population or study, but without more detailed context, it is difficult to determine the accuracy of the statement.\n\n2. UNKNOWN: Similarly to statement 1, without more context or specific medical recognition of Guadeloupe syndrome, it is not possible to accurately confirm the symptoms associated with it.\n\n3. UNKNOWN: Again, as Guadeloupe syndrome is not a recognized medical condition, we cannot confirm whether dementia presenting with these specific symptoms is characteristic of it.\n\n4. UNKNOWN: Without clear recognition and definition of Guadeloupe syndrome in medical literature, the association of autonomic dysfunction with the syndrome cannot be determined.\n\n5. UNKNOWN: Psychiatric symptoms being related to Guadeloupe syndrome cannot be confirmed without further context and recognition of the syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1 increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "yulan-chat-2-13b-fp16_response": "Yes, the concentration of the protein HIF-1 can increase after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).\nAmifostine is a prodrug that is converted in the body to its active form, which is called ethyol. Ethyol has been shown to have cytoprotective effects, meaning that it can protect cells from damage caused by oxidative stress.\nOne of the ways that ethyol exerts its cytoprotective effects is by activating the HIF-1 pathway. The HIF-1 pathway is a signaling pathway that is involved in the response to low oxygen levels (hypoxia) in the body. When hypoxia is detected, the HIF-1 protein is activated, which then leads to the activation of a number of genes that help to protect cells from damage.\nStudies have shown that administration of amifostine results in an increase in the concentration of HIF-1 in certain tissues, such as the kidney and the liver. This increase in HIF-1 concentration is thought to be responsible for the cytoprotective effects of amifostine.\nOverall, the concentration of HIF-1 can increase after the administration of amifostine, and this increase is thought to be related to the cytoprotective effects of the drug.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Amifostine is a prodrug that converts to its active form known as ethyol.\n2. Ethyol has cytoprotective effects that help protect cells from oxidative stress damage.\n3. The HIF-1 pathway is activated in response to low oxygen levels in the body.\n4. Administration of amifostine results in an increase in the concentration of HIF-1 in certain tissues.\n5. The increase in HIF-1 concentration is considered responsible for the cytoprotective effects of amifostine.",
    "yulan-chat-2-13b-fp16_fact": [
      "Amifostine is a prodrug that converts to its active form known as ethyol.",
      "Ethyol has cytoprotective effects that help protect cells from oxidative stress damage.",
      "The HIF-1 pathway is activated in response to low oxygen levels in the body.",
      "Administration of amifostine results in an increase in the concentration of HIF-1 in certain tissues.",
      "The increase in HIF-1 concentration is considered responsible for the cytoprotective effects of amifostine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Amifostine is a prodrug that converts to its active form known as WR-1065.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe first statement is false because the active form of Amifostine is WR-1065, not Ethyol. Ethyol is actually another name for Amifostine itself when used as a drug. The second and third statements are true because Ethyol (Amifostine) does have cytoprotective effects, and the HIF-1 pathway is indeed activated in response to hypoxia or low oxygen levels. Statements four and five are more specific and would require additional context or specific research references to confirm, hence they are marked as UNKNOWN. The relationship between the administration of Amifostine and changes in HIF-1 concentration, and whether this is responsible for Amifostine's cytoprotective effects, are not common knowledge and would need to be confirmed with scientific literature.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1578,
    "user_query": "Which are the main histone modifications associated with enhancers?",
    "yulan-chat-2-13b-fp16_response": "Histone modifications associated with enhancers can vary depending on the specific enhancer and the cell type, but some common modifications include:\n1. Acetylation: This modification is associated with active enhancers and is thought to promote transcriptional activation.\n2. Methylation: This modification can have both positive and negative effects on enhancer activity, depending on the specific residue and degree of methylation.\n3. Phosphorylation: This modification can also have both positive and negative effects on enhancer activity, depending on the specific residue and degree of phosphorylation.\n4. Ubiquitination: This modification can mark enhancers for degradation, leading to reduced enhancer activity.\nIt's important to note that these modifications can interact with each other and with other factors to regulate enhancer activity, and that the specific modifications present on an enhancer can vary depending on the cell type and context.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Acetylation of histones is associated with active enhancers and promotes transcriptional activation.\n2. Methylation of histones can affect enhancer activity, with positive or negative effects based on the specific residue and level of methylation.\n3. Phosphorylation of histones can influence enhancer activity, resulting in either positive or negative outcomes depending on the specific residue and level of phosphorylation.\n4. Ubiquitination of histones can lead to the marking of enhancers for degradation.\n5. The presence and effects of histone modifications can vary depending on the cell type and context.",
    "yulan-chat-2-13b-fp16_fact": [
      "Acetylation of histones is associated with active enhancers and promotes transcriptional activation.",
      "Methylation of histones can affect enhancer activity, with positive or negative effects based on the specific residue and level of methylation.",
      "Phosphorylation of histones can influence enhancer activity, resulting in either positive or negative outcomes depending on the specific residue and level of phosphorylation.",
      "Ubiquitination of histones can lead to the marking of enhancers for degradation.",
      "The presence and effects of histone modifications can vary depending on the cell type and context."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Ubiquitination of histones typically regulates transcriptional activity and DNA damage response, not the marking of enhancers for degradation.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1586,
    "user_query": "What is the principle of ATAC (Assay for Transposase-Accessible Chromatin) technique?",
    "yulan-chat-2-13b-fp16_response": "The principle of the ATAC (Assay for Transposase-Accessible Chromatin) technique is to assess the accessibility of chromatin to transposable elements, such as transposons or transposable genetic elements, in a given sample. The technique is based on the use of a transposase enzyme, which is capable of recognizing and inserting these elements into the genome at specific sites.\nThe ATAC technique involves isolating the transposable elements from the sample and then using them to analyze the accessibility of chromatin to transposase. This is done by performing a PCR (polymerase chain reaction) using primers that are specific for the transposable elements, and then sequencing the resulting products to determine the accessibility of chromatin to transposase.\nThe ATAC technique is useful for studying the epigenetic regulation of gene expression, as the accessibility of chromatin to transposase is influenced by various factors, such as DNA methylation and histone modifications, which can affect the binding of transposase to the chromatin. By measuring the accessibility of chromatin to transposase, researchers can gain insights into the epigenetic regulation of gene expression in different cell types and under different conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The ATAC technique assesses the accessibility of chromatin to transposable elements in a given sample.\n2. A transposase enzyme is used in the ATAC technique to insert elements into the genome at specific sites.\n3. The ATAC technique isolates transposable elements from the sample for analysis.\n4. Polymerase chain reaction (PCR) is performed with primers specific for the transposable elements in the ATAC technique.\n5. The ATAC technique is employed to study the epigenetic regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "The ATAC technique assesses the accessibility of chromatin to transposable elements in a given sample.",
      "A transposase enzyme is used in the ATAC technique to insert elements into the genome at specific sites.",
      "The ATAC technique isolates transposable elements from the sample for analysis.",
      "Polymerase chain reaction (PCR) is performed with primers specific for the transposable elements in the ATAC technique.",
      "The ATAC technique is employed to study the epigenetic regulation of gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The ATAC (Assay for Transposase-Accessible Chromatin) technique assesses the accessibility of chromatin in a given sample, not specifically to transposable elements.\n2. TRUE: A transposase enzyme is used in the ATAC technique to insert sequencing adapters into open regions of the chromatin.\n3. FALSE [correction]: The ATAC technique does not isolate transposable elements from the sample for analysis; instead, it uses a transposase to probe open chromatin regions for genomic accessibility.\n4. FALSE [correction]: Polymerase chain reaction (PCR) is performed with primers specific to the adapters inserted by the transposase, not for the transposable elements themselves.\n5. TRUE: The ATAC technique is used to study the regulation of gene expression and can provide insights into epigenetic regulation.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1587,
    "user_query": "Which are the main NMD factors in Saccharomyces cerevisiae?",
    "yulan-chat-2-13b-fp16_response": "In the yeast Saccharomyces cerevisiae, the main NMD (nonsense-mediated decay) factors include:\n1. Upf0542 protein (Essential for NMD)\n2. Upf0706 protein (Essential for NMD)\n3. Upf0708 protein (Essential for NMD)\n4. Upf1257 protein (Essential for NMD)\n5. Upf1260 protein (Essential for NMD)\n6. Upf1261 protein (Essential for NMD)\n7. Upf1262 protein (Essential for NMD)\n8. Upf1263 protein (Essential for NMD)\n9. Upf1264 protein (Essential for NMD)\n10. Upf1265 protein (Essential for NMD)\nNote: Upf stands for \"universal protein function\" and is a classification system for proteins involved in NMD.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Upf0542 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.\n2. Upf0706 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.\n3. Upf0708 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.\n4. Upf1257 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.\n5. Upf1260 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.",
    "yulan-chat-2-13b-fp16_fact": [
      "Upf0542 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.",
      "Upf0706 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.",
      "Upf0708 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.",
      "Upf1257 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae.",
      "Upf1260 protein is essential for nonsense-mediated decay (NMD) in Saccharomyces cerevisiae."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe information given does not match the standard nomenclature of proteins involved in nonsense-mediated decay (NMD) in Saccharomyces cerevisiae, nor does it provide sufficient detail to verify the statements. Proteins typically associated with NMD in Saccharomyces cerevisiae are known as Upf1, Upf2, and Upf3. Without additional context or clarification, the validity of the statements regarding Upf0542, Upf0706, Upf0708, Upf1257, and Upf1260 cannot be determined.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "yulan-chat-2-13b-fp16_response": "Set7 is a histone methyltransferase that primarily deposits the H3K4me3 mark on lysine 4 of histone H3. This mark is associated with active gene expression and is often found in the promoter regions of genes. However, Set7 can also deposit other histone marks, including H3K27ac, H3K27me3, and H3K4me1, on histone H3.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Set7 is a histone methyltransferase.\n2. Set7 primarily deposits the H3K4me3 mark on lysine 4 of histone H3.\n3. The H3K4me3 mark is associated with active gene expression.\n4. The H3K4me3 mark is often found in the promoter regions of genes.\n5. Set7 can also deposit marks such as H3K27ac, H3K27me3, and H3K4me1 on histone H3.",
    "yulan-chat-2-13b-fp16_fact": [
      "Set7 is a histone methyltransferase.",
      "Set7 primarily deposits the H3K4me3 mark on lysine 4 of histone H3.",
      "The H3K4me3 mark is associated with active gene expression.",
      "The H3K4me3 mark is often found in the promoter regions of genes.",
      "Set7 can also deposit marks such as H3K27ac, H3K27me3, and H3K4me1 on histone H3."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Set7 primarily deposits the H3K4me1 mark on lysine 4 of histone H3, not H3K4me3.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Set7 is specific for the methylation of lysine 4 on histone H3 to form H3K4me1; it does not deposit H3K27ac, H3K27me3, H3K4me1 is correct but is redundant in this list as it is Set7's primary activity.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1592,
    "user_query": "Which genes are associated with Ehlers-Danlos syndrome type I/II?",
    "yulan-chat-2-13b-fp16_response": "Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders that can affect the skin, joints, and other organs. There are several different types of EDS, including types I, II, III, IV, V, and VI.\nType I EDS is also known as classical EDS and is caused by mutations in the COL1A1 or COL1A2 genes. These genes provide instructions for making collagen, which is a protein that is essential for the structure and function of connective tissue. Mutations in these genes can lead to the production of abnormal collagen, which can cause the symptoms of EDS.\nType II EDS is also known as hyperelastic EDS and is caused by mutations in the COL1A3 gene. This gene also provides instructions for making collagen, and mutations in this gene can lead to the production of abnormal collagen that is more elastic than normal. This can cause the skin and other tissues to be more stretchy than they should be, which can lead to the symptoms of EDS.\nIt's important to note that there are many different mutations in these genes that can cause EDS, and not everyone with the condition has the same symptoms or severity of symptoms. If you have questions about EDS or your own risk for the condition, it's best to speak with a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ehlers-Danlos syndrome (EDS) is an inherited connective tissue disorder.\n2. Type I EDS, also known as classical EDS, is caused by mutations in the COL1A1 or COL1A2 genes.\n3. The COL1A1 and COL1A2 genes are responsible for making collagen.\n4. Type II EDS, also known as hyperelastic EDS, is caused by mutations in the COL1A3 gene.\n5. Mutations in the COL1A1, COL1A2, and COL1A3 genes can lead to the production of abnormal collagen.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ehlers-Danlos syndrome (EDS) is an inherited connective tissue disorder.",
      "Type I EDS, also known as classical EDS, is caused by mutations in the COL1A1 or COL1A2 genes.",
      "The COL1A1 and COL1A2 genes are responsible for making collagen.",
      "Type II EDS, also known as hyperelastic EDS, is caused by mutations in the COL1A3 gene.",
      "Mutations in the COL1A1, COL1A2, and COL1A3 genes can lead to the production of abnormal collagen."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Type I EDS, also known as classical EDS, is caused by mutations in the COL5A1 or COL5A2 genes, not the COL1A1 or COL1A2 genes.\n3. TRUE\n4. FALSE [correction]: There is no Type II EDS classified as \"hyperelastic EDS.\" Hypermobile EDS (hEDS), which is often thought to involve hyperelastic skin, has an unclear genetic cause, and there is no COL1A3 gene associated with EDS. The correct term for the related gene would be COL3A1, but it is not associated with hypermobile EDS. It is associated with vascular EDS.\n5. TRUE (assuming the intent was to refer to collagen-related genes properly associated with EDS, such as COL5A1, COL5A2 for classical EDS and COL3A1 for vascular EDS, despite the error in gene naming for statement 4)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1593,
    "user_query": "Which factors are considered in the ABCD2 score?",
    "yulan-chat-2-13b-fp16_response": "The ABCD2 score is a tool used to assess the risk of stroke in patients with acute ischemic stroke or transient ischemic attack (TIA). The score considers the following factors:\nA - Age: The patient's age is taken into account, with older patients considered to be at higher risk of stroke.\nB - Blood pressure: The patient's blood pressure measurement is taken into account, with higher blood pressure being a risk factor for stroke.\nC - Clinical features: The presence of certain clinical features, such as speech difficulty, facial weakness, and arm weakness, is taken into account. These features are indicative of a higher risk of stroke.\nD - Detection/diagnosis: The time it takes to diagnose the TIA or acute ischemic stroke is also taken into account. The sooner the diagnosis is made, the lower the risk of stroke.\nThe ABCD2 score is then calculated by assigning a score from 0 to 3 for each of the four factors, with a maximum score of 14. The higher the score, the greater the risk of stroke.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The ABCD2 score is used to assess the risk of stroke in patients with acute ischemic stroke or transient ischemic attack.\n2. Age is a factor in the ABCD2 score, with older patients considered to be at higher risk of stroke.\n3. Blood pressure measurement is a factor in the ABCD2 score, with higher blood pressure being a risk factor.\n4. Clinical features such as speech difficulty, facial weakness, and arm weakness are factors in the ABCD2 score, indicative of a higher risk of stroke.\n5. The time it takes to diagnose the TIA or acute ischemic stroke is a factor in the ABCD2 score, with a quicker diagnosis associated with a lower risk of stroke.",
    "yulan-chat-2-13b-fp16_fact": [
      "The ABCD2 score is used to assess the risk of stroke in patients with acute ischemic stroke or transient ischemic attack.",
      "Age is a factor in the ABCD2 score, with older patients considered to be at higher risk of stroke.",
      "Blood pressure measurement is a factor in the ABCD2 score, with higher blood pressure being a risk factor.",
      "Clinical features such as speech difficulty, facial weakness, and arm weakness are factors in the ABCD2 score, indicative of a higher risk of stroke.",
      "The time it takes to diagnose the TIA or acute ischemic stroke is a factor in the ABCD2 score, with a quicker diagnosis associated with a lower risk of stroke."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The time factor in the ABCD2 score refers to the duration of symptoms, not the time it takes to diagnose the TIA or acute ischemic stroke. A longer duration of symptoms is associated with a higher risk of stroke.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1594,
    "user_query": "Is Tuberous Sclerosis a genetic disease?",
    "yulan-chat-2-13b-fp16_response": "Yes, Tuberous Sclerosis is a genetic disease. It is caused by mutations in the TSC1 or TSC2 genes, which encode for proteins that regulate cell growth and division. These mutations lead to the overactivation of certain signaling pathways, resulting in the development of tumors and other symptoms associated with the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tuberous Sclerosis is a genetic disease.\n2. Mutations in the TSC1 or TSC2 genes cause Tuberous Sclerosis.\n3. The proteins encoded by the TSC1 or TSC2 genes regulate cell growth and division.\n4. Mutations in these genes lead to the overactivation of certain signaling pathways.\n5. The overactivation of signaling pathways due to these mutations results in the development of tumors and other symptoms of Tuberous Sclerosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tuberous Sclerosis is a genetic disease.",
      "Mutations in the TSC1 or TSC2 genes cause Tuberous Sclerosis.",
      "The proteins encoded by the TSC1 or TSC2 genes regulate cell growth and division.",
      "Mutations in these genes lead to the overactivation of certain signaling pathways.",
      "The overactivation of signaling pathways due to these mutations results in the development of tumors and other symptoms of Tuberous Sclerosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1598,
    "user_query": "What type of DNA repair pathways is initiated by AlkA glycosylase?",
    "yulan-chat-2-13b-fp16_response": "AlkA glycosylase is an enzyme that initiates the base excision repair (BER) pathway in DNA. The BER pathway is one of the major DNA repair pathways that cells use to repair damaged DNA. It is activated when AlkA glycosylase recognizes and removes a damaged base from the DNA molecule. The damaged base is then replaced with a correct base, and the repaired DNA molecule is released. The BER pathway is particularly important for repairing damage caused by reactive oxygen species, such as the oxidation of guanine to form 8-oxo-guanine.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. AlkA glycosylase initiates the base excision repair (BER) pathway in DNA.\n2. The BER pathway repairs damaged DNA by recognizing and removing damaged bases.\n3. After removal of the damaged base by AlkA glycosylase, the base is replaced with a correct one.\n4. The BER pathway is essential for repairing damage caused by reactive oxygen species.\n5. Reactive oxygen species can cause the oxidation of guanine to form 8-oxo-guanine, which is repaired by the BER pathway.",
    "yulan-chat-2-13b-fp16_fact": [
      "AlkA glycosylase initiates the base excision repair (BER) pathway in DNA.",
      "The BER pathway repairs damaged DNA by recognizing and removing damaged bases.",
      "After removal of the damaged base by AlkA glycosylase, the base is replaced with a correct one.",
      "The BER pathway is essential for repairing damage caused by reactive oxygen species.",
      "Reactive oxygen species can cause the oxidation of guanine to form 8-oxo-guanine, which is repaired by the BER pathway."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: AlkA glycosylase is one of several glycosylases that can initiate the base excision repair (BER) pathway in DNA, but it is not the only one.\n2. TRUE\n3. TRUE  After removal of the damaged base by a glycosylase (such as AlkA in bacteria), the site is eventually restored with the correct base through the actions of other enzymes in the BER pathway.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1605,
    "user_query": "What is the mechanism of cementogenesis in pulp regeneration?",
    "yulan-chat-2-13b-fp16_response": "Cementogenesis is the process of forming cementum, which is a hard tissue that covers the root of a tooth. In pulp regeneration, cementogenesis is an important mechanism for the formation of a new cementum layer around the newly formed dentin.\nThe process of cementogenesis in pulp regeneration involves the differentiation of cells called cementoblasts, which are located on the surface of the dentin bridge that is formed during pulp capping. These cells differentiate into cementocytes, which produce the cementum.\nThe cementocytes secrete a matrix of collagen and other proteins, which mineralizes to form the cementum. The process of cementogenesis is stimulated by the presence of dentin, which provides a surface for the cementoblasts to attach to and a source of signaling molecules that promote cementogenesis.\nIn addition to the cementocytes, other cells are involved in cementogenesis, including fibroblasts, which produce the extracellular matrix, and osteoclasts, which help to resorb the old cementum and create space for the new cementum to form.\nOverall, cementogenesis is a complex process that involves the differentiation and function of multiple cell types, and is regulated by a variety of signaling molecules and growth factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cementogenesis is the process of forming cementum, which covers the root of a tooth.\n2. Cementoblasts, located on the surface of the dentin bridge formed during pulp capping, differentiate into cementocytes in pulp regeneration.\n3. Cementocytes secrete a matrix of collagen and other proteins which mineralizes to form cementum.\n4. Dentin provides a surface for cementoblasts to attach to and supplies signaling molecules that promote cementogenesis.\n5. Fibroblasts produce the extracellular matrix and osteoclasts resorb old cementum to create space for new cementum during cementogenesis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cementogenesis is the process of forming cementum, which covers the root of a tooth.",
      "Cementoblasts, located on the surface of the dentin bridge formed during pulp capping, differentiate into cementocytes in pulp regeneration.",
      "Cementocytes secrete a matrix of collagen and other proteins which mineralizes to form cementum.",
      "Dentin provides a surface for cementoblasts to attach to and supplies signaling molecules that promote cementogenesis.",
      "Fibroblasts produce the extracellular matrix and osteoclasts resorb old cementum to create space for new cementum during cementogenesis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Cementoblasts, which differentiate into cementocytes as they become embedded in the cementum they secrete, are not located on the surface of the dentin bridge formed during pulp capping; they are located on the dental root surface.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Fibroblasts produce the extracellular matrix within the periodontal ligament, not cementum. Osteoclasts resorb bone rather than cementum; the cells responsible for the resorption of cementum are called cementoclasts.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1606,
    "user_query": "What are the reported adverse effects of gabapentin used in children?",
    "yulan-chat-2-13b-fp16_response": "Gabapentin is an anticonvulsant medication that is sometimes used to treat seizures in children. As with any medication, there are potential adverse effects associated with its use. Some of the reported adverse effects of gabapentin used in children include:\n1. Drowsiness or dizziness\n2. Fatigue or lethargy\n3. Nausea or vomiting\n4. Diarrhea\n5. Difficulty with coordination or balance\n6. Hostility or aggressive behavior\n7. Agitation or restlessness\n8. Changes in appetite or weight\n9. Rash or skin reaction\n10. Eye problems, such as double vision or dilated pupils\nIt's important to note that not all children will experience these side effects, and many will tolerate gabapentin well. If you have concerns about your child taking gabapentin, it's important to discuss them with their healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gabapentin is used to treat seizures in children.\n2. Adverse effects of gabapentin in children can include drowsiness or dizziness.\n3. Fatigue or lethargy is a reported adverse effect of gabapentin when used in children.\n4. Children taking gabapentin may experience nausea or vomiting.\n5. Gabapentin usage in children can lead to difficulty with coordination or balance.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gabapentin is used to treat seizures in children.",
      "Adverse effects of gabapentin in children can include drowsiness or dizziness.",
      "Fatigue or lethargy is a reported adverse effect of gabapentin when used in children.",
      "Children taking gabapentin may experience nausea or vomiting.",
      "Gabapentin usage in children can lead to difficulty with coordination or balance."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1617,
    "user_query": "What are the skeletal muscle satellite cells?",
    "yulan-chat-2-13b-fp16_response": "Skeletal muscle satellite cells are a type of stem cell that are found in the skeletal muscle tissue. They are called satellite cells because they are located outside of the main muscle fibers and are \"satellite\" to them. These cells have the ability to differentiate into new muscle fibers, which can help repair damaged muscle tissue. Additionally, satellite cells can also undergo self-renewal, which allows them to divide and maintain their stem cell status. Because of their ability to regenerate muscle tissue, satellite cells are of great interest for the treatment of muscle-related diseases and injuries.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Skeletal muscle satellite cells are a type of stem cell found in skeletal muscle tissue.\n2. Satellite cells are located outside of the main muscle fibers.\n3. Skeletal muscle satellite cells can differentiate into new muscle fibers to repair damaged muscle tissue.\n4. Satellite cells have the ability to undergo self-renewal.\n5. Satellite cells are of interest for the treatment of muscle-related diseases and injuries.",
    "yulan-chat-2-13b-fp16_fact": [
      "Skeletal muscle satellite cells are a type of stem cell found in skeletal muscle tissue.",
      "Satellite cells are located outside of the main muscle fibers.",
      "Skeletal muscle satellite cells can differentiate into new muscle fibers to repair damaged muscle tissue.",
      "Satellite cells have the ability to undergo self-renewal.",
      "Satellite cells are of interest for the treatment of muscle-related diseases and injuries."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1618,
    "user_query": "What is the role of neurogranin in Alzheimer's disease patients?",
    "yulan-chat-2-13b-fp16_response": "Neurogranin is a protein that is found in the brain and has been implicated in Alzheimer's disease. Studies have shown that levels of neurogranin are decreased in the brains of patients with Alzheimer's disease, and that this decrease may contribute to the development and progression of the disease. It is thought that neurogranin may play a role in the formation and maintenance of synapses, the connections between neurons, and that its depletion may lead to synaptic loss and cognitive decline. However, more research is needed to fully understand the role of neurogranin in Alzheimer's disease and to determine its potential as a therapeutic target.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neurogranin is a protein found in the brain.\n2. Studies have indicated that levels of neurogranin are decreased in the brains of patients with Alzheimer's disease.\n3. The decrease of neurogranin may contribute to the development and progression of Alzheimer's disease.\n4. Neurogranin is thought to play a role in the formation and maintenance of synapses in the brain.\n5. Depletion of neurogranin may lead to synaptic loss and cognitive decline in Alzheimer's disease patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neurogranin is a protein found in the brain.",
      "Studies have indicated that levels of neurogranin are decreased in the brains of patients with Alzheimer's disease.",
      "The decrease of neurogranin may contribute to the development and progression of Alzheimer's disease.",
      "Neurogranin is thought to play a role in the formation and maintenance of synapses in the brain.",
      "Depletion of neurogranin may lead to synaptic loss and cognitive decline in Alzheimer's disease patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Studies have indicated that levels of neurogranin are increased in the brains of patients with Alzheimer's disease.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1619,
    "user_query": "Does triiodothyronine play a regulatory role in insulin secretion from pancreas?",
    "yulan-chat-2-13b-fp16_response": "Yes, triiodothyronine (T3) has been shown to play a regulatory role in insulin secretion from the pancreas. T3 is a thyroid hormone that affects metabolism in various tissues and organs, including the pancreas.\nStudies have shown that T3 can increase insulin secretion from the pancreas, particularly in response to low-glucose levels. This is thought to occur through the activation of the adenylate cyclase-cAMP-protein kinase A (AC-cAMP-PKA) signaling pathway, which leads to increased insulin secretion.\nHowever, T3 can also have opposing effects on insulin secretion under different conditions. For example, high levels of T3 can inhibit insulin secretion, particularly in response to high-glucose levels. This is thought to occur through the activation of the cAMP-protein kinase C (cAMP-PKC) signaling pathway, which leads to decreased insulin secretion.\nOverall, the relationship between T3 and insulin secretion is complex and can depend on various factors, including the concentration of T3, the glucose level, and the activation of different signaling pathways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas.\n2. T3 is a thyroid hormone that affects metabolism in various tissues, including the pancreas.\n3. T3 can increase insulin secretion from the pancreas in response to low-glucose levels.\n4. High levels of T3 can inhibit insulin secretion in response to high-glucose levels.\n5. The activation of the adenylate cyclase-cAMP-protein kinase A (AC-cAMP-PKA) signaling pathway by T3 leads to increased insulin secretion.",
    "yulan-chat-2-13b-fp16_fact": [
      "Triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas.",
      "T3 is a thyroid hormone that affects metabolism in various tissues, including the pancreas.",
      "T3 can increase insulin secretion from the pancreas in response to low-glucose levels.",
      "High levels of T3 can inhibit insulin secretion in response to high-glucose levels.",
      "The activation of the adenylate cyclase-cAMP-protein kinase A (AC-cAMP-PKA) signaling pathway by T3 leads to increased insulin secretion."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas. T3 is known to affect the function of the pancreas, which includes insulin secretion.\n\n2. TRUE: T3 is a thyroid hormone that affects metabolism in various tissues, including the heart, muscle, liver, and brain, as well as the pancreas. \n\n3. TRUE: T3 can increase insulin secretion from the pancreas in response to glucose levels, although stating specifically \"low-glucose levels\" is somewhat misleading. Typically, insulin secretion is increased in response to high-glucose levels to facilitate glucose entry into cells. \n\n4. FALSE [correction]: High levels of T3 generally promote insulin secretion. It's high insulin levels that act via feedback mechanisms to regulate and inhibit further insulin secretion, not high T3 levels. \n\n5. TRUE: T3 can activate the AC-cAMP-PKA signaling pathway, and this pathway plays a crucial role in the regulation of various physiological processes, including the modulation of insulin secretion.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "yulan-chat-2-13b-fp16_response": "Hepcidin is a protein that plays a role in regulating iron metabolism. It is composed of four helical domains, which are regions of the protein that are structurally similar to helices. Each of these domains contains a disulfide bridge, which is a covalent bond between two cysteine residues in the protein. Therefore, hepcidin has a total of four disulfide bridges.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hepcidin is a protein involved in the regulation of iron metabolism.\n2. Hepcidin is composed of four helical domains.\n3. Each helical domain in hepcidin contains a disulfide bridge.\n4. A disulfide bridge is a covalent bond between two cysteine residues in a protein.\n5. Hepcidin has a total of four disulfide bridges.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hepcidin is a protein involved in the regulation of iron metabolism.",
      "Hepcidin is composed of four helical domains.",
      "Each helical domain in hepcidin contains a disulfide bridge.",
      "A disulfide bridge is a covalent bond between two cysteine residues in a protein.",
      "Hepcidin has a total of four disulfide bridges."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Hepcidin does not have a structure described in terms of helical domains. It is a small peptide hormone composed of 25 amino acids that can form beta-sheets and loop structures, but not distinct, separate helical domains.\n3. UNKNOWN [clarification]: Without a clear definition of \"helical domain\" in the context of hepcidin, it's difficult to determine the veracity of this statement. However, hepcidin does indeed contain disulfide bridges, which are important for its structure.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1622,
    "user_query": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?",
    "yulan-chat-2-13b-fp16_response": "Human Chk2 (checkpoint kinase 2) is a protein that plays a key role in the DNA damage response and cell cycle checkpoint control. There are several major intramolecular phosphorylation sites of Chk2 that are involved in cell cycle control:\n1. Serine 345: This site is phosphorylated by the kinase CDK1 during the S-phase of the cell cycle. Phosphorylation at this site is required for Chk2 to activate the DNA repair machinery and prevent cell cycle progression through mitosis.\n2. Threonine 677: This site is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle. Phosphorylation at this site is required for Chk2 to activate the DNA repair machinery and prevent cell cycle progression through mitosis.\n3. Serine 512: This site is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle. Phosphorylation at this site is required for Chk2 to activate the DNA repair machinery and prevent cell cycle progression through mitosis.\n4. Serine 317: This site is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle. Phosphorylation at this site is required for Chk2 to activate the DNA repair machinery and prevent cell cycle progression through mitosis.\n5. Serine 337: This site is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle. Phosphorylation at this site is required for Chk2 to activate the DNA repair machinery and prevent cell cycle progression through mitosis.\nOverall, these phosphorylation sites play a critical role in regulating the DNA damage response and cell cycle checkpoint control by activating the DNA repair machinery and preventing cell cycle progression through mitosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Serine 345 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the S-phase of the cell cycle.\n2. Threonine 677 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle.\n3. Serine 512 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle.\n4. Serine 317 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle.\n5. Serine 337 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle.",
    "yulan-chat-2-13b-fp16_fact": [
      "Serine 345 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the S-phase of the cell cycle.",
      "Threonine 677 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle.",
      "Serine 512 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle.",
      "Serine 317 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle.",
      "Serine 337 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Serine 345 is a phosphorylation site on human Chk2 that is phosphorylated by the kinase ATR, predominantly in response to DNA damage, not by CDK1 during the S-phase of the cell cycle.\n2. UNKNOWN (The statement regarding Threonine 677 is specific, and without access to current biological databases or literature, it's difficult to confirm its accuracy at this moment.)\n3. FALSE [correction]: According to available literature, Serine 512 on human Chk2 is phosphorylated by the kinase ATM, not CDK1, and usually in response to double-stranded DNA breaks rather than being phase-specific.\n4. TRUE (According to available literature, Serine 317 is a known phosphorylation site on human Chk2 that can be phosphorylated by the kinase CDK1 during the G2 phase of the cell cycle.)\n5. UNKNOWN (The statement regarding Serine 337 is specific, and without access to current biological databases or literature, it's difficult to confirm its accuracy at this moment.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1628,
    "user_query": "Which receptors can be evaluated with the [18F]altanserin?",
    "yulan-chat-2-13b-fp16_response": "[18F]Altanserin is a radioligand that can be used to evaluate the activity of serotonin receptors, specifically the 5-HT2 receptor subtype. This receptor is involved in various physiological and pathological processes, including mood regulation, anxiety, and cognitive function.\nThe 5-HT2 receptor is a G protein-coupled receptor (GPCR) that is activated by the neurotransmitter serotonin. It has several subtypes (5-HT2A, 5-HT2B, and 5-HT2C), each with distinct functions and expression patterns in the brain. [18F]Altanserin binds to the 5-HT2 receptor with high affinity and can be used to measure the density and function of this receptor in the brain using positron emission tomography (PET) imaging.\nIn addition to its use in research, [18F]Altanserin may have potential as a diagnostic tool for certain neurological and psychiatric disorders, such as depression, anxiety, and schizophrenia, which are associated with altered serotonin signaling in the brain. However, further research is needed to fully evaluate its potential as a clinical tool.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. [18F]Altanserin can be used to evaluate the activity of serotonin receptors.\n2. [18F]Altanserin specifically targets the 5-HT2 receptor subtype.\n3. The 5-HT2 receptor is a G protein-coupled receptor activated by serotonin.\n4. [18F]Altanserin can measure the density and function of 5-HT2 receptors in the brain via PET imaging.\n5. [18F]Altanserin has potential use as a diagnostic tool for neurological and psychiatric disorders like depression, anxiety, and schizophrenia.",
    "yulan-chat-2-13b-fp16_fact": [
      "[18F]Altanserin can be used to evaluate the activity of serotonin receptors.",
      "[18F]Altanserin specifically targets the 5-HT2 receptor subtype.",
      "The 5-HT2 receptor is a G protein-coupled receptor activated by serotonin.",
      "[18F]Altanserin can measure the density and function of 5-HT2 receptors in the brain via PET imaging.",
      "[18F]Altanserin has potential use as a diagnostic tool for neurological and psychiatric disorders like depression, anxiety, and schizophrenia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: [18F]Altanserin is a radioligand used in positron emission tomography (PET) imaging to evaluate the activity of serotonin receptors.\n2. TRUE: [18F]Altanserin is known to specifically target the 5-HT2A receptor subtype, which is a subset of serotonin receptors.\n3. TRUE: The 5-HT2 receptor, including the 5-HT2A subtype, is indeed a G protein-coupled receptor that is activated by serotonin.\n4. TRUE: [18F]Altanserin is used in PET imaging to measure the density and function of 5-HT2A receptors in the brain, which can be indicative of various physiological and pathological conditions.\n5. TRUE: [18F]Altanserin has potential use in research as a diagnostic tool for investigating the role of 5-HT2A receptors in a variety of neurological and psychiatric disorders, including depression, anxiety, and schizophrenia.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1630,
    "user_query": "Which extra thyroid tissues have thyrotropin (TSH) receptors?",
    "yulan-chat-2-13b-fp16_response": "Thyrotropin (TSH) receptors are found on the cells of the thyroid gland, which is a small gland located in the neck that produces hormones that regulate metabolism. TSH receptors are also found on certain other types of cells outside of the thyroid gland, including:\n1. Cells in the pituitary gland: The pituitary gland is a small gland located at the base of the brain that produces hormones that regulate other glands and organs in the body. TSH receptors are found on the cells of the pituitary gland that produce TSH, which is a hormone that stimulates the thyroid gland to produce thyroid hormones.\n2. Cells in the hypothalamus: The hypothalamus is an area of the brain that regulates various bodily functions, including metabolism. TSH receptors are found on the cells of the hypothalamus that produce thyrotropin-releasing hormone (TRH), which stimulates the pituitary gland to produce TSH.\n3. Cells in the liver: TSH receptors are also found on the cells of the liver, which is a large organ that helps to detoxify the body and produces bile to aid in the digestion of fats. The presence of TSH receptors on liver cells suggests that TSH may play a role in regulating liver function.\nOverall, TSH receptors are found on a variety of cells throughout the body, but they are most commonly associated with the thyroid gland and the pituitary gland.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thyrotropin (TSH) receptors are found on the cells of the thyroid gland.\n2. The thyroid gland is located in the neck and produces hormones that regulate metabolism.\n3. TSH receptors are found on cells in the pituitary gland at the base of the brain.\n4. TSH receptors are present on cells in the hypothalamus, an area of the brain that regulates metabolism.\n5. Liver cells have TSH receptors, indicating that TSH may play a role in liver function.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thyrotropin (TSH) receptors are found on the cells of the thyroid gland.",
      "The thyroid gland is located in the neck and produces hormones that regulate metabolism.",
      "TSH receptors are found on cells in the pituitary gland at the base of the brain.",
      "TSH receptors are present on cells in the hypothalamus, an area of the brain that regulates metabolism.",
      "Liver cells have TSH receptors, indicating that TSH may play a role in liver function."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TSH receptors are not found on cells in the pituitary gland; rather, the pituitary gland produces TSH, which then acts on the TSH receptors in the thyroid gland.\n4. FALSE [correction]: TSH receptors are not present on cells in the hypothalamus. The hypothalamus produces TRH (thyrotropin-releasing hormone), which stimulates the pituitary gland to secrete TSH.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1631,
    "user_query": "Which histone modifications distinguish between promoters and enhancers?",
    "yulan-chat-2-13b-fp16_response": "Histone modifications are one of the key mechanisms that distinguish between promoters and enhancers. Promoters are regions of DNA that are associated with the transcriptional start site of a gene, and they are typically marked by a specific set of histone modifications, including H3K4me3 (tri-methylation of lysine 4 on histone H3) and H3K27ac (acetylation of lysine 27 on histone H3). These modifications are thought to recruit the RNA polymerase II complex and other transcriptional co-factors to the promoter region, initiating transcription of the gene.\nEnhancers, on the other hand, are regulatory regions of DNA that can be located upstream or downstream of a gene, and they play a role in regulating the level of gene expression. Enhancers are typically marked by a different set of histone modifications, including H3K4me1 (monomethylation of lysine 4 on histone H3) and H3K27me3 (trimethylation of lysine 27 on histone H3). These modifications are thought to recruit transcriptional co-factors that can either enhance or suppress gene expression.\nOther histone modifications, such as H3K9ac and H3K27ac, have also been associated with enhancers, and the specific combination and distribution of these modifications can help to distinguish enhancers from other regulatory regions of the genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Promoters are associated with the transcriptional start site of a gene.\n2. Promoters are typically marked by histone modifications such as H3K4me3 and H3K27ac.\n3. Enhancers can be located upstream or downstream of a gene and influence the level of gene expression.\n4. Enhancers are typically marked by histone modifications such as H3K4me1 and H3K27me3.\n5. Other histone modifications like H3K9ac and H3K27ac are associated with enhancers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Promoters are associated with the transcriptional start site of a gene.",
      "Promoters are typically marked by histone modifications such as H3K4me3 and H3K27ac.",
      "Enhancers can be located upstream or downstream of a gene and influence the level of gene expression.",
      "Enhancers are typically marked by histone modifications such as H3K4me1 and H3K27me3.",
      "Other histone modifications like H3K9ac and H3K27ac are associated with enhancers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Enhancers are typically marked by histone modifications such as H3K4me1 and H3K27ac.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1632,
    "user_query": "Where is the metaxin complex localized?",
    "yulan-chat-2-13b-fp16_response": "The metaxin complex is localized in the mitochondria of eukaryotic cells. The metaxin protein is a member of the mitochondrial matrix protein family and is involved in the regulation of mitochondrial dynamics and the maintenance of mitochondrial structure and function. The metaxin complex is thought to play a role in the regulation of cellular metabolism and energy production.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The metaxin complex is localized in the mitochondria of eukaryotic cells.\n2. The metaxin protein belongs to the mitochondrial matrix protein family.\n3. The metaxin complex is involved in the regulation of mitochondrial dynamics.\n4. The metaxin complex contributes to the maintenance of mitochondrial structure and function.\n5. The metaxin complex is associated with the regulation of cellular metabolism and energy production.",
    "yulan-chat-2-13b-fp16_fact": [
      "The metaxin complex is localized in the mitochondria of eukaryotic cells.",
      "The metaxin protein belongs to the mitochondrial matrix protein family.",
      "The metaxin complex is involved in the regulation of mitochondrial dynamics.",
      "The metaxin complex contributes to the maintenance of mitochondrial structure and function.",
      "The metaxin complex is associated with the regulation of cellular metabolism and energy production."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The metaxin protein is not categorized under the mitochondrial matrix protein family; instead, it is part of the outer mitochondrial membrane protein complex involved in protein import.\n3. TRUE: The metaxin complex has been implicated in the regulation of mitochondrial dynamics, including processes such as fusion and fission of mitochondria.\n4. TRUE: The metaxin complex does contribute to the maintenance of mitochondrial structure and function, particularly through its role in protein import.\n5. TRUE: Given the metaxin complex's role in the import of proteins into mitochondria and its impact on mitochondrial dynamics, it is indirectly associated with the regulation of cellular metabolism and energy production since these are central functions of mitochondria.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1633,
    "user_query": "What are the major classes of retrotransposons active in the human genome?",
    "yulan-chat-2-13b-fp16_response": "There are several major classes of retrotransposons active in the human genome, including:\n1. Long interspersed nuclear elements (LINs): These are the most abundant retrotransposons in the human genome and are responsible for a significant portion of genome expansion.\n2. Short interspersed nuclear elements (SINs): These are smaller than LINs and are also active in the human genome.\n3. Retrotransposon-like elements (RLEs): These elements are related to retrotransposons but are not able to transpose independently.\n4. Penelope elements: These are a class of retrotransposons that are active in mammals and are characterized by a unique structure.\n5. Maverick elements: These are a class of retrotransposons that are related to LINs but have a different structure and are less active in the human genome.\nIt's worth noting that retrotransposons are constantly evolving and new classes may be discovered in the future.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Long interspersed nuclear elements (LINEs) are the most abundant retrotransposons in the human genome.\n2. Short interspersed nuclear elements (SINEs) are smaller than LINEs and are active in the human genome.\n3. Retrotransposon-like elements (RLEs) are related to retrotransposons but cannot transpose independently.\n4. Penelope elements are a class of retrotransposons that are active in mammals.\n5. Maverick elements are a class of retrotransposons related to LINEs but have a different structure and are less active in the human genome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Long interspersed nuclear elements (LINEs) are the most abundant retrotransposons in the human genome.",
      "Short interspersed nuclear elements (SINEs) are smaller than LINEs and are active in the human genome.",
      "Retrotransposon-like elements (RLEs) are related to retrotransposons but cannot transpose independently.",
      "Penelope elements are a class of retrotransposons that are active in mammals.",
      "Maverick elements are a class of retrotransposons related to LINEs but have a different structure and are less active in the human genome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Long interspersed nuclear elements (LINEs) are indeed the most abundant retrotransposons in the human genome.\n2. TRUE: Short interspersed nuclear elements (SINEs) are generally smaller than LINEs and some are active in the human genome.\n3. TRUE: Retrotransposon-like elements (RLEs), also sometimes referred to as retrotransposon-like sequences, are indeed related to retrotransposons but typically lack the ability to transpose independently because they do not encode the proteins needed for their own mobilization.\n4. FALSE [correction]: Penelope elements are a class of retrotransposons that are not known to be active in mammals; they have been studied primarily in invertebrates like the fruit fly.\n5. TRUE: Maverick elements, also known as Polintons, are indeed a class of retrotransposons that are related to LINEs but have a different structure. They are typically less active in the human genome.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1634,
    "user_query": "Which are the clinical characteristics of Diamond-Blackfan anemia?",
    "yulan-chat-2-13b-fp16_response": "Diamond-Blackfan anemia (DBA) is a rare genetic disorder characterized by a deficiency of red blood cells (RBCs) in the body. The clinical features of DBA can vary widely, but some common symptoms include:\n1. Fatigue: People with DBA often experience persistent fatigue due to the decreased number of RBCs in their bloodstream.\n2. Pale skin: The lack of RBCs can cause a decrease in hemoglobin, which gives blood its red color. This can result in pale or yellowish skin.\n3. Shortness of breath: DBA can cause a decrease in the amount of oxygen in the blood, which can lead to shortness of breath, especially during physical activity.\n4. Heart problems: DBA can increase the risk of heart problems, such as heart failure, abnormal heart rhythms, and blood clots.\n5. Delayed growth and development: Children with DBA may grow more slowly than their peers and may experience delays in development.\n6. Jaundice: In some cases, DBA can cause jaundice, which is a yellowing of the skin and eyes due to a buildup of bilirubin in the blood.\n7. Anemia: The primary symptom of DBA is anemia, which is a condition in which there are not enough RBCs in the blood to carry oxygen to the body's tissues. Symptoms of anemia can include weakness, fatigue, pale skin, and shortness of breath.\nIt's important to note that not everyone with DBA will experience all of these symptoms, and some people may have more severe symptoms than others. If you are concerned that you or a loved one may have DBA, it's important to speak with a healthcare provider for an accurate diagnosis and appropriate treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Diamond-Blackfan anemia (DBA) is a rare genetic disorder characterized by a deficiency of red blood cells (RBCs).\n2. Common symptoms of DBA include persistent fatigue due to the decreased number of RBCs in the bloodstream.\n3. Individuals with DBA can experience pale or yellowish skin due to a decrease in hemoglobin.\n4. People with DBA can have an increased risk of heart problems, such as heart failure, abnormal heart rhythms, and blood clots.\n5. DBA can cause delayed growth and development in children.",
    "yulan-chat-2-13b-fp16_fact": [
      "Diamond-Blackfan anemia (DBA) is a rare genetic disorder characterized by a deficiency of red blood cells (RBCs).",
      "Common symptoms of DBA include persistent fatigue due to the decreased number of RBCs in the bloodstream.",
      "Individuals with DBA can experience pale or yellowish skin due to a decrease in hemoglobin.",
      "People with DBA can have an increased risk of heart problems, such as heart failure, abnormal heart rhythms, and blood clots.",
      "DBA can cause delayed growth and development in children."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Individuals with DBA can have an increased risk of congenital anomalies, including those affecting the heart, but the specific heart problems listed (such as heart failure, abnormal heart rhythms, and blood clots) are not typically associated with DBA. Patients with any chronic anemia may have an increased risk for heart problems due to the heart working harder to compensate for the reduced oxygen-carrying capacity of the blood.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1638,
    "user_query": "Which is the receptor for the immunosuppressive drug cyclosporin A (CsA)?",
    "yulan-chat-2-13b-fp16_response": "The receptor for the immunosuppressive drug cyclosporin A (CsA) is the cyclophilin protein. Cyclophilin is a protein found in the cells of many tissues and organs in the body, including the kidneys, liver, and lymph nodes. Cyclosporin binds to cyclophilin and inhibits the activity of the immune system, which can help to prevent the rejection of transplanted organs. Cyclosporin is often used to prevent the rejection of transplanted organs, and it is also sometimes used to treat other conditions, such as psoriasis and nephrotic syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cyclosporin A (CsA) has a receptor known as the cyclophilin protein.\n2. Cyclophilin protein is found in the cells of many tissues and organs including the kidneys, liver, and lymph nodes.\n3. Cyclosporin's mechanism involves binding to cyclophilin to inhibit the immune system's activity.\n4. Cyclosporin A is commonly used to prevent rejection of transplanted organs.\n5. Cyclosporin A is also used to treat conditions such as psoriasis and nephrotic syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cyclosporin A (CsA) has a receptor known as the cyclophilin protein.",
      "Cyclophilin protein is found in the cells of many tissues and organs including the kidneys, liver, and lymph nodes.",
      "Cyclosporin's mechanism involves binding to cyclophilin to inhibit the immune system's activity.",
      "Cyclosporin A is commonly used to prevent rejection of transplanted organs.",
      "Cyclosporin A is also used to treat conditions such as psoriasis and nephrotic syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Cyclosporin's mechanism involves binding to cyclophilin; however, the actual immune suppression occurs when the cyclosporin-cyclophilin complex inhibits calcineurin, which is crucial for activating T-cells of the immune system.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1642,
    "user_query": "In which types of DNA repair is the UvrAB complex involved?",
    "yulan-chat-2-13b-fp16_response": "The UvrAB complex is involved in two main types of DNA repair:\n1. Nucleotide excision repair (NER): NER is a mechanism that removes bulky DNA lesions, such as UV-induced photoproducts, from the genome. The UvrAB complex is involved in the processing of these lesions by unwinding the DNA and facilitating the binding of other repair proteins to the site of damage.\n2. Mismatch repair (MMR): MMR is a mechanism that corrects errors that occur during DNA replication, such as mismatched base pairs. The UvrAB complex is involved in the processing of mismatched bases by unwinding the DNA and facilitating the binding of other repair proteins to the site of damage.\nOverall, the UvrAB complex plays an important role in maintaining the accuracy and stability of the genome by facilitating the repair of DNA damage.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The UvrAB complex is involved in nucleotide excision repair (NER).\n2. Nucleotide excision repair (NER) is a mechanism that removes bulky DNA lesions such as UV-induced photoproducts.\n3. The UvrAB complex helps in the processing of bulky DNA lesions by unwinding the DNA.\n4. The UvrAB complex is also involved in mismatch repair (MMR).\n5. Mismatch repair (MMR) is a mechanism that corrects errors that occur during DNA replication, like mismatched base pairs.",
    "yulan-chat-2-13b-fp16_fact": [
      "The UvrAB complex is involved in nucleotide excision repair (NER).",
      "Nucleotide excision repair (NER) is a mechanism that removes bulky DNA lesions such as UV-induced photoproducts.",
      "The UvrAB complex helps in the processing of bulky DNA lesions by unwinding the DNA.",
      "The UvrAB complex is also involved in mismatch repair (MMR).",
      "Mismatch repair (MMR) is a mechanism that corrects errors that occur during DNA replication, like mismatched base pairs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The UvrAB complex is not involved in mismatch repair (MMR); it is specific to nucleotide excision repair (NER). Mismatch repair is performed by different protein complexes, including MutS and MutL in prokaryotes, and MSH and MLH proteins in eukaryotes.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "yulan-chat-2-13b-fp16_response": "The protein encoded by the gene DNAJC11 is localized to the mitochondria. Specifically, it is a member of the DNAJ (DnaJ homolog) protein family, which are heat shock proteins that play a role in protein folding and mitochondrial protein import. DNAJC11 has been shown to interact with other mitochondrial proteins and is involved in the regulation of mitochondrial function and apoptosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The protein encoded by the gene DNAJC11 is localized to the mitochondria.\n2. DNAJC11 is a member of the DNAJ (DnaJ homolog) protein family.\n3. Proteins in the DNAJ family play a role in protein folding.\n4. DNAJC11 is involved in mitochondrial protein import.\n5. DNAJC11 plays a role in the regulation of mitochondrial function and apoptosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "The protein encoded by the gene DNAJC11 is localized to the mitochondria.",
      "DNAJC11 is a member of the DNAJ (DnaJ homolog) protein family.",
      "Proteins in the DNAJ family play a role in protein folding.",
      "DNAJC11 is involved in mitochondrial protein import.",
      "DNAJC11 plays a role in the regulation of mitochondrial function and apoptosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nBased on the statements provided, it is generally possible to confirm the first three as true:\n\n1. It is accurate that DNAJC11 is encoded by a gene and is known to be localized to the mitochondria.\n2. DNAJC11 is indeed a member of the DNAJ protein family, which are homologs to the DnaJ protein in E. coli.\n3. Proteins in the DNAJ family are known to be involved in protein folding, often acting as chaperones that assist other proteins in achieving their functional conformation.\n\nHowever, for statements 4 and 5, without specific references to literature or scientific studies, it is difficult to validate the specifics of DNAJC11's involvement in mitochondrial protein import or its role in the regulation of mitochondrial function and apoptosis. These roles can differ among members of the DNAJ family, and the functions of some specific proteins may not be as well characterized. Without additional information, the truth of these statements remains unknown.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1646,
    "user_query": "Which hormone abnormalities are characteristic to Pendred syndrome?",
    "yulan-chat-2-13b-fp16_response": "Pendred syndrome is a rare genetic disorder that is characterized by hearing loss and a hormonal imbalance. The hormonal abnormality that is characteristic of Pendred syndrome is an excess of the hormone cortisol. This is due to a defect in the Pendred syndrome gene, which is involved in the production of the hormone corticotrophin-releasing hormone (CRH). CRH regulates the release of cortisol from the pituitary gland, and in Pendred syndrome, the defect in the Pendred syndrome gene leads to an overproduction of CRH, which in turn leads to an overproduction of cortisol. This hormonal abnormality can cause a range of symptoms, including hearing loss, short stature, and a characteristic facial appearance. Pendred syndrome is named after Dr. David Pendred, who first described the condition in 1963.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pendred syndrome is characterized by hearing loss and hormonal imbalance.\n2. A hormonal abnormality characteristic of Pendred syndrome is an excess of the hormone cortisol.\n3. The hormone corticotrophin-releasing hormone (CRH), which regulates the release of cortisol from the pituitary gland, is overproduced in Pendred syndrome.\n4. Symptoms of Pendred syndrome may include hearing loss, short stature, and a characteristic facial appearance.\n5. Pendred syndrome was first described by Dr. David Pendred in 1963.\n\nHowever, it is important to note that the description of Pendred syndrome's hormonal abnormality in this task is incorrect. Pendred syndrome typically involves defects in the creation of thyroid hormones, not an overproduction of cortisol. This error undermines the validity and verifiability of the provided factual statements related to the hormonal aspects of the disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pendred syndrome is characterized by hearing loss and hormonal imbalance.",
      "A hormonal abnormality characteristic of Pendred syndrome is an excess of the hormone cortisol.",
      "The hormone corticotrophin-releasing hormone (CRH), which regulates the release of cortisol from the pituitary gland, is overproduced in Pendred syndrome.",
      "Symptoms of Pendred syndrome may include hearing loss, short stature, and a characteristic facial appearance.",
      "Pendred syndrome was first described by Dr. David Pendred in 1963.",
      "wever, it is important to note that the description of Pendred syndrome's hormonal abnormality in this task is incorrect. Pendred syndrome typically involves defects in the creation of thyroid hormones, not an overproduction of cortisol. This error undermines the validity and verifiability of the provided factual statements related to the hormonal aspects of the disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: A hormonal abnormality characteristic of Pendred syndrome is not an excess of the hormone cortisol, but a defect in the thyroid gland related to iodine processing, often leading to hypothyroidism.\n3. FALSE [correction]: The overproduction of corticotrophin-releasing hormone (CRH) is not associated with Pendred syndrome. Instead, Pendred syndrome involves abnormalities with the thyroid gland and inner ear.\n4. FALSE [correction]: Symptoms of Pendred syndrome typically include hearing loss and goiter due to thyroid dysfunction. Short stature and a characteristic facial appearance are not standard symptoms of this condition.\n5. FALSE [correction]: Pendred syndrome was first described by Vaughan Pendred in 1896.\n6. TRUE.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1647,
    "user_query": "What is the mode of inheritance of  long QT  Jervell and Lange-Nielsen syndrome?",
    "yulan-chat-2-13b-fp16_response": "Long QT Jervell and Lange-Nielsen syndrome is a genetic disorder that affects the electrical activity of the heart. It is caused by mutations in the SCN5A gene, which codes for a protein called the alpha-subunit of the voltage-gated sodium channel. The mode of inheritance of this disorder is autosomal recessive, which means that a person must inherit two copies of the mutated gene (one from each parent) in order to develop the condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Long QT Jervell and Lange-Nielsen syndrome affects the electrical activity of the heart.\n2. It is caused by mutations in the SCN5A gene.\n3. The SCN5A gene codes for a protein called the alpha-subunit of the voltage-gated sodium channel.\n4. The mode of inheritance for Long QT Jervell and Lange-Nielsen syndrome is autosomal recessive.\n5. To develop the condition, a person must inherit two copies of the mutated gene, one from each parent.",
    "yulan-chat-2-13b-fp16_fact": [
      "Long QT Jervell and Lange-Nielsen syndrome affects the electrical activity of the heart.",
      "It is caused by mutations in the SCN5A gene.",
      "The SCN5A gene codes for a protein called the alpha-subunit of the voltage-gated sodium channel.",
      "The mode of inheritance for Long QT Jervell and Lange-Nielsen syndrome is autosomal recessive.",
      "To develop the condition, a person must inherit two copies of the mutated gene, one from each parent."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Long QT Jervell and Lange-Nielsen syndrome is typically caused by mutations in the KCNQ1 or KCNE1 gene, not the SCN5A gene.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1648,
    "user_query": "List programs suitable for protein docking",
    "yulan-chat-2-13b-fp16_response": "There are several programs that are suitable for protein docking, including:\n1. AutoDock: A widely used program for docking small molecules to proteins.\n2. PatchDock: An extension of AutoDock that allows for the docking of flexible ligands and peptides.\n3. RosettaDock: A docking program that uses a force field to predict the binding of small molecules to proteins.\n4. Glide: A docking program that uses a hybrid approach to predict the binding of small molecules to proteins.\n5. HADDOCK: A program that uses a coarse-grained representation of proteins and ligands to predict their binding interactions.\n6. LIGPLANE: A program that uses a graph-based approach to predict the binding of small molecules to proteins.\n7. PatchDock-RDKit: A wrapper for PatchDock that uses the RDKit library for molecular manipulation and scoring.\n8. PyDock: A Python-based docking program that uses a force field to predict the binding of small molecules to proteins.\n9. RaptorDock: A docking program that uses a combination of molecular dynamics simulations and machine learning to predict the binding of small molecules to proteins.\n10. Vina: A program that uses a scoring function to predict the binding of small molecules to proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. AutoDock is a program used for docking small molecules to proteins.\n2. PatchDock is designed to dock flexible ligands and peptides to proteins.\n3. RosettaDock predicts the binding of small molecules to proteins using a force field.\n4. Glide is a docking program that employs a hybrid approach for predicting protein-small molecule binding.\n5. HADDOCK utilizes a coarse-grained representation for predicting binding interactions between proteins and ligands.",
    "yulan-chat-2-13b-fp16_fact": [
      "AutoDock is a program used for docking small molecules to proteins.",
      "PatchDock is designed to dock flexible ligands and peptides to proteins.",
      "RosettaDock predicts the binding of small molecules to proteins using a force field.",
      "Glide is a docking program that employs a hybrid approach for predicting protein-small molecule binding.",
      "HADDOCK utilizes a coarse-grained representation for predicting binding interactions between proteins and ligands."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: RosettaDock is used primarily to predict protein-protein interactions, not the binding of small molecules to proteins.\n4. TRUE\n5. FALSE [correction]: HADDOCK is especially known for protein-protein and protein-nucleic acid docking; it doesn't typically use a coarse-grained representation for predicting binding interactions.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1649,
    "user_query": "Which genes have been found mutated in Gray platelet syndrome patients?",
    "yulan-chat-2-13b-fp16_response": "Gray platelet syndrome is a rare autosomal recessive disorder characterized by thrombocytopenia, platelet agonist resistance, and an increased risk of bleeding. The syndrome is caused by mutations in the RAC3 gene, which encodes for the Rac3 GTPase protein.\nThe RAC3 gene is involved in regulating the actin cytoskeleton, which is important for platelet function. Mutations in the RAC3 gene lead to abnormal platelet function, including decreased aggregation and adhesion to damaged blood vessels, which results in thrombocytopenia and an increased risk of bleeding.\nSeveral mutations in the RAC3 gene have been identified in patients with Gray platelet syndrome, including missense mutations, nonsense mutations, and splicing mutations. These mutations disrupt the normal function of the Rac3 protein, leading to the characteristic symptoms of the disorder.\nIt is important to note that Gray platelet syndrome is a rare disorder, and there is still much to be learned about its genetic basis and clinical presentation. If you have questions or concerns about this condition, it is best to consult with a medical professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gray platelet syndrome is a rare autosomal recessive disorder.\n2. The syndrome is caused by mutations in the RAC3 gene.\n3. Mutations in the RAC3 gene can affect the actin cytoskeleton regulation.\n4. Different types of mutations in the RAC3 gene include missense mutations, nonsense mutations, and splicing mutations.\n5. The RAC3 gene mutations lead to abnormal platelet function and an increased risk of bleeding in Gray platelet syndrome patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gray platelet syndrome is a rare autosomal recessive disorder.",
      "The syndrome is caused by mutations in the RAC3 gene.",
      "Mutations in the RAC3 gene can affect the actin cytoskeleton regulation.",
      "Different types of mutations in the RAC3 gene include missense mutations, nonsense mutations, and splicing mutations.",
      "The RAC3 gene mutations lead to abnormal platelet function and an increased risk of bleeding in Gray platelet syndrome patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Gray platelet syndrome is a rare autosomal dominant disorder, not recessive.\n2. FALSE [correction]: The syndrome is caused by mutations in the NBEAL2 gene, not the RAC3 gene.\n3. FALSE [correction]: Since Gray platelet syndrome is caused by mutations in the NBEAL2 gene, it is not directly related to mutations in the RAC3 gene affecting the actin cytoskeleton regulation. Instead, NBEAL2 mutations are implicated in the regulation of alpha-granule formation in platelets.\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1652,
    "user_query": "Is cardiac magnetic resonance imaging indicated in the pre-participation screening of athletes?",
    "yulan-chat-2-13b-fp16_response": "Cardiac magnetic resonance imaging (MRI) is a non-invasive imaging test that uses a strong magnetic field and radio waves to produce detailed images of the heart and surrounding tissues. It is considered a valuable tool in the pre-participation screening of athletes, particularly those who participate in sports that are associated with a high risk of sudden cardiac death, such as basketball, football, and soccer.\nCardiac MRI can detect structural abnormalities in the heart, such as myocardial thickening, ventricular dysfunction, and valve abnormalities, which may increase the risk of sudden cardiac death during physical activity. It can also identify cardiac conditions that may increase the risk of sudden cardiac death, such as hypertrophic cardiomyopathy, arrhythmias, and congenital heart disease.\nHowever, it is important to note that cardiac MRI is not a routine part of pre-participation screening for athletes. The decision to perform cardiac MRI should be based on the individual's medical history, physical examination, and other diagnostic tests, such as an electrocardiogram (ECG) and echocardiogram.\nIn summary, cardiac MRI may be indicated in the pre-participation screening of athletes who are at high risk of sudden cardiac death, but the decision to perform the test should be made on a case-by-case basis by a qualified healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cardiac magnetic resonance imaging (MRI) is a non-invasive imaging test that produces detailed images of the heart and surrounding tissues using a strong magnetic field and radio waves.\n2. Cardiac MRI is considered valuable in the pre-participation screening of athletes, especially those in high-risk sports for sudden cardiac death like basketball, football, and soccer.\n3. Cardiac MRI can detect heart structural abnormalities such as myocardial thickening, ventricular dysfunction, and valve abnormalities.\n4. Cardiac MRI can identify cardiac conditions that may increase the risk of sudden cardiac death, including hypertrophic cardiomyopathy, arrhythmias, and congenital heart disease.\n5. Cardiac MRI is not a routine part of pre-participation screening for athletes and is typically considered based on the individual's medical history, physical examination, and other diagnostic tests.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cardiac magnetic resonance imaging (MRI) is a non-invasive imaging test that produces detailed images of the heart and surrounding tissues using a strong magnetic field and radio waves.",
      "Cardiac MRI is considered valuable in the pre-participation screening of athletes, especially those in high-risk sports for sudden cardiac death like basketball, football, and soccer.",
      "Cardiac MRI can detect heart structural abnormalities such as myocardial thickening, ventricular dysfunction, and valve abnormalities.",
      "Cardiac MRI can identify cardiac conditions that may increase the risk of sudden cardiac death, including hypertrophic cardiomyopathy, arrhythmias, and congenital heart disease.",
      "Cardiac MRI is not a routine part of pre-participation screening for athletes and is typically considered based on the individual's medical history, physical examination, and other diagnostic tests."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1654,
    "user_query": "What is the function of the MTH1 enzyme in cancer cells?",
    "yulan-chat-2-13b-fp16_response": "The MTH1 enzyme is involved in the process of autophagy, which is a cellular recycling process that involves the degradation of cellular components and the recycling of their building blocks. In cancer cells, MTH1 has been shown to play a role in promoting tumor growth and survival by facilitating the degradation of certain molecules that are toxic to the cell. Additionally, MTH1 has been implicated in the development of drug resistance in cancer cells. Therefore, targeting MTH1 has been proposed as a potential therapeutic strategy for cancer treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The MTH1 enzyme is involved in the process of autophagy, a cellular recycling process.\n2. In cancer cells, MTH1 plays a role in promoting tumor growth and survival.\n3. MTH1 facilitates the degradation of molecules that are toxic to the cell.\n4. MTH1 has been implicated in the development of drug resistance in cancer cells.\n5. Targeting MTH1 has been proposed as a therapeutic strategy for cancer treatment.",
    "yulan-chat-2-13b-fp16_fact": [
      "The MTH1 enzyme is involved in the process of autophagy, a cellular recycling process.",
      "In cancer cells, MTH1 plays a role in promoting tumor growth and survival.",
      "MTH1 facilitates the degradation of molecules that are toxic to the cell.",
      "MTH1 has been implicated in the development of drug resistance in cancer cells.",
      "Targeting MTH1 has been proposed as a therapeutic strategy for cancer treatment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The MTH1 enzyme is involved in preventing the incorporation of oxidized nucleotides into DNA, not in autophagy.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "yulan-chat-2-13b-fp16_response": "Yes, ultraconserved elements (UCEs) are often depleted among copy number variants (CNVs). UCEs are regions of the genome that are highly conserved across species and are thought to be functionally important. CNVs are large deletions or duplications of genetic material that can occur in the genome and are known to be associated with a variety of genetic disorders and diseases.\nStudies have shown that UCEs are often underrepresented in CNVs compared to other regions of the genome. This is likely due to the fact that UCEs are highly conserved and are therefore under selective pressure to maintain their integrity. As a result, CNVs that involve UCEs are less likely to occur than CNVs that involve other regions of the genome.\nHowever, it's important to note that the impact of UCE depletion in CNVs can vary depending on the specific context and the genetic mechanisms underlying CNV formation. Additionally, recent studies have suggested that some UCEs may be more prone to deletion than others, and that the depletion of UCEs in CNVs may be a complex and context-dependent process.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ultraconserved elements (UCEs) are regions of the genome that are highly conserved across species.\n2. Copy number variants (CNVs) are large deletions or duplications of genetic material within the genome.\n3. UCEs are typically underrepresented in CNVs as compared to other regions of the genome.\n4. The presence of UCEs within the genome is under selective pressure to maintain their integrity.\n5. CNVs can be associated with a variety of genetic disorders and diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ultraconserved elements (UCEs) are regions of the genome that are highly conserved across species.",
      "Copy number variants (CNVs) are large deletions or duplications of genetic material within the genome.",
      "UCEs are typically underrepresented in CNVs as compared to other regions of the genome.",
      "The presence of UCEs within the genome is under selective pressure to maintain their integrity.",
      "CNVs can be associated with a variety of genetic disorders and diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE: Ultraconserved elements (UCEs) are indeed typically underrepresented in copy number variants (CNVs), suggesting a strong selective pressure to maintain these sequences.\n4. TRUE: The presence of UCEs within the genome is usually under strong selective pressure to maintain their integrity due to their functional importance and high degree of conservation across species.\n5. TRUE: Copy number variants can be associated with a variety of genetic disorders and diseases, as they can disrupt gene function or regulation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1660,
    "user_query": "Which population has a high frequency of the HLA-B*1502 allele?",
    "yulan-chat-2-13b-fp16_response": "The HLA-B\\*1502 allele is most commonly found in individuals of Han Chinese descent. This allele is particularly prevalent in southern Han Chinese populations, with a frequency of up to 20% in some regions. However, it is also found in other populations, including those of Taiwanese, Vietnamese, and Thai descent.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The HLA-B*1502 allele is most commonly found in individuals of Han Chinese descent.\n2. The HLA-B*1502 allele frequency can be up to 20% in some southern Han Chinese populations.\n3. Populations of Taiwanese descent also have the HLA-B*1502 allele.\n4. Individuals of Vietnamese descent have been found with the HLA-B*1502 allele.\n5. The HLA-B*1502 allele is present in Thai populations.",
    "yulan-chat-2-13b-fp16_fact": [
      "The HLA-B*1502 allele is most commonly found in individuals of Han Chinese descent.",
      "The HLA-B*1502 allele frequency can be up to 20% in some southern Han Chinese populations.",
      "Populations of Taiwanese descent also have the HLA-B*1502 allele.",
      "Individuals of Vietnamese descent have been found with the HLA-B*1502 allele.",
      "The HLA-B*1502 allele is present in Thai populations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe HLA-B*1502 allele is most commonly associated with individuals of Southeast Asian descent, including Han Chinese, Taiwanese, Vietnamese, and Thai populations, where it has been found at varying frequencies. The allele is particularly noted for its role in hypersensitivity reactions to certain drugs such as carbamazepine. The statements provided are generally consistent with these facts.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1663,
    "user_query": "What is the role of the Tsix gene during X chromosome inactivation?",
    "yulan-chat-2-13b-fp16_response": "The Tsix gene is a non-coding RNA gene located near the inactive X chromosome (Xi) in female mammals. Its function is to silence the Xi by promoting the formation of a heterochromatin structure, which is characterized by the condensation of DNA and the presence of repressive histone marks.\nDuring X chromosome inactivation (XCI), one of the two X chromosomes in female mammals is randomly selected to be inactivated. The Tsix gene is transcribed from the inactive X chromosome and its transcript covers most of the Xi. The Tsix transcript then interacts with the Xist gene product, a non-coding RNA, which coats the Xi and recruits proteins that form a heterochromatin structure. This process leads to the inactivation of the Xi, which is necessary to ensure that female mammals do not have twice as many genes as males, who have only one X chromosome.\nIn summary, the Tsix gene plays a crucial role in X chromosome inactivation by promoting the formation of a heterochromatin structure on the inactive X chromosome in female mammals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Tsix gene is a non-coding RNA gene located near the inactive X chromosome (Xi) in female mammals.\n2. The Tsix gene helps to silence the Xi by promoting the formation of a heterochromatin structure.\n3. During X chromosome inactivation, one of the two X chromosomes in female mammals is randomly selected to be inactivated.\n4. The Tsix transcript interacts with the Xist gene product to aid in the inactivation of the X chromosome.\n5. The inactivation of one of the X chromosomes in female mammals is necessary to ensure that they do not have twice as many X chromosome-linked genes as males, who have only one X chromosome.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Tsix gene is a non-coding RNA gene located near the inactive X chromosome (Xi) in female mammals.",
      "The Tsix gene helps to silence the Xi by promoting the formation of a heterochromatin structure.",
      "During X chromosome inactivation, one of the two X chromosomes in female mammals is randomly selected to be inactivated.",
      "The Tsix transcript interacts with the Xist gene product to aid in the inactivation of the X chromosome.",
      "The inactivation of one of the X chromosomes in female mammals is necessary to ensure that they do not have twice as many X chromosome-linked genes as males, who have only one X chromosome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The Tsix gene is involved in the regulation of X chromosome inactivation, but it does not help to silence the Xi by promoting the formation of heterochromatin; instead, it acts as a negative regulator of Xist gene expression, thereby playing a role in preventing X chromosome inactivation.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "yulan-chat-2-13b-fp16_response": "The substrate of the haspin kinase during mitosis is not well understood. Haspin kinase is a protein kinase that plays a role in regulating cell cycle progression, and it is primarily active during mitosis. However, the specific substrates of haspin kinase during mitosis are not yet fully characterized. Some studies have suggested that haspin kinase may phosphorylate various proteins involved in mitotic processes, such as microtubules, spindle poles, and chromosomes, but more research is needed to fully understand the substrates and functions of haspin kinase during mitosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Haspin kinase is a protein kinase that plays a role in regulating cell cycle progression.\n2. Haspin kinase is primarily active during mitosis.\n3. The specific substrates of haspin kinase during mitosis are not yet fully characterized.",
    "yulan-chat-2-13b-fp16_fact": [
      "Haspin kinase is a protein kinase that plays a role in regulating cell cycle progression.",
      "Haspin kinase is primarily active during mitosis.",
      "The specific substrates of haspin kinase during mitosis are not yet fully characterized."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1668,
    "user_query": "What is the advantage of neutral loss detection in phosphoproteomics?",
    "yulan-chat-2-13b-fp16_response": "Neutral loss detection is a technique used in phosphoproteomics to identify and quantify phosphorylated peptides in complex mixtures. The advantage of neutral loss detection is that it allows for the detection of phosphorylated peptides that would otherwise be missed by traditional phosphoproteomics methods, which typically rely on the detection of charged ions.\nNeutral loss detection involves the detection of neutral loss peptides, which are peptides that are not charged and do not produce ions in the mass spectrometer. These peptides are often missed by traditional phosphoproteomics methods because they do not produce ions that can be detected by the mass spectrometer.\nBy detecting neutral loss peptides, researchers can identify and quantify phosphorylated peptides that would otherwise be missed, providing a more complete picture of the phosphoproteome. This is particularly important for studying complex biological systems, where there may be a large number of phosphorylated peptides that are present at low abundance.\nOverall, neutral loss detection is a valuable tool in phosphoproteomics that allows for the detection and quantification of a wider range of phosphorylated peptides, providing a more comprehensive understanding of the role of phosphorylation in biological processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neutral loss detection is a technique used in phosphoproteomics to identify and quantify phosphorylated peptides.\n2. Traditional phosphoproteomics methods typically rely on the detection of charged ions.\n3. Neutral loss peptides do not produce ions that can be detected by the mass spectrometer.\n4. By using neutral loss detection, researchers can detect phosphorylated peptides that are present at low abundance.\n5. Neutral loss detection enables a more comprehensive understanding of the role of phosphorylation in biological processes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neutral loss detection is a technique used in phosphoproteomics to identify and quantify phosphorylated peptides.",
      "Traditional phosphoproteomics methods typically rely on the detection of charged ions.",
      "Neutral loss peptides do not produce ions that can be detected by the mass spectrometer.",
      "By using neutral loss detection, researchers can detect phosphorylated peptides that are present at low abundance.",
      "Neutral loss detection enables a more comprehensive understanding of the role of phosphorylation in biological processes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Neutral loss peptides do produce ions during mass spectrometry, but there is a loss of a neutral fragment, such as a phosphate group, which can be indicative of phosphorylation events.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1672,
    "user_query": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?",
    "yulan-chat-2-13b-fp16_response": "Bmi-1 regulates the expression of the cyclin-dependent kinase inhibitor p27Kip1.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bmi-1 regulates the expression of the cyclin-dependent kinase inhibitor p27Kip1.",
    "yulan-chat-2-13b-fp16_fact": [
      "Bmi-1 regulates the expression of the cyclin-dependent kinase inhibitor p27Kip1."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 1675,
    "user_query": "List inhibtors targeting the mitochondrial permeability transition pore.",
    "yulan-chat-2-13b-fp16_response": "The mitochondrial permeability transition pore (mPTP) is a protein complex located in the outer membrane of mitochondria that plays a key role in regulating cellular apoptosis and necrosis. Several inhibitors have been identified that target the mPTP and can modulate its activity. Here are some examples:\n1. Cyclosporin A: This is a well-known inhibitor of the mPTP that binds to the pore and prevents its opening. It has been shown to protect cells against apoptosis induced by various stimuli, including oxidative stress and chemotherapeutic drugs.\n2. Anisomycin: This is an inhibitor of protein synthesis that has been shown to induce mPTP opening and subsequent cell death in cancer cells.\n3. Carbamazepine: This is an antiepileptic drug that has been shown to inhibit the mPTP and protect cells against apoptosis.\n4. Hydroethyl stilbamidine (HESTAMIDINE): This is a natural product that has been shown to inhibit the mPTP and protect cells against apoptosis induced by various stimuli.\n5. Mitochondrial-targeted antioxidants: Several antioxidants, such as idebenone and EPI-743, have been shown to target mitochondria and inhibit the mPTP, leading to increased mitochondrial stability and reduced apoptosis.\nIt's important to note that the effects of these inhibitors can vary depending on the specific context and cell type, and further research is needed to fully understand their mechanisms of action and potential therapeutic applications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cyclosporin A is an inhibitor of the mitochondrial permeability transition pore (mPTP).\n2. Anisomycin is an inhibitor that can induce mPTP opening.\n3. Carbamazepine is an antiepileptic drug that has been shown to inhibit the mPTP.\n4. Hydroethyl stilbamidine (HESTAMIDINE) has been reported to inhibit the mPTP.\n5. Idebenone and EPI-743 are mitochondrial-targeted antioxidants that inhibit the mPTP.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cyclosporin A is an inhibitor of the mitochondrial permeability transition pore (mPTP).",
      "Anisomycin is an inhibitor that can induce mPTP opening.",
      "Carbamazepine is an antiepileptic drug that has been shown to inhibit the mPTP.",
      "Hydroethyl stilbamidine (HESTAMIDINE) has been reported to inhibit the mPTP.",
      "Idebenone and EPI-743 are mitochondrial-targeted antioxidants that inhibit the mPTP."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Cyclosporin A is an inhibitor of cyclophilin D, which is associated with the mitochondrial permeability transition pore (mPTP), but it is not a direct inhibitor of the mPTP itself.\n2. TRUE\n3. TRUE\n4. UNKNOWN: The compound Hydroethyl stilbamidine (also known as HEST or HESTAMIDINE) is not well-known or widely documented in the context of mPTP inhibition, therefore its effects on mPTP are not clear.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1678,
    "user_query": "Which is the process that Conserved noncoding elements mostly regulate?",
    "yulan-chat-2-13b-fp16_response": "Conserved noncoding elements (CNEs) are DNA sequences that are highly conserved across different species and are believed to play important roles in regulating gene expression. While the exact function of CNEs is not yet fully understood, it is thought that they primarily regulate the process of transcription, which is the process by which DNA is copied into RNA.\nCNEs can act as enhancers or silencers of gene expression, depending on their location and the genes they interact with. Enhancers are DNA sequences that can increase the level of gene expression, while silencers are DNA sequences that can decrease the level of gene expression. CNEs can also interact with other regulatory elements, such as promoters and splice sites, to modulate gene expression.\nIn addition to regulating transcription, CNEs may also play a role in other aspects of gene regulation, such as RNA processing, RNA stability, and post-transcriptional modification. However, the majority of CNEs are thought to regulate transcription, and their function is often studied in the context of gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Conserved noncoding elements (CNEs) are highly conserved across different species.\n2. CNEs are believed to primarily regulate the process of transcription, which copies DNA into RNA.\n3. CNEs can act as enhancers, increasing the level of gene expression.\n4. CNEs can also function as silencers, decreasing the level of gene expression.\n5. CNEs may play a role in RNA processing, RNA stability, and post-transcriptional modification.",
    "yulan-chat-2-13b-fp16_fact": [
      "Conserved noncoding elements (CNEs) are highly conserved across different species.",
      "CNEs are believed to primarily regulate the process of transcription, which copies DNA into RNA.",
      "CNEs can act as enhancers, increasing the level of gene expression.",
      "CNEs can also function as silencers, decreasing the level of gene expression.",
      "CNEs may play a role in RNA processing, RNA stability, and post-transcriptional modification."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1689,
    "user_query": "Is Achondroplasia associated with hearing loss?",
    "yulan-chat-2-13b-fp16_response": "Yes, Achondroplasia is sometimes associated with hearing loss. Achondroplasia is the most common form of short-limbed dwarfism, which is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene. This mutation can affect the development of the inner ear, leading to hearing loss.\nStudies have shown that up to 40% of individuals with Achondroplasia have some degree of hearing loss, which can range from mild to severe. The hearing loss is usually bilateral (affecting both ears) and can be detected in childhood or adolescence.\nThe exact mechanism behind the hearing loss in Achondroplasia is not fully understood, but it is thought to be related to the abnormal development of the cochlea, which is the spiral-shaped organ in the inner ear that converts sound waves into electrical signals that the brain can interpret.\nIf you have concerns about hearing loss or any other symptoms related to Achondroplasia, it is important to speak with a healthcare professional for proper evaluation and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Achondroplasia is sometimes associated with hearing loss.\n2. Achondroplasia is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.\n3. Up to 40% of individuals with Achondroplasia have some degree of hearing loss.\n4. The hearing loss in individuals with Achondroplasia is usually bilateral.\n5. The cochlea's abnormal development may play a role in the hearing loss associated with Achondroplasia.",
    "yulan-chat-2-13b-fp16_fact": [
      "Achondroplasia is sometimes associated with hearing loss.",
      "Achondroplasia is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.",
      "Up to 40% of individuals with Achondroplasia have some degree of hearing loss.",
      "The hearing loss in individuals with Achondroplasia is usually bilateral.",
      "The cochlea's abnormal development may play a role in the hearing loss associated with Achondroplasia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN (The exact percentage can vary, and without a definitive source, the statement is difficult to confirm.)\n4. TRUE (It is common for the hearing loss in individuals with Achondroplasia to affect both ears, though without specific data it's difficult to assert always.)\n5. TRUE (Abnormal development of the ear structures, including the cochlea, may contribute to hearing loss in individuals with Achondroplasia.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1691,
    "user_query": "Is STAT3 transcription factor regulated by mTORC1?",
    "yulan-chat-2-13b-fp16_response": "Yes, STAT3 transcription factor can be regulated by mTORC1 (mammalian target of rapamycin complex 1). mTORC1 is a key regulator of cell growth and metabolism, and it can modulate the activity of STAT3 by phosphorylating it at specific residues.\nPhosphorylation of STAT3 by mTORC1 can inhibit its transcriptional activity, leading to a decrease in the expression of STAT3-regulated genes. This inhibition is thought to be important for maintaining cellular homeostasis and preventing excessive immune responses.\nHowever, the regulation of STAT3 by mTORC1 can be complex and context-dependent, and other factors such as cellular stress, nutrient availability, and cytokine signaling can also influence the activity of STAT3.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. mTORC1 can regulate the STAT3 transcription factor by phosphorylating it at specific residues.\n2. Phosphorylation of STAT3 by mTORC1 can inhibit its transcriptional activity.\n3. Regulation of STAT3 by mTORC1 is involved in maintaining cellular homeostasis and preventing excessive immune responses.\n4. Cellular stress, nutrient availability, and cytokine signaling can influence the activity of STAT3.",
    "yulan-chat-2-13b-fp16_fact": [
      "mTORC1 can regulate the STAT3 transcription factor by phosphorylating it at specific residues.",
      "Phosphorylation of STAT3 by mTORC1 can inhibit its transcriptional activity.",
      "Regulation of STAT3 by mTORC1 is involved in maintaining cellular homeostasis and preventing excessive immune responses.",
      "Cellular stress, nutrient availability, and cytokine signaling can influence the activity of STAT3."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n\nThe activity of STAT3 can indeed be influenced by various factors such as cellular stress, nutrient availability, and cytokine signaling. However, for statements 1, 2, and 3, without specific scientific references or details regarding the research showing direct regulation of STAT3 by mTORC1, the truthfulness of these statements cannot be established. The relationships between molecules like mTORC1 and STAT3 can be complex and context-dependent, and thus a definitive answer would require specific empirical evidence.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1693,
    "user_query": "List components of the CRSP/Med complex.",
    "yulan-chat-2-13b-fp16_response": "The CRSP/Med complex is a protein complex that plays a role in regulating gene expression. It consists of several components, including:\n1. CRISPR-associated protein 9 (Cas9) - an RNA-guided endonuclease that cleaves DNA\n2. CRISPR RNA (crRNA) - a small RNA molecule that guides Cas9 to the target DNA sequence\n3. Transfer RNA (tracrRNA) - a small RNA molecule that serves as a scaffold for crRNA and Cas9 to bind to\n4. Med - a protein that acts as a bridge between the CRISPR complex and the target DNA\n5. Other proteins - the complex may also include additional proteins that help to regulate its activity, such as the protein complex Csn (Cullin-RING ubiquitin ligase)",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The CRISPR-associated protein 9 (Cas9) is an RNA-guided endonuclease that cleaves DNA.\n2. CRISPR RNA (crRNA) is a small RNA molecule that guides Cas9 to the target DNA sequence.\n3. Transfer RNA (tracrRNA) is a small RNA molecule that serves as a scaffold for crRNA and Cas9 binding.\n4. Med is a protein that acts as a bridge between the CRISPR complex and the target DNA.\n5. The CRSP/Med complex may include additional proteins like the protein complex Csn (Cullin-RING ubiquitin ligase) to help regulate its activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "The CRISPR-associated protein 9 (Cas9) is an RNA-guided endonuclease that cleaves DNA.",
      "CRISPR RNA (crRNA) is a small RNA molecule that guides Cas9 to the target DNA sequence.",
      "Transfer RNA (tracrRNA) is a small RNA molecule that serves as a scaffold for crRNA and Cas9 binding.",
      "Med is a protein that acts as a bridge between the CRISPR complex and the target DNA.",
      "The CRSP/Med complex may include additional proteins like the protein complex Csn (Cullin-RING ubiquitin ligase) to help regulate its activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The tracrRNA (trans-activating crRNA) is a small RNA molecule that, together with the crRNA, forms a complex with Cas9 and allows the crRNA to guide the Cas9 to the target DNA sequence. It does not serve as a guide itself but assists in the process.\n4. FALSE [correction]: \"Med\" is not a well-established term in the CRISPR literature as a protein that acts as a bridge. It is possible that there may be a misunderstanding or confusion with another component, but with the information given, no established protein named \"Med\" can be identified as having this function in the CRISPR-Cas system.\n5. FALSE [correction]: The term \"CRSP/Med\" does not accurately reflect known CRISPR-associated complexes. The Mediator complex (often abbreviated as Med) plays a role in regulating transcription in eukaryotic cells, and it is unrelated to the CRISPR-Cas system. Csn (Cullin-RING ubiquitin ligase), on the other hand, is a different protein complex involved in protein degradation pathways and does not typically regulate CRISPR activity. CRISPR-associated complexes do often involve additional proteins, but not typically those referred to as \"Csn.\"",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "yulan-chat-2-13b-fp16_response": "Viroids are the smallest known agents of biological inheritance, consisting of a single, circular RNA molecule. They lack both DNA and protein components, and instead rely on host cell machinery to replicate and propagate. The mechanism of viroid replication is unique and different from that of other RNA viruses.\nThe replication of viroids occurs in the cytoplasm of the host cell and involves three main steps: initiation, elongation, and termination. The process is highly dependent on the host cell machinery, particularly the RNA-dependent RNA polymerase (RdRp) and other factors that facilitate RNA replication.\nInitiation:\nThe initiation of viroid replication involves the binding of the viroid RNA molecule to the RdRp, which is typically a small protein that lacks DNA-binding activity. The RdRp recognizes specific sequences in the viroid RNA, known as the initiation sequence (IS) and the promoter region, which serve as binding sites for the enzyme. Once bound, the RdRp catalyzes the formation of a primer-template complex, which serves as the starting point for RNA synthesis.\nElongation:\nIn the elongation step, the RdRp catalyzes the synthesis of new RNA strands by using the viroid RNA molecule as a template. The RdRp adds nucleotides to the growing RNA chain in a 5' to 3' direction, using the primer as a starting point. The RdRp continues to add nucleotides until it reaches the end of the viroid RNA molecule or a termination signal.\nTermination:\nThe termination step involves the recognition of specific sequences in the viroid RNA that signal the end of the replication cycle. The RdRp binds to these sequences and catalyzes the formation of a stable RNA structure that prevents further RNA synthesis. The newly synthesized RNA molecules are then released from the RdRp and can serve as templates for further rounds of replication.\nOverall, the replication of viroids is a highly efficient process that allows for rapid propagation of the RNA molecule. The lack of a protein component and the reli",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Viroids consist of a single, circular RNA molecule and lack both DNA and protein components.\n2. Viroids rely on host cell machinery to replicate and propagate.\n3. The replication of viroids occurs in the cytoplasm of the host cell and involves initiation, elongation, and termination.\n4. The RNA-dependent RNA polymerase (RdRp) and other host factors facilitate RNA replication of viroids.\n5. The RdRp catalyzes the synthesis of new RNA strands in the elongation step of viroid replication by using the viroid RNA molecule as a template.",
    "yulan-chat-2-13b-fp16_fact": [
      "Viroids consist of a single, circular RNA molecule and lack both DNA and protein components.",
      "Viroids rely on host cell machinery to replicate and propagate.",
      "The replication of viroids occurs in the cytoplasm of the host cell and involves initiation, elongation, and termination.",
      "The RNA-dependent RNA polymerase (RdRp) and other host factors facilitate RNA replication of viroids.",
      "The RdRp catalyzes the synthesis of new RNA strands in the elongation step of viroid replication by using the viroid RNA molecule as a template."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The replication of viroids typically occurs in the nucleus or chloroplast of plant host cells, not in the cytoplasm.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1698,
    "user_query": "Mutation of which gene is associated with McLeod syndrome?",
    "yulan-chat-2-13b-fp16_response": "McLeod syndrome is associated with mutations in the NAX5 gene, which is located on the long (q) arm of chromosome 22 at position 11.11 and spans approximately 100 kb. The NAX5 gene encodes a protein called NaX5, which is a component of the NaX complex, a group of proteins that play a role in the regulation of gene expression. Mutations in the NAX5 gene have been shown to cause McLeod syndrome, a rare genetic disorder characterized by a range of symptoms including intellectual disability, seizures, and distinctive facial features.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. McLeod syndrome is associated with mutations in the NAX5 gene.\n2. The NAX5 gene is located on the long (q) arm of chromosome 22 at position 11.11.\n3. The NAX5 gene spans approximately 100 kilobases.\n4. Mutations in the NAX5 gene cause McLeod syndrome.\n5. McLeod syndrome is characterized by symptoms including intellectual disability, seizures, and distinctive facial features.",
    "yulan-chat-2-13b-fp16_fact": [
      "McLeod syndrome is associated with mutations in the NAX5 gene.",
      "The NAX5 gene is located on the long (q) arm of chromosome 22 at position 11.11.",
      "The NAX5 gene spans approximately 100 kilobases.",
      "Mutations in the NAX5 gene cause McLeod syndrome.",
      "McLeod syndrome is characterized by symptoms including intellectual disability, seizures, and distinctive facial features."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: McLeod syndrome is associated with mutations in the XK gene.\n2. FALSE [correction]: The XK gene, responsible for McLeod syndrome, is located on the long (q) arm of chromosome X at position 28.\n3. UNKNOWN: Without specific information about the gene size, the actual size of the XK gene cannot be confirmed.\n4. TRUE: Mutations in the XK gene cause McLeod syndrome.\n5. FALSE [correction]: McLeod syndrome is characterized by symptoms including neuromuscular and hematological abnormalities, but intellectual disability, seizures, and distinctive facial features are not typically described as characteristic of McLeod syndrome. Instead, the main features include hemolytic anemia, myopathy, chorea, and acanthocytosis.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 1699,
    "user_query": "Is RIP1 (RIP-1) part of the necrosome?",
    "yulan-chat-2-13b-fp16_response": "Yes, RIP1 (RIP-1) is a component of the necrosome, which is a multiprotein complex that plays a key role in regulating programmed cell death, also known as apoptosis. The necrosome is composed of RIP1, RIP3, and MLKL (mixed lineage kinase domain-like protein), and is activated in response to various cellular stressors, such as infection, injury, or genetic mutations.\nRIP1 is a kinase that plays a central role in the activation of the necrosome. It is activated by a variety of stimuli, including Toll-like receptor (TLR) ligands, cytokines, and reactive oxygen species (ROS). Once activated, RIP1 phosphorylates and activates RIP3, which in turn activates MLKL. MLKL forms large oligomeric structures that insert into the outer membrane of the mitochondria, leading to the release of pro-apoptotic factors and ultimately cell death.\nSo, in summary, RIP1 is an essential component of the necrosome, which plays a critical role in regulating programmed cell death in response to various cellular stressors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RIP1 (RIP-1) is a component of the necrosome.\n2. The necrosome plays a key role in regulating programmed cell death, known as apoptosis.\n3. The necrosome is activated in response to cellular stressors such as infection, injury, or genetic mutations.\n4. RIP1 activates RIP3, which then activates MLKL within the necrosome.\n5. MLKL forms oligomeric structures that insert into the outer membrane of the mitochondria, resulting in cell death.",
    "yulan-chat-2-13b-fp16_fact": [
      "RIP1 (RIP-1) is a component of the necrosome.",
      "The necrosome plays a key role in regulating programmed cell death, known as apoptosis.",
      "The necrosome is activated in response to cellular stressors such as infection, injury, or genetic mutations.",
      "RIP1 activates RIP3, which then activates MLKL within the necrosome.",
      "MLKL forms oligomeric structures that insert into the outer membrane of the mitochondria, resulting in cell death."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The necrosome actually plays a key role in regulating necroptosis, which is a form of programmed cell death that is distinct from apoptosis.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: MLKL forms oligomeric structures that insert into the plasma membrane, not the mitochondria, resulting in cell death.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1700,
    "user_query": "Which is the molecular target of the immunosuppressant drug Rapamycin?",
    "yulan-chat-2-13b-fp16_response": "The molecular target of the immunosuppressant drug Rapamycin is a protein called mTOR (mammalian target of rapamycin). mTOR is a key regulator of cell growth and proliferation, and rapamycin inhibits its activity, leading to immunosuppression and other effects.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The molecular target of the immunosuppressant drug Rapamycin is the mTOR protein.\n2. mTOR stands for mammalian target of rapamycin.\n3. mTOR is a key regulator of cell growth and proliferation.\n4. Rapamycin inhibits the activity of mTOR.",
    "yulan-chat-2-13b-fp16_fact": [
      "The molecular target of the immunosuppressant drug Rapamycin is the mTOR protein.",
      "mTOR stands for mammalian target of rapamycin.",
      "mTOR is a key regulator of cell growth and proliferation.",
      "Rapamycin inhibits the activity of mTOR."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1702,
    "user_query": "PBT2 has been tested for which disorder?",
    "yulan-chat-2-13b-fp16_response": "PBT2 (also known as PTBP4) is a protein that has been studied in the context of several disorders, including:\n1. Cancer: PBT2 has been found to be overexpressed in several types of cancer, including breast cancer, ovarian cancer, and lung cancer. It has been suggested that PBT2 may play a role in cancer progression and may be a potential therapeutic target.\n2. Neurodegenerative disorders: PBT2 has been implicated in several neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. It has been suggested that PBT2 may contribute to the pathology of these disorders by altering gene expression and protein stability.\n3. Cardiovascular disease: PBT2 has been found to be involved in the regulation of cardiac genes and may play a role in the development of cardiovascular disease.\nOverall, while PBT2 has been studied in the context of several disorders, more research is needed to fully understand its role in these conditions and to determine its potential as a therapeutic target.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PBT2 has been overexpressed in several types of cancer, including breast cancer, ovarian cancer, and lung cancer.\n2. PBT2 has been implicated in several neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.\n3. PBT2 may contribute to the pathology of neurodegenerative disorders by altering gene expression and protein stability.\n4. PBT2 has been found to be involved in the regulation of cardiac genes.\n5. PBT2 may play a role in the development of cardiovascular disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "PBT2 has been overexpressed in several types of cancer, including breast cancer, ovarian cancer, and lung cancer.",
      "PBT2 has been implicated in several neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.",
      "PBT2 may contribute to the pathology of neurodegenerative disorders by altering gene expression and protein stability.",
      "PBT2 has been found to be involved in the regulation of cardiac genes.",
      "PBT2 may play a role in the development of cardiovascular disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: PBT2 has not been found to be involved in the regulation of cardiac genes; it is a metal protein attenuating compound that affects metal-protein interactions in the brain.\n5. FALSE [correction]: PBT2 has not been implicated in the development of cardiovascular disease; its primary focus has been on neurodegenerative diseases.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 1704,
    "user_query": "How does long-range epigenetic silencing (LRES) occur?",
    "yulan-chat-2-13b-fp16_response": "Long-range epigenetic silencing (LRES) is a process by which epigenetic modifications, such as DNA methylation and histone modifications, are propagated over long distances along a chromosome. This can result in the silencing of genes that are located far away from the site of the initial epigenetic modification.\nOne mechanism by which LRES can occur is through the action of chromatin remodeling complexes, which can move epigenetic modifications from one location on a chromosome to another. These complexes can also recruit other proteins that can maintain or reinforce the epigenetic modification, leading to the establishment of a silenced chromatin state over a larger region.\nAnother mechanism by which LRES can occur is through the action of non-coding RNAs, such as microRNAs, which can bind to the DNA and recruit proteins that can maintain or reinforce the epigenetic modification. This can result in the silencing of genes that are located downstream of the site of the initial epigenetic modification.\nOverall, LRES is thought to play an important role in the regulation of gene expression and the maintenance of chromatin structure in cells. It can have significant effects on the development and function of organisms, and dysregulation of LRES has been implicated in a number of diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Long-range epigenetic silencing (LRES) involves the propagation of epigenetic modifications over long distances along a chromosome.\n2. DNA methylation and histone modifications are types of epigenetic modifications involved in LRES.\n3. Chromatin remodeling complexes can move epigenetic modifications from one location on a chromosome to another as part of LRES.\n4. Non-coding RNAs, such as microRNAs, can recruit proteins to maintain or reinforce epigenetic modifications in LRES.\n5. Dysregulation of LRES has been implicated in various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Long-range epigenetic silencing (LRES) involves the propagation of epigenetic modifications over long distances along a chromosome.",
      "DNA methylation and histone modifications are types of epigenetic modifications involved in LRES.",
      "Chromatin remodeling complexes can move epigenetic modifications from one location on a chromosome to another as part of LRES.",
      "Non-coding RNAs, such as microRNAs, can recruit proteins to maintain or reinforce epigenetic modifications in LRES.",
      "Dysregulation of LRES has been implicated in various diseases, including cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Chromatin remodeling complexes do not move epigenetic modifications from one location to another but rather facilitate the ability of other molecules to access or modify the chromatin structure, thereby affecting the epigenetic state.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1706,
    "user_query": "Can RNAPolII function as an RNA-dependent RNA-polymerase?",
    "yulan-chat-2-13b-fp16_response": "Yes, RNAPolII can function as an RNA-dependent RNA-polymerase (RdRp) under certain conditions. RNAPolII is the main polymerase involved in transcribing DNA into mRNA in eukaryotic cells. However, under certain stress conditions, such as viral infection or cellular damage, RNAPolII can also synthesize RNA from RNA templates, making it function as an RdRp.\nThis process is known as retrotranscription, where RNA is reverse-transcribed from an RNA template into DNA, which can then be integrated into the host genome or serve as a template for further RNA synthesis. RNAPolII can also synthesize double-stranded RNA (dsRNA) from an RNA template, which can serve as a template for the synthesis of small RNAs, such as microRNAs.\nHowever, it's important to note that RNAPolII is not the primary RdRp for most RNA viruses, which have their own dedicated viral polymerases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNAPolII can function as an RNA-dependent RNA-polymerase under certain conditions.\n2. RNAPolII is primarily involved in transcribing DNA into mRNA in eukaryotic cells.\n3. Under stress conditions like viral infection or cellular damage, RNAPolII can synthesize RNA from RNA templates.\n4. The process where RNA is reverse-transcribed from an RNA template into DNA is known as retrotranscription.\n5. RNAPolII is not the primary RNA-dependent RNA-polymerase for most RNA viruses.",
    "yulan-chat-2-13b-fp16_fact": [
      "RNAPolII can function as an RNA-dependent RNA-polymerase under certain conditions.",
      "RNAPolII is primarily involved in transcribing DNA into mRNA in eukaryotic cells.",
      "Under stress conditions like viral infection or cellular damage, RNAPolII can synthesize RNA from RNA templates.",
      "The process where RNA is reverse-transcribed from an RNA template into DNA is known as retrotranscription.",
      "RNAPolII is not the primary RNA-dependent RNA-polymerase for most RNA viruses."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: The process where RNA is reverse-transcribed from an RNA template into DNA is known as reverse transcription.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 1708,
    "user_query": "List sclerostin interaction partners.",
    "yulan-chat-2-13b-fp16_response": "Sclerostin is a protein that inhibits bone formation and is involved in the regulation of bone mass. It interacts with several proteins, including:\n1. Wnt signaling pathway proteins: Sclerostin interacts with Wnt signaling pathway proteins, such as beta-catenin and DKK1 (dickkopf-1), to inhibit bone formation.\n2. Sclerostin-deficient osteoporosis-related protein 1 (SOSTEP1): SOSTEP1 is a protein that is involved in the regulation of bone mass and interacts with sclerostin to enhance bone formation.\n3. Osteoprotegerin (OPG): OPG is a protein that inhibits osteoclast activity and interacts with sclerostin to enhance bone formation.\n4. RANKL (receptor activator of nuclear factor kappa-B ligand): RANKL is a protein that stimulates osteoclast activity and interacts with sclerostin to inhibit bone resorption.\n5. Sclerostin-deficient osteoporosis-related protein 2 (SOSTEP2): SOSTEP2 is a protein that interacts with sclerostin to enhance bone formation and regulate bone mass.\nThese interactions suggest that sclerostin plays a critical role in the regulation of bone mass and bone formation, and that alterations in sclerostin levels or interactions with its interaction partners may contribute to the development of bone-related disorders such as osteoporosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Sclerostin interacts with proteins in the Wnt signaling pathway, such as beta-catenin and DKK1, to inhibit bone formation.\n2. Sclerostin interacts with Sclerostin-deficient osteoporosis-related protein 1 (SOSTEP1) to enhance bone formation.\n3. Sclerostin interacts with Osteoprotegerin (OPG) to enhance bone formation.\n4. Sclerostin interacts with RANKL (receptor activator of nuclear factor kappa-B ligand) to inhibit bone resorption.\n5. Sclerostin interacts with Sclerostin-deficient osteoporosis-related protein 2 (SOSTEP2) to regulate bone mass and enhance bone formation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Sclerostin interacts with proteins in the Wnt signaling pathway, such as beta-catenin and DKK1, to inhibit bone formation.",
      "Sclerostin interacts with Sclerostin-deficient osteoporosis-related protein 1 (SOSTEP1) to enhance bone formation.",
      "Sclerostin interacts with Osteoprotegerin (OPG) to enhance bone formation.",
      "Sclerostin interacts with RANKL (receptor activator of nuclear factor kappa-B ligand) to inhibit bone resorption.",
      "Sclerostin interacts with Sclerostin-deficient osteoporosis-related protein 2 (SOSTEP2) to regulate bone mass and enhance bone formation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no known protein called Sclerostin-deficient osteoporosis-related protein 1 (SOSTEP1) that interacts with sclerostin; sclerostin is known to inhibit bone formation rather than enhance it.\n3. FALSE [correction]: While Osteoprotegerin (OPG) does play a role in bone metabolism, it interacts with RANKL to inhibit bone resorption. There is no direct interaction documented between sclerostin and OPG to enhance bone formation as stated.\n4. FALSE [correction]: Sclerostin actually inhibits bone formation, and its interaction with RANKL is not directly involved in inhibiting bone resorption. RANKL, through its interaction with its receptor RANK, promotes bone resorption.\n5. FALSE [correction]: There is no known protein called Sclerostin-deficient osteoporosis-related protein 2 (SOSTEP2). The statement is not accurate as presented, and the role of such a protein, if it existed, in interaction with sclerostin to regulate bone mass and enhance bone formation cannot be confirmed.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1711,
    "user_query": "Which are currently available software tools for detecting rare codon clusters in coding sequences?",
    "yulan-chat-2-13b-fp16_response": "There are several software tools available for detecting rare codon clusters in coding sequences. Some of the commonly used tools are:\n1. RareCluster: It is a tool that identifies rare codon clusters in a given DNA sequence. It uses a statistical model to identify clusters of rare codons and can detect both known and novel clusters.\n2. Codontree: It is a tool that constructs a tree of codon usage based on the frequency of each codon in a given DNA sequence. It can be used to identify rare codon clusters and study the evolution of codon usage.\n3. MEGA: It is a software tool that is widely used for molecular evolutionary genetics analysis. It can be used to identify rare codon clusters by analyzing the frequency of each codon in a given DNA sequence.\n4. PAML: It is a software tool that is used for phylogenetic analysis of molecular sequences. It can be used to identify rare codon clusters by analyzing the frequency of each codon in a given DNA sequence and studying the evolution of codon usage.\n5. CODONUS: It is a tool that identifies rare codon clusters in a given DNA sequence by analyzing the frequency of each codon and comparing it to a reference database of known rare codons.\nThese tools can be used to identify rare codon clusters in coding sequences and study the evolution of codon usage in different organisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RareCluster is a software tool that identifies rare codon clusters in DNA sequences using a statistical model.\n2. Codontree constructs a tree of codon usage to identify rare codon clusters in DNA sequences.\n3. MEGA is a software tool used for molecular evolutionary genetics analysis and can be employed to identify rare codon clusters.\n4. PAML is used for phylogenetic analysis of molecular sequences and can be utilized to identify rare codon clusters.\n5. CODONUS identifies rare codon clusters in DNA sequences by comparing codon frequencies to a reference database.",
    "yulan-chat-2-13b-fp16_fact": [
      "RareCluster is a software tool that identifies rare codon clusters in DNA sequences using a statistical model.",
      "Codontree constructs a tree of codon usage to identify rare codon clusters in DNA sequences.",
      "MEGA is a software tool used for molecular evolutionary genetics analysis and can be employed to identify rare codon clusters.",
      "PAML is used for phylogenetic analysis of molecular sequences and can be utilized to identify rare codon clusters.",
      "CODONUS identifies rare codon clusters in DNA sequences by comparing codon frequencies to a reference database."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. FALSE [correction]: MEGA is a software tool used for molecular evolutionary genetics analysis, but it is not specialized in identifying rare codon clusters in DNA sequences.\n4. FALSE [correction]: PAML is used for phylogenetic analysis and calculating maximum likelihood of molecular sequences, but it is not specifically designed to identify rare codon clusters.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1714,
    "user_query": "Where does CTCF colocalize with cohesin?",
    "yulan-chat-2-13b-fp16_response": "CTCF (Catenin-associated Transcriptional Complex Facilitator) is a transcriptional regulator that plays a role in maintaining the stability of chromatin structures and regulating gene expression. Cohesin is a protein complex that plays a role in regulating gene expression by associating with DNA and recruiting other factors to regulate transcription. CTCF and cohesin can colocalize at specific regions of chromatin, such as promoters and enhancers, where they work together to regulate gene expression. This colocalization is thought to be important for maintaining the stability of chromatin structures and regulating the expression of genes in a coordinated manner.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CTCF (Catenin-associated Transcriptional Complex Facilitator) is a transcriptional regulator involved in chromatin structure stability and gene expression regulation.\n2. Cohesin is a protein complex that associates with DNA and recruits other factors to regulate transcription.\n3. CTCF and cohesin colocalize at specific regions of chromatin, including promoters and enhancers.\n4. The colocalization of CTCF and cohesin is important for maintaining chromatin structure stability.\n5. CTCF and cohesin together play a role in the coordinated regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "CTCF (Catenin-associated Transcriptional Complex Facilitator) is a transcriptional regulator involved in chromatin structure stability and gene expression regulation.",
      "Cohesin is a protein complex that associates with DNA and recruits other factors to regulate transcription.",
      "CTCF and cohesin colocalize at specific regions of chromatin, including promoters and enhancers.",
      "The colocalization of CTCF and cohesin is important for maintaining chromatin structure stability.",
      "CTCF and cohesin together play a role in the coordinated regulation of gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: CTCF stands for CCCTC-binding factor, not Catenin-associated Transcriptional Complex Facilitator. It is a transcriptional regulator involved in chromatin structure stability and gene expression regulation.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1715,
    "user_query": "Name triad of Wernicke encephalopathy.",
    "yulan-chat-2-13b-fp16_response": "The name triad of Wernicke encephalopathy includes three main symptoms:\n1. Oculomotor abnormalities: These are changes in the way the eyes move and focus, such as nystagmus (involuntary eye movements), strabismus (crossed or misaligned eyes), and ophthalmoplegia (paralysis of the eye muscles).\n2. Ataxia: This is a lack of coordination or balance, which can cause difficulty walking, speaking, or performing other complex movements.\n3. Confusion or altered mental status: This includes symptoms such as disorientation, memory loss, and difficulty with concentration or decision-making.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The triad of Wernicke encephalopathy includes oculomotor abnormalities, ataxia, and confusion or altered mental status.\n2. Oculomotor abnormalities may manifest as nystagmus, strabismus, or ophthalmoplegia.\n3. Ataxia refers to a lack of coordination or balance affecting movement and speech.\n4. Confusion or altered mental status in Wernicke encephalopathy can involve disorientation and memory loss.",
    "yulan-chat-2-13b-fp16_fact": [
      "The triad of Wernicke encephalopathy includes oculomotor abnormalities, ataxia, and confusion or altered mental status.",
      "Oculomotor abnormalities may manifest as nystagmus, strabismus, or ophthalmoplegia.",
      "Ataxia refers to a lack of coordination or balance affecting movement and speech.",
      "Confusion or altered mental status in Wernicke encephalopathy can involve disorientation and memory loss."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1718,
    "user_query": "How many and which are the different isoforms for the ryanodine receptor?",
    "yulan-chat-2-13b-fp16_response": "The ryanodine receptor is a calcium channel found in the sarcoplasmic reticulum (SR) of muscle cells. It is a serine/threonine protein kinase that plays a key role in the regulation of calcium release from the SR. There are three main isoforms of the ryanodine receptor: the type 1 receptor (RyR1), the type 2 receptor (RyR2), and the type 3 receptor (RyR3). These isoforms are differentially expressed in different tissues and have different functions. RyR1 is the most widely expressed isoform and is found in skeletal and cardiac muscle, as well as in some non-muscle tissues. RyR2 is found primarily in the brain and pancreas, and RyR3 is found primarily in the heart.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The ryanodine receptor is found in the sarcoplasmic reticulum of muscle cells.\n2. The ryanodine receptor functions as a serine/threonine protein kinase.\n3. There are three main isoforms of the ryanodine receptor: RyR1, RyR2, and RyR3.\n4. RyR1 is expressed in skeletal and cardiac muscle, as well as in some non-muscle tissues.\n5. RyR2 is primarily found in the brain and pancreas, while RyR3 is primarily found in the heart.",
    "yulan-chat-2-13b-fp16_fact": [
      "The ryanodine receptor is found in the sarcoplasmic reticulum of muscle cells.",
      "The ryanodine receptor functions as a serine/threonine protein kinase.",
      "There are three main isoforms of the ryanodine receptor: RyR1, RyR2, and RyR3.",
      "RyR1 is expressed in skeletal and cardiac muscle, as well as in some non-muscle tissues.",
      "RyR2 is primarily found in the brain and pancreas, while RyR3 is primarily found in the heart."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The ryanodine receptor functions as a calcium release channel, not a serine/threonine protein kinase.\n3. TRUE\n4. FALSE [correction]: RyR1 is primarily expressed in skeletal muscle and in some non-muscle tissues, but not in cardiac muscle.\n5. FALSE [correction]: RyR2 is primarily found in cardiac muscle, while RyR3 is expressed in both muscle (including skeletal) and non-muscle tissues, but not specifically in the brain and pancreas.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "yulan-chat-2-13b-fp16_response": "Fibronectin is a protein that is involved in the formation of connective tissue and is found in many tissues throughout the body. It has been suggested that fibronectin may be a biomarker for Duchenne muscular dystrophy (DMD), a genetic disorder that is characterized by progressive muscle weakness and wasting.\nStudies have shown that levels of fibronectin in the blood are increased in patients with DMD compared to healthy individuals. However, it is important to note that fibronectin is not specific to DMD and can be elevated in a variety of conditions, including muscular dystrophy, other muscle diseases, and some cancers.\nTherefore, while fibronectin may be a useful biomarker for DMD, it is not a definitive diagnostic test and should be interpreted in conjunction with other clinical and laboratory findings. Additionally, more research is needed to determine the potential utility of fibronectin as a biomarker for DMD and to evaluate its sensitivity and specificity in different patient populations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fibronectin is involved in the formation of connective tissue.\n2. Studies have shown increased levels of fibronectin in the blood of patients with Duchenne muscular dystrophy (DMD) compared to healthy individuals.\n3. Fibronectin is not specific to DMD and can be elevated in other conditions, including other muscle diseases and some cancers.\n4. Fibronectin as a biomarker for DMD is not a definitive diagnostic test.\n5. More research is needed to determine the utility of fibronectin as a biomarker for DMD including its sensitivity and specificity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fibronectin is involved in the formation of connective tissue.",
      "Studies have shown increased levels of fibronectin in the blood of patients with Duchenne muscular dystrophy (DMD) compared to healthy individuals.",
      "Fibronectin is not specific to DMD and can be elevated in other conditions, including other muscle diseases and some cancers.",
      "Fibronectin as a biomarker for DMD is not a definitive diagnostic test.",
      "More research is needed to determine the utility of fibronectin as a biomarker for DMD including its sensitivity and specificity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1732,
    "user_query": "What is the association between number of pregnancies and rheumatoid arthritis",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that there may be an association between the number of pregnancies and the risk of developing rheumatoid arthritis (RA). Some studies have found that women who have had multiple pregnancies may be at increased risk of developing RA, while others have found no such association.\nOne study published in the journal Arthritis and Rheumatism in 2003 found that women who had four or more full-term pregnancies were more than twice as likely to develop RA compared to women who had one or two pregnancies. However, other studies have found no association between the number of pregnancies and the risk of developing RA.\nIt is important to note that the evidence on this topic is not definitive and more research is needed to fully understand the relationship between pregnancies and RA. It is also worth noting that other factors, such as genetics and environmental factors, may also play a role in the development of RA.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Some studies suggest women who have had multiple pregnancies may be at increased risk of developing rheumatoid arthritis (RA).\n2. A study published in the journal Arthritis and Rheumatism in 2003 found women who had four or more full-term pregnancies were more likely to develop RA.\n3. Other studies have found no association between the number of pregnancies and the risk of developing RA.\n4. The evidence on the association between the number of pregnancies and rheumatoid arthritis risk is not definitive.\n5. Genetics and environmental factors may play a role in the development of rheumatoid arthritis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Some studies suggest women who have had multiple pregnancies may be at increased risk of developing rheumatoid arthritis (RA).",
      "A study published in the journal Arthritis and Rheumatism in 2003 found women who had four or more full-term pregnancies were more likely to develop RA.",
      "Other studies have found no association between the number of pregnancies and the risk of developing RA.",
      "The evidence on the association between the number of pregnancies and rheumatoid arthritis risk is not definitive.",
      "Genetics and environmental factors may play a role in the development of rheumatoid arthritis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1737,
    "user_query": "Can we use prodrug amifostine to protect healthy cell during chemotherapy?",
    "yulan-chat-2-13b-fp16_response": "Yes, prodrug amifostine can be used to protect healthy cells during chemotherapy. Amifostine is a drug that is converted in the body to a compound called WR-2723, which has been shown to protect healthy cells from the toxic effects of chemotherapy. It works by scavenging free radicals and other harmful byproducts of chemotherapy, which can help to reduce the damage to healthy cells. Amifostine is often used in combination with chemotherapy drugs to help protect against the toxic effects of treatment. However, it is important to note that amifostine may also have side effects, and it is not suitable for everyone. It is important to discuss the potential benefits and risks of amifostine with your doctor before using it.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prodrug amifostine can be used to protect healthy cells during chemotherapy.\n2. Amifostine is converted in the body to a compound called WR-2723.\n3. WR-2723 is known to protect healthy cells from the toxic effects of chemotherapy.\n4. Amifostine works by scavenging free radicals and other harmful byproducts of chemotherapy.\n5. Amifostine can be used in combination with chemotherapy drugs to protect against their toxic effects.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prodrug amifostine can be used to protect healthy cells during chemotherapy.",
      "Amifostine is converted in the body to a compound called WR-2723.",
      "WR-2723 is known to protect healthy cells from the toxic effects of chemotherapy.",
      "Amifostine works by scavenging free radicals and other harmful byproducts of chemotherapy.",
      "Amifostine can be used in combination with chemotherapy drugs to protect against their toxic effects."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Amifostine is converted in the body to a compound called WR-1065.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1738,
    "user_query": "Which is the main difference between Alu and B1 repeats?",
    "yulan-chat-2-13b-fp16_response": "Alu and B1 repeats are both types of short repetitive sequences found in the genome, but they have some key differences:\n1. Origin: Alu sequences are thought to have originated from a genetic element called an Alu retroposon, which was active in our genome in the distant past. B1 repeats, on the other hand, are believed to have originated from a different genetic element called a B1 transposon.\n2. Structure: Alu sequences are typically 300-350 base pairs long and have a characteristic structure that includes a 12-base pair loop. B1 repeats are shorter, typically 100-150 base pairs long, and have a different structure.\n3. Distribution: Alu sequences are found throughout the genome, with particularly high levels in the non-coding regions. B1 repeats are more localized, often found in the coding regions of genes.\n4. Function: Alu sequences are thought to have a variety of functions, including helping to regulate gene expression and providing raw material for evolutionary change through mutation and recombination. B1 repeats are also thought to have various functions, but their exact role is less well understood.\nOverall, while both Alu and B1 repeats are important components of the genome, they differ in their origin, structure, distribution, and function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alu sequences originate from an Alu retroposon.\n2. B1 repeats are believed to have originated from a B1 transposon.\n3. Alu sequences are typically 300-350 base pairs long with a 12-base pair loop in their structure.\n4. B1 repeats are typically 100-150 base pairs long and have a structure different from Alu sequences.\n5. Alu sequences are prevalent throughout the genome, especially in non-coding regions, whereas B1 repeats are often found in the coding regions of genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alu sequences originate from an Alu retroposon.",
      "B1 repeats are believed to have originated from a B1 transposon.",
      "Alu sequences are typically 300-350 base pairs long with a 12-base pair loop in their structure.",
      "B1 repeats are typically 100-150 base pairs long and have a structure different from Alu sequences.",
      "Alu sequences are prevalent throughout the genome, especially in non-coding regions, whereas B1 repeats are often found in the coding regions of genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: B1 repeats are typically around 140-170 base pairs long but do not have a distinct \"loop\" like Alu sequences; instead, they have a different structure.\n5. FALSE [correction]: Alu sequences are indeed prevalent throughout the genome, particularly in non-coding regions, but B1 repeats are also primarily found in non-coding regions rather than in the coding regions of genes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1740,
    "user_query": "What is the frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis?",
    "yulan-chat-2-13b-fp16_response": "Ethylnitrosourea (ENU) is a powerful mutagen that is commonly used to induce mutations in animals for research purposes. The frequency of mutations induced spontaneously through ENU mutagenesis can vary depending on the dose and route of administration, as well as the strain of animal being used.\nIn general, the frequency of mutations induced by ENU is relatively low, with an estimated mutation rate of around 1-2 mutations per cell per division. However, this rate can increase with higher doses of ENU, and the frequency of mutations can also be influenced by factors such as the age and sex of the animal, as well as the duration of treatment.\nIt's worth noting that ENU mutagenesis can induce a wide range of mutations, including point mutations, small insertions and deletions, and larger chromosomal rearrangements. The specific types of mutations that are induced by ENU can vary depending on the dose and treatment conditions, and can also be influenced by the tissues and cells that are targeted by the mutagen.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ethylnitrosourea (ENU) is used to induce mutations in animals for research purposes.\n2. The estimated mutation rate induced by ENU is around 1-2 mutations per cell per division.\n3. The frequency of mutations induced by ENU can increase with higher doses.\n4. The frequency of mutations can be influenced by the age and sex of the animal.\n5. ENU mutagenesis can induce point mutations, small insertions and deletions, and larger chromosomal rearrangements.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ethylnitrosourea (ENU) is used to induce mutations in animals for research purposes.",
      "The estimated mutation rate induced by ENU is around 1-2 mutations per cell per division.",
      "The frequency of mutations induced by ENU can increase with higher doses.",
      "The frequency of mutations can be influenced by the age and sex of the animal.",
      "ENU mutagenesis can induce point mutations, small insertions and deletions, and larger chromosomal rearrangements."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The estimated mutation rate induced by ENU is approximately 1-2 mutations per gamete (not per cell division).\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1758,
    "user_query": "Has Glucose-6-phosphate dehydrogenase (G6PD) deficiency an X-linked inheritance?",
    "yulan-chat-2-13b-fp16_response": "Yes, Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked inheritance. It is caused by mutations in the G6PD gene, which is located on the X chromosome. The deficiency affects red blood cells and can lead to hemolysis, a condition in which red blood cells are broken down prematurely. The severity of the deficiency can vary, and some individuals may not experience any symptoms. G6PD deficiency is most common in people of African, Mediterranean, and Asian descent.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Glucose-6-phosphate dehydrogenase (G6PD) deficiency has an X-linked inheritance pattern.\n2. Mutations in the G6PD gene are the cause of G6PD deficiency.\n3. The G6PD gene is located on the X chromosome.\n4. G6PD deficiency can lead to hemolysis, which is the premature breakdown of red blood cells.\n5. The deficiency is most common among people of African, Mediterranean, and Asian descent.",
    "yulan-chat-2-13b-fp16_fact": [
      "Glucose-6-phosphate dehydrogenase (G6PD) deficiency has an X-linked inheritance pattern.",
      "Mutations in the G6PD gene are the cause of G6PD deficiency.",
      "The G6PD gene is located on the X chromosome.",
      "G6PD deficiency can lead to hemolysis, which is the premature breakdown of red blood cells.",
      "The deficiency is most common among people of African, Mediterranean, and Asian descent."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1760,
    "user_query": "Which mutated genes are associated with the Tourette's syndrome?",
    "yulan-chat-2-13b-fp16_response": "Tourette's syndrome is a neurodevelopmental disorder characterized by the presence of multiple motor and vocal tics. It is believed that the condition is caused by a combination of genetic and environmental factors.\nSeveral genes have been identified as potential candidates for Tourette's syndrome. One of the most well-studied genes is the dopamine D2 receptor (DRD2) gene. Mutations in this gene have been associated with an increased risk of developing Tourette's syndrome. Other genes that have been implicated in the condition include the serotonin transporter (5-HTT) gene, the GABA receptor beta 2 (GABRB2) gene, and the glutamate decarboxylase 67 (GAD67) gene.\nIt is important to note that while genetic factors may play a role in the development of Tourette's syndrome, the condition is not solely determined by genetics. Environmental factors, such as stress and exposure to toxins, may also contribute to the development of the disorder.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tourette's syndrome is characterized by multiple motor and vocal tics.\n2. The dopamine D2 receptor (DRD2) gene mutation is associated with an increased risk of developing Tourette's syndrome.\n3. The serotonin transporter (5-HTT) gene is implicated in Tourette's syndrome.\n4. The GABA receptor beta 2 (GABRB2) gene has been implicated in Tourette's syndrome.\n5. Mutations in the glutamate decarboxylase 67 (GAD67) gene are associated with Tourette's syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tourette's syndrome is characterized by multiple motor and vocal tics.",
      "The dopamine D2 receptor (DRD2) gene mutation is associated with an increased risk of developing Tourette's syndrome.",
      "The serotonin transporter (5-HTT) gene is implicated in Tourette's syndrome.",
      "The GABA receptor beta 2 (GABRB2) gene has been implicated in Tourette's syndrome.",
      "Mutations in the glutamate decarboxylase 67 (GAD67) gene are associated with Tourette's syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe first statement is a well-known characterization of Tourette's syndrome. Statements 2 through 5 involve specific genetic factors which may have varying levels of evidence implicating them in Tourette's syndrome or may be the subject of current research. Without current and specific research data provided, the status of their association can't be definitively confirmed or denied.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "yulan-chat-2-13b-fp16_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n1. The ENCODE (Encyclopedia of DNA Elements) project, which aims to identify and characterize all functional elements in the human genome, including regulatory elements.\n2. The Epigenomic Landscape of Human Activation Classes (Epigenomic LAND) project, which aims to identify and characterize the epigenetic landscape of human brain development and function.\n3. The Roadmap Epigenomics project, which aims to generate high-resolution epigenomic maps for multiple tissue types and cell types, including immune cells, brain cells, and cancer cells.\n4. The Human Epigenome Project (HEP), which aims to identify and characterize the epigenetic changes that occur during human development and aging.\n5. The BLUEPRINT project, which aims to generate high-resolution epigenomic maps for multiple tissue types and cell types, including immune cells, brain cells, and cancer cells.\nThese projects provide a wealth of epigenomic data that can be accessed through the DeepBlue server, including DNA methylation, histone modification, and chromatin accessibility data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The DeepBlue epigenomic data server contains data from the ENCODE (Encyclopedia of DNA Elements) project.\n2. The Epigenomic LAND (Landscape of Human Activation Classes) project data is included in the DeepBlue server.\n3. The DeepBlue epigenomic data server houses data from the Roadmap Epigenomics project.\n4. The Human Epigenome Project (HEP) data is accessible through the DeepBlue epigenomic data server.\n5. Data from the BLUEPRINT project is available on the DeepBlue epigenomic data server.",
    "yulan-chat-2-13b-fp16_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE (Encyclopedia of DNA Elements) project.",
      "The Epigenomic LAND (Landscape of Human Activation Classes) project data is included in the DeepBlue server.",
      "The DeepBlue epigenomic data server houses data from the Roadmap Epigenomics project.",
      "The Human Epigenome Project (HEP) data is accessible through the DeepBlue epigenomic data server.",
      "Data from the BLUEPRINT project is available on the DeepBlue epigenomic data server."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe DeepBlue epigenomic data server indeed contains data from the ENCODE project, and the Roadmap Epigenomics project. However, without more context or additional information, it's not possible to confidently assert the presence of the Epigenomic LAND project data, Human Epigenome Project (HEP) data, or BLUEPRINT project data in the DeepBlue server. These specifics would need to be confirmed by checking the current contents of the DeepBlue server or its documentation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1765,
    "user_query": "Is the toxin produced by Clostridium botulinum always deadly?",
    "yulan-chat-2-13b-fp16_response": "No, the toxin produced by Clostridium botulinum is not always deadly. In fact, the toxin is used in a number of medical treatments, such as cosmetic injections to smooth wrinkles and treat muscle spasms.\nHowever, the toxin can be deadly if it is ingested or if it is not treated in a medical setting. The toxin is highly potent and can cause a serious illness called botulism, which can be fatal if not treated promptly.\nBotulism occurs when the toxin enters the body and blocks the nerve signals that control muscle movement. This can lead to muscle weakness, paralysis, and difficulty breathing, which can be life-threatening.\nIt is important to note that the toxin is highly potent and should only be used in a medical setting by trained professionals. If you suspect that you or someone else may have botulism, it is important to seek medical attention immediately.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The toxin produced by Clostridium botulinum is used in medical treatments, such as cosmetic injections to smooth wrinkles and to treat muscle spasms.\n2. The toxin can be deadly if it is ingested or not treated in a medical setting.\n3. Botulism is a serious illness caused by the toxin produced by Clostridium botulinum.\n4. Botulism can lead to muscle weakness, paralysis, and difficulty breathing.\n5. Botulism can be fatal if not treated promptly.",
    "yulan-chat-2-13b-fp16_fact": [
      "The toxin produced by Clostridium botulinum is used in medical treatments, such as cosmetic injections to smooth wrinkles and to treat muscle spasms.",
      "The toxin can be deadly if it is ingested or not treated in a medical setting.",
      "Botulism is a serious illness caused by the toxin produced by Clostridium botulinum.",
      "Botulism can lead to muscle weakness, paralysis, and difficulty breathing.",
      "Botulism can be fatal if not treated promptly."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1771,
    "user_query": "Describe mechanism of action of Eteplirsen?",
    "yulan-chat-2-13b-fp16_response": "Eteplirsen is a phosphodiesterase inhibitor that acts on the enzyme phosphodiesterase type 9 (PDE9). PDE9 is an enzyme that breaks down a molecule called cyclic guanosine monophosphate (cGMP), which is important for the relaxation of smooth muscle. By inhibiting PDE9, eteplirsen increases the levels of cGMP in the smooth muscle, leading to relaxation of the smooth muscle.\nEteplirsen is used to treat Duchenne muscular dystrophy (DMD) in patients who have a specific genetic mutation that affects the dystrophin gene. This mutation results in the production of a truncated form of dystrophin, which is not functional. Dystrophin is a protein that helps to maintain the structural integrity of muscle cells, and without it, muscle cells are more susceptible to damage and degeneration.\nEteplirsen works by increasing the production of functional dystrophin in muscle cells. It does this by binding to a specific RNA sequence in the dystrophin messenger RNA (mRNA) and stabilizing it, allowing for more complete and accurate processing of the dystrophin mRNA by the cell's machinery. This leads to the production of more functional dystrophin protein, which helps to support the structural integrity of muscle cells and improve their function.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1777,
    "user_query": "Which gene-defect causes the Vel-blood type?",
    "yulan-chat-2-13b-fp16_response": "The Vel-blood type is caused by a genetic defect in the gene that codes for the protein beta-globin. This gene is located on the long (q) arm of the fifth chromosome at position 31.31 and is known as the beta-globin gene. The beta-globin gene provides instructions for making a protein called beta-globin, which is a component of hemoglobin, the molecule that carries oxygen in the blood. In people with the Vel-blood type, a genetic mutation in the beta-globin gene leads to the production of an abnormal form of beta-globin that causes the red blood cells to become deformed and unable to carry oxygen effectively. This results in anemia and other related health problems.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1782,
    "user_query": "What are the exonic splice enhancers?",
    "yulan-chat-2-13b-fp16_response": "Exonic splice enhancers (ESEs) are a class of RNA sequences that can enhance the binding of spliceosomal complexes to pre-mRNA splice sites, thereby promoting exon inclusion in the mature mRNA. ESEs are located within the exons of a gene and are recognized by specific spliceosomal proteins, including the U1, U2, U4, and U5 snRNPs, as well as other splicing factors.\nESEs can be identified by their sequence characteristics, which include the presence of short, conserved motifs that are often found in introns or exons adjacent to the splice site. These motifs are typically 10-20 nucleotides in length and can have a significant impact on the efficiency of splicing.\nESEs play a critical role in the splicing process by promoting the recognition and binding of spliceosomal complexes to the pre-mRNA, thereby increasing the likelihood that the correct splice site will be selected and the exon will be included in the mature mRNA. Mutations in ESEs can lead to aberrant splicing and contribute to the pathogenesis of various human diseases, including genetic disorders and cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Exonic splice enhancers (ESEs) are RNA sequences that enhance the binding of spliceosomal complexes to pre-mRNA splice sites.\n2. ESEs are located within the exons of a gene.\n3. ESEs are recognized by specific spliceosomal proteins, including the U1, U2, U4, and U5 snRNPs.\n4. ESEs have sequence characteristics such as the presence of short, conserved motifs typically 10-20 nucleotides in length.\n5. Mutations in ESEs can contribute to the pathogenesis of various human diseases, including genetic disorders and cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Exonic splice enhancers (ESEs) are RNA sequences that enhance the binding of spliceosomal complexes to pre-mRNA splice sites.",
      "ESEs are located within the exons of a gene.",
      "ESEs are recognized by specific spliceosomal proteins, including the U1, U2, U4, and U5 snRNPs.",
      "ESEs have sequence characteristics such as the presence of short, conserved motifs typically 10-20 nucleotides in length.",
      "Mutations in ESEs can contribute to the pathogenesis of various human diseases, including genetic disorders and cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: ESEs are recognized by specific proteins known as serine/arginine-rich (SR) proteins, not by the U1, U2, U4, and U5 snRNPs which are components of the spliceosome involved in other aspects of the splicing process.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1784,
    "user_query": "What is Neisseria adhesin A?",
    "yulan-chat-2-13b-fp16_response": "Neisserial adhesin A (NadA) is a type of protein found on the surface of certain bacteria belonging to the genus Neisseria. These bacteria are known to cause a variety of infections in humans, including respiratory tract infections, meningitis, and sexually transmitted infections such as gonorrhea.\nNadA is a member of the immunoglobulin A (IgA) superfamily of proteins, which are involved in mediating immune responses and in cell adhesion. NadA is expressed on the surface of Neisseria bacteria and plays a role in the bacteria's ability to attach to and colonize host tissues.\nIn addition to its role in bacterial adhesion, NadA has also been implicated in the development of antibiotic resistance in Neisseria species. Some strains of Neisseria bacteria have been found to produce NadA variants that are resistant to certain antibiotics, making these infections more difficult to treat.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neisserial adhesin A (NadA) is a protein found on the surface of certain bacteria in the genus Neisseria.\n2. The bacteria that express NadA are known to cause respiratory tract infections, meningitis, and sexually transmitted infections such as gonorrhea in humans.\n3. NadA is a member of the immunoglobulin A (IgA) superfamily of proteins.\n4. The role of NadA includes mediating bacterial adhesion to host tissues.\n5. NadA has been implicated in the development of antibiotic resistance in Neisseria species.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neisserial adhesin A (NadA) is a protein found on the surface of certain bacteria in the genus Neisseria.",
      "The bacteria that express NadA are known to cause respiratory tract infections, meningitis, and sexually transmitted infections such as gonorrhea in humans.",
      "NadA is a member of the immunoglobulin A (IgA) superfamily of proteins.",
      "The role of NadA includes mediating bacterial adhesion to host tissues.",
      "NadA has been implicated in the development of antibiotic resistance in Neisseria species."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Neisserial adhesin A (NadA) is not a member of the immunoglobulin A (IgA) superfamily of proteins; it is a member of the Oca (Oligomeric coiled-coil adhesin) family.\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1785,
    "user_query": "Which R package is used for the detection of chromosomal abnormalities from microarray data?",
    "yulan-chat-2-13b-fp16_response": "There are several R packages that can be used for the detection of chromosomal abnormalities from microarray data, including:\n1. SNPstats: This package provides functions for the analysis of genome-wide association studies (GWAS) and genome-wide expression studies (e.g., microarray data). It includes functions for detecting copy number variations (CNVs) and other chromosomal abnormalities.\n2. CNAseq: This package is specifically designed for the detection of copy number variations (CNVs) from RNA-seq data. It uses a statistical model to identify CNVs based on the read depth of the sequenced transcripts.\n3. ChromHMM: This package uses a hidden Markov model to identify chromosomal segments that are likely to be active or inactive in a given sample. It can be used to detect both gain and loss of chromosomal segments, as well as changes in gene expression.\n4. CircularBinaryOUtline: This package is used for the detection of circular genomic structures, such as rings and other circular chromosomal abnormalities. It uses a statistical model to identify these structures based on the read depth of the sequenced DNA.\nThese packages can be used to detect a variety of chromosomal abnormalities, including deletions, duplications, inversions, and translocations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SNPstats is an R package used for the analysis of GWAS and genome-wide expression studies, including the detection of CNVs and other chromosomal abnormalities.\n2. CNAseq is an R package designed specifically for the detection of CNVs from RNA-seq data.\n3. ChromHMM is an R package that employs a hidden Markov model to identify chromosomal segments that might be active or inactive, and is used for detecting chromosomal segment variations.\n4. The CircularBinarySegmentation package is used for the detection of circular genomic structures in sequenced DNA.\n5. These R packages help detect a variety of chromosomal abnormalities such as deletions, duplications, inversions, and translocations.",
    "yulan-chat-2-13b-fp16_fact": [
      "SNPstats is an R package used for the analysis of GWAS and genome-wide expression studies, including the detection of CNVs and other chromosomal abnormalities.",
      "CNAseq is an R package designed specifically for the detection of CNVs from RNA-seq data.",
      "ChromHMM is an R package that employs a hidden Markov model to identify chromosomal segments that might be active or inactive, and is used for detecting chromosomal segment variations.",
      "The CircularBinarySegmentation package is used for the detection of circular genomic structures in sequenced DNA.",
      "These R packages help detect a variety of chromosomal abnormalities such as deletions, duplications, inversions, and translocations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: SNPstats is an R package used for the analysis of genetic association studies, but it does not include features for the detection of CNVs or other chromosomal abnormalities.\n2. FALSE [correction]: CNAseq is not a widely recognized R package for the detection of CNVs from RNA-seq data. CNVs are typically detected from DNA-seq data rather than RNA-seq data.\n3. FALSE [correction]: ChromHMM is not an R package; it is a standalone Java software that employs a hidden Markov model (HMM) to identify chromatin states across the genome, not specifically for detecting chromosomal segment variations.\n4. FALSE [correction]: The CircularBinarySegmentation (CBS) is an algorithm used within the DNAcopy package in R for segmenting DNA copy number data and detecting CNVs, not for the detection of circular genomic structures.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "yulan-chat-2-13b-fp16_response": "One tool that employs self-organizing maps (SOMs) for analyzing synonymous codon usage is the GenePattern software. GenePattern is a web-based tool that uses SOMs to visualize and analyze gene expression data, including the identification of co-regulated genes and the detection of patterns of gene expression. It can also be used to analyze synonymous codon usage and identify genes that use specific sets of synonymous codons. Other tools that use SOMs for analyzing gene expression data include the TreeView and MultiExperimentViewer software packages.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GenePattern software employs self-organizing maps (SOMs) for analyzing synonymous codon usage.\n2. GenePattern is a web-based tool.\n3. GenePattern can be used to visualize and analyze gene expression data.\n4. TreeView and MultiExperimentViewer are other software packages that use self-organizing maps for analyzing gene expression data.",
    "yulan-chat-2-13b-fp16_fact": [
      "GenePattern software employs self-organizing maps (SOMs) for analyzing synonymous codon usage.",
      "GenePattern is a web-based tool.",
      "GenePattern can be used to visualize and analyze gene expression data.",
      "TreeView and MultiExperimentViewer are other software packages that use self-organizing maps for analyzing gene expression data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n\nThe accuracy of statement 4 cannot be confirmed without specific knowledge about TreeView and MultiExperimentViewer software packages concerning their current features at the time of the knowledge cutoff. These packages may or may not support self-organizing maps for analyzing gene expression data.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have any information about a concept or technology called \"MINDY-1\". It is possible that it is a proprietary technology or concept that is not widely known or documented. If you have any additional information or context about MINDY-1, please provide it and I'll do my best to help you.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1805,
    "user_query": "What is BioCreative?",
    "yulan-chat-2-13b-fp16_response": "BioCreative is a community-driven initiative aimed at advancing the development and application of computational methods for analyzing biological data. The initiative brings together researchers from various fields, including bioinformatics, computer science, and statistics, to work on challenging problems in the field of biology.\nBioCreative organizes biennial competitions in which teams of researchers are tasked with developing and evaluating computational methods for solving specific biological problems. These competitions provide a platform for researchers to showcase their latest advances and to receive feedback from the community.\nIn addition to the competitions, BioCreative also hosts workshops and other events to facilitate collaboration and knowledge sharing among researchers. The initiative also provides resources and tools to support the development and evaluation of computational methods for analyzing biological data.\nOverall, BioCreative is a dynamic and collaborative community that is dedicated to advancing the field of bioinformatics and computational biology.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. BioCreative is an initiative aimed at advancing computational methods for analyzing biological data.\n2. BioCreative organizes biennial competitions for researchers to develop computational biology methods.\n3. Researchers from fields such as bioinformatics, computer science, and statistics participate in BioCreative.\n4. BioCreative hosts workshops and events for collaboration and knowledge sharing among researchers.\n5. The initiative offers resources and tools for the development and evaluation of computational biology methods.",
    "yulan-chat-2-13b-fp16_fact": [
      "BioCreative is an initiative aimed at advancing computational methods for analyzing biological data.",
      "BioCreative organizes biennial competitions for researchers to develop computational biology methods.",
      "Researchers from fields such as bioinformatics, computer science, and statistics participate in BioCreative.",
      "BioCreative hosts workshops and events for collaboration and knowledge sharing among researchers.",
      "The initiative offers resources and tools for the development and evaluation of computational biology methods."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: BioCreative does not specifically organize biennial competitions; the frequency of the challenges may vary.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1808,
    "user_query": "What type of mutation is causing the industrial melanism phenotype in peppered moths?",
    "yulan-chat-2-13b-fp16_response": "The industrial melanism phenotype in peppered moths is caused by a mutation in the gene that controls the production of melanin, a pigment that determines the moth's coloration. Specifically, the mutation results in an increase in the production of melanin, causing the moths to have a darker, sootier coloration that helps them blend in with the darkened trees during the industrial revolution when pollution from factories darkened the environment. This mutation is a point mutation, specifically a substitution of a single nucleotide in the DNA sequence of the gene.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The industrial melanism phenotype in peppered moths is caused by a mutation that controls melanin production.\n2. The mutation results in increased production of melanin.\n3. The increased melanin causes peppered moths to have a darker coloration.\n4. The industrial revolution caused pollution that darkened trees in the environment.\n5. The mutation in peppered moths responsible for darker coloration is a point mutation involving a substitution of a single nucleotide.",
    "yulan-chat-2-13b-fp16_fact": [
      "The industrial melanism phenotype in peppered moths is caused by a mutation that controls melanin production.",
      "The mutation results in increased production of melanin.",
      "The increased melanin causes peppered moths to have a darker coloration.",
      "The industrial revolution caused pollution that darkened trees in the environment.",
      "The mutation in peppered moths responsible for darker coloration is a point mutation involving a substitution of a single nucleotide."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "yulan-chat-2-13b-fp16_response": "There are several software packages available for the analysis of conserved genomic loci. Some popular options include:\n1. UCSC Genome Browser: This is a web-based genome browser that allows users to visualize and analyze genomic data, including conservation tracks across multiple species.\n2. MEME Suite: This is a software package that can be used to discover and analyze conserved genomic motifs, including those found in non-coding regions of the genome.\n3. CONSECT: This is a software package that can be used to identify conserved non-coding elements in genomic sequences, and to predict their functions.\n4. Glimmer: This is a software package that can be used to identify conserved non-coding sequences in genomic data, and to predict their functions.\n5. MEME Suite: This is a software package that can be used to discover and analyze conserved genomic motifs, including those found in non-coding regions of the genome.\n6. MotifFinder: This is a software package that can be used to identify conserved non-coding sequences in genomic data, and to predict their functions.\n7. T-Buster: This is a software package that can be used to identify conserved non-coding sequences in genomic data, and to predict their functions.\n8. Genomatix: This is a software package that can be used to identify conserved non-coding sequences in genomic data, and to predict their functions.\n9. AMEIS: This is a software package that can be used to identify conserved non-coding sequences in genomic data, and to predict their functions.\n10. AMEIS: This is a software package that can be used to identify conserved non-coding sequences in genomic data, and to predict their functions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. UCSC Genome Browser is a web-based tool for visualizing and analyzing genomic data, including conservation tracks.\n2. MEME Suite is a software package used for discovering and analyzing conserved genomic motifs.\n3. CONSECT is a software package designed to identify conserved non-coding elements in genomic sequences.\n4. Glimmer is a software package that can identify conserved non-coding sequences in genomic data.\n5. Genomatix is a software used for identifying conserved non-coding sequences in genomic data and predicting their functions.",
    "yulan-chat-2-13b-fp16_fact": [
      "UCSC Genome Browser is a web-based tool for visualizing and analyzing genomic data, including conservation tracks.",
      "MEME Suite is a software package used for discovering and analyzing conserved genomic motifs.",
      "CONSECT is a software package designed to identify conserved non-coding elements in genomic sequences.",
      "Glimmer is a software package that can identify conserved non-coding sequences in genomic data.",
      "Genomatix is a software used for identifying conserved non-coding sequences in genomic data and predicting their functions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CONSECT is not a known standard software package used for identifying conserved non-coding elements. A possible correction could be referring to a different software package such as PhastCons or ConSite, but without the proper name, the specific correction cannot be determined.\n4. FALSE [correction]: Glimmer is a system for finding genes in microbial DNA, especially the genomes of bacteria, archaea, and viruses, not specifically for identifying conserved non-coding sequences.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1812,
    "user_query": "What is Eteplirsen (Exondys 51)?",
    "yulan-chat-2-13b-fp16_response": "Eteplirsen, sold under the brand name Exondys 51, is a medication and the first and only approved treatment for Duchenne muscular dystrophy (DMD) in patients who have a specific genetic mutation known as a deletion of exon 51 in the dystrophin gene. DMD is a rare genetic disorder that affects muscle strength and function, and eventually leads to progressive muscle weakness and loss of mobility.\nEteplirsen works by using a technique called exon skipping, which involves delivering a modified messenger RNA (mRNA) to the body that encourages the production of a functional dystrophin protein, which is missing or defective in people with DMD due to genetic mutations. By skipping over the exon 51 region in the dystrophin gene, eteplirsen helps to produce a functional dystrophin protein, which can improve muscle function and slow the progression of the disease.\nEteplirsen is administered by injection into a muscle and is typically used in patients who are at least 5 years old and have a genetic confirmation of a deletion of exon 51 in the dystrophin gene. The efficacy and safety of eteplirsen have been demonstrated in clinical trials, and it has been approved by regulatory agencies in several countries, including the United States, the European Union, and Japan.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eteplirsen is sold under the brand name Exondys 51.\n2. Eteplirsen is approved for the treatment of Duchenne muscular dystrophy (DMD) in patients with a deletion of exon 51 in the dystrophin gene.\n3. Eteplirsen employs exon skipping by delivering a modified mRNA to encourage the production of functional dystrophin protein.\n4. The medication is typically used in patients who are at least 5 years old.\n5. Eteplirsen has been approved by regulatory agencies in the United States, the European Union, and Japan.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eteplirsen is sold under the brand name Exondys 51.",
      "Eteplirsen is approved for the treatment of Duchenne muscular dystrophy (DMD) in patients with a deletion of exon 51 in the dystrophin gene.",
      "Eteplirsen employs exon skipping by delivering a modified mRNA to encourage the production of functional dystrophin protein.",
      "The medication is typically used in patients who are at least 5 years old.",
      "Eteplirsen has been approved by regulatory agencies in the United States, the European Union, and Japan."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The medication's use is not typically age-restricted to patients who are at least 5 years old. Eteplirsen can be used in DMD patients who meet the genetic criteria, regardless of their age.\n5. FALSE [correction]: As of my knowledge cutoff date in 2023, eteplirsen has been approved by the FDA in the United States but not by the European Medicines Agency (EMA) in the European Union or by the Japanese regulatory agencies.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1813,
    "user_query": "What are the SINEUPs?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with the term \"SINEUPs.\" Can you provide more context or information about what you are referring to?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1815,
    "user_query": "What is the mechanism of action of raxibacumab?",
    "yulan-chat-2-13b-fp16_response": "Raxibacumab is a monoclonal antibody that targets and neutralizes the bacterial toxin Bordetella pertussis toxin (BPT). BPT is produced by Bordetella pertussis, a gram-negative bacterium that is the causative agent of whooping cough.\nThe mechanism of action of raxibacumab involves binding to BPT and preventing it from entering and causing damage to host cells. BPT is a protein that consists of a protective antigen (PA) and a permeability-increasing toxin (PITP) component. PA is responsible for the initial binding of BPT to host cells, while PITP causes the cell to become permeable to ions and water, leading to cell swelling and lysis.\nRaxibacumab binds to and neutralizes PA, thereby preventing BPT from entering host cells and causing damage. By neutralizing BPT, raxibacumab can reduce the severity and duration of pertussis symptoms, including coughing, choking, and difficulty breathing.\nOverall, the mechanism of action of raxibacumab is to target and neutralize the bacterial toxin BPT, thereby reducing the severity of pertussis infections.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Raxibacumab is a monoclonal antibody that targets and neutralizes Bordetella pertussis toxin (BPT).\n2. Bordetella pertussis is a gram-negative bacterium that causes whooping cough.\n3. BPT consists of a protective antigen (PA) and a permeability-increasing toxin (PITP) component.\n4. Raxibacumab binds to and neutralizes PA, preventing BPT from entering host cells.\n5. The neutralization of BPT by raxibacumab can reduce the severity and duration of pertussis symptoms.",
    "yulan-chat-2-13b-fp16_fact": [
      "Raxibacumab is a monoclonal antibody that targets and neutralizes Bordetella pertussis toxin (BPT).",
      "Bordetella pertussis is a gram-negative bacterium that causes whooping cough.",
      "BPT consists of a protective antigen (PA) and a permeability-increasing toxin (PITP) component.",
      "Raxibacumab binds to and neutralizes PA, preventing BPT from entering host cells.",
      "The neutralization of BPT by raxibacumab can reduce the severity and duration of pertussis symptoms."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Raxibacumab is a monoclonal antibody that targets the anthrax toxin's protective antigen (PA), not Bordetella pertussis toxin (BPT).\n2. TRUE\n3. FALSE [correction]: Bordetella pertussis toxin (BPT) consists of multiple subunits but is not characterized by a protective antigen (PA) and a permeability-increasing toxin (PITP) component; these are parts of the anthrax toxin.\n4. FALSE [correction]: Raxibacumab is not known to bind to and neutralize Bordetella pertussis toxin's components as it is an anthrax treatment. If we were discussing the anthrax toxin, raxibacumab would bind to the protective antigen (PA) component of the anthrax toxin, not BPT.\n5. FALSE [correction]: Since raxibacumab targets the anthrax toxin, not Bordetella pertussis toxin, it does not reduce the severity and duration of pertussis symptoms.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1817,
    "user_query": "Is SUMOylation a post-translational modification in eukaryotes?",
    "yulan-chat-2-13b-fp16_response": "Yes, SUMOylation (Small Ubiquitin-like Modifier) is a post-translational modification in eukaryotes. It is a type of protein modification in which a small protein called SUMO (Small Ubiquitin-like Modifier) is covalently attached to a lysine residue of a target protein. This modification can affect the stability, localization, and activity of the modified protein. SUMOylation is involved in various cellular processes, including DNA repair, transcriptional regulation, and protein degradation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SUMOylation is a post-translational modification in eukaryotes.\n2. SUMOylation involves the covalent attachment of a small protein called SUMO to a lysine residue of a target protein.\n3. The SUMOylation modification can affect the stability, localization, and activity of the modified protein.\n4. SUMOylation plays a role in DNA repair.\n5. SUMOylation is involved in transcriptional regulation and protein degradation.",
    "yulan-chat-2-13b-fp16_fact": [
      "SUMOylation is a post-translational modification in eukaryotes.",
      "SUMOylation involves the covalent attachment of a small protein called SUMO to a lysine residue of a target protein.",
      "The SUMOylation modification can affect the stability, localization, and activity of the modified protein.",
      "SUMOylation plays a role in DNA repair.",
      "SUMOylation is involved in transcriptional regulation and protein degradation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1823,
    "user_query": "Is Annexin V an apoptotic marker?",
    "yulan-chat-2-13b-fp16_response": "Yes, Annexin V is an apoptotic marker. It is a fluorescent probe that binds to phosphatidylserine (PS) exposed on the outer leaflet of the plasma membrane of apoptotic cells. In healthy cells, PS is located on the inner leaflet of the membrane and is protected by a lipid bilayer. However, during apoptosis, the membrane bilayer becomes fragmented, and PS is exposed on the outer leaflet. Annexin V can bind to this exposed PS and can be detected by fluorescence microscopy or flow cytometry. The binding of Annexin V to PS is considered a reliable indicator of apoptosis in cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Annexin V is an apoptotic marker.\n2. Annexin V binds to phosphatidylserine (PS) when it is exposed on the outer leaflet of the plasma membrane of apoptotic cells.\n3. In healthy cells, phosphatidylserine is located on the inner leaflet of the membrane and is protected by a lipid bilayer.\n4. During apoptosis, the membrane bilayer becomes fragmented, exposing PS on the outer leaflet.\n5. The binding of Annexin V to exposed PS can be detected by fluorescence microscopy or flow cytometry.",
    "yulan-chat-2-13b-fp16_fact": [
      "Annexin V is an apoptotic marker.",
      "Annexin V binds to phosphatidylserine (PS) when it is exposed on the outer leaflet of the plasma membrane of apoptotic cells.",
      "In healthy cells, phosphatidylserine is located on the inner leaflet of the membrane and is protected by a lipid bilayer.",
      "During apoptosis, the membrane bilayer becomes fragmented, exposing PS on the outer leaflet.",
      "The binding of Annexin V to exposed PS can be detected by fluorescence microscopy or flow cytometry."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: During apoptosis, the membrane bilayer does not become fragmented; rather, phosphatidylserine (PS) flips from the inner leaflet to the outer leaflet of the plasma membrane, becoming exposed.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1825,
    "user_query": "What are PD-1 inhibitors?",
    "yulan-chat-2-13b-fp16_response": "PD-1 inhibitors are a class of drugs that block the PD-1 protein on immune cells, which helps to enhance the immune system's ability to recognize and attack cancer cells. PD-1 is a protein found on the surface of T cells, which are a type of immune cell that plays a critical role in the immune response. When PD-1 interacts with its ligand, PD-L1 (Programmed Death-Ligand 1), on cancer cells, it sends a signal to the T cell to become inactive and not attack the cancer cell. By blocking this interaction, PD-1 inhibitors help to enhance the immune response against cancer cells. PD-1 inhibitors are used to treat various types of cancer, including lung cancer, melanoma, and bladder cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PD-1 inhibitors are drugs that block the PD-1 protein on immune cells.\n2. PD-1 is a protein found on the surface of T cells, which are a type of immune cell.\n3. The interaction between PD-1 and its ligand PD-L1 can cause T cells to become inactive.\n4. PD-1 inhibitors are used to enhance the immune system's ability to recognize and attack cancer cells.\n5. PD-1 inhibitors are used in the treatment of various types of cancer, including lung cancer, melanoma, and bladder cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "PD-1 inhibitors are drugs that block the PD-1 protein on immune cells.",
      "PD-1 is a protein found on the surface of T cells, which are a type of immune cell.",
      "The interaction between PD-1 and its ligand PD-L1 can cause T cells to become inactive.",
      "PD-1 inhibitors are used to enhance the immune system's ability to recognize and attack cancer cells.",
      "PD-1 inhibitors are used in the treatment of various types of cancer, including lung cancer, melanoma, and bladder cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1828,
    "user_query": "Is Migalastat used for treatment of Fabry Disease?",
    "yulan-chat-2-13b-fp16_response": "Migalastat is a medication that is used to treat Fabry disease. It is a pharmacological chaperone that works by stabilizing the alpha-galactosidase A enzyme, which is deficient in Fabry disease. Migalastat is taken by mouth and is used to reduce the accumulation of fatty substances in the body that are caused by the lack of alpha-galactosidase A. It is not a cure for Fabry disease, but it can help to manage the symptoms of the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Migalastat is used to treat Fabry disease.\n2. It functions as a pharmacological chaperone by stabilizing the alpha-galactosidase A enzyme.\n3. Fabry disease is characterized by a deficiency of the alpha-galactosidase A enzyme.\n4. Migalastat is administered orally.\n5. Migalastat helps to reduce the accumulation of fatty substances in the body caused by Fabry disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Migalastat is used to treat Fabry disease.",
      "It functions as a pharmacological chaperone by stabilizing the alpha-galactosidase A enzyme.",
      "Fabry disease is characterized by a deficiency of the alpha-galactosidase A enzyme.",
      "Migalastat is administered orally.",
      "Migalastat helps to reduce the accumulation of fatty substances in the body caused by Fabry disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1829,
    "user_query": "Where are Paneth cells located?",
    "yulan-chat-2-13b-fp16_response": "Paneth cells are located in the small intestine of mammals, specifically in the lining of the duodenum, which is the first part of the small intestine. These cells are named after the German pathologist Paul Paneth, who discovered them in 1882.\nPaneth cells are specialized cells that produce and secrete digestive enzymes into the lumen of the small intestine. They are also involved in the production of mucus, which helps to protect the lining of the intestine and facilitate the movement of food through the digestive tract.\nIn addition to their role in digestion, Paneth cells have been implicated in the immune system of the gut. They are able to produce antimicrobial peptides, which help to protect the body against infections caused by harmful bacteria.\nOverall, Paneth cells play an important role in the digestive and immune systems of mammals, and their function is essential for maintaining the health of the small intestine.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Paneth cells are located in the small intestine of mammals.\n2. These cells specifically reside in the lining of the duodenum, which is the first part of the small intestine.\n3. Paneth cells were discovered by German pathologist Paul Paneth in 1882.\n4. The cells produce and secrete digestive enzymes into the lumen of the small intestine.\n5. Paneth cells produce antimicrobial peptides which help protect the body against infections caused by harmful bacteria.",
    "yulan-chat-2-13b-fp16_fact": [
      "Paneth cells are located in the small intestine of mammals.",
      "These cells specifically reside in the lining of the duodenum, which is the first part of the small intestine.",
      "Paneth cells were discovered by German pathologist Paul Paneth in 1882.",
      "The cells produce and secrete digestive enzymes into the lumen of the small intestine.",
      "Paneth cells produce antimicrobial peptides which help protect the body against infections caused by harmful bacteria."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Paneth cells were described by Austrian physician Josef Paneth in 1888, not by a German pathologist named Paul Paneth in 1882.\n4. FALSE [correction]: Paneth cells do not primarily produce digestive enzymes; instead, they secrete antimicrobial molecules such as lysozyme and defensins into the intestinal lumen to contribute to gut immunity.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1832,
    "user_query": "Which pipelines are used for analyzing data from ChIP-nexus experiments?",
    "yulan-chat-2-13b-fp16_response": "ChIP-nexus (chromatin interaction capture using high-resolution tiling arrays) is a technique used to identify protein-DNA interactions at a genome-wide scale. The data generated from ChIP-nexus experiments is typically analyzed using a combination of bioinformatics pipelines. Here are some of the commonly used pipelines:\n1. ChIPseeker: This is a popular bioinformatics tool used for ChIP-nexus data analysis. It provides a user-friendly interface for visualizing and analyzing ChIP-nexus data. ChIPseeker can identify peaks of enrichment, calculate enrichment scores, and perform statistical analysis to determine the significance of the observed interactions.\n2. MACS2: The Model-based Analysis of ChIP-Seq (MACS2) is a widely used tool for analyzing ChIP-seq data. It can also be used for ChIP-nexus data analysis. MACS2 uses a statistical model to identify significant peaks of enrichment and can perform peak sorting and annotation.\n3. Picard: The Genome Analysis Toolkit (GATK) is a popular suite of tools for analyzing high-throughput sequencing data. Picard is a module within GATK that provides a set of tools for analyzing ChIP-nexus data. It can perform quality control checks, identify and remove low-quality probes, and perform peak calling.\n4. DeepSeq: DeepSeq is a tool for identifying differentially bound regions in ChIP-seq and ChIP-nexus data. It uses a statistical model to identify significant peaks of enrichment and can perform peak sorting and annotation.\nThese are just a few examples of the many bioinformatics pipelines available for analyzing ChIP-nexus data. The choice of pipeline will depend on the specific goals of the analysis and the characteristics of the data being analyzed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ChIP-nexus is a technique used to identify protein-DNA interactions at a genome-wide scale.\n2. ChIPseeker is used for analyzing ChIP-nexus data and can identify peaks of enrichment and perform statistical analysis.\n3. The Model-based Analysis of ChIP-Seq (MACS2) is applicable for both ChIP-seq and ChIP-nexus data analysis.\n4. Picard is a module within the Genome Analysis Toolkit (GATK) that is used for analyzing ChIP-nexus data including performing quality control checks.\n5. DeepSeq is a tool that can identify differentially bound regions in both ChIP-seq and ChIP-nexus data.",
    "yulan-chat-2-13b-fp16_fact": [
      "ChIP-nexus is a technique used to identify protein-DNA interactions at a genome-wide scale.",
      "ChIPseeker is used for analyzing ChIP-nexus data and can identify peaks of enrichment and perform statistical analysis.",
      "The Model-based Analysis of ChIP-Seq (MACS2) is applicable for both ChIP-seq and ChIP-nexus data analysis.",
      "Picard is a module within the Genome Analysis Toolkit (GATK) that is used for analyzing ChIP-nexus data including performing quality control checks.",
      "DeepSeq is a tool that can identify differentially bound regions in both ChIP-seq and ChIP-nexus data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Picard is a set of Java-based command-line utilities that work with high-throughput sequencing data (BAM and VCF files) for quality control and preprocessing, but it is independent of the Genome Analysis Toolkit (GATK), which is used primarily for variant discovery analysis.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1833,
    "user_query": "What do statins do?",
    "yulan-chat-2-13b-fp16_response": "Statins are a type of medication that are used to lower cholesterol levels in the blood. They work by inhibiting the production of cholesterol in the liver. High levels of cholesterol in the blood can increase the risk of developing heart disease, so statins are often prescribed to people who have high cholesterol levels or who are at risk of developing heart disease. In addition to lowering cholesterol levels, statins may also have other benefits, such as reducing the risk of stroke and improving blood pressure.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Statins are used to lower cholesterol levels in the blood.\n2. Statins work by inhibiting the production of cholesterol in the liver.\n3. High levels of cholesterol can increase the risk of developing heart disease.\n4. Statins are often prescribed to people with high cholesterol levels or who are at risk of heart disease.\n5. Statins may reduce the risk of stroke and improve blood pressure.",
    "yulan-chat-2-13b-fp16_fact": [
      "Statins are used to lower cholesterol levels in the blood.",
      "Statins work by inhibiting the production of cholesterol in the liver.",
      "High levels of cholesterol can increase the risk of developing heart disease.",
      "Statins are often prescribed to people with high cholesterol levels or who are at risk of heart disease.",
      "Statins may reduce the risk of stroke and improve blood pressure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE (While statins are primarily known for reducing cholesterol levels, they have also been associated with a reduced risk of stroke. However, their direct effects on improving blood pressure are not as prominent, they might indirectly benefit blood pressure by improving overall cardiovascular health.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1835,
    "user_query": "Do statins cause diabetes?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that statins, which are a type of medication used to lower cholesterol levels, may increase the risk of developing type 2 diabetes. However, the overall risk is still relatively low, and the benefits of taking statins in terms of reducing the risk of heart disease and stroke may outweigh the potential risk of developing diabetes. It is important to discuss any concerns you may have about taking statins with your doctor, who can help you weigh the potential risks and benefits based on your individual health situation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Statins are a type of medication used to lower cholesterol levels.\n2. There is evidence suggesting that statins may increase the risk of developing type 2 diabetes.\n3. The overall risk of developing diabetes due to statin use is considered relatively low.\n4. Statins are prescribed for reducing the risk of heart disease and stroke.\n5. It is recommended to discuss concerns about taking statins with a doctor.",
    "yulan-chat-2-13b-fp16_fact": [
      "Statins are a type of medication used to lower cholesterol levels.",
      "There is evidence suggesting that statins may increase the risk of developing type 2 diabetes.",
      "The overall risk of developing diabetes due to statin use is considered relatively low.",
      "Statins are prescribed for reducing the risk of heart disease and stroke.",
      "It is recommended to discuss concerns about taking statins with a doctor."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1841,
    "user_query": "What is the composition of the gamma-secretase complex?",
    "yulan-chat-2-13b-fp16_response": "The gamma-secretase complex is a membrane-bound protein complex that plays a crucial role in the processing of various transmembrane proteins, including the amyloid precursor protein (APP) and the Notch receptor. The complex consists of four subunits: gamma-secretase, annexin IV, presenilin, and nicastrin.\nGamma-secretase is a transmembrane protein that serves as the anchor for the complex in the membrane. It contains a protease domain that is responsible for cleaving the transmembrane domain of APP and other substrates.\nAnnexin IV is a cytoplasmic protein that interacts with gamma-secretase and helps to recruit other components of the complex. It also plays a role in regulating the activity of gamma-secretase.\nPresenilin is a transmembrane protein that is essential for the proteolytic activity of gamma-secretase. It contains a protease domain that is responsible for cleaving the substrates, and mutations in presenilin genes are associated with early-onset Alzheimer's disease.\nNicastrin is a cytoplasmic protein that interacts with presenilin and helps to form the active gamma-secretase complex. It also plays a role in regulating the activity of gamma-secretase.\nOverall, the gamma-secretase complex is a complex and highly regulated machinery that plays a critical role in the processing of transmembrane proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The gamma-secretase complex consists of four subunits: gamma-secretase, annexin IV, presenilin, and nicastrin.\n2. Gamma-secretase is a transmembrane protein with a protease domain that cleaves the transmembrane domain of substrates such as the amyloid precursor protein.\n3. Annexin IV is a cytoplasmic protein that interacts with gamma-secretase and contributes to the recruitment of other complex components and activity regulation.\n4. Presenilin is a transmembrane protein with a protease domain essential for the proteolytic activity of gamma-secretase and is associated with early-onset Alzheimer's disease when mutated.\n5. Nicastrin is a cytoplasmic protein that forms the active gamma-secretase complex with presenilin and regulates gamma-secretase activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "The gamma-secretase complex consists of four subunits: gamma-secretase, annexin IV, presenilin, and nicastrin.",
      "Gamma-secretase is a transmembrane protein with a protease domain that cleaves the transmembrane domain of substrates such as the amyloid precursor protein.",
      "Annexin IV is a cytoplasmic protein that interacts with gamma-secretase and contributes to the recruitment of other complex components and activity regulation.",
      "Presenilin is a transmembrane protein with a protease domain essential for the proteolytic activity of gamma-secretase and is associated with early-onset Alzheimer's disease when mutated.",
      "Nicastrin is a cytoplasmic protein that forms the active gamma-secretase complex with presenilin and regulates gamma-secretase activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The gamma-secretase complex consists of four subunits: presenilin, nicastrin, APH-1 (anterior pharynx-defective 1), and PEN-2 (presenilin enhancer 2). Annexin IV is not one of the subunits.\n2. TRUE\n3. FALSE [correction]: Annexin IV is not one of the components of the gamma-secretase complex; rather, it is a calcium/phospholipid-binding protein that may have a role in exocytosis, but its interaction with gamma-secretase is not established.\n4. TRUE\n5. FALSE [correction]: Nicastrin is a type I transmembrane glycoprotein, not a cytoplasmic protein, that forms the active gamma-secretase complex with presenilin, APH-1, and PEN-2, and it helps regulate gamma-secretase activity by serving as a substrate receptor.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1844,
    "user_query": "What is the role of the UBC9 enzyme in the protein sumoylation pathway?",
    "yulan-chat-2-13b-fp16_response": "The UBC9 enzyme is a member of the E1 enzyme family in the protein sumoylation pathway. Its primary role is to activate the small ubiquitin-like modifier (SUMO) molecule by transferring it to an awaiting E2 enzyme, which then transfers the modified SUMO to the target protein. This process, known as sumoylation, adds a SUMO protein to lysine residues on target proteins, which can alter their function, localization, and interactions with other proteins. UBC9 is essential for the initiation of the sumoylation pathway and plays a critical role in regulating various cellular processes, including transcription, DNA repair, and protein turnover.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. UBC9 enzyme is a member of the E1 enzyme family in the protein sumoylation pathway.\n2. The primary role of UBC9 is to activate the small ubiquitin-like modifier (SUMO) molecule.\n3. UBC9 transfers the SUMO molecule to an E2 enzyme in the sumoylation process.\n4. Sumoylation involves adding a SUMO protein to lysine residues on target proteins.\n5. UBC9 is essential for the initiation of the sumoylation pathway.",
    "yulan-chat-2-13b-fp16_fact": [
      "UBC9 enzyme is a member of the E1 enzyme family in the protein sumoylation pathway.",
      "The primary role of UBC9 is to activate the small ubiquitin-like modifier (SUMO) molecule.",
      "UBC9 transfers the SUMO molecule to an E2 enzyme in the sumoylation process.",
      "Sumoylation involves adding a SUMO protein to lysine residues on target proteins.",
      "UBC9 is essential for the initiation of the sumoylation pathway."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: UBC9 enzyme is a member of the E2 enzyme family in the protein sumoylation pathway.\n2. FALSE [correction]: The primary role of UBC9 is not to activate the SUMO molecule but to conjugate it to target substrates. The activation of the SUMO molecule is carried out by an E1 activating enzyme.\n3. FALSE [correction]: UBC9 directly transfers the SUMO molecule to target substrates, not to an E2 enzyme, because UBC9 itself is the E2 conjugating enzyme in the sumoylation process.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1849,
    "user_query": "What is the role of cohesins at the IFNG locus?",
    "yulan-chat-2-13b-fp16_response": "Cohesins are a group of proteins that play a critical role in regulating gene expression by forming a ring-like structure around the DNA and recruiting other proteins to the site. At the IFNG locus, cohesins help to regulate the expression of the IFNG gene, which encodes the protein interferon-gamma.\nInterferon-gamma is an important cytokine that plays a key role in the immune response to viral infections and other pathogens. It is produced by immune cells called T cells and natural killer cells, and it helps to activate other immune cells and coordinate the immune response.\nCohesins help to regulate the expression of the IFNG gene by recruiting other proteins to the site, including transcription factors that bind to specific sequences in the DNA and control the rate of transcription. By regulating the expression of the IFNG gene, cohesins help to ensure that the immune response is appropriately activated and regulated in response to infection or other threats.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cohesins form a ring-like structure around DNA and recruit other proteins to the site.\n2. At the IFNG locus, cohesins regulate the expression of the IFNG gene.\n3. The IFNG gene encodes the protein interferon-gamma.\n4. Interferon-gamma is produced by T cells and natural killer cells.\n5. Interferon-gamma plays a key role in the immune response to viral infections and other pathogens.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cohesins form a ring-like structure around DNA and recruit other proteins to the site.",
      "At the IFNG locus, cohesins regulate the expression of the IFNG gene.",
      "The IFNG gene encodes the protein interferon-gamma.",
      "Interferon-gamma is produced by T cells and natural killer cells.",
      "Interferon-gamma plays a key role in the immune response to viral infections and other pathogens."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1853,
    "user_query": "Could hypophosphatemic rickets cause craniosynostosis?",
    "yulan-chat-2-13b-fp16_response": "Hypophosphatemic rickets is a rare genetic disorder that is characterized by the absence or decreased levels of phosphate in the bones, which can lead to weakened bones and abnormal bone growth. Craniosynostosis is a condition in which the bones of the skull fuse prematurely, limiting the growth of the brain and potentially causing serious neurological problems.\nWhile hypophosphatemic rickets can cause bone abnormalities, there is no evidence to suggest that it can directly cause craniosynostosis. Craniosynostosis is typically caused by mutations in certain genes that regulate bone growth and development, and it is not directly related to phosphate levels in the bones.\nHowever, it is possible that hypophosphatemic rickets could contribute to the development of craniosynostosis in some cases, as both conditions involve abnormalities in bone growth and development. It is important to note that the relationship between these two conditions is not well understood, and further research is needed to determine the potential links between them.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hypophosphatemic rickets is a rare genetic disorder characterized by low levels or absence of phosphate in the bones.\n2. The disorder leads to weakened bones and abnormal bone growth.\n3. Craniosynostosis is a condition where the bones of the skull fuse prematurely.\n4. Craniosynostosis can cause serious neurological problems due to limited brain growth. \n5. There is no evidence to suggest that hypophosphatemic rickets can directly cause craniosynostosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hypophosphatemic rickets is a rare genetic disorder characterized by low levels or absence of phosphate in the bones.",
      "The disorder leads to weakened bones and abnormal bone growth.",
      "Craniosynostosis is a condition where the bones of the skull fuse prematurely.",
      "Craniosynostosis can cause serious neurological problems due to limited brain growth.",
      "There is no evidence to suggest that hypophosphatemic rickets can directly cause craniosynostosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE (based on the information given, if there is no evidence presented in the statements to suggest a direct cause, this statement is true)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1854,
    "user_query": "Is vortioxetine effective for treatment of depression?",
    "yulan-chat-2-13b-fp16_response": "Vortioxetine is a medication that is used to treat depression. It is a selective serotonin reuptake inhibitor (SSRI) and works by increasing the levels of serotonin in the brain. Studies have shown that vortioxetine can be effective in treating depression, although it may not work as well as other antidepressants in some people. It is important to note that like all medications, vortioxetine can have side effects and may not be suitable for everyone. It is best to discuss the potential benefits and risks of vortioxetine with a healthcare professional to determine if it is the right treatment option for you.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vortioxetine is a medication used to treat depression.\n2. It functions as a selective serotonin reuptake inhibitor (SSRI).\n3. Vortioxetine works by increasing levels of serotonin in the brain.\n4. Studies have indicated that vortioxetine can be effective in treating depression.\n5. Vortioxetine may not work as well as other antidepressants in some individuals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vortioxetine is a medication used to treat depression.",
      "It functions as a selective serotonin reuptake inhibitor (SSRI).",
      "Vortioxetine works by increasing levels of serotonin in the brain.",
      "Studies have indicated that vortioxetine can be effective in treating depression.",
      "Vortioxetine may not work as well as other antidepressants in some individuals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Vortioxetine is not just a selective serotonin reuptake inhibitor (SSRI); it is known as a serotonin modulator and stimulator (SMS) or multimodal antidepressant. It works on several different serotonin receptors in addition to inhibiting the reuptake of serotonin.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1859,
    "user_query": "Where do the Schwann cells and melanocytes originate from?",
    "yulan-chat-2-13b-fp16_response": "Schwann cells and melanocytes both originate from the neural crest, a transient cell population during embryonic development that gives rise to a variety of cell types in the body.\nSchwann cells are responsible for the formation of the protective covering around peripheral nerves, known as the myelin sheath. They develop from neural crest cells that migrate to the peripheral nervous system and differentiate into oligodendrocytes, which form the myelin sheath around the axons of neurons in the central nervous system, and Schwann cells, which form the myelin sheath around the axons of neurons in the peripheral nervous system.\nMelanocytes, on the other hand, are responsible for the production of melanin, a pigment that gives skin, hair, and eyes their color. They develop from neural crest cells that migrate to the skin and differentiate into melanocytes. Melanocytes are found in the epidermis, the outermost layer of the skin, and are responsible for producing the pigment melanin, which helps protect the skin from harmful UV radiation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Schwann cells originate from the neural crest.\n2. Melanocytes originate from the neural crest.\n3. Schwann cells form the myelin sheath around the axons of neurons in the peripheral nervous system.\n4. Melanocytes are responsible for the production of melanin, the pigment that colors skin, hair, and eyes.\n5. Melanocytes are found in the epidermis and help protect the skin from harmful UV radiation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Schwann cells originate from the neural crest.",
      "Melanocytes originate from the neural crest.",
      "Schwann cells form the myelin sheath around the axons of neurons in the peripheral nervous system.",
      "Melanocytes are responsible for the production of melanin, the pigment that colors skin, hair, and eyes.",
      "Melanocytes are found in the epidermis and help protect the skin from harmful UV radiation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "yulan-chat-2-13b-fp16_response": "1. X-linked hereditary lymphedema type 2 (LYMPH2)\n2. Familial lymphedema-atherosclerosis syndrome (FLAS)\n3. Lymphatic malformation",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1862,
    "user_query": "Where is the protein slitrk1 localized?",
    "yulan-chat-2-13b-fp16_response": "Slitrk1 is a protein that is involved in the development and function of the nervous system. It is a member of the Slit family of proteins, which are known to play a role in the guidance of nerve cells.\nSlitrk1 is expressed in a variety of tissues, including the brain, spinal cord, and peripheral nervous system. It is localized to the extracellular space, where it can interact with other proteins to influence the growth and direction of nerve cells. In particular, Slitrk1 is thought to play a role in the development of the neural circuitry in the brain, and it may also be involved in the regulation of pain sensation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Slitrk1 is a protein that is involved in the development and function of the nervous system.\n2. Slitrk1 is a member of the Slit family of proteins.\n3. The Slit family of proteins is known to play a role in the guidance of nerve cells.\n4. Slitrk1 is expressed in the brain, spinal cord, and peripheral nervous system.\n5. Slitrk1 is localized to the extracellular space.",
    "yulan-chat-2-13b-fp16_fact": [
      "Slitrk1 is a protein that is involved in the development and function of the nervous system.",
      "Slitrk1 is a member of the Slit family of proteins.",
      "The Slit family of proteins is known to play a role in the guidance of nerve cells.",
      "Slitrk1 is expressed in the brain, spinal cord, and peripheral nervous system.",
      "Slitrk1 is localized to the extracellular space."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Although Slitrk1 is similar in name to the Slit family of proteins, it is not a member of the Slit family; it belongs to the SLITRK family, which is a different group of proteins.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Slitrk1 is a transmembrane protein, not localized to the extracellular space; it is present in the cellular membrane and may affect interactions both inside and outside the cell.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1863,
    "user_query": "Describe clinical manifestation of the Harlequin syndrome.",
    "yulan-chat-2-13b-fp16_response": "The Harlequin syndrome is a rare genetic disorder that is characterized by a unique pattern of skin pigmentation and a specific type of facial dysmorphism. The clinical manifestations of the syndrome typically become apparent at birth or in early childhood and include:\n1. Skin pigmentation: Individuals with Harlequin syndrome have a mottled or marbled appearance to their skin, which is caused by a combination of hyperpigmentation and hypopigmentation. This can result in a \"harlequin\" or \"mask-like\" appearance to the skin.\n2. Facial dysmorphism: People with Harlequin syndrome have a specific type of facial dysmorphism, which is characterized by a broad forehead, a prominent scalp, a short, upturned nose, and a wide, open mouth. This facial dysmorphism is caused by a combination of skull abnormalities and malformations of the midface.\n3. Intellectual disability: Some individuals with Harlequin syndrome may have intellectual disability or developmental delay.\n4. Short stature: Many people with Harlequin syndrome are short in stature, although this is not always the case.\n5. Other features: In some cases, individuals with Harlequin syndrome may have other features such as webbed neck, low-set ears, and abnormalities of the hands and feet.\nIt is important to note that not all individuals with Harlequin syndrome will have all of these features, and the severity of the symptoms can vary widely. The syndrome is caused by mutations in the COL17A1 gene, which is involved in the production of collagen.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Harlequin syndrome is characterized by a unique pattern of skin pigmentation due to a combination of hyperpigmentation and hypopigmentation.\n2. Individuals with Harlequin syndrome display a specific type of facial dysmorphism, including a broad forehead, prominent scalp, short upturned nose, and wide open mouth.\n3. Some individuals with Harlequin syndrome may exhibit intellectual disability or developmental delay.\n4. Many people with Harlequin syndrome have a shorter stature.\n5. The Harlequin syndrome is associated with mutations in the COL17A1 gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Harlequin syndrome is characterized by a unique pattern of skin pigmentation due to a combination of hyperpigmentation and hypopigmentation.",
      "Individuals with Harlequin syndrome display a specific type of facial dysmorphism, including a broad forehead, prominent scalp, short upturned nose, and wide open mouth.",
      "Some individuals with Harlequin syndrome may exhibit intellectual disability or developmental delay.",
      "Many people with Harlequin syndrome have a shorter stature.",
      "The Harlequin syndrome is associated with mutations in the COL17A1 gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Harlequin syndrome is characterized by asymmetric sweating and flushing of the face and upper thorax, not a unique pattern of skin pigmentation.\n2. FALSE [correction]: The description provided fits the characteristics of a condition known as Harlequin ichthyosis, which involves severe skin abnormalities, rather than Harlequin syndrome, which affects the autonomic nervous system.\n3. UNKNOWN: Without a clear distinction between Harlequin ichthyosis (a severe skin disorder) and Harlequin syndrome (autonomic nervous system disorder), it cannot be determined if this statement is true or false in the context of Harlequin syndrome.\n4. UNKNOWN: Similar to statement 3, without clarification of the condition referred toHarlequin ichthyosis or Harlequin syndromethis statement's accuracy is uncertain.\n5. FALSE [correction]: Mutations in the ABCA12 gene are associated with Harlequin ichthyosis, a severe skin disease, while there is no known consistent genetic cause for Harlequin syndrome, which is an autonomic nervous system disorder.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1864,
    "user_query": "What is the role of the constitutive photomorphogenesis 9 signalosome (CSN)?",
    "yulan-chat-2-13b-fp16_response": "The constitutive photomorphogenesis 9 signalosome (CSN) is a complex of proteins in plants that regulates the expression of genes in response to changes in the environment, particularly light. The CSN consists of nine proteins, including the basic helix-loop-helix (bHLH) transcription factors, CRYPTOCHROME 1 and 2 (CRY1 and CRY2), and the inhibitors of CRY1 and CRY2, HY5 and HY5-like proteins.\nThe CSN plays a crucial role in regulating the plant's response to light by sensing and integrating light signals and transmitting them to the nucleus to activate or repress specific genes. The CSN complex acts as a signaling hub, transmitting information from the photoreceptors, phototropin and cryptochrome, to the rest of the cell.\nThe CSN complex also regulates the plant's circadian rhythm, which is the internal biological clock that controls the timing of various physiological processes, such as growth, development, and metabolism. The CSN complex interacts with other proteins, such as PHYTOCHROMES, to regulate the plant's circadian rhythm and ensure that it is synchronized with the external environment.\nOverall, the CSN complex plays a critical role in regulating the plant's response to light and the circadian rhythm, and its dysfunction can lead to various developmental and physiological disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The constitutive photomorphogenesis 9 signalosome (CSN) is a complex of proteins in plants.\n2. The CSN regulates the expression of genes in response to environmental changes, particularly light.\n3. The CSN complex includes proteins such as the basic helix-loop-helix (bHLH) transcription factors, CRYPTOCHROME 1 and 2 (CRY1 and CRY2).\n4. The CSN plays a role in regulating the plant's response to light and its circadian rhythm.\n5. Dysfunction of the CSN complex can lead to various developmental and physiological disorders in plants.",
    "yulan-chat-2-13b-fp16_fact": [
      "The constitutive photomorphogenesis 9 signalosome (CSN) is a complex of proteins in plants.",
      "The CSN regulates the expression of genes in response to environmental changes, particularly light.",
      "The CSN complex includes proteins such as the basic helix-loop-helix (bHLH) transcription factors, CRYPTOCHROME 1 and 2 (CRY1 and CRY2).",
      "The CSN plays a role in regulating the plant's response to light and its circadian rhythm.",
      "Dysfunction of the CSN complex can lead to various developmental and physiological disorders in plants."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The basic helix-loop-helix (bHLH) transcription factors, CRYPTOCHROME 1 and 2 (CRY1 and CRY2) are not proteins within the CSN complex itself. Instead, CRY1 and CRY2 are photoreceptors that interact with the CSN but are not part of it.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "yulan-chat-2-13b-fp16_response": "ERAP1-ERAP2 dimerization promotes the processing of proteins by the endoplasmic reticulum (ER) associated degradation (ERAD) pathway. This pathway is a quality control mechanism that identifies and removes misfolded or damaged proteins from the ER. The ERAD pathway is important for maintaining cellular homeostasis and preventing the accumulation of toxic protein aggregates. The ERAP1-ERAP2 dimer is a key component of the ERAD pathway, as it facilitates the recognition and cleavage of target proteins by the proteasome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ERAP1-ERAP2 dimerization promotes the processing of proteins by the endoplasmic reticulum associated degradation (ERAD) pathway.\n2. The ERAD pathway functions as a quality control mechanism to identify and remove misfolded or damaged proteins from the endoplasmic reticulum.\n3. Maintaining cellular homeostasis and preventing the accumulation of toxic protein aggregates are roles of the ERAD pathway.\n4. The ERAP1-ERAP2 dimer is a component of the ERAD pathway.\n5. The ERAP1-ERAP2 dimer aids in the recognition and cleavage of target proteins by the proteasome.",
    "yulan-chat-2-13b-fp16_fact": [
      "ERAP1-ERAP2 dimerization promotes the processing of proteins by the endoplasmic reticulum associated degradation (ERAD) pathway.",
      "The ERAD pathway functions as a quality control mechanism to identify and remove misfolded or damaged proteins from the endoplasmic reticulum.",
      "Maintaining cellular homeostasis and preventing the accumulation of toxic protein aggregates are roles of the ERAD pathway.",
      "The ERAP1-ERAP2 dimer is a component of the ERAD pathway.",
      "The ERAP1-ERAP2 dimer aids in the recognition and cleavage of target proteins by the proteasome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: ERAP1 and ERAP2 are aminopeptidases involved in the processing of peptides for presentation by MHC class I molecules, not the ERAD pathway.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While ERAP1 and ERAP2 are involved in protein processing, they are not components of the ERAD pathway. They function in the context of antigen presentation.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1868,
    "user_query": "What is plantar fasciitis",
    "yulan-chat-2-13b-fp16_response": "Plantar fasciitis is a common condition that causes pain in the heel and bottom of the foot. It occurs when the plantar fascia, a band of tissue that supports the arch of your foot, becomes inflamed or damaged. This can happen from repeated stress on the foot, such as from running or jumping, or from other causes such as obesity, flat feet, or high arches. Symptoms of plantar fasciitis include pain in the heel and bottom of the foot, stiffness in the foot, and difficulty walking or standing for long periods of time. Treatment for plantar fasciitis typically includes rest, ice, physical therapy, and medication, and in some cases, surgery may be necessary.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Plantar fasciitis is a condition that causes pain in the heel and bottom of the foot.\n2. The condition occurs when the plantar fascia becomes inflamed or damaged.\n3. Common causes of plantar fasciitis include repeated stress on the foot, obesity, flat feet, or high arches.\n4. Symptoms of plantar fasciitis include heel pain, foot stiffness, and difficulty walking or standing for long periods.\n5. Treatments for plantar fasciitis may include rest, ice, physical therapy, medication, and potentially surgery.",
    "yulan-chat-2-13b-fp16_fact": [
      "Plantar fasciitis is a condition that causes pain in the heel and bottom of the foot.",
      "The condition occurs when the plantar fascia becomes inflamed or damaged.",
      "Common causes of plantar fasciitis include repeated stress on the foot, obesity, flat feet, or high arches.",
      "Symptoms of plantar fasciitis include heel pain, foot stiffness, and difficulty walking or standing for long periods.",
      "Treatments for plantar fasciitis may include rest, ice, physical therapy, medication, and potentially surgery."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1869,
    "user_query": "Which is the enzymatic activity of OTULIN?",
    "yulan-chat-2-13b-fp16_response": "OTULIN (O-linked N-acetylglucosamine transferase) is an enzyme that catalyzes the transfer of N-acetyl-alpha-D-glucosamine (GlcNAc) moieties from UDP-alpha-D-xylose to serine or threonine residues of proteins. This enzymatic activity is also known as O-GlcNAc transferase activity. OTULIN plays a role in the regulation of various cellular processes, including cell signaling, protein turnover, and cellular stress response.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1874,
    "user_query": "Is there an association between Muenke Syndrome and FGFR3 gene mutation?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is a strong association between Muenke Syndrome and mutations in the FGFR3 gene. Muenke Syndrome is a rare genetic disorder that is characterized by the development of coronal craniosynostosis (the premature fusion of the coronal sutures of the skull), midface hypoplasia, and other craniofacial abnormalities. It is caused by mutations in the FGFR3 gene, which encodes a protein that is involved in the development of bones and other tissues in the body. These mutations lead to the overactivation of the FGFR3 signaling pathway, which disrupts the normal development of the skull and face. Muenke Syndrome is one of several craniosynostosis syndromes that are caused by mutations in the FGFR3 gene.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Muenke Syndrome is a rare genetic disorder characterized by the development of coronal craniosynostosis.\n2. The disorder includes symptoms such as midface hypoplasia and other craniofacial abnormalities.\n3. Muenke Syndrome is caused by mutations in the FGFR3 gene.\n4. The FGFR3 gene encodes a protein involved in the development of bones and other tissues in the body.\n5. Mutations in the FGFR3 gene lead to overactivation of the FGFR3 signaling pathway, which disrupts normal skull and face development.",
    "yulan-chat-2-13b-fp16_fact": [
      "Muenke Syndrome is a rare genetic disorder characterized by the development of coronal craniosynostosis.",
      "The disorder includes symptoms such as midface hypoplasia and other craniofacial abnormalities.",
      "Muenke Syndrome is caused by mutations in the FGFR3 gene.",
      "The FGFR3 gene encodes a protein involved in the development of bones and other tissues in the body.",
      "Mutations in the FGFR3 gene lead to overactivation of the FGFR3 signaling pathway, which disrupts normal skull and face development."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1875,
    "user_query": "Which R package is used for visualization of linear and circular karyotypes?",
    "yulan-chat-2-13b-fp16_response": "The R package used for visualization of linear and circular karyotypes is called \"circle\". This package provides functions for creating circular and linear plots of genomic data, including karyograms, ideograms, and linkage maps. It also includes tools for working with genomic data in a variety of file formats, including BED, BAM, and SAM.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The \"circle\" R package is used for visualization of linear and circular karyotypes.\n2. The \"circle\" package can create circular and linear plots of genomic data.\n3. The package includes functions for creating karyograms and ideograms.\n4. The package also provides tools for creating linkage maps.\n5. It supports working with genomic data in BED, BAM, and SAM file formats.",
    "yulan-chat-2-13b-fp16_fact": [
      "The \"circle\" R package is used for visualization of linear and circular karyotypes.",
      "The \"circle\" package can create circular and linear plots of genomic data.",
      "The package includes functions for creating karyograms and ideograms.",
      "The package also provides tools for creating linkage maps.",
      "It supports working with genomic data in BED, BAM, and SAM file formats."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The \"circlize\" R package is used for visualization of linear and circular karyotypes, not \"circle.\"\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The \"circlize\" package is primarily known for creating circular visualization of genomic data. Tools for creating linkage maps are typically found in other packages like \"linkage\" or \"qtl.\"\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1882,
    "user_query": "What is Bartter syndrome?",
    "yulan-chat-2-13b-fp16_response": "Bartter syndrome is a rare genetic disorder that affects the kidneys and blood vessels. It is caused by a mutation in one of several genes that regulate the levels of certain electrolytes in the body, including potassium, sodium, and chloride.\nThe symptoms of Bartter syndrome can vary widely, but they typically include high levels of potassium in the blood (hyperkalemia), low levels of sodium in the blood (hyponatremia), and abnormal acidity in the blood (metabolic acidosis). These symptoms can lead to a range of complications, including muscle weakness, heart rhythm disturbances, and kidney stones.\nBartter syndrome is usually diagnosed in childhood, and treatment typically involves a combination of medications and lifestyle changes. In some cases, a kidney transplant may be necessary. With proper treatment, most people with Bartter syndrome are able to lead normal, healthy lives.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bartter syndrome is a rare genetic disorder that affects the kidneys and blood vessels.\n2. The disorder is caused by mutations in genes that regulate the levels of electrolytes such as potassium, sodium, and chloride.\n3. Common symptoms of Bartter syndrome include hyperkalemia (high levels of potassium in the blood), hyponatremia (low levels of sodium in the blood), and metabolic acidosis (abnormal acidity in the blood).\n4. Bartter syndrome is typically diagnosed in childhood.\n5. Treatment for Bartter syndrome may include medications, lifestyle changes, and potentially a kidney transplant.",
    "yulan-chat-2-13b-fp16_fact": [
      "Bartter syndrome is a rare genetic disorder that affects the kidneys and blood vessels.",
      "The disorder is caused by mutations in genes that regulate the levels of electrolytes such as potassium, sodium, and chloride.",
      "Common symptoms of Bartter syndrome include hyperkalemia (high levels of potassium in the blood), hyponatremia (low levels of sodium in the blood), and metabolic acidosis (abnormal acidity in the blood).",
      "Bartter syndrome is typically diagnosed in childhood.",
      "Treatment for Bartter syndrome may include medications, lifestyle changes, and potentially a kidney transplant."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Common symptoms of Bartter syndrome include hypokalemia (low levels of potassium in the blood), not hyperkalemia. Patients may also have hypochloremia and metabolic alkalosis, not metabolic acidosis.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1884,
    "user_query": "List RNA modifications databases",
    "yulan-chat-2-13b-fp16_response": "There are several databases that provide information on RNA modifications:\n1. RNAmod (<https://rnamod.bioleads.org/>) - a database of RNA modifications that provides information on the type, location, and prevalence of RNA modifications.\n2. RNAmodes (<http://rna.bioleads.org/RNAmodes/>) - a database of RNA modification patterns and their associated functional implications.\n3. RNAmodmap (<http://rna.bioleads.org/RNAmodmap/>) - a database of RNA modification maps and annotations.\n4. ModBase (<http://modbase.bioleads.org/>) - a database of RNA modifications, including information on the type, location, and prevalence of modifications.\n5. RNAmodes (<https://www.ncbi.nlm.nih.gov/gene/565987>) - a database of RNA modification patterns and their associated functional implications.\n6. RNAmodmap (<https://www.ncbi.nlm.nih.gov/gene/565988>) - a database of RNA modification maps and annotations.\n7. RNAmodes (<https://www.ncbi.nlm.nih.gov/gene/565989>) - a database of RNA modification patterns and their associated functional implications.\n8. RNAmodmap (<https://www.ncbi.nlm.nih.gov/gene/565990>) - a database of RNA modification maps and annotations.\n9. RNAmodes (<https://www.ncbi.nlm.nih.gov/gene/565991>) - a database of RNA modification patterns and their associated functional implications.\n10. RNAmodmap (<https://www.ncbi.nlm.nih.gov/gene/565992>) - a database of RNA modification maps and annotations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNAmod is a database that provides information on the type, location, and prevalence of RNA modifications.\n2. RNAmodes is a database of RNA modification patterns and their associated functional implications.\n3. RNAmodmap is a database of RNA modification maps and annotations.\n4. ModBase is a database of RNA modifications, including information on the type, location, and prevalence of modifications.\n5. The web addresses for the RNAmod, RNAmodes, and RNAmodmap databases are provided (with specific URLs for accessing each database).",
    "yulan-chat-2-13b-fp16_fact": [
      "RNAmod is a database that provides information on the type, location, and prevalence of RNA modifications.",
      "RNAmodes is a database of RNA modification patterns and their associated functional implications.",
      "RNAmodmap is a database of RNA modification maps and annotations.",
      "ModBase is a database of RNA modifications, including information on the type, location, and prevalence of modifications.",
      "The web addresses for the RNAmod, RNAmodes, and RNAmodmap databases are provided (with specific URLs for accessing each database)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: This statement could be a misconception. No well-known database by the name \"RNAmodes\" exists providing RNA modification patterns and their associated functional implications. \n3. UNKNOWN: Without specific knowledge of a database named RNAmodmap, the status of this statement cannot be confirmed.\n4. UNKNOWN: It is unclear whether there's a database specifically named \"ModBase\" that focuses exclusively on RNA modifications. However, the name \"ModBase\" is commonly associated with a database of comparative protein structure models.\n5. FALSE [correction]: Without providing the specific URLs, the statement is false as the web addresses are not given.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1888,
    "user_query": "What gene is mutated in Sickle Cell Anemia?",
    "yulan-chat-2-13b-fp16_response": "Sickle Cell Anemia is caused by a mutation in the \"HBB\" gene. This gene provides instructions for making a protein called beta-globin, which is a component of hemoglobin, the molecule that carries oxygen in red blood cells. The mutation in the HBB gene results in the production of a different form of beta-globin, which causes red blood cells to become stiff and misshapen, leading to a number of health problems.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Sickle Cell Anemia is caused by a mutation in the \"HBB\" gene.\n2. The \"HBB\" gene provides instructions for making a protein called beta-globin.\n3. Beta-globin is a component of hemoglobin, which carries oxygen in red blood cells.\n4. The mutation in the HBB gene causes the production of a different form of beta-globin.\n5. The altered beta-globin leads to red blood cells becoming stiff and misshapen in Sickle Cell Anemia.",
    "yulan-chat-2-13b-fp16_fact": [
      "Sickle Cell Anemia is caused by a mutation in the \"HBB\" gene.",
      "The \"HBB\" gene provides instructions for making a protein called beta-globin.",
      "Beta-globin is a component of hemoglobin, which carries oxygen in red blood cells.",
      "The mutation in the HBB gene causes the production of a different form of beta-globin.",
      "The altered beta-globin leads to red blood cells becoming stiff and misshapen in Sickle Cell Anemia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The altered beta-globin leads to red blood cells becoming flexible and disc-shaped in Sickle Cell Anemia.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1889,
    "user_query": "What is the function of the Indian hedgehog protein in chondrocytes?",
    "yulan-chat-2-13b-fp16_response": "The Indian hedgehog protein (IHH) is a member of the hedgehog (Hh) family of signaling proteins, which play important roles in the development and maintenance of various tissues and organs in animals, including humans. In chondrocytes, the cells that produce cartilage, IHH has been shown to play a number of important roles.\nOne of the key functions of IHH in chondrocytes is to regulate the differentiation and proliferation of these cells. IHH signaling has been shown to promote the proliferation of chondrocytes, and to induce the differentiation of these cells into mature chondrocytes, which are responsible for the production of cartilage tissue.\nIn addition to its role in regulating chondrocyte proliferation and differentiation, IHH has also been shown to play a role in the maintenance of the integrity of cartilage tissue. For example, IHH signaling has been shown to regulate the production of proteoglycans, which are important components of cartilage tissue that help to maintain its structure and function.\nOverall, the Indian hedgehog protein plays a number of important roles in the development and maintenance of cartilage tissue, and dysregulation of IHH signaling has been implicated in a number of cartilage disorders, including osteoarthritis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Indian hedgehog protein (IHH) is a member of the hedgehog family of signaling proteins.\n2. In chondrocytes, IHH regulates the differentiation and proliferation of these cells.\n3. IHH signaling promotes the proliferation of chondrocytes.\n4. IHH induces the differentiation of chondrocytes into mature cells responsible for cartilage production.\n5. IHH signaling regulates the production of proteoglycans, important components of cartilage tissue.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Indian hedgehog protein (IHH) is a member of the hedgehog family of signaling proteins.",
      "In chondrocytes, IHH regulates the differentiation and proliferation of these cells.",
      "IHH signaling promotes the proliferation of chondrocytes.",
      "IHH induces the differentiation of chondrocytes into mature cells responsible for cartilage production.",
      "IHH signaling regulates the production of proteoglycans, important components of cartilage tissue."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe Indian hedgehog protein (IHH) is indeed a member of the hedgehog family of signaling proteins, which are critical in various developmental processes. In chondrocytes, IHH is known to regulate both the proliferation (the process by which cells divide to increase their number) and differentiation (the process through which cells become specialized) of these cells. IHH plays a role in the maturation of chondrocytes, which are responsible for the production of cartilage. Moreover, IHH signaling influences the production of extracellular matrix components such as proteoglycans, which are essential for the structure and function of cartilage tissue.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "yulan-chat-2-13b-fp16_response": "R-spondin 1 and noggin are proteins that play important roles in the development and maintenance of the nervous system. In non-damaged gallbladders, it is likely that these proteins are not present or are present at very low levels. The function of R-spondin 1 and noggin in non-damaged gallbladders is therefore not well understood.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1897,
    "user_query": "Which is the genome browser database for DNA shape annotations?",
    "yulan-chat-2-13b-fp16_response": "The genome browser database for DNA shape annotations is called the \"DNA Shape Annotation Database\" (DSA-DB). It is a publicly available database that contains shape annotations for a variety of organisms, including humans, mice, and zebrafish. The database allows researchers to visualize and analyze the three-dimensional structure of DNA, which can provide insights into the regulation of gene expression and other biological processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The \"DNA Shape Annotation Database\" (DSA-DB) is a genome browser database for DNA shape annotations.\n2. DSA-DB is a publicly available database.\n3. The database includes shape annotations for humans, mice, and zebrafish among other organisms.\n4. DSA-DB allows researchers to visualize the three-dimensional structure of DNA.\n5. The database can provide insights into the regulation of gene expression and other biological processes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The \"DNA Shape Annotation Database\" (DSA-DB) is a genome browser database for DNA shape annotations.",
      "DSA-DB is a publicly available database.",
      "The database includes shape annotations for humans, mice, and zebrafish among other organisms.",
      "DSA-DB allows researchers to visualize the three-dimensional structure of DNA.",
      "The database can provide insights into the regulation of gene expression and other biological processes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1903,
    "user_query": "Where is the respirasome located?",
    "yulan-chat-2-13b-fp16_response": "The respirasome is a large protein complex that is located in the inner mitochondrial membrane. It is involved in the process of oxidative phosphorylation, which is the production of ATP from the electron transport chain in the mitochondria. The respirasome is composed of multiple copies of three main proteins: complex I, complex III, and complex IV of the electron transport chain, as well as other proteins that help to stabilize the complex and facilitate its function. It is thought to play a key role in the efficient transfer of electrons and protons across the inner mitochondrial membrane, and is essential for the proper functioning of the mitochondrial respiratory chain.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The respirasome is located in the inner mitochondrial membrane.\n2. It is involved in the oxidative phosphorylation process.\n3. The respirasome production of ATP is from the electron transport chain in the mitochondria.\n4. The respirasome is composed of multiple copies of complex I, complex III, and complex IV of the electron transport chain.\n5. The respirasome is essential for the proper functioning of the mitochondrial respiratory chain.",
    "yulan-chat-2-13b-fp16_fact": [
      "The respirasome is located in the inner mitochondrial membrane.",
      "It is involved in the oxidative phosphorylation process.",
      "The respirasome production of ATP is from the electron transport chain in the mitochondria.",
      "The respirasome is composed of multiple copies of complex I, complex III, and complex IV of the electron transport chain.",
      "The respirasome is essential for the proper functioning of the mitochondrial respiratory chain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1906,
    "user_query": "What kind of analyses are performed with the software tool \"unipept\"",
    "yulan-chat-2-13b-fp16_response": "unipept is a software tool used for the analysis of protein sequences and their properties. It can perform a variety of analyses, including:\n1. Sequence alignment: unipept can align protein sequences to identify similarities and differences between them.\n2. Protein structure prediction: unipept can use various algorithms to predict the 3D structure of a protein based on its amino acid sequence.\n3. Protein properties prediction: unipept can predict various properties of proteins, such as their molecular weight, isoelectric point, and hydrophobicity.\n4. Protein classification: unipept can classify proteins into different categories based on their properties and features.\n5. Protein annotation: unipept can annotate proteins with functional information, such as gene ontology (GO) terms and protein domain information.\nOverall, unipept is a versatile tool that can be used to analyze various aspects of protein sequences and properties.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. unipept is used for the analysis of protein sequences and their properties.\n2. unipept can align protein sequences to identify similarities and differences.\n3. unipept can use algorithms to predict the 3D structure of proteins based on amino acid sequences.\n4. unipept is capable of predicting protein properties such as molecular weight, isoelectric point, and hydrophobicity.\n5. unipept can classify proteins into different categories and annotate proteins with functional information.",
    "yulan-chat-2-13b-fp16_fact": [
      "unipept is used for the analysis of protein sequences and their properties.",
      "unipept can align protein sequences to identify similarities and differences.",
      "unipept can use algorithms to predict the 3D structure of proteins based on amino acid sequences.",
      "unipept is capable of predicting protein properties such as molecular weight, isoelectric point, and hydrophobicity.",
      "unipept can classify proteins into different categories and annotate proteins with functional information."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: unipept mainly focuses on peptidomics and proteomics data analysis such as metaproteomics but does not specialize in aligning protein sequences, which is a task usually done by tools like BLAST.\n3. FALSE [correction]: unipept is designed for peptidomics analysis, such as taxonomic classification and functional analysis, and does not predict the 3D structure of proteins. Protein structure prediction is typically done by specialized software, like AlphaFold.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1907,
    "user_query": "What is the role of gamma-secreatase complex in Alzheimer's Disease?",
    "yulan-chat-2-13b-fp16_response": "The gamma-secretase complex is a protein complex that plays a role in the cleavage of certain proteins, including the amyloid precursor protein (APP), which is involved in the development of Alzheimer's disease. The complex consists of several proteins, including presenilin, nicastrin, and APH-1.\nIn Alzheimer's disease, mutations in the genes that encode for presenilin and other components of the gamma-secretase complex have been linked to an increased risk of developing the disease. The complex cleaves the APP protein, leading to the release of soluble amyloid precursor protein (sAPP) and amyloid-beta (A) peptides. The accumulation of A peptides in the brain is a hallmark of Alzheimer's disease.\nThe gamma-secretase complex also cleaves other proteins involved in Alzheimer's disease, including the tau protein. The cleavage of tau protein leads to the formation of neurofibrillary tangles, which are a characteristic feature of the disease.\nIn summary, the gamma-secretase complex plays a crucial role in the development of Alzheimer's disease by regulating the cleavage of key proteins involved in the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The gamma-secretase complex is involved in the cleavage of the amyloid precursor protein (APP), which is related to the development of Alzheimer's disease.\n2. The gamma-secretase complex includes several proteins, such as presenilin, nicastrin, and APH-1.\n3. Mutations in genes encoding for components of the gamma-secretase complex can increase the risk of developing Alzheimer's disease.\n4. The accumulation of amyloid-beta (A) peptides in the brain, which results from the cleavage of APP by the gamma-secretase complex, is a hallmark of Alzheimer's disease.\n5. Cleavage of the tau protein by the gamma-secretase complex leads to the formation of neurofibrillary tangles, which are characteristic of Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "The gamma-secretase complex is involved in the cleavage of the amyloid precursor protein (APP), which is related to the development of Alzheimer's disease.",
      "The gamma-secretase complex includes several proteins, such as presenilin, nicastrin, and APH-1.",
      "Mutations in genes encoding for components of the gamma-secretase complex can increase the risk of developing Alzheimer's disease.",
      "The accumulation of amyloid-beta (A) peptides in the brain, which results from the cleavage of APP by the gamma-secretase complex, is a hallmark of Alzheimer's disease.",
      "Cleavage of the tau protein by the gamma-secretase complex leads to the formation of neurofibrillary tangles, which are characteristic of Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Cleavage of the amyloid precursor protein by the gamma-secretase complex leads to the formation of amyloid-beta (A) peptides, not neurofibrillary tangles. Neurofibrillary tangles are primarily associated with the aggregation of hyperphosphorylated tau protein, which is a separate process from the cleavage of APP by gamma-secretase.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1912,
    "user_query": "List peptide fragmentations methods in mass spectrometry",
    "yulan-chat-2-13b-fp16_response": "There are several peptide fragmentation methods used in mass spectrometry, including:\n1. Collision-induced dissociation (CID): This method involves fragmenting peptides by colliding them with an inert gas, such as argon or nitrogen, in a collision cell.\n2. Electron-capture dissociation (ECD): This method involves fragmenting peptides by capturing an electron from the peptide and breaking a peptide bond.\n3. Isobaric tagging: This method involves labeling peptides with a stable isotope, such as 13C or 15N, and fragmenting them using CID or ECD.\n4. High-energy collision-induced dissociation (HCD): This method involves fragmenting peptides by colliding them with an accelerated beam of ions in a collision cell.\n5. Reverse-phase protein sequencing: This method involves fragmenting peptides and separating them based on their hydrophobicity and charge.\n6. Multistage mass spectrometry (MSn): This method involves fragmenting peptides multiple times in a series of stages to generate a sequence of fragment ions that can be used to identify the peptide.\n7. Tandem mass spectrometry (MS/MS): This method involves fragmenting peptides in a first mass spectrometry stage and analyzing the resulting fragment ions in a second mass spectrometry stage.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Collision-induced dissociation (CID) fragments peptides by colliding them with an inert gas.\n2. Electron-capture dissociation (ECD) fragments peptides by capturing an electron.\n3. Isobaric tagging labels peptides with stable isotopes such as 13C or 15N.\n4. High-energy collision-induced dissociation (HCD) fragments peptides with an accelerated beam of ions.\n5. Multistage mass spectrometry (MSn) involves multiple fragmentation stages to generate a sequence of fragment ions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Collision-induced dissociation (CID) fragments peptides by colliding them with an inert gas.",
      "Electron-capture dissociation (ECD) fragments peptides by capturing an electron.",
      "Isobaric tagging labels peptides with stable isotopes such as 13C or 15N.",
      "High-energy collision-induced dissociation (HCD) fragments peptides with an accelerated beam of ions.",
      "Multistage mass spectrometry (MSn) involves multiple fragmentation stages to generate a sequence of fragment ions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: High-energy collision-induced dissociation (HCD) fragments peptides by colliding them with an inert gas at higher energies compared to traditional collision-induced dissociation (CID).\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1915,
    "user_query": "Which infection can be prevented with Dapivirine?",
    "yulan-chat-2-13b-fp16_response": "Dapivirine is an antiviral medication that is used to prevent HIV infection. It belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs), which work by blocking the reverse transcriptase enzyme that is needed for the HIV virus to reproduce. Dapivirine is typically used as a component of a combination therapy that includes other antiviral medications. It is usually taken as a tablet or a gel by people who are at risk of HIV infection, such as sex workers or people in relationships with HIV-positive partners.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dapivirine is used to prevent HIV infection.\n2. It belongs to the class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs).\n3. NNRTIs work by blocking the reverse transcriptase enzyme required for HIV to reproduce.\n4. Dapivirine is often used in combination with other antiviral medications.\n5. Dapivirine can be administered as a tablet or a gel.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dapivirine is used to prevent HIV infection.",
      "It belongs to the class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs).",
      "NNRTIs work by blocking the reverse transcriptase enzyme required for HIV to reproduce.",
      "Dapivirine is often used in combination with other antiviral medications.",
      "Dapivirine can be administered as a tablet or a gel."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Dapivirine is used in the form of a vaginal ring for HIV prevention, not as a tablet or a gel.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1917,
    "user_query": "Is there a role for gamma knife in treatment of Obsessive-Compulsive Disorder?",
    "yulan-chat-2-13b-fp16_response": "Gamma knife radiosurgery is a non-invasive procedure that uses highly focused gamma rays to treat various conditions, including brain disorders. While it has been studied as a potential treatment for Obsessive-Compulsive Disorder (OCD), its use is not yet widely accepted as a standard treatment option.\nStudies have suggested that gamma knife radiosurgery may be effective in reducing the activity of the brain's orbitofrontal cortex, a region that has been implicated in the development of OCD. However, the evidence is still limited, and more research is needed to determine its efficacy and safety as a treatment for OCD.\nGamma knife radiosurgery is typically reserved for patients who have not responded to other treatments, such as medication and psychotherapy. If you are considering gamma knife radiosurgery for OCD, it is important to discuss the potential benefits and risks with your healthcare provider and to carefully weigh your options.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gamma knife radiosurgery is a non-invasive procedure that uses highly focused gamma rays to treat various conditions.\n2. Gamma knife radiosurgery has been studied as a potential treatment for Obsessive-Compulsive Disorder (OCD).\n3. The procedure may be effective in reducing the activity of the brain's orbitofrontal cortex, a region implicated in the development of OCD.\n4. The use of gamma knife radiosurgery for OCD is not widely accepted as a standard treatment option.\n5. Gamma knife radiosurgery is typically considered for patients who have not responded to other treatments, such as medication and psychotherapy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gamma knife radiosurgery is a non-invasive procedure that uses highly focused gamma rays to treat various conditions.",
      "Gamma knife radiosurgery has been studied as a potential treatment for Obsessive-Compulsive Disorder (OCD).",
      "The procedure may be effective in reducing the activity of the brain's orbitofrontal cortex, a region implicated in the development of OCD.",
      "The use of gamma knife radiosurgery for OCD is not widely accepted as a standard treatment option.",
      "Gamma knife radiosurgery is typically considered for patients who have not responded to other treatments, such as medication and psychotherapy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nGamma knife radiosurgery is indeed a non-invasive treatment method that uses gamma rays. It has been studied as a treatment for various conditions, including OCD. The orbitofrontal cortex is an area of the brain that has been implicated in OCD, and targeting it may potentially reduce symptoms. However, the use of gamma knife radiosurgery for OCD is not standard practice and is generally considered when other treatments have failed.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1918,
    "user_query": "What is the mechanism of action of the biguanide class of diabetes drugs?",
    "yulan-chat-2-13b-fp16_response": "The biguanide class of diabetes drugs works by inhibiting the enzyme responsible for breaking down glucose in the liver and other tissues. This leads to a reduction in the amount of glucose produced by the liver, which helps to lower blood glucose levels. Additionally, biguanides may also increase the sensitivity of cells to insulin, which can improve the body's ability to use insulin effectively and lower blood glucose levels.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The biguanide class of diabetes drugs inhibits an enzyme responsible for breaking down glucose in the liver and other tissues.\n2. Biguanides reduce the amount of glucose produced by the liver.\n3. This class of drugs helps to lower blood glucose levels.\n4. They may also increase the sensitivity of cells to insulin.\n5. Biguanides can improve the body's ability to use insulin effectively.",
    "yulan-chat-2-13b-fp16_fact": [
      "The biguanide class of diabetes drugs inhibits an enzyme responsible for breaking down glucose in the liver and other tissues.",
      "Biguanides reduce the amount of glucose produced by the liver.",
      "This class of drugs helps to lower blood glucose levels.",
      "They may also increase the sensitivity of cells to insulin.",
      "Biguanides can improve the body's ability to use insulin effectively."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The biguanide class of diabetes drugs, such as metformin, does not inhibit an enzyme responsible for breaking down glucose. Instead, they primarily reduce the amount of glucose produced by the liver.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1919,
    "user_query": "Where is the proteasome located?",
    "yulan-chat-2-13b-fp16_response": "The proteasome is a large, barrel-shaped protein complex that is located in the cells of eukaryotic organisms, including humans. It is found in the cytoplasm of the cell, where it functions as a protease, or protein-degrading enzyme. The proteasome is responsible for breaking down and recycling proteins that are damaged or no longer needed by the cell. It is an important part of the cell's quality control system and plays a role in maintaining the proper functioning of the cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The proteasome is located in the cells of eukaryotic organisms.\n2. It is found in the cytoplasm of the cell.\n3. The proteasome functions as a protease, or protein-degrading enzyme.\n4. It is responsible for breaking down and recycling proteins that are damaged or no longer needed.\n5. The proteasome is part of the cell's quality control system and helps maintain proper cell functioning.",
    "yulan-chat-2-13b-fp16_fact": [
      "The proteasome is located in the cells of eukaryotic organisms.",
      "It is found in the cytoplasm of the cell.",
      "The proteasome functions as a protease, or protein-degrading enzyme.",
      "It is responsible for breaking down and recycling proteins that are damaged or no longer needed.",
      "The proteasome is part of the cell's quality control system and helps maintain proper cell functioning."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1923,
    "user_query": "List available circular RNA prediction tools.",
    "yulan-chat-2-13b-fp16_response": "There are several tools available for predicting circular RNA (circRNA) from RNA-seq data. Some of the popular ones are:\n1. Circular RNA Detection Tool (CDT): This tool uses a de novo assembly-based approach to detect circRNAs from RNA-seq data. It can detect both exon-intron and intron-exon circRNAs.\n2. Circular RNA Identification Tool (CRID): This tool uses a combination of de novo assembly and statistical analysis to identify circRNAs from RNA-seq data. It can also detect exon-intron and intron-exon circRNAs.\n3. Circular RNA Explorer (CRE): This tool uses a de novo assembly-based approach to detect circRNAs from RNA-seq data. It can also detect exon-intron and intron-exon circRNAs.\n4. Circular RNA Prediction Tool (CRPT): This tool uses a de novo assembly-based approach to detect circRNAs from RNA-seq data. It can also detect exon-intron and intron-exon circRNAs.\n5. Circular RNA Detection Toolkit (CRDT): This tool uses a de novo assembly-based approach to detect circRNAs from RNA-seq data. It can also detect exon-intron and intron-exon circRNAs.\n6. Circular RNA Identification Toolkit (CRIDT): This tool uses a de novo assembly-based approach to detect circRNAs from RNA-seq data. It can also detect exon-intron and intron-exon circRNAs.\n7. Circular RNA Prediction Toolkit (CRPTT): This tool uses a de novo assembly-based approach to detect circRNAs from RNA-seq data. It can also detect exon-intron and intron-exon circRNAs.\n8. Circular RNA Detection Toolkit (CRDTT): This tool uses a de novo assembly-based approach to detect circRNAs from RNA-seq data. It can also detect exon-intron and intron-exon circRNAs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Circular RNA Detection Tool (CDT) is a tool that uses a de novo assembly-based approach to detect circular RNAs from RNA-seq data.\n2. The Circular RNA Identification Tool (CRID) combines de novo assembly and statistical analysis to identify circular RNAs from RNA-seq data.\n3. The Circular RNA Explorer (CRE) uses a de novo assembly-based approach for the detection of circular RNAs from RNA-seq data.\n4. The Circular RNA Prediction Tool (CRPT) utilizes a de novo assembly-based approach to detect circular RNAs from RNA-seq data.\n5. The Circular RNA Detection Toolkit (CRDT) employs a de novo assembly-based method to detect circular RNAs from RNA-seq data.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Circular RNA Detection Tool (CDT) is a tool that uses a de novo assembly-based approach to detect circular RNAs from RNA-seq data.",
      "The Circular RNA Identification Tool (CRID) combines de novo assembly and statistical analysis to identify circular RNAs from RNA-seq data.",
      "The Circular RNA Explorer (CRE) uses a de novo assembly-based approach for the detection of circular RNAs from RNA-seq data.",
      "The Circular RNA Prediction Tool (CRPT) utilizes a de novo assembly-based approach to detect circular RNAs from RNA-seq data.",
      "The Circular RNA Detection Toolkit (CRDT) employs a de novo assembly-based method to detect circular RNAs from RNA-seq data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: The statement could be true, as circular RNA detection tools can use de novo assembly-based approaches, but without specific information about a tool named \"CDT,\" the truthfulness of the statement cannot be verified.\n\n2. UNKNOWN: Similar to statement 1, the statement could be true for circular RNA detection tools. However, without specific information about a tool named \"CRID,\" the truthfulness of the statement cannot be verified.\n\n3. UNKNOWN: Once again, the statement could be true, as circular RNA detection tools can use de novo assembly-based approaches. The truthfulness of this statement cannot be verified without specific information about a tool named \"CRE.\"\n\n4. UNKNOWN: The truthfulness of this statement cannot be evaluated without specific information about a tool named \"CRPT.\"\n\n5. UNKNOWN: The truthfulness of this statement cannot be evaluated without specific information about a tool named \"CRDT.\"",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1924,
    "user_query": "Which disease is treated with Nusinersen?",
    "yulan-chat-2-13b-fp16_response": "Nusinersen is a medication used to treat spinal muscular atrophy (SMA) with splicing errors. SMA is a rare genetic disease that affects the motor neurons in the spinal cord and brainstem, leading to progressive muscle weakness and atrophy. Nusinersen works by altering the splicing of a specific gene, called survival motor neuron 1 (SMN1), which is involved in the production of motor neurons. By doing so, nusinersen helps to increase the production of functional motor neurons and improve motor function in people with SMA.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nusinersen is used to treat spinal muscular atrophy (SMA).\n2. Spinal muscular atrophy is a rare genetic disease that affects motor neurons in the spinal cord and brainstem.\n3. SMA leads to progressive muscle weakness and atrophy.\n4. Nusinersen alters the splicing of the survival motor neuron 1 (SMN1) gene.\n5. Nusinersen helps to increase the production of functional motor neurons and improve motor function in SMA patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nusinersen is used to treat spinal muscular atrophy (SMA).",
      "Spinal muscular atrophy is a rare genetic disease that affects motor neurons in the spinal cord and brainstem.",
      "SMA leads to progressive muscle weakness and atrophy.",
      "Nusinersen alters the splicing of the survival motor neuron 1 (SMN1) gene.",
      "Nusinersen helps to increase the production of functional motor neurons and improve motor function in SMA patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Nusinersen alters the splicing of the survival motor neuron 2 (SMN2) gene.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1925,
    "user_query": "Which disease the London mutation involved in?",
    "yulan-chat-2-13b-fp16_response": "The London mutation refers to a specific genetic variation that is associated with an increased risk of developing certain diseases, including certain types of cancer and autoimmune disorders. The exact diseases that are associated with the London mutation can vary depending on the specific genetic variation that is being referred to.\nOne of the most well-known associations between the London mutation and disease is its link to an increased risk of developing breast cancer. Studies have shown that women who carry certain London mutations have a higher risk of developing breast cancer compared to women who do not have these mutations.\nIn addition to breast cancer, the London mutation has also been linked to an increased risk of developing other types of cancer, including ovarian cancer and prostate cancer. It has also been associated with an increased risk of developing autoimmune disorders, such as lupus and rheumatoid arthritis.\nIt is important to note that the London mutation is just one of many genetic variations that can affect a person's risk of developing certain diseases. While it can provide useful information for predicting disease risk, it is only one factor among many that can influence a person's overall health.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The London mutation is associated with an increased risk of developing certain diseases, such as certain types of cancer and autoimmune disorders.\n2. Carriers of certain London mutations have a higher risk of developing breast cancer.\n3. The London mutation has been linked to an increased risk of ovarian cancer.\n4. The London mutation is associated with an increased risk of prostate cancer.\n5. The London mutation has been associated with autoimmune disorders like lupus and rheumatoid arthritis.",
    "yulan-chat-2-13b-fp16_fact": [
      "The London mutation is associated with an increased risk of developing certain diseases, such as certain types of cancer and autoimmune disorders.",
      "Carriers of certain London mutations have a higher risk of developing breast cancer.",
      "The London mutation has been linked to an increased risk of ovarian cancer.",
      "The London mutation is associated with an increased risk of prostate cancer.",
      "The London mutation has been associated with autoimmune disorders like lupus and rheumatoid arthritis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or a clear definition of what the \"London mutation\" refers to, it is not possible to determine the truth of the statements related to diseases and genetic mutations. Genetic mutations are indeed linked to various diseases, but without knowing exactly what the \"London mutation\" is, it's not possible to confirm these statements. The term \"London mutation\" is not commonly used in scientific literature and might be specific to the passage from which these statements were taken.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1930,
    "user_query": "Viliuisk encephalomyelitis is diagnosed in which geographical area?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not sure what you are referring to with \"Viliuisk encephalomyelitis.\" Could you please provide more context or clarify your question?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1934,
    "user_query": "What makes telomerase a good drug target?",
    "yulan-chat-2-13b-fp16_response": "Telomerase is an enzyme that helps to maintain the length of telomeres, which are the protective caps on the ends of chromosomes. Telomeres play an important role in the health of cells, and they are often shorter in cells that have undergone a large number of divisions. As a result, telomerase is an attractive drug target because inhibiting its activity can lead to cell death or senescence, which could be useful in the treatment of certain diseases. Additionally, many cancers are characterized by abnormal telomerase activity, so inhibiting telomerase could be a useful strategy for cancer therapy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Telomerase is an enzyme that helps maintain the length of telomeres on the ends of chromosomes.\n2. Telomeres are protective caps on the ends of chromosomes.\n3. Telomeres tend to be shorter in cells that have divided many times.\n4. Inhibiting the activity of telomerase can lead to cell death or senescence.\n5. Many cancers are characterized by abnormal telomerase activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Telomerase is an enzyme that helps maintain the length of telomeres on the ends of chromosomes.",
      "Telomeres are protective caps on the ends of chromosomes.",
      "Telomeres tend to be shorter in cells that have divided many times.",
      "Inhibiting the activity of telomerase can lead to cell death or senescence.",
      "Many cancers are characterized by abnormal telomerase activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "yulan-chat-2-13b-fp16_response": "NADPH oxidase 5 (NOX5) is a membrane-bound enzyme that is involved in the production of reactive oxygen species (ROS) in a variety of cell types. While NOX5 is a standalone enzyme and can function on its own, it can also form heterodimers with other NADPH oxidase family members, such as NOX1 and NOX4, to enhance its activity.\nIn addition to forming heterodimers with other NADPH oxidases, NOX5 can also form a complex with other proteins, such as p47phox, which is a component of the phagocytic NADPH oxidase (NOX) complex. This complex is involved in the generation of ROS in phagocytic cells, such as neutrophils and macrophages, and plays a role in the immune response.\nOverall, while NOX5 can function on its own, it can also form complexes with other proteins to enhance its activity and contribute to various biological processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NADPH oxidase 5 (NOX5) is a membrane-bound enzyme involved in the production of reactive oxygen species (ROS).\n2. NOX5 can function on its own without requiring any additional subunit.\n3. NOX5 can also form heterodimers with other NADPH oxidase family members like NOX1 and NOX4.\n4. NOX5 can form a complex with the protein p47phox.\n5. The complex involving NOX5 and p47phox is involved in the generation of ROS in phagocytic cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "NADPH oxidase 5 (NOX5) is a membrane-bound enzyme involved in the production of reactive oxygen species (ROS).",
      "NOX5 can function on its own without requiring any additional subunit.",
      "NOX5 can also form heterodimers with other NADPH oxidase family members like NOX1 and NOX4.",
      "NOX5 can form a complex with the protein p47phox.",
      "The complex involving NOX5 and p47phox is involved in the generation of ROS in phagocytic cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE: NOX5 is unique among NOX family members since it does not require additional cytosolic subunits for activity, though it can be regulated by calcium ions.\n3. FALSE [correction]: NOX5 does not form heterodimers with other NOX family members as it functions independently. NOX1 and NOX4 typically interact with other subunits like p22phox, but NOX5 is active on its own and regulated by calcium binding.\n4. FALSE [correction]: The protein p47phox is a cytosolic subunit that is involved in the activation of the NOX2 complex, not NOX5. NOX5 does not require p47phox or any of the other typical NOX subunits for its activation.\n5. FALSE [correction]: While the p47phox is indeed involved in ROS generation in phagocytic cells, it is part of the NOX2 complex, not a complex with NOX5. The NOX2 complex (which includes p47phox) is involved in ROS generation in phagocytes, not NOX5.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1940,
    "user_query": "What is the doRiNA database?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with a database called \"doRiNA.\" It's possible that it's a relatively new or obscure database, or it could be a misspelling or abbreviation of a different database name.\nIf you have any additional information or context about the database you're referring to, I may be able to provide more information or help you find the correct resource.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 1942,
    "user_query": "Is pseudouridine a RNA modification?",
    "yulan-chat-2-13b-fp16_response": "Yes, pseudouridine is a type of RNA modification. It is a modification of the nucleoside uridine, where the nitrogen atom of the uracil ring is bonded to the carbon atom of the sugar ring instead of the oxygen atom. This modification is also known as \"uridine-51\" or \"pseudouridine-51.\" It is one of several modifications of uridine that can occur in RNA, and it can affect the stability and folding of RNA molecules.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pseudouridine is a type of RNA modification.\n2. In pseudouridine, the nitrogen atom of the uracil ring is bonded to the carbon atom of the sugar ring.\n3. Pseudouridine is also known as \"uridine-51\" or \"pseudouridine-51.\"\n4. Pseudouridine is one of several modifications of uridine that can occur in RNA.\n5. Pseudouridine can affect the stability and folding of RNA molecules.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pseudouridine is a type of RNA modification.",
      "In pseudouridine, the nitrogen atom of the uracil ring is bonded to the carbon atom of the sugar ring.",
      "Pseudouridine is also known as \"uridine-51\" or \"pseudouridine-51.\"",
      "Pseudouridine is one of several modifications of uridine that can occur in RNA.",
      "Pseudouridine can affect the stability and folding of RNA molecules."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Pseudouridine is also known as \"psi\", \"\", or \"5-ribosyluracil\" and not as \"uridine-51\" or \"pseudouridine-51\". The \"-51\" could potentially be a reference to the numbering of a specific uridine residue in tRNA, where pseudouridine often occurs at position 55 (often noted as \"55\") or other positions, but is not a general name for pseudouridine.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1943,
    "user_query": "What does the human ABCC gene  product do?",
    "yulan-chat-2-13b-fp16_response": "The ABCC gene in humans encodes for a protein called the ABCC transporter. The ABCC transporter is a member of the superfamily of ATP-binding cassette (ABC) transporters, which play important roles in membrane transport and energy metabolism.\nThe ABCC transporter is involved in the transport of various molecules across the membrane of cells, including organic ions, sugars, and steroids. It functions as a secondary active transporter, which means that it requires energy in the form of ATP to drive the transport of these molecules.\nThe ABCC transporter is expressed in various tissues and organs, including the liver, intestine, kidney, and brain. In these tissues, it plays important roles in maintaining the balance of various molecules and ions, and in regulating the absorption and secretion of substances.\nMutations in the ABCC gene have been associated with various diseases, including Wilson's disease, Dubin-Johnson syndrome, and other disorders of organic acid transport.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The ABCC gene in humans encodes for a protein called the ABCC transporter.\n2. The ABCC transporter is part of the superfamily of ATP-binding cassette (ABC) transporters.\n3. This transporter is involved in the transport of various molecules across cellular membranes, including organic ions, sugars, and steroids.\n4. The ABCC transporter is expressed in various tissues such as the liver, intestine, kidney, and brain.\n5. Mutations in the ABCC gene have been linked with diseases including Wilson's disease and Dubin-Johnson syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "The ABCC gene in humans encodes for a protein called the ABCC transporter.",
      "The ABCC transporter is part of the superfamily of ATP-binding cassette (ABC) transporters.",
      "This transporter is involved in the transport of various molecules across cellular membranes, including organic ions, sugars, and steroids.",
      "The ABCC transporter is expressed in various tissues such as the liver, intestine, kidney, and brain.",
      "Mutations in the ABCC gene have been linked with diseases including Wilson's disease and Dubin-Johnson syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in the ATP7B gene are linked with Wilson's disease, not the ABCC gene. Mutations in the ABCC2 gene have been linked with Dubin-Johnson syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "yulan-chat-2-13b-fp16_response": "Furin and hepcidin are both proteins that are involved in the regulation of iron metabolism in the body. Furin is an enzyme that is involved in the processing of various proteins, including the pro-hormone pro-opiomelanocortin (pre-pro-opiomelanocortin) into smaller peptides. Hepcidin, on the other hand, is a small peptide hormone that is synthesized in the liver and plays a key role in regulating iron homeostasis by inhibiting iron absorption from the gut and promoting iron excretion from the body.\nThe connection between furin and hepcidin lies in the fact that hepcidin is also processed by furin into smaller peptides, which can affect its activity and half-life in the body. In particular, cleavage of hepcidin by furin results in the formation of a 25-amino acid peptide (called \"hepcidin-25\") that is more potent than the full-length hepcidin peptide in inhibiting iron absorption and promoting iron excretion. This processing of hepcidin by furin is thought to be an important mechanism for regulating the activity and half-life of hepcidin in the body, and may play a role in the regulation of iron metabolism under different physiological conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Furin is an enzyme involved in the processing of various proteins, including the pro-hormone pro-opiomelanocortin into smaller peptides.\n2. Hepcidin is a peptide hormone synthesized in the liver that regulates iron homeostasis by inhibiting iron absorption from the gut and promoting iron excretion.\n3. Furin processes hepcidin into smaller peptides.\n4. Cleavage of hepcidin by furin produces a 25-amino acid peptide known as \"hepcidin-25\".\n5. Hepcidin-25 is more potent than the full-length hepcidin peptide in inhibiting iron absorption and promoting iron excretion.",
    "yulan-chat-2-13b-fp16_fact": [
      "Furin is an enzyme involved in the processing of various proteins, including the pro-hormone pro-opiomelanocortin into smaller peptides.",
      "Hepcidin is a peptide hormone synthesized in the liver that regulates iron homeostasis by inhibiting iron absorption from the gut and promoting iron excretion.",
      "Furin processes hepcidin into smaller peptides.",
      "Cleavage of hepcidin by furin produces a 25-amino acid peptide known as \"hepcidin-25\".",
      "Hepcidin-25 is more potent than the full-length hepcidin peptide in inhibiting iron absorption and promoting iron excretion."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Furin does not process hepcidin into smaller peptides. Hepcidin is synthesized as an 84-amino acid prepropeptide, and its maturation involves cleavage by other enzymes, but furin's role in processing hepcidin is not established.\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1951,
    "user_query": "What is the incidence of new cases of X-linked adrenoleukodystrophy (ALD) in Australian and New Zealand in the late 1990's?",
    "yulan-chat-2-13b-fp16_response": "X-linked adrenoleukodystrophy (X-ALD) is a rare genetic disorder that affects the nervous system. It is caused by mutations in the ABCD1 gene, which is located on the X chromosome.\nIn the late 1990s, the incidence of new cases of X-ALD in Australia and New Zealand was estimated to be around 1 in 50,000 to 1 in 70,000 male births per year. However, it is important to note that this is just an estimate and the actual incidence may be different.\nX-ALD is a relatively rare disorder, and it is often difficult to get accurate estimates of its incidence due to the small number of cases that occur each year. It is also possible that the incidence of X-ALD has changed over time due to changes in genetic factors or other factors that may affect the development of the disorder.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. X-linked adrenoleukodystrophy (X-ALD) is a genetic disorder that affects the nervous system.\n2. The disorder is caused by mutations in the ABCD1 gene, which is located on the X chromosome.\n3. In the late 1990s, the estimated incidence of new cases of X-ALD in Australia and New Zealand was between 1 in 50,000 to 1 in 70,000 male births per year.",
    "yulan-chat-2-13b-fp16_fact": [
      "X-linked adrenoleukodystrophy (X-ALD) is a genetic disorder that affects the nervous system.",
      "The disorder is caused by mutations in the ABCD1 gene, which is located on the X chromosome.",
      "In the late 1990s, the estimated incidence of new cases of X-ALD in Australia and New Zealand was between 1 in 50,000 to 1 in 70,000 male births per year."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1952,
    "user_query": "Can telomere length shortening be reversed by telomerase?",
    "yulan-chat-2-13b-fp16_response": "Yes, telomere length shortening can be reversed by telomerase. Telomerase is an enzyme that can add nucleotides to the ends of chromosomes, which can lengthen telomeres. Telomeres are repetitive DNA sequences that protect the ends of chromosomes from degradation and mutation. They naturally shorten with each cell division, which can lead to cell senescence or death. By reactivating telomerase, telomere length can be maintained or even restored, allowing cells to continue dividing and potentially regenerate tissues. However, it's important to note that telomerase is not active in most adult cells, and reactivating it can have unintended consequences, such as promoting cancer growth.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Telomerase can reverse telomere length shortening by adding nucleotides to the ends of chromosomes.\n2. Telomere lengthening can potentially allow cells to continue dividing and regenerate tissues.\n3. Telomeres themselves are repetitive DNA sequences that protect the ends of chromosomes from degradation and mutation.\n4. Telomeres naturally shorten with each cell division, which can lead to cell senescence or death.\n5. Telomerase is not active in most adult cells and reactivating it can have unintended consequences, such as promoting cancer growth.",
    "yulan-chat-2-13b-fp16_fact": [
      "Telomerase can reverse telomere length shortening by adding nucleotides to the ends of chromosomes.",
      "Telomere lengthening can potentially allow cells to continue dividing and regenerate tissues.",
      "Telomeres themselves are repetitive DNA sequences that protect the ends of chromosomes from degradation and mutation.",
      "Telomeres naturally shorten with each cell division, which can lead to cell senescence or death.",
      "Telomerase is not active in most adult cells and reactivating it can have unintended consequences, such as promoting cancer growth."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1953,
    "user_query": "Is ABCE1 involved in ribosomal recycling?",
    "yulan-chat-2-13b-fp16_response": "Yes, ABCE1 (ATP-binding cassette transporter subfamily E member 1) is involved in ribosomal recycling.\nRibosomal recycling is a process by which ribosomes are recycled and reused for subsequent rounds of protein synthesis. ABCE1 is a member of the ATP-binding cassette (ABC) transporter family, which is involved in various cellular processes, including ribosomal recycling. ABCE1 is localized to the endoplasmic reticulum (ER) and plays a key role in the retrieval of ribosomes from the ER lumen to the ER membrane, where they can be reused for subsequent rounds of protein synthesis.\nABCE1 functions in ribosomal recycling by interacting with ribosomal proteins and facilitating their translocation across the ER membrane. ABCE1 also plays a role in the degradation of damaged ribosomes, which can otherwise accumulate in the ER lumen and interfere with protein synthesis.\nOverall, ABCE1 is an important regulator of ribosomal recycling and plays a critical role in maintaining the quality of ribosome synthesis and protein production in the cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ABCE1 is involved in the process of ribosomal recycling.\n2. Ribosomal recycling is a process that recycles ribosomes for subsequent rounds of protein synthesis.\n3. ABCE1 is a member of the ATP-binding cassette (ABC) transporter family.\n4. ABCE1 is localized to the endoplasmic reticulum (ER).\n5. ABCE1 plays a key role in retrieving ribosomes from the ER lumen to the ER membrane for reuse.",
    "yulan-chat-2-13b-fp16_fact": [
      "ABCE1 is involved in the process of ribosomal recycling.",
      "Ribosomal recycling is a process that recycles ribosomes for subsequent rounds of protein synthesis.",
      "ABCE1 is a member of the ATP-binding cassette (ABC) transporter family.",
      "ABCE1 is localized to the endoplasmic reticulum (ER).",
      "ABCE1 plays a key role in retrieving ribosomes from the ER lumen to the ER membrane for reuse."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: ABCE1 is not localized to the endoplasmic reticulum (ER); it is generally found in the cytoplasm where it functions in ribosome recycling.\n5. FALSE [correction]: ABCE1 does not play a role in retrieving ribosomes from the ER lumen to the ER membrane for reuse. Its role is in the process of ribosome recycling in the cytoplasm after translation has completed.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1955,
    "user_query": "Does oculocutaneous albinism show an autosomal recessive inheritance?",
    "yulan-chat-2-13b-fp16_response": "Yes, oculocutaneous albinism (OCA) is a genetic disorder that shows an autosomal recessive inheritance pattern. This means that a person must inherit two copies of the altered gene (one from each parent) in order to develop the condition. If both parents are carriers of a mutated OCA gene, there is a 25% chance that their child will inherit two copies of the mutated gene and develop the condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Oculocutaneous albinism (OCA) is a genetic disorder with an autosomal recessive inheritance pattern.\n2. A person must inherit two altered copies of the gene, one from each parent, to develop oculocutaneous albinism.\n3. If both parents are carriers of a mutated OCA gene, there is a 25% chance their child will inherit the condition.",
    "yulan-chat-2-13b-fp16_fact": [
      "Oculocutaneous albinism (OCA) is a genetic disorder with an autosomal recessive inheritance pattern.",
      "A person must inherit two altered copies of the gene, one from each parent, to develop oculocutaneous albinism.",
      "If both parents are carriers of a mutated OCA gene, there is a 25% chance their child will inherit the condition."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "yulan-chat-2-13b-fp16_response": "The largest metabolic gene cluster in yeast is the ADH2-6-8-10-12 gene cluster, which encodes for alcohol dehydrogenase enzymes involved in ethanol metabolism.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The largest metabolic gene cluster in yeast is known as the ADH2-6-8-10-12 gene cluster.\n2. This gene cluster encodes for alcohol dehydrogenase enzymes.\n3. The enzymes involved in this cluster are related to ethanol metabolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "The largest metabolic gene cluster in yeast is known as the ADH2-6-8-10-12 gene cluster.",
      "This gene cluster encodes for alcohol dehydrogenase enzymes.",
      "The enzymes involved in this cluster are related to ethanol metabolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1958,
    "user_query": "Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?",
    "yulan-chat-2-13b-fp16_response": "The ApoE4 isoform is associated with an increased risk of developing atherosclerosis and Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The ApoE4 isoform is associated with an increased risk of developing atherosclerosis.\n2. The ApoE4 isoform is associated with an increased risk of developing Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "The ApoE4 isoform is associated with an increased risk of developing atherosclerosis.",
      "The ApoE4 isoform is associated with an increased risk of developing Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1960,
    "user_query": "What organism causes woolsorter's disease",
    "yulan-chat-2-13b-fp16_response": "Woolsorter's disease is caused by the fungus Histoplasma capsulatum. This fungus is found in the dried bird droppings and bat guano that are commonly used as a substrate in the cultivation of mushrooms. When the fungus is inhaled, it can cause an infection known as histoplasmosis. The disease is primarily spread through the inhalation of spores of the fungus, but it can also be spread through direct contact with contaminated soil or animal feed. Symptoms of histoplasmosis can include fever, cough, and chest pain, and the disease can be treated with antifungal medications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Woolsorter's disease is caused by the fungus Histoplasma capsulatum.\n2. Histoplasma capsulatum is found in dried bird droppings and bat guano.\n3. Woolsorter's disease can cause an infection known as histoplasmosis.\n4. Histoplasmosis can be transmitted through inhalation of spores of the fungus.\n5. Symptoms of histoplasmosis include fever, cough, and chest pain.",
    "yulan-chat-2-13b-fp16_fact": [
      "Woolsorter's disease is caused by the fungus Histoplasma capsulatum.",
      "Histoplasma capsulatum is found in dried bird droppings and bat guano.",
      "Woolsorter's disease can cause an infection known as histoplasmosis.",
      "Histoplasmosis can be transmitted through inhalation of spores of the fungus.",
      "Symptoms of histoplasmosis include fever, cough, and chest pain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Woolsorter's disease is caused by the bacterium Bacillus anthracis.\n2. TRUE\n3. FALSE [correction]: Woolsorter's disease, also known as anthrax, is different from histoplasmosis, which is caused by Histoplasma capsulatum.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1963,
    "user_query": "Which protein complexes recognize centromeric (CEN) DNA in yeast?",
    "yulan-chat-2-13b-fp16_response": "In yeast, the protein complexes that recognize centromeric (CEN) DNA are the centromere-specific proteins, such as Cse1, Cse2, and Cse3. These proteins form a complex called the Cse4 complex, which is responsible for attaching the CEN DNA to the centromere. Additionally, the protein CENP-A is also involved in recognizing and binding to CEN DNA in yeast.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cse1, Cse2, and Cse3 are centromere-specific proteins that recognize centromeric (CEN) DNA in yeast.\n2. The Cse4 complex is formed by centromere-specific proteins and is responsible for attaching CEN DNA to the centromere in yeast.\n3. CENP-A is a protein involved in recognizing and binding to CEN DNA in yeast.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cse1, Cse2, and Cse3 are centromere-specific proteins that recognize centromeric (CEN) DNA in yeast.",
      "The Cse4 complex is formed by centromere-specific proteins and is responsible for attaching CEN DNA to the centromere in yeast.",
      "CENP-A is a protein involved in recognizing and binding to CEN DNA in yeast."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Cse4 is not a complex but rather a centromere-specific histone H3 variant that replaces the conventional histone H3 in the nucleosome core of centromeric DNA in yeast.\n3. FALSE [correction]: CENP-A is a protein that is functionally similar to yeast Cse4, but it is involved in centromere function in humans, not yeast.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1966,
    "user_query": "What is the function of yeast Clr4 on chromatin?",
    "yulan-chat-2-13b-fp16_response": "Clr4 is a protein that functions as a histone H3-H4 chaperone in yeast. It plays a key role in the maintenance of chromatin structure and the regulation of gene expression. Clr4 interacts with histone H3 and H4 and helps to ensure that they are correctly assembled into nucleosomes, the basic units of chromatin. It also helps to regulate the levels of histone H3-H4 dimers, which are important for the proper functioning of the genome. In addition to its role in histone chaperoning, Clr4 has also been shown to interact with other proteins that play important roles in chromatin organization and gene expression, including the SIR2 silencing regulatory protein and the ASH1 activator protein.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Clr4 functions as a histone H3-H4 chaperone in yeast.\n2. Clr4 plays a key role in the maintenance of chromatin structure.\n3. Clr4 regulates the levels of histone H3-H4 dimers.\n4. Clr4 interacts with histone H3 and H4 to assist in their assembly into nucleosomes.\n5. Clr4 has been shown to interact with proteins that are involved in chromatin organization and gene expression, such as SIR2 and ASH1.",
    "yulan-chat-2-13b-fp16_fact": [
      "Clr4 functions as a histone H3-H4 chaperone in yeast.",
      "Clr4 plays a key role in the maintenance of chromatin structure.",
      "Clr4 regulates the levels of histone H3-H4 dimers.",
      "Clr4 interacts with histone H3 and H4 to assist in their assembly into nucleosomes.",
      "Clr4 has been shown to interact with proteins that are involved in chromatin organization and gene expression, such as SIR2 and ASH1."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Clr4 is the histone H3 lysine 9 methyltransferase in fission yeast and does not function as a histone chaperone.\n2. TRUE\n3. FALSE [correction]: Clr4 does not regulate the levels of histone H3-H4 dimers; instead, it catalyzes the methylation of histone H3 at lysine 9.\n4. FALSE [correction]: Clr4 does not assist in the assembly of histones into nucleosomes as a chaperone; its main role is to methylate histone H3 on lysine 9 which is a part of chromatin structure modification.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "yulan-chat-2-13b-fp16_response": "Long intergenic non-coding RNA (LINC00152) is a type of RNA molecule that does not encode proteins but plays important regulatory roles in gene expression. The exact function of LINC00152 is not fully understood, but it has been implicated in various biological processes, including cell differentiation, development, and cancer progression.\nStudies have shown that LINC00152 can act as a \"master regulator\" of gene expression by regulating the expression of multiple genes through interactions with chromatin and transcription factors. It has also been shown to play a role in the regulation of the epigenetic landscape by modulating DNA methylation and histone modifications.\nIn addition to its regulatory roles in gene expression, LINC00152 has also been implicated in the regulation of alternative splicing, RNA stability, and translation.\nOverall, the exact role of LINC00152 in various biological processes is still being investigated, but it is clear that it plays an important regulatory role in gene expression and may have implications for the development of various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LINC00152 is a long intergenic non-coding RNA molecule that does not encode proteins.\n2. LINC00152 has been implicated in various biological processes such as cell differentiation, development, and cancer progression.\n3. LINC00152 can regulate gene expression by interacting with chromatin and transcription factors.\n4. LINC00152 is involved in the regulation of the epigenetic landscape, which includes modulating DNA methylation and histone modifications.\n5. LINC00152 has been implicated in the regulation of alternative splicing, RNA stability, and translation.",
    "yulan-chat-2-13b-fp16_fact": [
      "LINC00152 is a long intergenic non-coding RNA molecule that does not encode proteins.",
      "LINC00152 has been implicated in various biological processes such as cell differentiation, development, and cancer progression.",
      "LINC00152 can regulate gene expression by interacting with chromatin and transcription factors.",
      "LINC00152 is involved in the regulation of the epigenetic landscape, which includes modulating DNA methylation and histone modifications.",
      "LINC00152 has been implicated in the regulation of alternative splicing, RNA stability, and translation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll of the provided statements regarding LINC00152 are generally in alignment with what is known about long intergenic non-coding RNAs (lincRNAs) such as LINC00152. They are recognized for their roles in various biological processes and their mechanisms of action, including gene regulation, involvement in epigenetic modification, and influence on post-transcriptional events. However, the specifics of these functions can vary between different lincRNAs, and while LINC00152 has been studied in these contexts, ongoing research may further refine our understanding of its precise mechanisms and functions in various biological processes and diseases.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1969,
    "user_query": "What are Kupffer cells and what is their role?",
    "yulan-chat-2-13b-fp16_response": "Kupffer cells are a type of liver sinusoidal endothelial cells (SEECs) that are specialized cells found in the liver sinusoids, which are the blood vessels that carry blood through the liver. They are named after the German pathologist Adolf Kupffer, who first described them in 1874.\nKupffer cells play a crucial role in the immune system of the body. They act as the first line of defense against pathogens and foreign particles that enter the bloodstream. Kupffer cells are responsible for removing these particles from the blood and presenting them to immune cells called T cells, which then mount an immune response to eliminate the pathogens.\nIn addition to their immune functions, Kupffer cells also play a role in liver regeneration and repair. They are involved in the clearance of damaged or necrotic liver cells and in the production of extracellular matrix components that help to repair damaged liver tissue.\nOverall, Kupffer cells are essential for maintaining the health and function of the liver and for protecting the body against infections and other harmful substances that enter the bloodstream.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Kupffer cells are a type of liver sinusoidal endothelial cells (SEECs) found in the blood vessels of the liver.\n2. They are named after German pathologist Adolf Kupffer, who first described them in 1874.\n3. Kupffer cells function as a part of the body's immune system.\n4. They participate in the removal of pathogens and foreign particles from the blood.\n5. Kupffer cells are involved in liver regeneration and repair, including the clearance of damaged liver cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Kupffer cells are a type of liver sinusoidal endothelial cells (SEECs) found in the blood vessels of the liver.",
      "They are named after German pathologist Adolf Kupffer, who first described them in 1874.",
      "Kupffer cells function as a part of the body's immune system.",
      "They participate in the removal of pathogens and foreign particles from the blood.",
      "Kupffer cells are involved in liver regeneration and repair, including the clearance of damaged liver cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Kupffer cells are a type of macrophage found in the liver, not liver sinusoidal endothelial cells (LSECs).\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1971,
    "user_query": "Is golimumab effective for ulcerative colitis?",
    "yulan-chat-2-13b-fp16_response": "Golimumab is a medication that is used to treat ulcerative colitis. It is a monoclonal antibody that works by blocking certain proteins in the body that can cause inflammation. Studies have shown that golimumab can be effective in reducing symptoms of ulcerative colitis and improving the quality of life for people with the condition. However, it is important to note that golimumab is not a cure for ulcerative colitis and it may not work for everyone. It is typically used in combination with other treatments, such as corticosteroids, to achieve the best possible outcomes. It is important to discuss the use of golimumab with a healthcare professional to determine if it is the right treatment option for you.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Golimumab is used to treat ulcerative colitis.\n2. Golimumab is a monoclonal antibody.\n3. Golimumab functions by blocking proteins in the body that cause inflammation.\n4. Studies indicate golimumab can reduce symptoms of ulcerative colitis.\n5. Golimumab is often used in combination with other treatments, such as corticosteroids.",
    "yulan-chat-2-13b-fp16_fact": [
      "Golimumab is used to treat ulcerative colitis.",
      "Golimumab is a monoclonal antibody.",
      "Golimumab functions by blocking proteins in the body that cause inflammation.",
      "Studies indicate golimumab can reduce symptoms of ulcerative colitis.",
      "Golimumab is often used in combination with other treatments, such as corticosteroids."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1976,
    "user_query": "What is the aim of the TRAP assay?",
    "yulan-chat-2-13b-fp16_response": "The TRAP (Tissue Responsive-element Amplification of the Polymerase chain reaction) assay is a molecular biology technique used to detect the presence of specific DNA sequences in a sample. The aim of the TRAP assay is to amplify and detect the presence of specific DNA sequences that are associated with certain diseases or conditions.\nThe TRAP assay is commonly used in the diagnosis and monitoring of certain viral infections, such as HIV and hepatitis C, as well as in the detection of genetic mutations that are associated with certain cancers. The assay works by using a polymerase chain reaction (PCR) to amplify the target DNA sequences, and then using a specific DNA-binding protein to bind to the amplified DNA and generate a visible signal.\nThe TRAP assay is considered a sensitive and specific method for detecting the presence of specific DNA sequences, and it has been widely used in research and clinical settings for a variety of applications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The TRAP (Tissue Responsive-element Amplification of the Polymerase chain reaction) assay is used to detect the presence of specific DNA sequences in a sample.\n2. The aim of the TRAP assay is to amplify and detect DNA sequences associated with certain diseases or conditions.\n3. The TRAP assay is commonly used in the diagnosis and monitoring of viral infections like HIV and hepatitis C.\n4. The TRAP assay can detect genetic mutations associated with certain cancers.\n5. The TRAP assay uses a polymerase chain reaction to amplify target DNA sequences.",
    "yulan-chat-2-13b-fp16_fact": [
      "The TRAP (Tissue Responsive-element Amplification of the Polymerase chain reaction) assay is used to detect the presence of specific DNA sequences in a sample.",
      "The aim of the TRAP assay is to amplify and detect DNA sequences associated with certain diseases or conditions.",
      "The TRAP assay is commonly used in the diagnosis and monitoring of viral infections like HIV and hepatitis C.",
      "The TRAP assay can detect genetic mutations associated with certain cancers.",
      "The TRAP assay uses a polymerase chain reaction to amplify target DNA sequences."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The TRAP (Telomeric Repeat Amplification Protocol) assay is primarily used to measure telomerase activity, not to detect specific DNA sequences.\n2. TRUE\n3. FALSE [correction]: The TRAP assay is commonly used to detect telomerase activity, which may be associated with cancer, rather than for diagnosis and monitoring of viral infections like HIV and hepatitis C.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1979,
    "user_query": "Which disease is associated with mutations in SLC40A1 gene?",
    "yulan-chat-2-13b-fp16_response": "The SLC40A1 gene is associated with mutations that can cause a rare inherited disorder called primary hyperoxaluria type 2. This condition is characterized by an abnormally high level of oxalate in the blood, which can lead to the formation of calcium oxalate crystals in the kidneys and other organs. These crystals can cause damage to the affected organs and lead to a range of symptoms, including kidney stones, chronic kidney disease, and recurrent kidney infections. Primary hyperoxaluria type 2 is caused by a deficiency in the activity of the SLC40A1 protein, which is involved in the transport of oxalate in the body.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the SLC40A1 gene can cause primary hyperoxaluria type 2.\n2. Primary hyperoxaluria type 2 is characterized by an abnormally high level of oxalate in the blood.\n3. People with primary hyperoxaluria type 2 can form calcium oxalate crystals in the kidneys and other organs.\n4. The condition can result in symptoms like kidney stones, chronic kidney disease, and recurrent kidney infections.\n5. A deficiency in the activity of the SLC40A1 protein leads to primary hyperoxaluria type 2.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the SLC40A1 gene can cause primary hyperoxaluria type 2.",
      "Primary hyperoxaluria type 2 is characterized by an abnormally high level of oxalate in the blood.",
      "People with primary hyperoxaluria type 2 can form calcium oxalate crystals in the kidneys and other organs.",
      "The condition can result in symptoms like kidney stones, chronic kidney disease, and recurrent kidney infections.",
      "A deficiency in the activity of the SLC40A1 protein leads to primary hyperoxaluria type 2."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Mutations in the GRHPR gene can cause primary hyperoxaluria type 2. \n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: A deficiency in the activity of the glyoxylate reductase/hydroxypyruvate reductase (GRHPR) enzyme due to mutations in the GRHPR gene leads to primary hyperoxaluria type 2.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1982,
    "user_query": "Is lenvatinib effective for renal cell carcinoma?",
    "yulan-chat-2-13b-fp16_response": "Lenvatinib is an oral multi-kinase inhibitor that has been shown to be effective in the treatment of advanced renal cell carcinoma (RCC).\nIn clinical trials, lenvatinib has been shown to improve progression-free survival (PFS) and overall survival (OS) in patients with advanced RCC who have received prior treatment with anti-angiogenic therapy. It has also been shown to be effective in patients with advanced RCC who have not received any prior treatment.\nLenvatinib works by inhibiting multiple kinases that are involved in the development and progression of RCC, including vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR). By inhibiting these kinases, lenvatinib can slow down the growth and spread of cancer cells.\nOverall, lenvatinib is a promising treatment option for patients with advanced RCC who have limited options for treatment. However, as with any treatment, it is important to discuss the potential benefits and risks with a healthcare provider to determine if it is the best option for an individual patient.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lenvatinib is an oral multi-kinase inhibitor used in the treatment of advanced renal cell carcinoma (RCC).\n2. Clinical trials have shown that lenvatinib can improve progression-free survival (PFS) and overall survival (OS) in patients with advanced RCC who have received prior anti-angiogenic therapy.\n3. Lenvatinib has been shown to be effective in patients with advanced RCC who have not received any prior treatment.\n4. Lenvatinib inhibits kinases involved in the development and progression of RCC, such as VEGFR and FGFR.\n5. Lenvatinib can slow down the growth and spread of cancer cells in RCC.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lenvatinib is an oral multi-kinase inhibitor used in the treatment of advanced renal cell carcinoma (RCC).",
      "Clinical trials have shown that lenvatinib can improve progression-free survival (PFS) and overall survival (OS) in patients with advanced RCC who have received prior anti-angiogenic therapy.",
      "Lenvatinib has been shown to be effective in patients with advanced RCC who have not received any prior treatment.",
      "Lenvatinib inhibits kinases involved in the development and progression of RCC, such as VEGFR and FGFR.",
      "Lenvatinib can slow down the growth and spread of cancer cells in RCC."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN [Correction: Statement 3 cannot be verified without specific clinical trial data or more detailed information regarding its efficacy in treatment-naive patients.]\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "yulan-chat-2-13b-fp16_response": "The R/Bioconductor package that is commonly used for performing SNP enrichment analysis is called \"Enrichr\". This package allows for the analysis of SNPs in the context of gene sets, such as genes associated with a particular disease or pathway, and provides a variety of statistical tests to determine if the SNPs are significantly enriched in those gene sets. Other packages that can be used for SNP enrichment analysis include \"SnpSert\" and \"SNPeffect\".",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The R/Bioconductor package \"Enrichr\" is used for performing SNP enrichment analysis.\n2. \"Enrichr\" allows for the analysis of SNPs in the context of gene sets.\n3. \"Enrichr\" provides various statistical tests to determine significant enrichment of SNPs in gene sets.\n4. Other packages for SNP enrichment analysis include \"SnpSert\" and \"SNPeffect\".",
    "yulan-chat-2-13b-fp16_fact": [
      "The R/Bioconductor package \"Enrichr\" is used for performing SNP enrichment analysis.",
      "\"Enrichr\" allows for the analysis of SNPs in the context of gene sets.",
      "\"Enrichr\" provides various statistical tests to determine significant enrichment of SNPs in gene sets.",
      "Other packages for SNP enrichment analysis include \"SnpSert\" and \"SNPeffect\"."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The R/Bioconductor package \"Enrichr\" is not used for SNP enrichment analysis; it is designed for gene-set enrichment analysis.\n2. FALSE [correction]: Since \"Enrichr\" is for gene-set enrichment and not SNP enrichment, it does not analyze SNPs in the context of gene sets.\n3. TRUE: Assuming the statement refers to gene-set enrichment (the actual purpose of Enrichr), then \"Enrichr\" does provide various statistical tests to determine significant enrichment in gene sets.\n4. UNKNOWN: \"SnpSert\" and \"SNPeffect\" are not standard or widely recognized packages for SNP enrichment analysis. The correctness of this statement cannot be determined without more context on these specific packages, and their existence or functionality is not verifiable based on the provided information.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1988,
    "user_query": "Describe crowned dens syndrome.",
    "yulan-chat-2-13b-fp16_response": "Crowned dens syndrome, also known as dens calcis, is a rare condition that affects the joint at the base of the skull, where it connects with the spine. In this condition, the dens (the bony protuberance at the base of the skull) is enlarged and presses against the spinal cord, causing a range of symptoms.\nThe symptoms of crowned dens syndrome can vary from person to person, but they often include:\n* Neck pain or stiffness\n* Headaches or migraines\n* Weakness or numbness in the arms or legs\n* Loss of balance or coordination\n* Bladder or bowel incontinence\n* Loss of sensation in the face or hands\nCrowned dens syndrome is usually diagnosed through a combination of physical examination, medical imaging (such as X-rays or MRI scans), and other tests. Treatment options may include medications to manage pain or inflammation, physical therapy to improve strength and flexibility, or surgery to relieve pressure on the spinal cord.\nIt's important to note that crowned dens syndrome is a relatively rare condition, and most cases are caused by genetic mutations. However, in some cases, the condition may be associated with other medical conditions or injuries that affect the neck or spine. If you are experiencing any of the symptoms of crowned dens syndrome, it's important to speak with a healthcare provider for proper diagnosis and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Crowned dens syndrome affects the joint at the base of the skull where it connects with the spine.\n2. In crowned dens syndrome, the dens is enlarged and can press against the spinal cord.\n3. Symptoms of crowned dens syndrome can include neck pain or stiffness, headaches, weakness or numbness in limbs, loss of balance or coordination, and bladder or bowel incontinence.\n4. Diagnosis of crowned dens syndrome typically involves physical examinations and medical imaging such as X-rays or MRI scans.\n5. Treatment options for crowned dens syndrome may include medications, physical therapy, or surgery.",
    "yulan-chat-2-13b-fp16_fact": [
      "Crowned dens syndrome affects the joint at the base of the skull where it connects with the spine.",
      "In crowned dens syndrome, the dens is enlarged and can press against the spinal cord.",
      "Symptoms of crowned dens syndrome can include neck pain or stiffness, headaches, weakness or numbness in limbs, loss of balance or coordination, and bladder or bowel incontinence.",
      "Diagnosis of crowned dens syndrome typically involves physical examinations and medical imaging such as X-rays or MRI scans.",
      "Treatment options for crowned dens syndrome may include medications, physical therapy, or surgery."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: In crowned dens syndrome, calcification around the dens, not enlargement of the dens itself, can create pressure against surrounding tissues, including potentially the spinal cord.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1989,
    "user_query": "Does CRISPR inversion of CTCF sites alter genome topology?",
    "yulan-chat-2-13b-fp16_response": "Yes, CRISPR inversion of CTCF sites can alter genome topology. CTCF (CCCTC-binding factor) is a transcription factor that plays a role in regulating gene expression and genome organization. It binds to specific DNA sequences, including the CTCF sites, and uses them as \"anchor points\" to form topologically associating domains (TADs). TADs are regions of the genome that are tightly packed and have a high degree of chromatin accessibility, which can influence gene expression and other cellular processes.\nCRISPR inversion of CTCF sites can disrupt the formation of TADs and alter the genome topology. When CTCF sites are inverted, CTCF can no longer bind to them, and the TADs that were formed around these sites may collapse or become fragmented. This can lead to changes in gene expression and other cellular processes that depend on the proper organization of the genome.\nIt's worth noting that the effects of CTCF site inversion on genome topology and cellular processes may depend on the specific context and the extent of the inversion. In some cases, the effects may be subtle or even negligible, while in others they may be more significant.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CRISPR inversion of CTCF sites can alter genome topology.\n2. CTCF (CCCTC-binding factor) is a transcription factor that regulates gene expression and genome organization.\n3. CTCF binds to specific DNA sequences to form topologically associating domains (TADs).\n4. Inversion of CTCF sites can disrupt the formation of TADs.\n5. Changes in the organization of the genome, such as the collapse or fragmentation of TADs, can lead to changes in gene expression and other cellular processes.",
    "yulan-chat-2-13b-fp16_fact": [
      "CRISPR inversion of CTCF sites can alter genome topology.",
      "CTCF (CCCTC-binding factor) is a transcription factor that regulates gene expression and genome organization.",
      "CTCF binds to specific DNA sequences to form topologically associating domains (TADs).",
      "Inversion of CTCF sites can disrupt the formation of TADs.",
      "Changes in the organization of the genome, such as the collapse or fragmentation of TADs, can lead to changes in gene expression and other cellular processes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1999,
    "user_query": "What is Mondor's disease?",
    "yulan-chat-2-13b-fp16_response": "Mondor's disease, also known as epulis fetida or epulis vulgaris, is a rare condition that affects the blood vessels in the skin. It typically occurs on the lower legs, but can also occur on the arms or other areas of the body. The condition is characterized by a painful, raised, and hardened mass of blood vessels that can range in size from a few millimeters to several centimeters.\nMondor's disease is thought to be caused by a blockage or narrowing of the blood vessels in the affected area, which leads to increased pressure and inflammation. The exact cause of the blockage is not fully understood, but it is believed to be related to a combination of genetic and environmental factors.\nSymptoms of Mondor's disease include a painful, red, and swollen mass on the skin, which can be tender to the touch. The mass may also be warm to the touch and may be accompanied by fever, chills, and general malaise. In some cases, the condition may resolve on its own within a few weeks, but it can also persist for several months or even years.\nTreatment for Mondor's disease typically involves antibiotics to treat any underlying infection, as well as pain relief measures such as ice packs, elevation of the affected area, and over-the-counter pain medications. In severe cases, surgery may be necessary to remove the affected blood vessels.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mondor's disease affects the blood vessels in the skin.\n2. It is characterized by a painful, raised, and hardened mass of blood vessels.\n3. Symptoms of Mondor's disease include painful, red, and swollen mass on the skin, which may be accompanied by fever, chills, and general malaise.\n4. Treatment for Mondor's disease can involve antibiotics, pain relief measures, and potentially surgery.\n5. The condition can occur on the lower legs, arms, or other areas of the body.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mondor's disease affects the blood vessels in the skin.",
      "It is characterized by a painful, raised, and hardened mass of blood vessels.",
      "Symptoms of Mondor's disease include painful, red, and swollen mass on the skin, which may be accompanied by fever, chills, and general malaise.",
      "Treatment for Mondor's disease can involve antibiotics, pain relief measures, and potentially surgery.",
      "The condition can occur on the lower legs, arms, or other areas of the body."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Mondor's disease is characterized by a painful, raised, and hardened cord under the skin, not a mass of blood vessels.\n3. FALSE [correction]: Symptoms of Mondor's disease typically involve a painful, red, and cord-like vein visible beneath the skin, without the presence of fever, chills, and general malaise, which are not commonly associated with this condition.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2000,
    "user_query": "List metalloenzyme inhibitors.",
    "yulan-chat-2-13b-fp16_response": "Metalloenzymes are enzymes that require a metal ion for their activity, and metalloenzyme inhibitors are compounds that can bind to and inhibit the activity of these enzymes. Some examples of metalloenzyme inhibitors include:\n1. EDTA (ethylenediaminetetraacetic acid) - a chelating agent that can bind to and sequester metal ions, inhibiting their participation in metalloenzyme reactions.\n2. TMB (tetramethylbenzidine) - a substrate for metalloenzymes that can be used to assay enzyme activity, as well as a potential inhibitor in some cases.\n3. AMD (aminomethylphosphonate) - a phosphorus-containing compound that can act as a metalloenzyme inhibitor by mimicking the binding of metal ions to the enzyme.\n4. DMS (dimethylsulfide) - a sulfur-containing compound that can act as a metalloenzyme inhibitor by binding to the metal ion and preventing it from binding to the enzyme.\n5. DTPA (diethylene triamine pentaacetic acid) - a chelating agent that can bind to and sequester metal ions, inhibiting their participation in metalloenzyme reactions.\n6. NTA (nitrilotriacetic acid) - a chelating agent that can bind to and sequester metal ions, inhibiting their participation in metalloenzyme reactions.\n7. TPEN (tetrakis(2-pyridyl)ethylenediamine) - a chelating agent that can bind to and sequester metal ions, inhibiting their participation in metalloenzyme reactions.\n8. Zincotaxine - a metalloenzyme inhibitor that specifically inhibits the activity of metalloenzymes that require zinc ions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. EDTA is a chelating agent that can inhibit metalloenzymes by sequestering metal ions.\n2. TMB can be used as an inhibitor for some metalloenzymes.\n3. AMD is a phosphorus-containing compound that can inhibit metalloenzymes.\n4. DMS is a sulfur-containing compound that can inhibit metalloenzymes by interacting with metal ions.\n5. DTPA is a chelating agent that can inhibit metalloenzymes by binding to metal ions.",
    "yulan-chat-2-13b-fp16_fact": [
      "EDTA is a chelating agent that can inhibit metalloenzymes by sequestering metal ions.",
      "TMB can be used as an inhibitor for some metalloenzymes.",
      "AMD is a phosphorus-containing compound that can inhibit metalloenzymes.",
      "DMS is a sulfur-containing compound that can inhibit metalloenzymes by interacting with metal ions.",
      "DTPA is a chelating agent that can inhibit metalloenzymes by binding to metal ions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: TMB (3,3',5,5'-Tetramethylbenzidine) is not an inhibitor but rather a chromogenic substrate used in enzyme-linked immunosorbent assays (ELISA), not as an inhibitor for metalloenzymes.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2007,
    "user_query": "Is the mouse Sry gene locus free of repetitive sequences?",
    "yulan-chat-2-13b-fp16_response": "The Sry gene is a sex determining gene found in mammals, including mice. It is located on the Y chromosome and is responsible for determining the sex of an individual. The Sry gene locus is not free of repetitive sequences, as it contains a number of repetitive elements, including transposable elements and other repetitive DNA sequences. These repetitive elements can affect the expression of the Sry gene and may have played a role in the evolution of the gene. However, the specific composition of repetitive elements in the Sry gene locus can vary between different species and individuals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Sry gene is a sex determining gene found in mammals, including mice.\n2. The Sry gene is located on the Y chromosome.\n3. The Sry gene locus contains repetitive elements, including transposable elements and other repetitive DNA sequences.\n4. These repetitive elements can affect the expression of the Sry gene.\n5. The composition of repetitive elements in the Sry gene locus can vary between different species and individuals.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Sry gene is a sex determining gene found in mammals, including mice.",
      "The Sry gene is located on the Y chromosome.",
      "The Sry gene locus contains repetitive elements, including transposable elements and other repetitive DNA sequences.",
      "These repetitive elements can affect the expression of the Sry gene.",
      "The composition of repetitive elements in the Sry gene locus can vary between different species and individuals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2011,
    "user_query": "Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?",
    "yulan-chat-2-13b-fp16_response": "Oculocutaneous albinism type 1 (OCA1) is caused by a mutation in the TYRP1 gene, which encodes for the enzyme tyrosinase-related protein 1 (TRP1). Tyrosinase is an enzyme that plays a critical role in the production of melanin, which is responsible for the pigmentation of skin, hair, and eyes. Mutations in the TYRP1 gene result in reduced or absent tyrosinase activity, leading to the characteristic features of OCA1, including pale skin, hair, and eye color.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Oculocutaneous albinism type 1 (OCA1) is caused by a mutation in the TYRP1 gene.\n2. The TYRP1 gene encodes for the enzyme tyrosinase-related protein 1 (TRP1).\n3. Tyrosinase is responsible for the production of melanin.\n4. Melanin is responsible for the pigmentation of skin, hair, and eyes.\n5. Mutations in the TYRP1 gene can lead to reduced or absent tyrosinase activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Oculocutaneous albinism type 1 (OCA1) is caused by a mutation in the TYRP1 gene.",
      "The TYRP1 gene encodes for the enzyme tyrosinase-related protein 1 (TRP1).",
      "Tyrosinase is responsible for the production of melanin.",
      "Melanin is responsible for the pigmentation of skin, hair, and eyes.",
      "Mutations in the TYRP1 gene can lead to reduced or absent tyrosinase activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Oculocutaneous albinism type 1 (OCA1) is caused by a mutation in the TYR gene, not the TYRP1 gene.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in the TYRP1 gene can affect melanin production, but it is mutations in the TYR gene that lead to reduced or absent tyrosinase activity, which is directly associated with OCA1.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2014,
    "user_query": "Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?",
    "yulan-chat-2-13b-fp16_response": "The protein that mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae is called the H2A.Z histone exchange factor (H2A.Z-HEF). This protein is responsible for recognizing and binding to the H2A.Z histone and then exchanging it for the H2A histone in the nucleosome. The H2A.Z-HEF protein is essential for the proper functioning of the yeast cell and is required for the replacement of H2A by H2A.Z during DNA replication and other cellular processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The H2A.Z histone exchange factor (H2A.Z-HEF) mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae.\n2. The H2A.Z-HEF protein is responsible for recognizing and binding to the H2A.Z histone.\n3. The H2A.Z-HEF protein exchanges H2A.Z for the H2A histone in the nucleosome.\n4. The H2A.Z-HEF protein is essential for the proper functioning of the yeast Saccharomyces cerevisiae cell.\n5. The replacement of H2A by H2A.Z by H2A.Z-HEF occurs during DNA replication and other cellular processes in yeast Saccharomyces cerevisiae.",
    "yulan-chat-2-13b-fp16_fact": [
      "The H2A.Z histone exchange factor (H2A.Z-HEF) mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae.",
      "The H2A.Z-HEF protein is responsible for recognizing and binding to the H2A.Z histone.",
      "The H2A.Z-HEF protein exchanges H2A.Z for the H2A histone in the nucleosome.",
      "The H2A.Z-HEF protein is essential for the proper functioning of the yeast Saccharomyces cerevisiae cell.",
      "The replacement of H2A by H2A.Z by H2A.Z-HEF occurs during DNA replication and other cellular processes in yeast Saccharomyces cerevisiae."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The H2A.Z-HEF, also known as SWR1 or SWR1-complex, does not recognize and bind to the H2A.Z histone itself; rather, it recognizes the H2A in the nucleosome and facilitates the exchange of H2A for H2A.Z.\n3. TRUE\n4. TRUE: While the term \"essential\" can have varying degrees of meaning in biology, in general, the proteins involved in histone exchange, like H2A.Z-HEF, play critical roles in chromatin organization and transcription regulation, which are important for cell function. However, whether it is essential (meaning that cells cannot live without it) can vary and is typically established through experiments that delete the gene encoding for the protein.\n5. TRUE: The exchange of histone H2A with H2A.Z can occur during DNA replication and transcription as part of chromatin remodeling processes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "yulan-chat-2-13b-fp16_response": "Radial glial cells (RGCs) are a type of glial cell that give rise to a variety of different cell types in the central nervous system (CNS), including ependymal cells. The process of RGC specification to ependymal cells is not well understood, but there are several key players that have been identified.\nOne important factor in the specification of RGCs to ependymal cells is the transcription factor Olig2. Olig2 is a master regulator of oligodendrocyte differentiation and has been shown to play a role in the specification of RGCs to ependymal cells. Another important factor is the signaling molecule Sonic hedgehog (Shh), which has been shown to promote the specification of RGCs to ependymal cells.\nOther factors that may be involved in the specification of RGCs to ependymal cells include the transcription factors Nkx6.1 and Nkx6.2, as well as the signaling molecules BMP and Wnt. However, the exact mechanisms underlying the specification of RGCs to ependymal cells are still being studied and are not yet fully understood.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Radial glial cells give rise to a variety of different cell types in the central nervous system, including ependymal cells.\n2. The transcription factor Olig2 is involved in the specification of radial glial cells to ependymal cells.\n3. Olig2 is also a master regulator of oligodendrocyte differentiation.\n4. Sonic hedgehog (Shh) promotes the specification of radial glial cells to ependymal cells.\n5. Transcription factors Nkx6.1 and Nkx6.2, as well as signaling molecules BMP and Wnt, may be involved in the specification of radial glial cells to ependymal cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Radial glial cells give rise to a variety of different cell types in the central nervous system, including ependymal cells.",
      "The transcription factor Olig2 is involved in the specification of radial glial cells to ependymal cells.",
      "Olig2 is also a master regulator of oligodendrocyte differentiation.",
      "Sonic hedgehog (Shh) promotes the specification of radial glial cells to ependymal cells.",
      "Transcription factors Nkx6.1 and Nkx6.2, as well as signaling molecules BMP and Wnt, may be involved in the specification of radial glial cells to ependymal cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: Sonic hedgehog (Shh) signaling is primarily associated with the promotion of motor neuron and oligodendrocyte differentiation, not specifically the specification of radial glial cells to ependymal cells.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2018,
    "user_query": "What fruit causes Jamaican vomiting sickness?",
    "yulan-chat-2-13b-fp16_response": "Jamaican vomiting sickness is caused by a type of bacteria called Bacillus cereus, which can be found in a variety of foods, including fruit. The bacteria produce a toxin that can cause symptoms such as vomiting, diarrhea, and abdominal cramps.\nIt is not a specific fruit that causes Jamaican vomiting sickness, but rather the bacteria that can contaminate any type of food. The bacteria can grow and multiply in food that is not stored or cooked properly, so it is important to take precautions to prevent the bacteria from multiplying. This includes properly storing and reheating food, as well as washing hands and utensils before handling food.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2022,
    "user_query": "What are Degrons?",
    "yulan-chat-2-13b-fp16_response": "Degrons are regions in proteins that are recognized by proteases, which are enzymes that break down proteins. Degrons are typically short amino acid sequences that are rich in specific amino acids, such as lysine or arginine, and are often found at the C-terminal end of a protein. When a protease recognizes a degron, it cleaves the protein at that site, leading to the degradation of the protein. Degrons are important for regulating protein turnover and degradation, and are often used as targets for developing small molecule inhibitors of proteases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Degrons are regions in proteins recognized by proteases.\n2. Proteases are enzymes that break down proteins.\n3. Degrons are usually short amino acid sequences rich in amino acids like lysine or arginine.\n4. Degrons are often found at the C-terminal end of a protein.\n5. Degrons play a role in regulating protein turnover and degradation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Degrons are regions in proteins recognized by proteases.",
      "Proteases are enzymes that break down proteins.",
      "Degrons are usually short amino acid sequences rich in amino acids like lysine or arginine.",
      "Degrons are often found at the C-terminal end of a protein.",
      "Degrons play a role in regulating protein turnover and degradation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Degrons are regions in proteins recognized by the ubiquitin-proteasome system, not directly by proteases.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Degrons can be found not only at the C-terminal end but also within the protein or at the N-terminal end.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2023,
    "user_query": "Which disease is associated with mutated Sox2?",
    "yulan-chat-2-13b-fp16_response": "Mutations in the SOX2 gene have been associated with several developmental disorders, including:\n1. Waardenburg syndrome type 2: a rare genetic disorder characterized by a wide range of symptoms, including white or light-colored hair, light-colored eyes, and a distinctive facial appearance.\n2. Craniofacial differences: Mutations in SOX2 have been linked to craniofacial differences, such as cleft palate and abnormalities in the development of the jaw and face.\n3. Congenital heart defects: SOX2 mutations have been implicated in the development of congenital heart defects, such as septal defects and atrial and ventricular septal defects.\n4. Limb defects: SOX2 mutations have been associated with limb defects, such as amelia (absence of the limb) and symbrachydactyly (reduced number of fingers or toes).\nIt's important to note that SOX2 mutations can lead to a wide range of developmental disorders, and the specific symptoms can vary widely depending on the individual and the specific mutation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the SOX2 gene are associated with Waardenburg syndrome type 2.\n2. SOX2 gene mutations have been linked to craniofacial differences, such as cleft palate and jaw and facial development abnormalities.\n3. SOX2 mutations have been implicated in the development of congenital heart defects, such as septal defects.\n4. SOX2 mutations can cause limb defects, including amelia and symbrachydactyly.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the SOX2 gene are associated with Waardenburg syndrome type 2.",
      "SOX2 gene mutations have been linked to craniofacial differences, such as cleft palate and jaw and facial development abnormalities.",
      "SOX2 mutations have been implicated in the development of congenital heart defects, such as septal defects.",
      "SOX2 mutations can cause limb defects, including amelia and symbrachydactyly."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Mutations in the SOX2 gene are not typically associated with Waardenburg syndrome type 2; instead, mutations in genes like MITF, SOX10, and others are linked to this condition. SOX2 mutations are often associated with syndromes affecting the eye and brain development, such as anophthalmia and microphthalmia.\n2. TRUE\n3. FALSE [correction]: While SOX2 gene mutations can cause a variety of developmental issues, there is no strong association with congenital heart defects such as septal defects. Congenital heart defects are more commonly associated with mutations in other genes.\n4. FALSE [correction]: SOX2 mutations are not commonly linked to limb defects such as amelia and symbrachydactyly. These types of limb abnormalities are usually caused by mutations or deletions of other genes or environmental factors.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2024,
    "user_query": "Is the enzyme EPRS phosphorylated?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have enough information to answer your question. Could you please provide more context or clarify what you are asking?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2038,
    "user_query": "Which disease(s) are caused by HEX A deficiency?",
    "yulan-chat-2-13b-fp16_response": "HEX A deficiency is a rare genetic disorder that is caused by a deficiency of alpha-L-handarotmane, a type of carbohydrate found in the blood. This deficiency can lead to a number of health problems, including:\n* Hemolytic anemia: This is a condition in which red blood cells are destroyed faster than they can be produced, leading to anemia.\n* Neurological problems: HEX A deficiency can also cause neurological problems, such as developmental delay, intellectual disability, and seizures.\n* Kidney problems: Some people with HEX A deficiency may also have kidney problems, such as proteinuria (excess protein in the urine) and nephrotic syndrome (a condition in which the kidneys leak large amounts of protein into the urine).\n* Other problems: In addition to these symptoms, HEX A deficiency can also cause a variety of other health problems, including heart problems, liver problems, and skin rashes.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2046,
    "user_query": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?",
    "yulan-chat-2-13b-fp16_response": "JASPAR 2016 is an open-access database of transcription factor (TF) binding profiles that includes a wide range of additions and improvements over previous versions. Some of the key additions to JASPAR 2016 include:\n1. Expanded coverage of vertebrate species: JASPAR 2016 includes TF binding profiles for a wider range of vertebrate species, including several new mammals, birds, and reptiles.\n2. Improved data quality: JASPAR 2016 includes only high-quality TF binding profile data, with strict quality control measures in place to ensure accuracy and reliability.\n3. Enhanced data integration: JASPAR 2016 integrates data from multiple sources, including ChIP-seq, DNase footprinting, and other high-throughput experimental techniques, as well as literature-based data.\n4. New data types: JASPAR 2016 includes new data types, such as DNA motif predictions and TF binding site conservation across multiple species, which can help researchers to better understand the functional significance of TF binding sites.\n5. User-friendly interface: JASPAR 2016 has a new, user-friendly interface that makes it easier for researchers to search and browse TF binding profiles, and to access additional information and resources related to each TF.\nOverall, the additions and improvements in JASPAR 2016 make it a valuable resource for researchers studying TFs and their roles in gene regulation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. JASPAR 2016 is an open-access database that contains transcription factor binding profiles.\n2. The database includes expanded coverage of vertebrate species, incorporating new mammals, birds, and reptiles.\n3. JASPAR 2016 employs strict quality control measures to ensure the accuracy and reliability of the data.\n4. The database integrates data from various sources, such as ChIP-seq and DNase footprinting.\n5. JASPAR 2016 features a new user-friendly interface designed to facilitate the search and browsing of transcription factor binding profiles.",
    "yulan-chat-2-13b-fp16_fact": [
      "JASPAR 2016 is an open-access database that contains transcription factor binding profiles.",
      "The database includes expanded coverage of vertebrate species, incorporating new mammals, birds, and reptiles.",
      "JASPAR 2016 employs strict quality control measures to ensure the accuracy and reliability of the data.",
      "The database integrates data from various sources, such as ChIP-seq and DNase footprinting.",
      "JASPAR 2016 features a new user-friendly interface designed to facilitate the search and browsing of transcription factor binding profiles."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE - While this statement provides an assertion that could be correct, without specific details on the quality control measures for JASPAR 2016, we generally assume databases like these employ quality control measures, but it should be noted that the statement's validity depends on the specific processes employed by JASPAR 2016.\n4. TRUE\n5. TRUE - This statement could be true if JASPAR 2016 was updated with a new user interface at the time of its release, however without a direct comparison to previous versions or user testimonials it's difficult to assess the user-friendliness of the interface. But databases typically advertise improvements like this, so this will be accepted as accurate for our purposes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2047,
    "user_query": "What is the function of the protein tafazzin?",
    "yulan-chat-2-13b-fp16_response": "Tafazzin is a protein that plays a role in the metabolism of fatty acids. It is a member of the acyltransferase family of enzymes, which are involved in the synthesis and degradation of lipids (fats) in the body. Tafazzin is specifically involved in the process of esterification, which is the formation of ester bonds between fatty acids and other molecules. In the context of tafazzin, this process occurs on the surface of the endoplasmic reticulum, a type of membrane that is involved in the synthesis of lipids. Tafazzin is thought to be involved in the synthesis of certain types of lipids, such as cardiolipin, which is a type of lipid that is found in the inner membrane of mitochondria. Mutations in the gene that encodes tafazzin can lead to a condition called cardiomyopathy, which is a type of heart disease that is characterized by the weakening of the heart muscle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tafazzin is involved in the metabolism of fatty acids.\n2. Tafazzin is a member of the acyltransferase family of enzymes.\n3. Tafazzin participates in the process of esterification on the surface of the endoplasmic reticulum.\n4. Tafazzin is associated with the synthesis of cardiolipin in mitochondria.\n5. Mutations in the gene encoding tafazzin can lead to cardiomyopathy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tafazzin is involved in the metabolism of fatty acids.",
      "Tafazzin is a member of the acyltransferase family of enzymes.",
      "Tafazzin participates in the process of esterification on the surface of the endoplasmic reticulum.",
      "Tafazzin is associated with the synthesis of cardiolipin in mitochondria.",
      "Mutations in the gene encoding tafazzin can lead to cardiomyopathy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Tafazzin is involved in the remodeling of cardiolipin on the inner mitochondrial membrane, not the process of esterification on the surface of the endoplasmic reticulum.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2051,
    "user_query": "Where is base J found in the genome of Leishmania tarentolae?",
    "yulan-chat-2-13b-fp16_response": "The base J (T) is found in the genome of Leishmania tarentolae in the mitochondrial DNA (mtDNA) of the parasite. Specifically, it is located in the ND4 gene, which encodes a subunit of complex I of the electron transport chain in the mitochondrial inner membrane. The base change from T to G (T>G) at position 3240 in the ND4 gene of L. tarentolae is a known mutation that confers resistance to the antileishmanial drug pentamidine.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Base J is found in the mitochondrial DNA of Leishmania tarentolae.\n2. Base J is located in the ND4 gene of Leishmania tarentolae.\n3. The ND4 gene encodes a subunit of complex I of the electron transport chain in the mitochondrial inner membrane.\n4. A known mutation in the ND4 gene of L. tarentolae is a base change from T to G at position 3240.\n5. The mutation at position 3240 in the ND4 gene of L. tarentolae confers resistance to the antileishmanial drug pentamidine.",
    "yulan-chat-2-13b-fp16_fact": [
      "Base J is found in the mitochondrial DNA of Leishmania tarentolae.",
      "Base J is located in the ND4 gene of Leishmania tarentolae.",
      "The ND4 gene encodes a subunit of complex I of the electron transport chain in the mitochondrial inner membrane.",
      "A known mutation in the ND4 gene of L. tarentolae is a base change from T to G at position 3240.",
      "The mutation at position 3240 in the ND4 gene of L. tarentolae confers resistance to the antileishmanial drug pentamidine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Base J (beta-D-glucosyl-hydroxymethyluracil) is indeed a modified base found in the mitochondrial DNA of kinetoplastid protozoan parasites, including Leishmania species.\n2. UNKNOWN: Without specific reference to scientific literature detailing the location of Base J within the mitochondrial DNA of Leishmania tarentolae, it's not possible to confirm or deny its presence in the ND4 gene specifically.\n3. TRUE: The ND4 gene typically encodes for one of the subunits of complex I (NADH dehydrogenase) of the electron transport chain in the mitochondrial inner membrane across various species, including protozoa.\n4. UNKNOWN: The specific mutation at position 3240 in the ND4 gene of L. tarentolae and the base involved would require validation through scientific studies or genetic sequence data, which are not provided here.\n5. UNKNOWN: The capacity of a mutation at a specific position within the ND4 gene to confer resistance to pentamidine or any other antileishmanial drug would need to be confirmed by specific scientific research or clinical data, which is not available in this prompt.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2052,
    "user_query": "Which tool is available for predicting regulatory interactions from ChIP-seq data?",
    "yulan-chat-2-13b-fp16_response": "There are several tools available for predicting regulatory interactions from ChIP-seq data, including:\n1. ChIA-PET: a tool that uses a Hi-C-based approach to identify long-range interactions between regulatory elements and their target genes.\n2. RADAR2: a tool that uses a de novo assembly-based approach to identify regulatory interactions between transcription factors and their target genes.\n3. ChIPseeker: a tool that identifies peaks of enrichment for transcription factors and other regulatory proteins, and then searches for significant associations between these peaks and genes or other regulatory elements.\n4. MACS2: a tool that performs statistical analysis of ChIP-seq data to identify significant peaks of binding for transcription factors and other regulatory proteins, and then uses these peaks to identify regulatory interactions with other genetic elements.\n5. PICK: a tool that uses a de novo assembly-based approach to identify regulatory interactions between transcription factors and their target genes, and then uses these interactions to predict the effects of genetic variants on gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ChIA-PET is a tool designed to identify long-range interactions between regulatory elements and their target genes using a Hi-C-based approach.\n2. RADAR2 is a tool that identifies regulatory interactions between transcription factors and their target genes through a de novo assembly-based approach.\n3. ChIPseeker is a tool that identifies peaks of enrichment for transcription factors and other regulatory proteins and looks for significant associations with genes or other regulatory elements.\n4. MACS2 performs statistical analysis of ChIP-seq data to identify significant binding peaks and uses them to identify regulatory interactions with other genetic elements.\n5. PICK is a tool that identifies regulatory interactions and predicts the effects of genetic variants on gene expression, also using a de novo assembly-based approach.",
    "yulan-chat-2-13b-fp16_fact": [
      "ChIA-PET is a tool designed to identify long-range interactions between regulatory elements and their target genes using a Hi-C-based approach.",
      "RADAR2 is a tool that identifies regulatory interactions between transcription factors and their target genes through a de novo assembly-based approach.",
      "ChIPseeker is a tool that identifies peaks of enrichment for transcription factors and other regulatory proteins and looks for significant associations with genes or other regulatory elements.",
      "MACS2 performs statistical analysis of ChIP-seq data to identify significant binding peaks and uses them to identify regulatory interactions with other genetic elements.",
      "PICK is a tool that identifies regulatory interactions and predicts the effects of genetic variants on gene expression, also using a de novo assembly-based approach."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: ChIA-PET is a tool designed to identify long-range interactions between regulatory elements and their target genes, but it uses a chromatin interaction analysis with paired-end tag sequencing approach, not specifically a Hi-C-based approach.\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2053,
    "user_query": "Where are the unipolar brush cells localized?",
    "yulan-chat-2-13b-fp16_response": "Unipolar brush cells are found in the epithelial cells lining the ducts of the mammary gland. They are specialized cells that are responsible for the secretion of milk from the mammary gland. These cells are located in the luminal surface of the ducts and are arranged in a brush-like pattern, which gives them their name.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2054,
    "user_query": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?",
    "yulan-chat-2-13b-fp16_response": "Diffuse Intrinsic Pontine Glioma (DIPG) is a type of brain tumor that occurs in the brainstem, specifically in the pons region. While the exact cause of DIPG is not yet fully understood, genetic mutations have been identified as a potential contributing factor.\nOne of the most common driver mutations found in DIPG is a mutation in the HDAC2 gene. Other genes that have been implicated in the development of DIPG include the TP53 gene, the EGFRvIII gene, and the PDGFRA gene.\nIt is important to note that DIPG is a complex disease and the underlying genetic mutations can vary from case to case. While genetic mutations may play a role in the development of DIPG, they are not the sole cause of the disease. A combination of genetic, environmental, and other factors may contribute to the development of DIPG.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Diffuse Intrinsic Pontine Glioma (DIPG) is a brain tumor that occurs in the brainstem, specifically in the pons region.\n2. Genetic mutations have been identified as a potential contributing factor to DIPG.\n3. The HDAC2 gene mutation is one of the most common driver mutations found in DIPG.\n4. The TP53 gene has been implicated in the development of DIPG.\n5. Mutations in the EGFRvIII gene and the PDGFRA gene have also been associated with DIPG.",
    "yulan-chat-2-13b-fp16_fact": [
      "Diffuse Intrinsic Pontine Glioma (DIPG) is a brain tumor that occurs in the brainstem, specifically in the pons region.",
      "Genetic mutations have been identified as a potential contributing factor to DIPG.",
      "The HDAC2 gene mutation is one of the most common driver mutations found in DIPG.",
      "The TP53 gene has been implicated in the development of DIPG.",
      "Mutations in the EGFRvIII gene and the PDGFRA gene have also been associated with DIPG."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: One of the most common mutations found in DIPG is in the gene histone H3, specifically the H3 K27M mutation, not the HDAC2 gene mutation.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2059,
    "user_query": "What is the enzymatic activity of PARL?",
    "yulan-chat-2-13b-fp16_response": "PARL (Prostate-specific antigen-regulatory protein) is an enzyme that regulates the levels of prostate-specific antigen (PSA) in the blood. PARL is a serine protease that cleaves PSA into smaller fragments, including a glycoprotein called PSA-IgG, which is responsible for the majority of PSA activity in the blood. PARL also has other substrates, including prostate-specific acid phosphatase (PSAP) and prostate-specific membrane antigen (PSMA).\nThe enzymatic activity of PARL is important for regulating PSA levels in the blood and maintaining prostate gland health. PARL deficiency has been associated with increased PSA levels and an increased risk of prostate cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PARL stands for Prostate-specific antigen-regulatory protein.\n2. PARL is a serine protease enzyme that cleaves prostate-specific antigen (PSA) into smaller fragments.\n3. One of the cleavage products of PSA by PARL is a glycoprotein called PSA-IgG.\n4. PARL is responsible for the majority of PSA activity in the blood.\n5. Deficiency in PARL is associated with increased PSA levels and an increased risk of prostate cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "PARL stands for Prostate-specific antigen-regulatory protein.",
      "PARL is a serine protease enzyme that cleaves prostate-specific antigen (PSA) into smaller fragments.",
      "One of the cleavage products of PSA by PARL is a glycoprotein called PSA-IgG.",
      "PARL is responsible for the majority of PSA activity in the blood.",
      "Deficiency in PARL is associated with increased PSA levels and an increased risk of prostate cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: PARL stands for Presenilins-associated rhomboid-like protein, which is not related to prostate-specific antigen-regulatory protein.\n2. FALSE [correction]: PARL is actually a mitochondrial protease involved in various cellular processes, not a serine protease enzyme that cleaves prostate-specific antigen (PSA).\n3. FALSE [correction]: Given that PARL is not involved in cleaving PSA, it does not produce a glycoprotein called PSA-IgG as a cleavage product.\n4. FALSE [correction]: Since PARL is not related to PSA cleavage, it is not responsible for the majority of PSA activity in the blood.\n5. FALSE [correction]: Deficiency in PARL has not been established as being associated with increased PSA levels or an increased risk of prostate cancer since PARL is not involved with PSA.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2064,
    "user_query": "What is the mechanism of action of verubecestat?",
    "yulan-chat-2-13b-fp16_response": "Verubecestat is an experimental drug being developed for the treatment of Alzheimer's disease. It works by inhibiting the activity of an enzyme called BACE1 (beta-secretase 1), which is involved in the production of amyloid-beta protein. Amyloid-beta protein is thought to play a role in the development and progression of Alzheimer's disease. By inhibiting BACE1, verubecestat is expected to reduce the amount of amyloid-beta protein in the brain, which may help to slow down or stop the progression of the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Verubecestat is an experimental drug developed for the treatment of Alzheimer's disease.\n2. Verubecestat inhibits the activity of the enzyme BACE1 (beta-secretase 1).\n3. BACE1 is involved in the production of amyloid-beta protein.\n4. Amyloid-beta protein is implicated in the development and progression of Alzheimer's disease.\n5. The inhibition of BACE1 by verubecestat is expected to lead to a reduction of amyloid-beta protein in the brain.",
    "yulan-chat-2-13b-fp16_fact": [
      "Verubecestat is an experimental drug developed for the treatment of Alzheimer's disease.",
      "Verubecestat inhibits the activity of the enzyme BACE1 (beta-secretase 1).",
      "BACE1 is involved in the production of amyloid-beta protein.",
      "Amyloid-beta protein is implicated in the development and progression of Alzheimer's disease.",
      "The inhibition of BACE1 by verubecestat is expected to lead to a reduction of amyloid-beta protein in the brain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "yulan-chat-2-13b-fp16_response": "Triple negative gliomas are a subtype of glioma, which is a type of brain tumor. They are characterized by the absence of three specific markers on the surface of the tumor cells: EGFR, Receptor tyrosine-mutated (RTM) and MET. These markers are proteins that are involved in cell growth and division, and their absence suggests that the tumor cells are less likely to respond to treatments that target these proteins. Triple negative gliomas are generally more aggressive and have a poorer prognosis than other types of gliomas. They typically occur in adults and are more common in women than men.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Triple negative gliomas are a subtype of glioma, which is a type of brain tumor.\n2. They are characterized by the absence of three specific markers: EGFR, Receptor tyrosine-mutated (RTM), and MET.\n3. The absence of EGFR, RTM, and MET markers suggests tumor cells are less likely to respond to treatments targeting these proteins.\n4. Triple negative gliomas are generally more aggressive and have a poorer prognosis than other types of gliomas.\n5. Triple negative gliomas typically occur in adults and are more common in women than men.",
    "yulan-chat-2-13b-fp16_fact": [
      "Triple negative gliomas are a subtype of glioma, which is a type of brain tumor.",
      "They are characterized by the absence of three specific markers: EGFR, Receptor tyrosine-mutated (RTM), and MET.",
      "The absence of EGFR, RTM, and MET markers suggests tumor cells are less likely to respond to treatments targeting these proteins.",
      "Triple negative gliomas are generally more aggressive and have a poorer prognosis than other types of gliomas.",
      "Triple negative gliomas typically occur in adults and are more common in women than men."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Triple negative gliomas are characterized by the absence of three specific receptor proteins which could include but are not limited to EGFR (epidermal growth factor receptor), but RTM (Receptor tyrosine-mutated) is not a widely recognized marker; instead, other markers typically include IDH1 (Isocitrate dehydrogenase 1) and 1p/19q co-deletion, as seen in triple-negative glioblastomas.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2068,
    "user_query": "What is the function of gasdermin D?",
    "yulan-chat-2-13b-fp16_response": "Gasdermin D is a protein that is involved in the immune response. It is a member of the gasdermin family of proteins, which are expressed in a variety of cells in the body, including immune cells such as macrophages and dendritic cells.\nThe function of gasdermin D is not fully understood, but it is thought to play a role in the regulation of the immune response. It may be involved in the activation of immune cells, and it may also play a role in the clearance of pathogens from the body.\nGasdermin D is also thought to have a role in the regulation of cell death, or apoptosis. It may help to trigger apoptosis in cells that are infected with pathogens or that are otherwise damaged, which helps to eliminate these cells from the body.\nOverall, the function of gasdermin D is important for the proper functioning of the immune system and for the maintenance of tissue homeostasis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gasdermin D is a protein that is involved in the immune response.\n2. Gasdermin D is a member of the gasdermin family of proteins.\n3. Gasdermin D is expressed in various cells in the body, including immune cells like macrophages and dendritic cells.\n4. Gasdermin D is thought to play a role in the regulation of immune cell activation.\n5. Gasdermin D is believed to help trigger apoptosis in cells that are infected with pathogens or that are damaged.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gasdermin D is a protein that is involved in the immune response.",
      "Gasdermin D is a member of the gasdermin family of proteins.",
      "Gasdermin D is expressed in various cells in the body, including immune cells like macrophages and dendritic cells.",
      "Gasdermin D is thought to play a role in the regulation of immune cell activation.",
      "Gasdermin D is believed to help trigger apoptosis in cells that are infected with pathogens or that are damaged."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Gasdermin D is believed to trigger pyroptosis, a form of programmed cell death that is inflammatory, rather than apoptosis, which is non-inflammatory.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "yulan-chat-2-13b-fp16_response": "TOPAZ1 is a protein that in humans is encoded by the \"TOPAZ1\" gene. The function of TOPAZ1 is not well understood, but it has been suggested to be involved in regulating the activity of other genes. It is a member of the Topaz family of proteins, which are characterized by a conserved Topaz domain.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TOPAZ1 is a protein in humans.\n2. The TOPAZ1 gene encodes the TOPAZ1 protein.\n3. The function of TOPAZ1 is not well understood.\n4. TOPAZ1 is speculated to be involved in regulating the activity of other genes.\n5. TOPAZ1 is part of the Topaz family of proteins, which have a conserved Topaz domain.",
    "yulan-chat-2-13b-fp16_fact": [
      "TOPAZ1 is a protein in humans.",
      "The TOPAZ1 gene encodes the TOPAZ1 protein.",
      "The function of TOPAZ1 is not well understood.",
      "TOPAZ1 is speculated to be involved in regulating the activity of other genes.",
      "TOPAZ1 is part of the Topaz family of proteins, which have a conserved Topaz domain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: There is no known \"Topaz family of proteins\" with a conserved Topaz domain. However, the name TOPAZ1 appears to be a hypothetical or incorrect term, as there are no widely recognized references to a human protein or gene by this name in scientific literature as of my last update. It is possible that it may be a typo or a name used within a specific research context not recognized broadly.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2070,
    "user_query": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?",
    "yulan-chat-2-13b-fp16_response": "G6PD deficiency is a genetic disorder that affects the red blood cells. The symptoms of G6PD deficiency can vary from person to person and can range from mild to severe. Some common symptoms of G6PD deficiency include:\n1. Hemolysis: G6PD deficiency can cause the red blood cells to break down prematurely, leading to hemolysis. Hemolysis can cause symptoms such as back pain, abdominal pain, and jaundice (yellowing of the skin and eyes).\n2. Fatigue: Fatigue is a common symptom of G6PD deficiency, as the body may not have enough red blood cells to carry oxygen to the muscles.\n3. Pale skin: G6PD deficiency can cause a lack of oxygen in the body, which can lead to pale skin.\n4. Shortness of breath: G6PD deficiency can cause shortness of breath, as the body may not have enough red blood cells to carry oxygen to the lungs.\n5. Headaches: Headaches are a common symptom of G6PD deficiency, as the body may not have enough oxygen to supply the brain.\n6. Heart palpitations: G6PD deficiency can cause heart palpitations, which are an irregular heartbeat.\n7. Enlarged spleen: G6PD deficiency can cause an enlarged spleen, which can lead to abdominal pain and discomfort.\nIt is important to note that not everyone with G6PD deficiency will experience symptoms, and some people may only experience symptoms during certain times in their life, such as after exposure to certain medications or infections.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. G6PD deficiency can cause red blood cells to break down prematurely, leading to hemolysis.\n2. Common symptoms of G6PD deficiency include back pain, abdominal pain, and jaundice.\n3. Fatigue can occur in individuals with G6PD deficiency due to a reduced number of red blood cells.\n4. Shortness of breath is a symptom of G6PD deficiency caused by insufficient red blood cells to carry oxygen to the lungs.\n5. G6PD deficiency can lead to an enlarged spleen.",
    "yulan-chat-2-13b-fp16_fact": [
      "G6PD deficiency can cause red blood cells to break down prematurely, leading to hemolysis.",
      "Common symptoms of G6PD deficiency include back pain, abdominal pain, and jaundice.",
      "Fatigue can occur in individuals with G6PD deficiency due to a reduced number of red blood cells.",
      "Shortness of breath is a symptom of G6PD deficiency caused by insufficient red blood cells to carry oxygen to the lungs.",
      "G6PD deficiency can lead to an enlarged spleen."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Shortness of breath is a symptom of G6PD deficiency caused by insufficient oxygen being carried to the body's tissues due to a reduced number of red blood cells; the lungs themselves receive oxygen normally.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2071,
    "user_query": "Has the gorilla genome been determined?",
    "yulan-chat-2-13b-fp16_response": "Yes, the gorilla genome has been determined. In 2007, an international consortium of researchers announced that they had sequenced the genome of the eastern gorilla, one of two species of gorillas. The sequencing was done using a combination of traditional Sanger sequencing and next-generation sequencing technologies. The gorilla genome is one of the most complex genomes ever sequenced, with a total of around 3.2 billion base pairs. The gorilla genome is particularly important for conservation efforts, as it provides valuable information about the genetic diversity and evolutionary history of this endangered species.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The gorilla genome has been sequenced.\n2. The sequencing of the eastern gorilla genome was announced by an international consortium of researchers in 2007.\n3. A combination of traditional Sanger sequencing and next-generation sequencing technologies was used to sequence the gorilla genome.\n4. The gorilla genome comprises approximately 3.2 billion base pairs.\n5. The sequencing of the gorilla genome is critical for conservation efforts, providing information about genetic diversity and evolutionary history of the species.",
    "yulan-chat-2-13b-fp16_fact": [
      "The gorilla genome has been sequenced.",
      "The sequencing of the eastern gorilla genome was announced by an international consortium of researchers in 2007.",
      "A combination of traditional Sanger sequencing and next-generation sequencing technologies was used to sequence the gorilla genome.",
      "The gorilla genome comprises approximately 3.2 billion base pairs.",
      "The sequencing of the gorilla genome is critical for conservation efforts, providing information about genetic diversity and evolutionary history of the species."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The sequencing of the western lowland gorilla genome, not the eastern gorilla genome, was announced by an international consortium of researchers in 2012, not 2007.\n3. UNKNOWN\n4. FALSE [correction]: The gorilla genome comprises approximately 3 billion base pairs, not 3.2 billion.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 2073,
    "user_query": "Are mutations in the C9orf72  gene associated with macular degeneration?",
    "yulan-chat-2-13b-fp16_response": "Yes, mutations in the C9orf72 gene have been associated with macular degeneration, a common cause of vision loss in older adults. The C9orf72 gene is located on the long arm of chromosome 9 (9q22.31) and encodes a protein that is involved in the regulation of gene expression.\nSeveral studies have shown that mutations in the C9orf72 gene are a major genetic cause of age-related macular degeneration (AMD), particularly the dry form of the disease. These mutations are thought to disrupt the normal function of the protein encoded by the C9orf72 gene, leading to the accumulation of toxic substances in cells of the retina, which can cause damage and lead to vision loss.\nIt is estimated that up to 10% of people with AMD carry a mutation in the C9orf72 gene, and these mutations are more common in people of European ancestry. If you are concerned about your risk for macular degeneration or have questions about genetic testing or counseling, you should speak with your doctor or a genetic counselor.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the C9orf72 gene are associated with macular degeneration.\n2. The C9orf72 gene is located on chromosome 9 at position 9q22.31.\n3. Mutations in the C9orf72 gene are a major genetic cause of age-related macular degeneration, particularly the dry form.\n4. Up to 10% of people with age-related macular degeneration carry a mutation in the C9orf72 gene.\n5. These mutations in the C9orf72 gene are more common in people of European ancestry.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the C9orf72 gene are associated with macular degeneration.",
      "The C9orf72 gene is located on chromosome 9 at position 9q22.31.",
      "Mutations in the C9orf72 gene are a major genetic cause of age-related macular degeneration, particularly the dry form.",
      "Up to 10% of people with age-related macular degeneration carry a mutation in the C9orf72 gene.",
      "These mutations in the C9orf72 gene are more common in people of European ancestry."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Mutations in the C9orf72 gene are associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, not macular degeneration.\n2. TRUE\n3. FALSE [correction]: Mutations in the C9orf72 gene are not associated with age-related macular degeneration; they are associated with neurological conditions such as ALS and frontotemporal dementia.\n4. FALSE [correction]: Since mutations in the C9orf72 gene are not linked to age-related macular degeneration, this statement regarding the percentage of people with the condition carrying the mutation is incorrect.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "yulan-chat-2-13b-fp16_response": "The gene that controls the expression of GATA-1 isoforms is called GATA-1. GATA-1 is a transcription factor that regulates the expression of genes involved in the development and maintenance of blood and blood-related cells. It is a key regulator of hematopoiesis, the process by which blood cells are produced. GATA-1 is expressed in many different cell types, including hematopoietic stem cells, progenitor cells, and mature blood cells. It plays a critical role in the development and maintenance of the hematopoietic system, and mutations in the GATA-1 gene can lead to a variety of hematological disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The GATA-1 gene controls the expression of GATA-1 isoforms.\n2. GATA-1 is a transcription factor involved in the development and maintenance of blood and blood-related cells.\n3. GATA-1 regulates hematopoiesis, the process by which blood cells are produced.\n4. GATA-1 is expressed in various cell types including hematopoietic stem cells, progenitor cells, and mature blood cells.\n5. Mutations in the GATA-1 gene can lead to various hematological disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "The GATA-1 gene controls the expression of GATA-1 isoforms.",
      "GATA-1 is a transcription factor involved in the development and maintenance of blood and blood-related cells.",
      "GATA-1 regulates hematopoiesis, the process by which blood cells are produced.",
      "GATA-1 is expressed in various cell types including hematopoietic stem cells, progenitor cells, and mature blood cells.",
      "Mutations in the GATA-1 gene can lead to various hematological disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "yulan-chat-2-13b-fp16_response": "MIRA-seq is a sequencing technology that uses RNA sequencing (RNA-seq) to profile small RNA molecules, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs), in a sample. It is a high-throughput sequencing method that can analyze thousands of small RNA molecules in a single experiment. MIRA-seq can be used to study the expression and function of miRNAs and siRNAs in a variety of biological contexts, including cancer, development, and immune responses.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MIRA-seq is a sequencing technology associated with RNA sequencing.\n2. It is designed to profile small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs).\n3. MIRA-seq is a high-throughput sequencing method.\n4. This technology can analyze thousands of small RNA molecules in a single experiment.\n5. MIRA-seq can be utilized to study the expression and function of miRNAs and siRNAs in contexts such as cancer, development, and immune responses.",
    "yulan-chat-2-13b-fp16_fact": [
      "MIRA-seq is a sequencing technology associated with RNA sequencing.",
      "It is designed to profile small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs).",
      "MIRA-seq is a high-throughput sequencing method.",
      "This technology can analyze thousands of small RNA molecules in a single experiment.",
      "MIRA-seq can be utilized to study the expression and function of miRNAs and siRNAs in contexts such as cancer, development, and immune responses."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: MIRA-seq refers to Methylated CpG Island Recovery Assay sequencing, which is associated with DNA methylation detection, not RNA sequencing.\n2. FALSE [correction]: MIRA-seq is meant to analyze DNA methylation patterns, not profile small RNA molecules.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Given that MIRA-seq is used for analyzing DNA methylation, it would be utilized to study epigenetic regulation and methylation patterns, not specifically the expression and function of miRNAs and siRNAs.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2077,
    "user_query": "How does Ssu72 mediate gene looping?",
    "yulan-chat-2-13b-fp16_response": "Ssu72 is a protein that is involved in the process of gene looping, which is a mechanism by which genetic information is transferred from one location to another within a cell. It is part of a complex called the Ssu72-SNAP complex, which is responsible for the recognition and transfer of RNA molecules between the nucleus and the cytoplasm.\nThe Ssu72 protein interacts with the SNAP (Stable Nucleic Acid-Binding Protein) protein to form the Ssu72-SNAP complex. This complex is localized to the nuclear envelope and is involved in the recognition and binding of RNA molecules. Once an RNA molecule has been bound by the complex, it is then transferred to the cytoplasm, where it can be used for protein synthesis.\nIt is thought that Ssu72 and the Ssu72-SNAP complex play a critical role in the regulation of gene expression by facilitating the transfer of RNA molecules between the nucleus and the cytoplasm. However, the exact mechanisms by which Ssu72 mediates gene looping are not fully understood and are an area of ongoing research.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ssu72 is a protein involved in the process of gene looping.\n2. Gene looping is a mechanism that transfers genetic information within a cell.\n3. The Ssu72 protein forms a complex with the SNAP protein called the Ssu72-SNAP complex.\n4. The Ssu72-SNAP complex is localized to the nuclear envelope.\n5. The Ssu72-SNAP complex is involved in the recognition, binding, and transfer of RNA molecules between the nucleus and the cytoplasm.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ssu72 is a protein involved in the process of gene looping.",
      "Gene looping is a mechanism that transfers genetic information within a cell.",
      "The Ssu72 protein forms a complex with the SNAP protein called the Ssu72-SNAP complex.",
      "The Ssu72-SNAP complex is localized to the nuclear envelope.",
      "The Ssu72-SNAP complex is involved in the recognition, binding, and transfer of RNA molecules between the nucleus and the cytoplasm."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Gene looping is a mechanism that brings the promoter and terminator regions of a gene into proximity, facilitating transcription re-initiation.\n3. FALSE [correction]: Ssu72 does form complexes with other proteins, but it is commonly known for its association with RNA polymerase II and the CPF complex, rather than with a protein called SNAP.\n4. FALSE [correction]: The localization of the Ssu72-SNAP complex to the nuclear envelope cannot be confirmed without more context, and Ssu72 is generally associated with transcription machinery rather than the nuclear envelope.\n5. FALSE [correction]: The Ssu72-SNAP complex is not known for the recognition, binding, and transfer of RNA molecules between the nucleus and the cytoplasm. Ssu72 is involved in transcription and RNA processing, but the described functions are more typically associated with other molecules like exportins or the mRNA export machinery.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2081,
    "user_query": "What is the Glasgow Coma score?",
    "yulan-chat-2-13b-fp16_response": "The Glasgow Coma Scale (GCS) is a score used to assess the level of consciousness in a person. It is a standardized scale that assigns a score from 3 to 15, with 3 being the lowest level of consciousness and 15 being the highest. The GCS is used to monitor changes in a person's level of consciousness over time, and it is often used in the emergency department and intensive care unit to help healthcare providers determine the severity of a person's injury or illness.\nThe GCS is based on three factors: eye opening, verbal response, and motor response. Each factor is assigned a score from 1 to 4, with 1 being the lowest level of response and 4 being the highest. The scores for each factor are then added together to determine the person's total GCS score. A GCS score of 13 or 14 is generally considered to be a good prognostic indicator, while a score of 3 to 8 is indicative of a severe head injury or other serious condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Glasgow Coma Scale (GCS) is used to assess the level of consciousness in a person.\n2. The GCS is a standardized scale that assigns a score from 3 to 15.\n3. A score of 3 is the lowest level of consciousness on the GCS, and 15 is the highest.\n4. The GCS evaluates three factors: eye opening, verbal response, and motor response.\n5. A Glasgow Coma Scale score of 13 or 14 is generally considered a good prognostic indicator.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Glasgow Coma Scale (GCS) is used to assess the level of consciousness in a person.",
      "The GCS is a standardized scale that assigns a score from 3 to 15.",
      "A score of 3 is the lowest level of consciousness on the GCS, and 15 is the highest.",
      "The GCS evaluates three factors: eye opening, verbal response, and motor response.",
      "A Glasgow Coma Scale score of 13 or 14 is generally considered a good prognostic indicator."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2083,
    "user_query": "Which is the main cause of the Patau syndrome?",
    "yulan-chat-2-13b-fp16_response": "Patau syndrome is caused by a chromosomal abnormality known as trisomy 13, which occurs when an individual has three copies of chromosome 13 instead of the usual two. This extra genetic material can cause a range of physical and developmental problems, including intellectual disability, delayed development, and various physical abnormalities.\nTrisomy 13 is typically the result of an error in cell division during the development of the egg or sperm, or during the early stages of embryonic development. In some cases, the condition may also be caused by a random error in cell division that occurs after fertilization, known as mitotic non-disjunction.\nIt is important to note that Patau syndrome is a rare condition, affecting only about 1 in every 2,500 to 3,500 live births. Despite its serious nature, there are supportive treatments and therapies available to help individuals with Patau syndrome and their families manage the condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Patau syndrome is caused by a chromosomal abnormality known as trisomy 13.\n2. An individual with Patau syndrome has three copies of chromosome 13 instead of the usual two.\n3. The occurrence of trisomy 13 can be due to an error in cell division during the development of the egg or sperm, or during early embryonic development.\n4. Patau syndrome can also be caused by a random error after fertilization known as mitotic non-disjunction.\n5. Patau syndrome affects about 1 in every 2,500 to 3,500 live births.",
    "yulan-chat-2-13b-fp16_fact": [
      "Patau syndrome is caused by a chromosomal abnormality known as trisomy 13.",
      "An individual with Patau syndrome has three copies of chromosome 13 instead of the usual two.",
      "The occurrence of trisomy 13 can be due to an error in cell division during the development of the egg or sperm, or during early embryonic development.",
      "Patau syndrome can also be caused by a random error after fertilization known as mitotic non-disjunction.",
      "Patau syndrome affects about 1 in every 2,500 to 3,500 live births."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Patau syndrome can also be caused by a random error after fertilization but this would typically be termed mosaic Patau syndrome, not caused by mitotic non-disjunction but rather as a post-zygotic mutation leading to mosaicism where some cells have the typical number of chromosomes and others have the extra chromosome.\n5. FALSE [correction]: Patau syndrome is rarer and affects approximately 1 in every 16,000 to 25,000 live births.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2085,
    "user_query": "Is Musclin a secretory peptide?",
    "yulan-chat-2-13b-fp16_response": "Musclin is a protein that is expressed in skeletal muscle and has been suggested to play a role in regulating muscle growth and development. It is not a secretory peptide, which is a type of signaling molecule that is secreted by cells and has a specific function in intercellular communication. Secretory peptides are typically synthesized and secreted by specialized cells, such as endocrine cells or neuroendocrine cells, and they can have a variety of different functions, such as regulating hormone levels, immune response, or cell proliferation. Musclin, on the other hand, is synthesized and expressed within skeletal muscle cells and is involved in intracellular signaling pathways that regulate muscle growth and development.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Musclin is expressed in skeletal muscle.\n2. Musclin has been suggested to play a role in regulating muscle growth and development.\n3. Musclin is not a secretory peptide.\n4. Secretory peptides are typically synthesized and secreted by specialized cells such as endocrine cells or neuroendocrine cells.\n5. Musclin is involved in intracellular signaling pathways within skeletal muscle cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Musclin is expressed in skeletal muscle.",
      "Musclin has been suggested to play a role in regulating muscle growth and development.",
      "Musclin is not a secretory peptide.",
      "Secretory peptides are typically synthesized and secreted by specialized cells such as endocrine cells or neuroendocrine cells.",
      "Musclin is involved in intracellular signaling pathways within skeletal muscle cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Musclin is a secretory peptide.\n4. TRUE\n5. FALSE [correction]: Musclin acts as a hormone and does not have intracellular signaling roles within skeletal muscle cells; instead, it is secreted and involved in signaling pathways that affect muscle tissues and other body systems.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2091,
    "user_query": "What happens to H2AX upon DNA bouble strand breaks?",
    "yulan-chat-2-13b-fp16_response": "H2AX is a protein that plays a key role in the DNA damage response to double-strand breaks (DSBs) in chromatin. When a DSB occurs, H2AX is rapidly recruited to the site of the break, where it forms a foci that marks the location of the damage. This foci is known as a histone H2AX-containing foci or H2AX foci.\nThe recruitment of H2AX to the site of the DSB is important because it serves as a signal for the recruitment of other proteins that are involved in the DNA damage response, such as the repair machinery. The H2AX foci also serves as a platform for the assembly of other proteins that are involved in the regulation of the DNA damage response, such as the chromatin-associated protein NCOA4.\nIn addition to its role in the DNA damage response, H2AX also plays a role in the regulation of gene expression. It can be phosphorylated at serine 139 by protein kinase C (PKC) in response to DNA damage, which promotes the recruitment of the histone methyltransferase EZH2 to the site of the damage, leading to the activation of genes involved in the DNA damage response.\nOverall, H2AX plays a critical role in the DNA damage response to double-strand breaks, and its recruitment to the site of the damage serves as a key signal for the activation of the DNA damage response pathway.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. H2AX is rapidly recruited to the site of DNA double-strand breaks where it forms a foci.\n2. The formation of H2AX foci at the site of DNA damage marks the location of the double-strand breaks.\n3. H2AX recruitment serves as a signal for the recruitment of other proteins involved in the DNA damage response.\n4. H2AX can be phosphorylated at serine 139 by protein kinase C (PKC) in response to DNA damage.\n5. Phosphorylation of H2AX promotes the recruitment of the histone methyltransferase EZH2 to the site of the damage.",
    "yulan-chat-2-13b-fp16_fact": [
      "H2AX is rapidly recruited to the site of DNA double-strand breaks where it forms a foci.",
      "The formation of H2AX foci at the site of DNA damage marks the location of the double-strand breaks.",
      "H2AX recruitment serves as a signal for the recruitment of other proteins involved in the DNA damage response.",
      "H2AX can be phosphorylated at serine 139 by protein kinase C (PKC) in response to DNA damage.",
      "Phosphorylation of H2AX promotes the recruitment of the histone methyltransferase EZH2 to the site of the damage."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: H2AX can be phosphorylated at serine 139, known as H2AX, in response to DNA damage, but the phosphorylation is primarily mediated by PI3K-related kinases such as ATM, ATR, and DNA-PK, not protein kinase C (PKC).\n5. FALSE [correction]: Phosphorylation of H2AX promotes the recruitment of repair proteins such as MDC1, 53BP1, and the MRN complex, rather than the histone methyltransferase EZH2, to the site of the damage. EZH2 is more closely associated with the formation of repressive chromatin marks, and its role in DNA damage repair is not as directly linked to H2AX phosphorylation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2095,
    "user_query": "What is the inheritance of Barth syndrome?",
    "yulan-chat-2-13b-fp16_response": "Barth syndrome is a rare genetic disorder that is caused by a mutation in the TAF1 gene. This gene is located on the long (q) arm of the chromosome at position 22.131, also known as chromosome 22.131. The mutation in the TAF1 gene leads to a deficiency of the TAF1 protein, which is a component of the TFIID complex, a protein complex that plays a role in the regulation of gene expression.\nBarth syndrome is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. Most cases of Barth syndrome occur due to new mutations in the TAF1 gene, which means that the mutations are not inherited from the parents. However, some cases may be inherited from a parent who has the mutated gene.\nIt is important to note that the inheritance pattern of Barth syndrome can vary, and it is possible for the disorder to be inherited in other ways. If you have questions about the inheritance of Barth syndrome or your own risk of developing the disorder, it is best to speak with a genetic counselor or a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Barth syndrome is a rare genetic disorder caused by a mutation in the TAF1 gene.\n2. The TAF1 gene is located on the long (q) arm of chromosome 22 at position 22.131.\n3. The mutation in the TAF1 gene leads to a deficiency of the TAF1 protein.\n4. Barth syndrome is inherited in an autosomal recessive pattern.\n5. Most cases of Barth syndrome occur due to new mutations in the TAF1 gene and are not inherited from the parents.",
    "yulan-chat-2-13b-fp16_fact": [
      "Barth syndrome is a rare genetic disorder caused by a mutation in the TAF1 gene.",
      "The TAF1 gene is located on the long (q) arm of chromosome 22 at position 22.131.",
      "The mutation in the TAF1 gene leads to a deficiency of the TAF1 protein.",
      "Barth syndrome is inherited in an autosomal recessive pattern.",
      "Most cases of Barth syndrome occur due to new mutations in the TAF1 gene and are not inherited from the parents."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Barth syndrome is a rare genetic disorder caused by a mutation in the TAZ gene (also known as G4.5).\n2. FALSE [correction]: The TAZ gene is located on the long (q) arm of the X chromosome at position 28.\n3. FALSE [correction]: The mutation in the TAZ gene leads to a deficiency or malfunction of the tafazzin protein, not the TAF1 protein.\n4. TRUE\n5. FALSE [correction]: Most cases of Barth syndrome are inherited from the mother, as it is an X-linked condition. It is less common for cases to occur due to new mutations; instead, male offspring inherit the mutated gene from their carrier mothers.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2096,
    "user_query": "Is Cryptococcus neoformans a frequent cause of isolated skin infections in immunocompromised individuals",
    "yulan-chat-2-13b-fp16_response": "Cryptococcus neoformans is a fungal pathogen that can cause infections in immunocompromised individuals. It can cause a variety of infections, including meningitis, pulmonary infections, and disseminated infections. However, it is not a frequent cause of isolated skin infections in immunocompromised individuals.\nSkin infections can be caused by a variety of microorganisms, including bacteria, viruses, and fungi. In immunocompromised individuals, the risk of developing skin infections is increased due to a weakened immune system. However, Cryptococcus neoformans is not typically considered a common cause of skin infections in this population.\nOther fungal pathogens, such as Candida spp. and Aspergillus spp., are more commonly associated with skin infections in immunocompromised individuals. It is important to note that the specific causative agent of a skin infection may vary depending on the individual's underlying health conditions and other risk factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cryptococcus neoformans can cause infections in immunocompromised individuals.\n2. Cryptococcus neoformans can lead to various infections including meningitis, pulmonary infections, and disseminated infections.\n3. Cryptococcus neoformans is not a frequent cause of isolated skin infections in immunocompromised individuals.\n4. Candida spp. and Aspergillus spp. are more commonly associated with skin infections in immunocompromised individuals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cryptococcus neoformans can cause infections in immunocompromised individuals.",
      "Cryptococcus neoformans can lead to various infections including meningitis, pulmonary infections, and disseminated infections.",
      "Cryptococcus neoformans is not a frequent cause of isolated skin infections in immunocompromised individuals.",
      "Candida spp. and Aspergillus spp. are more commonly associated with skin infections in immunocompromised individuals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2098,
    "user_query": "What are sirtuins?",
    "yulan-chat-2-13b-fp16_response": "Sirtuins are a family of proteins that are found in many organisms, including bacteria, yeast, plants, and animals. They are characterized by a conserved catalytic core domain that is involved in the transfer of nucleotides, such as NAD+, between proteins. Sirtuins are best known for their role in the regulation of cellular metabolism and the response to stress. They are also involved in a variety of other cellular processes, including DNA repair, cell cycle progression, and apoptosis. Sirtuins are named after the sirtuin protein, which was first identified in yeast and is homologous to the human protein SIR2.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Sirtuins are a family of proteins found in organisms like bacteria, yeast, plants, and animals.\n2. These proteins have a conserved catalytic core domain involved in the transfer of nucleotides such as NAD+.\n3. Sirtuins play a role in the regulation of cellular metabolism and the response to stress.\n4. Sirtuins are involved in various cellular processes, including DNA repair, cell cycle progression, and apoptosis.\n5. The sirtuin protein, which the family is named after, was first identified in yeast and is homologous to the human SIR2 protein.",
    "yulan-chat-2-13b-fp16_fact": [
      "Sirtuins are a family of proteins found in organisms like bacteria, yeast, plants, and animals.",
      "These proteins have a conserved catalytic core domain involved in the transfer of nucleotides such as NAD+.",
      "Sirtuins play a role in the regulation of cellular metabolism and the response to stress.",
      "Sirtuins are involved in various cellular processes, including DNA repair, cell cycle progression, and apoptosis.",
      "The sirtuin protein, which the family is named after, was first identified in yeast and is homologous to the human SIR2 protein."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE - However, to clarify, sirtuins typically use NAD+ to remove acetyl groups from proteins, in a process known as deacetylation.\n3. TRUE\n4. TRUE\n5. TRUE - The sirtuin family is indeed named after the silent information regulator 2 (SIR2) protein in yeast, which is homologous to the human sirtuin proteins.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2100,
    "user_query": "Which technique led to the elucidation of the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C?",
    "yulan-chat-2-13b-fp16_response": "The technique that led to the elucidation of the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C is likely to be molecular biology techniques such as gene knockdown or overexpression, followed by functional assays to measure the effects on lymphatic endothelial cell behavior. These techniques allow researchers to manipulate the expression of specific genes, such as HOXD10, and observe the resulting changes in cell behavior and signaling pathways. In this case, it is likely that the researchers used gene knockdown or overexpression to demonstrate that HOXD10 is necessary for lymphatic endothelial cells to respond to VEGF-C, a key signaling molecule involved in lymphatic vessel formation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Molecular biology techniques like gene knockdown or overexpression were used to elucidate the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C.\n2. Functional assays were conducted to measure effects on lymphatic endothelial cell behavior.\n3. Manipulation of the expression of specific genes, like HOXD10, allowed researchers to observe changes in cell behavior and signaling pathways.\n4. Researchers likely demonstrated that HOXD10 is necessary for lymphatic endothelial cells to respond to VEGF-C.\n5. VEGF-C is involved in lymphatic vessel formation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Molecular biology techniques like gene knockdown or overexpression were used to elucidate the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C.",
      "Functional assays were conducted to measure effects on lymphatic endothelial cell behavior.",
      "Manipulation of the expression of specific genes, like HOXD10, allowed researchers to observe changes in cell behavior and signaling pathways.",
      "Researchers likely demonstrated that HOXD10 is necessary for lymphatic endothelial cells to respond to VEGF-C.",
      "VEGF-C is involved in lymphatic vessel formation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2101,
    "user_query": "Is Obeticholic Acid used for treatment of Primary Biliary Cholangitis?",
    "yulan-chat-2-13b-fp16_response": "Obeticholic acid is a medication that is being studied for the treatment of primary biliary cholangitis (PBC). PBC is a chronic liver disease that affects the bile ducts in the liver. Obeticholic acid works by blocking a protein called farnesoid X receptor (FXR), which is involved in the regulation of bile acid synthesis and transport.\nStudies have shown that obeticholic acid can reduce inflammation and improve liver function in patients with PBC. However, more research is needed to fully understand the safety and effectiveness of this medication for the treatment of PBC.\nObeticholic acid is currently being studied in clinical trials, and it is not yet approved by the FDA for the treatment of PBC. It is important to discuss any treatment options with a healthcare professional, as they can provide the most up-to-date information and advice.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Obeticholic acid is being studied for the treatment of primary biliary cholangitis (PBC).\n2. Primary biliary cholangitis is a chronic liver disease that affects bile ducts in the liver.\n3. Obeticholic acid blocks a protein called farnesoid X receptor (FXR).\n4. Studies have indicated that obeticholic acid can reduce inflammation and improve liver function in patients with PBC.\n5. Obeticholic acid has not yet been approved by the FDA for the treatment of PBC.",
    "yulan-chat-2-13b-fp16_fact": [
      "Obeticholic acid is being studied for the treatment of primary biliary cholangitis (PBC).",
      "Primary biliary cholangitis is a chronic liver disease that affects bile ducts in the liver.",
      "Obeticholic acid blocks a protein called farnesoid X receptor (FXR).",
      "Studies have indicated that obeticholic acid can reduce inflammation and improve liver function in patients with PBC.",
      "Obeticholic acid has not yet been approved by the FDA for the treatment of PBC."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Obeticholic acid is an agonist of the farnesoid X receptor (FXR), meaning it activates, rather than blocks, this receptor.\n4. TRUE\n5. FALSE [correction]: Obeticholic acid has been approved by the FDA for the treatment of PBC, specifically for use in adults with an inadequate response to ursodeoxycholic acid (UDCA), or as monotherapy in adults unable to tolerate UDCA.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2102,
    "user_query": "What alternate indication has Vanoxerine been repositioned for?",
    "yulan-chat-2-13b-fp16_response": "Vanoxerine is a drug that was originally developed as a potential treatment for Alzheimer's disease, but it was later repositioned for a different indication. Vanoxerine is now being investigated as a potential treatment for cognitive impairment in patients with schizophrenia. It works by blocking the activity of certain neurotransmitters in the brain, which is thought to improve cognitive function in these patients. However, it is important to note that clinical trials are ongoing and the safety and efficacy of vanoxerine for this indication have not yet been fully established.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vanoxerine was originally developed as a potential treatment for Alzheimer's disease.\n2. Vanoxerine has been repositioned to potentially treat cognitive impairment in patients with schizophrenia.\n3. Vanoxerine works by blocking the activity of certain neurotransmitters in the brain.\n4. Clinical trials for vanoxerine as a treatment for cognitive impairment in schizophrenia are ongoing.\n5. The safety and efficacy of vanoxerine for the treatment of cognitive impairment in schizophrenia have not yet been fully established.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vanoxerine was originally developed as a potential treatment for Alzheimer's disease.",
      "Vanoxerine has been repositioned to potentially treat cognitive impairment in patients with schizophrenia.",
      "Vanoxerine works by blocking the activity of certain neurotransmitters in the brain.",
      "Clinical trials for vanoxerine as a treatment for cognitive impairment in schizophrenia are ongoing.",
      "The safety and efficacy of vanoxerine for the treatment of cognitive impairment in schizophrenia have not yet been fully established."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Vanoxerine was originally developed as a potential treatment for cocaine addiction.\n2. FALSE [correction]: While vanoxerine has been investigated for various conditions, there's no widely recognized evidence it has been repositioned specifically for treating cognitive impairment in patients with schizophrenia.\n3. TRUE\n4. UNKNOWN: Without current information on the clinical trials status, we cannot verify if they are still ongoing.\n5. TRUE: Given that vanoxerine is not an established treatment for cognitive impairment in schizophrenia, its safety and efficacy for this purpose have not yet been fully established.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2105,
    "user_query": "Does the word ovine refers to goats?",
    "yulan-chat-2-13b-fp16_response": "Yes, the word \"ovine\" refers to goats or other female sheep.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "yulan-chat-2-13b-fp16_response": "ARCALYST is a prescription medication that is used to treat a rare autoimmune disorder called paroxysmal nocturnal hemoglobinuria (PNH). PNH is a condition in which the body's immune system attacks its own red blood cells, leading to anemia and other symptoms. ARCALYST is a monoclonal antibody that works by blocking a protein on the surface of the immune cells that are responsible for the attack on the red blood cells. This helps to reduce the number of red blood cells that are destroyed and can help to improve symptoms and quality of life for people with PNH.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ARCALYST is a prescription medication used to treat paroxysmal nocturnal hemoglobinuria (PNH).\n2. Paroxysmal nocturnal hemoglobinuria is a condition where the body's immune system attacks its own red blood cells.\n3. ARCALYST works by blocking a protein on the surface of immune cells responsible for the attack on red blood cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "ARCALYST is a prescription medication used to treat paroxysmal nocturnal hemoglobinuria (PNH).",
      "Paroxysmal nocturnal hemoglobinuria is a condition where the body's immune system attacks its own red blood cells.",
      "ARCALYST works by blocking a protein on the surface of immune cells responsible for the attack on red blood cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: ARCALYST (rilonacept) is not used to treat paroxysmal nocturnal hemoglobinuria (PNH). It is approved for the treatment of cryopyrin-associated periodic syndromes (CAPS) and other inflammatory conditions.\n2. TRUE\n3. FALSE [correction]: ARCALYST works by blocking interleukin-1 (IL-1), a cytokine that plays a role in the inflammatory response, not by blocking a protein on the surface of immune cells responsible for the attack on red blood cells.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2114,
    "user_query": "Where is the TAZ (G4.5) is located in humans?",
    "yulan-chat-2-13b-fp16_response": "The TAZ (tibialis anterior zone) is a specific location on the G4.5 (genomic region 4.5) of the human genome. The TAZ region is located on chromosome 2 and contains a gene called \"TIBIA\", which encodes for the protein called Tibialis Anterior. This gene is responsible for the development and maintenance of the tibialis anterior muscle, which is a muscle in the lower leg that helps to control movement and support the body. The TAZ region is also known to be associated with muscle development and function, and has been studied for its potential role in muscle-related diseases and disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The TAZ (tibialis anterior zone) is located on the G4.5 (genomic region 4.5) of the human genome.\n2. The TAZ region is found on chromosome 2.\n3. The TAZ region contains a gene called \"TIBIA\".\n4. The TIBIA gene encodes for the protein called Tibialis Anterior.\n5. The Tibialis Anterior muscle is involved in controlling movement and supporting the body in the lower leg.",
    "yulan-chat-2-13b-fp16_fact": [
      "The TAZ (tibialis anterior zone) is located on the G4.5 (genomic region 4.5) of the human genome.",
      "The TAZ region is found on chromosome 2.",
      "The TAZ region contains a gene called \"TIBIA\".",
      "The TIBIA gene encodes for the protein called Tibialis Anterior.",
      "The Tibialis Anterior muscle is involved in controlling movement and supporting the body in the lower leg."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The TAZ (tibialis anterior zone) is not a recognized genomic region in standard genetics terminologies. G4.5 does not correspond to a recognized location format on the human genome.\n2. UNKNOWN: Since the TAZ (tibialis anterior zone) is not a recognized genomic region, it cannot be accurately stated that it is found on chromosome 2. \n3. FALSE [correction]: There is no gene known as \"TIBIA\" linked with the tibialis anterior muscle in the human genome.\n4. FALSE [correction]: No gene by the name \"TIBIA\" exists that encodes for the Tibialis Anterior protein; the actual gene responsible for encoding the protein that affects the tibialis anterior muscle function is not known as TIBIA.\n5. TRUE: The Tibialis Anterior muscle is indeed involved in controlling movement, specifically dorsiflexion of the foot, and supports the body in the lower leg.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2115,
    "user_query": "What do nerve-associated peripheral glial progenitors give rise to?",
    "yulan-chat-2-13b-fp16_response": "Nerve-associated peripheral glial progenitors (NPCs) give rise to oligodendrocytes, which are glial cells that form the myelin sheath around peripheral nerve fibers. Oligodendrocytes are responsible for the formation and maintenance of the myelin sheath, which is essential for the proper functioning of the nervous system.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nerve-associated peripheral glial progenitors give rise to oligodendrocytes.\n2. Oligodendrocytes form the myelin sheath around peripheral nerve fibers.\n3. Oligodendrocytes are responsible for the formation and maintenance of the myelin sheath.\n4. The myelin sheath is essential for the proper functioning of the nervous system.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nerve-associated peripheral glial progenitors give rise to oligodendrocytes.",
      "Oligodendrocytes form the myelin sheath around peripheral nerve fibers.",
      "Oligodendrocytes are responsible for the formation and maintenance of the myelin sheath.",
      "The myelin sheath is essential for the proper functioning of the nervous system."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Schwann cells, not oligodendrocytes, are the nerve-associated peripheral glial progenitors that give rise to the myelin sheath around peripheral nerve fibers.\n2. FALSE [correction]: Schwann cells form the myelin sheath around peripheral nerve fibers, whereas oligodendrocytes form the myelin sheath around nerve fibers in the central nervous system.\n3. TRUE (with clarification): Oligodendrocytes are responsible for the formation and maintenance of the myelin sheath, but this statement is true specifically in the context of the central nervous system, not the peripheral nervous system.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2117,
    "user_query": "Is Lennox-Gastaut Syndrome usually diagnosed in older adults?",
    "yulan-chat-2-13b-fp16_response": "Lennox-Gastaut Syndrome (LGS) can be diagnosed in people of all ages, including older adults. However, it is more commonly diagnosed in childhood, with the peak age of onset being between 3 and 5 years old. LGS is a rare and complex neurological disorder that affects the brain and causes various symptoms such as recurrent seizures, intellectual disability, and delayed development. While it can occur at any age, it is more common in children and adolescents.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lennox-Gastaut Syndrome (LGS) can be diagnosed in people of all ages.\n2. LGS is more commonly diagnosed in childhood.\n3. The peak age of onset for LGS is between 3 and 5 years old.\n4. LGS is a rare and complex neurological disorder.\n5. LGS can cause recurrent seizures, intellectual disability, and delayed development.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lennox-Gastaut Syndrome (LGS) can be diagnosed in people of all ages.",
      "LGS is more commonly diagnosed in childhood.",
      "The peak age of onset for LGS is between 3 and 5 years old.",
      "LGS is a rare and complex neurological disorder.",
      "LGS can cause recurrent seizures, intellectual disability, and delayed development."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Lennox-Gastaut Syndrome (LGS) is typically diagnosed in childhood, not in people of all ages.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2119,
    "user_query": "Describe ATR-16 syndrome.",
    "yulan-chat-2-13b-fp16_response": "ATR-16 syndrome is a rare genetic disorder that is caused by a mutation in the ATR gene. This gene is involved in the repair of damaged DNA, and mutations in the ATR gene can lead to a range of symptoms, including:\n* Developmental delay and intellectual disability\n* Short stature and short-limbed dwarfism\n* Abnormalities of the hands and feet, such as short fingers and toes\n* Congenital heart defects\n* Abnormalities of the eyes, such as cataracts and glaucoma\n* Immune system deficiencies\n* Increased risk of cancer\nATR-16 syndrome is usually diagnosed in childhood, and there is no known cure. Treatment is focused on managing the symptoms and improving quality of life.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ATR-16 syndrome is a rare genetic disorder caused by a mutation in the ATR gene.\n2. The ATR gene is involved in the repair of damaged DNA.\n3. Symptoms of ATR-16 syndrome can include developmental delay and intellectual disability.\n4. Short stature and short-limbed dwarfism are among the possible physical characteristics of ATR-16 syndrome.\n5. ATR-16 syndrome is generally diagnosed in childhood and there is no known cure for it.",
    "yulan-chat-2-13b-fp16_fact": [
      "ATR-16 syndrome is a rare genetic disorder caused by a mutation in the ATR gene.",
      "The ATR gene is involved in the repair of damaged DNA.",
      "Symptoms of ATR-16 syndrome can include developmental delay and intellectual disability.",
      "Short stature and short-limbed dwarfism are among the possible physical characteristics of ATR-16 syndrome.",
      "ATR-16 syndrome is generally diagnosed in childhood and there is no known cure for it."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: ATR-16 syndrome is associated with alpha-thalassemia and developmental anomalies, but not typically characterized by short stature and short-limbed dwarfism. These are more commonly associated with conditions such as achondroplasia.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2120,
    "user_query": "What is the results of inactivated ANGPLT3?",
    "yulan-chat-2-13b-fp16_response": "ANGPTL3 (Angiopoietin-like protein 3) is a protein that plays a role in regulating lipid metabolism and inflammation. Inactivated ANGPTL3 may have various effects on the body, depending on the specific context and mechanism of inactivation.\nIn general, inactivating ANGPTL3 may lead to increased levels of high-density lipoprotein (HDL) cholesterol, which is often referred to as the \"good\" cholesterol. This is because HDL cholesterol helps to remove excess cholesterol from the blood and transport it back to the liver for processing. Higher levels of HDL cholesterol have been associated with a lower risk of cardiovascular disease.\nInactivating ANGPTL3 may also have anti-inflammatory effects, as ANGPTL3 has been implicated in the regulation of inflammatory responses. By inhibiting ANGPTL3 activity, it may be possible to reduce inflammation and improve outcomes in conditions such as atherosclerosis and metabolic disorders.\nHowever, it is important to note that the effects of inactivating ANGPTL3 may depend on the specific context and mechanism of inactivation. For example, some studies have suggested that inhibiting ANGPTL3 may have unintended consequences, such as increasing the risk of insulin resistance or impairing liver function. Therefore, further research is needed to fully understand the potential benefits and risks of inactivating ANGPTL3.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ANGPTL3 is a protein involved in regulating lipid metabolism and inflammation.\n2. Inactivating ANGPTL3 may lead to increased levels of high-density lipoprotein (HDL) cholesterol.\n3. Higher levels of HDL cholesterol are associated with a lower risk of cardiovascular disease.\n4. ANGPTL3 has been implicated in the regulation of inflammatory responses.\n5. Inactivating ANGPTL3 may have anti-inflammatory effects and improve outcomes in conditions such as atherosclerosis and metabolic disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "ANGPTL3 is a protein involved in regulating lipid metabolism and inflammation.",
      "Inactivating ANGPTL3 may lead to increased levels of high-density lipoprotein (HDL) cholesterol.",
      "Higher levels of HDL cholesterol are associated with a lower risk of cardiovascular disease.",
      "ANGPTL3 has been implicated in the regulation of inflammatory responses.",
      "Inactivating ANGPTL3 may have anti-inflammatory effects and improve outcomes in conditions such as atherosclerosis and metabolic disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Inactivating ANGPTL3 may lead to decreased levels of high-density lipoprotein (HDL) cholesterol.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2127,
    "user_query": "Which deep learning-based algorithms are used for enhancer prediction?",
    "yulan-chat-2-13b-fp16_response": "There are several deep learning-based algorithms that have been used for enhancer prediction, including:\n1. Convolutional Neural Networks (CNNs): These are commonly used for enhancer prediction and have been shown to achieve high accuracy.\n2. Recurrent Neural Networks (RNNs): These can be used to model the sequence dependencies in enhancers and have been shown to be effective in enhancer prediction.\n3. Long Short-Term Memory (LSTM) networks: These are a type of RNN that are particularly well-suited for modeling long-term dependencies and have been used for enhancer prediction.\n4. Transformers: These are a type of neural network that are particularly well-suited for modeling the relationships between different parts of a sequence and have been used for enhancer prediction.\n5. Graph Neural Networks (GNNs): These are a type of neural network that can be used to model the relationships between different regions in a genome and have been used for enhancer prediction.\nOverall, the choice of algorithm will depend on the specific characteristics of the data and the research question being addressed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Convolutional Neural Networks (CNNs) are used for enhancer prediction.\n2. Recurrent Neural Networks (RNNs) are used to model the sequence dependencies in enhancers.\n3. Long Short-Term Memory (LSTM) networks are a type of RNN used for enhancer prediction.\n4. Transformers are used for enhancer prediction to model the relationships between different parts of a sequence.\n5. Graph Neural Networks (GNNs) are used to model relationships between different regions in a genome for enhancer prediction.",
    "yulan-chat-2-13b-fp16_fact": [
      "Convolutional Neural Networks (CNNs) are used for enhancer prediction.",
      "Recurrent Neural Networks (RNNs) are used to model the sequence dependencies in enhancers.",
      "Long Short-Term Memory (LSTM) networks are a type of RNN used for enhancer prediction.",
      "Transformers are used for enhancer prediction to model the relationships between different parts of a sequence.",
      "Graph Neural Networks (GNNs) are used to model relationships between different regions in a genome for enhancer prediction."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Convolutional Neural Networks (CNNs) are indeed used for enhancer prediction in the field of bioinformatics, as they are well-suited to process and analyze image data, which can include representations of genetic sequences.\n\n2. TRUE: Recurrent Neural Networks (RNNs) are used to model sequential data, which includes understanding sequence dependencies in genetic sequences such as enhancers.\n\n3. TRUE: Long Short-Term Memory (LSTM) networks are a special kind of RNN that are capable of learning long-term dependencies, and they are used for various sequence prediction tasks, including enhancer prediction.\n\n4. TRUE: Transformers, which are models that use self-attention mechanisms, have been successfully applied to a variety of sequence modeling tasks and are increasingly being used for biological sequence analysis, including enhancer prediction.\n\n5. TRUE: Graph Neural Networks (GNNs) are used to model relationships between data points that are structured as graphs, and they can be used to model the relationships between different regions in a genome for tasks like enhancer prediction.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2128,
    "user_query": "Is Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin?",
    "yulan-chat-2-13b-fp16_response": "Yes, that is correct. Beta-thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin. Beta-thalassemia is a genetic disorder that affects the production of hemoglobin, a protein in red blood cells that carries oxygen from the lungs to the body's tissues. In beta-thalassemia, there is a deficiency of beta-globin, a component of hemoglobin, which leads to anemia and other health problems. The mutation or deletion of the gene that codes for alpha globin, a related protein, results in the production of abnormal hemoglobin molecules that are unable to function properly.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Beta-thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin.\n2. Beta-thalassemia is a genetic disorder that affects the production of hemoglobin.\n3. In beta-thalassemia, there is a deficiency of beta-globin.\n4. Beta-thalassemia leads to anemia and other health problems.\n5. The mutation or deletion of the gene that codes for alpha globin results in the production of abnormal hemoglobin molecules.",
    "yulan-chat-2-13b-fp16_fact": [
      "Beta-thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin.",
      "Beta-thalassemia is a genetic disorder that affects the production of hemoglobin.",
      "In beta-thalassemia, there is a deficiency of beta-globin.",
      "Beta-thalassemia leads to anemia and other health problems.",
      "The mutation or deletion of the gene that codes for alpha globin results in the production of abnormal hemoglobin molecules."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Beta-thalassemia is associated with a mutation or deletion of the gene that codes for beta globin, not alpha globin.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The mutation or deletion of the gene that codes for beta globin results in the production of abnormal hemoglobin molecules or a reduced amount of beta-globin. A mutation in the alpha globin gene would be related to alpha-thalassemia.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2132,
    "user_query": "What is the mechanism of action of Romosozumab?",
    "yulan-chat-2-13b-fp16_response": "Romosozumab is a monoclonal antibody that binds to and neutralizes the activity of alkaline phosphatase, an enzyme that is involved in bone resorption. By inhibiting the activity of this enzyme, romosozumab reduces bone turnover and promotes bone formation, leading to an increase in bone density and a reduction in the risk of fractures.\nThe mechanism of action of romosozumab is thought to involve several different processes. First, by inhibiting bone resorption, romosozumab reduces the amount of bone fragments that are released into the bloodstream, which can otherwise contribute to the formation of calcified soft tissue (CSF) in other organs such as the kidneys. This may help to prevent the development of kidney stones and other complications associated with high levels of CSF.\nSecond, romosozumab may help to promote bone formation by stimulating the activity of osteoblasts, which are cells that are responsible for building new bone tissue. This may be due to the fact that romosozumab increases the levels of certain growth factors, such as bone morphogenetic protein-7 (BMP-7), which are known to stimulate osteoblast activity.\nOverall, the mechanism of action of romosozumab is thought to involve the inhibition of bone resorption and the promotion of bone formation, leading to an overall increase in bone density and a reduction in the risk of fractures.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Romosozumab is a monoclonal antibody that binds to and neutralizes the activity of alkaline phosphatase.\n2. Alkaline phosphatase is an enzyme involved in bone resorption.\n3. Inhibition of alkaline phosphatase by romosozumab reduces bone turnover.\n4. Romosozumab promotes bone formation, leading to an increase in bone density.\n5. The mechanism of action for romosozumab includes stimulation of osteoblast activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Romosozumab is a monoclonal antibody that binds to and neutralizes the activity of alkaline phosphatase.",
      "Alkaline phosphatase is an enzyme involved in bone resorption.",
      "Inhibition of alkaline phosphatase by romosozumab reduces bone turnover.",
      "Romosozumab promotes bone formation, leading to an increase in bone density.",
      "The mechanism of action for romosozumab includes stimulation of osteoblast activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Romosozumab is a monoclonal antibody that binds to and inhibits the activity of sclerostin, not alkaline phosphatase.\n2. FALSE [correction]: Alkaline phosphatase is an enzyme that is involved in bone mineralization, not bone resorption.\n3. FALSE [correction]: Inhibition of alkaline phosphatase would actually be detrimental to bone mineralization. Romosozumab inhibits sclerostin, which results in increased bone formation and reduced bone resorption, thereby increasing bone turnover.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2134,
    "user_query": "What is the function of the Mis18 protein?",
    "yulan-chat-2-13b-fp16_response": "The function of the Mis18 protein is not well understood. It is a protein that is found in yeast and is thought to be involved in the regulation of cell division. It may play a role in the formation of the spindle pole bodies, which are structures that are important for the proper segregation of chromosomes during cell division. However, more research is needed to fully understand the function of this protein.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Mis18 protein is found in yeast.\n2. It is thought to be involved in the regulation of cell division.\n3. The Mis18 protein may play a role in the formation of spindle pole bodies.\n4. Spindle pole bodies are important for the proper segregation of chromosomes during cell division.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Mis18 protein is found in yeast.",
      "It is thought to be involved in the regulation of cell division.",
      "The Mis18 protein may play a role in the formation of spindle pole bodies.",
      "Spindle pole bodies are important for the proper segregation of chromosomes during cell division."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2135,
    "user_query": "Are hepadnaviral minichromosomes free of nucleosomes?",
    "yulan-chat-2-13b-fp16_response": "Hepadnaviruses are small, icosahedral viruses that infect humans and other mammals. They are known to have a unique genome structure, which consists of a small circular DNA molecule that is not associated with nucleosomes.\nThe genome of hepadnaviruses is composed of a single open reading frame that encodes for both the capsid and the nucleocapsid proteins. The DNA is wrapped around a central protein core, which is composed of 180 copies of the nucleocapsid protein. The nucleocapsid protein forms a cage-like structure that surrounds the DNA, protecting it from degradation and providing a platform for replication.\nWhile the DNA of hepadnaviruses is not associated with nucleosomes, it is still subject to regulation by various factors, including transcription, replication, and repair mechanisms. These processes are essential for the maintenance and propagation of the viral genome, and they are tightly regulated by the host cell and the viral proteins.\nIn summary, hepadnaviral minichromosomes are free of nucleosomes, and their unique genome structure is optimized for efficient replication and propagation within the host cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hepadnaviruses infect humans and other mammals.\n2. Hepadnaviruses have a unique genome structure that consists of a small circular DNA molecule.\n3. The genome of hepadnaviruses is not associated with nucleosomes.\n4. The DNA of hepadnaviruses is wrapped around a central protein core composed of 180 copies of the nucleocapsid protein.\n5. The nucleocapsid protein forms a cage-like structure that surrounds the DNA of hepadnaviruses.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hepadnaviruses infect humans and other mammals.",
      "Hepadnaviruses have a unique genome structure that consists of a small circular DNA molecule.",
      "The genome of hepadnaviruses is not associated with nucleosomes.",
      "The DNA of hepadnaviruses is wrapped around a central protein core composed of 180 copies of the nucleocapsid protein.",
      "The nucleocapsid protein forms a cage-like structure that surrounds the DNA of hepadnaviruses."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: The DNA of hepadnaviruses is wrapped around a central protein core, but not necessarily composed of 180 copies of the nucleocapsid protein. The exact number can vary, and the core is formed by multiple copies of the core protein, which self-assembles into a capsid enclosing the viral DNA.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 2136,
    "user_query": "Is Cri Du Chat associated with an expansion of a repeat with in the gene found on chromosome 5?",
    "yulan-chat-2-13b-fp16_response": "Yes, Cri du Chat Syndrome is associated with an expansion of a repeat in the gene found on chromosome 5. The syndrome is caused by a deletion of a portion of chromosome 5 that includes the SH2D1A gene. This deletion results in a duplication of a portion of the gene that contains a repeated sequence, which is thought to disrupt the function of the SH2D1A gene and lead to the characteristic features of Cri du Chat Syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cri du Chat Syndrome is associated with an expansion of a repeat in a gene on chromosome 5.\n2. The syndrome is caused by a deletion of a portion of chromosome 5.\n3. The deletion that causes Cri du Chat Syndrome includes the SH2D1A gene.\n4. This deletion leads to a duplication of a portion of the gene.\n5. The duplication containing a repeated sequence is thought to disrupt the function of the SH2D1A gene, which contributes to the features of Cri du Chat Syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cri du Chat Syndrome is associated with an expansion of a repeat in a gene on chromosome 5.",
      "The syndrome is caused by a deletion of a portion of chromosome 5.",
      "The deletion that causes Cri du Chat Syndrome includes the SH2D1A gene.",
      "This deletion leads to a duplication of a portion of the gene.",
      "The duplication containing a repeated sequence is thought to disrupt the function of the SH2D1A gene, which contributes to the features of Cri du Chat Syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Cri du Chat Syndrome is not associated with an expansion of a repeat in a gene on chromosome 5, but rather with a deletion on the short (p) arm of chromosome 5.\n2. TRUE\n3. FALSE [correction]: The deletion that causes Cri du Chat Syndrome typically does not include the SH2D1A gene, which is located on the X chromosome. The common deletion associated with Cri du Chat Syndrome generally includes the area around the 5p15.2 to 5p15.3 region.\n4. FALSE [correction]: This deletion leads to a loss of genetic material, not a duplication.\n5. FALSE [correction]: Since the syndrome is caused by a deletion and not a duplication containing a repeated sequence, the statement is incorrect. Disruption in the function of genes within the deleted region contributes to the features of Cri du Chat Syndrome, not a duplication.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2141,
    "user_query": "Is osteocrin expressed exclusively in the bone?",
    "yulan-chat-2-13b-fp16_response": "Osteocrin is a protein that is expressed primarily in bone tissue, particularly in osteoblasts and osteoclasts, which are cells involved in bone formation and resorption. However, it is important to note that osteocrin expression is not exclusive to the bone.\nRecent studies have shown that osteocrin can also be expressed in other tissues and cells outside of the bone, including adipose tissue, muscle, and the liver. In these tissues, osteocrin may play a role in regulating energy metabolism, muscle function, and lipid metabolism, among other functions.\nTherefore, while osteocrin is primarily known for its role in bone tissue, it is now clear that it has broader functions and is expressed in multiple tissues throughout the body.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Osteocrin is expressed primarily in bone tissue.\n2. Osteoblasts and osteoclasts, cells involved in bone formation and resorption, express osteocrin.\n3. Osteocrin expression is not exclusive to the bone.\n4. Osteocrin is also expressed in tissues such as adipose tissue, muscle, and the liver.\n5. In tissues outside of the bone, osteocrin may help regulate energy metabolism, muscle function, and lipid metabolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "Osteocrin is expressed primarily in bone tissue.",
      "Osteoblasts and osteoclasts, cells involved in bone formation and resorption, express osteocrin.",
      "Osteocrin expression is not exclusive to the bone.",
      "Osteocrin is also expressed in tissues such as adipose tissue, muscle, and the liver.",
      "In tissues outside of the bone, osteocrin may help regulate energy metabolism, muscle function, and lipid metabolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nNote: Osteocrin is known to be expressed in bone tissues and play a role with cells like osteoblasts and osteoclasts. Indeed, its expression is not exclusive to the bone and has been found in other tissues, where it is involved in various metabolic processes. However, these are current understandings and could evolve with further research.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2142,
    "user_query": "What is  Achondroplasia?",
    "yulan-chat-2-13b-fp16_response": "Achondroplasia is the most common form of short-limbed dwarfism, a genetic disorder that affects the growth of the cartilage and bones in the body. It is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, which is responsible for regulating bone growth.\nPeople with achondroplasia are typically shorter than average and have short arms and legs, a short torso, and a broad chest. They may also have a relatively large head, a flat nasal bridge, and a forward-pointing chin. In some cases, the joints may also be affected, leading to limited mobility and an increased risk of arthritis.\nAchondroplasia affects about 1 in 25,000 to 1 in 50,000 people, regardless of ethnicity. It is usually diagnosed in childhood, and there is no known cure. However, treatment can be used to manage related health problems, such as joint pain and sleep apnea.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Achondroplasia is a genetic disorder that affects the growth of cartilage and bones in the body.\n2. It is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.\n3. People with achondroplasia typically have a characteristically short stature with short arms and legs, and may also exhibit a large head and flat nasal bridge.\n4. Achondroplasia affects approximately 1 in 25,000 to 1 in 50,000 people across different ethnicities.\n5. While there is no cure for achondroplasia, treatments are available to manage related health issues.",
    "yulan-chat-2-13b-fp16_fact": [
      "Achondroplasia is a genetic disorder that affects the growth of cartilage and bones in the body.",
      "It is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.",
      "People with achondroplasia typically have a characteristically short stature with short arms and legs, and may also exhibit a large head and flat nasal bridge.",
      "Achondroplasia affects approximately 1 in 25,000 to 1 in 50,000 people across different ethnicities.",
      "While there is no cure for achondroplasia, treatments are available to manage related health issues."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2156,
    "user_query": "Do circRNAs remain untranslated?",
    "yulan-chat-2-13b-fp16_response": "Circular RNAs (circRNAs) are a type of RNA molecule that forms a covalently closed loop, without a 5' or 3' end. They are transcribed from the genome in the same way as linear RNAs, but they are then processed by the cell's machinery to form a circular structure.\nWhile some circRNAs have been found to be untranslated (i.e., they do not code for a protein), others have been found to be translated. The translation of circRNAs can occur through the process of ribosomal scanning, where the ribosome \"scans\" the circular RNA and initiates translation at a random point. This can result in the production of multiple different peptides from a single circRNA molecule.\nIt is important to note that the translation of circRNAs is not well understood and is an area of active research. Additionally, the function of circRNAs is still being investigated, and it is possible that some circRNAs may have functions that are unrelated to protein translation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Circular RNAs (circRNAs) are a type of RNA molecule that forms a covalently closed loop without a 5' or 3' end.\n2. CircRNAs are transcribed from the genome like linear RNAs.\n3. Some circRNAs have been found to be untranslated and do not code for a protein.\n4. Other circRNAs have been found to be translated, potentially producing multiple peptides from a single circRNA molecule.\n5. The translation of circRNAs can occur through a process called ribosomal scanning.",
    "yulan-chat-2-13b-fp16_fact": [
      "Circular RNAs (circRNAs) are a type of RNA molecule that forms a covalently closed loop without a 5' or 3' end.",
      "CircRNAs are transcribed from the genome like linear RNAs.",
      "Some circRNAs have been found to be untranslated and do not code for a protein.",
      "Other circRNAs have been found to be translated, potentially producing multiple peptides from a single circRNA molecule.",
      "The translation of circRNAs can occur through a process called ribosomal scanning."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The translation of circRNAs does not occur through the conventional mechanism of ribosomal scanning, which is characteristic of linear mRNAs. Instead, translation of circRNAs can happen through alternative mechanisms, such as internal ribosome entry site (IRES)-driven translation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2158,
    "user_query": "What is Uhl's anomaly?",
    "yulan-chat-2-13b-fp16_response": "Uhl's anomaly is a rare congenital heart defect in which the aorta is not completely separated from the pulmonary artery. It is also known as aortic pulmonary valve stenosis. This condition is characterized by a narrowing of the valve between the aorta and the pulmonary artery, which can lead to difficulty breathing, heart failure, and other complications. Uhl's anomaly is usually diagnosed in infancy or early childhood and may require surgical intervention to correct the defect.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Uhl's anomaly is a congenital heart defect.\n2. In Uhl's anomaly, the aorta is not completely separated from the pulmonary artery.\n3. The condition is also known as aortic pulmonary valve stenosis.\n4. A characteristic of Uhl's anomaly is the narrowing of the valve between the aorta and the pulmonary artery.\n5. Uhl's anomaly can lead to complications such as difficulty breathing and heart failure.",
    "yulan-chat-2-13b-fp16_fact": [
      "Uhl's anomaly is a congenital heart defect.",
      "In Uhl's anomaly, the aorta is not completely separated from the pulmonary artery.",
      "The condition is also known as aortic pulmonary valve stenosis.",
      "A characteristic of Uhl's anomaly is the narrowing of the valve between the aorta and the pulmonary artery.",
      "Uhl's anomaly can lead to complications such as difficulty breathing and heart failure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Uhl's anomaly is characterized by the absence or near absence of the myocardium (heart muscle) of the right ventricle, not by the lack of separation between the aorta and pulmonary artery.\n3. FALSE [correction]: Uhl's anomaly is not known as aortic pulmonary valve stenosis. It is characterized by a parchment-like right ventricle and is also known as \"parchment heart.\"\n4. FALSE [correction]: This statement confuses Uhl's anomaly with a condition like tetralogy of Fallot or pulmonary stenosis. Uhls anomaly does not specifically involve the narrowing of the valve between the aorta and the pulmonary artery.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2159,
    "user_query": "Is autophagy the process where bacteria ingest viral particles?",
    "yulan-chat-2-13b-fp16_response": "No, autophagy is not the process where bacteria ingest viral particles. Autophagy is a process in which a cell digests and recycles its own components, such as damaged organelles or proteins. It is a natural process that occurs in both eukaryotic and prokaryotic cells, and it plays a crucial role in maintaining cellular homeostasis and survival.\nOn the other hand, phagocytosis is the process by which cells, including bacteria, engulf and digest foreign particles, such as bacteria, viruses, and other debris. This process is particularly important for immune cells, which use phagocytosis to eliminate pathogens and other harmful substances from the body.\nIn summary, while both autophagy and phagocytosis involve the ingestion of particles, they are distinct processes that serve different functions in the cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Autophagy is a process where a cell digests and recycles its own components.\n2. Autophagy occurs in both eukaryotic and prokaryotic cells.\n3. Autophagy plays a crucial role in maintaining cellular homeostasis and survival.\n4. Phagocytosis is a process where cells, including bacteria, engulf and digest foreign particles like bacteria and viruses.\n5. Immune cells use phagocytosis to eliminate pathogens and harmful substances from the body.",
    "yulan-chat-2-13b-fp16_fact": [
      "Autophagy is a process where a cell digests and recycles its own components.",
      "Autophagy occurs in both eukaryotic and prokaryotic cells.",
      "Autophagy plays a crucial role in maintaining cellular homeostasis and survival.",
      "Phagocytosis is a process where cells, including bacteria, engulf and digest foreign particles like bacteria and viruses.",
      "Immune cells use phagocytosis to eliminate pathogens and harmful substances from the body."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Autophagy mainly occurs in eukaryotic cells. Prokaryotic cells do not perform autophagy in the same manner as eukaryotic cells, as they lack the specialized cellular organelles required for this process.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2161,
    "user_query": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?",
    "yulan-chat-2-13b-fp16_response": "The pre-replication complex (pre-RC) is a large protein complex that forms on the genome before replication begins. It is composed of several different proteins, including:\n1. Cdc45: a protein that helps to activate the MCM helicase, which unwinds the DNA double helix.\n2. Cdc6: a protein that binds to the origin of replication and recruits other pre-RC proteins.\n3. Cdt1: a protein that binds to the DNA and helps to stabilize the pre-RC complex.\n4. Orc: a protein that binds to the DNA and helps to load the replication machinery onto the DNA.\n5. Rpa: a protein that binds to the DNA and helps to prevent the replication machinery from unwinding the DNA too far.\n6. Rpc: a protein that binds to the DNA and helps to prevent the replication machinery from unwinding the DNA too far.\n7. Dbf4: a protein that helps to load the replication machinery onto the DNA.\n8. GINS: a group of proteins that help to load the replication machinery onto the DNA.\nThese proteins work together to prepare the DNA for replication and to ensure that the replication process proceeds smoothly.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cdc45 is a protein that helps activate the MCM helicase in the pre-replication complex.\n2. Cdc6 is a protein that binds to the origin of replication and recruits other proteins to the pre-RC.\n3. Cdt1 is a protein in the pre-RC that binds to the DNA and helps stabilize the complex.\n4. OriC is a component of the pre-RC that binds to DNA to help load the replication machinery.\n5. GINS is a group of proteins in the pre-RC that assist in loading the replication machinery onto DNA.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cdc45 is a protein that helps activate the MCM helicase in the pre-replication complex.",
      "Cdc6 is a protein that binds to the origin of replication and recruits other proteins to the pre-RC.",
      "Cdt1 is a protein in the pre-RC that binds to the DNA and helps stabilize the complex.",
      "OriC is a component of the pre-RC that binds to DNA to help load the replication machinery.",
      "GINS is a group of proteins in the pre-RC that assist in loading the replication machinery onto DNA."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Cdc45 is a protein that, along with other factors, helps activate the MCM (minichromosome maintenance) helicase, thus being crucial in the formation of the pre-replication complex (pre-RC).\n2. TRUE: Cdc6 is indeed a protein that binds to the origin of replication and has a role in recruiting other essential proteins to form the pre-RC.\n3. TRUE: Cdt1 is a protein that interacts with the origin of replication as part of the pre-RC and is involved in the recruitment and stabilization of the MCM complex onto the DNA.\n4. FALSE [correction]: OriC is the origin of replication in E. coli bacteria, not a component of the pre-RC. However, it serves as the binding site where the replication machinery assembles, enabling replication to begin.\n5. TRUE: GINS is a complex of proteins that, along with Cdc45 and the MCM helicase, forms the CMG complex, which is critical for the loading and activation of the replication machinery on DNA during the initiation of DNA replication.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2162,
    "user_query": "What is the inheritance of hypophosphatemic rickets?",
    "yulan-chat-2-13b-fp16_response": "Hypophosphatemic rickets is a genetic disorder that is caused by a deficiency of phosphate in the blood. It is usually inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene (one from each parent) in order to develop the condition.\nThe gene responsible for hypophosphatemic rickets is called the PHEX gene, and it provides instructions for making a protein that is involved in the regulation of phosphate levels in the body. Mutations in the PHEX gene can lead to a deficiency of phosphate, which can cause the symptoms of hypophosphatemic rickets, such as weakened bones and bowing of the legs.\nIf both parents carry a mutated copy of the PHEX gene, there is a 25% chance that their child will inherit two mutated copies and develop hypophosphatemic rickets. If both parents have only one mutated copy of the gene, there is a 50% chance that their child will inherit two mutated copies and develop the condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hypophosphatemic rickets is a genetic disorder caused by a deficiency of phosphate in the blood.\n2. The disorder is typically inherited in an autosomal recessive pattern.\n3. To develop hypophosphatemic rickets, a person must inherit two copies of the mutated gene, one from each parent.\n4. The PHEX gene is responsible for hypophosphatemic rickets and is involved in the regulation of phosphate levels in the body.\n5. Mutations in the PHEX gene can lead to symptoms of hypophosphatemic rickets such as weakened bones and bowing of the legs.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hypophosphatemic rickets is a genetic disorder caused by a deficiency of phosphate in the blood.",
      "The disorder is typically inherited in an autosomal recessive pattern.",
      "To develop hypophosphatemic rickets, a person must inherit two copies of the mutated gene, one from each parent.",
      "The PHEX gene is responsible for hypophosphatemic rickets and is involved in the regulation of phosphate levels in the body.",
      "Mutations in the PHEX gene can lead to symptoms of hypophosphatemic rickets such as weakened bones and bowing of the legs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Hypophosphatemic rickets is typically inherited in an X-linked dominant pattern, not an autosomal recessive pattern.\n3. FALSE [correction]: To develop hypophosphatemic rickets in the case of an X-linked dominant inheritance, a person only needs to inherit one copy of the mutated gene, which can be from either parent.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2167,
    "user_query": "Which server is used for generating modes of pseudo components of DNA, RNA and protein sequences?",
    "yulan-chat-2-13b-fp16_response": "There are several servers that can be used for generating modes of pseudo components of DNA, RNA, and protein sequences. One such server is the NCBI BLAST (Basic Local Alignment Search Tool) server, which can be used to perform sequence similarity searches and identify conserved regions in DNA, RNA, and protein sequences. Another server that can be used is the UCSC Genome Browser, which provides a variety of tools for visualizing and analyzing DNA, RNA, and protein sequences, including the ability to generate modes of pseudo components. Additionally, there are several other bioinformatics tools and resources that can be used for this purpose, such as ClustalW, MUSCLE, and MAFFT.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NCBI BLAST (Basic Local Alignment Search Tool) server can be used to perform sequence similarity searches on DNA, RNA, and protein sequences.\n2. NCBI BLAST server can identify conserved regions in DNA, RNA, and protein sequences.\n3. The UCSC Genome Browser provides tools for visualizing and analyzing DNA, RNA, and protein sequences.\n4. The UCSC Genome Browser can generate modes of pseudo components for DNA, RNA, and protein sequences.\n5. Bioinformatics tools such as ClustalW, MUSCLE, and MAFFT can be used for generating modes of pseudo components of DNA, RNA, and protein sequences.",
    "yulan-chat-2-13b-fp16_fact": [
      "NCBI BLAST (Basic Local Alignment Search Tool) server can be used to perform sequence similarity searches on DNA, RNA, and protein sequences.",
      "NCBI BLAST server can identify conserved regions in DNA, RNA, and protein sequences.",
      "The UCSC Genome Browser provides tools for visualizing and analyzing DNA, RNA, and protein sequences.",
      "The UCSC Genome Browser can generate modes of pseudo components for DNA, RNA, and protein sequences.",
      "Bioinformatics tools such as ClustalW, MUSCLE, and MAFFT can be used for generating modes of pseudo components of DNA, RNA, and protein sequences."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The UCSC Genome Browser does not generate modes of pseudo components for sequences; it is primarily used for visualization and analysis, including viewing the genome sequences, annotations, and comparative genomics.\n5. FALSE [correction]: ClustalW, MUSCLE, and MAFFT are bioinformatics tools used for multiple sequence alignments, not for generating \"modes of pseudo components.\" The phrase \"modes of pseudo components\" is not clearly defined in this context and these tools serve to align sequences to identify conserved regions and relationships between sequences.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2169,
    "user_query": "Which class of genes are mutated in Diamond Blackfan Anemia patients?",
    "yulan-chat-2-13b-fp16_response": "Diamond Blackfan anemia is a rare genetic disorder characterized by a deficiency of erythropoietin (EPO), which is a hormone that stimulates the production of red blood cells. It is caused by mutations in the genes that encode for erythroid transcription factors, specifically GATA1, FOG1/NBPF1, and NF-E2. These genes are involved in the regulation of gene expression in erythroid cells, which are responsible for producing red blood cells. Mutations in these genes disrupt the normal functioning of erythroid cells and lead to the anemia associated with Diamond Blackfan anemia.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Diamond Blackfan anemia is a rare genetic disorder.\n2. Diamond Blackfan anemia is characterized by a deficiency of erythropoietin (EPO).\n3. Mutations in genes encoding erythroid transcription factors cause Diamond Blackfan anemia.\n4. GATA1, FOG1/NBPF1, and NF-E2 are genes involved in the regulation of gene expression in erythroid cells.\n5. Erythroid cells are responsible for producing red blood cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Diamond Blackfan anemia is a rare genetic disorder.",
      "Diamond Blackfan anemia is characterized by a deficiency of erythropoietin (EPO).",
      "Mutations in genes encoding erythroid transcription factors cause Diamond Blackfan anemia.",
      "GATA1, FOG1/NBPF1, and NF-E2 are genes involved in the regulation of gene expression in erythroid cells.",
      "Erythroid cells are responsible for producing red blood cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Diamond Blackfan anemia is characterized by a failure of the bone marrow to produce red blood cells, not necessarily by a deficiency of erythropoietin (EPO).\n3. TRUE\n4. FALSE [correction]: GATA1 and FOG1 (ZFPM1) are indeed involved in the regulation of gene expression in erythroid cells, but NF-E2 is not associated with causing Diamond Blackfan anemia. Instead, mutations in ribosomal protein genes are known causes of Diamond Blackfan anemia.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "yulan-chat-2-13b-fp16_response": "Robertsonian translocation involves the exchange of segments between two acrocentric chromosomes (chromosomes 13, 14, 15, 21, and 22). Specifically, the long arm of chromosome 14 is translocated to the short arm of chromosome 13, and the short arm of chromosome 14 is translocated to the long arm of chromosome 13. This results in the formation of a new chromosome with a ring chromosome structure, which is unstable and can lead to genetic abnormalities.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chromosomes 13, 14, 15, 21, and 22 are human acrocentric chromosomes.\n2. Robertsonian translocation involves the exchange of segments between two acrocentric chromosomes.\n3. In a Robertsonian translocation, the long arm of chromosome 14 can be translocated to the short arm of chromosome 13.\n4. The short arm of chromosome 14 can be translocated to the long arm of chromosome 13.\n5. Robertsonian translocation can result in the formation of a new chromosome with a ring structure.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chromosomes 13, 14, 15, 21, and 22 are human acrocentric chromosomes.",
      "Robertsonian translocation involves the exchange of segments between two acrocentric chromosomes.",
      "In a Robertsonian translocation, the long arm of chromosome 14 can be translocated to the short arm of chromosome 13.",
      "The short arm of chromosome 14 can be translocated to the long arm of chromosome 13.",
      "Robertsonian translocation can result in the formation of a new chromosome with a ring structure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In a Robertsonian translocation, it is typically the long arms of two acrocentric chromosomes that join together; the short arms are usually lost.\n4. FALSE [correction]: In a Robertsonian translocation, the short arms of the chromosomes are usually lost, and it is the long arms that join.\n5. FALSE [correction]: Robertsonian translocation typically results in the formation of a new chromosome that is not a ring but a fusion of the long arms of two acrocentric chromosomes. A ring chromosome is a different structural abnormality where the ends of a chromosome have fused together to form a ring.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2171,
    "user_query": "Is tirilazad effective for treatment of aneurysmal subarachnoid haemorrhage?",
    "yulan-chat-2-13b-fp16_response": "Tirilazad is an experimental drug that has been studied for the treatment of aneurysmal subarachnoid hemorrhage (SAH), which is a serious and life-threatening condition caused by the rupture of an aneurysm, or a weakened area in the wall of a blood vessel in the brain.\nWhile there have been some studies that suggest that tirilazad may be effective in reducing the risk of rebleeding and improving outcomes in patients with SAH, these studies have been limited in size and scope, and the drug has not yet been approved by regulatory agencies for the treatment of SAH.\nIn fact, in 2005, the US Food and Drug Administration (FDA) issued a complete response letter to the manufacturer of tirilazad, citing concerns about the drug's safety and efficacy. Since then, there have been some small, positive studies, but the drug has not been widely adopted for the treatment of SAH.\nOverall, while there is some evidence to suggest that tirilazad may be effective in the treatment of SAH, more research is needed to confirm its safety and efficacy, and the drug is not yet considered a standard treatment for this condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tirilazad is an experimental drug studied for the treatment of aneurysmal subarachnoid hemorrhage (SAH).\n2. There have been studies suggesting tirilazad may reduce the risk of rebleeding and improve outcomes in patients with SAH.\n3. The studies on tirilazad have been limited in size and scope.\n4. The US Food and Drug Administration (FDA) issued a complete response letter regarding tirilazad in 2005.\n5. Tirilazad has not been approved by regulatory agencies for the treatment of SAH.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tirilazad is an experimental drug studied for the treatment of aneurysmal subarachnoid hemorrhage (SAH).",
      "There have been studies suggesting tirilazad may reduce the risk of rebleeding and improve outcomes in patients with SAH.",
      "The studies on tirilazad have been limited in size and scope.",
      "The US Food and Drug Administration (FDA) issued a complete response letter regarding tirilazad in 2005.",
      "Tirilazad has not been approved by regulatory agencies for the treatment of SAH."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: The FDA does not issue a complete response letter in 2005 specifically for tirilazad, as my knowledge does not include this specific event. Furthermore, the complete response letter is a response to a new drug application, which would occur at the time of the initial application review rather than a specific year afterward.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 2175,
    "user_query": "List viral vectors used in gene therapy.",
    "yulan-chat-2-13b-fp16_response": "Viral vectors are used in gene therapy to deliver therapeutic genes to target cells. Some of the commonly used viral vectors in gene therapy include:\n1. Adenovirus: Adenovirus vectors are commonly used in gene therapy due to their ability to infect a wide range of cell types and their relatively low immunogenicity.\n2. Adeno-associated virus (AAV): AAV vectors are also commonly used in gene therapy due to their ability to infect a wide range of cell types, their low immunogenicity, and their ability to integrate into the host genome.\n3. Lentivirus: Lentivirus vectors are commonly used in gene therapy for their ability to infect a wide range of cell types, their ability to integrate into the host genome, and their ability to express genes stably.\n4. Herpes simplex virus (HSV): HSV vectors are commonly used in gene therapy due to their ability to infect a wide range of cell types and their ability to express genes in a persistent manner.\n5. Retrovirus: Retrovirus vectors are commonly used in gene therapy for their ability to integrate into the host genome and their ability to express genes stably.\n6. Tol2: Tol2 is a viral vector that uses a site-specific recombination system to insert therapeutic genes into the host genome.\n7. Zinc finger nucleases (ZFNs): ZFNs are artificial nucleases that can be designed to target specific DNA sequences, and they can be used to create targeted mutations or insertions in the genome.\n8. Transcription activator-like effector nucleases (TALENs): TALENs are similar to ZFNs, but they use a different type of DNA-binding domain.\n9. Clustered regularly interspaced short palindromic repeats (CRISPR): CRISPR is a revolutionary gene editing technology that uses a bacterial immune system to target specific DNA sequences.\nThese viral vectors have different advantages and disadvantages, and the choice of vector depends on the specific application and target cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Adenovirus vectors are used in gene therapy to infect a wide range of cell types.\n2. Adeno-associated virus (AAV) vectors can integrate into the host genome and are used in gene therapy.\n3. Lentivirus vectors are used in gene therapy for stable gene expression and their integration capability into the host genome.\n4. Herpes simplex virus (HSV) vectors are utilized in gene therapy for their persistent gene expression capabilities.\n5. Retrovirus vectors are used in gene therapy due to their ability to integrate into the host genome and express genes stably.",
    "yulan-chat-2-13b-fp16_fact": [
      "Adenovirus vectors are used in gene therapy to infect a wide range of cell types.",
      "Adeno-associated virus (AAV) vectors can integrate into the host genome and are used in gene therapy.",
      "Lentivirus vectors are used in gene therapy for stable gene expression and their integration capability into the host genome.",
      "Herpes simplex virus (HSV) vectors are utilized in gene therapy for their persistent gene expression capabilities.",
      "Retrovirus vectors are used in gene therapy due to their ability to integrate into the host genome and express genes stably."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Adeno-associated virus (AAV) vectors generally do not integrate into the host genome; instead, they exist mainly as episomal, non-integrating vectors, which is beneficial in reducing the risk of insertional mutagenesis.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2178,
    "user_query": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura).",
    "yulan-chat-2-13b-fp16_response": "Moschcowitz syndrome, also known as thrombotic thrombocytopenic purpura, is a rare blood disorder characterized by the formation of blood clots in small blood vessels throughout the body. The classical symptoms of Moschcowitz syndrome include:\n1. Purpura: a characteristic rash that appears as pinpoint red spots on the skin, usually on the legs and buttocks\n2. Thrombocytopenia: a decrease in the number of platelets in the blood, which can lead to bruising and bleeding\n3. Thrombosis: the formation of blood clots in small blood vessels, which can cause blockages and damage to organs and tissues\n4. Neutropenia: a decrease in the number of neutrophils, a type of white blood cell that helps fight infections\n5. Anemia: a decrease in the number of red blood cells, which can cause fatigue and weakness\nOther symptoms of Moschcowitz syndrome may include fever, nausea, vomiting, abdominal pain, and kidney failure. It is important to note that not all cases of Moschcowitz syndrome present with all of these symptoms, and some cases may be asymptomatic.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Moschcowitz syndrome is characterized by the formation of blood clots in small blood vessels throughout the body.\n2. A classical symptom of Moschcowitz syndrome is Purpura, seen as pinpoint red spots on the skin, usually on the legs and buttocks.\n3. Thrombocytopenia, defined as a decrease in the number of platelets in the blood, is another symptom of Moschcowitz syndrome.\n4. Neutropenia, a decrease in the number of neutrophils, is a symptom of Moschcowitz syndrome.\n5. Anemia, shown by a decrease in red blood cell count, is a symptom associated with Moschcowitz syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Moschcowitz syndrome is characterized by the formation of blood clots in small blood vessels throughout the body.",
      "A classical symptom of Moschcowitz syndrome is Purpura, seen as pinpoint red spots on the skin, usually on the legs and buttocks.",
      "Thrombocytopenia, defined as a decrease in the number of platelets in the blood, is another symptom of Moschcowitz syndrome.",
      "Neutropenia, a decrease in the number of neutrophils, is a symptom of Moschcowitz syndrome.",
      "Anemia, shown by a decrease in red blood cell count, is a symptom associated with Moschcowitz syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Neutropenia, a decrease in the number of neutrophils, is not a typical symptom of Moschcowitz syndrome, which is also known as thrombotic thrombocytopenic purpura (TTP). Symptoms of TTP are more closely related to blood clotting issues and their effects, such as low platelet counts, rather than a decrease in specific white blood cell types like neutrophils.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2181,
    "user_query": "Which is the major RNA editing enzyme in Drosophila melanogaster?",
    "yulan-chat-2-13b-fp16_response": "The major RNA editing enzyme in Drosophila melanogaster is called ADAR (Adenosine Deaminase Acting on RNA). ADAR is an RNA editing enzyme that catalyzes the deamination of adenosine (A) to inosine (I) in RNA, which can be translated as guanine (G) during translation. This process is called RNA editing and can change the coding sequence of the RNA, leading to changes in the protein sequence and function. ADAR is responsible for the majority of RNA editing events in Drosophila melanogaster and other organisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The major RNA editing enzyme in Drosophila melanogaster is called ADAR (Adenosine Deaminase Acting on RNA).\n2. ADAR catalyzes the deamination of adenosine (A) to inosine (I) in RNA.\n3. The process of deamination of adenosine to inosine in RNA is referred to as RNA editing.\n4. RNA editing can change the coding sequence of RNA, potentially leading to alterations in protein sequence and function.\n5. ADAR is responsible for the majority of RNA editing events in Drosophila melanogaster and other organisms.",
    "yulan-chat-2-13b-fp16_fact": [
      "The major RNA editing enzyme in Drosophila melanogaster is called ADAR (Adenosine Deaminase Acting on RNA).",
      "ADAR catalyzes the deamination of adenosine (A) to inosine (I) in RNA.",
      "The process of deamination of adenosine to inosine in RNA is referred to as RNA editing.",
      "RNA editing can change the coding sequence of RNA, potentially leading to alterations in protein sequence and function.",
      "ADAR is responsible for the majority of RNA editing events in Drosophila melanogaster and other organisms."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While ADAR is responsible for many RNA editing events in Drosophila melanogaster, it is not responsible for the majority of RNA editing events in all organisms. Other organisms have different types of RNA editing enzymes and systems.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2182,
    "user_query": "What is the CEGA catalog?",
    "yulan-chat-2-13b-fp16_response": "CEGA is an acronym that stands for the California Environmental Genomics Analysis. The CEGA catalog is a publicly available database that contains genomic and metagenomic data from a variety of environmental samples, including soil, water, air, and plant and animal tissues. The catalog is maintained by the University of California, Davis and is used by researchers to study the microbial diversity and function in different environments. The CEGA catalog is a valuable resource for scientists studying environmental microbiology, ecology, and biogeochemistry.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CEGA stands for the California Environmental Genomics Analysis.\n2. The CEGA catalog is a publicly available database.\n3. The database contains genomic and metagenomic data from environmental samples like soil, water, air, and plant and animal tissues.\n4. The University of California, Davis maintains the CEGA catalog.\n5. The catalog is utilized by researchers for studying microbial diversity and function in various environments.",
    "yulan-chat-2-13b-fp16_fact": [
      "CEGA stands for the California Environmental Genomics Analysis.",
      "The CEGA catalog is a publicly available database.",
      "The database contains genomic and metagenomic data from environmental samples like soil, water, air, and plant and animal tissues.",
      "The University of California, Davis maintains the CEGA catalog.",
      "The catalog is utilized by researchers for studying microbial diversity and function in various environments."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: CEGA typically stands for the Center for Effective Global Action, which is not related to Environmental Genomics.\n2. UNKNOWN: Without information on which specific CEGA catalog is referenced, it's unclear whether it is publicly available. \n3. UNKNOWN: Based on the correction in statement 1, it is difficult to assess the contents of the CEGA catalog without additional context.\n4. UNKNOWN: Due to the lack of clarity about which CEGA catalog is being referenced, it's not possible to confirm which institution maintains it.\n5. UNKNOWN: Given the corrections and unknowns in the previous statements, we cannot verify the use of the catalog.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2183,
    "user_query": "Which protein is associated with hyperemesis gravidarum during pregrancy?",
    "yulan-chat-2-13b-fp16_response": "Hyperemesis gravidarum is a condition characterized by persistent vomiting during pregnancy. It is associated with changes in the levels of certain hormones, including human chorionic gonadotropin (hCG) and estrogen. There is no specific protein that is definitively linked to hyperemesis gravidarum. However, some studies have suggested that high levels of certain proteins, such as serum progesterone and cortisol, may be associated with an increased risk of developing the condition. Additionally, some research has suggested that certain genetic variations in the genes that control the metabolism of hormones may be associated with an increased risk of hyperemesis gravidarum.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hyperemesis gravidarum is a condition characterized by persistent vomiting during pregnancy.\n2. The condition is associated with changes in the levels of hormones like human chorionic gonadotropin (hCG) and estrogen.\n3. High levels of certain proteins, such as serum progesterone and cortisol, may be associated with an increased risk of hyperemesis gravidarum.\n4. Genetic variations in the genes that control hormone metabolism may be linked to an increased risk of hyperemesis gravidarum.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hyperemesis gravidarum is a condition characterized by persistent vomiting during pregnancy.",
      "The condition is associated with changes in the levels of hormones like human chorionic gonadotropin (hCG) and estrogen.",
      "High levels of certain proteins, such as serum progesterone and cortisol, may be associated with an increased risk of hyperemesis gravidarum.",
      "Genetic variations in the genes that control hormone metabolism may be linked to an increased risk of hyperemesis gravidarum."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: While hormone levels such as hCG and estrogen are associated with hyperemesis gravidarum, the specific mention of \"high levels of serum progesterone and cortisol\" is misleading. The exact roles of progesterone and cortisol in hyperemesis gravidarum are not well-established and may not be directly associated with an increased risk, so this statement is too specific to be accurate without additional context.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2187,
    "user_query": "Is edema a symptom of nephrotic syndrome?",
    "yulan-chat-2-13b-fp16_response": "Yes, edema is a common symptom of nephrotic syndrome. Nephrotic syndrome is a group of symptoms that occur when the kidneys are not able to filter blood properly. One of the symptoms of nephrotic syndrome is edema, which is the accumulation of excess fluid in the body's tissues. This can cause swelling in the feet, ankles, and legs. Other symptoms of nephrotic syndrome include proteinuria (the presence of protein in the urine), hyperlipidemia (high levels of fats in the blood), and hypertension (high blood pressure).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Edema is a symptom of nephrotic syndrome.\n2. Nephrotic syndrome occurs when the kidneys are not able to filter blood properly.\n3. One of the symptoms of nephrotic syndrome includes swelling in the feet, ankles, and legs.\n4. Proteinuria, which is the presence of protein in the urine, is a symptom of nephrotic syndrome.\n5. Hyperlipidemia and hypertension are symptoms of nephrotic syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Edema is a symptom of nephrotic syndrome.",
      "Nephrotic syndrome occurs when the kidneys are not able to filter blood properly.",
      "One of the symptoms of nephrotic syndrome includes swelling in the feet, ankles, and legs.",
      "Proteinuria, which is the presence of protein in the urine, is a symptom of nephrotic syndrome.",
      "Hyperlipidemia and hypertension are symptoms of nephrotic syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. PARTIALLY TRUE [correction]: Hyperlipidemia, which is elevated lipid levels in the blood, is a symptom of nephrotic syndrome, but hypertension (high blood pressure) is not considered a symptom of nephrotic syndrome. However, hypertension can be a complication or associated condition related to the disease.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2195,
    "user_query": "Borden classification is used for which disease?",
    "yulan-chat-2-13b-fp16_response": "Borden classification is a system used to classify the severity of acute kidney injury (AKI), which is a sudden and often reversible loss of kidney function. It is based on the changes in serum creatinine levels and urine output in patients with AKI. The classification system has three stages:\n1. Stage 1: Mild AKI - Characterized by a small increase in serum creatinine (less than 1.2 mg/dL in women and less than 1.5 mg/dL in men) and/or a decrease in urine output (less than 0.5 mL/kg/min) that persists for less than 48 hours.\n2. Stage 2: Moderate AKI - Characterized by an increase in serum creatinine of 1.2-1.9 mg/dL in women and 1.5-2.0 mg/dL in men, and/or an decrease in urine output of 0.5-1.0 mL/kg/min that persists for 48-72 hours.\n3. Stage 3: Severe AKI - Characterized by an increase in serum creatinine of greater than 1.9 mg/dL in women and greater than 2.0 mg/dL in men, and/or an decrease in urine output of less than 0.5 mL/kg/min that persists for more than 72 hours.\nIt is important to note that Borden classification is not used as a standalone tool for diagnosis of AKI, but rather as a guide to help clinicians assess the severity of AKI in patients.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Borden classification is used to classify the severity of acute kidney injury (AKI).\n2. Stage 1 of Borden classification is characterized by a small increase in serum creatinine, specifically less than 1.2 mg/dL in women and less than 1.5 mg/dL in men.\n3. Stage 2 of Borden classification is characterized by an increase in serum creatinine of 1.2-1.9 mg/dL in women and 1.5-2.0 mg/dL in men.\n4. Stage 3 of Borden classification is characterized by an increase in serum creatinine greater than 1.9 mg/dL in women and greater than 2.0 mg/dL in men.\n5. Borden classification stages also take into account the urine output and the duration for which specific changes persist.",
    "yulan-chat-2-13b-fp16_fact": [
      "Borden classification is used to classify the severity of acute kidney injury (AKI).",
      "Stage 1 of Borden classification is characterized by a small increase in serum creatinine, specifically less than 1.2 mg/dL in women and less than 1.5 mg/dL in men.",
      "Stage 2 of Borden classification is characterized by an increase in serum creatinine of 1.2-1.9 mg/dL in women and 1.5-2.0 mg/dL in men.",
      "Stage 3 of Borden classification is characterized by an increase in serum creatinine greater than 1.9 mg/dL in women and greater than 2.0 mg/dL in men.",
      "Borden classification stages also take into account the urine output and the duration for which specific changes persist."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The classification system used for acute kidney injury is not known as Borden classification, but rather as the KDIGO (Kidney Disease: Improving Global Outcomes) classification.\n2. FALSE [correction]: KDIGO Stage 1 AKI is characterized by a 1.5 to 1.9 times increase from baseline serum creatinine, or a rise by 0.3 mg/dL (26.5 mol/L) within 48 hours, or urine output <0.5 mL/kg/h for 6-12 hours.\n3. FALSE [correction]: KDIGO Stage 2 AKI is characterized by a 2.0 to 2.9 times increase from baseline serum creatinine or urine output <0.5 mL/kg/h for 12 hours.\n4. FALSE [correction]: KDIGO Stage 3 AKI is characterized by a 3.0 times increase from baseline serum creatinine or increase in serum creatinine to 4.0 mg/dL (353.6 mol/L) with an acute rise of at least 0.5 mg/dL (44.2 mol/L), or initiation of renal replacement therapy, or urine output <0.3 mL/kg/h for 24 hours, or anuria for 12 hours.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2198,
    "user_query": "What is the function of mTOR?",
    "yulan-chat-2-13b-fp16_response": "mTOR (mechanistic target of rapamycin) is a protein that plays a key role in regulating cell growth and metabolism. It is a central controller of cellular processes that affect cell growth, proliferation, differentiation, and survival.\nThe function of mTOR is to sense and integrate various signals from the cellular environment, such as nutrients, growth factors, and oxygen levels, and then activate or inhibit specific downstream pathways that control cellular processes.\nmTOR exists in two forms: mTORC1 and mTORC2. mTORC1 is activated by growth factors and amino acids and promotes cell growth and proliferation, while mTORC2 is activated by cellular stress and promotes cell survival and metabolism.\nIn summary, the function of mTOR is to regulate cell growth and metabolism by sensing and integrating various signals from the cellular environment and activating or inhibiting specific downstream pathways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. mTOR is a protein that regulates cell growth and metabolism.\n2. mTOR serves as a central controller of processes affecting cell growth, proliferation, differentiation, and survival.\n3. The function of mTOR includes sensing and integrating signals like nutrients, growth factors, and oxygen levels.\n4. mTOR exists in two forms: mTORC1 and mTORC2.\n5. mTORC1 is activated by growth factors and amino acids, promoting cell growth and proliferation, whereas mTORC2 is activated by cellular stress and promotes cell survival and metabolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "mTOR is a protein that regulates cell growth and metabolism.",
      "mTOR serves as a central controller of processes affecting cell growth, proliferation, differentiation, and survival.",
      "The function of mTOR includes sensing and integrating signals like nutrients, growth factors, and oxygen levels.",
      "mTOR exists in two forms: mTORC1 and mTORC2.",
      "mTORC1 is activated by growth factors and amino acids, promoting cell growth and proliferation, whereas mTORC2 is activated by cellular stress and promotes cell survival and metabolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: mTORC1 is activated by growth factors and amino acids, promoting cell growth and proliferation; however, mTORC2 is primarily involved in the regulation of the cytoskeleton and also responds to growth factors, but not cellular stress as primarily indicated. It also plays a role in cell survival and metabolism.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2203,
    "user_query": "List cardinal features of the Triple A syndrome.",
    "yulan-chat-2-13b-fp16_response": "The Triple A syndrome, also known as Allgrove syndrome, is a rare genetic disorder characterized by the following cardinal features:\n1. Acromegaly: This is a condition that results from the overproduction of growth hormone (GH) after the epiphyseal plates have closed. It is characterized by abnormal growth and enlargement of the bones, soft tissues, and organs.\n2. Acromegalic features: These include coarse facial features, enlarged hands and feet, a deep voice, and joint pain and stiffness.\n3. Autism: Individuals with the Triple A syndrome often have autistic behaviors and social difficulties, including impaired communication and repetitive behaviors.\nOther features of the Triple A syndrome may include diabetes, high blood pressure, sleep apnea, and heart disease. The disorder is caused by mutations in the GHRH receptor gene and is typically diagnosed in childhood or adolescence. Treatment typically involves surgery to remove the pituitary gland, which produces the growth hormone, and hormone replacement therapy to address any deficiencies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Triple A syndrome is a rare genetic disorder.\n2. Acromegaly, characterized by the overproduction of growth hormone resulting in abnormal growth, is a cardinal feature of Triple A syndrome.\n3. Individuals with Triple A syndrome often exhibit acromegalic features such as coarse facial features, enlarged hands and feet, and joint pain.\n4. Autism, including impaired communication and repetitive behaviors, is associated with Triple A syndrome.\n5. The disorder is caused by mutations in the GHRH receptor gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "Triple A syndrome is a rare genetic disorder.",
      "Acromegaly, characterized by the overproduction of growth hormone resulting in abnormal growth, is a cardinal feature of Triple A syndrome.",
      "Individuals with Triple A syndrome often exhibit acromegalic features such as coarse facial features, enlarged hands and feet, and joint pain.",
      "Autism, including impaired communication and repetitive behaviors, is associated with Triple A syndrome.",
      "The disorder is caused by mutations in the GHRH receptor gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Acromegaly is not a feature of Triple A syndrome. Triple A syndrome (also known as Allgrove syndrome) is characterized by alacrima, achalasia, and adrenal insufficiency.\n3. FALSE [correction]: Individuals with Triple A syndrome do not typically exhibit acromegalic features. Instead, they commonly have symptoms related to alacrima, achalasia, and adrenal insufficiency.\n4. UNKNOWN (Triple A syndrome primarily involves alacrima, achalasia, and adrenal insufficiency. Autism is not typically described as a characteristic feature of Triple A syndrome; however, without specific information on the comorbidities of Triple A syndrome, it's not possible to definitively say this statement is false.)\n5. FALSE [correction]: The disorder is caused by mutations in the AAAS gene, which codes for the protein ALADIN.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2205,
    "user_query": "Does the Abelson-related gene (ARG) gene encode for a serine kinase?",
    "yulan-chat-2-13b-fp16_response": "The Abelson-related gene (ARG) is a gene that encodes for a protein called Abelson tyrosine-protein kinase (Abl). Abl is a serine kinase that plays a role in various cellular processes, including cell growth, differentiation, and survival. It is involved in signaling pathways that regulate the cell cycle and is often mutated in cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Abelson-related gene (ARG) encodes for a protein called Abelson tyrosine-protein kinase (Abl).\n2. Abelson tyrosine-protein kinase (Abl) is a serine kinase.\n3. Abl plays a role in cellular processes such as cell growth, differentiation, and survival.\n4. Abl is involved in signaling pathways that regulate the cell cycle.\n5. The Abelson tyrosine-protein kinase (Abl) is often mutated in cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Abelson-related gene (ARG) encodes for a protein called Abelson tyrosine-protein kinase (Abl).",
      "Abelson tyrosine-protein kinase (Abl) is a serine kinase.",
      "Abl plays a role in cellular processes such as cell growth, differentiation, and survival.",
      "Abl is involved in signaling pathways that regulate the cell cycle.",
      "The Abelson tyrosine-protein kinase (Abl) is often mutated in cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Abelson tyrosine-protein kinase (Abl) is a tyrosine kinase, not a serine kinase.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2207,
    "user_query": "Is Prochlorococcus the most abundant photosynthetic organism?",
    "yulan-chat-2-13b-fp16_response": "Prochlorococcus is one of the most abundant photosynthetic organisms in the ocean, but it is not the most abundant overall. There are other photosynthetic organisms, such as cyanobacteria and green sulfur bacteria, that are also very abundant in the ocean and in other environments. Prochlorococcus is unique in that it is one of the smallest known photosynthetic organisms, and it has a very high growth rate. It is also one of the most important photosynthetic organisms in the ocean, as it plays a key role in the marine food web and in the global carbon cycle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prochlorococcus is one of the most abundant photosynthetic organisms in the ocean.\n2. Prochlorococcus is not the most abundant photosynthetic organism overall.\n3. Prochlorococcus is one of the smallest known photosynthetic organisms.\n4. Prochlorococcus has a high growth rate.\n5. Prochlorococcus plays a key role in the marine food web and the global carbon cycle.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prochlorococcus is one of the most abundant photosynthetic organisms in the ocean.",
      "Prochlorococcus is not the most abundant photosynthetic organism overall.",
      "Prochlorococcus is one of the smallest known photosynthetic organisms.",
      "Prochlorococcus has a high growth rate.",
      "Prochlorococcus plays a key role in the marine food web and the global carbon cycle."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Prochlorococcus is considered to be the most abundant photosynthetic organism overall on the planet.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2208,
    "user_query": "List 3 features of IRVAN syndrome.",
    "yulan-chat-2-13b-fp16_response": "IRVAN syndrome is a rare genetic disorder that affects the development of the brain and skull. Some of the key features of this condition include:\n1. Intellectual disability: People with IRVAN syndrome typically have below-average intelligence and may struggle with learning and communication.\n2. Seizures: Seizures are a common symptom of IRVAN syndrome, and can occur at any age. These seizures can be caused by abnormal electrical activity in the brain.\n3. Abnormal skull development: People with IRVAN syndrome often have an abnormally shaped skull, which can be caused by abnormalities in the bones of the skull or in the way the brain develops. This can lead to a range of other symptoms, such as vision problems, hearing loss, and difficulty with balance and coordination.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. IRVAN syndrome is a rare genetic disorder that affects the development of the brain and skull.\n2. Individuals with IRVAN syndrome typically experience intellectual disability.\n3. Seizures are a common symptom of IRVAN syndrome.\n4. Abnormal skull development is a key feature of IRVAN syndrome.\n5. Abnormalities in the development of the skull in IRVAN syndrome can lead to vision problems, hearing loss, and challenges with balance and coordination.",
    "yulan-chat-2-13b-fp16_fact": [
      "IRVAN syndrome is a rare genetic disorder that affects the development of the brain and skull.",
      "Individuals with IRVAN syndrome typically experience intellectual disability.",
      "Seizures are a common symptom of IRVAN syndrome.",
      "Abnormal skull development is a key feature of IRVAN syndrome.",
      "Abnormalities in the development of the skull in IRVAN syndrome can lead to vision problems, hearing loss, and challenges with balance and coordination."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: IRVAN syndrome, also known as Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis, is not a genetic disorder affecting brain and skull development, but a rare inflammatory eye condition that affects the retina.\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: Abnormal skull development is not a feature of IRVAN syndrome, as it predominantly affects the eyes, specifically the retina.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2211,
    "user_query": "List active ingredients of the Stribild polypill.",
    "yulan-chat-2-13b-fp16_response": "Stribild is a fixed-dose combination tablet containing four active ingredients: elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate. These four drugs are all antiretroviral medications used to treat HIV infection. Elvitegravir and tenofovir are nucleoside reverse transcriptase inhibitors, which target the viral replication cycle. Cobicistat is a pharmacokinetic enhancer that increases the levels of elvitegravir in the bloodstream. Emtricitabine is a nucleoside reverse transcriptase inhibitor that targets the viral replication cycle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Stribild is a fixed-dose combination tablet that contains elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate as active ingredients.\n2. The medications in Stribild are used to treat HIV infection.\n3. Elvitegravir and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors.\n4. Cobicistat is a pharmacokinetic enhancer that increases the levels of elvitegravir in the bloodstream.\n5. Emtricitabine is also a nucleoside reverse transcriptase inhibitor.",
    "yulan-chat-2-13b-fp16_fact": [
      "Stribild is a fixed-dose combination tablet that contains elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate as active ingredients.",
      "The medications in Stribild are used to treat HIV infection.",
      "Elvitegravir and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors.",
      "Cobicistat is a pharmacokinetic enhancer that increases the levels of elvitegravir in the bloodstream.",
      "Emtricitabine is also a nucleoside reverse transcriptase inhibitor."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Elvitegravir is an integrase inhibitor, and tenofovir disoproxil fumarate is a nucleotide reverse transcriptase inhibitor.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2215,
    "user_query": "Does the histone chaperone ASF1 interact with histones H1/H2?",
    "yulan-chat-2-13b-fp16_response": "Yes, the histone chaperone ASF1 (Asf1p) has been shown to interact with both histones H1 and H2.\nASF1 is a protein that plays a key role in the regulation of gene expression in eukaryotic cells. It acts as a chaperone for histones, helping to facilitate their assembly into nucleosomes and also helping to maintain the stability of nucleosomes.\nASF1 has been shown to interact with both histone H1 and H2, although the exact mechanisms of interaction are not fully understood. It has been suggested that ASF1 may interact with H1 and H2 through its N-terminal domain, which contains a histone-binding motif. This domain is thought to be involved in the recognition and binding of histones by ASF1.\nOverall, the interaction between ASF1 and histones H1/H2 is thought to be important for the proper functioning of the histone chaperone system and for the regulation of gene expression in eukaryotic cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The histone chaperone ASF1 interacts with histones H1 and H2.\n2. ASF1 plays a role in the regulation of gene expression in eukaryotic cells.\n3. ASF1 functions as a chaperone for histones and assists in their assembly into nucleosomes.\n4. ASF1 helps maintain the stability of nucleosomes.\n5. The N-terminal domain of ASF1, containing a histone-binding motif, is thought to be involved in the recognition and binding of histones.",
    "yulan-chat-2-13b-fp16_fact": [
      "The histone chaperone ASF1 interacts with histones H1 and H2.",
      "ASF1 plays a role in the regulation of gene expression in eukaryotic cells.",
      "ASF1 functions as a chaperone for histones and assists in their assembly into nucleosomes.",
      "ASF1 helps maintain the stability of nucleosomes.",
      "The N-terminal domain of ASF1, containing a histone-binding motif, is thought to be involved in the recognition and binding of histones."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The histone chaperone ASF1 interacts with histones H3 and H4, not H1 and H2.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2218,
    "user_query": "How many times is CLAST faster than BLAST?",
    "yulan-chat-2-13b-fp16_response": "It is difficult to compare the speed of CLAST and BLAST directly, as the performance of these algorithms can depend on a variety of factors, such as the size of the dataset, the complexity of the search space, and the specific implementation used.\nThat being said, CLAST (Constant Time Language Identification Algorithm) is generally faster than BLAST (Basic Local Alignment Search Tool) for identifying languages in DNA and RNA sequences. This is because CLAST uses a constant time algorithm that does not rely on heuristics or approximate matches, whereas BLAST uses a dynamic programming approach that can be slower for larger datasets.\nHowever, it is important to note that CLAST may not be as accurate as BLAST in some cases, as it makes certain assumptions about the structure of the language and may not be able to identify all possible matches in a sequence. Additionally, BLAST has a wider range of applications beyond language identification, including protein sequence alignment and evolutionary analysis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CLAST stands for Constant Time Language Identification Algorithm.\n2. BLAST stands for Basic Local Alignment Search Tool.\n3. CLAST uses a constant time algorithm that does not rely on heuristics or approximate matches.\n4. BLAST employs a dynamic programming approach for alignments.\n5. BLAST is capable of protein sequence alignment and evolutionary analysis, which are applications beyond language identification.",
    "yulan-chat-2-13b-fp16_fact": [
      "CLAST stands for Constant Time Language Identification Algorithm.",
      "BLAST stands for Basic Local Alignment Search Tool.",
      "CLAST uses a constant time algorithm that does not rely on heuristics or approximate matches.",
      "BLAST employs a dynamic programming approach for alignments.",
      "BLAST is capable of protein sequence alignment and evolutionary analysis, which are applications beyond language identification."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: CLAST stands for Conserved Loci Amplification Sequence Typing.\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: BLAST does not employ a full dynamic programming approach for alignments; it uses a heuristic algorithm to find local sequence alignments.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 2221,
    "user_query": "Which tool is used for the identification of recurrent variants in noncoding regions?",
    "yulan-chat-2-13b-fp16_response": "There are several tools that can be used for the identification of recurrent variants in noncoding regions, including:\n1. GATK (Genome Analysis Toolkit) - a widely used tool for variant discovery and genotyping.\n2. SAMtools - a suite of utilities for manipulating BAM files, including the ability to identify recurrent variants.\n3. Picard - a collection of algorithms for working with high-throughput sequencing data, including the ability to identify recurrent variants.\n4. FreeBayes - a software package for variant discovery and genotyping, including the identification of recurrent variants in noncoding regions.\n5. VarScan - a tool for identifying variants in both coding and noncoding regions, including the ability to identify recurrent variants.\nThe choice of tool may depend on the specific needs and requirements of the project, as well as the type and format of the sequencing data being analyzed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GATK (Genome Analysis Toolkit) is used for variant discovery and genotyping.\n2. SAMtools is used for manipulating BAM files and can identify recurrent variants.\n3. Picard is a collection of algorithms used for working with high-throughput sequencing data and can identify recurrent variants.\n4. FreeBayes is a software package for variant discovery and genotyping that includes identifying recurrent variants in noncoding regions.\n5. VarScan is a tool used for identifying variants in both coding and noncoding regions, including recurrent variants.",
    "yulan-chat-2-13b-fp16_fact": [
      "GATK (Genome Analysis Toolkit) is used for variant discovery and genotyping.",
      "SAMtools is used for manipulating BAM files and can identify recurrent variants.",
      "Picard is a collection of algorithms used for working with high-throughput sequencing data and can identify recurrent variants.",
      "FreeBayes is a software package for variant discovery and genotyping that includes identifying recurrent variants in noncoding regions.",
      "VarScan is a tool used for identifying variants in both coding and noncoding regions, including recurrent variants."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: SAMtools is used for manipulating BAM files, but it doesn't specifically identify recurrent variants; it's mainly for operations like viewing, sorting, and indexing sequences.\n3. FALSE [correction]: Picard is a set of command-line tools for manipulating high-throughput sequencing (HTS) data and formats like SAM/BAM, not for identifying recurrent variants specifically.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2222,
    "user_query": "What body parts are also known as phalanges?",
    "yulan-chat-2-13b-fp16_response": "Phalanges are the bones in the fingers and toes. They are also known as the finger bones or toe bones. There are usually five phalanges in each finger and five in each toe, with the exception of the big toe, which only has four. The phalanges are connected to the bones in the hand and foot, and they allow for movement and flexibility in the fingers and toes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phalanges are the bones located in the fingers and toes.\n2. They are commonly referred to as finger bones or toe bones.\n3. Each finger typically has five phalanges.\n4. Each toe usually has five phalanges, except for the big toe, which has four.\n5. The phalanges are connected to the bones in the hand and foot and provide movement and flexibility.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phalanges are the bones located in the fingers and toes.",
      "They are commonly referred to as finger bones or toe bones.",
      "Each finger typically has five phalanges.",
      "Each toe usually has five phalanges, except for the big toe, which has four.",
      "The phalanges are connected to the bones in the hand and foot and provide movement and flexibility."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Each finger typically has three phalanges, except for the thumb, which usually has two.\n4. FALSE [correction]: Each toe usually has three phalanges, except for the big toe, which typically has two.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2223,
    "user_query": "Are selenium supplements recommended for prostate cancer prevention?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that selenium may have a role in prostate cancer prevention, but the evidence is not definitive and more research is needed. Selenium is a trace element that is essential for the proper functioning of various bodily processes, including the immune system. Some studies have suggested that higher levels of selenium in the diet may be associated with a reduced risk of prostate cancer, but other studies have not found this association.\nThe National Institutes of Health (NIH) recommends that men with a high risk of prostate cancer, such as those with a family history of the disease or those with a history of prostate cancer themselves, consider taking a daily supplement containing 200 micrograms of selenium. However, the NIH also notes that more research is needed to confirm the potential benefits of selenium supplementation for prostate cancer prevention.\nIt is important to note that selenium supplements can have side effects, including gastrointestinal disturbances, nausea, and diarrhea. Additionally, taking high doses of selenium can be toxic, so it is important to talk to a healthcare provider before starting any supplement regimen.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Selenium is a trace element that is essential for the proper functioning of various bodily processes, including the immune system.\n2. Some studies have suggested that higher levels of selenium in the diet may be associated with a reduced risk of prostate cancer.\n3. The National Institutes of Health (NIH) recommends men with a high risk of prostate cancer consider taking a daily supplement containing 200 micrograms of selenium.\n4. The NIH notes that more research is needed to confirm the potential benefits of selenium supplementation for prostate cancer prevention.\n5. Taking high doses of selenium can be toxic.",
    "yulan-chat-2-13b-fp16_fact": [
      "Selenium is a trace element that is essential for the proper functioning of various bodily processes, including the immune system.",
      "Some studies have suggested that higher levels of selenium in the diet may be associated with a reduced risk of prostate cancer.",
      "The National Institutes of Health (NIH) recommends men with a high risk of prostate cancer consider taking a daily supplement containing 200 micrograms of selenium.",
      "The NIH notes that more research is needed to confirm the potential benefits of selenium supplementation for prostate cancer prevention.",
      "Taking high doses of selenium can be toxic."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The National Institutes of Health (NIH) does not specifically recommend that men with a high risk of prostate cancer take a daily supplement containing 200 micrograms of selenium without a healthcare provider's advice. It's important to consult a healthcare provider before starting any supplement regimen, as individual needs may vary and over-supplementation can have harmful effects.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2227,
    "user_query": "Is Downs syndrome associated with decreased risk of leukemia?",
    "yulan-chat-2-13b-fp16_response": "No, Down syndrome is not associated with a decreased risk of leukemia. In fact, individuals with Down syndrome have an increased risk of developing leukemia compared to the general population.\nStudies have shown that individuals with Down syndrome have a higher incidence of leukemia than the general population, with the most common type being acute lymphoblastic leukemia (ALL). The exact reason for this increased risk is not fully understood, but it is thought to be related to the extra genetic material present in individuals with Down syndrome, which can lead to changes in the regulation of cell growth and division.\nIt is important to note that while individuals with Down syndrome may have an increased risk of developing leukemia, they are also at an increased risk of other health problems, including heart disease and Alzheimer's disease. Regular medical check-ups and monitoring are important for individuals with Down syndrome to ensure early detection and treatment of any health issues.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Individuals with Down syndrome have an increased risk of developing leukemia compared to the general population.\n2. The most common type of leukemia in individuals with Down syndrome is acute lymphoblastic leukemia (ALL).\n3. The increased risk of leukemia in individuals with Down syndrome is thought to be related to the extra genetic material they have.\n4. Individuals with Down syndrome are also at an increased risk of other health problems, including heart disease and Alzheimer's disease.\n5. Regular medical check-ups and monitoring are important for individuals with Down syndrome for early detection and treatment of health issues.",
    "yulan-chat-2-13b-fp16_fact": [
      "Individuals with Down syndrome have an increased risk of developing leukemia compared to the general population.",
      "The most common type of leukemia in individuals with Down syndrome is acute lymphoblastic leukemia (ALL).",
      "The increased risk of leukemia in individuals with Down syndrome is thought to be related to the extra genetic material they have.",
      "Individuals with Down syndrome are also at an increased risk of other health problems, including heart disease and Alzheimer's disease.",
      "Regular medical check-ups and monitoring are important for individuals with Down syndrome for early detection and treatment of health issues."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The most common type of leukemia in individuals with Down syndrome is acute myeloid leukemia (AML), specifically the megakaryoblastic subtype, although they are at increased risk for both AML and ALL.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2230,
    "user_query": "Hy's law measures failure for what organ?",
    "yulan-chat-2-13b-fp16_response": "Hy's law is a measure of the failure of the left ventricle of the heart. It is used to assess the ability of the left ventricle to fill with blood and pump it out to the body. The law is named after Dr. William Hyde, who first described it in the early 20th century.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "yulan-chat-2-13b-fp16_response": "There are several R packages that could be used for the identification of pediatric brain tumors, depending on the specific analysis or application. Some examples of R packages that may be relevant include:\n* \"Microarray\" for analyzing gene expression data\n* \"RandomForest\" for classification and prediction\n* \"caret\" for machine learning and model selection\n* \"survival\" for survival analysis\n* \"rgdal\" for reading and writing geospatial data\nIt's important to note that the choice of R package will depend on the specific research question and data type. Additionally, it's always a good idea to consult with a bioinformatics expert or statistician to ensure that the analysis is appropriate and correctly performed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The \"Microarray\" R package can be used for analyzing gene expression data.\n2. The \"RandomForest\" R package can be used for classification and prediction tasks.\n3. The \"caret\" R package is utilized for machine learning and model selection.\n4. The \"survival\" R package is intended for survival analysis.\n5. The \"rgdal\" R package is used for reading and writing geospatial data.",
    "yulan-chat-2-13b-fp16_fact": [
      "The \"Microarray\" R package can be used for analyzing gene expression data.",
      "The \"RandomForest\" R package can be used for classification and prediction tasks.",
      "The \"caret\" R package is utilized for machine learning and model selection.",
      "The \"survival\" R package is intended for survival analysis.",
      "The \"rgdal\" R package is used for reading and writing geospatial data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2243,
    "user_query": "Which factors drive replisome disassembly during DNA replication termination and mitosis?",
    "yulan-chat-2-13b-fp16_response": "Replisome disassembly during DNA replication termination and mitosis is driven by several factors, including:\n1. DNA replication termination: DNA replication termination is a process that marks the end of DNA replication. It is triggered by the binding of specific proteins, such as the Cdc18p protein in Saccharomyces cerevisiae, to the replication fork. These proteins recruit other proteins that cleave the DNA strands, leading to the disassembly of the replisome.\n2. Mitotic exit: Mitotic exit is the process by which cells exit the mitotic cell cycle and enter the interphase. During mitotic exit, the replisome is disassembled to allow for the segregation of sister chromatids during cell division. This process is triggered by the activation of the separase enzyme, which cleaves the cohesin complex that holds the sister chromatids together.\n3. Chromosome condensation: Chromosome condensation is the process by which chromosomes are condensed and prepared for mitosis. During chromosome condensation, the replisome is disassembled, and the DNA is coiled into a more compact form. This process is driven by the action of condensin complexes, which are responsible for the organization of chromosomes during mitosis.\n4. DNA damage response: In response to DNA damage, the replisome can be disassembled to allow for the repair of the damaged DNA. This process is triggered by the activation of DNA damage response pathways, which recruit proteins that disassemble the replisome and initiate DNA repair processes.\nOverall, the disassembly of the replisome during DNA replication termination and mitosis is a complex process that is regulated by multiple factors. These factors ensure that the DNA is properly replicated and segregated during cell division, and that any damage to the DNA is repaired in a timely manner.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. In Saccharomyces cerevisiae, the binding of specific proteins such as Cdc18p to the replication fork triggers DNA replication termination and replisome disassembly.\n2. The activation of separase enzyme triggers mitotic exit by cleaving the cohesin complex, which leads to replisome disassembly.\n3. Chromosome condensation involves the condensin complexes and leads to replisome disassembly during the process.\n4. The DNA damage response can trigger the disassembly of the replisome to allow for DNA repair processes.\n5. Replisome disassembly is crucial for the segregation of sister chromatids during cell division.",
    "yulan-chat-2-13b-fp16_fact": [
      "In Saccharomyces cerevisiae, the binding of specific proteins such as Cdc18p to the replication fork triggers DNA replication termination and replisome disassembly.",
      "The activation of separase enzyme triggers mitotic exit by cleaving the cohesin complex, which leads to replisome disassembly.",
      "Chromosome condensation involves the condensin complexes and leads to replisome disassembly during the process.",
      "The DNA damage response can trigger the disassembly of the replisome to allow for DNA repair processes.",
      "Replisome disassembly is crucial for the segregation of sister chromatids during cell division."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: In Saccharomyces cerevisiae, the binding of specific proteins such as Cdc18p is involved in the initiation of DNA replication, not its termination and replisome disassembly.\n2. TRUE\n3. FALSE [correction]: Chromosome condensation involves the condensin complex but this process does not directly lead to replisome disassembly.\n4. TRUE\n5. FALSE [correction]: Though replisome disassembly is a part of the overall process of cell division, it is not in itself crucial for the segregation of sister chromatids; segregation relies on the separation of sister chromatids which is facilitated by the cleavage of the cohesin complex, among other things.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2244,
    "user_query": "Does RNA polymerase II have RNA cleavage activity?",
    "yulan-chat-2-13b-fp16_response": "RNA polymerase II is an enzyme that catalyzes the transcription of DNA into RNA in eukaryotic cells. It does not have RNA cleavage activity, which is the ability to cleave RNA molecules. RNA cleavage activity is typically associated with enzymes such as RNAse A, which is an endoribonuclease that cleaves RNA molecules within the ribosome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNA polymerase II catalyzes the transcription of DNA into RNA in eukaryotic cells.\n2. RNA polymerase II does not have RNA cleavage activity.\n3. RNA cleavage activity is typically associated with enzymes like RNAse A.\n4. RNAse A is an endoribonuclease that cleaves RNA molecules within the ribosome.",
    "yulan-chat-2-13b-fp16_fact": [
      "RNA polymerase II catalyzes the transcription of DNA into RNA in eukaryotic cells.",
      "RNA polymerase II does not have RNA cleavage activity.",
      "RNA cleavage activity is typically associated with enzymes like RNAse A.",
      "RNAse A is an endoribonuclease that cleaves RNA molecules within the ribosome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: RNAse A is an endoribonuclease that cleaves single-stranded RNA. It does not cleave RNA molecules within the ribosome; ribosomes are the cellular structures where protein synthesis takes place, and RNase A acts elsewhere.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2245,
    "user_query": "Is there a sequence bias in MNase digestion patterns?",
    "yulan-chat-2-13b-fp16_response": "MNase (methylation-sensitive restriction enzyme) digestion is a technique used to analyze the methylation status of DNA. It involves digesting DNA with a methylation-sensitive restriction enzyme, which cuts the DNA at specific sites depending on the methylation status of the cytosine residues.\nThere is no inherent sequence bias in MNase digestion patterns. The restriction enzyme used in MNase digestion is designed to recognize and cut DNA at specific sites based on the methylation status of the cytosine residues. The specificity of the restriction enzyme ensures that the digestion patterns are not influenced by the sequence context of the DNA.\nHowever, it is important to note that there may be technical biases in MNase digestion that can affect the results. For example, the efficiency of the restriction enzyme may vary depending on the methylation status of the DNA, leading to differences in the digestion patterns. Additionally, the efficiency of the digestion may be affected by the concentration of salt or other components in the reaction buffer, or by the temperature or time of the reaction. These technical biases should be carefully controlled and minimized to ensure accurate and reliable results from MNase digestion.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MNase digestion is used to analyze the methylation status of DNA.\n2. MNase utilizes a methylation-sensitive restriction enzyme to cut DNA at specific sites.\n3. The specificity of the methylation-sensitive restriction enzyme is based on the methylation status of cytosine residues.\n4. MNase digestion patterns are not inherently biased by the sequence context of the DNA.\n5. Technical biases in MNase digestion can affect results due to factors like enzyme efficiency, salt concentration, temperature, or reaction time.",
    "yulan-chat-2-13b-fp16_fact": [
      "MNase digestion is used to analyze the methylation status of DNA.",
      "MNase utilizes a methylation-sensitive restriction enzyme to cut DNA at specific sites.",
      "The specificity of the methylation-sensitive restriction enzyme is based on the methylation status of cytosine residues.",
      "MNase digestion patterns are not inherently biased by the sequence context of the DNA.",
      "Technical biases in MNase digestion can affect results due to factors like enzyme efficiency, salt concentration, temperature, or reaction time."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: MNase digestion is used to analyze the chromatin structure, not the methylation status of DNA. It cuts DNA where it is not protected by nucleosomes.\n2. FALSE [correction]: MNase (Micrococcal Nuclease) is not a methylation-sensitive restriction enzyme. It is an endonuclease that digests unprotected DNA, often used to study chromatin structure and nucleosome positioning.\n3. FALSE [correction]: Since MNase is not a methylation-sensitive restriction enzyme, its specificity is not based on methylation status but rather on accessibility of the DNA within chromatin.\n4. FALSE [correction]: MNase digestion patterns can be influenced by the sequence context of DNA because it can affect how DNA is wrapped around nucleosomes and the accessibility of the DNA to the enzyme.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "yulan-chat-2-13b-fp16_response": "Yes, NEMO (Nucleotide-binding oligomerization domain containing) is a zinc finger protein. Zinc finger proteins are a class of transcription factors that bind to specific DNA sequences and regulate gene expression. NEMO is a key regulator of the NF-B (Nuclear factor kappa B) signaling pathway, which plays a crucial role in the immune response and inflammation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NEMO is a zinc finger protein.\n2. Zinc finger proteins are transcription factors that bind to specific DNA sequences to regulate gene expression.\n3. NEMO regulates the NF-B signaling pathway.\n4. The NF-B signaling pathway is involved in the immune response and inflammation.",
    "yulan-chat-2-13b-fp16_fact": [
      "NEMO is a zinc finger protein.",
      "Zinc finger proteins are transcription factors that bind to specific DNA sequences to regulate gene expression.",
      "NEMO regulates the NF-B signaling pathway.",
      "The NF-B signaling pathway is involved in the immune response and inflammation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: NEMO is not a zinc finger protein; it is an essential regulatory protein that is a part of the IB kinase (IKK) complex, which is involved in the NF-B signaling pathway.\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "yulan-chat-2-13b-fp16_response": "Yes, TFIIS (transcription factor II initial binding site) can affect nucleosome positioning.\nNucleosomes are structures composed of DNA wrapped around a core of histone proteins, and their positioning plays a crucial role in regulating gene expression. Transcription factors can interact with nucleosomes and influence their positioning by either promoting or inhibiting the recruitment of histone modifying enzymes or by directly interacting with histones.\nTFIIS is a transcription factor that binds to the promoter region of genes and initiates the transcription of genes. It has been shown to affect nucleosome positioning by recruiting histone modifying enzymes to the promoter region, which can lead to changes in the positioning of nucleosomes. Additionally, TFIIS can also directly interact with histones and influence their positioning.\nOverall, TFIIS can play an important role in regulating gene expression by affecting nucleosome positioning.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TFIIS can affect nucleosome positioning.\n2. Nucleosomes are composed of DNA wrapped around a core of histone proteins.\n3. The positioning of nucleosomes plays a crucial role in regulating gene expression.\n4. TFIIS is a transcription factor that binds to the promoter region of genes.\n5. TFIIS affects nucleosome positioning by recruiting histone modifying enzymes and interacting with histones.",
    "yulan-chat-2-13b-fp16_fact": [
      "TFIIS can affect nucleosome positioning.",
      "Nucleosomes are composed of DNA wrapped around a core of histone proteins.",
      "The positioning of nucleosomes plays a crucial role in regulating gene expression.",
      "TFIIS is a transcription factor that binds to the promoter region of genes.",
      "TFIIS affects nucleosome positioning by recruiting histone modifying enzymes and interacting with histones."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: TFIIS is a transcription elongation factor that functions by enhancing the activity of RNA polymerase II's intrinsic cleavage activity to help clear transcription blockages, not specifically by binding to the promoter region of genes.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2250,
    "user_query": "What is metaSPAdes?",
    "yulan-chat-2-13b-fp16_response": "metaSPAdes is a software tool for analyzing and visualizing genomic datasets. It is designed to work with data from single-cell RNA sequencing (scRNA-seq) experiments, which produce a large amount of data by sequencing the RNA molecules in individual cells.\nmetaSPADES uses a combination of computational and statistical methods to analyze the scRNA-seq data and extract meaningful information from it. It can be used to identify different cell types in the sample, characterize the gene expression patterns of each cell type, and identify genetic variants that are specific to certain cell types.\nOne of the key features of metaSPADES is its ability to perform spatial transcriptomics analysis, which allows researchers to study the spatial organization of cells within tissues. This is achieved by using in situ hybridization (ISH) or other imaging techniques to label the cells of interest, and then using scRNA-seq data to analyze the gene expression patterns of the labeled cells.\nmetaSPADES is an open-source software tool, which means that its source code is available for anyone to use, modify, and distribute. It is written in the Python programming language and is available on GitHub.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. metaSPAdes is a software tool for analyzing and visualizing genomic datasets.\n2. It is designed to work with data from single-cell RNA sequencing (scRNA-seq) experiments.\n3. metaSPAdes can be used to identify different cell types in the sample and characterize gene expression patterns.\n4. It has the capability to perform spatial transcriptomics analysis.\n5. metaSPAdes is open-source software written in Python and is available on GitHub.",
    "yulan-chat-2-13b-fp16_fact": [
      "metaSPAdes is a software tool for analyzing and visualizing genomic datasets.",
      "It is designed to work with data from single-cell RNA sequencing (scRNA-seq) experiments.",
      "metaSPAdes can be used to identify different cell types in the sample and characterize gene expression patterns.",
      "It has the capability to perform spatial transcriptomics analysis.",
      "metaSPAdes is open-source software written in Python and is available on GitHub."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: metaSPAdes is a software tool for assembling metagenomic data (DNA sequences from complex microbial communities), not for analyzing and visualizing genomic datasets. \n2. FALSE [correction]: metaSPAdes is designed for metagenomic assembly, not specifically for data from single-cell RNA sequencing (scRNA-seq) experiments. \n3. FALSE [correction]: metaSPAdes is used for assembling metagenomic sequences, not for identifying different cell types or characterizing gene expression patterns in scRNA-seq data.\n4. FALSE [correction]: metaSPAdes does not have the capability to perform spatial transcriptomics analysis; it is focused on sequence assembly for metagenomics.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2257,
    "user_query": "What is the difference between ganglion mother cells (GMC) and intermediate neural precursor cells (INP) in Drosophila?",
    "yulan-chat-2-13b-fp16_response": "Ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are two types of cells found in the developing nervous system of Drosophila melanogaster, a fruit fly commonly used as a model organism in neuroscience research.\nGMCs are a type of neural stem cell that give rise to the majority of neurons in the Drosophila nervous system. They are found in the ganglionic precursor cells (GPCs) of the embryonic nervous system, and they divide and differentiate into either more GMCs or into immature neurons called neuroblasts. GMCs are characterized by their ability to self-renew and their potential to give rise to a wide range of neuronal cell types.\nINPs, on the other hand, are a type of precursor cell that are intermediate between GMCs and mature neurons. They are found in the ventral nerve cord of the Drosophila embryo and are characterized by their ability to give rise to both GMCs and neurons. INPs are thought to play a key role in the generation of neuronal diversity in the Drosophila nervous system.\nIn summary, GMCs are a type of neural stem cell that give rise to the majority of neurons in the Drosophila nervous system, while INPs are a type of precursor cell that are intermediate between GMCs and mature neurons and play a key role in the generation of neuronal diversity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ganglion mother cells (GMCs) are a type of neural stem cell found in the developing nervous system of Drosophila melanogaster.\n2. GMCs give rise to the majority of neurons in the Drosophila nervous system.\n3. Intermediate neural precursor cells (INPs) are found in the ventral nerve cord of the Drosophila embryo.\n4. INPs can give rise to both GMCs and neurons.\n5. INPs are involved in generating neuronal diversity in the Drosophila nervous system.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ganglion mother cells (GMCs) are a type of neural stem cell found in the developing nervous system of Drosophila melanogaster.",
      "GMCs give rise to the majority of neurons in the Drosophila nervous system.",
      "Intermediate neural precursor cells (INPs) are found in the ventral nerve cord of the Drosophila embryo.",
      "INPs can give rise to both GMCs and neurons.",
      "INPs are involved in generating neuronal diversity in the Drosophila nervous system."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Ganglion mother cells (GMCs) are not stem cells, but rather they are the progeny of neural stem cells called neuroblasts in the developing nervous system of Drosophila melanogaster.\n2. TRUE\n3. UNKNOWN [clarification needed]: Intermediate neural precursors (INPs) are indeed a type of progenitor cell in Drosophila, but whether they are specific to the ventral nerve cord of the embryo might require more specific developmental context which is not provided here.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "yulan-chat-2-13b-fp16_response": "The origins of replication in yeast are located near centromeres, and they typically fire early in the cell cycle. This means that they initiate DNA replication before the cell enters the S phase of the cell cycle, when the chromosomes are replicated in preparation for cell division. The firing of the origins of replication is controlled by a complex set of proteins, including the origin recognition complex (ORC), which is responsible for initiating DNA replication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Origins of replication in yeast are located near centromeres.\n2. In yeast, these origins typically fire early in the cell cycle.\n3. They initiate DNA replication before the cell enters the S phase.\n4. DNA replication is in preparation for cell division in the S phase of the cell cycle.\n5. The origin recognition complex (ORC) is involved in initiating DNA replication in yeast.",
    "yulan-chat-2-13b-fp16_fact": [
      "Origins of replication in yeast are located near centromeres.",
      "In yeast, these origins typically fire early in the cell cycle.",
      "They initiate DNA replication before the cell enters the S phase.",
      "DNA replication is in preparation for cell division in the S phase of the cell cycle.",
      "The origin recognition complex (ORC) is involved in initiating DNA replication in yeast."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Origins of replication in yeast are not typically located near centromeres; they are often found at autonomously replicating sequences (ARS) throughout the genome.\n2. TRUE\n3. FALSE [correction]: DNA replication is initiated as the cell enters the S phase, not before.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "yulan-chat-2-13b-fp16_response": "GA-sequences are a type of genetic element found in mammals that are involved in regulating gene expression. Some properties of mammalian GA-sequences include:\n1. GA-sequences are found in the promoter regions of genes and can act as enhancers or silencers of gene expression.\n2. GA-sequences are composed of a core element, which is typically around 60-70 base pairs long, and flanking elements that can vary in length.\n3. The core element of GA-sequences contains a consensus sequence that is recognized by a group of transcription factors called GA-binding proteins.\n4. GA-sequences can be regulated by epigenetic modifications, such as DNA methylation and histone modifications, which can affect their activity.\n5. GA-sequences can also be regulated by other factors, such as chromatin structure and transcriptional coactivators and repressors.\n6. GA-sequences can be modular, meaning that they can be composed of multiple functional elements that can be rearranged to create different combinations of regulatory effects.\n7. GA-sequences can be highly variable among individuals and can be subject to natural selection, which can lead to their evolution and diversification.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GA-sequences are found in the promoter regions of genes in mammals.\n2. The core element of mammalian GA-sequences is typically around 60-70 base pairs long.\n3. GA-binding proteins are a group of transcription factors that recognize the consensus sequence in the core element of GA-sequences.\n4. Epigenetic modifications such as DNA methylation and histone modifications can regulate the activity of GA-sequences.\n5. GA-sequences can be modular and composed of multiple functional elements.",
    "yulan-chat-2-13b-fp16_fact": [
      "GA-sequences are found in the promoter regions of genes in mammals.",
      "The core element of mammalian GA-sequences is typically around 60-70 base pairs long.",
      "GA-binding proteins are a group of transcription factors that recognize the consensus sequence in the core element of GA-sequences.",
      "Epigenetic modifications such as DNA methylation and histone modifications can regulate the activity of GA-sequences.",
      "GA-sequences can be modular and composed of multiple functional elements."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The core element of mammalian GA-sequences does not have a defined length of 60-70 base pairs long. GA-sequences can vary in length, and the core element is typically a short sequence motif recognized by GA-binding proteins.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2272,
    "user_query": "What is the origin of XUT transcripts in yeast?",
    "yulan-chat-2-13b-fp16_response": "XUT (Xenopus U6 transcript) is a non-coding RNA molecule found in the genome of the model organism Saccharomyces cerevisiae (baker's yeast). It is a member of the H/ACA snoRNA (histone/acetyltransferase snoRNA) family, which are small RNA molecules that guide the site-specific modification of uridines to cytosines in pre-mRNA splicing.\nThe origin of XUT transcripts in yeast is not well understood. However, it is likely that XUT was derived from a gene that was duplicated and then evolved to perform a different function. This is supported by the fact that XUT is found in many eukaryotic species, including animals, plants, and fungi, suggesting that it has been conserved over a long period of evolution.\nIn yeast, XUT is thought to play a role in the regulation of gene expression by interacting with the spliceosome complex, which is responsible for removing introns from pre-mRNA during splicing. Specifically, XUT is thought to interact with the U6 snRNA (small nuclear RNA) component of the spliceosome, and may help to stabilize the complex during splicing.\nOverall, the origin of XUT transcripts in yeast is not fully understood, but it is likely that it evolved from a duplicated gene and has been conserved over a long period of evolution due to its important role in gene expression regulation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. XUT transcripts are found in the genome of Saccharomyces cerevisiae (baker's yeast).\n2. XUT is a member of the H/ACA snoRNA family which guides site-specific modification of uridines to cytosines in pre-mRNA splicing.\n3. XUT is likely derived from a gene that was duplicated and evolved to perform a different function.\n4. XUT is conserved across many eukaryotic species, including animals, plants, and fungi.\n5. In yeast, XUT is thought to play a role in regulating gene expression by interacting with the U6 snRNA component of the spliceosome complex.",
    "yulan-chat-2-13b-fp16_fact": [
      "XUT transcripts are found in the genome of Saccharomyces cerevisiae (baker's yeast).",
      "XUT is a member of the H/ACA snoRNA family which guides site-specific modification of uridines to cytosines in pre-mRNA splicing.",
      "XUT is likely derived from a gene that was duplicated and evolved to perform a different function.",
      "XUT is conserved across many eukaryotic species, including animals, plants, and fungi.",
      "In yeast, XUT is thought to play a role in regulating gene expression by interacting with the U6 snRNA component of the spliceosome complex."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: XUTs (Xrn1-sensitive unstable transcripts) are not members of the H/ACA snoRNA family, which guides the pseudouridylation of RNA. XUTs are instead a class of cryptic unstable transcripts.\n3. UNKNOWN\n4. FALSE [correction]: XUTs are not conserved across many eukaryotic species. They are generally not as well conserved as other RNA species like H/ACA snoRNAs and are specifically identified in Saccharomyces cerevisiae.\n5. FALSE [correction]: XUTs are involved in regulating gene expression, but they do not interact with the U6 snRNA component of the spliceosome complex. Instead, XUTs are believed to function by affecting the decay of regular transcripts.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2274,
    "user_query": "Is autophagy modulated in a circadian fashion?",
    "yulan-chat-2-13b-fp16_response": "Yes, autophagy is modulated in a circadian fashion. Studies have shown that the process of autophagy is regulated by the body's internal clock, also known as the circadian rhythm. This means that the rate of autophagy can vary depending on the time of day, with higher levels of autophagy occurring during certain times of the day and lower levels occurring during others.\nThe circadian regulation of autophagy is thought to be mediated by a variety of factors, including changes in the levels of key autophagy-related proteins, such as Atg5 and Atg7, as well as changes in the activity of cellular processes that are involved in the initiation and execution of autophagy.\nThe circadian regulation of autophagy is thought to play an important role in maintaining cellular homeostasis and ensuring that the body is able to properly metabolize and eliminate damaged or dysfunctional cellular components. Dysregulation of the circadian clock or autophagy has been implicated in a variety of diseases, including metabolic disorders, neurodegenerative diseases, and cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Autophagy is regulated by the body's internal clock, known as the circadian rhythm.\n2. The rate of autophagy varies depending on the time of day.\n3. Higher levels of autophagy occur during certain times of the day and lower levels during others.\n4. Changes in the levels of key autophagy-related proteins, such as Atg5 and Atg7, are involved in the circadian regulation of autophagy.\n5. Dysregulation of the circadian clock or autophagy has been implicated in diseases such as metabolic disorders, neurodegenerative diseases, and cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Autophagy is regulated by the body's internal clock, known as the circadian rhythm.",
      "The rate of autophagy varies depending on the time of day.",
      "Higher levels of autophagy occur during certain times of the day and lower levels during others.",
      "Changes in the levels of key autophagy-related proteins, such as Atg5 and Atg7, are involved in the circadian regulation of autophagy.",
      "Dysregulation of the circadian clock or autophagy has been implicated in diseases such as metabolic disorders, neurodegenerative diseases, and cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEach of the statements relates to well-documented interactions between autophagy (the cellular process for degrading and recycling cellular components) and the circadian rhythm (the body's internal biological clock). It is known that autophagy is influenced by the circadian rhythm, with levels varying across the day, and that important autophagy-related proteins are subject to circadian regulation. Moreover, disruptions in either the circadian clock or autophagy processes have been linked to various health issues, including metabolic conditions, neurodegenerative diseases, and cancers.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2275,
    "user_query": "Is Drk essential for anesthesia-resistant memory (ARM) in Drosophila?",
    "yulan-chat-2-13b-fp16_response": "Drk is a gene that encodes for a protein called dark, which is involved in the regulation of cell death in Drosophila melanogaster. While Drk has been implicated in the regulation of memory formation in Drosophila, it is not essential for anesthesia-resistant memory (ARM), which is a specific form of long-term memory that is resistant to disruption by anesthesia.\nSeveral studies have investigated the role of Drk in memory formation in Drosophila, and while some have suggested a role for Drk in the regulation of ARM, others have found no significant effect of Drk mutations on memory formation. For example, one study found that Drk mutants exhibited normal levels of ARM, while another study found that Drk was not required for the formation of long-term memory in Drosophila.\nOverall, while Drk may play a role in memory formation in Drosophila, it is not essential for the formation of ARM, and its exact role in this process remains unclear.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Drk is a gene that encodes for a protein called dark in Drosophila melanogaster.\n2. Drk is involved in the regulation of cell death in Drosophila melanogaster.\n3. Drk has been implicated in the regulation of memory formation in Drosophila.\n4. Drk is not essential for anesthesia-resistant memory (ARM) in Drosophila.\n5. Some studies have found that Drk mutations do not significantly affect memory formation in Drosophila.",
    "yulan-chat-2-13b-fp16_fact": [
      "Drk is a gene that encodes for a protein called dark in Drosophila melanogaster.",
      "Drk is involved in the regulation of cell death in Drosophila melanogaster.",
      "Drk has been implicated in the regulation of memory formation in Drosophila.",
      "Drk is not essential for anesthesia-resistant memory (ARM) in Drosophila.",
      "Some studies have found that Drk mutations do not significantly affect memory formation in Drosophila."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Drk is essential for anesthesia-resistant memory (ARM) in Drosophila.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2284,
    "user_query": "Has IVIG been tested in clinical trials for the treatment of Alzheimer's disease?",
    "yulan-chat-2-13b-fp16_response": "Yes, IVIG (Intravenous Immunoglobulin) has been tested in clinical trials for the treatment of Alzheimer's disease. However, the results of these trials have been mixed, and more research is needed to determine the efficacy of IVIG as a treatment for Alzheimer's. Some studies have shown promising results, while others have not found any significant benefits. Overall, IVIG is considered an experimental treatment for Alzheimer's and more research is needed to fully understand its potential benefits and risks.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. IVIG (Intravenous Immunoglobulin) has been tested in clinical trials for the treatment of Alzheimer's disease.\n2. The results of these trials have been mixed.\n3. IVIG is considered an experimental treatment for Alzheimer's disease.\n4. More research is needed to determine the efficacy of IVIG as a treatment for Alzheimer's.",
    "yulan-chat-2-13b-fp16_fact": [
      "IVIG (Intravenous Immunoglobulin) has been tested in clinical trials for the treatment of Alzheimer's disease.",
      "The results of these trials have been mixed.",
      "IVIG is considered an experimental treatment for Alzheimer's disease.",
      "More research is needed to determine the efficacy of IVIG as a treatment for Alzheimer's."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2285,
    "user_query": "Which type of urinary incontinence is diagnosed with the Q tip test?",
    "yulan-chat-2-13b-fp16_response": "The Q tip test is not a diagnostic test for any specific type of urinary incontinence. It is a simple test that can be used to assess the ability of a person to hold their urine. The test involves inserting a Q tip or small piece of cotton into the urethra, which is the tube that carries urine out of the body. If the person is able to hold their urine with the Q tip in place, it suggests that the muscles of the bladder and urethra are functioning properly. However, this test cannot diagnose any underlying condition that may be causing urinary incontinence. If you are experiencing symptoms of urinary incontinence, it is important to see a healthcare provider for a proper evaluation and diagnosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2288,
    "user_query": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication",
    "yulan-chat-2-13b-fp16_response": "Cdc48 is a protein complex in budding yeast that plays a key role in the disassembly of ubiquitylated CMG helicase at the end of chromosome replication. The following are some of the important partners of Cdc48 that contribute to this process:\n1. Ubp8: Ubp8 is a ubiquitin-binding protein that is part of the Cdc48 complex. It helps to recognize and bind to ubiquitinated CMG helicase, allowing Cdc48 to disassemble it.\n2. Cdc48-Scc1: Cdc48-Scc1 is a protein complex that consists of Cdc48 and Scc1. Cdc48 is the ATPase that drives the disassembly of CMG helicase, while Scc1 is a metal ion-dependent protease that cleaves the CMG helicase into smaller fragments.\n3. Ubp14: Ubp14 is another ubiquitin-binding protein that is involved in the disassembly of CMG helicase by Cdc48. It helps to stabilize the complex between Cdc48 and ubiquitinated CMG helicase.\n4. Cdc48-Ubp6: Cdc48-Ubp6 is a protein complex that consists of Cdc48 and Ubp6. Ubp6 is a ubiquitin ligase that helps to ubiquitinate CMG helicase, making it accessible to Cdc48 for disassembly.\n5. Cdc48-Ubp4: Cdc48-Ubp4 is a protein complex that consists of Cdc48 and Ubp4. Ubp4 is a ubiquitin-binding protein that helps to stabilize the Cdc48 complex on ubiquitinated CMG helicase.\nOverall, these partners of Cdc48 work together to ensure the proper disassembly of CMG helicase at the end of chromosome replication, thereby ensuring the accuracy of DNA replication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cdc48 is involved in the disassembly of ubiquitylated CMG helicase at the end of chromosome replication in budding yeast.\n2. Ubp8 is a ubiquitin-binding protein that is part of the Cdc48 complex and assists in binding to ubiquitinated CMG helicase.\n3. Cdc48-Scc1 is a protein complex involving Cdc48 and Scc1, where Scc1 acts as a metal ion-dependent protease.\n4. Ubp14 is a ubiquitin-binding protein involved in stabilizing the complex between Cdc48 and ubiquitinated CMG helicase.\n5. Cdc48-Ubp6 is a protein complex consisting of Cdc48 and Ubp6, with Ubp6 functioning as a ubiquitin ligase.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cdc48 is involved in the disassembly of ubiquitylated CMG helicase at the end of chromosome replication in budding yeast.",
      "Ubp8 is a ubiquitin-binding protein that is part of the Cdc48 complex and assists in binding to ubiquitinated CMG helicase.",
      "Cdc48-Scc1 is a protein complex involving Cdc48 and Scc1, where Scc1 acts as a metal ion-dependent protease.",
      "Ubp14 is a ubiquitin-binding protein involved in stabilizing the complex between Cdc48 and ubiquitinated CMG helicase.",
      "Cdc48-Ubp6 is a protein complex consisting of Cdc48 and Ubp6, with Ubp6 functioning as a ubiquitin ligase."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Ubp8 is a ubiquitin-binding protein that is part of the SAGA complex and assists with deubiquitination of histones, not directly with the Cdc48 complex.\n3. FALSE [correction]: Cdc48 is known to form complexes with cofactors such as Ufd1-Npl4 but not Scc1. Scc1/Mcd1 is a subunit of the cohesin complex, which is involved in sister chromatid cohesion, not a metal ion-dependent protease.\n4. FALSE [correction]: Ubp14 (also known as Ubp6) is a deubiquitinating enzyme that associates with Cdc48 to recycle ubiquitin from substrate proteins. It does not stabilize the complex between Cdc48 and ubiquitinated CMG helicase; its function is to disassemble polyubiquitin chains on substrates to recycle ubiquitin.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "yulan-chat-2-13b-fp16_response": "There are 7 Groucho-related genes (GRGs) in the mouse genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The mouse genome contains 7 Groucho-related genes (GRGs).",
    "yulan-chat-2-13b-fp16_fact": [
      "The mouse genome contains 7 Groucho-related genes (GRGs)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "UNKNOWN\n\nGiven the specific and technical nature of this statement, without direct access to current and accurate scientific sources, I cannot confirm the veracity of the statement regarding the number of Groucho-related genes (GRGs) in the mouse genome. Genomic data can be subject to updates and reinterpretations as new research and technologies become available.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown"
    ]
  },
  {
    "id": 2295,
    "user_query": "Which are the main manifestations of Ohdo syndrome?",
    "yulan-chat-2-13b-fp16_response": "Ohdo syndrome, also known as congenital hypertrichosis lanuginosa, is a rare genetic disorder characterized by excessive hair growth on the body. The main manifestations of Ohdo syndrome include:\n1. Abnormal hair growth: The most prominent feature of Ohdo syndrome is the presence of thick, soft, and downy hair covering the entire body, including the face, trunk, arms, and legs. The hair may be longer and thicker than normal, and may be present on areas of the body where hair is not typically found, such as the palms of the hands and soles of the feet.\n2. Delayed hair development: In some cases, individuals with Ohdo syndrome may experience delayed hair development on the scalp, which can lead to a balding appearance in later life.\n3. Thickened nails: The nails of individuals with Ohdo syndrome may be thickened and have a rough texture.\n4. Mild to moderate intellectual disability: Some individuals with Ohdo syndrome may have mild to moderate intellectual disability, although this is not always the case.\n5. Other physical features: In addition to the excessive hair growth, individuals with Ohdo syndrome may have other physical features such as a broad forehead, a prominent nose, and a large jaw.\nIt's important to note that not all individuals with Ohdo syndrome will have all of these symptoms, and the severity of the condition can vary widely among individuals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ohdo syndrome is characterized by excessive hair growth on the body, including the face, trunk, arms, and legs.\n2. Individuals with Ohdo syndrome may have thick, soft, and downy hair covering their body.\n3. Ohdo syndrome can cause delayed hair development on the scalp in some cases.\n4. The nails of individuals with Ohdo syndrome may be thickened and rough textured.\n5. Some individuals with Ohdo syndrome may have mild to moderate intellectual disability.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ohdo syndrome is characterized by excessive hair growth on the body, including the face, trunk, arms, and legs.",
      "Individuals with Ohdo syndrome may have thick, soft, and downy hair covering their body.",
      "Ohdo syndrome can cause delayed hair development on the scalp in some cases.",
      "The nails of individuals with Ohdo syndrome may be thickened and rough textured.",
      "Some individuals with Ohdo syndrome may have mild to moderate intellectual disability."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Ohdo syndrome is not characterized by excessive hair growth on the body; it is characterized by congenital blepharophimosis, which is a narrowing of the eye openings.\n2. FALSE [correction]: Ohdo syndrome does not typically result in thick, soft, and downy hair covering the body. This statement might be confusing Ohdo syndrome with hypertrichosis.\n3. UNKNOWN: There is limited information regarding the specifics of hair development on the scalp related to Ohdo syndrome.\n4. UNKNOWN: There is no widely recognized association between Ohdo syndrome and specific nail abnormalities, but various genetic conditions can have differing effects on nails.\n5. TRUE: Individuals with Ohdo syndrome may indeed have mild to moderate intellectual disability, among other possible features.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2296,
    "user_query": "Which algorithm is used by the UCSC Genome Browser?",
    "yulan-chat-2-13b-fp16_response": "The UCSC Genome Browser uses a variety of algorithms to analyze and display genome data. Some of the key algorithms used by the Genome Browser include:\n1. BLAST: The Basic Local Alignment Search Tool (BLAST) is used to compare DNA and protein sequences and identify regions of similarity.\n2. MUMmer: MUMmer is a software package used for identifying and aligning repetitive DNA sequences, such as transposable elements.\n3. Needleman-Wunsch algorithm: This algorithm is used for global alignment of nucleotide or protein sequences, taking into account the scoring of matches and mismatches.\n4. Smith-Waterman algorithm: This algorithm is similar to the Needleman-Wunsch algorithm, but allows for local alignment of sequences.\n5. BLAT: The Basic Local Alignment Search Tool (BLAST) is used to search for short exact matches in large DNA sequences.\n6. FASTA: The FASTA format is used to represent nucleotide or protein sequences in a simple, text-based format.\n7. FASTQ: The FASTQ format is used to represent high-throughput sequencing data, including base calls, quality scores, and sequence tags.\nThese algorithms are used in various combinations and configurations to analyze and display genome data in the UCSC Genome Browser.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The UCSC Genome Browser uses the Basic Local Alignment Search Tool (BLAST) to compare DNA and protein sequences.\n2. MUMmer is a software package utilized by the UCSC Genome Browser for identifying and aligning repetitive DNA sequences.\n3. The UCSC Genome Browser employs the Needleman-Wunsch algorithm for global alignment of nucleotide or protein sequences.\n4. The Smith-Waterman algorithm, which allows for local alignment of sequences, is used by the UCSC Genome Browser.\n5. BLAT is utilized by the UCSC Genome Browser to search for short exact matches in large DNA sequences.",
    "yulan-chat-2-13b-fp16_fact": [
      "The UCSC Genome Browser uses the Basic Local Alignment Search Tool (BLAST) to compare DNA and protein sequences.",
      "MUMmer is a software package utilized by the UCSC Genome Browser for identifying and aligning repetitive DNA sequences.",
      "The UCSC Genome Browser employs the Needleman-Wunsch algorithm for global alignment of nucleotide or protein sequences.",
      "The Smith-Waterman algorithm, which allows for local alignment of sequences, is used by the UCSC Genome Browser.",
      "BLAT is utilized by the UCSC Genome Browser to search for short exact matches in large DNA sequences."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The UCSC Genome Browser uses BLAT (BLAST-like Alignment Tool), not BLAST, for sequence comparison.\n2. UNKNOWN\n3. TRUE: The Needleman-Wunsch algorithm is indeed a method for global alignment which might be used in various sequence comparison tasks, though I cannot confirm without specific evidence that the UCSC Genome Browser uses this algorithm by default for all global alignment queries.\n4. UNKNOWN\n5. TRUE: BLAT (BLAST-like Alignment Tool) is indeed utilized by the UCSC Genome Browser for rapid sequence alignment, particularly suited for finding short exact matches in large DNA sequences.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2297,
    "user_query": "Which aminoacid position in the human CREB protein is phosphorylated?",
    "yulan-chat-2-13b-fp16_response": "The human CREB (cAMP-response element binding protein) protein can be phosphorylated at several amino acid positions, including serine 133, serine 1427, and threonine 1442. These phosphorylation sites are important for regulating CREB activity and its involvement in various cellular processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The human CREB protein can be phosphorylated at serine 133.\n2. Serine 1427 is a phosphorylation site on the human CREB protein.\n3. Threonine 1442 is a phosphorylation site on the human CREB protein.\n4. Phosphorylation sites on the CREB protein are significant for the regulation of its activity.\n5. Phosphorylation of the CREB protein is involved in various cellular processes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The human CREB protein can be phosphorylated at serine 133.",
      "Serine 1427 is a phosphorylation site on the human CREB protein.",
      "Threonine 1442 is a phosphorylation site on the human CREB protein.",
      "Phosphorylation sites on the CREB protein are significant for the regulation of its activity.",
      "Phosphorylation of the CREB protein is involved in various cellular processes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The human CREB protein, which is a relatively small protein, does not have a serine at position 1427. Its known phosphorylation site relevant to its activation is serine 133.\n3. FALSE [correction]: Threonine 1442 cannot be a phosphorylation site on the human CREB protein because CREB does not have that many amino acids.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2298,
    "user_query": "Which gene is the paralog of yeast UPC2?",
    "yulan-chat-2-13b-fp16_response": "The paralog of yeast UPC2 is the gene UPC2A.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The gene UPC2A is the paralog of yeast UPC2.",
    "yulan-chat-2-13b-fp16_fact": [
      "The gene UPC2A is the paralog of yeast UPC2."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown"
    ]
  },
  {
    "id": 2299,
    "user_query": "Where is the enzyme PM20D1 localized?",
    "yulan-chat-2-13b-fp16_response": "PM20D1 is a gene that encodes for a protein called phosphatidylcholine-4-monooxygenase 20D1. This enzyme is localized in the endoplasmic reticulum (ER) of eukaryotic cells. The ER is a network of membranous tubules and flattened sacs that are interconnected and continuous with each other, and are present in the cells of eukaryotic organisms. The enzyme PM20D1 is involved in the metabolism of phospholipids, which are important components of cell membranes. It is specifically localized to the ER because this is where phospholipids are synthesized and processed in eukaryotic cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PM20D1 encodes for a protein called phosphatidylcholine-4-monooxygenase 20D1.\n2. The enzyme PM20D1 is localized in the endoplasmic reticulum of eukaryotic cells.\n3. The endoplasmic reticulum is a network of membranous tubules and flattened sacs.\n4. The endoplasmic reticulum is continuous and interconnected within eukaryotic cells.\n5. The function of PM20D1 is involved in the metabolism of phospholipids.",
    "yulan-chat-2-13b-fp16_fact": [
      "PM20D1 encodes for a protein called phosphatidylcholine-4-monooxygenase 20D1.",
      "The enzyme PM20D1 is localized in the endoplasmic reticulum of eukaryotic cells.",
      "The endoplasmic reticulum is a network of membranous tubules and flattened sacs.",
      "The endoplasmic reticulum is continuous and interconnected within eukaryotic cells.",
      "The function of PM20D1 is involved in the metabolism of phospholipids."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The function of PM20D1 is involved in the metabolism of fatty acids, not phospholipids.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2301,
    "user_query": "How does increased GDF15 affect body weight?",
    "yulan-chat-2-13b-fp16_response": "GDF15 is a protein that is produced by the gut in response to certain types of dietary fat. It has been suggested that increased levels of GDF15 may be associated with increased body weight, particularly in individuals who consume a diet high in fat. However, the exact mechanisms by which GDF15 affects body weight are not well understood and more research is needed to determine the relationship between GDF15 and weight.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GDF15 is a protein produced by the gut.\n2. GDF15 production is a response to certain types of dietary fat.\n3. Increased levels of GDF15 may be associated with increased body weight.\n4. This association is particularly noted in individuals who consume a diet high in fat.\n5. The exact mechanisms by which GDF15 affects body weight are not well understood.",
    "yulan-chat-2-13b-fp16_fact": [
      "GDF15 is a protein produced by the gut.",
      "GDF15 production is a response to certain types of dietary fat.",
      "Increased levels of GDF15 may be associated with increased body weight.",
      "This association is particularly noted in individuals who consume a diet high in fat.",
      "The exact mechanisms by which GDF15 affects body weight are not well understood."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: GDF15 is a protein that is expressed in various tissues, not just the gut.\n2. TRUE\n3. FALSE [correction]: Increased levels of GDF15 may be associated with a decrease in body weight or appetite suppression.\n4. FALSE [correction]: The association is typically noted as GDF15 acting to decrease body weight, especially in the context of diets high in fat, by reducing appetite or increasing energy expenditure.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "yulan-chat-2-13b-fp16_response": "The RNA polymerase II subunit that carries RNA cleavage activity is called the C-terminal domain (CTD). The CTD is a large structure that is attached to the C-terminus (the end of the protein) of the RPB1 subunit of RNA polymerase II. The CTD contains a number of protein-coding genes, including those that encode for the RNA cleavage complex (RCC), which is responsible for cleaving the RNA molecule during transcription. The RCC complex is composed of several proteins, including the RNA helicase RIG-I, which helps to unwind the RNA molecule, and the RNA-dependent RNA polymerase (RdRp) polymerase beta, which synthesizes new RNA molecules from the cleaved RNA template.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The RNA polymerase II subunit that carries RNA cleavage activity is the C-terminal domain (CTD).\n2. The CTD is attached to the C-terminus of the RPB1 subunit of RNA polymerase II.\n3. The CTD contains genes that encode for the RNA cleavage complex (RCC).\n4. The RCC complex is responsible for cleaving the RNA molecule during transcription.\n5. The RCC complex includes the protein RNA helicase RIG-I, which helps to unwind the RNA molecule.",
    "yulan-chat-2-13b-fp16_fact": [
      "The RNA polymerase II subunit that carries RNA cleavage activity is the C-terminal domain (CTD).",
      "The CTD is attached to the C-terminus of the RPB1 subunit of RNA polymerase II.",
      "The CTD contains genes that encode for the RNA cleavage complex (RCC).",
      "The RCC complex is responsible for cleaving the RNA molecule during transcription.",
      "The RCC complex includes the protein RNA helicase RIG-I, which helps to unwind the RNA molecule."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The RNA polymerase II subunit that carries RNA cleavage activity is not the C-terminal domain (CTD) itself, but rather associated factors like the cleavage and polyadenylation specificity factor (CPSF) and cleavage stimulation factor (CstF) interact with the CTD during the cleavage process.\n2. TRUE\n3. FALSE [correction]: The CTD does not contain genes; it is a region of the RPB1 subunit of RNA polymerase II that is rich in repeats of the amino acid sequence tyrosine-serine-proline-threonine-serine-proline-serine (YSPTSPS) and serves as a platform for the binding of various transcription proteins.\n4. TRUE\n5. FALSE [correction]: The protein RNA helicase RIG-I is involved in innate immunity, recognizing viral RNA in the cell and triggering an immune response. It is not part of the RNA cleavage complex (RCC) responsible for cleaving RNA during transcription.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2306,
    "user_query": "How many PML isoforms exist in the human genome?",
    "yulan-chat-2-13b-fp16_response": "There are 14 PML isoforms known to exist in the human genome. PML (promyelocytic leukemia) is a protein that plays a role in regulating gene expression and is involved in a number of cellular processes, including cell differentiation and apoptosis. It is expressed in a variety of tissues and cell types, and is known to have multiple isoforms that are generated through alternative splicing. These isoforms differ in their amino acid sequences and are thought to have different functions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There are 14 known PML isoforms in the human genome.\n2. PML stands for promyelocytic leukemia.\n3. PML is a protein involved in regulating gene expression.\n4. PML plays a role in various cellular processes, including cell differentiation and apoptosis.\n5. PML isoforms are generated through alternative splicing.",
    "yulan-chat-2-13b-fp16_fact": [
      "There are 14 known PML isoforms in the human genome.",
      "PML stands for promyelocytic leukemia.",
      "PML is a protein involved in regulating gene expression.",
      "PML plays a role in various cellular processes, including cell differentiation and apoptosis.",
      "PML isoforms are generated through alternative splicing."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2312,
    "user_query": "Which tendons are affected in the Dequervain's tenosynovitis?",
    "yulan-chat-2-13b-fp16_response": "Dequervain's tenosynovitis is a condition that affects the tendons of the thumb. Specifically, it involves the tendons that control the movement of the thumb's extensor muscles. These tendons are the extensor pollicis longus, extensor pollicis brevis, and abductor pollicis brevis tendons. Inflammation of these tendons leads to swelling and pain, which can make it difficult to move the thumb or perform everyday activities.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dequervain's tenosynovitis affects the tendons of the thumb.\n2. The condition involves tendons that control the movement of the thumb's extensor muscles.\n3. The extensor pollicis longus, extensor pollicis brevis, and abductor pollicis brevis tendons are involved in Dequervain's tenosynovitis.\n4. Inflammation of these tendons in Dequervain's tenosynovitis leads to swelling and pain.\n5. Dequervain's tenosynovitis can make it difficult to move the thumb or perform everyday activities.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dequervain's tenosynovitis affects the tendons of the thumb.",
      "The condition involves tendons that control the movement of the thumb's extensor muscles.",
      "The extensor pollicis longus, extensor pollicis brevis, and abductor pollicis brevis tendons are involved in Dequervain's tenosynovitis.",
      "Inflammation of these tendons in Dequervain's tenosynovitis leads to swelling and pain.",
      "Dequervain's tenosynovitis can make it difficult to move the thumb or perform everyday activities."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The extensor pollicis brevis and the abductor pollicis longus tendons are involved in Dequervain's tenosynovitis, not the extensor pollicis longus.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2314,
    "user_query": "What does davunetide do to microtubules?",
    "yulan-chat-2-13b-fp16_response": "Davidson's stain, also known as Giemsa, is a histological stain used to stain microtubules in cells. It binds to tubulin, a protein that makes up the microtubules, and stains them a deep blue color. The stain does not affect the structure or function of the microtubules themselves.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2317,
    "user_query": "Which proteins are controlling sterol metabolism in S. cerevisiae?",
    "yulan-chat-2-13b-fp16_response": "Sterol metabolism in S. cerevisiae is controlled by a complex network of proteins, including transporters, isomerases, and regulatory proteins. Some of the key proteins involved in sterol metabolism in S. cerevisiae include:\n1. Ergosterol biosynthesis: Ergosterol is the main sterol in S. cerevisiae, and its biosynthesis is regulated by a complex network of enzymes, including squalene synthase (ERG6), squalene epoxidase (ERG8), and sterol C-14 reductase (ERG5).\n2. Ergosterol catabolism: The breakdown of ergosterol is regulated by several enzymes, including sterol 14-alpha-demethylase (ERG2), sterol 14-alpha-hydroxylase (ERG3), and sterol 14-alpha-oxidase (ERG4).\n3. Sterol uptake and transport: Sterols are taken up from the environment by sterol transporters, such as the high-affinity sterol transporter (Srt1) and the low-affinity sterol transporter (Srt2). These transporters are regulated by sterol regulatory element-binding proteins (SREBPs), which control the expression of genes involved in sterol metabolism.\n4. Sterol regulatory element-binding proteins (SREBPs): SREBPs are transcription factors that control the expression of genes involved in sterol metabolism. They are activated in response to changes in sterol levels and bind to sterol regulatory elements (SREs) in the promoter regions of target genes.\n5. Sterol-sensing proteins: Sterol-sensing proteins, such as the sterol-regulated element-binding protein (Sre1), respond to changes in sterol levels and regulate the expression of genes involved in sterol metabolism.\nOverall, sterol metabolism in S. cerevisiae is a complex process that is tightly regulated by a network of proteins, including transporters, isomerases, and regulatory proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ergosterol is the main sterol in Saccharomyces cerevisiae (S. cerevisiae).\n2. Enzymes involved in ergosterol biosynthesis include squalene synthase (ERG6), squalene epoxidase (ERG8), and sterol C-14 reductase (ERG5).\n3. Enzymes involved in ergosterol catabolism include sterol 14-alpha-demethylase (ERG2), sterol 14-alpha-hydroxylase (ERG3), and sterol 14-alpha-oxidase (ERG4).\n4. Srt1 and Srt2 are transporters involved in sterol uptake and transport in S. cerevisiae.\n5. Sterol regulatory element-binding proteins (SREBPs) are transcription factors that control the expression of genes involved in sterol metabolism in S. cerevisiae.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ergosterol is the main sterol in Saccharomyces cerevisiae (S. cerevisiae).",
      "Enzymes involved in ergosterol biosynthesis include squalene synthase (ERG6), squalene epoxidase (ERG8), and sterol C-14 reductase (ERG5).",
      "Enzymes involved in ergosterol catabolism include sterol 14-alpha-demethylase (ERG2), sterol 14-alpha-hydroxylase (ERG3), and sterol 14-alpha-oxidase (ERG4).",
      "Srt1 and Srt2 are transporters involved in sterol uptake and transport in S. cerevisiae.",
      "Sterol regulatory element-binding proteins (SREBPs) are transcription factors that control the expression of genes involved in sterol metabolism in S. cerevisiae."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Enzymes involved in ergosterol biosynthesis include squalene synthase (ERG9), squalene epoxidase (ERG1), and sterol C-14 reductase (ERG24).\n3. FALSE [correction]: Enzymes involved in ergosterol biosynthesis include sterol 14-alpha-demethylase (ERG11), not ergosterol catabolism. Sterol 14-alpha-hydroxylase (ERG3) is involved in ergosterol biosynthesis as well. The enzyme sterol 14-alpha-oxidase (ERG4) is involved in the last step of ergosterol biosynthesis not catabolism.\n4. FALSE [correction]: Aus1 and PDR11 are transporters involved in sterol uptake and are ATP-binding cassette (ABC) transporters in S. cerevisiae, not Srt1 and Srt2, which appear to be a typo or incorrect name.\n5. FALSE [correction]: Sterol regulatory element-binding proteins (SREBPs) are transcription factors that control the expression of genes involved in sterol metabolism in mammals, not in S. cerevisiae. S. cerevisiae does not have SREBPs; instead, sterol regulation is primarily controlled by the transcription factors UPC2 and Ecm22.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2318,
    "user_query": "Which enzymes are responsible for base J creation in Trypanosoma brucei?",
    "yulan-chat-2-13b-fp16_response": "In Trypanosoma brucei, base J creation is mediated by the activity of the enzyme trypanosomatid cytochrome c oxidase (TCO) complex. This complex is composed of three subunits: cytochrome c, cytochrome b, and a third subunit known as the TCO complex specific subunit. The TCO complex catalyzes the oxidation of ubiquinone to ubiquinol, which is then reduced to ubichinone by the electron transfer chain. The ubichinone is then used to reduce the protonated form of guanine to create base J.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "yulan-chat-2-13b-fp16_response": "Osteogenesis imperfecta (OI) is a genetic disorder that is caused by mutations in the genes that encode for type I collagen. Type I collagen is a protein that is essential for the strength and flexibility of connective tissues, such as bones, cartilage, and tendons.\nOI is inherited in a dominant negative pattern, which means that a person only needs one copy of the mutated gene to develop the disorder. If a person inherits a mutated gene from one parent, they will have a 50% chance of passing the mutation on to their offspring.\nThere are several different types of OI, which are classified based on the severity of the symptoms and the age of onset. The most common type, OI type I, is characterized by mild to severe bone fragility, while OI type II is characterized by severe bone fragility and other symptoms such as blue scleral color, hyperelastic skin, and hypermobility of joints.\nThe genetic basis of OI was discovered in the 1990s, when researchers identified the COL1A1 and COL1A2 genes as the culprits behind the disorder. These genes encode for the alpha-1 and alpha-2 chains of type I collagen, respectively. Mutations in these genes disrupt the structure and function of type I collagen, leading to the characteristic symptoms of OI.\nSince then, many more mutations in these genes have been identified, and researchers have also discovered that mutations in other genes, such as COL10, can also cause OI.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Osteogenesis imperfecta (OI) is a genetic disorder caused by mutations in the genes that encode for type I collagen.\n2. OI is inherited in a dominant negative pattern, meaning a single copy of the mutated gene can lead to the disorder.\n3. The genetic basis of osteogenesis imperfecta was discovered in the 1990s.\n4. Researchers identified the COL1A1 and COL1A2 genes as responsible for osteogenesis imperfecta.\n5. Mutations in the COL1A1 and COL1A2 genes disrupt the structure and function of type I collagen.",
    "yulan-chat-2-13b-fp16_fact": [
      "Osteogenesis imperfecta (OI) is a genetic disorder caused by mutations in the genes that encode for type I collagen.",
      "OI is inherited in a dominant negative pattern, meaning a single copy of the mutated gene can lead to the disorder.",
      "The genetic basis of osteogenesis imperfecta was discovered in the 1990s.",
      "Researchers identified the COL1A1 and COL1A2 genes as responsible for osteogenesis imperfecta.",
      "Mutations in the COL1A1 and COL1A2 genes disrupt the structure and function of type I collagen."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2326,
    "user_query": "How may CTCF mediate splicing?",
    "yulan-chat-2-13b-fp16_response": "CTCF (Catenin-associated transcriptional complex factor) is a transcriptional regulator that plays a role in various cellular processes, including splicing. CTCF is known to interact with the splicing factors and can regulate alternative splicing by modulating the activity of splicing factors. CTCF can also directly interact with RNA polymerase II and other transcriptional machinery, which can affect the splicing efficiency of pre-mRNA. CTCF can also regulate splicing by binding to chromatin and modifying the chromatin structure, which can affect the accessibility of splicing factors to pre-mRNA. Overall, CTCF can mediate splicing by regulating the activity of splicing factors, modifying the chromatin structure, and interacting with the transcriptional machinery.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CTCF is known to interact with splicing factors.\n2. CTCF can regulate alternative splicing by modulating the activity of splicing factors.\n3. CTCF can directly interact with RNA polymerase II.\n4. CTCF can affect the splicing efficiency of pre-mRNA.\n5. CTCF can regulate splicing by binding to chromatin and modifying the chromatin structure.",
    "yulan-chat-2-13b-fp16_fact": [
      "CTCF is known to interact with splicing factors.",
      "CTCF can regulate alternative splicing by modulating the activity of splicing factors.",
      "CTCF can directly interact with RNA polymerase II.",
      "CTCF can affect the splicing efficiency of pre-mRNA.",
      "CTCF can regulate splicing by binding to chromatin and modifying the chromatin structure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nCTCF (CCCTC-binding factor) is a multifunctional nuclear protein involved in various aspects of gene regulation including transcriptional regulation, insulator activity, and chromatin organization. It is known to interact with splicing factors and influence alternative splicing, can modulate the activity of these factors, and has been shown to directly interact with RNA polymerase II. Moreover, CTCF can affect the efficiency of pre-mRNA splicing and regulate splicing by binding to chromatin, which in turn can modify the chromatin structure affecting gene expression.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2329,
    "user_query": "What is the function of the TFIIS transcriptional factor (Dst1) in yeast?",
    "yulan-chat-2-13b-fp16_response": "TFIIS (Dst1) is a transcription factor in yeast that plays a key role in the regulation of gene expression during DNA repair. Specifically, TFIIS binds to the upstream region of genes involved in the DNA damage response and activates their transcription. This helps to ensure that the necessary repair proteins are produced in a timely manner to repair any damage to the genome. In addition to its role in DNA repair, TFIIS may also be involved in other processes that require rapid activation of gene expression, such as stress response and cell cycle progression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TFIIS (Dst1) is a transcription factor in yeast.\n2. TFIIS is involved in the regulation of gene expression during DNA repair.\n3. TFIIS binds to the upstream region of genes involved in the DNA damage response.\n4. TFIIS activates the transcription of genes involved in DNA repair.\n5. TFIIS may also be involved in processes such as stress response and cell cycle progression.",
    "yulan-chat-2-13b-fp16_fact": [
      "TFIIS (Dst1) is a transcription factor in yeast.",
      "TFIIS is involved in the regulation of gene expression during DNA repair.",
      "TFIIS binds to the upstream region of genes involved in the DNA damage response.",
      "TFIIS activates the transcription of genes involved in DNA repair.",
      "TFIIS may also be involved in processes such as stress response and cell cycle progression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TFIIS (Dst1) does not bind directly to the upstream region of genes; it functions by stimulating the intrinsic nuclease activity of RNA polymerase II (Pol II) to assist with the cleavage of nascent RNA at the site of transcription arrest, rather than binding to specific gene regions.\n4. FALSE [correction]: TFIIS does not activate transcription of genes directly; it helps to resume the process of transcription by enabling RNA polymerase II to overcome transcriptional arrest.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "yulan-chat-2-13b-fp16_response": "The R/Bioconductor package that has been developed for the analysis of psychiatric disease genes is called \"psychiatricgenome\". This package provides a set of tools for analyzing genome-wide association studies (GWAS) of psychiatric diseases, including tools for quality control, genotype imputation, and association testing. It also includes a database of genetic variants that have been associated with psychiatric diseases in published GWAS studies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The R/Bioconductor package developed for the analysis of psychiatric disease genes is named \"psychiatricgenome\".\n2. The \"psychiatricgenome\" package includes tools for quality control, genotype imputation, and association testing in the context of genome-wide association studies.\n3. The package also contains a database of genetic variants associated with psychiatric diseases from published GWAS studies.",
    "yulan-chat-2-13b-fp16_fact": [
      "The R/Bioconductor package developed for the analysis of psychiatric disease genes is named \"psychiatricgenome\".",
      "The \"psychiatricgenome\" package includes tools for quality control, genotype imputation, and association testing in the context of genome-wide association studies.",
      "The package also contains a database of genetic variants associated with psychiatric diseases from published GWAS studies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: There isn't a specific R/Bioconductor package with the name \"psychiatricgenome\" known for the analysis of psychiatric disease genes. The name does not match any widely recognized package in the R/Bioconductor ecosystem.\n2. UNKNOWN: Without correct identification of the package, we can't definitively confirm the tools included.\n3. UNKNOWN: Similarly, we cannot confirm the contents of the package's database without the correct identification.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2335,
    "user_query": "What is the function of the gene MDA5?",
    "yulan-chat-2-13b-fp16_response": "The function of the MDA5 gene is not well understood. It has been suggested that it may play a role in the immune system or in the development of the nervous system, but further research is needed to confirm these theories.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2336,
    "user_query": "Which is the conserved motif of DEAD box proteins?",
    "yulan-chat-2-13b-fp16_response": "The conserved motif of DEAD box proteins is the helix-turn-helix (HTH) motif, which is found in the DNA-binding domain of these proteins. The HTH motif is a structural element that is composed of two helices that are connected by a loop region. This motif is important for the recognition of specific DNA sequences by DEAD box proteins, which are involved in various cellular processes, including RNA processing, DNA replication, and transcriptional regulation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DEAD box proteins have a conserved helix-turn-helix (HTH) motif.\n2. The HTH motif is found in the DNA-binding domain of DEAD box proteins.\n3. This motif consists of two helices connected by a loop region.\n4. The HTH motif is vital for the recognition of specific DNA sequences by DEAD box proteins.\n5. DEAD box proteins are involved in various cellular processes, including RNA processing, DNA replication, and transcriptional regulation.",
    "yulan-chat-2-13b-fp16_fact": [
      "DEAD box proteins have a conserved helix-turn-helix (HTH) motif.",
      "The HTH motif is found in the DNA-binding domain of DEAD box proteins.",
      "This motif consists of two helices connected by a loop region.",
      "The HTH motif is vital for the recognition of specific DNA sequences by DEAD box proteins.",
      "DEAD box proteins are involved in various cellular processes, including RNA processing, DNA replication, and transcriptional regulation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: DEAD box proteins are characterized by a conserved motif known as the \"DEAD\" motif (Asp-Glu-Ala-Asp), and do not typically have a helix-turn-helix (HTH) motif.\n2. FALSE [correction]: Since DEAD box proteins do not have a HTH motif, the HTH motif is not found in their DNA-binding domain. Instead, the DEAD box proteins have an ATPase domain that is involved in RNA binding and unwinding.\n3. FALSE [correction]: This statement is regarding the HTH motif, which DEAD box proteins do not have. A HTH motif does consist of two helices connected by a short loop region, but this description is not applicable to DEAD box proteins.\n4. FALSE [correction]: The HTH motif is not part of DEAD box proteins, thus it is not vital for the recognition of specific DNA sequences by them. DEAD box proteins are involved in RNA metabolism and do not typically recognize specific DNA sequences; they interact with RNA molecules.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2338,
    "user_query": "Describe GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types)",
    "yulan-chat-2-13b-fp16_response": "GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types) is a tool used in genetics research to analyze genome-wide association studies (GWAS) data and predict the cell types and tissues that are most likely to be affected by a particular genetic variant. It does this by using statistical models to identify patterns in the data that are associated with specific cell types and tissues. GARLIC can be used to study a wide range of diseases and conditions, and it is a valuable tool for understanding the genetic basis of complex traits and disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GARLIC stands for GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types.\n2. GARLIC is a tool used in genetics research to analyze genome-wide association studies (GWAS) data.\n3. The toolkit predicts the cell types and tissues likely to be affected by specific genetic variants.\n4. It uses statistical models to identify patterns associated with specific cell types and tissues in GWAS data.\n5. GARLIC helps study a wide range of diseases and understand the genetic basis of complex traits and disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "GARLIC stands for GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types.",
      "GARLIC is a tool used in genetics research to analyze genome-wide association studies (GWAS) data.",
      "The toolkit predicts the cell types and tissues likely to be affected by specific genetic variants.",
      "It uses statistical models to identify patterns associated with specific cell types and tissues in GWAS data.",
      "GARLIC helps study a wide range of diseases and understand the genetic basis of complex traits and disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: GARLIC stands for Genetic Association Recommender Lite for Interpreting Cells and does not mean \"GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types.\"\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2345,
    "user_query": "What is the function of yeast TERRA RNAs?",
    "yulan-chat-2-13b-fp16_response": "TERRA (Telomeric repeat-containing RNA) is a type of non-coding RNA found in the nuclei of eukaryotic cells, including yeast. The primary function of TERRA is to stabilize the telomeres, which are the protective caps on the ends of chromosomes that prevent them from degrading or fusing with one another.\nIn yeast, TERRA RNAs are thought to play a similar role in stabilizing telomeres as in other eukaryotic organisms. They do this by forming a complex with the telomeric DNA and the telomerase enzyme, which helps to maintain the length of the telomeres. Additionally, TERRA RNAs may also play a role in regulating the activity of telomerase and other factors involved in telomere maintenance.\nOverall, the function of TERRA RNAs in yeast is to help ensure the stability and integrity of the telomeres, which are essential for maintaining the genetic information contained within the chromosomes and for the survival of the cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TERRA (Telomeric repeat-containing RNA) is a non-coding RNA found in the nuclei of eukaryotic cells.\n2. The primary function of TERRA is to stabilize telomeres.\n3. Telomeres are protective caps on the ends of chromosomes that prevent them from degrading or fusing with each other.\n4. In yeast, TERRA RNAs form a complex with telomeric DNA and the telomerase enzyme.\n5. TERRA RNAs are involved in regulating the activity of telomerase and other factors in telomere maintenance.",
    "yulan-chat-2-13b-fp16_fact": [
      "TERRA (Telomeric repeat-containing RNA) is a non-coding RNA found in the nuclei of eukaryotic cells.",
      "The primary function of TERRA is to stabilize telomeres.",
      "Telomeres are protective caps on the ends of chromosomes that prevent them from degrading or fusing with each other.",
      "In yeast, TERRA RNAs form a complex with telomeric DNA and the telomerase enzyme.",
      "TERRA RNAs are involved in regulating the activity of telomerase and other factors in telomere maintenance."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE: While it's broadly correct that TERRA plays a role in the maintenance and stabilization of telomeres, stating this as the primary function could be misleading depending on the latest research, which might reveal additional roles or a more nuanced understanding of its primary function.\n3. TRUE\n4. FALSE [correction]: In yeast, TERRA RNAs associate with telomeric DNA but they interact with a protein complex known as the RAP1 complex, not directly with the telomerase enzyme. This interaction helps in the regulation of telomere length and structure.\n5. TRUE: TERRA RNAs are indeed known to be involved in the regulation of telomerase activity and telomere maintenance, although the precise mechanisms and interactions can be complex and are subject to ongoing research.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2347,
    "user_query": "Do bacteria from the genus Morexella cause respiratory infections?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information on whether bacteria from the genus Morexella specifically cause respiratory infections. However, there are many different types of bacteria that can cause respiratory infections, including Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus, among others. These bacteria can cause a range of respiratory infections, including pneumonia, bronchitis, and sinusitis. It's important to seek medical attention if you suspect that you have a respiratory infection, as treatment will depend on the specific cause of the infection.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2349,
    "user_query": "Do chromatin features predict genes associated with eQTLs?",
    "yulan-chat-2-13b-fp16_response": "Chromatin features, such as DNA methylation, histone modifications, and chromatin accessibility, can provide information about the regulatory potential of a gene and predict its association with expression quantitative trait loci (eQTLs). eQTLs are genetic variants that are associated with changes in gene expression levels, and understanding the mechanisms behind these associations can provide insights into the regulation of gene expression.\nStudies have shown that chromatin features can be used to predict the presence of eQTLs. For example, DNA methylation has been shown to be associated with eQTLs, with methylation levels at certain genomic regions being linked to changes in gene expression. Histone modifications, such as H3K4me3 and H3K27ac, have also been shown to be associated with eQTLs, with modifications at certain genomic regions being linked to changes in gene expression.\nChromatin accessibility, as measured by assays such as ATAC-seq, has also been shown to be associated with eQTLs. Regions of the genome that are more accessible to transcription factors and other regulatory proteins are more likely to be associated with eQTLs.\nOverall, chromatin features can provide valuable information about the regulatory potential of a gene and can be used to predict its association with eQTLs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chromatin features such as DNA methylation and histone modifications can predict the association of genes with expression quantitative trait loci (eQTLs).\n2. eQTLs are genetic variants that are associated with changes in gene expression levels.\n3. DNA methylation levels at certain genomic regions are linked to changes in gene expression.\n4. Histone modifications, including H3K4me3 and H3K27ac, are associated with eQTLs.\n5. Chromatin accessibility, as measured by ATAC-seq, has been shown to have an association with eQTLs.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chromatin features such as DNA methylation and histone modifications can predict the association of genes with expression quantitative trait loci (eQTLs).",
      "eQTLs are genetic variants that are associated with changes in gene expression levels.",
      "DNA methylation levels at certain genomic regions are linked to changes in gene expression.",
      "Histone modifications, including H3K4me3 and H3K27ac, are associated with eQTLs.",
      "Chromatin accessibility, as measured by ATAC-seq, has been shown to have an association with eQTLs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Chromatin features such as DNA methylation and histone modifications can predict the association of genes with expression quantitative trait loci (eQTLs).\n2. TRUE: eQTLs are genetic variants that are associated with changes in gene expression levels.\n3. TRUE: DNA methylation levels at certain genomic regions are linked to changes in gene expression.\n4. TRUE: Histone modifications, including H3K4me3 and H3K27ac, are associated with eQTLs according to scientific literature, as they play a role in regulating gene activity and can influence gene expression.\n5. TRUE: Chromatin accessibility, as measured by techniques such as ATAC-seq, can reflect the openness of chromatin which affects the binding of transcription factors and consequently has been shown to have an association with eQTLs.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2350,
    "user_query": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta",
    "yulan-chat-2-13b-fp16_response": "The six genes associated with the autosomal recessive form of Osteogenesis imperfecta are:\n1. COL1A1\n2. COL1A2\n3. COL3A1\n4. COL3A2\n5. BMP1\n6. BMP2\nOsteogenesis imperfecta is a genetic disorder characterized by brittle bones that fracture easily, often from minimal trauma or no apparent cause. The autosomal recessive form of the disorder is caused by mutations in one of the six genes listed above, which are all involved in the production of type I and type III collagen, two essential components of bone tissue.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The COL1A1 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.\n2. The COL1A2 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.\n3. The COL3A1 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.\n4. The BMP1 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.\n5. The BMP2 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.",
    "yulan-chat-2-13b-fp16_fact": [
      "The COL1A1 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.",
      "The COL1A2 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.",
      "The COL3A1 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.",
      "The BMP1 gene is associated with the autosomal recessive form of Osteogenesis imperfecta.",
      "The BMP2 gene is associated with the autosomal recessive form of Osteogenesis imperfecta."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The COL1A1 gene is associated with the autosomal dominant form of Osteogenesis imperfecta.\n2. FALSE [correction]: The COL1A2 gene is also associated with the autosomal dominant form of Osteogenesis imperfecta.\n3. UNKNOWN: The COL3A1 gene is primarily associated with a different connective tissue disorder called Ehlers-Danlos syndrome (vascular type), but the relationship to Osteogenesis imperfecta, if any, is not specified from the given statements.\n4. UNKNOWN: The BMP1 gene plays a role in the biosynthetic processing of collagen; however, without additional context, it's unclear if it is associated with the autosomal recessive form of Osteogenesis imperfecta or not.\n5. UNKNOWN: The BMP2 gene is involved in the bone development process; however, without additional context, it's unclear if it is associated with the autosomal recessive form of Osteogenesis imperfecta or not.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2354,
    "user_query": "What is the mode of action of teriparatide?",
    "yulan-chat-2-13b-fp16_response": "Teriparatide is a medication that is used to treat osteoporosis, a condition in which the bones become weak and fragile. It works by stimulating the formation of new bone tissue and increasing bone density.\nThe mode of action of teriparatide is based on its ability to mimic the action of parathyroid hormone (PTH), a natural hormone that plays a key role in regulating bone metabolism. PTH stimulates the formation of new bone tissue and increases bone density by activating osteoblasts, the cells that are responsible for building new bone.\nTeriparatide works by binding to the same receptors as PTH, causing a similar increase in the activity of osteoblasts. This leads to an increase in the formation of new bone tissue and an increase in bone density, which helps to strengthen the bones and reduce the risk of fractures.\nIn addition to its effects on bone metabolism, teriparatide may also have other effects on the body, such as increasing calcium absorption from the gut and increasing the reabsorption of calcium from the kidneys. However, these effects are thought to be secondary to its primary action of stimulating bone formation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Teriparatide is used to treat osteoporosis.\n2. Teriparatide stimulates the formation of new bone tissue and increases bone density.\n3. Teriparatide mimics the action of parathyroid hormone (PTH).\n4. PTH plays a key role in regulating bone metabolism by activating osteoblasts.\n5. Teriparatide binds to the same receptors as PTH and increases the activity of osteoblasts.",
    "yulan-chat-2-13b-fp16_fact": [
      "Teriparatide is used to treat osteoporosis.",
      "Teriparatide stimulates the formation of new bone tissue and increases bone density.",
      "Teriparatide mimics the action of parathyroid hormone (PTH).",
      "PTH plays a key role in regulating bone metabolism by activating osteoblasts.",
      "Teriparatide binds to the same receptors as PTH and increases the activity of osteoblasts."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2355,
    "user_query": "What is the Strelka workflow?",
    "yulan-chat-2-13b-fp16_response": "The Strelka workflow is a design process developed by the Strelka Institute for Media, Architecture, and Design in Moscow, Russia. It is a multidisciplinary approach to design that emphasizes collaboration, experimentation, and rapid prototyping.\nThe Strelka workflow consists of the following steps:\n1. Research: The first step is to conduct extensive research on the project, including background information, user needs, and technological possibilities.\n2. Conceptualization: Based on the research, the team generates a range of ideas and concepts. These ideas are discussed, refined, and developed into a cohesive conceptual framework.\n3. Prototyping: The team creates rapid prototypes of the design, using a variety of media such as sketches, models, and digital simulations. These prototypes are used to test and refine the design concept.\n4. Iteration: The team continually iterates on the design, incorporating feedback from users and stakeholders, and refining the prototype based on new insights and information.\n5. Implementation: Once the design concept is finalized, the team implements the design, working with engineers, fabricators, and other specialists as needed.\nThe Strelka workflow is designed to be flexible and adaptable, allowing the team to respond quickly to changing circumstances and user needs. It emphasizes collaboration and communication, with a focus on creating innovative and effective designs that meet the needs of users and society as a whole.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Strelka Institute for Media, Architecture, and Design in Moscow, Russia developed the Strelka workflow.\n2. The Strelka workflow is a multidisciplinary approach to design.\n3. It consists of steps including research, conceptualization, prototyping, iteration, and implementation.\n4. The workflow emphasizes collaboration, experimentation, and rapid prototyping.\n5. It incorporates feedback from users and stakeholders during the iteration step of the design process.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Strelka Institute for Media, Architecture, and Design in Moscow, Russia developed the Strelka workflow.",
      "The Strelka workflow is a multidisciplinary approach to design.",
      "It consists of steps including research, conceptualization, prototyping, iteration, and implementation.",
      "The workflow emphasizes collaboration, experimentation, and rapid prototyping.",
      "It incorporates feedback from users and stakeholders during the iteration step of the design process."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements 2-5 describe common elements of many design thinking or creative problem-solving methodologies, including a multidisciplinary approach, emphasis on different stages like research, conceptualization, prototyping, iteration, and implementation, as well as the focus on collaboration, experimentation, rapid prototyping, and incorporating feedback. However, without specific information about the \"Strelka workflow\" as developed by the Strelka Institute for Media, Architecture, and Design, I cannot verify the first statement or provide a correction if necessary.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2359,
    "user_query": "Describe mechanism of action of Ozanimod.",
    "yulan-chat-2-13b-fp16_response": "Ozanimod is a sphingosine receptor modulator that acts as an agonist of the S1P1 and S1P5 receptors, and an antagonist of the S1P3 and S1P4 receptors.\nThe S1P receptors are expressed in various cells of the immune system, including lymphocytes, macrophages, and dendritic cells. Activation of the S1P1 and S1P5 receptors by ozanimod leads to inhibition of the proliferation and differentiation of T and B lymphocytes, as well as the migration and activation of macrophages and dendritic cells. This results in reduced inflammation and autoimmune responses.\nIn addition to its immunomodulatory effects, ozanimod also has an impact on the central nervous system. It has been shown to increase the levels of certain neurotransmitters, such as dopamine and serotonin, and to reduce the levels of others, such as glutamate. These effects may contribute to the therapeutic potential of ozanimod in the treatment of multiple sclerosis and other neurological disorders.\nOverall, the mechanism of action of ozanimod is complex and involves multiple pathways and cell types. Its ability to modulate the immune system and the central nervous system make it a promising therapeutic agent for a variety of diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ozanimod is a sphingosine receptor modulator that acts as an agonist of the S1P1 and S1P5 receptors.\n2. Ozanimod acts as an antagonist of the S1P3 and S1P4 receptors.\n3. Activation of the S1P1 and S1P5 receptors by ozanimod inhibits the proliferation and differentiation of T and B lymphocytes.\n4. Ozanimod inhibits the migration and activation of macrophages and dendritic cells.\n5. Ozanimod has been shown to influence neurotransmitter levels in the central nervous system, affecting substances such as dopamine, serotonin, and glutamate.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ozanimod is a sphingosine receptor modulator that acts as an agonist of the S1P1 and S1P5 receptors.",
      "Ozanimod acts as an antagonist of the S1P3 and S1P4 receptors.",
      "Activation of the S1P1 and S1P5 receptors by ozanimod inhibits the proliferation and differentiation of T and B lymphocytes.",
      "Ozanimod inhibits the migration and activation of macrophages and dendritic cells.",
      "Ozanimod has been shown to influence neurotransmitter levels in the central nervous system, affecting substances such as dopamine, serotonin, and glutamate."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Ozanimod does not act as an antagonist of the S1P3 and S1P4 receptors; rather, it is less potent at these receptors compared to S1P1 and S1P5.\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nWhile it is known that ozanimod has immunomodulatory effects through S1P receptor modulation, which can influence the central nervous system due to lymphocyte migration inhibition, the specific claim about altering neurotransmitter levels directly is not well-established in the available literature without further context. Therefore, it's difficult to determine the truthfulness of this statement.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "yulan-chat-2-13b-fp16_response": "The swirl sign is a characteristic imaging finding seen on computed tomography (CT) scans in patients with intracerebral hemorrhage (ICH). It is caused by the swirling movement of blood within the ventricular system of the brain, which can be seen as a \"swirl\" pattern on the CT scan. This sign is often seen in the early stages of ICH and can be an indicator of a poor prognosis. The swirl sign is thought to be caused by the disruption of the normal flow of cerebrospinal fluid within the ventricular system, which is caused by the presence of blood within the ventricles.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The swirl sign is an imaging finding observed on computed tomography (CT) scans.\n2. It is associated with intracerebral hemorrhage (ICH).\n3. The swirl sign is characterized by the presence of a \"swirl\" pattern on the CT scan.\n4. It is typically seen in the early stages of intracerebral hemorrhage.\n5. The presence of the swirl sign can be an indicator of a poor prognosis in ICH patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "The swirl sign is an imaging finding observed on computed tomography (CT) scans.",
      "It is associated with intracerebral hemorrhage (ICH).",
      "The swirl sign is characterized by the presence of a \"swirl\" pattern on the CT scan.",
      "It is typically seen in the early stages of intracerebral hemorrhage.",
      "The presence of the swirl sign can be an indicator of a poor prognosis in ICH patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2361,
    "user_query": "What is Morgellons disease?",
    "yulan-chat-2-13b-fp16_response": "Morgellons disease is a poorly understood, controversial illness characterized by the presence of unusual skin lesions, as well as other symptoms such as fatigue, joint pain, and cognitive difficulties. The disease is named after Mary Leitao, who first described the symptoms in 2001.\nPeople with Morgellons disease often report the presence of small, white, thread-like fibers under the skin, which can be easily extracted. These fibers are sometimes referred to as \"Morgellons fibers.\" The skin lesions can be itchy, painful, and often leave behind a characteristic \"granulated\" appearance.\nThe cause of Morgellons disease is unknown, and there is currently no cure or standard treatment. Some researchers have suggested that the disease may be related to Lyme disease or other tick-borne illnesses, while others have proposed a connection to environmental toxins or chemical sensitivities. However, these theories have not been widely accepted by the medical community.\nBecause Morgellons disease is not recognized as a legitimate medical condition by most health organizations, people with the disease often face skepticism and disbelief from doctors and other healthcare professionals. As a result, many sufferers have turned to online support groups and alternative therapies in an attempt to manage their symptoms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Morgellons disease is characterized by unusual skin lesions, fatigue, joint pain, and cognitive difficulties.\n2. Morgellons disease was first described by Mary Leitao in 2001.\n3. People with Morgellons disease often report the presence of small, white, thread-like fibers under the skin.\n4. The cause of Morgellons disease is currently unknown, and there is no cure or standard treatment.\n5. The medical community does not widely recognize Morgellons disease as a legitimate medical condition.",
    "yulan-chat-2-13b-fp16_fact": [
      "Morgellons disease is characterized by unusual skin lesions, fatigue, joint pain, and cognitive difficulties.",
      "Morgellons disease was first described by Mary Leitao in 2001.",
      "People with Morgellons disease often report the presence of small, white, thread-like fibers under the skin.",
      "The cause of Morgellons disease is currently unknown, and there is no cure or standard treatment.",
      "The medical community does not widely recognize Morgellons disease as a legitimate medical condition."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Morgellons disease was first described by Mary Leitao in 2002, not 2001.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2363,
    "user_query": "What is the asosciation between the eustachian tube and the palatine muscle of the uvula?",
    "yulan-chat-2-13b-fp16_response": "The Eustachian tube and the palatine muscle of the uvula are both structures in the ear that are involved in the process of equalizing air pressure in the middle ear.\nThe Eustachian tube is a small tube that connects the middle ear to the back of the throat. It helps to equalize air pressure by opening and closing in response to changes in air pressure, allowing air to flow between the middle ear and the environment.\nThe palatine muscle of the uvula is a muscle that is located at the back of the throat, near the uvula. It is also involved in the process of equalizing air pressure in the middle ear by helping to lift the uvula and open the Eustachian tube.\nWhen air pressure in the middle ear changes, such as during ascent or descent in an airplane, the palatine muscle of the uvula contracts to lift the uvula and open the Eustachian tube, allowing air to flow between the middle ear and the environment and equalize the air pressure.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Eustachian tube connects the middle ear to the back of the throat.\n2. The function of the Eustachian tube includes equalizing air pressure in the middle ear with the external environment.\n3. The palatine muscle of the uvula is located at the back of the throat, near the uvula.\n4. The palatine muscle of the uvula helps in the equalization of air pressure in the middle ear.\n5. The palatine muscle of the uvula contracts to open the Eustachian tube in response to changes in air pressure, such as during ascent or descent in an airplane.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Eustachian tube connects the middle ear to the back of the throat.",
      "The function of the Eustachian tube includes equalizing air pressure in the middle ear with the external environment.",
      "The palatine muscle of the uvula is located at the back of the throat, near the uvula.",
      "The palatine muscle of the uvula helps in the equalization of air pressure in the middle ear.",
      "The palatine muscle of the uvula contracts to open the Eustachian tube in response to changes in air pressure, such as during ascent or descent in an airplane."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is no specific \"palatine muscle of the uvula.\" The muscle associated with the uvula is the musculus uvulae, which is part of the soft palate muscle group.\n4. FALSE [correction]: It is the tensor veli palatini muscle that helps in the equalization of air pressure in the middle ear by opening the Eustachian tube, not a muscle specifically associated with the uvula.\n5. FALSE [correction]: The muscle responsible for opening the Eustachian tube in response to changes in air pressure is the tensor veli palatini, not the musculus uvulae.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2366,
    "user_query": "Which virus can be diagnosed with the monospot test?",
    "yulan-chat-2-13b-fp16_response": "The monospot test is used to diagnose infectious mononucleosis, also known as \"mono.\" It is caused by the Epstein-Barr virus (EBV), which is a member of the herpesvirus family of viruses. EBV is one of the most common viruses that infects humans, and it is responsible for a range of diseases, including infectious mononucleosis, chronic fatigue syndrome, and various types of cancer. The monospot test is a blood test that detects the presence of EBV-infected white blood cells in the bloodstream. It is commonly used to diagnose infectious mononucleosis, but it can also be used to detect other infections caused by members of the herpesvirus family of viruses.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The monospot test is used to diagnose infectious mononucleosis.\n2. Infectious mononucleosis is commonly known as \"mono.\"\n3. The Epstein-Barr virus (EBV) causes infectious mononucleosis.\n4. Epstein-Barr virus is a member of the herpesvirus family of viruses.\n5. The monospot test detects the presence of EBV-infected white blood cells in the bloodstream.",
    "yulan-chat-2-13b-fp16_fact": [
      "The monospot test is used to diagnose infectious mononucleosis.",
      "Infectious mononucleosis is commonly known as \"mono.\"",
      "The Epstein-Barr virus (EBV) causes infectious mononucleosis.",
      "Epstein-Barr virus is a member of the herpesvirus family of viruses.",
      "The monospot test detects the presence of EBV-infected white blood cells in the bloodstream."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The monospot test detects heterophile antibodies that are produced in response to an Epstein-Barr virus infection, not the presence of EBV-infected white blood cells in the bloodstream.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2376,
    "user_query": "What is the most common histological diagnosis of \"butterfly glioma\"?",
    "yulan-chat-2-13b-fp16_response": "Butterfly glioma, also known as glioblastoma multiforme (GBM), is a type of brain tumor characterized by a butterfly-shaped pattern on imaging studies. It is the most common and aggressive form of glioma, a type of brain cancer.\nThe most common histological diagnosis of butterfly glioma is glioblastoma multiforme (GBM). This type of tumor is highly malignant and can infiltrate into surrounding brain tissue, making it difficult to remove surgically. GBM is characterized by the presence of star-shaped cells and abnormal blood vessels in the tumor. Other histological subtypes of butterfly glioma include anaplastic astrocytoma and glioma grade III.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Butterfly glioma is also known as glioblastoma multiforme (GBM).\n2. Butterfly glioma is the most common and aggressive form of glioma.\n3. Glioblastoma multiforme (GBM) is characterized by a butterfly-shaped pattern on imaging studies.\n4. Glioblastoma multiforme (GBM) contains star-shaped cells and abnormal blood vessels in the tumor.\n5. Other histological subtypes of butterfly glioma include anaplastic astrocytoma and glioma grade III.",
    "yulan-chat-2-13b-fp16_fact": [
      "Butterfly glioma is also known as glioblastoma multiforme (GBM).",
      "Butterfly glioma is the most common and aggressive form of glioma.",
      "Glioblastoma multiforme (GBM) is characterized by a butterfly-shaped pattern on imaging studies.",
      "Glioblastoma multiforme (GBM) contains star-shaped cells and abnormal blood vessels in the tumor.",
      "Other histological subtypes of butterfly glioma include anaplastic astrocytoma and glioma grade III."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Anaplastic astrocytoma and glioma grade III are other subtypes of gliomas, but not subtypes of glioblastoma multiforme (GBM). GBM itself is classified as a grade IV glioma, which is distinct from grade III gliomas such as anaplastic astrocytoma.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2377,
    "user_query": "Which chromosomes are implicated in the Emanuel syndrome?",
    "yulan-chat-2-13b-fp16_response": "The Emanuel syndrome is caused by a deletion or mutation in the 22q11.21 chromosome. This chromosome contains several genes that are important for normal development and function, including the TBX1 gene, which is responsible for the characteristic facial features and heart defects seen in individuals with the syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2379,
    "user_query": "Are loop domains preserved upon cohesin loss?",
    "yulan-chat-2-13b-fp16_response": "Cohesin is a protein complex that plays a key role in maintaining the stability of chromosomes and regulating gene expression. It is involved in the process of DNA replication and segregation, as well as the regulation of gene expression. Loop domains are regions of DNA that are looped out from the rest of the genome and are involved in the regulation of gene expression.\nIt is not clear whether loop domains are preserved upon cohesin loss. Some studies have suggested that cohesin loss can lead to changes in the structure and organization of chromosomes, including the loss of loop domains. However, other studies have suggested that cohesin loss may not have a significant impact on the structure and organization of chromosomes.\nOverall, more research is needed to fully understand the effects of cohesin loss on loop domains and the organization of chromosomes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cohesin is a protein complex that plays a key role in maintaining the stability of chromosomes and regulating gene expression.\n2. Cohesin is involved in the process of DNA replication and segregation.\n3. Loop domains are regions of DNA that are looped out from the rest of the genome and play a role in regulating gene expression.\n4. Some studies have suggested that cohesin loss can lead to changes in the structure and organization of chromosomes, including the loss of loop domains.\n5. Other studies have indicated that cohesin loss may not significantly impact the structure and organization of chromosomes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cohesin is a protein complex that plays a key role in maintaining the stability of chromosomes and regulating gene expression.",
      "Cohesin is involved in the process of DNA replication and segregation.",
      "Loop domains are regions of DNA that are looped out from the rest of the genome and play a role in regulating gene expression.",
      "Some studies have suggested that cohesin loss can lead to changes in the structure and organization of chromosomes, including the loss of loop domains.",
      "Other studies have indicated that cohesin loss may not significantly impact the structure and organization of chromosomes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2380,
    "user_query": "Which workflow in Bioconductor has been developed for accessing human RNA-seq samples?",
    "yulan-chat-2-13b-fp16_response": "The workflow for accessing human RNA-seq samples in Bioconductor is called \"edgeR\".",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bioconductor has a workflow for accessing human RNA-seq samples.\n2. The workflow in Bioconductor for accessing human RNA-seq samples is named \"edgeR\".",
    "yulan-chat-2-13b-fp16_fact": [
      "Bioconductor has a workflow for accessing human RNA-seq samples.",
      "The workflow in Bioconductor for accessing human RNA-seq samples is named \"edgeR\"."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: \"edgeR\" is a software package within Bioconductor used for analyzing RNA-seq data, but it is not specifically a workflow for accessing human RNA-seq samples. Bioconductor has various other tools and workflows for accessing such data, such as the \"GEOquery\" package for querying and downloading data from the NCBI GEO database.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 2387,
    "user_query": "List polyubiquitin binding proteins involved in NF-kappaB signaling.",
    "yulan-chat-2-13b-fp16_response": "There are several polyubiquitin binding proteins involved in NF-kappaB signaling, including:\n1. TRAF6 (Toll-like receptor-associated factor 6)\n2. OTUB1 (O-linked N-acetyl-alpha-D-xylysine-protein isomerase/ubiquitin carboxyl-terminal hydrolase 1)\n3. USP7 (Ubiquitin specific peptidase 7)\n4. USP14 (Ubiquitin specific peptidase 14)\n5. UBE2N (Ubiquitin E2 nucleotide hydrolase 2 homolog)\n6. UBE2V2 (Ubiquitin E2 variant 2)\n7. UBE3A (Ubiquitin-conjugating enzyme E3 component A)\n8. UBE3B (Ubiquitin-conjugating enzyme E3 component B)\n9. UBE3C (Ubiquitin-conjugating enzyme E3 component C)\n10. UBE3D (Ubiquitin-conjugating enzyme E3 component D)\n11. UBE4B (Ubiquitin-conjugating enzyme E2 4B)\n12. UBE4I (Ubiquitin-conjugating enzyme E2 4I)\n13. UBE52 (Ubiquitin-conjugating enzyme E2 52 kDa)\n14. UBE53 (Ubiquitin-conjugating enzyme E2 53 kDa)\n15. UBE55 (Ubiquitin-conjugating enzyme E2 55 kDa)\n16. UBE56 (Ubiquitin-conjugating enzyme E2 56 kDa)\n17. UBE58 (Ubiquitin-conjugating enzyme E2 58 kDa)\n18. UBE66 (Ubiquitin-conjugating enzyme E2 66 kDa)\n19. U",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TRAF6 (Toll-like receptor-associated factor 6) is a polyubiquitin binding protein involved in NF-kappaB signaling.\n2. OTUB1 (O-linked N-acetyl-alpha-D-xylysine-protein isomerase/ubiquitin carboxyl-terminal hydrolase 1) is involved in NF-kappaB signaling.\n3. USP7 (Ubiquitin specific peptidase 7) is a polyubiquitin binding protein associated with NF-kappaB signaling.\n4. USP14 (Ubiquitin specific peptidase 14) plays a role in NF-kappaB signaling.\n5. UBE2N (Ubiquitin E2 nucleotide hydrolase 2 homolog) is part of the NF-kappaB signaling pathway.",
    "yulan-chat-2-13b-fp16_fact": [
      "TRAF6 (Toll-like receptor-associated factor 6) is a polyubiquitin binding protein involved in NF-kappaB signaling.",
      "OTUB1 (O-linked N-acetyl-alpha-D-xylysine-protein isomerase/ubiquitin carboxyl-terminal hydrolase 1) is involved in NF-kappaB signaling.",
      "USP7 (Ubiquitin specific peptidase 7) is a polyubiquitin binding protein associated with NF-kappaB signaling.",
      "USP14 (Ubiquitin specific peptidase 14) plays a role in NF-kappaB signaling.",
      "UBE2N (Ubiquitin E2 nucleotide hydrolase 2 homolog) is part of the NF-kappaB signaling pathway."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: TRAF6 is indeed a protein that is associated with the NF-kappaB signaling pathway, and functions as a signal transducer in the innate immunity pathway by binding polyubiquitin chains.\n2. UNKNOWN: OTUB1 is a deubiquitinating enzyme, and while it may interact with components of the NF-kappaB pathway, its primary role is not well-defined as being involved in NF-kappaB signaling without specific context. More information would be necessary to confirm its involvement.\n3. TRUE: USP7 is known to interact with and deubiquitinate components of the NF-kappaB signaling pathway, which can affect the pathway's activity.\n4. UNKNOWN: USP14 is a deubiquitinating enzyme that is associated with the proteasome and is involved in the regulation of protein degradation. Its direct role in NF-kappaB signaling is not well-established without additional context.\n5. TRUE: UBE2N, also known as UBC13, is an E2 ubiquitin-conjugating enzyme that works together with E3 ligases, such as TRAF6, in the ubiquitination process critical for NF-kappaB activation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2388,
    "user_query": "What are the prednisone side effects in DMD patients?",
    "yulan-chat-2-13b-fp16_response": "Prednisone is a corticosteroid medication that is sometimes used to treat Duchenne muscular dystrophy (DMD). While it can be effective in improving muscle strength and function in some patients, prednisone can also cause a number of side effects.\nSome of the most common side effects of prednisone in DMD patients include:\n1. Weight gain\n2. Increased appetite\n3. Mood changes (such as irritability or anxiety)\n4. Insomnia\n5. Fatigue\n6. Acne\n7. Thinning of the skin\n8. Stretch marks\n9. Menstrual irregularities\n10. Increased risk of infections\nPrednisone can also have more serious side effects, such as:\n1. Osteoporosis (thinning of the bones)\n2. High blood pressure\n3. Increased risk of developing diabetes\n4. Stomach ulcers\n5. Swelling (edema)\n6. Easy bruising or bleeding\n7. Risk of developing cataracts or glaucoma\nIt is important to talk to your doctor about the potential side effects of prednisone before starting treatment, and to report any side effects that you experience while taking the medication. Your doctor may be able to adjust your dosage or recommend alternative treatments to help manage the side effects.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prednisone is used to treat Duchenne muscular dystrophy (DMD).\n2. Common side effects of prednisone in DMD patients include weight gain and increased appetite.\n3. Prednisone can cause mood changes and insomnia in DMD patients.\n4. Serious side effects of prednisone use in DMD patients can include osteoporosis and an increased risk of developing diabetes.\n5. Prednisone has been associated with an increased risk of infections in DMD patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prednisone is used to treat Duchenne muscular dystrophy (DMD).",
      "Common side effects of prednisone in DMD patients include weight gain and increased appetite.",
      "Prednisone can cause mood changes and insomnia in DMD patients.",
      "Serious side effects of prednisone use in DMD patients can include osteoporosis and an increased risk of developing diabetes.",
      "Prednisone has been associated with an increased risk of infections in DMD patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "yulan-chat-2-13b-fp16_response": "ROF1 (ROFL1) is a gene that encodes for a protein called ROFLAID, which is involved in the regulation of plant growth and development. In Arabidopsis, the expression of ROF1 is induced by various environmental and developmental cues.\nOne of the key factors that induce ROF1 expression is light. Exposure to light, particularly blue light, can stimulate the transcription of ROF1 in Arabidopsis. This is because the photoreceptor protein, phototropin, binds to the promoter region of the ROF1 gene and activates its transcription.\nAnother factor that can induce ROF1 expression is cold stress. Cold stress is known to activate the expression of several genes involved in the regulation of plant growth and development, including ROF1. This is because cold stress triggers the activation of several signaling pathways, including the abscisic acid (ABA) signaling pathway, which ultimately leads to the activation of ROF1 expression.\nIn addition to light and cold stress, ROF1 expression can also be induced by other factors such as hormone signaling, nutrient availability, and biotic and abiotic stresses. Overall, the regulation of ROF1 expression is complex and involves the interplay of multiple signaling pathways and environmental cues.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. In Arabidopsis, the expression of ROF1 is induced by various environmental and developmental cues.\n2. Light exposure, particularly blue light, can stimulate the transcription of the ROF1 gene in Arabidopsis.\n3. The photoreceptor protein phototropin binds to the promoter region of the ROF1 gene to activate its transcription.\n4. Cold stress activates the expression of the ROF1 gene in Arabidopsis.\n5. The abscisic acid (ABA) signaling pathway is involved in the activation of ROF1 expression due to cold stress.",
    "yulan-chat-2-13b-fp16_fact": [
      "In Arabidopsis, the expression of ROF1 is induced by various environmental and developmental cues.",
      "Light exposure, particularly blue light, can stimulate the transcription of the ROF1 gene in Arabidopsis.",
      "The photoreceptor protein phototropin binds to the promoter region of the ROF1 gene to activate its transcription.",
      "Cold stress activates the expression of the ROF1 gene in Arabidopsis.",
      "The abscisic acid (ABA) signaling pathway is involved in the activation of ROF1 expression due to cold stress."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: In Arabidopsis, ROF1 (AtFKBP62) is known to be a gene whose expression can be induced by various environmental and developmental cues.\n2. UNKNOWN: While light exposure is a common environmental cue that can affect gene expression in plants, without specific information it is unclear whether blue light, in particular, stimulates the transcription of the ROF1 gene in Arabidopsis.\n3. FALSE [correction]: The photoreceptor proteins that generally respond to blue light in Arabidopsis are called phototropins; however, there's no specific evidence provided here that phototropin or any other photoreceptor binds directly to the promoter region of the ROF1 gene to activate its transcription. Phototropin's role usually involves plant growth responses to light, such as phototropism.\n4. UNKNOWN: Although plants commonly respond to cold stress by activating various genes, without specific information, it cannot be confirmed that cold stress activates the expression of the ROF1 gene in Arabidopsis.\n5. UNKNOWN: The ABA signaling pathway is indeed involved in plant responses to abiotic stress, including cold stress. However, without specific information, it cannot be confirmed that the ABA signaling pathway is involved in the activation of ROF1 expression due to cold stress in Arabidopsis.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2393,
    "user_query": "What is the preferred orientation of CTCF binding sites for chromatin looping?",
    "yulan-chat-2-13b-fp16_response": "CTCF (CCCTC-binding factor) is a transcription factor that plays a key role in regulating gene expression by binding to specific DNA sequences. CTCF binding sites are typically found at the boundaries of topologically associating domains (TADs), which are large chromosomal regions that are tightly packed and show little chromatin movement.\nThe preferred orientation of CTCF binding sites for chromatin looping is thought to be perpendicular to the direction of looping. This means that the CTCF binding sites are located at the edges of the TADs, where the chromatin is in contact with itself, rather than in the middle of the TADs, where the chromatin is looped around a central axis.\nThis orientation is thought to be important for maintaining the stability of the TADs and for regulating gene expression within them. CTCF binding at the edges of the TADs helps to anchor the chromatin in place, preventing it from becoming disorganized or fragmented. Additionally, CTCF binding at the edges of the TADs can regulate the expression of genes within the TADs by controlling the accessibility of the chromatin to transcription factors and other regulatory proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CTCF (CCCTC-binding factor) is a transcription factor that regulates gene expression by binding to specific DNA sequences.\n2. CTCF binding sites are found at the boundaries of topologically associating domains (TADs).\n3. TADs are large chromosomal regions that are tightly packed and show little chromatin movement.\n4. The preferred orientation of CTCF binding sites for chromatin looping is thought to be perpendicular to the direction of looping.\n5. CTCF binding at the edges of TADs helps to anchor chromatin and can regulate the expression of genes within TADs.",
    "yulan-chat-2-13b-fp16_fact": [
      "CTCF (CCCTC-binding factor) is a transcription factor that regulates gene expression by binding to specific DNA sequences.",
      "CTCF binding sites are found at the boundaries of topologically associating domains (TADs).",
      "TADs are large chromosomal regions that are tightly packed and show little chromatin movement.",
      "The preferred orientation of CTCF binding sites for chromatin looping is thought to be perpendicular to the direction of looping.",
      "CTCF binding at the edges of TADs helps to anchor chromatin and can regulate the expression of genes within TADs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TADs are large chromosomal regions that are not necessarily tightly packed; they are defined by their high degree of self-interaction and can show chromatin movement within the domain, but they are insulated from interactions with other chromosomal regions.\n4. UNKNOWN: The statement as given is not clear because the orientation of CTCF binding sites for effective chromatin looping is typically described in terms of convergent or divergent relative to the loop, not perpendicular.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2395,
    "user_query": "How many amino acids does davunetide consist of?",
    "yulan-chat-2-13b-fp16_response": "Davunetide is a synthetic peptide composed of 35 amino acids.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Davunetide is a synthetic peptide.\n2. Davunetide is composed of 35 amino acids.",
    "yulan-chat-2-13b-fp16_fact": [
      "Davunetide is a synthetic peptide.",
      "Davunetide is composed of 35 amino acids."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Davunetide is composed of 8 amino acids.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "yulan-chat-2-13b-fp16_response": "The most common protein that causes hereditary renal amyloidosis is called apolipoprotein A-1 (APOA1). When the APOA1 protein misfolds and forms clumps, they can accumulate in the kidneys and interfere with their ability to function properly, leading to kidney damage and disease. Hereditary renal amyloidosis is a rare genetic disorder that can be inherited from one's parents and can also occur sporadically without a clear cause.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Apolipoprotein A-1 (APOA1) is the most common protein that causes hereditary renal amyloidosis.\n2. Misfolding and accumulation of APOA1 protein can interfere with kidney function and lead to kidney damage.\n3. Hereditary renal amyloidosis is a rare genetic disorder.\n4. Hereditary renal amyloidosis can be inherited from one's parents.\n5. The condition can occur sporadically without a clear cause.",
    "yulan-chat-2-13b-fp16_fact": [
      "Apolipoprotein A-1 (APOA1) is the most common protein that causes hereditary renal amyloidosis.",
      "Misfolding and accumulation of APOA1 protein can interfere with kidney function and lead to kidney damage.",
      "Hereditary renal amyloidosis is a rare genetic disorder.",
      "Hereditary renal amyloidosis can be inherited from one's parents.",
      "The condition can occur sporadically without a clear cause."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Apolipoprotein A-1 (APOA1) is not the most common protein that causes hereditary renal amyloidosis. The most common form of hereditary renal amyloidosis is caused by mutations in the gene encoding for transthyretin (TTR).\n2. TRUE \n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2401,
    "user_query": "Where do centromeres locate according to the Rabl orientation of eukaryotic nuclei?",
    "yulan-chat-2-13b-fp16_response": "In eukaryotic nuclei, centromeres are located near the kinetochores, which are structures that attach the chromosomes to the microtubules of the mitotic spindle during cell division. The Rabl orientation model describes the spatial arrangement of chromosomes during mitosis, where the centromeres are located at the equator of the nuclear envelope and the poles are occupied by the sister chromatids. This means that centromeres are located in the middle of the chromosome and are responsible for the proper alignment and separation of chromosomes during cell division.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Centromeres in eukaryotic nuclei are located near the kinetochores.\n2. Kinetochores are structures that attach chromosomes to the microtubules of the mitotic spindle.\n3. The Rabl orientation model describes the spatial arrangement of chromosomes during mitosis.\n4. According to the Rabl orientation model, centromeres are located at the equator of the nuclear envelope during mitosis.\n5. The poles of the nuclear envelope during mitosis are occupied by sister chromatids according to the Rabl orientation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Centromeres in eukaryotic nuclei are located near the kinetochores.",
      "Kinetochores are structures that attach chromosomes to the microtubules of the mitotic spindle.",
      "The Rabl orientation model describes the spatial arrangement of chromosomes during mitosis.",
      "According to the Rabl orientation model, centromeres are located at the equator of the nuclear envelope during mitosis.",
      "The poles of the nuclear envelope during mitosis are occupied by sister chromatids according to the Rabl orientation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: According to the Rabl orientation model, centromeres are typically located towards the nuclear envelope's periphery opposite the spindle pole during interphase, not at the equator during mitosis.\n5. FALSE [correction]: The Rabl orientation suggests that telomeres cluster at one pole of the nucleus, opposite the centromeres, and not that sister chromatids occupy the poles of the nuclear envelope during mitosis. Sister chromatids do align at the metaphase plate during mitosis and are then pulled towards opposite poles during anaphase.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2404,
    "user_query": "What is the mode of action of the drug Prolia?",
    "yulan-chat-2-13b-fp16_response": "Prolia is a medication that is used to treat osteoporosis, a condition in which the bones become weak and fragile. It is a monoclonal antibody that works by binding to a protein called sclerostin, which is involved in the regulation of bone formation. By binding to sclerostin, Prolia inhibits the activity of this protein, leading to an increase in bone density and a reduction in the risk of fractures. Prolia is administered by injection and is typically used in postmenopausal women and men with osteoporosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prolia is used to treat osteoporosis, a condition where bones become weak and fragile.\n2. Prolia is a monoclonal antibody.\n3. Prolia works by binding to a protein called sclerostin.\n4. Binding to sclerostin by Prolia leads to an increase in bone density.\n5. Prolia is administered by injection and is typically used in postmenopausal women and men with osteoporosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prolia is used to treat osteoporosis, a condition where bones become weak and fragile.",
      "Prolia is a monoclonal antibody.",
      "Prolia works by binding to a protein called sclerostin.",
      "Binding to sclerostin by Prolia leads to an increase in bone density.",
      "Prolia is administered by injection and is typically used in postmenopausal women and men with osteoporosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Prolia works by binding to a protein called RANKL (receptor activator of nuclear factor kappa-B ligand), not sclerostin.\n4. FALSE [correction]: Prolia leads to an increase in bone density by preventing RANKL from activating its receptor, RANK, on the surface of osteoclasts, thereby decreasing bone resorption.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "yulan-chat-2-13b-fp16_response": "Yes, the proteome of the mouse hippocampus has been analyzed. The hippocampus is a brain region that plays a crucial role in learning and memory, and it has been the subject of many proteomic studies.\nOne example of a study that analyzed the proteome of the mouse hippocampus is a paper published in the journal Proteomics in 2011 by Zhang et al. In this study, the authors used tandem mass spectrometry to identify and quantify proteins in the mouse hippocampus. They identified a total of 1,171 proteins, of which 847 were previously unknown.\nAnother example is a study published in the journal Journal of Proteome Research in 2017 by Wang et al. In this study, the authors used a combination of tandem mass spectrometry and liquid chromatography to analyze the proteome of the mouse hippocampus. They identified a total of 1,376 proteins, of which 1,048 were previously unknown.\nThese studies, along with many others, have contributed to our understanding of the proteome of the mouse hippocampus and have provided insights into the molecular mechanisms underlying learning and memory.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The proteome of the mouse hippocampus has been analyzed through various proteomic studies.\n2. A study by Zhang et al. published in the journal Proteomics in 2011 identified a total of 1,171 proteins in the mouse hippocampus.\n3. Of the proteins identified by Zhang et al., 847 were previously unknown.\n4. A study by Wang et al. published in the journal Journal of Proteome Research in 2017 identified a total of 1,376 proteins in the mouse hippocampus.\n5. Of the proteins identified by Wang et al., 1,048 were previously unknown.",
    "yulan-chat-2-13b-fp16_fact": [
      "The proteome of the mouse hippocampus has been analyzed through various proteomic studies.",
      "A study by Zhang et al. published in the journal Proteomics in 2011 identified a total of 1,171 proteins in the mouse hippocampus.",
      "Of the proteins identified by Zhang et al., 847 were previously unknown.",
      "A study by Wang et al. published in the journal Journal of Proteome Research in 2017 identified a total of 1,376 proteins in the mouse hippocampus.",
      "Of the proteins identified by Wang et al., 1,048 were previously unknown."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe responses to statements 2, 3, 4, and 5 are \"UNKNOWN\" because without access to the specific studies by Zhang et al. and Wang et al., it is impossible to verify the exact numbers and details of the proteins they identified as well as how many were previously unknown within this context.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "yulan-chat-2-13b-fp16_response": "Yes, mouse chromosomes are acrocentric. Acrocentric chromosomes have a short telomere (the protective cap at the end of a chromosome) on one end and a long telomere on the other end. This is in contrast to submetacentric chromosomes, which have two short telomeres. The karyotype of a mouse is 40 chromosomes, including 20 pairs of autosomes and two sex chromosomes (X and Y).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mouse chromosomes are acrocentric.\n2. Acrocentric chromosomes have a short telomere on one end and a long telomere on the other end.\n3. Submetacentric chromosomes have two short telomeres.\n4. The karyotype of a mouse consists of 40 chromosomes.\n5. Mice have 20 pairs of autosomes and two sex chromosomes (X and Y).",
    "yulan-chat-2-13b-fp16_fact": [
      "Mouse chromosomes are acrocentric.",
      "Acrocentric chromosomes have a short telomere on one end and a long telomere on the other end.",
      "Submetacentric chromosomes have two short telomeres.",
      "The karyotype of a mouse consists of 40 chromosomes.",
      "Mice have 20 pairs of autosomes and two sex chromosomes (X and Y)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Acrocentric chromosomes have a short arm (p arm) and a long arm (q arm) with the centromere situated closer to one end, creating the appearance of one arm being much shorter than the other. Telomeres are present at the ends of both arms regardless of length.\n3. FALSE [correction]: Submetacentric chromosomes have a shorter arm and a longer arm with the centromere off-center, not two short telomeres. Telomeres are located at the ends of chromosomes, not dictated by the centromere position.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2414,
    "user_query": "Which disease risk can be estimated with the Stop-Bang questionnaire?",
    "yulan-chat-2-13b-fp16_response": "The Stop-Bang questionnaire is primarily used to assess the risk of obstructive sleep apnea (OSA) in individuals. It consists of a series of questions that evaluate the presence of symptoms such as snoring, gasping, and choking during sleep, as well as daytime sleepiness and other related symptoms.\nWhile the Stop-Bang questionnaire is not designed to assess the risk of other diseases, some of the symptoms it evaluates, such as excessive daytime sleepiness and fatigue, may be indicative of other sleep-related disorders or underlying medical conditions. Therefore, if you are experiencing symptoms that may be related to a disease other than OSA, it is important to discuss them with a healthcare professional who can evaluate your symptoms and determine the appropriate course of action.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Stop-Bang questionnaire is used to assess the risk of obstructive sleep apnea (OSA) in individuals.\n2. The questionnaire evaluates symptoms such as snoring, gasping, and choking during sleep.\n3. It also assesses daytime sleepiness and other related symptoms of obstructive sleep apnea.\n4. The Stop-Bang questionnaire is not designed to assess the risk of diseases other than OSA.\n5. Symptoms evaluated by the Stop-Bang questionnaire may be indicative of other sleep-related disorders or underlying medical conditions.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Stop-Bang questionnaire is used to assess the risk of obstructive sleep apnea (OSA) in individuals.",
      "The questionnaire evaluates symptoms such as snoring, gasping, and choking during sleep.",
      "It also assesses daytime sleepiness and other related symptoms of obstructive sleep apnea.",
      "The Stop-Bang questionnaire is not designed to assess the risk of diseases other than OSA.",
      "Symptoms evaluated by the Stop-Bang questionnaire may be indicative of other sleep-related disorders or underlying medical conditions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nWhile the Stop-Bang questionnaire is specifically designed to assess the risk of obstructive sleep apnea, it's important to note that some symptoms it evaluates can be common in other sleep-related disorders or medical conditions, which is why the last statement can also be considered true. However, the primary intention of the Stop-Bang questionnaire is to assess OSA risk.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2415,
    "user_query": "List indications for palivizumab for treatment of RSV-induced bronchiolitis.",
    "yulan-chat-2-13b-fp16_response": "Palivizumab is a monoclonal antibody used to treat respiratory syncytial virus (RSV) infection in infants and young children. It is indicated for the treatment of RSV-induced bronchiolitis in premature infants and young children with a history of prematurity or chronic lung disease who are at increased risk of severe RSV-related respiratory illness. Palivizumab is not indicated for the treatment of RSV infection in children without these risk factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Palivizumab is used to treat respiratory syncytial virus (RSV) infection in infants and young children.\n2. Palivizumab is indicated for the treatment of RSV-induced bronchiolitis in premature infants.\n3. Palivizumab is also indicated for young children with a history of prematurity or chronic lung disease who are at an increased risk of severe RSV-related respiratory illness.\n4. Palivizumab is not indicated for the treatment of RSV infection in children without risk factors such as prematurity or chronic lung disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Palivizumab is used to treat respiratory syncytial virus (RSV) infection in infants and young children.",
      "Palivizumab is indicated for the treatment of RSV-induced bronchiolitis in premature infants.",
      "Palivizumab is also indicated for young children with a history of prematurity or chronic lung disease who are at an increased risk of severe RSV-related respiratory illness.",
      "Palivizumab is not indicated for the treatment of RSV infection in children without risk factors such as prematurity or chronic lung disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "yulan-chat-2-13b-fp16_response": "There are several siRNA-based drugs that are currently in clinical trials for the treatment of pancreatic cancer. Some examples include:\n1. MTL-CEBPA: This is a siRNA-based drug that targets the CEBPA gene, which is overexpressed in pancreatic cancer cells. It is being developed by Metacure Ltd and is currently in Phase 1 clinical trials.\n2. STP701: This is a siRNA-based drug that targets the Survivin gene, which is overexpressed in many cancers, including pancreatic cancer. It is being developed by Survivors of Stomach Cancer Foundation and is currently in Phase 1 clinical trials for the treatment of pancreatic cancer.\n3. LHG-10: This is a siRNA-based drug that targets the HGF gene, which is overexpressed in pancreatic cancer cells. It is being developed by LifeHealthcare Group and is currently in Phase 1 clinical trials for the treatment of pancreatic cancer.\nIt's important to note that while these drugs show promise in early clinical trials, it may be several years before they are approved for widespread use by regulatory agencies such as the FDA.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MTL-CEBPA is a siRNA-based drug that targets the CEBPA gene and is in Phase 1 clinical trials.\n2. STP701 is a siRNA-based drug that targets the Survivin gene and is in Phase 1 clinical trials for pancreatic cancer.\n3. LHG-10 is a siRNA-based drug that targets the HGF gene and is in Phase 1 clinical trials for the treatment of pancreatic cancer.\n4. MTL-CEBPA is being developed by Metacure Ltd.\n5. STP701 is being developed by Survivors of Stomach Cancer Foundation.",
    "yulan-chat-2-13b-fp16_fact": [
      "MTL-CEBPA is a siRNA-based drug that targets the CEBPA gene and is in Phase 1 clinical trials.",
      "STP701 is a siRNA-based drug that targets the Survivin gene and is in Phase 1 clinical trials for pancreatic cancer.",
      "LHG-10 is a siRNA-based drug that targets the HGF gene and is in Phase 1 clinical trials for the treatment of pancreatic cancer.",
      "MTL-CEBPA is being developed by Metacure Ltd.",
      "STP701 is being developed by Survivors of Stomach Cancer Foundation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: MTL-CEBPA is being developed by Silence Therapeutics.\n5. FALSE [correction]: STP701 is not associated with the Survivors of Stomach Cancer Foundation; the development of siRNA drugs would typically involve biotechnology or pharmaceutical companies, but without specific information on STP701, the developer cannot be confirmed.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "yulan-chat-2-13b-fp16_response": "The HPG pore, also known as the high-pressure gate (HPG) or the mechanosensitive ion channel of mammalian cells, is a type of ion channel found in the cell membrane of mammalian cells. It is a mechanosensitive ion channel, meaning that it responds to mechanical stimuli, such as changes in pressure or stretching of the cell membrane.\nThe HPG pore is a voltage-gated ion channel that is activated by a decrease in the membrane potential, which allows calcium ions to enter the cell. This increase in calcium ion concentration then triggers the opening of the HPG pore, which allows sodium ions to flow into the cell. The influx of sodium ions causes the membrane potential to depolarize, which in turn inhibits the HPG pore and causes it to close.\nThe HPG pore plays an important role in regulating the cell's response to mechanical stimuli, such as stretching or compression. It is involved in a variety of physiological processes, including the regulation of cell shape, the control of cell growth and division, and the response to injury or disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The HPG pore stands for high-pressure gate or the mechanosensitive ion channel of mammalian cells.\n2. It is found in the cell membrane of mammalian cells.\n3. The HPG pore is activated by a decrease in membrane potential.\n4. Activation of the HPG pore allows calcium ions to enter the cell, which then triggers the opening of the HPG pore to allow sodium ions to flow into the cell.\n5. The HPG pore is involved in regulating the cell's response to mechanical stimuli and plays a role in physiological processes such as regulation of cell shape, control of cell growth and division, and response to injury or disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "The HPG pore stands for high-pressure gate or the mechanosensitive ion channel of mammalian cells.",
      "It is found in the cell membrane of mammalian cells.",
      "The HPG pore is activated by a decrease in membrane potential.",
      "Activation of the HPG pore allows calcium ions to enter the cell, which then triggers the opening of the HPG pore to allow sodium ions to flow into the cell.",
      "The HPG pore is involved in regulating the cell's response to mechanical stimuli and plays a role in physiological processes such as regulation of cell shape, control of cell growth and division, and response to injury or disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The HPG pore stands for the \"hypotonicity-induced ion channel\" also known as the volume-regulated anion channel (VRAC), not \"high-pressure gate.\"\n2. TRUE\n3. FALSE [correction]: The HPG pore, also known as VRAC, is typically activated by cell swelling, not a decrease in membrane potential.\n4. FALSE [correction]: The primary function of the HPG pore/VRAC is to allow the flow of chloride and organic osmolytes to restore cell volume, not specifically calcium and sodium ions.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2422,
    "user_query": "Which R/Bioconductor package has been developed for cancer subtype identification?",
    "yulan-chat-2-13b-fp16_response": "There are several R/Bioconductor packages that have been developed for cancer subtype identification, including:\n1. limma: This package provides functions for the analysis of affymetrix and other high-density microarray data. It can be used for differential gene expression analysis, normalization, and limma-voom transformation.\n2. survival: This package provides functions for survival analysis, including Kaplan-Meier curves, log-rank tests, and Cox proportional hazards models.\n3. R2: This package provides functions for the analysis of gene expression data, including clustering, classification, and pathway analysis.\n4. OncoArray: This package provides functions for the analysis of cancer genome-wide association studies (GWAS) data.\n5. cancerMethylator: This package provides functions for the analysis of DNA methylation data, including detection of differential methylation and association with cancer subtypes.\n6. Rsubtype: This package provides functions for the identification of cancer subtypes based on gene expression data.\nThese packages can be used for various types of cancer, including breast cancer, lung cancer, and colorectal cancer. It is important to note that the choice of package may depend on the specific research question and type of data being analyzed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The limma package is used for analysis of affymetrix and other high-density microarray data in R/Bioconductor.\n2. The survival package provides functions for survival analysis in R/Bioconductor.\n3. The R2 package in R/Bioconductor is used for gene expression data analysis.\n4. OncoArray is a package in R/Bioconductor developed for the analysis of cancer GWAS data.\n5. The cancerMethylator package in R/Bioconductor is used for the analysis of DNA methylation data.",
    "yulan-chat-2-13b-fp16_fact": [
      "The limma package is used for analysis of affymetrix and other high-density microarray data in R/Bioconductor.",
      "The survival package provides functions for survival analysis in R/Bioconductor.",
      "The R2 package in R/Bioconductor is used for gene expression data analysis.",
      "OncoArray is a package in R/Bioconductor developed for the analysis of cancer GWAS data.",
      "The cancerMethylator package in R/Bioconductor is used for the analysis of DNA methylation data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The R2 package is not a package in R/Bioconductor. R2 is a web-based application for the analysis of gene expression data, but it is not part of the Bioconductor project.\n4. FALSE [correction]: There is no package specifically called \"OncoArray\" in R/Bioconductor for the analysis of cancer GWAS data. However, there are other packages in Bioconductor for genomic analysis, such as GenomicRanges, that could be used for analyzing GWAS data.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2423,
    "user_query": "Is Solanezumab effective for Alzheimer's Disease?",
    "yulan-chat-2-13b-fp16_response": "Solanezumab is a monoclonal antibody that was developed for the treatment of Alzheimer's disease. It works by binding to and reducing the levels of amyloid-beta, a protein that is thought to play a role in the development and progression of Alzheimer's disease.\nIn 2018, the US Food and Drug Administration (FDA) approved solanezumab for the treatment of mild dementia due to Alzheimer's disease. However, since then, the FDA has revised the label for the drug to include a warning about the potential for increased risk of death in some patients treated with the drug.\nSeveral clinical trials have been conducted to evaluate the safety and efficacy of solanezumab for the treatment of Alzheimer's disease. While some of these trials showed a modest slowing of cognitive decline in patients treated with the drug, other trials did not demonstrate significant benefits.\nOverall, the evidence for the effectiveness of solanezumab for Alzheimer's disease is mixed, and more research is needed to fully understand its potential benefits and risks. It is important to note that there is currently no cure for Alzheimer's disease, and available treatments can only help to manage symptoms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Solanezumab is a monoclonal antibody developed to treat Alzheimer's disease.\n2. The US Food and Drug Administration approved solanezumab for the treatment of mild dementia due to Alzheimer's disease in 2018.\n3. Following its approval, the FDA has added a warning about a potential increased risk of death in some patients treated with solanezumab.\n4. Clinical trials have produced mixed results regarding the efficacy of solanezumab in slowing cognitive decline in Alzheimer's patients.\n5. As of the knowledge cutoff date, there is no cure for Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Solanezumab is a monoclonal antibody developed to treat Alzheimer's disease.",
      "The US Food and Drug Administration approved solanezumab for the treatment of mild dementia due to Alzheimer's disease in 2018.",
      "Following its approval, the FDA has added a warning about a potential increased risk of death in some patients treated with solanezumab.",
      "Clinical trials have produced mixed results regarding the efficacy of solanezumab in slowing cognitive decline in Alzheimer's patients.",
      "As of the knowledge cutoff date, there is no cure for Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: As of my knowledge cutoff in early 2023, solanezumab has not been approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer's disease.\n3. FALSE [correction]: Since solanezumab was not approved by the FDA, there cannot be an FDA warning about an increased risk of death in some patients.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2424,
    "user_query": "Are organisms in the genus Morexella associated with sepsis?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have enough information to answer your question. Could you provide more context or clarify what you are asking?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2427,
    "user_query": "Which R/bioconductor package has been developed to aid in epigenomic analysis?",
    "yulan-chat-2-13b-fp16_response": "The R/bioconductor package that has been developed to aid in epigenomic analysis is called \"epigenetic\". This package provides a wide range of tools for analyzing epigenetic data, including DNA methylation, histone modification, and chromatin accessibility data. It includes functions for quality control, normalization, and differential epigenetic feature analysis, as well as for visualization and integration of epigenetic data with gene expression data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The R/bioconductor package developed for epigenomic analysis is called \"epigenetic\".\n2. The \"epigenetic\" package includes tools for analyzing DNA methylation data.\n3. The package provides tools for analyzing histone modification data.\n4. The package contains functions for quality control and normalization of epigenetic data.\n5. The \"epigenetic\" package allows integration of epigenetic data with gene expression data.",
    "yulan-chat-2-13b-fp16_fact": [
      "The R/bioconductor package developed for epigenomic analysis is called \"epigenetic\".",
      "The \"epigenetic\" package includes tools for analyzing DNA methylation data.",
      "The package provides tools for analyzing histone modification data.",
      "The package contains functions for quality control and normalization of epigenetic data.",
      "The \"epigenetic\" package allows integration of epigenetic data with gene expression data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: There is no R/Bioconductor package named \"epigenetic\" known for epigenomic analysis; however, there are packages like \"minfi\", \"ChAMP\", \"missMethyl\", among others, developed for such analyses.\n2. UNKNOWN (Based on the previous correction, the specific features cannot be confirmed for a non-existent package named \"epigenetic.\")\n3. UNKNOWN (Same reasoning as statement 2.)\n4. UNKNOWN (Same reasoning as statement 2.)\n5. UNKNOWN (Same reasoning as statement 2.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2431,
    "user_query": "What is miravirsen?",
    "yulan-chat-2-13b-fp16_response": "Miravirsen is an experimental drug being developed for the treatment of hepatitis C virus (HCV) infection. It is a small interfering RNA (siRNA) molecule designed to target and silence the expression of a specific protein called NS5, which is essential for the replication of HCV. By inhibiting the production of this protein, miravirsen aims to reduce the amount of HCV in the body and potentially clear the infection. Miravirsen is currently in clinical trials and has shown promising results in early studies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Miravirsen is an experimental drug being developed to treat hepatitis C virus (HCV) infection.\n2. Miravirsen functions as a small interfering RNA (siRNA) molecule.\n3. The drug targets and silences the expression of the NS5 protein.\n4. NS5 protein is essential for the replication of the hepatitis C virus.\n5. Miravirsen is currently undergoing clinical trials and has indicated promising results in early studies.",
    "yulan-chat-2-13b-fp16_fact": [
      "Miravirsen is an experimental drug being developed to treat hepatitis C virus (HCV) infection.",
      "Miravirsen functions as a small interfering RNA (siRNA) molecule.",
      "The drug targets and silences the expression of the NS5 protein.",
      "NS5 protein is essential for the replication of the hepatitis C virus.",
      "Miravirsen is currently undergoing clinical trials and has indicated promising results in early studies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Miravirsen is not a small interfering RNA (siRNA) molecule; it is an antagomir, which is a kind of antisense oligonucleotide designed to silence microRNA (specifically miR-122).\n3. FALSE [correction]: The drug targets and silences the expression of microRNA miR-122, not the NS5 protein.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2435,
    "user_query": "Which are the main transcriptional activators of circadian oscillations?",
    "yulan-chat-2-13b-fp16_response": "The main transcriptional activators of circadian oscillations are the basic helix-loop-helix (bHLH) transcription factors, CLOCK and BMAL1, and the PAS (peripheral clock genes) transcription factors, DBP and PER. These transcription factors form heterodimers and bind to E-box elements in the promoter regions of clock-associated genes, leading to their transcriptional activation and regulation of circadian rhythms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CLOCK and BMAL1 are basic helix-loop-helix (bHLH) transcription factors involved in the activation of circadian oscillations.\n2. DBP and PER are PAS (peripheral clock genes) transcription factors that play a role in circadian oscillations.\n3. CLOCK and BMAL1 form heterodimers to function in the regulation of circadian rhythms.\n4. These transcription factors bind to E-box elements in the promoter regions of clock-associated genes.\n5. The binding of these factors to E-box elements leads to transcriptional activation of clock-associated genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "CLOCK and BMAL1 are basic helix-loop-helix (bHLH) transcription factors involved in the activation of circadian oscillations.",
      "DBP and PER are PAS (peripheral clock genes) transcription factors that play a role in circadian oscillations.",
      "CLOCK and BMAL1 form heterodimers to function in the regulation of circadian rhythms.",
      "These transcription factors bind to E-box elements in the promoter regions of clock-associated genes.",
      "The binding of these factors to E-box elements leads to transcriptional activation of clock-associated genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: DBP is a transcription factor, but PER stands for Period proteins, which are not transcription factors but rather part of the negative feedback loop in circadian rhythms. PER proteins interact with other proteins such as CRY (Cryptochrome) to regulate the effects of CLOCK and BMAL1.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2444,
    "user_query": "List the ten types of conjoined twins.",
    "yulan-chat-2-13b-fp16_response": "1. Ichthyopagus twins: These are the most common type of conjoined twins where two babies are joined at the head or upper body area.\n2. Pterygium twins: These are conjoined twins where the two babies are joined at the back of the head and share a common skull.\n3. Ischiopagus twins: These are also known as \"parapagus\" twins where two babies are joined at the pelvis and share a single lower body.\n4. Diplopagus twins: These are conjoined twins where two babies are joined at the chest and share a common upper body.\n5. Heteropagus twins: These are conjoined twins where two babies are joined at an uncommon location such as the abdomen or arms.\n6. Isodiamniotic twins: These are conjoined twins where the two fetuses share a single amniotic sac.\n7. Conjoined twins with a shared heart: This is a rare type of conjoined twins where the two babies share a single heart.\n8. Conjoined twins with a shared liver: This is another rare type of conjoined twins where the two babies share a liver.\n9. Conjoined twins with a shared intestine: This is a rare type of conjoined twins where the two babies share a single intestine.\n10. Conjoined twins with a shared kidney: This is a rare type of conjoined twins where the two babies share a single kidney.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ichthyopagus twins are a type of conjoined twins joined at the head or upper body area.\n2. Pterygium twins are conjoined twins joined at the back of the head and share a common skull.\n3. Ischiopagus twins, also known as parapagus twins, are conjoined twins joined at the pelvis with a shared lower body.\n4. Diplopagus twins are conjoined twins joined at the chest with a shared upper body.\n5. Heteropagus twins are conjoined twins joined at an uncommon location such as the abdomen or arms.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ichthyopagus twins are a type of conjoined twins joined at the head or upper body area.",
      "Pterygium twins are conjoined twins joined at the back of the head and share a common skull.",
      "Ischiopagus twins, also known as parapagus twins, are conjoined twins joined at the pelvis with a shared lower body.",
      "Diplopagus twins are conjoined twins joined at the chest with a shared upper body.",
      "Heteropagus twins are conjoined twins joined at an uncommon location such as the abdomen or arms."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Craniopagus twins are conjoined twins joined at the head, sometimes sharing a common skull.\n3. TRUE\n4. FALSE [correction]: Thoracopagus twins are conjoined twins joined at the chest with a shared upper body. Diplopagus or Duplication refers to a form of conjoined twins where there is a duplication of parts, generally side by side.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2449,
    "user_query": "Is cilengitide effective for treatment of glioblastoma?",
    "yulan-chat-2-13b-fp16_response": "Cilengitide is an experimental drug that is being studied for the treatment of various types of cancer, including glioblastoma. It works by targeting a protein called alpha-vbeta-6 integrin, which is expressed on the surface of certain types of cancer cells.\nThere have been several clinical trials evaluating the safety and effectiveness of cilengitide for the treatment of glioblastoma. While some of these trials have shown promising results, others have been disappointing.\nOverall, the evidence for the effectiveness of cilengitide for the treatment of glioblastoma is still limited and inconclusive. More research is needed to fully understand its potential as a cancer treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cilengitide is an experimental drug being studied for the treatment of various types of cancer, including glioblastoma.\n2. Cilengitide targets a protein called alpha-vbeta-6 integrin.\n3. Alpha-vbeta-6 integrin is expressed on the surface of certain types of cancer cells.\n4. There have been several clinical trials evaluating cilengitide for the treatment of glioblastoma.\n5. The evidence for the effectiveness of cilengitide for the treatment of glioblastoma is limited and inconclusive.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cilengitide is an experimental drug being studied for the treatment of various types of cancer, including glioblastoma.",
      "Cilengitide targets a protein called alpha-vbeta-6 integrin.",
      "Alpha-vbeta-6 integrin is expressed on the surface of certain types of cancer cells.",
      "There have been several clinical trials evaluating cilengitide for the treatment of glioblastoma.",
      "The evidence for the effectiveness of cilengitide for the treatment of glioblastoma is limited and inconclusive."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Cilengitide primarily targets integrins alpha-v beta-3 and alpha-v beta-5.\n3. TRUE, but this statement is slightly vague as it doesn't specify which types and how prevalent alpha-v beta-6 integrin expression is among cancer cells; it could be misleading if alpha-v beta-6 is not typically associated with the types of cancer for which cilengitide is being considered.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2453,
    "user_query": "What is TCGA2BED?",
    "yulan-chat-2-13b-fp16_response": "TCGA2BED is a tool that converts data from the The Cancer Genome Atlas (TCGA) into a format called BED (Browser Extensible Data). BED is a simple text format for storing genomic annotations, such as gene boundaries, variant calls, and expression levels. TCGA2BED allows researchers to easily convert TCGA data into a format that can be used in a variety of genomic analysis tools, such as the Universal Gene Corpus (UGC) and the Genome Browser.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TCGA2BED converts data from The Cancer Genome Atlas (TCGA) into the BED format.\n2. BED stands for Browser Extensible Data, which is a text format for storing genomic annotations.\n3. The BED format is used for storing information like gene boundaries, variant calls, and expression levels.\n4. TCGA2BED helps researchers convert TCGA data for use in genomic analysis tools.\n5. The Universal Gene Corpus (UGC) and the Genome Browser are examples of tools that can use the data formatted by TCGA2BED.",
    "yulan-chat-2-13b-fp16_fact": [
      "TCGA2BED converts data from The Cancer Genome Atlas (TCGA) into the BED format.",
      "BED stands for Browser Extensible Data, which is a text format for storing genomic annotations.",
      "The BED format is used for storing information like gene boundaries, variant calls, and expression levels.",
      "TCGA2BED helps researchers convert TCGA data for use in genomic analysis tools.",
      "The Universal Gene Corpus (UGC) and the Genome Browser are examples of tools that can use the data formatted by TCGA2BED."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Universal Gene Corpus (UGC) is not a known standard tool for genomic analysis. However, the UCSC Genome Browser is an example of a tool that can use data formatted in BED format by TCGA2BED.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2455,
    "user_query": "Is LDB1-mediated enhancer looping dependent on cohesin?",
    "yulan-chat-2-13b-fp16_response": "LDB1 (Lysine Demethylase 1) is an epigenetic modifier that catalyzes the conversion of 5-methylcytosine to 5-hydroxymethylcytosine, which plays a role in regulating gene expression. Enhancer looping is a process by which enhancers interact with promoters to regulate gene expression. It is not clear if LDB1-mediated enhancer looping is dependent on cohesin. Cohesin is a protein complex that plays a role in regulating chromosome organization and gene expression by associating with and stabilizing chromatin structures. It is possible that cohesin may be involved in regulating LDB1-mediated enhancer looping, but more research is needed to understand the specific mechanisms involved.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LDB1 (Lysine Demethylase 1) catalyzes the conversion of 5-methylcytosine to 5-hydroxymethylcytosine.\n2. Enhancer looping is a process where enhancers interact with promoters to regulate gene expression.\n3. Cohesin is a protein complex that plays a role in chromosome organization and gene expression by stabilizing chromatin structures.\n4. It is not definitively established whether LDB1-mediated enhancer looping is dependent on cohesin.\n5. More research is needed to understand the specific mechanisms involved in the potential regulation of LDB1-mediated enhancer looping by cohesin.",
    "yulan-chat-2-13b-fp16_fact": [
      "LDB1 (Lysine Demethylase 1) catalyzes the conversion of 5-methylcytosine to 5-hydroxymethylcytosine.",
      "Enhancer looping is a process where enhancers interact with promoters to regulate gene expression.",
      "Cohesin is a protein complex that plays a role in chromosome organization and gene expression by stabilizing chromatin structures.",
      "It is not definitively established whether LDB1-mediated enhancer looping is dependent on cohesin.",
      "More research is needed to understand the specific mechanisms involved in the potential regulation of LDB1-mediated enhancer looping by cohesin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: LDB1 (Lysine Demethylase 1) does not catalyze the conversion of 5-methylcytosine to 5-hydroxymethylcytosine. It is involved in chromatin remodeling and gene regulation. The enzyme that catalyzes the conversion of 5-methylcytosine to 5-hydroxymethylcytosine is ten-eleven translocation (TET) methylcytosine dioxygenase.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2456,
    "user_query": "Describe nursemaid's elbow injury.",
    "yulan-chat-2-13b-fp16_response": "Nursemaid's elbow, also known as elbow subluxation, is an injury that occurs when the radius bone in the elbow joint is dislocated or partially dislocated from the humerus bone. This injury typically occurs in children between the ages of 4 and 10 years old, and it is most commonly caused by a fall onto the elbow with the arm extended out in front of the body.\nThe symptoms of nursemaid's elbow include pain, swelling, and limited range of motion in the elbow. The child may also have difficulty using the arm or experiencing numbness or tingling in the fingers. A physical examination by a healthcare provider can confirm the diagnosis, which may involve X-rays to visualize the elbow joint.\nTreatment for nursemaid's elbow typically involves a combination of rest, ice, compression, and elevation of the affected arm. In some cases, the elbow may need to be immobilized with a splint or cast for several weeks to allow the bones to heal properly. Physical therapy may also be recommended to help regain range of motion and strength in the elbow.\nPrevention of nursemaid's elbow involves supervising children during playtime and ensuring that they are not engaged in activities that may put them at risk for injury. Additionally, parents can teach their children to fall with their arms close to their bodies to help prevent injury to the elbow joint.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nursemaid's elbow is an injury where the radius bone in the elbow joint is dislocated or partially dislocated from the humerus bone.\n2. This injury typically occurs in children between the ages of 4 and 10 years old.\n3. The common cause of nursemaid's elbow is a fall onto the elbow with the arm extended out in front of the body.\n4. Symptoms of nursemaid's elbow include pain, swelling, and limited range of motion in the elbow.\n5. Treatment for nursemaid's elbow may include rest, ice, compression, elevation, and in some cases, immobilization with a splint or cast.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nursemaid's elbow is an injury where the radius bone in the elbow joint is dislocated or partially dislocated from the humerus bone.",
      "This injury typically occurs in children between the ages of 4 and 10 years old.",
      "The common cause of nursemaid's elbow is a fall onto the elbow with the arm extended out in front of the body.",
      "Symptoms of nursemaid's elbow include pain, swelling, and limited range of motion in the elbow.",
      "Treatment for nursemaid's elbow may include rest, ice, compression, elevation, and in some cases, immobilization with a splint or cast."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: This injury typically occurs in children between the ages of 1 and 4 years old.\n3. FALSE [correction]: The common cause of nursemaid's elbow is a sudden pulling or traction on the extended arm, such as when a child is lifted or swung by their arms.\n4. TRUE\n5. FALSE [correction]: Treatment for nursemaid's elbow typically involves a healthcare professional performing a gentle manipulation, known as a reduction, to move the radius bone back into place. Rest, ice, compression, and elevation are not the primary treatments for this injury, and immobilization with a splint or cast is rarely necessary.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2458,
    "user_query": "What is mechanism of action of Benralizumab?",
    "yulan-chat-2-13b-fp16_response": "Benralizumab is a monoclonal antibody that targets the alpha-S1 subunit of the interleukin-13 (IL-13) receptor, which is involved in the pathogenesis of asthma and other allergic diseases.\nBy binding to the IL-13 receptor, benralizumab inhibits the binding of IL-13 to its receptor, thereby preventing the activation of downstream signaling pathways that contribute to airway inflammation, mucus production, and other symptoms of asthma.\nIn addition to its direct effects on IL-13 signaling, benralizumab has also been shown to induce the degradation of excess mucus in the airways, which further contributes to its efficacy in treating asthma.\nOverall, the mechanism of action of benralizumab is to disrupt the signaling pathways that drive asthma and other allergic diseases, leading to reduced inflammation and improved lung function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Benralizumab is a monoclonal antibody that targets the alpha-S1 subunit of the interleukin-13 (IL-13) receptor.\n2. The alpha-S1 subunit of the IL-13 receptor is involved in the pathogenesis of asthma and other allergic diseases.\n3. By binding to the IL-13 receptor, benralizumab inhibits the binding of IL-13 to its receptor.\n4. Inhibition of IL-13 binding to its receptor prevents the activation of downstream signaling pathways that contribute to airway inflammation and mucus production in asthma.\n5. Benralizumab induces the degradation of excess mucus in the airways.",
    "yulan-chat-2-13b-fp16_fact": [
      "Benralizumab is a monoclonal antibody that targets the alpha-S1 subunit of the interleukin-13 (IL-13) receptor.",
      "The alpha-S1 subunit of the IL-13 receptor is involved in the pathogenesis of asthma and other allergic diseases.",
      "By binding to the IL-13 receptor, benralizumab inhibits the binding of IL-13 to its receptor.",
      "Inhibition of IL-13 binding to its receptor prevents the activation of downstream signaling pathways that contribute to airway inflammation and mucus production in asthma.",
      "Benralizumab induces the degradation of excess mucus in the airways."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Benralizumab is a monoclonal antibody that targets the interleukin-5 receptor alpha (IL-5R), not the IL-13 receptor.\n2. UNKNOWN (The statement regarding the alpha-S1 subunit of the IL-13 receptor is very specific, and without further context, it's unclear if the \"alpha-S1\" designation is accurate. However, the IL-13 receptor is indeed involved in the pathogenesis of asthma and other allergic diseases.)\n3. FALSE [correction]: By binding to the IL-5 receptor, benralizumab inhibits the binding of interleukin-5, not interleukin-13.\n4. TRUE (This statement is true for the correct inhibition mechanism related to IL-5 and not IL-13. Inhibition of IL-5 binding to its receptor prevents the activation of eosinophils, which are part of the downstream signaling pathways that contribute to airway inflammation in asthma.)\n5. FALSE [correction]: Benralizumab does not induce the degradation of excess mucus. Its primary mechanism is the reduction of eosinophils, which are cells that contribute to airway inflammation, not directly acting on mucus production.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2459,
    "user_query": "Is there any link between ERCC1-XPF and cohesin?",
    "yulan-chat-2-13b-fp16_response": "ERCC1-XPF and cohesin are two different protein complexes that have distinct functions in the cell. ERCC1-XPF is a DNA repair complex that is involved in the nucleotide excision repair (NER) pathway, which helps to protect the cell against DNA damage caused by UV radiation and certain chemicals. Cohesin, on the other hand, is a protein complex that plays a role in chromosome organization and regulation of gene expression.\nThere is some evidence to suggest that ERCC1-XPF and cohesin may interact with each other, but the nature of this interaction is not well understood. Some studies have suggested that cohesin may help to recruit ERCC1-XPF to sites of DNA damage, while others have suggested that ERCC1-XPF may play a role in regulating the activity of cohesin. However, more research is needed to fully understand the relationship between these two protein complexes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ERCC1-XPF is a DNA repair complex involved in the nucleotide excision repair pathway.\n2. ERCC1-XPF helps protect the cell against DNA damage caused by UV radiation and certain chemicals.\n3. Cohesin is a protein complex that plays a role in chromosome organization and regulation of gene expression.\n4. Some evidence suggests that ERCC1-XPF and cohesin may interact with each other.\n5. Cohesin potentially helps to recruit ERCC1-XPF to sites of DNA damage.",
    "yulan-chat-2-13b-fp16_fact": [
      "ERCC1-XPF is a DNA repair complex involved in the nucleotide excision repair pathway.",
      "ERCC1-XPF helps protect the cell against DNA damage caused by UV radiation and certain chemicals.",
      "Cohesin is a protein complex that plays a role in chromosome organization and regulation of gene expression.",
      "Some evidence suggests that ERCC1-XPF and cohesin may interact with each other.",
      "Cohesin potentially helps to recruit ERCC1-XPF to sites of DNA damage."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nNote: Statements 4 and 5 are based on current scientific understanding which suggests interactions between different protein complexes involved in DNA repair and chromosome organization. These are areas of ongoing research, and future studies might refine these understandings.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2461,
    "user_query": "Does Evolocumab improve cognitive function?",
    "yulan-chat-2-13b-fp16_response": "Evolocumab is a medication that is used to lower cholesterol levels in the blood. It is a monoclonal antibody that works by inhibiting the activity of a protein called PCSK9, which is involved in the regulation of cholesterol metabolism.\nThere is some evidence to suggest that reducing high cholesterol levels with medication may have a positive impact on cognitive function. However, there are currently no studies that have specifically evaluated the effects of evolocumab on cognitive function.\nIt is important to note that while managing high cholesterol levels through medication may have potential benefits for cognitive function, this should not be considered a guarantee. It is also important to discuss any concerns about cholesterol medication with a healthcare provider, as they can provide personalized guidance and advice.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Evolocumab is a medication used to lower cholesterol levels in the blood.\n2. Evolocumab works by inhibiting the activity of PCSK9, a protein involved in the regulation of cholesterol metabolism.\n3. Some evidence suggests that reducing high cholesterol levels with medication may positively impact cognitive function.\n4. No studies have specifically evaluated the effects of evolocumab on cognitive function.\n5. It is recommended to discuss concerns about cholesterol medication with a healthcare provider for personalized guidance.",
    "yulan-chat-2-13b-fp16_fact": [
      "Evolocumab is a medication used to lower cholesterol levels in the blood.",
      "Evolocumab works by inhibiting the activity of PCSK9, a protein involved in the regulation of cholesterol metabolism.",
      "Some evidence suggests that reducing high cholesterol levels with medication may positively impact cognitive function.",
      "No studies have specifically evaluated the effects of evolocumab on cognitive function.",
      "It is recommended to discuss concerns about cholesterol medication with a healthcare provider for personalized guidance."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE (Although this statement is generally true, the specific impact of cholesterol reduction on cognitive function can vary and may depend on a number of factors, including the individual's overall health profile and the type of medication used.)\n4. FALSE [correction]: Studies have evaluated the effects of evolocumab on cognitive function; for example, data from the EBBINGHAUS trial addressed cognitive function in patients taking evolocumab. However, the results of different studies can vary, and its important to review the latest clinical research for the most current information.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2462,
    "user_query": "Can radius fracture cause carpal tunnel syndrome?",
    "yulan-chat-2-13b-fp16_response": "Yes, a radius fracture can potentially cause carpal tunnel syndrome. The carpal tunnel is a narrow passageway located on the palm side of the wrist that contains the median nerve and tendons that bend the fingers. A radius fracture, which is a break in the forearm bone, can cause swelling and pressure on the median nerve as it passes through the carpal tunnel. This pressure can lead to carpal tunnel syndrome, which is characterized by numbness, tingling, and pain in the hand and fingers. However, not all radius fractures will lead to carpal tunnel syndrome, and other factors such as age, gender, and underlying medical conditions can also play a role in the development of this condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A radius fracture is a break in the forearm bone.\n2. Carpal tunnel syndrome can be characterized by numbness, tingling, and pain in the hand and fingers. \n3. The carpal tunnel contains the median nerve and tendons that bend the fingers.\n4. Swelling and pressure on the median nerve due to a radius fracture can lead to carpal tunnel syndrome. \n5. Factors such as age, gender, and underlying medical conditions can influence the development of carpal tunnel syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "A radius fracture is a break in the forearm bone.",
      "Carpal tunnel syndrome can be characterized by numbness, tingling, and pain in the hand and fingers.",
      "The carpal tunnel contains the median nerve and tendons that bend the fingers.",
      "Swelling and pressure on the median nerve due to a radius fracture can lead to carpal tunnel syndrome.",
      "Factors such as age, gender, and underlying medical conditions can influence the development of carpal tunnel syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE \n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2464,
    "user_query": "Is Marfan syndrome associated with chordal rupture?",
    "yulan-chat-2-13b-fp16_response": "Marfan syndrome is a genetic disorder that affects the body's connective tissue, which is responsible for providing structure and support to the body's organs and tissues. One of the potential complications of Marfan syndrome is the development of aortic dissection, which is a tear in the inner lining of the aorta, the large blood vessel that carries blood from the heart to the rest of the body. Aortic dissection can be life-threatening if it is not diagnosed and treated promptly.\nWhile Marfan syndrome is not directly associated with chordal rupture, it is possible for individuals with Marfan syndrome to experience chordal rupture as a complication of aortic dissection. The aorta has three layers, and in Marfan syndrome, the middle layer (the aortic media) is often weakened and can tear, leading to aortic dissection. The aortic media is made up of elastic fibers, which are also affected in Marfan syndrome. These elastic fibers help to maintain the shape and flexibility of the aorta, and when they are damaged, the aorta can become enlarged and weakened, increasing the risk of rupture.\nIn summary, Marfan syndrome is not directly associated with chordal rupture, but it can increase the risk of aortic dissection, which can lead to chordal rupture as a complication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Marfan syndrome is a genetic disorder that affects the body's connective tissue.\n2. A potential complication of Marfan syndrome is the development of aortic dissection.\n3. Aortic dissection is a tear in the inner lining of the aorta.\n4. Aortic dissection can be life-threatening if not diagnosed and treated promptly.\n5. In Marfan syndrome, the middle layer of the aorta, the aortic media, can be weakened and at risk of tearing.",
    "yulan-chat-2-13b-fp16_fact": [
      "Marfan syndrome is a genetic disorder that affects the body's connective tissue.",
      "A potential complication of Marfan syndrome is the development of aortic dissection.",
      "Aortic dissection is a tear in the inner lining of the aorta.",
      "Aortic dissection can be life-threatening if not diagnosed and treated promptly.",
      "In Marfan syndrome, the middle layer of the aorta, the aortic media, can be weakened and at risk of tearing."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2465,
    "user_query": "What is the mechanism of action of Fremanezumab?",
    "yulan-chat-2-13b-fp16_response": "Fremanezumab is a medication that is used to prevent migraines. It works by blocking the activity of a protein called calcitonin gene-related peptide (CGRP), which is involved in the transmission of pain signals in the brain. By blocking the activity of CGRP, fremanezumab helps to prevent the onset of migraines and reduce the severity of symptoms. It is administered by injection and is available in several doses.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fremanezumab is used to prevent migraines.\n2. It blocks the activity of a protein called calcitonin gene-related peptide (CGRP).\n3. CGRP is involved in the transmission of pain signals in the brain.\n4. Fremanezumab is administered by injection.\n5. Fremanezumab is available in several doses.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fremanezumab is used to prevent migraines.",
      "It blocks the activity of a protein called calcitonin gene-related peptide (CGRP).",
      "CGRP is involved in the transmission of pain signals in the brain.",
      "Fremanezumab is administered by injection.",
      "Fremanezumab is available in several doses."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2466,
    "user_query": "Is trastuzumab associated cardiotoxicity reversible?",
    "yulan-chat-2-13b-fp16_response": "Trastuzumab is a monoclonal antibody drug used to treat certain types of breast cancer. It works by blocking the HER2 protein on cancer cells, which helps to slow or stop the growth of the cancer. However, trastuzumab can also cause cardiotoxicity, or damage to the heart. This can occur in up to 2% of patients who receive the drug.\nIt is not clear whether the cardiotoxicity caused by trastuzumab is reversible. Some studies have suggested that the heart damage may be reversible in some patients, while others have found that the damage can be permanent. The risk of cardiotoxicity is generally greater in patients who have pre-existing heart disease or who receive high doses of trastuzumab.\nIf you are receiving trastuzumab treatment and experience any symptoms of heart problems, such as shortness of breath, swelling of the feet or ankles, or rapid or irregular heartbeat, it is important to speak with your doctor right away. Your doctor may recommend regular monitoring of your heart function while you are receiving trastuzumab treatment to help detect any potential problems early.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Trastuzumab is a monoclonal antibody drug used to treat certain types of breast cancer.\n2. Trastuzumab works by blocking the HER2 protein on cancer cells.\n3. Trastuzumab can cause cardiotoxicity, which is damage to the heart.\n4. Cardiotoxicity from trastuzumab can occur in up to 2% of patients who receive the drug.\n5. Regular monitoring of heart function is recommended for patients receiving trastuzumab treatment.",
    "yulan-chat-2-13b-fp16_fact": [
      "Trastuzumab is a monoclonal antibody drug used to treat certain types of breast cancer.",
      "Trastuzumab works by blocking the HER2 protein on cancer cells.",
      "Trastuzumab can cause cardiotoxicity, which is damage to the heart.",
      "Cardiotoxicity from trastuzumab can occur in up to 2% of patients who receive the drug.",
      "Regular monitoring of heart function is recommended for patients receiving trastuzumab treatment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Cardiotoxicity from trastuzumab can occur in a higher percentage of patients, estimates vary but it can be over 10% in certain populations and conditions.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2470,
    "user_query": "Describe mechanism of action of Nusinersen.",
    "yulan-chat-2-13b-fp16_response": "Nusinersen is an antisense oligonucleotide drug used to treat spinal muscular atrophy (SMA) in patients. It works by selectively targeting and binding to a specific messenger RNA (mRNA) molecule that is involved in the production of the survival motor neuron (SMN) protein.\nThe SMN protein is essential for the survival of motor neurons, which are the nerve cells that control muscle movement. In SMA, there is a genetic defect that leads to a reduction in the amount of SMN protein produced, which results in the progressive weakening and eventual death of motor neurons.\nNusinersen works by binding to a specific region of the SMN2 mRNA molecule, which is the backup gene that is activated when the primary SMN gene is mutated. By binding to this region, nusinersen alters the normal splicing process of the SMN2 mRNA, resulting in the production of a modified SMN protein that is resistant to degradation. This leads to an increase in the amount of functional SMN protein available to motor neurons, which helps to prevent their degeneration and death.\nOverall, the mechanism of action of nusinersen is to selectively target and modify the mRNA molecule that is involved in the production of the SMN protein, leading to increased production of this critical protein and improved motor neuron function in patients with SMA.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nusinersen is used to treat spinal muscular atrophy (SMA).\n2. Nusinersen is an antisense oligonucleotide drug.\n3. It functions by targeting and binding to a specific messenger RNA (mRNA) molecule involved in the production of the survival motor neuron (SMN) protein.\n4. Nusinersen binds to a region of the SMN2 mRNA molecule, affecting the splicing process and resulting in production of a modified SMN protein.\n5. The treatment with nusinersen leads to an increase in the amount of functional SMN protein available to motor neurons.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nusinersen is used to treat spinal muscular atrophy (SMA).",
      "Nusinersen is an antisense oligonucleotide drug.",
      "It functions by targeting and binding to a specific messenger RNA (mRNA) molecule involved in the production of the survival motor neuron (SMN) protein.",
      "Nusinersen binds to a region of the SMN2 mRNA molecule, affecting the splicing process and resulting in production of a modified SMN protein.",
      "The treatment with nusinersen leads to an increase in the amount of functional SMN protein available to motor neurons."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Nusinersen binds to a region of the SMN2 mRNA molecule, affecting the splicing process and resulting in the production of a full-length, functional SMN protein rather than a modified one.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "yulan-chat-2-13b-fp16_response": "The 959 Nematode Genomes initiative is a project aimed at sequencing and annotating the genomes of 959 different species of nematodes, which are small, roundworms that are among the most diverse and numerous multicellular organisms on the planet. Nematodes are found in virtually every habitat, from the deep sea to the soil, and they play important roles in many ecosystems as decomposers, detritivores, and predators. They are also important models for studying animal development, behavior, and evolution, and they have been used in a variety of biotechnological applications, including medicine, agriculture, and environmental remediation.\nThe 959 Nematode Genomes initiative was launched in 2018 by a consortium of researchers from around the world, with the goal of sequencing and annotating the genomes of all known species of nematodes by 2025. The project is being carried out using a combination of high-throughput sequencing technologies and computational tools for genome annotation and analysis. The resulting genomic data will be made available to the scientific community through public databases, and it is expected to provide new insights into the evolution, diversity, and biology of nematodes, as well as their potential applications in a variety of fields.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The 959 Nematode Genomes initiative aims to sequence and annotate the genomes of 959 different species of nematodes.\n2. Nematodes are found in a wide range of habitats, including deep sea and soil.\n3. The initiative began in 2018 and aims to complete the sequencing by 2025.\n4. A consortium of international researchers is conducting the 959 Nematode Genomes initiative.\n5. The genomic data from the initiative will be shared with the scientific community through public databases.",
    "yulan-chat-2-13b-fp16_fact": [
      "The 959 Nematode Genomes initiative aims to sequence and annotate the genomes of 959 different species of nematodes.",
      "Nematodes are found in a wide range of habitats, including deep sea and soil.",
      "The initiative began in 2018 and aims to complete the sequencing by 2025.",
      "A consortium of international researchers is conducting the 959 Nematode Genomes initiative.",
      "The genomic data from the initiative will be shared with the scientific community through public databases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The initiative's timeline is not specified in the provided information, so the start date and completion year cannot be verified.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2475,
    "user_query": "What is the drug target(s) for Belsomra?",
    "yulan-chat-2-13b-fp16_response": "Belsomra is a medication that is used to treat insomnia, which is a condition characterized by difficulty falling asleep or staying asleep. Belsomra works by binding to certain receptors in the brain that are involved in regulating sleep and wakefulness. Specifically, Belsomra targets a type of receptor called the orexin receptor, which is involved in the regulation of wakefulness. By binding to these receptors, Belsomra helps to promote sleep by reducing wakefulness and increasing the amount of time that a person spends in the deep, restorative stages of sleep.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Belsomra is used to treat insomnia.\n2. Belsomra works by binding to receptors in the brain that regulate sleep and wakefulness.\n3. Belsomra specifically targets the orexin receptor.\n4. The orexin receptor is involved in the regulation of wakefulness.\n5. Belsomra helps promote sleep by reducing wakefulness and increasing time spent in deep sleep stages.",
    "yulan-chat-2-13b-fp16_fact": [
      "Belsomra is used to treat insomnia.",
      "Belsomra works by binding to receptors in the brain that regulate sleep and wakefulness.",
      "Belsomra specifically targets the orexin receptor.",
      "The orexin receptor is involved in the regulation of wakefulness.",
      "Belsomra helps promote sleep by reducing wakefulness and increasing time spent in deep sleep stages."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2476,
    "user_query": "Can canagliflozin cause euglycemic diabetic ketoacidosis?",
    "yulan-chat-2-13b-fp16_response": "Yes, canagliflozin, a medication used to treat type 2 diabetes, has been associated with a risk of euglycemic diabetic ketoacidosis (DKA).\nEuglycemic DKA is a rare but serious condition that occurs when the body produces high levels of ketones, but the blood sugar levels are not significantly elevated. This can occur in people with type 1 diabetes or type 2 diabetes who are taking medications like canagliflozin.\nSymptoms of euglycemic DKA may include nausea, vomiting, abdominal pain, fatigue, and a fruity breath. If left untreated, euglycemic DKA can lead to serious complications, such as coma and death.\nIt is important to talk to your doctor if you are taking canagliflozin and experience any symptoms of DKA, even if your blood sugar levels are normal. Your doctor may recommend changes to your medication regimen or other treatments to help prevent DKA from occurring.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Canagliflozin is a medication used to treat type 2 diabetes.\n2. Canagliflozin has been associated with a risk of euglycemic diabetic ketoacidosis (DKA).\n3. Euglycemic DKA is a condition where the body produces high levels of ketones with normal blood sugar levels.\n4. Symptoms of euglycemic DKA include nausea, vomiting, abdominal pain, fatigue, and a fruity breath odor.\n5. Untreated euglycemic DKA can lead to serious complications such as coma and death.",
    "yulan-chat-2-13b-fp16_fact": [
      "Canagliflozin is a medication used to treat type 2 diabetes.",
      "Canagliflozin has been associated with a risk of euglycemic diabetic ketoacidosis (DKA).",
      "Euglycemic DKA is a condition where the body produces high levels of ketones with normal blood sugar levels.",
      "Symptoms of euglycemic DKA include nausea, vomiting, abdominal pain, fatigue, and a fruity breath odor.",
      "Untreated euglycemic DKA can lead to serious complications such as coma and death."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2478,
    "user_query": "Is there an association between Klinefelter syndrome and breast cancer?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is an association between Klinefelter syndrome and breast cancer. Men with Klinefelter syndrome have an increased risk of developing breast cancer due to the presence of estrogen receptors in their cells. Klinefelter syndrome is a genetic disorder in which a person is born with an extra X chromosome, resulting in XXY chromosomes instead of the typical XY. This extra X chromosome leads to an imbalance of hormones, including estrogen, which can increase the risk of breast cancer in these individuals. However, it is important to note that the risk of breast cancer in men with Klinefelter syndrome is still relatively low.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Men with Klinefelter syndrome have an increased risk of developing breast cancer compared to typical XY individuals.\n2. Klinefelter syndrome is a genetic disorder characterized by the presence of an extra X chromosome, resulting in XXY chromosomes.\n3. The extra X chromosome in Klinefelter syndrome leads to an imbalance of hormones, including estrogen.\n4. The presence of estrogen receptors in cells contributes to the increased risk of breast cancer in men with Klinefelter syndrome.\n5. Despite the increased risk, the likelihood of breast cancer in men with Klinefelter syndrome remains relatively low.",
    "yulan-chat-2-13b-fp16_fact": [
      "Men with Klinefelter syndrome have an increased risk of developing breast cancer compared to typical XY individuals.",
      "Klinefelter syndrome is a genetic disorder characterized by the presence of an extra X chromosome, resulting in XXY chromosomes.",
      "The extra X chromosome in Klinefelter syndrome leads to an imbalance of hormones, including estrogen.",
      "The presence of estrogen receptors in cells contributes to the increased risk of breast cancer in men with Klinefelter syndrome.",
      "Despite the increased risk, the likelihood of breast cancer in men with Klinefelter syndrome remains relatively low."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2479,
    "user_query": "Which R packages have been developed for the discovery of mutational signatures in cancer?",
    "yulan-chat-2-13b-fp16_response": "Several R packages have been developed for the discovery of mutational signatures in cancer, including:\n1. MutSignatures: This package provides functions for the detection and classification of mutational signatures in cancer genome sequencing data.\n2. SomaticMutator: This package implements a method for discovering mutational signatures in cancer genomes using a statistical model-based approach.\n3. CancerMutationStats: This package provides functions for the analysis of mutational data from cancer genomes, including the detection of mutational signatures.\n4. MutationAnalysis: This package provides tools for the analysis of mutational data from cancer genomes, including the detection of mutational signatures using various statistical methods.\n5. SomaticSources: This package identifies the sources of mutations in cancer genomes, including the detection of mutational signatures.\nThese packages can be used to identify and classify mutational signatures in cancer genomes, which can provide insights into the underlying mechanisms of mutagenesis and potential therapeutic targets.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The R package MutSignatures provides functions for the detection and classification of mutational signatures in cancer genome sequencing data.\n2. The R package SomaticMutator implements a method for discovering mutational signatures in cancer genomes using a statistical model-based approach.\n3. The R package CancerMutationStats provides functions for the analysis of mutational data from cancer genomes, including the detection of mutational signatures.\n4. The R package MutationAnalysis provides tools for the analysis of mutational data from cancer genomes, including the detection of mutational signatures using various statistical methods.\n5. The R package SomaticSources identifies the sources of mutations in cancer genomes, including the detection of mutational signatures.",
    "yulan-chat-2-13b-fp16_fact": [
      "The R package MutSignatures provides functions for the detection and classification of mutational signatures in cancer genome sequencing data.",
      "The R package SomaticMutator implements a method for discovering mutational signatures in cancer genomes using a statistical model-based approach.",
      "The R package CancerMutationStats provides functions for the analysis of mutational data from cancer genomes, including the detection of mutational signatures.",
      "The R package MutationAnalysis provides tools for the analysis of mutational data from cancer genomes, including the detection of mutational signatures using various statistical methods.",
      "The R package SomaticSources identifies the sources of mutations in cancer genomes, including the detection of mutational signatures."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nNote: While the first two statements are about real R packages, as of my knowledge cutoff in early 2023, \"CancerMutationStats\", \"MutationAnalysis\", and \"SomaticSources\" are not standard names for known R packages within the field of bioinformatics, particularly for the analysis of mutational data in cancer genomes. It is possible they could be hypothetical, lesser-known, or newly-released packages, and without current or specific information on these packages, we cannot determine the truthfulness of these statements.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2484,
    "user_query": "Which data simulator is available for CLIP-SEQ experiments?",
    "yulan-chat-2-13b-fp16_response": "CLIP-SEQ (Chromatin Interaction Promoted by In vitro Transcription of RNA) is an experimental technique used to study the three-dimensional organization of chromatin in cells. There are several data simulators available for CLIP-SEQ experiments, including:\n1. CLIPsim: CLIPsim is a software tool that can simulate CLIP-SEQ data from a given chromatin conformation. It uses a statistical model to predict the location and intensity of RNA-mediated chromatin interactions.\n2. ChromHMM: ChromHMM is a software tool that can simulate CLIP-SEQ data by modeling the chromatin state as a combination of active and inactive regions. It can also predict the location and intensity of RNA-mediated chromatin interactions.\n3. RNAfold: RNAfold is a software tool that can simulate CLIP-SEQ data by predicting the secondary structure of RNA molecules. It can also predict the location and intensity of RNA-mediated chromatin interactions.\n4. RNAfold2: RNAfold2 is an updated version of RNAfold that can simulate CLIP-SEQ data by predicting the secondary structure of RNA molecules and their interactions with chromatin.\nThese data simulators can be used to generate synthetic CLIP-SEQ data sets that can be used to test the performance of algorithms for analyzing CLIP-SEQ data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CLIP-SEQ is an experimental technique used to study the three-dimensional organization of chromatin in cells.\n2. CLIPsim is a software tool that simulates CLIP-SEQ data from a given chromatin conformation using a statistical model.\n3. ChromHMM is a software tool used for simulating CLIP-SEQ data by modeling chromatin states as a combination of active and inactive regions.\n4. RNAfold is a software tool that simulates CLIP-SEQ data by predicting the secondary structure of RNA molecules.\n5. RNAfold2 is an updated version of RNAfold that simulates CLIP-SEQ data by predicting secondary structures of RNA molecules and their interactions with chromatin.",
    "yulan-chat-2-13b-fp16_fact": [
      "CLIP-SEQ is an experimental technique used to study the three-dimensional organization of chromatin in cells.",
      "CLIPsim is a software tool that simulates CLIP-SEQ data from a given chromatin conformation using a statistical model.",
      "ChromHMM is a software tool used for simulating CLIP-SEQ data by modeling chromatin states as a combination of active and inactive regions.",
      "RNAfold is a software tool that simulates CLIP-SEQ data by predicting the secondary structure of RNA molecules.",
      "RNAfold2 is an updated version of RNAfold that simulates CLIP-SEQ data by predicting secondary structures of RNA molecules and their interactions with chromatin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: CLIP-SEQ (Cross-Linking and ImmunoPrecipitation followed by sequencing) is an experimental technique used to study protein-RNA interactions within cells, not specifically the three-dimensional organization of chromatin.\n2. UNKNOWN\n3. FALSE [correction]: ChromHMM is a software tool used for learning and characterizing chromatin states based on histone modification data, not for simulating CLIP-SEQ data.\n4. FALSE [correction]: RNAfold is a software tool that predicts the secondary structure of RNA molecules based on their sequence, not for simulating CLIP-SEQ data.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2487,
    "user_query": "Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?",
    "yulan-chat-2-13b-fp16_response": "Yes, Dlx1 and Dlx2 transcription factors have been shown to play important roles in the development and function of cortical interneurons.\nCortical interneurons are a diverse population of neurons that play critical roles in information processing in the cerebral cortex. They are characterized by their distinct morphology and firing properties, and they can be divided into several subtypes based on their location, connectivity, and function.\nDlx1 and Dlx2 are members of the Distal-less homeobox gene family, which are essential for the development of the nervous system. They are transcription factors that bind to DNA and regulate the expression of target genes involved in neural development and function.\nStudies have shown that Dlx1 and Dlx2 are expressed in cortical interneurons and regulate their development and function. For example, Dlx1 and Dlx2 have been shown to promote the differentiation of GABAergic interneurons, which are inhibitory interneurons that play critical roles in regulating neural activity in the cerebral cortex. They also regulate the development of other types of interneurons, such as fast-spiking interneurons and chandelier cells.\nIn addition to regulating interneuron development, Dlx1 and Dlx2 have also been shown to regulate the function of cortical interneurons. For example, they have been shown to regulate the expression of ion channels and receptors that are important for neural signaling, and they can also regulate the connectivity of interneurons with other neurons in the cerebral cortex.\nOverall, Dlx1 and Dlx2 transcription factors play important roles in the development and function of cortical interneurons, and their dysregulation has been implicated in several neurological disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dlx1 and Dlx2 transcription factors play important roles in the development and function of cortical interneurons.\n2. Cortical interneurons are characterized by distinct morphology and firing properties.\n3. Dlx1 and Dlx2 belong to the Distal-less homeobox gene family, which is essential for the development of the nervous system.\n4. Dlx1 and Dlx2 promote the differentiation of GABAergic interneurons in the cerebral cortex.\n5. Dysregulation of Dlx1 and Dlx2 has been implicated in several neurological disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dlx1 and Dlx2 transcription factors play important roles in the development and function of cortical interneurons.",
      "Cortical interneurons are characterized by distinct morphology and firing properties.",
      "Dlx1 and Dlx2 belong to the Distal-less homeobox gene family, which is essential for the development of the nervous system.",
      "Dlx1 and Dlx2 promote the differentiation of GABAergic interneurons in the cerebral cortex.",
      "Dysregulation of Dlx1 and Dlx2 has been implicated in several neurological disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll statements provided are true based on current scientific understanding. The Dlx family of transcription factors, which includes Dlx1 and Dlx2, are indeed crucial for the development of the nervous system, including the differentiation of GABAergic interneurons, and dysregulation can be implicated in various neurological disorders.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2489,
    "user_query": "What is SMiLE-seq?",
    "yulan-chat-2-13b-fp16_response": "SMiLE-seq is a sequencing technology that enables the simultaneous sequencing of both strands of DNA and RNA, providing a more complete view of the genome and transcriptome. It is a high-throughput sequencing technology that uses a single-molecule sequencing platform and a novel sequencing chemistry that enables the sequencing of both strands of DNA and RNA in a single reaction. This allows for more accurate and comprehensive analysis of genetic variation, gene expression, and splicing.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SMiLE-seq is a sequencing technology capable of simultaneously sequencing both strands of DNA and RNA.\n2. SMiLE-seq provides a more comprehensive view of the genome and transcriptome.\n3. It is a high-throughput sequencing technology.\n4. SMiLE-seq uses a single-molecule sequencing platform.\n5. The technology employs a novel sequencing chemistry that enables the sequencing of both DNA and RNA strands in a single reaction.",
    "yulan-chat-2-13b-fp16_fact": [
      "SMiLE-seq is a sequencing technology capable of simultaneously sequencing both strands of DNA and RNA.",
      "SMiLE-seq provides a more comprehensive view of the genome and transcriptome.",
      "It is a high-throughput sequencing technology.",
      "SMiLE-seq uses a single-molecule sequencing platform.",
      "The technology employs a novel sequencing chemistry that enables the sequencing of both DNA and RNA strands in a single reaction."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: SMiLE-seq stands for \"Single Molecule Linker-mediated Exonuclease Resistance\" sequencing; it is a technique used for identifying DNA-protein interactions and not for directly sequencing DNA and RNA simultaneously.\n2. FALSE [correction]: Since SMiLE-seq is not a sequencing technology capable of sequencing both DNA and RNA, it does not provide a comprehensive view of the genome and transcriptome in the way that statement suggests. It is rather a method used to study protein-DNA interactions more comprehensively.\n3. TRUE: SMiLE-seq is considered high-throughput as it allows the analysis of DNA-protein interactions on a genome-wide scale.\n4. UNKNOWN: Without specific information about the underlying technology of SMiLE-seq relating to whether it uses a single-molecule sequencing platform, this cannot be confirmed or denied.\n5. FALSE [correction]: SMiLE-seq does not employ a novel sequencing chemistry for sequencing both DNA and RNA strands in a single reaction. Instead, it permits the targeted sequencing of genomic regions that are protected from exonuclease activity by bound proteins.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2493,
    "user_query": "Describe JACUSA",
    "yulan-chat-2-13b-fp16_response": "JACUSA is a software tool that is used to analyze and optimize the performance of computer systems. It is a comprehensive performance analysis tool that can be used to monitor and analyze the performance of a wide range of computer systems, including servers, workstations, and embedded systems.\nJACUSA is designed to provide detailed information about the performance of computer systems, including CPU usage, memory usage, disk usage, network usage, and system latency. It can be used to identify performance bottlenecks and optimize system performance by identifying areas of the system that are underutilized or overutilized.\nJACUSA is a powerful tool that is used by system administrators, performance engineers, and developers to troubleshoot performance issues, optimize system performance, and ensure that computer systems are running at their best. It is a versatile tool that can be used to analyze and optimize the performance of both Windows and Linux systems, and it is compatible with a wide range of hardware and software configurations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. JACUSA is a software tool designed for analyzing and optimizing the performance of computer systems.\n2. It provides detailed information about CPU usage, memory usage, disk usage, network usage, and system latency.\n3. JACUSA can identify performance bottlenecks in computer systems.\n4. The tool is used by system administrators, performance engineers, and developers.\n5. JACUSA is compatible with both Windows and Linux operating systems.",
    "yulan-chat-2-13b-fp16_fact": [
      "JACUSA is a software tool designed for analyzing and optimizing the performance of computer systems.",
      "It provides detailed information about CPU usage, memory usage, disk usage, network usage, and system latency.",
      "JACUSA can identify performance bottlenecks in computer systems.",
      "The tool is used by system administrators, performance engineers, and developers.",
      "JACUSA is compatible with both Windows and Linux operating systems."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: JACUSA (Java-based analysis of C to U editing sites in RNA) is a bioinformatics software tool designed for detecting RNA editing events in sequence data, not for analyzing and optimizing the performance of computer systems.\n2. FALSE [correction]: JACUSA provides detailed information about RNA editing events, particularly C to U changes, not about system performance metrics like CPU or memory usage.\n3. FALSE [correction]: JACUSA helps to identify RNA editing sites within sequence data, not performance bottlenecks in computer systems.\n4. FALSE [correction]: JACUSA is used by bioinformaticians and researchers in the field of genomics and transcriptomics, not typically by system administrators or performance engineers.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2507,
    "user_query": "CURB65 score is used for stratification of which disease?",
    "yulan-chat-2-13b-fp16_response": "The CURB65 score is used for stratification of patients with community-acquired pneumonia (CAP). CAP is a common respiratory infection that can be caused by a variety of bacteria, viruses, and other pathogens. The CURB65 score is a clinical assessment tool that helps healthcare providers predict the severity of illness in patients with CAP. It takes into account six clinical variables: age, respiratory rate, heart rate, mentation, sodium, and blood urea nitrogen (BUN). The score ranges from 0 to 20, with higher scores indicating a greater likelihood of mortality or the need for intensive care. The CURB65 score is used to guide treatment decisions and to identify patients who may benefit from early intervention, such as intravenous antibiotics or admission to the hospital.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The CURB65 score is used for stratification of patients with community-acquired pneumonia (CAP).\n2. The CURB65 score is a clinical assessment tool used to predict the severity of illness in patients with CAP.\n3. The CURB65 score includes six clinical variables: age, respiratory rate, heart rate, mentation, sodium, and blood urea nitrogen (BUN).\n4. The CURB65 score ranges from 0 to 20.\n5. Higher CURB65 scores indicate a greater likelihood of mortality or the need for intensive care for patients with CAP.",
    "yulan-chat-2-13b-fp16_fact": [
      "The CURB65 score is used for stratification of patients with community-acquired pneumonia (CAP).",
      "The CURB65 score is a clinical assessment tool used to predict the severity of illness in patients with CAP.",
      "The CURB65 score includes six clinical variables: age, respiratory rate, heart rate, mentation, sodium, and blood urea nitrogen (BUN).",
      "The CURB65 score ranges from 0 to 20.",
      "Higher CURB65 scores indicate a greater likelihood of mortality or the need for intensive care for patients with CAP."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The CURB65 score includes five clinical variables, which are Confusion, Urea (or BUN) level, Respiratory rate, Blood pressure, and age 65 years (each factor scores one point, hence '65').\n4. FALSE [correction]: The CURB65 score ranges from 0 to 5, with one point for each clinical variable.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2509,
    "user_query": "Is creatinine assessment included in the MELD score?",
    "yulan-chat-2-13b-fp16_response": "Creatinine is not typically included in the MELD score (Meld score for End-Stage Liver Disease). The MELD score is used to assess the severity of liver disease and predict the likelihood of survival in patients with end-stage liver disease. It takes into account various clinical and laboratory parameters such as bilirubin, INR, and platelet count, but creatinine is not one of them. Creatinine is typically used to assess kidney function and is not directly related to liver function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Creatinine is not typically included in the MELD score.\n2. The MELD score is used to assess the severity of liver disease.\n3. The MELD score predicts the likelihood of survival in patients with end-stage liver disease.\n4. The MELD score takes into account parameters such as bilirubin, INR, and platelet count.\n5. Creatinine is typically used to assess kidney function, not liver function.",
    "yulan-chat-2-13b-fp16_fact": [
      "Creatinine is not typically included in the MELD score.",
      "The MELD score is used to assess the severity of liver disease.",
      "The MELD score predicts the likelihood of survival in patients with end-stage liver disease.",
      "The MELD score takes into account parameters such as bilirubin, INR, and platelet count.",
      "Creatinine is typically used to assess kidney function, not liver function."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The MELD score takes into account parameters such as bilirubin, INR, and creatinine, not platelet count.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2516,
    "user_query": "What cellular process are okazaki fragments associated with?",
    "yulan-chat-2-13b-fp16_response": "Okazaki fragments are associated with the process of DNA replication, specifically with the elongation phase of DNA replication. During DNA replication, the DNA double helix is unwound and separated into two strands. The strands then serve as templates for the synthesis of new strands, which are complementary to the original strands.\nDuring elongation, new strands are synthesized by a complex of enzymes called the replisome. One of the key enzymes in this complex is DNA polymerase, which adds new nucleotides to the growing strand. However, DNA polymerase can only add nucleotides to the template strand in a 5' to 3' direction. As a result, when it encounters a region of the template strand that has already been synthesized, it can only add nucleotides to the newly synthesized strand in a 3' to 5' direction.\nThis creates a gap, or a \"nick,\" in the newly synthesized strand. The gap is then filled in by DNA polymerase delta, which adds nucleotides to the gap in the 5' to 3' direction. The result is a fragment of DNA, called an Okazaki fragment, that has a different nucleotide sequence at its 3' end than at its 5' end.\nOkazaki fragments are important because they allow DNA polymerase to continue synthesizing new strands without getting stuck at the site of the original template strand. Once the gap is filled in by DNA polymerase delta, the two newly synthesized strands are sealed together by DNA ligase, creating a continuous double helix.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Okazaki fragments are associated with the process of DNA replication.\n2. DNA replication includes an elongation phase where Okazaki fragments are produced.\n3. DNA polymerase is a key enzyme in the replisome complex that adds new nucleotides to the growing DNA strand.\n4. DNA polymerase can only add nucleotides in a 5' to 3' direction.\n5. DNA polymerase delta fills in gaps in the newly synthesized strand where Okazaki fragments are present.",
    "yulan-chat-2-13b-fp16_fact": [
      "Okazaki fragments are associated with the process of DNA replication.",
      "DNA replication includes an elongation phase where Okazaki fragments are produced.",
      "DNA polymerase is a key enzyme in the replisome complex that adds new nucleotides to the growing DNA strand.",
      "DNA polymerase can only add nucleotides in a 5' to 3' direction.",
      "DNA polymerase delta fills in gaps in the newly synthesized strand where Okazaki fragments are present."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2518,
    "user_query": "Clue cells are characteristics to which causative bacteria of vaginitis?",
    "yulan-chat-2-13b-fp16_response": "Vaginitis is an inflammation of the vagina that can have a variety of causes, including bacterial infections. Some common bacteria that can cause vaginitis include:\n* Streptococcus agalactiae\n* Staphylococcus aureus\n* Escherichia coli\n* Lactobacillus infections\n* Candida albicans\nClue cells are a type of white blood cell that can be present in the vagina during an infection. They are often seen in vaginal discharge and can be used to diagnose certain types of vaginal infections, such as bacterial vaginosis. However, the presence of clue cells does not necessarily indicate that a specific bacteria is the causative agent of the infection. It is important to note that vaginitis can have many different causes, and a proper diagnosis should be made by a healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2519,
    "user_query": "What is included in the fourth generation HIV test?",
    "yulan-chat-2-13b-fp16_response": "The fourth generation HIV test is a blood test that checks for both antibodies to HIV and the actual virus itself. This means that it can detect both recent and past infections. The test looks for the presence of HIV-1 and HIV-2 antibodies, as well as the genetic material of the virus. It is considered to be more accurate than previous generations of HIV tests, as it can detect the virus sooner after exposure and is less likely to produce false negative results.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The fourth generation HIV test is a blood test.\n2. The test checks for antibodies to HIV and the HIV virus itself.\n3. It can detect both recent and past infections of HIV.\n4. It looks for the presence of HIV-1 and HIV-2 antibodies and the genetic material of the virus.\n5. The fourth generation HIV test is considered more accurate than previous generations, detecting the virus sooner after exposure with fewer false negatives.",
    "yulan-chat-2-13b-fp16_fact": [
      "The fourth generation HIV test is a blood test.",
      "The test checks for antibodies to HIV and the HIV virus itself.",
      "It can detect both recent and past infections of HIV.",
      "It looks for the presence of HIV-1 and HIV-2 antibodies and the genetic material of the virus.",
      "The fourth generation HIV test is considered more accurate than previous generations, detecting the virus sooner after exposure with fewer false negatives."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2520,
    "user_query": "Which disease is diagnosed using the Finkelstein's test?",
    "yulan-chat-2-13b-fp16_response": "Finkelstein's test is not used to diagnose any specific disease. It is a physical examination test used to assess the flexibility and stability of the thumb. The test is performed by having the patient hold the thumb in flexion (bent) and then it against resistance. The degree of flexion and stability of the thumb is then evaluated. The test is commonly used to assess the severity of rheumatoid arthritis, but it may also be used to evaluate the effectiveness of treatment or to assess the outcome of surgery.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2521,
    "user_query": "For which type of cancer can uc.189 be used as a potential prognostic biomarker?",
    "yulan-chat-2-13b-fp16_response": "UC.189 is a potential prognostic biomarker for various types of cancer, including but not limited to:\n* Lung cancer\n* Breast cancer\n* Colorectal cancer\n* Pancreatic cancer\n* Ovarian cancer\n* Prostate cancer\nHowever, it is important to note that the clinical significance of UC.189 as a biomarker may vary depending on the specific type of cancer and the stage of the disease. Further research is needed to fully understand its potential as a prognostic biomarker in different types of cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. UC.189 is a potential prognostic biomarker for lung cancer.\n2. UC.189 is a potential prognostic biomarker for breast cancer.\n3. UC.189 is a potential prognostic biomarker for colorectal cancer.\n4. UC.189 is a potential prognostic biomarker for pancreatic cancer.\n5. UC.189 is a potential prognostic biomarker for ovarian cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "UC.189 is a potential prognostic biomarker for lung cancer.",
      "UC.189 is a potential prognostic biomarker for breast cancer.",
      "UC.189 is a potential prognostic biomarker for colorectal cancer.",
      "UC.189 is a potential prognostic biomarker for pancreatic cancer.",
      "UC.189 is a potential prognostic biomarker for ovarian cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: UC.189 has not been commonly identified as a potential prognostic biomarker for breast cancer.\n3. FALSE [correction]: UC.189 has not been commonly identified as a potential prognostic biomarker for colorectal cancer.\n4. FALSE [correction]: UC.189 has not been commonly identified as a potential prognostic biomarker for pancreatic cancer.\n5. FALSE [correction]: UC.189 has not been commonly identified as a potential prognostic biomarker for ovarian cancer.\n\nNote: The information provided here is based on the assumption that UC.189 is specifically identified as a biomarker for lung cancer. The state of scientific knowledge is always advancing, and specific biomarkers may be researched for various types of cancers. It is essential to consult the latest research for the most recent information on cancer biomarkers.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2525,
    "user_query": "Which package in Bioconductor has been developed with the aim to analyze differential DNA loops from sequencing data?",
    "yulan-chat-2-13b-fp16_response": "The package \"differential loops\" in Bioconductor has been developed to analyze differential DNA loops from sequencing data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The package named \"differential loops\" exists in Bioconductor.\n2. The purpose of the \"differential loops\" package is to analyze differential DNA loops.\n3. The \"differential loops\" package is used to analyze sequencing data.",
    "yulan-chat-2-13b-fp16_fact": [
      "The package named \"differential loops\" exists in Bioconductor.",
      "The purpose of the \"differential loops\" package is to analyze differential DNA loops.",
      "The \"differential loops\" package is used to analyze sequencing data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2526,
    "user_query": "Which disease can be diagnosed with the \"probe to bone\" test?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with a \"probe to bone\" test for diagnosing any specific disease. It is possible that you may be referring to a specific medical procedure or test that I am not aware of. If you could provide more context or information about the test, I may be able to help you better.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2527,
    "user_query": "Can doxycycline cause photosensitivity?",
    "yulan-chat-2-13b-fp16_response": "Yes, doxycycline can cause photosensitivity. Photosensitivity is a reaction to sunlight or other sources of ultraviolet (UV) light. It is a known side effect of doxycycline and can occur in people who take the medication.\nThe photosensitivity reaction caused by doxycycline can vary in severity, ranging from mild to severe. Symptoms may include skin redness, itching, and blistering; headache; dizziness; and nausea. In severe cases, photosensitivity can cause a rash, fever, and joint pain.\nIf you are taking doxycycline and experience symptoms of photosensitivity, it is important to contact your doctor right away. Your doctor may recommend avoiding direct sunlight or using protective clothing and sunscreen to minimize your exposure to UV light.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Doxycycline can cause photosensitivity.\n2. Photosensitivity is a reaction to sunlight or other sources of ultraviolet (UV) light.\n3. Symptoms of photosensitivity due to doxycycline can include skin redness, itching, and blistering.\n4. In severe cases, doxycycline-induced photosensitivity can cause a rash, fever, and joint pain.\n5. Doctors may recommend avoiding direct sunlight or using protective clothing and sunscreen for patients experiencing photosensitivity while taking doxycycline.",
    "yulan-chat-2-13b-fp16_fact": [
      "Doxycycline can cause photosensitivity.",
      "Photosensitivity is a reaction to sunlight or other sources of ultraviolet (UV) light.",
      "Symptoms of photosensitivity due to doxycycline can include skin redness, itching, and blistering.",
      "In severe cases, doxycycline-induced photosensitivity can cause a rash, fever, and joint pain.",
      "Doctors may recommend avoiding direct sunlight or using protective clothing and sunscreen for patients experiencing photosensitivity while taking doxycycline."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While a rash may occur due to doxycycline-induced photosensitivity, fever and joint pain are not typical symptoms of photosensitivity itself. Instead, fever and joint pain could be symptoms of a more severe reaction or a different condition.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2530,
    "user_query": "What is the normal body temperature in dogs?",
    "yulan-chat-2-13b-fp16_response": "The normal body temperature in dogs is between 101.2F and 102.5F (38.5C to 39.1C).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The normal body temperature in dogs ranges from 101.2F to 102.5F. \n2. In Celsius, the normal body temperature for dogs is between 38.5C and 39.1C.",
    "yulan-chat-2-13b-fp16_fact": [
      "The normal body temperature in dogs ranges from 101.2F to 102.5F.",
      "In Celsius, the normal body temperature for dogs is between 38.5C and 39.1C."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: In Celsius, the normal body temperature for dogs is between approximately 38.3C and 39.2C.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 2531,
    "user_query": "List symptoms of Heerfordt syndrome.",
    "yulan-chat-2-13b-fp16_response": "Heerfordt syndrome is a rare autoimmune disorder that affects the nerves and blood vessels. The symptoms of Heerfordt syndrome can vary from person to person, but some common symptoms include:\n1. Weakness or numbness in the face, arms, or legs\n2. Pain, tingling, or burning sensations in the nerves\n3. Vision problems, such as double vision or blind spots in the visual field\n4. Dizziness or loss of balance\n5. Fatigue or weakness\n6. Headaches or migraines\n7. Shortness of breath or difficulty breathing\n8. Chest pain or pressure\n9. Swelling or inflammation in the hands and feet\n10. A sensation of heaviness or tightness in the chest\nIt's important to note that not everyone with Heerfordt syndrome will experience all of these symptoms, and some people may have additional symptoms not listed here. If you are experiencing any of these symptoms, it's important to speak with a healthcare provider for proper diagnosis and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Heerfordt syndrome is a rare autoimmune disorder.\n2. Common symptoms of Heerfordt syndrome include weakness or numbness in the face, arms, or legs.\n3. People with Heerfordt syndrome may experience vision problems, such as double vision or blind spots.\n4. Symptoms of Heerfordt syndrome can include dizziness or loss of balance.\n5. Heerfordt syndrome may cause fatigue or weakness.",
    "yulan-chat-2-13b-fp16_fact": [
      "Heerfordt syndrome is a rare autoimmune disorder.",
      "Common symptoms of Heerfordt syndrome include weakness or numbness in the face, arms, or legs.",
      "People with Heerfordt syndrome may experience vision problems, such as double vision or blind spots.",
      "Symptoms of Heerfordt syndrome can include dizziness or loss of balance.",
      "Heerfordt syndrome may cause fatigue or weakness."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Heerfordt syndrome, also known as uveoparotid fever, is not typically classified as an autoimmune disorder, but rather a rare manifestation of sarcoidosis, which is a disease involving abnormal collections of inflammatory cells that can form as nodules in multiple organs.\n\n2. FALSE [correction]: Common symptoms of Heerfordt syndrome do not usually include weakness or numbness in the arms or legs, which are more characteristic of neurological disorders. Heerfordt syndrome is chiefly associated with uveitis (eye inflammation), parotid gland enlargement, and sometimes facial nerve palsy.\n\n3. TRUE: People with Heerfordt syndrome may experience vision problems due to uveitis, which can cause symptoms like double vision or blind spots.\n\n4. UNKNOWN: While dizziness or loss of balance is not commonly cited as a symptom of Heerfordt syndrome, it could occur if there is central nervous system involvement in sarcoidosis, but this is not specific or unique to Heerfordt syndrome.\n\n5. TRUE: Fatigue can be a symptom of Heerfordt syndrome, as it is a common symptom of sarcoidosis and many other inflammatory disorders.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2532,
    "user_query": "In quadruped mammals, what bones make up the stifle?",
    "yulan-chat-2-13b-fp16_response": "In quadruped mammals, the stifle is the joint between the femur (thigh bone) and the tibia and fibula (lower leg bones). The stifle is also known as the knee joint in humans.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The stifle in quadruped mammals is the joint between the femur and the tibia and fibula.\n2. The stifle is equivalent to the knee joint in humans.",
    "yulan-chat-2-13b-fp16_fact": [
      "The stifle in quadruped mammals is the joint between the femur and the tibia and fibula.",
      "The stifle is equivalent to the knee joint in humans."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2535,
    "user_query": "Which tool exists for microsatellite (SSR) loci detection and primer design?",
    "yulan-chat-2-13b-fp16_response": "There are several tools available for microsatellite (SSR) loci detection and primer design. Some of the commonly used tools are:\n1. MICROSAT: It is a software that can detect SSRs in DNA sequences and design primers for PCR amplification of these loci. It can also analyze the frequency and distribution of SSRs in a genome.\n2. MITSUR: It is a software that can detect SSRs in DNA sequences and design primers for PCR amplification of these loci. It can also analyze the frequency and distribution of SSRs in a genome.\n3. SSRanalyzer: It is a software that can detect SSRs in DNA sequences and design primers for PCR amplification of these loci. It can also analyze the frequency and distribution of SSRs in a genome.\n4. Primer3: It is a tool that can design primers for PCR amplification of SSR loci. It can also analyze the frequency and distribution of SSRs in a genome.\n5. PRIMER4: It is a tool that can design primers for PCR amplification of SSR loci. It can also analyze the frequency and distribution of SSRs in a genome.\n6. SSR-Plex: It is a tool that can design primers for multiplex PCR amplification of SSR loci. It can also analyze the frequency and distribution of SSRs in a genome.\nThese tools can be used for a variety of applications, including genetic mapping, genetic diversity analysis, and marker development for genetic association studies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MICROSAT is a software tool used for detecting microsatellite (SSR) loci and designing primers for their PCR amplification.\n2. MITSUR is a software tool for detecting SSRs in DNA sequences and designing primers for PCR amplification.\n3. SSRanalyzer is a software for detection of SSR loci and primer design for PCR amplification.\n4. Primer3 is a tool that can design primers for PCR amplification of SSR loci.\n5. SSR-Plex is designed for designing primers for multiplex PCR amplification of SSR loci.",
    "yulan-chat-2-13b-fp16_fact": [
      "MICROSAT is a software tool used for detecting microsatellite (SSR) loci and designing primers for their PCR amplification.",
      "MITSUR is a software tool for detecting SSRs in DNA sequences and designing primers for PCR amplification.",
      "SSRanalyzer is a software for detection of SSR loci and primer design for PCR amplification.",
      "Primer3 is a tool that can design primers for PCR amplification of SSR loci.",
      "SSR-Plex is designed for designing primers for multiplex PCR amplification of SSR loci."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no widely recognized software tool named MITSUR for detecting SSRs in DNA sequences. This might be a typo or a fictional name.\n3. UNKNOWN\n4. TRUE - Primer3 is a widely used tool for primer design and can be used for various applications, including SSR loci.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2544,
    "user_query": "What is the preDIVA clinical trial?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information about a clinical trial called \"preDIVA.\" It's possible that the trial is still ongoing and therefore details about it have not yet been made public. If you have additional information about the trial, such as the full name or a study ID number, I may be able to provide more information.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2548,
    "user_query": "Milwaukee protocol was tested for treatment of which disease?",
    "yulan-chat-2-13b-fp16_response": "The Milwaukee protocol was a treatment protocol used to treat individuals with severe acute respiratory syndrome (SARS) during the 2003 outbreak. SARS is a viral respiratory illness that was first identified in China in November 2002 and quickly spread to other countries, causing widespread fear and panic. The Milwaukee protocol involved the use of high doses of the antiviral drug ribavirin, in combination with the steroid dexamethasone, to treat SARS patients. The protocol was developed by a team of doctors at the National Institutes of Health (NIH) in Milwaukee, Wisconsin, and was considered to be one of the most promising treatments for SARS at the time. However, the use of the Milwaukee protocol was later discontinued due to concerns about its safety and efficacy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Milwaukee protocol was used to treat individuals with severe acute respiratory syndrome (SARS).\n2. The SARS outbreak occurred in 2003.\n3. SARS was first identified in China in November 2002.\n4. The protocol included high doses of the antiviral drug ribavirin and the steroid dexamethasone.\n5. The Milwaukee protocol was developed by doctors at the National Institutes of Health (NIH) in Milwaukee, Wisconsin.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Milwaukee protocol was used to treat individuals with severe acute respiratory syndrome (SARS).",
      "The SARS outbreak occurred in 2003.",
      "SARS was first identified in China in November 2002.",
      "The protocol included high doses of the antiviral drug ribavirin and the steroid dexamethasone.",
      "The Milwaukee protocol was developed by doctors at the National Institutes of Health (NIH) in Milwaukee, Wisconsin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Milwaukee protocol was used to treat rabies, not severe acute respiratory syndrome (SARS).\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: The Milwaukee protocol was developed by Dr. Rodney Willoughby and his team at the Children's Hospital of Wisconsin in Milwaukee, not by doctors at the National Institutes of Health (NIH).",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2552,
    "user_query": "Is the consumption of chocolate associated with an increase in cardiovascular disease?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that consuming large amounts of chocolate, especially chocolate with high sugar content, may increase the risk of cardiovascular disease due to its high calorie and sugar content. However, moderate consumption of dark chocolate, which contains antioxidants and flavonoids that may have cardiovascular benefits, has been associated with a lower risk of cardiovascular disease. It is important to note that the effects of chocolate consumption on cardiovascular health may vary depending on the type and amount of chocolate consumed, as well as other individual factors such as overall diet and lifestyle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Consuming large amounts of chocolate, particularly chocolate high in sugar, may increase the risk of cardiovascular disease.\n2. Chocolate's high calorie and sugar content are cited as reasons for its potential to increase cardiovascular disease risk.\n3. Moderate consumption of dark chocolate has been associated with a lower risk of cardiovascular disease.\n4. Dark chocolate contains antioxidants and flavonoids that may have cardiovascular benefits.\n5. The effects of chocolate consumption on cardiovascular health can vary based on type and amount of chocolate, overall diet, and lifestyle.",
    "yulan-chat-2-13b-fp16_fact": [
      "Consuming large amounts of chocolate, particularly chocolate high in sugar, may increase the risk of cardiovascular disease.",
      "Chocolate's high calorie and sugar content are cited as reasons for its potential to increase cardiovascular disease risk.",
      "Moderate consumption of dark chocolate has been associated with a lower risk of cardiovascular disease.",
      "Dark chocolate contains antioxidants and flavonoids that may have cardiovascular benefits.",
      "The effects of chocolate consumption on cardiovascular health can vary based on type and amount of chocolate, overall diet, and lifestyle."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2553,
    "user_query": "What is the association of circular RNA to breast cancer?",
    "yulan-chat-2-13b-fp16_response": "Circular RNA (circRNA) has been identified as a potential biomarker for breast cancer. Studies have shown that the expression levels of certain circRNAs are altered in breast cancer compared to healthy tissues, and that these circRNAs may play a role in the development and progression of breast cancer. For example, some circRNAs have been found to act as oncogenes (genes that promote cancer growth) or tumor suppressors (genes that inhibit cancer growth), while others have been implicated in breast cancer subtypes and drug resistance. However, further research is needed to fully understand the role of circRNAs in breast cancer and their potential as diagnostic or therapeutic targets.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Circular RNA (circRNA) has been identified as a potential biomarker for breast cancer.\n2. The expression levels of certain circRNAs are altered in breast cancer compared to healthy tissues.\n3. Some circRNAs may play a role in the development and progression of breast cancer.\n4. Certain circRNAs can act as oncogenes or tumor suppressors.\n5. CircRNAs have been implicated in breast cancer subtypes and drug resistance.",
    "yulan-chat-2-13b-fp16_fact": [
      "Circular RNA (circRNA) has been identified as a potential biomarker for breast cancer.",
      "The expression levels of certain circRNAs are altered in breast cancer compared to healthy tissues.",
      "Some circRNAs may play a role in the development and progression of breast cancer.",
      "Certain circRNAs can act as oncogenes or tumor suppressors.",
      "CircRNAs have been implicated in breast cancer subtypes and drug resistance."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEach statement is consistent with current scientific understanding that circular RNAs (circRNAs) are a type of non-coding RNA which, while once thought to be non-functional byproducts, have been implicated in various biological processes including cancer. They have indeed been identified as potential biomarkers for breast cancer, can have differing expression levels in cancerous versus healthy tissue, may play a role in the disease's development and progression, and have been shown to act as either oncogenes or tumor suppressors. CircRNAs are also implicated in breast cancer subtypes and drug resistance.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "yulan-chat-2-13b-fp16_response": "The R package \"npT\" has been developed for analyzing Non-invasive prenatal testing (NIPT) data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The R package \"npT\" is developed for analyzing Non-invasive prenatal testing (NIPT) data.",
    "yulan-chat-2-13b-fp16_fact": [
      "The R package \"npT\" is developed for analyzing Non-invasive prenatal testing (NIPT) data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n\nNote: Without additional context or access to a comprehensive repository of R packages, I cannot verify the existence or purpose of an R package named \"npT.\" It is possible that there is an R package intended for Non-Invasive Prenatal Testing (NIPT) analysis, but the name \"npT\" cannot be confirmed as correct without further information.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown"
    ]
  },
  {
    "id": 2558,
    "user_query": "Is the gene CDKN2A nevogenic?",
    "yulan-chat-2-13b-fp16_response": "CDKN2A is a tumor suppressor gene that encodes for two proteins: p16INK4a and ARF (alternatively spliced). Both proteins play important roles in regulating cell cycle progression and preventing cancer formation.\nWhile CDKN2A is not strictly nevogenic, it does have a key role in preventing the formation of tumors. The p16INK4a protein binds to and inhibits the activity of cyclin-dependent kinases (CDKs), which are important regulators of the cell cycle. By inhibiting CDK activity, p16INK4a slows down cell proliferation and prevents cells from entering the phase of the cell cycle where they can become cancerous.\nThe ARF protein, on the other hand, plays a role in the ubiquitin-proteasome pathway, which is responsible for degrading abnormal or damaged proteins within cells. By promoting the degradation of oncogenic proteins, ARF helps to prevent the accumulation of genetic alterations that can lead to cancer.\nMutations in the CDKN2A gene have been implicated in various types of cancer, including melanoma, lung cancer, and breast cancer. Loss of function mutations in CDKN2A can lead to the loss of p16INK4a and ARF proteins, which can contribute to the development and progression of tumors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CDKN2A is a tumor suppressor gene that encodes for the proteins p16INK4a and ARF.\n2. The p16INK4a protein binds to and inhibits the activity of cyclin-dependent kinases (CDKs).\n3. By inhibiting CDK activity, p16INK4a slows down cell proliferation.\n4. The ARF protein is involved in the ubiquitin-proteasome pathway, which degrades abnormal or damaged proteins.\n5. Mutations in the CDKN2A gene have been implicated in various types of cancer, including melanoma, lung cancer, and breast cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "CDKN2A is a tumor suppressor gene that encodes for the proteins p16INK4a and ARF.",
      "The p16INK4a protein binds to and inhibits the activity of cyclin-dependent kinases (CDKs).",
      "By inhibiting CDK activity, p16INK4a slows down cell proliferation.",
      "The ARF protein is involved in the ubiquitin-proteasome pathway, which degrades abnormal or damaged proteins.",
      "Mutations in the CDKN2A gene have been implicated in various types of cancer, including melanoma, lung cancer, and breast cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The ARF protein (also known as p14ARF in humans and p19Arf in mice) is involved in the p53 tumor suppressor pathway, where it can activate p53 by sequestering MDM2, a negative regulator of p53. The ubiquitin-proteasome pathway is not the primary pathway ARF is involved with in regards to its role in tumor suppression.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2559,
    "user_query": "Are there ways of joint Bayesian inference of risk variants?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are ways of performing joint Bayesian inference of risk variants. One approach is to use a Bayesian network, which is a probabilistic graphical model that represents the relationships between variables of interest through a directed acyclic graph. In a Bayesian network, the variables are represented as nodes, and the conditional dependencies between the variables are represented by directed edges between the nodes.\nTo perform joint Bayesian inference of risk variants, you would need to construct a Bayesian network that includes the risk variants as well as any other relevant variables, such as genetic markers or environmental factors. You would then use Bayesian inference to estimate the posterior probability distributions of the risk variants and the other variables given the available data.\nThere are several software tools that can be used to construct and analyze Bayesian networks, including Bayesian networks software such as BayesNet, BN++ and BNFinder. These tools can be used to perform joint Bayesian inference of risk variants and other variables, and to estimate the posterior probability distributions of the risk variants and the other variables given the available data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Joint Bayesian inference of risk variants can be performed using a Bayesian network.\n2. A Bayesian network is a probabilistic graphical model that includes variables and their conditional dependencies represented using a directed acyclic graph.\n3. Risk variants, genetic markers, and environmental factors can be included as variables within a Bayesian network for joint Bayesian inference.\n4. Bayesian inference is used to estimate the posterior probability distributions of the variables given available data.\n5. Software tools like BayesNet, BN++, and BNFinder are used to construct and analyze Bayesian networks.",
    "yulan-chat-2-13b-fp16_fact": [
      "Joint Bayesian inference of risk variants can be performed using a Bayesian network.",
      "A Bayesian network is a probabilistic graphical model that includes variables and their conditional dependencies represented using a directed acyclic graph.",
      "Risk variants, genetic markers, and environmental factors can be included as variables within a Bayesian network for joint Bayesian inference.",
      "Bayesian inference is used to estimate the posterior probability distributions of the variables given available data.",
      "Software tools like BayesNet, BN++, and BNFinder are used to construct and analyze Bayesian networks."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Software tools like BayesiaLab, Netica, and SamIam are commonly used for constructing and analyzing Bayesian networks. The tools listed, BayesNet, BN++, and BNFinder may not be recognized tools or are possibly named incorrectly.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbachs syndrome.",
    "yulan-chat-2-13b-fp16_response": "Achenbach's syndrome, also known as Achenbach's line, is a term used in the field of optics to describe a phenomenon that occurs when a thin, dark line appears across the center of a bright light source, such as a lamp or the sun. This line is caused by the interference of light waves as they pass through a small gap in a lens or other transparent material. The line appears as a result of the constructive and destructive interference of the light waves as they pass through the gap, creating a series of dark and light bands that converge on the center of the light source. Achenbach's syndrome is named after the German physicist Adolf Achenbach, who first described the phenomenon in 1925.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2561,
    "user_query": "Has intepirdine been evaluated in clinical trials? (November 2017)",
    "yulan-chat-2-13b-fp16_response": "I am not able to find any information on clinical trials for Intepirdine. It is possible that the drug is still in the development phase and has not yet been evaluated in clinical trials. I would recommend checking with the manufacturer or a healthcare professional for more information.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2565,
    "user_query": "Does armodafinil improve fatigue of glioma patients?",
    "yulan-chat-2-13b-fp16_response": "Armodafinil is a wakefulness-promoting agent that is sometimes used to improve fatigue in certain populations. However, there is limited research on the use of armodafinil specifically for fatigue in patients with glioma, which is a type of brain tumor.\nOne small study published in the journal Neurology in 2013 found that armodafinil was effective in improving fatigue in patients with various types of brain tumors, including glioma. The study involved 22 patients who were given armodafinil for 12 weeks. At the end of the study, patients reported significant improvements in fatigue levels.\nHowever, it is important to note that this study was small and had a limited sample size. Additionally, the study did not compare armodafinil to a placebo or other treatments for fatigue, so it is unclear whether armodafinil was truly effective or if the improvements were due to other factors.\nOverall, while armodafinil may have potential as a treatment for fatigue in patients with glioma, more research is needed to confirm its effectiveness and safety in this population. It is important to discuss any potential treatment options with a healthcare provider, who can provide guidance based on individual needs and circumstances.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Armodafinil is used to improve fatigue in certain populations.\n2. There is limited research on the use of armodafinil specifically for fatigue in patients with glioma.\n3. A study published in the journal Neurology in 2013 involved 22 patients with various types of brain tumors, including glioma, who were given armodafinil for 12 weeks.\n4. Patients in the 2013 study reported significant improvements in fatigue levels after taking armodafinil for 12 weeks.\n5. The study referenced did not compare armodafinil to a placebo or other treatments for fatigue.",
    "yulan-chat-2-13b-fp16_fact": [
      "Armodafinil is used to improve fatigue in certain populations.",
      "There is limited research on the use of armodafinil specifically for fatigue in patients with glioma.",
      "A study published in the journal Neurology in 2013 involved 22 patients with various types of brain tumors, including glioma, who were given armodafinil for 12 weeks.",
      "Patients in the 2013 study reported significant improvements in fatigue levels after taking armodafinil for 12 weeks.",
      "The study referenced did not compare armodafinil to a placebo or other treatments for fatigue."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE - Armodafinil is used to improve wakefulness in patients with excessive sleepiness associated with conditions that may result in fatigue.\n2. TRUE - Research specifically focusing on armodafinil for fatigue in glioma patients is indeed limited.\n3. UNKNOWN - Without access to the specific study, it is not possible to confirm the details such as the number of patients involved or the types of brain tumors included.\n4. UNKNOWN - Again, without access to the study results, it is not possible to confirm if the patients reported significant improvements in fatigue levels.\n5. UNKNOWN - Without reviewing the study, we cannot confirm whether it compared armodafinil to a placebo or other treatments.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2566,
    "user_query": "What is the role of tankyrases in response to Double Strand Breaks (DSBs)?",
    "yulan-chat-2-13b-fp16_response": "Tankyrases are a family of proteins that play a role in the response to double-strand breaks (DSBs) in DNA. DSBs are a type of DNA damage that occurs when both strands of the DNA molecule are broken, and they are a particularly dangerous form of DNA damage because they can lead to the loss of genetic information if not repaired properly.\nTankyrases help to repair DSBs by stabilizing the DNA repair protein complexes that are responsible for repairing the breaks. They do this by binding to the ends of the broken DNA molecules and recruiting other proteins to the site of the damage. This helps to stabilize the DNA repair complexes and facilitate the repair process.\nIn addition to their role in repairing DSBs, tankyrases have also been shown to play a role in other aspects of DNA damage response, including the regulation of the cell cycle and the activation of DNA damage response pathways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tankyrases are a family of proteins that are involved in the response to double-strand breaks (DSBs) in DNA.\n2. Double-strand breaks in DNA occur when both strands of the DNA molecule are broken.\n3. Tankyrases help to repair DNA by stabilizing the repair protein complexes responsible for fixing the breaks.\n4. Tankyrases bind to the ends of broken DNA molecules to recruit other proteins for damage repair.\n5. Besides repairing DSBs, tankyrases also participate in the regulation of the cell cycle and activation of DNA damage response pathways.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tankyrases are a family of proteins that are involved in the response to double-strand breaks (DSBs) in DNA.",
      "Double-strand breaks in DNA occur when both strands of the DNA molecule are broken.",
      "Tankyrases help to repair DNA by stabilizing the repair protein complexes responsible for fixing the breaks.",
      "Tankyrases bind to the ends of broken DNA molecules to recruit other proteins for damage repair.",
      "Besides repairing DSBs, tankyrases also participate in the regulation of the cell cycle and activation of DNA damage response pathways."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Tankyrases are a family of proteins that are involved in various cellular processes, including telomere maintenance and Wnt signaling, but they are not directly involved in the response to double-strand breaks (DSBs) in DNA.\n2. TRUE\n3. FALSE [correction]: Although tankyrases are involved in some aspects of DNA repair, their role is not primarily in stabilizing repair protein complexes responsible for fixing double-strand breaks; they are more involved in processes such as telomere maintenance and Wnt signaling.\n4. FALSE [correction]: Tankyrases do not bind directly to the ends of broken DNA molecules; instead, they modify certain proteins involved in cellular signaling and homeostasis through ADP-ribosylation.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2569,
    "user_query": "Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?",
    "yulan-chat-2-13b-fp16_response": "There are several methods available for whole genome identification of pathogenic regulatory variants in Mendelian diseases. Some of the commonly used methods include:\n1. Whole genome sequencing (WGS): This method involves sequencing the entire genome of an individual and can identify all types of genetic variants, including regulatory variants.\n2. Chromatin immunoprecipitation sequencing (ChIP-seq): This method involves identifying DNA fragments that are bound by a specific transcription factor or other proteins that regulate gene expression.\n3. DNase I footprinting: This method involves identifying regions of the genome where a transcription factor binds and prevents the degradation of DNA by DNase I.\n4. Assay for transposable elements (ATE): This method involves identifying regions of the genome where transposable elements are inserted and can disrupt the binding of transcription factors.\n5. Genome-wide association studies (GWAS): This method involves comparing the genomes of affected individuals to those of unaffected individuals to identify genetic variants that are associated with the disease.\nThese methods can be used alone or in combination to identify pathogenic regulatory variants in Mendelian diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Whole genome sequencing (WGS) is a method that sequences the entire genome of an individual to identify genetic variants, including regulatory variants.\n2. Chromatin immunoprecipitation sequencing (ChIP-seq) identifies DNA fragments bound by specific transcription factors or proteins regulating gene expression.\n3. DNase I footprinting identifies genome regions where transcription factors bind and protect DNA from degradation by DNase I.\n4. Assay for transposable elements (ATE) identifies genome regions where transposable elements are inserted, potentially disrupting transcription factor binding.\n5. Genome-wide association studies (GWAS) compare genomes of affected individuals to those of unaffected individuals to identify genetic variants associated with disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Whole genome sequencing (WGS) is a method that sequences the entire genome of an individual to identify genetic variants, including regulatory variants.",
      "Chromatin immunoprecipitation sequencing (ChIP-seq) identifies DNA fragments bound by specific transcription factors or proteins regulating gene expression.",
      "DNase I footprinting identifies genome regions where transcription factors bind and protect DNA from degradation by DNase I.",
      "Assay for transposable elements (ATE) identifies genome regions where transposable elements are inserted, potentially disrupting transcription factor binding.",
      "Genome-wide association studies (GWAS) compare genomes of affected individuals to those of unaffected individuals to identify genetic variants associated with disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) identifies regions of the genome that are open and likely accessible to transcription factors and other proteins. There is no widely recognized method called \"Assay for transposable elements (ATE)\" in the context of identifying transcription factor binding sites. However, \"ATE\" might be a misinterpretation or typo for ATAC-seq.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2576,
    "user_query": "Which algorithm has been proposed for efficient storage of WGS variant calls?",
    "yulan-chat-2-13b-fp16_response": "There are several algorithms that have been proposed for efficient storage of WGS variant calls, including:\n1. Burrows-Wheeler Alignment (BWA) index: This is a widely used algorithm for efficient storage of variant calls in WGS data. It creates an index of the reference genome that allows for fast alignment of reads to the genome and efficient storage of variant calls.\n2. GATK Best Practices for Genome Analysis: This is a set of guidelines and tools developed by the Broad Institute for efficient analysis of WGS data. It includes several algorithms for efficient storage of variant calls, including the Variant Caller algorithm, which uses a local de Bruijn graph to store variant calls.\n3. SAMtools: This is a set of tools for manipulating sequencing data in the SAM/BAM format. It includes several algorithms for efficient storage of variant calls, including the SAMtools mpileup command, which can be used to efficiently calculate read depth and variant calls for a region of the genome.\n4. Picard: This is a collection of algorithms for working with high-throughput sequencing data, developed by the Broad Institute. It includes several algorithms for efficient storage of variant calls, including the Picard CollectCoverage command, which can be used to collect read coverage information for a set of variants.\nOverall, there are many different algorithms that can be used for efficient storage of WGS variant calls, and the choice of algorithm will depend on the specific needs and requirements of the analysis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Burrows-Wheeler Alignment (BWA) index is used for efficient storage of variant calls in WGS data.\n2. The Genome Analysis Toolkit (GATK) Best Practices include a Variant Caller algorithm which utilizes a local de Bruijn graph for storing variant calls.\n3. SAMtools is a toolset that handles sequencing data in SAM/BAM format, which includes algorithms for efficient variant call storage.\n4. Picard is a collection of algorithms used for handling high-throughput sequencing data and includes methods for storage of variant calls, such as the CollectCoverage command.",
    "yulan-chat-2-13b-fp16_fact": [
      "Burrows-Wheeler Alignment (BWA) index is used for efficient storage of variant calls in WGS data.",
      "The Genome Analysis Toolkit (GATK) Best Practices include a Variant Caller algorithm which utilizes a local de Bruijn graph for storing variant calls.",
      "SAMtools is a toolset that handles sequencing data in SAM/BAM format, which includes algorithms for efficient variant call storage.",
      "Picard is a collection of algorithms used for handling high-throughput sequencing data and includes methods for storage of variant calls, such as the CollectCoverage command."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Burrows-Wheeler Alignment (BWA) index is used for efficient alignment of sequencing reads to a reference genome in WGS data, not specifically for the storage of variant calls.\n2. TRUE (but note that while GATK does include various algorithms for variant calling, it's important to confirm the specific reference to the use of a de Bruijn graph by the Variant Caller algorithm.)\n3. TRUE (but it should be noted that SAMtools primarily provides utilities for manipulating alignments in the SAM/BAM format, rather than specializing in storage of variant calls. It includes functionalities like indexing, sorting, and variant calling among others.)\n4. FALSE [correction]: Picard is a set of Java command line tools for manipulating high-throughput sequencing (HTS) data and files, but it is not primarily focused on the storage of variant calls. The CollectCoverage command is used for collecting sequencing coverage statistics, not storing variant calls.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2577,
    "user_query": "Is Citrobacter rodentium pathogenic?",
    "yulan-chat-2-13b-fp16_response": "Citrobacter rodentium is a gram-negative, non-motile, oxidase-positive bacterium that is commonly found in the intestinal tracts of rodents. While it is not considered to be a pathogenic bacterium in humans, it has been used as a model organism to study the pathogenesis of enteric diseases, such as Crohn's disease.\nCitrobacter rodentium is capable of causing disease in rodents, and it has been shown to be a primary causative agent of a self-limited, inflammatory bowel disease in mice. However, it is not known to cause disease in humans.\nIt is important to note that the ability of a bacterium to cause disease can depend on a variety of factors, including the host's immune status, the dose and route of exposure, and the virulence of the bacterium. Therefore, while Citrobacter rodentium is not considered to be a pathogenic bacterium in humans, it is still important to practice good hygiene and sanitation to prevent the spread of any bacteria that may cause illness.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Citrobacter rodentium is a gram-negative, non-motile, oxidase-positive bacterium.\n2. It is commonly found in the intestinal tracts of rodents.\n3. Citrobacter rodentium has been used as a model organism to study the pathogenesis of enteric diseases such as Crohn's disease.\n4. Citrobacter rodentium is capable of causing disease in rodents.\n5. It is not known to cause disease in humans.",
    "yulan-chat-2-13b-fp16_fact": [
      "Citrobacter rodentium is a gram-negative, non-motile, oxidase-positive bacterium.",
      "It is commonly found in the intestinal tracts of rodents.",
      "Citrobacter rodentium has been used as a model organism to study the pathogenesis of enteric diseases such as Crohn's disease.",
      "Citrobacter rodentium is capable of causing disease in rodents.",
      "It is not known to cause disease in humans."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Citrobacter rodentium is a gram-negative, non-motile, oxidase-negative bacterium.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While Citrobacter rodentium primarily causes disease in rodents, certain strains of the broader Citrobacter genus can cause opportunistic infections in humans.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2578,
    "user_query": "List two human monoclonal antibodies against Clostridium difficile toxins.",
    "yulan-chat-2-13b-fp16_response": "Two human monoclonal antibodies against Clostridium difficile toxins are:\n1. Clostridium difficile toxin A monoclonal antibody (CAT A)\n2. Clostridium difficile toxin B monoclonal antibody (CAT B)",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2579,
    "user_query": "List ribosomal biogenesis proteins.",
    "yulan-chat-2-13b-fp16_response": "Ribosomal biogenesis proteins are a group of proteins that play a crucial role in the formation and maintenance of ribosomes, which are the molecular machines that synthesize proteins in cells. Here is a list of some of the key ribosomal biogenesis proteins:\n1. Ribosomal protein S6 kinase (RSK)\n2. Ribosomal protein S15 (RPS15)\n3. Ribosomal protein L1 (RPL1)\n4. Ribosomal protein L2 (RPL2)\n5. Ribosomal protein L3 (RPL3)\n6. Ribosomal protein L4 (RPL4)\n7. Ribosomal protein L5 (RPL5)\n8. Ribosomal protein L10 (RPL10)\n9. Ribosomal protein L11 (RPL11)\n10. Ribosomal protein L12 (RPL12)\n11. Ribosomal protein L13 (RPL13)\n12. Ribosomal protein L14 (RPL14)\n13. Ribosomal protein L15 (RPL15)\n14. Ribosomal protein L16 (RPL16)\n15. Ribosomal protein L17 (RPL17)\n16. Ribosomal protein L18 (RPL18)\n17. Ribosomal protein L19 (RPL19)\n18. Ribosomal protein L20 (RPL20)\n19. Ribosomal protein L21 (RPL21)\n20. Ribosomal protein L22 (RPL22)\n21. Ribosomal protein L23 (RPL23)\n22. Ribosomal protein L24 (RPL24)\n23. Ribosomal protein L25 (RPL25)\n24. Ribosomal protein L26 (RPL26)\n25. Ribosomal protein L27 (RPL27)\n26. Ribosomal protein L28 (RPL",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ribosomal protein S6 kinase (RSK) is considered one of the ribosomal biogenesis proteins.\n2. Ribosomal protein S15 (RPS15) is a ribosomal biogenesis protein.\n3. Ribosomal protein L1 (RPL1) is a ribosomal biogenesis protein.\n4. Ribosomal protein L2 (RPL2) is a ribosomal biogenesis protein.\n5. Ribosomal protein L3 (RPL3) is listed as a ribosomal biogenesis protein.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ribosomal protein S6 kinase (RSK) is considered one of the ribosomal biogenesis proteins.",
      "Ribosomal protein S15 (RPS15) is a ribosomal biogenesis protein.",
      "Ribosomal protein L1 (RPL1) is a ribosomal biogenesis protein.",
      "Ribosomal protein L2 (RPL2) is a ribosomal biogenesis protein.",
      "Ribosomal protein L3 (RPL3) is listed as a ribosomal biogenesis protein."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Ribosomal protein S6 kinase (RSK) is not a ribosomal biogenesis protein, it is a kinase that acts downstream of the signal transduction pathway and can regulate various cellular processes including cell growth and proliferation.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "yulan-chat-2-13b-fp16_response": "There are several algorithms that can be used for the detection of long repeat expansions, including:\n1. Long Range PCR (LRPCR): This technique allows for the amplification of DNA fragments up to several kilobases in length, making it useful for detecting repeat expansions that are too large to be detected by other methods.\n2. Next-Generation Sequencing (NGS): NGS technologies can sequence entire genomes or specific regions of interest, allowing for the detection of repeat expansions and other genetic variations.\n3. Array-based technologies: Array-based technologies, such as genome-wide microarrays or targeted arrays, can be used to detect copy number variations (CNVs) and other genetic alterations, including repeat expansions.\n4. Tandem Affinity Purification (TAP): TAP is a technique that allows for the enrichment of specific proteins or protein complexes from cell lysates, followed by mass spectrometry analysis. This can be useful for detecting proteins that are associated with repeat expansions.\n5. Single-molecule sequencing: This technique allows for the direct sequencing of individual DNA molecules, providing high-resolution information about the structure and length of repeat expansions.\nThe choice of algorithm depends on the specific research question and the type of sample being analyzed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Long Range PCR (LRPCR) can amplify DNA fragments up to several kilobases in length.\n2. Next-Generation Sequencing (NGS) technologies can sequence entire genomes or specific regions, which facilitates the detection of repeat expansions.\n3. Array-based technologies can detect copy number variations and repeat expansions.\n4. Tandem Affinity Purification (TAP) involves enrichment of proteins or protein complexes for detection purposes.\n5. Single-molecule sequencing allows for direct sequencing of individual DNA molecules, providing detailed information on repeat expansions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Long Range PCR (LRPCR) can amplify DNA fragments up to several kilobases in length.",
      "Next-Generation Sequencing (NGS) technologies can sequence entire genomes or specific regions, which facilitates the detection of repeat expansions.",
      "Array-based technologies can detect copy number variations and repeat expansions.",
      "Tandem Affinity Purification (TAP) involves enrichment of proteins or protein complexes for detection purposes.",
      "Single-molecule sequencing allows for direct sequencing of individual DNA molecules, providing detailed information on repeat expansions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Array-based technologies can detect copy number variations, but they are not typically used for detection of repeat expansions. Techniques like PCR or Southern blot are generally utilized for detecting repeat expansions.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "yulan-chat-2-13b-fp16_response": "Neuroligins are a family of proteins that play important roles in the development and function of the nervous system. Neuroligin-3 (NL3) is a protein that is expressed in the brain and has been implicated in several brain disorders, including brain tumors.\nStudies have shown that NL3 is expressed in several types of brain tumors, including glioblastoma, medulloblastoma, and astrocytoma. In particular, NL3 has been found to promote the growth and survival of cancer cells in these tumors, making it a potential target for cancer therapy.\nHowever, it is important to note that more research is needed to fully understand the role of NL3 in brain tumors and to develop effective therapies that target this protein.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neuroligin-3 (NL3) is expressed in the brain and has been associated with several brain disorders.\n2. Studies have shown that NL3 is expressed in several types of brain tumors, including glioblastoma, medulloblastoma, and astrocytoma.\n3. NL3 has been found to promote the growth and survival of cancer cells in these brain tumors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neuroligin-3 (NL3) is expressed in the brain and has been associated with several brain disorders.",
      "Studies have shown that NL3 is expressed in several types of brain tumors, including glioblastoma, medulloblastoma, and astrocytoma.",
      "NL3 has been found to promote the growth and survival of cancer cells in these brain tumors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "yulan-chat-2-13b-fp16_response": "Gas vesicles are typically much smaller than balloons. They are usually less than 1 cm in diameter and can range in size from a few millimeters to a few centimeters. The size of gas vesicles can vary depending on the organism that produces them and the conditions under which they are formed. In general, gas vesicles are much smaller than the balloon-like structures produced by some animals, such as frogs and some species of fish, which can be several feet in diameter.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gas vesicles are usually less than 1 cm in diameter.\n2. The size of gas vesicles can range from a few millimeters to a few centimeters.\n3. The size variation of gas vesicles is influenced by the organism that produces them.\n4. The size variation of gas vesicles is influenced by the conditions under which they are formed.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gas vesicles are usually less than 1 cm in diameter.",
      "The size of gas vesicles can range from a few millimeters to a few centimeters.",
      "The size variation of gas vesicles is influenced by the organism that produces them.",
      "The size variation of gas vesicles is influenced by the conditions under which they are formed."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2588,
    "user_query": "Are osteoclasts specialized in bone degradation?",
    "yulan-chat-2-13b-fp16_response": "Yes, osteoclasts are specialized cells that are responsible for bone resorption and degradation. They are multinucleated cells that form on the surface of bone tissue and secrete enzymes and acids that break down the mineral component of bone, known as the bone matrix. Osteoclasts then absorb the dissolved minerals and release them back into the bloodstream to be used by the body.\nOsteoclasts are essential for bone remodeling, which is the process by which old or damaged bone tissue is removed and replaced with new bone tissue. This process is important for maintaining bone health and adapting to changes in physical activity or stress. Osteoclasts work in conjunction with osteoblasts, which are specialized cells that are responsible for bone formation and repair.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Osteoclasts are specialized cells responsible for bone resorption and degradation.\n2. Osteoclasts are multinucleated cells that form on the surface of bone tissue.\n3. Osteoclasts secrete enzymes and acids to break down the mineral component of bone known as the bone matrix.\n4. Osteoclasts absorb dissolved minerals and release them into the bloodstream.\n5. Osteoclasts work in conjunction with osteoblasts, which are specialized cells responsible for bone formation and repair.",
    "yulan-chat-2-13b-fp16_fact": [
      "Osteoclasts are specialized cells responsible for bone resorption and degradation.",
      "Osteoclasts are multinucleated cells that form on the surface of bone tissue.",
      "Osteoclasts secrete enzymes and acids to break down the mineral component of bone known as the bone matrix.",
      "Osteoclasts absorb dissolved minerals and release them into the bloodstream.",
      "Osteoclasts work in conjunction with osteoblasts, which are specialized cells responsible for bone formation and repair."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "yulan-chat-2-13b-fp16_response": "BET proteins (Bromodomain and Extra-Terminal domain proteins) are a family of proteins that play a role in regulating gene expression by modifying chromatin structure. They are characterized by the presence of bromodomains, which are protein modules that bind to acetylated lysine residues on histone proteins and non-histone proteins. Some of the best-known BET proteins include:\n* BRD4 (Bromodomain-containing protein 4)\n* BRD3 (Bromodomain-containing protein 3)\n* BRD2 (Bromodomain-containing protein 2)\n* BET bromodomain proteins (BET bromodomain proteins are a family of proteins that share a bromodomain and include: BET bromodomain protein 1, BET bromodomain protein 2, BET bromodomain protein 3, BET bromodomain protein 4, BET bromodomain protein 5, BET bromodomain protein 6, BET bromodomain protein 7, BET bromodomain protein 8, BET bromodomain protein 9, BET bromodomain protein 10, BET bromodomain protein 11, BET bromodomain protein 12, BET bromodomain protein 13, BET bromodomain protein 14, BET bromodomain protein 15, BET bromodomain protein 16, BET bromodomain protein 17, BET bromodomain protein 18, BET bromodomain protein 19, BET bromodomain protein 20, BET bromodomain protein 21, BET bromodomain protein 22, BET bromodomain protein 23, BET bromodomain protein 24, BET bromodomain protein 25, BET bromodomain protein 26, BET bromodomain protein 27, BET bromodomain",
    "yulan-chat-2-13b-fp16_fact_raw": "1. BET proteins are involved in regulating gene expression by modifying chromatin structure.\n2. BET proteins are characterized by the presence of bromodomains.\n3. Bromodomains are protein modules that bind to acetylated lysine residues on histone and non-histone proteins.\n4. BRD4 is a member of the BET protein family and is known as Bromodomain-containing protein 4.\n5. BRD3 and BRD2 are members of the BET protein family, known as Bromodomain-containing protein 3 and Bromodomain-containing protein 2, respectively.",
    "yulan-chat-2-13b-fp16_fact": [
      "BET proteins are involved in regulating gene expression by modifying chromatin structure.",
      "BET proteins are characterized by the presence of bromodomains.",
      "Bromodomains are protein modules that bind to acetylated lysine residues on histone and non-histone proteins.",
      "BRD4 is a member of the BET protein family and is known as Bromodomain-containing protein 4.",
      "BRD3 and BRD2 are members of the BET protein family, known as Bromodomain-containing protein 3 and Bromodomain-containing protein 2, respectively."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2593,
    "user_query": "How does neuronal activity affect neuroligin-3?",
    "yulan-chat-2-13b-fp16_response": "Neuronal activity can affect the expression and function of neuroligins, a family of synaptic proteins that play important roles in synaptic transmission and development. Neuroligin-3 (NL3) is one of the neuronal cell adhesion molecules that are involved in the formation and maintenance of synapses.\nStudies have shown that neuronal activity can regulate the expression of NL3 in several ways. For example, long-term potentiation (LTP), a form of synaptic plasticity that strengthens the connection between neurons, has been shown to increase the expression of NL3 in the postsynaptic dendrites of hippocampal neurons. On the other hand, long-term depression (LTD), a form of synaptic plasticity that weakens the connection between neurons, has been shown to decrease the expression of NL3 in the same region.\nIn addition to regulating NL3 expression, neuronal activity can also affect the function of NL3. For example, NL3 has been shown to play a role in the trafficking of AMPA receptors, which are important for fast synaptic transmission, to the postsynaptic membrane. Neuronal activity has been shown to regulate the trafficking of AMPA receptors, and thus, the function of NL3 in this process.\nOverall, the regulation of NL3 by neuronal activity is an important mechanism for the fine-tuning of synaptic function and plasticity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neuronal activity can affect the expression and function of neuroligins, which are synaptic proteins important for synaptic transmission and development.\n2. Neuroligin-3 (NL3) is involved in the formation and maintenance of synapses.\n3. Long-term potentiation (LTP) has been shown to increase the expression of NL3 in the postsynaptic dendrites of hippocampal neurons.\n4. Long-term depression (LTD) has been shown to decrease the expression of NL3 in the hippocampal neurons.\n5. NL3 plays a role in the trafficking of AMPA receptors to the postsynaptic membrane.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neuronal activity can affect the expression and function of neuroligins, which are synaptic proteins important for synaptic transmission and development.",
      "Neuroligin-3 (NL3) is involved in the formation and maintenance of synapses.",
      "Long-term potentiation (LTP) has been shown to increase the expression of NL3 in the postsynaptic dendrites of hippocampal neurons.",
      "Long-term depression (LTD) has been shown to decrease the expression of NL3 in the hippocampal neurons.",
      "NL3 plays a role in the trafficking of AMPA receptors to the postsynaptic membrane."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nNeuroligins are indeed involved in the formation and maintenance of synapses, and changes in their expression levels have been associated with synaptic plasticity events such as LTP and LTD. Neuroligin-3 (NL3) is one of the neuroligins with roles in these processes. In the case of LTP, it has been demonstrated that there can be an increase in the expression of neuroligins, including NL3. Similarly, for LTD, changes in neuroligin expression, including a decrease, can be associated with this form of synaptic plasticity. Lastly, NL3 has been implicated in AMPA receptor trafficking, which is an important process for synaptic transmission and plasticity.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2596,
    "user_query": "What is PARP inhibitor (PARPi) resistance?",
    "yulan-chat-2-13b-fp16_response": "PARP inhibitors (PARPi) are a class of drugs that target poly (ADP-ribose) polymerase (PARP), an enzyme that plays a role in DNA repair. PARPi are used to treat cancer, particularly breast and ovarian cancer, by inhibiting the ability of cancer cells to repair their DNA, leading to cell death.\nHowever, some cancer cells can become resistant to PARPi through various mechanisms. One way this can happen is through the activation of alternative DNA repair pathways that bypass the block in PARP-mediated DNA repair. For example, cancer cells may activate the homologous recombination repair (HRR) pathway, which is independent of PARP, to repair DNA damage.\nAnother mechanism of resistance to PARPi is through the activation of a different PARP isoform, PARP2, which can also mediate DNA repair. PARP2 has a different substrate specificity than PARP1, the isoform targeted by PARPi, and its activation can lead to resistance to PARPi.\nFinally, cancer cells may also develop secondary mutations in genes involved in DNA repair, such as BRCA1 or BRCA2, which can confer resistance to PARPi.\nOverall, PARP inhibitor resistance can occur through multiple mechanisms, and it is important to develop strategies to overcome or prevent resistance in order to maximize the clinical benefit of PARPi in the treatment of cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PARP inhibitors are used to treat cancer, specifically breast and ovarian cancer.\n2. One mechanism of PARP inhibitor resistance is the activation of alternative DNA repair pathways such as the homologous recombination repair pathway.\n3. The activation of an alternative PARP isoform, PARP2, can mediate DNA repair and lead to PARP inhibitor resistance.\n4. Cancer cells may develop secondary mutations in DNA repair genes like BRCA1 or BRCA2, which can confer resistance to PARP inhibitors.\n5. Poly (ADP-ribose) polymerase (PARP) is an enzyme involved in DNA repair.",
    "yulan-chat-2-13b-fp16_fact": [
      "PARP inhibitors are used to treat cancer, specifically breast and ovarian cancer.",
      "One mechanism of PARP inhibitor resistance is the activation of alternative DNA repair pathways such as the homologous recombination repair pathway.",
      "The activation of an alternative PARP isoform, PARP2, can mediate DNA repair and lead to PARP inhibitor resistance.",
      "Cancer cells may develop secondary mutations in DNA repair genes like BRCA1 or BRCA2, which can confer resistance to PARP inhibitors.",
      "Poly (ADP-ribose) polymerase (PARP) is an enzyme involved in DNA repair."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2597,
    "user_query": "What is the association of the protein RAB10 and Alzheimers disease?",
    "yulan-chat-2-13b-fp16_response": "RAB10 is a protein that plays a role in the transport of molecules within cells. There is some evidence to suggest that mutations in the RAB10 gene may be associated with an increased risk of Alzheimer's disease, although the exact nature of this association is not well understood. Some studies have suggested that RAB10 may be involved in the transport of amyloid-beta, a protein that is thought to play a role in the development of Alzheimer's disease. However, more research is needed to fully understand the relationship between RAB10 and Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RAB10 is a protein involved in the transport of molecules within cells.\n2. Mutations in the RAB10 gene could be associated with an increased risk of Alzheimer's disease.\n3. Some studies suggest RAB10 may be involved in the transport of amyloid-beta.\n4. Amyloid-beta is thought to play a role in the development of Alzheimer's disease.\n5. More research is needed to fully understand the relationship between RAB10 and Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "RAB10 is a protein involved in the transport of molecules within cells.",
      "Mutations in the RAB10 gene could be associated with an increased risk of Alzheimer's disease.",
      "Some studies suggest RAB10 may be involved in the transport of amyloid-beta.",
      "Amyloid-beta is thought to play a role in the development of Alzheimer's disease.",
      "More research is needed to fully understand the relationship between RAB10 and Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2599,
    "user_query": "A bite from the Lone Star Tick Amblyomma americanum, can cause the victim to become allergic to red meat, yes or no?",
    "yulan-chat-2-13b-fp16_response": "Yes, a bite from the Lone Star Tick Amblyomma americanum can cause the victim to become allergic to red meat. This is because the tick transmits a sugar molecule called alpha-gal into the victim's bloodstream, which can trigger an immune response and lead to the development of an allergy to red meat, as alpha-gal is present in the muscle tissue of mammals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A bite from the Lone Star Tick Amblyomma americanum can cause an individual to develop an allergy to red meat.\n2. The Lone Star Tick transmits a sugar molecule called alpha-gal into the victim's bloodstream.\n3. Alpha-gal is present in the muscle tissue of mammals.",
    "yulan-chat-2-13b-fp16_fact": [
      "A bite from the Lone Star Tick Amblyomma americanum can cause an individual to develop an allergy to red meat.",
      "The Lone Star Tick transmits a sugar molecule called alpha-gal into the victim's bloodstream.",
      "Alpha-gal is present in the muscle tissue of mammals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2600,
    "user_query": "What are pQTLs?",
    "yulan-chat-2-13b-fp16_response": "pQTLs stands for \"polygenic quantitative trait loci.\" They are regions of the genome that are associated with variation in the expression of multiple genes, and can contribute to the heritability of complex traits and diseases. pQTLs can be identified through genome-wide association studies (GWAS) or other methods that analyze genetic variation and gene expression data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. pQTLs stand for \"polygenic quantitative trait loci.\"\n2. pQTLs are associated with variations in the expression of multiple genes.\n3. pQTLs contribute to the heritability of complex traits and diseases.\n4. pQTLs can be identified through genome-wide association studies (GWAS).\n5. Methods that analyze genetic variation and gene expression data can identify pQTLs.",
    "yulan-chat-2-13b-fp16_fact": [
      "pQTLs stand for \"polygenic quantitative trait loci.\"",
      "pQTLs are associated with variations in the expression of multiple genes.",
      "pQTLs contribute to the heritability of complex traits and diseases.",
      "pQTLs can be identified through genome-wide association studies (GWAS).",
      "Methods that analyze genetic variation and gene expression data can identify pQTLs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: pQTLs stand for \"protein quantitative trait loci.\"\n2. FALSE [correction]: pQTLs are associated with variations in the levels of proteins, not necessarily the expression of multiple genes.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2603,
    "user_query": "What is the \"protein inference problem\"?",
    "yulan-chat-2-13b-fp16_response": "The protein inference problem is a challenge in bioinformatics and computational biology, which involves predicting the presence and identity of proteins in a biological sample or organism based on experimental data.\nProteins are complex molecules that play crucial roles in many biological processes. They are made up of long chains of amino acids, which can be modified in various ways to give them different properties and functions. Determining the identity and quantity of proteins in a biological sample is important for understanding the underlying biology and for developing new therapies and diagnostic tools.\nHowever, it can be difficult to directly detect and identify proteins using experimental methods. Instead, researchers often use a variety of techniques to measure the activity, expression, and interaction of proteins, and then use computational methods to infer the presence and identity of proteins from these data.\nThe protein inference problem arises because there are many possible ways that proteins can be expressed and interact with other molecules in a biological system, and there may be multiple proteins that can give rise to a particular experimental signal. Therefore, it can be challenging to accurately predict the identity and quantity of proteins based on experimental data alone.\nTo address the protein inference problem, researchers use a combination of experimental and computational methods. This may involve developing new experimental techniques to improve the sensitivity and specificity of protein detection, as well as developing new computational algorithms and models to better integrate and interpret experimental data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The protein inference problem is a challenge in bioinformatics and computational biology.\n2. The goal of the protein inference problem is to predict the presence and identity of proteins in a biological sample or organism from experimental data.\n3. Proteins are complex molecules composed of chains of amino acids.\n4. Researchers use various techniques to measure the activity, expression, and interaction of proteins.\n5. The protein inference problem occurs because multiple proteins may contribute to a particular experimental signal.",
    "yulan-chat-2-13b-fp16_fact": [
      "The protein inference problem is a challenge in bioinformatics and computational biology.",
      "The goal of the protein inference problem is to predict the presence and identity of proteins in a biological sample or organism from experimental data.",
      "Proteins are complex molecules composed of chains of amino acids.",
      "Researchers use various techniques to measure the activity, expression, and interaction of proteins.",
      "The protein inference problem occurs because multiple proteins may contribute to a particular experimental signal."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2604,
    "user_query": "What is the link between lithium use during pregnancy and Ebstein anomaly?",
    "yulan-chat-2-13b-fp16_response": "There is no established link between lithium use during pregnancy and Ebstein anomaly. Ebstein anomaly is a rare congenital heart defect that affects the tricuspid valve, which separates the right atrium and right ventricle of the heart. It is caused by a genetic mutation and is not directly related to lithium use during pregnancy.\nHowever, there have been some case reports and studies that suggest an association between lithium use during pregnancy and congenital heart defects, including Ebstein anomaly. These reports suggest that lithium exposure during pregnancy may increase the risk of congenital heart defects, but the evidence is not conclusive.\nIt is important for women who are taking lithium during pregnancy to discuss this with their healthcare provider. The potential risks and benefits of lithium use during pregnancy should be carefully weighed, and alternative treatments should be considered if possible. Women who are taking lithium and are pregnant or planning to become pregnant should also be closely monitored by their healthcare provider for any potential effects on themselves and their developing baby.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ebstein anomaly affects the tricuspid valve of the heart.\n2. Ebstein anomaly is a rare congenital heart defect.\n3. There have been case reports and studies that suggest an association between lithium use during pregnancy and congenital heart defects, including Ebstein anomaly.\n4. The evidence suggesting lithium exposure during pregnancy may increase the risk of congenital heart defects is not conclusive.\n5. Women taking lithium are advised to discuss the risks and benefits with their healthcare provider, especially during pregnancy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ebstein anomaly affects the tricuspid valve of the heart.",
      "Ebstein anomaly is a rare congenital heart defect.",
      "There have been case reports and studies that suggest an association between lithium use during pregnancy and congenital heart defects, including Ebstein anomaly.",
      "The evidence suggesting lithium exposure during pregnancy may increase the risk of congenital heart defects is not conclusive.",
      "Women taking lithium are advised to discuss the risks and benefits with their healthcare provider, especially during pregnancy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2605,
    "user_query": "Does verubecestat activate BACE?",
    "yulan-chat-2-13b-fp16_response": "Verubecestat is an inhibitor of BACE1, an enzyme that plays a key role in the production of amyloid-beta peptides, which are associated with the pathology of Alzheimer's disease. It is not expected to activate BACE1.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Verubecestat is an inhibitor of BACE1.\n2. BACE1 is an enzyme involved in the production of amyloid-beta peptides.\n3. Amyloid-beta peptides are associated with the pathology of Alzheimer's disease.\n4. Verubecestat is not expected to activate BACE1.",
    "yulan-chat-2-13b-fp16_fact": [
      "Verubecestat is an inhibitor of BACE1.",
      "BACE1 is an enzyme involved in the production of amyloid-beta peptides.",
      "Amyloid-beta peptides are associated with the pathology of Alzheimer's disease.",
      "Verubecestat is not expected to activate BACE1."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2607,
    "user_query": "What is emicizumab?",
    "yulan-chat-2-13b-fp16_response": "Emicizumab is a medication that is used to prevent bleeding episodes in people with hemophilia A with inhibitors. It is a bispecific antibody that works by binding to both factor VIII and factor IX, two clotting factors that are deficient in people with hemophilia A. By binding to both of these factors, emicizumab helps to restore the body's ability to form blood clots and prevent bleeding episodes. It is given by injection under the skin or into a muscle and is used on-demand before activities that may cause bleeding or as needed to control bleeding episodes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Emicizumab is a medication used to prevent bleeding episodes in people with hemophilia A with inhibitors.\n2. It is a bispecific antibody that binds to factor VIII and factor IX.\n3. Factor VIII and factor IX are clotting factors that are deficient in people with hemophilia A.\n4. Emicizumab is administered by injection under the skin or into a muscle.\n5. Emicizumab can be used on-demand before activities that may cause bleeding or as needed to control bleeding episodes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Emicizumab is a medication used to prevent bleeding episodes in people with hemophilia A with inhibitors.",
      "It is a bispecific antibody that binds to factor VIII and factor IX.",
      "Factor VIII and factor IX are clotting factors that are deficient in people with hemophilia A.",
      "Emicizumab is administered by injection under the skin or into a muscle.",
      "Emicizumab can be used on-demand before activities that may cause bleeding or as needed to control bleeding episodes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Emicizumab is a bispecific antibody that bridges factor IXa and factor X to restore the function of missing activated factor VIII that is needed for effective hemostasis.\n3. TRUE\n4. TRUE \n5. FALSE [correction]: Emicizumab is typically used as a prophylactic treatment to prevent bleeding episodes, not on an on-demand basis for hemophilia A with inhibitors.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2608,
    "user_query": "What illness is transmitted by the Lone Star Tick, Amblyomma americanum?",
    "yulan-chat-2-13b-fp16_response": "The Lone Star Tick, Amblyomma americanum, is known to transmit a disease called Southern Tick-associated Rash Illness (STARI). STARI is a type of tick-borne rash illness that is similar to Rocky Mountain spotted fever, but generally has milder symptoms. However, the Lone Star Tick has also been associated with the transmission of a disease called Chronic Lyme disease, which is a controversial and poorly understood condition. It is important to note that not all experts recognize Chronic Lyme disease as a real condition, and there is ongoing debate and research in this area.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Lone Star Tick, Amblyomma americanum, transmits Southern Tick-associated Rash Illness (STARI).\n2. STARI is a tick-borne rash illness that is similar to Rocky Mountain spotted fever.\n3. STARI generally has milder symptoms compared to Rocky Mountain spotted fever.\n4. The Lone Star Tick has been associated with the transmission of a disease called Chronic Lyme disease.\n5. There is ongoing debate and research regarding the recognition of Chronic Lyme disease as a real condition.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Lone Star Tick, Amblyomma americanum, transmits Southern Tick-associated Rash Illness (STARI).",
      "STARI is a tick-borne rash illness that is similar to Rocky Mountain spotted fever.",
      "STARI generally has milder symptoms compared to Rocky Mountain spotted fever.",
      "The Lone Star Tick has been associated with the transmission of a disease called Chronic Lyme disease.",
      "There is ongoing debate and research regarding the recognition of Chronic Lyme disease as a real condition."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: STARI is a tick-borne rash illness that can be similar to Lyme disease, not Rocky Mountain spotted fever.\n3. TRUE\n4. FALSE [correction]: There is controversy over \"Chronic Lyme disease,\" but it is not specifically associated with the Lone Star Tick. The Lone Star Tick has been associated with causing a red meat allergy known as alpha-gal syndrome.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "yulan-chat-2-13b-fp16_response": "There have been several deep learning algorithms developed for the prediction of protein subcellular localization. Some of the popular ones include:\n1. Convolutional Neural Networks (CNNs): CNNs have been widely used for the prediction of protein subcellular localization. They are effective in learning the spatial features of proteins and can classify them accordingly.\n2. Recurrent Neural Networks (RNNs): RNNs are useful in modeling the temporal dependencies in protein sequences and can be used for the prediction of protein subcellular localization.\n3. Long Short-Term Memory (LSTM) networks: LSTM networks are a type of RNN that can learn long-term dependencies in protein sequences. They have been used for the prediction of protein subcellular localization with good accuracy.\n4. Graph Convolutional Networks (GCNs): GCNs are a type of deep learning algorithm that can model the complex interactions between amino acids in protein sequences. They have been used for the prediction of protein subcellular localization with high accuracy.\nOverall, the choice of algorithm depends on the specific problem and dataset being used.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Convolutional Neural Networks (CNNs) have been used for the prediction of protein subcellular localization.\n2. Recurrent Neural Networks (RNNs) model temporal dependencies in protein sequences for predicting protein subcellular localization.\n3. Long Short-Term Memory (LSTM) networks are a type of RNN that learns long-term dependencies in protein sequences and have been used for protein subcellular localization prediction.\n4. Graph Convolutional Networks (GCNs) model interactions between amino acids in protein sequences for subcellular localization prediction.\n5. The accuracy of the prediction of protein subcellular localization can depend on the algorithm and specific dataset used.",
    "yulan-chat-2-13b-fp16_fact": [
      "Convolutional Neural Networks (CNNs) have been used for the prediction of protein subcellular localization.",
      "Recurrent Neural Networks (RNNs) model temporal dependencies in protein sequences for predicting protein subcellular localization.",
      "Long Short-Term Memory (LSTM) networks are a type of RNN that learns long-term dependencies in protein sequences and have been used for protein subcellular localization prediction.",
      "Graph Convolutional Networks (GCNs) model interactions between amino acids in protein sequences for subcellular localization prediction.",
      "The accuracy of the prediction of protein subcellular localization can depend on the algorithm and specific dataset used."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEach of these statements reasonably aligns with concepts found in computational biology and machine learning. Convolutional Neural Networks, Recurrent Neural Networks, and their variant Long Short-Term Memory networks, as well as Graph Convolutional Networks, are all types of neural network architectures that have been applied to problems in bioinformatics, including the prediction of protein subcellular localization. The accuracy of such predictions indeed depends on the specific algorithm used and the dataset it is trained and tested on.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2614,
    "user_query": "What is included in the Mentzer index?",
    "yulan-chat-2-13b-fp16_response": "The Mentzer index, also known as the \"Mentzer score,\" is a tool used in medicine to assess the severity of a patient's heart failure. It is based on a patient's symptoms, physical examination findings, and laboratory test results. The index is named after its developer, Dr. Dietrich Mentzer.\nThe Mentzer index is calculated using the following variables:\n1. Symptoms: The patient's symptoms are evaluated using a standardized questionnaire. The questionnaire asks about symptoms such as shortness of breath, fatigue, swelling, and cough. Each symptom is assigned a score based on its severity, with a maximum score of 4.\n2. Physical examination: The patient's physical examination is evaluated based on the presence of certain signs and symptoms, such as jugular venous distension, hepatic ascites, and pedal edema. Each sign is assigned a score based on its severity, with a maximum score of 3.\n3. Laboratory test results: The patient's laboratory test results, including blood tests and imaging studies, are evaluated to determine the severity of their heart failure. The following variables are included in the Mentzer index:\n* Blood urea nitrogen (BUN) level: A high BUN level indicates kidney dysfunction, which can be a sign of heart failure.\n* Creatinine level: A high creatinine level indicates kidney dysfunction, which can be a sign of heart failure.\n* Hemoglobin level: A low hemoglobin level indicates anemia, which can be a sign of heart failure.\n* Hematocrit level: A low hematocrit level indicates anemia, which can be a sign of heart failure.\n* Serum sodium level: A low serum sodium level indicates fluid accumulation, which can be a sign of heart failure.\n* Serum potassium level: A low serum potassium level indicates kidney dysfunction, which can be a sign of heart failure.\n* Ejection fraction: The ejection fraction is a measure of the heart's ability to pump blood. A low ejection fraction indicates heart failure.\nThe Mentzer index is calculated by adding up the scores for each variable, with a maximum possible score",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Mentzer index is a tool used in medicine to assess the severity of a patient's heart failure.\n2. It is calculated using variables such as symptoms, physical examination findings, and laboratory test results.\n3. Symptoms are evaluated using a standardized questionnaire, with each symptom being assigned a score based on severity.\n4. Physical examination findings that are considered include jugular venous distention, hepatic ascites, and pedal edema, with each sign assigned a score.\n5. Laboratory test results used in the Mentzer index calculation include levels of blood urea nitrogen (BUN), creatinine, hemoglobin, hematocrit, serum sodium, serum potassium, and ejection fraction.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Mentzer index is a tool used in medicine to assess the severity of a patient's heart failure.",
      "It is calculated using variables such as symptoms, physical examination findings, and laboratory test results.",
      "Symptoms are evaluated using a standardized questionnaire, with each symptom being assigned a score based on severity.",
      "Physical examination findings that are considered include jugular venous distention, hepatic ascites, and pedal edema, with each sign assigned a score.",
      "Laboratory test results used in the Mentzer index calculation include levels of blood urea nitrogen (BUN), creatinine, hemoglobin, hematocrit, serum sodium, serum potassium, and ejection fraction."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Mentzer index is used in medicine to differentiate between iron deficiency anemia and beta-thalassemia.\n2. FALSE [correction]: It is calculated using the red blood cell count and the mean corpuscular volume.\n3. FALSE [correction]: Symptoms are not part of the Mentzer index calculation; it is based on complete blood count parameters.\n4. FALSE [correction]: Physical examination findings are not included in the Mentzer index calculation.\n5. FALSE [correction]: The laboratory test results used in the Mentzer index calculation include mainly the red blood cell count and mean corpuscular volume (MCV), not the other parameters listed.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2615,
    "user_query": "Which disease is treated with Fexinidazole?",
    "yulan-chat-2-13b-fp16_response": "Fexinidazole is an antiparasitic drug that is used to treat a type of parasitic infection called African trypanosomiasis, also known as sleeping sickness. This infection is caused by the protozoan parasite Trypanosoma brucei gambiense and is transmitted to humans through the bite of an infected tsetse fly. Fexinidazole is effective against the bloodstream form of the parasite and is often used in combination with other drugs to treat the infection.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fexinidazole is an antiparasitic drug used to treat African trypanosomiasis.\n2. African trypanosomiasis is also known as sleeping sickness.\n3. The disease is caused by the protozoan parasite Trypanosoma brucei gambiense.\n4. African trypanosomiasis is transmitted to humans by the bite of an infected tsetse fly.\n5. Fexinidazole is effective against the bloodstream form of Trypanosoma brucei gambiense.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fexinidazole is an antiparasitic drug used to treat African trypanosomiasis.",
      "African trypanosomiasis is also known as sleeping sickness.",
      "The disease is caused by the protozoan parasite Trypanosoma brucei gambiense.",
      "African trypanosomiasis is transmitted to humans by the bite of an infected tsetse fly.",
      "Fexinidazole is effective against the bloodstream form of Trypanosoma brucei gambiense."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE - However, it's worth noting that African trypanosomiasis can be caused by Trypanosoma brucei gambiense or Trypanosoma brucei rhodesiense.\n4. TRUE\n5. TRUE - Fexinidazole is indeed effective against the bloodstream form of Trypanosoma brucei gambiense, which is important for the treatment of the disease.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2620,
    "user_query": "Is DNA polymerase  involved in DNA repair?",
    "yulan-chat-2-13b-fp16_response": "Yes, DNA polymerase  (Pol) is involved in DNA repair, specifically in the base excision repair (BER) pathway. Pol is one of the enzymes that helps to repair damaged DNA by catalyzing the synthesis of new DNA strands. In BER, Pol synthesizes new DNA strands to replace the damaged or missing section of the DNA molecule. Pol is also involved in other DNA repair pathways, such as the nucleotide excision repair (NER) and the single-strand annealing (SSA) pathways.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DNA polymerase  (Pol) is involved in DNA repair.\n2. Pol functions in the base excision repair (BER) pathway.\n3. Pol catalyzes the synthesis of new DNA strands to repair damaged DNA.\n4. In the base excision repair pathway, Pol replaces damaged or missing sections of the DNA molecule.\n5. Pol is also involved in the nucleotide excision repair (NER) and single-strand annealing (SSA) pathways.",
    "yulan-chat-2-13b-fp16_fact": [
      "DNA polymerase  (Pol) is involved in DNA repair.",
      "Pol functions in the base excision repair (BER) pathway.",
      "Pol catalyzes the synthesis of new DNA strands to repair damaged DNA.",
      "In the base excision repair pathway, Pol replaces damaged or missing sections of the DNA molecule.",
      "Pol is also involved in the nucleotide excision repair (NER) and single-strand annealing (SSA) pathways."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Pol functions primarily in the alternative end-joining (alt-EJ) pathway for DNA repair, not in the base excision repair (BER) pathway.\n3. TRUE\n4. FALSE [correction]: In the base excision repair pathway, DNA polymerase  (Pol ) typically replaces damaged or missing sections of the DNA molecule, not Pol.\n5. TRUE [partially correct, requires clarification]: Pol is involved in the single-strand annealing (SSA) pathway, but its role in the nucleotide excision repair (NER) is not well-established. It is primarily known for its role in homologous recombination and alternative end-joining repair mechanisms.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2623,
    "user_query": "Which algorithms are used for compression of SAM files?",
    "yulan-chat-2-13b-fp16_response": "SAM (Sequence Alignment/Map) files are typically compressed using the gzip or bzip2 algorithms. These are widely used compression algorithms that are supported by many programming languages and operating systems.\nThe gzip algorithm is a fast compression algorithm that is commonly used for compressing data on the fly. It is a lossless compression algorithm, which means that the original data can be fully restored from the compressed data.\nThe bzip2 algorithm is a slower but more effective compression algorithm than gzip. It uses a different compression algorithm and is able to compress data more effectively than gzip, resulting in smaller file sizes. However, bzip2 is also a lossless compression algorithm, so it can't achieve the same level of compression as lossy algorithms like JPEG or MP3.\nBoth gzip and bzip2 are widely used for compressing SAM files, and the choice of which one to use often depends on the specific requirements of the application that will be using the compressed file.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SAM (Sequence Alignment/Map) files are typically compressed using the gzip algorithm.\n2. SAM files can also be compressed using the bzip2 algorithm.\n3. The gzip algorithm is known for being a fast compression algorithm.\n4. The gzip algorithm is a lossless compression algorithm.\n5. The bzip2 algorithm can compress data more effectively than gzip, resulting in smaller file sizes.",
    "yulan-chat-2-13b-fp16_fact": [
      "SAM (Sequence Alignment/Map) files are typically compressed using the gzip algorithm.",
      "SAM files can also be compressed using the bzip2 algorithm.",
      "The gzip algorithm is known for being a fast compression algorithm.",
      "The gzip algorithm is a lossless compression algorithm.",
      "The bzip2 algorithm can compress data more effectively than gzip, resulting in smaller file sizes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: SAM (Sequence Alignment/Map) files are typically uncompressed when in the SAM format; however, their binary equivalent, BAM (Binary Alignment/Map) files, are compressed and often additionally compressed using the gzip algorithm.\n2. TRUE: While not typical, SAM files can technically be compressed using any general-purpose compression algorithm, including bzip2.\n3. TRUE: The gzip algorithm is known for its relatively fast compression and decompression speeds.\n4. TRUE: The gzip algorithm is a lossless compression algorithm, which means no data is lost during the compression process.\n5. TRUE: The bzip2 algorithm typically achieves higher compression ratios than gzip, often resulting in smaller compressed file sizes.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2629,
    "user_query": "What drug cures hepatitis C?",
    "yulan-chat-2-13b-fp16_response": "There are several drugs that can be used to treat hepatitis C, but the most commonly used ones are called direct-acting antivirals (DAAs). These drugs include:\n* Sofosbuvir\n* Daclatasvir\n* Asunaprevir\n* Beclatasvir\n* Grazoprevir\n* Elbasvir\n* Velpatasvir\n* Glecaprevir\n* Pibrentasvir\nThese drugs work by targeting the hepatitis C virus and preventing it from replicating. They are usually used in combination with each other to increase their effectiveness. The specific drug or combination of drugs used to treat hepatitis C will depend on the individual patient's circumstances, such as the stage of the disease and any other health conditions they may have. It is important to consult a healthcare professional for proper diagnosis and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Direct-acting antivirals (DAAs) are commonly used to treat hepatitis C.\n2. Sofosbuvir is a drug that can be used to treat hepatitis C.\n3. Daclatasvir is a drug that can be used to treat hepatitis C.\n4. The combination of direct-acting antivirals increases their effectiveness in treating hepatitis C.\n5. The specific drug or combination of drugs for treating hepatitis C depends on individual patient circumstances, including the stage of the disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Direct-acting antivirals (DAAs) are commonly used to treat hepatitis C.",
      "Sofosbuvir is a drug that can be used to treat hepatitis C.",
      "Daclatasvir is a drug that can be used to treat hepatitis C.",
      "The combination of direct-acting antivirals increases their effectiveness in treating hepatitis C.",
      "The specific drug or combination of drugs for treating hepatitis C depends on individual patient circumstances, including the stage of the disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2632,
    "user_query": "What can be predicted with the Wells criteria?",
    "yulan-chat-2-13b-fp16_response": "The Wells criteria are a set of guidelines used to predict the likelihood of a patient with chest pain having a myocardial infarction (heart attack). The criteria take into account various clinical and laboratory findings, such as the patient's age, sex, medical history, and the results of various diagnostic tests, such as an electrocardiogram (ECG).\nThe Wells criteria are typically used to predict the likelihood of a patient having an acute coronary syndrome (ACS), which includes both myocardial infarction and unstable angina. The criteria are based on a point system, with each clinical and laboratory finding assigned a certain number of points. The total score is then used to estimate the likelihood of a patient having ACS.\nThe Wells criteria can be used to predict the likelihood of a patient having a myocardial infarction, but they are not diagnostic tools and should not be used to make a definitive diagnosis. Instead, they are intended to guide clinical decision-making and help healthcare providers determine which patients with chest pain are most likely to benefit from further testing and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Wells criteria are used to predict the likelihood of a patient with chest pain having a myocardial infarction.\n2. The Wells criteria consider clinical and laboratory findings such as age, sex, medical history, and ECG results.\n3. The Wells criteria are also used to estimate the likelihood of a patient having acute coronary syndrome (ACS).\n4. A point system based on clinical and laboratory findings is used in the Wells criteria to estimate this likelihood.\n5. While the Wells criteria are used to guide clinical decision-making, they are not diagnostic tools for definitive diagnosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Wells criteria are used to predict the likelihood of a patient with chest pain having a myocardial infarction.",
      "The Wells criteria consider clinical and laboratory findings such as age, sex, medical history, and ECG results.",
      "The Wells criteria are also used to estimate the likelihood of a patient having acute coronary syndrome (ACS).",
      "A point system based on clinical and laboratory findings is used in the Wells criteria to estimate this likelihood.",
      "While the Wells criteria are used to guide clinical decision-making, they are not diagnostic tools for definitive diagnosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Wells criteria are used to assess the probability of deep vein thrombosis (DVT) and pulmonary embolism (PE), not myocardial infarction.\n2. UNKNOWN\n3. FALSE [correction]: The Wells criteria are not used for estimating the likelihood of having acute coronary syndrome (ACS); they are used for assessing the probability of DVT and PE.\n4. TRUE: While the specifics of the criteria are inaccurate as previously stated, it is true that the Wells criteria use a point system based on clinical findings to estimate the probability of DVT and PE.\n5. TRUE: The Wells criteria are indeed used to guide clinical decision-making by providing a probabilistic assessment, rather than offering a definitive diagnosis.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with the term \"MULTOVL.\" It could be a misspelling, a new term that I'm not aware of, or a term that is specific to a certain context or field. If you could provide more information or context, I would be happy to try to help you better.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2643,
    "user_query": "What is the alternative lengthening of telomeres?",
    "yulan-chat-2-13b-fp16_response": "The alternative lengthening of telomeres (ALT) is a process by which telomeres, the protective caps on the ends of chromosomes, are lengthened without the use of the enzyme telomerase. Telomerase is an enzyme that is active in most normal cells and can extend telomeres, but it is not active in some types of cells, such as adult stem cells. In these cells, ALT is used to lengthen telomeres. ALT is a complex process that involves the activation of a reverse transcriptase enzyme, which can add RNA molecules to the ends of telomeres, leading to the extension of the telomere. ALT is an important mechanism for maintaining the stability of the genome and for allowing certain cells to continue to divide and function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The alternative lengthening of telomeres (ALT) is a mechanism by which telomeres are lengthened without the enzyme telomerase.\n2. Telomerase is an enzyme that extends telomeres and is active in most normal cells.\n3. Telomerase is not active in some types of cells, such as adult stem cells.\n4. The ALT process involves the activation of a reverse transcriptase enzyme.\n5. The reverse transcriptase enzyme in ALT can add RNA molecules to the ends of telomeres.",
    "yulan-chat-2-13b-fp16_fact": [
      "The alternative lengthening of telomeres (ALT) is a mechanism by which telomeres are lengthened without the enzyme telomerase.",
      "Telomerase is an enzyme that extends telomeres and is active in most normal cells.",
      "Telomerase is not active in some types of cells, such as adult stem cells.",
      "The ALT process involves the activation of a reverse transcriptase enzyme.",
      "The reverse transcriptase enzyme in ALT can add RNA molecules to the ends of telomeres."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Telomerase is an enzyme that extends telomeres but is typically not active in most somatic (normal) cells; it is active in germ cells, stem cells, and certain cancer cells.\n3. FALSE [correction]: Telomerase is active in adult stem cells, which helps them maintain telomere length for continued cell division.\n4. FALSE [correction]: The ALT process does not involve the activation of a reverse transcriptase enzyme. Instead, it is believed to involve homologous recombination that helps extend the telomeres.\n5. FALSE [correction]: Reverse transcriptase is associated with the action of telomerase, where it adds DNA to the ends of telomeres based on an RNA template within the enzyme itself. The ALT mechanism does not use reverse transcriptase to add RNA molecules to the ends of telomeres; it uses DNA through recombination-based methods.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2646,
    "user_query": "What is break induced replication?",
    "yulan-chat-2-13b-fp16_response": "Break-induced replication (BIR) is a process in which double-stranded DNA is broken, and the ends of the broken strands are used as templates for the synthesis of new strands. This process is also known as \"replication-induced breakage and repair\" (RIBR).\nBIR is a mechanism that cells use to repair double-stranded DNA breaks that occur during DNA replication. When DNA replication occurs, the two strands of the double helix separate, and each strand serves as a template for the synthesis of a new strand. However, sometimes the replication process can cause a break in one of the strands.\nTo repair this break, the cell uses a process called non-homologous end joining (NHEJ), which involves the ligation of the broken ends of the DNA strand. However, this process can sometimes result in the insertion or deletion of nucleotides, which can lead to genetic mutations.\nBIR is thought to play a role in the maintenance of genome stability, as it can help to prevent the accumulation of mutations that could be harmful to the cell. However, it is also thought to be a contributor to the development of certain types of cancer, as errors in the BIR process can lead to the formation of chromosomal translocations or inversions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Break-induced replication (BIR) involves the use of broken DNA strands as templates for the synthesis of new strands.\n2. BIR is used by cells to repair double-stranded DNA breaks during DNA replication.\n3. Non-homologous end joining (NHEJ) is a process that ligates broken ends of a DNA strand to repair breaks.\n4. Incorrectly performed BIR can result in genetic mutations.\n5. Errors in the BIR process can contribute to the development of certain types of cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Break-induced replication (BIR) involves the use of broken DNA strands as templates for the synthesis of new strands.",
      "BIR is used by cells to repair double-stranded DNA breaks during DNA replication.",
      "Non-homologous end joining (NHEJ) is a process that ligates broken ends of a DNA strand to repair breaks.",
      "Incorrectly performed BIR can result in genetic mutations.",
      "Errors in the BIR process can contribute to the development of certain types of cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2652,
    "user_query": "Name 4 circular RNA molecules associated with carcinogenesis.",
    "yulan-chat-2-13b-fp16_response": "1. Circular RNA-100397 (circ-100397)\n2. Circular RNA-4517 (circ-4517)\n3. Circular RNA-5324 (circ-5324)\n4. Circular RNA-7200044 (circ-7200044)",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Circular RNA-100397 is associated with carcinogenesis.\n2. Circular RNA-4517 is associated with carcinogenesis.\n3. Circular RNA-5324 is associated with carcinogenesis.\n4. Circular RNA-7200044 is associated with carcinogenesis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Circular RNA-100397 is associated with carcinogenesis.",
      "Circular RNA-4517 is associated with carcinogenesis.",
      "Circular RNA-5324 is associated with carcinogenesis.",
      "Circular RNA-7200044 is associated with carcinogenesis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "UNKNOWN\n\nThe provided statements refer to specific circular RNAs and their association with carcinogenesis. Without additional context or scientific references, it is not possible to accurately determine the truthfulness of these statements. Circular RNAs are a type of non-coding RNA which have been implicated in various biological processes, and some may be involved in cancer, but without specific literature or studies to refer to, the association of the listed circular RNAs with carcinogenesis cannot be confirmed or denied.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2653,
    "user_query": "Which is the enzymatic activity of nardilysin?",
    "yulan-chat-2-13b-fp16_response": "Nardilysin is an enzyme that belongs to the metalloproteinase family of enzymes. Its specific enzymatic activity is to hydrolyze peptide bonds in proteins. Specifically, nardilysin is able to cleave peptide bonds between basic amino acids, such as lysine and arginine, resulting in the release of smaller peptides and amino acids. This enzymatic activity is important for a variety of biological processes, including the degradation of extracellular matrix proteins, the regulation of cell signaling pathways, and the activation of pro-enzymes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nardilysin is an enzyme that belongs to the metalloproteinase family.\n2. Nardilysin has the enzymatic activity of hydrolyzing peptide bonds in proteins.\n3. Nardilysin can cleave peptide bonds between basic amino acids such as lysine and arginine.\n4. The enzymatic activity of nardilysin is involved in the degradation of extracellular matrix proteins.\n5. Nardilysin plays a role in the regulation of cell signaling pathways and the activation of pro-enzymes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nardilysin is an enzyme that belongs to the metalloproteinase family.",
      "Nardilysin has the enzymatic activity of hydrolyzing peptide bonds in proteins.",
      "Nardilysin can cleave peptide bonds between basic amino acids such as lysine and arginine.",
      "The enzymatic activity of nardilysin is involved in the degradation of extracellular matrix proteins.",
      "Nardilysin plays a role in the regulation of cell signaling pathways and the activation of pro-enzymes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Nardilysin is typically not involved in the degradation of extracellular matrix proteins; rather, it has roles in processing various bioactive peptides.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2654,
    "user_query": "The Mantoux test detects what latent infection/disease?",
    "yulan-chat-2-13b-fp16_response": "The Mantoux test, also known as the tuberculin skin test (TST), is used to detect latent infection with Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). Latent TB infection means that a person has been infected with TB bacteria, but the bacteria are in a dormant (inactive) state in their body and are not causing any symptoms. People with latent TB infection are not contagious and do not have any symptoms of TB disease, but they may develop active TB disease later in life if they do not receive treatment. The Mantoux test works by injecting a small amount of a substance called tuberculin into the skin, which causes a reaction if the person has been infected with TB bacteria. The size of the reaction is measured and used to determine if a person has a latent TB infection.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Mantoux test is used to detect latent infection with Mycobacterium tuberculosis.\n2. Latent TB infection means the TB bacteria are dormant and not causing symptoms in the body.\n3. People with latent TB infection are not contagious.\n4. The Mantoux test involves injecting a substance called tuberculin into the skin.\n5. The size of the skin reaction is measured to determine latent TB infection.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Mantoux test is used to detect latent infection with Mycobacterium tuberculosis.",
      "Latent TB infection means the TB bacteria are dormant and not causing symptoms in the body.",
      "People with latent TB infection are not contagious.",
      "The Mantoux test involves injecting a substance called tuberculin into the skin.",
      "The size of the skin reaction is measured to determine latent TB infection."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2657,
    "user_query": "Are AAV vectors considered for the treatment of retinal dystrophies?",
    "yulan-chat-2-13b-fp16_response": "Yes, AAV vectors are being considered for the treatment of retinal dystrophies. AAV (adeno-associated virus) is a type of viral vector that has been shown to be effective in delivering genes to cells in the body. Retinal dystrophies are a group of genetic disorders that affect the retina, the light-sensitive tissue at the back of the eye. Some forms of retinal dystrophies are caused by mutations in genes that are essential for the function of the retina, and researchers are exploring the use of AAV vectors as a way to deliver functional copies of these genes to the retina. Clinical trials are ongoing to evaluate the safety and efficacy of AAV-based gene therapy for retinal dystrophies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. AAV vectors are considered for the treatment of retinal dystrophies.\n2. AAV stands for adeno-associated virus.\n3. Retinal dystrophies are genetic disorders that affect the retina.\n4. AAV vectors are used to deliver genes to cells in the body.\n5. Clinical trials are evaluating the safety and efficacy of AAV-based gene therapy for retinal dystrophies.",
    "yulan-chat-2-13b-fp16_fact": [
      "AAV vectors are considered for the treatment of retinal dystrophies.",
      "AAV stands for adeno-associated virus.",
      "Retinal dystrophies are genetic disorders that affect the retina.",
      "AAV vectors are used to deliver genes to cells in the body.",
      "Clinical trials are evaluating the safety and efficacy of AAV-based gene therapy for retinal dystrophies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "yulan-chat-2-13b-fp16_response": "GDF15 (Growth Differentiation Factor 15) is a protein that has been studied as a potential biomarker for various diseases, including cancer and diabetes. However, there is limited research on whether GDF15 can be used as a biomarker for metformin treatment.\nMetformin is a commonly used medication for type 2 diabetes that works by reducing glucose production in the liver and improving insulin sensitivity in the body. Some studies have suggested that GDF15 levels may be altered in response to metformin treatment, but the clinical significance of these changes is not well understood.\nWhile GDF15 may have potential as a biomarker for metformin treatment, more research is needed to confirm its utility in this context. Additionally, other biomarkers, such as blood glucose levels and hemoglobin A1c, are more commonly used to monitor the effectiveness of metformin treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GDF15 stands for Growth Differentiation Factor 15.\n2. Metformin is a medication used to treat type 2 diabetes.\n3. Metformin works by reducing glucose production in the liver.\n4. Metformin improves insulin sensitivity in the body.\n5. GDF15 levels may change in response to metformin treatment according to some studies.",
    "yulan-chat-2-13b-fp16_fact": [
      "GDF15 stands for Growth Differentiation Factor 15.",
      "Metformin is a medication used to treat type 2 diabetes.",
      "Metformin works by reducing glucose production in the liver.",
      "Metformin improves insulin sensitivity in the body.",
      "GDF15 levels may change in response to metformin treatment according to some studies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2662,
    "user_query": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
    "yulan-chat-2-13b-fp16_response": "Oncogene-induced DNA replication stress can contribute to genomic instability, but it is not the only factor that determines genomic stability.\nOncogenes are genes that have the potential to cause cancer when they are overexpressed or mutated. Some oncogenes can induce DNA replication stress, which occurs when the DNA replication machinery is unable to keep up with the demand for new DNA synthesis. This can lead to stalled replication forks, single-stranded DNA gaps, and other forms of replication stress.\nReplication stress can cause a variety of genomic instabilities, including chromosomal aberrations, DNA double-strand breaks, and defects in DNA repair. These defects can lead to mutations, genomic rearrangements, and other forms of genomic instability that can contribute to the development and progression of cancer.\nHowever, other factors also contribute to genomic instability, including defects in DNA repair, changes in chromatin structure, and alterations in the activity of tumor suppressor genes. Therefore, while oncogene-induced DNA replication stress can contribute to genomic instability, it is not the only factor that determines genomic stability.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Oncogene-induced DNA replication stress can contribute to genomic instability.\n2. Oncogenes can cause cancer when they are overexpressed or mutated.\n3. Some oncogenes can induce DNA replication stress, leading to stalled replication forks and single-stranded DNA gaps.\n4. Replication stress can lead to chromosomal aberrations, DNA double-strand breaks, and defects in DNA repair.\n5. Factors other than oncogene-induced DNA replication stress also contribute to genomic instability, such as defects in DNA repair, changes in chromatin structure, and alterations in tumor suppressor gene activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Oncogene-induced DNA replication stress can contribute to genomic instability.",
      "Oncogenes can cause cancer when they are overexpressed or mutated.",
      "Some oncogenes can induce DNA replication stress, leading to stalled replication forks and single-stranded DNA gaps.",
      "Replication stress can lead to chromosomal aberrations, DNA double-strand breaks, and defects in DNA repair.",
      "Factors other than oncogene-induced DNA replication stress also contribute to genomic instability, such as defects in DNA repair, changes in chromatin structure, and alterations in tumor suppressor gene activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "yulan-chat-2-13b-fp16_response": "Recursive splicing is a process by which a transcript is spliced together from multiple exons, and the spliced exons themselves can be further spliced together recursively to form a single transcript. This process is not limited to short or long introns, and can occur in both types of introns.\nRecursive splicing is thought to be a mechanism for generating diversity in gene expression, as it allows for the production of multiple transcripts from a single gene. It is not uncommon to see recursive splicing in some genes, but it is not a universal feature of all genes. The frequency of recursive splicing in a particular gene or set of genes can depend on a variety of factors, including the length of the introns, the presence of splice sites, and the activity of splicing factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Recursive splicing is a process that involves splicing together multiple exons from a transcript.\n2. In recursive splicing, the spliced exons can be further spliced together to form a single transcript.\n3. Recursive splicing can occur in both short and long introns.\n4. Recursive splicing is a mechanism that can generate diversity in gene expression.\n5. The frequency of recursive splicing can depend on factors such as intron length, splice sites, and splicing factors activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Recursive splicing is a process that involves splicing together multiple exons from a transcript.",
      "In recursive splicing, the spliced exons can be further spliced together to form a single transcript.",
      "Recursive splicing can occur in both short and long introns.",
      "Recursive splicing is a mechanism that can generate diversity in gene expression.",
      "The frequency of recursive splicing can depend on factors such as intron length, splice sites, and splicing factors activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Recursive splicing is a process whereby an exon is spliced to an upstream 5' splice site within the same intron.\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2667,
    "user_query": "Is transcription of eRNA bidirectional?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not sure what you mean by \"eRNA.\" Could you please provide more context or clarify your question?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2668,
    "user_query": "Is the protein pelota a ribosomal rescue factor?",
    "yulan-chat-2-13b-fp16_response": "Pelota is a protein that is involved in the biogenesis of ribosomes, which are the molecular machines that synthesize proteins in cells. Ribosomes are composed of four main components: a small subunit (SSU), a large subunit (LSU), and two ribosomal proteins called Pelota and Dom38.\nPelota is a ribosomal protein that plays a role in the assembly and maturation of ribosomes. It is involved in the formation of the ribosomal P site, which is a key site for protein synthesis. Pelota also interacts with other ribosomal proteins, such as Dom38 and Rpl5, to help stabilize the ribosome and promote its biogenesis.\nWhile Pelota is not a ribosomal rescue factor per se, it plays a critical role in the biogenesis and stability of ribosomes, which are essential for protein synthesis in cells. Ribosomal rescue factors are proteins that help to stabilize and repair damaged ribosomes, ensuring that protein synthesis can continue even in the face of stress or damage to the ribosome. Pelota is not involved in this process directly, but its role in ribosome biogenesis is important for maintaining the overall health and function of the ribosome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pelota is involved in the biogenesis of ribosomes.\n2. Ribosomes are molecular machines that synthesize proteins in cells.\n3. Ribosomes consist of a small subunit, a large subunit, and ribosomal proteins, including Pelota.\n4. Pelota plays a role in the assembly and maturation of ribosomes.\n5. Pelota interacts with other ribosomal proteins, such as Dom38 and Rpl5.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pelota is involved in the biogenesis of ribosomes.",
      "Ribosomes are molecular machines that synthesize proteins in cells.",
      "Ribosomes consist of a small subunit, a large subunit, and ribosomal proteins, including Pelota.",
      "Pelota plays a role in the assembly and maturation of ribosomes.",
      "Pelota interacts with other ribosomal proteins, such as Dom38 and Rpl5."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: Ribosomes consist of a small subunit, a large subunit, ribosomal RNA, and ribosomal proteins, but not specifically including Pelota as a structural component.\n4. TRUE\n5. FALSE [correction]: Pelota interacts with ribosomal proteins and other factors involved in ribosome quality control, but Dom38 is not a recognized ribosomal protein. It could potentially be a misprint or a confusion with nomenclatures. Pelota is known to interact with proteins such as Hbs1 and Rpl10.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2671,
    "user_query": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
    "yulan-chat-2-13b-fp16_response": "Yes, a mutation in the Zika virus's (ZIKV) membrane protein precursor (prM) is believed to be responsible for the microcephaly observed in new-born infants. Specifically, a mutation in the prM protein that results in the substitution of glutamic acid for lysine at position 267 (E267K) has been associated with the development of microcephaly in fetuses infected with ZIKV.\nThis mutation is thought to affect the way the virus interacts with host cells and may increase the virus's ability to infect and replicate in brain cells, leading to the development of microcephaly. However, it's important to note that other factors, such as genetic predispositions and environmental influences, may also contribute to the development of microcephaly in infected new-borns.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A mutation in the Zika virus's membrane protein precursor (prM) is believed to be responsible for microcephaly in newborn infants.\n2. The specific mutation involves a substitution of glutamic acid for lysine at position 267 (E267K) in the prM protein.\n3. This mutation may affect how the Zika virus interacts with host cells.\n4. The E267K mutation can increase the virus's ability to infect and replicate in brain cells.\n5. Other factors like genetic predispositions and environmental influences may also contribute to the development of microcephaly in infected newborns.",
    "yulan-chat-2-13b-fp16_fact": [
      "A mutation in the Zika virus's membrane protein precursor (prM) is believed to be responsible for microcephaly in newborn infants.",
      "The specific mutation involves a substitution of glutamic acid for lysine at position 267 (E267K) in the prM protein.",
      "This mutation may affect how the Zika virus interacts with host cells.",
      "The E267K mutation can increase the virus's ability to infect and replicate in brain cells.",
      "Other factors like genetic predispositions and environmental influences may also contribute to the development of microcephaly in infected newborns."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE\n\nPlease note that the veracity of statements 2 and 4 is based on the best available information as of my last update, and without the specific research reference, I cannot confirm the precise details of the mutation such as the position number (267) and the exact amino acids involved (E267K). Therefore, I've marked statement 2 as UNKNOWN, as you would need to cross-reference this with the latest scientific literature for confirmation. Statement 4 is consistent with the understanding that certain mutations can affect the virus's tropism and replication efficacy.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2673,
    "user_query": "What is the basis of the Sp3 procedure used in proteomics?",
    "yulan-chat-2-13b-fp16_response": "The Sp3 procedure is a method used in proteomics to identify and quantify proteins in a sample. It is based on the principle of isobaric tagging, which involves labeling peptides with a stable isotope-labeled amino acid.\nIn the Sp3 procedure, a mixture of six isobaric tags (SILAC) is used to label peptides in a sample. The six tags are labeled with different stable isotopes of carbon and nitrogen, which have the same atomic mass but different isotopic composition. The tags are incorporated into the peptides during protein synthesis, either in vitro or in vivo.\nAfter labeling, the sample is digested with proteases to generate peptides, which are then separated by liquid chromatography and analyzed by tandem mass spectrometry. The mass spectrometer can distinguish between the different isotopes of carbon and nitrogen, allowing for the quantification of the peptides and the identification of the proteins they come from.\nThe Sp3 procedure has several advantages over other proteomic methods, including its ability to quantify multiple proteins in a single experiment, its high sensitivity, and its ability to detect post-translational modifications. It has been widely used in a variety of applications, including the study of protein-protein interactions, signaling pathways, and disease biomarkers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Sp3 procedure uses isobaric tagging to identify and quantify proteins in a sample.\n2. A mixture of six isobaric tags (SILAC) is utilized in the Sp3 procedure.\n3. These tags are labeled with different stable isotopes of carbon and nitrogen.\n4. The peptides labeled in the Sp3 procedure are separated by liquid chromatography and analyzed by tandem mass spectrometry.\n5. The Sp3 procedure can detect post-translational modifications in proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Sp3 procedure uses isobaric tagging to identify and quantify proteins in a sample.",
      "A mixture of six isobaric tags (SILAC) is utilized in the Sp3 procedure.",
      "These tags are labeled with different stable isotopes of carbon and nitrogen.",
      "The peptides labeled in the Sp3 procedure are separated by liquid chromatography and analyzed by tandem mass spectrometry.",
      "The Sp3 procedure can detect post-translational modifications in proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The Sp3 procedure does not use a mixture of six isobaric tags; instead, it is often associated with the combination of solid-phase extraction and covalent chemistry for protein digestion and sample preparation. SILAC (Stable Isotope Labeling by Amino acids in Cell culture) is a different technique.\n3. FALSE [correction]: Though isobaric tagging involves labeling with stable isotopes, the statement is linked to the SILAC method, not the Sp3 procedure, and therefore is not accurately describing the Sp3 method.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2678,
    "user_query": "What is ATAC-seq?",
    "yulan-chat-2-13b-fp16_response": "ATAC-seq (Assay for Transposase-Accessible Chromatin sequencing) is a technique used to analyze the chromatin structure of a genome. It is a method for mapping the locations of open chromatin, which is DNA that is accessible to transposable elements and other mobile genetic elements. This technique is used to identify regions of the genome that are actively transcribed, or being expressed, and to study the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ATAC-seq stands for Assay for Transposase-Accessible Chromatin sequencing.\n2. ATAC-seq is a technique used to analyze the chromatin structure of a genome.\n3. The method maps locations of open chromatin, which is DNA accessible to transposable elements and other mobile genetic elements.\n4. ATAC-seq is used to identify regions of the genome that are actively transcribed or expressed.\n5. ATAC-seq is applied to study the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "ATAC-seq stands for Assay for Transposase-Accessible Chromatin sequencing.",
      "ATAC-seq is a technique used to analyze the chromatin structure of a genome.",
      "The method maps locations of open chromatin, which is DNA accessible to transposable elements and other mobile genetic elements.",
      "ATAC-seq is used to identify regions of the genome that are actively transcribed or expressed.",
      "ATAC-seq is applied to study the regulation of gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: ATAC-seq is used to identify regions of open chromatin, which may be associated with active transcription but does not directly measure transcription or gene expression.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "yulan-chat-2-13b-fp16_response": "TALE-iD (Transposable Element Affinity Labelling of Inherited Differences) is a genetic mapping technique used to identify and map specific DNA sequences in an organism's genome. It is particularly useful for identifying genetic variations that are inherited from one generation to the next, such as single nucleotide polymorphisms (SNPs) and small insertions or deletions (indels).\nThe TALE-iD method works by using transposable elements, which are DNA sequences that can move from one location in the genome to another. These elements are often referred to as \"jumping genes\" because they can copy and paste themselves into new locations. By identifying specific transposable elements in the genome and using them as probes, researchers can identify and map the locations of inherited genetic variations.\nTALE-iD has several advantages over other genetic mapping techniques. It is relatively fast and inexpensive, and it can be used to map a large number of genetic variations in a single experiment. It is also highly sensitive, meaning that it can detect small genetic variations that may be missed by other methods.\nOverall, the TALE-iD method is a valuable tool for researchers studying the genetics of complex traits and diseases, as well as for identifying genetic variations that may be associated with specific diseases or conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TALE-iD (Transposable Element Affinity Labelling of Inherited Differences) is used for genetic mapping to identify and map specific DNA sequences in an organism's genome.\n2. TALE-iD is useful for identifying genetic variations that are inherited from one generation to the next, such as SNPs (single nucleotide polymorphisms) and indels (insertions or deletions).\n3. The method involves using transposable elements, DNA sequences that can move around within the genome, as probes to identify and map genetic variations.\n4. TALE-iD is considered to be relatively fast and inexpensive compared to other genetic mapping techniques.\n5. The technique is described as highly sensitive, capable of detecting small genetic variations that may be missed by other methods.",
    "yulan-chat-2-13b-fp16_fact": [
      "TALE-iD (Transposable Element Affinity Labelling of Inherited Differences) is used for genetic mapping to identify and map specific DNA sequences in an organism's genome.",
      "TALE-iD is useful for identifying genetic variations that are inherited from one generation to the next, such as SNPs (single nucleotide polymorphisms) and indels (insertions or deletions).",
      "The method involves using transposable elements, DNA sequences that can move around within the genome, as probes to identify and map genetic variations.",
      "TALE-iD is considered to be relatively fast and inexpensive compared to other genetic mapping techniques.",
      "The technique is described as highly sensitive, capable of detecting small genetic variations that may be missed by other methods."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: TALE-iD (Transposable Element Locator - Inherited Disease) is a technique used to identify the presence of transposable elements associated with inherited diseases, not for genetic mapping to identify and map specific DNA sequences in an organism's genome.\n2. FALSE [correction]: While TALE-iD might indirectly correlate with identifying genetic variations that are inherited, its main purpose is to identify transposable elements associated with diseases rather than mapping SNPs or indels specifically.\n3. TRUE\n4. UNKNOWN: Without specific data comparing TALE-iD to other techniques in terms of cost and speed, it's not possible to ascertain the truth of this statement.\n5. UNKNOWN: The sensitivity of TALE-iD as compared to other methods would need to be supported by empirical evidence or comparative studies which are not provided in this context.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2681,
    "user_query": "What is the function of penicillinase, also known as beta lactamase?",
    "yulan-chat-2-13b-fp16_response": "Penicillinase, also known as beta lactamase, is an enzyme produced by certain bacteria that can break down beta-lactam antibiotics, such as penicillins and cephalosporins. Beta-lactam antibiotics work by binding to and inhibiting the synthesis of bacterial cell walls, but penicillinase can hydrolyze the beta-lactam ring of these antibiotics, rendering them ineffective. Penicillinase is therefore a mechanism by which bacteria can become resistant to beta-lactam antibiotics.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Penicillinase is an enzyme produced by certain bacteria.\n2. Penicillinase is also known as beta lactamase.\n3. This enzyme can break down beta-lactam antibiotics, including penicillins and cephalosporins.\n4. Beta-lactam antibiotics function by inhibiting the synthesis of bacterial cell walls.\n5. Penicillinase can hydrolyze the beta-lactam ring of these antibiotics, making them ineffective.",
    "yulan-chat-2-13b-fp16_fact": [
      "Penicillinase is an enzyme produced by certain bacteria.",
      "Penicillinase is also known as beta lactamase.",
      "This enzyme can break down beta-lactam antibiotics, including penicillins and cephalosporins.",
      "Beta-lactam antibiotics function by inhibiting the synthesis of bacterial cell walls.",
      "Penicillinase can hydrolyze the beta-lactam ring of these antibiotics, making them ineffective."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2684,
    "user_query": "What is the dardarin protein?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with the term \"dardarin protein.\" It's possible that you may have misspelled the term or that it's a relatively new or obscure protein that I'm not aware of. If you have any additional information or context about this protein, I may be able to help you better.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2685,
    "user_query": "In which syndrome is the RPS19 gene most frequently mutated?",
    "yulan-chat-2-13b-fp16_response": "The RPS19 gene is most frequently mutated in the syndrome known as DBA (Diamond-Blackfan anemia). DBA is a rare genetic disorder characterized by anemia, bone marrow failure, and a high risk of developing leukemia. The RPS19 gene provides instructions for making a protein called ribosomal protein S19, which is essential for the normal function of ribosomes, the molecular machines that assemble proteins from amino acids. Mutations in the RPS19 gene can lead to the production of abnormal ribosomes, which can interfere with protein synthesis and cause the symptoms of DBA.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The RPS19 gene is most frequently mutated in Diamond-Blackfan anemia (DBA).\n2. Diamond-Blackfan anemia is characterized by anemia, bone marrow failure, and a high risk of developing leukemia.\n3. The RPS19 gene provides instructions for making ribosomal protein S19.\n4. Ribosomal protein S19 is essential for the normal function of ribosomes.\n5. Mutations in the RPS19 gene can lead to the production of abnormal ribosomes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The RPS19 gene is most frequently mutated in Diamond-Blackfan anemia (DBA).",
      "Diamond-Blackfan anemia is characterized by anemia, bone marrow failure, and a high risk of developing leukemia.",
      "The RPS19 gene provides instructions for making ribosomal protein S19.",
      "Ribosomal protein S19 is essential for the normal function of ribosomes.",
      "Mutations in the RPS19 gene can lead to the production of abnormal ribosomes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Diamond-Blackfan anemia (DBA) is characterized by anemia and bone marrow failure, but it does not inherently carry a high risk of developing leukemia. However, people with DBA may have an increased risk of developing other cancers.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2686,
    "user_query": "What type of sequences do enhancers evolve from?",
    "yulan-chat-2-13b-fp16_response": "Enhancers are regulatory elements that can control the expression of genes by binding to specific transcription factors and initiating the recruitment of the RNA polymerase and other transcriptional machinery. They can be found in both prokaryotes and eukaryotes and can be located upstream or downstream of the gene they regulate.\nThe origin of enhancers is not well understood, but it is thought that they may have evolved from other regulatory sequences such as promoters or operator sequences. Promoters are regions of DNA that are recognized by RNA polymerase and initiate the transcription of a gene, while operator sequences are regions of DNA that bind to repressor proteins and inhibit transcription.\nIt is possible that enhancers evolved from promoter-like sequences that were co-opted for a new function, or from operator sequences that were modified to allow for the binding of activator proteins instead of repressor proteins. Alternatively, enhancers may have evolved de novo through a process of gene duplication and divergence, where a new regulatory sequence was created through the duplication of a promoter or other regulatory element and then evolved to acquire new binding sites and functions.\nOverall, the evolution of enhancers is a complex process that is still not well understood, and ongoing research is needed to shed light on the origins and evolution of these important regulatory elements.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Enhancers are regulatory elements that control gene expression by binding to specific transcription factors.\n2. Enhancers can be located upstream or downstream of the gene they regulate.\n3. Promoters are regions of DNA that are recognized by RNA polymerase to initiate transcription of a gene.\n4. Operator sequences are regions of DNA that bind to repressor proteins to inhibit transcription.\n5. Enhancers may have evolved from promoter-like sequences or operator sequences that were modified for new functions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Enhancers are regulatory elements that control gene expression by binding to specific transcription factors.",
      "Enhancers can be located upstream or downstream of the gene they regulate.",
      "Promoters are regions of DNA that are recognized by RNA polymerase to initiate transcription of a gene.",
      "Operator sequences are regions of DNA that bind to repressor proteins to inhibit transcription.",
      "Enhancers may have evolved from promoter-like sequences or operator sequences that were modified for new functions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2687,
    "user_query": "What nerve is involved in carpal tunnel syndrome?",
    "yulan-chat-2-13b-fp16_response": "Carpal tunnel syndrome is caused by compression of the median nerve as it passes through the carpal tunnel, a narrow passageway formed by the bones and ligaments of the wrist. The median nerve provides sensation to the thumb, index, middle, and half of the ring finger, as well as motor function to the muscles in the hand that control movement. In carpal tunnel syndrome, the compression of the median nerve can lead to symptoms such as numbness, tingling, and pain in the hand and fingers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Carpal tunnel syndrome involves the compression of the median nerve.\n2. The median nerve passes through the carpal tunnel in the wrist.\n3. The median nerve provides sensation to the thumb, index, middle, and half of the ring finger.\n4. The median nerve also provides motor function to some muscles in the hand.\n5. Symptoms of carpal tunnel syndrome can include numbness, tingling, and pain in the hand and fingers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Carpal tunnel syndrome involves the compression of the median nerve.",
      "The median nerve passes through the carpal tunnel in the wrist.",
      "The median nerve provides sensation to the thumb, index, middle, and half of the ring finger.",
      "The median nerve also provides motor function to some muscles in the hand.",
      "Symptoms of carpal tunnel syndrome can include numbness, tingling, and pain in the hand and fingers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2689,
    "user_query": "Please list 3 diseases treated with Valtrex(valacyclovir)",
    "yulan-chat-2-13b-fp16_response": "Valtrex (valacyclovir) is an antiviral medication that is primarily used to treat herpes simplex virus (HSV) infections, including both HSV-1 and HSV-2. It can also be used to treat varicella-zoster virus (VZV) infections, including chickenpox and shingles. In addition to these viral infections, Valtrex may be used off-label to treat other viral infections, such as cytomegalovirus (CMV) and herpes zoster.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Valtrex (valacyclovir) is used to treat herpes simplex virus (HSV) infections.\n2. Valtrex can be used to treat varicella-zoster virus (VZV) infections, including chickenpox and shingles.\n3. Valtrex may be used off-label to treat cytomegalovirus (CMV) infections.",
    "yulan-chat-2-13b-fp16_fact": [
      "Valtrex (valacyclovir) is used to treat herpes simplex virus (HSV) infections.",
      "Valtrex can be used to treat varicella-zoster virus (VZV) infections, including chickenpox and shingles.",
      "Valtrex may be used off-label to treat cytomegalovirus (CMV) infections."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE [clarification]: While Valtrex is not approved by the FDA for the treatment of CMV infections, it may be used off-label for this purpose in some cases, as clinicians sometimes prescribe medications off-label based on their clinical judgment. However, it is not the standard antiviral medication for CMV, and ganciclovir or valganciclovir are more commonly used for treating CMV infections.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2690,
    "user_query": "Which olfactory gene senses androsterone?",
    "yulan-chat-2-13b-fp16_response": "Androsterone is a steroid hormone that is produced in the body and has a strong, musky odor. It is primarily produced by the adrenal glands and is a major metabolite of testosterone.\nThere is no specific olfactory gene that is dedicated to sensing androsterone. However, there are certain olfactory receptor genes that are known to be involved in detecting and processing steroids, including androsterone.\nOne such olfactory receptor gene is OR2AT4, which is expressed in the olfactory epithelium and has been shown to be involved in detecting androsterone. Other olfactory receptor genes that may be involved in detecting androsterone include OR2AG1, OR2AG2, and OR3AR1.\nIt's worth noting that the ability to detect androsterone may vary between individuals and can be influenced by a variety of factors, including genetics, environmental factors, and individual experiences.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Androsterone is a steroid hormone produced in the body.\n2. Androsterone is primarily produced by the adrenal glands.\n3. Androsterone is a major metabolite of testosterone.\n4. The olfactory receptor gene OR2AT4 is expressed in the olfactory epithelium and can detect androsterone.\n5. Other olfactory receptor genes that may be involved in detecting androsterone include OR2AG1, OR2AG2, and OR3AR1.",
    "yulan-chat-2-13b-fp16_fact": [
      "Androsterone is a steroid hormone produced in the body.",
      "Androsterone is primarily produced by the adrenal glands.",
      "Androsterone is a major metabolite of testosterone.",
      "The olfactory receptor gene OR2AT4 is expressed in the olfactory epithelium and can detect androsterone.",
      "Other olfactory receptor genes that may be involved in detecting androsterone include OR2AG1, OR2AG2, and OR3AR1."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Androsterone is primarily produced in the testes, but it can also be produced in the adrenal glands, liver, and brain.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2696,
    "user_query": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
    "yulan-chat-2-13b-fp16_response": "The high-altitude adaptation of Tibetans is primarily due to genetic changes that have occurred over thousands of years of living at high altitudes. Several genes have been identified as playing a role in this adaptation, including:\n1. EPAS1: This gene encodes a transcription factor that regulates the expression of genes in response to low oxygen levels. Tibetans have a specific variant of EPAS1 that is associated with increased activity at high altitudes.\n2. EGLN1: This gene encodes a protein that helps to regulate blood oxygen levels by controlling the production of red blood cells. Tibetans have a specific variant of EGLN1 that is associated with increased activity at high altitudes.\n3. HMBS: This gene encodes a protein that is involved in the production of hemoglobin, the protein that carries oxygen in the blood. Tibetans have a specific variant of HMBS that is associated with increased activity at high altitudes.\n4. VHL: This gene encodes a protein that is involved in the regulation of blood oxygen levels. Tibetans have a specific variant of VHL that is associated with increased activity at high altitudes.\nThese genes are just a few examples of the many genes that have been implicated in the high-altitude adaptation of Tibetans. Further research is needed to fully understand the genetic basis of this adaptation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The EPAS1 gene has been identified as playing a role in the high-altitude adaptation of Tibetans, with a specific variant that is associated with increased activity at high altitudes.\n2. The EGLN1 gene is involved in high-altitude adaptation, with a specific variant in Tibetans that contributes to their ability to regulate blood oxygen levels.\n3. Tibetans have a specific variant of the HMBS gene that is linked to increased activity at high altitudes and is involved in the production of hemoglobin.\n4. The VHL gene, which is involved in the regulation of blood oxygen levels, has a specific variant in Tibetans associated with high-altitude adaptation.\n5. The genetic changes that allow for Tibetans' high-altitude adaptation have occurred over thousands of years.",
    "yulan-chat-2-13b-fp16_fact": [
      "The EPAS1 gene has been identified as playing a role in the high-altitude adaptation of Tibetans, with a specific variant that is associated with increased activity at high altitudes.",
      "The EGLN1 gene is involved in high-altitude adaptation, with a specific variant in Tibetans that contributes to their ability to regulate blood oxygen levels.",
      "Tibetans have a specific variant of the HMBS gene that is linked to increased activity at high altitudes and is involved in the production of hemoglobin.",
      "The VHL gene, which is involved in the regulation of blood oxygen levels, has a specific variant in Tibetans associated with high-altitude adaptation.",
      "The genetic changes that allow for Tibetans' high-altitude adaptation have occurred over thousands of years."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The specific gene variant of the HMBS gene that contributes to high-altitude adaptation in Tibetans has not been established as significant. Instead, other genes such as EPAS1 and EGLN1 have been more commonly associated with high-altitude adaptation.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2699,
    "user_query": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
    "yulan-chat-2-13b-fp16_response": "The human monoamine oxidase A (MAOA) gene has been associated with several personality traits, including aggression, impulsivity, and risk-taking behavior. People with a genetic variation in the MAOA gene have been found to be more likely to experience anger, hostility, and violent behavior. However, it is important to note that genetics alone do not determine behavior, and environmental and social factors also play a significant role in shaping personality and behavior.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The human monoamine oxidase A (MAOA) gene has been associated with the personality traits aggression, impulsivity, and risk-taking behavior.\n2. Individuals with a genetic variation in the MAOA gene are more likely to experience anger, hostility, and violent behavior.\n3. Environmental and social factors also influence personality and behavior, apart from the genetic makeup determined by the MAOA gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "The human monoamine oxidase A (MAOA) gene has been associated with the personality traits aggression, impulsivity, and risk-taking behavior.",
      "Individuals with a genetic variation in the MAOA gene are more likely to experience anger, hostility, and violent behavior.",
      "Environmental and social factors also influence personality and behavior, apart from the genetic makeup determined by the MAOA gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2702,
    "user_query": "Which human gene encode for DNA polymerase ?",
    "yulan-chat-2-13b-fp16_response": "The human gene that encodes for DNA polymerase  is called \"POLH.\" This gene is located on chromosome 17 and provides instructions for making the protein called DNA polymerase .",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The gene that encodes for DNA polymerase  is known as \"POLH.\"\n2. The POLH gene is located on chromosome 17.",
    "yulan-chat-2-13b-fp16_fact": [
      "The gene that encodes for DNA polymerase  is known as \"POLH.\"",
      "The POLH gene is located on chromosome 17."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The gene that encodes for DNA polymerase  is known as \"POLQ.\"\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 2705,
    "user_query": "Which are the two main bacterial phyla in human gut?",
    "yulan-chat-2-13b-fp16_response": "The two main bacterial phyla found in the human gut are Firmicutes and Bacteroidetes. These phyla make up a large proportion of the bacterial community in the gut and play important roles in various physiological processes, such as nutrient metabolism and immune system function. There are also many other bacterial phyla present in the gut in smaller numbers, and the composition of the gut microbiota can vary between individuals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Firmicutes is one of the main bacterial phyla found in the human gut.\n2. Bacteroidetes is one of the main bacterial phyla found in the human gut.\n3. The bacterial phyla Firmicutes and Bacteroidetes make up a large proportion of the bacterial community in the human gut.\n4. These bacterial phyla play important roles in nutrient metabolism and immune system function.\n5. The composition of the gut microbiota can vary between individuals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Firmicutes is one of the main bacterial phyla found in the human gut.",
      "Bacteroidetes is one of the main bacterial phyla found in the human gut.",
      "The bacterial phyla Firmicutes and Bacteroidetes make up a large proportion of the bacterial community in the human gut.",
      "These bacterial phyla play important roles in nutrient metabolism and immune system function.",
      "The composition of the gut microbiota can vary between individuals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2710,
    "user_query": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
    "yulan-chat-2-13b-fp16_response": "Cytochrome P450 CYP3A is an enzyme that plays a major role in the metabolism of many drugs and xenobiotics in the liver. Rifampicin is an antibiotic that is known to induce CYP3A enzyme activity, which can lead to increased metabolism and decreased efficacy of drugs that are metabolized by this enzyme.\nRifampicin is commonly used to treat a variety of bacterial infections, including tuberculosis, legionnaires' disease, and bacterial meningitis. It is also sometimes used in combination with other antibiotics to treat drug-resistant strains of these and other bacterial infections.\nIn addition to its antibacterial properties, rifampicin has been shown to have antiviral activity against some viruses, including HIV and hepatitis C virus. However, it is not typically used as a standalone treatment for viral infections, but rather in combination with other antiviral drugs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cytochrome P450 CYP3A is an enzyme that metabolizes many drugs and xenobiotics in the liver.\n2. Rifampicin is known to induce the activity of the CYP3A enzyme.\n3. Induction of CYP3A by rifampicin can lead to increased metabolism and decreased efficacy of drugs metabolized by this enzyme.\n4. Rifampicin is used to treat tuberculosis, legionnaires' disease, and bacterial meningitis.\n5. Rifampicin has antiviral activity against HIV and hepatitis C virus.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cytochrome P450 CYP3A is an enzyme that metabolizes many drugs and xenobiotics in the liver.",
      "Rifampicin is known to induce the activity of the CYP3A enzyme.",
      "Induction of CYP3A by rifampicin can lead to increased metabolism and decreased efficacy of drugs metabolized by this enzyme.",
      "Rifampicin is used to treat tuberculosis, legionnaires' disease, and bacterial meningitis.",
      "Rifampicin has antiviral activity against HIV and hepatitis C virus."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE (Rifampicin is used primarily to treat tuberculosis and also used in the treatment of certain other bacterial infections, but it is typically not used for treating bacterial meningitis without tuberculosis as an underlying cause. This could be misleading.)\n5. FALSE [correction]: While Rifampicin is used to treat bacterial infections, it is not used to treat viral infections such as HIV and hepatitis C virus. Drugs specific to these viruses are used in their treatment.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2712,
    "user_query": "Where is the EpCam protein mainly located?",
    "yulan-chat-2-13b-fp16_response": "The EpCam protein is mainly located in the epithelial cells of various tissues in the body. EpCam stands for Epithelial cell adhesion molecule, and it is a member of the immunoglobulin superfamily of cell adhesion molecules. EpCam is expressed in epithelial cells of various tissues, including the gastrointestinal tract, pancreas, liver, lung, kidney, and urinary bladder. It plays a role in maintaining the integrity of the epithelial barrier and regulating epithelial cell proliferation and differentiation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The EpCam protein is primarily located in epithelial cells.\n2. EpCam stands for Epithelial cell adhesion molecule.\n3. EpCam is a member of the immunoglobulin superfamily of cell adhesion molecules.\n4. EpCam is expressed in epithelial cells of various tissues, including the gastrointestinal tract, pancreas, liver, lung, kidney, and urinary bladder.\n5. EpCam plays a role in maintaining the integrity of the epithelial barrier and regulating epithelial cell proliferation and differentiation.",
    "yulan-chat-2-13b-fp16_fact": [
      "The EpCam protein is primarily located in epithelial cells.",
      "EpCam stands for Epithelial cell adhesion molecule.",
      "EpCam is a member of the immunoglobulin superfamily of cell adhesion molecules.",
      "EpCam is expressed in epithelial cells of various tissues, including the gastrointestinal tract, pancreas, liver, lung, kidney, and urinary bladder.",
      "EpCam plays a role in maintaining the integrity of the epithelial barrier and regulating epithelial cell proliferation and differentiation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: EpCam is not a member of the immunoglobulin superfamily of cell adhesion molecules; it is actually a transmembrane glycoprotein.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2719,
    "user_query": "What is the clathrin triskelia structure?",
    "yulan-chat-2-13b-fp16_response": "Clathrin is a protein that forms a lattice-like structure called a clathrin cage or clathrin triskelion. The clathrin triskelia structure is composed of three identical subunits, or triskels, that form the edges of the cage. These triskels are arranged in a triangular shape and are held together by three intertriskelional (IT) loops. The clathrin triskelia structure is important for the formation of vesicles and the endocytosis of material from the extracellular space.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Clathrin is a protein that forms a structure known as clathrin cage or clathrin triskelion.\n2. The clathrin triskelia structure is made up of three identical subunits called triskels.\n3. These triskels are arranged in a triangular shape.\n4. Three intertriskelional (IT) loops hold the triskels together.\n5. The clathrin triskelia structure plays a role in the formation of vesicles and endocytosis of material from the extracellular space.",
    "yulan-chat-2-13b-fp16_fact": [
      "Clathrin is a protein that forms a structure known as clathrin cage or clathrin triskelion.",
      "The clathrin triskelia structure is made up of three identical subunits called triskels.",
      "These triskels are arranged in a triangular shape.",
      "Three intertriskelional (IT) loops hold the triskels together.",
      "The clathrin triskelia structure plays a role in the formation of vesicles and endocytosis of material from the extracellular space."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The triskels are held together by interactions between their legs, not \"intertriskelional (IT) loops.\" The term \"intertriskelional loops\" is not standard in describing the structure of clathrin.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2721,
    "user_query": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
    "yulan-chat-2-13b-fp16_response": "Yes, Brucella abortus is the organism that causes brucellosis, also known as Malta fever or Bang's disease, and it is known to cause spontaneous abortions in humans.\nBrucella abortus is a gram-negative bacterium that is commonly found in cattle, sheep, and goats. It can be transmitted to humans through contact with infected animals or their secretions, such as milk, urine, and feces.\nIn humans, brucellosis can cause a range of symptoms, including fever, headache, muscle pain, and fatigue. In pregnant women, it can also cause spontaneous abortions, premature birth, and stillbirth.\nBrucella abortus infection is a zoonotic disease, meaning it can be transmitted from animals to humans. It is a common disease worldwide and is a significant public health concern in areas where livestock are raised.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Brucella abortus causes brucellosis, also known as Malta fever or Bang's disease.\n2. Brucella abortus is known to cause spontaneous abortions in humans.\n3. Brucella abortus is a gram-negative bacterium found in cattle, sheep, and goats.\n4. Brucellosis can be transmitted to humans through contact with infected animal secretions.\n5. Brucella abortus is a zoonotic disease capable of transmission from animals to humans.",
    "yulan-chat-2-13b-fp16_fact": [
      "Brucella abortus causes brucellosis, also known as Malta fever or Bang's disease.",
      "Brucella abortus is known to cause spontaneous abortions in humans.",
      "Brucella abortus is a gram-negative bacterium found in cattle, sheep, and goats.",
      "Brucellosis can be transmitted to humans through contact with infected animal secretions.",
      "Brucella abortus is a zoonotic disease capable of transmission from animals to humans."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Brucella abortus is known to cause spontaneous abortions in cattle, not humans. In humans, it can cause fever, sweats, malaise, anorexia, headache, muscle pain, joint pain, and fatigue.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2722,
    "user_query": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
    "yulan-chat-2-13b-fp16_response": "The percentage of Homo sapiens DNA that is of Neanderthal origin varies among individuals, but on average, it is estimated to be around 2-4%. This percentage can vary depending on the individual's ancestry and the specific region of the genome that is being analyzed. Neanderthals are known to have interbred with the ancestors of modern humans, and this interbreeding is thought to have occurred multiple times over a period of tens of thousands of years. As a result, the Neanderthal genetic contribution to the human genome is not evenly distributed and can vary significantly among individuals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The average estimated percentage of Homo sapiens DNA that is of Neanderthal origin is around 2-4%.\n2. The proportion of Neanderthal DNA in modern humans can vary depending on the individual's ancestry.\n3. Neanderthals interbred with the ancestors of modern humans.\n4. The interbreeding between Neanderthals and modern human ancestors occurred multiple times over tens of thousands of years.\n5. The Neanderthal genetic contribution to the human genome is not evenly distributed among individuals.",
    "yulan-chat-2-13b-fp16_fact": [
      "The average estimated percentage of Homo sapiens DNA that is of Neanderthal origin is around 2-4%.",
      "The proportion of Neanderthal DNA in modern humans can vary depending on the individual's ancestry.",
      "Neanderthals interbred with the ancestors of modern humans.",
      "The interbreeding between Neanderthals and modern human ancestors occurred multiple times over tens of thousands of years.",
      "The Neanderthal genetic contribution to the human genome is not evenly distributed among individuals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2723,
    "user_query": "What is Dupuytren's contracture?",
    "yulan-chat-2-13b-fp16_response": "Dupuytren's contracture is a condition in which the fingers become permanently bent and cannot be straightened. It is caused by the thickening of the connective tissue in the hand, which leads to the development of cords or bands of tissue that pull the fingers into a curved position. The condition typically affects the ring and little fingers, and can progress over time, causing the fingers to become increasingly bent and immobile.\nDupuytren's contracture is a type of hand disorder known as a \"progressive fibrotic contracture,\" which means that it is caused by the abnormal growth of fibrous tissue in the hand. The exact cause of the condition is not known, but it is believed to be related to a combination of genetic and environmental factors.\nTreatment for Dupuytren's contracture may include medications, such as corticosteroids, to help reduce inflammation and slow the progression of the condition. In more severe cases, surgery may be necessary to release the bands of tissue that are causing the contracture.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dupuytren's contracture causes the fingers to become permanently bent and unable to be straightened.\n2. The condition is caused by the thickening of the connective tissue in the hand.\n3. Dupuytren's contracture typically affects the ring and little fingers.\n4. It is classified as a \"progressive fibrotic contracture.\"\n5. Treatment options for Dupuytren's contracture may include medications like corticosteroids or surgery to release the bands of tissue.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dupuytren's contracture causes the fingers to become permanently bent and unable to be straightened.",
      "The condition is caused by the thickening of the connective tissue in the hand.",
      "Dupuytren's contracture typically affects the ring and little fingers.",
      "It is classified as a \"progressive fibrotic contracture.\"",
      "Treatment options for Dupuytren's contracture may include medications like corticosteroids or surgery to release the bands of tissue."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2728,
    "user_query": "Are human enhancers or promoters evolving faster?",
    "yulan-chat-2-13b-fp16_response": "It is difficult to compare the rate of evolution of human enhancers or promoters with other organisms, as the concept of \"evolution\" can be applied in different ways.\nIn the context of genetics, human enhancers or promoters are regulatory elements of DNA that control the expression of genes. These elements can evolve through various mechanisms, such as mutation, duplication, and deletion, and can change the regulation of nearby genes.\nThe rate of evolution of human enhancers or promoters can vary depending on the specific element and the population being studied. Some enhancers or promoters may evolve more rapidly than others, while others may remain relatively stable over long periods of time.\nIt is also important to note that the evolution of enhancers or promoters is not necessarily related to the evolution of the organism as a whole. While changes in these regulatory elements can have significant effects on gene expression and potentially on the phenotype of an organism, the rate of evolution of enhancers or promoters is not necessarily correlated with the rate of evolution of the organism's other genetic elements or with its overall rate of evolution.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Human enhancers or promoters are regulatory elements of DNA that control gene expression.\n2. These elements can evolve through mechanisms such as mutation, duplication, and deletion.\n3. The rate of evolution for human enhancers or promoters can vary between different elements and populations.\n4. Some enhancers or promoters may evolve more rapidly than others.\n5. The evolution of human enhancers or promoters is not necessarily correlated with the overall rate of evolution of the organism.",
    "yulan-chat-2-13b-fp16_fact": [
      "Human enhancers or promoters are regulatory elements of DNA that control gene expression.",
      "These elements can evolve through mechanisms such as mutation, duplication, and deletion.",
      "The rate of evolution for human enhancers or promoters can vary between different elements and populations.",
      "Some enhancers or promoters may evolve more rapidly than others.",
      "The evolution of human enhancers or promoters is not necessarily correlated with the overall rate of evolution of the organism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2729,
    "user_query": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
    "yulan-chat-2-13b-fp16_response": "As of November 2017, the three antidotes for anticoagulant drugs, including factor Xa inhibitors, are:\n1. Prothrombin complex concentrate (PCC): This is a concentrated mixture of coagulation factors II, VII, IX, and X, which can be used to reverse the effects of factor Xa inhibitors. PCC works by increasing the clotting ability of the blood, which can help to counteract the anticoagulant effect of the drug.\n2. Fresh frozen plasma (FFP): FFP is a plasma product that contains clotting factors, including factor VIII and von Willebrand factor. It can be used to reverse the effects of factor Xa inhibitors by providing additional clotting factors to the blood.\n3. Human activated protein C (APC): APC is a protein that can be used to reverse the effects of factor Xa inhibitors by promoting the breakdown of clotting factors. APC works by activating the protein C pathway, which is a natural anticoagulant system in the body.\nIt's important to note that the use of these antidotes should be guided by the specific drug that the patient is taking, as well as the patient's medical history and condition. It's also important to consult with a healthcare professional for proper dosing and administration of these antidotes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prothrombin complex concentrate (PCC) is used to reverse the effects of factor Xa inhibitors by increasing the blood's clotting ability.\n2. Fresh frozen plasma (FFP) contains clotting factors and can reverse the effects of factor Xa inhibitors.\n3. Human activated protein C (APC) can reverse the effects of factor Xa inhibitors by promoting the breakdown of clotting factors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prothrombin complex concentrate (PCC) is used to reverse the effects of factor Xa inhibitors by increasing the blood's clotting ability.",
      "Fresh frozen plasma (FFP) contains clotting factors and can reverse the effects of factor Xa inhibitors.",
      "Human activated protein C (APC) can reverse the effects of factor Xa inhibitors by promoting the breakdown of clotting factors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Human activated protein C (APC) has anticoagulant effects by promoting the breakdown of clotting factors and does not reverse the effects of factor Xa inhibitors. It can actually increase the anticoagulant effect.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2730,
    "user_query": "Which genes are associated with Epidermolysis Bullosa Simplex?",
    "yulan-chat-2-13b-fp16_response": "Epidermolysis Bullosa Simplex (EB Simplex) is a group of genetic disorders that affect the skin and mucous membranes. It is caused by mutations in the genes that encode for keratin, a protein that forms the structural framework of the skin and other tissues.\nThere are four genes that are associated with EB Simplex:\n1. KRT5: This gene provides instructions for making the protein keratin 5, which is a component of the skin's outer layer. Mutations in this gene are associated with EB Simplex type 1.\n2. KRT14: This gene provides instructions for making the protein keratin 14, which is also a component of the skin's outer layer. Mutations in this gene are associated with EB Simplex type 2.\n3. KRT16: This gene provides instructions for making the protein keratin 16, which is a component of the skin's outer layer. Mutations in this gene are associated with EB Simplex type 3.\n4. KRT10: This gene provides instructions for making the protein keratin 10, which is a component of the skin's outer layer. Mutations in this gene are associated with EB Simplex type 4.\nMutations in any of these genes can lead to the development of EB Simplex, which can cause severe blistering of the skin and mucous membranes, as well as other symptoms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Epidermolysis Bullosa Simplex (EB Simplex) is caused by mutations in genes that encode for keratin.\n2. The KRT5 gene is associated with EB Simplex type 1 and provides instructions for making keratin 5.\n3. The KRT14 gene is associated with EB Simplex type 2 and provides instructions for making keratin 14.\n4. The KRT16 gene is associated with EB Simplex type 3 and provides instructions for making keratin 16.\n5. The KRT10 gene is associated with EB Simplex type 4 and provides instructions for making keratin 10.",
    "yulan-chat-2-13b-fp16_fact": [
      "Epidermolysis Bullosa Simplex (EB Simplex) is caused by mutations in genes that encode for keratin.",
      "The KRT5 gene is associated with EB Simplex type 1 and provides instructions for making keratin 5.",
      "The KRT14 gene is associated with EB Simplex type 2 and provides instructions for making keratin 14.",
      "The KRT16 gene is associated with EB Simplex type 3 and provides instructions for making keratin 16.",
      "The KRT10 gene is associated with EB Simplex type 4 and provides instructions for making keratin 10."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The KRT14 gene is associated with EB Simplex and provides instructions for making keratin 14, but it is not specifically limited to \"type 2\" as the classification of EB Simplex types may not be numbered this way.\n4. UNKNOWN: Without more context on EB Simplex classifications or specific types, it's unclear if there is a \"type 3\" associated with the KRT16 gene.\n5. UNKNOWN: Similarly to statement 4, without additional context, it is unclear if there is a type 4 associated with the KRT10 gene or if the KRT10 gene is involved in EB Simplex at all.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2738,
    "user_query": "What part of the body is affected by mesotheliomia?",
    "yulan-chat-2-13b-fp16_response": "Mesothelioma is a type of cancer that affects the mesothelium, a thin layer of tissue that covers and protects the internal organs, such as the lungs, heart, and abdominal organs. It is usually found in the lining of the lungs, but it can also affect the lining of the abdomen or the heart.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mesothelioma is a type of cancer.\n2. Mesothelioma affects the mesothelium, which is a thin layer of tissue covering internal organs.\n3. The mesothelium protects internal organs like the lungs, heart, and abdominal organs.\n4. Mesothelioma is usually found in the lining of the lungs.\n5. Mesothelioma can also affect the lining of the abdomen or the heart.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mesothelioma is a type of cancer.",
      "Mesothelioma affects the mesothelium, which is a thin layer of tissue covering internal organs.",
      "The mesothelium protects internal organs like the lungs, heart, and abdominal organs.",
      "Mesothelioma is usually found in the lining of the lungs.",
      "Mesothelioma can also affect the lining of the abdomen or the heart."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2741,
    "user_query": "What is PNPPP?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with the term \"PNPPP.\" It could be an abbreviation or acronym that is specific to a certain field or organization, or it could be a made-up term. Without more context or information, I'm unable to provide a more specific answer.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2746,
    "user_query": "Which genomic positions are preferentially selected for transposon insertion?",
    "yulan-chat-2-13b-fp16_response": "Transposable elements, also known as transposons, are DNA elements that can move from one location in a genome to another. These elements can be active or inactive, and their insertion into a genome can have various effects, including disrupting gene function or regulation. The genomic positions that are preferentially selected for transposon insertion can vary depending on the specific type of transposon and the genome in which it is present.\nIn general, transposons tend to insert into regions of the genome that are relatively devoid of functional genes, such as intergenic regions or introns. This may be because these regions are less likely to disrupt important gene functions, or because they provide a favorable environment for transposon insertion.\nSome studies have suggested that transposons may also be more likely to insert into regions of the genome that are rich in certain types of sequences, such as CpG islands or GC-rich regions. These sequences may provide a favorable environment for transposon insertion, or may be targets of selection by the transposon itself.\nOverall, the genomic positions that are preferentially selected for transposon insertion can vary depending on the specific type of transposon and the genome in which it is present. However, transposons tend to insert into regions of the genome that are relatively devoid of functional genes, and may be more likely to insert into regions that are rich in certain types of sequences.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Transposable elements, also known as transposons, can move from one location in a genome to another.\n2. Transposons insertion can disrupt gene function or regulation.\n3. Transposons tend to insert into regions of the genome that are relatively devoid of functional genes, such as intergenic regions or introns.\n4. Transposons may also be more likely to insert into regions of the genome that are rich in certain types of sequences, such as CpG islands or GC-rich regions.\n5. The preference for genomic positions for transposon insertion can vary depending on the specific type of transposon and the genome in which it is present.",
    "yulan-chat-2-13b-fp16_fact": [
      "Transposable elements, also known as transposons, can move from one location in a genome to another.",
      "Transposons insertion can disrupt gene function or regulation.",
      "Transposons tend to insert into regions of the genome that are relatively devoid of functional genes, such as intergenic regions or introns.",
      "Transposons may also be more likely to insert into regions of the genome that are rich in certain types of sequences, such as CpG islands or GC-rich regions.",
      "The preference for genomic positions for transposon insertion can vary depending on the specific type of transposon and the genome in which it is present."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE - While transposons can insert into various parts of the genome, it is generally accepted that there is a preference for insertion into regions that are less likely to disrupt gene function, such as intergenic regions or introns.\n4. FALSE [correction]: Transposons are generally more likely to insert into regions of the genome that are less likely to cause detrimental effects on the host organism, such as intergenic regions or introns. While certain types of transposons might target specific sequences, it is not accurate to say that transposons have a generalized preference for CpG islands or GC-rich regions.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "yulan-chat-2-13b-fp16_response": "One Lisp framework that has been developed for image processing is Common Graphics. Common Graphics is a standard for representing and manipulating 2D graphics, including images, on a variety of platforms. It provides a set of functions and data types for working with images, including loading and saving image files, manipulating image pixels, and performing image processing operations such as filtering and resizing. Common Graphics is implemented in a number of programming languages, including Lisp and Scheme.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Common Graphics is a Lisp framework developed for image processing.\n2. Common Graphics is a standard for representing and manipulating 2D graphics.\n3. It provides functions and data types for loading and saving image files.\n4. Common Graphics allows manipulation of image pixels and performing image processing operations like filtering and resizing.\n5. Common Graphics is implemented in Lisp and Scheme programming languages.",
    "yulan-chat-2-13b-fp16_fact": [
      "Common Graphics is a Lisp framework developed for image processing.",
      "Common Graphics is a standard for representing and manipulating 2D graphics.",
      "It provides functions and data types for loading and saving image files.",
      "Common Graphics allows manipulation of image pixels and performing image processing operations like filtering and resizing.",
      "Common Graphics is implemented in Lisp and Scheme programming languages."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Common Graphics is not specifically a Lisp framework for image processing; it is a graphical user interface toolkit for Lisp systems.\n2. FALSE [correction]: Common Graphics is not a standard for 2D graphics representation and manipulation; it is a part of LispWorks, an IDE for Common Lisp, and is used for creating GUI applications.\n3. UNKNOWN: Without more context, it's uncertain whether Common Graphics includes functions for loading and saving image files as this might pertain more to an image processing library than to a GUI toolkit.\n4. FALSE [correction]: Common Graphics primarily provides functionality for GUI elements and does not directly deal with image processing operations like filtering and resizing; these would likely require a different library or framework.\n5. FALSE [correction]: Common Graphics is implemented for the Lisp programming language, but there is no information to suggest it is implemented in Scheme. Scheme is a different dialect of Lisp and would likely have its own tools and libraries.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2751,
    "user_query": "List four features of the WHIM syndrome.",
    "yulan-chat-2-13b-fp16_response": "1. Inflammation: WHIM syndrome is characterized by chronic inflammation in various parts of the body, including the skin, joints, and digestive system.\n2. Neutropenia: WHIM syndrome is associated with a deficiency in neutrophils, which are a type of white blood cell that plays a crucial role in fighting infections.\n3. Increased susceptibility to infections: Due to the neutropenia that is present in WHIM syndrome, individuals with the condition are more susceptible to recurrent and severe infections.\n4. Autoimmune disorders: WHIM syndrome is also associated with an increased risk of developing autoimmune disorders, such as rheumatoid arthritis and lupus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. WHIM syndrome is characterized by chronic inflammation in various parts of the body, including the skin, joints, and digestive system.\n2. WHIM syndrome is associated with neutropenia, a deficiency in neutrophils.\n3. Individuals with WHIM syndrome are more susceptible to recurrent and severe infections due to neutropenia.\n4. WHIM syndrome increases the risk of developing autoimmune disorders, such as rheumatoid arthritis and lupus.",
    "yulan-chat-2-13b-fp16_fact": [
      "WHIM syndrome is characterized by chronic inflammation in various parts of the body, including the skin, joints, and digestive system.",
      "WHIM syndrome is associated with neutropenia, a deficiency in neutrophils.",
      "Individuals with WHIM syndrome are more susceptible to recurrent and severe infections due to neutropenia.",
      "WHIM syndrome increases the risk of developing autoimmune disorders, such as rheumatoid arthritis and lupus."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: WHIM syndrome is characterized by Warts, Hypogammaglobulinemia, Infections, and Myelokathexis; it is not typically described as involving chronic inflammation in various parts of the body like the skin, joints, and digestive system.\n2. TRUE\n3. TRUE\n4. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2753,
    "user_query": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?",
    "yulan-chat-2-13b-fp16_response": "There is limited research on the specific bacteria that are enriched in the gut microbiome of infants following exposure to furry pets. However, some studies have suggested that exposure to pets may increase the abundance of certain bacterial taxa, such as Bifidobacterium and Lactobacillus, which are known to be beneficial for human health. Additionally, exposure to pets may also lead to an increase in the diversity of the gut microbiome, which is associated with improved health outcomes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Some studies suggest that exposure to furry pets may increase the abundance of Bifidobacterium in the gut microbiome of infants.\n2. Some research indicates that exposure to furry pets may increase the abundance of Lactobacillus in the gut microbiome of infants.\n3. Exposure to furry pets may also lead to an increase in the diversity of the gut microbiome.\n4. The increase in the diversity of the gut microbiome is associated with improved health outcomes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Some studies suggest that exposure to furry pets may increase the abundance of Bifidobacterium in the gut microbiome of infants.",
      "Some research indicates that exposure to furry pets may increase the abundance of Lactobacillus in the gut microbiome of infants.",
      "Exposure to furry pets may also lead to an increase in the diversity of the gut microbiome.",
      "The increase in the diversity of the gut microbiome is associated with improved health outcomes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nIt is generally supported by scientific evidence that exposure to furry pets can influence the gut microbiome by increasing the abundance of certain beneficial bacteria like Bifidobacteria and Lactobacilli, promoting diversity in the microbiome, and that increased diversity in the gut microbiome is often associated with positive health outcomes. However, as with any scientific claim, the exact outcomes can vary and are subject to further research and investigation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2755,
    "user_query": "Is Baloxavir effective for influenza?",
    "yulan-chat-2-13b-fp16_response": "Baloxavir is a medication that is effective for the treatment of influenza, also known as the flu. It is a type of antiviral medication that works by targeting and inhibiting the activity of the influenza virus. Baloxavir is specifically designed to target the cap-snatching activity of the influenza virus, which is necessary for the virus to replicate and spread in the body.\nClinical trials have shown that baloxavir is effective at reducing the severity and duration of symptoms of the flu, as well as reducing the risk of complications from the virus. In a phase 3 clinical trial, baloxavir was found to be superior to placebo in reducing the severity of symptoms and the duration of illness in patients with influenza.\nBaloxavir is also effective against influenza strains that are resistant to other antiviral medications, such as oseltamivir and peramivir. It is approved for use in the United States and other countries for the treatment of acute uncomplicated influenza in patients who have been diagnosed with the virus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Baloxavir is used for the treatment of influenza.\n2. Baloxavir works by inhibiting the influenza virus's cap-snatching activity required for replication.\n3. Clinical trials have indicated that baloxavir reduces the severity and duration of flu symptoms.\n4. Baloxavir has been found to be superior to placebo in phase 3 clinical trials for reducing symptom severity and illness duration in flu patients.\n5. Baloxavir is approved in the United States for the treatment of acute uncomplicated influenza.",
    "yulan-chat-2-13b-fp16_fact": [
      "Baloxavir is used for the treatment of influenza.",
      "Baloxavir works by inhibiting the influenza virus's cap-snatching activity required for replication.",
      "Clinical trials have indicated that baloxavir reduces the severity and duration of flu symptoms.",
      "Baloxavir has been found to be superior to placebo in phase 3 clinical trials for reducing symptom severity and illness duration in flu patients.",
      "Baloxavir is approved in the United States for the treatment of acute uncomplicated influenza."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "yulan-chat-2-13b-fp16_response": "Saccharomyces cerevisiae, also known as baker's yeast, underwent an ancient whole genome duplication event approximately 40 million years ago. This event resulted in the duplication of all genes in the genome, which are known as duplicate genes. It is estimated that approximately 15-20% of the genes in S. cerevisiae are the result of this ancient whole genome duplication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Saccharomyces cerevisiae underwent an ancient whole genome duplication event approximately 40 million years ago.\n2. The whole genome duplication resulted in the duplication of all genes in the genome of Saccharomyces cerevisiae.\n3. It is estimated that 15-20% of the genes in S. cerevisiae are the result of the ancient whole genome duplication.",
    "yulan-chat-2-13b-fp16_fact": [
      "Saccharomyces cerevisiae underwent an ancient whole genome duplication event approximately 40 million years ago.",
      "The whole genome duplication resulted in the duplication of all genes in the genome of Saccharomyces cerevisiae.",
      "It is estimated that 15-20% of the genes in S. cerevisiae are the result of the ancient whole genome duplication."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Saccharomyces cerevisiae underwent an ancient whole genome duplication event approximately 100 million years ago.\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor  (Esrrb)?",
    "yulan-chat-2-13b-fp16_response": "Estrogen-related receptor beta (Esrrb) is a transcription factor that binds to specific DNA sequences known as estrogen-responsive elements (EREs). These EREs are found in the promoter regions of genes involved in various biological processes, including cell proliferation, differentiation, and survival.\nEsrrb is a member of the steroid hormone receptor superfamily, which includes estrogen receptor alpha (ER) and progesterone receptor (PR). Like these receptors, Esrrb plays a crucial role in regulating gene expression in response to hormonal signals.\nThe complexes bound by Esrrb can vary depending on the specific genes and promoter regions involved. However, some of the genes known to be regulated by Esrrb include those involved in the regulation of cell cycle progression, cell differentiation, and angiogenesis.\nOverall, Esrrb plays an important role in the regulation of gene expression in a variety of tissues and cell types, particularly in the reproductive and cardiovascular systems.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Estrogen-related receptor beta (Esrrb) binds to estrogen-responsive elements (EREs) in DNA.\n2. Esrrb is a member of the steroid hormone receptor superfamily.\n3. The steroid hormone receptor superfamily also includes estrogen receptor alpha (ER) and progesterone receptor (PR).\n4. Esrrb is involved in regulating gene expression in response to hormonal signals.\n5. Esrrb regulates genes involved in cell cycle progression, cell differentiation, and angiogenesis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Estrogen-related receptor beta (Esrrb) binds to estrogen-responsive elements (EREs) in DNA.",
      "Esrrb is a member of the steroid hormone receptor superfamily.",
      "The steroid hormone receptor superfamily also includes estrogen receptor alpha (ER) and progesterone receptor (PR).",
      "Esrrb is involved in regulating gene expression in response to hormonal signals.",
      "Esrrb regulates genes involved in cell cycle progression, cell differentiation, and angiogenesis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Estrogen-related receptor beta (Esrrb) does not bind to estrogen-responsive elements (EREs) in DNA; it is an orphan receptor meaning it has no known endogenous ligand.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2773,
    "user_query": "Which database associates human noncoding SNPs with their three-dimensional interacting genes?",
    "yulan-chat-2-13b-fp16_response": "There are several databases that associate human noncoding SNPs with their three-dimensional interacting genes, but one of the most well-known and widely used is the ENCODE (Encyclopedia of DNA Elements) database. ENCODE is a public resource that provides a comprehensive and integrated view of the human genome, including information on noncoding regions and their regulatory elements. The database includes information on SNPs and their effects on gene expression, as well as information on the three-dimensional structure of the genome and how SNPs may affect gene interactions. Other databases that may be useful for this purpose include the NCBI SNP database, the SNPnexus database, and the SNPinfo database.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ENCODE (Encyclopedia of DNA Elements) database is known for associating human noncoding SNPs with their three-dimensional interacting genes.\n2. ENCODE provides a comprehensive and integrated view of the human genome.\n3. The ENCODE database includes information on the effects of SNPs on gene expression.\n4. The ENCODE database contains information on the three-dimensional structure of the genome.",
    "yulan-chat-2-13b-fp16_fact": [
      "ENCODE (Encyclopedia of DNA Elements) database is known for associating human noncoding SNPs with their three-dimensional interacting genes.",
      "ENCODE provides a comprehensive and integrated view of the human genome.",
      "The ENCODE database includes information on the effects of SNPs on gene expression.",
      "The ENCODE database contains information on the three-dimensional structure of the genome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nENCODE aims to catalog all the functional elements in the human genome. The project provides insights into how noncoding SNPs may affect gene regulation and expression. The database includes information about functional genomic elements, transcription factor binding sites, and other genomic features, including the 3D structure of the genome which helps in understanding long-range gene-gene interactions.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2778,
    "user_query": "What is the role of fucokinase?",
    "yulan-chat-2-13b-fp16_response": "Fucosyltransferase is an enzyme that catalyzes the transfer of fucose molecules from a donor molecule, such as GDP-fucose, to an acceptor molecule, such as a protein or lipid. This enzyme plays a key role in the biosynthesis of glycolipids and glycoproteins, which are important for cell recognition, cell-cell interaction, and immune response. Fucosyltransferase is also involved in the biosynthesis of mucins, which are glycoproteins that play a crucial role in the formation of mucus in the respiratory and digestive tracts. Mutations in the genes that encode fucosyltransferase have been associated with various diseases, including congenital disorders of glycosylation and some forms of cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fucosyltransferase catalyzes the transfer of fucose molecules from a donor molecule to an acceptor molecule.\n2. The enzyme plays a key role in the biosynthesis of glycolipids and glycoproteins.\n3. Glycolipids and glycoproteins are important for cell recognition, cell-cell interaction, and immune response.\n4. Fucosyltransferase is involved in the biosynthesis of mucins, which are essential for the formation of mucus in the respiratory and digestive tracts.\n5. Mutations in the genes encoding fucosyltransferase have been linked to congenital disorders of glycosylation and certain cancers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fucosyltransferase catalyzes the transfer of fucose molecules from a donor molecule to an acceptor molecule.",
      "The enzyme plays a key role in the biosynthesis of glycolipids and glycoproteins.",
      "Glycolipids and glycoproteins are important for cell recognition, cell-cell interaction, and immune response.",
      "Fucosyltransferase is involved in the biosynthesis of mucins, which are essential for the formation of mucus in the respiratory and digestive tracts.",
      "Mutations in the genes encoding fucosyltransferase have been linked to congenital disorders of glycosylation and certain cancers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2785,
    "user_query": "Are whole-genome duplications more divergent than small-scale duplications in yeast?",
    "yulan-chat-2-13b-fp16_response": "In yeast, whole-genome duplications (WGDs) are more divergent than small-scale duplications. This is because WGDs result in the duplication of the entire genome, which can lead to the accumulation of deleterious mutations and the divergence of duplicate genes. Small-scale duplications, on the other hand, only involve the duplication of a small number of genes, and are therefore not as likely to result in the accumulation of deleterious mutations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Whole-genome duplications in yeast are more divergent than small-scale duplications.\n2. Whole-genome duplications involve the duplication of the entire genome.\n3. Whole-genome duplications can lead to the accumulation of deleterious mutations.\n4. Small-scale duplications only involve the duplication of a small number of genes.\n5. Small-scale duplications are less likely to result in the accumulation of deleterious mutations.",
    "yulan-chat-2-13b-fp16_fact": [
      "Whole-genome duplications in yeast are more divergent than small-scale duplications.",
      "Whole-genome duplications involve the duplication of the entire genome.",
      "Whole-genome duplications can lead to the accumulation of deleterious mutations.",
      "Small-scale duplications only involve the duplication of a small number of genes.",
      "Small-scale duplications are less likely to result in the accumulation of deleterious mutations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Whole-genome duplications in yeast are indeed more divergent than small-scale duplications because they involve the duplication of the entire set of chromosomes, leading to a greater potential for genetic variation and divergence over time.\n2. TRUE: Whole-genome duplications, by definition, involve the duplication of an organism's entire genome, which means every chromosome and gene is duplicated.\n3. TRUE: Whole-genome duplications can lead to the accumulation of deleterious mutations, as the increase in genetic material provides more opportunities for mutations, some of which may be harmful.\n4. TRUE: Small-scale duplications refer to the duplication of small segments of DNA, which can range from a single gene to a few genes, rather than the entire genome.\n5. UNKNOWN: The relationship between small-scale duplications and the accumulation of deleterious mutations can be complex. Small-scale duplications may result in a lower likelihood of accumulating deleterious mutations compared to whole-genome duplications because they affect fewer genes. However, this is not a rule as the outcome depends on various factors, including the specific genes duplicated and the evolutionary pressures on the organism. Therefore, without specific context, it is difficult to determine the truth value of this statement.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2791,
    "user_query": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?",
    "yulan-chat-2-13b-fp16_response": "Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells. It is primarily used to treat anemia, but has also been investigated as a potential treatment for amyotrophic lateral sclerosis (ALS).\nALS is a progressive neurological disorder that affects the nerve cells in the brain and spinal cord, leading to muscle weakness and eventual loss of the ability to perform daily activities. While there is currently no cure for ALS, there are treatments available to manage symptoms and slow the progression of the disease.\nStudies have shown that EPO may have neuroprotective effects and may help to slow the progression of ALS. One study published in the journal Neurology found that patients with ALS who received EPO treatment had a slower rate of decline in lung function compared to those who did not receive EPO. Another study published in the journal PLoS One found that EPO treatment improved muscle strength and function in mice with ALS.\nHowever, more research is needed to fully understand the potential benefits of EPO as a treatment for ALS. While some studies have shown promising results, others have been inconclusive or have found no significant benefits. Additionally, EPO can have side effects, including high blood pressure and fluid retention, so it is important to carefully monitor patients who receive this treatment.\nIn summary, while EPO shows promise as a potential treatment for ALS, more research is needed to fully understand its effectiveness and potential risks. If you are considering EPO as a treatment for ALS, it is important to discuss the potential benefits and risks with your healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Erythropoietin (EPO) is a hormone used primarily to treat anemia.\n2. Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder that affects nerve cells in the brain and spinal cord.\n3. There is no cure for ALS, but treatments are available to manage symptoms and slow disease progression.\n4. One study in the journal Neurology suggested that EPO treatment may slow the rate of decline in lung function in ALS patients.\n5. Another study in the journal PLoS One found that EPO treatment improved muscle strength and function in mice with ALS.",
    "yulan-chat-2-13b-fp16_fact": [
      "Erythropoietin (EPO) is a hormone used primarily to treat anemia.",
      "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder that affects nerve cells in the brain and spinal cord.",
      "There is no cure for ALS, but treatments are available to manage symptoms and slow disease progression.",
      "One study in the journal Neurology suggested that EPO treatment may slow the rate of decline in lung function in ALS patients.",
      "Another study in the journal PLoS One found that EPO treatment improved muscle strength and function in mice with ALS."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN (Without the specific details of the study or the ability to validate the claim, the statement's accuracy cannot be ascertained.)\n5. UNKNOWN (Similar to the statement above, the accuracy of the results from the study mentioned cannot be verified without further information.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2795,
    "user_query": "Is chlorotoxin a peptide?",
    "yulan-chat-2-13b-fp16_response": "Yes, chlorotoxin is a peptide. It is a 33-amino acid peptide that is found in the venom of the scorpion Androctonus australis, also known as the desert scorpion. Chlorotoxin has been studied for its potential medical applications, including as a pain reliever and as a treatment for cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chlorotoxin is a peptide.\n2. Chlorotoxin consists of 33 amino acids.\n3. Chlorotoxin is found in the venom of the scorpion Androctonus australis.\n4. The scorpion Androctonus australis is also known as the desert scorpion.\n5. Chlorotoxin has potential medical applications, such as pain relief and cancer treatment.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chlorotoxin is a peptide.",
      "Chlorotoxin consists of 33 amino acids.",
      "Chlorotoxin is found in the venom of the scorpion Androctonus australis.",
      "The scorpion Androctonus australis is also known as the desert scorpion.",
      "Chlorotoxin has potential medical applications, such as pain relief and cancer treatment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Chlorotoxin consists of 36 amino acids.\n3. FALSE [correction]: Chlorotoxin is found in the venom of the scorpion Leiurus quinquestriatus, not Androctonus australis.\n4. FALSE [correction]: The scorpion Androctonus australis is commonly known as the fat-tailed scorpion.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2797,
    "user_query": "Is selenocysteine an aminoacid?",
    "yulan-chat-2-13b-fp16_response": "Yes, selenocysteine is an amino acid. It is a non-essential amino acid, meaning that the human body can synthesize it from other compounds. Selenocysteine contains selenium, a trace element, in place of sulfur in the amino acid cysteine. It is important for the proper functioning of several enzymes, including those involved in the metabolism of thyroid hormones.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Selenocysteine is an amino acid.\n2. Selenocysteine is considered a non-essential amino acid.\n3. The human body can synthesize selenocysteine from other compounds.\n4. Selenocysteine contains selenium in place of sulfur.\n5. Selenocysteine is important for the proper functioning of several enzymes, including those involved in the metabolism of thyroid hormones.",
    "yulan-chat-2-13b-fp16_fact": [
      "Selenocysteine is an amino acid.",
      "Selenocysteine is considered a non-essential amino acid.",
      "The human body can synthesize selenocysteine from other compounds.",
      "Selenocysteine contains selenium in place of sulfur.",
      "Selenocysteine is important for the proper functioning of several enzymes, including those involved in the metabolism of thyroid hormones."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Selenocysteine is considered a conditionally essential amino acid because it is synthesized by the human body but also requires dietary selenium intake for its synthesis.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2812,
    "user_query": "Which is the basis of the ATAC-Seq protocol?",
    "yulan-chat-2-13b-fp16_response": "The ATAC-Seq protocol is based on the principle of sequencing the transcriptome of a cell or tissue. It is a technique used to analyze the active regions of chromatin, which are the regions where genes are actively transcribed. The protocol involves isolating the active regions of chromatin using a chemical treatment, followed by sequencing the DNA fragments that are obtained. This allows researchers to identify the specific genes that are being actively transcribed in a particular cell or tissue, and to study the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ATAC-Seq protocol is used to analyze the active regions of chromatin.\n2. The technique focuses on regions where genes are actively transcribed.\n3. ATAC-Seq involves isolating active regions of chromatin using a chemical treatment.\n4. The DNA fragments obtained from this chemical treatment are then sequenced.\n5. The protocol helps in identifying specific genes being transcribed in a particular cell or tissue.",
    "yulan-chat-2-13b-fp16_fact": [
      "ATAC-Seq protocol is used to analyze the active regions of chromatin.",
      "The technique focuses on regions where genes are actively transcribed.",
      "ATAC-Seq involves isolating active regions of chromatin using a chemical treatment.",
      "The DNA fragments obtained from this chemical treatment are then sequenced.",
      "The protocol helps in identifying specific genes being transcribed in a particular cell or tissue."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: ATAC-Seq involves isolating open (accessible) regions of chromatin using an enzyme, not a chemical treatment. The enzyme is transposase, which cuts and tags these regions.\n4. TRUE\n5. FALSE [correction]: The protocol helps in identifying accessible (open) chromatin regions, not specifically the genes being transcribed. It gives insight into regulatory regions that might be active in gene expression, but it does not directly identify specific genes being transcribed.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2813,
    "user_query": "What is vcfanno?",
    "yulan-chat-2-13b-fp16_response": "vCardFormatter is a Java library for parsing and generating vCard files. It allows you to read the contents of a vCard file and modify its fields, then write the modified contents back to a new vCard file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is useful for working with vCard files in Java applications. It can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is a Java library that can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is a Java library that can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is a Java library that can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is a Java library that can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is a Java library that can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is a Java library that can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is a Java library that can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCardFormatter is a Java library that can be used to read and modify the contents of a vCard file, then write the modified contents to a new file. It can also be used to generate a vCard file from scratch.\nvCard",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2816,
    "user_query": "What are the \"Ohnologs\"?",
    "yulan-chat-2-13b-fp16_response": "Ohnologs are a type of protein that is found in both prokaryotes (organisms without a nucleus) and eukaryotes (organisms with a nucleus). They are thought to be the result of a process called gene duplication, in which a gene is copied and then evolves to perform a new function. Ohnologs are similar in sequence to each other, but they may have different functions in different organisms. They are called \"ohnologs\" because they are thought to be the ancestral forms of proteins that have been conserved throughout the history of life on Earth.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2818,
    "user_query": "Describe OligoSTORM",
    "yulan-chat-2-13b-fp16_response": "OligoSTORM is a single-stranded DNA-binding protein that is commonly used in molecular biology research. It is a member of the storm family of proteins, which are characterized by their ability to bind to single-stranded DNA with high affinity and specificity.\nOligoSTORM is typically used in combination with other proteins, such as the Oligo dT20-28 primer, to facilitate the binding of RNA to a solid support surface for hybridization-based assays, such as northern blotting or RNA sequencing. It is also used in the construction of DNA libraries, such as the Sanger DNA library, and in the purification of single-stranded DNA.\nOverall, OligoSTORM is a valuable tool in molecular biology research, as it allows for the efficient binding and manipulation of single-stranded DNA, which is essential for many experiments in the field.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2825,
    "user_query": "What forms part of the senescence associated secretory phenotype, or SASP?",
    "yulan-chat-2-13b-fp16_response": "The senescence associated secretory phenotype (SASP) is a characteristic feature of senescent cells, which are cells that have undergone cellular senescence in response to various types of stress or damage. Senescent cells secrete a variety of factors, including cytokines, chemokines, growth factors, and extracellular matrix components, which can have both local and systemic effects on neighboring cells and tissues.\nSome of the key components of the SASP include:\n1. Cytokines and chemokines: Senescent cells secrete a variety of pro-inflammatory cytokines and chemokines, such as IL-6, TNF-, and CXCL8, which can promote inflammation and recruit immune cells to the site of injury or infection.\n2. Growth factors: Senescent cells also secrete various growth factors, such as TGF- and FGF, which can stimulate the proliferation and survival of neighboring cells.\n3. Extracellular matrix components: Senescent cells can secrete matrix components such as fibronectin, collagen, and elastin, which can alter the extracellular matrix and contribute to tissue stiffening.\n4. Reactive oxygen species: Senescent cells can generate reactive oxygen species (ROS), which can damage nearby cells and contribute to chronic inflammation.\n5. Apoptosis-inducing factors: Senescent cells can also secrete factors that promote apoptosis (programmed cell death) in neighboring cells, which can contribute to tissue turnover and repair.\nOverall, the SASP can have both beneficial and harmful effects on tissue homeostasis and repair, and is an area of active research in the field of aging and age-related diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Senescent cells secrete cytokines and chemokines including IL-6, TNF-, and CXCL8 as part of the SASP.\n2. SASP involves the secretion of growth factors such as TGF- and FGF by senescent cells.\n3. Senescent cells contribute to the extracellular matrix components by secreting fibronectin, collagen, and elastin.\n4. Reactive oxygen species are generated by senescent cells as an element of SASP.\n5. Senescent cells can secrete apoptosis-inducing factors which are part of the SASP.",
    "yulan-chat-2-13b-fp16_fact": [
      "Senescent cells secrete cytokines and chemokines including IL-6, TNF-, and CXCL8 as part of the SASP.",
      "SASP involves the secretion of growth factors such as TGF- and FGF by senescent cells.",
      "Senescent cells contribute to the extracellular matrix components by secreting fibronectin, collagen, and elastin.",
      "Reactive oxygen species are generated by senescent cells as an element of SASP.",
      "Senescent cells can secrete apoptosis-inducing factors which are part of the SASP."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nSenescent cells are known to secrete a variety of factors as part of the senescence-associated secretory phenotype (SASP), and these include pro-inflammatory cytokines such as IL-6 and TNF-, chemokines such as CXCL8, growth factors like TGF- and FGF, extracellular matrix components such as fibronectin, collagen, and elastin, as well as reactive oxygen species (ROS). These secretions can have different effects on the tissue environment and can induce a variety of biological responses including apoptosis in nearby cells.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2826,
    "user_query": "How many pseudogenes are contained in the C. elegans genome?",
    "yulan-chat-2-13b-fp16_response": "There are approximately 30,000 pseudogenes in the C. elegans genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The C. elegans genome contains approximately 30,000 pseudogenes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The C. elegans genome contains approximately 30,000 pseudogenes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The C. elegans genome is not known to contain approximately 30,000 pseudogenes. The number of pseudogenes in C. elegans is actually much lower; a frequently cited study reports around 176 pseudogenes.",
    "yulan-chat-2-13b-fp16_judge": [
      "false"
    ]
  },
  {
    "id": 2827,
    "user_query": "What is a Aquaporin channel?",
    "yulan-chat-2-13b-fp16_response": "Aquaporin channels are membrane proteins that facilitate the transport of water molecules across biological membranes. They are found in a variety of organisms, including bacteria, plants, and animals.\nAquaporin channels are composed of six transmembrane domains and form a pore that allows water molecules to pass through the membrane. The channels are selective for water and play important roles in maintaining the balance of water in cells and tissues.\nIn humans, aquaporin channels are found in various tissues, including the kidneys, lungs, and sweat glands. They are involved in the regulation of fluid balance, and dysfunction of these channels has been linked to various diseases, such as diabetes insipidus and nephrogenic diabetes insipidus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aquaporin channels are membrane proteins that facilitate the transport of water molecules across biological membranes.\n2. These channels are found in organisms such as bacteria, plants, and animals.\n3. Aquaporin channels consist of six transmembrane domains and provide a pore specifically for water molecules.\n4. In humans, aquaporin channels are located in tissues including the kidneys, lungs, and sweat glands.\n5. Dysfunction in aquaporin channels is associated with diseases like diabetes insipidus and nephrogenic diabetes insipidus.",
    "yulan-chat-2-13b-fp16_fact": [
      "Aquaporin channels are membrane proteins that facilitate the transport of water molecules across biological membranes.",
      "These channels are found in organisms such as bacteria, plants, and animals.",
      "Aquaporin channels consist of six transmembrane domains and provide a pore specifically for water molecules.",
      "In humans, aquaporin channels are located in tissues including the kidneys, lungs, and sweat glands.",
      "Dysfunction in aquaporin channels is associated with diseases like diabetes insipidus and nephrogenic diabetes insipidus."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Aquaporin channels consist of typically six transmembrane alpha-helices, but a complete aquaporin channel has two half-channels that each act like a mirror image, resulting in a structure with a total of twelve transmembrane domains.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2832,
    "user_query": "Is durvalumab used for lung cancer treatment?",
    "yulan-chat-2-13b-fp16_response": "Durvalumab is a monoclonal antibody that is used to treat certain types of lung cancer. It is approved for the treatment of non-small cell lung cancer (NSCLC) in combination with chemotherapy and as a single agent for the treatment of NSCLC after chemotherapy and radiation therapy. Durvalumab works by blocking a protein called PD-L1, which helps to enhance the immune system's ability to recognize and attack cancer cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Durvalumab is a monoclonal antibody used to treat certain types of lung cancer.\n2. It is approved for the treatment of non-small cell lung cancer (NSCLC).\n3. Durvalumab can be used in combination with chemotherapy for NSCLC treatment.\n4. Durvalumab is also used as a single agent for NSCLC treatment after chemotherapy and radiation therapy.\n5. Durvalumab works by blocking a protein called PD-L1, aiding in the enhancement of the immune system's ability to attack cancer cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Durvalumab is a monoclonal antibody used to treat certain types of lung cancer.",
      "It is approved for the treatment of non-small cell lung cancer (NSCLC).",
      "Durvalumab can be used in combination with chemotherapy for NSCLC treatment.",
      "Durvalumab is also used as a single agent for NSCLC treatment after chemotherapy and radiation therapy.",
      "Durvalumab works by blocking a protein called PD-L1, aiding in the enhancement of the immune system's ability to attack cancer cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2836,
    "user_query": "Describe information obtained by immunophenotyping.",
    "yulan-chat-2-13b-fp16_response": "Immunophenotyping is a laboratory technique used to identify and characterize the surface antigens expressed on the surface of cells. This technique is commonly used in the field of immunology to identify and classify different types of cells, particularly in the context of cancer research.\nThe information obtained by immunophenotyping includes:\n1. Cell surface antigen expression: Immunophenotyping can identify the specific antigens expressed on the surface of cells, which can help to classify cells into different groups based on their surface antigen expression patterns.\n2. Cell type identification: Immunophenotyping can be used to identify the cell type of a particular sample, which can be useful in diagnosing various diseases.\n3. Disease diagnosis: Immunophenotyping can be used to diagnose various diseases, including cancer, by identifying specific surface antigens that are expressed on cancer cells but not on normal cells.\n4. Monitoring disease progression: Immunophenotyping can be used to monitor the progression of a disease over time by comparing the expression of surface antigens between different samples.\n5. Assessing treatment response: Immunophenotyping can be used to assess the response of cancer cells to treatment by measuring changes in surface antigen expression.\nOverall, immunophenotyping is a valuable tool in the field of immunology and can provide important information about the surface antigen expression patterns of cells, which can be used for diagnosis, monitoring, and treatment of various diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Immunophenotyping is used to identify and characterize surface antigens on cells.\n2. The technique is commonly used in cancer research to classify different types of cells.\n3. Immunophenotyping aids in cell type identification for diagnosing various diseases.\n4. It can be employed to monitor the progression of diseases by analyzing changes in surface antigen expression.\n5. Immunophenotyping is used to assess how cancer cells respond to treatment by observing alterations in their surface antigen expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Immunophenotyping is used to identify and characterize surface antigens on cells.",
      "The technique is commonly used in cancer research to classify different types of cells.",
      "Immunophenotyping aids in cell type identification for diagnosing various diseases.",
      "It can be employed to monitor the progression of diseases by analyzing changes in surface antigen expression.",
      "Immunophenotyping is used to assess how cancer cells respond to treatment by observing alterations in their surface antigen expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2837,
    "user_query": "What is the mechanism of action of Emicizumab?",
    "yulan-chat-2-13b-fp16_response": "Emicizumab is a monoclonal antibody that works by binding to the activated factor X (Xa) protein on the surface of blood-clotting cells, preventing the Xa protein from interacting with its target, the substrate. This inhibits the formation of new blood clots and helps to dissolve existing ones. By binding to the Xa protein, emicizumab also prevents the Xa protein from binding to and inhibiting the activity of antithrombin, an endogenous blood-clotting protein that helps to break down blood clots. This allows antithrombin to more effectively break down blood clots, further reducing the risk of thrombosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Emicizumab is a monoclonal antibody.\n2. Emicizumab binds to the activated factor X (Xa) protein.\n3. The binding of emicizumab to Xa protein inhibits the formation of new blood clots.\n4. Emicizumab's action helps to dissolve existing blood clots.\n5. Emicizumab prevents the Xa protein from binding to and inhibiting the activity of antithrombin.",
    "yulan-chat-2-13b-fp16_fact": [
      "Emicizumab is a monoclonal antibody.",
      "Emicizumab binds to the activated factor X (Xa) protein.",
      "The binding of emicizumab to Xa protein inhibits the formation of new blood clots.",
      "Emicizumab's action helps to dissolve existing blood clots.",
      "Emicizumab prevents the Xa protein from binding to and inhibiting the activity of antithrombin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Emicizumab binds to factors IXa and X, bringing them into close proximity, which facilitates the activation of factor X and mimics the function of missing activated factor VIII in hemophilia A patients, but it does not bind directly to the activated factor X (Xa) protein.\n3. FALSE [correction]: Emicizumab does not inhibit the formation of new blood clots but rather acts as a bridge between factors IXa and X to restore the function of missing activated factor VIII in hemophilia A patients, which is required for effective blood clotting.\n4. FALSE [correction]: Emicizumab does not dissolve existing blood clots; it's used as a prophylactic treatment to prevent bleeding episodes in hemophilia A patients by substituting for the deficient factor VIII.\n5. FALSE [correction]: Emicizumab does not prevent the Xa protein from binding to antithrombin nor does it inhibit the activity of antithrombin; rather, it brings together factors IXa and X to facilitate effective blood clotting in patients with hemophilia A. Antithrombin is a protein that inhibits thrombosis, and its activity is not the target of emicizumab's action.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2841,
    "user_query": "What is the function of GFRAL?",
    "yulan-chat-2-13b-fp16_response": "GFRAL (Glomerular Filtration Rate, Albumin, and Lactate dehydrogenase) is a blood test that measures the levels of creatinine, blood urea nitrogen (BUN), albumin, and lactate dehydrogenase (LDH) in the blood.\nThe primary function of GFRAL is to estimate the glomerular filtration rate (GFR), which is the rate at which the kidneys filter waste products from the blood. GFRAL is often used to diagnose and monitor kidney disease, as well as to assess the effectiveness of kidney replacement therapy.\nThe test results are used to calculate the estimated GFR (eGFR) by using a formula that takes into account the patient's age, gender, race, and serum creatinine level. The eGFR is then compared to the patient's measured GFR to determine if there is any discrepancy, which may indicate underlying kidney disease or other conditions that affect kidney function.\nIn addition to estimating GFR, GFRAL can also provide information about the levels of albumin and LDH in the blood. High levels of albumin in the blood may indicate kidney damage or other conditions such as diabetes, while high levels of LDH may indicate muscle damage or other conditions such as liver disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GFRAL is a blood test that measures levels of creatinine, blood urea nitrogen (BUN), albumin, and lactate dehydrogenase (LDH) in the blood.\n2. The primary function of GFRAL is to estimate the glomerular filtration rate (GFR).\n3. GFRAL is used to diagnose and monitor kidney disease, and assess the effectiveness of kidney replacement therapy.\n4. The test results of GFRAL are used to calculate the estimated GFR (eGFR) using a formula that includes patient's age, gender, race, and serum creatinine level.\n5. High levels of albumin in the blood may indicate kidney damage or conditions such as diabetes.",
    "yulan-chat-2-13b-fp16_fact": [
      "GFRAL is a blood test that measures levels of creatinine, blood urea nitrogen (BUN), albumin, and lactate dehydrogenase (LDH) in the blood.",
      "The primary function of GFRAL is to estimate the glomerular filtration rate (GFR).",
      "GFRAL is used to diagnose and monitor kidney disease, and assess the effectiveness of kidney replacement therapy.",
      "The test results of GFRAL are used to calculate the estimated GFR (eGFR) using a formula that includes patient's age, gender, race, and serum creatinine level.",
      "High levels of albumin in the blood may indicate kidney damage or conditions such as diabetes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: GFRAL is not a blood test; rather, GFR stands for \"glomerular filtration rate,\" and GFR tests often measure levels of creatinine in the blood to estimate kidney function.\n2. TRUE: GFRAL does not exist; however, the primary function of GFR testing is to estimate the glomerular filtration rate (GFR).\n3. FALSE [correction]: Since GFRAL is not an actual test, it is not used to diagnose and monitor kidney disease. GFR, not GFRAL, testing is used for these purposes.\n4. TRUE: Although GFRAL is not a test, when calculating estimated GFR (eGFR) for kidney function, a formula that includes a patient's age, gender, race, and serum creatinine level is indeed used.\n5. TRUE: High levels of albumin in the blood, known as albuminuria, may be an indicator of kidney damage or disease, and it is a concern in conditions such as diabetes.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "yulan-chat-2-13b-fp16_response": "Zinc finger CCHC-type containing 17 (ZCCHC17) is a protein that in humans is encoded by the \"ZCCHC17\" gene. The exact role of ZCCHC17 is not well understood, as it has not been extensively studied. However, based on its sequence and domain analysis, it is thought to be involved in some aspect of gene regulation or chromatin organization.\nZCCHC17 belongs to the zinc finger superfamily of proteins, which are characterized by a conserved zinc ion binding to a nucleic acid molecule. Zinc fingers are important for the recognition and binding of DNA, and many zinc finger proteins play key roles in transcriptional regulation, DNA repair, and other processes related to gene expression.\nThe CCHC domain, which is present in ZCCHC17, is a conserved protein domain that is found in a variety of proteins involved in DNA binding and repair. It is thought to be involved in recognizing and binding to DNA, although the exact mechanism of DNA binding is not well understood.\nOverall, while the exact role of ZCCHC17 is not known, it is likely to be involved in some aspect of gene regulation or chromatin organization, and may play a role in maintaining the integrity of the genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ZCCHC17 is a protein in humans encoded by the \"ZCCHC17\" gene.\n2. The exact role of ZCCHC17 has not been extensively studied.\n3. The protein is thought to be involved in some aspect of gene regulation or chromatin organization based on its sequence and domain analysis.\n4. ZCCHC17 belongs to the zinc finger superfamily of proteins, which are involved in the recognition and binding of DNA.\n5. The CCHC domain present in ZCCHC17 is a conserved protein domain found in proteins involved in DNA binding and repair.",
    "yulan-chat-2-13b-fp16_fact": [
      "ZCCHC17 is a protein in humans encoded by the \"ZCCHC17\" gene.",
      "The exact role of ZCCHC17 has not been extensively studied.",
      "The protein is thought to be involved in some aspect of gene regulation or chromatin organization based on its sequence and domain analysis.",
      "ZCCHC17 belongs to the zinc finger superfamily of proteins, which are involved in the recognition and binding of DNA.",
      "The CCHC domain present in ZCCHC17 is a conserved protein domain found in proteins involved in DNA binding and repair."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: The CCHC domain present in ZCCHC17 is a conserved protein domain found in proteins that typically bind RNA, not DNA.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 2844,
    "user_query": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?",
    "yulan-chat-2-13b-fp16_response": "There is no evidence to suggest that epidural anesthesia for pain management during labor has a significant impact on the Apgar score of the infant. The Apgar score is a measure of the newborn's condition at birth, and it is typically evaluated at one minute and five minutes after birth. Factors such as the mother's age, weight, and medical history, as well as the duration of labor and the use of other medications or interventions, can all affect the Apgar score. However, studies have shown that epidural anesthesia for pain management during labor does not have a significant impact on the Apgar score. In fact, epidural anesthesia is often considered a safe and effective option for managing pain during labor, and it can help to reduce the need for other medications or interventions that may have a greater impact on the infant's health.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Epidural anesthesia for pain management during labor does not have a significant impact on the Apgar score of the infant.\n2. The Apgar score is a measure of a newborn's condition at birth.\n3. The Apgar score is typically evaluated at one minute and five minutes after birth.\n4. Factors that can affect the Apgar score include the mother's age, weight, and medical history, as well as the duration of labor and the use of other medications or interventions.\n5. Epidural anesthesia is considered a safe and effective option for managing pain during labor.",
    "yulan-chat-2-13b-fp16_fact": [
      "Epidural anesthesia for pain management during labor does not have a significant impact on the Apgar score of the infant.",
      "The Apgar score is a measure of a newborn's condition at birth.",
      "The Apgar score is typically evaluated at one minute and five minutes after birth.",
      "Factors that can affect the Apgar score include the mother's age, weight, and medical history, as well as the duration of labor and the use of other medications or interventions.",
      "Epidural anesthesia is considered a safe and effective option for managing pain during labor."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Epidural anesthesia is generally considered not to have a significant impact on the Apgar score of the infant. While there may be some controversy, evidence suggests that when appropriately managed, epidurals do not adversely affect the Apgar score.\n2. TRUE: The Apgar score is indeed a measure of a newborn's condition at birth, assessing their physical condition and helping to determine whether immediate medical care is necessary.\n3. TRUE: The Apgar score is typically evaluated at one minute and five minutes after birth to assess the newborn's health status immediately and after some time has passed.\n4. TRUE: Factors that can affect the Apgar score include the health and condition of the mother and baby, the presence of any complications, the type of delivery, and medical interventions during labor.\n5. TRUE: Epidural anesthesia is widely considered to be a safe and effective option for pain management during labor and is commonly used in many parts of the world. However, like all medical interventions, there can be risks and side effects.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2846,
    "user_query": "Is phospholipid hydroperoxide glutathione peroxidase a selenoprotein?",
    "yulan-chat-2-13b-fp16_response": "Yes, phospholipid hydroperoxide glutathione peroxidase (GPx) is a selenoprotein. Selenoproteins are proteins that contain selenium, a trace element that is essential for the proper functioning of many biological processes. GPx is an enzyme that plays a role in protecting cells from oxidative damage by catalyzing the reduction of hydroperoxides to hydroxides. It is found in many tissues and organs in the body, including the liver, lung, and brain. The selenium atom in GPx is essential for its activity, and mutations in the gene that encodes this enzyme can lead to a deficiency in GPx activity and an increased risk of oxidative stress-related diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phospholipid hydroperoxide glutathione peroxidase (GPx) is a selenoprotein.\n2. Selenoproteins contain the trace element selenium.\n3. The enzyme GPx plays a role in protecting cells from oxidative damage.\n4. GPx is found in many tissues and organs in the body, including the liver, lung, and brain.\n5. The selenium atom is essential for the activity of GPx.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phospholipid hydroperoxide glutathione peroxidase (GPx) is a selenoprotein.",
      "Selenoproteins contain the trace element selenium.",
      "The enzyme GPx plays a role in protecting cells from oxidative damage.",
      "GPx is found in many tissues and organs in the body, including the liver, lung, and brain.",
      "The selenium atom is essential for the activity of GPx."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2851,
    "user_query": "Is TIAM1 favoring tumor progression in colorectal cancer (CRC)?",
    "yulan-chat-2-13b-fp16_response": "TIAM1 (T cell-independent activating molecule 1) is a protein that has been implicated in various types of cancer, including colorectal cancer (CRC). Some studies have suggested that TIAM1 may favor tumor progression in CRC, while others have found conflicting results.\nOne study published in the journal Cancer Research in 2013 found that TIAM1 was overexpressed in CRC tissues compared to normal colon tissues, and that it promoted the growth and invasion of CRC cells in vitro. The study also found that TIAM1 interacted with the transcription factor STAT3, which is known to be involved in cancer progression, and that this interaction was necessary for TIAM1 to promote CRC cell growth and invasion.\nHowever, another study published in the journal Oncogene in 2017 found that TIAM1 was downregulated in CRC tissues compared to normal colon tissues, and that it inhibited the growth and migration of CRC cells in vitro. This study also found that TIAM1 interacted with the transcription factor TGF-beta, which is known to play a role in tumor suppression, and that this interaction was necessary for TIAM1 to inhibit CRC cell growth and migration.\nOverall, the evidence is mixed regarding the role of TIAM1 in CRC progression, and more research is needed to fully understand its effects in this context.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TIAM1 (T cell-independent activating molecule 1) is a protein implicated in various types of cancer, including colorectal cancer (CRC).\n2. A study published in Cancer Research in 2013 reported TIAM1 overexpression in CRC tissues compared to normal colon tissues.\n3. The same 2013 study indicated that TIAM1 promoted growth and invasion of CRC cells in vitro and interacted with the transcription factor STAT3.\n4. A study in the journal Oncogene in 2017 found that TIAM1 was downregulated in CRC tissues as compared to normal colon tissues.\n5. The 2017 study reported that TIAM1 inhibited the growth and migration of CRC cells in vitro and interacted with the transcription factor TGF-beta.",
    "yulan-chat-2-13b-fp16_fact": [
      "TIAM1 (T cell-independent activating molecule 1) is a protein implicated in various types of cancer, including colorectal cancer (CRC).",
      "A study published in Cancer Research in 2013 reported TIAM1 overexpression in CRC tissues compared to normal colon tissues.",
      "The same 2013 study indicated that TIAM1 promoted growth and invasion of CRC cells in vitro and interacted with the transcription factor STAT3.",
      "A study in the journal Oncogene in 2017 found that TIAM1 was downregulated in CRC tissues as compared to normal colon tissues.",
      "The 2017 study reported that TIAM1 inhibited the growth and migration of CRC cells in vitro and interacted with the transcription factor TGF-beta."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: It's inconsistent that TIAM1 would be both overexpressed and downregulated in CRC tissues as compared to normal colon tissues based on the earlier statement. However, without access to the specific studies, an accurate correction cannot be provided. Usually, either overexpression or downregulation would be observed, not both.\n5. FALSE [correction]: Based on the previous correction, this statement is likely false if it contradicts the findings of the 2013 study regarding the role of TIAM1. However, it is also possible that TIAM1 has varying effects under different conditions or that there are nuances to these research findings that are not captured in these simplified statements. Full access to the 2017 study would be required for accurate correction.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2854,
    "user_query": "Is pacritinib effective for treatment of myelofibrosis?",
    "yulan-chat-2-13b-fp16_response": "Pacritinib is an experimental drug that is being studied for the treatment of myelofibrosis. It works by blocking certain proteins that are involved in the growth and spread of cancer cells. Some early studies have shown that pacritinib may be effective in treating myelofibrosis, but more research is needed to confirm its effectiveness and to determine the best dosage and treatment schedule. Pacritinib is still in the testing phase and is not yet approved for use by regulatory agencies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pacritinib is an experimental drug being studied for the treatment of myelofibrosis.\n2. Pacritinib works by blocking certain proteins involved in the growth and spread of cancer cells.\n3. Early studies suggest that pacritinib may be effective in treating myelofibrosis.\n4. Further research is required to confirm the effectiveness of pacritinib and determine the appropriate dosage and treatment schedule.\n5. Pacritinib has not been approved for use by regulatory agencies as of the knowledge cutoff date.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pacritinib is an experimental drug being studied for the treatment of myelofibrosis.",
      "Pacritinib works by blocking certain proteins involved in the growth and spread of cancer cells.",
      "Early studies suggest that pacritinib may be effective in treating myelofibrosis.",
      "Further research is required to confirm the effectiveness of pacritinib and determine the appropriate dosage and treatment schedule.",
      "Pacritinib has not been approved for use by regulatory agencies as of the knowledge cutoff date."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nNote: While the above responses are true based on the context and usual developments in experimental drugs at the time of the knowledge cutoff in 2023, the status of pacritinib's approval by regulatory agencies could change rapidly as new data emerges and regulatory decisions are made. Always refer to the latest sources for the most current information on drug approvals.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "yulan-chat-2-13b-fp16_response": "The nuclear pore basket in human cells is composed of proteins known as nucleoporins. There are more than 50 different nucleoporins, which can be classified into three main groups based on their location and function:\n1. The nucleoporins that form the scaffold of the nuclear pore basket, which includes the proteins Nup1, Nup2, Nup3, Nup4, Nup5, Nup6, Nup98, and Nup153.\n2. The nucleoporins that form the selective filter, which is the narrow passage through which nucleic acids and other large molecules can enter or leave the nucleus. These include the proteins Nup96, Nup145, Nup157, Nup214, and Nup315.\n3. The nucleoporins that form the inner and outer rings of the nuclear pore basket, which help to anchor the basket to the nuclear envelope. These include the proteins POM121, POM122, POM123, and POM124.\nTogether, these nucleoporins form a complex and dynamic structure that regulates the flow of molecules between the nucleus and the cytoplasm.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The nuclear pore basket in human cells is composed of nucleoporins.\n2. There are more than 50 different nucleoporins categorized into three groups.\n3. Nucleoporins such as Nup1, Nup2, Nup3, Nup4, Nup5, Nup6, Nup98, and Nup153 form the scaffold of the nuclear pore basket.\n4. Nucleoporins like Nup96, Nup145, Nup157, Nup214, and Nup315 form the selective filter of the nuclear pore basket.\n5. Proteins POM121, POM122, POM123, and POM124 are nucleoporins that form the inner and outer rings of the nuclear pore basket.",
    "yulan-chat-2-13b-fp16_fact": [
      "The nuclear pore basket in human cells is composed of nucleoporins.",
      "There are more than 50 different nucleoporins categorized into three groups.",
      "Nucleoporins such as Nup1, Nup2, Nup3, Nup4, Nup5, Nup6, Nup98, and Nup153 form the scaffold of the nuclear pore basket.",
      "Nucleoporins like Nup96, Nup145, Nup157, Nup214, and Nup315 form the selective filter of the nuclear pore basket.",
      "Proteins POM121, POM122, POM123, and POM124 are nucleoporins that form the inner and outer rings of the nuclear pore basket."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN [Although there are indeed more than 30 nucleoporins, the exact categorization into three groups and the statement \"more than 50\" cannot be verified without specific reference to a scientific source that supports this categorization.]\n3. FALSE [correction]: While Nup1, Nup2, Nup98, and Nup153 are examples of nucleoporins, not all of them are necessarily part of the scaffold of the nuclear pore basket. Also, Nup3, Nup4, Nup5, and Nup6 are not universally recognized as nucleoporins. The scaffold typically includes members of the Nup107-160 complex (not the ones listed in this statement).]\n4. UNKNOWN [Without specific scientific literature to confirm the roles of the listed nucleoporins in forming the selective filter, their exact functions cannot be verified.]\n5. FALSE [correction]: POM121 is a known nucleoporin that indeed contributes to the nuclear pore complex structure, however, POM122, POM123, and POM124 are not recognized as standard nucleoporins. Also, calling them specifically as the formers of the inner and outer rings is inaccurate without specifying their assembly into known complexes or substructures such as the nuclear pore complex (NPC) scaffold or anchors in the pore membrane system.]",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2862,
    "user_query": "Does lucatumumab bind to CD140?",
    "yulan-chat-2-13b-fp16_response": "Yes, lucatumumab is a monoclonal antibody that binds to CD140, also known as the p53 receptor or the tumor necrosis factor receptor superfamily member 10 (TNFRSF10). CD140 is a transmembrane protein that plays a role in regulating cell survival, apoptosis, and inflammation. Lucatumumab is a therapeutic antibody that is being developed for the treatment of various cancers, including ovarian cancer, lung cancer, and gastric cancer. It works by blocking the binding of CD140 to its ligand, which can lead to the inhibition of tumor growth and the induction of apoptosis in cancer cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lucatumumab is a monoclonal antibody that binds to CD140.\n2. CD140 is also known as the p53 receptor or the tumor necrosis factor receptor superfamily member 10 (TNFRSF10).\n3. CD140 is a transmembrane protein involved in regulating cell survival, apoptosis, and inflammation.\n4. Lucatumumab is being developed for the treatment of various cancers, including ovarian cancer, lung cancer, and gastric cancer.\n5. Lucatumumab works by blocking the binding of CD140 to its ligand, leading to potential inhibition of tumor growth and induction of apoptosis in cancer cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lucatumumab is a monoclonal antibody that binds to CD140.",
      "CD140 is also known as the p53 receptor or the tumor necrosis factor receptor superfamily member 10 (TNFRSF10).",
      "CD140 is a transmembrane protein involved in regulating cell survival, apoptosis, and inflammation.",
      "Lucatumumab is being developed for the treatment of various cancers, including ovarian cancer, lung cancer, and gastric cancer.",
      "Lucatumumab works by blocking the binding of CD140 to its ligand, leading to potential inhibition of tumor growth and induction of apoptosis in cancer cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Lucatumumab is a monoclonal antibody that binds to CD40, not CD140.\n2. FALSE [correction]: CD140 is actually known as the Platelet-derived growth factor receptor (PDGFR), not the p53 receptor or TNFRSF10 which corresponds to other proteins.\n3. TRUE (assuming the statement refers to CD140 as PDGFR, which fits the description provided)\n4. TRUE (assuming the clinical development of Lucatumumab targets various cancers as stated)\n5. FALSE [correction]: Lucatumumab works by binding to CD40, not CD140, which could potentially lead to the inhibition of tumor growth and induction of apoptosis in cancer cells.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2872,
    "user_query": "Which molecule is targeted by Olaratumab?",
    "yulan-chat-2-13b-fp16_response": "Olaratumab is a monoclonal antibody that targets the human tumor necrosis factor superfamily member 15 (TNFSF15), also known as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). TRAIL is a cytokine that plays a role in regulating cell death and inflammation. Olaratumab is being developed as a potential treatment for various types of cancer, including solid tumors and blood cancers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Olaratumab is a monoclonal antibody.\n2. Olaratumab targets the human tumor necrosis factor superfamily member 15 (TNFSF15).\n3. TNFSF15 is also known as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).\n4. TRAIL is a cytokine involved in regulating cell death and inflammation.\n5. Olaratumab is being developed as a potential treatment for various types of cancer, including solid tumors and blood cancers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Olaratumab is a monoclonal antibody.",
      "Olaratumab targets the human tumor necrosis factor superfamily member 15 (TNFSF15).",
      "TNFSF15 is also known as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).",
      "TRAIL is a cytokine involved in regulating cell death and inflammation.",
      "Olaratumab is being developed as a potential treatment for various types of cancer, including solid tumors and blood cancers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Olaratumab targets platelet-derived growth factor receptor alpha (PDGFR), not TNFSF15.\n3. FALSE [correction]: TNFSF15 is also known as Vascular Endothelial Growth Inhibitor (VEGI), not tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2874,
    "user_query": "Are phagosomal proteins ubiquitinated?",
    "yulan-chat-2-13b-fp16_response": "Phagosomal proteins can be ubiquitinated, but it depends on the specific protein and the cellular context. Ubiquitination is a post-translational modification in which a ubiquitin protein is covalently attached to a lysine residue on a target protein, typically leading to protein degradation by the proteasome or lysosome.\nIn the context of phagocytosis, some phagosomal proteins may be ubiquitinated as part of the degradation process. For example, after engulfment of pathogens or damaged cells, phagosomes are often fused with lysosomes to form phagolysosomes, where the contents of the phagosome are degraded by lysosomal enzymes. Some of these proteins may be ubiquitinated as part of the degradation process.\nHowever, not all phagosomal proteins are ubiquitinated. Some may be degraded through other mechanisms, such as autophagy or chaperone-mediated autophagy. Additionally, the fate of a protein within a phagosome may depend on factors such as the cell type, the nature of the engulfed material, and the signaling pathways activated during phagocytosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phagosomal proteins can be ubiquitinated depending on the specific protein and the cellular context.\n2. Ubiquitination is a post-translational modification where a ubiquitin protein is attached to a lysine residue on a target protein.\n3. Ubiquitination typically leads to protein degradation by the proteasome or lysosome.\n4. Phagosomes can fuse with lysosomes to form phagolysosomes where contents are degraded by lysosomal enzymes.\n5. The fate of a protein within a phagosome can depend on factors such as cell type, nature of the engulfed material, and activated signaling pathways during phagocytosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phagosomal proteins can be ubiquitinated depending on the specific protein and the cellular context.",
      "Ubiquitination is a post-translational modification where a ubiquitin protein is attached to a lysine residue on a target protein.",
      "Ubiquitination typically leads to protein degradation by the proteasome or lysosome.",
      "Phagosomes can fuse with lysosomes to form phagolysosomes where contents are degraded by lysosomal enzymes.",
      "The fate of a protein within a phagosome can depend on factors such as cell type, nature of the engulfed material, and activated signaling pathways during phagocytosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2876,
    "user_query": "Does tremelimumab improve survival of mesothelioma patients?",
    "yulan-chat-2-13b-fp16_response": "Tremelimumab is an immune checkpoint inhibitor drug that has been studied in the treatment of mesothelioma, a type of cancer that affects the lining of the lungs, abdomen, or heart.\nThere have been several clinical trials evaluating the use of tremelimumab in mesothelioma patients, but the results have been mixed. Some studies have shown a modest improvement in survival, while others have not found any benefit.\nFor example, a phase 2 clinical trial published in the Journal of Clinical Oncology in 2017 evaluated the use of tremelimumab in combination with the chemotherapy drug pemetrexed in patients with advanced mesothelioma. The study found that the combination treatment resulted in a median overall survival of 14.3 months, which was significantly longer than the 9.1 months observed with pemetrexed alone.\nHowever, a phase 3 clinical trial published in the same journal in 2020 evaluated the same combination treatment in a larger group of patients and found no significant improvement in overall survival compared to the chemotherapy drug alone.\nOverall, while some studies have suggested that tremelimumab may improve survival in mesothelioma patients, the results have been inconsistent and more research is needed to fully understand its potential benefits and risks in this population.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tremelimumab is an immune checkpoint inhibitor drug used in the study of mesothelioma treatment.\n2. Mesothelioma is a type of cancer that affects the lining of the lungs, abdomen, or heart.\n3. A phase 2 clinical trial published in the Journal of Clinical Oncology in 2017 found that the combination of tremelimumab and pemetrexed resulted in a median overall survival of 14.3 months.\n4. The median overall survival with pemetrexed alone was observed to be 9.1 months in the above-mentioned trial.\n5. A phase 3 clinical trial published in the Journal of Clinical Oncology in 2020 found no significant improvement in overall survival when using tremelimumab in combination with pemetrexed compared to pemetrexed alone.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tremelimumab is an immune checkpoint inhibitor drug used in the study of mesothelioma treatment.",
      "Mesothelioma is a type of cancer that affects the lining of the lungs, abdomen, or heart.",
      "A phase 2 clinical trial published in the Journal of Clinical Oncology in 2017 found that the combination of tremelimumab and pemetrexed resulted in a median overall survival of 14.3 months.",
      "The median overall survival with pemetrexed alone was observed to be 9.1 months in the above-mentioned trial.",
      "A phase 3 clinical trial published in the Journal of Clinical Oncology in 2020 found no significant improvement in overall survival when using tremelimumab in combination with pemetrexed compared to pemetrexed alone."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN (The specific results of the trial as stated without providing the title or authors of the study, these details are difficult to verify.)\n4. UNKNOWN (Similar to statement 3, without further details, these results are also difficult to verify.)\n5. UNKNOWN (Without access to the specific article or study results, the outcomes of the phase 3 clinical trial cannot be confirmed.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2878,
    "user_query": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?",
    "yulan-chat-2-13b-fp16_response": "The TAM (Tyrosine-protein kinase Atemo) family of receptor tyrosine kinases (RTKs) includes the following membrane proteins:\n1. Tyrosine-protein kinase Atemo (also known as Atemo or TAM)\n2. Tyrosine-protein kinase Mertk (also known as Mertk or TAM-like kinase)\n3. Tyrosine-protein kinase Ret (also known as GDNF receptor alpha)\nThese receptors play important roles in various biological processes, including cell survival, differentiation, and migration. They are involved in the signaling pathways of several growth factors and neurotrophic factors, including GDNF (Glial cell line-derived neurotrophic factor), VEGF (Vascular endothelial growth factor), and EGF (Epidermal growth factor).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The TAM family of receptor tyrosine kinases includes Tyrosine-protein kinase Atemo.\n2. Tyrosine-protein kinase Mertk is a member of the TAM family of receptor tyrosine kinases.\n3. Tyrosine-protein kinase Ret is also part of the TAM family of receptor tyrosine kinases.\n4. TAM family receptors are involved in cell survival, differentiation, and migration.\n5. TAM receptors are involved in the signaling pathways of growth factors such as GDNF, VEGF, and EGF.",
    "yulan-chat-2-13b-fp16_fact": [
      "The TAM family of receptor tyrosine kinases includes Tyrosine-protein kinase Atemo.",
      "Tyrosine-protein kinase Mertk is a member of the TAM family of receptor tyrosine kinases.",
      "Tyrosine-protein kinase Ret is also part of the TAM family of receptor tyrosine kinases.",
      "TAM family receptors are involved in cell survival, differentiation, and migration.",
      "TAM receptors are involved in the signaling pathways of growth factors such as GDNF, VEGF, and EGF."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The TAM family of receptor tyrosine kinases includes Tyro3, Axl, and Mer, but not Tyrosine-protein kinase Atemo.\n2. TRUE\n3. FALSE [correction]: Tyrosine-protein kinase Ret is not part of the TAM family of receptor tyrosine kinases. It is a member of a different family of receptor tyrosine kinases.\n4. TRUE\n5. FALSE [correction]: TAM receptors are mainly involved with the signaling pathways of growth factors such as Gas6 and protein S, not typically GDNF, VEGF, and EGF.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2880,
    "user_query": "What is CPX351?",
    "yulan-chat-2-13b-fp16_response": "CPX351 is an experimental drug being developed for the treatment of certain types of cancer, specifically acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN). It works by inhibiting an enzyme called IDH1, which is involved in the production of energy in cells. This enzyme is often overactive in cancer cells, and by inhibiting its activity, CPX351 may help to slow or stop the growth of cancer cells. CPX351 is still in the early stages of development and has not yet been approved for use by regulatory authorities. It is being tested in clinical trials to assess its safety and effectiveness as a cancer treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CPX351 is developed for the treatment of certain types of cancer, including acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN).\n2. CPX351 works by inhibiting an enzyme called IDH1.\n3. The IDH1 enzyme is involved in the production of energy in cells.\n4. CPX351 has not yet been approved for use by regulatory authorities.\n5. CPX351 is being tested in clinical trials to determine its safety and effectiveness as a cancer treatment.",
    "yulan-chat-2-13b-fp16_fact": [
      "CPX351 is developed for the treatment of certain types of cancer, including acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN).",
      "CPX351 works by inhibiting an enzyme called IDH1.",
      "The IDH1 enzyme is involved in the production of energy in cells.",
      "CPX351 has not yet been approved for use by regulatory authorities.",
      "CPX351 is being tested in clinical trials to determine its safety and effectiveness as a cancer treatment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: CPX351 is a liposomal formulation of cytarabine and daunorubicin. It does not work by inhibiting the IDH1 enzyme; instead, it works by intercalating into DNA and inhibiting the topoisomerase II enzyme, leading to a decrease in DNA replication and repair, and an increase in DNA damage.\n3. TRUE \n4. FALSE [correction]: CPX351 has been approved for use by regulatory authorities. In the United States, for instance, it was approved by the FDA in 2017 for the treatment of adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2881,
    "user_query": "Is collagen the most abundant human protein?",
    "yulan-chat-2-13b-fp16_response": "Collagen is not the most abundant human protein. The most abundant human protein is hemoglobin, which is a protein found in red blood cells that is responsible for carrying oxygen from the lungs to the body's tissues. Collagen is a fibrous protein that is found in the connective tissues, such as skin, bones, and cartilage, and it is an important component of these tissues, but it is not the most abundant protein in the body.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hemoglobin is the most abundant human protein.\n2. Hemoglobin is responsible for carrying oxygen from the lungs to the body's tissues.\n3. Collagen is found in connective tissues such as skin, bones, and cartilage.\n4. Collagen is an important component of connective tissues.\n5. Collagen is not the most abundant protein in the human body.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hemoglobin is the most abundant human protein.",
      "Hemoglobin is responsible for carrying oxygen from the lungs to the body's tissues.",
      "Collagen is found in connective tissues such as skin, bones, and cartilage.",
      "Collagen is an important component of connective tissues.",
      "Collagen is not the most abundant protein in the human body."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Hemoglobin is not the most abundant human protein; albumin is the most abundant protein in the blood, and collagen is the most abundant protein in the human body as a whole.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Collagen is the most abundant protein in the human body.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2886,
    "user_query": "What is the role of the Leucosporidium ice-binding protein",
    "yulan-chat-2-13b-fp16_response": "Leucosporidium is a genus of fungi that is known to produce ice-binding proteins (IBPs). The exact role of these proteins in the biology of the fungus is not well understood, but it is thought that they may play a role in the fungus' ability to survive and grow in cold environments.\nIBPs are a class of proteins that are found in a variety of organisms, including bacteria, plants, and animals. These proteins are able to bind to ice crystals and prevent them from sticking to each other, which can help to inhibit the formation of ice dams and other ice-related damage.\nIt is possible that the IBPs produced by Leucosporidium may play a similar role in the fungus' ability to survive in cold environments. However, more research is needed to fully understand the function of these proteins in the biology of the fungus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Leucosporidium is a genus of fungi known to produce ice-binding proteins (IBPs).\n2. Ice-binding proteins are found in a variety of organisms, including bacteria, plants, and animals.\n3. Ice-binding proteins can bind to ice crystals and prevent them from sticking to each other.\n4. The role of ice-binding proteins in Leucosporidium is thought to be related to the fungus' ability to survive in cold environments.",
    "yulan-chat-2-13b-fp16_fact": [
      "Leucosporidium is a genus of fungi known to produce ice-binding proteins (IBPs).",
      "Ice-binding proteins are found in a variety of organisms, including bacteria, plants, and animals.",
      "Ice-binding proteins can bind to ice crystals and prevent them from sticking to each other.",
      "The role of ice-binding proteins in Leucosporidium is thought to be related to the fungus' ability to survive in cold environments."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ice-binding proteins can bind to ice crystals and inhibit their growth or recrystallization rather than preventing them from sticking to each other.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2892,
    "user_query": "Name 3 diseases for which lucatumumab is being tested?",
    "yulan-chat-2-13b-fp16_response": "Lucatumumab is a monoclonal antibody that is being developed for the treatment of various diseases. According to clinicaltrials.gov, it is currently being tested for the following three diseases:\n1. Neutropenia: Lucatumumab is being studied for the treatment of neutropenia, a condition in which there are abnormally low levels of neutrophils (a type of white blood cell) in the blood. It is being tested in a Phase 2 clinical trial for the treatment of neutropenia in patients with hematological malignancies (blood cancers).\n2. Acute Respiratory Distress Syndrome (ARDS): Lucatumumab is also being studied for the treatment of ARDS, a life-threatening condition in which the lungs become severely inflamed and fill with fluid. It is being tested in a Phase 2 clinical trial for the treatment of ARDS in patients with severe COVID-19.\n3. Sepsis: Lucatumumab is being studied for the treatment of sepsis, a life-threatening condition that can occur when the body's response to an infection becomes uncontrolled and causes damage to multiple organs. It is being tested in a Phase 2 clinical trial for the treatment of sepsis in patients with COVID-19.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lucatumumab is a monoclonal antibody that is being developed for the treatment of various diseases.\n2. Lucatumumab is being tested in a Phase 2 clinical trial for the treatment of neutropenia in patients with hematological malignancies.\n3. Lucatumumab is being tested in a Phase 2 clinical trial for the treatment of Acute Respiratory Distress Syndrome (ARDS) in patients with severe COVID-19.\n4. Lucatumumab is being tested in a Phase 2 clinical trial for the treatment of sepsis in patients with COVID-19.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lucatumumab is a monoclonal antibody that is being developed for the treatment of various diseases.",
      "Lucatumumab is being tested in a Phase 2 clinical trial for the treatment of neutropenia in patients with hematological malignancies.",
      "Lucatumumab is being tested in a Phase 2 clinical trial for the treatment of Acute Respiratory Distress Syndrome (ARDS) in patients with severe COVID-19.",
      "Lucatumumab is being tested in a Phase 2 clinical trial for the treatment of sepsis in patients with COVID-19."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout additional context on the current research and development status of Lucatumumab, it is difficult to confirm statements 2 through 4, which are very specific. The development of drugs and their clinical trial phases can vary over time, and without up-to-date information, one cannot determine the veracity of these statements.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2893,
    "user_query": "Which transcription factor binding site is contained in Alu repeats?",
    "yulan-chat-2-13b-fp16_response": "Alu repeats are non-coding DNA sequences that are present in the genome of many organisms, including humans. They are known to play a role in the regulation of gene expression, and they are often found in the promoter regions of genes. Alu repeats are characterized by a specific DNA sequence that is recognized by a transcription factor called Alu-binding protein (ABP). ABP is a member of the helix-loop-helix (HLH) family of transcription factors, which are involved in the regulation of gene expression. ABP binds to Alu repeats in the promoter regions of genes and can activate or repress transcription, depending on the specific context.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alu repeats are non-coding DNA sequences present in the genome of many organisms, including humans.\n2. Alu repeats play a role in the regulation of gene expression.\n3. Alu repeats are often found in the promoter regions of genes.\n4. Alu-binding protein (ABP) recognizes and binds to the specific DNA sequence of Alu repeats.\n5. Alu-binding protein (ABP) is a member of the helix-loop-helix family of transcription factors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alu repeats are non-coding DNA sequences present in the genome of many organisms, including humans.",
      "Alu repeats play a role in the regulation of gene expression.",
      "Alu repeats are often found in the promoter regions of genes.",
      "Alu-binding protein (ABP) recognizes and binds to the specific DNA sequence of Alu repeats.",
      "Alu-binding protein (ABP) is a member of the helix-loop-helix family of transcription factors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Alu repeats are typically not found in the promoter regions of genes; they are most often found in introns and intergenic regions.\n4. FALSE [correction]: There is no well-characterized Alu-binding protein (ABP) that specifically recognizes and binds to Alu repeats. Instead, various proteins may interact with Alu sequences in different contexts.\n5. FALSE [correction]: Since the Alu-binding protein (ABP) is not a well-defined entity, it cannot be classified as a member of the helix-loop-helix family of transcription factors.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2894,
    "user_query": "What is ferroptosis?",
    "yulan-chat-2-13b-fp16_response": "Ferroptosis is a type of cell death that is characterized by the accumulation of iron in the cell and the subsequent formation of reactive oxygen species (ROS), which leads to lipid peroxidation and cell lysis. It is a form of regulated cell death that is mediated by the iron-dependent catalytic activity of the enzyme ferritin, which is a protein that stores iron in the cell. Ferroptosis plays a role in various biological processes, including the removal of damaged cells and the regulation of iron homeostasis. It has also been implicated in various diseases, including neurodegenerative disorders and cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ferroptosis is a type of cell death characterized by the accumulation of iron in the cell and the formation of reactive oxygen species (ROS).\n2. The process of ferroptosis leads to lipid peroxidation and cell lysis.\n3. Ferroptosis is mediated by the iron-dependent catalytic activity of the enzyme ferritin.\n4. Ferritin is a protein that stores iron in the cell.\n5. Ferroptosis has been implicated in various diseases, including neurodegenerative disorders and cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ferroptosis is a type of cell death characterized by the accumulation of iron in the cell and the formation of reactive oxygen species (ROS).",
      "The process of ferroptosis leads to lipid peroxidation and cell lysis.",
      "Ferroptosis is mediated by the iron-dependent catalytic activity of the enzyme ferritin.",
      "Ferritin is a protein that stores iron in the cell.",
      "Ferroptosis has been implicated in various diseases, including neurodegenerative disorders and cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ferroptosis is mediated by the iron-dependent catalytic activity of enzymes such as lipoxygenases, not ferritin.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2896,
    "user_query": "Name 4 side effects of enasidenib",
    "yulan-chat-2-13b-fp16_response": "Enasidenib is a drug used to treat certain types of cancer, and like all medications, it can cause side effects. Some of the most common side effects of enasidenib include:\n1. Nausea: Feeling sick to your stomach or vomiting.\n2. Fatigue: Feeling tired or weak.\n3. Diarrhea: Loose or watery stools.\n4. Constipation: Difficulty having a bowel movement or hard stools.\nOther possible side effects of enasidenib include headache, fever, cough, and changes in liver function tests. It's important to talk to your doctor if you experience any side effects while taking this medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Enasidenib is used to treat certain types of cancer.\n2. Common side effects of enasidenib include nausea.\n3. Fatigue is a common side effect of enasidenib.\n4. Diarrhea is a common side effect of enasidenib.\n5. Constipation is a common side effect of enasidenib.",
    "yulan-chat-2-13b-fp16_fact": [
      "Enasidenib is used to treat certain types of cancer.",
      "Common side effects of enasidenib include nausea.",
      "Fatigue is a common side effect of enasidenib.",
      "Diarrhea is a common side effect of enasidenib.",
      "Constipation is a common side effect of enasidenib."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEnasidenib is a medication used to treat certain types of cancer, specifically acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation. Common side effects of enasidenib do include nausea, fatigue, diarrhea, and constipation, among others.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2903,
    "user_query": "Should dacomitinib be used for treatment of glioblastoma patients?",
    "yulan-chat-2-13b-fp16_response": "Dacomitinib is a drug that is being studied for the treatment of glioblastoma, a type of brain cancer. It works by blocking certain proteins that are involved in the growth and spread of cancer cells.\nThere is currently limited information available about the use of dacomitinib for the treatment of glioblastoma. It is still being studied in clinical trials, and more research is needed to determine its effectiveness and safety in this population.\nIt is important to note that the decision to use a particular treatment for glioblastoma is typically made by a healthcare provider based on a number of factors, including the specific characteristics of the tumor, the patient's overall health, and their preferences. Your healthcare provider can provide more information about the potential benefits and risks of dacomitinib and help you make an informed decision about your treatment options.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dacomitinib is being studied for the treatment of glioblastoma, a type of brain cancer.\n2. Dacomitinib works by blocking proteins involved in cancer cell growth and spread.\n3. The use of dacomitinib for treating glioblastoma is still under examination in clinical trials.\n4. There is currently limited information available regarding dacomitinib's effectiveness and safety for glioblastoma patients.\n5. Healthcare providers consider factors like tumor characteristics and patient health when deciding on glioblastoma treatments.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dacomitinib is being studied for the treatment of glioblastoma, a type of brain cancer.",
      "Dacomitinib works by blocking proteins involved in cancer cell growth and spread.",
      "The use of dacomitinib for treating glioblastoma is still under examination in clinical trials.",
      "There is currently limited information available regarding dacomitinib's effectiveness and safety for glioblastoma patients.",
      "Healthcare providers consider factors like tumor characteristics and patient health when deciding on glioblastoma treatments."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nBased on the context provided and general knowledge, these statements about dacomitinib are consistent with what one might expect from a drug being examined for the treatment of brain cancer. It is true that healthcare providers consider various factors including tumor characteristics and patient health when deciding on treatments for diseases such as glioblastoma. Additionally, the mention that information might be limited due to ongoing examination in clinical trials is plausible for many drugs in development.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2906,
    "user_query": "What is the function of Plasminogen activator inhibitor 1?",
    "yulan-chat-2-13b-fp16_response": "Plasminogen activator inhibitor-1 (PAI-1) is a protein that inhibits the activity of plasminogen activators, which are enzymes that break down fibrin, a protein that forms the basis of blood clots. PAI-1 is produced by various cells, including endothelial cells, smooth muscle cells, and macrophages, and is involved in the regulation of blood clot formation and maintenance.\nThe main function of PAI-1 is to maintain the integrity of the blood clot by inhibiting the activity of plasminogen activators, which would otherwise dissolve the clot. PAI-1 also plays a role in the regulation of cell adhesion and migration, and has been implicated in the development and progression of various diseases, including thrombosis, cancer, and atherosclerosis.\nIn addition to its role in blood clot formation and maintenance, PAI-1 has also been shown to play a role in the regulation of tissue remodeling and wound healing. PAI-1 is produced by various cells in the extracellular matrix and is involved in the regulation of cell migration and proliferation during tissue repair and regeneration.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Plasminogen activator inhibitor-1 (PAI-1) inhibits the activity of plasminogen activators.\n2. Plasminogen activators are enzymes that break down fibrin, a protein that forms the basis of blood clots.\n3. PAI-1 is produced by cells such as endothelial cells, smooth muscle cells, and macrophages.\n4. The main function of PAI-1 is to maintain the integrity of blood clots by inhibiting the activity of plasminogen activators.\n5. PAI-1 has been implicated in the development and progression of various diseases, including thrombosis, cancer, and atherosclerosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Plasminogen activator inhibitor-1 (PAI-1) inhibits the activity of plasminogen activators.",
      "Plasminogen activators are enzymes that break down fibrin, a protein that forms the basis of blood clots.",
      "PAI-1 is produced by cells such as endothelial cells, smooth muscle cells, and macrophages.",
      "The main function of PAI-1 is to maintain the integrity of blood clots by inhibiting the activity of plasminogen activators.",
      "PAI-1 has been implicated in the development and progression of various diseases, including thrombosis, cancer, and atherosclerosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The main function of PAI-1 is to regulate fibrinolysis by inhibiting the activity of plasminogen activators, which prevents the excessive breakdown of blood clots, rather than maintaining the integrity of existing clots.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2913,
    "user_query": "Endolymphatic hydrops is associated with Menieres disease. Please provide a summary of endoymphatic hydrops including the symptoms and affected body part.",
    "yulan-chat-2-13b-fp16_response": "Endolymphatic hydrops is a condition that occurs when there is an accumulation of fluid in the inner ear, specifically in the cochlea. The cochlea is responsible for converting sound waves into electrical signals that are sent to the brain.\nSymptoms of endolymphatic hydrops include episodes of vertigo, which is a spinning sensation that can last for several hours or even days. Other symptoms may include tinnitus, hearing loss, and a feeling of fullness or pressure in the affected ear.\nEndolymphatic hydrops is a complication of Menieres disease, which is a disorder of the inner ear that can cause vertigo, tinnitus, and hearing loss. In Menieres disease, the fluid in the inner ear becomes excessive, leading to endolymphatic hydrops.\nTreatment for endolymphatic hydrops typically involves controlling the symptoms through medications, such as diuretics, antihistamines, and anti-nausea drugs. In severe cases, surgery may be necessary to relieve the pressure in the inner ear.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Endolymphatic hydrops occurs when there is an accumulation of fluid in the inner ear, specifically in the cochlea.\n2. Symptoms of endolymphatic hydrops include vertigo, tinnitus, hearing loss, and a feeling of fullness or pressure in the ear.\n3. The condition is a complication of Meniere's disease, a disorder of the inner ear.\n4. In Meniere's disease, the fluid in the inner ear becomes excessive.\n5. Treatment for endolymphatic hydrops can involve medications like diuretics, antihistamines, and anti-nausea drugs, and in severe cases, surgery may be needed.",
    "yulan-chat-2-13b-fp16_fact": [
      "Endolymphatic hydrops occurs when there is an accumulation of fluid in the inner ear, specifically in the cochlea.",
      "Symptoms of endolymphatic hydrops include vertigo, tinnitus, hearing loss, and a feeling of fullness or pressure in the ear.",
      "The condition is a complication of Meniere's disease, a disorder of the inner ear.",
      "In Meniere's disease, the fluid in the inner ear becomes excessive.",
      "Treatment for endolymphatic hydrops can involve medications like diuretics, antihistamines, and anti-nausea drugs, and in severe cases, surgery may be needed."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Endolymphatic hydrops is the accumulation of fluid in the inner ear, but specifically in the endolymphatic sac, not the cochlea.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2916,
    "user_query": "Is there any role for HUWE1 in MYC signalling?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is a role for HUWE1 in MYC signaling. HUWE1 (Heterogeneity Unfolding by factors Homolog E1) is a protein that plays a role in regulating the expression of genes involved in various cellular processes, including cell growth and differentiation.\nMYC is a transcription factor that plays a key role in regulating cell growth and proliferation. It is known to regulate the expression of a large number of target genes, many of which are involved in cell growth and division.\nStudies have shown that HUWE1 can interact with MYC and regulate its activity. Specifically, HUWE1 can act as a co-repressor of MYC, binding to MYC and blocking its ability to activate target genes. This interaction is thought to play a role in regulating cell growth and preventing uncontrolled proliferation.\nOverall, the interaction between HUWE1 and MYC is an important mechanism for regulating cell growth and proliferation, and dysregulation of this interaction has been implicated in various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. HUWE1 is a protein that regulates the expression of genes involved in cell growth and differentiation.\n2. MYC is a transcription factor that is critical in regulating cell growth and proliferation.\n3. MYC regulates the expression of numerous genes related to cell growth and division.\n4. HUWE1 can interact with MYC and regulate its activity.\n5. Dysregulation of the interaction between HUWE1 and MYC has been implicated in various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "HUWE1 is a protein that regulates the expression of genes involved in cell growth and differentiation.",
      "MYC is a transcription factor that is critical in regulating cell growth and proliferation.",
      "MYC regulates the expression of numerous genes related to cell growth and division.",
      "HUWE1 can interact with MYC and regulate its activity.",
      "Dysregulation of the interaction between HUWE1 and MYC has been implicated in various diseases, including cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "yulan-chat-2-13b-fp16_response": "Gepotidacin is a topoisomerase I inhibitor. Topoisomerase I inhibitors are a class of drugs that target an enzyme called topoisomerase I, which is involved in the regulation of DNA replication and transcription. These drugs work by binding to the topoisomerase I enzyme and preventing it from relieving the tension in the DNA strand, leading to DNA damage and cell death. Gepotidacin is currently being developed as a potential treatment for various types of cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gepotidacin is a topoisomerase I inhibitor.\n2. Topoisomerase I inhibitors target the enzyme topoisomerase I.\n3. The function of topoisomerase I is involved in the regulation of DNA replication and transcription.\n4. Topoisomerase I inhibitors prevent the enzyme from relieving tension in the DNA strand.\n5. Gepotidacin is being developed as a potential treatment for various types of cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gepotidacin is a topoisomerase I inhibitor.",
      "Topoisomerase I inhibitors target the enzyme topoisomerase I.",
      "The function of topoisomerase I is involved in the regulation of DNA replication and transcription.",
      "Topoisomerase I inhibitors prevent the enzyme from relieving tension in the DNA strand.",
      "Gepotidacin is being developed as a potential treatment for various types of cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Gepotidacin is a topoisomerase II inhibitor, specifically targeting bacterial type II topoisomerases (DNA gyrase and Topo IV), not topoisomerase I.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Gepotidacin is being developed as a potential treatment for bacterial infections, not for various types of cancer.\n",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2941,
    "user_query": "Which disease is PGT121 used for?",
    "yulan-chat-2-13b-fp16_response": "PGT121 is an investigational gene therapy being developed for the treatment of genetic disorders, including lysosomal storage disorders such as Niemann-Pick Type C disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PGT121 is an investigational gene therapy.\n2. PGT121 is being developed for the treatment of genetic disorders.\n3. Lysosomal storage disorders, including Niemann-Pick Type C disease, are among the genetic disorders PGT121 is intended to treat.",
    "yulan-chat-2-13b-fp16_fact": [
      "PGT121 is an investigational gene therapy.",
      "PGT121 is being developed for the treatment of genetic disorders.",
      "Lysosomal storage disorders, including Niemann-Pick Type C disease, are among the genetic disorders PGT121 is intended to treat."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "yulan-chat-2-13b-fp16_response": "Canvas SPW, also known as Canvas Student Performance Widget, is a web-based platform designed to provide real-time student performance data to educators. It is a tool that allows teachers to monitor student progress and engagement during online or blended learning environments.\nCanvas SPW provides a range of features that enable educators to track student activity, including attendance, participation, and grades. It also offers insights into student behavior, such as time spent on assignments and interactions with course materials.\nOne of the key benefits of Canvas SPW is its ability to provide real-time data, allowing teachers to quickly identify and address any issues that may arise during the learning process. This can help to improve student outcomes and ensure that learners are staying on track with their coursework.\nIn addition to its core functionality, Canvas SPW also includes a range of customization options, allowing educators to tailor the platform to their specific needs and preferences. This can include setting up alerts and notifications for specific events, such as when a student submits an assignment or misses a class session.\nOverall, Canvas SPW is a powerful tool for educators looking to monitor and support student performance in online or blended learning environments. Its real-time data and customization options make it an effective solution for a wide range of educational settings.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Canvas SPW stands for Canvas Student Performance Widget.\n2. It is a web-based platform designed to provide real-time student performance data to educators.\n3. Canvas SPW allows educators to track student activity such as attendance, participation, and grades.\n4. The platform offers insights into student behavior like time spent on assignments and interactions with course materials.\n5. Canvas SPW includes customization options for educators to set up alerts and notifications for specific events.",
    "yulan-chat-2-13b-fp16_fact": [
      "Canvas SPW stands for Canvas Student Performance Widget.",
      "It is a web-based platform designed to provide real-time student performance data to educators.",
      "Canvas SPW allows educators to track student activity such as attendance, participation, and grades.",
      "The platform offers insights into student behavior like time spent on assignments and interactions with course materials.",
      "Canvas SPW includes customization options for educators to set up alerts and notifications for specific events."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nWithout specific information to the contrary, these statements about Canvas SPW (assuming SPW stands for Student Performance Widget) seem plausible. Canvas is a known web-based learning management system that provides various features to track and analyse student performance, and these statements align with the types of functionalities such platforms usually offer. If there are specific details about this platform that would contradict these statements, that information was not provided.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2950,
    "user_query": "Which algorithm has been developed for finding conserved non-coding elements (CNEs) in genomes?",
    "yulan-chat-2-13b-fp16_response": "There are several algorithms that have been developed for finding conserved non-coding elements (CNEs) in genomes. Some of the commonly used algorithms are:\n1. MEME Suite: It is a popular tool for discovering and analyzing protein and DNA sequence motifs. It can also be used to identify conserved non-coding elements in genomes.\n2. MotifFinder: It is another tool that can be used to identify conserved non-coding elements in genomes. It uses a variety of algorithms to detect motifs, including MEME and Gibbs sampling.\n3. CONSEAR: It is a tool that uses a combination of statistical and computational methods to identify conserved non-coding elements in genomes.\n4. NCBI BLAST: It is a tool that can be used to compare DNA or protein sequences against a database of known sequences. It can also be used to identify conserved non-coding elements in genomes.\n5. MEGABLAST: It is a tool that can be used to search for conserved non-coding elements in large DNA sequences. It uses a combination of statistical and computational methods to identify conserved elements.\nThese are some of the commonly used algorithms for identifying conserved non-coding elements in genomes. The choice of algorithm may depend on the specific research question and the characteristics of the genomic data being analyzed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The MEME Suite is used to discover and analyze protein and DNA sequence motifs and identify conserved non-coding elements in genomes.\n2. MotifFinder is a tool that detects motifs in genomes and can be used for identifying conserved non-coding elements.\n3. CONSEAR employs statistical and computational methods to detect conserved non-coding elements in genomes.\n4. NCBI BLAST can compare DNA or protein sequences against a known sequence database and identify conserved non-coding elements in genomes.\n5. MEGABLAST can search for conserved non-coding elements in large DNA sequences by using a combination of statistical and computational methods.",
    "yulan-chat-2-13b-fp16_fact": [
      "The MEME Suite is used to discover and analyze protein and DNA sequence motifs and identify conserved non-coding elements in genomes.",
      "MotifFinder is a tool that detects motifs in genomes and can be used for identifying conserved non-coding elements.",
      "CONSEAR employs statistical and computational methods to detect conserved non-coding elements in genomes.",
      "NCBI BLAST can compare DNA or protein sequences against a known sequence database and identify conserved non-coding elements in genomes.",
      "MEGABLAST can search for conserved non-coding elements in large DNA sequences by using a combination of statistical and computational methods."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN: While \"MotifFinder\" could be a name for a hypothetical tool that detects motifs in genomes, without more context it is unclear whether this tool exists within the MEME Suite or elsewhere and if it specifically identifies conserved non-coding elements.\n3. UNKNOWN: \"CONSEAR\" is not a well-known tool or acronym in bioinformatics as of my last knowledge update. Without additional context, it is impossible to verify the accuracy of this statement.\n4. FALSE [correction]: NCBI BLAST can compare DNA or protein sequences against a known sequence database but is primarily used to find regions of local similarity, not specifically to identify conserved non-coding elements in genomes.\n5. FALSE [correction]: MEGABLAST is a BLAST algorithm optimized for aligning sequences that are very similar and covering large DNA sequences. It is used mainly for comparing nucleotide sequences to sequence databases and is not specifically tuned to use a combination of statistical and computational methods to search for conserved non-coding elements.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2953,
    "user_query": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?",
    "yulan-chat-2-13b-fp16_response": "Ivosidenib is an experimental drug that is being studied for the treatment of acute myeloid leukemia (AML). It works by inhibiting the IDH1 enzyme, which is involved in the production of certain molecules that are important for the growth and survival of cancer cells.\nAs of my knowledge cutoff in September 2021, ivosidenib had not been approved by the US Food and Drug Administration (FDA) for the treatment of AML. However, it is being studied in clinical trials for this purpose, and if the results of these trials are promising, it may be approved for this use in the future.\nIt's important to note that experimental drugs like ivosidenib are not yet fully understood, and their safety and effectiveness have not been thoroughly evaluated by the FDA. As with any experimental drug, there may be significant risks and uncertainties associated with its use.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ivosidenib is an experimental drug being studied for the treatment of acute myeloid leukemia (AML).\n2. Ivosidenib works by inhibiting the IDH1 enzyme.\n3. As of September 2021, ivosidenib had not been approved by the US FDA for the treatment of AML.\n4. Ivosidenib is being studied in clinical trials for the treatment of AML.\n5. The safety and effectiveness of experimental drugs like ivosidenib have not been thoroughly evaluated by the FDA.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ivosidenib is an experimental drug being studied for the treatment of acute myeloid leukemia (AML).",
      "Ivosidenib works by inhibiting the IDH1 enzyme.",
      "As of September 2021, ivosidenib had not been approved by the US FDA for the treatment of AML.",
      "Ivosidenib is being studied in clinical trials for the treatment of AML.",
      "The safety and effectiveness of experimental drugs like ivosidenib have not been thoroughly evaluated by the FDA."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ivosidenib has been approved by the US FDA for the treatment of AML with a susceptible IDH1 mutation as of July 2018.\n4. TRUE\n5. FALSE [correction]: The safety and effectiveness of experimental drugs like ivosidenib are thoroughly evaluated by the FDA before they are approved for public use. However, if ivosidenib is still considered experimental for other indications or is in ongoing clinical trials, its safety and effectiveness for those uses may not be fully established yet.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "yulan-chat-2-13b-fp16_response": "STING (Stimulator of Interferon Genesis) is a cyclic dinucleotide (CDN) receptor that plays a key role in the innate immune response to certain types of microbial infections. STING agonists are molecules that activate the STING pathway, leading to the production of interferons and other cytokines that can help to control the infection.\nSome examples of STING agonists include:\n1. Cyclic di-GMP (cyclic di-guanosine monophosphate)\n2. 2'-O-methylcytidine (2'-OMC)\n3. 2'-O-methyl-alpha-thio-cytidine (2'-OMTCD)\n4. 2'-O-methyl-alpha-thio-guanosine (2'-OMTG)\n5. 2'-O-methyl-alpha-thio-adenosine (2'-OMA)\n6. 2'-O-methyl-alpha-thio-uridine (2'-OMTU)\n7. 2'-O-methyl-alpha-thio-cytidine-5'-monophosphate (2'-OMCMP)\n8. 2'-O-methyl-alpha-thio-cytidine-5'-diphosphate (2'-OMCDP)\n9. 2'-O-methyl-alpha-thio-guanosine-5'-monophosphate (2'-OMTGMP)\n10. 2'-O-methyl-alpha-thio-guanosine-5'-diphosphate (2'-OMTGDP)\nThese molecules are often used in research to study the role of the STING pathway in immune response and to develop new therapies for infectious diseases. However, it is important to note that some of these molecules may also have potential toxicity and caution should be exercised when using them.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. STING (Stimulator of Interferon Genesis) is a receptor involved in the innate immune response to microbial infections.\n2. STING agonists activate the STING pathway, leading to the production of interferons and other cytokines.\n3. Cyclic di-GMP is an example of a STING agonist.\n4. 2'-O-methylcytidine is an example of a STING agonist.\n5. STING agonists are used in research to study the immune response and to develop new therapies for infectious diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "STING (Stimulator of Interferon Genesis) is a receptor involved in the innate immune response to microbial infections.",
      "STING agonists activate the STING pathway, leading to the production of interferons and other cytokines.",
      "Cyclic di-GMP is an example of a STING agonist.",
      "2'-O-methylcytidine is an example of a STING agonist.",
      "STING agonists are used in research to study the immune response and to develop new therapies for infectious diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: 2'-O-methylcytidine is not a known STING agonist. cGAMP is an example of a STING agonist.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "yulan-chat-2-13b-fp16_response": "SLIC-CAGE is a method used in machine learning to select a subset of features from a larger set of input features. It stands for \"Selective Linearly Independent Criteria for Attribute Generalization and Extraction.\"\nThe method works by first transforming the original input features into a new set of features that are linearly related to the original features. These new features are then used to train a machine learning model. The method selects a subset of these new features that are most important for predicting the target variable.\nThe selection of the most important features is based on two criteria: selective linear independence and mutual information. The selective linear independence criterion ensures that the selected features are linearly independent of each other, which helps to avoid overfitting. The mutual information criterion measures the correlation between each feature and the target variable, which helps to select features that are most relevant for predicting the target variable.\nOverall, SLIC-CAGE is a useful method for feature selection in machine learning, as it helps to reduce the dimensionality of the input data while maintaining the accuracy of the model.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SLIC-CAGE is a method used in machine learning for feature selection.\n2. The acronym SLIC-CAGE stands for \"Selective Linearly Independent Criteria for Attribute Generalization and Extraction.\"\n3. SLIC-CAGE transforms the original input features into a new set of features that are linearly related to the original ones.\n4. The selection of important features in SLIC-CAGE is based on selective linear independence and mutual information criteria.\n5. The method aims to reduce the dimensionality of input data while maintaining model accuracy.",
    "yulan-chat-2-13b-fp16_fact": [
      "SLIC-CAGE is a method used in machine learning for feature selection.",
      "The acronym SLIC-CAGE stands for \"Selective Linearly Independent Criteria for Attribute Generalization and Extraction.\"",
      "SLIC-CAGE transforms the original input features into a new set of features that are linearly related to the original ones.",
      "The selection of important features in SLIC-CAGE is based on selective linear independence and mutual information criteria.",
      "The method aims to reduce the dimensionality of input data while maintaining model accuracy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nThe truth value of statements 1-4 cannot be determined as SLIC-CAGE is not a widely recognized acronym or method in machine learning for feature selection, at least up until my last knowledge update in 2023. Without more context or information, it is not possible to ascertain the accuracy of the specific technical details provided in statements 2-4. Statement 5, however, describes a common goal of feature selection methods in machine learning, which is to reduce the dimensionality of input data while maintaining or improving the model's accuracy, so it can be considered true as a general statement about feature selection methods.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2967,
    "user_query": "What is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "yulan-chat-2-13b-fp16_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene. BTK stands for Bruton's tyrosine kinase, which is an enzyme that plays a crucial role in the development and function of B cells, a type of white blood cell that produces antibodies. Mutations in the BTK gene can lead to a deficiency in B cells, which can increase the risk of infections and other complications. CVID is a primary immunodeficiency disorder that affects both children and adults and is characterized by a reduced number of B cells and an increased susceptibility to infections.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene.\n2. BTK stands for Bruton's tyrosine kinase.\n3. Bruton's tyrosine kinase is an enzyme crucial for the development and function of B cells.\n4. B cells are a type of white blood cell that produces antibodies.\n5. CVID is characterized by a reduced number of B cells and increased susceptibility to infections.",
    "yulan-chat-2-13b-fp16_fact": [
      "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene.",
      "BTK stands for Bruton's tyrosine kinase.",
      "Bruton's tyrosine kinase is an enzyme crucial for the development and function of B cells.",
      "B cells are a type of white blood cell that produces antibodies.",
      "CVID is characterized by a reduced number of B cells and increased susceptibility to infections."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The most common genetic defect in Europeans causing CVID is mutations in the ICOS, TNFRSF13B (TACI), or TNFRSF13C (BAFFR) genes, not in the BTK gene. Mutations in the BTK gene generally cause X-linked agammaglobulinemia.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: CVID is not typically characterized by a reduced number of B cells but rather by a defect in B-cell differentiation, leading to reduced production of immunoglobulins and an increased susceptibility to infections.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2968,
    "user_query": "List two indications of Letermovir?",
    "yulan-chat-2-13b-fp16_response": "Letermovir is a medication that is used to treat cytomegalovirus (CMV) infection in people who have weakened immune systems, such as those receiving chemotherapy or who have HIV. It is also being studied for the treatment of other viral infections.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Letermovir is used to treat cytomegalovirus (CMV) infection.\n2. Letermovir is used for individuals with weakened immune systems, such as those receiving chemotherapy or who have HIV.",
    "yulan-chat-2-13b-fp16_fact": [
      "Letermovir is used to treat cytomegalovirus (CMV) infection.",
      "Letermovir is used for individuals with weakened immune systems, such as those receiving chemotherapy or who have HIV."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2969,
    "user_query": "What is achalasia?",
    "yulan-chat-2-13b-fp16_response": "Achalasia is a rare genetic disorder that affects the nerves that control the muscles used for speaking, swallowing, and breathing. It is characterized by a lack of coordination and weakness in these muscles, which can lead to difficulty speaking, choking, and breathing problems. Achalasia can be life-threatening if not treated promptly. Treatment typically involves the use of medications and other supportive measures to help manage the symptoms of the disorder.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Achalasia is a disorder that affects the nerves controlling muscles used for speaking, swallowing, and breathing.\n2. Symptoms of achalasia include difficulty speaking, choking, and breathing problems.\n3. Without timely treatment, achalasia can be life-threatening.\n4. Treatment for achalasia usually involves medications and supportive measures to manage symptoms.",
    "yulan-chat-2-13b-fp16_fact": [
      "Achalasia is a disorder that affects the nerves controlling muscles used for speaking, swallowing, and breathing.",
      "Symptoms of achalasia include difficulty speaking, choking, and breathing problems.",
      "Without timely treatment, achalasia can be life-threatening.",
      "Treatment for achalasia usually involves medications and supportive measures to manage symptoms."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Achalasia is a disorder that primarily affects the esophagus, specifically the nerves controlling muscles used primarily for swallowing, not for speaking or breathing.\n2. FALSE [correction]: Symptoms of achalasia include difficulty swallowing, chest pain, and regurgitation of food or liquids, not difficulty speaking.\n3. TRUE\n4. FALSE [correction]: Treatment for achalasia often involves procedures to disrupt or relax the lower esophageal sphincter, such as pneumatic dilation, surgical myotomy, or peroral endoscopic myotomy (POEM). Medications may offer temporary relief, but they are not the primary treatment for achalasia.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2972,
    "user_query": "When is serum AFP used as marker?",
    "yulan-chat-2-13b-fp16_response": "Serum alpha-fetoprotein (AFP) is a protein produced by the liver and yolk sac in the developing fetus. It is also produced in small amounts by adults. Elevated levels of AFP in the blood can be a sign of certain types of liver disease, such as hepatocellular carcinoma (HCC), as well as other conditions such as germ cell tumors, and certain types of cancer.\nAFP is typically used as a marker to help diagnose and monitor liver cancer, particularly hepatocellular carcinoma (HCC). It is also sometimes used to monitor the response to treatment for HCC. In addition, AFP levels may be used to help differentiate between different types of liver disease, such as primary liver cancer and cirrhosis.\nAFP levels are usually measured in conjunction with other tests, such as liver function tests and imaging studies, to help diagnose and monitor liver disease. The normal range for AFP varies depending on the laboratory and the specific test used, but generally, levels below 20 IU/L are considered normal, and levels above 400 IU/L may indicate liver disease or cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Serum alpha-fetoprotein (AFP) is produced by the liver and yolk sac in the developing fetus and in small amounts by adults.\n2. Elevated levels of AFP in the blood can indicate certain types of liver disease, such as hepatocellular carcinoma (HCC).\n3. AFP is utilized as a marker to help diagnose and monitor liver cancer, particularly hepatocellular carcinoma.\n4. AFP levels may also be used in differentiating between different types of liver disease, such as primary liver cancer and cirrhosis.\n5. Normal AFP levels are usually below 20 IU/L, while levels above 400 IU/L may suggest liver disease or cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Serum alpha-fetoprotein (AFP) is produced by the liver and yolk sac in the developing fetus and in small amounts by adults.",
      "Elevated levels of AFP in the blood can indicate certain types of liver disease, such as hepatocellular carcinoma (HCC).",
      "AFP is utilized as a marker to help diagnose and monitor liver cancer, particularly hepatocellular carcinoma.",
      "AFP levels may also be used in differentiating between different types of liver disease, such as primary liver cancer and cirrhosis.",
      "Normal AFP levels are usually below 20 IU/L, while levels above 400 IU/L may suggest liver disease or cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with the term \"LEM-3.\" Could you provide more context or information about what you are referring to?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2981,
    "user_query": "What is the most common pediatric glioma?",
    "yulan-chat-2-13b-fp16_response": "The most common type of pediatric glioma is astrocytoma, which is a type of glioma that develops from astrocytes, a type of supportive cell in the brain. Astrocytoma is further classified into four grades, with grade I being the least aggressive and grade IV being the most aggressive. Other types of pediatric gliomas include ependymoma, oligodendrocytoma, and medulloblastoma.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Astrocytoma is the most common type of pediatric glioma.\n2. Astrocytomas develop from astrocytes, which are a type of supportive cell in the brain.\n3. Astrocytoma is classified into four grades, with grade I being the least aggressive and grade IV being the most aggressive.\n4. Ependymoma, oligodendrocytoma, and medulloblastoma are other types of pediatric gliomas.",
    "yulan-chat-2-13b-fp16_fact": [
      "Astrocytoma is the most common type of pediatric glioma.",
      "Astrocytomas develop from astrocytes, which are a type of supportive cell in the brain.",
      "Astrocytoma is classified into four grades, with grade I being the least aggressive and grade IV being the most aggressive.",
      "Ependymoma, oligodendrocytoma, and medulloblastoma are other types of pediatric gliomas."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2983,
    "user_query": "List uniparental disomy (UPD) detection algorithms",
    "yulan-chat-2-13b-fp16_response": "Uniparental disomy (UPD) is a genetic condition in which an individual has two copies of a single chromosome or part of a chromosome from one parent, and no copies from the other parent. There are several algorithms that can be used to detect UPD:\n1. Genotyping arrays: Genotyping arrays are a type of microarray that can be used to detect UPD by comparing the genotypes of an individual to a reference genome. These arrays can detect UPD by identifying segments of the genome that are not present in the reference genome.\n2. Single-nucleotide polymorphisms (SNPs): SNPs are variations in the DNA sequence at a single nucleotide position. By analyzing the genotypes of an individual at a set of SNPs, it is possible to detect UPD by identifying segments of the genome that are not present in the reference genome.\n3. Haplotype analysis: Haplotype analysis is a method for identifying the inherited pattern of nucleotide variation in a group of genes. By comparing the haplotypes of an individual to a reference genome, it is possible to detect UPD by identifying segments of the genome that are not present in the reference genome.\n4. Molecular cytogenetics: Molecular cytogenetics is a technique that uses molecular biology methods to analyze the structure and organization of chromosomes. By analyzing the DNA sequences of an individual's chromosomes, it is possible to detect UPD by identifying segments of the genome that are not present in the reference genome.\n5. Parental-specific probes: Parental-specific probes are DNA sequences that are specific to the parental chromosomes. By using parental-specific probes to analyze the DNA sequences of an individual's chromosomes, it is possible to detect UPD by identifying segments of the genome that are not present in the reference genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Genotyping arrays are a type of microarray used to detect uniparental disomy by comparing an individual's genotypes to a reference genome.\n2. Single-nucleotide polymorphisms (SNPs) can be utilized to detect UPD by identifying genome segments not present in the reference genome.\n3. Haplotype analysis compares the inherited pattern of nucleotide variation in a group of genes to a reference genome to detect UPD.\n4. Molecular cytogenetics is a technique that analyzes chromosome structure and organization to detect UPD.\n5. Parental-specific probes are DNA sequences that can be used to identify genomic segments not present in the reference genome, aiding in the detection of UPD.",
    "yulan-chat-2-13b-fp16_fact": [
      "Genotyping arrays are a type of microarray used to detect uniparental disomy by comparing an individual's genotypes to a reference genome.",
      "Single-nucleotide polymorphisms (SNPs) can be utilized to detect UPD by identifying genome segments not present in the reference genome.",
      "Haplotype analysis compares the inherited pattern of nucleotide variation in a group of genes to a reference genome to detect UPD.",
      "Molecular cytogenetics is a technique that analyzes chromosome structure and organization to detect UPD.",
      "Parental-specific probes are DNA sequences that can be used to identify genomic segments not present in the reference genome, aiding in the detection of UPD."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Genotyping arrays are indeed a type of microarray and can be used to detect uniparental disomy (UPD) by comparing an individual's genotypes to a reference genome.\n2. FALSE [correction]: Single-nucleotide polymorphisms (SNPs) are utilized to detect UPD by identifying stretches of the genome where both copies are derived from one parent, rather than identifying genomic segments not present in the reference genome.\n3. TRUE: Haplotype analysis does compare the inherited patterns of nucleotide variation to a reference to detect UPD.\n4. TRUE: Molecular cytogenetics, such as fluorescence in situ hybridization (FISH), can be used to analyze chromosome structures and detect abnormalities including UPD.\n5. FALSE [correction]: Parental-specific probes are DNA sequences that can recognize and bind to sequences specific to either the maternal or paternal chromosome, which can help in the detection of UPD by identifying which parent the genomic segments came from, rather than identifying segments not present in the reference genome.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2987,
    "user_query": "List major features of TEMPI Syndrome.",
    "yulan-chat-2-13b-fp16_response": "TEMPI Syndrome, also known as Mast Cell Activation Syndrome, is a condition characterized by an overactive immune system and mast cell activation. Some of the major features of TEMPI Syndrome include:\n1. Chronic inflammation: TEMPI Syndrome is characterized by chronic inflammation, which can lead to a range of symptoms such as fatigue, joint pain, and digestive issues.\n2. Mast cell activation: TEMPI Syndrome is caused by an overactive immune system and mast cell activation. This can lead to the release of histamine and other chemicals, which can cause a range of symptoms such as itching, hives, and swelling.\n3. Histamine intolerance: TEMPI Syndrome can cause histamine intolerance, which is a condition in which the body is unable to properly break down and eliminate histamine. This can lead to symptoms such as headaches, hives, and gastrointestinal issues.\n4. Food sensitivities: TEMPI Syndrome can cause food sensitivities, which can lead to symptoms such as bloating, gas, and digestive issues.\n5. Environmental sensitivities: TEMPI Syndrome can cause sensitivities to environmental triggers such as pollen, dust, and mold. This can lead to symptoms such as sneezing, itching, and congestion.\n6. Chronic fatigue: TEMPI Syndrome can cause chronic fatigue, which can be debilitating and affect a person's quality of life.\n7. Mood changes: TEMPI Syndrome can cause mood changes such as anxiety, depression, and irritability.\nIt's important to note that not everyone with TEMPI Syndrome will experience all of these symptoms, and the severity of symptoms can vary from person to person. If you are experiencing any of these symptoms, it's important to speak with a healthcare provider for proper diagnosis and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TEMPI Syndrome is characterized by chronic inflammation, which can lead to symptoms such as fatigue, joint pain, and digestive issues.\n2. Mast cell activation is a cause of TEMPI Syndrome, leading to symptoms such as itching, hives, and swelling.\n3. TEMPI Syndrome can cause histamine intolerance, resulting in symptoms like headaches, hives, and gastrointestinal issues.\n4. Individuals with TEMPI Syndrome may experience food sensitivities, with symptoms including bloating, gas, and digestive issues.\n5. TEMPI Syndrome may lead to environmental sensitivities to triggers like pollen, dust, and mold, causing symptoms such as sneezing, itching, and congestion.",
    "yulan-chat-2-13b-fp16_fact": [
      "TEMPI Syndrome is characterized by chronic inflammation, which can lead to symptoms such as fatigue, joint pain, and digestive issues.",
      "Mast cell activation is a cause of TEMPI Syndrome, leading to symptoms such as itching, hives, and swelling.",
      "TEMPI Syndrome can cause histamine intolerance, resulting in symptoms like headaches, hives, and gastrointestinal issues.",
      "Individuals with TEMPI Syndrome may experience food sensitivities, with symptoms including bloating, gas, and digestive issues.",
      "TEMPI Syndrome may lead to environmental sensitivities to triggers like pollen, dust, and mold, causing symptoms such as sneezing, itching, and congestion."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: TEMPI syndrome is not characterized by chronic inflammation but by Telangiectasias, Erythrocytosis with elevated erythropoietin levels, Monoclonal gammopathy, Perinephric fluid collections, and Intrapulmonary shunting.\n2. FALSE [correction]: Mast cell activation is not a cause of TEMPI Syndrome. The causes of the symptoms in TEMPI syndrome are not well understood but are not typically attributed to mast cell activation.\n3. FALSE [correction]: Histamine intolerance is not a known symptom of TEMPI Syndrome. TEMPI Syndrome symptoms are specific to the acronym TE-MP-I.\n4. FALSE [correction]: Although individuals with TEMPI Syndrome may experience a range of symptoms, food sensitivities are not a core component of the syndrome as defined by the TEMPI acronym.\n5. FALSE [correction]: Environmental sensitivities to triggers like pollen, dust, and mold are not a part of the TEMPI Syndrome definition; the symptoms of TEMPI are more specific than general environmental sensitivities.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2990,
    "user_query": "What is nyctinasty in plants?",
    "yulan-chat-2-13b-fp16_response": "Nyctinasty is a plant's ability to close its leaves at night or in response to changes in light levels. It is a type of nastic movement, which is a plant's ability to move in response to changes in light, touch, or other stimuli. Nyctinasty is a common adaptation in many plant species, particularly those that grow in areas with high levels of sunlight, as it helps to protect the plant's leaves from damage caused by extreme temperatures and UV radiation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nyctinasty is the ability of a plant to close its leaves at night or in response to changes in light levels.\n2. Nyctinasty is a type of nastic movement.\n3. Nastic movement is a response of plants to stimuli such as light, touch, or other triggers.\n4. Nyctinasty can help protect plant leaves from damage caused by extreme temperatures.\n5. Nyctinasty can also help shield plant leaves from UV radiation damage.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nyctinasty is the ability of a plant to close its leaves at night or in response to changes in light levels.",
      "Nyctinasty is a type of nastic movement.",
      "Nastic movement is a response of plants to stimuli such as light, touch, or other triggers.",
      "Nyctinasty can help protect plant leaves from damage caused by extreme temperatures.",
      "Nyctinasty can also help shield plant leaves from UV radiation damage."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Nyctinasty primarily helps to protect plants from herbivores or to conserve water during the night and is not directly linked with shielding leaves from UV radiation damage. UV radiation is generally not a concern during the night when nyctinastic movements typically occur.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not sure what you are referring to with \"tmVar.\" Could you please provide more context or clarify your question?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 2993,
    "user_query": "Which deep learning algorithm has been developed for variant calling?",
    "yulan-chat-2-13b-fp16_response": "There are several deep learning algorithms that have been developed for variant calling, including:\n1. Convolutional Neural Networks (CNNs)\n2. Recurrent Neural Networks (RNNs)\n3. Long Short-Term Memory (LSTM) networks\n4. Deep Belief Networks (DBNs)\n5. Generative Adversarial Networks (GANs)\nThese algorithms have been used to identify genetic variants associated with various diseases, such as cancer and genetic disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3000,
    "user_query": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III).",
    "yulan-chat-2-13b-fp16_response": "Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III), is caused by mutations in the genes that encode for the enzymes needed to break down certain types of sugar molecules called glycosaminoglycans (GAGs). These enzymes are called sulfatases, and there are four of them that are deficient in Sanfilippo syndrome:\n1. Sulfatase 1 (SUFU1)\n2. Sulfatase 2 (SUF2)\n3. Sulfatase 3 (SUF3)\n4. Sulfatase 4 (SUF4)\nMutations in any of these genes can lead to the accumulation of GAGs in the cells and tissues of the body, causing the symptoms associated with Sanfilippo syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3002,
    "user_query": "List clinical disorders or diseases where uc.189 is involved?",
    "yulan-chat-2-13b-fp16_response": "UC-189 is a protein that has been identified as a potential therapeutic target for several clinical disorders or diseases, including:\n1. Inflammatory bowel disease (IBD): UC-189 has been shown to play a role in the development of IBD, including Crohn's disease and ulcerative colitis.\n2. Cancer: UC-189 has been implicated in the development and progression of several types of cancer, including breast cancer, ovarian cancer, and lung cancer.\n3. Neurodegenerative diseases: UC-189 has been implicated in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\n4. Autoimmune diseases: UC-189 has been implicated in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.\n5. Fibrosis: UC-189 has been implicated in the development of fibrosis, a condition characterized by the excessive scarring of tissue.\nIt is important to note that while UC-189 has been implicated in these diseases, further research is needed to fully understand its role and to develop effective therapies that target this protein.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. UC-189 has been shown to play a role in the development of Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.\n2. UC-189 has been implicated in the development and progression of several types of cancer, such as breast cancer, ovarian cancer, and lung cancer.\n3. UC-189 has been implicated in the development of neurodegenerative diseases, like Alzheimer's disease and Parkinson's disease.\n4. UC-189 has been implicated in the development of autoimmune diseases, including rheumatoid arthritis and multiple sclerosis.\n5. UC-189 has been implicated in the development of fibrosis, a condition characterized by the excessive scarring of tissue.",
    "yulan-chat-2-13b-fp16_fact": [
      "UC-189 has been shown to play a role in the development of Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.",
      "UC-189 has been implicated in the development and progression of several types of cancer, such as breast cancer, ovarian cancer, and lung cancer.",
      "UC-189 has been implicated in the development of neurodegenerative diseases, like Alzheimer's disease and Parkinson's disease.",
      "UC-189 has been implicated in the development of autoimmune diseases, including rheumatoid arthritis and multiple sclerosis.",
      "UC-189 has been implicated in the development of fibrosis, a condition characterized by the excessive scarring of tissue."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: Without specific scientific literature or evidence to reference, the role of UC-189 in the development of Inflammatory bowel disease (IBD) cannot be confirmed or denied.\n\n2. UNKNOWN: The link between UC-189 and various types of cancer such as breast cancer, ovarian cancer, and lung cancer is not possible to determine without relevant studies or information.\n\n3. UNKNOWN: The connection between UC-189 and neurodegenerative diseases like Alzheimer's disease and Parkinson's disease cannot be ascertained without appropriate scientific evidence.\n\n4. UNKNOWN: There is not enough information to verify or refute the implication of UC-189 in the development of autoimmune diseases, including rheumatoid arthritis and multiple sclerosis.\n\n5. UNKNOWN: The involvement of UC-189 in the development of fibrosis and its characterized excessive scarring of tissue cannot be established without concrete scientific research or data.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3004,
    "user_query": "What is the role of metalloproteinase-17 (ADAM17) in NK cells?",
    "yulan-chat-2-13b-fp16_response": "Metalloproteinase-17 (ADAM17) is an enzyme that plays a role in the regulation of various cellular processes, including immune responses. In natural killer (NK) cells, ADAM17 has been shown to play a role in the regulation of NK cell activation and function.\nStudies have suggested that ADAM17 can modulate NK cell activity by cleaving various cytokines and chemokines, including IL-12, IL-18, and IFN-gamma, which are important for NK cell activation and effector function. ADAM17 has also been shown to regulate the expression of activating receptors on NK cells, such as NKG2D and NKp46, which are important for NK cell recognition and killing of tumor cells.\nIn addition, ADAM17 has been implicated in the regulation of NK cell differentiation and maintenance. For example, ADAM17 has been shown to be involved in the regulation of the transcription factor T-bet, which is important for the development of effector NK cells.\nOverall, ADAM17 appears to play an important role in the regulation of NK cell activation and function, and may be a potential target for therapeutic intervention in diseases where NK cells are dysfunctional or overactive.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Metalloproteinase-17 (ADAM17) is an enzyme involved in regulating immune responses.\n2. ADAM17 is involved in the regulation of natural killer (NK) cell activation and function.\n3. ADAM17 can modulate NK cell activity by cleaving cytokines and chemokines, such as IL-12, IL-18, and IFN-gamma.\n4. ADAM17 regulates the expression of activating receptors on NK cells, including NKG2D and NKp46.\n5. ADAM17 has been implicated in the regulation of the transcription factor T-bet, which is important for effector NK cell development.",
    "yulan-chat-2-13b-fp16_fact": [
      "Metalloproteinase-17 (ADAM17) is an enzyme involved in regulating immune responses.",
      "ADAM17 is involved in the regulation of natural killer (NK) cell activation and function.",
      "ADAM17 can modulate NK cell activity by cleaving cytokines and chemokines, such as IL-12, IL-18, and IFN-gamma.",
      "ADAM17 regulates the expression of activating receptors on NK cells, including NKG2D and NKp46.",
      "ADAM17 has been implicated in the regulation of the transcription factor T-bet, which is important for effector NK cell development."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE - Metalloproteinase-17 (ADAM17) is known to be involved in the regulation of immune responses, including the shedding of membrane-bound cytokines and growth factors.\n2. TRUE - ADAM17 does play a role in the immune system and could impact natural killer (NK) cell activation and function, as it is involved in cleaving membrane-bound precursors of cytokines, which are important for NK cell activity.\n3. FALSE [correction]: ADAM17 modulates immune cell activity by releasing membrane-bound cytokines and their receptors, but it is not typically associated with the cleavage of soluble cytokines like IL-12, IL-18, and IFN-gamma. Instead, ADAM17 cleaves membrane-bound precursors such as pro-TNF- to affect immune response.\n4. UNKNOWN - While ADAM17 is known for shedding cell surface proteins, the statements specifying the regulation of expression of activating receptors on NK cells, such as NKG2D and NKp46, could require more specific scientific evidence.\n5. FALSE [correction]: The direct implication of ADAM17 in the regulation of the transcription factor T-bet specifically related to NK cell development is not well-established in the literature. T-bet is important for NK cell development, but direct regulation by ADAM17 is not commonly reported.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3005,
    "user_query": "What is the triad of Melkersson-Rosenthal syndrome?",
    "yulan-chat-2-13b-fp16_response": "Melkersson-Rosenthal syndrome is a rare congenital disorder characterized by the triad of:\n1. Fibromata (fibrous growths) on the face, most commonly on the nose and lips\n2. Granulomatous lobular inflammation of the skin (a type of inflammation that affects the skin's lobules)\n3. Episodic facial edema (swelling) that occurs in episodes or fits, often triggered by emotional stress or exertion.\nThe exact cause of Melkersson-Rosenthal syndrome is unknown, but it is believed to be a genetic disorder. It is named after the two doctors who first described the condition, Dr. Robert Melkersson and Dr. David Rosenthal.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Melkersson-Rosenthal syndrome is characterized by fibromata on the face, notably on the nose and lips.\n2. One feature of Melkersson-Rosenthal syndrome is granulomatous lobular inflammation of the skin.\n3. Another characteristic of Melkersson-Rosenthal syndrome is episodic facial edema.\n4. The syndrome is named after Dr. Robert Melkersson and Dr. David Rosenthal, who first described the condition.\n5. It is believed to be a genetic disorder.",
    "yulan-chat-2-13b-fp16_fact": [
      "Melkersson-Rosenthal syndrome is characterized by fibromata on the face, notably on the nose and lips.",
      "One feature of Melkersson-Rosenthal syndrome is granulomatous lobular inflammation of the skin.",
      "Another characteristic of Melkersson-Rosenthal syndrome is episodic facial edema.",
      "The syndrome is named after Dr. Robert Melkersson and Dr. David Rosenthal, who first described the condition.",
      "It is believed to be a genetic disorder."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Melkersson-Rosenthal syndrome is characterized by recurring facial paralysis, swelling of the face and lips (especially the upper lip), and the development of folds and furrows in the tongue. Fibromas are not a characteristic of the syndrome.\n2. FALSE [correction]: One feature of Melkersson-Rosenthal syndrome is granulomatous cheilitis, which is inflammation of the lips. It does not typically involve lobular inflammation of the skin.\n3. TRUE\n4. FALSE [correction]: The syndrome is named after Dr. Ernst Melkersson and Dr. Curt Rosenthal, who first described the condition.\n5. UNKNOWN (While Melkersson-Rosenthal syndrome might have a genetic component, the exact cause is not well understood, and it is not confirmed to be a genetic disorder.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3006,
    "user_query": "Is galcanezumab effective for treatment of migraine?",
    "yulan-chat-2-13b-fp16_response": "Galcanezumab is a medication that is used to prevent migraines. It is a monoclonal antibody that works by blocking the activity of calcitonin gene-related peptide (CGRP), which is a molecule that is involved in the transmission of pain signals in the body.\nStudies have shown that galcanezumab can be effective in preventing migraines. In clinical trials, people who took galcanezumab had fewer migraines and less severe migraines compared to those who took a placebo.\nIt is important to note that like all medications, galcanezumab can have side effects. The most common side effects of galcanezumab include injection site reactions, such as pain, redness, or swelling at the injection site, and constipation.\nIt is best to discuss with your doctor if galcanezumab is appropriate for you and if it is effective for your specific condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Galcanezumab is used to prevent migraines.\n2. It is a monoclonal antibody that blocks the activity of calcitonin gene-related peptide (CGRP).\n3. Clinical trials have indicated that patients taking galcanezumab experienced fewer and less severe migraines compared to those who took a placebo.\n4. Common side effects of galcanezumab include injection site reactions and constipation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Galcanezumab is used to prevent migraines.",
      "It is a monoclonal antibody that blocks the activity of calcitonin gene-related peptide (CGRP).",
      "Clinical trials have indicated that patients taking galcanezumab experienced fewer and less severe migraines compared to those who took a placebo.",
      "Common side effects of galcanezumab include injection site reactions and constipation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3011,
    "user_query": "Fecal transplantation is used to treat infection with what bacteria?",
    "yulan-chat-2-13b-fp16_response": "Fecal microbiota transplantation (FMT) is a medical procedure used to treat infections caused by Clostridioides difficile (C. difficile or C. diff), a type of bacteria that can cause severe diarrhea and colitis. C. diff infections are often associated with antibiotic use and can be difficult to treat, so fecal transplantation is sometimes used as a last resort to restore the normal balance of gut bacteria and eliminate the infection. The procedure involves transferring fecal matter from a healthy donor to the recipient's gut via colonoscopy, enema, or nasogastric tube.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fecal microbiota transplantation (FMT) is used to treat infections caused by Clostridioides difficile (C. difficile).\n2. C. difficile can cause severe diarrhea and colitis.\n3. C. diff infections are often associated with antibiotic use.\n4. Fecal transplantation is used as a last resort for treating C. difficile infections.\n5. The procedure for fecal transplantation involves transferring fecal matter from a healthy donor to the recipient's gut via colonoscopy, enema, or nasogastric tube.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fecal microbiota transplantation (FMT) is used to treat infections caused by Clostridioides difficile (C. difficile).",
      "C. difficile can cause severe diarrhea and colitis.",
      "C. diff infections are often associated with antibiotic use.",
      "Fecal transplantation is used as a last resort for treating C. difficile infections.",
      "The procedure for fecal transplantation involves transferring fecal matter from a healthy donor to the recipient's gut via colonoscopy, enema, or nasogastric tube."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3015,
    "user_query": "What are the CADD scores?",
    "yulan-chat-2-13b-fp16_response": "CADD scores, or Comorbidity Assessment Score for the Charlson Comorbidity Index, is a modification of the Charlson Comorbidity Index (CCI) that is used to assess the severity of comorbidities in patients with chronic kidney disease (CKD). The CCI is a widely used measure of comorbidity that assigns scores to 17 categories of comorbid conditions, with each category being assigned a score of 1, 2, or 3 based on the relative risk of mortality associated with that condition. The CADD scores include the same 17 categories of comorbid conditions as the CCI, but assigns additional points for certain conditions that are particularly relevant to patients with CKD, such as diabetes, hypertension, and anemia. The CADD scores range from 0 to 28, with higher scores indicating a greater severity of comorbidities.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CADD scores are a modification of the Charlson Comorbidity Index (CCI) used for patients with chronic kidney disease (CKD).\n2. The Charlson Comorbidity Index assigns scores to 17 categories of comorbid conditions.\n3. Each category in the CCI is assigned a score of 1, 2, or 3 based on the relative risk of mortality.\n4. The CADD scores include the same 17 categories of comorbid conditions as the CCI.\n5. CADD scores range from 0 to 28, with higher scores indicating greater severity of comorbidities.",
    "yulan-chat-2-13b-fp16_fact": [
      "CADD scores are a modification of the Charlson Comorbidity Index (CCI) used for patients with chronic kidney disease (CKD).",
      "The Charlson Comorbidity Index assigns scores to 17 categories of comorbid conditions.",
      "Each category in the CCI is assigned a score of 1, 2, or 3 based on the relative risk of mortality.",
      "The CADD scores include the same 17 categories of comorbid conditions as the CCI.",
      "CADD scores range from 0 to 28, with higher scores indicating greater severity of comorbidities."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: CADD scores (Chronic Disease Score) are not a modification of the Charlson Comorbidity Index (CCI); they are a separate tool used for predicting the risk of hospitalization and use of medical resources based on prescription medication data.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: CADD scores do not include the same 17 categories as the CCI. CADD scores are based on medication use rather than comorbid conditions.\n5. UNKNOWN (The range provided does not correspond to a known scoring range for CADD scores; however, without further context, it's unclear what the correct range should be. It's also possible that the statement refers to a modified index or system that is not well-documented.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "yulan-chat-2-13b-fp16_response": "There is no single database that comprehensively catalogs somatic mutations in normal cells. Somatic mutations are genetic changes that occur in individual cells throughout a person's lifetime, and they can contribute to the development of cancer and other diseases. However, most somatic mutations are not harmful and do not have any significant impact on an individual's health.\nThere are several databases that provide information on somatic mutations, including the following:\n1. The Cancer Genome Atlas (TCGA): TCGA is a large-scale initiative to characterize the genetic changes that occur in cancer cells. While TCGA does not specifically focus on somatic mutations in normal cells, it does provide a wealth of information on the genetic changes that occur in cancer cells, including somatic mutations.\n2. The Genomic Data Commons (GDC): The GDC is a public data repository that provides access to genomic and clinical data from a variety of cancer studies, including TCGA. The GDC includes information on somatic mutations in cancer cells.\n3. The International Network of Cancer Genomic Consortia (INCGC): INCGC is a global network of cancer genomics consortia that aims to improve our understanding of the genetic changes that occur in cancer cells. While INCGC does not have a dedicated database of somatic mutations in normal cells, it does provide access to genomic data from a variety of cancer studies, including information on somatic mutations.\n4. The National Center for Biotechnology Information's (NCBI) Cancer Genome Annotation Portal (CGAP): CGAP is a database that provides information on the genetic changes that occur in cancer cells, including somatic mutations.\nWhile these databases do not specifically focus on somatic mutations in normal cells, they do provide a wealth of information on the genetic changes that occur in cancer cells, which can help researchers better understand the mechanisms underlying the development of cancer and other diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Somatic mutations are genetic changes that occur in individual cells throughout a person's lifetime.\n2. The Cancer Genome Atlas (TCGA) is an initiative to characterize the genetic changes in cancer cells, including somatic mutations.\n3. The Genomic Data Commons (GDC) is a public data repository that provides access to genomic and clinical data from cancer studies.\n4. The International Network of Cancer Genomic Consortia (INCGC) is a global network that provides access to genomic data from cancer studies.\n5. The National Center for Biotechnology Information's Cancer Genome Annotation Portal (CGAP) provides information on genetic changes in cancer cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Somatic mutations are genetic changes that occur in individual cells throughout a person's lifetime.",
      "The Cancer Genome Atlas (TCGA) is an initiative to characterize the genetic changes in cancer cells, including somatic mutations.",
      "The Genomic Data Commons (GDC) is a public data repository that provides access to genomic and clinical data from cancer studies.",
      "The International Network of Cancer Genomic Consortia (INCGC) is a global network that provides access to genomic data from cancer studies.",
      "The National Center for Biotechnology Information's Cancer Genome Annotation Portal (CGAP) provides information on genetic changes in cancer cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The International Cancer Genome Consortium (ICGC) is the global network that provides access to genomic data from cancer studies; there is no organization called the International Network of Cancer Genomic Consortia (INCGC).\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3023,
    "user_query": "What periodontal disease associated bacteria is also associated with Alzheimer's disease?",
    "yulan-chat-2-13b-fp16_response": "Periodontal disease is associated with a variety of bacteria, including Porphyromonas gingivalis, Tannerella forsythia, and Campylobacter rectus. However, recent research has suggested that Porphyromonas gingivalis may be particularly linked to Alzheimer's disease. Studies have found that Porphyromonas gingivalis can infect and kill brain cells, leading to the buildup of beta-amyloid plaques, a hallmark of Alzheimer's disease. While more research is needed to confirm this link, it is clear that maintaining good oral hygiene and addressing periodontal disease may be important for overall brain health.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Porphyromonas gingivalis is associated with periodontal disease.\n2. Recent research suggests Porphyromonas gingivalis may be linked to Alzheimer's disease.\n3. Studies have found that Porphyromonas gingivalis can infect and kill brain cells.\n4. Infection by Porphyromonas gingivalis can lead to the buildup of beta-amyloid plaques.\n5. Beta-amyloid plaques are a hallmark of Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Porphyromonas gingivalis is associated with periodontal disease.",
      "Recent research suggests Porphyromonas gingivalis may be linked to Alzheimer's disease.",
      "Studies have found that Porphyromonas gingivalis can infect and kill brain cells.",
      "Infection by Porphyromonas gingivalis can lead to the buildup of beta-amyloid plaques.",
      "Beta-amyloid plaques are a hallmark of Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3025,
    "user_query": "How does the Cholera toxin enter a cell?",
    "yulan-chat-2-13b-fp16_response": "The Cholera toxin (CTX) enters a cell through receptor-mediated endocytosis. CTX is a protein that is produced by the bacterium Vibrio cholerae, which causes cholera. It binds to ganglioside receptors on the surface of cells, such as cells in the intestinal tract. Once CTX is bound to the receptor, the cell internalizes it through endocytosis, a process by which cells take in material from their environment. Once inside the cell, CTX is activated by the acidic environment of the endosome, which cleaves it into two parts: a catalytic A subunit and five B subunits. The A subunit then activates adenylate cyclase, which increases the levels of cyclic AMP (cAMP) in the cell. Elevated levels of cAMP cause secretion of large amounts of electrolytes and water into the intestinal tract, leading to diarrhea.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cholera toxin (CTX) enters a cell through receptor-mediated endocytosis.\n2. CTX is produced by the bacterium Vibrio cholerae.\n3. CTX binds to ganglioside receptors on the surface of cells, such as those in the intestinal tract.\n4. The acidic environment of the endosome activates CTX by cleaving it into a catalytic A subunit and five B subunits.\n5. The A subunit activates adenylate cyclase, which increases the levels of cyclic AMP (cAMP) in the cell, leading to the secretion of electrolytes and water into the intestinal tract and causing diarrhea.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cholera toxin (CTX) enters a cell through receptor-mediated endocytosis.",
      "CTX is produced by the bacterium Vibrio cholerae.",
      "CTX binds to ganglioside receptors on the surface of cells, such as those in the intestinal tract.",
      "The acidic environment of the endosome activates CTX by cleaving it into a catalytic A subunit and five B subunits.",
      "The A subunit activates adenylate cyclase, which increases the levels of cyclic AMP (cAMP) in the cell, leading to the secretion of electrolytes and water into the intestinal tract and causing diarrhea."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The acidic environment of the endosome does not activate CTX by cleaving it; instead, the A subunit and five B subunits are part of the CTX structure, and the acidic environment helps in the translocation of the A subunit into the cytosol.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3027,
    "user_query": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?",
    "yulan-chat-2-13b-fp16_response": "Mogamulizumab is an investigational drug that is being studied for the treatment of various types of cancer, including cutaneous T-cell lymphoma (CTCL). It is a monoclonal antibody that targets a protein called C-C motif chemokine ligand 2 (CCL2), which is believed to play a role in the development and progression of cancer.\nThere is limited information available on the use of mogamulizumab for the treatment of CTCL, as it has not yet been approved for this indication by regulatory authorities. However, some studies have shown promising results in the treatment of CTCL with mogamulizumab, particularly in combination with other therapies.\nFor example, a phase 1/2 clinical trial in patients with relapsed or refractory CTCL found that the combination of mogamulizumab and a chemotherapy drug called decitabine resulted in a partial or complete response in a significant proportion of patients. Another phase 1/2 trial in patients with advanced CTCL found that mogamulizumab was well-tolerated and had promising anti-tumor activity when given in combination with a targeted therapy called brentuximab vedotin.\nWhile these results are encouraging, more research is needed to fully understand the potential benefits and risks of mogamulizumab for the treatment of CTCL. It is important to note that mogamulizumab is still in the early stages of development and has not yet been approved for use in the United States or Europe.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mogamulizumab is being studied for the treatment of various types of cancer, including cutaneous T-cell lymphoma (CTCL).\n2. Mogamulizumab is a monoclonal antibody that targets the C-C motif chemokine ligand 2 (CCL2).\n3. Mogamulizumab has shown promising results in the treatment of CTCL in some studies, particularly when combined with other therapies.\n4. A phase 1/2 clinical trial showed that combining mogamulizumab with the chemotherapy drug decitabine resulted in a partial or complete response in a significant proportion of patients with relapsed or refractory CTCL.\n5. Mogamulizumab has not yet been approved for the treatment of CTCL by regulatory authorities.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mogamulizumab is being studied for the treatment of various types of cancer, including cutaneous T-cell lymphoma (CTCL).",
      "Mogamulizumab is a monoclonal antibody that targets the C-C motif chemokine ligand 2 (CCL2).",
      "Mogamulizumab has shown promising results in the treatment of CTCL in some studies, particularly when combined with other therapies.",
      "A phase 1/2 clinical trial showed that combining mogamulizumab with the chemotherapy drug decitabine resulted in a partial or complete response in a significant proportion of patients with relapsed or refractory CTCL.",
      "Mogamulizumab has not yet been approved for the treatment of CTCL by regulatory authorities."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Mogamulizumab is a monoclonal antibody that targets the C-C chemokine receptor type 4 (CCR4), not CCL2.\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Mogamulizumab has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of cutaneous T-cell lymphoma (CTCL), specifically for adult patients with relapsed or refractory mycosis fungoides (MF) and Szary syndrome (SS) who have received at least one prior systemic therapy.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3028,
    "user_query": "Which enzymes are inhibited by Duvelisib?",
    "yulan-chat-2-13b-fp16_response": "Duvelisib is an inhibitor of both PI3K and PI3K isoforms, which are enzymes that play a role in cellular signaling and are involved in various cellular processes, including cell growth, survival, and metabolism. These enzymes are also known to be involved in the development and progression of certain cancers, and inhibition of their activity may help to slow or stop the growth of cancer cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Duvelisib inhibits the enzymes PI3K and PI3K isoforms.\n2. PI3K and PI3K isoforms are involved in cellular signaling.\n3. The enzymes PI3K and PI3K are linked to cell growth, survival, and metabolism.\n4. PI3K and PI3K isoforms are involved in the development and progression of certain cancers.\n5. Inhibition of PI3K and PI3K isoforms may help to slow or stop the growth of cancer cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Duvelisib inhibits the enzymes PI3K and PI3K isoforms.",
      "PI3K and PI3K isoforms are involved in cellular signaling.",
      "The enzymes PI3K and PI3K are linked to cell growth, survival, and metabolism.",
      "PI3K and PI3K isoforms are involved in the development and progression of certain cancers.",
      "Inhibition of PI3K and PI3K isoforms may help to slow or stop the growth of cancer cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Duvelisib inhibits the enzymes PI3K and PI3K isoforms.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3029,
    "user_query": "List search engines used in proteomics.",
    "yulan-chat-2-13b-fp16_response": "Some search engines commonly used in proteomics include:\n1. UniProt: a comprehensive protein database that provides detailed information on protein sequences, structures, functions, and interactions.\n2. Swiss-Prot: a manually annotated protein sequence database that provides high-quality protein sequence and functional annotation.\n3. Protein Data Bank (PDB): a repository of three-dimensional protein structure data that can be accessed and analyzed using various software tools.\n4. NCBI BLAST: a bioinformatics tool that allows researchers to search for homologous protein sequences and identify potential protein targets.\n5. Pfam: a database of protein family and domain annotations that can be used to identify conserved protein motifs and domains.\n6. InterProScan: a protein sequence analysis tool that searches for protein domains and motifs, and provides functional annotation based on the presence of these features.\n7. STRING: a database of protein-protein interactions that can be used to infer functional relationships between proteins based on known or predicted interactions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. UniProt is a database that provides information on protein sequences, structures, functions, and interactions.\n2. Swiss-Prot is a manually annotated protein sequence database that includes protein sequence and functional annotation.\n3. Protein Data Bank (PDB) is a repository that contains three-dimensional protein structure data.\n4. NCBI BLAST is a tool used to search for homologous protein sequences and identify protein targets.\n5. Pfam is a database that annotates protein families and domains.",
    "yulan-chat-2-13b-fp16_fact": [
      "UniProt is a database that provides information on protein sequences, structures, functions, and interactions.",
      "Swiss-Prot is a manually annotated protein sequence database that includes protein sequence and functional annotation.",
      "Protein Data Bank (PDB) is a repository that contains three-dimensional protein structure data.",
      "NCBI BLAST is a tool used to search for homologous protein sequences and identify protein targets.",
      "Pfam is a database that annotates protein families and domains."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3035,
    "user_query": "Is Lasmiditan effective for migraine?",
    "yulan-chat-2-13b-fp16_response": "Lasmiditan is a medication that is specifically approved for the acute treatment of migraine with or without aura in adults. It belongs to a class of drugs called serotonin agonists, which work by constricting blood vessels and reducing the release of substances that cause inflammation and pain.\nStudies have shown that lasmiditan can effectively relieve the pain and associated symptoms of migraine, such as nausea and sensitivity to light and sound, in a significant number of people. However, like all medications, it may not work for everyone and may have side effects.\nIt is important to note that lasmiditan is not intended for use in preventing migraines or for prolonged use. It is only meant to provide relief for acute migraine attacks. If you are experiencing frequent or severe migraines, it is important to discuss treatment options with your healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lasmiditan is approved for the acute treatment of migraine with or without aura in adults.\n2. Lasmiditan belongs to a class of drugs known as serotonin agonists.\n3. Lasmiditan can relieve pain and associated symptoms of migraine such as nausea and sensitivity to light and sound.\n4. Lasmiditan is not intended for migraine prevention.\n5. Lasmiditan is meant to provide relief for acute migraine attacks only.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lasmiditan is approved for the acute treatment of migraine with or without aura in adults.",
      "Lasmiditan belongs to a class of drugs known as serotonin agonists.",
      "Lasmiditan can relieve pain and associated symptoms of migraine such as nausea and sensitivity to light and sound.",
      "Lasmiditan is not intended for migraine prevention.",
      "Lasmiditan is meant to provide relief for acute migraine attacks only."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Lasmiditan belongs to a class of drugs known as ditans, which are serotonin (5-HT) 1F receptor agonists, not general serotonin agonists.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are several graph kernel libraries available that have been implemented in Java. Graph kernels are used to compute similarity or distance between two graphs, which can be useful in a variety of applications such as recommendation systems, network analysis, and pattern recognition.\nHere are some popular graph kernel libraries implemented in Java:\n1. JaccardSimilarity: This is a simple implementation of the Jaccard similarity coefficient, which is a measure of similarity between two sets. It can be used to compute the similarity between two graphs.\n2. GraphSimilarity: This library provides several graph similarity measures, including the Jaccard similarity, Adamic/Adar index, and cosine similarity. It also includes implementations of graph kernels for learning graph representations.\n3. GraphKernels: This library provides a set of graph kernels for computing similarity between graphs, including the common neighborhood kernel, random walk kernel, and spectral kernel.\n4. WeightedGraphSimilarity: This library provides several weighted graph similarity measures, including the Jaccard similarity, Adamic/Adar index, and cosine similarity.\n5. GraphStream: This is a graph processing library that includes a graph kernel implementation for computing similarity between graphs.\nThese libraries can be used in a variety of applications that involve graph data, such as recommendation systems, network analysis, and pattern recognition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Graph kernels are used to compute similarity or distance between two graphs.\n2. JaccardSimilarity is a Java library implementing the Jaccard similarity coefficient for graphs.\n3. The GraphSimilarity library in Java includes measures like the Jaccard similarity, Adamic/Adar index, and cosine similarity.\n4. GraphKernels is a Java library offering graph kernels including the common neighborhood kernel, random walk kernel, and spectral kernel.\n5. GraphStream is a Java-based graph processing library that includes a graph kernel implementation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Graph kernels are used to compute similarity or distance between two graphs.",
      "JaccardSimilarity is a Java library implementing the Jaccard similarity coefficient for graphs.",
      "The GraphSimilarity library in Java includes measures like the Jaccard similarity, Adamic/Adar index, and cosine similarity.",
      "GraphKernels is a Java library offering graph kernels including the common neighborhood kernel, random walk kernel, and spectral kernel.",
      "GraphStream is a Java-based graph processing library that includes a graph kernel implementation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no specific library called JaccardSimilarity known for implementing the Jaccard similarity coefficient for graphs in Java. The Jaccard similarity coefficient, however, is a well-known measure used in various applications, including graph analysis, that can be implemented in Java.\n3. UNKNOWN: Without specific information, it's not possible to verify the existence or offerings of a library called \"GraphSimilarity\" in Java and whether it includes those measures.\n4. UNKNOWN: Similarly, without verification of a specific \"GraphKernels\" Java library and its offerings, it's not possible to confirm the truth of this statement.\n5. FALSE [correction]: GraphStream is indeed a Java-based graph processing library, but there is no clear evidence that it includes a graph kernel implementation. It is designed for dynamic and static graph processing, stream graph computations, and visualization. Graph kernels are specialized algorithms not typically included in general-purpose graph processing libraries.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3044,
    "user_query": "What is COG112?",
    "yulan-chat-2-13b-fp16_response": "COG112 is a protein that is encoded by the COG112 gene. The function of this protein is not well understood, but it is thought to be involved in some aspect of biological process.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. COG112 is a protein.\n2. The COG112 protein is encoded by the COG112 gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "COG112 is a protein.",
      "The COG112 protein is encoded by the COG112 gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: COG112 is not a known protein in standard biological references. It may refer to a component of the Conserved Oligomeric Golgi (COG) complex, which is involved in vesicle trafficking, but \"COG112\" as a specific protein name does not yield standard results in scientific databases.\n2. FALSE [correction]: Since COG112 is not established as a protein, it cannot be encoded by a gene of the same name. If COG112 were a protein, this statement might be true, but as it stands with the current knowledge, there's no gene specifically known as the COG112 gene encoding a COG112 protein.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "yulan-chat-2-13b-fp16_response": "The SHERLOCKv2 platform is an advanced molecular diagnostic system that integrates several technologies to provide rapid and accurate detection of infectious diseases. The four advances integrated into the SHERLOCKv2 platform are:\n1. DNA-based detection: SHERLOCKv2 uses a DNA-based detection method that allows for highly sensitive and specific detection of pathogens. This method involves amplifying and detecting specific DNA sequences that are unique to the target pathogen.\n2. Lateral flow assay: The SHERLOCKv2 platform uses a lateral flow assay, similar to a pregnancy test, that allows for rapid and easy detection of pathogens. The lateral flow assay involves flowing a sample through a series of test lines that bind to specific molecules in the sample.\n3. Sandwich assay: The SHERLOCKv2 platform uses a sandwich assay, which involves capturing the target pathogen between two probes. This method allows for highly specific detection of the pathogen, as the probes are designed to bind only to the target pathogen and not to other molecules.\n4. Quantitative detection: The SHERLOCKv2 platform can also provide quantitative detection of pathogens, allowing for accurate measurement of the amount of pathogen present in the sample. This is achieved by using a calibration curve that relates the intensity of the test line to the amount of pathogen present in the sample.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SHERLOCKv2 uses a DNA-based detection method for identifying specific DNA sequences unique to the target pathogen.\n2. The platform includes a lateral flow assay for rapid and easy detection of pathogens.\n3. SHERLOCKv2 utilizes a sandwich assay, designed for highly specific detection of the target pathogen.\n4. The platform is capable of quantitative detection of pathogens, providing a measurement of the amount of pathogen in the sample.\n5. The lateral flow assay used in SHERLOCKv2 is similar to a pregnancy test in its operational mechanism.",
    "yulan-chat-2-13b-fp16_fact": [
      "SHERLOCKv2 uses a DNA-based detection method for identifying specific DNA sequences unique to the target pathogen.",
      "The platform includes a lateral flow assay for rapid and easy detection of pathogens.",
      "SHERLOCKv2 utilizes a sandwich assay, designed for highly specific detection of the target pathogen.",
      "The platform is capable of quantitative detection of pathogens, providing a measurement of the amount of pathogen in the sample.",
      "The lateral flow assay used in SHERLOCKv2 is similar to a pregnancy test in its operational mechanism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: SHERLOCKv2 does not utilize a sandwich assay. It uses CRISPR technology, which includes a Cas enzyme and a guide RNA specific to the DNA or RNA sequence of a pathogen to detect its presence.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3055,
    "user_query": "What is MOV10?",
    "yulan-chat-2-13b-fp16_response": "MOV10 is a command used in the IBM mainframe operating system, z/OS, to move a file from one location to another. It is a basic file manipulation command that is commonly used in mainframe environments.\nThe MOV10 command is used to move a file from one member of a member-dependent pair to another member of the same pair. A member-dependent pair is a group of two files that are related to each other, where one file (the dependent file) is dependent on the other file (the member file). The dependent file is usually a copy of the member file, and it is updated automatically when changes are made to the member file.\nThe MOV10 command is used to move the dependent file to a new location, while keeping the member file in its original location. This can be useful in situations where the dependent file needs to be moved to a new storage location, but the member file needs to remain in its original location for compatibility with other systems that rely on it.\nThe basic syntax of the MOV10 command is:\n```\nMOV10   DDNAME(=LIB/DDF,DST=DESTLIB/DSTFILE)\n         DFHRPL(=SOURCELIB/SOURCEFILE)\n         RPLACING\n```\nIn this syntax, DDNAME specifies the dependent file to be moved, DST specifies the new location of the dependent file, DFHRPL specifies the member file that the dependent file is dependent on, and RPLACING specifies that the dependent file is being replaced by the member file.\nIt is important to note that the MOV10 command should only be used to move files within the same library or subsystem, and should not be used to move files between libraries or subsystems. For moving files between libraries or subsystems, other commands such as the MOV and MVCTL commands should be used.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MOV10 is a command in the z/OS operating system used for file manipulation.\n2. MOV10 moves a file from one member of a member-dependent pair to another within the same pair.\n3. The dependent file in a member-dependent pair is automatically updated when changes are made to the member file.\n4. The MOV10 command can be used when the dependent file needs to be moved to a new storage location while the member file remains in its original location.\n5. MOV10 should only be used to move files within the same library or subsystem and not between different libraries or subsystems.",
    "yulan-chat-2-13b-fp16_fact": [
      "MOV10 is a command in the z/OS operating system used for file manipulation.",
      "MOV10 moves a file from one member of a member-dependent pair to another within the same pair.",
      "The dependent file in a member-dependent pair is automatically updated when changes are made to the member file.",
      "The MOV10 command can be used when the dependent file needs to be moved to a new storage location while the member file remains in its original location.",
      "MOV10 should only be used to move files within the same library or subsystem and not between different libraries or subsystems."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: MOV10 is not a command in the z/OS operating system. z/OS does not use a command called MOV10 for file manipulation. The context seems to suggest something similar to the z/OS commands for data set or file operations, but MOV10 is not a recognized command in this environment.\n2. FALSE [correction]: Since statement 1 is false and MOV10 is not a z/OS command, this statement about the behavior of MOV10 is also false.\n3. FALSE [correction]: In z/OS, the concept of a \"member-dependent pair\" is not standard terminology, and automatic updates to a dependent file based on changes to another file are not a default behavior. Relationships between files or datasets and their updates are usually managed through application logic or other mechanisms, not automatically by the operating system.\n4. FALSE [correction]: As previously established, MOV10 is not a z/OS command, so it cannot be used for any purpose, including moving dependent files to a new storage location.\n5. FALSE [correction]: Since there is no MOV10 command in z/OS, recommendations on how it should be used, such as moving files within the same library or subsystem, are not applicable.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3057,
    "user_query": "Which cancer is associated with increased levels of Serum alpha fetoprotein (AFP) ?",
    "yulan-chat-2-13b-fp16_response": "Serum alpha fetoprotein (AFP) is a protein produced by the liver and also found in small amounts in the blood of a developing fetus. Elevated levels of AFP in the blood can be a sign of certain types of cancer, particularly cancer of the liver, pancreas, or testicles.\nThe most common cancer associated with increased levels of serum AFP is hepatocellular carcinoma (HCC), which is a type of liver cancer. In fact, AFP is often used as a biomarker to help diagnose HCC. Other cancers that can cause elevated AFP levels include germ cell tumors, such as testicular cancer, and some types of pancreatic cancer. However, it's important to note that elevated AFP levels can also be caused by non-cancerous conditions, such as liver disease or cirrhosis, so a diagnosis should be made by a healthcare professional after considering all relevant clinical information.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Elevated levels of Serum alpha fetoprotein (AFP) can indicate certain types of cancer.\n2. Hepatocellular carcinoma (HCC) is the most common cancer associated with increased levels of serum AFP.\n3. Serum AFP is often used as a biomarker to help diagnose hepatocellular carcinoma.\n4. Elevated AFP levels can also be associated with germ cell tumors, such as testicular cancer.\n5. Some types of pancreatic cancer can cause elevated AFP levels.",
    "yulan-chat-2-13b-fp16_fact": [
      "Elevated levels of Serum alpha fetoprotein (AFP) can indicate certain types of cancer.",
      "Hepatocellular carcinoma (HCC) is the most common cancer associated with increased levels of serum AFP.",
      "Serum AFP is often used as a biomarker to help diagnose hepatocellular carcinoma.",
      "Elevated AFP levels can also be associated with germ cell tumors, such as testicular cancer.",
      "Some types of pancreatic cancer can cause elevated AFP levels."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Elevated AFP levels are not typically associated with pancreatic cancer. Instead, elevated levels are more commonly linked to liver, testicular, and ovarian cancers. Pancreatic cancer may be associated with different biomarkers such as CA 19-9.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3060,
    "user_query": "Does the interaction of MOV10 and RNASEH2 promote L1 retrotransposition?",
    "yulan-chat-2-13b-fp16_response": "MOV10 and RNASEH2 are two proteins that have been implicated in the process of L1 retrotransposition, which is the process by which L1 elements, a type of retrotransposon, move from one location in the genome to another.\nMOV10 is a protein that is involved in the recruitment of other proteins to the L1 element, and it has been shown to be necessary for L1 retrotransposition in some contexts. RNASEH2 is an endonuclease that is involved in the processing of RNA, but it has also been shown to be involved in the processing of L1 elements.\nStudies have suggested that the interaction between MOV10 and RNASEH2 may be important for the promotion of L1 retrotransposition. For example, it has been shown that the interaction between MOV10 and RNASEH2 is necessary for the efficient processing of L1 elements in some contexts. Additionally, it has been suggested that the interaction between MOV10 and RNASEH2 may be important for the recruitment of other proteins to the L1 element, which could promote its retrotransposition.\nOverall, while the exact mechanisms by which MOV10 and RNASEH2 promote L1 retrotransposition are not fully understood, it is clear that they both play important roles in this process.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MOV10 is involved in the recruitment of other proteins to L1 elements and is necessary for L1 retrotransposition in some contexts.\n2. RNASEH2 is an endonuclease involved in RNA processing, as well as in processing L1 elements.\n3. Interaction between MOV10 and RNASEH2 has been suggested to be important for the efficient processing of L1 elements in some contexts.\n4. The interaction between MOV10 and RNASEH2 may be important for the recruitment of other proteins to the L1 element, which could promote retrotransposition.\n5. L1 retrotransposition is the process by which L1 elements move from one location in the genome to another.",
    "yulan-chat-2-13b-fp16_fact": [
      "MOV10 is involved in the recruitment of other proteins to L1 elements and is necessary for L1 retrotransposition in some contexts.",
      "RNASEH2 is an endonuclease involved in RNA processing, as well as in processing L1 elements.",
      "Interaction between MOV10 and RNASEH2 has been suggested to be important for the efficient processing of L1 elements in some contexts.",
      "The interaction between MOV10 and RNASEH2 may be important for the recruitment of other proteins to the L1 element, which could promote retrotransposition.",
      "L1 retrotransposition is the process by which L1 elements move from one location in the genome to another."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: RNASEH2 is an endonuclease that removes ribonucleotides misincorporated into DNA during replication, and is involved in RNA-DNA hybrid resolution, not primarily in RNA processing or processing of L1 elements.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3063,
    "user_query": "List features of the Triple A syndrome.",
    "yulan-chat-2-13b-fp16_response": "The Triple A syndrome, also known as Allgrove syndrome, is a rare genetic disorder that affects multiple systems in the body. Some of the key features of this syndrome include:\n1. Autosomal recessive inheritance: The Triple A syndrome is inherited in an autosomal recessive pattern, which means that a child needs to inherit two copies of the altered gene (one from each parent) to develop the condition.\n2. Ataxia: One of the most prominent features of the Triple A syndrome is ataxia, which is a lack of coordination and balance. This can affect the ability to walk, coordinate movements, and perform daily activities.\n3. Acanthosis nigricans: Many people with the Triple A syndrome have a condition called acanthosis nigricans, which is characterized by dark, thickened skin with a velvety texture. This can occur on the neck, armpits, groin, and other areas of the body.\n4. Alcohol intolerance: People with the Triple A syndrome may have difficulty metabolizing alcohol, which can lead to flushing, nausea, vomiting, and other symptoms after drinking even small amounts of alcohol.\n5. Other features: In addition to ataxia, acanthosis nigricans, and alcohol intolerance, the Triple A syndrome can also cause a variety of other symptoms, including hyperpigmentation, diabetes, obesity, and neurological problems such as seizures or dementia.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Triple A syndrome is also known as Allgrove syndrome.\n2. The Triple A syndrome is inherited in an autosomal recessive pattern.\n3. Ataxia, characterized by a lack of coordination and balance, is a key feature of the Triple A syndrome.\n4. Acanthosis nigricans, which results in dark, thickened skin with a velvety texture, is a symptom of the Triple A syndrome.\n5. People with the Triple A syndrome may exhibit alcohol intolerance, leading to adverse reactions after consuming alcohol.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Triple A syndrome is also known as Allgrove syndrome.",
      "The Triple A syndrome is inherited in an autosomal recessive pattern.",
      "Ataxia, characterized by a lack of coordination and balance, is a key feature of the Triple A syndrome.",
      "Acanthosis nigricans, which results in dark, thickened skin with a velvety texture, is a symptom of the Triple A syndrome.",
      "People with the Triple A syndrome may exhibit alcohol intolerance, leading to adverse reactions after consuming alcohol."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Acanthosis nigricans is not a symptom of the Triple A syndrome. Instead, a key feature of the syndrome is alacrima (lack of tear secretion).\n5. FALSE [correction]: There is no widely recognized association between alcohol intolerance and Triple A syndrome. The \"A\" in Triple A stands for alacrima, achalasia (a disorder of the esophagus), and ACTH insensitivity (adrenocorticotropic hormone insensitivity).",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3065,
    "user_query": "Which protein is the Mitochondrial carrier homolog 2 (MTCH2) receptor for?",
    "yulan-chat-2-13b-fp16_response": "Mitochondrial carrier homolog 2 (MTCH2) is a protein that functions as a mitochondrial carrier, which is a type of transporter that moves molecules across the inner mitochondrial membrane. It is known to be involved in the transport of various molecules, including dicarboxylates, amino acids, and peptides. However, it is not clear which specific molecule or molecules MTCH2 is the receptor for. It is likely that MTCH2 plays a role in the regulation of mitochondrial function and metabolism, and may be involved in the transport of molecules that are important for energy production within the mitochondria.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mitochondrial carrier homolog 2 (MTCH2) functions as a mitochondrial carrier.\n2. MTCH2 is involved in transporting molecules across the inner mitochondrial membrane.\n3. MTCH2 is involved in the transport of dicarboxylates, amino acids, and peptides.\n4. The specific molecule or molecules for which MTCH2 is the receptor is not clear.\n5. MTCH2 may play a role in the regulation of mitochondrial function and metabolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mitochondrial carrier homolog 2 (MTCH2) functions as a mitochondrial carrier.",
      "MTCH2 is involved in transporting molecules across the inner mitochondrial membrane.",
      "MTCH2 is involved in the transport of dicarboxylates, amino acids, and peptides.",
      "The specific molecule or molecules for which MTCH2 is the receptor is not clear.",
      "MTCH2 may play a role in the regulation of mitochondrial function and metabolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: While the name mitochondrial carrier homolog 2 (MTCH2) suggests a role in mitochondrial transport, MTCH2 does not function as a classical mitochondrial carrier.\n2. FALSE [correction]: MTCH2 is not directly involved in transporting molecules across the inner mitochondrial membrane, but rather it's thought to be involved in the process of apoptosis and metabolic signaling.\n3. FALSE [correction]: Since MTCH2 does not function as a classical mitochondrial carrier, it is not involved in the transport of dicarboxylates, amino acids, and peptides.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3066,
    "user_query": "What is PhenomeCentral?",
    "yulan-chat-2-13b-fp16_response": "PhenomeCentral is a database of genetic variants associated with human diseases and traits. It is a resource for researchers to access and analyze data related to the genetic basis of human health and disease. PhenomeCentral is maintained by the National Institutes of Health (NIH) and is available to the scientific community for use in research studies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PhenomeCentral is a database of genetic variants associated with human diseases and traits.\n2. It is designed to be a resource for researchers for data analysis related to genetic basis of human health and disease.\n3. PhenomeCentral is maintained by the National Institutes of Health (NIH).\n4. The database is available to the scientific community for research purposes.",
    "yulan-chat-2-13b-fp16_fact": [
      "PhenomeCentral is a database of genetic variants associated with human diseases and traits.",
      "It is designed to be a resource for researchers for data analysis related to genetic basis of human health and disease.",
      "PhenomeCentral is maintained by the National Institutes of Health (NIH).",
      "The database is available to the scientific community for research purposes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: PhenomeCentral is a research database focused on rare diseases, where clinicians and scientists can share phenotypic and genotypic data about cases they are working on.\n2. TRUE\n3. FALSE [correction]: PhenomeCentral is not maintained by the National Institutes of Health (NIH); it is a project of the Canadian organization, Care4Rare Canada Consortium.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3072,
    "user_query": "List sirtuin inhibitors.",
    "yulan-chat-2-13b-fp16_response": "Sirtuin inhibitors are a class of compounds that inhibit the activity of sirtuins, a family of proteins that play a role in various cellular processes, including metabolism, stress resistance, and longevity. Some examples of sirtuin inhibitors include:\n1. Resveratrol: A natural compound found in red wine, grapes, and some other plants. Resveratrol has been shown to inhibit the activity of SIRT1, one of the seven known sirtuins in mammals.\n2. SRT1720: A synthetic compound that was developed as a SIRT1 inhibitor. SRT1720 has been shown to increase the activity of SIRT1 in cells, leading to increased oxidative stress and decreased lifespan in animal models.\n3. Nicorandil: A drug used to treat angina, a type of chest pain. Nicorandil has been shown to inhibit the activity of SIRT2, another sirtuin that is involved in mitochondrial function and oxidative stress.\n4. TAK-438: A small molecule inhibitor of SIRT3, a sirtuin that is involved in mitochondrial function and oxidative stress. TAK-438 has been shown to increase oxidative stress and decrease lifespan in animal models.\n5. BPTES: A small molecule inhibitor of SIRT4, a sirtuin that is involved in mitochondrial function and oxidative stress. BPTES has been shown to increase oxidative stress and decrease lifespan in animal models.\nIt's important to note that while sirtuin inhibitors have shown promise in preclinical studies, more research is needed to determine their safety and efficacy in humans.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Resveratrol is a compound found in red wine, grapes, and some other plants that inhibits the activity of SIRT1.\n2. SRT1720 is a synthetic compound developed as a SIRT1 inhibitor.\n3. Nicorandil is a drug used to treat angina that also inhibits the activity of SIRT2.\n4. TAK-438 is a small molecule inhibitor of SIRT3.\n5. BPTES is a small molecule inhibitor of SIRT4.",
    "yulan-chat-2-13b-fp16_fact": [
      "Resveratrol is a compound found in red wine, grapes, and some other plants that inhibits the activity of SIRT1.",
      "SRT1720 is a synthetic compound developed as a SIRT1 inhibitor.",
      "Nicorandil is a drug used to treat angina that also inhibits the activity of SIRT2.",
      "TAK-438 is a small molecule inhibitor of SIRT3.",
      "BPTES is a small molecule inhibitor of SIRT4."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Resveratrol is a compound found in red wine, grapes, and some other plants that is believed to activate SIRT1, not inhibit it.\n2. FALSE [correction]: SRT1720 is a synthetic compound developed to activate SIRT1, not to inhibit it.\n3. UNKNOWN: The primary action of Nicorandil is to act as a vasodilator for treating angina; whether it inhibits the activity of SIRT2 is not well established or might not be the main action of the drug.\n4. UNKNOWN: TAK-438 (Vonoprazan) is known as a potassium-competitive acid blocker (P-CAB) that inhibits the gastric H+,K+-ATPase to treat acid-related diseases, and there is no well-established data indicating it acts as a SIRT3 inhibitor.\n5. UNKNOWN: BPTES is known as an allosteric inhibitor of glutaminase, particularly in cancer cells. Whether it also acts as a SIRT4 inhibitor is not well documented.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3073,
    "user_query": "Is the NLM medical text indexer (MTI) still useful and relevant?",
    "yulan-chat-2-13b-fp16_response": "The NLM Medical Text Indexer (MTI) is a tool developed by the National Library of Medicine (NLM) to assist in the indexing of medical literature. It is designed to extract relevant medical concepts from a text and to assign them to a controlled vocabulary, such as the Medical Subject Headings (MeSH) vocabulary.\nWhile the MTI is not actively maintained and updated, it is still relevant and useful for certain applications. For example, it can be used to extract medical concepts from a large corpus of text and to create a MeSH vocabulary-based index of the text. This can be helpful for tasks such as information retrieval, text mining, and natural language processing.\nHowever, it is important to note that the MTI may not be as accurate or up-to-date as other more recent tools and technologies for natural language processing and information extraction. Additionally, the MTI may not be able to handle more complex medical texts or specialized medical terminology. Therefore, it is recommended to use the MTI in conjunction with other tools and technologies, and to validate the output for accuracy and completeness.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The NLM Medical Text Indexer (MTI) was developed by the National Library of Medicine to assist in the indexing of medical literature.\n2. The MTI is designed to extract relevant medical concepts from text and assign them to the Medical Subject Headings (MeSH) vocabulary.\n3. The MTI can be used to create a MeSH vocabulary-based index of text, which is useful for information retrieval, text mining, and natural language processing.\n4. The MTI is not actively maintained and updated.\n5. The MTI may not be as accurate or up-to-date as more recent natural language processing and information extraction tools.",
    "yulan-chat-2-13b-fp16_fact": [
      "The NLM Medical Text Indexer (MTI) was developed by the National Library of Medicine to assist in the indexing of medical literature.",
      "The MTI is designed to extract relevant medical concepts from text and assign them to the Medical Subject Headings (MeSH) vocabulary.",
      "The MTI can be used to create a MeSH vocabulary-based index of text, which is useful for information retrieval, text mining, and natural language processing.",
      "The MTI is not actively maintained and updated.",
      "The MTI may not be as accurate or up-to-date as more recent natural language processing and information extraction tools."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The NLM Medical Text Indexer (MTI) is actively maintained and updated.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3075,
    "user_query": "What antibiotic is currently used as the standard of care for Clostridium Difficile infection as of 2018",
    "yulan-chat-2-13b-fp16_response": "As of 2018, the standard of care for Clostridium difficile infection typically involves the use of antibiotics such as metronidazole or vancomycin. These are the most commonly used antibiotics for the treatment of C. difficile infections, and they have been shown to be effective in clinical trials. However, it is important to note that the specific antibiotic used to treat a C. difficile infection may vary depending on the severity of the infection and the individual patient's medical history and other health factors. It is always best to consult with a healthcare professional for the most up-to-date and personalized treatment recommendations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Metronidazole is used as a standard treatment for Clostridium difficile infection as of 2018.\n2. Vancomycin is another antibiotic that is used as a standard treatment for Clostridium difficile infection as of 2018.\n3. The choice of antibiotic for treating a Clostridium difficile infection may vary based on the severity of the infection.\n4. A patient's medical history and other health factors can influence the specific antibiotic used to treat a Clostridium difficile infection.\n5. Consulting with a healthcare professional is recommended for the most current and personalized treatment recommendations for C. difficile infections.",
    "yulan-chat-2-13b-fp16_fact": [
      "Metronidazole is used as a standard treatment for Clostridium difficile infection as of 2018.",
      "Vancomycin is another antibiotic that is used as a standard treatment for Clostridium difficile infection as of 2018.",
      "The choice of antibiotic for treating a Clostridium difficile infection may vary based on the severity of the infection.",
      "A patient's medical history and other health factors can influence the specific antibiotic used to treat a Clostridium difficile infection.",
      "Consulting with a healthcare professional is recommended for the most current and personalized treatment recommendations for C. difficile infections."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Metronidazole was considered a first-line treatment for C. difficile infection, but as of 2018, guidelines favor vancomycin or fidaxomicin over metronidazole for most cases due to better efficacy and lower recurrence rates.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3077,
    "user_query": "Which features are evaluated with the CRAFFT screening test?",
    "yulan-chat-2-13b-fp16_response": "The CRAFFT screening test evaluates several features related to substance use and potential substance use disorders. These features include:\n1. C - Cannabis use: Have you ever used cannabis?\n2. R - Risk-taking: Have you ever done anything that could put you in danger of being hurt or killed?\n3. A - Alcohol use: How many times have you been drunk in the past month?\n4. F - Friends: Do you have any friends who have used drugs or who could get you drugs?\n5. T - Trouble: Have you ever gotten into trouble with the police or been arrested?\nThe CRAFFT screening test is designed to identify adolescents who may be at risk for substance use disorders and may benefit from further evaluation and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The CRAFFT screening test is used to evaluate potential substance use disorders.\n2. One feature the CRAFFT screening test evaluates is cannabis use.\n3. Another feature the CRAFFT screening test evaluates is risk-taking behaviors.\n4. Alcohol use is a feature evaluated by the CRAFFT screening test.\n5. The CRAFFT screening test includes questions about the individual's friends regarding drug use.",
    "yulan-chat-2-13b-fp16_fact": [
      "The CRAFFT screening test is used to evaluate potential substance use disorders.",
      "One feature the CRAFFT screening test evaluates is cannabis use.",
      "Another feature the CRAFFT screening test evaluates is risk-taking behaviors.",
      "Alcohol use is a feature evaluated by the CRAFFT screening test.",
      "The CRAFFT screening test includes questions about the individual's friends regarding drug use."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "yulan-chat-2-13b-fp16_response": "The bartender algorithm is a graph search algorithm used to find the shortest path between two nodes in a weighted graph. It is also known as the Viterbi algorithm or the single-source shortest-path algorithm.\nThe algorithm works by starting at a specific node (the \"source\") and exploring all of the neighboring nodes. It then selects the node with the lowest cost (the \"best\" neighbor) and explores its neighbors. This process is repeated until the destination node is reached or all nodes have been explored.\nThe algorithm uses a dynamic programming approach to keep track of the minimum cost path from the source to each node in the graph. At each step, the algorithm updates the cost of each node based on the cost of the previous node and the cost of the current edge.\nThe bartender algorithm is commonly used in computer networks to determine the shortest path between two nodes, as well as in speech recognition and natural language processing to find the most likely sequence of words given a set of input signals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The bartender algorithm is used to find the shortest path between two nodes in a weighted graph.\n2. It is also known as the Viterbi algorithm or the single-source shortest-path algorithm.\n3. The bartender algorithm starts at a specific node and explores all neighboring nodes, looking for the one with the lowest cost to continue the path.\n4. A dynamic programming approach is used by the algorithm to keep track of the minimum cost path from the source to each node in the graph.\n5. The algorithm is used in computer networks to determine the shortest path between two nodes and in speech recognition and natural language processing to find the most likely sequence of words.",
    "yulan-chat-2-13b-fp16_fact": [
      "The bartender algorithm is used to find the shortest path between two nodes in a weighted graph.",
      "It is also known as the Viterbi algorithm or the single-source shortest-path algorithm.",
      "The bartender algorithm starts at a specific node and explores all neighboring nodes, looking for the one with the lowest cost to continue the path.",
      "A dynamic programming approach is used by the algorithm to keep track of the minimum cost path from the source to each node in the graph.",
      "The algorithm is used in computer networks to determine the shortest path between two nodes and in speech recognition and natural language processing to find the most likely sequence of words."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: There is no known \"bartender algorithm\" for finding the shortest path in a graph. The description seems to be mixing elements of the Dijkstra's algorithm and Bellman-Ford algorithm or other shortest path algorithms.\n2. FALSE [correction]: The Viterbi algorithm is used for decoding the most likely sequence of hidden states in a stochastic model (e.g., Hidden Markov Model), and the single-source shortest-path algorithm can refer to multiple algorithms like Dijkstra's algorithm or the Bellman-Ford algorithm.\n3. UNKNOWN: Since the \"bartender algorithm\" is not a recognized term in computer science, it is unclear what the process would be, but the description aligns loosely with the concept of Dijkstra's algorithm. However, without a correct reference to the algorithm, the process described cannot be confirmed.\n4. UNKNOWN: Again, as we do not have a proper reference to the \"bartender algorithm\", we can only surmise that the statement seems to describe a characteristic of dynamic programming. Dynamic programming is indeed used in some pathfinding algorithms, like the Bellman-Ford algorithm, to keep track of paths.\n5. FALSE [correction]: The algorithm mentioned is not correctly named, which makes this statement incorrect. The shortest path algorithms such as Dijkstra's or Bellman-Ford are used in computer networks. However, the Viterbi algorithm is indeed used in speech recognition and natural language processing for the decoding of the most likely sequence of states (words or phrases, for instance), but it is not typically referred to as a shortest path algorithm.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3082,
    "user_query": "List two drugs that are included in the Akynzeo pill?",
    "yulan-chat-2-13b-fp16_response": "The Akynzeo pill contains two drugs:\n1. Aprepitant: This drug is used to prevent nausea and vomiting caused by chemotherapy.\n2. Fosaprepitant: This drug is used to prevent nausea and vomiting caused by chemotherapy. It is also used to prevent nausea and vomiting caused by radiation therapy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Akynzeo pill contains the drug aprepitant.\n2. The Akynzeo pill contains the drug fosaprepitant.\n3. Aprepitant is used to prevent nausea and vomiting caused by chemotherapy.\n4. Fosaprepitant is used to prevent nausea and vomiting caused by chemotherapy.\n5. Fosaprepitant is also used to prevent nausea and vomiting caused by radiation therapy.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Akynzeo pill contains the drug aprepitant.",
      "The Akynzeo pill contains the drug fosaprepitant.",
      "Aprepitant is used to prevent nausea and vomiting caused by chemotherapy.",
      "Fosaprepitant is used to prevent nausea and vomiting caused by chemotherapy.",
      "Fosaprepitant is also used to prevent nausea and vomiting caused by radiation therapy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Akynzeo pill contains the drugs netupitant and palonosetron, not aprepitant.\n2. FALSE [correction]: The Akynzeo pill does not contain fosaprepitant; it contains netupitant and palonosetron.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Fosaprepitant is used to prevent nausea and vomiting caused by chemotherapy, not by radiation therapy.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3087,
    "user_query": "Safinamide is approved for treatment of which disease?",
    "yulan-chat-2-13b-fp16_response": "Safinamide is a drug that is approved for the treatment of Parkinson's disease. Parkinson's disease is a progressive neurological disorder that affects movement and is characterized by the presence of tremors, rigidity, and bradykinesia (slowness of movement). Safinamide works by inhibiting the enzyme safinamide dehydrogenase, which is involved in the production of dopamine, a neurotransmitter that is deficient in Parkinson's disease. By inhibiting this enzyme, safinamide increases the levels of dopamine in the brain and helps to alleviate the symptoms of Parkinson's disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Safinamide is approved for the treatment of Parkinson's disease.\n2. Parkinson's disease is a progressive neurological disorder that affects movement.\n3. Symptoms of Parkinson's disease include tremors, rigidity, and bradykinesia.\n4. Safinamide inhibits the enzyme safinamide dehydrogenase.\n5. Safinamide increases the levels of dopamine in the brain to help alleviate Parkinson's disease symptoms.",
    "yulan-chat-2-13b-fp16_fact": [
      "Safinamide is approved for the treatment of Parkinson's disease.",
      "Parkinson's disease is a progressive neurological disorder that affects movement.",
      "Symptoms of Parkinson's disease include tremors, rigidity, and bradykinesia.",
      "Safinamide inhibits the enzyme safinamide dehydrogenase.",
      "Safinamide increases the levels of dopamine in the brain to help alleviate Parkinson's disease symptoms."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Safinamide is an MAO-B inhibitor, not an inhibitor of an enzyme called \"safinamide dehydrogenase.\"\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3091,
    "user_query": "What is the name of the Cas13 based diagnostic test for the Zika and dengue viruses?",
    "yulan-chat-2-13b-fp16_response": "The name of the Cas13 based diagnostic test for the Zika and dengue viruses is \"CRISPR-Cas13 SARS-CoV-2 detection kit\". This test uses the CRISPR-Cas13 system to detect the presence of viral RNA in patient samples, and it has been developed for the rapid and accurate diagnosis of both Zika and dengue viruses. It is a reliable and easy-to-use diagnostic tool that can be used in point-of-care settings, such as hospitals and clinics, to provide timely and accurate diagnoses to patients.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Cas13 based diagnostic test for the Zika and dengue viruses is named \"CRISPR-Cas13 SARS-CoV-2 detection kit.\"\n2. The test uses the CRISPR-Cas13 system to detect the presence of viral RNA.\n3. It has been developed for the diagnosis of both Zika and dengue viruses.\n4. The test is designed to be rapid and accurate.\n5. The \"CRISPR-Cas13 SARS-CoV-2 detection kit\" can be used in point-of-care settings like hospitals and clinics.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Cas13 based diagnostic test for the Zika and dengue viruses is named \"CRISPR-Cas13 SARS-CoV-2 detection kit.\"",
      "The test uses the CRISPR-Cas13 system to detect the presence of viral RNA.",
      "It has been developed for the diagnosis of both Zika and dengue viruses.",
      "The test is designed to be rapid and accurate.",
      "The \"CRISPR-Cas13 SARS-CoV-2 detection kit\" can be used in point-of-care settings like hospitals and clinics."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The name \"CRISPR-Cas13 SARS-CoV-2 detection kit\" implies that the test is for detecting SARS-CoV-2, not Zika or dengue viruses. The correct name for a test targeting Zika and dengue viruses would not reference SARS-CoV-2.\n2. TRUE\n3. TRUE, assuming that there is indeed a CRISPR-Cas13 based diagnostic test developed for Zika and dengue viruses, as the statement itself does not provide the name of the test.\n4. UNKNOWN (without further context or evidence regarding the specific performance of the test, it's difficult to verify the claim about its speed and accuracy)\n5. UNKNOWN (the usability of the \"CRISPR-Cas13 SARS-CoV-2 detection kit\" in point-of-care settings would depend on various factors, including its actual design and whether it has been specifically created for such settings; also, the name does not match the viruses in question, which adds to the confusion)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3092,
    "user_query": "What are CRISPR-Cas12a proteins?",
    "yulan-chat-2-13b-fp16_response": "CRISPR-Cas12a is a type of CRISPR-Cas system, which is a bacterial immune system that has been adapted for use as a gene editing tool. CRISPR-Cas12a consists of a guide RNA and a Cas12a protein, which can be used to cut DNA at specific locations. This allows scientists to edit genes by introducing mutations, deleting genes, or inserting new genes into the DNA of living cells. CRISPR-Cas12a is a relatively new gene editing tool, and researchers are still exploring its potential applications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CRISPR-Cas12a is a type of CRISPR-Cas system.\n2. The CRISPR-Cas system is originally a bacterial immune system.\n3. CRISPR-Cas12a employs a guide RNA and a Cas12a protein to cut DNA at specific locations.\n4. CRISPR-Cas12a can be used to edit genes by introducing mutations, deleting, or inserting new genes into DNA.\n5. CRISPR-Cas12a is considered a relatively new gene editing tool.",
    "yulan-chat-2-13b-fp16_fact": [
      "CRISPR-Cas12a is a type of CRISPR-Cas system.",
      "The CRISPR-Cas system is originally a bacterial immune system.",
      "CRISPR-Cas12a employs a guide RNA and a Cas12a protein to cut DNA at specific locations.",
      "CRISPR-Cas12a can be used to edit genes by introducing mutations, deleting, or inserting new genes into DNA.",
      "CRISPR-Cas12a is considered a relatively new gene editing tool."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3094,
    "user_query": "Can cardiospheres be produced from skin fibroblasts?",
    "yulan-chat-2-13b-fp16_response": "Yes, cardiospheres can be produced from skin fibroblasts. Cardiospheres are three-dimensional aggregates of cells that have the potential to differentiate into cardiac cells, such as heart muscle cells and blood vessel cells. They are often generated from mouse embryonic fibroblasts, but they can also be generated from adult fibroblasts, including skin fibroblasts.\nTo generate cardiospheres from skin fibroblasts, the fibroblasts are first isolated from the skin and then cultured in a specific medium that promotes the formation of cardiospheres. The cells are then allowed to form aggregates, which can be cultured further to allow them to differentiate into cardiac cells.\nWhile the use of cardiospheres for the treatment of heart disease is still an area of active research, the ability to generate cardiospheres from adult fibroblasts, including skin fibroblasts, provides a potential source of cells for regenerative therapies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cardiospheres can be produced from skin fibroblasts.\n2. Cardiospheres are capable of differentiating into cardiac cells, including heart muscle cells and blood vessel cells.\n3. Cardiospheres are traditionally generated from mouse embryonic fibroblasts, but can also be generated from adult fibroblasts.\n4. To generate cardiospheres from skin fibroblasts, the fibroblasts are first isolated and then cultured in a medium that encourages the formation of these aggregates.\n5. There is ongoing research regarding the use of cardiospheres for the treatment of heart disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cardiospheres can be produced from skin fibroblasts.",
      "Cardiospheres are capable of differentiating into cardiac cells, including heart muscle cells and blood vessel cells.",
      "Cardiospheres are traditionally generated from mouse embryonic fibroblasts, but can also be generated from adult fibroblasts.",
      "To generate cardiospheres from skin fibroblasts, the fibroblasts are first isolated and then cultured in a medium that encourages the formation of these aggregates.",
      "There is ongoing research regarding the use of cardiospheres for the treatment of heart disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Cardiospheres are generated from cardiac cells like cardiac stem cells, not skin fibroblasts. Skin fibroblasts are typically not used to produce cardiospheres.\n2. TRUE\n3. FALSE [correction]: Cardiospheres are traditionally generated from cardiac stem cells found in the heart, not mouse embryonic fibroblasts, although research might explore various sources for generating cardiospheres.\n4. UNKNOWN: While this process is typical for generating cell aggregates like cardiospheres from certain cell types, without specific context it's unclear if this statement is referring to the correct initial cell type or the precise methodology for cardiospheres.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3095,
    "user_query": "What the chromsomal location of the gene that is deleted in Potocki-Shaffer syndrome?",
    "yulan-chat-2-13b-fp16_response": "Potocki-Shaffer syndrome is caused by a deletion of a segment of chromosome 17q21.31. This deletion syndrome is characterized by intellectual disability, delayed bone age, and distinctive facial features. It is named after the two researchers who first described the condition in 2004. The deletion syndrome is caused by a loss of a segment of chromosome 17 that includes several genes, including the Shaffer gene and the Potocki-Lupski gene. The deletion syndrome is relatively rare, with only a few hundred cases reported in the medical literature.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Potocki-Shaffer syndrome is caused by a deletion of a segment of chromosome 17q21.31.\n2. The syndrome is characterized by intellectual disability, delayed bone age, and distinctive facial features.\n3. Potocki-Shaffer syndrome was first described in 2004.\n4. The deletion on chromosome 17 includes several genes, including the Shaffer gene and the Potocki-Lupski gene.\n5. Only a few hundred cases of Potocki-Shaffer syndrome have been reported in the medical literature.",
    "yulan-chat-2-13b-fp16_fact": [
      "Potocki-Shaffer syndrome is caused by a deletion of a segment of chromosome 17q21.31.",
      "The syndrome is characterized by intellectual disability, delayed bone age, and distinctive facial features.",
      "Potocki-Shaffer syndrome was first described in 2004.",
      "The deletion on chromosome 17 includes several genes, including the Shaffer gene and the Potocki-Lupski gene.",
      "Only a few hundred cases of Potocki-Shaffer syndrome have been reported in the medical literature."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Potocki-Shaffer syndrome was first described in 1996 by Potocki et al.\n4. FALSE [correction]: The deletion on chromosome 17 does not include genes named \"Shaffer gene\" and \"Potocki-Lupski gene.\" The syndrome is caused by the deletion of a segment on chromosome 17 that includes the genes ALX3, PHF23, and others.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3099,
    "user_query": "List features of the DOOR syndrome.",
    "yulan-chat-2-13b-fp16_response": "D.O.O.R. syndrome is a term used to describe a set of symptoms that may be experienced by individuals who have been exposed to traumatic events. The acronym stands for:\n1. Dissociation: This refers to a disconnection or disruption in the normal functioning of a person's thoughts, emotions, and behaviors. Dissociation can manifest in a variety of ways, such as feeling detached from oneself or one's surroundings, or experiencing flashbacks or dissociative episodes.\n2. Overwhelm: Traumatic events can be overwhelming and may cause a person to feel helpless, anxious, or depressed. This can lead to difficulty functioning in daily life, such as problems with sleeping, eating, or concentrating.\n3. Outbursts: Traumatic events can also cause a person to experience intense emotions, such as anger, frustration, or fear. These emotions may be expressed through outbursts or aggressive behavior.\n4. Re-experiencing: Traumatic events can cause a person to re-experience the event through flashbacks, nightmares, or intrusive thoughts. These experiences can be distressing and may cause a person to feel like they are reliving the traumatic event.\nIt's important to note that not everyone who experiences a traumatic event will develop D.O.O.R. syndrome, and that the severity of symptoms can vary widely. If you or someone you know is experiencing symptoms of D.O.O.R. syndrome, it is important to seek support from a mental health professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DOOR syndrome is associated with exposure to traumatic events.\n2. Dissociation in DOOR syndrome may include detachment from oneself or surroundings.\n3. Individuals with DOOR syndrome may feel overwhelmed, which can affect sleeping, eating, or concentrating.\n4. Outbursts and aggressive behavior are potential symptoms of DOOR syndrome.\n5. Re-experiencing the traumatic event through flashbacks, nightmares, or intrusive thoughts is a feature of DOOR syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "DOOR syndrome is associated with exposure to traumatic events.",
      "Dissociation in DOOR syndrome may include detachment from oneself or surroundings.",
      "Individuals with DOOR syndrome may feel overwhelmed, which can affect sleeping, eating, or concentrating.",
      "Outbursts and aggressive behavior are potential symptoms of DOOR syndrome.",
      "Re-experiencing the traumatic event through flashbacks, nightmares, or intrusive thoughts is a feature of DOOR syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: DOOR syndrome is not associated with exposure to traumatic events; it is a rare genetic disorder that is characterized by Deafness, Onychodystrophy (nail abnormalities), Osteodystrophy (bone development issues), and Mental Retardation (intellectual disability).\n2. FALSE [correction]: Dissociation involving detachment from oneself or surroundings is not a symptom of DOOR syndrome; it may be associated with psychological conditions such as dissociative disorders, which are unrelated to DOOR syndrome.\n3. UNKNOWN: Without more context, it is difficult to determine whether feelings of being overwhelmed and related symptoms are specifically associated with DOOR syndrome, as these can be general symptoms not exclusive to one condition.\n4. UNKNOWN: It is unclear whether outbursts and aggressive behavior are specific symptoms of DOOR syndrome. These behaviors can arise from a variety of disorders, including but not limited to intellectual disability; however, it is not specific enough to be attributed solely to DOOR syndrome without more context.\n5. FALSE [correction]: Re-experiencing the traumatic event through flashbacks, nightmares, or intrusive thoughts is a symptom of PTSD (Post-Traumatic Stress Disorder) and not a feature of DOOR syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "yulan-chat-2-13b-fp16_response": "There are several web-based pedigree editors available, including:\n1. FamilySearch: A free website that allows users to create and share their family trees, as well as access a vast collection of historical records.\n2. Ancestry.com: A subscription-based website that provides access to a vast collection of genealogical records, including census records, vital records, and immigration records.\n3. MyHeritage: A subscription-based website that provides access to a vast collection of genealogical records, as well as tools for creating and sharing family trees.\n4. Geni: A free website that allows users to create and share their family trees, as well as access a vast collection of historical records.\n5. Dynasty: A free web-based pedigree editor that allows users to create and share their family trees, as well as access a vast collection of historical records.\n6. Gramps: A free, open-source genealogy software that allows users to create and share their family trees, as well as access a vast collection of historical records.\n7. Legacy Family Tree: A paid genealogy software that allows users to create and share their family trees, as well as access a vast collection of historical records.\nThese are just a few examples of web-based pedigree editors available. It's important to research and compare the features and pricing of each program to determine which one is the best fit for your needs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FamilySearch is a free website that allows users to create, edit, and share their family trees.\n2. Ancestry.com is a subscription-based website that provides access to genealogical records.\n3. MyHeritage is a subscription-based website with tools for creating and sharing family trees.\n4. Geni is a free website where users can create and share their family trees.\n5. Gramps is a free, open-source genealogy software available to users.",
    "yulan-chat-2-13b-fp16_fact": [
      "FamilySearch is a free website that allows users to create, edit, and share their family trees.",
      "Ancestry.com is a subscription-based website that provides access to genealogical records.",
      "MyHeritage is a subscription-based website with tools for creating and sharing family trees.",
      "Geni is a free website where users can create and share their family trees.",
      "Gramps is a free, open-source genealogy software available to users."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Geni is not entirely free; it offers a basic free plan but requires a subscription for full access to all features.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3101,
    "user_query": "What is the mechanism of action of Solriamfetol?",
    "yulan-chat-2-13b-fp16_response": "Solriamfetol is a selective dopamine agonist that acts on the dopamine D1 and D2 receptors, as well as the norepinephrine alpha- and beta-receptors. It is a wake-promoting agent that is used to treat excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea/hypopnea syndrome (OSAHS).\nThe mechanism of action of solriamfetol is thought to involve its ability to selectively activate the dopamine D1 and D2 receptors, as well as the norepinephrine alpha- and beta-receptors. This leads to an increase in the release of dopamine and norepinephrine, which are neurotransmitters that play a role in regulating wakefulness and arousal.\nBy activating these receptors, solriamfetol increases the alertness and wakefulness of the individual, reducing the incidence and severity of excessive daytime sleepiness. It also has been shown to improve cognitive function and attention, as well as reduce the number of sleep apnea episodes in individuals with OSAHS.\nOverall, the mechanism of action of solriamfetol is thought to involve its ability to selectively activate dopamine and norepinephrine receptors, leading to an increase in alertness and wakefulness.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Solriamfetol acts as a selective dopamine agonist on dopamine D1 and D2 receptors.\n2. Solriamfetol also acts on norepinephrine alpha- and beta-receptors.\n3. It is used to treat excessive daytime sleepiness in narcolepsy and obstructive sleep apnea/hypopnea syndrome.\n4. Solriamfetol increases the release of dopamine and norepinephrine.\n5. It has been shown to improve cognitive function and attention in individuals with obstructive sleep apnea/hypopnea syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Solriamfetol acts as a selective dopamine agonist on dopamine D1 and D2 receptors.",
      "Solriamfetol also acts on norepinephrine alpha- and beta-receptors.",
      "It is used to treat excessive daytime sleepiness in narcolepsy and obstructive sleep apnea/hypopnea syndrome.",
      "Solriamfetol increases the release of dopamine and norepinephrine.",
      "It has been shown to improve cognitive function and attention in individuals with obstructive sleep apnea/hypopnea syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, not a selective dopamine agonist.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3102,
    "user_query": "What is the difference between the nuclease Cas13a and C2c2",
    "yulan-chat-2-13b-fp16_response": "Cas13a and C2c2 are both nucleases, enzymes that break down nucleic acids, but they have some key differences:\n1. Structure: Cas13a is a CRISPR-Cas13a nuclease, which is a type of RNA-guided endonuclease. It is a single-domain protein that contains both RNA-binding and nuclease domains. C2c2, on the other hand, is a bacterial endonuclease that is part of the C2c2 complex. It is a multimeric protein composed of several subunits, including a catalytic subunit and a regulatory subunit.\n2. Target specificity: Cas13a is guided by RNA, and can be programmed to target specific RNA sequences. C2c2, on the other hand, is not RNA-guided, and can cleave both RNA and DNA.\n3. Function: Cas13a is primarily used for RNA interference and gene regulation, while C2c2 is involved in DNA repair and recombination.\n4. Activity: Cas13a is active in both the presence and absence of RNA, while C2c2 is only active in the presence of RNA.\nOverall, while both Cas13a and C2c2 are nucleases, they have different structures, target specificities, functions, and activities.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cas13a is a CRISPR-Cas13a nuclease, a type of RNA-guided endonuclease with RNA-binding and nuclease domains.\n2. C2c2 is a bacterial endonuclease that is part of the C2c2 complex and is composed of several subunits, including a catalytic subunit and a regulatory subunit.\n3. Cas13a can be programmed to target specific RNA sequences due to its guidance by RNA.\n4. C2c2 can cleave both RNA and DNA and is not RNA-guided.\n5. Cas13a's functions include RNA interference and gene regulation, whereas C2c2 is involved in DNA repair and recombination.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cas13a is a CRISPR-Cas13a nuclease, a type of RNA-guided endonuclease with RNA-binding and nuclease domains.",
      "C2c2 is a bacterial endonuclease that is part of the C2c2 complex and is composed of several subunits, including a catalytic subunit and a regulatory subunit.",
      "Cas13a can be programmed to target specific RNA sequences due to its guidance by RNA.",
      "C2c2 can cleave both RNA and DNA and is not RNA-guided.",
      "Cas13a's functions include RNA interference and gene regulation, whereas C2c2 is involved in DNA repair and recombination."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: C2c2, now known as Cas13a, is not a bacterial endonuclease that is part of a \"C2c2 complex\" with multiple subunits. C2c2 (Cas13a) is a single-component RNA-targeting CRISPR effector.\n3. TRUE\n4. FALSE [correction]: Cas13a (formerly known as C2c2) is an RNA-guided RNA-targeting CRISPR effector; it does not cleave DNA.\n5. FALSE [correction]: Cas13as functions include RNA interference-like mechanisms and viral defense in bacteria, where it targets RNA. The description of C2c2s involvement in 'DNA repair and recombination' is incorrect, as C2c2 is another name for Cas13a and does not target DNA or function in DNA repair.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3103,
    "user_query": "Phlorotannin is extracted from what plant?",
    "yulan-chat-2-13b-fp16_response": "Phlorotannin is a type of tannin that is extracted from certain types of algae, particularly those that belong to the class Phycologia. These algae are commonly known as seaweeds and are found in marine environments around the world. Phlorotannins are a group of polyphenolic compounds that are known for their antioxidant and anti-inflammatory properties, and they have been studied for their potential health benefits. Some of the species of seaweed that are known to contain high levels of phlorotannins include kelp, wakame, and hijiki.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phlorotannin is a type of tannin extracted from certain types of algae.\n2. Algae that belong to the class Phycologia are known to contain phlorotannins.\n3. These algae, commonly known as seaweeds, are found in marine environments around the world.\n4. Phlorotannins are known for their antioxidant and anti-inflammatory properties.\n5. Kelp, wakame, and hijiki are species of seaweed known to contain high levels of phlorotannins.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phlorotannin is a type of tannin extracted from certain types of algae.",
      "Algae that belong to the class Phycologia are known to contain phlorotannins.",
      "These algae, commonly known as seaweeds, are found in marine environments around the world.",
      "Phlorotannins are known for their antioxidant and anti-inflammatory properties.",
      "Kelp, wakame, and hijiki are species of seaweed known to contain high levels of phlorotannins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Algae that belong to the class Phaeophyceae are known to contain phlorotannins.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3104,
    "user_query": "Where are pannexins localized?",
    "yulan-chat-2-13b-fp16_response": "Pannexins are a family of proteins that are localized to the plasma membrane of cells. They are particularly abundant in cells that form the outer layer of tissues, such as the skin, lung, and intestine. Pannexins are also found in other cell types, including immune cells, neurons, and muscle cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pannexins are a family of proteins localized to the plasma membrane of cells.\n2. Pannexins are abundant in cells that form the outer layer of tissues such as skin, lung, and intestine.\n3. Pannexins are found in immune cells, neurons, and muscle cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pannexins are a family of proteins localized to the plasma membrane of cells.",
      "Pannexins are abundant in cells that form the outer layer of tissues such as skin, lung, and intestine.",
      "Pannexins are found in immune cells, neurons, and muscle cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: While pannexins are found in the plasma membrane of many types of cells, the statement that they are \"abundant in cells that form the outer layer of tissues such as skin, lung, and intestine\" could be misleading. Pannexins are widely expressed in many tissues, including the brain, blood vessels, and immune cells, but without specific data on their abundance in these outer layer cells compared to other cell types, the statement could be inaccurate.\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3105,
    "user_query": "What is the mechanism of action of cariprazine?",
    "yulan-chat-2-13b-fp16_response": "Cariprazine is a drug that is used to treat schizophrenia and bipolar disorder. It works by blocking the action of a neurotransmitter called dopamine in the brain. Dopamine is a chemical that is involved in the regulation of mood, motivation, and cognition. By blocking the action of dopamine, cariprazine helps to reduce the symptoms of schizophrenia and bipolar disorder, such as hallucinations, delusions, and mood swings. It is thought to work by binding to a specific receptor in the brain called the D3 receptor, which is involved in the regulation of dopamine.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cariprazine is used to treat schizophrenia and bipolar disorder.\n2. It works by blocking the action of the neurotransmitter dopamine in the brain.\n3. Dopamine is involved in the regulation of mood, motivation, and cognition.\n4. Cariprazine is thought to bind to the D3 receptor in the brain.\n5. The D3 receptor is involved in the regulation of dopamine.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cariprazine is used to treat schizophrenia and bipolar disorder.",
      "It works by blocking the action of the neurotransmitter dopamine in the brain.",
      "Dopamine is involved in the regulation of mood, motivation, and cognition.",
      "Cariprazine is thought to bind to the D3 receptor in the brain.",
      "The D3 receptor is involved in the regulation of dopamine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Cariprazine doesn't block dopamine action; instead, it acts as a partial agonist at the dopamine D3 and D2 receptors. This means it can both activate and inhibit these receptors in a balanced way.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "yulan-chat-2-13b-fp16_response": "There are several curated databases available for spider-venom toxins. Some of the most well-known and widely used ones include:\n1. Spider Bite Database: This database is maintained by the University of California, Riverside and contains information on the venomous properties of spiders found in North America.\n2. Spider Toxin Database: This database is maintained by the University of Queensland in Australia and contains information on the venomous properties of spiders found in Australia and other parts of the world.\n3. Spider Toxin Collection: This collection is maintained by the University of California, Riverside and contains venom samples from a variety of spider species.\n4. Venomous Spider Toxins Database: This database is maintained by the University of Texas at Austin and contains information on the venomous properties of spiders found in Texas and other parts of the United States.\n5. Spider Toxin Research Database: This database is maintained by the University of Queensland in Australia and contains information on the venomous properties of spiders found in Australia and other parts of the world.\nThese databases are regularly updated and provide valuable information for researchers studying spider venom toxins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Spider Bite Database is maintained by the University of California, Riverside and focuses on spiders found in North America.\n2. The Spider Toxin Database is maintained by the University of Queensland in Australia and covers spider venoms from Australia and other regions.\n3. The University of California, Riverside also maintains a Spider Toxin Collection containing venom samples from various spider species.\n4. The Venomous Spider Toxins Database is managed by the University of Texas at Austin and includes information about venomous spiders in Texas and other parts of the United States.\n5. The Spider Toxin Research Database, maintained by the University of Queensland in Australia, provides information on the venomous properties of spiders located in Australia and globally.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Spider Bite Database is maintained by the University of California, Riverside and focuses on spiders found in North America.",
      "The Spider Toxin Database is maintained by the University of Queensland in Australia and covers spider venoms from Australia and other regions.",
      "The University of California, Riverside also maintains a Spider Toxin Collection containing venom samples from various spider species.",
      "The Venomous Spider Toxins Database is managed by the University of Texas at Austin and includes information about venomous spiders in Texas and other parts of the United States.",
      "The Spider Toxin Research Database, maintained by the University of Queensland in Australia, provides information on the venomous properties of spiders located in Australia and globally."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3108,
    "user_query": "What is the difference between CRISPR-Cas12a and CRISPR-Cpf1?",
    "yulan-chat-2-13b-fp16_response": "CRISPR-Cas12a and CRISPR-Cpf1 are both gene editing tools that use the CRISPR-Cas system to make targeted changes to DNA. However, there are some key differences between the two:\n1. Structure: CRISPR-Cas12a is a type of CRISPR-Cas system that uses a single RNA molecule to guide the Cas12a enzyme to the target DNA sequence. CRISPR-Cpf1, on the other hand, uses a different RNA molecule and a different enzyme (Cpf1) to cleave the DNA.\n2. Precision: Both systems can be programmed to target specific DNA sequences, but CRISPR-Cas12a is generally considered to be more precise than CRISPR-Cpf1 because it can make more specific cuts in the DNA.\n3. Off-target effects: Both systems can potentially cause off-target effects, meaning that they can cut DNA at unintended locations. However, CRISPR-Cas12a has been shown to have a higher risk of off-target effects than CRISPR-Cpf1.\n4. Efficiency: CRISPR-Cas12a is generally considered to be less efficient than CRISPR-Cpf1 because it requires a longer RNA molecule to guide the Cas12a enzyme to the target DNA sequence.\nOverall, both CRISPR-Cas12a and CRISPR-Cpf1 are powerful gene editing tools that have the potential to revolutionize the field of molecular biology. However, they have different strengths and weaknesses, and researchers will need to carefully consider which tool is best suited for their specific research needs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CRISPR-Cas12a uses a single RNA molecule to guide the Cas12a enzyme to the target DNA sequence.\n2. CRISPR-Cpf1 uses a different RNA molecule and the Cpf1 enzyme to cleave the DNA.\n3. CRISPR-Cas12a is generally considered more precise than CRISPR-Cpf1 in making cuts in DNA.\n4. CRISPR-Cas12a has a higher risk of off-target effects compared to CRISPR-Cpf1.\n5. CRISPR-Cpf1 is generally considered more efficient than CRISPR-Cas12a as it requires a shorter RNA molecule.",
    "yulan-chat-2-13b-fp16_fact": [
      "CRISPR-Cas12a uses a single RNA molecule to guide the Cas12a enzyme to the target DNA sequence.",
      "CRISPR-Cpf1 uses a different RNA molecule and the Cpf1 enzyme to cleave the DNA.",
      "CRISPR-Cas12a is generally considered more precise than CRISPR-Cpf1 in making cuts in DNA.",
      "CRISPR-Cas12a has a higher risk of off-target effects compared to CRISPR-Cpf1.",
      "CRISPR-Cpf1 is generally considered more efficient than CRISPR-Cas12a as it requires a shorter RNA molecule."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: CRISPR-Cas12a is generally considered to have a lower risk of off-target effects compared to CRISPR-Cpf1 due to its more stringent recognition requirements before cleaving DNA.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3109,
    "user_query": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection",
    "yulan-chat-2-13b-fp16_response": "As of my knowledge cutoff date in September 2021, there are two antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection:\n1. Beclomethasone dipropionate: This is a topical corticosteroid that is used to reduce inflammation and relieve symptoms of C. difficile infection. It is available as a foam or a suppository.\n2. Conivaptan: This is an oral medication that is used to treat C. difficile infection by binding to and inhibiting the action of a protein called serotonin. It is not an antibody, but rather a drug that works by targeting a different mechanism of the infection.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "yulan-chat-2-13b-fp16_response": "Axitinib is a drug that is used to treat certain types of cancer, including pancreatic cancer. It is a tyrosine kinase inhibitor, which means that it works by blocking certain proteins that are involved in the growth and spread of cancer cells.\nThere have been several clinical trials investigating the use of axitinib in the treatment of pancreatic cancer. One phase 3 clinical trial, called the ALTERNATE trial, evaluated the effectiveness of axitinib compared to standard of care therapy in patients with advanced pancreatic cancer who had not received previous treatment. The results of this trial showed that axitinib did not significantly improve overall survival compared to standard of care therapy.\nHowever, other clinical trials have shown that axitinib can be effective in treating certain types of pancreatic cancer, such as those that have certain genetic mutations. For example, a phase 2 clinical trial found that axitinib was effective in treating patients with advanced pancreatic cancer who had a specific genetic mutation known as FGFR1.\nOverall, while axitinib may be effective in treating some patients with pancreatic cancer, it is not yet clear if it can prolong survival in all patients with this disease. As with any cancer treatment, the effectiveness of axitinib will depend on a variety of factors, including the patient's individual characteristics and the specific characteristics of their cancer. It is important for patients to discuss the potential benefits and risks of axitinib with their healthcare provider to determine if it is an appropriate treatment option for them.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Axitinib is a drug used to treat certain types of cancer, including pancreatic cancer.\n2. Axitinib is a tyrosine kinase inhibitor, which blocks proteins involved in the growth and spread of cancer cells.\n3. The ALTERNATE trial, a phase 3 clinical trial, indicated that axitinib did not significantly improve overall survival compared to standard care therapy for patients with advanced pancreatic cancer who had not received previous treatment.\n4. A phase 2 clinical trial found axitinib to be effective in treating patients with advanced pancreatic cancer who had a specific genetic mutation known as FGFR1.\n5. Axitinib's effectiveness as a treatment varies based on individual patient characteristics and the specific characteristics of their cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Axitinib is a drug used to treat certain types of cancer, including pancreatic cancer.",
      "Axitinib is a tyrosine kinase inhibitor, which blocks proteins involved in the growth and spread of cancer cells.",
      "The ALTERNATE trial, a phase 3 clinical trial, indicated that axitinib did not significantly improve overall survival compared to standard care therapy for patients with advanced pancreatic cancer who had not received previous treatment.",
      "A phase 2 clinical trial found axitinib to be effective in treating patients with advanced pancreatic cancer who had a specific genetic mutation known as FGFR1.",
      "Axitinib's effectiveness as a treatment varies based on individual patient characteristics and the specific characteristics of their cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Axitinib is used to treat advanced renal cell carcinoma (kidney cancer) and not specifically for pancreatic cancer.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE (This statement is broadly correct as the effectiveness of most cancer treatments, including axitinib, can indeed vary based on individual patient characteristics and cancer-specific features.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3112,
    "user_query": "Which Python tool has been developed for network-based stratification of tumor mutations?",
    "yulan-chat-2-13b-fp16_response": "The Python tool that has been developed for network-based stratification of tumor mutations is called \"NetworkStrat\". It is a tool that uses network-based approaches to identify mutations that are likely to be driver mutations in cancer, based on their position in the protein-protein interaction network. NetworkStrat can also be used to identify genes that are likely to be involved in cancer development, based on their position in the network and their interactions with other genes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. \"NetworkStrat\" is a Python tool developed for network-based stratification of tumor mutations.\n2. NetworkStrat uses network-based approaches to identify potential driver mutations in cancer.\n3. The tool identifies mutations by their position in the protein-protein interaction network.\n4. NetworkStrat can also be used to identify genes likely to be involved in cancer development.\n5. The identification of genes is based on their position in the network and interactions with other genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "\"NetworkStrat\" is a Python tool developed for network-based stratification of tumor mutations.",
      "NetworkStrat uses network-based approaches to identify potential driver mutations in cancer.",
      "The tool identifies mutations by their position in the protein-protein interaction network.",
      "NetworkStrat can also be used to identify genes likely to be involved in cancer development.",
      "The identification of genes is based on their position in the network and interactions with other genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nWithout specific knowledge about a tool named \"NetworkStrat,\" I cannot confirm or refute its existence or its purpose, hence the UNKNOWN status for statement 1. However, statements 2 through 5 describe typical functions of network-based stratification tools in bioinformatics that analyze mutations and genes within the context of protein-protein interaction networks, which would be consistent with such a tool's expected functionalities.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "yulan-chat-2-13b-fp16_response": "MLP (Myosin Light Chain Protein) regulates F-actin dynamics through its interaction with the actin filaments. MLP binds to the barbed end of actin filaments and promotes the polymerization of actin filaments by increasing the rate of addition of monomeric actin subunits to the growing filament. MLP also promotes the severing of actin filaments by the actin depolymerizing factor (ADF) and helps to regulate the length and stability of actin filaments. Additionally, MLP can also interact with other proteins such as tropomyosin and troponin to regulate the availability of actin filaments for polymerization.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MLP (Myosin Light Chain Protein) interacts with actin filaments to regulate F-actin dynamics.\n2. MLP binds to the barbed end of actin filaments.\n3. MLP promotes the polymerization of actin filaments by increasing the rate of monomeric actin subunits addition.\n4. MLP aids in the severing of actin filaments by the actin depolymerizing factor (ADF).\n5. MLP can interact with proteins like tropomyosin and troponin to regulate actin filament availability for polymerization.",
    "yulan-chat-2-13b-fp16_fact": [
      "MLP (Myosin Light Chain Protein) interacts with actin filaments to regulate F-actin dynamics.",
      "MLP binds to the barbed end of actin filaments.",
      "MLP promotes the polymerization of actin filaments by increasing the rate of monomeric actin subunits addition.",
      "MLP aids in the severing of actin filaments by the actin depolymerizing factor (ADF).",
      "MLP can interact with proteins like tropomyosin and troponin to regulate actin filament availability for polymerization."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: MLP (Myosin Light Chain Protein) does not bind to the actin filaments; myosin light chains are regulatory subunits of myosin that modulate muscle contraction by phosphorylation but do not directly bind to actin filaments.\n3. FALSE [correction]: MLP does not directly promote the polymerization of actin filaments; it typically regulates myosin activity which, indirectly, can affect muscle contraction and thus the dynamics of actin filament structure in muscle cells.\n4. FALSE [correction]: MLP itself is not involved in the severing of actin filaments; the actin depolymerizing factor (ADF)/cofilin family is responsible for this activity.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3116,
    "user_query": "What is CVT-301?",
    "yulan-chat-2-13b-fp16_response": "CVT-301 is an investigational drug being developed for the treatment of various types of cancer, including solid tumors and blood cancers. It is a form of immunotherapy, which is a type of cancer treatment that harnesses the power of the immune system to fight cancer cells.\nCVT-301 works by targeting a protein called CD19, which is found on the surface of certain types of B cells, a type of white blood cell that plays a role in the immune system. By targeting CD19, CVT-301 aims to kill B cells that are cancerous or contributing to the growth of cancer.\nCVT-301 is being tested in clinical trials for the treatment of various types of cancer, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and chronic lymphocytic leukemia (CLL). Early data from clinical trials have shown promising results, with some patients experiencing complete remission of their cancer. However, more research is needed to fully understand the safety and effectiveness of CVT-301 as a cancer treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CVT-301 is an investigational drug being developed to treat various types of cancer.\n2. CVT-301 is a form of immunotherapy.\n3. The drug targets the protein CD19 found on certain types of B cells.\n4. It is being tested in clinical trials for cancers such as diffuse large B-cell lymphoma, mantle cell lymphoma, and chronic lymphocytic leukemia.\n5. Some patients have experienced complete remission of their cancer in early clinical trials of CVT-301.",
    "yulan-chat-2-13b-fp16_fact": [
      "CVT-301 is an investigational drug being developed to treat various types of cancer.",
      "CVT-301 is a form of immunotherapy.",
      "The drug targets the protein CD19 found on certain types of B cells.",
      "It is being tested in clinical trials for cancers such as diffuse large B-cell lymphoma, mantle cell lymphoma, and chronic lymphocytic leukemia.",
      "Some patients have experienced complete remission of their cancer in early clinical trials of CVT-301."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific or up-to-date information regarding CVT-301, and with no passage provided to extract details from, it is impossible to determine the truthfulness of these statements. If CVT-301 is indeed an investigational drug, its function, targets, and the types of cancer it is being tested for, as well as results from any clinical trials, would need to be verified with current scientific research or clinical trial data.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3117,
    "user_query": "Are there tools for visualizing and processing long-read sequencing data?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are several tools available for visualizing and processing long-read sequencing data. Some popular tools include:\n1. IGV (Integrated Genomics Viewer): A web-based tool developed by the University of California, Santa Cruz (UCSC) for visualizing and analyzing long-read sequencing data.\n2. Artemis: A genome visualization and annotation tool developed by the Wellcome Trust Sanger Institute.\n3. Longranger: A tool developed by the University of California, Santa Cruz (UCSC) for analyzing and visualizing long-read sequencing data.\n4. Flye: A tool developed by the University of California, San Diego for visualizing and analyzing long-read sequencing data.\n5. Hi-C: A tool for analyzing the three-dimensional structure of chromosomes using long-read sequencing data.\n6. Nanopolish: A tool for generating high-quality consensus sequences from long-read sequencing data.\n7. Racon: A tool for analyzing and visualizing long-read sequencing data, developed by the University of California, Santa Cruz (UCSC).\nThese tools can help researchers visualize and analyze long-read sequencing data, and can be used to identify structural variations, detect novel genes and splice variants, and more.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Integrated Genomics Viewer (IGV) is a tool for visualizing and analyzing long-read sequencing data developed by the University of California, Santa Cruz (UCSC).\n2. Artemis is a genome visualization and annotation tool developed by the Wellcome Trust Sanger Institute.\n3. Longranger is a tool for analyzing and visualizing long-read sequencing data developed by the University of California, Santa Cruz (UCSC).\n4. Flye is a tool for visualizing and analyzing long-read sequencing data developed by the University of California, San Diego.\n5. Nanopolish is a tool for generating high-quality consensus sequences from long-read sequencing data.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Integrated Genomics Viewer (IGV) is a tool for visualizing and analyzing long-read sequencing data developed by the University of California, Santa Cruz (UCSC).",
      "Artemis is a genome visualization and annotation tool developed by the Wellcome Trust Sanger Institute.",
      "Longranger is a tool for analyzing and visualizing long-read sequencing data developed by the University of California, Santa Cruz (UCSC).",
      "Flye is a tool for visualizing and analyzing long-read sequencing data developed by the University of California, San Diego.",
      "Nanopolish is a tool for generating high-quality consensus sequences from long-read sequencing data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Integrated Genomics Viewer (IGV) is a tool developed by the Broad Institute for visualizing a wide variety of genomic data, including both short and long-read sequencing data, but not specifically for long-read sequencing.\n2. TRUE\n3. FALSE [correction]: Long Ranger is developed by 10x Genomics and it is for analyzing genomics data obtained from 10x Genomics' Chromium platform; it is not specifically a visualization tool and is not developed by UCSC.\n4. UNKNOWN: Flye is a de novo assembler for single molecule sequencing reads, such as those produced by PacBio and Oxford Nanopore Technologies. However, the statement does not clarify whether it's correct about the developer being from the University of California, San Diego. Therefore, the place of development for Flye is not clearly established with the given information.\n5. TRUE: Nanopolish is indeed a tool for improving the accuracy of nanopore sequencing reads, which is considered long-read sequencing, and it aims to generate high-quality consensus sequences.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3118,
    "user_query": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019).",
    "yulan-chat-2-13b-fp16_response": "As of 2019, there were several siRNA drugs that had entered phase 2-3 clinical trials. Here are some examples:\n1. Onpattro (patisiran) - developed by Alnylam Pharmaceuticals, this siRNA drug is being tested for the treatment of hereditary transthyretin-mediated amyloidosis.\n2. Luspatercept (RUXOR) - developed by Celgene, this siRNA drug is being tested for the treatment of patients with beta-thalassemia and myelodysplastic syndrome.\n3. MTL-CEBPA - developed by Metabolic Technologies, this siRNA drug is being tested for the treatment of non-alcoholic fatty liver disease.\n4. Givosiran - developed by Ionis Pharmaceuticals, this siRNA drug is being tested for the treatment of patients with hereditary thrombophilia.\n5. Volixibat - developed by Ionis Pharmaceuticals, this siRNA drug is being tested for the treatment of patients with non-alcoholic fatty liver disease and constipation.\nIt's important to note that clinical trials are ongoing and the status of these drugs may have changed since 2019.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Onpattro (patisiran) is an siRNA drug developed by Alnylam Pharmaceuticals and was being tested for hereditary transthyretin-mediated amyloidosis.\n2. Luspatercept (RUXOR) is an siRNA drug developed by Celgene being tested for beta-thalassemia and myelodysplastic syndrome.\n3. MTL-CEBPA is an siRNA drug developed by Metabolic Technologies being tested for non-alcoholic fatty liver disease.\n4. Givosiran is an siRNA drug developed by Ionis Pharmaceuticals being tested for hereditary thrombophilia.\n5. Volixibat is an siRNA drug developed by Ionis Pharmaceuticals being tested for non-alcoholic fatty liver disease and constipation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Onpattro (patisiran) is an siRNA drug developed by Alnylam Pharmaceuticals and was being tested for hereditary transthyretin-mediated amyloidosis.",
      "Luspatercept (RUXOR) is an siRNA drug developed by Celgene being tested for beta-thalassemia and myelodysplastic syndrome.",
      "MTL-CEBPA is an siRNA drug developed by Metabolic Technologies being tested for non-alcoholic fatty liver disease.",
      "Givosiran is an siRNA drug developed by Ionis Pharmaceuticals being tested for hereditary thrombophilia.",
      "Volixibat is an siRNA drug developed by Ionis Pharmaceuticals being tested for non-alcoholic fatty liver disease and constipation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Luspatercept is not an siRNA drug; it is a recombinant fusion protein developed by Celgene, now part of Bristol Myers Squibb, being tested for beta-thalassemia and myelodysplastic syndrome.\n3. TRUE\n4. FALSE [correction]: Givosiran is an siRNA drug developed by Alnylam Pharmaceuticals being tested for acute hepatic porphyria, not hereditary thrombophilia.\n5. FALSE [correction]: Volixibat is not an siRNA drug; it is an inhibitor of the bile acid transporter developed by Mirum Pharmaceuticals being tested for conditions like progressive familial intrahepatic cholestasis and bile acid synthesis disorders. Ionis Pharmaceuticals is not associated with this drug.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3119,
    "user_query": "Where is fatty acid binding protein 2 expressed?",
    "yulan-chat-2-13b-fp16_response": "Fatty acid binding protein 2 (FABP2) is a protein that is expressed in many tissues and cells throughout the body, including the liver, adipose tissue, muscle, and brain. It is involved in the uptake and metabolism of fatty acids, and plays a role in regulating energy balance and lipid metabolism. FABP2 is also expressed in the placenta, where it plays a role in fetal development and nutrient transport.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fatty acid binding protein 2 (FABP2) is expressed in the liver.\n2. FABP2 is expressed in adipose tissue.\n3. FABP2 is found in muscle tissue.\n4. The brain is one of the tissues where FABP2 is expressed.\n5. FABP2 is also expressed in the placenta and is involved in fetal development and nutrient transport.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fatty acid binding protein 2 (FABP2) is expressed in the liver.",
      "FABP2 is expressed in adipose tissue.",
      "FABP2 is found in muscle tissue.",
      "The brain is one of the tissues where FABP2 is expressed.",
      "FABP2 is also expressed in the placenta and is involved in fetal development and nutrient transport."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Fatty acid binding protein 2 (FABP2) is primarily expressed in the intestinal epithelium, not the liver.\n2. FALSE [correction]: FABP2 is not typically expressed in adipose tissue; other types of fatty acid binding proteins are expressed in adipose tissue.\n3. FALSE [correction]: FABP2 is not found in muscle tissue; like adipose tissue, other fatty acid binding proteins are found in muscle.\n4. FALSE [correction]: The brain expresses different types of fatty acid binding proteins, but not typically FABP2.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3121,
    "user_query": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis",
    "yulan-chat-2-13b-fp16_response": "Several computational tools have been developed for the analysis of alternative polyadenylation (APA) sites. Some of the commonly used tools are:\n1. PASA (Polyadenylation Site Analysis): PASA is a popular tool for the identification and quantification of APA events. It uses a combination of statistical models and alignment algorithms to detect and quantify APA sites in RNA-seq data.\n2. APAsite: APAsite is a tool that uses a de novo assembly approach to identify APA sites. It first assembles the transcripts and then searches for alternative polyadenylation sites by comparing the alignment scores of the different isoforms.\n3. TAPAS (Transcripts per Million): TAPAS is a tool that calculates the number of transcripts per million (TPM) for each isoform and uses this information to identify APA sites. It also provides a visualization of the APA sites and their corresponding isoforms.\n4. Scripture: Scripture is a tool that uses a de novo assembly approach to identify APA sites and quantify their expression levels. It also provides a visualization of the APA sites and their corresponding isoforms.\n5. PACER (Polyadenylation site Analysis by Cross-validation and Evaluation of Rates): PACER is a tool that uses a cross-validation approach to identify APA sites and quantify their expression levels. It also provides a visualization of the APA sites and their corresponding isoforms.\nThese tools can be used to identify and quantify APA events in RNA-seq data and can provide valuable insights into the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PASA (Polyadenylation Site Analysis) is a computational tool designed for the identification and quantification of alternative polyadenylation (APA) events in RNA-seq data.\n2. APAsite is a computational tool that identifies alternative polyadenylation sites using a de novo assembly approach.\n3. TAPAS (Transcripts per Million) calculates the number of transcripts per million for each isoform to identify APA sites and offers visualization of them.\n4. Scripture is a computational tool that identifies APA sites and quantifies their expression levels through a de novo assembly approach, including visualization capabilities.\n5. PACER (Polyadenylation site Analysis by Cross-validation and Evaluation of Rates) uses a cross-validation approach to identify and quantify APA sites, also providing visualization.",
    "yulan-chat-2-13b-fp16_fact": [
      "PASA (Polyadenylation Site Analysis) is a computational tool designed for the identification and quantification of alternative polyadenylation (APA) events in RNA-seq data.",
      "APAsite is a computational tool that identifies alternative polyadenylation sites using a de novo assembly approach.",
      "TAPAS (Transcripts per Million) calculates the number of transcripts per million for each isoform to identify APA sites and offers visualization of them.",
      "Scripture is a computational tool that identifies APA sites and quantifies their expression levels through a de novo assembly approach, including visualization capabilities.",
      "PACER (Polyadenylation site Analysis by Cross-validation and Evaluation of Rates) uses a cross-validation approach to identify and quantify APA sites, also providing visualization."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TAPAS stands for TAPAS (Tool for alternative polyadenylation site analysis), but it does not calculate transcripts per million (TPM). TPM is a measure of transcript abundance that could be calculated by various RNA-seq analysis tools, but TAPAS specifically focuses on the identification, analysis, and visualization of alternative polyadenylation sites.\n4. FALSE [correction]: Scripture is a computational tool used for assembling transcripts in RNA-seq data, but it is not specifically focused on alternative polyadenylation sites (APA sites). Scripture uses a de novo assembly approach to reconstruct transcripts, but its primary purpose is not the identification and quantification of APA sites, nor does it specifically include visualization capabilities for APA sites.\n5. UNKNOWN - There's no widely recognized computational tool by the name PACER specifically associated with polyadenylation site analysis in the literature referenced by available information up to my knowledge cutoff date. This statement may refer to a hypothetical or less-known tool, or it may be incorrect or a mix-up with a different acronym. Further contextual information is required to assess the accuracy of the statement.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3124,
    "user_query": "Which curated data resources for ChIP-seq data are available?",
    "yulan-chat-2-13b-fp16_response": "There are several curated data resources available for ChIP-seq data. Here are a few examples:\n1. ENCODE: The ENCODE (Encyclopedia of DNA Elements) project is a large-scale effort to identify and characterize all the functional elements in the human genome. As part of this effort, they have generated and made available ChIP-seq data for a variety of cell types and conditions. The data is available through the ENCODE website and the NCBI Gene expression omnibus (GEO) database.\n2. NCBI GEO: The NCBI GEO database is a publicly accessible repository of gene expression data, including ChIP-seq data. The database contains data from a wide range of organisms, and the data is curated and annotated by NCBI staff.\n3. ChIP-Seq Consortium: The ChIP-Seq Consortium is a group of researchers who have collaborated to generate and make available ChIP-seq data for a variety of cell types and conditions. The data is available through the NCBI GEO database and the University of California, Santa Cruz (UCSC) Genome Browser.\n4. Epigenome Roadmap: The Epigenome Roadmap is a large-scale effort to map the human epigenome, including ChIP-seq data for a variety of cell types and conditions. The data is available through the NCBI GEO database and the EBI Epigenome Browser.\n5. EBI Epigenome Browser: The EBI Epigenome Browser is a web-based tool that provides access to a wide range of epigenome data, including ChIP-seq data. The data is curated and annotated by EBI staff, and is available for a variety of organisms.\nThese are just a few examples of the many curated data resources available for ChIP-seq data. It's important to carefully evaluate the quality and relevance of any data resource before using it for downstream analysis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The ENCODE project aims to identify and characterize all functional elements in the human genome and provides ChIP-seq data.\n2. The NCBI Gene Expression Omnibus (GEO) database is a publicly accessible repository that includes ChIP-seq data and is curated by NCBI staff.\n3. The ChIP-Seq Consortium has generated ChIP-seq data which is available through the NCBI GEO database and the UCSC Genome Browser.\n4. The Epigenome Roadmap project is an effort to map the human epigenome and offers ChIP-seq data through the NCBI GEO database and the EBI Epigenome Browser.\n5. The EBI Epigenome Browser is a web-based tool that provides curated epigenome data, including ChIP-seq data, annotated by EBI staff.",
    "yulan-chat-2-13b-fp16_fact": [
      "The ENCODE project aims to identify and characterize all functional elements in the human genome and provides ChIP-seq data.",
      "The NCBI Gene Expression Omnibus (GEO) database is a publicly accessible repository that includes ChIP-seq data and is curated by NCBI staff.",
      "The ChIP-Seq Consortium has generated ChIP-seq data which is available through the NCBI GEO database and the UCSC Genome Browser.",
      "The Epigenome Roadmap project is an effort to map the human epigenome and offers ChIP-seq data through the NCBI GEO database and the EBI Epigenome Browser.",
      "The EBI Epigenome Browser is a web-based tool that provides curated epigenome data, including ChIP-seq data, annotated by EBI staff."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is no formal group known as the \"ChIP-Seq Consortium\". However, various consortia and research groups have generated ChIP-seq data which is available through the NCBI GEO database and other platforms.\n4. FALSE [correction]: The effort to map the human epigenome is known as the Roadmap Epigenomics Project, not the Epigenome Roadmap project. It provides a variety of epigenomic data, which may include ChIP-seq data, and this data is accessible through repositories such as the NCBI GEO database, not specifically through the \"EBI Epigenome Browser.\"\n5. FALSE [correction]: The EBI provides various data browsing tools; however, as of my last update, the specific \"EBI Epigenome Browser\" is not a recognized tool. The Ensembl Genome Browser is one tool developed by EBI, which allows the exploration of genomic data, not exclusively epigenome data. EBI staff may curate datasets that could be accessed through different tools, such as Ensembl or other platforms like the UCSC Genome Browser.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "yulan-chat-2-13b-fp16_response": "The human kinome contains approximately 512 pseudokinases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The human kinome contains approximately 512 pseudokinases.",
    "yulan-chat-2-13b-fp16_fact": [
      "The human kinome contains approximately 512 pseudokinases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The human kinome is estimated to contain about 20% pseudokinases out of approximately 500-600 recognized human protein kinases. This would approximate to 100-120 pseudokinases rather than 512.",
    "yulan-chat-2-13b-fp16_judge": [
      "false"
    ]
  },
  {
    "id": 3126,
    "user_query": "What is the mechanism of action of Inclisiran?",
    "yulan-chat-2-13b-fp16_response": "Inclisiran is an investigational drug being developed for the treatment of chronic diseases, including cardiovascular disease and cancer. It works by inhibiting the production of a protein called siRNA, which is involved in the regulation of gene expression. By inhibiting the production of siRNA, inclisiran can increase the expression of specific genes, leading to changes in cell behavior that may be beneficial for the treatment of certain diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3127,
    "user_query": "Which tool has been developed for visualization of non-covalent contacts?",
    "yulan-chat-2-13b-fp16_response": "One tool that is commonly used for visualization of non-covalent contacts is the molecular visualization software PyMOL. PyMOL is a system for displaying and manipulating large biomolecular systems, including proteins, nucleic acids, and lipids. It allows users to visualize the atoms and bonds within a molecule, as well as the non-covalent interactions between molecules, such as hydrogen bonds, electrostatic interactions, and van der Waals forces. PyMOL also has a variety of tools for manipulating and analyzing molecular structures, including the ability to create animations and visualizations of molecular dynamics.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PyMOL is a tool used for visualization of non-covalent contacts.\n2. PyMOL can display and manipulate large biomolecular systems, including proteins, nucleic acids, and lipids.\n3. The software allows for visualization of atoms and bonds within a molecule.\n4. PyMOL can visualize non-covalent interactions such as hydrogen bonds, electrostatic interactions, and van der Waals forces.\n5. PyMOL offers tools for creating animations and visualizations of molecular dynamics.",
    "yulan-chat-2-13b-fp16_fact": [
      "PyMOL is a tool used for visualization of non-covalent contacts.",
      "PyMOL can display and manipulate large biomolecular systems, including proteins, nucleic acids, and lipids.",
      "The software allows for visualization of atoms and bonds within a molecule.",
      "PyMOL can visualize non-covalent interactions such as hydrogen bonds, electrostatic interactions, and van der Waals forces.",
      "PyMOL offers tools for creating animations and visualizations of molecular dynamics."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3130,
    "user_query": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?",
    "yulan-chat-2-13b-fp16_response": "Yes, apoE mimetics are being considered as a potential treatment for Alzheimer's disease. ApoE (apolipoprotein E) is a protein that plays a key role in the transport of cholesterol and other lipids in the brain. There are three variants of apoE: apoE2, apoE3, and apoE4. The apoE4 variant is associated with an increased risk of developing Alzheimer's disease.\nApoE mimetics are compounds that mimic the structure and function of apoE, with the goal of promoting brain health and reducing the risk of Alzheimer's disease. These compounds may be designed to selectively promote the production of apoE2 or apoE3, which are considered to be protective against Alzheimer's disease, while reducing the production of apoE4.\nSeveral studies have shown that apoE mimetics may have potential as a treatment for Alzheimer's disease. For example, a study published in the journal Nature Medicine in 2021 found that an apoE mimetic called C2N8Tg was able to reduce amyloid-beta plaques and improve cognitive function in a mouse model of Alzheimer's disease.\nHowever, it is important to note that the development of apoE mimetics as a treatment for Alzheimer's disease is still in the early stages, and much more research is needed to determine their safety and effectiveness in humans.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ApoE mimetics are being considered as potential treatments for Alzheimer's disease.\n2. ApoE is a protein involved in cholesterol and lipid transport in the brain.\n3. There are three variants of apoE: apoE2, apoE3, and apoE4.\n4. The apoE4 variant is associated with an increased risk of Alzheimer's disease.\n5. A study in the journal Nature Medicine in 2021 reported that an apoE mimetic, C2N8Tg, reduced amyloid-beta plaques and improved cognitive function in a mouse model of Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "ApoE mimetics are being considered as potential treatments for Alzheimer's disease.",
      "ApoE is a protein involved in cholesterol and lipid transport in the brain.",
      "There are three variants of apoE: apoE2, apoE3, and apoE4.",
      "The apoE4 variant is associated with an increased risk of Alzheimer's disease.",
      "A study in the journal Nature Medicine in 2021 reported that an apoE mimetic, C2N8Tg, reduced amyloid-beta plaques and improved cognitive function in a mouse model of Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN (without access to the specific study, the details cannot be verified)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3135,
    "user_query": "What does Prevnar 13 consist of?",
    "yulan-chat-2-13b-fp16_response": "Prevnar 13 is a pneumococcal conjugate vaccine used to protect infants, young children, and adults against disease caused by the pneumococcus bacterium. It is a conjugate vaccine, which means it contains a mixture of polysaccharides (sugar molecules) from the capsular polysaccharides of the 13 most common serotypes (strains) of the pneumococcus bacterium.\nThe 13 serotypes included in Prevnar 13 are: 1, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, and 18C. These serotypes are responsible for the majority of pneumococcal disease cases worldwide.\nPneumococcal disease can cause a variety of illnesses, including pneumonia, meningitis, and ear infections. The vaccine works by introducing small amounts of the polysaccharides from the 13 serotypes into the body, which stimulates the immune system to produce antibodies that can fight off the infection if the person is later exposed to the actual bacterium.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prevnar 13 is a pneumococcal conjugate vaccine.\n2. Prevnar 13 is used to protect against diseases caused by the pneumococcus bacterium.\n3. The vaccine contains a mixture of polysaccharides from the capsular polysaccharides of the 13 most common serotypes of the pneumococcus bacterium.\n4. The serotypes included in Prevnar 13 are 1, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, and 18C.\n5. Pneumococcal disease can lead to illnesses such as pneumonia, meningitis, and ear infections.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prevnar 13 is a pneumococcal conjugate vaccine.",
      "Prevnar 13 is used to protect against diseases caused by the pneumococcus bacterium.",
      "The vaccine contains a mixture of polysaccharides from the capsular polysaccharides of the 13 most common serotypes of the pneumococcus bacterium.",
      "The serotypes included in Prevnar 13 are 1, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, and 18C.",
      "Pneumococcal disease can lead to illnesses such as pneumonia, meningitis, and ear infections."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The vaccine contains a mixture of polysaccharides from the capsular polysaccharides of the 13 most common serotypes of the pneumococcus bacterium that are conjugated to a carrier protein.\n4. FALSE [correction]: The serotypes included in Prevnar 13 are 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3137,
    "user_query": "What is the cause of a STAG3 truncating variant?",
    "yulan-chat-2-13b-fp16_response": "A STAG3 truncating variant is a genetic mutation that occurs when a segment of DNA is missing from a gene. This type of mutation can occur in any gene, but it is particularly common in genes that are involved in the development and function of the nervous system.\nThe cause of a STAG3 truncating variant is typically a genetic error that occurs during the process of DNA replication. During DNA replication, the DNA double helix is unwound and each strand serves as a template for the synthesis of a new strand. If there is a mistake made during this process, such as the failure to properly separate the two strands of the DNA molecule, a STAG3 truncating variant can occur.\nIn the case of a STAG3 truncating variant, the mutation results in the deletion of a portion of the gene. This can lead to a number of different effects, depending on the function of the gene that is affected. In some cases, a STAG3 truncating variant can cause a genetic disorder or other health problems. In other cases, it may not have any noticeable effects on health.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A STAG3 truncating variant is a type of genetic mutation where a segment of DNA is missing from a gene.\n2. STAG3 truncating variants can occur in any gene but are commonly found in genes related to the development and function of the nervous system.\n3. The cause of a STAG3 truncating variant is typically a genetic error during DNA replication.\n4. A mistake in the separation of DNA strands during replication can lead to a STAG3 truncating variant.\n5. The mutation in a STAG3 truncating variant results in the deletion of a portion of the gene affected.",
    "yulan-chat-2-13b-fp16_fact": [
      "A STAG3 truncating variant is a type of genetic mutation where a segment of DNA is missing from a gene.",
      "STAG3 truncating variants can occur in any gene but are commonly found in genes related to the development and function of the nervous system.",
      "The cause of a STAG3 truncating variant is typically a genetic error during DNA replication.",
      "A mistake in the separation of DNA strands during replication can lead to a STAG3 truncating variant.",
      "The mutation in a STAG3 truncating variant results in the deletion of a portion of the gene affected."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: While STAG3 truncating variants do occur in the STAG3 gene, which is important for cell division and may affect various systems including the nervous system, this statement wrongly implies that STAG3 truncating variants are common in any genes related to the nervous system's development and function.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3138,
    "user_query": "Which tools have been developed for computing split-networks?",
    "yulan-chat-2-13b-fp16_response": "Split-networks are a type of network that can be used to analyze the behavior of a system or process. There are several tools that have been developed for computing split-networks, including:\n1. NetSpy: NetSpy is a tool that can be used to analyze the behavior of a system or process by computing split-networks. It is a graphical tool that allows users to visualize the split-networks and understand the relationships between the different components of the system.\n2. NetworkX: NetworkX is a Python library for the creation, manipulation, and analysis of complex networks. It can be used to compute split-networks and visualize the relationships between the different components of a system.\n3. Gephi: Gephi is an open-source software for network analysis and visualization. It can be used to compute split-networks and visualize the relationships between the different components of a system.\n4. Cytoscape: Cytoscape is an open-source software for network analysis and visualization. It can be used to compute split-networks and visualize the relationships between the different components of a system.\n5. NodeXL: NodeXL is an open-source, free, and extendable template for Microsoft Excel that can be used to create and visualize networks. It can be used to compute split-networks and visualize the relationships between the different components of a system.\nThese are some of the popular tools that have been developed for computing split-networks.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NetSpy is a tool designed for analyzing systems or processes by computing split-networks.\n2. NetworkX is a Python library that can compute split-networks.\n3. Gephi is an open-source software for network analysis that can compute split-networks.\n4. Cytoscape is an open-source software that can be used for computing split-networks.\n5. NodeXL is an extendable template for Microsoft Excel that can compute split-networks.",
    "yulan-chat-2-13b-fp16_fact": [
      "NetSpy is a tool designed for analyzing systems or processes by computing split-networks.",
      "NetworkX is a Python library that can compute split-networks.",
      "Gephi is an open-source software for network analysis that can compute split-networks.",
      "Cytoscape is an open-source software that can be used for computing split-networks.",
      "NodeXL is an extendable template for Microsoft Excel that can compute split-networks."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: NetworkX is a Python library used for the creation, manipulation, and study of the structure, dynamics, and functions of complex networks. It does not specifically compute split-networks, but could potentially be used as part of an analysis that includes split-networks.\n3. FALSE [correction]: Gephi is an open-source software for network analysis and visualization, but it is not specifically aimed at computing split-networks. It focuses more on network visualization and exploration.\n4. UNKNOWN\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "yulan-chat-2-13b-fp16_response": "ApoE mimetics are compounds that mimic the function of apolipoprotein E (ApoE), a protein that plays a key role in lipid metabolism and is involved in the development of several diseases, including atherosclerosis and Alzheimer's disease. Here are three examples of ApoE mimetics:\n1. Anle138b: Anle138b is a synthetic compound that has been shown to mimic the effects of ApoE on lipid metabolism and atherosclerosis in animal models. It has been studied as a potential treatment for atherosclerosis and other cardiovascular diseases.\n2. GSI-943: GSI-943 is a small molecule that has been developed as an ApoE mimetic. It has been shown to improve lipid profiles and reduce atherosclerosis in animal models. It is currently being studied as a potential treatment for atherosclerosis and other cardiovascular diseases.\n3. LC-1: LC-1 is a synthetic compound that has been shown to mimic the effects of ApoE on lipid metabolism and atherosclerosis in animal models. It has been studied as a potential treatment for atherosclerosis and other cardiovascular diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Anle138b is a synthetic compound that acts as an ApoE mimetic.\n2. GSI-943 is a small molecule developed as an ApoE mimetic.\n3. LC-1 is a synthetic compound that has been shown to mimic the effects of ApoE on lipid metabolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "Anle138b is a synthetic compound that acts as an ApoE mimetic.",
      "GSI-943 is a small molecule developed as an ApoE mimetic.",
      "LC-1 is a synthetic compound that has been shown to mimic the effects of ApoE on lipid metabolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Anle138b is a synthetic compound, but it is not an ApoE mimetic. It is designed to inhibit the aggregation of pathogenic protein assemblies like those found in Parkinson's and other neurodegenerative diseases.\n2. UNKNOWN\n3. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "yulan-chat-2-13b-fp16_response": "Studies have shown that there may be sex differences in SAMHD1 activity. For example, one study found that SAMHD1 expression was higher in the brains of male mice compared to female mice, and that this difference was associated with differences in behavior related to reward and addiction. Another study found that SAMHD1 activity was higher in the brains of male rats compared to female rats, and that this difference was associated with differences in the response to cocaine. However, more research is needed to fully understand the extent and mechanisms of sex differences in SAMHD1 activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A study found that SAMHD1 expression was higher in the brains of male mice compared to female mice.\n2. The study suggested that higher SAMHD1 expression in male mice was associated with differences in behavior related to reward and addiction.\n3. Another study observed that SAMHD1 activity was higher in the brains of male rats compared to female rats.\n4. The study on rats linked higher SAMHD1 activity in males with differences in the response to cocaine.",
    "yulan-chat-2-13b-fp16_fact": [
      "A study found that SAMHD1 expression was higher in the brains of male mice compared to female mice.",
      "The study suggested that higher SAMHD1 expression in male mice was associated with differences in behavior related to reward and addiction.",
      "Another study observed that SAMHD1 activity was higher in the brains of male rats compared to female rats.",
      "The study on rats linked higher SAMHD1 activity in males with differences in the response to cocaine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific references to the original studies or additional context that would verify these statements, I cannot accurately determine the truthfulness of the claims regarding SAMHD1 expression in male and female mice or rats, or the associated behavioral consequences.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3144,
    "user_query": "Is the protein Asporin related to disease?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I couldn't find any information about a protein called \"Asporin\" in my database. It's possible that it's a protein that has not been well-studied or documented.\nIf you have any additional information about Asporin, such as its full name or a description of its function, I may be able to provide more information or help you find relevant research.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3147,
    "user_query": "Which cells secrete lactotransferrin?",
    "yulan-chat-2-13b-fp16_response": "Lactotransferrin is a protein that is synthesized and secreted by various types of cells in the body, including:\n1. Liver cells (hepatocytes): The liver is the main site of lactotransferrin synthesis and secretion. Lactotransferrin is synthesized as a precursor protein in the rough endoplasmic reticulum (ER) of hepatocytes and is then transported to the Golgi apparatus for further processing and secretion.\n2. Milk-secreting cells (mammary epithelial cells): Lactotransferrin is also synthesized and secreted by mammary epithelial cells in the mammary gland, where it plays a role in protecting newborns from infections by binding to and removing bacteria from milk.\n3. Other secretory cells: Lactotransferrin is also synthesized and secreted by other secretory cells in the body, such as cells in the salivary glands, tear ducts, and pancreas.\nIn addition to these cells, lactotransferrin is also found in other tissues and bodily fluids, such as blood, cerebrospinal fluid, and sweat.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Liver cells (hepatocytes) synthesize and secrete lactotransferrin.\n2. Lactotransferrin is also synthesized and secreted by mammary epithelial cells in the mammary gland.\n3. Lactotransferrin plays a role in protecting newborns from infections by binding to and removing bacteria from milk.\n4. Cells in the salivary glands, tear ducts, and pancreas are among other secretory cells that synthesize and secrete lactotransferrin.\n5. Lactotransferrin is found in bodily fluids such as blood, cerebrospinal fluid, and sweat.",
    "yulan-chat-2-13b-fp16_fact": [
      "Liver cells (hepatocytes) synthesize and secrete lactotransferrin.",
      "Lactotransferrin is also synthesized and secreted by mammary epithelial cells in the mammary gland.",
      "Lactotransferrin plays a role in protecting newborns from infections by binding to and removing bacteria from milk.",
      "Cells in the salivary glands, tear ducts, and pancreas are among other secretory cells that synthesize and secrete lactotransferrin.",
      "Lactotransferrin is found in bodily fluids such as blood, cerebrospinal fluid, and sweat."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Liver cells do not synthesize and secrete lactotransferrin; instead, lactoferrin, which is a similar protein, is primarily secreted by glandular secretory cells, such as mammary epithelial cells, and found in various body fluids.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3150,
    "user_query": "What is the function of the protein Magt1?",
    "yulan-chat-2-13b-fp16_response": "Magt1 is a protein that in humans is encoded by the \"MT-TP1\" gene. The function of Magt1 is not well understood, as it has not been extensively studied. However, it is known to be a member of the mitochondrial TOM complex protein family, which is involved in the import of proteins into the mitochondrial matrix. Magt1 may play a role in regulating mitochondrial function and dynamics, but further research is needed to fully understand its function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Magt1 is a protein in humans.\n2. The gene encoding Magt1 is referred to as \"MT-TP1.\"\n3. Magt1 is a member of the mitochondrial TOM complex protein family.\n4. The mitochondrial TOM complex protein family is associated with the import of proteins into the mitochondrial matrix.",
    "yulan-chat-2-13b-fp16_fact": [
      "Magt1 is a protein in humans.",
      "The gene encoding Magt1 is referred to as \"MT-TP1.\"",
      "Magt1 is a member of the mitochondrial TOM complex protein family.",
      "The mitochondrial TOM complex protein family is associated with the import of proteins into the mitochondrial matrix."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The gene encoding Magt1 is referred to as \"MAGT1.\"\n3. FALSE [correction]: Magt1 is not a member of the mitochondrial TOM complex protein family; it is actually involved in magnesium transport.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3152,
    "user_query": "What is the function of the transcriptional co-activator p300?",
    "yulan-chat-2-13b-fp16_response": "The transcriptional co-activator p300 plays a key role in the regulation of gene expression by functioning as a bridge between transcription factors and the basal transcriptional machinery. Specifically, p300 associates with transcription factors and enhances their transcriptional activity by recruiting additional co-activators and modifying chromatin structure to facilitate the binding of RNA polymerase II to the promoter region of genes. Additionally, p300 has been shown to be involved in a variety of other cellular processes, including cell cycle progression, differentiation, and apoptosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The transcriptional co-activator p300 plays a key role in the regulation of gene expression.\n2. P300 functions as a bridge between transcription factors and the basal transcriptional machinery.\n3. It associates with transcription factors and enhances their transcriptional activity.\n4. P300 recruits additional co-activators and modifies chromatin structure to facilitate RNA polymerase II binding to promoters.\n5. P300 is involved in cellular processes such as cell cycle progression, differentiation, and apoptosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "The transcriptional co-activator p300 plays a key role in the regulation of gene expression.",
      "P300 functions as a bridge between transcription factors and the basal transcriptional machinery.",
      "It associates with transcription factors and enhances their transcriptional activity.",
      "P300 recruits additional co-activators and modifies chromatin structure to facilitate RNA polymerase II binding to promoters.",
      "P300 is involved in cellular processes such as cell cycle progression, differentiation, and apoptosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided describe well-known roles of the transcriptional co-activator p300 in gene expression regulation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3158,
    "user_query": "What is a mitosome?",
    "yulan-chat-2-13b-fp16_response": "Mitosomes are small, double-membrane-bound organelles found in some eukaryotic cells, such as yeast and some protists. They are thought to have evolved from mitochondria and are involved in various cellular processes, including energy production, calcium signaling, and cell cycle progression. Mitosomes are typically much smaller than mitochondria and lack many of the protein complexes found in mitochondria, but they still contain some of the genetic material necessary for their function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mitosomes are organelles found in some eukaryotic cells.\n2. They are double-membrane-bound organelles.\n3. Mitosomes are thought to have evolved from mitochondria.\n4. Mitosomes are involved in cellular processes such as energy production, calcium signaling, and cell cycle progression.\n5. Mitosomes are typically smaller than mitochondria and lack many of the protein complexes found in mitochondria.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mitosomes are organelles found in some eukaryotic cells.",
      "They are double-membrane-bound organelles.",
      "Mitosomes are thought to have evolved from mitochondria.",
      "Mitosomes are involved in cellular processes such as energy production, calcium signaling, and cell cycle progression.",
      "Mitosomes are typically smaller than mitochondria and lack many of the protein complexes found in mitochondria."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Mitosomes are single-membrane-bound organelles.\n3. TRUE\n4. FALSE [correction]: Mitosomes are not involved in energy production like mitochondria; some of their functions remain unclear, but they are not known for energy production.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3164,
    "user_query": "What is the effect of NFIA on astrocyte differentiation?",
    "yulan-chat-2-13b-fp16_response": "NFIA (Nuclear Factors, Inhibition of Appetite) is a transcription factor that plays a role in the regulation of energy balance and metabolism. It has been shown to have an effect on astrocyte differentiation, which is the process by which precursor cells develop into mature astrocytes, a type of glial cell in the brain.\nStudies have shown that NFIA can promote the differentiation of precursor cells into astrocytes by regulating the expression of genes that are involved in the development and function of these cells. NFIA can also help to maintain the stability and function of mature astrocytes by regulating the expression of genes that are involved in the maintenance of these cells.\nOverall, NFIA appears to have a positive effect on astrocyte differentiation and function, and it may play an important role in the regulation of brain development and function. However, more research is needed to fully understand the mechanisms by which NFIA affects astrocyte differentiation and to determine its potential therapeutic applications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NFIA (Nuclear Factors, Inhibition of Appetite) is a transcription factor involved in regulation of energy balance and metabolism.\n2. NFIA has been shown to affect the differentiation of precursor cells into astrocytes.\n3. Astrocyte differentiation is the process by which precursor cells develop into mature astrocytes, which are a type of glial cell in the brain.\n4. NFIA can regulate the expression of genes involved in the development and function of astrocytes.\n5. NFIA also plays a role in maintaining the stability and function of mature astrocytes through gene regulation.",
    "yulan-chat-2-13b-fp16_fact": [
      "NFIA (Nuclear Factors, Inhibition of Appetite) is a transcription factor involved in regulation of energy balance and metabolism.",
      "NFIA has been shown to affect the differentiation of precursor cells into astrocytes.",
      "Astrocyte differentiation is the process by which precursor cells develop into mature astrocytes, which are a type of glial cell in the brain.",
      "NFIA can regulate the expression of genes involved in the development and function of astrocytes.",
      "NFIA also plays a role in maintaining the stability and function of mature astrocytes through gene regulation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: NFIA stands for Nuclear Factor I/A, and although it is a transcription factor, it is not specifically known as \"Nuclear Factors, Inhibition of Appetite.\" Its role in the regulation of energy balance and metabolism is not well-established.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nWhile NFIA is indeed involved in astrocyte differentiation by regulating gene expression, the specific role in maintaining the stability and function of mature astrocytes through gene regulation is more complex and would need more context or specific scientific evidence to confirm.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3165,
    "user_query": "What is the mode of action for Tocilizumab?",
    "yulan-chat-2-13b-fp16_response": "Tocilizumab is a monoclonal antibody that works by binding to interleukin-6 (IL-6), a cytokine that plays a role in the immune system and inflammation. By binding to IL-6, tocilizumab inhibits its activity, which can help reduce inflammation and immune system activity.\nTocilizumab is used to treat a variety of conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, and cytokine storm syndrome associated with COVID-19. In these conditions, tocilizumab can help reduce inflammation and prevent or mitigate the overactive immune response that can cause damage to the body.\nOverall, the mode of action of tocilizumab is to target and inhibit the activity of a specific cytokine (IL-6) that is involved in the immune response and inflammation, leading to reduced inflammation and immune system activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tocilizumab is a monoclonal antibody.\n2. It works by binding to interleukin-6 (IL-6), which is a cytokine involved in the immune system and inflammation.\n3. The binding of tocilizumab to IL-6 inhibits its activity and can help reduce inflammation.\n4. Tocilizumab is used in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis.\n5. Tocilizumab is also used to treat cytokine storm syndrome associated with COVID-19.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tocilizumab is a monoclonal antibody.",
      "It works by binding to interleukin-6 (IL-6), which is a cytokine involved in the immune system and inflammation.",
      "The binding of tocilizumab to IL-6 inhibits its activity and can help reduce inflammation.",
      "Tocilizumab is used in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis.",
      "Tocilizumab is also used to treat cytokine storm syndrome associated with COVID-19."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The binding of tocilizumab to IL-6 receptors inhibits IL-6 signaling and can help reduce inflammation.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3166,
    "user_query": "Where is the protein protamine 2 expressed?",
    "yulan-chat-2-13b-fp16_response": "Protamine 2 is a protein that is expressed in the sperm of many animal species, including humans. It is a type of sperm protein that is involved in the formation of the sperm tail, and it is thought to play a role in the fertility of these animals. Protamine 2 is also found in other tissues and organs, including the brain, where it may have a protective function. It is not clear exactly how protamine 2 functions in these different tissues, but it is thought to play a role in protecting cells from damage and in regulating the activity of certain enzymes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Protamine 2 is expressed in the sperm of many animal species, including humans.\n2. Protamine 2 is involved in the formation of the sperm tail.\n3. It is thought that protamine 2 plays a role in animal fertility.\n4. Protamine 2 is found in other tissues and organs, including the brain.\n5. It is suggested that protamine 2 may have a protective function in cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Protamine 2 is expressed in the sperm of many animal species, including humans.",
      "Protamine 2 is involved in the formation of the sperm tail.",
      "It is thought that protamine 2 plays a role in animal fertility.",
      "Protamine 2 is found in other tissues and organs, including the brain.",
      "It is suggested that protamine 2 may have a protective function in cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Protamine 2 is involved in packaging DNA in sperm and is not responsible for the formation of the sperm tail. The formation of the sperm tail is generally associated with the structure called the flagellum.\n3. TRUE\n4. FALSE [correction]: Protamine 2 is primarily found in sperm cells; while it may be present in trace amounts elsewhere due to its specific function in sperm, it is not widely found in other tissues and organs like the brain.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3173,
    "user_query": "Can prevnar 13 be used in children?",
    "yulan-chat-2-13b-fp16_response": "Yes, Prevnar 13 (Pneumococcal Conjugate Vaccine) can be used in children. In fact, it is recommended for children as a part of the regular immunization schedule in many countries. The vaccine is designed to protect infants, young children, and adults against disease caused by the pneumococcal bacteria. It is generally given to children as young as 2 months old, and a series of doses are recommended to ensure optimal protection. It is important to consult with a healthcare provider to determine the specific vaccination schedule for your child.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Prevnar 13 is a Pneumococcal Conjugate Vaccine.\n2. Prevnar 13 is recommended for children in the regular immunization schedule in many countries.\n3. The vaccine aims to protect infants, young children, and adults from diseases caused by pneumococcal bacteria.\n4. Prevnar 13 is administered to children starting at 2 months old.\n5. A series of doses of Prevnar 13 is recommended for optimal protection.",
    "yulan-chat-2-13b-fp16_fact": [
      "Prevnar 13 is a Pneumococcal Conjugate Vaccine.",
      "Prevnar 13 is recommended for children in the regular immunization schedule in many countries.",
      "The vaccine aims to protect infants, young children, and adults from diseases caused by pneumococcal bacteria.",
      "Prevnar 13 is administered to children starting at 2 months old.",
      "A series of doses of Prevnar 13 is recommended for optimal protection."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3174,
    "user_query": "Was stelara developed by Amgen?",
    "yulan-chat-2-13b-fp16_response": "Yes, Stelara (ustekinumab) is a drug developed by Amgen. It is a monoclonal antibody that is used to treat a number of inflammatory conditions, including psoriasis, Crohn's disease, and ulcerative colitis. Stelara works by targeting and blocking certain proteins that play a role in the immune system's response to inflammation. It was approved by the US Food and Drug Administration (FDA) in 2012, and has since been approved in other countries as well.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Stelara, also known as ustekinumab, was developed by Amgen.\n2. Stelara is used to treat inflammatory conditions such as psoriasis, Crohn's disease, and ulcerative colitis.\n3. It is a monoclonal antibody that targets and blocks proteins involved in the immune response to inflammation.\n4. The US Food and Drug Administration approved Stelara in 2012.\n5. Stelara has been approved in other countries besides the United States.",
    "yulan-chat-2-13b-fp16_fact": [
      "Stelara, also known as ustekinumab, was developed by Amgen.",
      "Stelara is used to treat inflammatory conditions such as psoriasis, Crohn's disease, and ulcerative colitis.",
      "It is a monoclonal antibody that targets and blocks proteins involved in the immune response to inflammation.",
      "The US Food and Drug Administration approved Stelara in 2012.",
      "Stelara has been approved in other countries besides the United States."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Stelara, also known as ustekinumab, was developed by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The US Food and Drug Administration first approved Stelara in 2009 for the treatment of adults with moderate to severe plaque psoriasis.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3178,
    "user_query": "What is the cause of Krabbe disease?",
    "yulan-chat-2-13b-fp16_response": "Krabbe disease is caused by a genetic mutation that results in the absence of a specific enzyme called galactosylceramide beta-galactosidase. This enzyme is important for the proper functioning of the nervous system, and without it, nerve cells become damaged and eventually die. The mutation that causes Krabbe disease is inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated gene (one from each parent) in order to develop the disease. Krabbe disease is a rare and severe form of infantile neurological disorder that typically presents in the first few months of life, and unfortunately, there is currently no cure for the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Krabbe disease is caused by a genetic mutation that results in the absence of the enzyme galactosylceramide beta-galactosidase.\n2. The enzyme galactosylceramide beta-galactosidase is important for the proper functioning of the nervous system.\n3. In Krabbe disease, the absence of this enzyme leads to damage and death of nerve cells.\n4. The genetic mutation causing Krabbe disease is inherited in an autosomal recessive pattern.\n5. Krabbe disease typically presents in the first few months of life and currently has no cure.",
    "yulan-chat-2-13b-fp16_fact": [
      "Krabbe disease is caused by a genetic mutation that results in the absence of the enzyme galactosylceramide beta-galactosidase.",
      "The enzyme galactosylceramide beta-galactosidase is important for the proper functioning of the nervous system.",
      "In Krabbe disease, the absence of this enzyme leads to damage and death of nerve cells.",
      "The genetic mutation causing Krabbe disease is inherited in an autosomal recessive pattern.",
      "Krabbe disease typically presents in the first few months of life and currently has no cure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3182,
    "user_query": "What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome",
    "yulan-chat-2-13b-fp16_response": "Noonan syndrome is a genetic disorder that is characterized by a range of developmental problems and physical abnormalities. Some of the most common phenotypic features of Noonan syndrome include:\n* Short stature\n* Weak muscle tone (low muscle tone)\n* Short-fused fingers and toes\n* Wide spaces between the fingers and toes\n* A broad, upturned nose\n* A low-set, posteriorly tilted pelvis\n* A distinctive \"pulled-forward\" appearance of the ears\n* A characteristic facial expression, which may include a wide forehead, deep-set eyes, and a broad, flat nasal bridge\n* Delayed bone age\n* Short limbs\n* Short neck\n* Weakness of the muscles used for chewing and swallowing\n* Developmental delays\n* Learning disabilities\n* Short stature\n* Increased risk of cardiovascular problems, such as pulmonary valve stenosis and hypertrophic cardiomyopathy\nIt's important to note that not all people with Noonan syndrome will have all of these features, and some may have only a few. Additionally, some of these features may be present in people without Noonan syndrome, so a diagnosis can only be made by a medical professional with experience in genetic disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Noonan syndrome is characterized by short stature.\n2. Individuals with Noonan syndrome may have short-fused fingers and toes.\n3. A common feature of Noonan syndrome is a broad, upturned nose.\n4. Delayed bone age is a phenotypic feature of Noonan syndrome.\n5. Noonan syndrome can increase the risk of cardiovascular problems such as pulmonary valve stenosis and hypertrophic cardiomyopathy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Noonan syndrome is characterized by short stature.",
      "Individuals with Noonan syndrome may have short-fused fingers and toes.",
      "A common feature of Noonan syndrome is a broad, upturned nose.",
      "Delayed bone age is a phenotypic feature of Noonan syndrome.",
      "Noonan syndrome can increase the risk of cardiovascular problems such as pulmonary valve stenosis and hypertrophic cardiomyopathy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Individuals with Noonan syndrome may have short *webbed* fingers and toes, not \"short-fused.\"\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3186,
    "user_query": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are several anti-amyloid antibodies that have been approved as drugs for the treatment of Alzheimer's disease. Some of these include:\n1. Aducanumab: This is a monoclonal antibody that targets amyloid beta protein. It was approved by the FDA in 2021 for the treatment of Alzheimer's disease.\n2. Aducanumab-avwa: This is a similar drug to aducanumab, also targeting amyloid beta protein. It was approved by the FDA in 2021 for the treatment of Alzheimer's disease.\n3. Gantenerumab: This is a monoclonal antibody that targets amyloid beta protein. It is currently being tested in clinical trials for the treatment of Alzheimer's disease.\n4. Solanezumab: This is a monoclonal antibody that targets amyloid beta protein. It was approved by the FDA in 2019 for the treatment of Alzheimer's disease.\n5. Crenezumab: This is a monoclonal antibody that targets amyloid beta protein. It is currently being tested in clinical trials for the treatment of Alzheimer's disease.\nIt's important to note that while these drugs have shown promise in reducing amyloid beta levels in the brain, they have not been shown to slow down or stop the progression of Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aducanumab is a monoclonal antibody targeting amyloid beta protein, approved by the FDA in 2021 for the treatment of Alzheimer's disease.\n2. Aducanumab-avwa, similar to aducanumab, was approved by the FDA in 2021 for the treatment of Alzheimer's disease.\n3. Gantenerumab is currently being tested in clinical trials for the treatment of Alzheimer's disease.\n4. Solanezumab was approved by the FDA in 2019 for the treatment of Alzheimer's disease.\n5. Crenezumab is currently being tested in clinical trials for the treatment of Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Aducanumab is a monoclonal antibody targeting amyloid beta protein, approved by the FDA in 2021 for the treatment of Alzheimer's disease.",
      "Aducanumab-avwa, similar to aducanumab, was approved by the FDA in 2021 for the treatment of Alzheimer's disease.",
      "Gantenerumab is currently being tested in clinical trials for the treatment of Alzheimer's disease.",
      "Solanezumab was approved by the FDA in 2019 for the treatment of Alzheimer's disease.",
      "Crenezumab is currently being tested in clinical trials for the treatment of Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE (Aducanumab-avwa is the trade name Aduhelm, a form of aducanumab)\n3. TRUE (As of my last update, gantenerumab was indeed being tested in clinical trials for the treatment of Alzheimer's disease)\n4. FALSE [correction]: Solanezumab has not been approved by the FDA for the treatment of Alzheimer's disease as of my last update.\n5. UNKNOWN (Without current data, I cannot verify the status of crenezumab in clinical trials. As of my last update, it was being tested, but the status could have changed.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3192,
    "user_query": "List places in the body where somatostatin is produced.",
    "yulan-chat-2-13b-fp16_response": "Somatostatin is produced in several different locations throughout the body, including:\n1. The hypothalamus in the brain\n2. The pancreas\n3. The stomach\n4. The small intestine\n5. The kidneys\n6. The skin\n7. The lungs\n8. The heart\n9. The adrenal glands\n10. The thymus gland\n11. The ovaries or testes\nSomatostatin is a hormone that plays a regulatory role in many different physiological processes throughout the body. It is involved in the control of hunger, digestion, metabolism, and the release of other hormones.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Somatostatin is produced in the hypothalamus in the brain.\n2. Somatostatin is produced in the pancreas.\n3. Somatostatin is produced in the stomach.\n4. Somatostatin is produced in the small intestine.\n5. Somatostatin plays a regulatory role in processes such as hunger, digestion, metabolism, and the release of other hormones.",
    "yulan-chat-2-13b-fp16_fact": [
      "Somatostatin is produced in the hypothalamus in the brain.",
      "Somatostatin is produced in the pancreas.",
      "Somatostatin is produced in the stomach.",
      "Somatostatin is produced in the small intestine.",
      "Somatostatin plays a regulatory role in processes such as hunger, digestion, metabolism, and the release of other hormones."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3195,
    "user_query": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?",
    "yulan-chat-2-13b-fp16_response": "Human breast milk contains three types of immunoglobulin heavy chain-containing antibodies: IgA, IgG, and IgM. IgA and IgG are the most common, while IgM is present in lower levels. These antibodies provide passive immunity to the infant, helping to protect them from infections and diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Human breast milk contains three types of immunoglobulin heavy chain-containing antibodies: IgA, IgG, and IgM.\n2. IgA and IgG are the most common antibodies found in human breast milk.\n3. IgM is present in lower levels in human breast milk compared to IgA and IgG.\n4. The antibodies in human breast milk provide passive immunity to the infant.\n5. These antibodies help protect infants from infections and diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Human breast milk contains three types of immunoglobulin heavy chain-containing antibodies: IgA, IgG, and IgM.",
      "IgA and IgG are the most common antibodies found in human breast milk.",
      "IgM is present in lower levels in human breast milk compared to IgA and IgG.",
      "The antibodies in human breast milk provide passive immunity to the infant.",
      "These antibodies help protect infants from infections and diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Human breast milk primarily contains IgA, especially secretory IgA (sIgA), with only small amounts of IgG and very little, if any, IgM.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3196,
    "user_query": "What is a exposome?",
    "yulan-chat-2-13b-fp16_response": "The exposome is the sum of all the external exposures and experiences to which an individual is exposed throughout their lifetime and which may have an impact on their health. It encompasses all the environmental, social, and economic factors that can influence health, including air and water pollution, occupational exposures, diet, physical activity, and social and economic factors such as education and income. The exposome is a relatively new concept in public health and is still being studied and defined, but it is seen as a way to understand the complex interactions between environmental and genetic factors that contribute to health and disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The exposome includes all external exposures and experiences an individual encounters throughout their lifetime.\n2. The exposome can impact an individual's health.\n3. Environmental factors like air and water pollution are part of the exposome.\n4. Social and economic factors, such as education and income, are elements of the exposome.\n5. The concept of the exposome is a subject of ongoing study and definition in public health.",
    "yulan-chat-2-13b-fp16_fact": [
      "The exposome includes all external exposures and experiences an individual encounters throughout their lifetime.",
      "The exposome can impact an individual's health.",
      "Environmental factors like air and water pollution are part of the exposome.",
      "Social and economic factors, such as education and income, are elements of the exposome.",
      "The concept of the exposome is a subject of ongoing study and definition in public health."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3202,
    "user_query": "Which gene therapy treatment is FDA approved for retinal dystrophy?",
    "yulan-chat-2-13b-fp16_response": "As of my knowledge cutoff date of September 2021, there is only one FDA-approved gene therapy treatment for a retinal dystrophy called Leber congenital amaurosis (LCA). The treatment is called Luxturna (voretigene neparvovec-rzyl) and it is manufactured by Spark Therapeutics.\nLuxturna is a gene therapy that uses a viral vector to deliver a functional copy of the RPE65 gene to the retina, replacing the faulty or missing gene that causes LCA. LCA is a rare genetic disorder that affects the retina, causing progressive vision loss and blindness in childhood. Luxturna was approved by the FDA in 2017 and is indicated for the treatment of patients with LCA caused by mutations in the RPE65 gene.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Luxturna (voretigene neparvovec-rzyl) is FDA-approved for treating a retinal dystrophy called Leber congenital amaurosis (LCA).\n2. Luxturna is manufactured by Spark Therapeutics.\n3. Luxturna is a gene therapy that delivers a functional copy of the RPE65 gene to the retina.\n4. Leber congenital amaurosis is a rare genetic disorder that causes progressive vision loss and blindness in childhood.\n5. The FDA approved Luxturna for LCA caused by mutations in the RPE65 gene in 2017.",
    "yulan-chat-2-13b-fp16_fact": [
      "Luxturna (voretigene neparvovec-rzyl) is FDA-approved for treating a retinal dystrophy called Leber congenital amaurosis (LCA).",
      "Luxturna is manufactured by Spark Therapeutics.",
      "Luxturna is a gene therapy that delivers a functional copy of the RPE65 gene to the retina.",
      "Leber congenital amaurosis is a rare genetic disorder that causes progressive vision loss and blindness in childhood.",
      "The FDA approved Luxturna for LCA caused by mutations in the RPE65 gene in 2017."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "yulan-chat-2-13b-fp16_response": "I am not aware of any specific information about the effect of RUNX2 on astrocyte differentiation. Astrocytes are a type of glial cell in the brain that play a variety of important roles, including providing support and protection to neurons, regulating the extracellular environment, and participating in the blood-brain barrier. Astrocyte differentiation is the process by which precursor cells called astrocytes develop into mature astrocytes. It is possible that RUNX2 may have some effect on astrocyte differentiation, but I would need more information about the specific context in which it is being studied to provide a more detailed answer.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "yulan-chat-2-13b-fp16_response": "The Cobb-Stainsby excision arthroplasty is a surgical procedure that is used to treat joint pain and damage in the hand. It involves removing the damaged or arthritic joint and replacing it with an artificial joint made of metal and plastic. The procedure is typically performed in a hospital or surgical center, and it is usually done under general anesthesia, which means the patient is asleep and unaware of the procedure.\nThe specific location of the procedure will depend on the joint that is being treated. In the hand, the most common joints that are treated with Cobb-Stainsby excision arthroplasty are the thumb carpometacarpal joint and the wrist joint. The procedure is typically performed through small incisions in the skin, and the surgeon will use specialized instruments to remove the damaged joint and replace it with the artificial joint.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Cobb-Stainsby excision arthroplasty is used to treat joint pain and damage in the hand.\n2. The procedure involves removing a damaged or arthritic joint and replacing it with an artificial joint.\n3. Cobb-Stainsby excision arthroplasty is usually done under general anesthesia.\n4. Common joints in the hand treated with this procedure include the thumb carpometacarpal joint and the wrist joint.\n\n(Note: There seems to be a factual error in the context provided. The Cobb-Stainsby excision arthroplasty is more commonly associated with the lesser toes, not the hand. However, to adhere to the instruction, I have included the statements from the provided answer as facts that can be independently verified, even though they may be incorrect based on medical knowledge as of the knowledge cutoff date.)",
    "yulan-chat-2-13b-fp16_fact": [
      "The Cobb-Stainsby excision arthroplasty is used to treat joint pain and damage in the hand.",
      "The procedure involves removing a damaged or arthritic joint and replacing it with an artificial joint.",
      "Cobb-Stainsby excision arthroplasty is usually done under general anesthesia.",
      "Common joints in the hand treated with this procedure include the thumb carpometacarpal joint and the wrist joint.",
      "ote: There seems to be a factual error in the context provided. The Cobb-Stainsby excision arthroplasty is more commonly associated with the lesser toes, not the hand. However, to adhere to the instruction, I have included the statements from the provided answer as facts that can be independently verified, even though they may be incorrect based on medical knowledge as of the knowledge cutoff date.)"
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Cobb-Stainsby excision arthroplasty is used to treat joint pain and damage primarily in the lesser toes, not the hand.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Common joints treated with Cobb-Stainsby excision arthroplasty include joints in the lesser toes, particularly the metatarsophalangeal joints, rather than the thumb carpometacarpal joint and the wrist joint.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3213,
    "user_query": "What is a lipin 1 protein doing?",
    "yulan-chat-2-13b-fp16_response": "Lipin 1, also known as LIPC, is a protein that plays a role in regulating various cellular processes, including lipid metabolism, inflammation, and cellular stress response. It is a member of the lipovitellin-1 (LVT1) family of proteins, which are synthesized in the liver and released into the bloodstream.\nLipin 1 is involved in the regulation of lipid metabolism by acting as an inhibitor of the enzyme lipase, which is involved in the breakdown of fats in the body. It also plays a role in the regulation of inflammation by modulating the activity of pro-inflammatory cytokines and by promoting the production of anti-inflammatory cytokines.\nIn addition, lipin 1 is involved in the cellular stress response by activating a signaling pathway known as the AMP-activated protein kinase (AMPK) pathway. This pathway helps to regulate energy metabolism and cellular stress response in the body.\nOverall, lipin 1 plays an important role in maintaining metabolic homeostasis and regulating various cellular processes in the body.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lipin 1 plays a role in regulating lipid metabolism.\n2. Lipin 1 acts as an inhibitor of the enzyme lipase.\n3. It is involved in the regulation of inflammation and can modulate the activity of pro-inflammatory cytokines.\n4. Lipin 1 promotes the production of anti-inflammatory cytokines.\n5. Lipin 1 activates the AMP-activated protein kinase (AMPK) pathway, which regulates energy metabolism and cellular stress response.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lipin 1 plays a role in regulating lipid metabolism.",
      "Lipin 1 acts as an inhibitor of the enzyme lipase.",
      "It is involved in the regulation of inflammation and can modulate the activity of pro-inflammatory cytokines.",
      "Lipin 1 promotes the production of anti-inflammatory cytokines.",
      "Lipin 1 activates the AMP-activated protein kinase (AMPK) pathway, which regulates energy metabolism and cellular stress response."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Lipin 1 does not act as an inhibitor of the enzyme lipase; instead, it acts as a phosphatidic acid phosphatase, an enzyme involved in the synthesis of diacylglycerol, a precursor for triglycerides and phospholipids.\n3. TRUE\n4. UNKNOWN: The statements about Lipin 1's role in the promotion of anti-inflammatory cytokines are not well defined and require specific context or citation for confirmation.\n5. FALSE [correction]: Lipin 1 does not directly activate the AMP-activated protein kinase (AMPK) pathway. However, it is implicated in energy metabolism and might have an indirect effect on pathways such as AMPK due to its role in lipid metabolism.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3215,
    "user_query": "What protein is recruited by Crumbs to regulate tracheal development?",
    "yulan-chat-2-13b-fp16_response": "The protein recruited by Crumbs to regulate tracheal development is called Decapentaplegic (Dpp). Dpp is a member of the BMP (bone morphogenetic protein) family of growth factors, which play important roles in regulating cell differentiation and tissue development during embryogenesis. In the context of tracheal development, Dpp signaling acts as a key regulator of cell proliferation, differentiation, and patterning to control the formation and morphogenesis of the tracheal tubes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Crumbs recruits the protein Decapentaplegic (Dpp) to regulate tracheal development.\n2. Decapentaplegic (Dpp) is a member of the BMP (bone morphogenetic protein) family of growth factors.\n3. BMP family growth factors are involved in regulating cell differentiation and tissue development during embryogenesis.\n4. Dpp signaling is a key regulator of cell proliferation, differentiation, and patterning in tracheal development.\n5. Dpp signaling controls the formation and morphogenesis of the tracheal tubes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Crumbs recruits the protein Decapentaplegic (Dpp) to regulate tracheal development.",
      "Decapentaplegic (Dpp) is a member of the BMP (bone morphogenetic protein) family of growth factors.",
      "BMP family growth factors are involved in regulating cell differentiation and tissue development during embryogenesis.",
      "Dpp signaling is a key regulator of cell proliferation, differentiation, and patterning in tracheal development.",
      "Dpp signaling controls the formation and morphogenesis of the tracheal tubes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe specifics of whether Crumbs recruits Dpp in the context of tracheal development is a detail that requires specific scientific knowledge or literature, and without that specific context, it can't be determined as true or false. The rest of the statements about Decapentaplegic (Dpp) and BMP family growth factors are true based on known scientific information about their roles in development.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3223,
    "user_query": "Name three binding partners of cofilin 2.",
    "yulan-chat-2-13b-fp16_response": "Cofilin 2 is a protein that plays a role in the regulation of actin filaments in cells. Actin filaments are important for the formation of cellular structures such as the cytoskeleton and the cell membrane. Cofilin 2 is a member of the cofilin family of proteins, which are involved in the regulation of actin dynamics.\nThere are several binding partners of cofilin 2 that play a role in its function. Three examples of binding partners of cofilin 2 are:\n1. Arp2/3 complex: The Arp2/3 complex is a protein complex that plays a key role in the formation of actin filaments. Cofilin 2 binds to the Arp2/3 complex and helps to regulate the formation and disassembly of actin filaments.\n2. Formins: Formins are a family of proteins that play a role in the regulation of actin filaments. Cofilin 2 binds to formins and helps to regulate the formation and disassembly of actin filaments.\n3. Bash1: Bash1 is a protein that plays a role in the regulation of actin filaments. Cofilin 2 binds to Bash1 and helps to regulate the formation and disassembly of actin filaments.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Arp2/3 complex is a binding partner of cofilin 2.\n2. Cofilin 2 binds to proteins from the formin family.\n3. Bash1 is a protein that binds to cofilin 2.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Arp2/3 complex is a binding partner of cofilin 2.",
      "Cofilin 2 binds to proteins from the formin family.",
      "Bash1 is a protein that binds to cofilin 2."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Arp2/3 complex and cofilin 2 both bind to actin, but they have opposite effects; the Arp2/3 complex nucleates new branches on existing actin filaments while cofilin 2 disassembles actin filaments. They are not known to be direct binding partners.\n2. FALSE [correction]: Cofilin 2 is known to bind to actin filaments and promote their depolymerization. It does not typically bind to proteins from the formin family, which are involved in actin nucleation and elongation.\n3. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3224,
    "user_query": "What is the function of GvpA?",
    "yulan-chat-2-13b-fp16_response": "GvpA (green fluorescent protein augmented) is a protein that was developed as a fluorescent tag for use in biological research. It is a fusion protein that consists of the green fluorescent protein (GFP) from the jellyfish Aequorea victoria, linked to a specific target protein.\nThe function of GvpA is to allow researchers to visualize and track the localization and activity of the target protein within cells or tissues. This is achieved by expressing the GvpA fusion protein in the cells or tissues of interest, and then using fluorescence microscopy or other imaging techniques to visualize the GFP portion of the fusion protein.\nBy using GvpA, researchers can gain insights into the behavior of specific proteins within cells, and can track changes in their localization or activity over time. This can be particularly useful for studying complex biological processes, such as cell signaling, gene regulation, and disease progression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GvpA is a fluorescent tag used in biological research.\n2. GvpA is a fusion protein that includes green fluorescent protein (GFP) from the jellyfish Aequorea victoria.\n3. The function of GvpA is to visualize and track the localization and activity of a target protein within cells or tissues.\n4. The GvpA fusion protein is expressed in the cells or tissues of interest for visualization. \n5. Fluorescence microscopy or other imaging techniques are used to visualize the GFP portion of the GvpA fusion protein.",
    "yulan-chat-2-13b-fp16_fact": [
      "GvpA is a fluorescent tag used in biological research.",
      "GvpA is a fusion protein that includes green fluorescent protein (GFP) from the jellyfish Aequorea victoria.",
      "The function of GvpA is to visualize and track the localization and activity of a target protein within cells or tissues.",
      "The GvpA fusion protein is expressed in the cells or tissues of interest for visualization.",
      "Fluorescence microscopy or other imaging techniques are used to visualize the GFP portion of the GvpA fusion protein."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: GvpA itself is not a fusion protein and does not include GFP. GvpA, or Gas vesicle protein A, is a protein from gas vesicle-producing archaea or bacteria. GFP is a separate fluorescent tag used for its green fluorescence properties in biological research.\n3. FALSE [correction]: The function of GvpA typically refers to it being a structural protein in the gas vesicles of certain microorganisms, contributing to their buoyancy. The statement seems to confuse GvpA with GFP-tagged proteins, which are indeed used to visualize and track the localization and activity of a target protein within cells or tissues.\n4. UNKNOWN\n5. FALSE [correction]: The statement is not correct for GvpA itself, but rather for GFP-tagged proteins. Fluorescence microscopy or other imaging techniques are indeed used to visualize the GFP portion of GFP fusion proteins, not GvpA.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3225,
    "user_query": "What is a SMR based BCI?",
    "yulan-chat-2-13b-fp16_response": "A SMR based BCI refers to a Brain-Computer Interface that uses Signal Modulation and Regeneration technology. Signal Modulation and Regeneration (SMR) is a technology that enables the transmission and processing of neural signals over long distances with high fidelity. This technology can be used to develop a BCI that can interpret the user's brain signals and translate them into commands that can be used to control devices or systems.\nIn an SMR based BCI, the user's brain signals are first amplified and then transmitted over a wire or wireless link to a device that can interpret the signals. The device uses sophisticated algorithms to analyze the signals and determine the user's intent. Once the device has determined the user's intent, it can send commands to a device or system to carry out the desired action.\nOne of the advantages of an SMR based BCI is that it can provide high-resolution brain signal transmission, which can result in more accurate and reliable control of devices or systems. Additionally, the use of SMR technology can enable the development of BCIs that can be used over longer distances, such as in remote-control applications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. An SMR based BCI uses Signal Modulation and Regeneration technology.\n2. Signal Modulation and Regeneration technology enables the transmission and processing of neural signals over long distances with high fidelity.\n3. SMR based BCI interprets the user's brain signals and translates them into commands for controlling devices or systems.\n4. SMR based BCI involves amplifying the user's brain signals and transmitting them to a device that interprets the signals.\n5. SMR technology can provide high-resolution brain signal transmission for BCIs.",
    "yulan-chat-2-13b-fp16_fact": [
      "An SMR based BCI uses Signal Modulation and Regeneration technology.",
      "Signal Modulation and Regeneration technology enables the transmission and processing of neural signals over long distances with high fidelity.",
      "SMR based BCI interprets the user's brain signals and translates them into commands for controlling devices or systems.",
      "SMR based BCI involves amplifying the user's brain signals and transmitting them to a device that interprets the signals.",
      "SMR technology can provide high-resolution brain signal transmission for BCIs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: An SMR based BCI refers to a Brain-Computer Interface that utilizes Sensorimotor Rhythms.\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3226,
    "user_query": "Is myc a tumour suppressor gene?",
    "yulan-chat-2-13b-fp16_response": "Myc is a transcription factor that plays a role in regulating cell growth and differentiation. It is involved in many cellular processes, including cell cycle progression, apoptosis, and angiogenesis. In cancer, Myc is often overexpressed and can contribute to tumor formation and progression. However, Myc can also act as a tumor suppressor in certain contexts, such as in the development of certain immune cells. Overall, the role of Myc in tumor suppression is complex and context-dependent.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Myc is a transcription factor involved in regulating cell growth and differentiation.\n2. Myc is implicated in many cellular processes, including cell cycle progression, apoptosis, and angiogenesis.\n3. Myc is often overexpressed in cancer and can contribute to tumor formation and progression.\n4. Myc can act as a tumor suppressor in the development of certain immune cells.\n5. The role of Myc in tumor suppression is context-dependent.",
    "yulan-chat-2-13b-fp16_fact": [
      "Myc is a transcription factor involved in regulating cell growth and differentiation.",
      "Myc is implicated in many cellular processes, including cell cycle progression, apoptosis, and angiogenesis.",
      "Myc is often overexpressed in cancer and can contribute to tumor formation and progression.",
      "Myc can act as a tumor suppressor in the development of certain immune cells.",
      "The role of Myc in tumor suppression is context-dependent."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Myc is generally known as an oncogene rather than a tumor suppressor. It usually contributes to tumor formation and progression.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3227,
    "user_query": "Which syndrome is associated to SAMHD1 gene mutations?",
    "yulan-chat-2-13b-fp16_response": "The SAMHD1 gene mutations are associated with the Wiedemann-Steiner syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the SAMHD1 gene are associated with Wiedemann-Steiner syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the SAMHD1 gene are associated with Wiedemann-Steiner syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Mutations in the KMT2A gene (also known as MLL or HRX), not the SAMHD1 gene, are associated with Wiedemann-Steiner syndrome. Mutations in the SAMHD1 gene are actually associated with Aicardi-Goutires syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "false"
    ]
  },
  {
    "id": 3228,
    "user_query": "List proteins with RING domain.",
    "yulan-chat-2-13b-fp16_response": "Here is a list of some proteins that contain a RING domain:\n1. E3 ubiquitin protein ligase 1 (UBE1)\n2. E3 ubiquitin protein ligase 2 (UBE2)\n3. E3 ubiquitin protein ligase 3 (UBE3A)\n4. E3 ubiquitin protein ligase 4 (UBE4B)\n5. E3 ubiquitin protein ligase 5 (UBE5)\n6. E3 ubiquitin protein ligase 6 (UBE6)\n7. E3 ubiquitin protein ligase 7 (UBE7)\n8. E3 ubiquitin protein ligase 8 (UBE8)\n9. E3 ubiquitin protein ligase 9 (UBE9)\n10. E3 ubiquitin protein ligase 10 (UBE10)\n11. E3 ubiquitin protein ligase 11 (UBE11)\n12. E3 ubiquitin protein ligase 12 (UBE12)\n13. E3 ubiquitin protein ligase 13 (UBE13)\n14. E3 ubiquitin protein ligase 14 (UBE14)\n15. E3 ubiquitin protein ligase 15 (UBE15)\n16. E3 ubiquitin protein ligase 16 (UBE16)\n17. E3 ubiquitin protein ligase 17 (UBE17)\n18. E3 ubiquitin protein ligase 18 (UBE18)\n19. E3 ubiquitin protein ligase 19 (UBE19)\n20. E3 ubiquitin protein ligase 20 (UBE20)\n21. E3 ubiquitin protein ligase 21 (UBE21)\n22. E3 ubiquitin protein ligase 22 (UBE22)\n23. E3 ubiquitin protein ligase 23 (UBE23)\n24. E3 ubiquitin protein ligase 2",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3230,
    "user_query": "What is the results of mutations in the gene autoimmune regulator?",
    "yulan-chat-2-13b-fp16_response": "Mutations in the autoimmune regulator (AIRE) gene can lead to a variety of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and type 1 diabetes. These mutations can disrupt the normal function of the AIRE protein, which plays a key role in preventing the immune system from attacking the body's own cells and tissues. As a result, people with AIRE mutations may have an increased risk of developing autoimmune diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the autoimmune regulator (AIRE) gene can lead to autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and type 1 diabetes.\n2. The AIRE protein's normal function is to help prevent the immune system from attacking the body's own cells and tissues.\n3. People with mutations in the AIRE gene may have an increased risk of developing autoimmune diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the autoimmune regulator (AIRE) gene can lead to autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and type 1 diabetes.",
      "The AIRE protein's normal function is to help prevent the immune system from attacking the body's own cells and tissues.",
      "People with mutations in the AIRE gene may have an increased risk of developing autoimmune diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3232,
    "user_query": "Is subdural empyema a complication of sinusitis?",
    "yulan-chat-2-13b-fp16_response": "Subdural empyema is not a complication of sinusitis specifically. Subdural empyema is a type of brain infection that can occur as a complication of various conditions, including meningitis, head trauma, and skull fractures. It is characterized by the accumulation of fluid between the inner layer of the dura mater and the surface of the brain.\nSinusitis, on the other hand, is an infection of the sinuses, which are small, air-filled cavities in the skull that produce mucus. Sinusitis can cause a variety of symptoms, including facial pain, headache, congestion, and difficulty breathing through the nose. However, it is not typically associated with subdural empyema.\nIt's important to note that while sinusitis is generally not a serious condition, it can sometimes lead to complications, such as meningitis or a brain abscess, which can be life-threatening. If you are experiencing symptoms of sinusitis or any other medical condition, it is important to seek medical attention from a healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Subdural empyema is a type of brain infection.\n2. Subdural empyema can occur as a complication of conditions such as meningitis, head trauma, and skull fractures.\n3. Sinusitis is an infection of the sinuses.\n4. Sinusitis can cause symptoms including facial pain, headache, congestion, and difficulty breathing through the nose.\n5. Sinusitis can lead to complications such as meningitis or a brain abscess.",
    "yulan-chat-2-13b-fp16_fact": [
      "Subdural empyema is a type of brain infection.",
      "Subdural empyema can occur as a complication of conditions such as meningitis, head trauma, and skull fractures.",
      "Sinusitis is an infection of the sinuses.",
      "Sinusitis can cause symptoms including facial pain, headache, congestion, and difficulty breathing through the nose.",
      "Sinusitis can lead to complications such as meningitis or a brain abscess."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3237,
    "user_query": "Is the crystal structure of Pim-1 available?",
    "yulan-chat-2-13b-fp16_response": "Yes, the crystal structure of Pim-1 has been determined. Pim-1 is a protein that plays a role in cell proliferation and survival, and it is often implicated in cancer. The crystal structure of Pim-1 has been solved by X-ray crystallography and NMR spectroscopy, and it has been published in several scientific journals. The structure reveals the three-dimensional arrangement of the protein's amino acid building blocks and provides insights into its function and interactions with other molecules.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The crystal structure of Pim-1 has been determined.\n2. Pim-1 is involved in cell proliferation and survival.\n3. Pim-1 is often implicated in cancer.\n4. The crystal structure of Pim-1 has been solved by X-ray crystallography and NMR spectroscopy.\n5. The structure of Pim-1 has been published in scientific journals.",
    "yulan-chat-2-13b-fp16_fact": [
      "The crystal structure of Pim-1 has been determined.",
      "Pim-1 is involved in cell proliferation and survival.",
      "Pim-1 is often implicated in cancer.",
      "The crystal structure of Pim-1 has been solved by X-ray crystallography and NMR spectroscopy.",
      "The structure of Pim-1 has been published in scientific journals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE - The crystal structure of Pim-1 kinase has indeed been determined.\n2. TRUE - Pim-1 is a proto-oncogene and is involved in regulating cell proliferation and survival.\n3. TRUE - Pim-1 is implicated in various types of cancer, playing a role in tumor development and progression.\n4. TRUE - Crystal structures of Pim-1 can indeed be solved by X-ray crystallography, a common technique for determining crystal structures of proteins, and it is possible that NMR spectroscopy has been used to study Pim-1, although X-ray crystallography is more typically associated with determination of crystal structures.\n5. TRUE - It is standard for structures that have been determined to be published in scientific journals, and given the significance of Pim-1 in cancer, it is very likely that its structure has been published.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3238,
    "user_query": "Do tumour-associated macrophages have a prognostic role in gliomas?",
    "yulan-chat-2-13b-fp16_response": "Yes, tumor-associated macrophages (TAMs) have been shown to play a prognostic role in gliomas, which are a type of brain tumor. TAMs are a type of immune cell that can be recruited to the tumor site and can help to promote tumor growth and progression. Studies have shown that high levels of TAMs in gliomas are associated with poor patient outcomes, including reduced survival times. This suggests that TAMs may be a useful biomarker for predicting the prognosis of patients with gliomas. However, more research is needed to fully understand the role of TAMs in glioma progression and to develop effective strategies for targeting TAMs in the treatment of these tumors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tumor-associated macrophages (TAMs) play a prognostic role in gliomas, which are a type of brain tumor.\n2. TAMs are immune cells that can be recruited to the tumor site.\n3. High levels of TAMs in gliomas are associated with poor patient outcomes.\n4. High levels of TAMs in gliomas are associated with reduced survival times.\n5. TAMs may be a useful biomarker for predicting the prognosis of patients with gliomas.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tumor-associated macrophages (TAMs) play a prognostic role in gliomas, which are a type of brain tumor.",
      "TAMs are immune cells that can be recruited to the tumor site.",
      "High levels of TAMs in gliomas are associated with poor patient outcomes.",
      "High levels of TAMs in gliomas are associated with reduced survival times.",
      "TAMs may be a useful biomarker for predicting the prognosis of patients with gliomas."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nTumor-associated macrophages (TAMs) are indeed known to play roles in the tumor microenvironment of gliomas and various studies have linked them to prognostic implications. They are recruited to the tumor site where their presence, especially in high levels, has been associated with poor outcomes and reduced survival as they can promote tumor growth and suppress anti-tumor immunity. Consequently, TAMs are being researched as a potential biomarker for the prognosis of patients with such tumors.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "yulan-chat-2-13b-fp16_response": "GRHL2 (Glioma-associated oncogene homolog 2) is a transcription factor that has been implicated in various biological processes, including cell differentiation, proliferation, and survival. Some studies have suggested that GRHL2 over-expression can lead to epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose their polarity and adhesion and acquire mesenchymal characteristics, such as migration and invasion.\nHowever, the exact role of GRHL2 in EMT is still not fully understood, and the results from different studies are somewhat conflicting. Some studies have shown that GRHL2 over-expression can induce EMT in certain cell types, while others have found that GRHL2 inhibits EMT in other contexts.\nOverall, it appears that GRHL2 may play a complex role in EMT, and its effects on this process may depend on the cell type, the experimental conditions, and other factors. Further research is needed to fully understand the mechanisms underlying GRHL2-mediated EMT and its potential implications for cancer biology and therapy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GRHL2 is a transcription factor implicated in cell differentiation, proliferation, and survival.\n2. GRHL2 over-expression has been suggested by some studies to lead to epithelial-mesenchymal transition (EMT).\n3. EMT is a process where epithelial cells lose their polarity and adhesion and gain mesenchymal characteristics like migration and invasion.\n4. There is conflicting evidence regarding the role of GRHL2 in EMT, with some studies indicating it induces EMT and others suggesting it inhibits EMT.\n5. The effect of GRHL2 on EMT may vary depending on cell type and experimental conditions.",
    "yulan-chat-2-13b-fp16_fact": [
      "GRHL2 is a transcription factor implicated in cell differentiation, proliferation, and survival.",
      "GRHL2 over-expression has been suggested by some studies to lead to epithelial-mesenchymal transition (EMT).",
      "EMT is a process where epithelial cells lose their polarity and adhesion and gain mesenchymal characteristics like migration and invasion.",
      "There is conflicting evidence regarding the role of GRHL2 in EMT, with some studies indicating it induces EMT and others suggesting it inhibits EMT.",
      "The effect of GRHL2 on EMT may vary depending on cell type and experimental conditions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3245,
    "user_query": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?",
    "yulan-chat-2-13b-fp16_response": "Yes, the Fluzone intradermal and the Fluzone Intradermal Quadrivalent vaccines are produced by different companies.\nFluzone Intradermal is manufactured by Sanofi Pasteur, while Fluzone Intradermal Quadrivalent is produced by AstraZeneca AB.\nIt's important to note that while these two vaccines are similar in that they are both administered intradermally (into the skin), they differ in the number of flu strains they protect against. Fluzone Intradermal protects against three flu strains, while Fluzone Intradermal Quadrivalent protects against four.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Fluzone intradermal vaccine is manufactured by Sanofi Pasteur.\n2. The Fluzone Intradermal Quadrivalent vaccine is produced by AstraZeneca AB.\n3. The Fluzone Intradermal protects against three flu strains.\n4. The Fluzone Intradermal Quadrivalent protects against four flu strains.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Fluzone intradermal vaccine is manufactured by Sanofi Pasteur.",
      "The Fluzone Intradermal Quadrivalent vaccine is produced by AstraZeneca AB.",
      "The Fluzone Intradermal protects against three flu strains.",
      "The Fluzone Intradermal Quadrivalent protects against four flu strains."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The Fluzone Intradermal Quadrivalent vaccine is produced by Sanofi Pasteur, not AstraZeneca AB.\n3. FALSE [correction]: The Fluzone Intradermal Quadrivalent, as indicated by its name, protects against four flu strains, not three.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3251,
    "user_query": "List features of the Currarino triad.",
    "yulan-chat-2-13b-fp16_response": "The Currarino triad is a group of three congenital anomalies that commonly occur together:\n1. Anal atresia: This is a condition where the anus is not formed properly or is absent altogether.\n2. Exstrophy of the bladder: This is a condition where the bladder is not formed properly and is exposed on the outside of the body.\n3. Imperforate anus: This is a condition where the anus is closed or partially closed, preventing the passage of stool.\nThese three conditions are often referred to as the Currarino triad, named after the Italian surgeon who first described them in the 19th century. They are all congenital anomalies, meaning they are present at birth and are caused by abnormal development during fetal growth.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Currarino triad consists of three congenital anomalies.\n2. Anal atresia, one feature of the Currarino triad, is a condition where the anus is not formed properly or is absent.\n3. Exstrophy of the bladder, another feature of the Currarino triad, is where the bladder is not formed properly and is exposed externally.\n4. Imperforate anus is a condition where the anus is closed or partially closed, which is also part of the Currarino triad.\n5. The Currarino triad is named after an Italian surgeon who described these conditions in the 19th century.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Currarino triad consists of three congenital anomalies.",
      "Anal atresia, one feature of the Currarino triad, is a condition where the anus is not formed properly or is absent.",
      "Exstrophy of the bladder, another feature of the Currarino triad, is where the bladder is not formed properly and is exposed externally.",
      "Imperforate anus is a condition where the anus is closed or partially closed, which is also part of the Currarino triad.",
      "The Currarino triad is named after an Italian surgeon who described these conditions in the 19th century."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Exstrophy of the bladder is not a feature of the Currarino triad; the three features are partial or complete sacral agenesis (absence of the lower spine), presacral mass (which could be a teratoma, anterior meningocele, or both), and anorectal malformation, such as anal atresia.\n4. TRUE\n5. FALSE [correction]: The Currarino triad is named after Guido Currarino, a radiologist who helped characterize the syndrome in the 20th century.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3253,
    "user_query": "What are invasomes",
    "yulan-chat-2-13b-fp16_response": "Invasomes are a type of membrane structure that is formed when cells of a multicellular organism invade and penetrate the extracellular matrix, the structural component that provides mechanical support to tissues and organs. Invasomes are involved in various biological processes, including embryonic development, wound healing, and cancer progression. They are composed of a variety of proteins, including cadherins, integrins, and matrix metalloproteinases, which help to break down the extracellular matrix and allow the cells to invade and migrate. Invasomes are also thought to play a role in the regulation of cell behavior and signaling, and they have been implicated in a number of diseases, including cancer and atherosclerosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Invasomes are formed when cells of a multicellular organism invade and penetrate the extracellular matrix.\n2. The extracellular matrix provides mechanical support to tissues and organs.\n3. Invasomes are involved in embryonic development, wound healing, and cancer progression.\n4. Proteins that compose invasomes include cadherins, integrins, and matrix metalloproteinases.\n5. Invasomes have been implicated in a number of diseases, including cancer and atherosclerosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Invasomes are formed when cells of a multicellular organism invade and penetrate the extracellular matrix.",
      "The extracellular matrix provides mechanical support to tissues and organs.",
      "Invasomes are involved in embryonic development, wound healing, and cancer progression.",
      "Proteins that compose invasomes include cadherins, integrins, and matrix metalloproteinases.",
      "Invasomes have been implicated in a number of diseases, including cancer and atherosclerosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Invasomes are not formed by cells invading the extracellular matrix; rather, invasomes are vesicular formations used for enhancing the penetration of drugs through the skin, unrelated to cellular invasion of the extracellular matrix.\n2. TRUE\n3. FALSE [correction]: Invasomes, as previously corrected, are not involved in embryonic development, wound healing, and cancer progression; they are nanocarriers in the field of drug delivery. Processes involved in embryonic development, wound healing, and cancer progression include cell migration and invasion, but invasomes as defined above are not part of this biological context.\n4. FALSE [correction]: Since invasomes are related to drug delivery and not cellular structures involved in invasion, proteins like cadherins, integrins, and matrix metalloproteinases are not components of invasomes. These proteins are indeed involved in cell adhesion and the breakdown of the extracellular matrix but do not compose invasomes.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "yulan-chat-2-13b-fp16_response": "Several T-UCRs have been implicated in lung cancer, including:\n1. T-UCRs in the TCF7L1/Wnt signaling pathway: TCF7L1 is a transcription factor that is involved in the Wnt signaling pathway, which plays a role in cell proliferation and differentiation. Mutations in TCF7L1 have been associated with an increased risk of lung cancer.\n2. T-UCRs in the PI3K/AKT signaling pathway: The PI3K/AKT signaling pathway is involved in cell survival, growth, and metabolism. Mutations in genes that regulate this pathway, such as PIK3CA and AKT1, have been implicated in lung cancer.\n3. T-UCRs in the MAPK/ERK signaling pathway: The MAPK/ERK signaling pathway is involved in cell proliferation, differentiation, and survival. Mutations in genes that regulate this pathway, such as BRAF and NRAS, have been associated with lung cancer.\n4. T-UCRs in the TGF-beta signaling pathway: The TGF-beta signaling pathway is involved in cell proliferation, differentiation, and apoptosis. Mutations in genes that regulate this pathway, such as TGFBR1 and TGFBR2, have been implicated in lung cancer.\n5. T-UCRs in the Notch signaling pathway: The Notch signaling pathway is involved in cell proliferation, differentiation, and survival. Mutations in genes that regulate this pathway, such as NOTCH1 and NOTCH2, have been associated with lung cancer.\nThese are just a few examples of T-UCRs that have been implicated in lung cancer. It is important to note that the specific T-UCRs that are relevant to a particular case of lung cancer may vary depending on the genetic makeup of the individual and the specific mutations present in their tumor.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in TCF7L1, a transcription factor involved in the Wnt signaling pathway, have been associated with an increased risk of lung cancer.\n2. Mutations in genes that regulate the PI3K/AKT signaling pathway, such as PIK3CA and AKT1, have been implicated in lung cancer.\n3. Mutations in genes involved in the MAPK/ERK signaling pathway, such as BRAF and NRAS, have been associated with lung cancer.\n4. Mutations in genes that regulate the TGF-beta signaling pathway, like TGFBR1 and TGFBR2, have been implicated in lung cancer.\n5. Mutations in genes regulating the Notch signaling pathway, such as NOTCH1 and NOTCH2, have been associated with lung cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in TCF7L1, a transcription factor involved in the Wnt signaling pathway, have been associated with an increased risk of lung cancer.",
      "Mutations in genes that regulate the PI3K/AKT signaling pathway, such as PIK3CA and AKT1, have been implicated in lung cancer.",
      "Mutations in genes involved in the MAPK/ERK signaling pathway, such as BRAF and NRAS, have been associated with lung cancer.",
      "Mutations in genes that regulate the TGF-beta signaling pathway, like TGFBR1 and TGFBR2, have been implicated in lung cancer.",
      "Mutations in genes regulating the Notch signaling pathway, such as NOTCH1 and NOTCH2, have been associated with lung cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nWhile mutations in the genes mentioned in statements 2, 3, 4, and 5 have been associated with lung cancer according to scientific literature, the association mentioned in statement 1 between TCF7L1 mutations and lung cancer is less common or not as widely recognized in general literature. Therefore, without specific information or citation, the truth of statement 1 cannot be conclusively determined.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3255,
    "user_query": "Can Daptacel be used instead of IPOL?",
    "yulan-chat-2-13b-fp16_response": "Daptacel is a combination vaccine that contains diphtheria, tetanus, and pertussis (whooping cough) antigens. IPOL is a combination vaccine that contains inactivated poliovirus antigens.\nDaptacel and IPOL are different vaccines that protect against different diseases. Daptacel cannot be used instead of IPOL because they protect against different diseases. It is important to use the appropriate vaccine for the specific disease it is intended to protect against.\nIn general, it is recommended to follow the vaccination schedule and use the vaccines that are recommended for each disease by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). If you have any questions about vaccines or vaccine schedules, it is best to consult with a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Daptacel is a combination vaccine that contains diphtheria, tetanus, and pertussis antigens.\n2. IPOL is a combination vaccine that contains inactivated poliovirus antigens.\n3. Daptacel and IPOL protect against different diseases.\n4. Daptacel cannot be used instead of IPOL because they serve different purposes.\n5. The World Health Organization and the Centers for Disease Control and Prevention recommend specific vaccination schedules.",
    "yulan-chat-2-13b-fp16_fact": [
      "Daptacel is a combination vaccine that contains diphtheria, tetanus, and pertussis antigens.",
      "IPOL is a combination vaccine that contains inactivated poliovirus antigens.",
      "Daptacel and IPOL protect against different diseases.",
      "Daptacel cannot be used instead of IPOL because they serve different purposes.",
      "The World Health Organization and the Centers for Disease Control and Prevention recommend specific vaccination schedules."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3256,
    "user_query": "Is ACE2 expressed on cell surfaces?",
    "yulan-chat-2-13b-fp16_response": "Yes, ACE2 (angiotensin-converting enzyme 2) is expressed on the surface of many types of cells, including cells in the heart, blood vessels, kidneys, and brain. ACE2 plays a key role in regulating blood pressure and cardiovascular health by converting angiotensin II, a potent vasoconstrictor, into angiotensin (1-7), a weaker peptide that has vasodilatory and anti-inflammatory effects. ACE2 is also involved in the renin-angiotensin-aldosterone system (RAAS) and has been implicated in the pathophysiology of various diseases, including hypertension, diabetes, and COVID-19.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ACE2 (angiotensin-converting enzyme 2) is expressed on the surface of many types of cells.\n2. ACE2 is found in cells in the heart, blood vessels, kidneys, and brain.\n3. ACE2 is involved in regulating blood pressure and cardiovascular health.\n4. ACE2 converts angiotensin II into angiotensin (1-7), which has vasodilatory and anti-inflammatory effects.\n5. ACE2 has been implicated in the pathophysiology of various diseases, including hypertension, diabetes, and COVID-19.",
    "yulan-chat-2-13b-fp16_fact": [
      "ACE2 (angiotensin-converting enzyme 2) is expressed on the surface of many types of cells.",
      "ACE2 is found in cells in the heart, blood vessels, kidneys, and brain.",
      "ACE2 is involved in regulating blood pressure and cardiovascular health.",
      "ACE2 converts angiotensin II into angiotensin (1-7), which has vasodilatory and anti-inflammatory effects.",
      "ACE2 has been implicated in the pathophysiology of various diseases, including hypertension, diabetes, and COVID-19."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3259,
    "user_query": "List the cancers that are associated with SBLA syndrome.",
    "yulan-chat-2-13b-fp16_response": "SBLA (Schwannoma, Bleomycin, and Astrocytoma) syndrome is a rare genetic disorder that is associated with an increased risk of developing several types of cancer, including:\n1. Schwannomas (also known as neurilemmoma or peripheral nerve sheath tumors) - a type of tumor that develops from the covering of nerve cells.\n2. Bleomycin-induced lung cancer - bleomycin is a chemotherapy drug that is sometimes used to treat cancer, and it has been associated with an increased risk of lung cancer in some patients.\n3. Astrocytoma (also known as glioma) - a type of brain tumor that develops from the supportive cells of the brain called astrocytes.\nIt's important to note that not everyone with SBLA syndrome will develop these cancers, and the risk of developing cancer can vary depending on the specific genetic mutation involved. If you have concerns about your risk of developing cancer due to SBLA syndrome, it's important to speak with a healthcare professional for personalized advice and guidance.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SBLA syndrome is associated with an increased risk of developing Schwannomas.\n2. SBLA syndrome is associated with an increased risk of Bleomycin-induced lung cancer.\n3. SBLA syndrome is associated with an increased risk of developing Astrocytoma.\n4. Bleomycin is a chemotherapy drug.\n5. Astrocytomas develop from astrocytes, the supportive cells of the brain.",
    "yulan-chat-2-13b-fp16_fact": [
      "SBLA syndrome is associated with an increased risk of developing Schwannomas.",
      "SBLA syndrome is associated with an increased risk of Bleomycin-induced lung cancer.",
      "SBLA syndrome is associated with an increased risk of developing Astrocytoma.",
      "Bleomycin is a chemotherapy drug.",
      "Astrocytomas develop from astrocytes, the supportive cells of the brain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: SBLA syndrome does not specifically increase the risk of Bleomycin-induced lung cancer. Instead, it is associated with an increased risk of Lymphomas, Breast cancer, Sarcomas, and Adrenocortical cancer.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3264,
    "user_query": "What is Invaplex 50?",
    "yulan-chat-2-13b-fp16_response": "Invaplex 50 is a medication and a synthetic steroid hormone. It is a prodrug of DHEA, which is a natural hormone produced by the adrenal gland. Invaplex 50 is used to treat various medical conditions, including adrenal insufficiency, Addison's disease, and hyperpituitarism. It is also sometimes used off-label to improve athletic performance or to promote muscle growth. However, it is important to note that the use of Invaplex 50 for these purposes is not approved by the FDA and can be dangerous.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Invaplex 50 is a medication and a synthetic steroid hormone.\n2. It is a prodrug of DHEA.\n3. DHEA is a natural hormone produced by the adrenal gland.\n4. Invaplex 50 is used to treat conditions such as adrenal insufficiency, Addison's disease, and hyperpituitarism.\n5. The use of Invaplex 50 to improve athletic performance or promote muscle growth is not approved by the FDA.",
    "yulan-chat-2-13b-fp16_fact": [
      "Invaplex 50 is a medication and a synthetic steroid hormone.",
      "It is a prodrug of DHEA.",
      "DHEA is a natural hormone produced by the adrenal gland.",
      "Invaplex 50 is used to treat conditions such as adrenal insufficiency, Addison's disease, and hyperpituitarism.",
      "The use of Invaplex 50 to improve athletic performance or promote muscle growth is not approved by the FDA."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The correct name is Invokana, not Invaplex 50, and it is not a synthetic steroid hormone. Invokana is a medication used to treat type 2 diabetes.\n2. FALSE [correction]: Invokana is not a prodrug of DHEA. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. \n3. TRUE\n4. FALSE [correction]: Invokana is used to treat type 2 diabetes, not adrenal insufficiency, Addison's disease, or hyperpituitarism.\n5. TRUE: The use of any medication not approved by the FDA for a specific indication, such as improving athletic performance or promoting muscle growth, is considered off-label use and is generally not approved.\n",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3266,
    "user_query": "Which lncRNAS are regulated by SAM68?",
    "yulan-chat-2-13b-fp16_response": "As of my knowledge cutoff date in September 2021, there isn't a comprehensive list of long non-coding RNAs (lncRNAs) that are specifically regulated by SAM68 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin). However, SAM68 has been shown to play a role in the regulation of various lncRNAs, including:\n1. H19: H19 is an imprinted lncRNA that plays a role in gene regulation and epigenetic control. SAM68 has been shown to bind to the H19 promoter region and regulate its expression.\n2. Xist: Xist is a lncRNA that is essential for X-chromosome inactivation in females. SAM68 has been shown to interact with Xist and regulate its expression.\n3. Lin28: Lin28 is an lncRNA that plays a role in the regulation of pluripotency and stem cell maintenance. SAM68 has been shown to regulate the expression of Lin28 in embryonic stem cells.\n4. MALAT1: MALAT1 is an lncRNA that is highly expressed in cancer and plays a role in the regulation of gene expression. SAM68 has been shown to bind to the MALAT1 promoter region and regulate its expression.\nIt's important to note that the list is not exhaustive, and there may be other lncRNAs that are regulated by SAM68. Additionally, research in this area is ongoing, and new discoveries may have been made since my knowledge cutoff date.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SAM68 has been shown to bind to the H19 promoter region and regulate its expression.\n2. SAM68 interacts with and regulates the expression of the lncRNA Xist, which is essential for X-chromosome inactivation in females.\n3. SAM68 regulates the expression of the lncRNA Lin28 in embryonic stem cells.\n4. SAM68 binds to the MALAT1 promoter region and regulates its expression, an lncRNA highly expressed in cancer.\n5. The role of SAM68 in the regulation of lncRNAs is a subject of ongoing research, and the information may be updated beyond the September 2021 knowledge cutoff date.",
    "yulan-chat-2-13b-fp16_fact": [
      "SAM68 has been shown to bind to the H19 promoter region and regulate its expression.",
      "SAM68 interacts with and regulates the expression of the lncRNA Xist, which is essential for X-chromosome inactivation in females.",
      "SAM68 regulates the expression of the lncRNA Lin28 in embryonic stem cells.",
      "SAM68 binds to the MALAT1 promoter region and regulates its expression, an lncRNA highly expressed in cancer.",
      "The role of SAM68 in the regulation of lncRNAs is a subject of ongoing research, and the information may be updated beyond the September 2021 knowledge cutoff date."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: SAM68 does not regulate the expression of the lncRNA Lin28; it is involved in alternative splicing and other processes in embryonic stem cells, but there is no direct evidence linking it to Lin28 regulation.\n4. UNKNOWN\n5. TRUE\n\nNote: While the statements regarding SAM68 are in the realm of molecular biology, without specific references, it is challenging to confirm the interactions of SAM68 with specific long non-coding RNAs (lncRNAs) such as H19, Xist, Lin28, and MALAT1. Such interactions could be subject to ongoing research and discoveries beyond the knowledge cutoff date. Therefore, some responses must remain unknown, and the correction provided for statement 3 is based on the lack of widespread information regarding a direct regulatory relationship between SAM68 and Lin28. It is advised to consult the latest scientific literature for the most current information.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3267,
    "user_query": "How many proteins have been queried for protein partners by the Drosophila protein interaction map (DPiM)?",
    "yulan-chat-2-13b-fp16_response": "The Drosophila protein interaction map (DPiM) has queried the interactions of approximately 10,000 proteins in Drosophila melanogaster.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Drosophila protein interaction map (DPiM) has investigated the interactions of approximately 10,000 proteins.\n2. The proteins queried by DPiM are from Drosophila melanogaster.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Drosophila protein interaction map (DPiM) has investigated the interactions of approximately 10,000 proteins.",
      "The proteins queried by DPiM are from Drosophila melanogaster."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Drosophila protein interaction map (DPiM) has investigated the interactions of approximately 9,000 proteins.\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "yulan-chat-2-13b-fp16_response": "GPR151 is a member of the G-protein coupled receptor (GPCR) superfamily, which plays a role in sensing and responding to various stimuli. It is also known as the orphan receptor GPR151 because it was initially identified as a receptor with no known ligand or function.\nAlthough the exact function of GPR151 is not yet fully understood, studies have suggested that it may be involved in various physiological processes, including inflammation, immune response, and neurotransmission.\nRecent research has also suggested that GPR151 may play a role in the regulation of energy balance and body weight. It has been shown to be expressed in the hypothalamus, a region of the brain that plays a critical role in the regulation of energy balance and feeding behavior.\nFurthermore, GPR151 has been implicated in the pathophysiology of certain diseases, including cancer and neurodegenerative disorders.\nOverall, while the orphan receptor GPR151 is still not fully understood, ongoing research is shedding light on its potential role in various physiological processes and diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GPR151 is a member of the G-protein coupled receptor (GPCR) superfamily.\n2. GPR151 is also known as the orphan receptor because it was identified without a known ligand or function.\n3. Studies suggest that GPR151 may be involved in inflammation, immune response, and neurotransmission.\n4. GPR151 is thought to play a role in the regulation of energy balance and body weight, with expression noted in the hypothalamus.\n5. GPR151 has been implicated in the pathophysiology of certain diseases, including cancer and neurodegenerative disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "GPR151 is a member of the G-protein coupled receptor (GPCR) superfamily.",
      "GPR151 is also known as the orphan receptor because it was identified without a known ligand or function.",
      "Studies suggest that GPR151 may be involved in inflammation, immune response, and neurotransmission.",
      "GPR151 is thought to play a role in the regulation of energy balance and body weight, with expression noted in the hypothalamus.",
      "GPR151 has been implicated in the pathophysiology of certain diseases, including cancer and neurodegenerative disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nRationale:\nThe first two statements about GPR151 are commonly referred to information about G protein-coupled receptors (GPCRs) and the concept of \"orphan receptors\" which are indeed GPCRs identified without a known ligand. However, statements 3-5 discuss specific roles and implications that GPR151 might have, which would require specific research evidence to confirm as true. Without the specific context from current scientific literature or research data on GPR151, the truthfulness of those statements remains unknown.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3269,
    "user_query": "Is LiFraumeni syndrome a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development?",
    "yulan-chat-2-13b-fp16_response": "Yes, that is correct. LiFUMNeni syndrome is a rare genetic disorder that is caused by mutations in the TP53 gene, which is a tumor suppressor gene. This syndrome is characterized by an increased risk of developing various types of cancer, particularly breast cancer, osteosarcoma, and leukemia. It is autosomal recessive, meaning that a person must inherit two copies of the mutated gene (one from each parent) in order to develop the syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LiFraumeni syndrome is a rare genetic disorder.\n2. LiFraumeni syndrome is caused by mutations in the TP53 gene.\n3. The TP53 gene is a tumor suppressor gene.\n4. LiFraumeni syndrome increases the risk of developing various types of cancer, particularly breast cancer, osteosarcoma, and leukemia.\n5. LiFraumeni syndrome is autosomal recessive, requiring a person to inherit two copies of the mutated gene to develop the syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "LiFraumeni syndrome is a rare genetic disorder.",
      "LiFraumeni syndrome is caused by mutations in the TP53 gene.",
      "The TP53 gene is a tumor suppressor gene.",
      "LiFraumeni syndrome increases the risk of developing various types of cancer, particularly breast cancer, osteosarcoma, and leukemia.",
      "LiFraumeni syndrome is autosomal recessive, requiring a person to inherit two copies of the mutated gene to develop the syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: LiFraumeni syndrome is autosomal dominant, meaning a person only needs to inherit one copy of the mutated gene to develop the syndrome.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3271,
    "user_query": "Salzburg EEG criteria are used to diagnose which disorder?",
    "yulan-chat-2-13b-fp16_response": "The Salzburg EEG criteria are used to diagnose epilepsy, which is a neurological disorder characterized by recurrent seizures. The criteria are a set of guidelines that were developed by a group of experts in Salzburg, Austria in 1981 to help clinicians diagnose epilepsy based on the results of an electroencephalogram (EEG), which is a test that measures the electrical activity of the brain. The criteria include a number of different factors, such as the presence of specific EEG patterns and the absence of other conditions that could cause similar EEG findings.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Salzburg EEG criteria are used to diagnose epilepsy.\n2. Epilepsy is characterized by recurrent seizures.\n3. The Salzburg EEG criteria were developed in 1981.\n4. The Salzburg EEG criteria were developed by experts in Salzburg, Austria.\n5. An electroencephalogram (EEG) is a test that measures the electrical activity of the brain.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Salzburg EEG criteria are used to diagnose epilepsy.",
      "Epilepsy is characterized by recurrent seizures.",
      "The Salzburg EEG criteria were developed in 1981.",
      "The Salzburg EEG criteria were developed by experts in Salzburg, Austria.",
      "An electroencephalogram (EEG) is a test that measures the electrical activity of the brain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Salzburg EEG criteria were developed in 2015, not 1981.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3272,
    "user_query": "List the components of the COMPASS complex",
    "yulan-chat-2-13b-fp16_response": "The COMPASS complex is a group of proteins that work together to regulate gene expression by modifying the structure of DNA. The components of the COMPASS complex include:\n1. Cdc45 - a phosphatidylcholine-binding protein that helps to recruit other COMPASS components to the site of DNA modification\n2. Cdc65 - a protein that helps to recruit other COMPASS components to the site of DNA modification\n3. Cdt1 - a protein that helps to recruit other COMPASS components to the site of DNA modification\n4. Acetyltransferase - an enzyme that adds acetyl groups to lysine residues on histone proteins, which helps to loosen the tightly packed structure of DNA and make it more accessible to transcription factors\n5. Methyltransferase - an enzyme that adds methyl groups to lysine residues on histone proteins, which helps to tighten the packed structure of DNA and make it less accessible to transcription factors\n6. Isw2 - a protein that helps to recruit other COMPASS components to the site of DNA modification\n7. H3K4me3 - a histone protein that has been modified by the COMPASS complex to have three methyl groups on lysine residue 4, which helps to tighten the packed structure of DNA and make it less accessible to transcription factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The COMPASS complex regulates gene expression by modifying the structure of DNA.\n2. Cdc45 is a component of the COMPASS complex and is a phosphatidylcholine-binding protein.\n3. Acetyltransferase is an enzyme in the COMPASS complex that adds acetyl groups to lysine residues on histone proteins.\n4. Methyltransferase is an enzyme in the COMPASS complex that adds methyl groups to lysine residues on histone proteins.\n5. H3K4me3 is a histone protein that has been modified to have three methyl groups on lysine residue 4 by the COMPASS complex.",
    "yulan-chat-2-13b-fp16_fact": [
      "The COMPASS complex regulates gene expression by modifying the structure of DNA.",
      "Cdc45 is a component of the COMPASS complex and is a phosphatidylcholine-binding protein.",
      "Acetyltransferase is an enzyme in the COMPASS complex that adds acetyl groups to lysine residues on histone proteins.",
      "Methyltransferase is an enzyme in the COMPASS complex that adds methyl groups to lysine residues on histone proteins.",
      "H3K4me3 is a histone protein that has been modified to have three methyl groups on lysine residue 4 by the COMPASS complex."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The COMPASS complex regulates gene expression by modifying the structure of chromatin through methylation of histone proteins, not by directly modifying the structure of DNA.\n2. FALSE [correction]: Cdc45 is not a component of the COMPASS complex; it is involved in DNA replication. The COMPASS complex members are proteins related to Set1 and include Set1 itself in yeast.\n3. FALSE [correction]: Acetyltransferase enzymes, such as those in the NuA4 or SAGA complexes, add acetyl groups to lysine residues on histone proteins, but these enzymes are not part of the COMPASS complex, which includes methyltransferases for methylation.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3274,
    "user_query": "Central Vein Sign is characteristic to which disease?",
    "yulan-chat-2-13b-fp16_response": "The Central Vein Sign is a characteristic finding on chest X-rays that is typically seen in patients with a pulmonary embolism. A pulmonary embolism is a serious and potentially life-threatening condition that occurs when a blood clot blocks one of the blood vessels in the lungs. The Central Vein Sign is caused by the swelling and narrowing of the central vein, which is a large blood vessel that carries blood from the lungs to the heart. This swelling and narrowing can be seen on a chest X-ray as a widened mediastinum (the space between the lungs and the heart) and a central pulmonary artery that is not clearly visible. The Central Vein Sign is not specific to any one disease and can be seen in a variety of conditions that affect the lungs and the circulatory system. However, it is most commonly associated with pulmonary embolism.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Central Vein Sign is a characteristic finding on chest X-rays typically seen in patients with pulmonary embolism.\n2. A pulmonary embolism is a condition where a blood clot blocks a blood vessel in the lungs.\n3. The Central Vein Sign is caused by the swelling and narrowing of the central vein.\n4. On a chest X-ray, the Central Vein Sign can manifest as a widened mediastinum.\n5. The Central Vein Sign is most commonly associated with pulmonary embolism, but it is not specific to any one disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Central Vein Sign is a characteristic finding on chest X-rays typically seen in patients with pulmonary embolism.",
      "A pulmonary embolism is a condition where a blood clot blocks a blood vessel in the lungs.",
      "The Central Vein Sign is caused by the swelling and narrowing of the central vein.",
      "On a chest X-ray, the Central Vein Sign can manifest as a widened mediastinum.",
      "The Central Vein Sign is most commonly associated with pulmonary embolism, but it is not specific to any one disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Central Vein Sign is not typically seen on chest X-rays for pulmonary embolism; it is characteristic finding on MRI used to aid in the diagnosis of multiple sclerosis.\n2. TRUE\n3. FALSE [correction]: The Central Vein Sign is not caused by swelling and narrowing of the central vein. It refers to the presence of a central vein within white matter lesions on MRI scans, helping to distinguish multiple sclerosis from other diseases.\n4. FALSE [correction]: The Central Vein Sign does not manifest as a widened mediastinum on chest X-ray since it is not related to chest imaging; it's an MRI finding in the brain.\n5. FALSE [correction]: The Central Vein Sign is most commonly associated with multiple sclerosis and is not specific to pulmonary embolism. It is not exclusive to multiple sclerosis but is more characteristic of this condition than others.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3284,
    "user_query": "Do de novo truncating mutations in WASF1 cause cancer?",
    "yulan-chat-2-13b-fp16_response": "De novo truncating mutations in WASF1 have been associated with an increased risk of various types of cancer, including colorectal cancer, gastric cancer, and lung cancer. WASF1 is a gene that encodes a protein involved in regulating cell growth and division, and mutations that truncate the protein can disrupt this regulation and lead to uncontrolled cell growth, which is a hallmark of cancer. However, it's important to note that not all de novo truncating mutations in WASF1 necessarily lead to cancer, and other factors, such as environmental exposures and lifestyle choices, can also influence an individual's risk of developing cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. De novo truncating mutations in WASF1 are associated with an increased risk of various types of cancer.\n2. Types of cancer associated with these mutations include colorectal cancer, gastric cancer, and lung cancer.\n3. WASF1 is a gene that encodes a protein involved in cell growth and division regulation.\n4. Mutations that truncate the WASF1 protein can disrupt its regulatory function and lead to uncontrolled cell growth.\n5. Uncontrolled cell growth is a hallmark of cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "De novo truncating mutations in WASF1 are associated with an increased risk of various types of cancer.",
      "Types of cancer associated with these mutations include colorectal cancer, gastric cancer, and lung cancer.",
      "WASF1 is a gene that encodes a protein involved in cell growth and division regulation.",
      "Mutations that truncate the WASF1 protein can disrupt its regulatory function and lead to uncontrolled cell growth.",
      "Uncontrolled cell growth is a hallmark of cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: The statement about de novo truncating mutations in WASF1 being associated with an increased risk of cancer requires specific scientific evidence, and the information is not provided in the context.\n2. UNKNOWN: Similarly, the statement that types of cancer associated with these mutations include colorectal cancer, gastric cancer, and lung cancer requires specific scientific evidence, and the information is not provided in the context.\n3. FALSE [correction]: WASF1 is more commonly known as a gene that encodes a protein involved in actin filament branching and is not directly described as regulating cell growth and division. WASF family members are involved in actin cytoskeleton remodeling.\n4. UNKNOWN: The effect of truncating mutations in the WASF1 protein on its function would need to be substantiated by specific scientific research, which is not provided here.\n5. TRUE: Uncontrolled cell growth is indeed a hallmark of cancer.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "yulan-chat-2-13b-fp16_response": "Fluzone Intradermal Quadrivalent vaccine contains four attenuated live viruses:\n1. A/H1N1/Puerto Rico/8/1934 (H1N1)\n2. A/H3N2/Hong Kong/1/1968 (H3N2)\n3. B/Philippines/2/1955 (B)\n4. B/Brisbane/60/2008 (Yamagata lineage) (B)\nThese viruses are weakened versions of the influenza viruses that cause the flu, and they are used to stimulate the immune system to produce an immune response against the flu. The vaccine is administered by intradermal injection and is recommended for use in individuals aged 6 months and older.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3300,
    "user_query": "How is Slc22a3 imprinted?",
    "yulan-chat-2-13b-fp16_response": "SLC22A3 is a gene that encodes a protein called organic cation transporter 3 (OCT3). OCT3 is a membrane transporter that plays a role in the transport of organic cations across cell membranes. SLC22A3 is imprinted in the sense that it is expressed from one parental allele (either the paternal or maternal allele) depending on the parental origin of the allele. This means that the expression of SLC22A3 can be biased towards one parental allele, which can have important implications for the function of the gene in the developing organism. The imprinting pattern of SLC22A3 is determined by the parental allele that is expressed, and can vary depending on the tissue or cell type.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SLC22A3 is a gene that encodes for organic cation transporter 3 (OCT3).\n2. OCT3 is involved in the transport of organic cations across cell membranes.\n3. SLC22A3 is imprinted, meaning it is expressed from one parental allele.\n4. The expression of SLC22A3 can be biased towards the paternal or maternal allele.\n5. The imprinting pattern of SLC22A3 can vary depending on the tissue or cell type.",
    "yulan-chat-2-13b-fp16_fact": [
      "SLC22A3 is a gene that encodes for organic cation transporter 3 (OCT3).",
      "OCT3 is involved in the transport of organic cations across cell membranes.",
      "SLC22A3 is imprinted, meaning it is expressed from one parental allele.",
      "The expression of SLC22A3 can be biased towards the paternal or maternal allele.",
      "The imprinting pattern of SLC22A3 can vary depending on the tissue or cell type."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: SLC22A3 is not typically described as imprinted. Genomic imprinting refers to genes that are expressed only from one parent's allele (maternal or paternal), and there is no established evidence that SLC22A3 is subject to this process.\n4. FALSE [correction]: Since SLC22A3 is not generally considered an imprinted gene, the statement about expression bias towards the paternal or maternal allele is not applicable.\n5. UNKNOWN (This statement would require specific knowledge about the imprinting pattern of SLC22A3, if it were imprinted, but as per the previous corrections, it is not typically considered an imprinted gene.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3302,
    "user_query": "Is the tyrosine kinase BTK implicated in autoimmunity?",
    "yulan-chat-2-13b-fp16_response": "Yes, tyrosine kinase BTK (B-cell maturation antigen receptor-associated tyrosine kinase) has been implicated in autoimmunity. BTK is a key signaling molecule in the activation and survival of B cells, which are a type of immune cell that plays a central role in the production of antibodies.\nAutoimmunity occurs when the immune system mistakenly attacks the body's own tissues and organs, leading to inflammation and tissue damage. BTK has been shown to be involved in the development of certain autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and Sjogren's syndrome.\nIn these diseases, BTK signaling can contribute to the activation and proliferation of autoreactive B cells, which produce autoantibodies that target self-antigens. BTK inhibitors have been developed as a potential treatment for these diseases, as they can reduce B-cell activation and autoantibody production.\nHowever, it is important to note that BTK is not solely responsible for autoimmunity, and the underlying mechanisms of these diseases are complex and multifactorial.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tyrosine kinase BTK (B-cell maturation antigen receptor-associated tyrosine kinase) has been implicated in autoimmunity.\n2. BTK is a key signaling molecule in the activation and survival of B cells.\n3. B cells are involved in the production of antibodies.\n4. BTK signaling is involved in the development of certain autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and Sjogren's syndrome.\n5. BTK inhibitors are being developed as a potential treatment to reduce B-cell activation and autoantibody production in autoimmune diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tyrosine kinase BTK (B-cell maturation antigen receptor-associated tyrosine kinase) has been implicated in autoimmunity.",
      "BTK is a key signaling molecule in the activation and survival of B cells.",
      "B cells are involved in the production of antibodies.",
      "BTK signaling is involved in the development of certain autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and Sjogren's syndrome.",
      "BTK inhibitors are being developed as a potential treatment to reduce B-cell activation and autoantibody production in autoimmune diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Tyrosine kinase BTK (Bruton's tyrosine kinase) has been implicated in autoimmunity, not B-cell maturation antigen receptor-associated tyrosine kinase.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3303,
    "user_query": "What is the BioPlex network?",
    "yulan-chat-2-13b-fp16_response": "BioPlex is a network of researchers and institutions working together to develop and apply advanced computational methods to biomedical research. The network aims to accelerate the discovery of new treatments and therapies for diseases by leveraging the power of artificial intelligence, machine learning, and other advanced technologies.\nBioPlex brings together experts from a range of fields, including biology, medicine, computer science, and data science, to collaborate on projects that address important biomedical challenges. The network also provides training and education opportunities to help researchers develop the skills they need to work with these advanced technologies.\nOverall, the BioPlex network is a valuable resource for biomedical researchers who are looking to harness the power of computational methods to advance their work and improve human health.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. BioPlex is a network comprising researchers and institutions.\n2. The goal of BioPlex is to accelerate the discovery of new treatments and therapies for diseases.\n3. BioPlex utilizes artificial intelligence, machine learning, and other advanced technologies for biomedical research.\n4. The network includes experts from biology, medicine, computer science, and data science fields.\n5. BioPlex provides training and educational opportunities for researchers in computational methods.",
    "yulan-chat-2-13b-fp16_fact": [
      "BioPlex is a network comprising researchers and institutions.",
      "The goal of BioPlex is to accelerate the discovery of new treatments and therapies for diseases.",
      "BioPlex utilizes artificial intelligence, machine learning, and other advanced technologies for biomedical research.",
      "The network includes experts from biology, medicine, computer science, and data science fields.",
      "BioPlex provides training and educational opportunities for researchers in computational methods."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN\n\nThese responses are based on general knowledge about interdisciplinary research networks like BioPlex, where they often comprise researchers and institutions, aim to accelerate discoveries in disease treatments, and include experts from various fields. However, specific details about using artificial intelligence or providing training may vary and without further context cannot be confirmed.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3304,
    "user_query": "Which algorithm has been developed for detecting expansions of tandem repeats?",
    "yulan-chat-2-13b-fp16_response": "There are several algorithms that have been developed for detecting expansions of tandem repeats, including:\n1. RepeatMasker: This is a popular algorithm that uses a combination of de novo assembly and database searches to identify and mask repetitive elements in DNA sequences. It can detect tandem repeats and other types of repetitive elements, and can also identify novel repeats that are not present in the database.\n2. RepeatModeler: This is another popular algorithm for detecting and modeling repetitive elements in DNA sequences. It can detect and model tandem repeats, as well as other types of repetitive elements, and can also be used to predict the size of repeat expansions.\n3. LiftOver: This is a tool developed by the NCBI for aligning and annotating DNA sequences across multiple reference genomes. It can detect and align tandem repeats, and can also be used to predict the size of repeat expansions.\n4. RepeatExplorer: This is a web-based tool that can be used to detect and analyze repetitive elements in DNA sequences. It can detect and model tandem repeats, and can also be used to predict the size of repeat expansions.\nOverall, the choice of algorithm for detecting tandem repeat expansions will depend on the specific needs and requirements of the analysis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RepeatMasker is an algorithm that can detect tandem repeats and other types of repetitive elements in DNA sequences.\n2. RepeatModeler is an algorithm designed to detect and model repetitive elements in DNA sequences.\n3. LiftOver is a tool developed by the NCBI for aligning and annotating DNA sequences across multiple reference genomes, including the detection and alignment of tandem repeats.\n4. RepeatExplorer is a web-based tool used for detecting and analyzing repetitive elements in DNA sequences.",
    "yulan-chat-2-13b-fp16_fact": [
      "RepeatMasker is an algorithm that can detect tandem repeats and other types of repetitive elements in DNA sequences.",
      "RepeatModeler is an algorithm designed to detect and model repetitive elements in DNA sequences.",
      "LiftOver is a tool developed by the NCBI for aligning and annotating DNA sequences across multiple reference genomes, including the detection and alignment of tandem repeats.",
      "RepeatExplorer is a web-based tool used for detecting and analyzing repetitive elements in DNA sequences."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: RepeatMasker is an algorithm that detects and masks repetitive elements in DNA sequences, but it is not specifically known for detecting tandem repeats.\n2. TRUE\n3. FALSE [correction]: LiftOver is a tool developed by the UCSC Genome Bioinformatics Group for converting genome coordinates and genome annotation files between assemblies, not specifically for detecting and aligning tandem repeats.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3305,
    "user_query": "Which clotting factor is in the Andexxa?",
    "yulan-chat-2-13b-fp16_response": "Andexxa is a biological product that contains a fusion protein of activated Factor X and inhibited Factor IIa, which is also known as recombinant activated factor VII (rFVIIa). Factor X is a clotting factor that plays a role in the intrinsic pathway of blood coagulation, while Factor IIa is a clotting factor that plays a role in the extrinsic pathway of blood coagulation. The fusion protein in Andexxa is designed to mimic the activity of natural FVIIa, which is a potent initiator of the blood coagulation cascade. Andexxa is used to treat bleeding events in people with hemophilia A or B who have developed inhibitors to factor VIII or IX, respectively.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Andexxa contains a fusion protein of activated Factor X and inhibited Factor IIa.\n2. The fusion protein in Andexxa mimics the activity of natural FVIIa.\n3. Factor X is involved in the intrinsic pathway of blood coagulation.\n4. Factor IIa is involved in the extrinsic pathway of blood coagulation.\n5. Andexxa is used to treat bleeding events in people with hemophilia A or B who have developed inhibitors to factor VIII or IX.",
    "yulan-chat-2-13b-fp16_fact": [
      "Andexxa contains a fusion protein of activated Factor X and inhibited Factor IIa.",
      "The fusion protein in Andexxa mimics the activity of natural FVIIa.",
      "Factor X is involved in the intrinsic pathway of blood coagulation.",
      "Factor IIa is involved in the extrinsic pathway of blood coagulation.",
      "Andexxa is used to treat bleeding events in people with hemophilia A or B who have developed inhibitors to factor VIII or IX."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Andexxa contains a modified human Factor Xa protein, not a fusion of Factor X and Factor IIa.\n2. FALSE [correction]: The fusion protein in Andexxa is designed to mimic the activity of natural Factor Xa, not FVIIa.\n3. TRUE\n4. FALSE [correction]: Factor IIa, or thrombin, is involved in the common pathway, not just the extrinsic pathway, of blood coagulation.\n5. FALSE [correction]: Andexxa is used to reverse the effects of certain anticoagulants (e.g., rivaroxaban and apixaban) during bleeding events, not specifically for treating bleeding events in people with hemophilia A or B.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3315,
    "user_query": "What classes of drugs does Retapamulin belong to?",
    "yulan-chat-2-13b-fp16_response": "Retapamulin is a topical antibiotic that belongs to the class of drugs known as pleuromutilins. It is used to treat skin and skin structure infections caused by susceptible strains of Staphylococcus aureus and Streptococcus species.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Retapamulin is a topical antibiotic.\n2. Retapamulin belongs to the class of drugs known as pleuromutilins.\n3. It is used to treat skin and skin structure infections.\n4. Retapamulin treats infections caused by susceptible strains of Staphylococcus aureus.\n5. Retapamulin treats infections caused by susceptible strains of Streptococcus species.",
    "yulan-chat-2-13b-fp16_fact": [
      "Retapamulin is a topical antibiotic.",
      "Retapamulin belongs to the class of drugs known as pleuromutilins.",
      "It is used to treat skin and skin structure infections.",
      "Retapamulin treats infections caused by susceptible strains of Staphylococcus aureus.",
      "Retapamulin treats infections caused by susceptible strains of Streptococcus species."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3322,
    "user_query": "Which T-UCR has been implicated in prostate cancer?",
    "yulan-chat-2-13b-fp16_response": "Several T-UCRs have been implicated in prostate cancer, including:\n1. T-UCRs in the androgen receptor gene (AR): The androgen receptor (AR) is a nuclear receptor that plays a key role in the development and maintenance of prostate tissue. Mutations in the AR gene or its promoter region have been associated with an increased risk of prostate cancer.\n2. T-UCRs in the homeobox gene HoxA9: HoxA9 is a transcription factor that plays a critical role in prostate development and differentiation. Mutations in the HoxA9 gene or its promoter region have been linked to an increased risk of prostate cancer.\n3. T-UCRs in the zinc finger protein Zeb2: Zeb2 is a transcription factor that regulates prostate epithelial cell differentiation and proliferation. Mutations in the Zeb2 gene or its promoter region have been associated with an increased risk of prostate cancer.\n4. T-UCRs in the Krppel-like factor Klf4: Klf4 is a transcription factor that regulates cell proliferation and differentiation. Mutations in the Klf4 gene or its promoter region have been linked to an increased risk of prostate cancer.\nThese T-UCRs can contribute to the development and progression of prostate cancer by altering the expression of key genes involved in prostate tissue development and maintenance.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the androgen receptor gene (AR) have been associated with an increased risk of prostate cancer.\n2. Mutations in the homeobox gene HoxA9 have been linked to an increased risk of prostate cancer.\n3. Mutations in the zinc finger protein Zeb2 gene have been associated with an increased risk of prostate cancer.\n4. Mutations in the Krppel-like factor Klf4 gene have been linked to an increased risk of prostate cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the androgen receptor gene (AR) have been associated with an increased risk of prostate cancer.",
      "Mutations in the homeobox gene HoxA9 have been linked to an increased risk of prostate cancer.",
      "Mutations in the zinc finger protein Zeb2 gene have been associated with an increased risk of prostate cancer.",
      "Mutations in the Krppel-like factor Klf4 gene have been linked to an increased risk of prostate cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutations in the homeobox gene HoxA9 have not been directly linked to an increased risk of prostate cancer; they are more commonly associated with leukemia.\n3. UNKNOWN\n4. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3325,
    "user_query": "Which company sells the drug Afrezza since 2015?",
    "yulan-chat-2-13b-fp16_response": "Afrezza is a inhaled human insulin drug, which is used to treat diabetes. It is manufactured and sold by a company called MannKind Corporation. MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of therapeutic products for patients with serious and life-threatening conditions. Afrezza was approved by the US FDA in 2014 and has been on the market since 2015.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Afrezza is an inhaled human insulin drug used to treat diabetes.\n2. MannKind Corporation manufactures and sells Afrezza.\n3. MannKind Corporation specializes in the development and commercialization of therapeutic products for serious and life-threatening conditions.\n4. Afrezza was approved by the US FDA in 2014.\n5. Afrezza has been available on the market since 2015.",
    "yulan-chat-2-13b-fp16_fact": [
      "Afrezza is an inhaled human insulin drug used to treat diabetes.",
      "MannKind Corporation manufactures and sells Afrezza.",
      "MannKind Corporation specializes in the development and commercialization of therapeutic products for serious and life-threatening conditions.",
      "Afrezza was approved by the US FDA in 2014.",
      "Afrezza has been available on the market since 2015."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll the statements provided about Afrezza and MannKind Corporation are accurate. Afrezza is indeed an inhaled insulin product developed for the treatment of diabetes; MannKind Corporation is the manufacturer and marketer of this product. The company does focus on developing products for serious diseases, and Afrezza was approved by the FDA in 2014. It has been available on the market since 2015.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3327,
    "user_query": "Does Uc.63+ promote sensitivity to treatment in prostate cancer?",
    "yulan-chat-2-13b-fp16_response": "I am not aware of any specific study or research that suggests that Uc.63+ promotes sensitivity to treatment in prostate cancer. However, it is important to note that prostate cancer is a complex disease and treatment outcomes can vary widely depending on many factors, including the stage and aggressiveness of the cancer, the patient's age and overall health, and the specific treatment approach used.\nIn general, treatment for prostate cancer may include a combination of surgery, radiation therapy, hormone therapy, and/or chemotherapy. The most effective treatment approach will depend on the individual patient's circumstances and will be determined by a team of healthcare professionals, including a urologist, oncologist, and other specialists.\nIf you have concerns about your own prostate cancer treatment or would like more information about the latest treatment options, it is best to speak with a healthcare professional who can provide personalized advice and guidance based on your specific situation.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3332,
    "user_query": "What is OAC CHV?",
    "yulan-chat-2-13b-fp16_response": "OAC CHV stands for \"Online Assessment and Consultation for Health and Wellness.\" It is a program that provides individuals with access to health and wellness resources and support through an online platform. The program may include assessments, consultations, and other resources to help individuals improve their health and well-being.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3338,
    "user_query": "What does MVA85A stand for?",
    "yulan-chat-2-13b-fp16_response": "MVA85A is an acronym that stands for \"Motor Vehicle Accident\". It is often used in the context of legal or insurance reports to refer to a specific incident where a motor vehicle was involved in an accident.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3339,
    "user_query": "Can MVA85A confer immunity against smallpox?",
    "yulan-chat-2-13b-fp16_response": "MVA85A is a modified vaccinia Ankara (MVA) virus, which is a variant of the vaccinia virus. The vaccinia virus is a live, attenuated (weakened) virus that is used to create the smallpox vaccine. The smallpox vaccine is still considered to be effective in preventing smallpox, although it is not currently used as a routine vaccine due to the eradication of smallpox in 1980.\nMVA85A is a recombinant virus, meaning that it has been genetically modified to express certain proteins from other viruses. In the case of MVA85A, it has been modified to express a protein called the A27L protein from the smallpox virus. This modification was made in an effort to improve the safety of the vaccine and to make it more effective at protecting against smallpox.\nStudies have shown that MVA85A is safe and effective in protecting against smallpox. It has been shown to induce a strong immune response and to provide long-lasting immunity against smallpox. However, it is important to note that MVA85A is not currently licensed for use as a smallpox vaccine in the United States or any other country. It has been used in research studies to investigate its potential as a vaccine, but it has not yet been approved for widespread use.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MVA85A is a modified vaccinia Ankara (MVA) virus.\n2. Vaccinia virus is used to create the smallpox vaccine.\n3. Smallpox vaccination is still considered effective in preventing smallpox.\n4. Smallpox was eradicated in 1980.\n5. MVA85A is not currently licensed for use as a smallpox vaccine in the United States or any other country.",
    "yulan-chat-2-13b-fp16_fact": [
      "MVA85A is a modified vaccinia Ankara (MVA) virus.",
      "Vaccinia virus is used to create the smallpox vaccine.",
      "Smallpox vaccination is still considered effective in preventing smallpox.",
      "Smallpox was eradicated in 1980.",
      "MVA85A is not currently licensed for use as a smallpox vaccine in the United States or any other country."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE - Smallpox vaccination is considered effective in preventing smallpox although the disease was eradicated and the general public is no longer routinely vaccinated.\n4. TRUE\n5. TRUE - As of my knowledge cutoff in 2023, MVA85A is an experimental vaccine primarily being researched as a booster for Bacille Calmette-Gurin (BCG) in tuberculosis control, and is not licensed for use as a smallpox vaccine.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3342,
    "user_query": "List cohesinopathies",
    "yulan-chat-2-13b-fp16_response": "Cohesinopathies are a group of genetic disorders that are caused by mutations in genes that encode proteins involved in the cohesin complex. The cohesin complex is a large protein complex that plays a critical role in maintaining the stability of chromosomes and regulating gene expression. Cohesinopathies can lead to a wide range of developmental disorders and cancer. Some of the specific cohesinopathies include:\n1. Ring chromosome instability (RCI)\n2. Ring chromosome 22 (r(22))\n3. Ring chromosome 18 (r(18))\n4. Ring chromosome 17 (r(17))\n5. Ring chromosome 16 (r(16))\n6. Ring chromosome 2 (r(2))\n7. Partial trisomy 2q\n8. Partial trisomy 16q\n9. Partial trisomy 17q\n10. Partial trisomy 22q\n11. Partial trisomy 2q21.31\n12. Partial trisomy 16q22.11\n13. Partial trisomy 17q21.61\n14. Partial trisomy 22q11.21\n15. Partial trisomy 2q31.31\n16. Partial trisomy 16q31.31\n17. Partial trisomy 17q31.31\n18. Partial trisomy 22q31.31\n19. Partial trisomy 2q32.33\n20. Partial trisomy 16q32.33\n21. Partial trisomy 17q32.33\n22. Partial trisomy 22q33.33\n23. Partial trisomy 2q34.34\n24. Partial trisomy 16q34.34\n25. Partial trisomy 17q34.34\n26. Partial",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cohesinopathies are caused by mutations in genes related to the cohesin complex.\n2. The cohesin complex has a significant role in chromosome stability and gene expression regulation.\n3. Cohesinopathies can lead to developmental disorders and cancer.\n4. Ring chromosome instability (RCI) is a specific type of cohesinopathy.\n5. Partial trisomy 22q11.21 is listed as a cohesinopathy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cohesinopathies are caused by mutations in genes related to the cohesin complex.",
      "The cohesin complex has a significant role in chromosome stability and gene expression regulation.",
      "Cohesinopathies can lead to developmental disorders and cancer.",
      "Ring chromosome instability (RCI) is a specific type of cohesinopathy.",
      "Partial trisomy 22q11.21 is listed as a cohesinopathy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Ring chromosome instability (RCI) is associated with cohesinopathies, but it is not a type of cohesinopathy. It is one of the chromosomal abnormalities that can result from defects in the cohesin complex.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "yulan-chat-2-13b-fp16_response": "The genetic association between the TNFR2 gene and Systemic Lupus Erythematosus (SLE) has been identified with a specific region within the gene called the \"tNFR2-1394C/T\" polymorphism. This region contains a single nucleotide polymorphism (SNP) at position 1394, which can be either cytosine (C) or thymine (T). Studies have shown that the T allele of this SNP is associated with an increased risk of developing SLE, while the C allele is protective against the disease. It is important to note that genetics alone do not determine the development of SLE, and other factors such as environmental triggers and immune dysregulation also play a role in the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE).\n2. A specific region within the TNFR2 gene, called the \"TNFR2-1394C/T\" polymorphism, is associated with SLE.\n3. The \"TNFR2-1394C/T\" polymorphism has a single nucleotide polymorphism (SNP) at position 1394.\n4. The T allele of the SNP at position 1394 in the TNFR2 gene is associated with an increased risk of developing SLE.\n5. The C allele of the SNP at position 1394 in the TNFR2 gene is protective against the development of SLE.",
    "yulan-chat-2-13b-fp16_fact": [
      "The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE).",
      "A specific region within the TNFR2 gene, called the \"TNFR2-1394C/T\" polymorphism, is associated with SLE.",
      "The \"TNFR2-1394C/T\" polymorphism has a single nucleotide polymorphism (SNP) at position 1394.",
      "The T allele of the SNP at position 1394 in the TNFR2 gene is associated with an increased risk of developing SLE.",
      "The C allele of the SNP at position 1394 in the TNFR2 gene is protective against the development of SLE."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: The TNFR2 gene has been implicated in the pathogenesis of Systemic Lupus Erythematosus (SLE).\n2. UNKNOWN: Without specific literature to confirm the association of the \"TNFR2-1394C/T\" polymorphism with SLE, this statement cannot be verified as true or false.\n3. UNKNOWN: Similarly, without specific scientific literature, the exact location and existence of the \"TNFR2-1394C/T\" polymorphism cannot be confirmed.\n4. UNKNOWN: The association between the T allele of any SNP within the TNFR2 gene and the risk of developing SLE cannot be determined without specific evidence.\n5. UNKNOWN: The role of the C allele of any SNP within the TNFR2 gene regarding protection against the development of SLE cannot be confirmed without appropriate scientific evidence.\n\nNote: The statements regarding the specific polymorphism and its alleles within the TNFR2 gene require the consultation of scientific literature or research data to confirm their validity.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3348,
    "user_query": "Is Figitumumab effective for non-small cell lung cancer?",
    "yulan-chat-2-13b-fp16_response": "Figitumumab is an investigational drug that is being studied for the treatment of non-small cell lung cancer (NSCLC). It is a monoclonal antibody that targets the CD47 protein, which is found on the surface of cancer cells. CD47 plays a role in the immune system's ability to recognize and destroy cancer cells.\nThere have been several clinical trials evaluating the safety and effectiveness of figitumumab in patients with NSCLC. However, as of my knowledge cutoff date of September 2021, there is limited data available on the efficacy of figitumumab in treating NSCLC.\nIn a Phase 1b/2 trial, figitumumab was combined with pembrolizumab, an immune checkpoint inhibitor, in patients with advanced NSCLC. The study found that the combination of figitumumab and pembrolizumab was well-tolerated, but the overall response rate was low.\nAnother Phase 1b/2 trial evaluated the safety and efficacy of figitumumab in combination with carboplatin and paclitaxel in patients with advanced NSCLC. The study found that the combination was well-tolerated, but again, the overall response rate was low.\nWhile the results of these trials are encouraging, more research is needed to determine the efficacy of figitumumab in treating NSCLC. It is important to note that the safety and effectiveness of figitumumab have not been fully established, and it is still considered an experimental drug.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Figitumumab is an investigational drug being studied for the treatment of non-small cell lung cancer (NSCLC).\n2. Figitumumab is a monoclonal antibody that targets the CD47 protein on the surface of cancer cells.\n3. As of September 2021, there is limited data on the efficacy of figitumumab in treating NSCLC.\n4. In a Phase 1b/2 trial, figitumumab was combined with pembrolizumab and found to be well-tolerated but had a low overall response rate in patients with advanced NSCLC.\n5. In another Phase 1b/2 trial, figitumumab was evaluated in combination with carboplatin and paclitaxel, and while the combination was well-tolerated, the overall response rate was low.",
    "yulan-chat-2-13b-fp16_fact": [
      "Figitumumab is an investigational drug being studied for the treatment of non-small cell lung cancer (NSCLC).",
      "Figitumumab is a monoclonal antibody that targets the CD47 protein on the surface of cancer cells.",
      "As of September 2021, there is limited data on the efficacy of figitumumab in treating NSCLC.",
      "In a Phase 1b/2 trial, figitumumab was combined with pembrolizumab and found to be well-tolerated but had a low overall response rate in patients with advanced NSCLC.",
      "In another Phase 1b/2 trial, figitumumab was evaluated in combination with carboplatin and paclitaxel, and while the combination was well-tolerated, the overall response rate was low."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Figitumumab is a monoclonal antibody that targets the insulin-like growth factor 1 receptor (IGF-1R) on the surface of cancer cells, not the CD47 protein.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nNote: As my knowledge is cut off at 2023 and the pharmaceutical development landscape can change rapidly, I can't currently verify the status of ongoing clinical trials or the results of trials that may have been conducted after September 2021. For the most up-to-date information, one would need to refer to the latest clinical trial databases or medical literature.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3349,
    "user_query": "The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",
    "yulan-chat-2-13b-fp16_response": "Yes, the LINCS L1000 data set contains gene expression data for drug-treated human cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The LINCS L1000 data set contains gene expression data for drug-treated human cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "The LINCS L1000 data set contains gene expression data for drug-treated human cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 3351,
    "user_query": "Which database exists that contains regulatory SNPs which affect predicted transcription factor binding site affinity?",
    "yulan-chat-2-13b-fp16_response": "There are several databases that contain information on regulatory SNPs that affect predicted transcription factor binding site affinity. Here are a few examples:\n1. Regulatory SNPs (rsnpDB): This database contains information on SNPs that are located in the promoter regions of genes and are predicted to affect transcription factor binding. The database includes information on the SNP's location, functional effects, and experimental evidence.\n2. SNPs &amp; Genes (SNPgen): This database contains information on SNPs that are located in the promoter regions of genes and are predicted to affect transcription factor binding. The database includes information on the SNP's location, functional effects, and experimental evidence.\n3. Genomic Regulatory Blocks (GRBs): This database contains information on regulatory regions of the genome, including those that contain transcription factor binding sites. The database includes information on the location, function, and genomic context of these regulatory regions.\n4. Transcription Factor Binding Sites (TFBS): This database contains information on transcription factor binding sites in the promoter regions of genes. The database includes information on the location, function, and genomic context of these binding sites.\nIt's worth noting that these databases may not be comprehensive and may not include all regulatory SNPs that affect transcription factor binding site affinity. Additionally, the information in these databases may not be up-to-date, so it's important to verify the information with other sources.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Regulatory SNPs (rsnpDB) database contains SNPs located in the promoter regions of genes.\n2. The SNPs & Genes (SNPgen) database includes information on SNPs in the promoter regions of genes and their predicted impact on transcription factor binding.\n3. The Genomic Regulatory Blocks (GRBs) database provides information on regulatory regions containing transcription factor binding sites.\n4. The Transcription Factor Binding Sites (TFBS) database includes information on transcription factor binding sites in the promoter regions of genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Regulatory SNPs (rsnpDB) database contains SNPs located in the promoter regions of genes.",
      "The SNPs & Genes (SNPgen) database includes information on SNPs in the promoter regions of genes and their predicted impact on transcription factor binding.",
      "The Genomic Regulatory Blocks (GRBs) database provides information on regulatory regions containing transcription factor binding sites.",
      "The Transcription Factor Binding Sites (TFBS) database includes information on transcription factor binding sites in the promoter regions of genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nNote: The responses are based on the assumption that these databases exist and contain the specified information, as per the context provided. If they are hypothetical or the contents are different than mentioned, the responses could vary. Since the statements seem specific and plausible for such databases to contain, they are treated as true unless proven otherwise with more detailed information on each database.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3352,
    "user_query": "Which R package has been developed for MS-based label-free phosphoproteomics?",
    "yulan-chat-2-13b-fp16_response": "The R package that has been developed for MS-based label-free phosphoproteomics is called \"PhosphoSitePlus\". This package provides a user-friendly interface for searching for phosphorylation sites in protein sequences, as well as for visualizing and analyzing phosphoproteomic data. It also includes a number of tools for the identification and quantification of phosphorylation sites in MS-based data, including the use of various statistical tests and algorithms.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "yulan-chat-2-13b-fp16_response": "As of my knowledge cutoff in September 2021, there is no licensed vaccine for peanut allergy. However, there is ongoing research and development in this area, and there have been some promising results from clinical trials.\nOne of the most advanced approaches in this field is the development of oral immunotherapy (OIT) for peanut allergy. OIT involves gradually exposing individuals with peanut allergy to increasing amounts of peanut protein, with the goal of building tolerance to the allergen. This approach has shown promise in clinical trials, and is currently undergoing further testing and refinement.\nThere are also other strategies being explored for the prevention and treatment of peanut allergy, including the use of epinephrine and other medications, as well as new approaches to desensitization and immunomodulation. However, more research is needed to determine the safety and efficacy of these approaches, and to develop effective and accessible treatments for peanut allergy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. As of September 2021, there is no licensed vaccine for peanut allergy.\n2. Oral immunotherapy (OIT) for peanut allergy involves gradually exposing individuals to increasing amounts of peanut protein to build tolerance.\n3. Clinical trials have shown promise for the oral immunotherapy approach in treating peanut allergy.\n4. New strategies for the prevention and treatment of peanut allergy are being explored, such as the use of epinephrine and immunomodulation.\n5. Further research is required to verify the safety and efficacy of new treatments for peanut allergy.",
    "yulan-chat-2-13b-fp16_fact": [
      "As of September 2021, there is no licensed vaccine for peanut allergy.",
      "Oral immunotherapy (OIT) for peanut allergy involves gradually exposing individuals to increasing amounts of peanut protein to build tolerance.",
      "Clinical trials have shown promise for the oral immunotherapy approach in treating peanut allergy.",
      "New strategies for the prevention and treatment of peanut allergy are being explored, such as the use of epinephrine and immunomodulation.",
      "Further research is required to verify the safety and efficacy of new treatments for peanut allergy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: As of the knowledge cutoff in 2023, a peanut allergy vaccine is not yet licensed, but in September 2021, the United States Food and Drug Administration (FDA) approved Palforzia, which is an oral immunotherapy product for mitigating allergic reactions to peanuts for certain individuals aged 4 through 17 with a confirmed diagnosis of peanut allergy.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Epinephrine is not a new strategy for the treatment of peanut allergy; it is used for the emergency treatment of severe allergic reactions (anaphylaxis). Immunomodulation is being explored as a new strategy for the treatment of peanut allergy.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3358,
    "user_query": "What is Soluvia?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I am not familiar with the term \"Soluvia.\" It could be a brand name, a specific product, or a company name, or it could be a misspelling or a term that is not widely known. Can you provide more context or information about what you are looking for?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3361,
    "user_query": "What is the main difference between nascent and mature chromatin?",
    "yulan-chat-2-13b-fp16_response": "Nascent chromatin is the chromatin that is newly synthesized during DNA replication, while mature chromatin is the chromatin that has been fully formed and is present in the nucleus of a cell. Nascent chromatin is loosely packed and highly dynamic, while mature chromatin is more tightly packed and less dynamic. Additionally, mature chromatin is more condensed and has a higher level of histone modifications than nascent chromatin.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nascent chromatin is newly synthesized during DNA replication.\n2. Mature chromatin is fully formed and present in the nucleus of a cell.\n3. Nascent chromatin is loosely packed and highly dynamic compared to mature chromatin.\n4. Mature chromatin is more tightly packed and less dynamic than nascent chromatin.\n5. Mature chromatin is more condensed and has a higher level of histone modifications than nascent chromatin.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nascent chromatin is newly synthesized during DNA replication.",
      "Mature chromatin is fully formed and present in the nucleus of a cell.",
      "Nascent chromatin is loosely packed and highly dynamic compared to mature chromatin.",
      "Mature chromatin is more tightly packed and less dynamic than nascent chromatin.",
      "Mature chromatin is more condensed and has a higher level of histone modifications than nascent chromatin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3362,
    "user_query": "Is CTCF bound at nucleosome free regions?",
    "yulan-chat-2-13b-fp16_response": "CTCF (CCCTC-binding factor) is a transcription factor that plays a role in regulating gene expression and chromatin organization. It is known to bind to nucleosome-free regions, as well as to other specific DNA sequences.\nNucleosome-free regions, also known as nucleosome-depleted regions or NDRs, are regions of DNA that are relatively free of nucleosomes. Nucleosomes are the basic units of chromatin, and they consist of DNA wrapped around a core of histone proteins. Nucleosomes can be found at regular intervals along DNA, and the spacing between nucleosomes is typically around 1.6-1.8 kilobases (kb). However, there are regions of DNA where nucleosomes are absent or present at low density, and these regions are called nucleosome-free or NDRs.\nCTCF is known to bind to nucleosome-free regions, as well as to other specific DNA sequences. It is thought to play a role in regulating gene expression by binding to these regions and influencing the structure of chromatin. CTCF can also act as a \"master regulator\" of chromatin organization, by binding to specific sites and influencing the positioning of nucleosomes and the organization of chromatin domains.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CTCF (CCCTC-binding factor) is a transcription factor that can bind to nucleosome-free regions of DNA.\n2. Nucleosome-free regions are also known as nucleosome-depleted regions or NDRs.\n3. Nucleosomes consist of DNA wrapped around a core of histone proteins.\n4. The spacing between nucleosomes along DNA is typically around 1.6-1.8 kilobases.\n5. CTCF is thought to influence the structure of chromatin and assist in the regulation of gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "CTCF (CCCTC-binding factor) is a transcription factor that can bind to nucleosome-free regions of DNA.",
      "Nucleosome-free regions are also known as nucleosome-depleted regions or NDRs.",
      "Nucleosomes consist of DNA wrapped around a core of histone proteins.",
      "The spacing between nucleosomes along DNA is typically around 1.6-1.8 kilobases.",
      "CTCF is thought to influence the structure of chromatin and assist in the regulation of gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The spacing between nucleosomes along DNA, known as linker DNA, is typically around 10-60 base pairs long, not 1.6-1.8 kilobases.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3364,
    "user_query": "Is PRDM9 essential for meiosis?",
    "yulan-chat-2-13b-fp16_response": "PRDM9 is a protein that plays a critical role in the formation of meiotic chromosomes during the process of meiosis. Meiosis is a specialized form of cell division that occurs in the reproductive cells of many organisms, and is essential for the production of gametes (sex cells) that can combine with other gametes during fertilization to form a new organism.\nPRDM9 is involved in the process of DNA replication and repair that occurs during meiosis, and is also involved in the formation of the synaptonemal complex, a specialized protein structure that helps to align homologous chromosomes (chromosomes that are identical or nearly identical in sequence) during meiosis.\nWithout PRDM9, meiosis may not proceed normally, which could result in the production of gametes with abnormal numbers of chromosomes or other defects. Therefore, it is likely that PRDM9 is essential for the proper functioning of meiosis in many organisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PRDM9 plays a critical role in the formation of meiotic chromosomes during meiosis.\n2. Meiosis is a form of cell division that occurs in the reproductive cells of many organisms.\n3. Meiosis is essential for the production of gametes.\n4. PRDM9 is involved in DNA replication and repair during meiosis.\n5. PRDM9 contributes to the formation of the synaptonemal complex, which helps align homologous chromosomes during meiosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "PRDM9 plays a critical role in the formation of meiotic chromosomes during meiosis.",
      "Meiosis is a form of cell division that occurs in the reproductive cells of many organisms.",
      "Meiosis is essential for the production of gametes.",
      "PRDM9 is involved in DNA replication and repair during meiosis.",
      "PRDM9 contributes to the formation of the synaptonemal complex, which helps align homologous chromosomes during meiosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: PRDM9 is not directly involved in DNA replication and repair during meiosis. It is involved in the early stages of meiotic recombination, specifically in the positioning of double-strand breaks that lead to genetic recombination.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "yulan-chat-2-13b-fp16_response": "The mouse Fxy gene is located on chromosome 12. Specifically, it is located in the region between the D12Mit1 and D12Mit2 markers. The exact position of the gene may vary slightly depending on the strain of mouse being studied, as well as the specific genetic background. However, the general location of the Fxy gene on chromosome 12 is consistent across different mouse strains.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The mouse Fxy gene is located on chromosome 12.\n2. The Fxy gene is situated in the region between the D12Mit1 and D12Mit2 markers.\n3. The exact position of the Fxy gene may vary slightly depending on the strain of mouse.\n4. The general location of the Fxy gene on chromosome 12 is consistent across different mouse strains.",
    "yulan-chat-2-13b-fp16_fact": [
      "The mouse Fxy gene is located on chromosome 12.",
      "The Fxy gene is situated in the region between the D12Mit1 and D12Mit2 markers.",
      "The exact position of the Fxy gene may vary slightly depending on the strain of mouse.",
      "The general location of the Fxy gene on chromosome 12 is consistent across different mouse strains."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n\nWithout specific scientific context or references, the location of the mouse Fxy gene cannot be verified as true or false for statements 1 and 2. However, it is generally true for many genes that their exact position can vary slightly depending on the strain (statement 3), and it is also generally true that the location of a gene on a chromosome is consistent across different strains (statement 4), barring any significant chromosomal rearrangements or mutations.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3367,
    "user_query": "What does a PET (Positron Excitation Tomography) measure?",
    "yulan-chat-2-13b-fp16_response": "PET (Positron Emission Tomography) is a medical imaging technique that measures the metabolic activity of cells in the body. It uses a radioactive tracer, typically a sugar-based compound labeled with a positron-emitting isotope, to track the metabolic activity of cells in various organs and tissues.\nDuring a PET scan, the patient is injected with a small amount of the radioactive tracer, which is then taken up by cells in the body. The tracer emits positrons, which are the opposite of electrons, and these positrons interact with electrons in the body to produce gamma rays. A special camera called a PET scanner detects these gamma rays and uses them to create detailed images of the body's metabolic activity.\nPET scans are commonly used to diagnose and monitor a variety of conditions, including cancer, heart disease, and neurological disorders. They can help doctors identify areas of the body that are affected by disease or injury, and can provide information about the effectiveness of treatments.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PET (Positron Emission Tomography) is a medical imaging technique that measures the metabolic activity of cells in the body.\n2. PET uses a radioactive tracer, typically a sugar-based compound labeled with a positron-emitting isotope.\n3. Patients undergoing a PET scan are injected with a small amount of the radioactive tracer.\n4. PET scanners detect gamma rays produced by the interaction of positrons emitted from the tracer and electrons in the body.\n5. PET scans are used to diagnose and monitor conditions such as cancer, heart disease, and neurological disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "PET (Positron Emission Tomography) is a medical imaging technique that measures the metabolic activity of cells in the body.",
      "PET uses a radioactive tracer, typically a sugar-based compound labeled with a positron-emitting isotope.",
      "Patients undergoing a PET scan are injected with a small amount of the radioactive tracer.",
      "PET scanners detect gamma rays produced by the interaction of positrons emitted from the tracer and electrons in the body.",
      "PET scans are used to diagnose and monitor conditions such as cancer, heart disease, and neurological disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: PET scanners detect gamma rays produced by the annihilation of positrons emitted from the tracer and electrons in the body.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3371,
    "user_query": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?",
    "yulan-chat-2-13b-fp16_response": "There have been several clinical trials investigating the use of minocycline for amyotrophic lateral sclerosis (ALS), but the results have been mixed and the evidence is not definitive.\nOne small randomized, double-blind, placebo-controlled trial published in 2013 found that minocycline did not significantly slow the progression of ALS in patients taking part in the trial. However, another small randomized, double-blind, placebo-controlled trial published in 2017 found that minocycline did significantly slow the progression of ALS in patients taking part in the trial.\nThere have also been some observational studies that suggest a potential benefit of minocycline in ALS patients, but these studies are limited by their observational design and lack of a control group.\nOverall, while there is some evidence to suggest that minocycline may be beneficial for ALS patients, the evidence is not definitive and more research is needed to confirm these findings. It is important to note that minocycline can have side effects, and patients should discuss the potential benefits and risks of this treatment with their healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Several clinical trials have investigated the use of minocycline for amyotrophic lateral sclerosis (ALS).\n2. A randomized, double-blind, placebo-controlled trial published in 2013 reported that minocycline did not significantly slow ALS progression.\n3. Another randomized, double-blind, placebo-controlled trial published in 2017 indicated that minocycline significantly slowed the progression of ALS.\n4. Observational studies have suggested a potential benefit of minocycline for ALS patients, but they have limitations due to their design.\n5. There is not yet definitive evidence to confirm the benefits of minocycline for ALS patients, and more research is necessary.",
    "yulan-chat-2-13b-fp16_fact": [
      "Several clinical trials have investigated the use of minocycline for amyotrophic lateral sclerosis (ALS).",
      "A randomized, double-blind, placebo-controlled trial published in 2013 reported that minocycline did not significantly slow ALS progression.",
      "Another randomized, double-blind, placebo-controlled trial published in 2017 indicated that minocycline significantly slowed the progression of ALS.",
      "Observational studies have suggested a potential benefit of minocycline for ALS patients, but they have limitations due to their design.",
      "There is not yet definitive evidence to confirm the benefits of minocycline for ALS patients, and more research is necessary."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There are no published randomized, double-blind, placebo-controlled trials from 2017 that indicate minocycline significantly slowed the progression of ALS. Such trials have either shown no significant benefit or have not been conducted.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3374,
    "user_query": "What is the function of the ISW1 and CHD1 remodellers in yeast chromatin?",
    "yulan-chat-2-13b-fp16_response": "The ISW1 and CHD1 remodellers are proteins that function in the process of chromatin remodeling in yeast. Chromatin remodeling refers to the process by which chromatin, the complex of DNA and proteins that makes up the chromosomes, is modified in order to regulate gene expression.\nThe ISW1 remodeler is a member of the ISWI family of proteins, which are thought to act as \"molecular motors\" that move along DNA and remodel chromatin by sliding nucleosomes along the DNA strand. The ISW1 remodeler is thought to play a role in the regulation of gene expression by remodeling chromatin in response to changes in the cell's environment.\nThe CHD1 remodeler is a member of the CHD (chromatin-remodeling complex protein) family of proteins, which are thought to act as \"nucleosome-remodeling machines\" that use ATP hydrolysis to move nucleosomes along DNA and remodel chromatin. The CHD1 remodeler is thought to play a role in the regulation of gene expression by remodeling chromatin in response to changes in the cell's environment.\nOverall, the ISW1 and CHD1 remodellers play important roles in the regulation of gene expression in yeast by remodeling chromatin in response to changes in the cell's environment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The ISW1 and CHD1 remodelers function in chromatin remodeling in yeast.\n2. Chromatin remodeling regulates gene expression.\n3. The ISW1 remodeler is part of the ISWI family of proteins.\n4. The CHD1 remodeler is part of the CHD family of proteins and uses ATP hydrolysis to move nucleosomes along DNA.\n5. Both ISW1 and CHD1 remodelers are involved in the regulation of gene expression in response to changes in the cell's environment.",
    "yulan-chat-2-13b-fp16_fact": [
      "The ISW1 and CHD1 remodelers function in chromatin remodeling in yeast.",
      "Chromatin remodeling regulates gene expression.",
      "The ISW1 remodeler is part of the ISWI family of proteins.",
      "The CHD1 remodeler is part of the CHD family of proteins and uses ATP hydrolysis to move nucleosomes along DNA.",
      "Both ISW1 and CHD1 remodelers are involved in the regulation of gene expression in response to changes in the cell's environment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll of these statements are consistent with the current understanding of chromatin remodeling and the roles of the ISW1 and CHD1 remodelers in yeast. Both are involved in altering the structure of chromatin to regulate gene expression, which can include responses to environmental changes. ISW1 is indeed part of the ISWI family of proteins, and CHD1 is a member of the CHD family, which uses ATP hydrolysis to move nucleosomes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3382,
    "user_query": "What is the difference between Daptacel and Pentacel?",
    "yulan-chat-2-13b-fp16_response": "Daptacel and Pentacel are both vaccines that protect against various diseases, but they contain different combinations of vaccines and are used in different age groups.\nDaptacel is a vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough) as well as polio. It is recommended for infants, children, and adults and is typically given as a series of shots.\nPentacel is a vaccine that protects against diphtheria, tetanus, pertussis (whooping cough), and polio, as well as Haemophilus influenzae type b (Hib) and hepatitis B. It is recommended for infants and young children and is typically given as a series of shots.\nIn summary, Daptacel is a vaccine that protects against diphtheria, tetanus, pertussis (whooping cough), and polio, while Pentacel is a vaccine that protects against diphtheria, tetanus, pertussis (whooping cough), polio, Hib, and hepatitis B.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Daptacel is a vaccine that protects against diphtheria, tetanus, pertussis, and polio.\n2. Pentacel is a vaccine that protects against diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), and hepatitis B.\n3. Daptacel is recommended for use in infants, children, and adults.\n4. Pentacel is recommended for use in infants and young children.\n5. Both Daptacel and Pentacel are typically given as a series of shots.",
    "yulan-chat-2-13b-fp16_fact": [
      "Daptacel is a vaccine that protects against diphtheria, tetanus, pertussis, and polio.",
      "Pentacel is a vaccine that protects against diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), and hepatitis B.",
      "Daptacel is recommended for use in infants, children, and adults.",
      "Pentacel is recommended for use in infants and young children.",
      "Both Daptacel and Pentacel are typically given as a series of shots."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Daptacel is a vaccine that protects against diphtheria, tetanus, and pertussis, not polio.\n2. FALSE [correction]: Pentacel is a vaccine that protects against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib), not hepatitis B.\n3. TRUE: Daptacel is recommended for use in infants, children, and adults up to 64 years of age for protection against diphtheria, tetanus, and pertussis.\n4. TRUE: Pentacel is recommended for use in infants and young children between the ages of 2 months to 4 years (prior to the 5th birthday) for protection against diphtheria, tetanus, pertussis, polio, and Hib.\n5. TRUE: Both Daptacel and Pentacel are typically given as a series of shots, as part of the childhood vaccination schedule.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3389,
    "user_query": "What is herd immunity?",
    "yulan-chat-2-13b-fp16_response": "Herd immunity, also known as community immunity, is a concept in epidemiology that describes the situation that occurs when a sufficient proportion of a population is immune to a particular infectious disease, either through vaccination or previous infection, such that the disease is unable to spread easily through that population.\nWhen a significant portion of a population is immune to a disease, it creates a protective barrier, known as \"herd immunity,\" that prevents the spread of the disease to those who are susceptible, including those who have not been vaccinated or who have not had the disease before.\nThe exact proportion of the population that needs to be immune to achieve herd immunity varies depending on the disease, but it typically requires a significant proportion of the population to be immune in order to prevent the disease from spreading easily. For example, for measles, a disease that is highly contagious, herd immunity requires at least 95% of the population to be immune.\nHerd immunity is an important concept in public health, as it helps to protect vulnerable members of the population, such as newborns, elderly individuals, and those with underlying health conditions, who may not be able to receive vaccinations or who may be more susceptible to severe illness or complications from the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Herd immunity describes a situation where a sufficient proportion of a population is immune to an infectious disease, making its spread difficult.\n2. Immunity contributing to herd immunity can come from vaccination or previous infection.\n3. The presence of herd immunity can protect those who are susceptible but have not been vaccinated or have not had the disease.\n4. The proportion of the population required for herd immunity varies by disease.\n5. For measles, herd immunity typically requires at least 95% of the population to be immune.",
    "yulan-chat-2-13b-fp16_fact": [
      "Herd immunity describes a situation where a sufficient proportion of a population is immune to an infectious disease, making its spread difficult.",
      "Immunity contributing to herd immunity can come from vaccination or previous infection.",
      "The presence of herd immunity can protect those who are susceptible but have not been vaccinated or have not had the disease.",
      "The proportion of the population required for herd immunity varies by disease.",
      "For measles, herd immunity typically requires at least 95% of the population to be immune."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3391,
    "user_query": "List the stages/types of Multiple Sclerosis.",
    "yulan-chat-2-13b-fp16_response": "Multiple Sclerosis (MS) is a chronic autoimmune disorder that affects the central nervous system (CNS). It is characterized by inflammation, myelin destruction, and scarring in the CNS, which can lead to a wide range of symptoms, including muscle weakness, fatigue, difficulty with coordination and balance, and problems with vision, speech, and memory.\nMS can be divided into four main types, based on the pattern of disease progression and the severity of symptoms:\n1. Relapsing-remitting MS (RRMS): This is the most common form of MS, affecting about 85% of people with the condition. It is characterized by clearly defined relapses (acute attacks) followed by periods of remission. During relapses, new symptoms may appear or existing ones may worsen, and the patient may experience a range of symptoms, including vision problems, muscle weakness, fatigue, and difficulty with coordination and balance.\n2. Secondary progressive MS (SPMS): This type of MS usually develops several years after the initial diagnosis of RRMS. In SPMS, the disease gradually worsens over time, with a steady accumulation of disability. Some patients may experience relapses and new symptoms during this phase, while others may not.\n3. Primary progressive MS (PPMS): This type of MS is characterized by a steady worsening of symptoms from the beginning of the disease, with no distinct relapses or remissions. PPMS is relatively rare, affecting about 10-15% of people with MS.\n4. Progressive-relapsing MS (PRMS): This is the least common form of MS, affecting only about 5% of people with the condition. It is characterized by a sudden onset of severe symptoms, followed by a period of stability, and then a gradual worsening of the disease.\nIn addition to these main types, there are also several subtypes of MS, which are defined based on the specific symptoms and characteristics of the disease. These subtypes include:\n* Clinically isolated syndrome (CIS): This is a single episode of neurological symptoms that occurs in the absence of a confirmed MS diagnosis.\n* Multiple scleros",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Relapsing-remitting MS (RRMS) is a form of Multiple Sclerosis that affects about 85% of people with the condition, characterized by clear relapses followed by periods of remission.\n2. Secondary progressive MS (SPMS) usually develops several years after the initial diagnosis of RRMS and is marked by a gradual worsening of the disease over time.\n3. Primary progressive MS (PPMS) affects about 10-15% of people with Multiple Sclerosis and is characterized by continuous worsening of symptoms from the onset, without distinct relapses or remissions.\n4. Progressive-relapsing MS (PRMS) affects approximately 5% of those with Multiple Sclerosis and involves severe symptoms that worsen gradually after periods of stability.\n5. Clinically isolated syndrome (CIS) refers to a single neurological episode that occurs without a confirmed Multiple Sclerosis diagnosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Relapsing-remitting MS (RRMS) is a form of Multiple Sclerosis that affects about 85% of people with the condition, characterized by clear relapses followed by periods of remission.",
      "Secondary progressive MS (SPMS) usually develops several years after the initial diagnosis of RRMS and is marked by a gradual worsening of the disease over time.",
      "Primary progressive MS (PPMS) affects about 10-15% of people with Multiple Sclerosis and is characterized by continuous worsening of symptoms from the onset, without distinct relapses or remissions.",
      "Progressive-relapsing MS (PRMS) affects approximately 5% of those with Multiple Sclerosis and involves severe symptoms that worsen gradually after periods of stability.",
      "Clinically isolated syndrome (CIS) refers to a single neurological episode that occurs without a confirmed Multiple Sclerosis diagnosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Progressive-relapsing MS (PRMS) was recognized as a form of Multiple Sclerosis involving a steady worsening of disease from the beginning, with clear, acute relapses. However, with the 2013 revision of MS phenotypes, PRMS was essentially merged into primary progressive MS, and as of the knowledge cutoff in 2023, it is not considered a separate disease course.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3395,
    "user_query": "List Mcl-1 inhibitors.",
    "yulan-chat-2-13b-fp16_response": "Mcl-1 is a protein that plays a role in regulating cell survival and apoptosis (programmed cell death). Inhibitors of Mcl-1 can induce apoptosis in cells and may have potential therapeutic applications in the treatment of various diseases. Some examples of Mcl-1 inhibitors include:\n1. Quisqualic acid: a natural compound found in the spice Quisqualus ioco (grain of paradise) that has been shown to induce apoptosis in cancer cells by inhibiting Mcl-1.\n2. Obatoclax: a synthetic small molecule that selectively binds to and inhibits Mcl-1, leading to apoptosis in cancer cells.\n3. S63845: a synthetic compound that selectively inhibits Mcl-1 and induces apoptosis in cancer cells.\n4. JNJ-752605: a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in cancer cells.\n5. BM13080: a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in cancer cells.\n6. BM21487: a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in cancer cells.\n7. BM2201: a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in cancer cells.\n8. BM23432: a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in cancer cells.\n9. BM24024: a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in cancer cells.\n10. BM25474: a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in cancer cells.\nIt is important to note that the use of Mcl-1 inhibitors in humans is still in the experimental stage and more research is needed to fully understand their safety and efficacy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Quisqualic acid is found in the spice Quisqualus ioco and can inhibit Mcl-1 to induce apoptosis in cancer cells.\n2. Obatoclax is a synthetic small molecule that inhibits Mcl-1 and leads to apoptosis in cancer cells.\n3. S63845 is a synthetic compound that selectively inhibits Mcl-1 to induce apoptosis in cancer cells.\n4. JNJ-752605 is a small molecule inhibitor of Mcl-1 that induces apoptosis in cancer cells.\n5. The use of Mcl-1 inhibitors in humans is still in the experimental stage.",
    "yulan-chat-2-13b-fp16_fact": [
      "Quisqualic acid is found in the spice Quisqualus ioco and can inhibit Mcl-1 to induce apoptosis in cancer cells.",
      "Obatoclax is a synthetic small molecule that inhibits Mcl-1 and leads to apoptosis in cancer cells.",
      "S63845 is a synthetic compound that selectively inhibits Mcl-1 to induce apoptosis in cancer cells.",
      "JNJ-752605 is a small molecule inhibitor of Mcl-1 that induces apoptosis in cancer cells.",
      "The use of Mcl-1 inhibitors in humans is still in the experimental stage."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: The first statement is specific and cannot be verified without subject knowledge or a specific reference to support it. Quisqualic acid is found in the seeds of Quisqualis species like Quisqualis indica, but there is no verification for the spice \"Quisqualus ioco\" or its actions on Mcl-1 without more context.\n2. TRUE: Obatoclax is indeed a synthetic small molecule that inhibits Mcl-1, which is known to lead to apoptosis in cancer cells.\n3. TRUE: S63845 is a synthetic compound known for selectively inhibiting Mcl-1 and inducing apoptosis in cancer cells.\n4. UNKNOWN: The statement about JNJ-752605 being an Mcl-1 inhibitor is specific, and without additional information or references, the veracity of the claim cannot be ascertained.\n5. TRUE: To the best of my knowledge, Mcl-1 inhibitors' use in humans is indeed still considered experimental and is the subject of ongoing clinical trials, as they have not been widely approved for clinical use.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3396,
    "user_query": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",
    "yulan-chat-2-13b-fp16_response": "No, autophagy is not the process where a virus obtains nutrients from its host. Autophagy is a process in which a cell digests and recycles its own components, such as proteins and organelles, to maintain cellular homeostasis and survive under conditions of starvation or stress. This process is different from the way viruses obtain nutrients, which is typically by hijacking the host cell's machinery to produce and assemble new viral particles.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Autophagy is a process where a cell digests and recycles its own components.\n2. Autophagy is involved in maintaining cellular homeostasis.\n3. Autophagy can help cells survive under conditions of starvation or stress.\n4. Viruses obtain nutrients by hijacking the host cell's machinery to produce new viral particles.\n5. Autophagy is not the process where a virus obtains nutrients from its host.",
    "yulan-chat-2-13b-fp16_fact": [
      "Autophagy is a process where a cell digests and recycles its own components.",
      "Autophagy is involved in maintaining cellular homeostasis.",
      "Autophagy can help cells survive under conditions of starvation or stress.",
      "Viruses obtain nutrients by hijacking the host cell's machinery to produce new viral particles.",
      "Autophagy is not the process where a virus obtains nutrients from its host."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE (Autophagy is a cellular process used primarily for degradation and turnover of the cell's own components, while viral nutrient acquisition is not autophagy but rather hijacking the cell's machinery. Hence, the statement is true in the context that autophagy is not how viruses obtain nutrients.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "yulan-chat-2-13b-fp16_response": "Methidiumpropyl-EDTA sequencing (MPE-seq) is a method used to analyze the DNA methylation patterns in plant genomes. It is based on the principle that methylated cytosines in CpG islands are converted into 5-hydroxymethyl-2-furyl-RNA-3,8-oxido-5-oxocine (HmFO) by the enzyme cytosine-5-methyl-transferase (C5Mtase) in the presence of the reagent methidiumpropyl-EDTA. This conversion results in a specific pattern of methylation that can be detected and quantified using high-throughput sequencing technologies. The MPE-seq method allows for the detection of DNA methylation at single-base resolution across the entire genome, providing valuable information for understanding gene regulation and epigenetic inheritance.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Methidiumpropyl-EDTA sequencing (MPE-seq) is used to analyze DNA methylation patterns in plant genomes.\n2. Methylated cytosines in CpG islands are converted into 5-hydroxymethyl-2-furyl-RNA-3,8-oxido-5-oxocine (HmFO) by the enzyme cytosine-5-methyl-transferase (C5Mtase) during MPE-seq.\n3. The reagent methidiumpropyl-EDTA is used during the conversion process in MPE-seq.\n4. High-throughput sequencing technologies are utilized to detect and quantify the methylation pattern in MPE-seq.\n5. The MPE-seq method allows for the detection of DNA methylation at single-base resolution across the entire genome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Methidiumpropyl-EDTA sequencing (MPE-seq) is used to analyze DNA methylation patterns in plant genomes.",
      "Methylated cytosines in CpG islands are converted into 5-hydroxymethyl-2-furyl-RNA-3,8-oxido-5-oxocine (HmFO) by the enzyme cytosine-5-methyl-transferase (C5Mtase) during MPE-seq.",
      "The reagent methidiumpropyl-EDTA is used during the conversion process in MPE-seq.",
      "High-throughput sequencing technologies are utilized to detect and quantify the methylation pattern in MPE-seq.",
      "The MPE-seq method allows for the detection of DNA methylation at single-base resolution across the entire genome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Methidiumpropyl-EDTA sequencing (MPE-seq) is not a known method for analyzing DNA methylation patterns in plant genomes. Bisulfite sequencing is a common method for such analyses.\n2. FALSE [correction]: The statement contains a fictitious chemical compound. In bisulfite sequencing (a common method for methylation analysis), cytosines are converted to uracil if they are not methylated, not the complex chemical described.\n3. UNKNOWN: The use of the reagent methidiumpropyl-EDTA is not associated with a known DNA sequencing technique; without additional context, the accuracy of this statement cannot be assessed.\n4. TRUE: High-throughput sequencing technologies are indeed utilized to detect and quantify methylation patterns, although in the context of well-established methods like bisulfite sequencing or others, not MPE-seq.\n5. TRUE: Methods like bisulfite sequencing do allow for the detection of DNA methylation at single-base resolution across the entire genome, but the term MPE-seq seems to be incorrect or fictional.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3399,
    "user_query": "Does CXorf21 escape X chromosome inactivation?",
    "yulan-chat-2-13b-fp16_response": "CXorf21 (Crossing of the X-Chromosome Orientation in the Future) is a gene located on the X chromosome in humans. X chromosome inactivation (XCI) is a process that occurs in female mammals in which one of the two X chromosomes is inactivated in order to balance the expression of X-linked genes between females and males. It is not clear whether CXorf21 escapes XCI, as this would depend on the specific expression pattern of the gene and the specific cell types and tissues in which it is expressed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CXorf21 is a gene located on the X chromosome in humans.\n2. X chromosome inactivation (XCI) occurs in female mammals.\n3. XCI inactivates one of the two X chromosomes in female mammals to balance gene expression between the sexes.\n4. It is unclear if CXorf21 escapes X chromosome inactivation.",
    "yulan-chat-2-13b-fp16_fact": [
      "CXorf21 is a gene located on the X chromosome in humans.",
      "X chromosome inactivation (XCI) occurs in female mammals.",
      "XCI inactivates one of the two X chromosomes in female mammals to balance gene expression between the sexes.",
      "It is unclear if CXorf21 escapes X chromosome inactivation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE (Based on the phrasing \"It is unclear if...\", the statement itself suggests uncertainty about the status of CXorf21 in relation to X chromosome inactivation, which is difficult to refute without specific context or current research findings. Hence, the statement itself is considered true in acknowledging this uncertainty.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "yulan-chat-2-13b-fp16_response": "GWAR (GeneWalk Automated Reader) is a bioinformatics tool that has been implemented in Python programming language.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GWAR stands for GeneWalk Automated Reader.\n2. Python programming language has been used for implementing GWAR.",
    "yulan-chat-2-13b-fp16_fact": [
      "GWAR stands for GeneWalk Automated Reader.",
      "Python programming language has been used for implementing GWAR."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: GWAR stands for the heavy metal band \"Gwar,\" not GeneWalk Automated Reader.\n2. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 3401,
    "user_query": "Describe f-scLVM",
    "yulan-chat-2-13b-fp16_response": "f-scLVM (Flexible Storage Controller Logical Volume Manager) is a software-defined storage solution that provides a flexible and scalable way to manage storage in a data center. It is designed to work with Linux-based operating systems and is often used in conjunction with other open-source software-defined storage solutions, such as Ceph and GlusterFS.\nf-scLVM is built on top of the Linux Logical Volume Manager (LVM) and provides additional features and functionality, such as support for thin provisioning, snapshotting, and replication. It also allows for the creation of multi-tenant storage systems, where multiple virtual storage systems can be created within a single physical storage system.\nOne of the key benefits of f-scLVM is its ability to provide a highly available and fault-tolerant storage solution. It can be configured with multiple controllers and multiple storage backends, allowing for automatic failover and redundancy in the event of a controller or storage device failure.\nOverall, f-scLVM is a powerful and flexible storage solution that is well-suited for data centers and other large-scale storage environments.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. f-scLVM stands for Flexible Storage Controller Logical Volume Manager.\n2. It is a software-defined storage solution designed for Linux-based operating systems.\n3. f-scLVM works in conjunction with other open-source software-defined storage solutions like Ceph and GlusterFS.\n4. The software allows for features like thin provisioning, snapshotting, and replication.\n5. f-scLVM can be configured for high availability and fault tolerance with multiple controllers and storage backends.",
    "yulan-chat-2-13b-fp16_fact": [
      "f-scLVM stands for Flexible Storage Controller Logical Volume Manager.",
      "It is a software-defined storage solution designed for Linux-based operating systems.",
      "f-scLVM works in conjunction with other open-source software-defined storage solutions like Ceph and GlusterFS.",
      "The software allows for features like thin provisioning, snapshotting, and replication.",
      "f-scLVM can be configured for high availability and fault tolerance with multiple controllers and storage backends."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe abbreviation \"f-scLVM\" is not a widely recognized term in the context of software-defined storage solutions. Due to the lack of clear context regarding \"f-scLVM\" and its specifications or operations, the truthfulness of the statements cannot be determined.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3403,
    "user_query": "How large is a lncRNAs?",
    "yulan-chat-2-13b-fp16_response": "Long non-coding RNAs (lncRNAs) can vary in size, but on average they are larger than typical coding RNA genes. The length of an lncRNA can range from a few hundred to several thousand nucleotides. Some lncRNAs have been found to be over 10,000 nucleotides in length. In comparison, most coding RNA genes are less than 1000 nucleotides in length. The size of an lncRNA can vary depending on the species and the specific function it serves.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Long non-coding RNAs (lncRNAs) can vary in length from a few hundred to several thousand nucleotides.\n2. Some lncRNAs can be over 10,000 nucleotides in length.\n3. Most coding RNA genes are less than 1000 nucleotides in length.",
    "yulan-chat-2-13b-fp16_fact": [
      "Long non-coding RNAs (lncRNAs) can vary in length from a few hundred to several thousand nucleotides.",
      "Some lncRNAs can be over 10,000 nucleotides in length.",
      "Most coding RNA genes are less than 1000 nucleotides in length."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Most coding RNA genes, which are typically known as messenger RNAs (mRNAs), are often more than 1000 nucleotides in length, depending on the complexity of the proteins they encode.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "yulan-chat-2-13b-fp16_response": "Xaliproden is an experimental drug that has been studied for its potential to treat amyotrophic lateral sclerosis (ALS). However, it has not yet been approved for use by regulatory agencies, and there is limited information available on its effectiveness in improving the prognosis of ALS.\nALS is a progressive neurological disorder that affects the nerve cells in the brain and spinal cord, leading to muscle weakness and eventual loss of function. While there is no cure for ALS, there are treatments available that can help manage symptoms and slow the progression of the disease.\nXaliproden is a small molecule that has been shown to have neuroprotective effects in animal models of ALS. It works by inhibiting the activity of a protein called p38, which is involved in the inflammatory response and cell death. Some studies have suggested that xaliproden may be effective in reducing the severity of ALS symptoms and slowing the progression of the disease.\nHowever, clinical trials of xaliproden in humans have been limited, and the results have been mixed. Some studies have shown promising results, while others have not been able to replicate these findings. As a result, more research is needed to fully understand the potential benefits of xaliproden in treating ALS.\nIn summary, while xaliproden shows promise as a potential treatment for ALS, more research is needed to determine its effectiveness in improving the prognosis of the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Xaliproden is an experimental drug studied for the treatment of amyotrophic lateral sclerosis (ALS).\n2. Xaliproden has not been approved for use by regulatory agencies.\n3. ALS is a progressive neurological disorder that affects nerve cells in the brain and spinal cord.\n4. Xaliproden is known to inhibit the activity of a protein called p38.\n5. Clinical trials of xaliproden in humans have returned mixed results, necessitating further research.",
    "yulan-chat-2-13b-fp16_fact": [
      "Xaliproden is an experimental drug studied for the treatment of amyotrophic lateral sclerosis (ALS).",
      "Xaliproden has not been approved for use by regulatory agencies.",
      "ALS is a progressive neurological disorder that affects nerve cells in the brain and spinal cord.",
      "Xaliproden is known to inhibit the activity of a protein called p38.",
      "Clinical trials of xaliproden in humans have returned mixed results, necessitating further research."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3407,
    "user_query": "What is Telangiectasia?",
    "yulan-chat-2-13b-fp16_response": "Telangiectasia is a medical condition characterized by the dilation of small blood vessels just beneath the surface of the skin. It is also known as \"spider angiomas\" or \"spider telangiectasias.\"\nTelangiectasia can occur in various parts of the body, but it is most commonly found on the face, particularly on the nose and cheeks. It can also occur on the legs and other areas of the body.\nThe exact cause of telangiectasia is not known, but it is believed to be related to a combination of genetic and environmental factors. It is more common in women than men and tends to worsen with age.\nTelangiectasia is usually not a serious medical condition, but it can be a cosmetic concern for some people. Treatment options include laser therapy, sclerotherapy (injection of a solution to shrink the blood vessels), and topical creams or gels. However, these treatments are not always effective and may have side effects. In some cases, telangiectasia may be left untreated.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Telangiectasia is a medical condition characterized by the dilation of small blood vessels just beneath the surface of the skin.\n2. The condition is also referred to as \"spider angiomas\" or \"spider telangiectasias.\"\n3. Telangiectasia is most commonly found on the face, especially on the nose and cheeks.\n4. The condition is more prevalent in women than in men.\n5. Treatment options for telangiectasia include laser therapy, sclerotherapy, and topical creams or gels.",
    "yulan-chat-2-13b-fp16_fact": [
      "Telangiectasia is a medical condition characterized by the dilation of small blood vessels just beneath the surface of the skin.",
      "The condition is also referred to as \"spider angiomas\" or \"spider telangiectasias.\"",
      "Telangiectasia is most commonly found on the face, especially on the nose and cheeks.",
      "The condition is more prevalent in women than in men.",
      "Treatment options for telangiectasia include laser therapy, sclerotherapy, and topical creams or gels."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3409,
    "user_query": "Which tissues express the ACE2 protein?",
    "yulan-chat-2-13b-fp16_response": "The ACE2 protein is expressed in various tissues and cells throughout the body, including:\n1. Lungs: ACE2 is expressed in the alveolar epithelial cells of the lungs, where it plays a role in regulating fluid balance and preventing edema.\n2. Heart: ACE2 is expressed in the heart, where it helps to regulate blood pressure and cardiac function.\n3. Kidneys: ACE2 is expressed in the renal tubules and glomeruli of the kidneys, where it plays a role in regulating fluid and electrolyte balance.\n4. Brain: ACE2 is expressed in the brain, where it has been implicated in various cognitive functions, including learning and memory.\n5. Intestine: ACE2 is expressed in the intestinal epithelial cells, where it may play a role in regulating gut homeostasis and immune function.\n6. Liver: ACE2 is expressed in the liver, where it may play a role in regulating lipid metabolism and inflammation.\nOverall, ACE2 appears to be involved in a wide range of physiological processes throughout the body, and its expression patterns suggest that it may play an important role in maintaining overall health and well-being.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The ACE2 protein is expressed in the alveolar epithelial cells of the lungs.\n2. The ACE2 protein is expressed in the heart.\n3. The ACE2 protein is expressed in the renal tubules and glomeruli of the kidneys.\n4. The ACE2 protein is expressed in the brain.\n5. The ACE2 protein is expressed in the intestinal epithelial cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "The ACE2 protein is expressed in the alveolar epithelial cells of the lungs.",
      "The ACE2 protein is expressed in the heart.",
      "The ACE2 protein is expressed in the renal tubules and glomeruli of the kidneys.",
      "The ACE2 protein is expressed in the brain.",
      "The ACE2 protein is expressed in the intestinal epithelial cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe ACE2 protein is known to be expressed in various tissues in the human body, including the lungs, heart, kidneys, brain, and intestines. It serves different physiological roles and has been a point of interest, particularly in the context of SARS-CoV-2 infection, as it is a receptor for the virus.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "yulan-chat-2-13b-fp16_response": "The LiPS-A3S line is a transgenic line of soybean plants that have been genetically modified to produce phytoestrogens, which are plant-derived compounds that have estrogen-like effects in animals. The transgenes that confer this trait were inserted into the genome of the soybean plant using a gene gun delivery method.\nThe specific chromosome in which the transgenes were inserted in the LiPS-A3S line is not specified in the literature that I have access to. However, it is likely that the transgenes were inserted into multiple chromosomes, as this is a common approach for introducing foreign genetic material into plant genomes. The precise location of the transgenes within the genome will depend on the specific genetic construct used and the method of insertion.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3411,
    "user_query": "What is a J pouch?",
    "yulan-chat-2-13b-fp16_response": "A J-pouch is a type of surgical procedure used to treat ulcerative colitis and Crohn's disease. It involves creating a pouch in the remaining healthy part of the digestive system to replace the removed diseased portion of the colon. The pouch is shaped like a \"J\" and is made from the end of the ileum (the small intestine) and the beginning of the rectum. The pouch allows stool to pass through the digestive system without irritating the lining of the colon, which can help alleviate symptoms of inflammatory bowel disease (IBD).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A J-pouch is a surgical procedure used to treat ulcerative colitis and Crohn's disease.\n2. The procedure involves creating a pouch from the end of the ileum and the beginning of the rectum.\n3. The purpose of the J-pouch is to replace the removed diseased portion of the colon.\n4. The J-pouch is shaped like a \"J\".\n5. It allows stool to pass through the digestive system without irritating the lining of the colon.",
    "yulan-chat-2-13b-fp16_fact": [
      "A J-pouch is a surgical procedure used to treat ulcerative colitis and Crohn's disease.",
      "The procedure involves creating a pouch from the end of the ileum and the beginning of the rectum.",
      "The purpose of the J-pouch is to replace the removed diseased portion of the colon.",
      "The J-pouch is shaped like a \"J\".",
      "It allows stool to pass through the digestive system without irritating the lining of the colon."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The procedure involves creating a pouch from the end of the ileum, but not the beginning of the rectum. The pouch is typically connected to the anus, bypassing the removed rectum.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3412,
    "user_query": "What is the function of the protein encoded by the gene NKCC2?",
    "yulan-chat-2-13b-fp16_response": "The protein encoded by the gene NKCC2 is a member of the sodium potassium cotransporter (NKCC) family, which plays a critical role in regulating ion transport and cellular volume in various tissues, including the brain, kidney, and intestine. The NKCC2 protein functions as a cotransporter to facilitate the simultaneous movement of sodium and potassium ions across the cell membrane, which helps to maintain the balance of ion concentrations and cellular homeostasis. Mutations in the NKCC2 gene have been associated with various disorders, including epilepsy, hypertension, and congestive heart failure.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The protein encoded by the NKCC2 gene is a member of the sodium potassium cotransporter (NKCC) family.\n2. This protein regulates ion transport and cellular volume in different tissues such as the brain, kidney, and intestine.\n3. NKCC2 functions as a cotransporter that facilitates the movement of sodium and potassium ions across the cell membrane.\n4. Maintaining ion concentration balance and cellular homeostasis is one of the roles of the NKCC2 protein.\n5. Mutations in the NKCC2 gene have been linked to various disorders, including epilepsy, hypertension, and congestive heart failure.",
    "yulan-chat-2-13b-fp16_fact": [
      "The protein encoded by the NKCC2 gene is a member of the sodium potassium cotransporter (NKCC) family.",
      "This protein regulates ion transport and cellular volume in different tissues such as the brain, kidney, and intestine.",
      "NKCC2 functions as a cotransporter that facilitates the movement of sodium and potassium ions across the cell membrane.",
      "Maintaining ion concentration balance and cellular homeostasis is one of the roles of the NKCC2 protein.",
      "Mutations in the NKCC2 gene have been linked to various disorders, including epilepsy, hypertension, and congestive heart failure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The protein encoded by the NKCC2 gene regulates ion transport and cellular volume primarily in the kidney, particularly in the thick ascending limb of the loop of Henle, and not significantly in the brain or intestine.\n3. FALSE [correction]: NKCC2 functions as a cotransporter that facilitates the movement of sodium, potassium, and chlorine ions across the cell membrane, not just sodium and potassium.\n4. TRUE\n5. FALSE [correction]: Mutations in the NKCC2 gene have been linked to disorders like Bartter syndrome, which affects the kidney, rather than epilepsy, hypertension, and congestive heart failure directly.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3414,
    "user_query": "Is the protein MCL-1 anti-apoptotic?",
    "yulan-chat-2-13b-fp16_response": "Yes, MCL-1 (Membrane-Associated Cascade of Death Inhibitor 1) is an anti-apoptotic protein. It belongs to the Bcl-2 family of proteins, which play a crucial role in regulating programmed cell death or apoptosis.\nMCL-1 acts as a potent inhibitor of the mitochondrial-mediated apoptotic pathway by inhibiting the release of cytochrome c and the subsequent activation of caspases. It also interacts with the outer mitochondrial membrane and prevents the formation of the mitochondrial outer membrane permeabilization (MOMP) that leads to cytochrome c release and apoptosis induction.\nIn addition to its anti-apoptotic function, MCL-1 has been implicated in several other cellular processes, including cell survival, cell cycle progression, and cell differentiation. However, excessive expression of MCL-1 has been linked to various diseases, including cancer, and has been considered a potential therapeutic target.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MCL-1 (Membrane-Associated Cascade of Death Inhibitor 1) is an anti-apoptotic protein.\n2. MCL-1 belongs to the Bcl-2 family of proteins, which are involved in regulating apoptosis.\n3. MCL-1 inhibits the mitochondrial-mediated apoptotic pathway, including the release of cytochrome c.\n4. MCL-1 interacts with the outer mitochondrial membrane to prevent the formation of mitochondrial outer membrane permeabilization (MOMP).\n5. Excessive expression of MCL-1 has been linked to various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "MCL-1 (Membrane-Associated Cascade of Death Inhibitor 1) is an anti-apoptotic protein.",
      "MCL-1 belongs to the Bcl-2 family of proteins, which are involved in regulating apoptosis.",
      "MCL-1 inhibits the mitochondrial-mediated apoptotic pathway, including the release of cytochrome c.",
      "MCL-1 interacts with the outer mitochondrial membrane to prevent the formation of mitochondrial outer membrane permeabilization (MOMP).",
      "Excessive expression of MCL-1 has been linked to various diseases, including cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3417,
    "user_query": "Which disease is ZP-PTH used for?",
    "yulan-chat-2-13b-fp16_response": "ZP-PTH (Zolpidem phosphate; generic name for Ambien CR) is a medication that is used to treat insomnia, a sleep disorder characterized by difficulty falling asleep or staying asleep. It is a non-benzodiazepine sedative-hypnotic drug that works by binding to certain receptors in the brain to promote sleep.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ZP-PTH is a generic name for Ambien CR.\n2. ZP-PTH is used to treat insomnia.\n3. Insomnia is a sleep disorder characterized by difficulty falling asleep or staying asleep.\n4. ZP-PTH is a non-benzodiazepine sedative-hypnotic drug.\n5. ZP-PTH works by binding to certain receptors in the brain to promote sleep.",
    "yulan-chat-2-13b-fp16_fact": [
      "ZP-PTH is a generic name for Ambien CR.",
      "ZP-PTH is used to treat insomnia.",
      "Insomnia is a sleep disorder characterized by difficulty falling asleep or staying asleep.",
      "ZP-PTH is a non-benzodiazepine sedative-hypnotic drug.",
      "ZP-PTH works by binding to certain receptors in the brain to promote sleep."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: ZP-PTH is not the generic name for Ambien CR; zolpidem is the generic name for Ambien.\n2. UNKNOWN (The correctness of this statement depends on whether ZP-PTH is actually a known medication used to treat insomnia; without further context, it cannot be confirmed.)\n3. TRUE\n4. UNKNOWN (As ZP-PTH's actual identity is not confirmed, we cannot ascertain whether it is a non-benzodiazepine sedative-hypnotic drug.)\n5. UNKNOWN (Due to the uncertainty regarding what ZP-PTH is, we cannot confirm the mechanism by which it promotes sleep.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3424,
    "user_query": "When was vaxchora first licensed by the FDA?",
    "yulan-chat-2-13b-fp16_response": "Vaxchora, a live, attenuated (weakened) vaccine for the prevention of disease caused by the bacterium Streptococcus pneumoniae, was first licensed by the US Food and Drug Administration (FDA) in 2011. It is indicated for use in adults and children 2 years of age and older. Vaxchora is a recombinant protein vaccine that contains a fragment of the pneumococcal capsular polysaccharide (PnCP) antigen, which is a major virulence factor of S. pneumoniae. The vaccine is administered intramuscularly in a single dose.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vaxchora was first licensed by the US Food and Drug Administration in 2011.\n2. It is a vaccine for the prevention of disease caused by the bacterium Streptococcus pneumoniae.\n3. Vaxchora is indicated for use in adults and children 2 years of age and older.\n4. The vaccine is a live, attenuated vaccine.\n5. The vaccine is administered intramuscularly in a single dose.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vaxchora was first licensed by the US Food and Drug Administration in 2011.",
      "It is a vaccine for the prevention of disease caused by the bacterium Streptococcus pneumoniae.",
      "Vaxchora is indicated for use in adults and children 2 years of age and older.",
      "The vaccine is a live, attenuated vaccine.",
      "The vaccine is administered intramuscularly in a single dose."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Vaxchora was first licensed by the US Food and Drug Administration in 2016.\n2. FALSE [correction]: It is a vaccine for the prevention of disease caused by the bacterium Vibrio cholerae.\n3. FALSE [correction]: Vaxchora is indicated for use in adults 18 through 64 years of age.\n4. TRUE\n5. FALSE [correction]: The vaccine is administered orally in a single dose.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3427,
    "user_query": "Which type of distance is used in the R-package XenofilteR?",
    "yulan-chat-2-13b-fp16_response": "The R-package XenofilteR uses the \"euclidean\" distance as the default distance metric for its algorithms. The Euclidean distance is a measure of the straight-line distance between two points in n-dimensional space. It is defined as the square root of the sum of the squared differences between the corresponding elements of the two vectors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The R-package XenofilteR uses \"euclidean\" distance as the default distance metric for its algorithms.\n2. The Euclidean distance is measured as the straight-line distance between two points in n-dimensional space.\n3. The Euclidean distance is calculated as the square root of the sum of the squared differences between corresponding elements of two vectors.",
    "yulan-chat-2-13b-fp16_fact": [
      "The R-package XenofilteR uses \"euclidean\" distance as the default distance metric for its algorithms.",
      "The Euclidean distance is measured as the straight-line distance between two points in n-dimensional space.",
      "The Euclidean distance is calculated as the square root of the sum of the squared differences between corresponding elements of two vectors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "yulan-chat-2-13b-fp16_response": "There are several tools that use deep learning for predicting drug synergy. Some examples include:\n* DeepDrug: A tool that uses deep learning to predict the effect of mutations on protein function and drug binding.\n* DrugBank: A database that includes information on drug interactions and includes a deep learning module for predicting drug synergy.\n* CERT: A tool that uses deep learning to predict the potential toxicity of drugs and predict drug-drug interactions.\n* Graph-based methods: These methods use graph-based representations of drug-drug interactions and apply deep learning techniques such as graph convolutional networks to predict drug synergy.\nIt's worth noting that these tools are still in development and their performance and accuracy may vary. It's also important to consider that drug synergy is a complex and multifactorial process, and no single tool can fully capture all the factors involved.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DeepDrug is a tool that uses deep learning to predict the effect of mutations on protein function and drug binding.\n2. DrugBank is a database that includes a deep learning module for predicting drug synergy.\n3. CERT uses deep learning to predict drug toxicity and drug-drug interactions.\n4. Graph-based methods for drug synergy prediction involve graph convolutional networks.",
    "yulan-chat-2-13b-fp16_fact": [
      "DeepDrug is a tool that uses deep learning to predict the effect of mutations on protein function and drug binding.",
      "DrugBank is a database that includes a deep learning module for predicting drug synergy.",
      "CERT uses deep learning to predict drug toxicity and drug-drug interactions.",
      "Graph-based methods for drug synergy prediction involve graph convolutional networks."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: DrugBank is a database that provides information on drugs and drug targets, but it does not include a deep learning module for predicting drug synergy.\n3. UNKNOWN\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3431,
    "user_query": "Is ozanezumab effective for amyotrophic lateral sclerosis?",
    "yulan-chat-2-13b-fp16_response": "Ozanezumab is an investigational drug that is being studied for the treatment of amyotrophic lateral sclerosis (ALS). It is a monoclonal antibody that targets a protein called Nogo-A, which is believed to inhibit the growth and function of nerve cells.\nThere have been some promising results from early-stage clinical trials of ozanezumab in people with ALS, but more research is needed to confirm its effectiveness and safety. As of my knowledge cutoff in September 2021, there was limited clinical data available on the use of ozanezumab for ALS, and it was still in the early stages of development.\nIt is important to note that while there is ongoing research into potential treatments for ALS, there is currently no cure for the disease and no approved treatments that can slow or stop its progression. If you or someone you know has been diagnosed with ALS, it is important to discuss the best treatment options with a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ozanezumab is an investigational drug being studied for the treatment of amyotrophic lateral sclerosis (ALS).\n2. Ozanezumab is a monoclonal antibody that targets the Nogo-A protein.\n3. The Nogo-A protein is believed to inhibit the growth and function of nerve cells.\n4. Early-stage clinical trials of ozanezumab have shown some promising results for people with ALS.\n5. As of September 2021, there was no cure for ALS and no approved treatments to slow or stop its progression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ozanezumab is an investigational drug being studied for the treatment of amyotrophic lateral sclerosis (ALS).",
      "Ozanezumab is a monoclonal antibody that targets the Nogo-A protein.",
      "The Nogo-A protein is believed to inhibit the growth and function of nerve cells.",
      "Early-stage clinical trials of ozanezumab have shown some promising results for people with ALS.",
      "As of September 2021, there was no cure for ALS and no approved treatments to slow or stop its progression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: As of September 2021, there were approved treatments for ALS, such as riluzole and edaravone, which can slow disease progression in some individuals, but there is no cure for the disease.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3432,
    "user_query": "Is Dexmecamylamine effective for depression?",
    "yulan-chat-2-13b-fp16_response": "Dexmecamylamine is not an approved treatment for depression. It is a sympathomimetic drug that was previously used as a nasal decongestant, but it has been withdrawn from the market due to safety concerns. There is no scientific evidence to support its use as a treatment for depression. In fact, using it for this purpose could be dangerous and could lead to serious side effects. If you are experiencing depression, it is important to talk to a healthcare professional about approved treatments, such as therapy and medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dexmecamylamine is not an approved treatment for depression.\n2. Dexmecamylamine was used as a nasal decongestant in the past.\n3. Dexmecamylamine has been withdrawn from the market due to safety concerns.\n4. There is no scientific evidence to support the use of Dexmecamylamine as a treatment for depression.\n5. Using Dexmecamylamine for depression could lead to serious side effects.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dexmecamylamine is not an approved treatment for depression.",
      "Dexmecamylamine was used as a nasal decongestant in the past.",
      "Dexmecamylamine has been withdrawn from the market due to safety concerns.",
      "There is no scientific evidence to support the use of Dexmecamylamine as a treatment for depression.",
      "Using Dexmecamylamine for depression could lead to serious side effects."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The correct name of the compound is dexbrompheniramine, which was used as a nasal decongestant in the past, not dexmecamylamine.\n3. UNKNOWN: Without specific information about the reason for dexmecamylamine being withdrawn from the market, I cannot verify this statement.\n4. UNKNOWN: Since the accurate use and research regarding dexmecamylamine are not specified, there's no way to confirm or deny the presence of scientific evidence related to its use for treating depression.\n5. UNKNOWN: Without clinical data on dexmecamylamine, it is impossible to assess the potential side effects of using it for depression. However, it is generally true that using any unapproved drugs for depression could potentially lead to serious side effects.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "yulan-chat-2-13b-fp16_response": "One example of a cloud-based platform for comparing GWAS (Genome-Wide Association Studies) is the GWAS Pipeline for Cloud (GPC) developed by the University of California, San Francisco. GPC is a web-based platform that allows researchers to perform GWAS analysis on large-scale genetic data sets using cloud computing resources. It provides a user-friendly interface for uploading and analyzing genetic data, as well as tools for visualizing and interpreting GWAS results. Other cloud-based platforms for GWAS analysis include Amazon Web Services (AWS) and Microsoft Azure.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GWAS Pipeline for Cloud (GPC) is a cloud-based platform developed by the University of California, San Francisco for comparing Genome-Wide Association Studies (GWAS).\n2. GPC is a web-based platform that supports GWAS analysis on large-scale genetic data sets.\n3. GPC offers a user-friendly interface for uploading and analyzing genetic data.\n4. GPC provides tools for visualizing and interpreting GWAS results.\n5. Amazon Web Services (AWS) and Microsoft Azure are other cloud-based platforms that can be used for GWAS analysis.",
    "yulan-chat-2-13b-fp16_fact": [
      "GWAS Pipeline for Cloud (GPC) is a cloud-based platform developed by the University of California, San Francisco for comparing Genome-Wide Association Studies (GWAS).",
      "GPC is a web-based platform that supports GWAS analysis on large-scale genetic data sets.",
      "GPC offers a user-friendly interface for uploading and analyzing genetic data.",
      "GPC provides tools for visualizing and interpreting GWAS results.",
      "Amazon Web Services (AWS) and Microsoft Azure are other cloud-based platforms that can be used for GWAS analysis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nExplanation: Without specific knowledge about the \"GWAS Pipeline for Cloud (GPC)\" to confirm its development by the specified university or its features, the truth of statements 1, 2, 3, and 4 cannot be assessed. However, statement 5 can be verified to be true because Amazon Web Services (AWS) and Microsoft Azure are indeed cloud-based platforms and they offer various services, including computational resources, that can be used for GWAS analysis, along with other types of data-intensive analyses.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "yulan-chat-2-13b-fp16_response": "CMB305 is a drug that is being developed for the treatment of various types of solid tumors, including sarcomas. Sarcomas are a type of cancer that arises from cells in connective tissue, such as bone, cartilage, or muscle. CMB305 works by inhibiting a protein called CDK7, which is involved in the regulation of gene expression and is required for the growth and proliferation of cancer cells.\nThere have been some preclinical studies and early clinical trials that suggest that CMB305 may be effective in treating certain types of sarcomas. However, more research is needed to fully understand the potential of CMB305 as a treatment for sarcomas and to determine its safety and effectiveness in different patient populations.\nIt is important to note that CMB305 is still in the early stages of development and has not yet been approved by regulatory authorities for the treatment of any type of cancer. It is being tested in clinical trials, and it may be some time before it is available for widespread use. If you have questions about CMB305 or other treatments for sarcomas, it is best to speak with a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. CMB305 is being developed to treat various types of solid tumors, including sarcomas.\n2. Sarcomas arise from cells in connective tissue such as bone, cartilage, or muscle.\n3. CMB305 inhibits a protein called CDK7, which is important for cancer cell growth and proliferation.\n4. Preclinical studies and early clinical trials have suggested that CMB305 may be effective in treating certain types of sarcomas.\n5. CMB305 has not yet been approved by regulatory authorities for the treatment of any type of cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "CMB305 is being developed to treat various types of solid tumors, including sarcomas.",
      "Sarcomas arise from cells in connective tissue such as bone, cartilage, or muscle.",
      "CMB305 inhibits a protein called CDK7, which is important for cancer cell growth and proliferation.",
      "Preclinical studies and early clinical trials have suggested that CMB305 may be effective in treating certain types of sarcomas.",
      "CMB305 has not yet been approved by regulatory authorities for the treatment of any type of cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or source information about CMB305, its mechanism of action, and its stage of research or clinical trial results, I cannot accurately verify these statements. The general information about sarcomas is correct, but the specific details about CMB305 require additional data to confirm.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3435,
    "user_query": "What is Quadracel?",
    "yulan-chat-2-13b-fp16_response": "Quadracel is a brand name for a vaccine that is used to protect against four different types of bacteria: Haemophilus influenzae type b (Hib), Streptococcus pneumoniae (the pneumococcus), and two types of Streptococcus pyogenes (the group A and group C strains). These bacteria can cause serious infections, such as meningitis, pneumonia, and sepsis, in children and adults. The vaccine is typically given to infants and young children, and is also recommended for certain high-risk individuals, such as those with compromised immune systems.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Quadracel is a vaccine used to protect against four types of bacteria.\n2. The bacteria that Quadracel protects against include Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae.\n3. Quadracel also protects against two types of Streptococcus pyogenes (group A and group C strains).\n4. This vaccine is typically administered to infants and young children.\n5. It is recommended for certain high-risk individuals, such as those with compromised immune systems.",
    "yulan-chat-2-13b-fp16_fact": [
      "Quadracel is a vaccine used to protect against four types of bacteria.",
      "The bacteria that Quadracel protects against include Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae.",
      "Quadracel also protects against two types of Streptococcus pyogenes (group A and group C strains).",
      "This vaccine is typically administered to infants and young children.",
      "It is recommended for certain high-risk individuals, such as those with compromised immune systems."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Quadracel is a vaccine used to protect against four types of diseases caused by bacteria and viruses, not four types of bacteria.\n2. FALSE [correction]: Quadracel does not protect against Haemophilus influenzae type b (Hib) or Streptococcus pneumoniae. It is used to protect against diphtheria, tetanus, pertussis (whooping cough), and poliovirus.\n3. FALSE [correction]: Quadracel does not protect against any strains of Streptococcus pyogenes. It protects against diphtheria, tetanus, pertussis, and poliovirus.\n4. TRUE\n5. TRUE, but it should be noted that the recommendation for high-risk individuals would depend on age, existing health conditions, and other specific factors as determined by healthcare providers. Quadracel is generally recommended for the pediatric population according to immunization schedules.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3436,
    "user_query": "What delivery system is used for the Fluzone Intradermal vaccine?",
    "yulan-chat-2-13b-fp16_response": "The Fluzone Intradermal vaccine is administered using a needle and syringe delivery system. The vaccine is injected into the skin in the upper arm, using a thin needle that is inserted just beneath the surface of the skin. This type of injection is typically quick and relatively painless, and it is a common method of administering vaccines. It is important to follow the instructions of the healthcare provider administering the vaccine to ensure that it is given correctly and to minimize any potential side effects.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Fluzone Intradermal vaccine is administered using a needle and syringe delivery system.\n2. The vaccine is injected into the skin in the upper arm.\n3. A thin needle is used for the Fluzone Intradermal vaccine injection.\n4. The needle for the Fluzone Intradermal vaccine is inserted just beneath the surface of the skin.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Fluzone Intradermal vaccine is administered using a needle and syringe delivery system.",
      "The vaccine is injected into the skin in the upper arm.",
      "A thin needle is used for the Fluzone Intradermal vaccine injection.",
      "The needle for the Fluzone Intradermal vaccine is inserted just beneath the surface of the skin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Fluzone Intradermal vaccine is administered using a microinjection system, not a standard needle and syringe.\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3450,
    "user_query": "How many genes belong to the KRAB-ZNF family in the human genome?",
    "yulan-chat-2-13b-fp16_response": "The KRAB-ZNF family is a group of transcription factors that play important roles in regulating gene expression. In the human genome, there are approximately 100 genes that belong to the KRAB-ZNF family. These genes encode proteins that contain a KRAB (Krppel-associated box) domain and a Zinc finger (ZNF) domain, which are involved in recognizing and binding to specific DNA sequences. The KRAB-ZNF proteins are involved in a variety of biological processes, including development, cell differentiation, and tumor suppression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There are approximately 100 genes in the KRAB-ZNF family present in the human genome.\n2. Genes in the KRAB-ZNF family encode proteins that contain a KRAB domain.\n3. Proteins encoded by the KRAB-ZNF gene family also contain a Zinc finger domain.\n4. KRAB-ZNF proteins are involved in recognizing and binding to specific DNA sequences.\n5. The KRAB-ZNF proteins have roles in development, cell differentiation, and tumor suppression.",
    "yulan-chat-2-13b-fp16_fact": [
      "There are approximately 100 genes in the KRAB-ZNF family present in the human genome.",
      "Genes in the KRAB-ZNF family encode proteins that contain a KRAB domain.",
      "Proteins encoded by the KRAB-ZNF gene family also contain a Zinc finger domain.",
      "KRAB-ZNF proteins are involved in recognizing and binding to specific DNA sequences.",
      "The KRAB-ZNF proteins have roles in development, cell differentiation, and tumor suppression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: There are approximately 800 genes in the KRAB-ZNF family present in the human genome.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3451,
    "user_query": "Which molecule is targeted by Asciminib?",
    "yulan-chat-2-13b-fp16_response": "Asciminib is a drug that targets the BCR-ABL kinase, which is a protein that is formed when the BCR and ABL genes fuse together in a process known as the Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML). The BCR-ABL kinase is an important factor in the development and progression of Ph+ CML, and Asciminib works by inhibiting its activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Asciminib is a drug that targets the BCR-ABL kinase.\n2. BCR-ABL kinase is a protein formed from the fusion of the BCR and ABL genes.\n3. The formation of the BCR-ABL kinase is associated with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML).\n4. The BCR-ABL kinase plays a significant role in the development and progression of Ph+ CML.\n5. Asciminib inhibits the activity of the BCR-ABL kinase.",
    "yulan-chat-2-13b-fp16_fact": [
      "Asciminib is a drug that targets the BCR-ABL kinase.",
      "BCR-ABL kinase is a protein formed from the fusion of the BCR and ABL genes.",
      "The formation of the BCR-ABL kinase is associated with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML).",
      "The BCR-ABL kinase plays a significant role in the development and progression of Ph+ CML.",
      "Asciminib inhibits the activity of the BCR-ABL kinase."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3453,
    "user_query": "What is characteristic to Fitz-HughCurtis syndrome?",
    "yulan-chat-2-13b-fp16_response": "Fitz-HughCurtis syndrome is a cardiac arrhythmia that is characterized by a specific pattern of electrical activity in the heart. It is caused by abnormal electrical activity in the atria, which can lead to rapid and irregular heartbeats. The syndrome is named after the two physicians who first described it, William Fitz-Hugh and James Curtis. It is also sometimes referred to as \"atrial tachycardia-premature atrial contraction\" (AT-PAC) syndrome.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3454,
    "user_query": "What is the trade name of sildenafil?",
    "yulan-chat-2-13b-fp16_response": "The trade name of sildenafil is Viagra.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The trade name of sildenafil is Viagra.",
    "yulan-chat-2-13b-fp16_fact": [
      "The trade name of sildenafil is Viagra."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 3455,
    "user_query": "How large is the SARS-CoV  proteome?",
    "yulan-chat-2-13b-fp16_response": "The SARS-CoV (Severe Acute Respiratory Syndrome Coronavirus) proteome is relatively large, consisting of approximately 30 structural proteins and nonstructural proteins. These proteins play various roles in the virus's life cycle, including replication, assembly, and virulence. The size of the proteome can vary slightly depending on the specific strain of the virus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The SARS-CoV proteome consists of approximately 30 structural and nonstructural proteins.\n2. The proteins in the SARS-CoV proteome are involved in the virus's life cycle.\n3. The functions of the proteins include replication, assembly, and virulence.\n4. The size of the SARS-CoV proteome can vary slightly depending on the strain.",
    "yulan-chat-2-13b-fp16_fact": [
      "The SARS-CoV proteome consists of approximately 30 structural and nonstructural proteins.",
      "The proteins in the SARS-CoV proteome are involved in the virus's life cycle.",
      "The functions of the proteins include replication, assembly, and virulence.",
      "The size of the SARS-CoV proteome can vary slightly depending on the strain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3460,
    "user_query": "Can radiotherapy cause radiation induced osteosarcoma?",
    "yulan-chat-2-13b-fp16_response": "Radiotherapy, also known as radiation therapy, is a medical treatment that uses high-energy radiation to kill cancer cells. It is commonly used to treat various types of cancer, including breast cancer, lung cancer, and brain tumors.\nWhile radiotherapy is an effective treatment for cancer, it can also cause side effects. One of the potential side effects of radiotherapy is radiation-induced osteosarcoma, which is a type of bone cancer that develops as a result of exposure to ionizing radiation.\nRadiation-induced osteosarcoma is a rare condition, and the risk of developing this type of cancer is low. However, the risk is higher in people who have received radiotherapy to the bones or in people who have been exposed to high doses of ionizing radiation.\nIt is important to note that the risk of developing radiation-induced osteosarcoma is generally low, and the benefits of radiotherapy in treating cancer far outweigh the risks. If you have received radiotherapy or are considering this treatment, it is important to discuss the potential risks and benefits with your healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Radiotherapy is a medical treatment that uses high-energy radiation to kill cancer cells.\n2. Radiotherapy is used to treat various types of cancer, including breast cancer, lung cancer, and brain tumors.\n3. One of the potential side effects of radiotherapy is radiation-induced osteosarcoma, a type of bone cancer.\n4. Radiation-induced osteosarcoma develops as a result of exposure to ionizing radiation.\n5. The risk of developing radiation-induced osteosarcoma is higher in individuals who have received radiotherapy to the bones or been exposed to high doses of ionizing radiation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Radiotherapy is a medical treatment that uses high-energy radiation to kill cancer cells.",
      "Radiotherapy is used to treat various types of cancer, including breast cancer, lung cancer, and brain tumors.",
      "One of the potential side effects of radiotherapy is radiation-induced osteosarcoma, a type of bone cancer.",
      "Radiation-induced osteosarcoma develops as a result of exposure to ionizing radiation.",
      "The risk of developing radiation-induced osteosarcoma is higher in individuals who have received radiotherapy to the bones or been exposed to high doses of ionizing radiation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "yulan-chat-2-13b-fp16_response": "The Saint's Triad is a group of three powerful and benevolent deities in the Pathfinder Adventure Path, Rise of the Runelords. The three deities are known as Sarenrae, Ileosa, and Calistria. Each of these deities has a unique set of manifestations that reflect their personality and beliefs.\n1. Sarenrae: Sarenrae is the goddess of redemption and healing. She is often depicted as a beautiful, radiant woman with golden skin and long, flowing hair. Her manifestations include healing rays that can cure diseases and injuries, as well as the power to raise the dead.\n2. Ileosa: Ileosa is the goddess of justice and righteousness. She is often depicted as a stern, disciplined woman with a sword and a shield. Her manifestations include the power to strike down evildoers with her sword, as well as the ability to inspire her followers with her unwavering sense of justice.\n3. Calistria: Calistria is the goddess of secrets and seduction. She is often depicted as a seductive, alluring woman with a serpent's tail. Her manifestations include the power to control the minds of others, as well as the ability to create illusions and manipulate reality.\nOverall, the manifestations of the Saint's Triad reflect their roles as protectors and guardians of the people, using their powers to promote justice, healing, and redemption.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3463,
    "user_query": "Are male or female persons more prone to autoimmunity?",
    "yulan-chat-2-13b-fp16_response": "Autoimmunity can occur in both males and females, and there is no clear evidence to suggest that one sex is more prone to autoimmunity than the other. However, some autoimmune diseases tend to be more common in females, while others are more common in males.\nFor example, autoimmune thyroid diseases such as Hashimoto's thyroiditis and Graves' disease are more common in females, while autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus tend to be more common in females but can also occur in males.\nIt's important to note that there are many factors that can influence the development of autoimmunity, including genetics, environment, and lifestyle. While sex may be one factor, it is not the only factor and cannot fully explain the complexity of autoimmune diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Autoimmunity can occur in both males and females.\n2. Some autoimmune diseases are more common in females.\n3. Autoimmune thyroid diseases such as Hashimoto's thyroiditis and Graves' disease are more prevalent in females.\n4. Autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus tend to be more common in females.\n5. Factors that can influence the development of autoimmunity include genetics, environment, and lifestyle.",
    "yulan-chat-2-13b-fp16_fact": [
      "Autoimmunity can occur in both males and females.",
      "Some autoimmune diseases are more common in females.",
      "Autoimmune thyroid diseases such as Hashimoto's thyroiditis and Graves' disease are more prevalent in females.",
      "Autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus tend to be more common in females.",
      "Factors that can influence the development of autoimmunity include genetics, environment, and lifestyle."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3469,
    "user_query": "What is Fuchs' Uveitis?",
    "yulan-chat-2-13b-fp16_response": "Fuchs' uveitis, also known as primary uveitis, is a type of inflammation that affects the uvea, which is the middle layer of the eye. The uvea consists of the iris, ciliary body, and choroid, and is responsible for the production of aqueous humor, the clear fluid that fills the front of the eye and helps to maintain its shape.\nFuchs' uveitis is a chronic and progressive condition that can cause damage to the eye over time. It is characterized by recurrent episodes of inflammation in the uvea, which can lead to the formation of scar tissue and the loss of vision. The exact cause of Fuchs' uveitis is unknown, but it is believed to be related to an abnormal immune response in the eye.\nSymptoms of Fuchs' uveitis may include eye pain, redness, and sensitivity to light. In more severe cases, the inflammation can cause the pressure within the eye to increase, leading to glaucoma. Treatment for Fuchs' uveitis typically involves the use of corticosteroids to reduce inflammation and prevent recurrences. In some cases, surgery may be necessary to remove scar tissue or to reduce pressure within the eye.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fuchs' uveitis is a type of inflammation that affects the uvea, the middle layer of the eye.\n2. The uvea includes the iris, ciliary body, and choroid.\n3. Fuchs' uveitis is a chronic and progressive condition that can lead to the formation of scar tissue and the loss of vision.\n4. Symptoms of Fuchs' uveitis can include eye pain, redness, and sensitivity to light.\n5. Treatment for Fuchs' uveitis may involve the use of corticosteroids or surgery in some cases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fuchs' uveitis is a type of inflammation that affects the uvea, the middle layer of the eye.",
      "The uvea includes the iris, ciliary body, and choroid.",
      "Fuchs' uveitis is a chronic and progressive condition that can lead to the formation of scar tissue and the loss of vision.",
      "Symptoms of Fuchs' uveitis can include eye pain, redness, and sensitivity to light.",
      "Treatment for Fuchs' uveitis may involve the use of corticosteroids or surgery in some cases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Symptoms of Fuchs' uveitis typically include decreased vision, floaters, and sometimes heterochromia; it is less commonly associated with pain, redness, or sensitivity to light.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "yulan-chat-2-13b-fp16_response": "I am not aware of any recent studies or data that specifically address the relationship between overexpression of LY6K and prognosis in non-small cell lung cancer (NSCLC) patients. However, LY6K has been identified as a potential biomarker for NSCLC and other types of cancer, and some studies have suggested that overexpression of LY6K may have a positive effect on cancer cell proliferation and survival.\nFor example, a study published in the journal Cancer Research in 2013 found that overexpression of LY6K in NSCLC cells was associated with increased cell proliferation and survival in vitro and in xenograft models. Another study published in the journal Oncology Reports in 2017 found that high levels of LY6K mRNA expression were associated with better survival in NSCLC patients.\nHowever, it is important to note that these studies are limited in scope and may not provide a comprehensive picture of the relationship between LY6K overexpression and prognosis in NSCLC patients. Further research is needed to confirm these findings and to fully understand the potential clinical implications of LY6K overexpression in NSCLC.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LY6K has been identified as a potential biomarker for non-small cell lung cancer (NSCLC) and other types of cancer.\n2. A study published in the journal Cancer Research in 2013 reported that overexpression of LY6K in NSCLC cells was associated with increased cell proliferation and survival in vitro and in xenograft models.\n3. A study published in the journal Oncology Reports in 2017 found that high levels of LY6K mRNA expression were associated with better survival in NSCLC patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "LY6K has been identified as a potential biomarker for non-small cell lung cancer (NSCLC) and other types of cancer.",
      "A study published in the journal Cancer Research in 2013 reported that overexpression of LY6K in NSCLC cells was associated with increased cell proliferation and survival in vitro and in xenograft models.",
      "A study published in the journal Oncology Reports in 2017 found that high levels of LY6K mRNA expression were associated with better survival in NSCLC patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: A study published in the journal Oncology Reports in 2017 found that high levels of LY6K mRNA expression were associated with poor survival in NSCLC patients, not better survival.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "yulan-chat-2-13b-fp16_response": "Cytokinesis is the final stage of cell division, during which the cytoplasm of the cell is divided and the cell membrane forms to separate the two daughter cells. During cytokinesis, several proteins are dephosphorylated, including:\n1. Cdc14: Cdc14 is a protein kinase that is dephosphorylated during cytokinesis to activate the anaphase-promoting complex (APC), which helps to separate the chromosomes and initiate the separation of the cell membrane.\n2. Cdc20: Cdc20 is a protein that is dephosphorylated during cytokinesis to activate the APC and promote the separation of the cell membrane.\n3. Bub1: Bub1 is a protein that is dephosphorylated during cytokinesis to inhibit the APC and promote the separation of the cell membrane.\n4. Aurora kinase: Aurora kinase is a protein kinase that is dephosphorylated during cytokinesis to promote the separation of the cell membrane.\n5. Cdk1: Cdk1 is a protein kinase that is dephosphorylated during cytokinesis to promote the separation of the cell membrane.\nThese proteins are all part of a complex network of signaling pathways that regulate cell division, and their dephosphorylation during cytokinesis is essential for the proper completion of cell division.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cdc14 is a protein kinase that is dephosphorylated during cytokinesis.\n2. Cdc20 is dephosphorylated during cytokinesis to activate the anaphase-promoting complex (APC).\n3. Bub1 is dephosphorylated during cytokinesis and its activity is related to inhibiting the APC.\n4. Aurora kinase is dephosphorylated during cytokinesis to aid in cell membrane separation.\n5. Cdk1 (Cyclin-dependent kinase 1) is a protein kinase that is dephosphorylated during cytokinesis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cdc14 is a protein kinase that is dephosphorylated during cytokinesis.",
      "Cdc20 is dephosphorylated during cytokinesis to activate the anaphase-promoting complex (APC).",
      "Bub1 is dephosphorylated during cytokinesis and its activity is related to inhibiting the APC.",
      "Aurora kinase is dephosphorylated during cytokinesis to aid in cell membrane separation.",
      "Cdk1 (Cyclin-dependent kinase 1) is a protein kinase that is dephosphorylated during cytokinesis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Cdc20 is not dephosphorylated; rather, it is activated during mitosis to activate the anaphase-promoting complex (APC).\n3. UNKNOWN: While Bub1 is involved in inhibiting the APC, the specifics of its phosphorylation state during cytokinesis are not provided, which makes this statement difficult to verify without additional context.\n4. FALSE [correction]: Aurora kinase is not dephosphorylated; it is a family of serine/threonine kinases that are active during mitosis and help in events like chromosome alignment and cytokinesis but their regulation is not solely by dephosphorylation during cytokinesis.\n5. FALSE [correction]: Cdk1 is inactivated during cytokinesis by dephosphorylation, but it is not directly dephosphorylated during cytokinesis. It is in fact a protein kinase that is active during mitosis and phosphorylates other proteins.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 3474,
    "user_query": "What is dystopia canthorum?",
    "yulan-chat-2-13b-fp16_response": "Dystopia canthorum is a term that refers to a hypothetical future society in which people with prominent or \"bulging\" canthus (the corner of the eye) are persecuted and discriminated against. The term was coined by Dr. Tien Giang, a Vietnamese-American ophthalmologist, in a 2017 article published in the Journal of Ophthalmology.\nDr. Giang's article was intended to be a thought experiment that highlights the potential dangers of discrimination and prejudice, and the importance of promoting diversity and inclusion in society. The concept of dystopia canthorum is not based on any real-world evidence or data, but rather serves as a cautionary tale about the dangers of discrimination and the need for tolerance and acceptance.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3476,
    "user_query": "What is Heterochromia Iridis?",
    "yulan-chat-2-13b-fp16_response": "Heterochromia iridis is a condition in which an individual's eyes have different colors. This can occur due to a variety of factors, including genetics, injury, or disease. In some cases, heterochromia can be a normal variation in eye color, while in other cases it may be a sign of an underlying medical condition. It is not a common condition, but it can occur in both humans and animals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Heterochromia iridis is a condition where an individual's eyes are different colors.\n2. This condition can be caused by genetics, injury, or disease.\n3. Heterochromia can be a normal variation in eye color.\n4. It may also indicate an underlying medical condition.\n5. Heterochromia iridis can occur in both humans and animals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Heterochromia iridis is a condition where an individual's eyes are different colors.",
      "This condition can be caused by genetics, injury, or disease.",
      "Heterochromia can be a normal variation in eye color.",
      "It may also indicate an underlying medical condition.",
      "Heterochromia iridis can occur in both humans and animals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3483,
    "user_query": "Is Ubrogepant effective for migraine?",
    "yulan-chat-2-13b-fp16_response": "Ubrogepant is a medication that is being studied for the treatment of migraine. It works by blocking the activity of a protein called calcitonin gene-related peptide (CGRP), which is involved in the transmission of pain signals in the brain.\nThere have been several clinical trials evaluating the effectiveness and safety of ubrogepant for the treatment of migraine. In these studies, ubrogepant has been shown to be effective at reducing the severity and duration of migraine attacks when taken at the beginning of an attack.\nHowever, it is important to note that ubrogepant is still under development and has not yet been approved by regulatory authorities for the treatment of migraine. Further research is ongoing to evaluate its potential as a treatment for this condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ubrogepant is a medication that is being studied for the treatment of migraine.\n2. Ubrogepant works by blocking the activity of the protein calcitonin gene-related peptide (CGRP).\n3. CGRP is involved in the transmission of pain signals in the brain.\n4. Clinical trials have shown ubrogepant to be effective at reducing the severity and duration of migraine attacks when taken at the beginning of an attack.\n5. Ubrogepant has not yet been approved by regulatory authorities for the treatment of migraine.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ubrogepant is a medication that is being studied for the treatment of migraine.",
      "Ubrogepant works by blocking the activity of the protein calcitonin gene-related peptide (CGRP).",
      "CGRP is involved in the transmission of pain signals in the brain.",
      "Clinical trials have shown ubrogepant to be effective at reducing the severity and duration of migraine attacks when taken at the beginning of an attack.",
      "Ubrogepant has not yet been approved by regulatory authorities for the treatment of migraine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Ubrogepant has been approved by regulatory authorities such as the FDA for the acute treatment of migraine with or without aura in adults.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3485,
    "user_query": "What is the protein product of the gene GBA2?",
    "yulan-chat-2-13b-fp16_response": "The protein product of the gene GBA2 is beta-glucosidase 2.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The gene GBA2 produces the protein beta-glucosidase 2.",
    "yulan-chat-2-13b-fp16_fact": [
      "The gene GBA2 produces the protein beta-glucosidase 2."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 3498,
    "user_query": "Has ProSavin undergone phase IV clinical trials by 2018?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information about ProSavin or whether it has undergone phase IV clinical trials by 2018. ProSavin is a combination of three drugs that have been used in the treatment of Parkinson's disease: levodopa, carbidopa, and entacapone. Levodopa and carbidopa are commonly used to treat Parkinson's disease, and entacapone is often used in combination with them to improve the effectiveness of the treatment.\nIt is possible that ProSavin has undergone clinical trials, but I don't have information about whether it has been approved for use or whether it has undergone phase IV clinical trials by 2018. I recommend discussing this with a healthcare professional for more information.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3502,
    "user_query": "What is ProSavin?",
    "yulan-chat-2-13b-fp16_response": "ProSavin is a medical treatment for Parkinson's disease that involves the administration of three different medications: levodopa, carbidopa, and entacapone. These medications work together to increase the levels of dopamine in the brain, which can help to alleviate the symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with movement. ProSavin is typically given to patients who have been diagnosed with Parkinson's disease and who are experiencing symptoms that are not well-controlled with other treatments. It is usually taken orally, in the form of tablets or capsules, and is typically prescribed by a doctor who specializes in the treatment of Parkinson's disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ProSavin is a medical treatment for Parkinson's disease.\n2. ProSavin involves the administration of levodopa, carbidopa, and entacapone.\n3. These medications are used to increase levels of dopamine in the brain.\n4. ProSavin is used to alleviate symptoms of Parkinson's disease such as tremors, stiffness, and difficulty with movement.\n5. ProSavin is typically prescribed for patients whose symptoms are not well-controlled with other treatments.",
    "yulan-chat-2-13b-fp16_fact": [
      "ProSavin is a medical treatment for Parkinson's disease.",
      "ProSavin involves the administration of levodopa, carbidopa, and entacapone.",
      "These medications are used to increase levels of dopamine in the brain.",
      "ProSavin is used to alleviate symptoms of Parkinson's disease such as tremors, stiffness, and difficulty with movement.",
      "ProSavin is typically prescribed for patients whose symptoms are not well-controlled with other treatments."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: ProSavin is a gene therapy treatment that delivers the genes for three enzymes necessary to synthesize dopamine directly into the brain, rather than involving the administration of levodopa, carbidopa, and entacapone.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3503,
    "user_query": "Are stretch enhancers transcribed more than super-enhancers?",
    "yulan-chat-2-13b-fp16_response": "Stretch enhancers and super-enhancers are both types of regulatory regions in DNA that can increase the likelihood of transcription, or the process by which DNA is used to make RNA. However, it is not accurate to say that one type is transcribed more than the other.\nStretch enhancers and super-enhancers both play important roles in regulating gene expression, but they do so in different ways. Stretch enhancers are located near the promoter region of a gene and can increase the efficiency of transcription by recruiting RNA polymerase, the enzyme that synthesizes RNA, to the promoter. Super-enhancers, on the other hand, are large regulatory regions that can span thousands of base pairs and can activate multiple genes. They do this by recruiting a complex of proteins that can alter the chromatin structure of the DNA, making it more accessible to the transcription machinery.\nBoth stretch enhancers and super-enhancers can be transcribed at different levels depending on the cell type, developmental stage, and other factors. Therefore, it is not accurate to say that one type is transcribed more than the other.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3507,
    "user_query": "Which diagnostic test is approved for coronavirus infection screening?",
    "yulan-chat-2-13b-fp16_response": "There are several diagnostic tests that have been approved by regulatory agencies for coronavirus infection screening. Some examples include the PCR (polymerase chain reaction) test, the antigen test, and the antibody test. It's important to note that the specific tests that are available in a given area may vary depending on a number of factors, including local regulations and supply chain issues. It's best to consult with a healthcare professional or your local health department for the most up-to-date information on which tests are approved and available in your area.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The PCR (polymerase chain reaction) test is approved for coronavirus infection screening.\n2. The antigen test is approved for coronavirus infection screening.\n3. The antibody test is approved for coronavirus infection screening.",
    "yulan-chat-2-13b-fp16_fact": [
      "The PCR (polymerase chain reaction) test is approved for coronavirus infection screening.",
      "The antigen test is approved for coronavirus infection screening.",
      "The antibody test is approved for coronavirus infection screening."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n\nAll three tests mentionedPCR, antigen, and antibodyare used for various aspects of coronavirus infection screening and diagnosis. PCR tests are considered the gold standard for detecting active infections, antigen tests are often used for rapid screening, and antibody tests can determine if someone has had a past infection.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I am not familiar with the term \"Xanamem.\" It is possible that you may have misspelled the word or that it is a term that is specific to a certain context or field. If you have any additional information or context about what Xanamem might refer to, I would be happy to try to help you further.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3509,
    "user_query": "Can nrf2 activation lead to resistance to radiotherapy?",
    "yulan-chat-2-13b-fp16_response": "NRF2 (Nuclear Factor Erythroid 2-Related Factor 2) is a transcription factor that plays a role in regulating the cellular response to oxidative stress and electrophilic insults. It has been shown to be involved in the regulation of DNA repair and cellular stress pathways.\nRadiotherapy is a cancer treatment that uses ionizing radiation to kill cancer cells. It works by damaging the DNA of the cancer cells, which leads to their death.\nThere is some evidence to suggest that activation of the NRF2 pathway can lead to resistance to radiotherapy in some cancer cells. This is because the activation of NRF2 can lead to the upregulation of genes involved in DNA repair and cellular stress response, which can help to protect cancer cells from the damage caused by radiotherapy.\nHowever, it is important to note that the role of NRF2 in radiotherapy resistance is still an area of active research, and more studies are needed to fully understand the mechanisms involved. Additionally, the clinical relevance of NRF2 inhibition in the context of radiotherapy is still being investigated, and more studies are needed to determine the potential benefits and risks of targeting NRF2 in cancer treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NRF2 plays a role in regulating the cellular response to oxidative stress and electrophilic insults.\n2. NRF2 is involved in the regulation of DNA repair and cellular stress pathways.\n3. Radiotherapy uses ionizing radiation to kill cancer cells by damaging their DNA.\n4. Activation of the NRF2 pathway can lead to resistance to radiotherapy in some cancer cells.\n5. NRF2 activation can upregulate genes involved in DNA repair and cellular stress response, which may protect cancer cells from damage caused by radiotherapy.",
    "yulan-chat-2-13b-fp16_fact": [
      "NRF2 plays a role in regulating the cellular response to oxidative stress and electrophilic insults.",
      "NRF2 is involved in the regulation of DNA repair and cellular stress pathways.",
      "Radiotherapy uses ionizing radiation to kill cancer cells by damaging their DNA.",
      "Activation of the NRF2 pathway can lead to resistance to radiotherapy in some cancer cells.",
      "NRF2 activation can upregulate genes involved in DNA repair and cellular stress response, which may protect cancer cells from damage caused by radiotherapy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3513,
    "user_query": "What is the role of Scc2/Nipbl?",
    "yulan-chat-2-13b-fp16_response": "Scc2 (also known as Nipbl in budding yeast) is a protein that plays a key role in the process of DNA replication in eukaryotic cells. It is a member of the RecQ helicase family of proteins, which are involved in maintaining the stability of DNA and ensuring the accuracy of DNA replication.\nIn the context of DNA replication, Scc2/Nipbl acts as a clamp that binds to the DNA strand that is being replicated, helping to stabilize the DNA and prevent it from unwinding prematurely. This is important because unwinding of the DNA strand can cause errors in the replication process. Scc2/Nipbl also helps to recruit other proteins to the replication fork, including DNA polymerase alpha, which is responsible for synthesizing new DNA strands.\nIn addition to its role in DNA replication, Scc2/Nipbl has also been implicated in other processes that involve DNA, such as homologous recombination and telomere maintenance. Mutations in the SCC2 gene have been associated with a number of human diseases, including cancer and developmental disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Scc2, also known as Nipbl in budding yeast, is involved in the process of DNA replication in eukaryotic cells.\n2. Scc2/Nipbl is a member of the RecQ helicase family of proteins.\n3. Scc2/Nipbl functions as a clamp on the DNA strand that is being replicated to stabilize the DNA.\n4. Scc2/Nipbl recruits other proteins to the replication fork, including DNA polymerase alpha.\n5. Mutations in the SCC2 gene have been linked to human diseases such as cancer and developmental disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "Scc2, also known as Nipbl in budding yeast, is involved in the process of DNA replication in eukaryotic cells.",
      "Scc2/Nipbl is a member of the RecQ helicase family of proteins.",
      "Scc2/Nipbl functions as a clamp on the DNA strand that is being replicated to stabilize the DNA.",
      "Scc2/Nipbl recruits other proteins to the replication fork, including DNA polymerase alpha.",
      "Mutations in the SCC2 gene have been linked to human diseases such as cancer and developmental disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Scc2, also known as Nipbl in humans (not budding yeast), is involved in sister chromatid cohesion during cell division, not directly in the process of DNA replication.\n2. FALSE [correction]: Scc2/Nipbl is not a member of the RecQ helicase family of proteins. It is a cohesin loading factor.\n3. FALSE [correction]: Scc2/Nipbl does not function as a clamp on the DNA strand that is being replicated. It aids in the loading of the cohesin complex onto DNA, which maintains sister chromatid cohesion.\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3515,
    "user_query": "Can brain derived exosomes carry APP molecules?",
    "yulan-chat-2-13b-fp16_response": "Yes, brain-derived exosomes can carry amyloid precursor protein (APP) molecules. Exosomes are small extracellular vesicles that are secreted by cells and contain molecules originating from the cell's interior, such as proteins, nucleic acids, and lipids. In the brain, cells such as astrocytes and neurons release exosomes that can carry various molecules, including APP.\nAPP is a protein that is cleaved by enzymes to form amyloid-beta (A) peptides, which can accumulate and form amyloid plaques in the brain. The cleavage of APP is regulated by a complex set of proteins, including the enzyme beta-secretase. Exosomes released from cells that express APP and beta-secretase can potentially carry A peptides or other APP fragments.\nStudies have shown that exosomes derived from brain cells can contain APP and other molecules associated with Alzheimer's disease, a neurodegenerative disorder characterized by the accumulation of amyloid plaques. Researchers are investigating the potential role of exosomes in the pathogenesis of Alzheimer's disease and exploring the use of exosomes as biomarkers for diagnosis and therapeutic targets.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Brain-derived exosomes can carry amyloid precursor protein (APP) molecules.\n2. Exosomes are small extracellular vesicles that contain proteins, nucleic acids, and lipids.\n3. Amyloid precursor protein (APP) can be cleaved to form amyloid-beta (A) peptides.\n4. Amyloid-beta peptides can accumulate and form amyloid plaques in the brain, which is associated with Alzheimer's disease.\n5. Exosomes derived from brain cells can contain APP and other molecules associated with Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Brain-derived exosomes can carry amyloid precursor protein (APP) molecules.",
      "Exosomes are small extracellular vesicles that contain proteins, nucleic acids, and lipids.",
      "Amyloid precursor protein (APP) can be cleaved to form amyloid-beta (A) peptides.",
      "Amyloid-beta peptides can accumulate and form amyloid plaques in the brain, which is associated with Alzheimer's disease.",
      "Exosomes derived from brain cells can contain APP and other molecules associated with Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3517,
    "user_query": "Which are the main G1/S transcription factors in yeast?",
    "yulan-chat-2-13b-fp16_response": "In yeast, the main G1/S transcription factors are the G1 cycle regulatory factors (GCRFs) and the S phase regulatory factors (SPRFs). The GCRFs include the G1 cyclins (Cln3, Cln4, and Cln6) and their associated regulatory proteins (Mcm1, Sbf1, and Sbf2). The SPRFs include the S phase cyclins (Cdc18 and Cdc24) and their associated regulatory proteins (Mcm1, Sbf1, and Sbf2). These transcription factors control the expression of genes involved in the G1 and S phases of the cell cycle, including those involved in DNA replication, cell growth, and cell division.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. In yeast, the G1 cycle regulatory factors (GCRFs) are considered main G1/S transcription factors.\n2. The G1 cyclins, part of the GCRFs, include Cln3, Cln4, and Cln6.\n3. Mcm1, Sbf1, and Sbf2 are regulatory proteins associated with the GCRFs.\n4. The S phase regulatory factors (SPRFs), another set of G1/S transcription factors, include the S phase cyclins Cdc18 and Cdc24.\n5. Mcm1, Sbf1, and Sbf2 are also associated with the S phase regulatory proteins (SPRFs).",
    "yulan-chat-2-13b-fp16_fact": [
      "In yeast, the G1 cycle regulatory factors (GCRFs) are considered main G1/S transcription factors.",
      "The G1 cyclins, part of the GCRFs, include Cln3, Cln4, and Cln6.",
      "Mcm1, Sbf1, and Sbf2 are regulatory proteins associated with the GCRFs.",
      "The S phase regulatory factors (SPRFs), another set of G1/S transcription factors, include the S phase cyclins Cdc18 and Cdc24.",
      "Mcm1, Sbf1, and Sbf2 are also associated with the S phase regulatory proteins (SPRFs)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The G1 cyclins in yeast include Cln3, but Cln4 and Cln6 are not recognized as yeast G1 cyclins. The known G1 cyclins in Saccharomyces cerevisiae are Cln1, Cln2, and Cln3.\n3. FALSE [correction]: Mcm1 is a transcription factor in yeast, but Sbf1 and Sbf2 do not appear to be standard abbreviations for yeast regulatory proteins. In yeast, SBF is a transcription factor complex that includes Swi4 and Swi6, not Sbf1 and Sbf2.\n4. FALSE [correction]: The S phase cyclins related to the S phase in yeast are Clb5 and Clb6, not Cdc18 and Cdc24. In yeast, Cdc18 is not found, and it is known as Cdc6, which is an initiator protein for DNA replication, not a cyclin. Cdc24 is a protein involved in cell polarity but is not an S phase cyclin.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "yulan-chat-2-13b-fp16_response": "The Hof1-Cyk3 interaction is a key regulatory mechanism in the cell cycle of yeast. Hof1 is a protein that binds to the Cdk phosphorylation site of the cyclin protein Cyk3, inhibiting its activity and preventing the cell from progressing through the cell cycle. This interaction is important for maintaining cell cycle progression and preventing premature entry into mitosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hof1-Cyk3 interaction is a regulatory mechanism in the cell cycle of yeast.\n2. Hof1 is a protein that binds to the Cdk phosphorylation site of Cyk3.\n3. The Hof1-Cyk3 interaction inhibits Cyk3 activity.\n4. This inhibition by Hof1 prevents the cell from progressing through the cell cycle.\n5. The interaction is important for preventing premature entry into mitosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hof1-Cyk3 interaction is a regulatory mechanism in the cell cycle of yeast.",
      "Hof1 is a protein that binds to the Cdk phosphorylation site of Cyk3.",
      "The Hof1-Cyk3 interaction inhibits Cyk3 activity.",
      "This inhibition by Hof1 prevents the cell from progressing through the cell cycle.",
      "The interaction is important for preventing premature entry into mitosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: The interaction between Hof1 and Cyk3 is actually associated with cytokinesis, which is the final step in the cell cycle where the cell divides into two. It is not directly involved in preventing premature entry into mitosis; that would be more related to regulatory mechanisms occurring earlier in the cell cycle.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3523,
    "user_query": "Is SATB1 positioned close to AT-rich sequences?",
    "yulan-chat-2-13b-fp16_response": "Yes, SATB1 is often positioned close to AT-rich sequences. SATB1 is a transcription factor that plays a role in regulating gene expression by binding to AT-rich regions in the genome. AT-rich sequences are regions of the genome that contain high levels of the nucleotides adenine (A) and thymine (T), which are often found in the promoter regions of genes. SATB1 is known to bind to these AT-rich regions and regulate the expression of genes by modifying the chromatin structure in the vicinity of the promoter region.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SATB1 is often positioned close to AT-rich sequences in the genome.\n2. SATB1 is a transcription factor involved in gene expression regulation.\n3. AT-rich sequences in the genome are regions with high levels of adenine and thymine.\n4. These AT-rich sequences are often found in the promoter regions of genes.\n5. SATB1 binds to AT-rich regions to regulate gene expression by altering chromatin structure.",
    "yulan-chat-2-13b-fp16_fact": [
      "SATB1 is often positioned close to AT-rich sequences in the genome.",
      "SATB1 is a transcription factor involved in gene expression regulation.",
      "AT-rich sequences in the genome are regions with high levels of adenine and thymine.",
      "These AT-rich sequences are often found in the promoter regions of genes.",
      "SATB1 binds to AT-rich regions to regulate gene expression by altering chromatin structure."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3526,
    "user_query": "What is known about PAI-1 in longevity in humans?",
    "yulan-chat-2-13b-fp16_response": "Plasminogen activator inhibitor-1 (PAI-1) is a protein that plays a role in the regulation of fibrin formation and degradation. It is known to be involved in the development of various diseases, including thrombosis, cancer, and Alzheimer's disease. There is some evidence to suggest that PAI-1 may also be involved in the aging process.\nStudies have shown that levels of PAI-1 increase with age in humans, and that high levels of the protein are associated with a number of age-related conditions, such as cardiovascular disease and cognitive decline. In addition, some research has suggested that reducing levels of PAI-1 may have beneficial effects on health and longevity.\nHowever, it is important to note that the relationship between PAI-1 and longevity is not fully understood, and more research is needed to determine the extent to which PAI-1 contributes to aging and age-related diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Plasminogen activator inhibitor-1 (PAI-1) is a protein that is involved in the regulation of fibrin formation and degradation.\n2. PAI-1 is known to be involved in the development of various diseases, including thrombosis, cancer, and Alzheimer's disease.\n3. Levels of PAI-1 increase with age in humans.\n4. High levels of PAI-1 are associated with a number of age-related conditions, such as cardiovascular disease and cognitive decline.\n5. Some research has suggested that reducing levels of PAI-1 may have beneficial effects on health and longevity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Plasminogen activator inhibitor-1 (PAI-1) is a protein that is involved in the regulation of fibrin formation and degradation.",
      "PAI-1 is known to be involved in the development of various diseases, including thrombosis, cancer, and Alzheimer's disease.",
      "Levels of PAI-1 increase with age in humans.",
      "High levels of PAI-1 are associated with a number of age-related conditions, such as cardiovascular disease and cognitive decline.",
      "Some research has suggested that reducing levels of PAI-1 may have beneficial effects on health and longevity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE - It's generally established that PAI-1 levels can increase with age and contribute to a pro-thrombotic state.\n4. TRUE - Elevated PAI-1 levels are indeed associated with an increased risk of cardiovascular diseases, and evidence suggests a link with cognitive decline.\n5. TRUE - Current research indicates that lowering PAI-1 could potentially reduce the risk of age-related diseases and improve healthspan, although more research is needed to fully understand the implications.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3530,
    "user_query": "What bacteria is associated with Gastric cancer and peptic ulcers?",
    "yulan-chat-2-13b-fp16_response": "Helicobacter pylori is a bacteria that is associated with gastric cancer and peptic ulcers. It is a spiral-shaped bacterium that lives in the stomach and can cause inflammation and damage to the lining of the stomach and duodenum, leading to the development of ulcers. H. pylori infection is a major risk factor for the development of gastric cancer, and it is estimated to be responsible for about 70-80% of all cases of gastric cancer. The bacteria is also associated with duodenal ulcers and gastric ulcers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Helicobacter pylori is associated with gastric cancer and peptic ulcers.\n2. Helicobacter pylori is a spiral-shaped bacterium that lives in the stomach.\n3. H. pylori infection can cause inflammation and damage to the lining of the stomach and duodenum.\n4. H. pylori infection is a major risk factor for the development of gastric cancer.\n5. H. pylori is estimated to be responsible for about 70-80% of all cases of gastric cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Helicobacter pylori is associated with gastric cancer and peptic ulcers.",
      "Helicobacter pylori is a spiral-shaped bacterium that lives in the stomach.",
      "H. pylori infection can cause inflammation and damage to the lining of the stomach and duodenum.",
      "H. pylori infection is a major risk factor for the development of gastric cancer.",
      "H. pylori is estimated to be responsible for about 70-80% of all cases of gastric cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE (Although the exact percentage can vary based on different studies and sources, it's widely acknowledged in the scientific community that H. pylori infection is responsible for a significant majority of gastric cancer cases. The provided range is commonly cited in literature.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3532,
    "user_query": "What is the purpose of the 123 dihydrorhodamine assay?",
    "yulan-chat-2-13b-fp16_response": "The 123 dihydrorhodamine assay is a method used to measure the activity of enzymes called dioxygenases, which are involved in the metabolism of various compounds in the body. The assay is based on the reaction of the enzyme with a substrate called 123 dihydrorhodamine, which is converted into a fluorescent product that can be measured in a test tube or in a microplate. The amount of fluorescence produced is proportional to the amount of enzyme present, and can be used to quantify the activity of the enzyme in a sample. The assay is commonly used to measure the activity of dioxygenases involved in the metabolism of drugs and other xenobiotics, and can be used to assess the potential toxicity or efficacy of these compounds.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The 123 dihydrorhodamine assay is used to measure the activity of enzymes called dioxygenases.\n2. Dioxygenases play a role in the metabolism of various compounds within the body.\n3. During the assay, 123 dihydrorhodamine is converted into a fluorescent product that can be measured.\n4. The amount of fluorescence produced is proportional to the amount of enzyme present in the sample.\n5. The assay can be performed in a test tube or in a microplate.",
    "yulan-chat-2-13b-fp16_fact": [
      "The 123 dihydrorhodamine assay is used to measure the activity of enzymes called dioxygenases.",
      "Dioxygenases play a role in the metabolism of various compounds within the body.",
      "During the assay, 123 dihydrorhodamine is converted into a fluorescent product that can be measured.",
      "The amount of fluorescence produced is proportional to the amount of enzyme present in the sample.",
      "The assay can be performed in a test tube or in a microplate."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The dihydrorhodamine 123 assay is typically used to measure reactive oxygen species (ROS) production, not the activity of dioxygenases.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3533,
    "user_query": "What is the mode of action of filgotinib?",
    "yulan-chat-2-13b-fp16_response": "Filgotinib is a small molecule inhibitor of janus kinase (JAK), which is a family of enzymes that play a critical role in the signaling of various cytokines and growth factors. By inhibiting JAK enzymes, filgotinib blocks the signaling of these cytokines and growth factors, which can help to reduce inflammation and immune responses in the body.\nThe mode of action of filgotinib is thought to involve its ability to selectively inhibit JAK enzymes, particularly JAK1 and JAK2, which are involved in the signaling of cytokines such as interleukin-12 (IL-12), interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha). These cytokines are involved in the regulation of immune responses and play a role in the pathogenesis of various inflammatory and autoimmune diseases.\nBy inhibiting the signaling of these cytokines, filgotinib has been shown to reduce inflammation and improve symptoms in clinical trials for a variety of inflammatory and autoimmune diseases, including rheumatoid arthritis, ulcerative colitis, and Crohn's disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Filgotinib is a small molecule inhibitor of janus kinase (JAK).\n2. Filgotinib works by blocking the signaling of cytokines and growth factors.\n3. The drug particularly inhibits JAK1 and JAK2 enzymes.\n4. Filgotinib affects cytokines such as interleukin-12 (IL-12), interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha).\n5. Clinical trials have shown that filgotinib can reduce inflammation and improve symptoms in various inflammatory and autoimmune diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Filgotinib is a small molecule inhibitor of janus kinase (JAK).",
      "Filgotinib works by blocking the signaling of cytokines and growth factors.",
      "The drug particularly inhibits JAK1 and JAK2 enzymes.",
      "Filgotinib affects cytokines such as interleukin-12 (IL-12), interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha).",
      "Clinical trials have shown that filgotinib can reduce inflammation and improve symptoms in various inflammatory and autoimmune diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Filgotinib particularly inhibits the JAK1 enzyme, with minor activity against JAK2.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3535,
    "user_query": "What is RiboTag profiling?",
    "yulan-chat-2-13b-fp16_response": "RiboTag profiling is a technique used to study protein synthesis and localization in cells. It involves the use of RiboTags, which are small peptide tags that are ligated to the nascent (newly synthesized) protein as it emerges from the ribosome during translation. These tags can be used to label the protein with a fluorescent dye or other reporter molecule, allowing researchers to track the protein's location and behavior within the cell. RiboTag profiling can provide valuable information about the dynamics of protein synthesis and the role of specific proteins in various cellular processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RiboTag profiling is a technique used to study protein synthesis and localization in cells.\n2. RiboTags are small peptide tags that are attached to newly synthesized proteins during translation.\n3. These peptide tags can be labeled with fluorescent dyes or other reporter molecules.\n4. Labeled proteins can be tracked to study their location and behavior within the cell.\n5. RiboTag profiling can offer insights into the dynamics of protein synthesis and the functions of proteins in cellular processes.",
    "yulan-chat-2-13b-fp16_fact": [
      "RiboTag profiling is a technique used to study protein synthesis and localization in cells.",
      "RiboTags are small peptide tags that are attached to newly synthesized proteins during translation.",
      "These peptide tags can be labeled with fluorescent dyes or other reporter molecules.",
      "Labeled proteins can be tracked to study their location and behavior within the cell.",
      "RiboTag profiling can offer insights into the dynamics of protein synthesis and the functions of proteins in cellular processes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: RiboTags are not peptide tags; they are genetic tags that allow ribosomes from specific cell types or cell states to be labeled and immuno-precipitated to isolate ribosome-bound mRNA.\n3. FALSE [correction]: RiboTags themselves are not labeled with fluorescent dyes or reporters. The technique involves immunoprecipitation of ribosome-bound mRNA, not the labeling of newly synthesized proteins.\n4. FALSE [correction]: RiboTag profiling does not involve tracking labeled proteins within the cell; it is used to isolate and analyze the mRNA associated with ribosomes from specific cell types or populations.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3537,
    "user_query": "What is foliglurax?",
    "yulan-chat-2-13b-fp16_response": "Foliglurax is a drug that is being developed for the treatment of neurological disorders, such as epilepsy and neuropathic pain. It is a selective modulator of the kainate receptor, which is a type of glutamate receptor that is involved in the transmission of signals in the brain. Foliglurax is thought to work by reducing the activity of the kainate receptor, which may help to reduce the frequency of seizures and alleviate neuropathic pain. It is currently in the early stages of development and has not yet been approved for use by any regulatory agencies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Foliglurax is a drug in development for the treatment of neurological disorders, including epilepsy and neuropathic pain.\n2. It is a selective modulator of the kainate receptor, a glutamate receptor in the brain.\n3. Foliglurax is designed to reduce the activity of the kainate receptor.\n4. The intention behind foliglurax is to help reduce the frequency of seizures and alleviate neuropathic pain.\n5. As of the knowledge cutoff, foliglurax has not been approved for use by any regulatory agencies.",
    "yulan-chat-2-13b-fp16_fact": [
      "Foliglurax is a drug in development for the treatment of neurological disorders, including epilepsy and neuropathic pain.",
      "It is a selective modulator of the kainate receptor, a glutamate receptor in the brain.",
      "Foliglurax is designed to reduce the activity of the kainate receptor.",
      "The intention behind foliglurax is to help reduce the frequency of seizures and alleviate neuropathic pain.",
      "As of the knowledge cutoff, foliglurax has not been approved for use by any regulatory agencies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Foliglurax is a drug in development for the treatment of Parkinson's disease, not specifically for epilepsy or neuropathic pain.\n2. FALSE [correction]: Foliglurax is a selective modulator of the metabotropic glutamate receptor 4 (mGluR4), not the kainate receptor.\n3. UNKNOWN [correction]: The statement is based on the incorrect premise that foliglurax modulates the kainate receptor. Instead, it is intended to modulate mGluR4.\n4. UNKNOWN: While reducing the frequency of seizures and alleviating neuropathic pain could be goals for a neurological drug, it is unclear whether these are the specific intentions behind foliglurax without correct context. The drug is aimed at Parkinson's disease treatment, so the intentions are likely related to addressing symptoms of this condition.\n5. TRUE: As of my knowledge cutoff in 2023, foliglurax has not been approved for use by any regulatory agencies.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3549,
    "user_query": "List symptoms of Allgrove syndrome.",
    "yulan-chat-2-13b-fp16_response": "Allgrove syndrome is a rare genetic disorder that affects multiple systems in the body. The symptoms of Allgrove syndrome can vary widely from person to person, but some common symptoms include:\n1. Abdominal pain and distension\n2. Vomiting and diarrhea\n3. Weight loss\n4. Fatigue and lethargy\n5. Jaundice (yellowing of the skin and eyes)\n6. Enlarged liver and spleen\n7. Abnormalities in blood clotting\n8. High blood pressure\n9. Skin rashes and lesions\n10. Developmental delay and intellectual disability\n11. Short stature\n12. Abnormalities in the heart and blood vessels\n13. Kidney problems\n14. Elevated levels of certain enzymes in the blood.\nIt's important to note that not everyone with Allgrove syndrome will experience all of these symptoms, and some people may have additional symptoms not listed here. If you are concerned that you or a loved one may have Allgrove syndrome, it's important to speak with a healthcare professional for proper diagnosis and treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Allgrove syndrome is a rare genetic disorder.\n2. Common symptoms of Allgrove syndrome include abdominal pain and distension.\n3. Symptoms of Allgrove syndrome can include vomiting and diarrhea.\n4. Jaundice is a symptom of Allgrove syndrome.\n5. Individuals with Allgrove syndrome may experience developmental delay and intellectual disability.",
    "yulan-chat-2-13b-fp16_fact": [
      "Allgrove syndrome is a rare genetic disorder.",
      "Common symptoms of Allgrove syndrome include abdominal pain and distension.",
      "Symptoms of Allgrove syndrome can include vomiting and diarrhea.",
      "Jaundice is a symptom of Allgrove syndrome.",
      "Individuals with Allgrove syndrome may experience developmental delay and intellectual disability."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Common symptoms of Allgrove syndrome include alacrima (lack of tear production), achalasia (difficulty swallowing), and adrenal insufficiency. Abdominal pain and distension are not listed as common symptoms by most sources as they are more directly related to achalasia.\n3. FALSE [correction]: While vomiting may occur in Allgrove syndrome as a consequence of achalasia, diarrhea is not a typical symptom of the syndrome.\n4. FALSE [correction]: Jaundice is not a symptom of Allgrove syndrome. Instead, adrenal insufficiency can lead to symptoms such as fatigue, weakness, and hypotension.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3551,
    "user_query": "How do the plasma concentrations of amantadine extended release and amantadine immediate release compare?",
    "yulan-chat-2-13b-fp16_response": "Amantadine extended release (ER) and amantadine immediate release (IR) are two formulations of the medication amantadine, which is used to treat Parkinson's disease and other movement disorders. The main difference between the two formulations is the way they are delivered to the body.\nAmantadine ER is designed to release the medication slowly and consistently over a longer period of time, while amantadine IR is designed to release the medication more quickly, providing a more immediate effect.\nIn terms of plasma concentrations, studies have shown that amantadine ER results in lower peak plasma concentrations and a more gradual increase in plasma levels compared to amantadine IR. This is because the medication is released slowly and steadily over time, rather than all at once.\nHowever, both formulations have been shown to be equally effective in treating Parkinson's disease and other movement disorders. The choice between the two formulations may depend on the specific needs of the individual patient, such as their symptoms, dosing schedule, and tolerance to the medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Amantadine is used to treat Parkinson's disease and other movement disorders.\n2. Amantadine extended release (ER) is designed to release the medication slowly over a longer period.\n3. Amantadine immediate release (IR) is designed to release the medication more quickly.\n4. Amantadine ER tends to result in lower peak plasma concentrations than amantadine IR.\n5. Both amantadine ER and IR have been shown to be equally effective in treating Parkinson's disease and other movement disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "Amantadine is used to treat Parkinson's disease and other movement disorders.",
      "Amantadine extended release (ER) is designed to release the medication slowly over a longer period.",
      "Amantadine immediate release (IR) is designed to release the medication more quickly.",
      "Amantadine ER tends to result in lower peak plasma concentrations than amantadine IR.",
      "Both amantadine ER and IR have been shown to be equally effective in treating Parkinson's disease and other movement disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3554,
    "user_query": "Which drugs are included in GI cocktail?",
    "yulan-chat-2-13b-fp16_response": "The \"GI cocktail\" is a term that is sometimes used to refer to a combination of medications that are used to treat gastrointestinal (GI) symptoms. The specific medications that are included in a GI cocktail can vary depending on the individual and the specific symptoms being treated. Some common medications that may be included in a GI cocktail include:\n* Antacids: These medications can help to neutralize stomach acid and relieve symptoms such as heartburn, indigestion, and acid reflux.\n* Laxatives: These medications can help to loosen stools and relieve constipation.\n* Anti-diarrheal medications: These medications can help to reduce the frequency and severity of diarrhea.\n* Antihistamines: These medications can help to reduce symptoms such as nausea, vomiting, and abdominal cramps.\n* PPIs: These medications can help to reduce stomach acid production and relieve symptoms such as heartburn and acid reflux.\nIt is important to note that the use of a GI cocktail should be under the guidance of a healthcare professional, as the combination of medications can have potential side effects and interactions with other medications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A \"GI cocktail\" refers to a combination of medications used to treat gastrointestinal symptoms.\n2. Antacids included in a GI cocktail can help to neutralize stomach acid.\n3. Laxatives may be part of a GI cocktail to relieve constipation.\n4. Anti-diarrheal medications in a GI cocktail can help reduce the frequency and severity of diarrhea.\n5. Antihistamines may be included in a GI cocktail to reduce symptoms like nausea, vomiting, and abdominal cramps.",
    "yulan-chat-2-13b-fp16_fact": [
      "A \"GI cocktail\" refers to a combination of medications used to treat gastrointestinal symptoms.",
      "Antacids included in a GI cocktail can help to neutralize stomach acid.",
      "Laxatives may be part of a GI cocktail to relieve constipation.",
      "Anti-diarrheal medications in a GI cocktail can help reduce the frequency and severity of diarrhea.",
      "Antihistamines may be included in a GI cocktail to reduce symptoms like nausea, vomiting, and abdominal cramps."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Laxatives are not typically part of a GI cocktail; a GI cocktail is aimed at relieving symptoms like heartburn or peptic ulcer pain, not constipation.\n4. UNKNOWN: While anti-diarrheal medications could theoretically be used to treat gastrointestinal symptoms, they are not traditional components of a GI cocktail, which is usually aimed at relieving upper gastrointestinal symptoms, not diarrhea.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3555,
    "user_query": "Is AZD5153 active in prostate cancer?",
    "yulan-chat-2-13b-fp16_response": "AZD5153 is an investigational drug that is being developed for the treatment of various types of cancer, including prostate cancer. However, as of my knowledge cutoff date of September 2021, clinical trials evaluating AZD5153 in prostate cancer were ongoing but not yet completed or fully reported. Therefore, it is not yet clear whether AZD5153 will prove to be an active treatment for prostate cancer or not.\nIt is important to note that the development of new cancer treatments is an ongoing process, and clinical trials are conducted to assess the safety and efficacy of new drugs. Results from early-stage clinical trials may not be predictive of the eventual outcome of larger, later-stage trials, and it may take several years for a drug to be approved for use by regulatory agencies such as the U.S. Food and Drug Administration (FDA).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. AZD5153 is an investigational drug being developed to treat various types of cancer, including prostate cancer.\n2. As of September 2021, clinical trials for AZD5153 in prostate cancer were ongoing.\n3. The trials evaluating the efficacy of AZD5153 in prostate cancer were not yet completed or fully reported as of September 2021.\n4. Clinical trials are used to assess the safety and efficacy of new cancer treatments.\n5. Results from early-stage clinical trials may not be predictive of the outcomes of later-stage trials.",
    "yulan-chat-2-13b-fp16_fact": [
      "AZD5153 is an investigational drug being developed to treat various types of cancer, including prostate cancer.",
      "As of September 2021, clinical trials for AZD5153 in prostate cancer were ongoing.",
      "The trials evaluating the efficacy of AZD5153 in prostate cancer were not yet completed or fully reported as of September 2021.",
      "Clinical trials are used to assess the safety and efficacy of new cancer treatments.",
      "Results from early-stage clinical trials may not be predictive of the outcomes of later-stage trials."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN (Without current data on the progress of clinical trials for AZD5153, we cannot confirm the status as of September 2021.)\n3. UNKNOWN (The statement about the completion and reporting of the trials for AZD5153 as of September 2021 cannot be verified without additional information on the trial status.)\n4. TRUE\n5. TRUE\n",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3556,
    "user_query": "Is GRG5 involved only in late embryonic mouse development?",
    "yulan-chat-2-13b-fp16_response": "GRG5 (Gli-related gene 5) is a transcription factor that belongs to the Gli family of genes, which are involved in the development and maintenance of neural stem cells in the brain. GRG5 is expressed mainly in the ventricular zone of the embryonic mouse brain, where it plays a role in the proliferation and differentiation of neural stem cells.\nWhile GRG5 is primarily involved in early brain development, it has also been shown to be expressed in other tissues and organs later in development. For example, GRG5 has been found to be expressed in the lung, liver, and pancreas during postnatal development in mice.\nIn the context of mouse development, GRG5 is primarily involved in early brain development, but it is not exclusively involved in late embryonic development. Its expression and function are important throughout embryonic and postnatal development.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. GRG5 is a transcription factor that belongs to the Gli family of genes.\n2. GRG5 is involved in the proliferation and differentiation of neural stem cells in the mouse brain.\n3. GRG5 is expressed mainly in the ventricular zone of the embryonic mouse brain.\n4. GRG5 has been found to be expressed in the lung, liver, and pancreas during postnatal development in mice.\n5. GRG5 is not exclusively involved in late embryonic development but is important throughout embryonic and postnatal development.",
    "yulan-chat-2-13b-fp16_fact": [
      "GRG5 is a transcription factor that belongs to the Gli family of genes.",
      "GRG5 is involved in the proliferation and differentiation of neural stem cells in the mouse brain.",
      "GRG5 is expressed mainly in the ventricular zone of the embryonic mouse brain.",
      "GRG5 has been found to be expressed in the lung, liver, and pancreas during postnatal development in mice.",
      "GRG5 is not exclusively involved in late embryonic development but is important throughout embryonic and postnatal development."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: GRG5 is not a member of the Gli family of genes. Instead, it is thought to be a transcriptional co-repressor that can interact with the Gli family among other transcription factors.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3558,
    "user_query": "Describe the mechanism of action of a drug Elagolix.",
    "yulan-chat-2-13b-fp16_response": "Elagolix is a gonadotropin-releasing hormone (GnRH) antagonist, which means that it works by blocking the release of gonadotropins (hormones that stimulate the production of sex cells) from the hypothalamus in the brain.\nSpecifically, Elagolix binds to GnRH receptors in the hypothalamus, preventing GnRH from attaching and triggering the release of gonadotropins. This results in a decrease in the production of sex hormones, such as estrogen and testosterone, which can help to treat a variety of conditions, including endometriosis, uterine fibroids, and prostate cancer.\nBy blocking the release of gonadotropins, Elagolix can also help to reduce symptoms associated with these conditions, such as pain, heavy menstrual bleeding, and the growth of uterine fibroids or prostate cancer cells. Elagolix is available in oral form and is taken once a month for the treatment of endometriosis and uterine fibroids, and once a month or every 4 weeks for the treatment of prostate cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Elagolix is a gonadotropin-releasing hormone (GnRH) antagonist.\n2. Elagolix operates by blocking the release of gonadotropins from the hypothalamus in the brain.\n3. Elagolix binds to GnRH receptors in the hypothalamus, preventing GnRH from attaching and triggering the release of gonadotropins.\n4. The action of Elagolix leads to a decrease in the production of sex hormones such as estrogen and testosterone.\n5. Elagolix is used in the treatment of conditions like endometriosis, uterine fibroids, and prostate cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Elagolix is a gonadotropin-releasing hormone (GnRH) antagonist.",
      "Elagolix operates by blocking the release of gonadotropins from the hypothalamus in the brain.",
      "Elagolix binds to GnRH receptors in the hypothalamus, preventing GnRH from attaching and triggering the release of gonadotropins.",
      "The action of Elagolix leads to a decrease in the production of sex hormones such as estrogen and testosterone.",
      "Elagolix is used in the treatment of conditions like endometriosis, uterine fibroids, and prostate cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Elagolix is used in the treatment of conditions like endometriosis and uterine fibroids. As of my last update, it is not indicated for the treatment of prostate cancer; drugs like degarelix are used for that purpose.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3567,
    "user_query": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?",
    "yulan-chat-2-13b-fp16_response": "There are several algorithms that have been developed for analyzing CRISPR/Cas9 knockout screen data. Some of the commonly used algorithms include:\n1. Gene ontology (GO) enrichment analysis: This algorithm is used to identify functional categories of genes that are enriched in the knockout screen data. It helps in identifying biological processes, molecular functions, and cellular components that are affected by the knockout of a particular gene.\n2. Weighted Gene Co-expression Network Analysis (WGCNA): This algorithm is used to identify groups of co-expressed genes and to identify key genes that control the expression of other genes in the network. It helps in identifying functional relationships between genes and identifying potential targets for further investigation.\n3. Pathway enrichment analysis: This algorithm is used to identify pathways that are enriched in the knockout screen data. It helps in identifying biological pathways that are affected by the knockout of a particular gene.\n4. Machine learning algorithms: These algorithms are used to identify patterns in the knockout screen data and to predict the function of genes that have not been experimentally validated. Examples of machine learning algorithms that have been used include random forests, support vector machines, and neural networks.\n5. Network-based approaches: These algorithms are used to construct gene interaction networks and to identify key genes that control the expression of other genes in the network. Examples of network-based approaches that have been used include Bayesian networks and dynamic network analysis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gene ontology (GO) enrichment analysis is an algorithm used to identify functional categories of genes enriched in CRISPR/Cas9 knockout screen data.\n2. Weighted Gene Co-expression Network Analysis (WGCNA) is an algorithm used to identify co-expressed gene groups and key regulatory genes in gene expression networks.\n3. Pathway enrichment analysis is an algorithm used to identify biological pathways affected by gene knockouts in CRISPR/Cas9 knockout screens.\n4. Machine learning algorithms, such as random forests, support vector machines, and neural networks, have been used to analyze CRISPR/Cas9 knockout screen data.\n5. Network-based approaches like Bayesian networks and dynamic network analysis are used to construct gene interaction networks from CRISPR/Cas9 knockout screen data.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gene ontology (GO) enrichment analysis is an algorithm used to identify functional categories of genes enriched in CRISPR/Cas9 knockout screen data.",
      "Weighted Gene Co-expression Network Analysis (WGCNA) is an algorithm used to identify co-expressed gene groups and key regulatory genes in gene expression networks.",
      "Pathway enrichment analysis is an algorithm used to identify biological pathways affected by gene knockouts in CRISPR/Cas9 knockout screens.",
      "Machine learning algorithms, such as random forests, support vector machines, and neural networks, have been used to analyze CRISPR/Cas9 knockout screen data.",
      "Network-based approaches like Bayesian networks and dynamic network analysis are used to construct gene interaction networks from CRISPR/Cas9 knockout screen data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll the statements relate to common techniques and analytical methods in genomics and systems biology:\n\n1. Gene ontology (GO) enrichment analysis is indeed used to find functions or biological processes that are overrepresented in a set of genes, such as those affected in a CRISPR/Cas9 knockout screen.\n2. Weighted Gene Co-expression Network Analysis (WGCNA) is used to find clusters (modules) of highly correlated genes and to relate these clusters to one another and to external sample traits.\n3. Pathway enrichment analysis aims to identify biological pathways that are enriched in a particular set of genes, like those altered by gene knockouts.\n4. Machine learning algorithms, including random forests, support vector machines, and neural networks, are utilized in a variety of biological data analyses, including interpreting CRISPR/Cas9 knockout screen data.\n5. Network-based approaches like Bayesian networks and dynamic network analysis are indeed methods used to infer gene interaction networks, which can be constructed from various types of data, including CRISPR/Cas9 knockout screens.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3569,
    "user_query": "PDQ39 questionnaires is design for which disease?",
    "yulan-chat-2-13b-fp16_response": "The PDQ39 questionnaire is a tool designed to assess the symptoms and impact of chronic pain in adults. It is not specific to any one particular disease, but rather can be used to evaluate pain in individuals with a variety of chronic pain conditions, such as back pain, arthritis, or neuropathic pain. The questionnaire assesses a range of pain-related symptoms, including the intensity and frequency of pain, as well as the impact of pain on daily activities and quality of life.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3570,
    "user_query": "Is palbociclib effective for glioblastoma?",
    "yulan-chat-2-13b-fp16_response": "Palbociclib is a drug that is primarily used to treat breast cancer by inhibiting the activity of cyclin-dependent kinases (CDKs) 4 and 6. There is currently no evidence to suggest that palbociclib is effective for treating glioblastoma, which is a type of brain cancer.\nGlioblastoma is typically treated with a combination of surgery, radiation therapy, and chemotherapy. However, the prognosis for patients with glioblastoma is generally poor, and the cancer often recurs despite treatment. Researchers are actively investigating new treatments for glioblastoma, including targeted therapies and immunotherapies, but palbociclib is not one of the drugs being studied for this indication.\nIf you have been diagnosed with glioblastoma, it is important to discuss your treatment options with a healthcare professional who specializes in brain tumors. They can help you find clinical trials or other treatments that may be effective for your specific condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Palbociclib is used primarily to treat breast cancer.\n2. Palbociclib works by inhibiting the activity of cyclin-dependent kinases 4 and 6.\n3. There is no evidence to suggest that palbociclib is effective for treating glioblastoma.\n4. Glioblastoma is usually treated with a combination of surgery, radiation therapy, and chemotherapy.\n5. The prognosis for glioblastoma patients is generally poor, and the cancer often recurs despite treatment.",
    "yulan-chat-2-13b-fp16_fact": [
      "Palbociclib is used primarily to treat breast cancer.",
      "Palbociclib works by inhibiting the activity of cyclin-dependent kinases 4 and 6.",
      "There is no evidence to suggest that palbociclib is effective for treating glioblastoma.",
      "Glioblastoma is usually treated with a combination of surgery, radiation therapy, and chemotherapy.",
      "The prognosis for glioblastoma patients is generally poor, and the cancer often recurs despite treatment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is evidence to suggest that palbociclib may have activity against glioblastoma. Researchers are investigating the potential benefits of palbociclib for treating glioblastoma and other types of cancer, although it is not currently a standard treatment for glioblastoma.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3572,
    "user_query": "Does the Mcm2-Ctf4-Pol axis play a role in transfer of histones to leading strand DNA at the replication forks?",
    "yulan-chat-2-13b-fp16_response": "The Mcm2-Ctf4-Pol axis plays a crucial role in the transfer of histones to leading strand DNA at the replication forks. This complex helps to unwind the DNA double helix and provides a template for the synthesis of new strands of DNA by the DNA polymerase alpha. The Mcm2-Ctf4-Pol complex also helps to ensure that the replication process proceeds in a timely and accurate manner by coordinating the activities of various proteins involved in DNA replication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Mcm2-Ctf4-Pol axis is involved in the transfer of histones to leading strand DNA at the replication forks.\n2. This complex assists in unwinding the DNA double helix.\n3. The Mcm2-Ctf4-Pol provides a template for the synthesis of new DNA strands by DNA polymerase alpha.\n4. The complex helps to coordinate the activities of various proteins involved in DNA replication.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Mcm2-Ctf4-Pol axis is involved in the transfer of histones to leading strand DNA at the replication forks.",
      "This complex assists in unwinding the DNA double helix.",
      "The Mcm2-Ctf4-Pol provides a template for the synthesis of new DNA strands by DNA polymerase alpha.",
      "The complex helps to coordinate the activities of various proteins involved in DNA replication."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The Mcm2-Ctf4-Pol axis does not assist in unwinding the DNA double helix; rather, this function is primarily performed by the DNA helicase which is part of the CMG complex (Cdc45-Mcm2-7-GINS complex).\n3. FALSE [correction]: The Mcm2-Ctf4-Pol complex itself does not provide the template for new DNA strand synthesis. The parental DNA strands serve as the template, and DNA polymerase alpha synthesizes the RNA-DNA primer needed for DNA replication to begin.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3574,
    "user_query": "Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?",
    "yulan-chat-2-13b-fp16_response": "The gene that is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) is the CNTNAP2 gene. Mutations in this gene have been associated with ADLD, also known as vanishing white matter disease. The CNTNAP2 gene provides instructions for making a protein that is involved in the development and maintenance of myelin, the fatty substance that surrounds nerve cells and helps them to function properly. Mutations in the CNTNAP2 gene can lead to the breakdown of myelin, which can cause the symptoms of ADLD, such as progressive weakness, spasticity, and cognitive decline.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The CNTNAP2 gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).\n2. Mutations in the CNTNAP2 gene have been associated with ADLD.\n3. ADLD is also known as vanishing white matter disease.\n4. The CNTNAP2 gene provides instructions for making a protein that is involved in the development and maintenance of myelin.\n5. Mutations in the CNTNAP2 gene can lead to the breakdown of myelin and cause symptoms such as progressive weakness, spasticity, and cognitive decline.",
    "yulan-chat-2-13b-fp16_fact": [
      "The CNTNAP2 gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD).",
      "Mutations in the CNTNAP2 gene have been associated with ADLD.",
      "ADLD is also known as vanishing white matter disease.",
      "The CNTNAP2 gene provides instructions for making a protein that is involved in the development and maintenance of myelin.",
      "Mutations in the CNTNAP2 gene can lead to the breakdown of myelin and cause symptoms such as progressive weakness, spasticity, and cognitive decline."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The CNTNAP2 gene is not frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD). It is the LMNB1 gene that is commonly associated with ADLD.\n2. TRUE\n3. FALSE [correction]: ADLD is not known as vanishing white matter disease. Vanishing white matter disease is a different condition, also known as Childhood Ataxia with Central Nervous System Hypomyelination (CACH) or leukoencephalopathy with vanishing white matter, which is most commonly caused by mutations in one of the five genes encoding the eukaryotic translation initiation factor 2B.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3577,
    "user_query": "Which is the main epigenetic difference between poised and constitutive enhancers?",
    "yulan-chat-2-13b-fp16_response": "Poised enhancers and constitutive enhancers are two types of gene regulatory regions that play important roles in controlling gene expression. The main difference between them lies in their epigenetic state and their ability to activate or repress gene expression.\nPoised enhancers are regions of the genome that are marked by specific epigenetic modifications, such as histone modifications and DNA methylation, which are associated with gene repression. These modifications create a closed chromatin structure that inhibits the binding of transcription factors and other regulatory proteins to the DNA. Poised enhancers are typically found in genomic regions that are silenced in a particular cell type or developmental stage, but can be reactivated under certain conditions.\nConstitutive enhancers, on the other hand, are regions of the genome that are marked by different epigenetic modifications, which are associated with gene activation. These modifications create an open chromatin structure that allows for the binding of transcription factors and other regulatory proteins to the DNA, leading to the activation of gene expression. Constitutive enhancers are typically found in genomic regions that are active in a particular cell type or developmental stage, and continue to drive gene expression in a consistent manner.\nIn summary, the main epigenetic difference between poised and constitutive enhancers is the type of epigenetic modifications they carry, which determines their ability to activate or repress gene expression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Poised enhancers are associated with epigenetic modifications related to gene repression.\n2. Poised enhancers have a closed chromatin structure that inhibits the binding of transcription factors.\n3. Constitutive enhancers are associated with epigenetic modifications related to gene activation.\n4. Constitutive enhancers have an open chromatin structure that allows the binding of transcription factors.\n5. The main epigenetic difference between poised and constitutive enhancers is the type of epigenetic modifications they carry.",
    "yulan-chat-2-13b-fp16_fact": [
      "Poised enhancers are associated with epigenetic modifications related to gene repression.",
      "Poised enhancers have a closed chromatin structure that inhibits the binding of transcription factors.",
      "Constitutive enhancers are associated with epigenetic modifications related to gene activation.",
      "Constitutive enhancers have an open chromatin structure that allows the binding of transcription factors.",
      "The main epigenetic difference between poised and constitutive enhancers is the type of epigenetic modifications they carry."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Poised enhancers are indeed associated with epigenetic modifications that usually keep genes in a repressed but 'ready' state, which allows for quick activation when needed.\n   \n2. FALSE [correction]: Poised enhancers actually have a chromatin structure that is neither fully open nor fully closed and often contain both activating and repressive epigenetic marks, hence they are poised and ready to respond, rather than being completely inhibitory.\n\n3. TRUE: Constitutive enhancers are typically associated with active gene expression and have epigenetic modifications that support this activity.\n\n4. TRUE: Constitutive enhancers generally have an open chromatin structure, which is accessible to transcription factors and associated with active gene transcription.\n\n5. UNKNOWN: While it can be true that the main epigenetic difference between poised and constitutive enhancers is the type of epigenetic modifications they carry, this statement is too vague without specific context or further detail on what 'type' refers to (such as specific histone modifications, DNA methylation, etc.). There may also be other important differences, such as the interaction with different cofactors or transcription factors, which are not specified in the statement.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3586,
    "user_query": "What is gamma sterilization used for?",
    "yulan-chat-2-13b-fp16_response": "Gamma sterilization is a process used to sterilize medical devices and equipment. It involves exposing the items to high-energy gamma rays, which kill bacteria, viruses, and other microorganisms on the surface of the items. This process is used to ensure that medical devices and equipment are sterile and free of contaminants, which can cause infections if they come into contact with a patient's skin or mucous membranes. Gamma sterilization is a common method used in hospitals and medical facilities to sterilize equipment before it is used on patients.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gamma sterilization is used to sterilize medical devices and equipment.\n2. The process involves exposing items to high-energy gamma rays.\n3. Gamma rays kill bacteria, viruses, and other microorganisms on the surfaces of items.\n4. The purpose of gamma sterilization is to make medical devices and equipment free of contaminants.\n5. Hospitals and medical facilities commonly use gamma sterilization to sterilize equipment before use on patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gamma sterilization is used to sterilize medical devices and equipment.",
      "The process involves exposing items to high-energy gamma rays.",
      "Gamma rays kill bacteria, viruses, and other microorganisms on the surfaces of items.",
      "The purpose of gamma sterilization is to make medical devices and equipment free of contaminants.",
      "Hospitals and medical facilities commonly use gamma sterilization to sterilize equipment before use on patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3589,
    "user_query": "What is the current regulation of eye lens radiation exposure?",
    "yulan-chat-2-13b-fp16_response": "The regulation of eye lens radiation exposure varies by country and industry. In the United States, the Occupational Safety and Health Administration (OSHA) has set permissible exposure limits (PELs) for occupational exposure to ionizing radiation, including radiation emitted from eye lenses. The PEL is 0.01 millisieverts per hour (mSv/h) for eye lens workers, and employers are required to monitor worker exposure and provide appropriate protective measures.\nIn Europe, the European Union Radiation Protection Regulation (EU RPR) sets limits on occupational exposure to ionizing radiation, including radiation from eye lenses. The EU RPR sets a dose limit of 20 millisieverts (mSv) per year for eye lens workers, with a dose limit of 100 micro sieverts (Sv) per hour during peak exposure periods.\nIn the eyewear industry, there are also industry-specific regulations and guidelines. For example, the European Standard EN 1836:2015 provides guidelines for the design, testing, and labeling of eye protective devices, including eye lenses used in radiation environments.\nIt is important to note that these regulations and guidelines are subject to change and may vary depending on the specific situation and country. It is important for companies and individuals to stay up-to-date with the latest regulations and guidelines to ensure proper protection from radiation exposure.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. In the United States, the Occupational Safety and Health Administration (OSHA) has set the permissible exposure limit for occupational eye lens radiation at 0.01 millisieverts per hour.\n2. Employers in the United States are required to monitor worker exposure to eye lens radiation and provide appropriate protective measures.\n3. The European Union Radiation Protection Regulation sets an occupational exposure limit for eye lens radiation at 20 millisieverts per year.\n4. The EU RPR also specifies a dose limit of 100 micro sieverts per hour during peak exposure periods for eye lens workers.\n5. The European Standard EN 1836:2015 provides guidelines for the design, testing, and labeling of eye protective devices used in radiation environments.",
    "yulan-chat-2-13b-fp16_fact": [
      "In the United States, the Occupational Safety and Health Administration (OSHA) has set the permissible exposure limit for occupational eye lens radiation at 0.01 millisieverts per hour.",
      "Employers in the United States are required to monitor worker exposure to eye lens radiation and provide appropriate protective measures.",
      "The European Union Radiation Protection Regulation sets an occupational exposure limit for eye lens radiation at 20 millisieverts per year.",
      "The EU RPR also specifies a dose limit of 100 micro sieverts per hour during peak exposure periods for eye lens workers.",
      "The European Standard EN 1836:2015 provides guidelines for the design, testing, and labeling of eye protective devices used in radiation environments."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: OSHA has set the permissible exposure limit for occupational radiation exposure to the lens of the eye at 50 millisieverts per year, not 0.01 millisieverts per hour.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The EU Radiation Protection Directive (Council Directive 2013/59/Euratom) does not specify a dose limit of 100 microsieverts per hour during peak exposure periods for eye lens workers, instead, it has adjusted the dose limits for the lens of the eye for occupational exposure to 20 millisieverts in a single year, and in special circumstances, a higher exposure of up to 50 millisieverts in a single year as part of a five-year average may be allowed.\n5. FALSE [correction]: EN 1836:2005+A1:2007 is a standard for sunglasses and sun glare filters for general use and concerns protection against solar radiation, not specifically for protective devices used in radiation environments. The standard relevant to eye protection in the context of radiation would be part of the EN 61331 series, such as EN 61331-3:2014 dealing with protective devices against diagnostic medical x-radiation.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3593,
    "user_query": "What is the cause of the disease Xeroderma Pigmentosum?",
    "yulan-chat-2-13b-fp16_response": "Xeroderma pigmentosum (XP) is a rare genetic disorder caused by a defect in the genes that repair damaged DNA. People with XP are extremely sensitive to sunlight and cannot safely go outside without protective clothing and sunscreen. The disorder is characterized by a high risk of skin cancer and a distinctive skin appearance, with freckling and pigmentation that starts in infancy. XP is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the defective gene (one from each parent) in order to develop the disorder.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Xeroderma pigmentosum (XP) is caused by a defect in the genes that repair damaged DNA.\n2. People with XP are extremely sensitive to sunlight.\n3. Individuals with XP have a high risk of developing skin cancer.\n4. Xeroderma pigmentosum starts to show skin freckling and pigmentation beginning in infancy.\n5. XP is inherited in an autosomal recessive pattern, requiring two copies of the defective gene, one from each parent, for the disorder to develop.",
    "yulan-chat-2-13b-fp16_fact": [
      "Xeroderma pigmentosum (XP) is caused by a defect in the genes that repair damaged DNA.",
      "People with XP are extremely sensitive to sunlight.",
      "Individuals with XP have a high risk of developing skin cancer.",
      "Xeroderma pigmentosum starts to show skin freckling and pigmentation beginning in infancy.",
      "XP is inherited in an autosomal recessive pattern, requiring two copies of the defective gene, one from each parent, for the disorder to develop."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Xeroderma pigmentosum symptoms such as freckling and pigmentation often first appear in early childhood, not necessarily beginning in infancy, as the timing can vary.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "yulan-chat-2-13b-fp16_response": "Several T-UCRs have been implicated in gastric cancer, including:\n1. HLA-C*0602-restricted T-UCRs: These T-UCRs are restricted by the HLA-C*0602 molecule and have been shown to be associated with gastric cancer in various ethnic populations.\n2. HLA-B*44-restricted T-UCRs: These T-UCRs are restricted by the HLA-B*44 molecule and have been shown to be associated with gastric cancer in Caucasian populations.\n3. HLA-A*02-restricted T-UCRs: These T-UCRs are restricted by the HLA-A*02 molecule and have been shown to be associated with gastric cancer in Asian populations.\n4. HLA-DRB1*0101-restricted T-UCRs: These T-UCRs are restricted by the HLA-DRB1*0101 molecule and have been shown to be associated with gastric cancer in African populations.\nIt is important to note that the association between T-UCRs and gastric cancer may vary depending on the ethnicity and genetic background of the population being studied. Additionally, the exact mechanisms by which T-UCRs contribute to gastric cancer susceptibility are not fully understood and are an area of ongoing research.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. HLA-C*0602-restricted T-UCRs have been associated with gastric cancer in various ethnic populations.\n2. HLA-B*44-restricted T-UCRs have been associated with gastric cancer in Caucasian populations.\n3. HLA-A*02-restricted T-UCRs have been associated with gastric cancer in Asian populations.\n4. HLA-DRB1*0101-restricted T-UCRs have been associated with gastric cancer in African populations.\n5. The association between T-UCRs and gastric cancer may vary based on ethnicity and genetic background.",
    "yulan-chat-2-13b-fp16_fact": [
      "HLA-C*0602-restricted T-UCRs have been associated with gastric cancer in various ethnic populations.",
      "HLA-B*44-restricted T-UCRs have been associated with gastric cancer in Caucasian populations.",
      "HLA-A*02-restricted T-UCRs have been associated with gastric cancer in Asian populations.",
      "HLA-DRB1*0101-restricted T-UCRs have been associated with gastric cancer in African populations.",
      "The association between T-UCRs and gastric cancer may vary based on ethnicity and genetic background."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nThe provided statements (1-4) refer to specific associations between HLA-restricted T-UCRs (ultra-conserved regions) and gastric cancer in various ethnic populations. Without specific scientific research references or data supporting these associations, the truthfulness of statements 1-4 cannot be determined; hence, they are marked as UNKNOWN. Statement 5 is true, as it is a general assertion that is well-supported in the field of genetics and disease research; the association between genetic factors such as T-UCRs and diseases like gastric cancer can indeed vary based on ethnicity and genetic background.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3600,
    "user_query": "Which de novo mutation in FGFR cause achondroplasia?",
    "yulan-chat-2-13b-fp16_response": "Achondroplasia is the most common form of short-limbed dwarfism and is caused by a de novo mutation in the FGFR3 gene. Specifically, the most common de novo mutation in FGFR3 that causes achondroplasia is a G3760A mutation, which results in the substitution of a glycine for an alanine at position 3760 in the FGFR3 protein. This mutation disrupts the signaling pathway that regulates bone growth and development, leading to the characteristic short-limbed dwarfism seen in individuals with achondroplasia.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Achondroplasia is the most common form of short-limbed dwarfism.\n2. Achondroplasia is caused by a de novo mutation in the FGFR3 gene.\n3. The most common de novo mutation in FGFR3 that causes achondroplasia is a G3760A mutation.\n4. The G3760A mutation in FGFR3 results in the substitution of a glycine for an alanine at position 3760 in the FGFR3 protein.\n5. The mutation disrupts the signaling pathway that regulates bone growth and development, leading to short-limbed dwarfism characteristics of achondroplasia.",
    "yulan-chat-2-13b-fp16_fact": [
      "Achondroplasia is the most common form of short-limbed dwarfism.",
      "Achondroplasia is caused by a de novo mutation in the FGFR3 gene.",
      "The most common de novo mutation in FGFR3 that causes achondroplasia is a G3760A mutation.",
      "The G3760A mutation in FGFR3 results in the substitution of a glycine for an alanine at position 3760 in the FGFR3 protein.",
      "The mutation disrupts the signaling pathway that regulates bone growth and development, leading to short-limbed dwarfism characteristics of achondroplasia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The most common de novo mutation in FGFR3 that causes achondroplasia is a G380R mutation, which means at position 380 of the protein, the amino acid glycine (G) is replaced with arginine (R), not G3760A.\n4. FALSE [correction]: The G380R mutation results in the substitution of a glycine for an arginine at position 380 in the FGFR3 protein, not glycine for alanine at position 3760.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3601,
    "user_query": "List types of DNA lesions caused by UV light.",
    "yulan-chat-2-13b-fp16_response": "UV light can cause various types of DNA lesions, including:\n1. Thymine dimers: UV light can cause cytosine and thymine bases to form thymine dimers, which can lead to incorrect DNA replication and transcription.\n2. Cyclobutane pyrimidine dimers: UV light can cause pyrimidine bases to form cyclobutane rings, which can also lead to incorrect DNA replication and transcription.\n3. Single-strand breaks: UV light can cause breaks in the backbone of the DNA molecule, resulting in single-strand breaks.\n4. Double-strand breaks: UV light can cause breaks in both strands of the DNA molecule, resulting in double-strand breaks.\n5. Base modifications: UV light can cause modifications to the bases of the DNA molecule, such as methylation and hydroxylation, which can affect gene expression and repair processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. UV light can cause the formation of thymine dimers in DNA.\n2. Cyclobutane pyrimidine dimers can be formed in DNA due to UV light exposure.\n3. UV light exposure can cause single-strand breaks in DNA.\n4. Double-strand breaks in DNA can result from UV light exposure.\n5. Base modifications such as methylation and hydroxylation in DNA can be induced by UV light.",
    "yulan-chat-2-13b-fp16_fact": [
      "UV light can cause the formation of thymine dimers in DNA.",
      "Cyclobutane pyrimidine dimers can be formed in DNA due to UV light exposure.",
      "UV light exposure can cause single-strand breaks in DNA.",
      "Double-strand breaks in DNA can result from UV light exposure.",
      "Base modifications such as methylation and hydroxylation in DNA can be induced by UV light."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Double-strand breaks in DNA are less commonly caused by UV light exposure than single-strand breaks or other forms of damage like pyrimidine dimers; they are more typically caused by ionizing radiation.\n5. FALSE [correction]: While UV light can induce various types of DNA damage, specific base modifications such as methylation are generally not induced by UV light; they may be caused by other types of chemical exposure or enzymatic processes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3604,
    "user_query": "Which software are used for the detection of selective sweeps?",
    "yulan-chat-2-13b-fp16_response": "Selective sweeps are typically detected using software tools that analyze genetic data, such as single nucleotide polymorphism (SNP) data or haplotype data. Some commonly used software for detecting selective sweeps include:\n1. Tajima's D: This is a statistical test that can be used to detect selective sweeps by comparing the observed and expected heterozygosity in a region of the genome.\n2. SFS: This is a software package that can be used to estimate the selection coefficient (s) for a set of SNPs.\n3. Haplotype-based methods: These methods use haplotype data to identify regions of the genome that have undergone strong selection. Examples include the haplotype-based method developed by Pritchard et al. (2000) and the iHS method developed by Li and Ballinger (2008).\n4. Bayesian methods: These methods use Bayesian inference to estimate the likelihood of a selective sweep occurring in a region of the genome. Examples include the Bayesian method developed by Pritchard et al. (2001) and the Bayesian model developed by Li and Ballinger (2008).\n5. Genomic region enrichment of significant variants (GRESV): This is a method that uses a combination of genome-wide association studies (GWAS) and selective sweep analysis to identify regions of the genome that are enriched for genetic variants that are associated with a particular trait.\nThese software tools can be used to detect selective sweeps in a variety of species, including humans, animals, and plants.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tajima's D is a statistical test used to detect selective sweeps by comparing the observed and expected heterozygosity in a genome region.\n2. The software package SFS can estimate the selection coefficient for a set of SNPs.\n3. Haplotype-based methods involving haplotype data can identify regions that have undergone strong selection.\n4. Bayesian methods employ Bayesian inference to estimate the likelihood of a selective sweep in a genome region.\n5. The Genomic region enrichment of significant variants (GRESV) method combines GWAS and selective sweep analysis to identify genome regions enriched for variants associated with a particular trait.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tajima's D is a statistical test used to detect selective sweeps by comparing the observed and expected heterozygosity in a genome region.",
      "The software package SFS can estimate the selection coefficient for a set of SNPs.",
      "Haplotype-based methods involving haplotype data can identify regions that have undergone strong selection.",
      "Bayesian methods employ Bayesian inference to estimate the likelihood of a selective sweep in a genome region.",
      "The Genomic region enrichment of significant variants (GRESV) method combines GWAS and selective sweep analysis to identify genome regions enriched for variants associated with a particular trait."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The software package SFS refers to the site frequency spectrum and is typically used to analyze the allele frequency spectrum, not specifically to estimate selection coefficients. Packages like SweepFinder or similar could be used to analyze selection in the context of site frequency spectrum.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3606,
    "user_query": "What is Amyand hernia?",
    "yulan-chat-2-13b-fp16_response": "Amyand's hernia is a type of hernia that occurs when the intestine protrudes through a weakened area in the abdominal wall, creating a bulge or lump that can be seen or felt. It is named after the English surgeon, Sir Astley Paston Cooper Roper Amyand, who first described the condition in 1876.\nAmyand's hernia is relatively rare and can occur in both men and women, although it is more common in men. It typically occurs in the groin area, where the thigh meets the abdomen, and can be caused by a variety of factors, including straining during bowel movements, heavy lifting, and chronic constipation.\nSymptoms of Amyand's hernia may include a visible bulge in the groin area, pain or discomfort in the abdomen or groin, and difficulty having a bowel movement. Treatment for Amyand's hernia typically involves surgery to repair the weakened area in the abdominal wall and return the intestine to its proper position.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Amyand's hernia occurs when the intestine protrudes through a weakened area in the abdominal wall.\n2. The condition is named after English surgeon Sir Astley Paston Cooper Roper Amyand, who first described it in 1876.\n3. Amyand's hernia is more common in men than in women.\n4. It typically occurs in the groin area, where the thigh meets the abdomen.\n5. Treatment for Amyand's hernia generally involves surgical repair of the abdominal wall.",
    "yulan-chat-2-13b-fp16_fact": [
      "Amyand's hernia occurs when the intestine protrudes through a weakened area in the abdominal wall.",
      "The condition is named after English surgeon Sir Astley Paston Cooper Roper Amyand, who first described it in 1876.",
      "Amyand's hernia is more common in men than in women.",
      "It typically occurs in the groin area, where the thigh meets the abdomen.",
      "Treatment for Amyand's hernia generally involves surgical repair of the abdominal wall."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Amyand's hernia occurs when the appendix protrudes through a weakened area in the abdominal wall.\n2. FALSE [correction]: The condition is named after French surgeon Claudius Amyand, who first described it in 1735.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "yulan-chat-2-13b-fp16_response": "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), which is a chronic autoimmune disease that can affect multiple organs and systems in the body. The LSI is based on a point system that assigns scores to various symptoms and laboratory findings associated with SLE, such as skin rash, joint pain, and abnormalities in blood tests.\nThe LSI is calculated by assigning a score to each of the following categories:\n1. Skin: 0-4 points\n2. Joints: 0-4 points\n3. Mouth and nasal pharynx: 0-3 points\n4. Muscle: 0-3 points\n5. Blood: 0-8 points\n6. Kidney: 0-6 points\n7. Cardio-pulmonary: 0-4 points\n8. Neuropsychiatric: 0-6 points\nThe maximum possible score on the LSI is 64, with higher scores indicating more severe disease. The LSI is used to guide treatment decisions and to monitor disease activity over time. It is important to note that the LSI is just one tool used to assess disease activity in SLE, and it should not be used alone to make treatment decisions. A healthcare provider should consider other factors, such as the patient's overall health and response to treatment, when making decisions about SLE management.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).\n2. SLE is a chronic autoimmune disease that can affect multiple organs and systems in the body.\n3. The LSI uses a point system, with scores assigned to symptoms and lab findings associated with SLE.\n4. The maximum possible score on the LSI is 64 points.\n5. A higher score on the LSI indicates more severe disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).",
      "SLE is a chronic autoimmune disease that can affect multiple organs and systems in the body.",
      "The LSI uses a point system, with scores assigned to symptoms and lab findings associated with SLE.",
      "The maximum possible score on the LSI is 64 points.",
      "A higher score on the LSI indicates more severe disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE (assuming that the Lupus Severity Index, whether fictional or real, would logically operate in such a way where a higher score indicates more severe disease; however, without specific knowledge about the LSI's scoring system, this response remains speculative based on typical assessment tools)",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3610,
    "user_query": "Is g-H2AX a marker for double strand breaks?",
    "yulan-chat-2-13b-fp16_response": "Yes, g-H2AX is a marker for double-strand breaks (DSBs) in DNA.\nDouble-strand breaks occur when both strands of DNA are separated at the same point, resulting in a complex of single-stranded DNA that is difficult to repair. When a cell experiences a DSB, it activates a signaling pathway that leads to the recruitment of various repair proteins to the site of the break. One of the early markers of DSBs is the phosphorylation of histone H2AX at serine 139 (S139) on the DNA strand that is not broken, which forms a phospho-H2AX protein. This phosphorylation event serves as a marker for the location of the DSB, and it recruits various repair proteins to the site of the break to initiate the repair process.\nThe g-H2AX protein is a variant of histone H2AX that lacks the N-terminal tails, which makes it more accessible to phosphorylation at S139. The presence of g-H2AX at a DSB site indicates that the DNA is broken and needs to be repaired. Therefore, g-H2AX is a useful marker for detecting DSBs and monitoring their repair in various cellular processes, including DNA damage response, genome stability, and cell cycle progression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. g-H2AX is a marker for double-strand breaks in DNA.\n2. Double-strand breaks occur when both strands of DNA are separated at the same point.\n3. Phosphorylation of histone H2AX at serine 139 is an early marker of double-strand breaks.\n4. This phosphorylation recruits repair proteins to initiate the repair process at the site of the break.\n5. The g-H2AX protein is a variant of histone H2AX that is more accessible to phosphorylation at serine 139.",
    "yulan-chat-2-13b-fp16_fact": [
      "g-H2AX is a marker for double-strand breaks in DNA.",
      "Double-strand breaks occur when both strands of DNA are separated at the same point.",
      "Phosphorylation of histone H2AX at serine 139 is an early marker of double-strand breaks.",
      "This phosphorylation recruits repair proteins to initiate the repair process at the site of the break.",
      "The g-H2AX protein is a variant of histone H2AX that is more accessible to phosphorylation at serine 139."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The \"g\" in g-H2AX refers to the gamma phosphorylation of histone H2AX at serine 139, not a variant of the protein itself.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3611,
    "user_query": "Which algorithm has been developed for finding conserved non-coding elements (CNEs)?",
    "yulan-chat-2-13b-fp16_response": "There are several algorithms that have been developed for finding conserved non-coding elements (CNEs). Some of the commonly used algorithms are:\n1. MEME Suite: It is a popular tool for discovering and analyzing protein and DNA sequence motifs. It includes several algorithms for discovering CNEs, such as MEME, MotifFinder, and MOTIF.\n2. Gibbs Sampling: It is a probabilistic algorithm that can be used to detect conserved non-coding elements in DNA sequences. It is based on the assumption that conserved non-coding elements are more likely to occur at certain positions in the DNA sequence.\n3. Markov Model: It is a statistical model that can be used to detect conserved non-coding elements in DNA sequences. It is based on the assumption that conserved non-coding elements have a certain pattern of nucleotides that is different from the rest of the sequence.\n4. Pattern Recognition: It is a machine learning algorithm that can be used to detect conserved non-coding elements in DNA sequences. It is based on the assumption that conserved non-coding elements have a certain pattern that can be recognized by a machine learning algorithm.\nThese algorithms can be used to detect conserved non-coding elements in DNA sequences, and they have been used in various studies to identify functional non-coding elements in the genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The MEME Suite is a tool used for discovering and analyzing protein and DNA sequence motifs and includes algorithms like MEME, MotifFinder, and MOTIF for finding CNEs.\n2. Gibbs Sampling is a probabilistic algorithm intended for detecting conserved non-coding elements in DNA sequences.\n3. A Markov Model is a statistical model that can detect conserved non-coding elements in DNA sequences.\n4. Pattern Recognition is a machine learning algorithm utilized to detect conserved non-coding elements in DNA sequences.\n5. These mentioned algorithms have been employed in various studies for the identification of functional non-coding elements in genomes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The MEME Suite is a tool used for discovering and analyzing protein and DNA sequence motifs and includes algorithms like MEME, MotifFinder, and MOTIF for finding CNEs.",
      "Gibbs Sampling is a probabilistic algorithm intended for detecting conserved non-coding elements in DNA sequences.",
      "A Markov Model is a statistical model that can detect conserved non-coding elements in DNA sequences.",
      "Pattern Recognition is a machine learning algorithm utilized to detect conserved non-coding elements in DNA sequences.",
      "These mentioned algorithms have been employed in various studies for the identification of functional non-coding elements in genomes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The MEME Suite is a tool used for discovering and analyzing protein and DNA sequence motifs but does not include an algorithm specifically named MotifFinder or MOTIF for finding CNEs. It includes algorithms like MEME, MAST, and Tomtom, among others.\n2. FALSE [correction]: Gibbs Sampling is a probabilistic algorithm intended for motif detection in sequences, which could include but is not exclusive to conserved non-coding elements (CNEs).\n3. TRUE: A Markov Model is a statistical model that can be used to detect conserved non-coding elements in DNA sequences among its various applications.\n4. TRUE: Pattern Recognition encompasses a wide range of machine learning algorithms that can indeed be utilized to detect conserved non-coding elements in DNA sequences.\n5. TRUE: Algorithms like those mentioned are employed in various studies for the identification of functional non-coding elements in genomes.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3612,
    "user_query": "What type of antagonist is istradefylline?",
    "yulan-chat-2-13b-fp16_response": "Istradefylline is a non-selective alpha-2 adrenergic receptor antagonist. It is a pharmaceutical drug that is used to treat various conditions, including hypertension, tachycardia, and anxiety. It works by blocking the action of the alpha-2 adrenergic receptors, which are found in the brain and other parts of the body. This leads to an increase in the activity of the sympathetic nervous system, which can cause an increase in heart rate and blood pressure. Istradefylline is a non-selective alpha-2 adrenergic receptor antagonist, meaning that it blocks the action of all three subtypes of alpha-2 adrenergic receptors.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "yulan-chat-2-13b-fp16_response": "De novo mutations in ZSWIM6 have been associated with several disorders, including:\n1. Intellectual disability: Several studies have reported de novo mutations in ZSWIM6 in individuals with intellectual disability of unknown cause.\n2. Congenital heart disease: A de novo mutation in ZSWIM6 has been linked to a case of congenital heart disease characterized by pulmonary valve stenosis, atrial septal defect, and patent ductus arteriosus.\n3. Developmental delay: A de novo mutation in ZSWIM6 has been associated with developmental delay and speech impairment in a child.\n4. Dilated cardiomyopathy: A de novo mutation in ZSWIM6 has been linked to a case of dilated cardiomyopathy in a child.\nIt is important to note that the full spectrum of disorders caused by de novo mutations in ZSWIM6 is not yet fully understood, and more research is needed to identify additional clinical phenotypes associated with this gene.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. De novo mutations in ZSWIM6 have been associated with intellectual disability.\n2. A case of congenital heart disease has been linked to a de novo mutation in ZSWIM6.\n3. A de novo mutation in ZSWIM6 has been linked to developmental delay and speech impairment in a child.\n4. A case of dilated cardiomyopathy in a child has been associated with a de novo mutation in ZSWIM6.",
    "yulan-chat-2-13b-fp16_fact": [
      "De novo mutations in ZSWIM6 have been associated with intellectual disability.",
      "A case of congenital heart disease has been linked to a de novo mutation in ZSWIM6.",
      "A de novo mutation in ZSWIM6 has been linked to developmental delay and speech impairment in a child.",
      "A case of dilated cardiomyopathy in a child has been associated with a de novo mutation in ZSWIM6."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n\nGiven that ZSWIM6 has been associated with intellectual disability and developmental issues, it is plausible that heart conditions could also be associated, but without specific references or evidence regarding congenital heart disease or dilated cardiomyopathy, the truthfulness of statements 2 and 4 cannot be confirmed.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3625,
    "user_query": "Which disease category is LB-100 mostly assessed for?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information about a specific disease category that LB-100 is assessed for. Can you provide more context or information about LB-100?",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "yulan-chat-2-13b-fp16_response": "The Koos Classification is a system used to classify musculoskeletal injuries. It is not used to classify diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "yulan-chat-2-13b-fp16_response": "AZD8601 is an investigational drug being developed for the treatment of various diseases, including cancer and autoimmune disorders. As of my knowledge cutoff date of September 2021, clinical trials evaluating the safety and efficacy of AZD8601 in humans were ongoing, and there were limited in vivo effects of AZD8601 available.\nHowever, preclinical studies have shown that AZD8601 has potential anti-tumor effects in various cancer models, including breast, ovarian, and lung cancer. It works by inhibiting the activity of a protein called CD73, which is involved in the production of adenosine, a molecule that can suppress the immune response and promote tumor growth. By inhibiting CD73, AZD8601 may help to enhance the immune response against tumors and slow or stop their growth.\nIn addition to its potential anti-tumor effects, AZD8601 has also been studied for its potential to treat autoimmune disorders. Preclinical studies have suggested that it may have immunosuppressive effects, which could be beneficial in treating certain autoimmune diseases.\nOverall, while the in vivo effects of AZD8601 are still being studied and its full potential is not yet fully understood, early research suggests that it may have potential as a treatment for various diseases, particularly cancer and autoimmune disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. AZD8601 is an investigational drug being developed for the treatment of diseases such as cancer and autoimmune disorders.\n2. Clinical trials evaluating the safety and efficacy of AZD8601 in humans were ongoing as of September 2021.\n3. Preclinical studies have indicated that AZD8601 may have anti-tumor effects in various cancer models.\n4. AZD8601 works by inhibiting the activity of CD73 protein, which is involved in adenosine production.\n5. AZD8601 has been studied for potential immunosuppressive effects that could treat autoimmune diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "AZD8601 is an investigational drug being developed for the treatment of diseases such as cancer and autoimmune disorders.",
      "Clinical trials evaluating the safety and efficacy of AZD8601 in humans were ongoing as of September 2021.",
      "Preclinical studies have indicated that AZD8601 may have anti-tumor effects in various cancer models.",
      "AZD8601 works by inhibiting the activity of CD73 protein, which is involved in adenosine production.",
      "AZD8601 has been studied for potential immunosuppressive effects that could treat autoimmune diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: AZD8601 is an investigational drug being developed for the treatment of heart disease, specifically designed to encode for a protein involved in restoring blood flow in damaged tissues rather than for cancer or autoimmune disorders.\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: AZD8601 works by delivering the mRNA for VEGF-A, which is a protein that stimulates blood vessel growth, rather than inhibiting the activity of CD73 protein.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3630,
    "user_query": "Which characteristics are used in the SLEDAI index for SLE patients?",
    "yulan-chat-2-13b-fp16_response": "The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) is a tool used to assess disease activity in patients with systemic lupus erythematosus (SLE). It includes the following characteristics:\n1. Anti-DNA antibodies\n2. Antiphlogistic antibodies\n3. Cutaneous lupus erythematosus\n4. Oral ulcers\n5. Malar rash\n6. Photosensitivity\n7. Arthritis\n8. Pleural or pericardial effusion\n9. Renal involvement\n10. Neuropsychiatric involvement\n11. Hemolytic anemia\n12. Leukopenia\n13. Thrombocytopenia\n14. Lymphopenia\n15. Elevated erythrocyte sedimentation rate (ESR)\n16. Elevated C-reactive protein (CRP)\nEach characteristic is assigned a score from 0 to 4, with 0 being no involvement and 4 being severe involvement. The total SLEDAI score ranges from 0 to 64, with higher scores indicating more severe disease activity.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) is used to assess disease activity in patients with systemic lupus erythematosus (SLE).\n2. The SLEDAI index includes the characteristic of anti-DNA antibodies.\n3. The SLEDAI index considers the presence of oral ulcers as one of the characteristics.\n4. Renal involvement is a characteristic used in the SLEDAI index for assessing SLE patients.\n5. The total SLEDAI score can range from 0 to 64, with higher scores indicating more severe disease activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) is used to assess disease activity in patients with systemic lupus erythematosus (SLE).",
      "The SLEDAI index includes the characteristic of anti-DNA antibodies.",
      "The SLEDAI index considers the presence of oral ulcers as one of the characteristics.",
      "Renal involvement is a characteristic used in the SLEDAI index for assessing SLE patients.",
      "The total SLEDAI score can range from 0 to 64, with higher scores indicating more severe disease activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The total SLEDAI score can range from 0 to 105, with higher scores indicating more severe disease activity.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3632,
    "user_query": "Describe the mechanism of action of Luspatercept.",
    "yulan-chat-2-13b-fp16_response": "Luspatercept is a medication that is used to treat anemia in patients with beta-thalassemia and myelodysplastic syndromes. It works by binding to a protein called activin, which is involved in the regulation of blood cell production. By binding to activin, luspatercept helps to stimulate the production of red blood cells, leading to an increase in the number of red blood cells in the bloodstream. This helps to alleviate the symptoms of anemia, such as fatigue and shortness of breath. Luspatercept is given by injection under the skin and is typically used in combination with other treatments for anemia.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Luspatercept is used to treat anemia in patients with beta-thalassemia.\n2. Luspatercept is also used to treat anemia in patients with myelodysplastic syndromes.\n3. It works by binding to activin, a protein that regulates blood cell production.\n4. Luspatercept stimulates the production of red blood cells.\n5. It is administered by injection under the skin.",
    "yulan-chat-2-13b-fp16_fact": [
      "Luspatercept is used to treat anemia in patients with beta-thalassemia.",
      "Luspatercept is also used to treat anemia in patients with myelodysplastic syndromes.",
      "It works by binding to activin, a protein that regulates blood cell production.",
      "Luspatercept stimulates the production of red blood cells.",
      "It is administered by injection under the skin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Luspatercept works by binding to select proteins, such as activin and growth differentiation factor (GDF) ligands, which are involved in the late stages of red blood cell production. \n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3633,
    "user_query": "Which method has been developed for mapping of Transcription Start Sites (TSS) starting from nanograms of RNA?",
    "yulan-chat-2-13b-fp16_response": "There are several methods that have been developed for mapping Transcription Start Sites (TSS) starting from nanograms of RNA. One such method is called \"RNA sequencing\" or \"RNA-seq\". RNA-seq is a high-throughput sequencing technology that allows for the quantification and identification of RNA transcripts in a sample. It can be used to identify TSS by mapping RNA-seq reads to a reference genome and identifying the location of the reads that align to the TSS. Other methods include \"RACE\" (Rapid Amplification of cDNA Ends) and \"TRAQ\" (Targeted RNA Quantification).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNA sequencing, or RNA-seq, is a method used for mapping Transcription Start Sites (TSS) starting from nanograms of RNA.\n2. RNA-seq is a high-throughput sequencing technology that quantifies and identifies RNA transcripts in a sample.\n3. RNA-seq can be used to identify TSS by mapping RNA-seq reads to a reference genome.\n4. The Rapid Amplification of cDNA Ends (RACE) is another method for mapping TSS.\n5. Targeted RNA Quantification (TRAQ) is a method developed for mapping TSS.",
    "yulan-chat-2-13b-fp16_fact": [
      "RNA sequencing, or RNA-seq, is a method used for mapping Transcription Start Sites (TSS) starting from nanograms of RNA.",
      "RNA-seq is a high-throughput sequencing technology that quantifies and identifies RNA transcripts in a sample.",
      "RNA-seq can be used to identify TSS by mapping RNA-seq reads to a reference genome.",
      "The Rapid Amplification of cDNA Ends (RACE) is another method for mapping TSS.",
      "Targeted RNA Quantification (TRAQ) is a method developed for mapping TSS."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: RNA sequencing, or RNA-seq, is not primarily used for mapping Transcription Start Sites (TSS); it is mainly used to identify and quantify RNA transcripts.\n2. TRUE\n3. FALSE [correction]: While RNA-seq can be used to give insights into transcriptional activity, it is not typically used for identifying TSS positions. For precise mapping of TSS, other techniques such as CAGE (Cap Analysis Gene Expression) would be more appropriate.\n4. TRUE - The Rapid Amplification of cDNA Ends (RACE) is a technique used to map RNA ends, including transcription start sites (TSS) and polyadenylation sites.\n5. FALSE [correction]: There is no widely recognized method known as Targeted RNA Quantification (TRAQ) developed specifically for mapping TSS. It may be a confusion with targeted RNA sequencing, which quantifies the abundance of RNA, or it could be fictitious or not widely accepted in the scientific community.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3637,
    "user_query": "Which mRNAs are sequestered in stress granules?",
    "yulan-chat-2-13b-fp16_response": "Stress granules are membraneless organelles that form in the cytoplasm of cells in response to various types of stress, such as exposure to high temperatures, oxidative stress, or viral infections. Stress granules are dynamic structures that can change in composition and location within the cell, and they play a role in the regulation of gene expression and cellular stress responses.\nThe mRNAs that are sequestered in stress granules can vary depending on the type of stress that is present and the specific cellular responses that are triggered. However, some general characteristics of the mRNAs that are typically found in stress granules include:\n1. mRNAs that encode for proteins involved in stress response pathways, such as chaperones, proteases, and other stress-inducible proteins.\n2. mRNAs that are involved in translation, such as ribosomal proteins and eIFs (eukaryotic initiation factors).\n3. mRNAs that are involved in autophagy, a process by which cells degrade and recycle their own components.\n4. mRNAs that are involved in the ubiquitin-proteasome pathway, a process by which cells degrade and recycle proteins.\n5. mRNAs that are involved in the unfolded protein response (UPR), a pathway that helps cells cope with the accumulation of misfolded proteins in the endoplasmic reticulum (ER).\nOverall, the mRNAs that are sequestered in stress granules are those that are involved in the cellular responses to stress, including those that help the cell to cope with stress and those that help the cell to degrade and recycle proteins that may be damaged or misfolded.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Stress granules form in the cytoplasm of cells in response to various types of stress.\n2. The composition of stress granules can change depending on the type of stress present.\n3. mRNAs that encode proteins involved in stress response pathways are typically found in stress granules.\n4. mRNAs involved in autophagy are sequestered in stress granules.\n5. mRNAs involved in the unfolded protein response (UPR) are sequestered in stress granules.",
    "yulan-chat-2-13b-fp16_fact": [
      "Stress granules form in the cytoplasm of cells in response to various types of stress.",
      "The composition of stress granules can change depending on the type of stress present.",
      "mRNAs that encode proteins involved in stress response pathways are typically found in stress granules.",
      "mRNAs involved in autophagy are sequestered in stress granules.",
      "mRNAs involved in the unfolded protein response (UPR) are sequestered in stress granules."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE \n4. TRUE \n5. TRUE \n\nStress granules are indeed dynamic cellular structures that form in response to stress and can sequester various mRNAs, including those involved in autophagy and the unfolded protein response, to regulate their translation. The composition of these granules can vary depending on the type of stress the cell is experiencing.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3638,
    "user_query": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?",
    "yulan-chat-2-13b-fp16_response": "PD-L1 (Programmed Death-Ligand 1) is a protein that is expressed on the surface of some cells and can interact with the PD-1 protein on T cells to inhibit their activity. PD-L1 expression has been used as a biomarker in immunotherapy to predict which patients are likely to respond to treatment with drugs that block the PD-1/PD-L1 pathway. However, there are several problems associated with the use of PD-L1 as a biomarker:\n1. Variability in PD-L1 expression: PD-L1 expression can vary widely between different individuals and even within the same individual over time. This makes it difficult to use PD-L1 expression as a reliable predictor of treatment response.\n2. Lack of standardization: There is currently no standardized method for measuring PD-L1 expression, which can lead to inconsistencies in the results obtained from different laboratories and different assays.\n3. False-positive and false-negative results: PD-L1 expression can be induced by various factors, such as infection or inflammation, which can lead to false-positive results. In addition, some cancer cells may express low levels of PD-L1, which can lead to false-negative results.\n4. Limited clinical utility: While PD-L1 expression has been shown to be associated with treatment response in some types of cancer, its clinical utility is limited in other types of cancer. For example, PD-L1 expression has not been shown to be a reliable predictor of treatment response in breast cancer.\n5. Cost: Measuring PD-L1 expression can be expensive, which may limit its use in some settings.\nOverall, while PD-L1 expression is an important biomarker in immunotherapy, it is not a perfect predictor of treatment response and should be used in conjunction with other factors, such as tumor mutation burden and patient clinical characteristics, to inform treatment decisions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PD-L1 expression can vary widely between individuals and within the same individual over time.\n2. There is currently no standardized method for measuring PD-L1 expression.\n3. PD-L1 expression can lead to false-positive and false-negative results due to various factors like infection or inflammation and low levels of PD-L1 expression in some cancer cells.\n4. PD-L1 expression has not been shown to be a reliable predictor of treatment response in breast cancer.\n5. Measuring PD-L1 expression can be expensive.",
    "yulan-chat-2-13b-fp16_fact": [
      "PD-L1 expression can vary widely between individuals and within the same individual over time.",
      "There is currently no standardized method for measuring PD-L1 expression.",
      "PD-L1 expression can lead to false-positive and false-negative results due to various factors like infection or inflammation and low levels of PD-L1 expression in some cancer cells.",
      "PD-L1 expression has not been shown to be a reliable predictor of treatment response in breast cancer.",
      "Measuring PD-L1 expression can be expensive."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: PD-L1 expression has been shown to be a potentially reliable predictor of treatment response in certain types of breast cancer, particularly in the context of therapies that target the PD-1/PD-L1 pathway.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3639,
    "user_query": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?",
    "yulan-chat-2-13b-fp16_response": "Poliosis circumscripta is a medical condition characterized by a white or unpigmented patch of hair or skin that is usually less than 1 cm in diameter. It is caused by a disorder of the hair follicles or skin pigment cells, and it is often associated with other medical conditions such as alopecia areata (a condition that causes patchy hair loss) or vitiligo (a condition that causes loss of skin pigmentation).\nPoliosis circumscripta is not another term for a white or unpigmented patch of hair or skin, but it is a specific medical term that refers to a specific condition that causes such patches.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Poliosis circumscripta is a medical condition characterized by a white or unpigmented patch of hair or skin.\n2. The affected patch in poliosis circumscripta is usually less than 1 cm in diameter.\n3. The condition is caused by a disorder of the hair follicles or skin pigment cells.\n4. Poliosis circumscripta is often associated with alopecia areata, which causes patchy hair loss.\n5. Poliosis circumscripta is often associated with vitiligo, which causes loss of skin pigmentation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Poliosis circumscripta is a medical condition characterized by a white or unpigmented patch of hair or skin.",
      "The affected patch in poliosis circumscripta is usually less than 1 cm in diameter.",
      "The condition is caused by a disorder of the hair follicles or skin pigment cells.",
      "Poliosis circumscripta is often associated with alopecia areata, which causes patchy hair loss.",
      "Poliosis circumscripta is often associated with vitiligo, which causes loss of skin pigmentation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The size of the affected patch in poliosis circumscripta can vary and is not necessarily less than 1 cm in diameter.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "yulan-chat-2-13b-fp16_response": "SAHFS, or Sentence-Final-Word-Frequency-Spectra, are created by analyzing a large corpus of text, such as a book or a collection of articles. The process involves counting the frequency of each word that appears at the end of a sentence in the text. The resulting data is then plotted on a graph, with the x-axis representing the frequency of the word and the y-axis representing the number of sentences in which the word appears. The resulting graph can provide insights into the most common words used to end sentences in the text, and can be used to analyze the writing style and tone of the author.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SAHFS stands for Sentence-Final-Word-Frequency-Spectra.\n2. They are created by analyzing a large corpus of text.\n3. The creation process counts the frequency of each word appearing at the end of sentences.\n4. The frequencies are plotted on a graph with the x-axis representing the frequency and the y-axis representing the number of sentences.\n5. SAHFS can be used to analyze an author's writing style and tone.",
    "yulan-chat-2-13b-fp16_fact": [
      "SAHFS stands for Sentence-Final-Word-Frequency-Spectra.",
      "They are created by analyzing a large corpus of text.",
      "The creation process counts the frequency of each word appearing at the end of sentences.",
      "The frequencies are plotted on a graph with the x-axis representing the frequency and the y-axis representing the number of sentences.",
      "SAHFS can be used to analyze an author's writing style and tone."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: SAHFS does not stand for Sentence-Final-Word-Frequency-Spectra. (The acronym's meaning cannot be corrected without the correct context)\n2. TRUE (assuming SAHFS refers to some kind of frequency analysis associated with corpora)\n3. TRUE (assuming the explanation of SAHFS is related to sentence-final words)\n4. UNKNOWN (the axes of the graph typically represent different variables, and without specific context, it's unclear what exactly SAHFS plots)\n5. TRUE (assuming that SAHFS relates to a linguistic analysis tool that could be used for such purposes)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3641,
    "user_query": "What is another name for AZD0530?",
    "yulan-chat-2-13b-fp16_response": "AZD0530 is also known as SAR245413.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. AZD0530 is also known by the name SAR245413.",
    "yulan-chat-2-13b-fp16_fact": [
      "AZD0530 is also known by the name SAR245413."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown"
    ]
  },
  {
    "id": 3647,
    "user_query": "What is the Match BAM to VCF method?",
    "yulan-chat-2-13b-fp16_response": "The Match BAM to VCF method is a bioinformatics tool used to map DNA sequences from a BAM file (a binary file format used to store high-throughput sequencing data) to a reference genome in a VCF (Variant Call Format) file. The VCF file contains information about genetic variations, such as single nucleotide polymorphisms (SNPs) and small insertions or deletions (indels), in the reference genome.\nThe Match BAM to VCF method works by aligning the reads in the BAM file to the reference genome and then comparing the aligned reads to the variants in the VCF file. The method identifies which reads support each variant in the VCF file and generates a new VCF file that includes information about which reads support each variant.\nThis method is useful for a variety of applications, such as identifying variants that are supported by reads in the BAM file, quantifying the frequency of variants in the sample, and identifying potential novel variants that were not present in the reference genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Match BAM to VCF method maps DNA sequences from a BAM file to a reference genome in a VCF file.\n2. A BAM file is a binary file format used to store high-throughput sequencing data.\n3. A VCF file contains information about genetic variations like single nucleotide polymorphisms and small insertions or deletions.\n4. The method identifies reads in the BAM file that support each variant in the VCF file.\n5. The Match BAM to VCF method is used to identify and quantify the frequency of genetic variants as well as identify potential novel variants.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Match BAM to VCF method maps DNA sequences from a BAM file to a reference genome in a VCF file.",
      "A BAM file is a binary file format used to store high-throughput sequencing data.",
      "A VCF file contains information about genetic variations like single nucleotide polymorphisms and small insertions or deletions.",
      "The method identifies reads in the BAM file that support each variant in the VCF file.",
      "The Match BAM to VCF method is used to identify and quantify the frequency of genetic variants as well as identify potential novel variants."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Match BAM to VCF method does not map DNA sequences from a BAM file to a reference genome in a VCF file. Instead, it would typically involve comparing existing variant calls in a VCF file with the sequence data in a BAM file to confirm the presence of the variants.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While the method can be used to confirm the presence and potentially quantify the frequency of genetic variants listed in a VCF file against sequence data in a BAM file, it does not typically identify potential novel variants. Novel variant discovery would generally require a separate process of variant calling using the sequence data itself.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3649,
    "user_query": "Is SATB1 expressed in thymocytes?",
    "yulan-chat-2-13b-fp16_response": "SATB1 (Spermatogenesis and testicular cancer associated transcript 1) is a transcription factor that plays a role in regulating gene expression in various cell types, including germ cells and various types of immune cells. However, I could not find specific information on whether SATB1 is expressed in thymocytes.\nThymocytes are a type of immune cell that develops and matures in the thymus gland. They are precursors to T cells, which play a critical role in the immune system. While SATB1 has been shown to be expressed in various immune cells, including T cells, its expression in thymocytes has not been well-studied.\nTherefore, I cannot confirm whether SATB1 is expressed in thymocytes or not. Further research would be needed to determine the expression of SATB1 in this cell type.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3652,
    "user_query": "Describe Twiddler Syndrome.",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I am not familiar with the term \"Twiddler Syndrome.\" It is possible that you may have misspelled the term or that it is a relatively new or uncommon condition. If you have any additional information or context about this term, I may be able to provide more helpful information.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3653,
    "user_query": "What are Drosophila's balancer chromosomes?",
    "yulan-chat-2-13b-fp16_response": "Drosophila melanogaster, the fruit fly, is a common model organism in genetics research. The female fruit fly has a unique type of sex chromosome called the \"balancer chromosome\" or \"B\" chromosome. These chromosomes are not homologous to the standard \"X\" and \"Y\" sex chromosomes found in humans and other mammals. Instead, they are a distinct type of chromosome that is present only in female fruit flies.\nThe balancer chromosomes in Drosophila are composed of two sister chromatids that are held together by a centromere, just like regular chromosomes. However, they lack the typical gene-carrying regions found on autosomal chromosomes or sex chromosomes. Instead, they contain a large array of transposable elements, which are DNA sequences that can move from one location in the genome to another. These transposable elements can disrupt the normal function of genes and cause genetic mutations.\nThe presence of balancer chromosomes in female fruit flies is thought to have evolved as a way to increase genetic diversity. Because they lack functional genes, the balancer chromosomes can act as a source of novel genetic material when they recombine with other chromosomes during meiosis. This can lead to the creation of new genetic combinations that may confer a selective advantage in certain environments.\nOverall, the balancer chromosomes of Drosophila are an interesting and unique feature of this model organism's genetics, and they continue to be studied by scientists to better understand the mechanisms of genetic diversity and evolution.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Drosophila melanogaster, commonly known as the fruit fly, is a model organism used in genetics research.\n2. The balancer chromosome, also known as the \"B\" chromosome, is a type of sex chromosome present in female fruit flies.\n3. The balancer chromosomes are not homologous to the standard \"X\" and \"Y\" sex chromosomes found in humans and other mammals.\n4. Balancer chromosomes in Drosophila are composed of sister chromatids and have a centromere.\n5. Balancer chromosomes contain transposable elements which can move within the genome and have the potential to cause genetic mutations.",
    "yulan-chat-2-13b-fp16_fact": [
      "Drosophila melanogaster, commonly known as the fruit fly, is a model organism used in genetics research.",
      "The balancer chromosome, also known as the \"B\" chromosome, is a type of sex chromosome present in female fruit flies.",
      "The balancer chromosomes are not homologous to the standard \"X\" and \"Y\" sex chromosomes found in humans and other mammals.",
      "Balancer chromosomes in Drosophila are composed of sister chromatids and have a centromere.",
      "Balancer chromosomes contain transposable elements which can move within the genome and have the potential to cause genetic mutations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: A balancer chromosome is not a type of sex chromosome but rather a modified chromosome used in genetic research to prevent crossing over and maintain specific gene combinations during breeding.\n3. TRUE\n4. FALSE [correction]: While it is true that all chromosomes are composed of sister chromatids and have a centromere, this statement is misleading because it presents balancer chromosomes as if they are unique in having these features. All chromosomes have these basic structural features, not just balancer chromosomes.\n5. TRUE (with caution) - Transposable elements are indeed present in many genomes, including Drosophila, and can cause genetic mutations. However, this statement could be misleading if it's suggesting that balancer chromosomes are defined by the presence of transposable elements, which they are not. Balancer chromosomes are characterized by their ability to suppress recombination and maintain genetic combinations rather than by the presence of transposable elements specifically.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3654,
    "user_query": "What is iodine thyroid blocking?",
    "yulan-chat-2-13b-fp16_response": "Iodine thyroid blocking is a condition that occurs when there is an excessive amount of iodine in the thyroid gland, leading to a decrease in the production of thyroid hormones. This can cause symptoms such as fatigue, weight gain, and an enlarged thyroid gland. The condition is usually treated by reducing the intake of iodine or by using medications to block the effects of excess iodine in the thyroid gland.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Iodine thyroid blocking occurs when the thyroid gland has an excessive amount of iodine.\n2. An excessive amount of iodine in the thyroid gland can lead to a decrease in the production of thyroid hormones.\n3. Symptoms of iodine thyroid blocking may include fatigue, weight gain, and an enlarged thyroid gland.\n4. Treatment for iodine thyroid blocking typically involves reducing the intake of iodine.\n5. Medications may be used to block the effects of excess iodine in the thyroid gland as part of the treatment.",
    "yulan-chat-2-13b-fp16_fact": [
      "Iodine thyroid blocking occurs when the thyroid gland has an excessive amount of iodine.",
      "An excessive amount of iodine in the thyroid gland can lead to a decrease in the production of thyroid hormones.",
      "Symptoms of iodine thyroid blocking may include fatigue, weight gain, and an enlarged thyroid gland.",
      "Treatment for iodine thyroid blocking typically involves reducing the intake of iodine.",
      "Medications may be used to block the effects of excess iodine in the thyroid gland as part of the treatment."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Iodine thyroid blocking refers to the prevention of thyroid gland absorption of radioactive iodine by introducing a stable form of iodine. It does not occur because of an excessive amount of iodine but is a protective measure taken in case of exposure to radioactive iodine.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3658,
    "user_query": "What is the mechanism of action of rogaratinib?",
    "yulan-chat-2-13b-fp16_response": "Rogaratinib is an investigational small molecule inhibitor of the JAK enzymes, specifically JAK1 and JAK2. These enzymes play a role in signaling for a variety of cytokines and growth factors, including those involved in inflammation, hematopoiesis, and immune response. By inhibiting JAK enzymes, rogaratinib may reduce the production of pro-inflammatory cytokines and potentially have anti-inflammatory effects. It is being developed for the treatment of various inflammatory and autoimmune diseases, as well as some cancers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Rogaratinib is an investigational small molecule inhibitor.\n2. Rogaratinib specifically inhibits the JAK1 and JAK2 enzymes.\n3. JAK enzymes are involved in signaling for cytokines and growth factors that are important in inflammation, hematopoiesis, and immune response.\n4. Inhibition of JAK enzymes by rogaratinib may lead to reduced production of pro-inflammatory cytokines.\n5. Rogaratinib is being developed for the treatment of inflammatory and autoimmune diseases, as well as some cancers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Rogaratinib is an investigational small molecule inhibitor.",
      "Rogaratinib specifically inhibits the JAK1 and JAK2 enzymes.",
      "JAK enzymes are involved in signaling for cytokines and growth factors that are important in inflammation, hematopoiesis, and immune response.",
      "Inhibition of JAK enzymes by rogaratinib may lead to reduced production of pro-inflammatory cytokines.",
      "Rogaratinib is being developed for the treatment of inflammatory and autoimmune diseases, as well as some cancers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Rogaratinib is not reported to specifically inhibit JAK1 and JAK2 enzymes. It is actually designed to target fibroblast growth factor receptors (FGFRs).\n3. TRUE\n4. FALSE [correction]: As rogaratinib is designed to inhibit FGFRs and not JAK enzymes, its inhibition would not be directly related to the production of pro-inflammatory cytokines through JAK pathways, but rather through FGFR pathways.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3661,
    "user_query": "List diseases that are caused by the Meningococcus B?",
    "yulan-chat-2-13b-fp16_response": "Meningococcus B is a type of bacteria that can cause meningitis, an inflammation of the membranes surrounding the brain and spinal cord, and sepsis, a severe infection in the bloodstream. Meningococcal disease is uncommon, but it can be very serious and can be life-threatening. Symptoms of meningococcal disease can include a sudden onset of fever, vomiting, headache, and a stiff neck. In addition to these general symptoms, meningococcal disease caused by Meningococcus B can also cause a characteristic rash called the \"meningococcal diaper rash\" or \"neck bulge\" which is a red spot or area on the neck, chest, or groin.\nMeningococcal disease is highly infectious and can spread quickly among people who are in close contact with an infected person. It is important to seek medical attention immediately if you suspect that you or someone you know may have meningococcal disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Meningococcus B can cause meningitis.\n2. Meningococcus B can cause sepsis.\n3. Meningococcal disease caused by Meningococcus B can be life-threatening.\n4. Symptoms of meningococcal disease include fever, vomiting, headache, and stiff neck.\n5. Meningococcal disease is highly infectious and can spread rapidly among people in close contact.",
    "yulan-chat-2-13b-fp16_fact": [
      "Meningococcus B can cause meningitis.",
      "Meningococcus B can cause sepsis.",
      "Meningococcal disease caused by Meningococcus B can be life-threatening.",
      "Symptoms of meningococcal disease include fever, vomiting, headache, and stiff neck.",
      "Meningococcal disease is highly infectious and can spread rapidly among people in close contact."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3664,
    "user_query": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved",
    "yulan-chat-2-13b-fp16_response": "TBC1 domain family member 16 (TBC1D16) is a protein that plays a role in regulating the growth and division of cells. Mutations in the TBC1D16 gene have been linked to several types of cancer, including:\n1. Breast cancer\n2. Colorectal cancer\n3. Ovarian cancer\n4. Prostate cancer\n5. Pancreatic cancer\n6. Kidney cancer\n7. Liver cancer\n8. Endometrial cancer\n9. Brain tumors\nIt's important to note that TBC1D16 is involved in various cellular processes and its role in cancer may vary depending on the type of cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the TBC1D16 gene have been linked to breast cancer.\n2. Mutations in the TBC1D16 gene have been linked to colorectal cancer.\n3. Mutations in the TBC1D16 gene have been linked to ovarian cancer.\n4. Mutations in the TBC1D16 gene have been linked to prostate cancer.\n5. Mutations in the TBC1D16 gene have been linked to pancreatic cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the TBC1D16 gene have been linked to breast cancer.",
      "Mutations in the TBC1D16 gene have been linked to colorectal cancer.",
      "Mutations in the TBC1D16 gene have been linked to ovarian cancer.",
      "Mutations in the TBC1D16 gene have been linked to prostate cancer.",
      "Mutations in the TBC1D16 gene have been linked to pancreatic cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Mutations in the TBC1D16 gene have not been prominently linked to breast cancer. Research often focuses on other genes like BRCA1 and BRCA2 in relation to breast cancer.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nGiven the specific nature of these statements and the need for up-to-date and detailed scientific research to confirm or deny the links between the TBC1D16 gene and various types of cancer, a true or false determination would require access to the latest scientific literature. As of my last knowledge update in early 2023, I cannot confirm the relationships between TBC1D16 mutations and the specific cancers listed without current data. Genetic associations can be complex, and the understanding of such links can evolve with new research. Therefore, statements 2 through 5 are unknown without further context or information from recent studies.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3665,
    "user_query": "What does osanetant and talnetant have in common?",
    "yulan-chat-2-13b-fp16_response": "Osanetant and talnetant are both drugs that belong to a class of medications called alpha-2 agonists. These drugs work by binding to alpha-2 receptors in the brain and throughout the body, which can have a variety of effects, including:\n* Reducing anxiety and agitation\n* Lowering blood pressure\n* Slowing heart rate\n* Reducing symptoms of attention deficit hyperactivity disorder (ADHD)\n* Treating certain types of headaches\nOsanetant is used primarily as a general anesthetic, while talnetant is used to treat certain types of headaches, such as cluster headaches. Both drugs can cause side effects, such as nausea, dizziness, and sleepiness, and should only be used under the supervision of a qualified healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Osanetant and talnetant are both alpha-2 agonist drugs.\n2. These drugs work by binding to alpha-2 receptors in the brain and throughout the body.\n3. Osanetant is used primarily as a general anesthetic.\n4. Talnetant is used to treat certain types of headaches, such as cluster headaches.\n5. Both osanetant and talnetant can cause side effects including nausea, dizziness, and sleepiness.",
    "yulan-chat-2-13b-fp16_fact": [
      "Osanetant and talnetant are both alpha-2 agonist drugs.",
      "These drugs work by binding to alpha-2 receptors in the brain and throughout the body.",
      "Osanetant is used primarily as a general anesthetic.",
      "Talnetant is used to treat certain types of headaches, such as cluster headaches.",
      "Both osanetant and talnetant can cause side effects including nausea, dizziness, and sleepiness."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Osanetant and talnetant are not alpha-2 agonist drugs; they are neurokinin-3 (NK3) receptor antagonists.\n2. FALSE [correction]: Since Osanetant and talnetant are NK3 receptor antagonists, they work by binding to NK3 receptors, not alpha-2 receptors. \n3. FALSE [correction]: Osanetant is not used as a general anesthetic; it has been studied in the context of treating schizophrenia and other CNS disorders.\n4. FALSE [correction]: There is no evidence that talnetant is used to treat headaches; it has been researched for the treatment of schizophrenia but is not a recognized treatment for headaches.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3666,
    "user_query": "List SLC25A46-related pathologies",
    "yulan-chat-2-13b-fp16_response": "SLC25A46 is a gene that provides instructions for making a protein called mitochondrial ATP synthase complex assembly factor 6 (ATP5A). Mutations in the SLC25A46 gene have been associated with several pathologies, including:\n1. Mitochondrial myopathy: This is a group of muscle diseases that are caused by dysfunctional mitochondria. Mitochondria are organelles within cells that produce energy in the form of ATP. Mitochondrial myopathy can cause muscle weakness, wasting, and atrophy.\n2. Leigh syndrome: This is a rare neurological disorder that affects the brain and the nervous system. It is characterized by progressive neurological deterioration, seizures, and developmental delay.\n3. Mitochondrial encephalomyopathy: This is a group of conditions that affect the brain and muscles. It can cause a range of symptoms, including seizures, cognitive impairment, muscle weakness, and ataxia.\n4. Mitochondrial neuropathy: This is a group of conditions that affect the nerves. It can cause symptoms such as numbness, tingling, pain, and weakness in the affected areas.\nIt's important to note that not all mutations in the SLC25A46 gene necessarily lead to pathology, and the severity of the associated symptoms can vary widely.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the SLC25A46 gene have been associated with mitochondrial myopathy, a group of muscle diseases.\n2. Leigh syndrome, a rare neurological disorder affecting the brain and nervous system, is associated with mutations in the SLC25A46 gene.\n3. Mutations in the SLC25A46 gene can lead to mitochondrial encephalomyopathy, a condition affecting the brain and muscles.\n4. Mitochondrial neuropathy, affecting the nerves, can be associated with mutations in the SLC25A46 gene.\n5. Not all mutations in the SLC25A46 gene necessarily lead to pathology.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the SLC25A46 gene have been associated with mitochondrial myopathy, a group of muscle diseases.",
      "Leigh syndrome, a rare neurological disorder affecting the brain and nervous system, is associated with mutations in the SLC25A46 gene.",
      "Mutations in the SLC25A46 gene can lead to mitochondrial encephalomyopathy, a condition affecting the brain and muscles.",
      "Mitochondrial neuropathy, affecting the nerves, can be associated with mutations in the SLC25A46 gene.",
      "Not all mutations in the SLC25A46 gene necessarily lead to pathology."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Leigh syndrome is associated with mutations in various genes, typically involved in mitochondrial function, but SLC25A46 is not commonly cited as one of them.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "yulan-chat-2-13b-fp16_response": "The PDZ domain is a protein module that is found in many proteins, including SATB1. The PDZ domain is named after the three proteins it was first identified in: Postsynaptic Density protein, Drosophila Disc large, and Zinc finger Cys2/His2 domain. The PDZ domain is involved in protein-protein interactions and plays a role in the organization and regulation of cellular processes, such as synaptic transmission, cell adhesion, and signal transduction.\nIn SATB1, the PDZ domain is located at the C-terminus of the protein and is involved in protein-protein interactions with other proteins. Specifically, the PDZ domain of SATB1 interacts with the PDZ motifs of other proteins, such as synaptic proteins and scaffolding proteins, which are involved in the organization and regulation of synaptic function. The PDZ domain of SATB1 also interacts with the PDZ domain of the transcription factor Oct-1, which is involved in the regulation of gene expression.\nOverall, the PDZ domain of SATB1 plays an important role in the regulation of synaptic function and gene expression by facilitating protein-protein interactions with other proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The PDZ domain is a protein module that is found in SATB1.\n2. The PDZ domain is named after the three proteins it was first identified in: Postsynaptic Density protein, Drosophila Disc large, and Zinc finger Cys2/His2 domain.\n3. The PDZ domain is involved in protein-protein interactions and plays a role in various cellular processes, such as synaptic transmission, cell adhesion, and signal transduction.\n4. In SATB1, the PDZ domain is located at the C-terminus of the protein.\n5. The PDZ domain of SATB1 interacts with the PDZ motifs of other proteins and the PDZ domain of the transcription factor Oct-1.",
    "yulan-chat-2-13b-fp16_fact": [
      "The PDZ domain is a protein module that is found in SATB1.",
      "The PDZ domain is named after the three proteins it was first identified in: Postsynaptic Density protein, Drosophila Disc large, and Zinc finger Cys2/His2 domain.",
      "The PDZ domain is involved in protein-protein interactions and plays a role in various cellular processes, such as synaptic transmission, cell adhesion, and signal transduction.",
      "In SATB1, the PDZ domain is located at the C-terminus of the protein.",
      "The PDZ domain of SATB1 interacts with the PDZ motifs of other proteins and the PDZ domain of the transcription factor Oct-1."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The PDZ domain is a common protein interaction module, but there is no indication that SATB1 contains a PDZ domain. SATB1 is recognized for its unique DNA-binding properties associated with scaffold/matrix attachment regions.\n2. FALSE [correction]: The PDZ domain is named after the first letters of three proteins where it was discovered: Post synaptic density protein (PSD-95), Drosophila disc large tumor suppressor (Dlg), and Zonula occludens-1 protein (ZO-1), not Zinc finger Cys2/His2 domain.\n3. TRUE\n4. FALSE [correction]: Since SATB1 is not known to contain a PDZ domain, it cannot be said that the PDZ domain in SATB1 is located at the C-terminus of the protein.\n5. FALSE [correction]: Since SATB1 does not contain a PDZ domain, it does not interact with PDZ motifs of other proteins through a PDZ domain. Additionally, there is no direct evidence to suggest an interaction between the PDZ domain of SATB1 (which it doesn't contain) and the PDZ domain of the transcription factor Oct-1.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3675,
    "user_query": "Which are the databases for intrinsic protein disorders?",
    "yulan-chat-2-13b-fp16_response": "There are several databases that provide information on intrinsic protein disorders, which are also known as genetic disorders caused by mutations in proteins. Some of the most well-known databases include:\n1. OMIM (Online Mendelian Inheritance in Man): This database provides comprehensive information on genetic disorders, including those caused by intrinsic protein disorders. It includes information on the genes and proteins involved, clinical features, and family data.\n2. UniProt: UniProt is a comprehensive protein database that provides detailed information on protein sequences, structures, functions, and interactions. It includes information on intrinsic protein disorders, as well as mutations that affect protein function.\n3. COSMIC (Catalogue of Somatic Mutations in Cancer): This database provides information on somatic mutations that occur in proteins, including those that cause intrinsic protein disorders. It includes information on the genes and proteins affected, as well as their functional consequences.\n4. ClinVar: This database provides a comprehensive collection of clinical genetic variation data, including information on intrinsic protein disorders. It includes data from multiple sources, including clinical diagnostic laboratories, researchers, and public databases.\n5. BRENDA (Enzyme Similarity Tool): This database provides information on enzymes and their functions, including those involved in intrinsic protein disorders. It includes information on the structure and function of enzymes, as well as their roles in disease.\nThese databases can be useful resources for researchers and healthcare professionals who are interested in learning more about intrinsic protein disorders and their underlying genetic causes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. OMIM (Online Mendelian Inheritance in Man) is a database that provides information on genetic disorders, including those caused by intrinsic protein disorders.\n2. UniProt is a comprehensive protein database that contains information on protein sequences, structures, functions, and interactions, including intrinsic protein disorders.\n3. COSMIC (Catalogue of Somatic Mutations in Cancer) provides information on somatic mutations in proteins, which can include intrinsic protein disorders.\n4. ClinVar is a database that offers a collection of clinical genetic variation data, including details on intrinsic protein disorders.\n5. BRENDA (Enzyme Similarity Tool) is a database that provides information on enzymes and their functions, relevant to their roles in disease, including intrinsic protein disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "OMIM (Online Mendelian Inheritance in Man) is a database that provides information on genetic disorders, including those caused by intrinsic protein disorders.",
      "UniProt is a comprehensive protein database that contains information on protein sequences, structures, functions, and interactions, including intrinsic protein disorders.",
      "COSMIC (Catalogue of Somatic Mutations in Cancer) provides information on somatic mutations in proteins, which can include intrinsic protein disorders.",
      "ClinVar is a database that offers a collection of clinical genetic variation data, including details on intrinsic protein disorders.",
      "BRENDA (Enzyme Similarity Tool) is a database that provides information on enzymes and their functions, relevant to their roles in disease, including intrinsic protein disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE  While COSMIC focuses on somatic mutations in cancer, these can include mutations that lead to intrinsic protein disorders, especially if the disorder contributes to the cancer phenotype.\n4. TRUE\n5. FALSE [correction]: BRENDA is a comprehensive enzyme information system providing data on enzyme function, kinetics, and more, but it is not specifically focused on enzymes' roles in disease or intrinsic protein disorders. It does not have an \"Enzyme Similarity Tool\" which is a phrase that seems misplaced here. Also, while it may contain some information relevant to diseases, that is not its main purpose.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3676,
    "user_query": "List the 5 different human immunoglobulin heavy chains.",
    "yulan-chat-2-13b-fp16_response": "There are five different types of human immunoglobulin heavy chains:\n1. IgG (gamma)\n2. IgM (mu)\n3. IgA (alpha)\n4. IgD (delta)\n5. IgE (epsilon)",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The human immunoglobulin heavy chain IgG is denoted by gamma.\n2. The human immunoglobulin heavy chain IgM is denoted by mu.\n3. The human immunoglobulin heavy chain IgA is denoted by alpha.\n4. The human immunoglobulin heavy chain IgD is denoted by delta.\n5. The human immunoglobulin heavy chain IgE is denoted by epsilon.",
    "yulan-chat-2-13b-fp16_fact": [
      "The human immunoglobulin heavy chain IgG is denoted by gamma.",
      "The human immunoglobulin heavy chain IgM is denoted by mu.",
      "The human immunoglobulin heavy chain IgA is denoted by alpha.",
      "The human immunoglobulin heavy chain IgD is denoted by delta.",
      "The human immunoglobulin heavy chain IgE is denoted by epsilon."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "yulan-chat-2-13b-fp16_response": "BLISS (Bi-directional Laminar Lift-off and Separation Control) is a technique used in the design of aircraft wings to control the separation of airflow over the wing's surface. The technique is based on the principle of laminar flow control, which aims to maintain a smooth, laminar flow of air over the wing's surface to reduce drag and increase lift.\nThe BLISS technique involves the use of small, raised features called \"blisters\" on the wing's surface, which disrupt the airflow and promote the growth of turbulent eddies. These eddies help to maintain a laminar flow of air over the wing's surface, reducing the likelihood of separation and improving the wing's overall performance.\nThe BLISS technique is particularly useful in the design of high-speed aircraft, such as supersonic fighters and business jets, where the separation of airflow over the wing's surface can significantly reduce lift and increase drag, leading to decreased performance and increased fuel consumption. By controlling the separation of airflow, the BLISS technique can improve the wing's performance and reduce the overall fuel consumption of the aircraft.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The BLISS technique is used in the design of aircraft wings to control the separation of airflow over the wing's surface.\n2. BLISS stands for Bi-directional Laminar Lift-off and Separation Control.\n3. The technique is based on the principle of laminar flow control which aims to maintain a smooth, laminar air flow.\n4. The BLISS technique involves the use of small, raised features called \"blisters\" on the wing's surface.\n5. The technique is useful in the design of high-speed aircraft such as supersonic fighters and business jets.",
    "yulan-chat-2-13b-fp16_fact": [
      "The BLISS technique is used in the design of aircraft wings to control the separation of airflow over the wing's surface.",
      "BLISS stands for Bi-directional Laminar Lift-off and Separation Control.",
      "The technique is based on the principle of laminar flow control which aims to maintain a smooth, laminar air flow.",
      "The BLISS technique involves the use of small, raised features called \"blisters\" on the wing's surface.",
      "The technique is useful in the design of high-speed aircraft such as supersonic fighters and business jets."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The BLISS (Boundary Layer Ingestion in Subsonic and Supersonic flows) technique is not specifically used in the design of aircraft wings to control airflow separation; rather, it is a concept focused on improving the efficiency of aircraft propulsion systems by ingesting the low-energy boundary layer air into the engines.\n2. FALSE [correction]: BLISS stands for Boundary Layer Ingestion in Subsonic and Supersonic flows, not \"Bi-directional Laminar Lift-off and Separation Control.\"\n3. TRUE\n4. FALSE [correction]: The BLISS technique does not involve the use of small, raised features called \"blisters\" on the wing's surface. Instead, it refers to the concept of boundary layer ingestion into the engines, which may involve redesign of the engine and airframe integration to optimize the inlet flow.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "yulan-chat-2-13b-fp16_response": "NK3 receptor antagonists are substances that block the activity of the NK3 receptor, which is a type of receptor found in the brain and other tissues. Some examples of NK3 receptor antagonists include:\n1. Atropine: Atropine is a medication that is used to treat a variety of conditions, including certain types of bradycardia (a slow heart rate), certain types of glaucoma, and certain types of poisoning. It works by blocking the activity of the NK3 receptor, which can help to slow down the heart rate and reduce eye pressure.\n2. Scopolamine: Scopolamine is a medication that is used to prevent and treat nausea and vomiting caused by motion sickness, anesthesia, or chemotherapy. It works by blocking the activity of the NK3 receptor, which can help to reduce nausea and vomiting.\n3. Dexmedetomidine: Dexmedetomidine is a medication that is used to help reduce the side effects of sedation and anesthesia, such as agitation and delirium. It works by blocking the activity of the NK3 receptor, which can help to reduce these side effects.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS\n\nThe answer contains inaccuracies. Atropine, scopolamine, and dexmedetomidine are not classified as NK3 receptor antagonists, and hence the statements given are not factual.",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3682,
    "user_query": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?",
    "yulan-chat-2-13b-fp16_response": "Indinavir is not typically used to treat amyotrophic lateral sclerosis (ALS). Indinavir is an HIV protease inhibitor, which means it is used to treat HIV infection by blocking the protease enzyme that is necessary for the virus to replicate.\nThere is currently no cure for ALS, and treatment options are limited. Treatment for ALS typically focuses on managing symptoms and slowing the progression of the disease. This may include physical therapy, speech therapy, and medications to manage muscle spasticity, pain, and other symptoms.\nThere is ongoing research into potential treatments for ALS, including experimental therapies such as gene therapy, stem cell transplantation, and drug therapies targeting various aspects of the disease. However, more research is needed to determine the safety and effectiveness of these treatments.\nIf you or a loved one has been diagnosed with ALS, it is important to work with a healthcare provider to develop a treatment plan that is tailored to your individual needs and circumstances.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Indinavir is an HIV protease inhibitor used to treat HIV infection.\n2. Indinavir blocks the protease enzyme that is necessary for HIV to replicate.\n3. There is no current cure for amyotrophic lateral sclerosis (ALS).\n4. Treatment for ALS typically focuses on managing symptoms and slowing the progression of the disease.\n5. Research into potential treatments for ALS includes experimental therapies such as gene therapy, stem cell transplantation, and drug therapies.",
    "yulan-chat-2-13b-fp16_fact": [
      "Indinavir is an HIV protease inhibitor used to treat HIV infection.",
      "Indinavir blocks the protease enzyme that is necessary for HIV to replicate.",
      "There is no current cure for amyotrophic lateral sclerosis (ALS).",
      "Treatment for ALS typically focuses on managing symptoms and slowing the progression of the disease.",
      "Research into potential treatments for ALS includes experimental therapies such as gene therapy, stem cell transplantation, and drug therapies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3685,
    "user_query": "What is ORMD-0801?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have any information on ORMD-0801. It is possible that ORMD-0801 is a proprietary name for a chemical or pharmaceutical compound that has not been widely disclosed or discussed in public forums. If you have any additional information or context about ORMD-0801, please provide it and I'll do my best to help you.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3686,
    "user_query": "Does saracatinib promote oncogenesis?",
    "yulan-chat-2-13b-fp16_response": "Saracatinib is a small molecule inhibitor of the tyrosine kinase activity of c-Met, a receptor tyrosine kinase that is involved in promoting cell proliferation, survival, and migration. While saracatinib has shown promise in preclinical studies as a potential therapeutic agent for cancer, there is limited clinical data available to assess its safety and efficacy.\nIn vitro studies have shown that saracatinib can inhibit the growth and migration of cancer cells, and it has been shown to induce cell cycle arrest and apoptosis in some cancer cell lines. However, there is also evidence to suggest that saracatinib may promote oncogenesis in certain contexts.\nFor example, a study published in the journal Cancer Research in 2018 found that saracatinib can promote the formation of lung tumors in mice when given at high doses. The study also suggested that saracatinib may promote the development of resistance to other cancer therapies by enhancing the activity of certain signaling pathways that are involved in cancer progression.\nOverall, while saracatinib has shown promise as a potential cancer therapy, more research is needed to fully understand its effects on oncogenesis and to determine its safety and efficacy in clinical settings.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Saracatinib is a small molecule inhibitor of the tyrosine kinase activity of c-Met.\n2. Saracatinib has shown promise in preclinical studies as a potential therapeutic agent for cancer.\n3. In vitro studies have indicated that saracatinib can inhibit the growth and migration of cancer cells.\n4. A study published in Cancer Research in 2018 found that saracatinib can promote the formation of lung tumors in mice when given at high doses.\n5. The same study from 2018 suggested that saracatinib could promote the development of resistance to other cancer therapies.",
    "yulan-chat-2-13b-fp16_fact": [
      "Saracatinib is a small molecule inhibitor of the tyrosine kinase activity of c-Met.",
      "Saracatinib has shown promise in preclinical studies as a potential therapeutic agent for cancer.",
      "In vitro studies have indicated that saracatinib can inhibit the growth and migration of cancer cells.",
      "A study published in Cancer Research in 2018 found that saracatinib can promote the formation of lung tumors in mice when given at high doses.",
      "The same study from 2018 suggested that saracatinib could promote the development of resistance to other cancer therapies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Saracatinib is a small molecule inhibitor of the Src family tyrosine kinases, not specifically the tyrosine kinase activity of c-Met.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nI cannot verify the specific contents and results of a study without the actual study reference. The statements #4 and #5 would require access to the specific study published in Cancer Research in 2018, which is not available in this context.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3687,
    "user_query": "Is BCL11B involved in schizophrenia?",
    "yulan-chat-2-13b-fp16_response": "BCL11B is a gene that has been implicated in the development of schizophrenia. Several studies have suggested that variations in the BCL11B gene may be associated with an increased risk of developing schizophrenia.\nOne study published in the journal Nature Genetics in 2014 found that a specific variation in the BCL11B gene was associated with an increased risk of schizophrenia in people of European ancestry. Another study published in the journal Molecular Psychiatry in 2016 found that the same variation in the BCL11B gene was also associated with an increased risk of schizophrenia in people of Asian ancestry.\nHowever, it is important to note that genetic studies are complex and the role of BCL11B in schizophrenia is still not fully understood. More research is needed to confirm the findings of these studies and to determine the exact mechanisms by which BCL11B may be involved in the development of schizophrenia.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. BCL11B is a gene that has been implicated in the development of schizophrenia.\n2. Variations in the BCL11B gene may be associated with an increased risk of developing schizophrenia.\n3. A study published in Nature Genetics in 2014 found that a specific variation in the BCL11B gene was associated with an increased risk of schizophrenia in people of European ancestry.\n4. A study published in Molecular Psychiatry in 2016 found that the same variation in the BCL11B gene was associated with an increased risk of schizophrenia in people of Asian ancestry.",
    "yulan-chat-2-13b-fp16_fact": [
      "BCL11B is a gene that has been implicated in the development of schizophrenia.",
      "Variations in the BCL11B gene may be associated with an increased risk of developing schizophrenia.",
      "A study published in Nature Genetics in 2014 found that a specific variation in the BCL11B gene was associated with an increased risk of schizophrenia in people of European ancestry.",
      "A study published in Molecular Psychiatry in 2016 found that the same variation in the BCL11B gene was associated with an increased risk of schizophrenia in people of Asian ancestry."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: BCL11B is a gene that has been implicated in the development of various conditions, including schizophrenia.\n2. TRUE: Variations in the BCL11B gene may be associated with an increased risk of developing schizophrenia, as has been suggested by genetic studies.\n3. UNKNOWN: Without specific access to the 2014 Nature Genetics study, it is not possible to confirm the claim about a specific variation in the BCL11B gene being associated with an increased risk of schizophrenia in people of European ancestry.\n4. UNKNOWN: Similarly, without access to the 2016 Molecular Psychiatry study, it cannot be confirmed if the same variation was also found to be associated with an increased risk of schizophrenia in people of Asian ancestry.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3690,
    "user_query": "What is a zoonotic virus?",
    "yulan-chat-2-13b-fp16_response": "A zoonotic virus is a type of virus that can be transmitted from animals to humans. These viruses can cause a range of illnesses, from mild flu-like symptoms to severe and potentially life-threatening diseases. Examples of zoonotic viruses include the viruses that cause COVID-19, Ebola, and HIV.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A zoonotic virus can be transmitted from animals to humans.\n2. Zoonotic viruses can cause illnesses that range from mild flu-like symptoms to severe and potentially life-threatening diseases.\n3. The virus that causes COVID-19 is an example of a zoonotic virus.\n4. Ebola is caused by a zoonotic virus.\n5. HIV is a zoonotic virus.",
    "yulan-chat-2-13b-fp16_fact": [
      "A zoonotic virus can be transmitted from animals to humans.",
      "Zoonotic viruses can cause illnesses that range from mild flu-like symptoms to severe and potentially life-threatening diseases.",
      "The virus that causes COVID-19 is an example of a zoonotic virus.",
      "Ebola is caused by a zoonotic virus.",
      "HIV is a zoonotic virus."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "yulan-chat-2-13b-fp16_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called \"KPT-101.\" KPT-101 is an experimental drug that is being developed to treat a variety of conditions, including obesity, type 2 diabetes, and Prader-Willi syndrome. It works by blocking the activity of the ghrelin receptor, which is a type of receptor that is found in the brain and other tissues. By blocking the activity of the ghrelin receptor, KPT-101 can help to reduce hunger and food intake, which may be useful for treating conditions like obesity and type 2 diabetes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The drug \"KPT-101\" is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. KPT-101 is an experimental drug intended to treat conditions such as obesity, type 2 diabetes, and Prader-Willi syndrome.\n3. KPT-101 works by blocking the activity of the ghrelin receptor.\n4. The ghrelin receptor is found in the brain and other tissues.\n5. Blocking the activity of the ghrelin receptor can help reduce hunger and food intake.",
    "yulan-chat-2-13b-fp16_fact": [
      "The drug \"KPT-101\" is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "KPT-101 is an experimental drug intended to treat conditions such as obesity, type 2 diabetes, and Prader-Willi syndrome.",
      "KPT-101 works by blocking the activity of the ghrelin receptor.",
      "The ghrelin receptor is found in the brain and other tissues.",
      "Blocking the activity of the ghrelin receptor can help reduce hunger and food intake."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: There is no publicly available information confirming or denying that \"KPT-101\" is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects as of my knowledge cutoff in early 2023.\n2. TRUE: Experimental drugs targeting ghrelin receptor inverse agonism would typically be intended to treat conditions such as obesity, type 2 diabetes, and Prader-Willi syndrome, which are associated with increased appetite and food intake.\n3. TRUE: As an inverse agonist, KPT-101 would work by binding to the ghrelin receptor and producing the opposite pharmacological effect to that of an agonist, thus blocking the activity of the receptor.\n4. TRUE: The ghrelin receptor, also known as the growth hormone secretagogue receptor, is found in the brain and other tissues such as the gastrointestinal tract.\n5. TRUE: Blocking the activity of the ghrelin receptor is a mechanism that can help reduce hunger signals, leading to reduced food intake, which is beneficial in the treatment of obesity and related conditions.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "yulan-chat-2-13b-fp16_response": "Vaxchora is a live, attenuated (weakened) vaccine that is approved for the prevention of cholera caused by Vibrio cholerae O1. The protective efficacy of Vaxchora against moderate to severe cholera has been shown in clinical trials.\nAccording to the Centers for Disease Control and Prevention (CDC), Vaxchora is estimated to be 80-90% effective in preventing severe cholera illness, including dehydration and death, caused by Vibrio cholerae O1. This means that for every 100 people vaccinated with Vaxchora, 80-90 people are protected against severe cholera illness.\nIt is important to note that the efficacy of Vaxchora may vary depending on factors such as the age and health status of the person being vaccinated, as well as the strain of Vibrio cholerae O1 that is circulating in the population.\nIt is also important to continue practicing good hygiene and sanitation measures, such as washing hands with soap and water, to reduce the risk of getting cholera even if you have been vaccinated with Vaxchora.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vaxchora is a live, attenuated vaccine approved for the prevention of cholera caused by Vibrio cholerae O1.\n2. Vaxchora has been shown to have a protective efficacy against moderate to severe cholera in clinical trials.\n3. The CDC estimates that Vaxchora is 80-90% effective in preventing severe cholera illness caused by Vibrio cholerae O1.\n4. The efficacy of Vaxchora may vary based on the age and health status of the person being vaccinated.\n5. Good hygiene and sanitation measures are recommended to reduce the risk of getting cholera in addition to vaccination with Vaxchora.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vaxchora is a live, attenuated vaccine approved for the prevention of cholera caused by Vibrio cholerae O1.",
      "Vaxchora has been shown to have a protective efficacy against moderate to severe cholera in clinical trials.",
      "The CDC estimates that Vaxchora is 80-90% effective in preventing severe cholera illness caused by Vibrio cholerae O1.",
      "The efficacy of Vaxchora may vary based on the age and health status of the person being vaccinated.",
      "Good hygiene and sanitation measures are recommended to reduce the risk of getting cholera in addition to vaccination with Vaxchora."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN (This statement requires specific statistical data from the CDC which is not provided in the given context)\n4. TRUE (While not specific, it is generally true for vaccines that their efficacy can vary based on individual factors such as age and health status)\n5. TRUE (Good hygiene and sanitation are widely recommended to reduce the risk of cholera and other infectious diseases)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3694,
    "user_query": "What is minodixil approved for?",
    "yulan-chat-2-13b-fp16_response": "Minodixil is not a medication that is approved by any regulatory agencies, including the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA). Therefore, it is not approved for any specific medical use.\nIt is possible that minodixil may be used off-label by some healthcare providers for certain conditions, but this would be determined on a case-by-case basis and would depend on the individual patient's medical history and needs. Off-label use of a medication means that it is being used in a way that is not included in the official labeling approved by the regulatory agency. The safety and effectiveness of off-label use of a medication have not been established and may not be supported by clinical evidence.\nIt is important to note that the use of any medication, including off-label use, should only be done under the supervision of a qualified healthcare provider.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Minodixil is not approved by the US Food and Drug Administration (FDA).\n2. Minodixil is not approved by the European Medicines Agency (EMA).\n3. Off-label use of a medication means it is used in a way not included in the official labeling approved by the regulatory agency.\n4. The safety and effectiveness of off-label use have not been established and may not be supported by clinical evidence.\n5. Medication use, including off-label use, should only be done under the supervision of a qualified healthcare provider.",
    "yulan-chat-2-13b-fp16_fact": [
      "Minodixil is not approved by the US Food and Drug Administration (FDA).",
      "Minodixil is not approved by the European Medicines Agency (EMA).",
      "Off-label use of a medication means it is used in a way not included in the official labeling approved by the regulatory agency.",
      "The safety and effectiveness of off-label use have not been established and may not be supported by clinical evidence.",
      "Medication use, including off-label use, should only be done under the supervision of a qualified healthcare provider."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Minoxidil is approved by the US Food and Drug Administration (FDA) for the treatment of hair loss.\n2. FALSE [correction]: Minoxidil is approved by the European Medicines Agency (EMA) as a treatment for hair loss, as well as for other conditions like hypertension when used in different formulations.\n3. TRUE\n4. TRUE: While off-label use may be based on clinical experience or studies, it is not always supported by rigorous clinical evidence that meets the criteria for FDA approval.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3697,
    "user_query": "Is SATB1 necessary for T-cell maturation?",
    "yulan-chat-2-13b-fp16_response": "SATB1 (Special AT-rich sequence-binding protein 1) is a transcription factor that plays a crucial role in the regulation of gene expression in various cell types, including immune cells. T-cells are a type of immune cell that plays a critical role in the adaptive immune response.\nWhile SATB1 has been shown to be involved in the regulation of T-cell development and function, it is not necessary for T-cell maturation. T-cells can develop and function normally in the absence of SATB1. However, SATB1 may play a role in optimizing T-cell function and promoting the differentiation of certain T-cell subsets.\nSATB1 has been shown to regulate the expression of genes involved in various aspects of T-cell development and function, including T-cell receptor signaling, proliferation, differentiation, and effector function. SATB1 may also play a role in the regulation of genes involved in the development of regulatory T-cells, which are important for maintaining immune homeostasis.\nIn summary, while SATB1 is not necessary for T-cell maturation, it can play an important role in regulating T-cell development and function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SATB1 (Special AT-rich sequence-binding protein 1) is a transcription factor that regulates gene expression in various cell types, including immune cells.\n2. SATB1 is involved in the regulation of T-cell development and function.\n3. T-cells can develop and function normally without SATB1.\n4. SATB1 regulates the expression of genes involved in T-cell receptor signaling, proliferation, differentiation, and effector function.\n5. SATB1 may play a role in the development of regulatory T-cells, which are important for maintaining immune homeostasis.",
    "yulan-chat-2-13b-fp16_fact": [
      "SATB1 (Special AT-rich sequence-binding protein 1) is a transcription factor that regulates gene expression in various cell types, including immune cells.",
      "SATB1 is involved in the regulation of T-cell development and function.",
      "T-cells can develop and function normally without SATB1.",
      "SATB1 regulates the expression of genes involved in T-cell receptor signaling, proliferation, differentiation, and effector function.",
      "SATB1 may play a role in the development of regulatory T-cells, which are important for maintaining immune homeostasis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: T-cells require SATB1 for normal development and function; SATB1 deficiency can lead to defects in T-cell development and function.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3700,
    "user_query": "What is the function of a viral peplomer?",
    "yulan-chat-2-13b-fp16_response": "A viral peplomer is a protein structure found on the surface of some viruses that plays a crucial role in the viral life cycle. The primary function of a viral peplomer is to attach the virus to the surface of the host cell and facilitate viral entry into the cell.\nThe peplomer is typically composed of multiple copies of a single protein subunit arranged in a symmetrical or asymmetrical pattern. The structure and composition of the peplomer can vary among different viruses, but they all share the common function of recognizing and binding to specific receptors on the host cell surface.\nOnce the virus has attached to the host cell, the peplomer may play a role in the release of the viral genome into the host cell. Some viral peplomers are also involved in the assembly of new virions within the host cell, helping to form the protective coat that surrounds the viral genome.\nOverall, the viral peplomer is an essential component of the viral life cycle, enabling the virus to infect and replicate within the host cell.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Viral peplomers are protein structures found on the surface of some viruses.\n2. The primary function of a viral peplomer is to attach the virus to the surface of the host cell.\n3. Viral peplomers facilitate viral entry into the host cell.\n4. Viral peplomers can vary in structure and composition among different viruses.\n5. Viral peplomers are involved in the release of the viral genome into the host cell and may assist in the assembly of new virions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Viral peplomers are protein structures found on the surface of some viruses.",
      "The primary function of a viral peplomer is to attach the virus to the surface of the host cell.",
      "Viral peplomers facilitate viral entry into the host cell.",
      "Viral peplomers can vary in structure and composition among different viruses.",
      "Viral peplomers are involved in the release of the viral genome into the host cell and may assist in the assembly of new virions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Viral peplomers, often referred to as spike proteins, are primarily involved in the attachment and entry of the virus into the host cell. The release of the viral genome into the host cell is facilitated by other mechanisms that occur after viral entry. The assembly of new virions is a separate process that generally occurs in the host cell and does not directly involve the peplomers.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3704,
    "user_query": "Does radiotherapy for prostate cancer increase bladder cancer risk?",
    "yulan-chat-2-13b-fp16_response": "Radiotherapy for prostate cancer can increase the risk of developing bladder cancer. The risk is generally low, but it can increase over time as the dose of radiation used in treatment increases.\nProstate cancer radiotherapy can damage the cells in the bladder, which can lead to the development of bladder cancer. The risk of developing bladder cancer is highest in men who have received radiotherapy to the pelvic area, which includes the prostate, bladder, and rectum.\nThe risk of developing bladder cancer from radiotherapy for prostate cancer is generally low, but it can increase over time as the dose of radiation used in treatment increases. The risk is also higher in men who have had a longer duration of radiation therapy or who have received higher doses of radiation.\nIt is important for men who have received radiotherapy for prostate cancer to be monitored regularly for signs of bladder cancer, such as blood in the urine or changes in urination patterns. If any concerning symptoms are detected, further testing may be necessary to determine if bladder cancer has developed.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Radiotherapy for prostate cancer can increase the risk of developing bladder cancer.\n2. The risk of developing bladder cancer is highest in men who have received radiotherapy to the pelvic area.\n3. The risk of developing bladder cancer from radiotherapy can increase as the dose of radiation used in treatment increases.\n4. Men who have had a longer duration of radiation therapy or higher doses of radiation have a higher risk of developing bladder cancer.\n5. Men who have received radiotherapy for prostate cancer should be monitored regularly for signs of bladder cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Radiotherapy for prostate cancer can increase the risk of developing bladder cancer.",
      "The risk of developing bladder cancer is highest in men who have received radiotherapy to the pelvic area.",
      "The risk of developing bladder cancer from radiotherapy can increase as the dose of radiation used in treatment increases.",
      "Men who have had a longer duration of radiation therapy or higher doses of radiation have a higher risk of developing bladder cancer.",
      "Men who have received radiotherapy for prostate cancer should be monitored regularly for signs of bladder cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Radiotherapy for prostate cancer can indeed increase the risk of developing secondary malignancies such as bladder cancer.\n2. TRUE: The risk of developing bladder cancer is generally higher in men who have received radiotherapy to the pelvic area, where both the prostate and bladder are located.\n3. TRUE: There is evidence suggesting that the risk of secondary cancers, including bladder cancer, can increase with higher doses of radiation used in treatment.\n4. TRUE: Longer duration and higher doses of radiation therapy are associated with an increased risk of developing bladder cancer.\n5. TRUE: It is recommended for men who have received radiotherapy for prostate cancer to be monitored regularly for any signs of bladder cancer due to their increased risk. Regular monitoring helps in the early detection and management of any secondary cancers.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3705,
    "user_query": "What is ESN364?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have any information about ESN364. It is possible that ESN364 is a proprietary product or technology that is not widely known or documented publicly. If you have more information about ESN364 or specific questions about its purpose or functionality, I'll do my best to help you.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3707,
    "user_query": "Has MLE4901 been tested in phase III clinical trials?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information on whether MLE4901 has been tested in phase III clinical trials. MLE4901 is a drug being developed by Moderna for the treatment of various diseases, including cancer, but I don't have information on the specific clinical trial results or progress for this drug. I suggest consulting with a healthcare professional or checking the Moderna website for the most up-to-date information on MLE4901 and its clinical trial status.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. MLE4901 is a drug being developed by Moderna.\n2. MLE4901 is intended for the treatment of various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "MLE4901 is a drug being developed by Moderna.",
      "MLE4901 is intended for the treatment of various diseases, including cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3713,
    "user_query": "What is the interaction between WAPL and PDS5 proteins?",
    "yulan-chat-2-13b-fp16_response": "WAPL (WW domain-associating protein with a PDZ domain-like motif) and PDS5 (Protein disulfide isomerase-like 5) are two proteins that interact with each other through their PDZ domains.\nPDZ domains are a type of protein module that can bind to short linear motifs (SLiMs) on other proteins. SLiMs are usually composed of three amino acids and can be found on the C-terminal end of many proteins. PDS5 contains an N-terminal PDZ domain that can bind to a SLiM on the C-terminal end of WAPL.\nThe interaction between WAPL and PDS5 is important for the localization of WAPL to the plasma membrane. WAPL is involved in regulating the trafficking of membrane proteins, and its localization to the plasma membrane is necessary for it to carry out its functions. PDS5 helps to stabilize WAPL at the plasma membrane by binding to it through their PDZ domains.\nIn addition to their interaction at the plasma membrane, WAPL and PDS5 can also interact with each other in the cytoplasm. In this context, they may play a role in regulating the localization and trafficking of other proteins.\nOverall, the interaction between WAPL and PDS5 is important for the proper localization and function of both proteins, and likely plays a role in regulating the trafficking and localization of other proteins as well.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. WAPL (WW domain-associating protein with a PDZ domain-like motif) interacts with PDS5 (Protein disulfide isomerase-like 5) through their PDZ domains.\n2. PDZ domains can bind to short linear motifs (SLiMs) composed usually of three amino acids found on the C-terminal end of many proteins.\n3. PDS5 contains an N-terminal PDZ domain that can bind to a SLiM on the C-terminal end of WAPL.\n4. The interaction between WAPL and PDS5 is necessary for the localization of WAPL to the plasma membrane.\n5. WAPL is involved in regulating the trafficking of membrane proteins.",
    "yulan-chat-2-13b-fp16_fact": [
      "WAPL (WW domain-associating protein with a PDZ domain-like motif) interacts with PDS5 (Protein disulfide isomerase-like 5) through their PDZ domains.",
      "PDZ domains can bind to short linear motifs (SLiMs) composed usually of three amino acids found on the C-terminal end of many proteins.",
      "PDS5 contains an N-terminal PDZ domain that can bind to a SLiM on the C-terminal end of WAPL.",
      "The interaction between WAPL and PDS5 is necessary for the localization of WAPL to the plasma membrane.",
      "WAPL is involved in regulating the trafficking of membrane proteins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe response for all UNKNOWN statements is given because, without specific information from scientific literature or detailed knowledge about WAPL or PDS5 proteins and their domains or interactions, it is not possible to confirm or correct the given statements. Only statement 2 regarding PDZ domains can be generally affirmed as true, given the common knowledge that PDZ domains often bind to short linear motifs at the C-terminal ends of proteins.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "yulan-chat-2-13b-fp16_response": "The first cholera vaccine approved in the United States was the inactivated whole cell cholera vaccine (WCVC) in 1963. It was developed by the Russian scientist Albert Sabin and was licensed for use in the US by the Food and Drug Administration (FDA) in 1963. The WCVC is made by inactivating the bacteria that causes cholera with formaldehyde and is administered orally in a liquid form. It is still used in some countries today, although it has been largely replaced by other types of cholera vaccines, such as the live attenuated oral cholera vaccine (LAOC).",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The first cholera vaccine approved in the United States was an inactivated whole cell cholera vaccine (WCVC) in 1963.\n2. The WCVC cholera vaccine was developed by Russian scientist Albert Sabin.\n3. The WCVC cholera vaccine was licensed for use in the United States by the Food and Drug Administration (FDA) in 1963.\n4. The WCVC cholera vaccine is made by inactivating the bacteria that causes cholera with formaldehyde.\n5. The WCVC cholera vaccine is administered orally in liquid form.",
    "yulan-chat-2-13b-fp16_fact": [
      "The first cholera vaccine approved in the United States was an inactivated whole cell cholera vaccine (WCVC) in 1963.",
      "The WCVC cholera vaccine was developed by Russian scientist Albert Sabin.",
      "The WCVC cholera vaccine was licensed for use in the United States by the Food and Drug Administration (FDA) in 1963.",
      "The WCVC cholera vaccine is made by inactivating the bacteria that causes cholera with formaldehyde.",
      "The WCVC cholera vaccine is administered orally in liquid form."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The first cholera vaccine approved in the United States was not in 1963. The vaccine approved that year was the oral killed (inactivated) cholera vaccine for U.S. military personnel, which differs from the WCVC mentioned.\n2. FALSE [correction]: Albert Sabin is known for developing the oral polio vaccine, not the cholera vaccine.\n3. TRUE: As corrected in statement 1, an oral killed cholera vaccine was indeed licensed by the FDA in 1963, although it was not referred to specifically as WCVC.\n4. TRUE: Whole cell vaccines, such as the WCVC, are often made by inactivating the bacteria using a chemical agent like formaldehyde.\n5. UNKNOWN: While inactivated whole cell vaccines can be administered orally, the specific details regarding the formulation (liquid or other forms) of the vaccine mentioned in 1963 are not provided, making this statement difficult to verify.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3718,
    "user_query": "Are there negative enhancers?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are negative enhancers in machine learning. A negative enhancer is a term used to describe a feature or attribute that has a negative impact on the performance of a machine learning model. These features can cause the model to overfit or underfit the data, leading to poor performance.\nNegative enhancers can be caused by a variety of factors, such as noisy or irrelevant data, poorly chosen hyperparameters, or incorrect model assumptions. Identifying and removing negative enhancers is an important step in the machine learning process, as they can have a significant impact on the accuracy and reliability of the model.\nIt's important to note that not all features or attributes will have a positive or negative impact on the performance of a machine learning model. Some may have no effect at all, while others may have a neutral effect. It's important to carefully evaluate and analyze the data and model to identify any negative enhancers and take steps to address them.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Negative enhancers in machine learning refer to features or attributes that negatively impact model performance.\n2. Negative enhancers can cause a machine learning model to overfit or underfit data.\n3. Factors contributing to negative enhancers include noisy or irrelevant data, poorly chosen hyperparameters, or incorrect model assumptions.\n4. Identifying and removing negative enhancers is crucial for the accuracy and reliability of a machine learning model.",
    "yulan-chat-2-13b-fp16_fact": [
      "Negative enhancers in machine learning refer to features or attributes that negatively impact model performance.",
      "Negative enhancers can cause a machine learning model to overfit or underfit data.",
      "Factors contributing to negative enhancers include noisy or irrelevant data, poorly chosen hyperparameters, or incorrect model assumptions.",
      "Identifying and removing negative enhancers is crucial for the accuracy and reliability of a machine learning model."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The term \"negative enhancers\" is not commonly used in machine learning. Instead, features or attributes that negatively impact model performance are typically referred to as \"noise\" or \"irrelevant features.\"\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3719,
    "user_query": "What is the function of WAPL protein on cohesin?",
    "yulan-chat-2-13b-fp16_response": "WAPL (Wring Apart Protein Like) is a protein that interacts with cohesin, a large protein complex involved in chromosome cohesion and separation during cell division. The exact function of WAPL on cohesin is not fully understood, but it is thought to play a role in regulating the activity of cohesin and maintaining chromosomal stability. WAPL may also be involved in the recruitment of other proteins to cohesin, and it has been implicated in several cellular processes, including DNA repair and transcription.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. WAPL interacts with cohesin, a protein complex involved in chromosome cohesion and separation during cell division.\n2. WAPL is believed to play a role in regulating cohesin's activity.\n3. WAPL has a role in maintaining chromosomal stability.\n4. WAPL may be involved in the recruitment of other proteins to cohesin.\n5. WAPL has been implicated in cellular processes such as DNA repair and transcription.",
    "yulan-chat-2-13b-fp16_fact": [
      "WAPL interacts with cohesin, a protein complex involved in chromosome cohesion and separation during cell division.",
      "WAPL is believed to play a role in regulating cohesin's activity.",
      "WAPL has a role in maintaining chromosomal stability.",
      "WAPL may be involved in the recruitment of other proteins to cohesin.",
      "WAPL has been implicated in cellular processes such as DNA repair and transcription."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3728,
    "user_query": "Which cells mature in the human thymus?",
    "yulan-chat-2-13b-fp16_response": "The human thymus is a gland located in the chest, just behind the sternum, that plays a crucial role in the development of the immune system. The thymus is responsible for the maturation of T cells, which are a type of white blood cell that plays a central role in the immune system.\nT cells, also known as T lymphocytes, are produced in the bone marrow and then migrate to the thymus, where they undergo maturation and differentiation. In the thymus, T cells undergo a process called positive and negative selection, which helps to ensure that they are functionally competent and able to recognize and respond to foreign invaders, such as viruses and bacteria.\nDuring positive selection, T cells that are able to recognize and bind to self-antigens, which are proteins found on the surface of the body's own cells, are eliminated by the immune system. This helps to prevent the immune system from attacking the body's own cells. T cells that are able to survive this process are then able to circulate in the blood and lymphatic system, where they can recognize and respond to foreign antigens.\nDuring negative selection, T cells that are unable to recognize foreign antigens are eliminated by the immune system. This helps to ensure that only T cells that are able to recognize and respond to foreign invaders are able to circulate in the blood and lymphatic system.\nOnce T cells have undergone maturation and differentiation in the thymus, they migrate to the bloodstream and lymphatic system, where they can circulate and respond to foreign invaders. T cells play a central role in the immune system, and they are involved in a wide range of immune responses, including cell-mediated immunity, which involves the activation of other immune cells, and humoral immunity, which involves the production of antibodies by B cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The thymus gland is responsible for the maturation of T cells, a type of white blood cell.\n2. T cells, also known as T lymphocytes, are produced in the bone marrow and then migrate to the thymus for maturation and differentiation.\n3. Positive selection in the thymus eliminates T cells that can recognize and bind to self-antigens, helping to prevent the immune system from attacking the body's own cells.\n4. Negative selection in the thymus eliminates T cells that are unable to recognize foreign antigens.\n5. Mature T cells circulate in the blood and lymphatic system and play roles in cell-mediated immunity and humoral immunity.",
    "yulan-chat-2-13b-fp16_fact": [
      "The thymus gland is responsible for the maturation of T cells, a type of white blood cell.",
      "T cells, also known as T lymphocytes, are produced in the bone marrow and then migrate to the thymus for maturation and differentiation.",
      "Positive selection in the thymus eliminates T cells that can recognize and bind to self-antigens, helping to prevent the immune system from attacking the body's own cells.",
      "Negative selection in the thymus eliminates T cells that are unable to recognize foreign antigens.",
      "Mature T cells circulate in the blood and lymphatic system and play roles in cell-mediated immunity and humoral immunity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Negative selection in the thymus eliminates T cells that can recognize and bind to self-antigens, helping to prevent the immune system from attacking the body's own cells.\n4. FALSE [correction]: Positive selection in the thymus ensures T cells can recognize foreign antigens presented by self-major histocompatibility complex (MHC) molecules.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3729,
    "user_query": "What are the eRNA-producing centers (EPCs)?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not familiar with the term \"eRNA-producing centers\" (EPCs). Can you provide more context or information about what you are referring to? This will help me to better understand your question and provide a more accurate response.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3731,
    "user_query": "When was vivotif first licenced in Europe?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information on Vivotif or when it was first licensed in Europe. Vivotif is not a widely known or widely used product, and I don't have access to information on all licensed products in Europe. If you have more specific information about Vivotif or its intended use, I may be able to help you find more information.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3735,
    "user_query": "Which molecules are inhibited by Gilteritinib?",
    "yulan-chat-2-13b-fp16_response": "Gilteritinib is a small molecule inhibitor that targets the kinase FLT3, which is involved in the development of acute myeloid leukemia (AML) and other hematological malignancies. FLT3 is a receptor tyrosine kinase that plays a critical role in the hematopoietic stem cell niche, regulating the proliferation, differentiation, and survival of hematopoietic cells.\nGilteritinib inhibits the activity of FLT3 by binding to its kinase domain, preventing it from phosphorylating and activating downstream signaling molecules. This leads to the inhibition of FLT3-mediated cell proliferation, survival, and differentiation, ultimately leading to cell death in cancer cells that rely on FLT3 signaling for survival.\nIn addition to FLT3, gilteritinib has also been shown to inhibit other kinases, including KIT, PDGFR, and c-FMS, which are involved in the pathogenesis of various hematological malignancies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gilteritinib targets and inhibits the FLT3 kinase.\n2. FLT3 is involved in the development of acute myeloid leukemia (AML) and other hematological malignancies.\n3. Gilteritinib inhibits the activity of FLT3 by binding to its kinase domain.\n4. The inhibition of FLT3 by gilteritinib leads to the inhibition of cell proliferation, survival, and differentiation in cancer cells.\n5. Gilteritinib also inhibits other kinases such as KIT, PDGFR, and c-FMS.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gilteritinib targets and inhibits the FLT3 kinase.",
      "FLT3 is involved in the development of acute myeloid leukemia (AML) and other hematological malignancies.",
      "Gilteritinib inhibits the activity of FLT3 by binding to its kinase domain.",
      "The inhibition of FLT3 by gilteritinib leads to the inhibition of cell proliferation, survival, and differentiation in cancer cells.",
      "Gilteritinib also inhibits other kinases such as KIT, PDGFR, and c-FMS."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nGilteritinib is indeed used as a treatment for certain types of AML and works by inhibiting the FLT3 kinase among others. The inhibition of FLT3 and other kinases leads to effects on cell proliferation, survival, and differentiation which can be therapeutic in the treatment of cancer.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "yulan-chat-2-13b-fp16_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene. This gene encodes for the Bruton's tyrosine kinase protein, which plays a crucial role in the development and activation of B cells, a type of immune cell that produces antibodies. Mutations in the BTK gene lead to impaired B cell development and function, resulting in CVID.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The BTK gene mutation is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.\n2. The BTK gene is responsible for encoding the Bruton's tyrosine kinase protein.\n3. Bruton's tyrosine kinase protein is crucial for the development and activation of B cells.\n4. B cells are a type of immune cell that produces antibodies.\n5. Mutations in the BTK gene can lead to impaired B cell development and function, causing CVID.",
    "yulan-chat-2-13b-fp16_fact": [
      "The BTK gene mutation is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
      "The BTK gene is responsible for encoding the Bruton's tyrosine kinase protein.",
      "Bruton's tyrosine kinase protein is crucial for the development and activation of B cells.",
      "B cells are a type of immune cell that produces antibodies.",
      "Mutations in the BTK gene can lead to impaired B cell development and function, causing CVID."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is not the BTK gene mutation. Mutations in the BTK gene cause X-linked agammaglobulinemia (XLA), which is different from CVID.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in the BTK gene lead to X-linked agammaglobulinemia (XLA), which results in impaired B cell development and function, not CVID. While CVID can be caused by mutations in various genes, BTK mutations are not typically associated with CVID.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3738,
    "user_query": "List 3 human diseases caused by  viruses in the family Paramyxoviridae.",
    "yulan-chat-2-13b-fp16_response": "1. Measles (Rubeola)\n2. Mumps (Parotitis)\n3. Rubella (German Measles)",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3740,
    "user_query": "What is the target of a drug pidilizumab?",
    "yulan-chat-2-13b-fp16_response": "Pidilizumab is an investigational drug that is being developed for the treatment of various diseases, including cancer and autoimmune disorders. However, as of my knowledge cutoff date of September 2021, there is limited information available on the specific target of pidilizumab. It is possible that the drug may target a specific protein or pathway that is involved in the development or progression of the diseases it is being studied for. However, further research is needed to confirm this and to fully understand the mechanism of action of pidilizumab.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3742,
    "user_query": "Han Wistar and Sprague Dawley are breeds of what laboratory animal?",
    "yulan-chat-2-13b-fp16_response": "Han Wistar and Sprague Dawley are breeds of laboratory mice, which are commonly used in scientific research and testing.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Han Wistar is a breed of laboratory mice.\n2. Sprague Dawley is a breed of laboratory mice.\n3. Laboratory mice are commonly used in scientific research and testing.",
    "yulan-chat-2-13b-fp16_fact": [
      "Han Wistar is a breed of laboratory mice.",
      "Sprague Dawley is a breed of laboratory mice.",
      "Laboratory mice are commonly used in scientific research and testing."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Han Wistar is not a recognized breed of laboratory mice; the correct term is Wistar, which is a common breed of laboratory rat.\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "yulan-chat-2-13b-fp16_response": "The IFIT1 gene has been implicated in the development of Systemic Lupus Erythematosus (SLE) through its role in regulating the immune response. SLE is an autoimmune disease characterized by the production of autoantibodies and the development of immune complexes that deposit in various tissues, leading to inflammation and tissue damage.\nStudies have shown that IFIT1 is a key regulator of the type I interferon pathway, which plays a crucial role in the immune response to viral infections. In SLE, it has been suggested that dysregulation of the type I interferon pathway may contribute to the development of autoimmunity and the production of autoantibodies.\nSpecifically, it has been found that IFIT1 levels are decreased in SLE patients, which may contribute to the dysregulation of the type I interferon pathway and the development of autoimmunity. Additionally, studies have shown that restoring IFIT1 levels may have therapeutic potential in SLE.\nOverall, the IFIT1 gene plays an important role in regulating the immune response and its dysregulation may contribute to the development of SLE.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The IFIT1 gene is implicated in the development of Systemic Lupus Erythematosus (SLE) through its role in the immune response.\n2. SLE is characterized by the production of autoantibodies and the development of immune complexes that lead to tissue inflammation and damage.\n3. IFIT1 is involved in the regulation of the type I interferon pathway, which is significant in the immune response to viral infections.\n4. IFIT1 levels have been found to be decreased in SLE patients, which may contribute to the dysregulation of the type I interferon pathway.\n5. Research indicates that restoring IFIT1 levels may have therapeutic potential for treating Systemic Lupus Erythematosus.",
    "yulan-chat-2-13b-fp16_fact": [
      "The IFIT1 gene is implicated in the development of Systemic Lupus Erythematosus (SLE) through its role in the immune response.",
      "SLE is characterized by the production of autoantibodies and the development of immune complexes that lead to tissue inflammation and damage.",
      "IFIT1 is involved in the regulation of the type I interferon pathway, which is significant in the immune response to viral infections.",
      "IFIT1 levels have been found to be decreased in SLE patients, which may contribute to the dysregulation of the type I interferon pathway.",
      "Research indicates that restoring IFIT1 levels may have therapeutic potential for treating Systemic Lupus Erythematosus."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: IFIT1 levels are often found to be increased in SLE patients, which may contribute to the dysregulation of the type I interferon pathway.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3744,
    "user_query": "Has tocilizumab been assessed against Covid-19?",
    "yulan-chat-2-13b-fp16_response": "Yes, tocilizumab has been assessed for its potential use in treating COVID-19. Tocilizumab is a monoclonal antibody that is used to treat rheumatoid arthritis and other autoimmune diseases. It works by blocking a protein called interleukin-6 (IL-6), which is involved in the immune response.\nSeveral studies have investigated the use of tocilizumab in patients with COVID-19, including the REMAP-CAP and ACTIBIOM trials. These studies looked at the safety and effectiveness of tocilizumab in patients with severe COVID-19 who were receiving mechanical ventilation or extracorporeal membrane oxygenation (ECMO).\nThe results of these studies suggest that tocilizumab may be beneficial for some patients with severe COVID-19, particularly those who are experiencing a hyperinflammatory response. However, more research is needed to fully understand the role of tocilizumab in the treatment of COVID-19.\nIt is important to note that tocilizumab is not a cure for COVID-19 and should not be used as a substitute for other treatments, such as supportive care and antiviral medications. It is also important to follow the guidance of healthcare professionals and government agencies regarding the use of tocilizumab and other treatments for COVID-19.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tocilizumab is a monoclonal antibody used to treat rheumatoid arthritis and other autoimmune diseases.\n2. Tocilizumab works by blocking a protein called interleukin-6 (IL-6).\n3. The REMAP-CAP and ACTIBIOM trials are among the studies that have investigated the use of tocilizumab in patients with COVID-19.\n4. These studies assessed the safety and effectiveness of tocilizumab in patients with severe COVID-19.\n5. The use of tocilizumab may be beneficial for COVID-19 patients experiencing a hyperinflammatory response.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tocilizumab is a monoclonal antibody used to treat rheumatoid arthritis and other autoimmune diseases.",
      "Tocilizumab works by blocking a protein called interleukin-6 (IL-6).",
      "The REMAP-CAP and ACTIBIOM trials are among the studies that have investigated the use of tocilizumab in patients with COVID-19.",
      "These studies assessed the safety and effectiveness of tocilizumab in patients with severe COVID-19.",
      "The use of tocilizumab may be beneficial for COVID-19 patients experiencing a hyperinflammatory response."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3745,
    "user_query": "Variants in which genes cause nonsyndromic retinal degeneration?",
    "yulan-chat-2-13b-fp16_response": "Nonsyndromic retinal degeneration is a genetic disorder that affects the retina, which is the light-sensitive tissue at the back of the eye. It is caused by mutations in various genes, including:\n1. RPE65: Mutations in this gene cause Leber congenital amaurosis, a rare, genetic disorder that affects the retina and causes vision loss from birth.\n2. LHON: Mutations in this gene cause Leber hereditary optic neuropathy, a rare genetic disorder that affects the optic nerve and causes vision loss.\n3. RPGR: Mutations in this gene cause retinitis pigmentosa, a genetic disorder that affects the retina and causes vision loss.\n4. CNGA3: Mutations in this gene cause autosomal recessive retinitis pigmentosa, a genetic disorder that affects the retina and causes vision loss.\n5. USH2A: Mutations in this gene cause Usher syndrome, a genetic disorder that affects both the retina and the inner ear and causes vision loss and deafness.\nThese are just a few examples of the genes that can cause nonsyndromic retinal degeneration. There are many other genes that have been implicated in this condition, and genetic testing can help identify the specific gene that is causing a person's retinal degeneration.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the RPE65 gene can cause Leber congenital amaurosis, which affects the retina and causes vision loss from birth.\n2. Mutations in the LHON gene can cause Leber hereditary optic neuropathy, which affects the optic nerve and leads to vision loss.\n3. Mutations in the RPGR gene can cause retinitis pigmentosa, a disorder that affects the retina and leads to vision loss.\n4. Mutations in the CNGA3 gene can cause autosomal recessive retinitis pigmentosa, which affects the retina and causes vision loss.\n5. Mutations in the USH2A gene can cause Usher syndrome, a disorder that affects the retina and the inner ear, leading to vision loss and deafness.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the RPE65 gene can cause Leber congenital amaurosis, which affects the retina and causes vision loss from birth.",
      "Mutations in the LHON gene can cause Leber hereditary optic neuropathy, which affects the optic nerve and leads to vision loss.",
      "Mutations in the RPGR gene can cause retinitis pigmentosa, a disorder that affects the retina and leads to vision loss.",
      "Mutations in the CNGA3 gene can cause autosomal recessive retinitis pigmentosa, which affects the retina and causes vision loss.",
      "Mutations in the USH2A gene can cause Usher syndrome, a disorder that affects the retina and the inner ear, leading to vision loss and deafness."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Mutations in the CNGA3 gene can cause achromatopsia, not autosomal recessive retinitis pigmentosa.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "yulan-chat-2-13b-fp16_response": "The Liverpool Elbow Score is a tool used to assess the severity of elbow pain in patients with elbow impingement, also known as radial tunnel syndrome or tennis elbow. It is a self-reported questionnaire that measures the level of pain, disability, and overall impact of elbow pain on a patient's quality of life.\nThe score is calculated based on the patient's responses to eight questions, which cover different aspects of elbow pain and function. The questions ask about the level of pain during specific activities, the degree of disability caused by the pain, and the impact of the pain on the patient's work and leisure activities.\nThe Liverpool Elbow Score is useful for healthcare professionals to assess the effectiveness of treatment for elbow impingement. It can also help to identify patients who may require further intervention or surgical intervention. The score has been widely used in research studies to evaluate the outcomes of different treatments for elbow pain, including physical therapy, medication, and surgery.\nOverall, the Liverpool Elbow Score is a valuable tool for healthcare professionals to assess the severity of elbow pain and to monitor the progress of treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Liverpool Elbow Score is used to assess the severity of elbow pain in patients.\n2. It is a self-reported questionnaire with eight questions.\n3. The questionnaire measures the level of pain, disability, and impact on quality of life due to elbow pain.\n4. The score is used by healthcare professionals to assess the effectiveness of treatments for elbow impingement.\n5. The Liverpool Elbow Score is utilized in research studies to evaluate treatment outcomes for elbow pain.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Liverpool Elbow Score is used to assess the severity of elbow pain in patients.",
      "It is a self-reported questionnaire with eight questions.",
      "The questionnaire measures the level of pain, disability, and impact on quality of life due to elbow pain.",
      "The score is used by healthcare professionals to assess the effectiveness of treatments for elbow impingement.",
      "The Liverpool Elbow Score is utilized in research studies to evaluate treatment outcomes for elbow pain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The Liverpool Elbow Score is a self-reported questionnaire with 10 questions, not eight.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3755,
    "user_query": "What is the function of the zelda transcription factor in D. melanogaster?",
    "yulan-chat-2-13b-fp16_response": "The Zeb2 transcription factor is a key regulator of cell fate determination and differentiation in Drosophila melanogaster. It is involved in the development of various tissues, including the nervous system, muscles, and gut. Zeb2 is also known to play a role in the regulation of proliferation, survival, and apoptosis of cells. In particular, it promotes the differentiation of neural progenitor cells and helps to maintain the stability of neural progenitor cell populations. Additionally, Zeb2 has been shown to regulate the expression of genes involved in various developmental processes, including cell adhesion, migration, and axon guidance. Overall, the function of Zeb2 in D. melanogaster is critical for the proper development and maintenance of various tissues and organs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Zeb2 transcription factor is a key regulator of cell fate determination and differentiation in Drosophila melanogaster.\n2. Zeb2 is involved in the development of the nervous system, muscles, and gut in Drosophila melanogaster.\n3. The transcription factor Zeb2 plays a role in the regulation of cell proliferation, survival, and apoptosis.\n4. Zeb2 promotes the differentiation of neural progenitor cells in Drosophila melanogaster.\n5. Zeb2 has been shown to regulate the expression of genes involved in cell adhesion, migration, and axon guidance.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Zeb2 transcription factor is a key regulator of cell fate determination and differentiation in Drosophila melanogaster.",
      "Zeb2 is involved in the development of the nervous system, muscles, and gut in Drosophila melanogaster.",
      "The transcription factor Zeb2 plays a role in the regulation of cell proliferation, survival, and apoptosis.",
      "Zeb2 promotes the differentiation of neural progenitor cells in Drosophila melanogaster.",
      "Zeb2 has been shown to regulate the expression of genes involved in cell adhesion, migration, and axon guidance."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE\n\nThe validity of statements 1, 2, and 4 is difficult to confirm without specific scientific references to studies on Drosophila melanogaster and the role of Zeb2 in this organism. While Zeb2 is known to be involved with such processes generally in vertebrates (especially in the context of neural development and cancer), its specific functions in Drosophila melanogaster would require direct evidence from research. Statement 3 is broadly correct for vertebrates but could be UNKNOWN for Drosophila without specific evidence. Statement 5 is generally true regarding the function of Zeb2, but confirmation in the context of Drosophila melanogaster specifically would require targeted research evidence.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3757,
    "user_query": "Which conditions are manifested by TRIM8 mutations?",
    "yulan-chat-2-13b-fp16_response": "TRIM8 mutations can lead to a variety of conditions, including:\n1. Immune dysfunction: TRIM8 plays a key role in regulating the immune system, and mutations in the TRIM8 gene can lead to immune dysfunction, making individuals more susceptible to infections and diseases.\n2. Neurodevelopmental disorders: TRIM8 has been implicated in the development of several neurodevelopmental disorders, including autism spectrum disorder, intellectual disability, and epilepsy.\n3. Cancer: TRIM8 has been shown to play a role in the regulation of cell growth and apoptosis, and mutations in the TRIM8 gene have been linked to an increased risk of several types of cancer, including breast cancer, ovarian cancer, and lung cancer.\n4. Autoimmune diseases: TRIM8 is involved in the regulation of the immune system, and mutations in the TRIM8 gene have been linked to an increased risk of autoimmune diseases, such as lupus and rheumatoid arthritis.\nIt's important to note that the specific conditions associated with TRIM8 mutations can vary depending on the individual and the specific mutation involved.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TRIM8 mutations can lead to immune dysfunction.\n2. Mutations in the TRIM8 gene have been implicated in the development of neurodevelopmental disorders, including autism spectrum disorder, intellectual disability, and epilepsy.\n3. Mutations in the TRIM8 gene have been linked to an increased risk of several types of cancer, including breast cancer, ovarian cancer, and lung cancer.\n4. Mutations in the TRIM8 gene have been linked to an increased risk of autoimmune diseases, such as lupus and rheumatoid arthritis.",
    "yulan-chat-2-13b-fp16_fact": [
      "TRIM8 mutations can lead to immune dysfunction.",
      "Mutations in the TRIM8 gene have been implicated in the development of neurodevelopmental disorders, including autism spectrum disorder, intellectual disability, and epilepsy.",
      "Mutations in the TRIM8 gene have been linked to an increased risk of several types of cancer, including breast cancer, ovarian cancer, and lung cancer.",
      "Mutations in the TRIM8 gene have been linked to an increased risk of autoimmune diseases, such as lupus and rheumatoid arthritis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The TRIM8 gene has been studied for its potential role in cancer, but clear evidence linking it specifically to an increased risk of breast cancer, ovarian cancer, and lung cancer is not established as of the knowledge cutoff in early 2023. Research into the role of TRIM8 in cancer is ongoing, and associations with specific cancer types need further confirmation.\n4. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3758,
    "user_query": "What is LY-CoV555?",
    "yulan-chat-2-13b-fp16_response": "LY-CoV555 is a COVID-19 antiviral drug candidate that is being developed by the pharmaceutical company Eli Lilly and Company. It is an inhibitor of the viral enzyme main protease, which is essential for the replication of the SARS-CoV-2 virus that causes COVID-19. The drug candidate is currently in Phase 3 clinical trials, which means that it is being tested in human volunteers to assess its safety and efficacy. If the trials are successful, LY-CoV555 could be approved for use as a treatment for COVID-19.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. LY-CoV555 is a COVID-19 antiviral drug candidate developed by Eli Lilly and Company.\n2. It acts as an inhibitor of the viral enzyme main protease that is essential for the replication of SARS-CoV-2.\n3. As of the knowledge cutoff, LY-CoV555 was in Phase 3 clinical trials.\n4. The purpose of the Phase 3 clinical trials is to assess the safety and efficacy of LY-CoV555 in human volunteers.\n5. If the Phase 3 clinical trials are successful, LY-CoV555 could be approved for use as a treatment for COVID-19.",
    "yulan-chat-2-13b-fp16_fact": [
      "LY-CoV555 is a COVID-19 antiviral drug candidate developed by Eli Lilly and Company.",
      "It acts as an inhibitor of the viral enzyme main protease that is essential for the replication of SARS-CoV-2.",
      "As of the knowledge cutoff, LY-CoV555 was in Phase 3 clinical trials.",
      "The purpose of the Phase 3 clinical trials is to assess the safety and efficacy of LY-CoV555 in human volunteers.",
      "If the Phase 3 clinical trials are successful, LY-CoV555 could be approved for use as a treatment for COVID-19."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: LY-CoV555 (also known as bamlanivimab) is a neutralizing monoclonal antibody, not an inhibitor of the viral enzyme main protease. It binds to the spike protein of SARS-CoV-2, thereby blocking the virus's ability to enter cells.\n3. FALSE [correction]: As of my knowledge cutoff in 2023, LY-CoV555 (bamlanivimab) has already been granted Emergency Use Authorization by the FDA and is not merely in Phase 3 clinical trials. However, further trials may still be ongoing to evaluate additional aspects or in different populations.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3760,
    "user_query": "Are bacteria in the genus Clostridium facultative anaerobes?",
    "yulan-chat-2-13b-fp16_response": "Yes, many species within the genus Clostridium are facultative anaerobes, meaning they can grow in the presence or absence of oxygen. However, not all species within Clostridium are facultative anaerobes, as some are strict anaerobes and require the absence of oxygen to grow.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Many species within the genus Clostridium are facultative anaerobes.\n2. Facultative anaerobes can grow in the presence or absence of oxygen.\n3. Some species within the genus Clostridium are strict anaerobes.\n4. Strict anaerobes require the absence of oxygen to grow.",
    "yulan-chat-2-13b-fp16_fact": [
      "Many species within the genus Clostridium are facultative anaerobes.",
      "Facultative anaerobes can grow in the presence or absence of oxygen.",
      "Some species within the genus Clostridium are strict anaerobes.",
      "Strict anaerobes require the absence of oxygen to grow."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Most species within the genus Clostridium are obligate anaerobes, not facultative anaerobes.\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "yulan-chat-2-13b-fp16_response": "The 100,000 Genomes Project is a UK national program that aims to sequence the genomes of 100,000 people, with the goal of improving diagnosis and treatment of rare diseases, including sarcoma. Sarcoma is a type of cancer that affects the body's connective tissues, such as bone, cartilage, fat, and muscle.\nThe 100,000 Genomes Project has made significant efforts to better understand the genetic basis of sarcoma. By sequencing the genomes of people with sarcoma, researchers have been able to identify specific genetic mutations and changes that contribute to the development of the disease. This information has helped to improve diagnosis and treatment of sarcoma, as well as to develop new targeted therapies.\nFor example, the project has identified specific genetic mutations that are present in some cases of sarcoma, such as the NTRK fusion gene mutation. This mutation is present in a subset of sarcoma patients and is associated with a positive response to a targeted therapy called larotrectinib, which specifically targets the NTRK fusion protein.\nIn addition to identifying specific genetic mutations, the 100,000 Genomes Project has also helped to improve understanding of the genetic changes that occur in sarcoma. For example, researchers have identified changes in the way that cells divide and grow in sarcoma, which may provide new targets for therapy.\nOverall, the efforts of the 100,000 Genomes Project have helped to improve understanding of the genetic basis of sarcoma and have led to the development of new targeted therapies for the disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The 100,000 Genomes Project is a UK initiative aimed at sequencing the genomes of 100,000 individuals, focusing on improving the diagnosis and treatment of rare diseases, including sarcoma.\n2. Sarcoma affects the body's connective tissues, such as bone, cartilage, fat, and muscle.\n3. The project has identified specific genetic mutations and changes in people with sarcoma that contribute to the development of the disease.\n4. The NTRK fusion gene mutation, identified by the project, is present in some cases of sarcoma and is associated with a positive response to the targeted therapy called larotrectinib.\n5. The 100,000 Genomes Project's research has led to improved understanding of the genetic changes in sarcoma and the development of new targeted therapies for the disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "The 100,000 Genomes Project is a UK initiative aimed at sequencing the genomes of 100,000 individuals, focusing on improving the diagnosis and treatment of rare diseases, including sarcoma.",
      "Sarcoma affects the body's connective tissues, such as bone, cartilage, fat, and muscle.",
      "The project has identified specific genetic mutations and changes in people with sarcoma that contribute to the development of the disease.",
      "The NTRK fusion gene mutation, identified by the project, is present in some cases of sarcoma and is associated with a positive response to the targeted therapy called larotrectinib.",
      "The 100,000 Genomes Project's research has led to improved understanding of the genetic changes in sarcoma and the development of new targeted therapies for the disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE - The NTRK fusion gene mutation is associated with a subset of various types of cancers, including some sarcomas, and targeted therapy like larotrectinib has been developed to treat tumors harboring such mutations. However, without more context, it's not possible to confirm the project identified this mutation specifically, even though the mutation exists and is relevant to the disease.\n5. TRUE - The goal of genomic projects such as the 100,000 Genomes Project is indeed to improve understanding of genetic factors in diseases and contribute to the development of new therapies. However, without specific data or results, the extent of this improvement from this particular project is difficult to ascertain.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3770,
    "user_query": "Describe the mechanism of action of pitolisant.",
    "yulan-chat-2-13b-fp16_response": "Pitolisant is a medication that is used to treat narcolepsy, a chronic neurological disorder characterized by excessive daytime sleepiness, sudden sleep onset, and cataplexy. The mechanism of action of pitolisant is not fully understood, but it is believed to work by modulating the activity of certain neurotransmitters in the brain, including histamine and dopamine.\nHistamine is a neurotransmitter that plays a role in regulating wakefulness and arousal. Pitolisant increases the activity of histamine in the brain, which helps to stimulate the wakefulness-promoting centers and reduce excessive daytime sleepiness.\nIn addition to its effects on histamine, pitolisant is also believed to increase the levels of dopamine in the brain, which may contribute to its wakefulness-promoting effects. Dopamine is a neurotransmitter that is involved in regulating motivation, reward, and attention, and it is thought to play a role in the regulation of wakefulness and arousal.\nOverall, the mechanism of action of pitolisant is complex and not fully understood, but it appears to involve the modulation of several neurotransmitter systems in the brain to promote wakefulness and reduce excessive daytime sleepiness in patients with narcolepsy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pitolisant is used to treat narcolepsy, a chronic neurological disorder.\n2. The exact mechanism of action of pitolisant is not fully understood.\n3. Pitolisant is believed to increase the activity of the neurotransmitter histamine in the brain.\n4. The increase in histamine activity by pitolisant is thought to help stimulate wakefulness-promoting centers in the brain.\n5. Pitolisant is also believed to increase the levels of dopamine in the brain.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pitolisant is used to treat narcolepsy, a chronic neurological disorder.",
      "The exact mechanism of action of pitolisant is not fully understood.",
      "Pitolisant is believed to increase the activity of the neurotransmitter histamine in the brain.",
      "The increase in histamine activity by pitolisant is thought to help stimulate wakefulness-promoting centers in the brain.",
      "Pitolisant is also believed to increase the levels of dopamine in the brain."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Pitolisant indirectly increases dopamine release in the brain, but it primarily acts by enhancing histamine neurotransmission through its action as an inverse agonist of the histamine H3 receptor.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3773,
    "user_query": "Do circular exons increase gene expression?",
    "yulan-chat-2-13b-fp16_response": "Circular exons are a type of exon that is not terminated by a polyadenylation site, and instead forms a circular RNA transcript. While there is limited research on the effect of circular exons on gene expression, some studies have suggested that they may increase gene expression.\nOne study published in the journal Nature in 2019 found that circular RNA transcripts, including circular exons, were more abundant in certain types of cancer cells compared to normal cells, and that this was associated with increased expression of the genes that these transcripts were derived from. The study suggested that circular RNA transcripts may play a role in promoting cancer progression.\nAnother study published in the journal Cell in 2018 found that circular RNA transcripts were more stable than linear RNA transcripts, and that this increased stability was associated with increased gene expression. While this study did not specifically investigate the effect of circular exons on gene expression, it suggests that the lack of a polyadenylation site may contribute to the stability and expression of circular RNA transcripts.\nOverall, while more research is needed to fully understand the effect of circular exons on gene expression, some studies suggest that they may play a role in regulating gene expression and promoting cancer progression.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Circular exons form a circular RNA transcript due to the absence of a polyadenylation site.\n2. A study published in the journal Nature in 2019 found circular RNA transcripts, including circular exons, to be more abundant in certain cancer cells than in normal cells.\n3. The study mentioned above from Nature also linked the abundance of circular RNA transcripts with increased expression of the genes they were derived from.\n4. Research published in the journal Cell in 2018 reported that circular RNA transcripts were more stable than linear RNA transcripts.\n5. The study from Cell suggested that the increased stability due to the lack of a polyadenylation site might be associated with increased gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Circular exons form a circular RNA transcript due to the absence of a polyadenylation site.",
      "A study published in the journal Nature in 2019 found circular RNA transcripts, including circular exons, to be more abundant in certain cancer cells than in normal cells.",
      "The study mentioned above from Nature also linked the abundance of circular RNA transcripts with increased expression of the genes they were derived from.",
      "Research published in the journal Cell in 2018 reported that circular RNA transcripts were more stable than linear RNA transcripts.",
      "The study from Cell suggested that the increased stability due to the lack of a polyadenylation site might be associated with increased gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The study in Nature mentioned that the abundance of circular RNA does not necessarily correlate with the increased expression of the genes they are derived from, and in some cases, there is no significant correlation between the abundance of circRNAs and the expression levels of their linear counterparts.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I don't have information on whether protein ALEX1 contains armadillo repeats. Armadillo repeats are a type of protein motif that is characterized by the repetition of a specific amino acid sequence, and they are found in many proteins involved in various cellular processes. However, the presence or absence of armadillo repeats in a protein depends on the specific sequence of the protein, and this information is not generally available for all proteins.\nTo determine whether protein ALEX1 contains armadillo repeats, you would need to consult a database of protein sequences, such as UniProt or NCBI's Protein database, and search for the presence of the armadillo repeat motif in the sequence of the protein. Alternatively, you could consult a scientific literature search engine, such as PubMed, and search for articles that discuss the structure or function of protein ALEX1, as this may provide information on whether it contains armadillo repeats.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3782,
    "user_query": "Does radiotherapy for cervical cancer increases risk of colon cancer?",
    "yulan-chat-2-13b-fp16_response": "Radiotherapy for cervical cancer can increase the risk of developing colon cancer, but the risk is relatively low.\nStudies have shown that women who receive radiotherapy to the pelvic area, including the rectum and colon, have an increased risk of developing colon cancer later in life. The risk is highest among women who received radiotherapy before the age of 30 or who received high doses of radiation.\nHowever, the overall risk of developing colon cancer after radiotherapy for cervical cancer is still low. According to some studies, the risk of developing colon cancer is less than 1% per year.\nIt is important to note that the benefits of radiotherapy for treating cervical cancer far outweigh the potential risks. Radiotherapy can be an effective treatment option for cervical cancer, and it can help to cure the disease or improve symptoms in many cases.\nIf you have received radiotherapy for cervical cancer, it is important to continue with regular screening for colon cancer. This may include colonoscopies at an earlier age than usual or more frequent screenings. Your healthcare provider can advise on the appropriate screening schedule for you based on your individual circumstances.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Radiotherapy for cervical cancer can increase the risk of developing colon cancer.\n2. Women who receive radiotherapy to the pelvic area have an increased risk of developing colon cancer later in life.\n3. The risk of developing colon cancer is highest among women who received radiotherapy before the age of 30 or who received high doses of radiation.\n4. The risk of developing colon cancer after radiotherapy for cervical cancer is less than 1% per year according to some studies.\n5. Regular screening for colon cancer is recommended for individuals who have received radiotherapy for cervical cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Radiotherapy for cervical cancer can increase the risk of developing colon cancer.",
      "Women who receive radiotherapy to the pelvic area have an increased risk of developing colon cancer later in life.",
      "The risk of developing colon cancer is highest among women who received radiotherapy before the age of 30 or who received high doses of radiation.",
      "The risk of developing colon cancer after radiotherapy for cervical cancer is less than 1% per year according to some studies.",
      "Regular screening for colon cancer is recommended for individuals who have received radiotherapy for cervical cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Radiotherapy for cervical cancer can indeed increase the risk of developing colon cancer due to the exposure of surrounding healthy tissue to radiation.\n2. TRUE: Women who receive radiotherapy to the pelvic area, such as for cervical cancer, are at an increased risk of developing secondary cancers, including colon cancer, later in life.\n3. TRUE: The risk of developing secondary cancers, including colon cancer, is often linked to the age at which radiotherapy is received and the dosage. Younger women and those who receive higher doses may have a higher risk.\n4. UNKNOWN: Without specific study references, it's difficult to confirm the accuracy of the statement regarding the percentage of risk per year. Risk percentages can vary based on different study designs, cohorts, and methodologies.\n5. TRUE: Regular screening is generally recommended for individuals with increased risk factors for colon cancer, which would include those who have received radiotherapy for cervical cancer, as they are at increased risk for secondary malignancies.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3785,
    "user_query": "Is yeast fbp1 affected by glucose starvation stress?",
    "yulan-chat-2-13b-fp16_response": "Yes, the yeast Fbp1 protein can be affected by glucose starvation stress. In yeast, Fbp1 is a key regulator of the cellular response to various stress conditions, including osmotic stress, high temperature, and low nutrient availability.\nGlucose starvation stress can occur when yeast cells are grown in the absence of glucose, and the cells are forced to use alternative sources of carbon such as ethanol or acetate. Under these conditions, Fbp1 can be induced to bind to specific DNA sequences, known as Fbp1 binding sites, in the promoter regions of target genes. This binding leads to the activation of these genes, which are involved in various stress response pathways, including the production of stress-responsive proteins, the regulation of metabolic flux, and the maintenance of cellular homeostasis.\nHowever, the exact effect of glucose starvation stress on Fbp1 activity can vary depending on the specific conditions and the downstream genes that are regulated. Some studies have shown that glucose starvation stress can lead to increased Fbp1 activity and the activation of stress response genes, while others have reported decreased Fbp1 activity and the repression of stress response genes.\nOverall, the effect of glucose starvation stress on Fbp1 activity is complex and can depend on various factors, including the severity and duration of the stress, the availability of alternative carbon sources, and the presence of other stressors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The yeast Fbp1 protein is involved in the cellular response to various stress conditions such as osmotic stress, high temperature, and low nutrient availability.\n2. Glucose starvation stress in yeast cells triggers the use of alternative carbon sources like ethanol or acetate.\n3. During glucose starvation, Fbp1 can bind to Fbp1 binding sites in the promoter regions of target genes.\n4. The binding of Fbp1 to these sites can lead to the activation of genes involved in stress response pathways.\n5. The effect of glucose starvation stress on Fbp1 activity and gene regulation can be variable and depends on factors like stress severity, duration, alternate carbon source availability, and presence of other stressors.",
    "yulan-chat-2-13b-fp16_fact": [
      "The yeast Fbp1 protein is involved in the cellular response to various stress conditions such as osmotic stress, high temperature, and low nutrient availability.",
      "Glucose starvation stress in yeast cells triggers the use of alternative carbon sources like ethanol or acetate.",
      "During glucose starvation, Fbp1 can bind to Fbp1 binding sites in the promoter regions of target genes.",
      "The binding of Fbp1 to these sites can lead to the activation of genes involved in stress response pathways.",
      "The effect of glucose starvation stress on Fbp1 activity and gene regulation can be variable and depends on factors like stress severity, duration, alternate carbon source availability, and presence of other stressors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: During glucose starvation, Fbp1 does not bind to DNA; instead, it is a fructose-1,6-bisphosphatase involved in gluconeogenesis, which is the process of producing glucose from non-carbohydrate sources.\n4. FALSE [correction]: Since Fbp1 is an enzyme involved in gluconeogenesis, it does not directly bind to promoter regions to activate genes. Gene activation would typically involve transcription factors, not enzymes like Fbp1.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3786,
    "user_query": "What does csDMARD stand for?",
    "yulan-chat-2-13b-fp16_response": "csDMARD stands for \"Clinical System for the Management of Medicines and the Recording of Adverse Reactions to Medicines.\" It is a clinical information system used in the UK National Health Service (NHS) to support the management of medicines and the recording of adverse reactions to medicines. The system is designed to help healthcare professionals make informed decisions about the use of medicines, improve patient safety, and support the management of medicines across different care settings.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3788,
    "user_query": "Is Semagacestat effective for Alzheimer's Disease?",
    "yulan-chat-2-13b-fp16_response": "Semagacestat is an experimental drug that was being developed for the treatment of Alzheimer's disease, but it was discontinued by its developer, Janssen Research & Development, in 2019 due to lack of efficacy in clinical trials.\nIn clinical trials, semagacestat did not meet its primary endpoint of slowing cognitive decline in patients with mild to moderate Alzheimer's disease. Additionally, the drug was associated with increased incidence of adverse events, including elevated liver enzymes and abnormal liver function tests.\nWhile semagacestat showed some promise in early preclinical studies, the clinical trial results were disappointing and the drug was ultimately discontinued. There are currently no FDA-approved drugs for the treatment of Alzheimer's disease, but there are several other experimental drugs in development that show promise.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Semagacestat is an experimental drug that was developed for the treatment of Alzheimer's disease.\n2. Semagacestat was discontinued by its developer, Janssen Research & Development, in 2019.\n3. In clinical trials, semagacestat failed to slow cognitive decline in patients with mild to moderate Alzheimer's disease.\n4. Use of semagacestat was associated with an increased incidence of adverse events, such as elevated liver enzymes and abnormal liver function tests.\n5. As of the knowledge cutoff date, there are no FDA-approved drugs specifically for the treatment of Alzheimer's disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Semagacestat is an experimental drug that was developed for the treatment of Alzheimer's disease.",
      "Semagacestat was discontinued by its developer, Janssen Research & Development, in 2019.",
      "In clinical trials, semagacestat failed to slow cognitive decline in patients with mild to moderate Alzheimer's disease.",
      "Use of semagacestat was associated with an increased incidence of adverse events, such as elevated liver enzymes and abnormal liver function tests.",
      "As of the knowledge cutoff date, there are no FDA-approved drugs specifically for the treatment of Alzheimer's disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN (The statement about the discontinuation may require more specific information such as the exact year and the entity responsible for discontinuation.)\n3. TRUE\n4. TRUE\n5. FALSE [correction]: As of the knowledge cutoff date, there are FDA-approved drugs specifically for the treatment of Alzheimer's disease, such as donepezil, rivastigmine, and memantine.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "yulan-chat-2-13b-fp16_response": "There are several enzymes that can remove histone modifications, including:\n1. Histone deacetylases (HDACs): These enzymes remove acetyl groups from histones, leading to a more compact chromatin structure.\n2. Histone demethylases: These enzymes remove methyl groups from histones, leading to a more open chromatin structure.\n3. Histone lysine deubiquitinases (HUSPs): These enzymes remove ubiquitin molecules from histones, which can help to stabilize the histone modifications.\n4. Histone kinases: These enzymes add phosphate groups to histones, which can help to stabilize the histone modifications.\n5. Histone chaperones: These proteins help to facilitate the exchange of histones in the nucleus, which can help to regulate the levels of histone modifications.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS\n\n(The response outlines the functions and general actions of certain types of enzymes and proteins but does not include specific, verifiable factual statements about individual enzymes or proteins.)",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3790,
    "user_query": "Roughly how many base pairs are in the human mitochondrial genome or mtDNA?",
    "yulan-chat-2-13b-fp16_response": "The human mitochondrial genome, or mtDNA, is approximately 16,569 base pairs in length.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The human mitochondrial genome, or mtDNA, is approximately 16,569 base pairs in length.",
    "yulan-chat-2-13b-fp16_fact": [
      "The human mitochondrial genome, or mtDNA, is approximately 16,569 base pairs in length."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 3791,
    "user_query": "Do nematodes contain a CTCF gene?",
    "yulan-chat-2-13b-fp16_response": "Yes, nematodes do contain a CTCF gene. CTCF (CCCTC-binding factor) is a transcription factor protein that plays important roles in regulating gene expression, chromatin organization, and cell-cell communication in various organisms, including humans, mice, and nematodes.\nIn nematodes, the CTCF gene has been identified in the genome of the model organism Caenorhabditis elegans, and it is thought to function in similar ways to its homologs in other species. CTCF has been shown to be involved in regulating a variety of developmental processes in C. elegans, including the determination of body planarity, the organization of the germ line, and the regulation of cell fate decisions.\nOverall, the presence of a CTCF gene in nematodes suggests that this protein is an important regulator of gene expression and development in these organisms, as it is in other species.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nematodes contain a CTCF gene.\n2. The CTCF gene is present in the genome of the nematode model organism Caenorhabditis elegans.\n3. CTCF in nematodes is implicated in regulating gene expression, chromatin organization, and cell-cell communication.\n4. In Caenorhabditis elegans, the CTCF gene is involved in developmental processes such as body planarity, germ line organization, and cell fate decisions.\n5. The CTCF protein acts as an important regulator of gene expression and development in nematodes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nematodes contain a CTCF gene.",
      "The CTCF gene is present in the genome of the nematode model organism Caenorhabditis elegans.",
      "CTCF in nematodes is implicated in regulating gene expression, chromatin organization, and cell-cell communication.",
      "In Caenorhabditis elegans, the CTCF gene is involved in developmental processes such as body planarity, germ line organization, and cell fate decisions.",
      "The CTCF protein acts as an important regulator of gene expression and development in nematodes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The CTCF gene is not present in the genome of the nematode model organism Caenorhabditis elegans.\n3. UNKNOWN (Specific functions of CTCF-like activity in nematodes might be hard to determine without more information, especially since statement 2 is false.)\n4. FALSE [correction]: Since Caenorhabditis elegans does not have the CTCF gene, it cannot be involved in developmental processes in C. elegans.\n5. UNKNOWN (While the CTCF protein is an important regulator of gene expression and development in many organisms, the direct functions in nematodes, especially given the absence in C. elegans, are hard to confirm without specific information.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3796,
    "user_query": "What does Retapamulin treat?",
    "yulan-chat-2-13b-fp16_response": "Retapamulin is an antibiotic that is used to treat skin and skin structure infections caused by susceptible strains of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). It works by interfering with the synthesis of bacterial cell walls, which ultimately leads to the death of the bacteria. Retapamulin is available in the form of a topical cream, gel, or ointment and is typically used to treat conditions such as impetigo, folliculitis, and cellulitis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Retapamulin is an antibiotic used to treat skin and skin structure infections.\n2. It is effective against susceptible strains of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA).\n3. Retapamulin operates by interfering with the synthesis of bacterial cell walls.\n4. It is available in forms of a topical cream, gel, or ointment.\n5. Retapamulin is typically used to treat conditions such as impetigo, folliculitis, and cellulitis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Retapamulin is an antibiotic used to treat skin and skin structure infections.",
      "It is effective against susceptible strains of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA).",
      "Retapamulin operates by interfering with the synthesis of bacterial cell walls.",
      "It is available in forms of a topical cream, gel, or ointment.",
      "Retapamulin is typically used to treat conditions such as impetigo, folliculitis, and cellulitis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Retapamulin operates by selectively inhibiting the bacterial protein synthesis at the level of the 50S ribosome.\n4. TRUE\n5. FALSE [correction]: Retapamulin is typically used to treat impetigo due to susceptible strains of Staphylococcus aureus and Streptococcus pyogenes. Folliculitis and cellulitis are generally treated with other antibiotics.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3797,
    "user_query": "Which histone mark distinguishes active from inactive enhancers?",
    "yulan-chat-2-13b-fp16_response": "Histone mark H3K4me3 is generally considered to be a distinguishing mark between active and inactive enhancers. H3K4me3 is associated with active promoters and enhancers and is characterized by the trimethylation of lysine 4 on the histone H3 protein. This mark is often used as a marker for active gene expression and is associated with the transcriptional activation of genes. In contrast, inactive enhancers are characterized by the absence of this mark or the presence of other histone marks, such as H3K27me3, which is associated with gene repression. However, it's important to note that histone marks are not the only factor that determines enhancer activity and that other factors such as DNA sequence, transcription factors, and chromatin structure also play important roles.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Histone mark H3K4me3 is associated with active promoters and enhancers.\n2. H3K4me3 is characterized by the trimethylation of lysine 4 on the histone H3 protein.\n3. The presence of H3K4me3 is often used as a marker for active gene expression.\n4. Inactive enhancers are characterized by the absence of H3K4me3 or the presence of other histone marks like H3K27me3.\n5. H3K27me3 is associated with gene repression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Histone mark H3K4me3 is associated with active promoters and enhancers.",
      "H3K4me3 is characterized by the trimethylation of lysine 4 on the histone H3 protein.",
      "The presence of H3K4me3 is often used as a marker for active gene expression.",
      "Inactive enhancers are characterized by the absence of H3K4me3 or the presence of other histone marks like H3K27me3.",
      "H3K27me3 is associated with gene repression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: The histone mark H3K4me3 is indeed associated with the transcriptional activation of genes and is commonly found at active promoters and enhancers.\n2. TRUE: H3K4me3 stands for histone H3 lysine 4 trimethylation, which means that three methyl groups are added to the lysine 4 amino acid residue of the histone H3 protein.\n3. TRUE: The presence of H3K4me3 is often used as an epigenetic marker for active gene expression because it is found at the promoters of actively transcribed genes.\n4. TRUE: Inactive enhancers typically lack the active mark H3K4me3 and can be characterized by the presence of other histone modifications, such as H3K27me3, that are associated with a more repressed chromatin state.\n5. TRUE: H3K27me3 is a histone mark associated with gene repression and can indicate a silenced or repressed state of the associated genomic region.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3800,
    "user_query": "What is targeted by Pexidartinib?",
    "yulan-chat-2-13b-fp16_response": "Pexidartinib is a small molecule inhibitor that targets a specific enzyme called tyrosine kinase, which is involved in the development and progression of certain types of cancer. Specifically, pexidartinib targets the receptor tyrosine kinase (RTK) family member KIT, which is overexpressed in certain cancers, including gastrointestinal stromal tumors (GIST) and systemic mastocytosis. By inhibiting the activity of KIT, pexidartinib can help slow or stop the growth and spread of these cancers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pexidartinib is a small molecule inhibitor that targets the enzyme tyrosine kinase.\n2. Tyrosine kinase is involved in the development and progression of certain types of cancer.\n3. Pexidartinib specifically targets a member of the receptor tyrosine kinase (RTK) family known as KIT.\n4. KIT is overexpressed in certain cancers, including gastrointestinal stromal tumors (GIST).\n5. Pexidartinib is used to slow or stop the growth and spread of cancers that overexpress KIT, including systemic mastocytosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pexidartinib is a small molecule inhibitor that targets the enzyme tyrosine kinase.",
      "Tyrosine kinase is involved in the development and progression of certain types of cancer.",
      "Pexidartinib specifically targets a member of the receptor tyrosine kinase (RTK) family known as KIT.",
      "KIT is overexpressed in certain cancers, including gastrointestinal stromal tumors (GIST).",
      "Pexidartinib is used to slow or stop the growth and spread of cancers that overexpress KIT, including systemic mastocytosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Pexidartinib specifically targets the colony-stimulating factor 1 receptor (CSF1R), not KIT.\n4. TRUE\n5. FALSE [correction]: Pexidartinib is used to treat tenosynovial giant cell tumor (TGCT) and not specifically indicated for systemic mastocytosis or cancers that overexpress KIT. However, systemic mastocytosis may involve the activation of KIT, but pexidartinib targets CSF1R.\n",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "yulan-chat-2-13b-fp16_response": "There is no evidence to suggest that using head CT scans increases the risk of developing brain tumors. CT scans use radiation, but the amount of radiation received during a CT scan is very small and is not considered to be a significant risk for developing brain tumors. It is important to discuss any concerns you may have with your doctor before undergoing any medical imaging tests.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Head CT scans use radiation.\n2. The amount of radiation received during a CT scan is very small.\n3. CT scans are not considered to be a significant risk for developing brain tumors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Head CT scans use radiation.",
      "The amount of radiation received during a CT scan is very small.",
      "CT scans are not considered to be a significant risk for developing brain tumors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The amount of radiation received during a CT scan is generally more than that of a standard X-ray but is still considered safe for diagnostic purposes. The amount is not \"very small,\" especially when compared to other imaging modalities like standard X-rays.\n3. TRUE: While there is some debate and ongoing research about the risk, generally, CT scans are not considered to be a significant risk for developing brain tumors, particularly when used judiciously and when the benefits outweigh the risks of radiation exposure. However, it is worth noting that the risk can be cumulative, and therefore, unnecessary scans are avoided to minimize radiation exposure over time.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3807,
    "user_query": "Which main viral protein is targeted by the drug remdesivir?",
    "yulan-chat-2-13b-fp16_response": "Remdesivir is an antiviral drug that targets the viral protein called \"polymerase,\" which is an enzyme that is essential for the replication of the virus. Specifically, remdesivir inhibits the activity of the polymerase, preventing the virus from producing new copies of itself. This can help to reduce the severity of the infection and speed up the recovery of the patient. Remdesivir has been used to treat a variety of viral infections, including Ebola and COVID-19.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Remdesivir is an antiviral drug that targets the viral polymerase protein.\n2. Polymerase is an enzyme essential for viral replication.\n3. Remdesivir inhibits the activity of the polymerase enzyme.\n4. The inhibition of polymerase by remdesivir can reduce the severity of viral infections.\n5. Remdesivir has been used in the treatment of Ebola and COVID-19.",
    "yulan-chat-2-13b-fp16_fact": [
      "Remdesivir is an antiviral drug that targets the viral polymerase protein.",
      "Polymerase is an enzyme essential for viral replication.",
      "Remdesivir inhibits the activity of the polymerase enzyme.",
      "The inhibition of polymerase by remdesivir can reduce the severity of viral infections.",
      "Remdesivir has been used in the treatment of Ebola and COVID-19."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "yulan-chat-2-13b-fp16_response": "Otx2 is a transcription factor that is associated with pluripotency in the early embryonic development of animals, including mice and fish. It is involved in the maintenance of pluripotency in the inner cell mass of the early embryo, and is required for the formation of the anterior visceral endoderm, a precursor to the foregut and other anterior body plans. Otx2 is also involved in the regulation of the expression of other transcription factors that are important for pluripotency, such as Nanog, Sox2, and Oct4.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Otx2 is a transcription factor associated with pluripotency in the early embryonic development of animals.\n2. Otx2 is involved in the maintenance of pluripotency in the inner cell mass of the early embryo.\n3. Otx2 is required for the formation of the anterior visceral endoderm.\n4. The anterior visceral endoderm is a precursor to the foregut and other anterior body plans.\n5. Otx2 regulates the expression of other transcription factors important for pluripotency including Nanog, Sox2, and Oct4.",
    "yulan-chat-2-13b-fp16_fact": [
      "Otx2 is a transcription factor associated with pluripotency in the early embryonic development of animals.",
      "Otx2 is involved in the maintenance of pluripotency in the inner cell mass of the early embryo.",
      "Otx2 is required for the formation of the anterior visceral endoderm.",
      "The anterior visceral endoderm is a precursor to the foregut and other anterior body plans.",
      "Otx2 regulates the expression of other transcription factors important for pluripotency including Nanog, Sox2, and Oct4."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Otx2 is a transcription factor but it is not associated with pluripotency. It is involved in the development of the brain and eye in mammals.\n2. FALSE [correction]: Otx2 is not involved in maintaining pluripotency in the inner cell mass of the early embryo. It is involved in the development of the rostral brain and other structures in mammals.\n3. TRUE: Otx2 is required for the formation of the anterior visceral endoderm (AVE).\n4. TRUE: The anterior visceral endoderm (AVE) plays a critical role in specifying foregut territories and has signaling functions that influence development of anterior structures in the mammalian embryo.\n5. FALSE [correction]: Otx2 itself regulates gene expression involved in brain and sensory organ development but is not directly responsible for the regulation of pluripotency transcription factors Nanog, Sox2, and Oct4, which are more closely associated with the maintenance of pluripotency.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3813,
    "user_query": "Is aggrephagy a variant of autophagy?",
    "yulan-chat-2-13b-fp16_response": "Yes, aggrephagy is a variant of autophagy.\nAutophagy is a cellular process in which cells degrade and recycle their own components, including organelles, proteins, and lipids. This process is important for maintaining cellular homeostasis, providing a source of nutrients during starvation, and eliminating damaged or abnormal cell components.\nAgrephagy, also known as xenophagy, is a type of autophagy that specifically targets extracellular material, such as bacteria, viruses, and other foreign particles. This process is important for clearing invading pathogens and debris from the body.\nAgrephagy is similar to autophagy in that it involves the formation of autophagosomes, which engulf and digest cellular components. However, the target of aggrephagy is external material, rather than internal cellular components.\nIn summary, aggrephagy is a type of autophagy that specifically targets extracellular material, and it is an important mechanism for clearing invading pathogens and debris from the body.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aggrephagy is a variant of autophagy.\n2. Autophagy is a cellular process where cells break down and recycle their components.\n3. Aggrephagy, also known as xenophagy, targets extracellular material such as bacteria and viruses.\n4. Aggrephagy involves the formation of autophagosomes for engulfing and digesting cellular components.\n5. Autophagy is important for maintaining cellular homeostasis and providing nutrients during starvation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Aggrephagy is a variant of autophagy.",
      "Autophagy is a cellular process where cells break down and recycle their components.",
      "Aggrephagy, also known as xenophagy, targets extracellular material such as bacteria and viruses.",
      "Aggrephagy involves the formation of autophagosomes for engulfing and digesting cellular components.",
      "Autophagy is important for maintaining cellular homeostasis and providing nutrients during starvation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Xenophagy is the process that targets extracellular material such as bacteria and viruses. Aggrephagy specifically targets aggregated proteins within cells.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "yulan-chat-2-13b-fp16_response": "There are approximately 10-15 DNaseI hypersensitive sites (DHS) that mark the murine beta globin locus region. However, the exact number can vary depending on the specific strain of mouse and the experimental conditions used to generate the DHS data.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There are approximately 10-15 DNaseI hypersensitive sites that mark the murine beta globin locus region.\n2. The exact number of DNaseI hypersensitive sites can vary depending on the specific strain of mouse.\n3. The number of DNaseI hypersensitive sites can also vary based on the experimental conditions used.",
    "yulan-chat-2-13b-fp16_fact": [
      "There are approximately 10-15 DNaseI hypersensitive sites that mark the murine beta globin locus region.",
      "The exact number of DNaseI hypersensitive sites can vary depending on the specific strain of mouse.",
      "The number of DNaseI hypersensitive sites can also vary based on the experimental conditions used."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3817,
    "user_query": "Which loss-of-function ABCC8 mutation is associated with Pulmonary Arterial Hypertension (PAH)?",
    "yulan-chat-2-13b-fp16_response": "The loss-of-function ABCC8 mutation that is associated with Pulmonary Arterial Hypertension (PAH) is called the \"R116X\" mutation. This mutation results in the loss of function of the potassium channel ABCC8, which is involved in the regulation of potassium ion transport in various cellular processes, including cellular homeostasis, cellular signaling, and cellular metabolism. The R116X mutation has been shown to be a common cause of hereditary PAH, a form of the disease that is inherited in an autosomal dominant manner. The R116X mutation is thought to increase the risk of developing PAH by disrupting the normal function of the ABCC8 potassium channel, which can lead to abnormal cellular signaling and cellular metabolism in the pulmonary arterial smooth muscle cells, leading to the development of PAH.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The \"R116X\" mutation in the ABCC8 gene is associated with Pulmonary Arterial Hypertension (PAH).\n2. The R116X mutation leads to a loss of function of the ABCC8 potassium channel.\n3. The ABCC8 potassium channel is involved in the regulation of potassium ion transport.\n4. The R116X mutation is a common cause of hereditary Pulmonary Arterial Hypertension.\n5. Hereditary PAH associated with the R116X mutation is inherited in an autosomal dominant manner.",
    "yulan-chat-2-13b-fp16_fact": [
      "The \"R116X\" mutation in the ABCC8 gene is associated with Pulmonary Arterial Hypertension (PAH).",
      "The R116X mutation leads to a loss of function of the ABCC8 potassium channel.",
      "The ABCC8 potassium channel is involved in the regulation of potassium ion transport.",
      "The R116X mutation is a common cause of hereditary Pulmonary Arterial Hypertension.",
      "Hereditary PAH associated with the R116X mutation is inherited in an autosomal dominant manner."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The \"R116X\" mutation in the ABCC8 gene is not associated with Pulmonary Arterial Hypertension (PAH). It is associated with Congenital Hyperinsulinism.\n2. TRUE: R116X mutation in the ABCC8 gene can lead to a loss of function of the ABCC8 potassium channel.\n3. TRUE: The ABCC8 gene encodes for the SUR1 subunit of the ATP-sensitive potassium (K-ATP) channel, which is involved in the regulation of potassium ion transport.\n4. FALSE [correction]: The R116X mutation is not a common cause of hereditary Pulmonary Arterial Hypertension. Instead, it is associated with Congenital Hyperinsulinism.\n5. UNKNOWN: The inheritance pattern of hereditary PAH associated with mutations in the ABCC8 gene is unclear from this statement since R116X is related to Congenital Hyperinsulinism. Typically, hereditary PAH can have different inheritance patterns depending on the specific genetic mutations involved.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3819,
    "user_query": "List the core SNARE complex proteins.",
    "yulan-chat-2-13b-fp16_response": "The core SNARE complex proteins are:\n1. SNAP-25\n2. V-ATPase subunit E\n3. syntaxin 1\n4. synaptobrevin 1\nThese proteins form the core SNARE complex, which is responsible for the fusion of vesicles with the plasma membrane in neurons.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. SNAP-25 is a core SNARE complex protein.\n2. Syntaxin 1 is a core SNARE complex protein.\n3. Synaptobrevin 1 is a core SNARE complex protein.\n4. The core SNARE complex is responsible for the fusion of vesicles with the plasma membrane in neurons.\n5. V-ATPase subunit E is incorrectly listed as a core SNARE complex protein (it is not a SNARE protein).",
    "yulan-chat-2-13b-fp16_fact": [
      "SNAP-25 is a core SNARE complex protein.",
      "Syntaxin 1 is a core SNARE complex protein.",
      "Synaptobrevin 1 is a core SNARE complex protein.",
      "The core SNARE complex is responsible for the fusion of vesicles with the plasma membrane in neurons.",
      "V-ATPase subunit E is incorrectly listed as a core SNARE complex protein (it is not a SNARE protein)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "yulan-chat-2-13b-fp16_response": "1. Aviomar\n2. Celvivo\n3. Flucelvax\n4. Flublok\n5. Fluzone\n6. Fluzone High-Dose\n7. Fluzone Quadrivalent\n8. Flumist\n9. Influenza A (H5N1) Monovalent Vaccine\n10. Influenza A (H7N9) Monovalent Vaccine\n11. Influenza A (H1N1) Monovalent Vaccine\n12. Influenza A (H3N2) Monovalent Vaccine\n13. Influenza B (Yamagata) Virus Monovalent Vaccine\n14. Influenza B (Victoria) Virus Monovalent Vaccine\n15. Influenza A (H5N1) Monovalent Vaccine\n16. Influenza A (H7N9) Monovalent Vaccine\n17. Influenza A (H1N1) Monovalent Vaccine\n18. Influenza A (H3N2) Monovalent Vaccine\n19. Influenza B (Yamagata) Virus Monovalent Vaccine\n20. Influenza B (Victoria) Virus Monovalent Vaccine",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aviomar is listed as a European influenza vaccine.\n2. Celvivo is listed as a European influenza vaccine.\n3. Flucelvax is listed as a European influenza vaccine.\n4. Flublok is listed as a European influenza vaccine.\n5. Fluzone is listed as a European influenza vaccine.",
    "yulan-chat-2-13b-fp16_fact": [
      "Aviomar is listed as a European influenza vaccine.",
      "Celvivo is listed as a European influenza vaccine.",
      "Flucelvax is listed as a European influenza vaccine.",
      "Flublok is listed as a European influenza vaccine.",
      "Fluzone is listed as a European influenza vaccine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE: Flucelvax is an influenza vaccine that is used in various countries, including within Europe.\n4. UNKNOWN\n5. UNKNOWN \n\nWithout specific data regarding the European Medicines Agency's (EMA) current list of approved influenza vaccines, I cannot confirm the status of Aviomar, Celvivo, Flublok, and Fluzone within the European context. The approval status of vaccines can change, and it is possible that these vaccines are marketed under different names in Europe or may not be approved for use in Europe as of my knowledge cutoff date.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3823,
    "user_query": "What is canSAR?",
    "yulan-chat-2-13b-fp16_response": "canSAR is an open-source software tool for the analysis of gene expression data. It is designed to provide a user-friendly interface for the analysis of gene expression data sets generated from microarray or sequencing technologies. canSAR is designed to help researchers identify differentially expressed genes, classify genes into functional categories, and identify potential biological pathways that are associated with the observed changes in gene expression. It also provides tools for the visualization of gene expression data and the identification of gene expression patterns.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. canSAR is an open-source software tool for the analysis of gene expression data.\n2. canSAR provides a user-friendly interface for analyzing gene expression data sets from microarray or sequencing technologies.\n3. canSAR assists researchers in identifying differentially expressed genes.\n4. canSAR includes functionality to classify genes into functional categories.\n5. canSAR offers tools for the visualization of gene expression data.",
    "yulan-chat-2-13b-fp16_fact": [
      "canSAR is an open-source software tool for the analysis of gene expression data.",
      "canSAR provides a user-friendly interface for analyzing gene expression data sets from microarray or sequencing technologies.",
      "canSAR assists researchers in identifying differentially expressed genes.",
      "canSAR includes functionality to classify genes into functional categories.",
      "canSAR offers tools for the visualization of gene expression data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: canSAR is an integrated knowledgebase that brings together multidisciplinary data across biology, chemistry, pharmacology, structural biology, cellular networks and clinical annotations, and is not specifically a tool for gene expression analysis.\n2. FALSE [correction]: As canSAR is not designed for gene expression data analysis, it does not provide a user interface specifically for that purpose.\n3. FALSE [correction]: canSAR does not assist researchers in identifying differentially expressed genes as its primary focus is not on gene expression data analysis.\n4. UNKNOWN: Without specific information about the full range of functionalities provided by canSAR, it's unclear if it includes the functionality to classify genes into functional categories.\n5. UNKNOWN: Similarly, without specific information on canSARs capabilities with respect to visualization, it's unclear if it offers tools for the visualization of gene expression data.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3824,
    "user_query": "What is the mechanism of action of magrolimab?",
    "yulan-chat-2-13b-fp16_response": "Magrolimab is a monoclonal antibody that targets CD47, a cell surface protein that is involved in the immune system and cancer. CD47 plays a role in the interaction between cells and the immune system, and it has been shown to be overexpressed on the surface of many cancer cells.\nThe mechanism of action of magrolimab is to bind to CD47 on the surface of cancer cells, which then prevents the binding of CD47 to its ligand, SIRP, on immune cells. This blocking of the CD47-SIRP interaction prevents the immune cells from being inhibited by cancer cells, allowing the immune cells to attack and destroy the cancer cells.\nIn addition to its direct effect on cancer cells, magrolimab may also stimulate the immune system by enhancing the activity of immune cells, such as T cells and natural killer cells, which can help to fight cancer.\nOverall, the mechanism of action of magrolimab is to target CD47 on cancer cells, which helps to activate the immune system and promote the destruction of cancer cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Magrolimab is a monoclonal antibody that targets CD47, a cell surface protein.\n2. CD47 is involved in immune system interactions and is overexpressed on many cancer cell surfaces.\n3. Magrolimab binds to CD47 on the surface of cancer cells, preventing it from binding to its ligand SIRP on immune cells.\n4. Blocking the CD47-SIRP interaction allows immune cells to attack and destroy cancer cells.\n5. Magrolimab may stimulate the immune system by enhancing the activity of T cells and natural killer cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "Magrolimab is a monoclonal antibody that targets CD47, a cell surface protein.",
      "CD47 is involved in immune system interactions and is overexpressed on many cancer cell surfaces.",
      "Magrolimab binds to CD47 on the surface of cancer cells, preventing it from binding to its ligand SIRP on immune cells.",
      "Blocking the CD47-SIRP interaction allows immune cells to attack and destroy cancer cells.",
      "Magrolimab may stimulate the immune system by enhancing the activity of T cells and natural killer cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Magrolimab may stimulate the immune system by enhancing the activity of macrophages to phagocytose cancer cells. It does not directly enhance the activity of T cells and natural killer cells.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3830,
    "user_query": "Should tirilazad be used for treatment of ischemic stroke?",
    "yulan-chat-2-13b-fp16_response": "Tirilazad is an experimental drug that has been studied for the treatment of ischemic stroke. Ischemic stroke occurs when blood flow to a part of the brain is blocked, leading to damage or death of brain cells.\nTirilazad is a synthetic molecule that works by inhibiting the activity of an enzyme called matrix metalloproteinase-9 (MMP-9). This enzyme is involved in the breakdown of blood vessels and other tissues, and is thought to play a role in the development of ischemic stroke.\nStudies have shown that tirilazad can improve outcomes in animal models of ischemic stroke, and it has also been tested in clinical trials in humans. However, the results of these trials have been mixed, and the drug has not yet been approved for use in the treatment of ischemic stroke.\nThere are several reasons why tirilazad may not be an effective treatment for ischemic stroke. One reason is that the drug can have side effects, such as bleeding and damage to the liver and kidneys. Additionally, the drug may not be able to reach the affected area of the brain quickly enough to be effective.\nOverall, while tirilazad shows promise as a potential treatment for ischemic stroke, more research is needed to determine its safety and effectiveness. It is important to note that there are other treatments available for ischemic stroke, such as tissue plasminogen activator (tPA) and mechanical thrombectomy, which should be used as first-line treatments.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tirilazad is an experimental drug that has been studied for the treatment of ischemic stroke.\n2. Ischemic stroke is caused by a blockage of blood flow to a part of the brain.\n3. Tirilazad works by inhibiting the activity of an enzyme called matrix metalloproteinase-9 (MMP-9).\n4. Tirilazad has improved outcomes in animal models of ischemic stroke.\n5. Tirilazad has been tested in clinical trials but has not been approved for the treatment of ischemic stroke.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tirilazad is an experimental drug that has been studied for the treatment of ischemic stroke.",
      "Ischemic stroke is caused by a blockage of blood flow to a part of the brain.",
      "Tirilazad works by inhibiting the activity of an enzyme called matrix metalloproteinase-9 (MMP-9).",
      "Tirilazad has improved outcomes in animal models of ischemic stroke.",
      "Tirilazad has been tested in clinical trials but has not been approved for the treatment of ischemic stroke."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Tirilazad works by reducing lipid peroxidation and inhibiting oxidative stress and inflammation. It is not specifically an MMP-9 inhibitor.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3831,
    "user_query": "List the major families of Histones.",
    "yulan-chat-2-13b-fp16_response": "There are five major families of histones:\n1. Histone H1\n2. Histone H2A\n3. Histone H2B\n4. Histone H3\n5. Histone H4",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There are five major families of histones.\n2. Histone H1 is one of the major families of histones.\n3. Histone H2A is one of the major families of histones.\n4. Histone H2B is one of the major families of histones.\n5. Histone H3 is one of the major families of histones.\n6. Histone H4 is one of the major families of histones.",
    "yulan-chat-2-13b-fp16_fact": [
      "There are five major families of histones.",
      "Histone H1 is one of the major families of histones.",
      "Histone H2A is one of the major families of histones.",
      "Histone H2B is one of the major families of histones.",
      "Histone H3 is one of the major families of histones.",
      "Histone H4 is one of the major families of histones."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE\n\nHistones are proteins that play a central role in the structure of chromatin in eukaryotic cells. There are indeed five major families of histones: H1, H2A, H2B, H3, and H4. These families work together to help organize DNA into nucleosomes, which are the basic units of chromatin structure, allowing for the compaction of DNA into the cell nucleus.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "yulan-chat-2-13b-fp16_response": "Yes, the Paramyxovirus genome is segmented and consists of negative-sense RNA.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3835,
    "user_query": "Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?",
    "yulan-chat-2-13b-fp16_response": "Kabuki syndrome type 1 (KS1) is caused by mutations in the KMT2D gene, which encodes a component of the histone methyltransferase complex. Mutations in exon 38 or 39 of the KMT2D gene have been reported to cause KS1 in some individuals. However, the exact frequency and penetrance of these variants in causing KS1 is not well established. It is important to note that not all individuals with KS1 have mutations in the KMT2D gene, and other genetic and environmental factors may also contribute to the development of this condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Kabuki syndrome type 1 (KS1) is caused by mutations in the KMT2D gene.\n2. The KMT2D gene encodes a component of the histone methyltransferase complex.\n3. Mutations in exon 38 or 39 of the KMT2D gene have been reported to cause KS1 in some individuals.\n4. Not all individuals with KS1 have mutations in the KMT2D gene.",
    "yulan-chat-2-13b-fp16_fact": [
      "Kabuki syndrome type 1 (KS1) is caused by mutations in the KMT2D gene.",
      "The KMT2D gene encodes a component of the histone methyltransferase complex.",
      "Mutations in exon 38 or 39 of the KMT2D gene have been reported to cause KS1 in some individuals.",
      "Not all individuals with KS1 have mutations in the KMT2D gene."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3836,
    "user_query": "The NoSAS Score can be used for screening of which disorders?",
    "yulan-chat-2-13b-fp16_response": "The NoSAS (No Screening Allergy Test) score is a tool used to assess the likelihood of a patient having a food allergy based on their clinical history and presentation. It is not used for screening any specific disorder, but rather to help healthcare professionals make a decision about whether to refer a patient for further allergy testing. The score is calculated based on a patient's symptoms, time of onset, and other factors, and is intended to be used in conjunction with a thorough medical history and physical examination.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3837,
    "user_query": "What is the chromosomal abnormality associated with Klinefelter Syndrome",
    "yulan-chat-2-13b-fp16_response": "Klinefelter Syndrome is a genetic disorder caused by the presence of an extra X chromosome in males. Thischromosomal abnormality is called \"supernumerary X chromosome\" or \"XXY\" syndrome. It occurs in about 1 in every 500 to 1,000 male births. The extra X chromosome results in a number of physical and developmental differences in males, including taller stature, breast enlargement, and infertility.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Klinefelter Syndrome is caused by the presence of an extra X chromosome in males.\n2. The condition is sometimes referred to as \"supernumerary X chromosome\" or \"XXY\" syndrome.\n3. Klinefelter Syndrome occurs in about 1 in every 500 to 1,000 male births.\n4. Physical and developmental differences in males with Klinefelter Syndrome can include taller stature, breast enlargement, and infertility.",
    "yulan-chat-2-13b-fp16_fact": [
      "Klinefelter Syndrome is caused by the presence of an extra X chromosome in males.",
      "The condition is sometimes referred to as \"supernumerary X chromosome\" or \"XXY\" syndrome.",
      "Klinefelter Syndrome occurs in about 1 in every 500 to 1,000 male births.",
      "Physical and developmental differences in males with Klinefelter Syndrome can include taller stature, breast enlargement, and infertility."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE (Although the exact incidence can vary, this is within the commonly cited range for the occurrence of Klinefelter Syndrome.)\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3838,
    "user_query": "What distinguishes RIDLs from other transpozable elements?",
    "yulan-chat-2-13b-fp16_response": "Retrotransposable elements (RTEs) are DNA elements that can move from one location in a genome to another. RIDLs (Retrotransposable Insertion Deletion-like elements) are a specific type of RTE that are characterized by their ability to insert into the genome in a copy-and-paste fashion, leaving behind a characteristic deletion/insertion pattern. This distinguishes them from other types of RTEs, such as long terminal repeat (LTR) elements, which have a different structure and insertion mechanism. Additionally, RIDLs are often more mobile than other types of RTEs, and can move across long distances in the genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RIDLs (Retrotransposable Insertion Deletion-like elements) are a specific type of retrotransposable elements (RTEs).\n2. RIDLs insert into the genome using a copy-and-paste mechanism.\n3. RIDLs leave behind a characteristic deletion/insertion pattern in the genome.\n4. RIDLs are different from long terminal repeat (LTR) elements, which have a different structure and insertion mechanism.\n5. RIDLs are often more mobile than other types of RTEs and can move across long distances in the genome.",
    "yulan-chat-2-13b-fp16_fact": [
      "RIDLs (Retrotransposable Insertion Deletion-like elements) are a specific type of retrotransposable elements (RTEs).",
      "RIDLs insert into the genome using a copy-and-paste mechanism.",
      "RIDLs leave behind a characteristic deletion/insertion pattern in the genome.",
      "RIDLs are different from long terminal repeat (LTR) elements, which have a different structure and insertion mechanism.",
      "RIDLs are often more mobile than other types of RTEs and can move across long distances in the genome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: RIDLs are not known to insert into the genome using a copy-and-paste mechanism. RIDLs refer to a genetic control strategy known as \"Release of Insects carrying a Dominant Lethal\" which is an approach in pest management, not an actual type of retrotransposable element.\n3. UNKNOWN (Given that statement 2 is false and RIDLs are not a type of retrotransposable element but a pest control strategy, the characteristic deletion/insertion pattern does not apply here.)\n4. TRUE (Assuming 'RIDLs' mentioned here refers to the Release of Insects carrying a Dominant Lethal strategy, it is indeed different from long terminal repeat (LTR) elements in terms of purpose and function.)\n5. FALSE [correction]: Since RIDLs pertain to a genetic pest control strategy and not retrotransposable elements, they do not \"move\" within a genome at all. The statement would be valid in describing the general nature of certain retrotransposable elements, but not for RIDLs as defined in the context of genetic control of pests.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 3839,
    "user_query": "What indication has FTY720 been approved for by the FDA?",
    "yulan-chat-2-13b-fp16_response": "FTY720 is a drug that has been approved by the US Food and Drug Administration (FDA) for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS, and secondary progressive MS. It is not approved for other indications at this time.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FTY720 is approved by the FDA for the treatment of relapsing forms of multiple sclerosis (MS).\n2. The FDA-approved indications for FTY720 include clinically isolated syndrome, relapsing-remitting MS, and secondary progressive MS.\n3. FTY720 is not approved for indications other than relapsing forms of multiple sclerosis at the time of the response.",
    "yulan-chat-2-13b-fp16_fact": [
      "FTY720 is approved by the FDA for the treatment of relapsing forms of multiple sclerosis (MS).",
      "The FDA-approved indications for FTY720 include clinically isolated syndrome, relapsing-remitting MS, and secondary progressive MS.",
      "FTY720 is not approved for indications other than relapsing forms of multiple sclerosis at the time of the response."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3846,
    "user_query": "Which type of analysis does DeSeq2 perform?",
    "yulan-chat-2-13b-fp16_response": "DeSeq2 is a popular algorithm used for differential gene expression analysis. It performs a variety of analyses, including:\n1. Descriptive statistics: DeSeq2 calculates various descriptive statistics for each gene, such as the mean, median, and standard deviation of gene expression levels across different conditions.\n2. Variance stabilizing transformation: DeSeq2 applies a variance stabilizing transformation to the data to account for differences in library size and sequencing depth between samples.\n3. Normalization: DeSeq2 uses a variety of normalization methods, such as TPM (Transcripts Per Million) and FPKM (Fragments Per Kilobase per Million), to account for differences in library size and sequencing depth between samples.\n4. Differential expression analysis: DeSeq2 performs differential expression analysis by comparing the variance of gene expression levels between different conditions. It uses a negative binomial model to estimate the variance of gene expression levels and performs statistical testing to identify genes that are differentially expressed between conditions.\n5. Gene ontology analysis: DeSeq2 can perform gene ontology analysis to identify functional categories that are enriched among differentially expressed genes.\n6. Pathway analysis: DeSeq2 can perform pathway analysis to identify biological pathways that are enriched among differentially expressed genes.\nOverall, DeSeq2 is a powerful tool for analyzing gene expression data and can provide valuable insights into the biological processes that are active in different conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DeSeq2 is an algorithm used for differential gene expression analysis.\n2. DeSeq2 calculates descriptive statistics for gene expression levels, such as mean, median, and standard deviation.\n3. DeSeq2 applies variance stabilizing transformation to adjust for differences in library size and sequencing depth.\n4. DeSeq2 uses negative binomial modeling for estimating variance in gene expression levels during differential expression analysis.\n5. DeSeq2 can perform gene ontology and pathway analysis to identify enriched functional categories and biological pathways among differentially expressed genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "DeSeq2 is an algorithm used for differential gene expression analysis.",
      "DeSeq2 calculates descriptive statistics for gene expression levels, such as mean, median, and standard deviation.",
      "DeSeq2 applies variance stabilizing transformation to adjust for differences in library size and sequencing depth.",
      "DeSeq2 uses negative binomial modeling for estimating variance in gene expression levels during differential expression analysis.",
      "DeSeq2 can perform gene ontology and pathway analysis to identify enriched functional categories and biological pathways among differentially expressed genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: DeSeq2 does not directly calculate descriptive statistics like mean, median, and standard deviation for gene expression levels. Instead, it analyzes count data from RNA-seq experiments to find differentially expressed genes, with an emphasis on using statistical methods suitable for the discrete nature of count data.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: DeSeq2 itself is not designed to perform gene ontology and pathway analysis. However, the results from DeSeq2 can be used as input for other tools and software specialized in gene ontology and pathway analysis, such as Gene Set Enrichment Analysis (GSEA) or the 'topGO' R package.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3848,
    "user_query": "Which computational methods are used for the definition of synteny?",
    "yulan-chat-2-13b-fp16_response": "Synteny is the conservation of chromosomal organization among related species, and it is typically studied by comparing the genetic maps of different species. There are several computational methods that can be used to define and analyze synteny, including:\n1. Genetic map alignment: This method involves aligning genetic maps of different species to identify conserved chromosomal segments and their order.\n2. Phylogenetic analysis: This method uses molecular sequence data to construct phylogenetic trees and identify evolutionary relationships among species. This information can be used to infer synteny and identify conserved chromosomal segments.\n3. Synteny analysis using physical mapping: This method involves mapping the physical location of genes or DNA sequences on chromosomes and comparing them across species to identify conserved segments.\n4. Synteny analysis using comparative genomics: This method involves comparing the genomic sequences of different species to identify conserved syntenic blocks and their order.\nOverall, these computational methods can help to identify syntenic relationships among species and provide insights into the evolution of chromosomal organization.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Genetic map alignment is used to compare genetic maps of different species to identify conserved chromosomal segments.\n2. Phylogenetic analysis uses molecular sequence data to establish evolutionary relationships which aid in inferring synteny.\n3. Synteny can be analyzed by mapping the physical locations of genes or DNA sequences on chromosomes across various species.\n4. Comparative genomics is a method for identifying conserved syntenic blocks by comparing the genomic sequences of different species.",
    "yulan-chat-2-13b-fp16_fact": [
      "Genetic map alignment is used to compare genetic maps of different species to identify conserved chromosomal segments.",
      "Phylogenetic analysis uses molecular sequence data to establish evolutionary relationships which aid in inferring synteny.",
      "Synteny can be analyzed by mapping the physical locations of genes or DNA sequences on chromosomes across various species.",
      "Comparative genomics is a method for identifying conserved syntenic blocks by comparing the genomic sequences of different species."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3850,
    "user_query": "How can B-cells transdifferentiate into macrophages?",
    "yulan-chat-2-13b-fp16_response": "B-cells are a type of white blood cell that plays a key role in the immune system by producing antibodies to neutralize pathogens. Macrophages, on the other hand, are a type of white blood cell that engulfs and destroys pathogens and cellular debris.\nTransdifferentiation is the process by which one cell type is converted into another cell type. While it is possible for B-cells to transdifferentiate into macrophages under certain conditions, the process is not well understood and is still an area of active research.\nOne proposed mechanism for B-cell transdifferentiation into macrophages involves the activation of specific transcription factors, which can induce the expression of macrophage-specific genes in B-cells. Another proposed mechanism involves the activation of a signaling pathway called the JAK-STAT pathway, which can promote the transdifferentiation of B-cells into macrophages.\nHowever, it is important to note that the process of B-cell transdifferentiation into macrophages is not well understood and is still an area of active research. Additionally, while it is possible for B-cells to transdifferentiate into macrophages under certain conditions, the efficiency of this process is low and the resulting macrophages may not be fully mature or functional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. B-cells are a type of white blood cell that produces antibodies to neutralize pathogens.\n2. Macrophages are a type of white blood cell that engulfs and destroys pathogens and cellular debris.\n3. Transdifferentiation is the process by which one cell type is converted into another cell type.\n4. The activation of specific transcription factors can induce the expression of macrophage-specific genes in B-cells, as a proposed mechanism for B-cell transdifferentiation into macrophages.\n5. The activation of the JAK-STAT pathway is another proposed mechanism that can promote the transdifferentiation of B-cells into macrophages.",
    "yulan-chat-2-13b-fp16_fact": [
      "B-cells are a type of white blood cell that produces antibodies to neutralize pathogens.",
      "Macrophages are a type of white blood cell that engulfs and destroys pathogens and cellular debris.",
      "Transdifferentiation is the process by which one cell type is converted into another cell type.",
      "The activation of specific transcription factors can induce the expression of macrophage-specific genes in B-cells, as a proposed mechanism for B-cell transdifferentiation into macrophages.",
      "The activation of the JAK-STAT pathway is another proposed mechanism that can promote the transdifferentiation of B-cells into macrophages."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3852,
    "user_query": "What is FeatureCounts used for?",
    "yulan-chat-2-13b-fp16_response": "FeatureCounts is a bioinformatics tool used for counting the number of features in a set of genomic regions, such as exons, introns, and regulatory regions. It is commonly used in the analysis of RNA-seq data, where the tool can be used to quantify gene expression levels and identify differentially expressed genes. FeatureCounts can also be used to count the number of reads that overlap with specific genomic regions, which can be useful for identifying genomic regions that are highly expressed or have a high level of sequence variation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. FeatureCounts is a bioinformatics tool designed for counting features in genomic regions like exons, introns, and regulatory regions.\n2. It is commonly utilized in the analysis of RNA-seq data.\n3. FeatureCounts is used to quantify gene expression levels.\n4. The tool helps identify differentially expressed genes.\n5. FeatureCounts can count the number of reads overlapping with specific genomic regions.",
    "yulan-chat-2-13b-fp16_fact": [
      "FeatureCounts is a bioinformatics tool designed for counting features in genomic regions like exons, introns, and regulatory regions.",
      "It is commonly utilized in the analysis of RNA-seq data.",
      "FeatureCounts is used to quantify gene expression levels.",
      "The tool helps identify differentially expressed genes.",
      "FeatureCounts can count the number of reads overlapping with specific genomic regions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3854,
    "user_query": "Are super enhancers structurally insulated in chromatin loops?",
    "yulan-chat-2-13b-fp16_response": "Super enhancers are regions of chromatin that are characterized by high levels of transcriptional activity and the presence of distinct chromatin marks, such as H3K27ac and H3K27me3. These regions are often found near gene promoters and play a key role in regulating gene expression.\nWhile super enhancers are not structurally insulated in the same way as chromosomal territories, they are often organized into chromatin loops. Chromatin loops are three-dimensional structures that form when chromatin fibers are looped around each other, creating a loop-like structure. Super enhancers can be located within these loops and can be positioned in different ways within the loop, depending on their location relative to other regulatory elements within the loop.\nSuper enhancers can also be influenced by the position effect of the enhancer, which refers to the phenomenon where the activity of an enhancer is influenced by its distance from the target gene. This means that the activity of a super enhancer can be influenced by its position within the chromatin loop and its proximity to other regulatory elements within the loop.\nOverall, while super enhancers are not structurally insulated in the same way as chromosomal territories, they are often organized into chromatin loops and can be influenced by the position effect of the enhancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Super enhancers are regions characterized by high levels of transcriptional activity.\n2. Super enhancers contain distinct chromatin marks such as H3K27ac and H3K27me3.\n3. Super enhancers are often found near gene promoters and play a key role in regulating gene expression.\n4. Super enhancers are organized into chromatin loops.\n5. The activity of a super enhancer can be influenced by its position within the chromatin loop and its proximity to other regulatory elements within the loop.",
    "yulan-chat-2-13b-fp16_fact": [
      "Super enhancers are regions characterized by high levels of transcriptional activity.",
      "Super enhancers contain distinct chromatin marks such as H3K27ac and H3K27me3.",
      "Super enhancers are often found near gene promoters and play a key role in regulating gene expression.",
      "Super enhancers are organized into chromatin loops.",
      "The activity of a super enhancer can be influenced by its position within the chromatin loop and its proximity to other regulatory elements within the loop."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Super enhancers are characterized by high levels of H3K27ac, which is a mark of active enhancers, but not usually by H3K27me3, which is a repressive mark generally associated with silenced genes.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3858,
    "user_query": "Which deep learning framework has been developed for cancer molecular subtype classification?",
    "yulan-chat-2-13b-fp16_response": "There are several deep learning frameworks that have been developed for cancer molecular subtype classification, including:\n1. TensorFlow: TensorFlow is an open-source deep learning framework developed by Google. It has been widely used for cancer molecular subtype classification, and several studies have reported good performance using TensorFlow.\n2. Keras: Keras is a high-level neural networks API written in Python that runs on top of TensorFlow. It has also been used for cancer molecular subtype classification, and has been reported to achieve good performance.\n3. PyTorch: PyTorch is another popular deep learning framework that has been used for cancer molecular subtype classification. It is known for its simplicity and flexibility, and has been reported to achieve good performance in several studies.\n4. Caffe: Caffe is an open-source deep learning framework that has been used for cancer molecular subtype classification. It is known for its speed and scalability, and has been reported to achieve good performance in several studies.\nOverall, the choice of deep learning framework for cancer molecular subtype classification depends on several factors, including the size and complexity of the dataset, the computational resources available, and the preferences of the researchers or developers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TensorFlow is an open-source deep learning framework developed by Google and has been used for cancer molecular subtype classification.\n2. Keras runs on top of TensorFlow and has been applied to cancer molecular subtype classification.\n3. PyTorch is a deep learning framework used for cancer molecular subtype classification.\n4. Caffe is an open-source deep learning framework that has been utilized for cancer molecular subtype classification.",
    "yulan-chat-2-13b-fp16_fact": [
      "TensorFlow is an open-source deep learning framework developed by Google and has been used for cancer molecular subtype classification.",
      "Keras runs on top of TensorFlow and has been applied to cancer molecular subtype classification.",
      "PyTorch is a deep learning framework used for cancer molecular subtype classification.",
      "Caffe is an open-source deep learning framework that has been utilized for cancer molecular subtype classification."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nAll statements are likely true given that TensorFlow, Keras, PyTorch, and Caffe are popular open-source deep learning frameworks used in various scientific research fields, including bioinformatics and health informatics, where tasks like cancer molecular subtype classification are common applications. However, without specific references to research or applications using these frameworks for that exact purpose, it is difficult to provide definitive proof.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3861,
    "user_query": "What drug, used to treat rheumatoid arthritis, is an interleukin-1 receptor antagonist?",
    "yulan-chat-2-13b-fp16_response": "Anakinra is an interleukin-1 receptor antagonist that is used to treat rheumatoid arthritis. It works by blocking the action of interleukin-1, a protein that plays a role in inflammation. By blocking the action of interleukin-1, anakinra can help reduce inflammation and improve symptoms of rheumatoid arthritis. It is usually given as an injection under the skin.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Anakinra is a drug used to treat rheumatoid arthritis.\n2. Anakinra is an interleukin-1 receptor antagonist.\n3. Anakinra works by blocking the action of the protein interleukin-1.\n4. Blocking interleukin-1 with anakinra helps reduce inflammation in rheumatoid arthritis.\n5. Anakinra is usually administered as an injection under the skin.",
    "yulan-chat-2-13b-fp16_fact": [
      "Anakinra is a drug used to treat rheumatoid arthritis.",
      "Anakinra is an interleukin-1 receptor antagonist.",
      "Anakinra works by blocking the action of the protein interleukin-1.",
      "Blocking interleukin-1 with anakinra helps reduce inflammation in rheumatoid arthritis.",
      "Anakinra is usually administered as an injection under the skin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3863,
    "user_query": "Is liraglutide effective for weight reduction?",
    "yulan-chat-2-13b-fp16_response": "Liraglutide is a medication that is used to treat type 2 diabetes. It is also sometimes used off-label for weight loss. Studies have shown that liraglutide can help people with type 2 diabetes lose weight, but it is not clear if it is effective for weight loss in people who do not have diabetes. Some studies have shown that it can help with weight loss, while others have not found any significant effect. It is important to talk to a doctor before starting any weight loss medication.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Liraglutide is a medication used to treat type 2 diabetes.\n2. Liraglutide is sometimes used off-label for weight loss.\n3. Studies have indicated that liraglutide can help people with type 2 diabetes lose weight.\n4. The effectiveness of liraglutide for weight loss in people without diabetes is not clear.\n5. There are conflicting study results regarding liraglutide's effectiveness for weight loss in individuals without diabetes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Liraglutide is a medication used to treat type 2 diabetes.",
      "Liraglutide is sometimes used off-label for weight loss.",
      "Studies have indicated that liraglutide can help people with type 2 diabetes lose weight.",
      "The effectiveness of liraglutide for weight loss in people without diabetes is not clear.",
      "There are conflicting study results regarding liraglutide's effectiveness for weight loss in individuals without diabetes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Liraglutide has been shown to be effective for weight loss in people without diabetes, which is why it is also approved for chronic weight management under a different brand name.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3865,
    "user_query": "Is Eflornithine and Sulindac are effective for prevention of progression in Familial Adenomatous Polyposis?",
    "yulan-chat-2-13b-fp16_response": "Eflornithine and sulindac are not typically used for the prevention of progression in Familial Adenomatous Polyposis (FAP).\nEflornithine, also known as Orlistat, is a medication that is used to treat obesity and to help reduce the risk of weight-related health problems such as heart disease, stroke, and diabetes. It works by blocking the absorption of fat in the gut, which helps to reduce the amount of fat that is absorbed and stored in the body.\nSulindac is a nonsteroidal anti-inflammatory drug (NSAID) that is used to relieve pain and inflammation. It is not specifically indicated for the treatment or prevention of FAP.\nFAP is a genetic disorder that is characterized by the development of numerous polyps in the lining of the colon. The primary treatment for FAP is usually surgery to remove the polyps and prevent them from becoming cancerous. Other medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and immunosuppressants, may be used to help manage symptoms and prevent the development of polyps. However, the effectiveness of these medications for the prevention of progression in FAP has not been well established. It is important to consult with a healthcare professional for proper diagnosis and treatment of FAP.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eflornithine and sulindac are not typically used for the prevention of progression in Familial Adenomatous Polyposis (FAP).\n2. Eflornithine is a medication used for the treatment of obesity.\n3. Sulindac is a nonsteroidal anti-inflammatory drug used to relieve pain and inflammation.\n4. Familial Adenomatous Polyposis (FAP) is a genetic disorder characterized by the development of numerous polyps in the colon lining.\n5. The primary treatment for Familial Adenomatous Polyposis is surgery to remove the polyps.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eflornithine and sulindac are not typically used for the prevention of progression in Familial Adenomatous Polyposis (FAP).",
      "Eflornithine is a medication used for the treatment of obesity.",
      "Sulindac is a nonsteroidal anti-inflammatory drug used to relieve pain and inflammation.",
      "Familial Adenomatous Polyposis (FAP) is a genetic disorder characterized by the development of numerous polyps in the colon lining.",
      "The primary treatment for Familial Adenomatous Polyposis is surgery to remove the polyps."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Eflornithine and sulindac are used in combination for the prevention of progression in Familial Adenomatous Polyposis (FAP).\n2. FALSE [correction]: Eflornithine is not used for the treatment of obesity, but rather for reducing unwanted facial hair in women and for the treatment of African trypanosomiasis (sleeping sickness).\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3867,
    "user_query": "Which cancers can be treated with Selpercatinib?",
    "yulan-chat-2-13b-fp16_response": "Selpercatinib is a drug that is being developed for the treatment of various types of cancer, including:\n1. Solid tumors: Selpercatinib is being investigated as a potential treatment for a variety of solid tumors, including those of the lung, breast, and liver.\n2. Acute myeloid leukemia (AML): Selpercatinib is being studied as a potential treatment for AML, a type of blood cancer that affects the bone marrow and blood cells.\n3. Neuroendocrine tumors (NETs): Selpercatinib is being investigated as a potential treatment for NETs, which are a type of tumor that can develop in the hormone-producing cells of the digestive system.\n4. Other cancers: Selpercatinib is also being studied as a potential treatment for other types of cancer, including ovarian, pancreatic, and colorectal cancer.\nIt's important to note that while selpercatinib has shown promise in early studies, it is still in the development phase and has not yet been approved for use by regulatory authorities. Further research is needed to fully understand its potential as a cancer treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Selpercatinib is being developed for the treatment of various types of cancer.\n2. Selpercatinib is being investigated as a potential treatment for solid tumors, including those of the lung, breast, and liver.\n3. Selpercatinib is being studied as a potential treatment for acute myeloid leukemia (AML).\n4. Selpercatinib is being investigated as a potential treatment for neuroendocrine tumors (NETs).\n5. Selpercatinib is still in the development phase and has not yet been approved for use by regulatory authorities.",
    "yulan-chat-2-13b-fp16_fact": [
      "Selpercatinib is being developed for the treatment of various types of cancer.",
      "Selpercatinib is being investigated as a potential treatment for solid tumors, including those of the lung, breast, and liver.",
      "Selpercatinib is being studied as a potential treatment for acute myeloid leukemia (AML).",
      "Selpercatinib is being investigated as a potential treatment for neuroendocrine tumors (NETs).",
      "Selpercatinib is still in the development phase and has not yet been approved for use by regulatory authorities."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Selpercatinib is not primarily known for being studied as a potential treatment for acute myeloid leukemia (AML). It targets RET-driven cancers, which are typically solid tumors, not hematological malignancies like AML.\n4. TRUE\n5. FALSE [correction]: As of my knowledge cutoff in early 2023, Selpercatinib (brand name Retevmo) has been approved by the FDA for use in certain types of thyroid and lung cancers.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3868,
    "user_query": "What is the target of Volanesorsen?",
    "yulan-chat-2-13b-fp16_response": "Volanesorsen is a medication that is being developed to treat a rare genetic disease called familial chylomicronaemia. This condition is caused by a mutation in the ABCA3 gene, which leads to the accumulation of certain fats in the bloodstream. Volanesorsen is designed to reduce the levels of these fats by blocking the activity of a protein called APOE. By doing so, it is hoped that volanesorsen will improve the symptoms of familial chylomicronaemia and improve the quality of life for people with this condition.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Volanesorsen is a medication developed to treat familial chylomicronemia.\n2. Familial chylomicronemia is a rare genetic disease caused by a mutation in the ABCA3 gene.\n3. This condition leads to the accumulation of certain fats in the bloodstream.\n4. Volanesorsen works by blocking the activity of a protein called APOE.\n5. The aim of Volanesorsen is to reduce the levels of fats in the bloodstream to improve symptoms of familial chylomicronemia.",
    "yulan-chat-2-13b-fp16_fact": [
      "Volanesorsen is a medication developed to treat familial chylomicronemia.",
      "Familial chylomicronemia is a rare genetic disease caused by a mutation in the ABCA3 gene.",
      "This condition leads to the accumulation of certain fats in the bloodstream.",
      "Volanesorsen works by blocking the activity of a protein called APOE.",
      "The aim of Volanesorsen is to reduce the levels of fats in the bloodstream to improve symptoms of familial chylomicronemia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Familial chylomicronemia, also known as familial chylomicronemia syndrome (FCS), is a rare genetic disease caused primarily by mutations in the LPL gene, which is responsible for the production of lipoprotein lipase, an enzyme needed to break down triglycerides.\n3. TRUE\n4. FALSE [correction]: Volanesorsen works by blocking the production of a protein called apolipoprotein C-III (APOC3), which is involved in triglyceride metabolism.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "yulan-chat-2-13b-fp16_response": "Roflumilast cream is a topical cream that is currently under development for the treatment of plaque psoriasis. It is an investigational drug that has not yet been approved by regulatory authorities for use in patients.\nRoflumilast is a phosphodiesterase inhibitor that works by blocking the enzyme phosphodiesterase 4 (PDE4). This enzyme is involved in the regulation of inflammation and immune responses in the body. By inhibiting PDE4, roflumilast may help to reduce inflammation and improve symptoms of plaque psoriasis.\nStudies have shown that roflumilast cream may be effective in reducing the severity of plaque psoriasis, as measured by measures such as the Psoriasis Area and Severity Index (PASI). However, more research is needed to fully understand the potential benefits and risks of this drug for the treatment of plaque psoriasis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Roflumilast cream is under development for the treatment of plaque psoriasis.\n2. Roflumilast is a phosphodiesterase inhibitor.\n3. The mechanism of action of roflumilast involves blocking the enzyme phosphodiesterase 4 (PDE4).\n4. Inhibition of PDE4 by roflumilast is associated with reduced inflammation and may improve symptoms of plaque psoriasis.\n5. Studies have indicated roflumilast cream may be effective in reducing the severity of plaque psoriasis as measured by the Psoriasis Area and Severity Index (PASI).",
    "yulan-chat-2-13b-fp16_fact": [
      "Roflumilast cream is under development for the treatment of plaque psoriasis.",
      "Roflumilast is a phosphodiesterase inhibitor.",
      "The mechanism of action of roflumilast involves blocking the enzyme phosphodiesterase 4 (PDE4).",
      "Inhibition of PDE4 by roflumilast is associated with reduced inflammation and may improve symptoms of plaque psoriasis.",
      "Studies have indicated roflumilast cream may be effective in reducing the severity of plaque psoriasis as measured by the Psoriasis Area and Severity Index (PASI)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll the statements are consistent with the currently available data regarding roflumilast and its use for treating plaque psoriasis. The drug's mechanism of action as a PDE4 inhibitor is associated with anti-inflammatory effects, which is relevant for the treatment of inflammatory conditions like plaque psoriasis. Studies using measures such as the PASI score would typically be used to assess the efficacy of treatments for psoriasis, including topical formulations like roflumilast cream.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3870,
    "user_query": "Describe the mechanism of action of Givosiran.",
    "yulan-chat-2-13b-fp16_response": "Givosiran is an experimental drug being developed for the treatment of various types of cancer, including liver cancer, pancreatic cancer, and ovarian cancer. It works by inhibiting the production of a protein called \"GIV\" or \"Group Inclusion Protocol,\" which is overexpressed in certain types of cancer cells.\nGivosiran is a small interfering RNA (siRNA) molecule that is designed to target and bind to the GIV mRNA sequence in cancer cells. Once bound, the siRNA molecule is internalized by the cells and broken down into smaller RNA fragments, which then trigger the degradation of the GIV protein. By inhibiting the production of GIV, givosiran can potentially reduce the growth and survival of cancer cells.\nIn addition to its direct effect on GIV expression, givosiran may also have indirect effects on cancer cells by modulating other signaling pathways and gene expression patterns. For example, GIV has been implicated in the regulation of several cellular processes, including cell proliferation, apoptosis, angiogenesis, and immune response. By disrupting these pathways, givosiran may enhance the sensitivity of cancer cells to chemotherapy or radiation therapy, or promote the activation of immune cells that can recognize and destroy cancer cells.\nOverall, the mechanism of action of givosiran is complex and multifaceted, and its therapeutic potential in cancer treatment is still being explored in preclinical and clinical studies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Givosiran is an experimental drug being developed for the treatment of liver cancer, pancreatic cancer, and ovarian cancer.\n2. It works by inhibiting the production of a protein called \"GIV\" or \"Group Inclusion Protocol,\" which is overexpressed in certain types of cancer cells.\n3. Givosiran is a small interfering RNA (siRNA) molecule that targets and binds to the GIV mRNA sequence in cancer cells.\n4. The siRNA molecule is designed to trigger the degradation of the GIV protein upon internalization by the cancer cells.\n5. Givosiran's therapeutic potential in cancer treatment is still being explored in preclinical and clinical studies.",
    "yulan-chat-2-13b-fp16_fact": [
      "Givosiran is an experimental drug being developed for the treatment of liver cancer, pancreatic cancer, and ovarian cancer.",
      "It works by inhibiting the production of a protein called \"GIV\" or \"Group Inclusion Protocol,\" which is overexpressed in certain types of cancer cells.",
      "Givosiran is a small interfering RNA (siRNA) molecule that targets and binds to the GIV mRNA sequence in cancer cells.",
      "The siRNA molecule is designed to trigger the degradation of the GIV protein upon internalization by the cancer cells.",
      "Givosiran's therapeutic potential in cancer treatment is still being explored in preclinical and clinical studies."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Givosiran is a medication developed for the treatment of acute hepatic porphyria, not for liver cancer, pancreatic cancer, or ovarian cancer.\n2. FALSE [correction]: Givosiran does not inhibit the production of a protein called \"GIV\" or \"Group Inclusion Protocol.\" It is designed to reduce the levels of aminolevulinic acid synthase 1 (ALAS1) in the liver, reducing the neurotoxic intermediates that cause porphyria attacks.\n3. FALSE [correction]: Givosiran targets and binds to the mRNA sequence for ALAS1, not GIV mRNA, as there is no known \"GIV\" mRNA relevant to givosiran's mechanism of action.\n4. UNKNOWN [Without the correct target protein, the statement's specifics regarding the siRNA molecule's design and function cannot be confirmed in this context.]\n5. FALSE [correction]: The statement is inaccurate, as givosirans therapeutic potential for the treatment of acute hepatic porphyria has already led to its approval, not just exploration in preclinical and clinical studies. However, its potential for other treatments, if any are being considered, could be in exploratory phases.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3871,
    "user_query": "Is Olaparib effective for prostate cancer?",
    "yulan-chat-2-13b-fp16_response": "Olaparib is a drug that is used to treat certain types of breast and ovarian cancer. It works by targeting a specific gene mutation that is found in some cancer cells. There is some evidence to suggest that olaparib may also be effective in treating prostate cancer, particularly in men with advanced disease who have certain genetic mutations. However, more research is needed to fully understand its potential role in treating prostate cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Olaparib is a drug used to treat certain types of breast and ovarian cancer.\n2. Olaparib targets a specific gene mutation found in some cancer cells.\n3. There is evidence to suggest that olaparib may be effective in treating prostate cancer.\n4. Olaparib may be particularly effective in men with advanced prostate cancer who have certain genetic mutations.\n5. More research is needed to fully understand olaparib's potential role in treating prostate cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Olaparib is a drug used to treat certain types of breast and ovarian cancer.",
      "Olaparib targets a specific gene mutation found in some cancer cells.",
      "There is evidence to suggest that olaparib may be effective in treating prostate cancer.",
      "Olaparib may be particularly effective in men with advanced prostate cancer who have certain genetic mutations.",
      "More research is needed to fully understand olaparib's potential role in treating prostate cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3876,
    "user_query": "Which company developed eptinezumab?",
    "yulan-chat-2-13b-fp16_response": "Eptinezumab is a medication that is being developed by the biotechnology company, Biogen. It is an investigational drug for the treatment of migraine, and is currently in clinical trials.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eptinezumab is a medication developed by Biogen.\n2. Eptinezumab is intended for the treatment of migraine.\n3. Eptinezumab is currently in clinical trials.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eptinezumab is a medication developed by Biogen.",
      "Eptinezumab is intended for the treatment of migraine.",
      "Eptinezumab is currently in clinical trials."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Eptinezumab was developed by Alder Biopharmaceuticals, which was later acquired by Lundbeck.\n2. TRUE\n3. FALSE [correction]: As of my knowledge cutoff in 2023, eptinezumab (brand name Vyepti) was approved by the FDA, which means it has completed clinical trials for the indications it has been approved for.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3878,
    "user_query": "Which drugs are included in the VIFUP regimen for breast cancer?",
    "yulan-chat-2-13b-fp16_response": "The VIFUP regimen for breast cancer typically includes the following drugs:\n1. Vinblastine: an alkylating agent that interferes with cell division and is used to treat various types of cancer, including breast cancer.\n2. Ifosfamide: an alkylating agent that interferes with cell division and is used to treat various types of cancer, including breast cancer.\n3. Fluorouracil: a synthetic antimetabolite that interferes with cell division and is used to treat various types of cancer, including breast cancer.\n4. Doxorubicin: an anthracycline antibiotic that interferes with cell division and is used to treat various types of cancer, including breast cancer.\nIt's important to note that the specific drugs and dosages used in the VIFUP regimen may vary depending on the individual patient and their specific cancer type and stage. It's always best to consult with a healthcare professional for the most accurate and up-to-date information.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vinblastine is used to treat various types of cancer, including breast cancer.\n2. Ifosfamide is used to treat various types of cancer, including breast cancer.\n3. Fluorouracil is used to treat various types of cancer, including breast cancer.\n4. Doxorubicin is used to treat various types of cancer, including breast cancer.\n5. The VIFUP regimen for breast cancer includes the drugs Vinblastine, Ifosfamide, Fluorouracil, and Doxorubicin.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vinblastine is used to treat various types of cancer, including breast cancer.",
      "Ifosfamide is used to treat various types of cancer, including breast cancer.",
      "Fluorouracil is used to treat various types of cancer, including breast cancer.",
      "Doxorubicin is used to treat various types of cancer, including breast cancer.",
      "The VIFUP regimen for breast cancer includes the drugs Vinblastine, Ifosfamide, Fluorouracil, and Doxorubicin."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The acronym VIFUP is not a standard or recognized chemotherapy regimen for breast cancer. Standard regimens for breast cancer might include drugs like Doxorubicin, but they are generally known by different acronyms like AC (Adriamycin/Cyclophosphamide) or FEC (5-Fluorouracil/Epirubicin/Cyclophosphamide).",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3881,
    "user_query": "Which network analysis method can you use for prioritization of metabolic disease genes?",
    "yulan-chat-2-13b-fp16_response": "There are several network analysis methods that can be used for prioritization of metabolic disease genes, including:\n1. Gene co-expression network analysis: This method involves constructing a network of genes based on their expression patterns and identifying modules or clusters of highly connected genes. Genes within these clusters may be functionally related and may be involved in the same biological pathways or processes.\n2. Protein-protein interaction network analysis: This method involves constructing a network of proteins based on their physical interactions and identifying highly connected proteins or subnetworks. Genes encoding proteins within these subnetworks may be involved in the same biological pathways or processes and may be potential targets for therapeutic intervention.\n3. Pathway enrichment analysis: This method involves identifying biological pathways or processes that are significantly enriched in a set of genes of interest. Genes within these pathways may be involved in the same metabolic processes and may be potential targets for therapeutic intervention.\n4. Functional enrichment analysis: This method involves identifying functional categories or processes that are significantly enriched in a set of genes of interest. Genes within these categories may be involved in the same metabolic processes and may be potential targets for therapeutic intervention.\nOverall, the choice of network analysis method will depend on the specific research question and the available data. A combination of these methods may also be used to prioritize metabolic disease genes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gene co-expression network analysis is used for the prioritization of metabolic disease genes by constructing a network based on gene expression patterns.\n2. Protein-protein interaction network analysis is used for the prioritization of metabolic disease genes by constructing a network based on physical interactions between proteins.\n3. Pathway enrichment analysis is a network analysis method that identifies biological pathways significantly enriched in a gene set for prioritization of metabolic disease genes.\n4. Functional enrichment analysis is a network analysis method that identifies functional categories significantly enriched in a gene set for prioritization of metabolic disease genes.\n5. A combination of different network analysis methods may be used to prioritize metabolic disease genes depending on the specific research question and available data.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gene co-expression network analysis is used for the prioritization of metabolic disease genes by constructing a network based on gene expression patterns.",
      "Protein-protein interaction network analysis is used for the prioritization of metabolic disease genes by constructing a network based on physical interactions between proteins.",
      "Pathway enrichment analysis is a network analysis method that identifies biological pathways significantly enriched in a gene set for prioritization of metabolic disease genes.",
      "Functional enrichment analysis is a network analysis method that identifies functional categories significantly enriched in a gene set for prioritization of metabolic disease genes.",
      "A combination of different network analysis methods may be used to prioritize metabolic disease genes depending on the specific research question and available data."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Pathway enrichment analysis is not a network analysis method. It is a statistical method that identifies biological pathways significantly enriched in a gene set, but it does not necessarily involve constructing a network.\n4. FALSE [correction]: Functional enrichment analysis is not a network analysis method. It is a statistical method that identifies functional categories or gene ontologies significantly enriched in a gene set, but, like pathway enrichment analysis, it does not typically involve the construction of a network.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3883,
    "user_query": "What are the targets of pemigatinib?",
    "yulan-chat-2-13b-fp16_response": "Pemigatinib is a small molecule inhibitor of FGFR1, FGFR2, and FGFR3, which are receptor tyrosine kinases involved in the regulation of cell growth, differentiation, and survival. These receptors are overexpressed in a variety of cancers, including bladder cancer, cholangiocarcinoma, and other types of solid tumors.\nPemigatinib is being developed for the treatment of various types of solid tumors, including:\n1. Bladder cancer: Pemigatinib is being investigated for the treatment of advanced or metastatic bladder cancer, including those with FGFR genetic alterations.\n2. Cholangiocarcinoma: Pemigatinib is being studied as a potential treatment for cholangiocarcinoma, a type of bile duct cancer that is often associated with FGFR genetic alterations.\n3. Other solid tumors: Pemigatinib is also being explored as a potential treatment for other types of solid tumors that express high levels of FGFRs, including ovarian cancer, pancreatic cancer, and prostate cancer.\nBy inhibiting FGFR signaling, pemigatinib may help to slow or stop the growth and spread of these cancers. However, more research is needed to fully understand its potential as a cancer treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pemigatinib is an inhibitor of receptor tyrosine kinases FGFR1, FGFR2, and FGFR3.\n2. FGFR1, FGFR2, and FGFR3 are involved in the regulation of cell growth, differentiation, and survival.\n3. Pemigatinib is being developed for the treatment of various types of solid tumors.\n4. Pemigatinib is being investigated for the treatment of advanced or metastatic bladder cancer with FGFR genetic alterations.\n5. Pemigatinib is being studied as a potential treatment for cholangiocarcinoma, which often has FGFR genetic alterations.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pemigatinib is an inhibitor of receptor tyrosine kinases FGFR1, FGFR2, and FGFR3.",
      "FGFR1, FGFR2, and FGFR3 are involved in the regulation of cell growth, differentiation, and survival.",
      "Pemigatinib is being developed for the treatment of various types of solid tumors.",
      "Pemigatinib is being investigated for the treatment of advanced or metastatic bladder cancer with FGFR genetic alterations.",
      "Pemigatinib is being studied as a potential treatment for cholangiocarcinoma, which often has FGFR genetic alterations."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "yulan-chat-2-13b-fp16_response": "Several tools have been developed for identifying and visualizing non-coding RNA (ncRNA) promoters. Here are some of the commonly used tools:\n1. NCBO Annotator: This tool is a web-based platform that provides functional annotation of genes and their products, including ncRNAs. It uses various databases to annotate the promoter regions of ncRNAs and predict their potential regulatory elements.\n2. Promoter Analysis: This tool is part of the Bioconductor package and is used for identifying promoter regions of genes. It can identify the promoter regions based on various features such as CpG islands, GC content, and distance from transcription start sites.\n3. FGENESH: This tool is a web-based platform that can identify and visualize the promoter regions of ncRNAs. It uses various databases to predict the regulatory elements in the promoter regions and provides a graphical representation of the promoter regions.\n4. Genomatix: This tool is a web-based platform that provides various functional annotations, including identification and visualization of ncRNA promoters. It uses various databases to predict the regulatory elements in the promoter regions and provides a graphical representation of the promoter regions.\n5. RegulonDB: This tool is a database of transcriptional regulation in bacteria. It provides information on the promoters of ncRNAs and other genes in bacteria, including their sequences and regulatory elements.\nThese tools can help researchers identify and visualize the promoter regions of ncRNAs and provide insights into their potential regulatory mechanisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. NCBO Annotator is a web-based platform designed for functional annotation of genes, including non-coding RNAs (ncRNAs).\n2. The tool known as \"Promoter Analysis\" is included in the Bioconductor package and assists in identifying promoter regions of genes.\n3. FGENESH is a web-based platform capable of identifying and visualizing ncRNA promoter regions.\n4. Genomatix is a tool that offers identification and visualization of ncRNA promoters among its various functional annotations.\n5. RegulonDB is a database that includes information on the promoters of ncRNAs and other genes in bacteria.",
    "yulan-chat-2-13b-fp16_fact": [
      "NCBO Annotator is a web-based platform designed for functional annotation of genes, including non-coding RNAs (ncRNAs).",
      "The tool known as \"Promoter Analysis\" is included in the Bioconductor package and assists in identifying promoter regions of genes.",
      "FGENESH is a web-based platform capable of identifying and visualizing ncRNA promoter regions.",
      "Genomatix is a tool that offers identification and visualization of ncRNA promoters among its various functional annotations.",
      "RegulonDB is a database that includes information on the promoters of ncRNAs and other genes in bacteria."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: While Bioconductor does include tools for promoter analysis, \"Promoter Analysis\" is not specifically known as a tool; instead, it is a general term for the type of analysis that can be done with various tools within the Bioconductor package.\n3. FALSE [correction]: FGENESH is an online gene prediction tool, primarily for eukaryotic genomes, not specifically for visualization of ncRNA promoter regions.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3889,
    "user_query": "Is Hunter's disease is associated with the X Chromosome?",
    "yulan-chat-2-13b-fp16_response": "Yes, Hunter syndrome is associated with the X chromosome. It is a genetic disorder caused by mutations in the MCR1 gene, which is located on the X chromosome. Hunter syndrome primarily affects males, as they only have one X chromosome (while females have two, and one of them is usually normal). The condition is named after the Hunters, an American family in which the first case was described in 1996.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Hunter syndrome is associated with the X chromosome.\n2. Hunter syndrome is caused by mutations in the MCR1 gene.\n3. The MCR1 gene is located on the X chromosome.\n4. Hunter syndrome primarily affects males because they have one X chromosome.\n5. The condition is named after the Hunters, an American family in which the first case of Hunter syndrome was described in 1996.",
    "yulan-chat-2-13b-fp16_fact": [
      "Hunter syndrome is associated with the X chromosome.",
      "Hunter syndrome is caused by mutations in the MCR1 gene.",
      "The MCR1 gene is located on the X chromosome.",
      "Hunter syndrome primarily affects males because they have one X chromosome.",
      "The condition is named after the Hunters, an American family in which the first case of Hunter syndrome was described in 1996."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Hunter syndrome is caused by mutations in the IDS gene, not the MCR1 gene.\n3. FALSE [correction]: The MCR1 gene is not located on the X chromosome; it is related to red hair and pale skin pigmentation. The IDS gene is located on the X chromosome.\n4. TRUE\n5. FALSE [correction]: Hunter syndrome is named after Charles Hunter, a British physician who first described the disease in 1917, not an American family in 1996.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3893,
    "user_query": "What is Aortitis?",
    "yulan-chat-2-13b-fp16_response": "Aortitis is a rare condition characterized by inflammation of the aorta, which is the largest artery in the body. The aorta carries blood from the heart to the rest of the body, and aortitis can cause narrowing or weakening of the aortic wall, which can lead to a variety of complications.\nAortitis can be caused by a variety of factors, including infections, autoimmune disorders, and other medical conditions. It can also be caused by trauma or injury to the aorta. Symptoms of aortitis may include chest pain, shortness of breath, and weakness, and the condition can be diagnosed through a variety of imaging tests, such as ultrasound, CT scan, or MRI.\nTreatment for aortitis depends on the underlying cause of the condition and the severity of the inflammation. In some cases, medications may be used to reduce inflammation and manage symptoms, while in other cases, surgery may be necessary to repair or replace damaged portions of the aorta. It is important for individuals with aortitis to work closely with their healthcare provider to develop an appropriate treatment plan and to monitor the condition for any changes or complications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Aortitis is characterized by inflammation of the aorta.\n2. The aorta is the largest artery in the body, carrying blood from the heart to the rest of the body.\n3. Aortitis can lead to narrowing or weakening of the aortic wall.\n4. Aortitis can be caused by infections, autoimmune disorders, and other medical conditions, or by trauma or injury to the aorta.\n5. Treatment for aortitis may include medication or surgery, depending on the cause and severity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Aortitis is characterized by inflammation of the aorta.",
      "The aorta is the largest artery in the body, carrying blood from the heart to the rest of the body.",
      "Aortitis can lead to narrowing or weakening of the aortic wall.",
      "Aortitis can be caused by infections, autoimmune disorders, and other medical conditions, or by trauma or injury to the aorta.",
      "Treatment for aortitis may include medication or surgery, depending on the cause and severity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3894,
    "user_query": "Please list the syndromes that are part of Castleman's disease AKA TAFRO",
    "yulan-chat-2-13b-fp16_response": "Castleman's disease, also known as TAFRO (Tymlosan-associated Fasciitis and Rhabdomyolysis), is a rare disorder characterized by lymph node swelling and muscle breakdown (rhabdomyolysis). It is caused by infection with the tymlosan bacterium.\nThere are two main types of Castleman's disease:\n1. Localized Castleman's disease: This type involves lymph node swelling in a single area of the body, such as the armpit or groin. It is the most common form of the disease and usually affects people between the ages of 15 and 40.\n2. Generalized Castleman's disease: This type involves lymph node swelling in multiple areas of the body, as well as other symptoms such as fever, weight loss, and fatigue. It is less common than localized Castleman's disease and usually affects people over the age of 50.\nBoth types of Castleman's disease can cause a range of symptoms, including:\n* Fatigue\n* Fever\n* Night sweats\n* Weight loss\n* Lymph node swelling\n* Muscle weakness\n* Muscle pain\n* Joint pain\n* Rash\n* Fever\n* Abdominal pain\nIt is important to note that Castleman's disease is a rare disorder and its symptoms can be similar to those of other conditions, so a diagnosis should be made by a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Castleman's disease is characterized by lymph node swelling and muscle breakdown (rhabdomyolysis).\n2. Localized Castleman's disease involves lymph node swelling in a single area and is the most common form of the disease.\n3. Generalized Castleman's disease involves lymph node swelling in multiple areas and is less common than localized Castleman's disease.\n4. Symptoms of Castleman's disease can include fatigue, fever, night sweats, weight loss, lymph node swelling, muscle weakness, muscle pain, joint pain, rash, and abdominal pain.\n5. Castleman's disease is a rare disorder.",
    "yulan-chat-2-13b-fp16_fact": [
      "Castleman's disease is characterized by lymph node swelling and muscle breakdown (rhabdomyolysis).",
      "Localized Castleman's disease involves lymph node swelling in a single area and is the most common form of the disease.",
      "Generalized Castleman's disease involves lymph node swelling in multiple areas and is less common than localized Castleman's disease.",
      "Symptoms of Castleman's disease can include fatigue, fever, night sweats, weight loss, lymph node swelling, muscle weakness, muscle pain, joint pain, rash, and abdominal pain.",
      "Castleman's disease is a rare disorder."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Castleman's disease is characterized by lymph node swelling, but muscle breakdown (rhabdomyolysis) is not commonly associated with it.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3904,
    "user_query": "Is Ixodes a species of tick?",
    "yulan-chat-2-13b-fp16_response": "Yes, Ixodes is a genus of ticks that includes several species known to transmit diseases to humans and animals. Some of the most well-known species of ticks within the genus Ixodes include the deer tick (Ixodes scapularis) and the western black-legged tick (Ixodes pacificus). These ticks can transmit diseases such as Lyme disease, anaplasmosis, and babesiosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ixodes is a genus of ticks, not a single species.\n2. The genus Ixodes includes several species known for transmitting diseases to humans and animals.\n3. Ixodes scapularis, commonly known as the deer tick, is a species within the genus Ixodes.\n4. Ixodes pacificus, known as the western black-legged tick, is another species within the genus Ixodes.\n5. Species within the genus Ixodes can transmit diseases such as Lyme disease, anaplasmosis, and babesiosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ixodes is a genus of ticks, not a single species.",
      "The genus Ixodes includes several species known for transmitting diseases to humans and animals.",
      "Ixodes scapularis, commonly known as the deer tick, is a species within the genus Ixodes.",
      "Ixodes pacificus, known as the western black-legged tick, is another species within the genus Ixodes.",
      "Species within the genus Ixodes can transmit diseases such as Lyme disease, anaplasmosis, and babesiosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3906,
    "user_query": "Which was  the first oral drug for the treatment of multiple sclerosis by the US Food and Drug Administration (FDA)?",
    "yulan-chat-2-13b-fp16_response": "The first oral drug for the treatment of multiple sclerosis approved by the US Food and Drug Administration (FDA) was called Imuran. It was approved in 1969. Imuran is a medication that is used to treat a variety of conditions, including multiple sclerosis. It is a type of immunosuppressant, which means that it helps to suppress the immune system. This can be helpful in the treatment of multiple sclerosis, as the immune system plays a role in the development of the disease. Imuran is taken by mouth in the form of a tablet. It is generally used to treat moderate to severe cases of multiple sclerosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The first oral drug for the treatment of multiple sclerosis approved by the FDA was called Imuran.\n2. Imuran was approved by the US Food and Drug Administration in 1969.\n3. Imuran is used to treat a variety of conditions, including multiple sclerosis.\n4. Imuran is a type of immunosuppressant, which helps to suppress the immune system.\n5. Imuran is taken by mouth in the form of a tablet.",
    "yulan-chat-2-13b-fp16_fact": [
      "The first oral drug for the treatment of multiple sclerosis approved by the FDA was called Imuran.",
      "Imuran was approved by the US Food and Drug Administration in 1969.",
      "Imuran is used to treat a variety of conditions, including multiple sclerosis.",
      "Imuran is a type of immunosuppressant, which helps to suppress the immune system.",
      "Imuran is taken by mouth in the form of a tablet."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The first oral drug for the treatment of multiple sclerosis approved by the FDA was called Fingolimod (brand name Gilenya), not Imuran.\n2. UNKNOWN \n3. FALSE [correction]: Imuran (azathioprine) is indeed used to treat a variety of conditions, but it is not specifically approved for the treatment of multiple sclerosis. It is commonly used for conditions such as rheumatoid arthritis and as an immunosuppressant in organ transplantation.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3909,
    "user_query": "What does fingolimod do to the grey matter of the brain?",
    "yulan-chat-2-13b-fp16_response": "Fingolimod is a drug that is used to treat multiple sclerosis. It works by blocking the activity of certain immune cells that are involved in the development of multiple sclerosis.\nThere is some evidence to suggest that fingolimod may also have an effect on the grey matter of the brain. Grey matter is a type of tissue that is made up of neurons and other cells that are involved in processing and transmitting information in the brain.\nStudies have shown that fingolimod may help to preserve grey matter volume in people with multiple sclerosis. It may also help to improve the function of certain areas of the brain that are involved in cognitive processes such as memory and attention.\nHowever, more research is needed to fully understand the effects of fingolimod on the grey matter of the brain. It is important to note that fingolimod can have side effects, and it is important to discuss any concerns you may have with your doctor.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fingolimod is a drug used to treat multiple sclerosis.\n2. Fingolimod works by blocking the activity of certain immune cells involved in multiple sclerosis development.\n3. Fingolimod may help preserve grey matter volume in people with multiple sclerosis.\n4. Fingolimod may improve the function of certain areas of the brain related to cognitive processes like memory and attention.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fingolimod is a drug used to treat multiple sclerosis.",
      "Fingolimod works by blocking the activity of certain immune cells involved in multiple sclerosis development.",
      "Fingolimod may help preserve grey matter volume in people with multiple sclerosis.",
      "Fingolimod may improve the function of certain areas of the brain related to cognitive processes like memory and attention."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nNote: While the statements are generally consistent with the known effects of fingolimod in the treatment of multiple sclerosis, the exact mechanisms and benefits can vary, and research is ongoing. Statements 3 and 4 are true based on research findings that suggest fingolimod may help to preserve brain volume and possibly improve cognitive functions, although individual responses to the medication can vary.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3913,
    "user_query": "Explain the action of Balovaptan.",
    "yulan-chat-2-13b-fp16_response": "Balovaptan is a drug that is being developed for the treatment of various conditions, including hypertension, diabetic nephropathy, and certain types of cancer. It works by inhibiting the activity of a protein called VEGF, which is involved in the growth and development of blood vessels. By inhibiting VEGF, balovaptan can reduce the growth of blood vessels in the body, which can help to lower blood pressure, reduce the risk of diabetic complications, and slow the growth of certain types of cancer. Balovaptan is currently being studied in clinical trials, and its safety and effectiveness are still being evaluated.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Balovaptan is a drug in development for the treatment of hypertension, diabetic nephropathy, and certain types of cancer.\n2. The mechanism of action for balovaptan involves inhibiting the activity of the VEGF protein.\n3. VEGF is a protein involved in the growth and development of blood vessels.\n4. Inhibiting VEGF can lead to a reduction in blood vessel growth.\n5. Balovaptan is currently undergoing clinical trials to evaluate its safety and effectiveness.",
    "yulan-chat-2-13b-fp16_fact": [
      "Balovaptan is a drug in development for the treatment of hypertension, diabetic nephropathy, and certain types of cancer.",
      "The mechanism of action for balovaptan involves inhibiting the activity of the VEGF protein.",
      "VEGF is a protein involved in the growth and development of blood vessels.",
      "Inhibiting VEGF can lead to a reduction in blood vessel growth.",
      "Balovaptan is currently undergoing clinical trials to evaluate its safety and effectiveness."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Balovaptan is a drug that was in development for the treatment of autism spectrum disorder, not hypertension, diabetic nephropathy, and certain types of cancer.\n2. FALSE [correction]: The mechanism of action for balovaptan is not related to inhibiting the VEGF protein. Balovaptan is thought to work by blocking the activity of the vasopressin 1a receptor (V1AR), which is involved in social behavior.\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nNote: The status of drug development trials can change rapidly, and without current data regarding balovaptan's clinical trials, the statement's truth cannot be verified as of the last available information. Balovaptan's trials for autism spectrum disorder, to my knowledge, have been discontinued, but the statement is not specific to that condition, nor does it specify a time frame, so its status is unknown.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "yulan-chat-2-13b-fp16_response": "The SWIM tool (Selecting When Imaging is Meaningful) is a computational tool that aims to identify genes that are differentially expressed in different diseases or conditions. It does this by analyzing gene expression data and identifying genes that are consistently expressed in a particular disease or condition.\nAs an example, I can provide you with a list of genes that have been identified as down-regulated in glioblastoma using the SWIM tool. However, please note that this list may not be exhaustive and may not reflect the most up-to-date research on the topic.\nHere are some examples of genes that have been identified as down-regulated in glioblastoma using the SWIM tool:\n1. CDKN2A\n2. TP53\n3. PTEN\n4. RB1\n5. E-cadherin\n6. Vimentin\n7. GATA4\n8. SOX2\n9. Nestin\n10. GFAP\nIt's important to note that glioblastoma is a complex and heterogeneous disease, and there may be many other genes that are down-regulated in different subtypes or stages of the disease. Additionally, the SWIM tool is just one of many tools and approaches that can be used to identify differentially expressed genes in glioblastoma and other diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The SWIM tool is a computational tool designed to identify genes that are differentially expressed in various diseases or conditions.\n2. The SWIM tool has identified CDKN2A as a gene that is down-regulated in glioblastoma.\n3. The SWIM tool has identified TP53 as a gene that is down-regulated in glioblastoma.\n4. The SWIM tool has identified PTEN as a gene that is down-regulated in glioblastoma.\n5. The SWIM tool has identified RB1 as a gene that is down-regulated in glioblastoma.",
    "yulan-chat-2-13b-fp16_fact": [
      "The SWIM tool is a computational tool designed to identify genes that are differentially expressed in various diseases or conditions.",
      "The SWIM tool has identified CDKN2A as a gene that is down-regulated in glioblastoma.",
      "The SWIM tool has identified TP53 as a gene that is down-regulated in glioblastoma.",
      "The SWIM tool has identified PTEN as a gene that is down-regulated in glioblastoma.",
      "The SWIM tool has identified RB1 as a gene that is down-regulated in glioblastoma."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE - SWIM (SWItchMiner) is a computational tool that is designed to identify genes that are differentially expressed in different states or conditions, which may include various diseases.\n2. UNKNOWN - Without specific research data provided, the status of CDKN2A identified by the SWIM tool in glioblastoma cannot be verified.\n3. UNKNOWN - Similar to statement 2, without specific data or results from a study using the SWIM tool, the regulation status of TP53 in glioblastoma is not determinable.\n4. UNKNOWN - Without specific data, it is not possible to confirm if the SWIM tool has identified PTEN as down-regulated in glioblastoma.\n5. UNKNOWN - Same as above, the status of RB1, as identified by the SWIM tool in glioblastoma, cannot be verified without concrete data or references.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3921,
    "user_query": "Which method has been developed for detection of ATAC-seq or ChIP-seq signals with DNA methylation?",
    "yulan-chat-2-13b-fp16_response": "Both ATAC-seq and ChIP-seq are methods used to detect DNA-binding sites and epigenetic modifications, but they do not directly detect DNA methylation. However, there are methods that combine ATAC-seq and DNA methylation analysis to detect both chromatin accessibility and methylation patterns. One such method is called \"5C\" (Five-prime ChiP-seq), which combines ChIP-seq and DNA methylation analysis to identify regions of the genome that are associated with specific transcription factors or other proteins of interest, as well as regions that are differentially methylated. Another method is called \"MeDIP-seq\" (Methylated DNA Immunoprecipitation sequencing), which is a modified ChIP-seq method that specifically captures DNA fragments that are bound by methyl-binding proteins, allowing for the detection of DNA methylation patterns.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ATAC-seq and ChIP-seq are methods used to detect DNA-binding sites and epigenetic modifications.\n2. ATAC-seq and ChIP-seq do not directly detect DNA methylation.\n3. \"5C\" or Five-prime ChiP-seq is a method that combines ChIP-seq and DNA methylation analysis.\n4. \"5C\" is used to identify regions of the genome associated with specific transcription factors or proteins and regions that are differentially methylated.\n5. \"MeDIP-seq\" stands for Methylated DNA Immunoprecipitation sequencing, a method for detecting DNA methylation patterns.",
    "yulan-chat-2-13b-fp16_fact": [
      "ATAC-seq and ChIP-seq are methods used to detect DNA-binding sites and epigenetic modifications.",
      "ATAC-seq and ChIP-seq do not directly detect DNA methylation.",
      "\"5C\" or Five-prime ChiP-seq is a method that combines ChIP-seq and DNA methylation analysis.",
      "\"5C\" is used to identify regions of the genome associated with specific transcription factors or proteins and regions that are differentially methylated.",
      "\"MeDIP-seq\" stands for Methylated DNA Immunoprecipitation sequencing, a method for detecting DNA methylation patterns."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: \"5C\" stands for Chromosome Conformation Capture Carbon Copy and is a method used to study the 3D structure of the genome. It is not a method combining ChIP-seq and DNA methylation analysis.\n4. FALSE [correction]: As \"5C\" actually refers to Chromosome Conformation Capture Carbon Copy, it is not used to identify regions associated with specific transcription factors or differentially methylated regions, but rather to analyze the three-dimensional organization of chromatin in a cell.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3922,
    "user_query": "Which protein is involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks?",
    "yulan-chat-2-13b-fp16_response": "The protein involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks is called Oct4 (also known as Sox2 in some species). Oct4 is a transcription factor that plays a crucial role in maintaining the pluripotency of stem cells and regulating the expression of genes involved in cellular differentiation and development. It forms a complex with other transcription factors, such as Sox2, Nanog, and Lin28, to regulate the expression of key genes that control the self-renewal and differentiation of stem cells. Oct4 and other transcription factors also interact with chromatin remodeling complexes to regulate the three-dimensional organization of chromatin and accessibility of enhancers to transcription factors, which is critical for maintaining pluripotency and cellular differentiation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The protein involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks is called Oct4.\n2. Oct4 is also known as Sox2 in some species.\n3. Oct4 is a transcription factor that is essential for maintaining the pluripotency of stem cells.\n4. Oct4, along with other transcription factors like Sox2, Nanog, and Lin28, regulates the expression of genes involved in cellular differentiation and development.\n5. Oct4 interacts with chromatin remodeling complexes to regulate the three-dimensional organization of chromatin and the accessibility of enhancers to transcription factors.",
    "yulan-chat-2-13b-fp16_fact": [
      "The protein involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks is called Oct4.",
      "Oct4 is also known as Sox2 in some species.",
      "Oct4 is a transcription factor that is essential for maintaining the pluripotency of stem cells.",
      "Oct4, along with other transcription factors like Sox2, Nanog, and Lin28, regulates the expression of genes involved in cellular differentiation and development.",
      "Oct4 interacts with chromatin remodeling complexes to regulate the three-dimensional organization of chromatin and the accessibility of enhancers to transcription factors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Oct4 is not the same as Sox2; they are distinct transcription factors involved in stem cell pluripotency. Sox2 is another transcription factor that works together with Oct4.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3923,
    "user_query": "Where is the agouti-related peptide expressed?",
    "yulan-chat-2-13b-fp16_response": "Agouti-related peptide (AgRP) is a neuropeptide that is primarily expressed in the hypothalamus, a region of the brain that plays a key role in regulating metabolism and energy balance. AgRP is produced by a subset of neurons in the arcuate nucleus of the hypothalamus, which are collectively known as the AgRP neurons. These neurons project to various other regions of the brain, including the paraventricular nucleus of the hypothalamus, the ventromedial hypothalamus, and the brainstem. AgRP is involved in regulating feeding behavior and body weight, and its expression is thought to be regulated by a variety of factors, including hormones, neurotransmitters, and stress.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Agouti-related peptide (AgRP) is expressed primarily in the hypothalamus.\n2. AgRP is produced by neurons in the arcuate nucleus of the hypothalamus.\n3. Neurons that produce AgRP are known as AgRP neurons.\n4. AgRP neurons project to other regions of the brain such as the paraventricular nucleus, the ventromedial hypothalamus, and the brainstem.\n5. AgRP is involved in the regulation of feeding behavior and body weight.",
    "yulan-chat-2-13b-fp16_fact": [
      "Agouti-related peptide (AgRP) is expressed primarily in the hypothalamus.",
      "AgRP is produced by neurons in the arcuate nucleus of the hypothalamus.",
      "Neurons that produce AgRP are known as AgRP neurons.",
      "AgRP neurons project to other regions of the brain such as the paraventricular nucleus, the ventromedial hypothalamus, and the brainstem.",
      "AgRP is involved in the regulation of feeding behavior and body weight."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3924,
    "user_query": "What is the function of ketohexokinase-A?",
    "yulan-chat-2-13b-fp16_response": "Ketohexokinase-A (KHK-A) is an enzyme that plays a key role in the metabolism of glucose and other carbohydrates in the liver and other tissues. The main function of KHK-A is to catalyze the first step in the breakdown of glucose, which is the conversion of glucose-6-phosphate to fructose-6-phosphate. This reaction is important for the production of energy and the synthesis of other molecules, such as glycerol and fatty acids. In addition to its role in carbohydrate metabolism, KHK-A has also been implicated in the regulation of cell growth and proliferation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Ketohexokinase-A (KHK-A) is an enzyme involved in the metabolism of glucose and other carbohydrates.\n2. The main function of KHK-A is to catalyze the conversion of glucose-6-phosphate to fructose-6-phosphate.\n3. This enzymatic reaction is a part of the breakdown of glucose.\n4. KHK-A plays a role in the production of energy and the synthesis of molecules like glycerol and fatty acids.\n5. KHK-A has been implicated in the regulation of cell growth and proliferation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Ketohexokinase-A (KHK-A) is an enzyme involved in the metabolism of glucose and other carbohydrates.",
      "The main function of KHK-A is to catalyze the conversion of glucose-6-phosphate to fructose-6-phosphate.",
      "This enzymatic reaction is a part of the breakdown of glucose.",
      "KHK-A plays a role in the production of energy and the synthesis of molecules like glycerol and fatty acids.",
      "KHK-A has been implicated in the regulation of cell growth and proliferation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Ketohexokinase (KHK) catalyzes the phosphorylation of fructose to fructose-1-phosphate; the conversion of glucose-6-phosphate to fructose-6-phosphate is catalyzed by phosphoglucose isomerase.\n3. FALSE [correction]: The primary substrate for ketohexokinase-A (KHK-A) is fructose, not glucose; thus, its enzymatic reaction is part of the fructose metabolism, not the breakdown of glucose.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3925,
    "user_query": "Are the major royal jelly proteins similar to the yellow proteins?",
    "yulan-chat-2-13b-fp16_response": "Yes, the major royal jelly proteins are similar to the yellow proteins. Both royal jelly and yellow pollen are rich sources of proteins, and the proteins in these two sources share some similarities in terms of their amino acid compositions and structures.\nThe major royal jelly proteins include royal jelly protein A (RJP-A), royal jelly protein B (RJP-B), and royal jelly protein C (RJP-C). These proteins are rich in amino acids such as glutamic acid, aspartic acid, and proline, which are also found in the yellow pollen proteins.\nThe yellow pollen proteins are a group of proteins that are responsible for the yellow color of pollen grains. These proteins are also rich in amino acids such as glutamic acid, aspartic acid, and proline, and they share some similarities in their amino acid compositions and structures with the major royal jelly proteins.\nOverall, the major royal jelly proteins and the yellow pollen proteins are similar in terms of their amino acid compositions and structures, which suggests that they may have similar functions and properties. However, further research is needed to fully understand the similarities and differences between these proteins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Major royal jelly proteins and yellow proteins share similarities in their amino acid compositions and structures.\n2. Major royal jelly proteins are rich in amino acids such as glutamic acid, aspartic acid, and proline.\n3. The major royal jelly proteins include royal jelly protein A (RJP-A), royal jelly protein B (RJP-B), and royal jelly protein C (RJP-C).\n4. Yellow pollen proteins are responsible for the yellow color of pollen grains.\n5. Yellow pollen proteins are also rich in amino acids such as glutamic acid, aspartic acid, and proline.",
    "yulan-chat-2-13b-fp16_fact": [
      "Major royal jelly proteins and yellow proteins share similarities in their amino acid compositions and structures.",
      "Major royal jelly proteins are rich in amino acids such as glutamic acid, aspartic acid, and proline.",
      "The major royal jelly proteins include royal jelly protein A (RJP-A), royal jelly protein B (RJP-B), and royal jelly protein C (RJP-C).",
      "Yellow pollen proteins are responsible for the yellow color of pollen grains.",
      "Yellow pollen proteins are also rich in amino acids such as glutamic acid, aspartic acid, and proline."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: While royal jelly does have specific proteins, they are not conventionally named as Royal Jelly Protein A (RJP-A), Royal Jelly Protein B (RJP-B), and Royal Jelly Protein C (RJP-C). They are usually abbreviated as MRJP1, MRJP2, MRJP3, etc.\n4. UNKNOWN: The term \"yellow pollen proteins\" is not a standard term in biochemistry or plant biology. Yellow color in pollen is typically due to pigments such as carotenoids rather than proteins.\n5. UNKNOWN: Without specific reference to \"yellow pollen proteins,\" it's unclear if such proteins have been characterized to the level of detail that would allow confirmation of their amino acid composition. The amino acid composition would also vary depending on the specific protein in question.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "yulan-chat-2-13b-fp16_response": "Several R packages have been developed for studying Topological Associative Domains (TADs), which are regions of the genome that are characterized by a specific chromatin conformation and are associated with functional elements such as promoters, enhancers, and gene bodies. Here are some of the commonly used R packages for studying TADs:\n1. `ChromHMM`: This package provides tools for analyzing chromatin state using the Chromatin State Model, which is based on the Hidden Markov Model (HMM) algorithm. It can be used to identify TADs and other chromatin features.\n2. `circular`: This package provides functions for analyzing circular chromosome conformation data, including identifying TADs and other chromatin features.\n3. `denovo`: This package provides functions for identifying TADs and other chromatin features using the denovo algorithm, which is based on the HMM algorithm.\n4. `tad`: This package provides functions for identifying TADs and other chromatin features using the tad algorithm, which is based on the HMM algorithm.\n5. `ChromSig`: This package provides functions for analyzing chromatin signatures, which are patterns of chromatin features that are associated with specific functional elements. It can be used to identify TADs and other chromatin features.\n6. `Chromatin`: This package provides functions for analyzing chromatin data, including identifying TADs and other chromatin features.\nThese packages provide a range of tools for analyzing TADs and other chromatin features, and can be used to gain insights into the organization and function of the genome.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. `ChromHMM` is an R package that provides tools for analyzing chromatin state with the application of Hidden Markov Model (HMM) algorithms.\n2. The `circular` R package provides functions for analyzing circular chromosome conformation data.\n3. The `denovo` R package is designed to identify Topological Associative Domains (TADs) using algorithms based on HMM.\n4. There is an R package called `tad` that provides functions based on the tad algorithm for identifying TADs and other chromatin features.\n5. `ChromSig` is an R package that analyzes chromatin signatures to identify TADs and other chromatin features.",
    "yulan-chat-2-13b-fp16_fact": [
      "`ChromHMM` is an R package that provides tools for analyzing chromatin state with the application of Hidden Markov Model (HMM) algorithms.",
      "The `circular` R package provides functions for analyzing circular chromosome conformation data.",
      "The `denovo` R package is designed to identify Topological Associative Domains (TADs) using algorithms based on HMM.",
      "There is an R package called `tad` that provides functions based on the tad algorithm for identifying TADs and other chromatin features.",
      "`ChromSig` is an R package that analyzes chromatin signatures to identify TADs and other chromatin features."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: `ChromHMM` is not an R package, it is a Java program that uses Hidden Markov Models for the characterization of chromatin state.\n2. FALSE [correction]: The `circular` R package is designed for circular statistics, such as for analyzing data with angular measurements, not specifically for chromosome conformation data.\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: `ChromSig` is not known as an R package for analyzing chromatin signatures to identify TADs and other chromatin features. There is a tool called ChromHMM that identifies chromatin states, but `ChromSig` does not seem to be a standard package for this purpose as of my knowledge cutoff date.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "yulan-chat-2-13b-fp16_response": "The bioconductor tool that has been developed for accessing bacterial regulatory networks is called \"Bactriome\".",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The bioconductor tool developed for accessing bacterial regulatory networks is called \"Bactriome\".",
    "yulan-chat-2-13b-fp16_fact": [
      "The bioconductor tool developed for accessing bacterial regulatory networks is called \"Bactriome\"."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The bioconductor tool developed for accessing bacterial regulatory networks is called \"RegulonDB\". \"Bacteriome\" does not correspond to a known Bioconductor tool for bacterial regulatory networks as described. Bioconductor is a project that provides tools for the analysis and comprehension of high-throughput genomic data, but \"Bactriome\" does not appear to be one of the tools associated with Bioconductor or for the purpose stated.",
    "yulan-chat-2-13b-fp16_judge": [
      "false"
    ]
  },
  {
    "id": 3928,
    "user_query": "Is the Apis mellifera genome available?",
    "yulan-chat-2-13b-fp16_response": "Yes, the genome of the western honey bee (Apis mellifera) has been sequenced and published. The first draft genome sequence was published in 2006, and since then, multiple improved versions have been released. The latest version is available on the NCBI GenBank database under the accession number APYMUS2. The genome is approximately 3.3 Gb in size and consists of 16 chromosomes. The genome sequence has been instrumental in understanding the biology and behavior of honey bees and has facilitated the development of new tools and techniques for beekeepers and researchers.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The genome of the western honey bee (Apis mellifera) has been sequenced and published.\n2. The first draft of the Apis mellifera genome sequence was published in 2006.\n3. Multiple improved versions of the Apis mellifera genome have been released since the first draft.\n4. The latest version of the Apis mellifera genome is available on the NCBI GenBank database under accession number APYMUS2.\n5. The Apis mellifera genome is approximately 3.3 Gb in size and consists of 16 chromosomes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The genome of the western honey bee (Apis mellifera) has been sequenced and published.",
      "The first draft of the Apis mellifera genome sequence was published in 2006.",
      "Multiple improved versions of the Apis mellifera genome have been released since the first draft.",
      "The latest version of the Apis mellifera genome is available on the NCBI GenBank database under accession number APYMUS2.",
      "The Apis mellifera genome is approximately 3.3 Gb in size and consists of 16 chromosomes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The accession number provided is incorrect or fictional, and the latest version of the Apis mellifera genome would likely have a different, specific accession number. The current correct accession number can be verified by searching the NCBI GenBank database.\n5. FALSE [correction]: The Apis mellifera genome is approximately 236 Mb (megabases) in size, not 3.3 Gb (gigabases), and consists of 16 chromosomes.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3929,
    "user_query": "What genes is implicated in myotonic goats and other  nondystrophic myotonias?",
    "yulan-chat-2-13b-fp16_response": "Myotonic goats and other nondystrophic myotonias are caused by mutations in the myotonic dystrophy protein kinase (DMPK) gene. This gene provides instructions for making a protein called myotonic dystrophy protein kinase, which plays a role in regulating muscle tone and the process of muscle cell division. Mutations in the DMPK gene can lead to the accumulation of abnormal protein in muscle cells, which can cause the characteristic features of myotonic goats and other nondystrophic myotonias, including stiffness, weakness, and wasting of muscles.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Myotonic goats and other nondystrophic myotonias are associated with mutations in the myotonic dystrophy protein kinase (DMPK) gene.\n2. The DMPK gene is responsible for the production of myotonic dystrophy protein kinase, which helps regulate muscle tone and muscle cell division.\n3. Mutations in the DMPK gene can cause the accumulation of abnormal protein in muscle cells.\n4. Features of myotonic goats and other nondystrophic myotonias include stiffness, muscle weakness, and wasting of muscles.",
    "yulan-chat-2-13b-fp16_fact": [
      "Myotonic goats and other nondystrophic myotonias are associated with mutations in the myotonic dystrophy protein kinase (DMPK) gene.",
      "The DMPK gene is responsible for the production of myotonic dystrophy protein kinase, which helps regulate muscle tone and muscle cell division.",
      "Mutations in the DMPK gene can cause the accumulation of abnormal protein in muscle cells.",
      "Features of myotonic goats and other nondystrophic myotonias include stiffness, muscle weakness, and wasting of muscles."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Myotonic goats and other nondystrophic myotonias are typically associated with mutations in the chloride channel gene (CLCN1), not the myotonic dystrophy protein kinase (DMPK) gene. The DMPK gene is associated with myotonic dystrophy type 1.\n2. TRUE\n3. FALSE [correction]: Mutations in the DMPK gene lead to the production of an abnormal mRNA that can sequester specific proteins, leading to a range of effects including myotonia, cataracts, and cardiac conduction defects. The accumulation of abnormal proteins in muscle cells is not the primary consequence of mutations in the DMPK gene.\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3931,
    "user_query": "Is cadherin a plasma membrane marker?",
    "yulan-chat-2-13b-fp16_response": "Cadherins are a family of transmembrane proteins that play important roles in the structure and function of cellular membranes, particularly in the formation and maintenance of adherens junctions, which are specialized regions of cell-cell contact that are important for the integrity and signaling capabilities of the plasma membrane. Cadherins are involved in a variety of cellular processes, including cell adhesion, signal transduction, and apoptosis. They are also involved in the regulation of cell differentiation, proliferation, and migration. Cadherins are expressed in many tissues and cell types, and they are often used as markers for the detection and characterization of different cell types in research and clinical settings.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cadherins are a family of transmembrane proteins.\n2. Cadherins play a role in the structure and function of cellular membranes.\n3. They are involved in the formation and maintenance of adherens junctions.\n4. Cadherins participate in cellular processes such as cell adhesion, signal transduction, and apoptosis.\n5. Cadherins are used as markers for the detection and characterization of different cell types in research and clinical settings.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cadherins are a family of transmembrane proteins.",
      "Cadherins play a role in the structure and function of cellular membranes.",
      "They are involved in the formation and maintenance of adherens junctions.",
      "Cadherins participate in cellular processes such as cell adhesion, signal transduction, and apoptosis.",
      "Cadherins are used as markers for the detection and characterization of different cell types in research and clinical settings."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "yulan-chat-2-13b-fp16_response": "The shikimate pathway is an anabolic metabolic pathway found in some bacteria, fungi, and plants that produces aromatic amino acids and other aromatic compounds. The end products of the shikimate pathway are:\n1. Aromatic amino acids: The shikimate pathway produces three aromatic amino acids - phenylalanine, tyrosine, and tryptophan. These amino acids are used to synthesize various important molecules in the cell, such as proteins, neurotransmitters, and hormones.\n2. Aromatic acids: The shikimate pathway also produces aromatic acids, such as benzoate and phenylpyruvate. These acids can be further metabolized to produce other important molecules, such as flavonoids and other plant pigments.\n3. Shikimate: The starting molecule of the shikimate pathway is phosphoenolpyruvate (PEP), which is converted into shikimate. Shikimate is not an end product of the pathway, but it serves as an intermediate in the synthesis of aromatic amino acids.\nOverall, the shikimate pathway is an important metabolic pathway that produces aromatic amino acids and other aromatic compounds, which are essential for the growth and survival of many organisms.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The shikimate pathway produces three aromatic amino acids: phenylalanine, tyrosine, and tryptophan.\n2. The pathway is found in some bacteria, fungi, and plants.\n3. Aromatic acids such as benzoate and phenylpyruvate are produced by the shikimate pathway.\n4. Phenylalanine, tyrosine, and tryptophan are used to synthesize various important molecules like proteins, neurotransmitters, and hormones.\n5. Shikimate serves as an intermediate in the synthesis of aromatic amino acids, not as an end product.",
    "yulan-chat-2-13b-fp16_fact": [
      "The shikimate pathway produces three aromatic amino acids: phenylalanine, tyrosine, and tryptophan.",
      "The pathway is found in some bacteria, fungi, and plants.",
      "Aromatic acids such as benzoate and phenylpyruvate are produced by the shikimate pathway.",
      "Phenylalanine, tyrosine, and tryptophan are used to synthesize various important molecules like proteins, neurotransmitters, and hormones.",
      "Shikimate serves as an intermediate in the synthesis of aromatic amino acids, not as an end product."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The shikimate pathway produces the aromatic amino acids, not aromatic acids such as benzoate and phenylpyruvate directly. However, the products of the shikimate pathway, like phenylalanine and tyrosine, can be further converted into aromatic compounds, including phenylpyruvate. Benzoate is not typically a direct product of this pathway.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3934,
    "user_query": "What are the uber-operons?",
    "yulan-chat-2-13b-fp16_response": "The term \"uber-operons\" refers to a type of regulatory unit in bacteria that contains multiple genes involved in a single metabolic pathway or process. These genes are transcribed together as a single unit, and their products often function together in a coordinated manner to carry out a specific function. Uber-operons are thought to be important for the efficient regulation of metabolism in bacteria, as they allow for the coordinated control of multiple genes involved in a single process.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Uber-operons are a type of regulatory unit in bacteria.\n2. Uber-operons contain multiple genes involved in a single metabolic pathway or process.\n3. The genes in uber-operons are transcribed together as a single unit.\n4. The gene products of uber-operons often function together in a coordinated manner.\n5. Uber-operons are considered important for the efficient regulation of metabolism in bacteria.",
    "yulan-chat-2-13b-fp16_fact": [
      "Uber-operons are a type of regulatory unit in bacteria.",
      "Uber-operons contain multiple genes involved in a single metabolic pathway or process.",
      "The genes in uber-operons are transcribed together as a single unit.",
      "The gene products of uber-operons often function together in a coordinated manner.",
      "Uber-operons are considered important for the efficient regulation of metabolism in bacteria."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "yulan-chat-2-13b-fp16_response": "Cabergoline is not typically used for the treatment of Nelson's syndrome. Nelson's syndrome is a rare condition that occurs in some people who have had a total thyroidectomy (surgical removal of the thyroid gland) for Graves' disease. It is characterized by the overproduction of growth hormone by the pituitary gland, which can lead to a variety of symptoms, including muscle weakness, joint pain, and swelling.\nCabergoline is a medication that is used to treat a variety of conditions, including Parkinson's disease, hyperprolactinemia, and certain types of headaches. It works by blocking the action of a neurotransmitter called dopamine, which can help to reduce the symptoms of these conditions. However, it is not effective for treating the symptoms of Nelson's syndrome, which are caused by an overproduction of growth hormone.\nTreatment for Nelson's syndrome typically involves the use of medications that target the overproduction of growth hormone, such as somatostatin analogues or growth hormone antagonists. Surgery to remove the pituitary gland may also be considered in some cases. It is important to discuss the best treatment approach for Nelson's syndrome with a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nelson's syndrome is a rare condition that can occur in individuals who have undergone a total thyroidectomy for Graves' disease.\n2. Nelson's syndrome is characterized by the overproduction of growth hormone by the pituitary gland.\n3. Cabergoline is used to treat conditions like Parkinson's disease, hyperprolactinemia, and certain types of headaches.\n4. Cabergoline works by blocking the action of the neurotransmitter dopamine.\n5. Treatment for Nelson's syndrome often involves medications such as somatostatin analogues or growth hormone antagonists, or may include surgery to remove the pituitary gland.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nelson's syndrome is a rare condition that can occur in individuals who have undergone a total thyroidectomy for Graves' disease.",
      "Nelson's syndrome is characterized by the overproduction of growth hormone by the pituitary gland.",
      "Cabergoline is used to treat conditions like Parkinson's disease, hyperprolactinemia, and certain types of headaches.",
      "Cabergoline works by blocking the action of the neurotransmitter dopamine.",
      "Treatment for Nelson's syndrome often involves medications such as somatostatin analogues or growth hormone antagonists, or may include surgery to remove the pituitary gland."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Nelson's Syndrome is a rare condition that can occur in individuals who have undergone the removal of their adrenal glands and typically occurs in people who have had Cushing's disease, not Graves' disease which affects the thyroid.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Cabergoline works by mimicking the action of dopamine, not by blocking it. It is a dopamine agonist.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "yulan-chat-2-13b-fp16_response": "Liebenberg syndrome, also known as \"sleepwalking with eyes open,\" is a rare disorder characterized by a combination of sleepwalking and sleep-related eating disorder. The main manifestation of Liebenberg syndrome is a person's ability to walk around and even perform complex tasks while they are asleep, but with their eyes open. This can include things like cooking, cleaning, or even driving a car. In addition to sleepwalking, people with Liebenberg syndrome may also experience other symptoms such as confusion, disorientation, and memory loss upon waking up. It is important to note that Liebenberg syndrome is a relatively rare disorder and is typically diagnosed in people who have a history of sleepwalking or other sleep disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Liebenberg syndrome is characterized by a combination of sleepwalking and sleep-related eating disorder.\n2. The main symptom of Liebenberg syndrome is the ability to walk around and perform tasks while asleep, with eyes open.\n3. Activities such as cooking, cleaning, or driving a car can occur during episodes of Liebenberg syndrome.\n4. People with Liebenberg syndrome may experience confusion, disorientation, and memory loss upon waking up.\n5. Liebenberg syndrome is typically diagnosed in individuals with a history of sleepwalking or other sleep disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "Liebenberg syndrome is characterized by a combination of sleepwalking and sleep-related eating disorder.",
      "The main symptom of Liebenberg syndrome is the ability to walk around and perform tasks while asleep, with eyes open.",
      "Activities such as cooking, cleaning, or driving a car can occur during episodes of Liebenberg syndrome.",
      "People with Liebenberg syndrome may experience confusion, disorientation, and memory loss upon waking up.",
      "Liebenberg syndrome is typically diagnosed in individuals with a history of sleepwalking or other sleep disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Liebenberg syndrome does not refer to a combination of sleepwalking and sleep-related eating disorder. It is actually a syndrome that results in the elbow-like development of the wrist.\n2. FALSE [correction]: This statement might be describing sleepwalking (somnambulism) rather than Liebenberg syndrome, which is not characterized by sleepwalking.\n3. UNKNOWN: This statement could apply to sleepwalking, but its unclear if its true regarding Liebenberg syndrome due to the incorrect identification of the syndrome.\n4. UNKNOWN: While this statement might be true for sleepwalking or similar sleep disorders, its unclear if it applies to Liebenberg syndrome due to the earlier mischaracterization of the syndrome.\n5. FALSE [correction]: Liebenberg syndrome is not diagnosed based on a history of sleepwalking or other sleep disorders. It is a genetic condition affecting limb development.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3940,
    "user_query": "Which IDH inhibitors by Agios Pharmaceuticals have been approved by the FDA?",
    "yulan-chat-2-13b-fp16_response": "Agios Pharmaceuticals has developed several IDH inhibitors, but only one of them has been approved by the FDA so far:\n* Enasidenib (Idhafarib): Enasidenib is an inhibitor of isocitrate dehydrogenase 2 (IDH2) that was approved by the FDA in 2019 for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation.\nIt is important to note that Agios is also developing other IDH inhibitors, such as ivosidenib (Idhafarib) for the treatment of IDH1-mutated AML, which is currently being tested in clinical trials.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Agios Pharmaceuticals has developed several IDH inhibitors.\n2. The FDA has approved only one IDH inhibitor developed by Agios Pharmaceuticals.\n3. Enasidenib (Idhafarib) is an inhibitor of isocitrate dehydrogenase 2 (IDH2).\n4. Enasidenib was approved by the FDA in 2019.\n5. Enasidenib is approved for the treatment of relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Agios Pharmaceuticals has developed several IDH inhibitors.",
      "The FDA has approved only one IDH inhibitor developed by Agios Pharmaceuticals.",
      "Enasidenib (Idhafarib) is an inhibitor of isocitrate dehydrogenase 2 (IDH2).",
      "Enasidenib was approved by the FDA in 2019.",
      "Enasidenib is approved for the treatment of relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The FDA has approved two IDH inhibitors developed by Agios Pharmaceuticals: enasidenib (Idhifa) and ivosidenib (Tibsovo).\n3. TRUE\n4. FALSE [correction]: Enasidenib was approved by the FDA on August 1, 2017.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3941,
    "user_query": "What is RADICL-seq?",
    "yulan-chat-2-13b-fp16_response": "RADICL-seq is a sequencing technology that stands for \"Random Access DNA end-point identification by Cycle Laser-induced Fluorescence\". It is a method for sequencing single-stranded DNA that uses a laser to detect the fluorescent labels attached to the ends of the DNA fragments. This method allows for high-throughput sequencing of millions of DNA fragments in parallel, and it has been used for a variety of applications, including genome sequencing, transcriptome sequencing, and epigenetic profiling.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RADICL-seq stands for \"Random Access DNA end-point identification by Cycle Laser-induced Fluorescence.\"\n2. RADICL-seq is a method for sequencing single-stranded DNA.\n3. RADICL-seq uses a laser to detect fluorescent labels attached to the ends of DNA fragments.\n4. The method allows for high-throughput sequencing of millions of DNA fragments in parallel.\n5. RADICL-seq has been used for applications like genome sequencing, transcriptome sequencing, and epigenetic profiling.",
    "yulan-chat-2-13b-fp16_fact": [
      "RADICL-seq stands for \"Random Access DNA end-point identification by Cycle Laser-induced Fluorescence.\"",
      "RADICL-seq is a method for sequencing single-stranded DNA.",
      "RADICL-seq uses a laser to detect fluorescent labels attached to the ends of DNA fragments.",
      "The method allows for high-throughput sequencing of millions of DNA fragments in parallel.",
      "RADICL-seq has been used for applications like genome sequencing, transcriptome sequencing, and epigenetic profiling."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: RADICL-seq stands for \"Random Access DNA Identification by Cycle sequencing.\"\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3942,
    "user_query": "Which disease is treated with AntiSiglec-8 Antibody?",
    "yulan-chat-2-13b-fp16_response": "Anti-Siglec-8 antibody is being investigated for the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases. However, as of my knowledge cutoff date of September 2021, there were no approved uses of Anti-Siglec-8 antibody for any disease.\nIn cancer, Siglec-8 has been implicated in promoting tumor growth and metastasis, and Anti-Siglec-8 antibody is being studied as a potential therapeutic agent for cancer treatment. It has shown promising results in preclinical studies, but further research is needed to determine its safety and efficacy in human clinical trials.\nIn autoimmune disorders, Siglec-8 has been implicated in regulating the immune system and preventing autoimmune reactions. Anti-Siglec-8 antibody may have potential in treating autoimmune disorders by modulating the immune response. However, more research is needed to determine its safety and efficacy in this application.\nIn infectious diseases, Siglec-8 has been implicated in the immune response to certain viruses, including HIV and hepatitis C virus. Anti-Siglec-8 antibody may have potential in treating these diseases by modulating the immune response to the virus. However, more research is needed to determine its safety and efficacy in this application.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Anti-Siglec-8 antibody is being investigated for the treatment of cancer.\n2. Anti-Siglec-8 antibody is being explored for use in treating autoimmune disorders.\n3. Anti-Siglec-8 antibody is being studied for potential treatment in infectious diseases.\n4. As of September 2021, there were no approved uses of Anti-Siglec-8 antibody for any disease.\n5. Siglec-8 has been implicated in promoting tumor growth and metastasis in cancer research.",
    "yulan-chat-2-13b-fp16_fact": [
      "Anti-Siglec-8 antibody is being investigated for the treatment of cancer.",
      "Anti-Siglec-8 antibody is being explored for use in treating autoimmune disorders.",
      "Anti-Siglec-8 antibody is being studied for potential treatment in infectious diseases.",
      "As of September 2021, there were no approved uses of Anti-Siglec-8 antibody for any disease.",
      "Siglec-8 has been implicated in promoting tumor growth and metastasis in cancer research."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: Anti-Siglec-8 antibodies are being investigated for the treatment of certain types of cancer because they are thought to be involved in the regulation of immune cell functions within the tumor microenvironment.\n2. TRUE: Anti-Siglec-8 antibody is being explored for use in treating autoimmune disorders, particularly those that involve eosinophils and mast cells, cell types which express Siglec-8.\n3. UNKNOWN: Research on Anti-Siglec-8 antibody primarily focuses on cancer and autoimmune disorders, but its potential in infectious diseases would depend on current or future studies, and there is no specific information provided here.\n4. UNKNOWN: Knowledge cutoff prevents providing a current status, and the statement is outdated. The approval status of any drug can change and it's necessary to consult the latest drug approval databases or press releases for the most current information.\n5. FALSE [correction]: Siglec-8 is not typically implicated in promoting tumor growth and metastasis. Rather, it is often targeted to help regulate immune cell function in the tumor microenvironment, which could potentially inhibit tumor growth and metastasis.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3945,
    "user_query": "What is the effect of notch in the division of neural progenitor cells in Drosophila?",
    "yulan-chat-2-13b-fp16_response": "In Drosophila, the Notch gene plays a key role in the regulation of neural progenitor cells. Mutations in the Notch gene can lead to abnormalities in the division of neural progenitor cells, resulting in developmental defects in the nervous system. Specifically, Notch signaling promotes the self-renewal of neural progenitor cells by inhibiting their differentiation into neurons. If Notch signaling is disrupted, the progenitor cells may prematurely differentiate into neurons, leading to a decrease in the number of progenitor cells and ultimately, a smaller and less complex nervous system.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Notch gene is involved in the regulation of neural progenitor cells in Drosophila.\n2. Mutations in the Notch gene can cause developmental defects in the nervous system of Drosophila.\n3. Notch signaling inhibits the differentiation of neural progenitor cells into neurons.\n4. Disruption of Notch signaling can lead to premature differentiation of progenitor cells into neurons in Drosophila.\n5. A disruption in Notch signaling can result in a smaller and less complex nervous system in Drosophila due to a decrease in the number of progenitor cells.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Notch gene is involved in the regulation of neural progenitor cells in Drosophila.",
      "Mutations in the Notch gene can cause developmental defects in the nervous system of Drosophila.",
      "Notch signaling inhibits the differentiation of neural progenitor cells into neurons.",
      "Disruption of Notch signaling can lead to premature differentiation of progenitor cells into neurons in Drosophila.",
      "A disruption in Notch signaling can result in a smaller and less complex nervous system in Drosophila due to a decrease in the number of progenitor cells."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE: The Notch gene is indeed involved in the regulation of neural progenitor cells in Drosophila, playing a crucial role in their development.\n2. TRUE: Mutations in the Notch gene can cause various developmental defects, including those in the nervous system of Drosophila.\n3. TRUE: Notch signaling typically acts to inhibit the differentiation of neural progenitor cells into neurons, maintaining the cells in an undifferentiated state.\n4. TRUE: Disruption of Notch signaling can indeed lead to premature differentiation of progenitor cells into neurons in Drosophila, as the inhibitory effect of Notch signaling is lost.\n5. TRUE: A disruption in Notch signaling can result in a smaller and less complex nervous system in Drosophila due to premature differentiation leading to a reduction in the pool of progenitor cells available to produce more neurons and glial cells.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3950,
    "user_query": "What syndrome is associated with mutations in lysine methyltransferase 2D KMT2D?",
    "yulan-chat-2-13b-fp16_response": "Mutations in lysine methyltransferase 2D (KMT2D) are associated with the Rett syndrome. Rett syndrome is a rare neurological disorder that primarily affects girls and is characterized by progressive loss of motor skills, speech, and cognitive abilities. It is caused by mutations in the MECP2 gene, which encodes a protein that binds to methylated DNA and recruits other proteins to regulate gene expression. Mutations in KMT2D, which is a gene that encodes a lysine methyltransferase enzyme, can also lead to Rett syndrome by disrupting the function of MECP2.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in lysine methyltransferase 2D (KMT2D) are associated with Rett syndrome.\n2. Rett syndrome primarily affects girls.\n3. Rett syndrome is characterized by progressive loss of motor skills, speech, and cognitive abilities.\n4. Rett syndrome is caused by mutations in the MECP2 gene.\n5. The MECP2 gene encodes a protein that binds to methylated DNA and recruits other proteins to regulate gene expression.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in lysine methyltransferase 2D (KMT2D) are associated with Rett syndrome.",
      "Rett syndrome primarily affects girls.",
      "Rett syndrome is characterized by progressive loss of motor skills, speech, and cognitive abilities.",
      "Rett syndrome is caused by mutations in the MECP2 gene.",
      "The MECP2 gene encodes a protein that binds to methylated DNA and recruits other proteins to regulate gene expression."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Mutations in lysine methyltransferase 2D (KMT2D) are associated with Kabuki syndrome, not Rett syndrome.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3951,
    "user_query": "Does steroid 5A-Reductase deficiency lead to hermaphroditism?",
    "yulan-chat-2-13b-fp16_response": "Steroid 5-Reductase deficiency is a rare genetic disorder that affects the production of certain hormones, including testosterone and dihydrotestosterone (DHT). This condition can lead to a variety of symptoms, including infertility, atrophy of the testes, and a lack of secondary sexual characteristics. However, it does not typically lead to hermaphroditism.\nHermaphroditism is a condition in which an individual has both male and female reproductive organs. It is rare and occurs in less than 1% of the population. Steroid 5-Reductase deficiency does not typically cause the development of both male and female reproductive organs.\nIt is important to note that the symptoms of steroid 5-Reductase deficiency can vary widely from person to person, and some individuals with the condition may have more severe symptoms than others. If you have questions about this condition or are concerned about your own health, it is best to speak with a healthcare professional.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Steroid 5-Reductase deficiency is a rare genetic disorder that affects hormone production, including testosterone and dihydrotestosterone (DHT).\n2. Symptoms of Steroid 5-Reductase deficiency can include infertility, atrophy of the testes, and a lack of secondary sexual characteristics.\n3. Steroid 5-Reductase deficiency does not typically lead to hermaphroditism.\n4. Hermaphroditism is a condition where an individual has both male and female reproductive organs.\n5. Hermaphroditism occurs in less than 1% of the population.",
    "yulan-chat-2-13b-fp16_fact": [
      "Steroid 5-Reductase deficiency is a rare genetic disorder that affects hormone production, including testosterone and dihydrotestosterone (DHT).",
      "Symptoms of Steroid 5-Reductase deficiency can include infertility, atrophy of the testes, and a lack of secondary sexual characteristics.",
      "Steroid 5-Reductase deficiency does not typically lead to hermaphroditism.",
      "Hermaphroditism is a condition where an individual has both male and female reproductive organs.",
      "Hermaphroditism occurs in less than 1% of the population."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Steroid 5-Reductase deficiency can lead to a condition known as 5-reductase deficiency, which may result in ambiguous genitalia or differences in sexual development, sometimes referred to as a form of intersex variation, although the term hermaphroditism is considered outdated and not accurate in a clinical context.\n4. FALSE [correction]: Hermaphroditism, now more accurately referred to as intersex, is a term historically used to describe the presence of both ovarian and testicular tissue in the same individual. However, the clinical and biological understanding of intersex conditions is more complex and can involve a variety of chromosomal, gonadal, or anatomic differences from typical male or female presentations.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3955,
    "user_query": "What is the function of osteolectin?",
    "yulan-chat-2-13b-fp16_response": "Osteolectin is a protein that is expressed in bone and is involved in the regulation of bone remodeling. It is a member of the osteoclast differentiation factor (ODF) family of proteins, which are involved in the development and function of osteoclasts, the cells responsible for bone resorption. Osteolectin has been shown to play a role in the regulation of bone density and in the pathogenesis of osteoporosis. It may also have other functions, such as in the regulation of cell adhesion and migration.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Osteolectin is expressed in bone.\n2. Osteolectin is involved in the regulation of bone remodeling.\n3. Osteolectin is a member of the osteoclast differentiation factor (ODF) family of proteins.\n4. Osteoclasts are responsible for bone resorption.\n5. Osteolectin plays a role in the regulation of bone density and in the pathogenesis of osteoporosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Osteolectin is expressed in bone.",
      "Osteolectin is involved in the regulation of bone remodeling.",
      "Osteolectin is a member of the osteoclast differentiation factor (ODF) family of proteins.",
      "Osteoclasts are responsible for bone resorption.",
      "Osteolectin plays a role in the regulation of bone density and in the pathogenesis of osteoporosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Osteolectin, also known as Clec11a, is not a member of the osteoclast differentiation factor (ODF) family of proteins; it's a secreted glycoprotein that promotes osteogenesis.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3959,
    "user_query": "Are PDXK mutations linked to polyneuropathy?",
    "yulan-chat-2-13b-fp16_response": "PDXK mutations have been linked to hereditary sensory and autonomic neuropathy type 1 (HSAN1), which is a form of polyneuropathy. HSAN1 is a rare genetic disorder that affects the nerves that control sensation and autonomic functions, such as blood pressure, heart rate, and digestion. It is characterized by progressive weakness, numbness, and pain in the hands and feet, as well as abnormal sensations such as hyperesthesia or hypoesthesia.\nPDXK is a gene that encodes for the protein plexin-D1, which is involved in the development and maintenance of the peripheral nervous system. Mutations in the PDXK gene have been found to cause HSAN1 by disrupting the function of plexin-D1, leading to abnormal nerve development and function.\nWhile PDXK mutations are specifically linked to HSAN1, other forms of polyneuropathy may be caused by mutations in other genes. It is important to consult with a medical professional for proper diagnosis and treatment of any neuropathy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. PDXK mutations have been linked to hereditary sensory and autonomic neuropathy type 1 (HSAN1).\n2. HSAN1 is a form of polyneuropathy and is a rare genetic disorder.\n3. HSAN1 affects nerves controlling sensation and autonomic functions like blood pressure, heart rate, and digestion.\n4. The PDXK gene codes for the protein plexin-D1, which is significant for the peripheral nervous system's development and maintenance.\n5. Mutations in the PDXK gene disrupt the function of plexin-D1, causing abnormal nerve development and function related to HSAN1.",
    "yulan-chat-2-13b-fp16_fact": [
      "PDXK mutations have been linked to hereditary sensory and autonomic neuropathy type 1 (HSAN1).",
      "HSAN1 is a form of polyneuropathy and is a rare genetic disorder.",
      "HSAN1 affects nerves controlling sensation and autonomic functions like blood pressure, heart rate, and digestion.",
      "The PDXK gene codes for the protein plexin-D1, which is significant for the peripheral nervous system's development and maintenance.",
      "Mutations in the PDXK gene disrupt the function of plexin-D1, causing abnormal nerve development and function related to HSAN1."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: PDXK mutations have been linked to pyridoxine-dependent epilepsy (PDE), not hereditary sensory and autonomic neuropathy type 1 (HSAN1). Instead, HSAN1 has been associated with mutations in other genes such as SPTLC1 and SPTLC2.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The PDXK gene codes for pyridoxal kinase, an enzyme involved in the metabolism of vitamin B6, not plexin-D1.\n5. FALSE [correction]: Mutations in the PDXK gene disrupt the function of pyridoxal kinase which can lead to conditions like pyridoxine-dependent epilepsy (PDE) due to a deficiency in the active form of vitamin B6, not abnormalities in nerve development and function related to HSAN1.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3963,
    "user_query": "Which RNA polymerase transcribes enhancer RNAs?",
    "yulan-chat-2-13b-fp16_response": "RNA polymerase III transcribes enhancer RNAs (eRNAs). eRNAs are a type of non-coding RNA molecule that play a role in the regulation of gene expression by interacting with the RNA-binding proteins that control alternative splicing and mRNA stability. They are transcribed from the genes located in the 5' end of the H19 gene on chromosome 11.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RNA polymerase III transcribes enhancer RNAs (eRNAs).\n2. Enhancer RNAs are a type of non-coding RNA molecule.\n3. Enhancer RNAs play a role in the regulation of gene expression.\n4. Enhancer RNAs interact with RNA-binding proteins that control alternative splicing and mRNA stability.\n5. Enhancer RNAs are transcribed from genes located in the 5' end of the H19 gene on chromosome 11.",
    "yulan-chat-2-13b-fp16_fact": [
      "RNA polymerase III transcribes enhancer RNAs (eRNAs).",
      "Enhancer RNAs are a type of non-coding RNA molecule.",
      "Enhancer RNAs play a role in the regulation of gene expression.",
      "Enhancer RNAs interact with RNA-binding proteins that control alternative splicing and mRNA stability.",
      "Enhancer RNAs are transcribed from genes located in the 5' end of the H19 gene on chromosome 11."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: RNA polymerase II, not III, transcribes enhancer RNAs (eRNAs).\n2. TRUE\n3. TRUE\n4. TRUE (However, this statement is a generalization and there could be exceptions; enhancer RNAs can interact with various proteins, including RNA-binding proteins, to regulate gene expression.)\n5. FALSE [correction]: Enhancer RNAs are transcribed from enhancer regions in the genome, which can be located at various positions relative to genes; they are not specifically transcribed from genes located in the 5' end of the H19 gene on chromosome 11. The H19 gene does have its own regulatory sequences, but the statement is incorrect by specifying enhancer RNAs as being transcribed from the H19 5' end. Enhancer RNAs can originate from many different enhancer regions throughout the genome.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3965,
    "user_query": "Is co-loss of BRCA2-RB1 associated with better prognosis for prostate cancer patients?",
    "yulan-chat-2-13b-fp16_response": "Co-loss of BRCA2 and RB1 is not typically associated with prostate cancer, as these genes are more commonly associated with breast and ovarian cancer. However, there is some evidence to suggest that co-loss of BRCA2 and RB1 may be associated with a worse prognosis for some types of prostate cancer.\nOne study found that co-loss of BRCA2 and RB1 was associated with more aggressive forms of prostate cancer, including those that were more likely to spread to other parts of the body. Another study found that co-loss of BRCA2 and RB1 was associated with a higher risk of developing prostate cancer in the first place.\nIt's important to note that these studies were small and more research is needed to confirm these findings. Additionally, it's important to remember that genetic testing for BRCA2 and RB1 is not typically recommended for prostate cancer patients, as these genes are not as closely associated with prostate cancer as they are with breast and ovarian cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. BRCA2 and RB1 genes are more commonly associated with breast and ovarian cancer rather than prostate cancer.\n2. Some evidence suggests that co-loss of BRCA2 and RB1 may correlate with a worse prognosis in certain types of prostate cancer.\n3. One study indicated that co-loss of BRCA2 and RB1 was linked with more aggressive forms of prostate cancer and a likelihood of the cancer spreading.\n4. Another study suggested that co-loss of BRCA2 and RB1 was associated with a higher risk of developing prostate cancer.\n5. Genetic testing for BRCA2 and RB1 is not commonly recommended for prostate cancer patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "BRCA2 and RB1 genes are more commonly associated with breast and ovarian cancer rather than prostate cancer.",
      "Some evidence suggests that co-loss of BRCA2 and RB1 may correlate with a worse prognosis in certain types of prostate cancer.",
      "One study indicated that co-loss of BRCA2 and RB1 was linked with more aggressive forms of prostate cancer and a likelihood of the cancer spreading.",
      "Another study suggested that co-loss of BRCA2 and RB1 was associated with a higher risk of developing prostate cancer.",
      "Genetic testing for BRCA2 and RB1 is not commonly recommended for prostate cancer patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: While BRCA2 is commonly associated with breast and ovarian cancer, it is also associated with an increased risk of prostate cancer. RB1 is a tumor suppressor gene and its mutations have also been linked to prostate cancer, though it is more famously associated with retinoblastoma.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Genetic testing for BRCA2 is recommended for men who are at high risk for prostate cancer. RB1 testing may not be as common but can be recommended in certain clinical scenarios or research settings.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3967,
    "user_query": "Which cell secretes the enzyme tryptase?",
    "yulan-chat-2-13b-fp16_response": "Tryptase is an enzyme that is secreted by mast cells. Mast cells are a type of immune system cell that plays a role in the body's response to injury and infection. They are found in many tissues throughout the body, including the skin, respiratory tract, and gastrointestinal tract. Mast cells are known for their ability to release a variety of chemical mediators, including histamine, cytokines, and proteases, in response to various stimuli. Tryptase is one of the proteases that is secreted by mast cells. It is a serine protease enzyme that is involved in the regulation of inflammation and blood clotting.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tryptase is an enzyme that is secreted by mast cells.\n2. Mast cells are a type of immune system cell.\n3. Mast cells play a role in the body's response to injury and infection.\n4. Mast cells are located in tissues throughout the body, such as the skin, respiratory tract, and gastrointestinal tract.\n5. Tryptase is a serine protease enzyme involved in regulation of inflammation and blood clotting.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tryptase is an enzyme that is secreted by mast cells.",
      "Mast cells are a type of immune system cell.",
      "Mast cells play a role in the body's response to injury and infection.",
      "Mast cells are located in tissues throughout the body, such as the skin, respiratory tract, and gastrointestinal tract.",
      "Tryptase is a serine protease enzyme involved in regulation of inflammation and blood clotting."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3974,
    "user_query": "How many groups of viruses exist  in the Baltimore Classification?",
    "yulan-chat-2-13b-fp16_response": "The Baltimore Classification is a system used to classify bacteria based on their physical and biochemical characteristics. It does not classify viruses.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "yulan-chat-2-13b-fp16_response": "As of my knowledge cutoff date of September 2021, there are several orally bioavailable MPS1 kinase inhibitors that are currently being investigated in clinical trials or have been approved for use:\n1. Seliciclib (CYT387) - This is a selective MPS1 kinase inhibitor that has shown promising results in preclinical studies and is currently being tested in Phase 1 clinical trials for the treatment of various cancers.\n2. SKL-I - This is another selective MPS1 kinase inhibitor that has shown efficacy in preclinical studies and is currently being tested in Phase 1 clinical trials for the treatment of various cancers.\n3. S63845 - This is a highly selective MPS1 kinase inhibitor that has shown promising results in preclinical studies and is currently being tested in Phase 1 clinical trials for the treatment of various cancers.\n4. MPS1-IN-1 - This is a highly selective MPS1 kinase inhibitor that has shown efficacy in preclinical studies and is currently being tested in Phase 1 clinical trials for the treatment of various cancers.\n5. SKL-II - This is another highly selective MPS1 kinase inhibitor that has shown promising results in preclinical studies and is currently being tested in Phase 1 clinical trials for the treatment of various cancers.\nIt's important to note that the development of new drugs is an ongoing process and new compounds may have been discovered since my knowledge cutoff date of September 2021.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Seliciclib (CYT387) is an MPS1 kinase inhibitor that is in Phase 1 clinical trials for the treatment of various cancers.\n2. SKL-I is an MPS1 kinase inhibitor being tested in Phase 1 clinical trials for the treatment of various cancers.\n3. S63845 is an MPS1 kinase inhibitor in Phase 1 clinical trials for the treatment of various cancers.\n4. MPS1-IN-1 is a selective MPS1 kinase inhibitor in Phase 1 clinical trials for treating various cancers.\n5. SKL-II is an MPS1 kinase inhibitor currently being tested in Phase 1 clinical trials for the treatment of various cancers.",
    "yulan-chat-2-13b-fp16_fact": [
      "Seliciclib (CYT387) is an MPS1 kinase inhibitor that is in Phase 1 clinical trials for the treatment of various cancers.",
      "SKL-I is an MPS1 kinase inhibitor being tested in Phase 1 clinical trials for the treatment of various cancers.",
      "S63845 is an MPS1 kinase inhibitor in Phase 1 clinical trials for the treatment of various cancers.",
      "MPS1-IN-1 is a selective MPS1 kinase inhibitor in Phase 1 clinical trials for treating various cancers.",
      "SKL-II is an MPS1 kinase inhibitor currently being tested in Phase 1 clinical trials for the treatment of various cancers."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Seliciclib, also known as CYC202 or R-roscovitine, is actually a cyclin-dependent kinase (CDK) inhibitor, not an MPS1 kinase inhibitor, and has been in clinical trials for the treatment of various cancers.\n2. UNKNOWN: Without further context about SKL-I, its status as an MPS1 kinase inhibitor in clinical trials cannot be confirmed.\n3. FALSE [correction]: S63845 is not an MPS1 kinase inhibitor; it is a MCL-1 inhibitor that has been studied for the treatment of various cancers.\n4. FALSE [correction]: MPS1-IN-1 is indeed a selective MPS1 kinase inhibitor, but there is no information provided on its clinical trial phase, so the statement's accuracy regarding the clinical trial phase is uncertain.\n5. UNKNOWN: Without further context about SKL-II, its status as an MPS1 kinase inhibitor in clinical trials cannot be confirmed.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3982,
    "user_query": "When did eptinezumab get its first FDA approval?",
    "yulan-chat-2-13b-fp16_response": "Eptinezumab is a medication that is used to treat migraines. It is a monoclonal antibody that binds to calcitonin gene-related peptide (CGRP), which is a molecule that is involved in the transmission of pain signals in the body.\nEptinezumab was first approved by the US Food and Drug Administration (FDA) in February 2020. It was approved for the treatment of acute migraine in adults who have been diagnosed with migraines and have a history of episodic migraines, which are defined as occurring less than 15 days per month. Eptinezumab is given as an intravenous (IV) infusion and is typically administered in a doctor's office or clinic. It is not currently available for use at home.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eptinezumab is used to treat migraines.\n2. Eptinezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP).\n3. The FDA first approved eptinezumab in February 2020.\n4. Eptinezumab is prescribed for acute treatment of migraines in adults with a history of episodic migraines.\n5. Eptinezumab is administered through an intravenous (IV) infusion.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eptinezumab is used to treat migraines.",
      "Eptinezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP).",
      "The FDA first approved eptinezumab in February 2020.",
      "Eptinezumab is prescribed for acute treatment of migraines in adults with a history of episodic migraines.",
      "Eptinezumab is administered through an intravenous (IV) infusion."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Eptinezumab is prescribed for the preventive treatment of migraines in adults, not for acute treatment.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3983,
    "user_query": "Which database exists that contains regulatory sites for splicing in human basal ganglia?",
    "yulan-chat-2-13b-fp16_response": "There are several databases that contain information on regulatory sites for splicing in human basal ganglia. One such database is the Basal Ganglia Splicing Database (BGSD), which is a publicly available database that contains information on alternative splicing events in the human basal ganglia. The BGSD includes information on exonic and intronic regulatory elements, as well as information on the effects of mutations on splicing in the basal ganglia. Other databases that may contain information on regulatory sites for splicing in the human basal ganglia include the NCBI Gene database and the UCSC Genome Browser.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Basal Ganglia Splicing Database (BGSD) is a publicly available database.\n2. BGSD contains information on alternative splicing events in the human basal ganglia.\n3. The BGSD database includes information on exonic and intronic regulatory elements.\n4. BGSD provides information on the effects of mutations on splicing in the basal ganglia.\n5. The NCBI Gene database and the UCSC Genome Browser may contain information on regulatory sites for splicing in the human basal ganglia.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Basal Ganglia Splicing Database (BGSD) is a publicly available database.",
      "BGSD contains information on alternative splicing events in the human basal ganglia.",
      "The BGSD database includes information on exonic and intronic regulatory elements.",
      "BGSD provides information on the effects of mutations on splicing in the basal ganglia.",
      "The NCBI Gene database and the UCSC Genome Browser may contain information on regulatory sites for splicing in the human basal ganglia."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3985,
    "user_query": "What is pyroptosis?",
    "yulan-chat-2-13b-fp16_response": "Pyroptosis is a form of programmed cell death that is characterized by the activation of a caspase-1-dependent inflammatory response. It is a type of cell death that is mediated by the activation of a protein called pyroptosome, which is composed of the caspase-1 protein and a protein adaptor called the gasdermin protein. Pyroptosis is often induced in response to infection or other forms of cellular stress, and it plays a role in the immune response by triggering the release of inflammatory molecules that help to recruit immune cells to the site of infection or injury. Pyroptosis is also thought to play a role in the pathogenesis of certain diseases, including septic shock and neurodegenerative disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Pyroptosis is a form of programmed cell death.\n2. Pyroptosis involves the activation of a caspase-1-dependent inflammatory response.\n3. The activation of a protein called pyroptosome is mediated by caspase-1 and a protein adaptor called the gasdermin protein.\n4. Pyroptosis can be induced in response to infection or other forms of cellular stress.\n5. Pyroptosis plays a role in the immune response by triggering the release of inflammatory molecules.",
    "yulan-chat-2-13b-fp16_fact": [
      "Pyroptosis is a form of programmed cell death.",
      "Pyroptosis involves the activation of a caspase-1-dependent inflammatory response.",
      "The activation of a protein called pyroptosome is mediated by caspase-1 and a protein adaptor called the gasdermin protein.",
      "Pyroptosis can be induced in response to infection or other forms of cellular stress.",
      "Pyroptosis plays a role in the immune response by triggering the release of inflammatory molecules."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The activation of the pyroptosome is mediated by caspase-1, but the term \"pyroptosome\" refers to a large supramolecular complex of ASC, which is an adaptor protein involved in the inflammasome assembly that leads to caspase-1 activation, not a protein itself. It's the cleavage of gasdermin proteins, particularly gasdermin D, by activated caspase-1 that induces pyroptosis.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3986,
    "user_query": "What is a HapMap",
    "yulan-chat-2-13b-fp16_response": "HapMap (short for \"Haplotype Map\") is a project that aimed to identify and map common genetic variations in the human genome. The project was launched in 2002 and involved researchers from around the world who worked together to create a detailed map of the genetic variations that occur in human populations.\nThe HapMap project used DNA samples from individuals of African, Asian, and European ancestry to identify common genetic variations, or haplotypes, in the human genome. The project produced a set of genetic maps that showed the location and frequency of these variations across different populations.\nThe HapMap project was an important step in understanding the genetic basis of human diseases and traits. By identifying common genetic variations, researchers can better understand how these variations affect health and disease, and can use this information to develop new treatments and therapies.\nThe HapMap project was completed in 2005, but the data and resources generated by the project continue to be used by researchers today.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The HapMap project aimed to identify and map common genetic variations in the human genome.\n2. The HapMap project was launched in 2002.\n3. The project involved an international collaboration of researchers.\n4. DNA samples from individuals of African, Asian, and European ancestry were used in the HapMap project.\n5. The HapMap project was completed in 2005.",
    "yulan-chat-2-13b-fp16_fact": [
      "The HapMap project aimed to identify and map common genetic variations in the human genome.",
      "The HapMap project was launched in 2002.",
      "The project involved an international collaboration of researchers.",
      "DNA samples from individuals of African, Asian, and European ancestry were used in the HapMap project.",
      "The HapMap project was completed in 2005."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The HapMap project was not completed in 2005. The initial results of the project were published in 2005, but the project continued and the final phase was published in 2010.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3987,
    "user_query": "Which cancer types are associated with mutations in the TWIST1 gene?",
    "yulan-chat-2-13b-fp16_response": "The TWIST1 gene is a key regulator of embryonic development and is involved in the control of cell proliferation, differentiation, and survival. Mutations in the TWIST1 gene have been associated with several types of cancer, including:\n1. Liver cancer (hepatocellular carcinoma)\n2. Lung cancer\n3. Colorectal cancer\n4. Pancreatic cancer\n5. Ovarian cancer\n6. Uterine sarcoma\n7. Prostate cancer\n8. Breast cancer\n9. Kidney cancer (renal cell carcinoma)\n10. Brain tumors\nIt is important to note that while TWIST1 mutations have been linked to these cancers, they are not the sole cause and other genetic and environmental factors also play a role in cancer development.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mutations in the TWIST1 gene have been associated with liver cancer (hepatocellular carcinoma).\n2. Mutations in the TWIST1 gene have been associated with lung cancer.\n3. Mutations in the TWIST1 gene have been associated with colorectal cancer.\n4. Mutations in the TWIST1 gene have been associated with pancreatic cancer.\n5. Mutations in the TWIST1 gene have been associated with ovarian cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mutations in the TWIST1 gene have been associated with liver cancer (hepatocellular carcinoma).",
      "Mutations in the TWIST1 gene have been associated with lung cancer.",
      "Mutations in the TWIST1 gene have been associated with colorectal cancer.",
      "Mutations in the TWIST1 gene have been associated with pancreatic cancer.",
      "Mutations in the TWIST1 gene have been associated with ovarian cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe association of TWIST1 gene mutations with specific types of cancer is a very specialized topic that requires expert knowledge in the field of genetics or oncology. Without specific information from the passage that these statements are derived from, or access to relevant scientific data, it is not possible to accurately determine the veracity of these statements.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3991,
    "user_query": "List 3 therapeutic uses for botulism toxin.",
    "yulan-chat-2-13b-fp16_response": "Botulinum toxin is a neurotoxin that is commonly used in medicine for therapeutic purposes. Here are three therapeutic uses for botulism toxin:\n1. Treatment of muscle spasms: Botulinum toxin can be used to treat muscle spasms caused by conditions such as dystonia, hemiballism, and spasticity. It works by blocking the signal from the nerve to the muscle, which reduces muscle contractions.\n2. Treatment of wrinkles: Botulinum toxin is commonly used in cosmetic treatments to reduce the appearance of wrinkles and fine lines on the face. It works by temporarily paralyzing the muscles that cause wrinkles, resulting in smoother skin.\n3. Treatment of hyperhidrosis: Botulinum toxin can be used to treat excessive sweating (hyperhidrosis) in the underarms, palms, and soles of the feet. It works by blocking the nerve signals that trigger sweating, resulting in reduced sweating.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Botulinum toxin is used to treat muscle spasms such as dystonia, hemiballism, and spasticity.\n2. Botulinum toxin is used in cosmetic treatments to reduce the appearance of facial wrinkles and fine lines.\n3. Botulinum toxin is used to treat excessive sweating (hyperhidrosis) in areas like underarms, palms, and soles of the feet.",
    "yulan-chat-2-13b-fp16_fact": [
      "Botulinum toxin is used to treat muscle spasms such as dystonia, hemiballism, and spasticity.",
      "Botulinum toxin is used in cosmetic treatments to reduce the appearance of facial wrinkles and fine lines.",
      "Botulinum toxin is used to treat excessive sweating (hyperhidrosis) in areas like underarms, palms, and soles of the feet."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3997,
    "user_query": "What are the 4 types of holoprosencephaly?",
    "yulan-chat-2-13b-fp16_response": "Holoprosencephaly is a rare congenital brain defect in which the forebrain fails to divide into two hemispheres, resulting in a single hemisphere with a midline cleft or fissure. There are four types of holoprosencephaly, which are classified based on the severity and specific features of the defect. The four types are:\n1. Allocephalic holoprosencephaly: This is the most severe form of holoprosencephaly, in which the brain is completely fused and lacks a separation between the right and left hemispheres. The skull is typically large and abnormally shaped, and the forehead is often low and receded. Infants with this condition often have severe developmental delays and may have other birth defects, such as cleft lip and palate, eye abnormalities, and heart defects.\n2. Semi-allocephalic holoprosencephaly: In this type of holoprosencephaly, the brain is partially fused, with a small cleft or fissure between the two hemispheres. The skull is typically enlarged, and the forehead may be low and receded. Infants with this condition may have mild to moderate developmental delays and other birth defects.\n3. Diplocephalic holoprosencephaly: This type of holoprosencephaly is characterized by a partial separation of the two hemispheres of the brain, with a large cleft or fissure between them. The skull is typically enlarged, and the forehead may be high and prominent. Infants with this condition may have mild developmental delays and other birth defects, such as cleft lip and palate, eye abnormalities, and heart defects.\n4. Triple holoprosencephaly: This is a rare and severe form of holoprosencephaly in which there are three separate brain hemispheres instead of the usual two. The skull is typically large and abnormally shaped, and infants with this condition may have severe developmental delays and other birth defects.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Holoprosencephaly is a congenital brain defect where the forebrain fails to divide into two hemispheres.\n2. The most severe form of holoprosencephaly is allocephalic holoprosencephaly, where the brain is completely fused without separation between hemispheres.\n3. Semi-allocephalic holoprosencephaly is a type where the brain is partially fused with a small cleft between the hemispheres.\n4. Diplocephalic holoprosencephaly is characterized by a partial separation of the brain hemispheres with a large cleft between them.\n5. Triple holoprosencephaly is a rare form where three separate brain hemispheres are present instead of the usual two.",
    "yulan-chat-2-13b-fp16_fact": [
      "Holoprosencephaly is a congenital brain defect where the forebrain fails to divide into two hemispheres.",
      "The most severe form of holoprosencephaly is allocephalic holoprosencephaly, where the brain is completely fused without separation between hemispheres.",
      "Semi-allocephalic holoprosencephaly is a type where the brain is partially fused with a small cleft between the hemispheres.",
      "Diplocephalic holoprosencephaly is characterized by a partial separation of the brain hemispheres with a large cleft between them.",
      "Triple holoprosencephaly is a rare form where three separate brain hemispheres are present instead of the usual two."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The most severe form of holoprosencephaly is alobar holoprosencephaly, where the brain is completely fused without proper separation between hemispheres.\n3. FALSE [correction]: The term \"semi-allocephalic holoprosencephaly\" is not recognized in medical literature. A moderate form of holoprosencephaly is semi-lobar holoprosencephaly, where there is partial formation of the hemispheres.\n4. FALSE [correction]: Diplocephalic is not a term used in the context of holoprosencephaly. The term you might be looking for is \"lobar holoprosencephaly,\" where there is more significant separation between the hemispheres with a large cleft between them than in semi-lobar holoprosencephaly.\n5. FALSE [correction]: There is no recognized form of holoprosencephaly known as \"triple holoprosencephaly\" where three separate brain hemispheres are present. The brain normally has two hemispheres; holoprosencephaly is characterized by varying degrees of incomplete separation into these two hemispheres.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3998,
    "user_query": "Which yeast genes encode for condensin?",
    "yulan-chat-2-13b-fp16_response": "Condensin is a protein complex that plays a crucial role in the process of mitotic chromosome condensation, which is the formation of highly condensed chromatin structures that are necessary for the proper segregation of genetic material during cell division. In yeast, the condensin complex is composed of two proteins, Cdc7 and Cdc4. The genes that encode for these proteins are CDC7 and CDC4, respectively.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Condensin is a protein complex involved in mitotic chromosome condensation.\n2. Cdc7 and Cdc4 are proteins that compose the condensin complex in yeast.\n3. The genes that encode for the Cdc7 protein in yeast is CDC7.\n4. The genes that encode for the Cdc4 protein in yeast is CDC4.",
    "yulan-chat-2-13b-fp16_fact": [
      "Condensin is a protein complex involved in mitotic chromosome condensation.",
      "Cdc7 and Cdc4 are proteins that compose the condensin complex in yeast.",
      "The genes that encode for the Cdc7 protein in yeast is CDC7.",
      "The genes that encode for the Cdc4 protein in yeast is CDC4."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Cdc7 is a protein kinase involved in the initiation of DNA replication, and Cdc4 is part of the SCF (Skp, Cullin, F-box containing) ubiquitin ligase complex; neither are components of the condensin complex.\n3. TRUE\n4. FALSE [correction]: The gene that encodes for the Cdc4 protein in yeast is actually named CDC4, but it does not encode a component of the condensin complex; instead, it encodes a protein that is part of the SCF ubiquitin ligase complex.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3999,
    "user_query": "What is another name for the drug AMG334?",
    "yulan-chat-2-13b-fp16_response": "AMG 334 is another name for the drug AMG 330.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4004,
    "user_query": "Which gene is primarily associated with the Saethre-Chotzen syndrome?",
    "yulan-chat-2-13b-fp16_response": "The Saethre-Chotzen syndrome is a rare genetic disorder that is caused by mutations in the TGFB3 gene. This gene is responsible for producing a protein that helps to regulate the growth and development of bones and other tissues in the body. Mutations in the TGFB3 gene can lead to a variety of symptoms, including cleft palate, abnormalities of the skull and facial bones, and short stature. The Saethre-Chotzen syndrome is typically diagnosed in childhood, and there is no known cure for the condition. Treatment is focused on managing the symptoms and improving quality of life.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Saethre-Chotzen syndrome is caused by mutations in the TGFB3 gene.\n2. The TGFB3 gene is responsible for producing a protein that regulates the growth and development of bones and other tissues in the body.\n3. Mutations in the TGFB3 gene can lead to symptoms such as cleft palate and abnormalities of the skull and facial bones.\n4. Saethre-Chotzen syndrome is usually diagnosed in childhood.\n5. There is no known cure for Saethre-Chotzen syndrome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Saethre-Chotzen syndrome is caused by mutations in the TGFB3 gene.",
      "The TGFB3 gene is responsible for producing a protein that regulates the growth and development of bones and other tissues in the body.",
      "Mutations in the TGFB3 gene can lead to symptoms such as cleft palate and abnormalities of the skull and facial bones.",
      "Saethre-Chotzen syndrome is usually diagnosed in childhood.",
      "There is no known cure for Saethre-Chotzen syndrome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Saethre-Chotzen syndrome is caused by mutations in the TWIST1 gene, not the TGFB3 gene.\n2. TRUE\n3. PARTIALLY FALSE [correction]: While mutations in the TGFB3 gene can lead to developmental issues, the specific symptoms described (such as cleft palate and abnormalities of the skull and facial bones) are more accurately associated with conditions resulting from mutations in different genes, like Saethre-Chotzen syndrome which is caused by mutations in the TWIST1 gene.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4008,
    "user_query": "Which are the parts of a flaggelum?",
    "yulan-chat-2-13b-fp16_response": "A flagellum is a whip-like appendage found on the surface of some bacterial cells that helps the cell move by rotating. It is composed of three main parts:\n1. Filament: The filament is the long, thin part of the flagellum that extends from the cell body. It is made up of a protein called flagellin.\n2. Hook: The hook is a short, curved structure at the opposite end of the filament from the cell body. It is also made up of flagellin protein.\n3. Motor: The motor is the rotary motor that powers the movement of the flagellum. It is located at the base of the filament, near the cell body. The motor is made up of several proteins that work together to produce rotation.\nTogether, these three parts allow the flagellum to rotate and propel the bacterial cell forward.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A flagellum is found on the surface of some bacterial cells.\n2. The flagellum assists in cell movement by rotating.\n3. The flagellum is composed of the filament, hook, and motor.\n4. The filament is the long, thin part of the flagellum made up of flagellin protein.\n5. The motor is located at the base of the filament and powers the movement of the flagellum.",
    "yulan-chat-2-13b-fp16_fact": [
      "A flagellum is found on the surface of some bacterial cells.",
      "The flagellum assists in cell movement by rotating.",
      "The flagellum is composed of the filament, hook, and motor.",
      "The filament is the long, thin part of the flagellum made up of flagellin protein.",
      "The motor is located at the base of the filament and powers the movement of the flagellum."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4013,
    "user_query": "Givosiran is used for treatment of which disease?",
    "yulan-chat-2-13b-fp16_response": "Givosiran is used for the treatment of acute hepatic porphyria.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Givosiran is used for the treatment of acute hepatic porphyria.",
    "yulan-chat-2-13b-fp16_fact": [
      "Givosiran is used for the treatment of acute hepatic porphyria."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 4019,
    "user_query": "Inhaled Molgramostim can be used for treatment of which disease?",
    "yulan-chat-2-13b-fp16_response": "Inhaled molgramostim is an investigational drug being developed for the treatment of respiratory diseases, including cystic fibrosis and chronic obstructive pulmonary disease (COPD). It works by stimulating the growth and repair of lung tissue, and has shown promising results in early clinical trials. However, further research is needed to fully understand its safety and efficacy as a treatment for these conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Inhaled molgramostim is being developed for the treatment of respiratory diseases.\n2. Cystic fibrosis and chronic obstructive pulmonary disease (COPD) are conditions for which inhaled molgramostim is being investigated as a treatment.\n3. The drug works by stimulating the growth and repair of lung tissue.\n4. Inhaled molgramostim has shown promising results in early clinical trials.",
    "yulan-chat-2-13b-fp16_fact": [
      "Inhaled molgramostim is being developed for the treatment of respiratory diseases.",
      "Cystic fibrosis and chronic obstructive pulmonary disease (COPD) are conditions for which inhaled molgramostim is being investigated as a treatment.",
      "The drug works by stimulating the growth and repair of lung tissue.",
      "Inhaled molgramostim has shown promising results in early clinical trials."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n\n[Because the last statement requires access to specific and current medical trial results which are not provided in the context, it cannot be verified without additional information.]",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4021,
    "user_query": "Please list the 2 vaccines for herpes zoster(shingles)",
    "yulan-chat-2-13b-fp16_response": "The two vaccines for herpes zoster (shingles) are:\n1. Zostavax (Zoster Vaccine, Live) - This vaccine is made from a live, weakened version of the virus that causes shingles. It is recommended for people aged 50 and older.\n2. Shingrix (Zoster Vaccine Recombinant, Adjuvanted) - This vaccine is made from a recombinant DNA technology and contains a non-live component. It is recommended for people aged 50 and older.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Zostavax (Zoster Vaccine, Live) is a vaccine for herpes zoster recommended for people aged 50 and older.\n2. Zostavax is made from a live, weakened version of the virus that causes shingles.\n3. Shingrix (Zoster Vaccine Recombinant, Adjuvanted) is a vaccine for herpes zoster recommended for people aged 50 and older.\n4. Shingrix is made from recombinant DNA technology and contains a non-live component.",
    "yulan-chat-2-13b-fp16_fact": [
      "Zostavax (Zoster Vaccine, Live) is a vaccine for herpes zoster recommended for people aged 50 and older.",
      "Zostavax is made from a live, weakened version of the virus that causes shingles.",
      "Shingrix (Zoster Vaccine Recombinant, Adjuvanted) is a vaccine for herpes zoster recommended for people aged 50 and older.",
      "Shingrix is made from recombinant DNA technology and contains a non-live component."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4028,
    "user_query": "What does \"28\" stand for in the Disease Activity Score DAS28?",
    "yulan-chat-2-13b-fp16_response": "The Disease Activity Score (DAS) is a tool used to measure the level of disease activity in rheumatoid arthritis (RA). The DAS28 is a modified version of the DAS that includes 28 variables that are used to calculate a score between 0 and 10, with higher scores indicating greater disease activity. The \"28\" in DAS28 refers to the number of variables that are included in the score. These variables include things like the number of swollen and tender joints, the level of inflammation, and the presence of other symptoms such as fatigue and fever. The DAS28 is widely used to monitor disease activity in patients with RA and to guide treatment decisions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Disease Activity Score (DAS) is used to measure the level of disease activity in rheumatoid arthritis (RA).\n2. The \"28\" in DAS28 refers to the number of variables included in the score.\n3. The DAS28 generates a score that ranges between 0 and 10.\n4. Higher scores on the DAS28 indicate greater disease activity.\n5. The DAS28 is used to monitor disease activity in patients with RA and to guide treatment decisions.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Disease Activity Score (DAS) is used to measure the level of disease activity in rheumatoid arthritis (RA).",
      "The \"28\" in DAS28 refers to the number of variables included in the score.",
      "The DAS28 generates a score that ranges between 0 and 10.",
      "Higher scores on the DAS28 indicate greater disease activity.",
      "The DAS28 is used to monitor disease activity in patients with RA and to guide treatment decisions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The \"28\" in DAS28 refers to the number of joints examined in the assessment.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "yulan-chat-2-13b-fp16_response": "Golimumab is a monoclonal antibody that is used to treat rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking the activity of a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in inflammation.\nAs far as I know, golimumab has not been tested for diabetes. It is not approved for the treatment of diabetes, and there is no evidence to suggest that it has any effect on blood sugar levels or diabetes management.\nIf you have diabetes and are considering using golimumab or any other medication, it is important to discuss the potential risks and benefits with your healthcare provider. They can help you determine whether golimumab is a safe and appropriate treatment option for you.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Golimumab is used to treat rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.\n2. Golimumab works by blocking the activity of tumor necrosis factor-alpha (TNF-alpha).\n3. Golimumab has not been tested for the treatment of diabetes, as far as the information provided suggests.\n4. Golimumab is not approved for the treatment of diabetes.\n5. There is no evidence to suggest that golimumab has an effect on blood sugar levels or diabetes management.",
    "yulan-chat-2-13b-fp16_fact": [
      "Golimumab is used to treat rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.",
      "Golimumab works by blocking the activity of tumor necrosis factor-alpha (TNF-alpha).",
      "Golimumab has not been tested for the treatment of diabetes, as far as the information provided suggests.",
      "Golimumab is not approved for the treatment of diabetes.",
      "There is no evidence to suggest that golimumab has an effect on blood sugar levels or diabetes management."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN (The statement is too vague to be assessed without knowing if \"the information provided\" refers to some specific data source or general knowledge.)\n4. TRUE (Unless there has been a very recent change not accounted for in my knowledge base, golimumab is not approved for the treatment of diabetes.)\n5. FALSE [correction]: While the primary use of golimumab is not for diabetes management, there is evidence to suggest that TNF inhibitors like golimumab can have effects on blood sugar levels and may improve insulin sensitivity. However, this does not mean golimumab is used or approved for diabetes management.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 4032,
    "user_query": "Is G3BP1 found in stress granules?",
    "yulan-chat-2-13b-fp16_response": "Yes, G3BP1 (G3BP1 protein) is found in stress granules. Stress granules are membrane-less organelles that form in the cells of many eukaryotic organisms in response to various types of stress, such as exposure to high temperatures, oxidative stress, or viral infections. G3BP1 is one of the key proteins that is recruited to stress granules, where it plays a role in regulating the stability and function of the granules.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. G3BP1 is a protein that is found in stress granules.\n2. Stress granules form in the cells of many eukaryotic organisms in response to stress.\n3. Types of stress that induce the formation of stress granules include high temperatures, oxidative stress, or viral infections.\n4. G3BP1 plays a role in regulating the stability and function of stress granules.",
    "yulan-chat-2-13b-fp16_fact": [
      "G3BP1 is a protein that is found in stress granules.",
      "Stress granules form in the cells of many eukaryotic organisms in response to stress.",
      "Types of stress that induce the formation of stress granules include high temperatures, oxidative stress, or viral infections.",
      "G3BP1 plays a role in regulating the stability and function of stress granules."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4036,
    "user_query": "Is colistin an antibiotic?",
    "yulan-chat-2-13b-fp16_response": "Yes, colistin is an antibiotic. It is a polymyxin antibiotic that is used to treat a variety of infections caused by bacteria, including those that are resistant to other antibiotics. Colistin works by disrupting the cell wall of bacteria, causing them to die. It is often used as a last resort antibiotic when other antibiotics have failed. However, it is important to note that colistin can also have negative effects on the gut microbiome and should be used with caution.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Colistin is an antibiotic.\n2. Colistin is used to treat bacterial infections, including those resistant to other antibiotics.\n3. Colistin disrupts the cell wall of bacteria, causing them to die.\n4. Colistin is often used as a last resort antibiotic when other treatments have failed.\n5. Colistin can have negative effects on the gut microbiome.",
    "yulan-chat-2-13b-fp16_fact": [
      "Colistin is an antibiotic.",
      "Colistin is used to treat bacterial infections, including those resistant to other antibiotics.",
      "Colistin disrupts the cell wall of bacteria, causing them to die.",
      "Colistin is often used as a last resort antibiotic when other treatments have failed.",
      "Colistin can have negative effects on the gut microbiome."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Colistin disrupts the cell membrane of bacteria, not the cell wall.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4038,
    "user_query": "Is the process of DNA loop-extrusion independent of ATP?",
    "yulan-chat-2-13b-fp16_response": "The process of DNA loop-extrusion, also known as the \"opening of the DNA double helix,\" is a process that occurs during DNA replication and transcription. It is driven by the action of the enzyme helicase, which unwinds the DNA double helix by breaking the hydrogen bonds between the complementary base pairs.\nATP (adenosine triphosphate) is not directly involved in the process of DNA loop-extrusion. However, helicase requires energy to perform its function, and ATP can be used as a source of energy for the enzyme. In fact, some helicases are ATP-dependent, meaning that they require ATP to drive the unwinding of DNA.\nTherefore, while ATP is not directly involved in the process of DNA loop-extrusion, it can indirectly contribute to the energy required for the enzyme to perform its function.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. DNA loop-extrusion occurs during DNA replication and transcription.\n2. The enzyme helicase unwinds the DNA double helix by breaking the hydrogen bonds between the complementary base pairs during DNA loop-extrusion.\n3. ATP is not directly involved in the process of DNA loop-extrusion.\n4. Helicase requires energy to unwind the DNA and can use ATP as a source of energy.\n5. Some helicases are ATP-dependent for the unwinding of DNA.",
    "yulan-chat-2-13b-fp16_fact": [
      "DNA loop-extrusion occurs during DNA replication and transcription.",
      "The enzyme helicase unwinds the DNA double helix by breaking the hydrogen bonds between the complementary base pairs during DNA loop-extrusion.",
      "ATP is not directly involved in the process of DNA loop-extrusion.",
      "Helicase requires energy to unwind the DNA and can use ATP as a source of energy.",
      "Some helicases are ATP-dependent for the unwinding of DNA."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The enzyme helicase unwinds the DNA double helix by breaking the hydrogen bonds between the complementary base pairs during DNA replication and, separately, during processes that may involve DNA loop-extrusion, but loop-extrusion itself refers to the process by which certain proteins such as cohesin or condensin extrude loops of DNA to organize and compact the genome. Helicase action and DNA loop-extrusion can be part of larger DNA manipulation mechanisms in the cell, but they are distinct processes.\n3. FALSE [correction]: ATP is directly involved in the process of DNA loop-extrusion, as the motor proteins that catalyze this process, such as cohesin and condensin, utilize ATP to change their conformation and exert forces on the DNA molecule.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4048,
    "user_query": "Where is the organ of Corti located?",
    "yulan-chat-2-13b-fp16_response": "The organ of Corti is located in the cochlea of the inner ear. The cochlea is a spiral-shaped structure that is responsible for converting sound waves into electrical signals that can be interpreted by the brain. The organ of Corti is a structure within the cochlea that is responsible for detecting sound vibrations. It is named after the Italian anatomist, Bartolomeo Panizza, who first described it in 1711, and the French anatomist, Jean-Baptiste Labb, who later studied it in detail.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The organ of Corti is located in the cochlea of the inner ear.\n2. The cochlea is responsible for converting sound waves into electrical signals for the brain.\n3. The organ of Corti detects sound vibrations.\n4. Italian anatomist Bartolomeo Panizza first described the organ of Corti.\n5. French anatomist Jean-Baptiste Labb studied the organ of Corti in detail.",
    "yulan-chat-2-13b-fp16_fact": [
      "The organ of Corti is located in the cochlea of the inner ear.",
      "The cochlea is responsible for converting sound waves into electrical signals for the brain.",
      "The organ of Corti detects sound vibrations.",
      "Italian anatomist Bartolomeo Panizza first described the organ of Corti.",
      "French anatomist Jean-Baptiste Labb studied the organ of Corti in detail."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: It was Italian anatomist Alfonso Corti who first described the organ of Corti.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "yulan-chat-2-13b-fp16_response": "Yes, progeria is caused by an autosomal recessive gene. The specific gene that is mutated in progeria is the LMNA gene, which provides instructions for making a protein called lamin A. Lamin A plays an important role in maintaining the structure and function of the nuclear envelope, which is the membrane that surrounds the nucleus of a cell and contains the genetic material. In progeria, mutations in the LMNA gene lead to the production of an abnormal form of lamin A called progerin, which accumulates in the nuclear envelope and disrupts its normal function. This disruption leads to the characteristic features of progeria, including premature aging, hair loss, and cardiovascular disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Progeria is caused by a mutation in the LMNA gene.\n2. The LMNA gene provides instructions for making the protein lamin A.\n3. Lamin A is important for maintaining the structure and function of the nuclear envelope.\n4. Mutations in the LMNA gene cause the production of an abnormal form of lamin A called progerin.\n5. The accumulation of progerin in the nuclear envelope leads to the characteristic features of progeria, such as premature aging, hair loss, and cardiovascular disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Progeria is caused by a mutation in the LMNA gene.",
      "The LMNA gene provides instructions for making the protein lamin A.",
      "Lamin A is important for maintaining the structure and function of the nuclear envelope.",
      "Mutations in the LMNA gene cause the production of an abnormal form of lamin A called progerin.",
      "The accumulation of progerin in the nuclear envelope leads to the characteristic features of progeria, such as premature aging, hair loss, and cardiovascular disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4060,
    "user_query": "What is the cause of the Kleefstra syndrome?",
    "yulan-chat-2-13b-fp16_response": "Kleefstra syndrome is a rare genetic disorder that is caused by mutations in the ECHDC1 gene. This gene provides instructions for making a protein that is important for the proper development and function of nerve cells. Mutations in the ECHDC1 gene can lead to abnormalities in the structure of nerve cells, which can affect their ability to communicate with each other and with other parts of the body. These abnormalities can cause the characteristic features of Kleefstra syndrome, including intellectual disability, delayed bone age, and distinctive facial features.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Kleefstra syndrome is caused by mutations in the ECHDC1 gene.\n2. The ECHDC1 gene is responsible for making a protein important for the development and function of nerve cells.\n3. Mutations in the ECHDC1 gene can cause abnormalities in the structure of nerve cells.\n4. These abnormalities can affect the ability of nerve cells to communicate with each other and other parts of the body.\n5. Characteristic features of Kleefstra syndrome include intellectual disability, delayed bone age, and distinctive facial features.",
    "yulan-chat-2-13b-fp16_fact": [
      "Kleefstra syndrome is caused by mutations in the ECHDC1 gene.",
      "The ECHDC1 gene is responsible for making a protein important for the development and function of nerve cells.",
      "Mutations in the ECHDC1 gene can cause abnormalities in the structure of nerve cells.",
      "These abnormalities can affect the ability of nerve cells to communicate with each other and other parts of the body.",
      "Characteristic features of Kleefstra syndrome include intellectual disability, delayed bone age, and distinctive facial features."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Kleefstra syndrome is caused by mutations in the EHMT1 gene, not the ECHDC1 gene.\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4066,
    "user_query": "List proteins that promotes calcification.",
    "yulan-chat-2-13b-fp16_response": "There are several proteins that have been identified to promote calcification, including:\n1. Osteocalcin: This is a protein that is produced by osteoblasts, the cells that form bone. Osteocalcin promotes calcium absorption and mobilization from the bones, and also helps to regulate calcium and phosphate levels in the blood.\n2. Osteopontin: This protein is also produced by osteoblasts and plays a role in bone formation and mineralization. It can promote calcium and phosphate absorption from the gut and also helps to regulate calcium and phosphate levels in the blood.\n3. Bone morphogenetic protein (BMP): This is a family of proteins that are involved in bone formation and mineralization. BMPs can stimulate the differentiation of osteoblasts and promote calcium and phosphate absorption from the gut.\n4. Parathyroid hormone (PTH): This hormone is produced by the parathyroid gland and plays a key role in regulating calcium and phosphate levels in the blood. PTH can stimulate the release of calcium from the bones and also promotes calcium absorption from the gut.\n5. Vitamin K-dependent proteins: Vitamin K is necessary for the carboxylation of certain proteins, including osteocalcin and matrix gla protein, which are involved in bone formation and mineralization. Vitamin K deficiency can lead to decreased bone density and increased risk of fractures.\nIt's important to note that while these proteins play a role in promoting calcification, an imbalance or excess of any of these proteins can lead to negative health outcomes, such as kidney stones or calcification of soft tissues.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Osteocalcin is produced by osteoblasts and promotes calcium absorption and mobilization from bones.\n2. Osteopontin is produced by osteoblasts and is involved in bone formation and mineralization.\n3. Bone morphogenetic proteins (BMPs) are involved in bone formation and mineralization and can stimulate the differentiation of osteoblasts.\n4. Parathyroid hormone (PTH) is produced by the parathyroid gland and regulates calcium and phosphate levels in the blood.\n5. Vitamin K is necessary for the carboxylation of certain proteins, including osteocalcin and matrix gla protein, which are involved in bone formation and mineralization.",
    "yulan-chat-2-13b-fp16_fact": [
      "Osteocalcin is produced by osteoblasts and promotes calcium absorption and mobilization from bones.",
      "Osteopontin is produced by osteoblasts and is involved in bone formation and mineralization.",
      "Bone morphogenetic proteins (BMPs) are involved in bone formation and mineralization and can stimulate the differentiation of osteoblasts.",
      "Parathyroid hormone (PTH) is produced by the parathyroid gland and regulates calcium and phosphate levels in the blood.",
      "Vitamin K is necessary for the carboxylation of certain proteins, including osteocalcin and matrix gla protein, which are involved in bone formation and mineralization."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4067,
    "user_query": "Please list 3 small molecule CGRP-Receptor antagonists for migraine",
    "yulan-chat-2-13b-fp16_response": "1. Erenumab\n2. Fremanezumab\n3. Galcanezumab",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4069,
    "user_query": "Why is fingolimod considered a prodrug?",
    "yulan-chat-2-13b-fp16_response": "Fingolimod is considered a prodrug because it is converted into an active metabolite in the body that is responsible for its pharmacological effects.\nA prodrug is a compound that is administered in its inactive form, but is converted into an active form in the body. In the case of fingolimod, it is administered as an inactive compound that is then converted into its active metabolite, which is called S-236288.\nS-236288 is a drug that acts as an immunomodulatory agent, meaning that it modulates the immune system. It works by blocking the activity of certain immune cells called lymphocytes, which are involved in the immune response. By blocking the activity of these cells, fingolimod helps to reduce the frequency and severity of relapses in patients with multiple sclerosis.\nFingolimod is considered a prodrug because it is not active in its original form, but is converted into an active form in the body that produces the desired therapeutic effect. This is in contrast to a drug that is already in its active form and can be administered directly to produce the desired effect.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fingolimod is considered a prodrug because it is converted into an active metabolite within the body that is responsible for its pharmacological effects.\n2. The active metabolite of fingolimod, responsible for its effect, is called S-236288.\n3. S-236288 acts as an immunomodulatory agent by modulating the immune system.\n4. Fingolimod works by blocking the activity of immune cells called lymphocytes, which are involved in the immune response.\n5. Fingolimod helps to reduce the frequency and severity of relapses in patients with multiple sclerosis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fingolimod is considered a prodrug because it is converted into an active metabolite within the body that is responsible for its pharmacological effects.",
      "The active metabolite of fingolimod, responsible for its effect, is called S-236288.",
      "S-236288 acts as an immunomodulatory agent by modulating the immune system.",
      "Fingolimod works by blocking the activity of immune cells called lymphocytes, which are involved in the immune response.",
      "Fingolimod helps to reduce the frequency and severity of relapses in patients with multiple sclerosis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The active metabolite of fingolimod, responsible for its effect, is called fingolimod-phosphate or FTY720-P.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4081,
    "user_query": "What is the Oncomine Dx Target test?",
    "yulan-chat-2-13b-fp16_response": "Oncomine Dx Target is a next-generation sequencing (NGS) assay designed to detect genetic mutations in cancer cells. The test is used to identify specific mutations in cancer-related genes that may be driving the growth and spread of cancer.\nThe Oncomine Dx Target test analyzes DNA from cancer cells obtained through a biopsy or surgical resection. The test uses NGS technology to sequence the entire coding region of over 500 cancer-related genes, as well as selected intronic regions. This allows the test to detect both somatic and heterozygous mutations, which are key drivers of cancer progression.\nThe test results provide information on the presence or absence of specific mutations in cancer-related genes, as well as the frequency of mutations in each gene. This information can be used by oncologists to select the most appropriate treatment for the patient, based on the specific genetic profile of their cancer.\nOverall, the Oncomine Dx Target test is a valuable tool for cancer diagnosis and treatment, as it provides valuable information on the genetic drivers of cancer and can help guide personalized treatment decisions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Oncomine Dx Target test is a next-generation sequencing assay for detecting genetic mutations in cancer cells.\n2. It is used to identify specific mutations in cancer-related genes that influence cancer growth and spread.\n3. The test analyzes DNA from cancer cells using NGS technology to sequence over 500 cancer-related genes and selected intronic regions.\n4. It can detect both somatic and heterozygous mutations.\n5. The results of the Oncomine Dx Target test help oncologists to select personalized treatment options for cancer patients.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Oncomine Dx Target test is a next-generation sequencing assay for detecting genetic mutations in cancer cells.",
      "It is used to identify specific mutations in cancer-related genes that influence cancer growth and spread.",
      "The test analyzes DNA from cancer cells using NGS technology to sequence over 500 cancer-related genes and selected intronic regions.",
      "It can detect both somatic and heterozygous mutations.",
      "The results of the Oncomine Dx Target test help oncologists to select personalized treatment options for cancer patients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Oncomine Dx Target Test does not sequence over 500 cancer-related genes and selected intronic regions. It is designed to target specific genes relevant for certain types of cancer treatment decisions.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "yulan-chat-2-13b-fp16_response": "The 12q14 and 12q24 regions of the genome are associated with several genetic variants that have been linked to various diseases and conditions. Here are some of the common variants associated with these regions:\n12q14:\n* rs944289: This variant is located near the MEF2 genes and has been associated with increased risk of coronary artery disease, type 2 diabetes, and obesity.\n* rs1293379: This variant is located near the NADAS18 gene and has been associated with increased risk of coronary artery disease and type 2 diabetes.\n* rs1048031: This variant is located near the KCNJ11 gene and has been associated with increased risk of type 2 diabetes.\n12q24:\n* rs6465084: This variant is located near the CDKAL1 gene and has been associated with increased risk of type 2 diabetes.\n* rs1001015: This variant is located near the ZNF217 gene and has been associated with increased risk of type 2 diabetes.\n* rs11655239: This variant is located near the TCF7L2 gene and has been associated with increased risk of type 2 diabetes.\nIt's important to note that genetic variants are just one of many factors that can contribute to the development of diseases and conditions, and not everyone with these variants will develop the associated conditions. Additionally, the relationship between genetic variants and disease is complex and can be influenced by a variety of environmental and lifestyle factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The genetic variant rs944289 is associated with increased risk of coronary artery disease, type 2 diabetes, and obesity.\n2. The genetic variant rs1293379 has been associated with increased risk of coronary artery disease and type 2 diabetes.\n3. The genetic variant rs1048031 has been associated with increased risk of type 2 diabetes.\n4. The genetic variant rs6465084 is located near the CDKAL1 gene and has been associated with increased risk of type 2 diabetes.\n5. The genetic variant rs11655239 is located near the TCF7L2 gene and has been associated with increased risk of type 2 diabetes.",
    "yulan-chat-2-13b-fp16_fact": [
      "The genetic variant rs944289 is associated with increased risk of coronary artery disease, type 2 diabetes, and obesity.",
      "The genetic variant rs1293379 has been associated with increased risk of coronary artery disease and type 2 diabetes.",
      "The genetic variant rs1048031 has been associated with increased risk of type 2 diabetes.",
      "The genetic variant rs6465084 is located near the CDKAL1 gene and has been associated with increased risk of type 2 diabetes.",
      "The genetic variant rs11655239 is located near the TCF7L2 gene and has been associated with increased risk of type 2 diabetes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The genetic variant rs944289 is associated with increased risk of thyroid cancer, particularly papillary thyroid carcinoma, not coronary artery disease, type 2 diabetes, and obesity.\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE: The genetic variant rs6465084 is indeed located near the CDKAL1 gene and has been associated with increased risk of type 2 diabetes.\n5. TRUE: The genetic variant rs11655239, located near the TCF7L2 gene, has been associated with an increased risk of type 2 diabetes.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4087,
    "user_query": "What is AZD8601?",
    "yulan-chat-2-13b-fp16_response": "AZD8601 is an investigational drug being developed by AstraZeneca for the treatment of cancer. It is a selective inhibitor of the Menin-MLL binding interface, which is a key regulatory mechanism for the MLL complex, a group of proteins that are involved in the regulation of gene expression and are frequently altered in cancer. By inhibiting the Menin-MLL binding interface, AZD8601 is thought to disrupt the activity of the MLL complex and potentially halt the progression of cancer.\nAZD8601 is currently being tested in clinical trials for the treatment of various types of cancer, including acute myeloid leukemia, myelodysplastic syndrome, and solid tumors. Early results from these trials have shown promising activity and a favorable safety profile, leading to its designation as a \"breakthrough therapy\" by the US Food and Drug Administration (FDA) in 2021. However, more research is needed to fully understand its potential as a cancer treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. AZD8601 is an investigational drug developed by AstraZeneca.\n2. AZD8601 is a selective inhibitor of the Menin-MLL binding interface.\n3. The MLL complex, which AZD8601 targets, is involved in the regulation of gene expression and is often altered in cancer.\n4. AZD8601 is being tested in clinical trials for the treatment of acute myeloid leukemia, myelodysplastic syndrome, and solid tumors.\n5. The US Food and Drug Administration designated AZD8601 as a \"breakthrough therapy\" in 2021.",
    "yulan-chat-2-13b-fp16_fact": [
      "AZD8601 is an investigational drug developed by AstraZeneca.",
      "AZD8601 is a selective inhibitor of the Menin-MLL binding interface.",
      "The MLL complex, which AZD8601 targets, is involved in the regulation of gene expression and is often altered in cancer.",
      "AZD8601 is being tested in clinical trials for the treatment of acute myeloid leukemia, myelodysplastic syndrome, and solid tumors.",
      "The US Food and Drug Administration designated AZD8601 as a \"breakthrough therapy\" in 2021."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: AZD8601 is not a selective inhibitor of the Menin-MLL binding interface. AZD8601 is an mRNA-based therapy that codes for the protein VEGF-A, which is involved in the healing of damaged tissues by promoting blood vessel growth.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nIt's important to note that while the role of the MLL (mixed lineage leukemia) complex in the regulation of gene expression and its alteration in cancer is well-documented, and \"breakthrough therapy\" is a designation by the US FDA for certain promising therapies, without specific information about AZD8601 concerning these contexts, it is not possible to confirm the veracity of statements 3, 4, and 5.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "yulan-chat-2-13b-fp16_response": "The Roundabout (Robo) receptors are a family of ligand-gated ion channels that are activated by a variety of ligands, including:\n1. Spermine - a polyamine molecule that is found in high concentrations in the brain and spinal cord.\n2. Spermine N-acetyltransferase (SNAT) - an enzyme that is involved in the synthesis of spermine.\n3. Decoy receptor 3 (DcR3) - a member of the TGF-beta superfamily of ligands that binds to the Robo receptors and inhibits their activity.\n4. Slit - a secreted protein that is involved in the development and maintenance of the nervous system.\n5. Robo ligands - a family of proteins that are structurally related to Slit and bind to the Robo receptors.\nThe specific ligand that binds to a particular Robo receptor can vary depending on the cell type and the developmental context.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Spermine is a ligand that activates Roundabout (Robo) receptors and is found in high concentrations in the brain and spinal cord.\n2. Spermine N-acetyltransferase (SNAT) is involved in the synthesis of spermine and is a ligand that activates Robo receptors.\n3. Decoy receptor 3 (DcR3) is a ligand of the TGF-beta superfamily that binds to Robo receptors and inhibits their activity.\n4. Slit is a secreted protein that acts as a ligand for Robo receptors and is involved in the development and maintenance of the nervous system.\n5. Robo ligands are structurally related to Slit and bind to Robo receptors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Spermine is a ligand that activates Roundabout (Robo) receptors and is found in high concentrations in the brain and spinal cord.",
      "Spermine N-acetyltransferase (SNAT) is involved in the synthesis of spermine and is a ligand that activates Robo receptors.",
      "Decoy receptor 3 (DcR3) is a ligand of the TGF-beta superfamily that binds to Robo receptors and inhibits their activity.",
      "Slit is a secreted protein that acts as a ligand for Robo receptors and is involved in the development and maintenance of the nervous system.",
      "Robo ligands are structurally related to Slit and bind to Robo receptors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Spermine is not a ligand that activates Roundabout (Robo) receptors. It is a polyamine that is found in high concentrations in the brain and spinal cord but has different biological functions, primarily concerning cellular metabolism and stabilization of cellular components.\n2. FALSE [correction]: Spermine N-acetyltransferase (SNAT) is involved in the catabolic processing of spermine but is not a ligand for Robo receptors.\n3. FALSE [correction]: Decoy receptor 3 (DcR3) is a member of the tumor necrosis factor receptor superfamily that can bind certain members of the TNF family of ligands but does not bind to Robo receptors.\n4. TRUE: Slit is indeed a secreted protein that acts as a ligand for Robo receptors and is crucial in axon guidance and neuronal migration.\n5. FALSE [correction]: While Slit is a ligand for Robo receptors, not all Robo ligands are structurally related to Slit. Robo ligands comprise a few different molecules such as Slit proteins and other factors that might interact with Robo receptors in varying contexts.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 4111,
    "user_query": "Which proteins does RG-7992 target?",
    "yulan-chat-2-13b-fp16_response": "RG-7992 is a monoclonal antibody drug that targets a protein called CD20, which is found on the surface of certain types of B cells. B cells are a type of white blood cell that plays a key role in the immune system by producing antibodies to help fight infections. RG-7992 works by binding to CD20 on the surface of B cells and triggering a process that leads to the destruction of the cells. This can be useful in treating certain diseases, such as certain types of cancer and autoimmune disorders.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. RG-7992 is a monoclonal antibody drug.\n2. RG-7992 targets a protein called CD20.\n3. CD20 is found on the surface of certain types of B cells.\n4. B cells contribute to the immune system by producing antibodies for fighting infections.\n5. RG-7992 may be used in treating certain types of cancer and autoimmune disorders.",
    "yulan-chat-2-13b-fp16_fact": [
      "RG-7992 is a monoclonal antibody drug.",
      "RG-7992 targets a protein called CD20.",
      "CD20 is found on the surface of certain types of B cells.",
      "B cells contribute to the immune system by producing antibodies for fighting infections.",
      "RG-7992 may be used in treating certain types of cancer and autoimmune disorders."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nJustification for the \"UNKNOWN\" responses:\n1. Without additional context or information about RG-7992, it's not possible to determine whether this is a factual statement about a real drug.\n2. The targeting of the CD20 protein is characteristic of certain known monoclonal antibody drugs, like rituximab. However, without specific knowledge about RG-7992, it can't be confirmed that this statement is true.\n5. Monoclonal antibodies that target CD20, like rituximab, are indeed used to treat certain cancers and autoimmune disorders, but since the actual existence or function of RG-7992 is not confirmed, it cannot be stated with certainty that this drug is used for such treatments.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "yulan-chat-2-13b-fp16_response": "Yes, there is a role for TFII-I in megakaryopoiesis. TFII-I is a transcription factor that plays a key role in the regulation of gene expression. In megakaryopoiesis, TFII-I is involved in the regulation of genes that are important for the development and function of megakaryocytes, which are cells that play a critical role in blood clotting.\nTFII-I is a member of the TFIID complex, which is a large complex of proteins that is responsible for the transcriptional activation of genes. In megakaryopoiesis, TFII-I is involved in the activation of genes that are important for the differentiation and function of megakaryocytes. For example, TFII-I has been shown to bind to the promoter regions of genes such as GATA1, which is a key transcription factor for megakaryocyte development, and CXCL12, which is a cytokine that is important for the survival and function of megakaryocytes.\nOverall, TFII-I plays an important role in the regulation of gene expression during megakaryopoiesis, and its dysregulation can contribute to the development of disorders related to blood clotting and thrombosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. TFII-I is a transcription factor that plays a role in the regulation of gene expression during megakaryopoiesis.\n2. Megakaryocytes, which TFII-I influences, are essential for blood clotting.\n3. TFII-I is part of the TFIID complex, which is involved in the transcriptional activation of genes.\n4. TFII-I can bind to the promoter regions of genes such as GATA1, which is crucial for megakaryocyte development.\n5. TFII-I also is involved in regulating the gene for CXCL12, a cytokine important for megakaryocyte survival and function.",
    "yulan-chat-2-13b-fp16_fact": [
      "TFII-I is a transcription factor that plays a role in the regulation of gene expression during megakaryopoiesis.",
      "Megakaryocytes, which TFII-I influences, are essential for blood clotting.",
      "TFII-I is part of the TFIID complex, which is involved in the transcriptional activation of genes.",
      "TFII-I can bind to the promoter regions of genes such as GATA1, which is crucial for megakaryocyte development.",
      "TFII-I also is involved in regulating the gene for CXCL12, a cytokine important for megakaryocyte survival and function."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TFII-I is not part of the TFIID complex; it is a separate transcription factor that can influence gene expression independently.\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4118,
    "user_query": "Which R/Bioconductor package has been developed for network-based differential expression analysis?",
    "yulan-chat-2-13b-fp16_response": "The R/Bioconductor package that has been developed for network-based differential expression analysis is called \"WGCNA\". It stands for Weighted Gene Co-expression Network Analysis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A R/Bioconductor package called \"WGCNA\" has been developed for network-based differential expression analysis.\n2. \"WGCNA\" stands for Weighted Gene Co-expression Network Analysis.",
    "yulan-chat-2-13b-fp16_fact": [
      "A R/Bioconductor package called \"WGCNA\" has been developed for network-based differential expression analysis.",
      "\"WGCNA\" stands for Weighted Gene Co-expression Network Analysis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 4119,
    "user_query": "Can propofol cause green urine?",
    "yulan-chat-2-13b-fp16_response": "It is possible for propofol to cause green urine, although this is not a common side effect. Propofol is a medication that is used to induce and maintain anesthesia during surgery or other medical procedures. It works by depressing the central nervous system, which can cause a decrease in blood pressure, heart rate, and breathing.\nOne possible explanation for why propofol might cause green urine is that it can lead to a decrease in the body's ability to filter waste products out of the blood. This can cause the excretion of certain substances, such as bilirubin, which can give urine a greenish color. However, it is important to note that this is a rare side effect and is usually not a cause for concern.\nIf you have green urine after taking propofol, it is important to speak with your doctor to determine the cause. There may be other factors contributing to this symptom, and your doctor will be able to provide you with the appropriate treatment and advice.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Propofol is a medication used to induce and maintain anesthesia.\n2. Propofol can cause a decrease in blood pressure, heart rate, and breathing.\n3. Green urine can be a rare side effect of propofol.\n4. Decreased ability of the body to filter waste products due to propofol may lead to the excretion of substances like bilirubin, which can color the urine green.\n5. Green urine is usually not a cause for concern, but it should be discussed with a doctor.",
    "yulan-chat-2-13b-fp16_fact": [
      "Propofol is a medication used to induce and maintain anesthesia.",
      "Propofol can cause a decrease in blood pressure, heart rate, and breathing.",
      "Green urine can be a rare side effect of propofol.",
      "Decreased ability of the body to filter waste products due to propofol may lead to the excretion of substances like bilirubin, which can color the urine green.",
      "Green urine is usually not a cause for concern, but it should be discussed with a doctor."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While propofol can cause green urine, the coloring is not due to bilirubin or decreased filtering of waste products by the body. Green urine is a known but uncommon side effect of propofol and is thought to be due to a phenolic metabolite of propofol.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4125,
    "user_query": "Is vocimagene amiretrorepvec effective for glioblastoma?",
    "yulan-chat-2-13b-fp16_response": "Vocimagene amiretrorepvec is an investigational gene therapy being developed for the treatment of various types of cancer, including glioblastoma. It is a recombinant adeno-associated viral vector-based gene therapy that encodes for antisense RNA molecules that target specific messenger RNA (mRNA) transcripts.\nAs of my knowledge cutoff date of September 2021, clinical trials evaluating the safety and efficacy of vocimagene amiretrorepvec for the treatment of glioblastoma were ongoing but not yet complete.\nTherefore, it is too early to determine the overall effectiveness of vocimagene amiretrorepvec for the treatment of glioblastoma. However, preclinical studies have shown some promising results, suggesting that it may have potential as a therapeutic option for this aggressive form of brain cancer.\nIt is important to note that gene therapies are a relatively new and rapidly evolving field, and the safety and efficacy of these treatments are still being studied and refined. As such, it is crucial for patients to discuss the potential benefits and risks of any investigational therapy with their healthcare provider to determine if it is an appropriate treatment option for them.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vocimagene amiretrorepvec is an investigational gene therapy developed for the treatment of various types of cancer, including glioblastoma.\n2. Vocimagene amiretrorepvec is a recombinant adeno-associated viral vector-based gene therapy.\n3. The therapy encodes for antisense RNA molecules that target specific messenger RNA (mRNA) transcripts.\n4. As of September 2021, clinical trials for vocimagene amiretrorepvec were ongoing and not yet complete.\n5. Preclinical studies have shown some promising results for the use of vocimagene amiretrorepvec in treating glioblastoma.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vocimagene amiretrorepvec is an investigational gene therapy developed for the treatment of various types of cancer, including glioblastoma.",
      "Vocimagene amiretrorepvec is a recombinant adeno-associated viral vector-based gene therapy.",
      "The therapy encodes for antisense RNA molecules that target specific messenger RNA (mRNA) transcripts.",
      "As of September 2021, clinical trials for vocimagene amiretrorepvec were ongoing and not yet complete.",
      "Preclinical studies have shown some promising results for the use of vocimagene amiretrorepvec in treating glioblastoma."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Vocimagene amiretrorepvec is not based on adeno-associated viral vectors; it is a recombinant retroviral replicating vector gene therapy.\n3. FALSE [correction]: The therapy does not encode for antisense RNA molecules; instead, it delivers the gene for an enzyme that converts a prodrug into an active chemotherapy drug.\n4. UNKNOWN (Without up-to-date information beyond the knowledge cutoff date in 2023, the status of clinical trials as of September 2021 cannot be confirmed.)\n5. TRUE (Preclinical studies showing promising results is consistent with the nature of how investigational therapies are typically developed, though specific data would be needed to confirm this statement's veracity.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4131,
    "user_query": "Can Panitumumab cause trichomegaly?",
    "yulan-chat-2-13b-fp16_response": "Panitumumab is a monoclonal antibody drug that is used to treat certain types of cancer, specifically metastatic colorectal cancer and metastatic pancreatic cancer. As far as I know, there is no evidence to suggest that panitumumab can cause trichomegaly.\nTrichomegaly is a rare genetic disorder characterized by the presence of extra hair growth on the body, which is caused by a mutation in the androgen receptor gene. While panitumumab may have various side effects, such as diarrhea, nausea, and skin rash, it is not known to be associated with trichomegaly.\nIf you are concerned about potential side effects of panitumumab or any other medication, it is important to discuss them with your healthcare provider. They can provide you with more information and help you manage any side effects that you may experience.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Panitumumab is used to treat certain types of cancer, including metastatic colorectal cancer and metastatic pancreatic cancer.\n2. Trichomegaly is characterized by extra hair growth on the body and is caused by a mutation in the androgen receptor gene.\n3. The side effects of panitumumab may include diarrhea, nausea, and skin rash.\n4. There is no evidence to suggest that panitumumab causes trichomegaly.",
    "yulan-chat-2-13b-fp16_fact": [
      "Panitumumab is used to treat certain types of cancer, including metastatic colorectal cancer and metastatic pancreatic cancer.",
      "Trichomegaly is characterized by extra hair growth on the body and is caused by a mutation in the androgen receptor gene.",
      "The side effects of panitumumab may include diarrhea, nausea, and skin rash.",
      "There is no evidence to suggest that panitumumab causes trichomegaly."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Panitumumab is used to treat certain types of cancer, including metastatic colorectal cancer, but not metastatic pancreatic cancer.\n2. FALSE [correction]: Trichomegaly is characterized by excessive growth of the eyelashes and can be caused by various conditions, including as a side effect of certain medications, but not specifically by a mutation in the androgen receptor gene.\n3. TRUE\n4. FALSE [correction]: While not commonly discussed, there have been reports in medical literature suggesting that panitumumab can cause trichomegaly among its side effects.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 4135,
    "user_query": "What is the mechanism of action of vosoritide?",
    "yulan-chat-2-13b-fp16_response": "Vosoritide is an experimental drug being developed for the treatment of various conditions, including osteoporosis and muscle wasting. It is a synthetic peptide that is structurally related to the natural hormone, osteocalcin.\nThe mechanism of action of vosoritide is thought to involve its ability to activate a specific signaling pathway known as the Wnt pathway. This pathway plays a key role in regulating bone and muscle mass, and is thought to be involved in the development and maintenance of these tissues.\nVosoritide is believed to stimulate the production of new bone and muscle cells by promoting the differentiation and proliferation of precursor cells. It may also help to inhibit the breakdown of existing bone and muscle tissue, which can help to prevent the loss of these tissues that occurs in conditions such as osteoporosis and muscle wasting.\nIn addition to its effects on bone and muscle tissue, vosoritide may also have other potential therapeutic effects, including the promotion of insulin sensitivity and the reduction of inflammation. However, further research is needed to fully understand the mechanism of action of vosoritide and its potential therapeutic applications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vosoritide is an experimental drug being developed for the treatment of osteoporosis and muscle wasting.\n2. It is a synthetic peptide structurally related to osteocalcin.\n3. Vosoritide is thought to activate the Wnt signaling pathway, which is important for bone and muscle mass regulation.\n4. The drug is believed to stimulate production of new bone and muscle cells through differentiation and proliferation of precursor cells.\n5. Vosoritide may help inhibit the breakdown of existing bone and muscle tissue.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vosoritide is an experimental drug being developed for the treatment of osteoporosis and muscle wasting.",
      "It is a synthetic peptide structurally related to osteocalcin.",
      "Vosoritide is thought to activate the Wnt signaling pathway, which is important for bone and muscle mass regulation.",
      "The drug is believed to stimulate production of new bone and muscle cells through differentiation and proliferation of precursor cells.",
      "Vosoritide may help inhibit the breakdown of existing bone and muscle tissue."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Vosoritide is an experimental drug developed for the treatment of achondroplasia, not osteoporosis and muscle wasting.\n2. FALSE [correction]: Vosoritide is a synthetic peptide analog of C-type natriuretic peptide (CNP), not osteocalcin.\n3. FALSE [correction]: Vosoritide is thought to activate the cyclic guanosine monophosphate (cGMP) signaling pathway, not the Wnt signaling pathway, which increases bone growth.\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4141,
    "user_query": "What is the mechanism of action of idasanutlin?",
    "yulan-chat-2-13b-fp16_response": "Idasanutlin is an experimental drug that is being developed for the treatment of various cancers, including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It works by inhibiting the activity of a protein called S63845, which is involved in the regulation of cell division and survival. By inhibiting the activity of S63845, idasanutlin is thought to promote the apoptosis (programmed cell death) of cancer cells, while sparing normal cells. In addition to its anti-cancer effects, idasanutlin has also been shown to have anti-inflammatory and anti-fibrotic effects, which may be beneficial in the treatment of certain diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "yulan-chat-2-13b-fp16_response": "Yes, atenolol is metabolized by the cytochrome P450 enzyme CYP2D6. CYP2D6 is a member of the cytochrome P450 superfamily of enzymes, which are responsible for the metabolism of many drugs and other xenobiotics in the body. CYP2D6 is expressed in the liver, intestine, and kidney, and it plays a major role in the metabolism of many drugs, including atenolol.\nAtenolol is a beta-blocker that is used to treat a variety of conditions, including hypertension, angina, and arrhythmias. It works by blocking the effects of epinephrine and norepinephrine, which are hormones that stimulate the heart rate and blood pressure. Atenolol is metabolized by CYP2D6 to form several inactive metabolites, which are then excreted in the urine.\nThe metabolism of atenolol by CYP2D6 can vary significantly among individuals, depending on the specific genetic characteristics of the CYP2D6 enzyme. Some people have a genetic variant of CYP2D6 that results in reduced enzyme activity, while others have a genetic variant that results in increased enzyme activity. This can affect the rate at which atenolol is metabolized and the effectiveness of the drug.\nIt is important to note that the use of atenolol and other beta-blockers can be contraindicated in certain individuals, such as those with certain heart conditions or those who are taking other medications that may interact with atenolol. It is important to speak with a healthcare provider to determine if atenolol is appropriate for a specific individual and to monitor for potential side effects or interactions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Atenolol is metabolized by the cytochrome P450 enzyme CYP2D6.\n2. CYP2D6 is expressed in the liver, intestine, and kidney.\n3. Atenolol is used to treat hypertension, angina, and arrhythmias.\n4. Atenolol works by blocking the effects of epinephrine and norepinephrine on the heart.\n5. Metabolism of atenolol by CYP2D6 can vary significantly among individuals due to genetic variants of the enzyme.",
    "yulan-chat-2-13b-fp16_fact": [
      "Atenolol is metabolized by the cytochrome P450 enzyme CYP2D6.",
      "CYP2D6 is expressed in the liver, intestine, and kidney.",
      "Atenolol is used to treat hypertension, angina, and arrhythmias.",
      "Atenolol works by blocking the effects of epinephrine and norepinephrine on the heart.",
      "Metabolism of atenolol by CYP2D6 can vary significantly among individuals due to genetic variants of the enzyme."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Atenolol is not significantly metabolized by the liver and has minimal interaction with the cytochrome P450 enzyme system, including CYP2D6.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Since atenolol is not significantly metabolized by cytochrome P450 enzymes such as CYP2D6, its metabolism would not vary significantly among individuals due to genetic variants of these enzymes.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4151,
    "user_query": "Which pharmacogenetic test is recommended prior to administering carbamazepine and why?",
    "yulan-chat-2-13b-fp16_response": "The pharmacogenetic test recommended prior to administering carbamazepine is the CYP2C19 genotyping test. Carbamazepine is metabolized by the cytochrome P450 enzyme CYP2C19, and individuals with genetic variations in this gene may have altered metabolism of the drug, leading to differences in drug efficacy and toxicity. Knowing an individual's CYP2C19 genotype can help determine the appropriate dosage and potential risks associated with using carbamazepine.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The CYP2C19 genotyping test is recommended before administering carbamazepine.\n2. Carbamazepine is metabolized by the cytochrome P450 enzyme CYP2C19.\n3. Genetic variations in the CYP2C19 gene can lead to altered metabolism of carbamazepine.\n4. Different CYP2C19 genotypes can influence drug efficacy and toxicity of carbamazepine.\n5. Knowing an individual's CYP2C19 genotype can help determine the appropriate dosage of carbamazepine.",
    "yulan-chat-2-13b-fp16_fact": [
      "The CYP2C19 genotyping test is recommended before administering carbamazepine.",
      "Carbamazepine is metabolized by the cytochrome P450 enzyme CYP2C19.",
      "Genetic variations in the CYP2C19 gene can lead to altered metabolism of carbamazepine.",
      "Different CYP2C19 genotypes can influence drug efficacy and toxicity of carbamazepine.",
      "Knowing an individual's CYP2C19 genotype can help determine the appropriate dosage of carbamazepine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The CYP2C19 genotyping test is not typically recommended before administering carbamazepine; instead, it is often associated with the antiplatelet drug clopidogrel. For carbamazepine, CYP2C9 and HLA-B*1502 genotyping may be considered, especially in populations at higher risk for severe skin reactions.\n2. FALSE [correction]: Carbamazepine is metabolized primarily by the cytochrome P450 enzyme CYP3A4, not CYP2C19.\n3. TRUE: Genetic variations in the genes encoding for metabolizing enzymes (like CYP2C9 for carbamazepine) can lead to altered drug metabolism, which is true for many drugs.\n4. TRUE: Different genotypes related to drug metabolism enzymes can influence the efficacy and toxicity of various drugs, including carbamazepine, though the specific gene of interest for carbamazepine is generally CYP2C9 rather than CYP2C19.\n5. TRUE: Knowing an individual's genotype for drug-metabolizing enzymes, such as CYP2C9 and HLA-B*1502 in the case of carbamazepine, can help determine the appropriate dosage and reduce the risk of adverse drug reactions.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4153,
    "user_query": "Which drugs are included in the MAID chemotherapy regimen for sarcoma?",
    "yulan-chat-2-13b-fp16_response": "MAID (Multi-Agent Initiation Therapy) is a chemotherapy regimen that is used to treat various types of cancer, including sarcoma. The specific drugs used in the MAID regimen may vary depending on the type of sarcoma and the patient's individual needs. However, the MAID regimen typically includes a combination of drugs that are known to be effective against sarcoma cells. These drugs may include:\n* Doxorubicin\n* Epirubicin\n* Cyclophosphamide\n* Ifosfamide\n* Paclitaxel\n* Gemcitabine\n* Cisplatin\n* Carboplatin\nIt's important to note that the specific drugs used in the MAID regimen may vary depending on the type of sarcoma and the patient's individual needs. Your doctor will determine the best treatment plan for you based on your specific diagnosis and medical history.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The MAID chemotherapy regimen is used to treat various types of cancer, including sarcoma.\n2. Doxorubicin is typically included in the MAID chemotherapy regimen for sarcoma.\n3. Epirubicin may be used in the MAID chemotherapy regimen for sarcoma.\n4. Ifosfamide is one of the drugs that can be included in the MAID chemotherapy regimen for sarcoma.\n5. The specific drugs used in the MAID regimen can vary based on the type of sarcoma and the patient's individual needs.",
    "yulan-chat-2-13b-fp16_fact": [
      "The MAID chemotherapy regimen is used to treat various types of cancer, including sarcoma.",
      "Doxorubicin is typically included in the MAID chemotherapy regimen for sarcoma.",
      "Epirubicin may be used in the MAID chemotherapy regimen for sarcoma.",
      "Ifosfamide is one of the drugs that can be included in the MAID chemotherapy regimen for sarcoma.",
      "The specific drugs used in the MAID regimen can vary based on the type of sarcoma and the patient's individual needs."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Epirubicin is not typically included in the MAID chemotherapy regimen for sarcoma. The \"A\" in MAID stands for Doxorubicin (also known as Adriamycin), not Epirubicin.\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4155,
    "user_query": "Who received the Nobel prize for development of CRISPR?",
    "yulan-chat-2-13b-fp16_response": "The Nobel Prize for the development of CRISPR has not been awarded yet. However, the Nobel Prize in Physiology or Medicine for 2020 was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of the hepatitis C virus.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Nobel Prize for the development of CRISPR has not been awarded yet.\n2. The Nobel Prize in Physiology or Medicine for 2020 was awarded to Harvey J. Alter, Michael Houghton, and Charles M. Rice.\n3. Harvey J. Alter, Michael Houghton and Charles M. Rice were awarded for their discovery of the hepatitis C virus.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Nobel Prize for the development of CRISPR has not been awarded yet.",
      "The Nobel Prize in Physiology or Medicine for 2020 was awarded to Harvey J. Alter, Michael Houghton, and Charles M. Rice.",
      "Harvey J. Alter, Michael Houghton and Charles M. Rice were awarded for their discovery of the hepatitis C virus."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The Nobel Prize for the development of CRISPR, specifically the Nobel Prize in Chemistry for 2020, was awarded to Emmanuelle Charpentier and Jennifer A. Doudna for the development of the CRISPR-Cas9 genome editing method.\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4156,
    "user_query": "How are super enhancers defined?",
    "yulan-chat-2-13b-fp16_response": "Super enhancers are defined as genomic regions that exhibit increased levels of gene expression compared to other regions of the genome. They are characterized by the presence ofancers, which are DNA elements that can increase the transcriptional activity of genes by binding to specific transcription factors. Super enhancers are often associated with developmental genes and play important roles in regulating cellular differentiation and proliferation. They are also known to be involved in the development of various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Super enhancers are genomic regions with increased levels of gene expression relative to other genome regions.\n2. Super enhancers are characterized by the presence of enhancers, which are DNA elements.\n3. These enhancers can increase the transcriptional activity of genes through binding to specific transcription factors.\n4. Super enhancers are often associated with developmental genes.\n5. Super enhancers play roles in regulating cellular differentiation and proliferation and are involved in the development of various diseases, including cancer.",
    "yulan-chat-2-13b-fp16_fact": [
      "Super enhancers are genomic regions with increased levels of gene expression relative to other genome regions.",
      "Super enhancers are characterized by the presence of enhancers, which are DNA elements.",
      "These enhancers can increase the transcriptional activity of genes through binding to specific transcription factors.",
      "Super enhancers are often associated with developmental genes.",
      "Super enhancers play roles in regulating cellular differentiation and proliferation and are involved in the development of various diseases, including cancer."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE \n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "yulan-chat-2-13b-fp16_response": "ExpansionHunter is a popular Minecraft mod that allows players to easily find and install new mods for Minecraft. The mod has gone through several versions since its initial release. Here is a list of the major versions of ExpansionHunter:\n1. ExpansionHunter 1.0 - This was the initial release of the mod and introduced the basic functionality of finding and installing mods.\n2. ExpansionHunter 1.1 - This version added support for custom mod directories and improved the mod discovery process.\n3. ExpansionHunter 1.2 - This version introduced a new user interface and improved mod management features.\n4. ExpansionHunter 1.3 - This version added support for modpacks and improved the mod installation process.\n5. ExpansionHunter 1.4 - This version introduced a new mod browser and improved mod compatibility.\n6. ExpansionHunter 1.5 - This version added support for mod updates and improved the mod installation process.\n7. ExpansionHunter 1.6 - This version introduced a new mod management system and improved mod compatibility.\n8. ExpansionHunter 1.7 - This version added support for mod categories and improved the mod discovery process.\n9. ExpansionHunter 1.8 - This version introduced a new mod installation wizard and improved mod management features.\n10. ExpansionHunter 1.9 - This version added support for mod comments and improved the mod discovery process.\n11. ExpansionHunter 1.10 - This version introduced a new mod installation system and improved mod compatibility.\n12. ExpansionHunter 1.11 - This version added support for mod version checking and improved the mod management system.\n13. ExpansionHunter 1.12 - This version introduced a new mod installation system and improved mod compatibility.\n14. ExpansionHunter 1.13 - This version added support for mod updates and improved the mod management system.\n15. ExpansionHunter 1.14 - This version introduced a new mod installation system and improved mod compatibility.\n16. ExpansionHunter 1.15 - This version added support for mod categories and improved the mod discovery process.\n17. ExpansionHunter 1.16 - This version introduced a new mod installation system and improved mod compatibility.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. ExpansionHunter 1.0 was the initial release of the mod.\n2. ExpansionHunter 1.1 added support for custom mod directories.\n3. ExpansionHunter 1.2 introduced a new user interface.\n4. ExpansionHunter 1.3 added support for modpacks.\n5. ExpansionHunter 1.4 introduced a new mod browser.",
    "yulan-chat-2-13b-fp16_fact": [
      "ExpansionHunter 1.0 was the initial release of the mod.",
      "ExpansionHunter 1.1 added support for custom mod directories.",
      "ExpansionHunter 1.2 introduced a new user interface.",
      "ExpansionHunter 1.3 added support for modpacks.",
      "ExpansionHunter 1.4 introduced a new mod browser."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nExplanation:\nWithout specific context about what \"ExpansionHunter\" refers to, it's difficult to verify these statements. If \"ExpansionHunter\" refers to a software tool, mod for a game, or any other specific application, its version history and features would need to be referenced from a reliable source to verify the accuracy of these statements. There might be release notes, official documentation, or a community changelog that could provide this information. Without such context, it is not possible to confirm or correct these statements.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4160,
    "user_query": "What is the proteoglycan Tsukushi?",
    "yulan-chat-2-13b-fp16_response": "Tsukushi is a proteoglycan, which is a type of molecule that is composed of proteins and glycosaminoglycans (GAGs). Proteoglycans are found in the extracellular matrix of many tissues, including bone, cartilage, and skin. They play a variety of important roles in the body, including providing structural support, facilitating cell adhesion, and regulating cell growth and differentiation.\nTsukushi is a specific proteoglycan that is found in the cartilage of the trachea, which is the tube that connects the lungs to the throat. It is one of several proteoglycans that are found in the cartilage of the trachea, and it is thought to play a role in maintaining the structural integrity of the trachea and protecting it from damage.\nTsukushi is named after the Japanese city of Fukuoka, which is known for its beautiful scenery and cultural heritage. It was first identified in the cartilage of the trachea in 2003 by a team of researchers led by Dr. Yasuyuki Tsukushi at the University of Tokyo. Since then, it has been the subject of further research, and it is now recognized as an important component of the extracellular matrix in the trachea.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tsukushi is a type of proteoglycan.\n2. Proteoglycans are found in the extracellular matrix of many tissues, including bone, cartilage, and skin.\n3. Tsukushi specifically is found in the cartilage of the trachea.\n4. Tsukushi was first identified in the cartilage of the trachea in 2003.\n5. The research team that first identified Tsukushi was led by Dr. Yasuyuki Tsukushi at the University of Tokyo.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tsukushi is a type of proteoglycan.",
      "Proteoglycans are found in the extracellular matrix of many tissues, including bone, cartilage, and skin.",
      "Tsukushi specifically is found in the cartilage of the trachea.",
      "Tsukushi was first identified in the cartilage of the trachea in 2003.",
      "The research team that first identified Tsukushi was led by Dr. Yasuyuki Tsukushi at the University of Tokyo."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: The naming of the protein Tsukushi does not indicate who discovered it or where it was first identified. It is a common misconception that the name of a discovered element or compound is related to the discoverer's name. The name \"Tsukushi\" likely refers to the protein's characteristics or functions and is not indicative of the researcher's name who identified it. Without specific context or a publication reference, the claim about Dr. Yasuyuki Tsukushi and the University of Tokyo cannot be verified.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 4163,
    "user_query": "Which biological drugs are EMA approved for pediatric psoriasis?",
    "yulan-chat-2-13b-fp16_response": "The European Medicines Agency (EMA) has approved several biological drugs for the treatment of pediatric psoriasis. These include:\n1. Adalimumab (Amgen, HUMIRA): Adalimumab is a tumor necrosis factor (TNF) blocker that is indicated for the treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 6 years and older.\n2. Etanercept (Amgen, ERELZIN): Etanercept is a TNF blocker that is indicated for the treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 2 years and older.\n3. Infliximab (Sanofi, REMICADE): Infliximab is a TNF blocker that is indicated for the treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 6 years and older.\n4. Ustekinumab (Pfizer, STELARA): Ustekinumab is a monoclonal antibody that is indicated for the treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 12 years and older.\nIt is important to note that the use of these drugs should be determined by a physician based on the individual needs and medical history of the patient.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Adalimumab (HUMIRA) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 6 years and older.\n2. Etanercept (ERELZIN) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 2 years and older.\n3. Infliximab (REMICADE) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 6 years and older.\n4. Ustekinumab (STELARA) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 12 years and older.",
    "yulan-chat-2-13b-fp16_fact": [
      "Adalimumab (HUMIRA) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 6 years and older.",
      "Etanercept (ERELZIN) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 2 years and older.",
      "Infliximab (REMICADE) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 6 years and older.",
      "Ustekinumab (STELARA) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 12 years and older."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE - Adalimumab (HUMIRA) is indeed approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 6 years and older.\n2. FALSE [correction]: Etanercept is branded as ENBREL, not ERELZIN. It is approved by the EMA for treatment of chronic moderate to severe plaque psoriasis in children and adolescents from the age of 6 years old.\n3. TRUE - Infliximab (REMICADE) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 6 years and older.\n4. TRUE - Ustekinumab (STELARA) is approved by the EMA for treatment of moderate to severe chronic plaque psoriasis in children and adolescents aged 12 years and older.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "yulan-chat-2-13b-fp16_response": "Adamts18 is a protein that has been shown to play a role in hormone receptor signaling. Hormone receptors are proteins that are found in the cells of many different tissues in the body, and they play a critical role in regulating various physiological processes. When a hormone binds to its receptor, it can activate a signaling pathway that leads to changes in the behavior of the cell.\nAdamts18 has been shown to interact with the estrogen receptor alpha (ER), which is a hormone receptor that is involved in the regulation of various physiological processes, including the development and maintenance of female reproductive tissues. It is thought that Adamts18 may play a role in regulating the activity of ER by modulating its interaction with other proteins or by affecting its localization within the cell.\nThere is still much to learn about the role of Adamts18 in hormone receptor signaling, and further research is needed to fully understand its function in this process.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Adamts18 is a protein that plays a role in hormone receptor signaling.\n2. Hormone receptors regulate various physiological processes in the body.\n3. Adamts18 interacts with the estrogen receptor alpha (ER).\n4. The estrogen receptor alpha is involved in the development and maintenance of female reproductive tissues.\n5. Adamts18 may regulate the activity of ER by affecting its interaction with other proteins or its localization within the cell.",
    "yulan-chat-2-13b-fp16_fact": [
      "Adamts18 is a protein that plays a role in hormone receptor signaling.",
      "Hormone receptors regulate various physiological processes in the body.",
      "Adamts18 interacts with the estrogen receptor alpha (ER).",
      "The estrogen receptor alpha is involved in the development and maintenance of female reproductive tissues.",
      "Adamts18 may regulate the activity of ER by affecting its interaction with other proteins or its localization within the cell."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Adamts18 is a protein, but it is known for its role in the development and pathology of tissues, such as the eyes and heart, rather than specifically in hormone receptor signaling.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4166,
    "user_query": "Which are the lactate isomers?",
    "yulan-chat-2-13b-fp16_response": "Lactate is a naturally occurring compound that is produced in the body during the breakdown of glucose. It has two isomers, known as D-lactate and L-lactate.\nD-lactate is the most common isomer and is produced by the fermentation of glucose in the absence of oxygen. It is a naturally occurring compound that is found in many foods, including milk, cheese, and yogurt, as well as in some fermented products such as wine and beer.\nL-lactate, on the other hand, is a less common isomer that is produced by the oxidation of pyruvate in the presence of oxygen. It is a naturally occurring compound that is found in some foods, such as meat and dairy products, as well as in some fermented products such as vinegar and sourdough bread.\nBoth D-lactate and L-lactate are used in the food industry as preservatives and as flavorings. They are also used in the production of certain medications and as research tools in the study of metabolism and other biological processes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Lactate has two isomers: D-lactate and L-lactate.\n2. D-lactate is commonly produced by fermentation of glucose in the absence of oxygen.\n3. L-lactate is produced by the oxidation of pyruvate in the presence of oxygen.\n4. Both D-lactate and L-lactate are found in many foods including dairy products.\n5. D-lactate and L-lactate are used in the food industry as preservatives and flavorings.",
    "yulan-chat-2-13b-fp16_fact": [
      "Lactate has two isomers: D-lactate and L-lactate.",
      "D-lactate is commonly produced by fermentation of glucose in the absence of oxygen.",
      "L-lactate is produced by the oxidation of pyruvate in the presence of oxygen.",
      "Both D-lactate and L-lactate are found in many foods including dairy products.",
      "D-lactate and L-lactate are used in the food industry as preservatives and flavorings."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4168,
    "user_query": "Are enhancers directional in their targeting of gene promoters?",
    "yulan-chat-2-13b-fp16_response": "Enhancers are generally directional in their targeting of gene promoters, meaning that they can interact with specific regions of DNA that are located upstream or downstream of the promoter region of a gene. Enhancers can be located up to several kilobases away from the gene they regulate, and they typically contain binding sites for specific transcription factors that can recognize and bind to the target DNA sequence.\nThe directionality of enhancer-promoter interactions is important because it allows for the precise regulation of gene expression. By targeting specific gene promoters, enhancers can control the timing, level, and duration of gene expression in response to different environmental or developmental cues.\nHowever, it's important to note that enhancers can also interact with other regulatory elements, such as silencers or gene fusions, which can affect their directional targeting and regulation of gene expression. Additionally, the precise mechanisms of enhancer-promoter interactions are still being studied, and there is ongoing research to better understand the complexity and variability of these interactions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Enhancers generally target specific regions of DNA that are located upstream or downstream of the promoter region of a gene.\n2. Enhancers can be located up to several kilobases away from the gene they regulate.\n3. Enhancers contain binding sites for specific transcription factors.\n4. The directionality of enhancer-promoter interactions plays a role in the precise regulation of gene expression.\n5. Enhancers can also interact with other regulatory elements, such as silencers or gene fusions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Enhancers generally target specific regions of DNA that are located upstream or downstream of the promoter region of a gene.",
      "Enhancers can be located up to several kilobases away from the gene they regulate.",
      "Enhancers contain binding sites for specific transcription factors.",
      "The directionality of enhancer-promoter interactions plays a role in the precise regulation of gene expression.",
      "Enhancers can also interact with other regulatory elements, such as silencers or gene fusions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE (Though \"gene fusions\" are typically discussed in the context of genomic rearrangements leading to oncogenic events, not regular gene regulation, enhancers can indeed interact with various regulatory elements, including silencers. The term \"gene fusions\" here is slightly out of context but doesn't make the statement false as enhancers may have a role in the expression of fusion genes in certain cases.)",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4171,
    "user_query": "What is the role of phenylbutyratetaurursodiol for amyotrophic lateral sclerosis?",
    "yulan-chat-2-13b-fp16_response": "Phenylbutyrate and taurursodiol are both potential therapeutic agents that have been studied for their potential role in treating amyotrophic lateral sclerosis (ALS).\nPhenylbutyrate is a drug that has been shown to have neuroprotective effects in animal models of ALS. It works by inhibiting the activity of a protein called GSK-3beta, which is involved in the pathology of ALS. Phenylbutyrate has also been shown to increase the levels of a protein called superoxide dismutase (SOD), which is involved in protecting cells against oxidative stress.\nTaurursodiol is a natural compound that has been shown to have neuroprotective effects in animal models of ALS. It works by reducing inflammation and oxidative stress in the brain, which are both thought to contribute to the development of ALS. Taurursodiol has also been shown to increase the levels of a protein called glutathione, which is involved in protecting cells against oxidative stress.\nWhile both phenylbutyrate and taurursodiol have shown promise in preclinical studies, more research is needed to determine their efficacy as a treatment for ALS in humans. Clinical trials are ongoing to evaluate the safety and effectiveness of these agents for the treatment of ALS.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phenylbutyrate has neuroprotective effects in animal models of amyotrophic lateral sclerosis (ALS).\n2. Phenylbutyrate works by inhibiting the activity of a protein called GSK-3beta, which is involved in the pathology of ALS.\n3. Phenylbutyrate increases the levels of a protein called superoxide dismutase (SOD), involved in protecting cells against oxidative stress.\n4. Taurursodiol shows neuroprotective effects in animal models of ALS by reducing inflammation and oxidative stress.\n5. Taurursodiol increases the levels of a protein called glutathione, which is involved in protecting cells against oxidative stress.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phenylbutyrate has neuroprotective effects in animal models of amyotrophic lateral sclerosis (ALS).",
      "Phenylbutyrate works by inhibiting the activity of a protein called GSK-3beta, which is involved in the pathology of ALS.",
      "Phenylbutyrate increases the levels of a protein called superoxide dismutase (SOD), involved in protecting cells against oxidative stress.",
      "Taurursodiol shows neuroprotective effects in animal models of ALS by reducing inflammation and oxidative stress.",
      "Taurursodiol increases the levels of a protein called glutathione, which is involved in protecting cells against oxidative stress."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE - Phenylbutyrate has shown neuroprotective effects in animal models of ALS in various studies.\n2. UNKNOWN - The specific mechanism of action of Phenylbutyrate in the context of ALS is complex and can involve various pathways. Without specific information, it's difficult to confirm the inhibition of GSK-3beta.\n3. UNKNOWN - Similar to statement 2, the effects of Phenylbutyrate on specific protein levels, such as superoxide dismutase, in the context of ALS would require specific evidence or studies to confirm.\n4. TRUE - Taurursodiol, also known as TUDCA, has shown neuroprotective effects in animal models of ALS, which includes reducing inflammation and oxidative stress among other mechanisms.\n5. TRUE - Taurursodiol is known to help increase glutathione levels, which is an antioxidant that helps protect cells from oxidative stress.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4172,
    "user_query": "What is known about growth arrest-specific 6 protein?",
    "yulan-chat-2-13b-fp16_response": "Growth arrest and DNA damage-inducible gene 6 protein (GADD45A) is a protein that plays a role in the regulation of cell growth and the cell cycle. It is a member of the GADD45 family of proteins, which are induced by DNA damage and other cellular stresses. GADD45A is a transcription coactivator that binds to the promoter regions of target genes and enhances their transcription. It is involved in the regulation of a variety of cellular processes, including cell cycle progression, apoptosis, and DNA repair. GADD45A has been implicated in the development of various cancers, and it is a potential therapeutic target.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Growth arrest and DNA damage-inducible gene 6 protein (GADD45A) is involved in the regulation of cell growth and the cell cycle.\n2. GADD45A is a member of the GADD45 family of proteins.\n3. The GADD45 family of proteins is induced by DNA damage and other cellular stresses.\n4. GADD45A functions as a transcription coactivator that enhances the transcription of target genes.\n5. GADD45A has been implicated in the development of various cancers and is considered a potential therapeutic target.",
    "yulan-chat-2-13b-fp16_fact": [
      "Growth arrest and DNA damage-inducible gene 6 protein (GADD45A) is involved in the regulation of cell growth and the cell cycle.",
      "GADD45A is a member of the GADD45 family of proteins.",
      "The GADD45 family of proteins is induced by DNA damage and other cellular stresses.",
      "GADD45A functions as a transcription coactivator that enhances the transcription of target genes.",
      "GADD45A has been implicated in the development of various cancers and is considered a potential therapeutic target."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: GADD45A does not function as a transcription coactivator but is involved in DNA repair mechanisms and in the control of cell cycle arrest.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4174,
    "user_query": "What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?",
    "yulan-chat-2-13b-fp16_response": "The percentage of Rheumatoid Arthritis (RA) patients who do not respond to anti-TNF therapy can vary depending on the specific population being studied and the criteria used to define non-response. However, in general, it is estimated that up to 30% of RA patients may not respond to anti-TNF therapy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Up to 30% of Rheumatoid Arthritis (RA) patients may not respond to anti-TNF therapy.",
    "yulan-chat-2-13b-fp16_fact": [
      "Up to 30% of Rheumatoid Arthritis (RA) patients may not respond to anti-TNF therapy."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true"
    ]
  },
  {
    "id": 4178,
    "user_query": "Do bacteria release extracellular vesicles?",
    "yulan-chat-2-13b-fp16_response": "Yes, bacteria release extracellular vesicles, also known as bacteriovenomas or bacterial outer membrane vesicles (OMVs). These vesicles are membrane-bound structures that are released from the outer membrane of the bacterial cell and contain a variety of molecules, including proteins, lipids, and nucleic acids.\nOMVs play a number of roles in bacterial physiology, including cell signaling, biofilm formation, and evasion of host immune systems. They can also play a role in the spread of antibiotic resistance genes and other pathogenic factors.\nResearchers are also investigating the potential use of OMVs as vaccine adjuvants and as therapeutic agents for a variety of diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Bacteria release extracellular vesicles known as bacterial outer membrane vesicles (OMVs).\n2. OMVs are membrane-bound structures released from the outer membrane of the bacterial cell.\n3. OMVs contain proteins, lipids, and nucleic acids.\n4. OMVs are involved in cell signaling, biofilm formation, and immune system evasion in bacterial physiology.\n5. Bacterial OMVs may contribute to the spread of antibiotic resistance genes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Bacteria release extracellular vesicles known as bacterial outer membrane vesicles (OMVs).",
      "OMVs are membrane-bound structures released from the outer membrane of the bacterial cell.",
      "OMVs contain proteins, lipids, and nucleic acids.",
      "OMVs are involved in cell signaling, biofilm formation, and immune system evasion in bacterial physiology.",
      "Bacterial OMVs may contribute to the spread of antibiotic resistance genes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4179,
    "user_query": "What is the effect of the venom of the cone snail, Conus tulipa?",
    "yulan-chat-2-13b-fp16_response": "The venom of the cone snail, Conus tulipa, is a complex mix of compounds that can cause severe pain, paralysis, and even death in humans. The venom contains a variety of toxins, including conotoxins, which are known for their ability to interact with and disrupt the function of ion channels in nerve cells.\nIn addition to causing pain and paralysis, the venom of Conus tulipa can also cause respiratory failure, cardiac arrest, and other serious health problems. In some cases, the venom can even lead to death if left untreated.\nIt is important to note that the venom of Conus tulipa is highly potent and should be handled with caution. If you are bitten by a cone snail, it is important to seek medical attention immediately.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The venom of the cone snail, Conus tulipa, can cause severe pain.\n2. Conus tulipa venom may induce paralysis in humans.\n3. Death can result from the effects of the venom of Conus tulipa.\n4. The venom contains conotoxins, which disrupt the function of ion channels in nerve cells.\n5. The venom of Conus tulipa can lead to respiratory failure and cardiac arrest.",
    "yulan-chat-2-13b-fp16_fact": [
      "The venom of the cone snail, Conus tulipa, can cause severe pain.",
      "Conus tulipa venom may induce paralysis in humans.",
      "Death can result from the effects of the venom of Conus tulipa.",
      "The venom contains conotoxins, which disrupt the function of ion channels in nerve cells.",
      "The venom of Conus tulipa can lead to respiratory failure and cardiac arrest."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nCone snail venoms, including that of Conus tulipa, are known to be potent and can indeed cause severe pain, paralysis, and potentially death as they contain conotoxins that interfere with ion channels in nerves. Respiratory failure and cardiac arrest are among the severe effects that can result from the venom's action on the body.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4180,
    "user_query": "Which component of the Influenza A Virus affects mRNA transcription termination?",
    "yulan-chat-2-13b-fp16_response": "The component of the Influenza A Virus that affects mRNA transcription termination is the Pol protein. The Pol protein is a multifunctional protein that plays a crucial role in the viral life cycle. It is responsible for the replication and transcription of the viral genome, and it also terminates mRNA transcription. The Pol protein has a heterodimeric structure, consisting of a polymerase and a polymerase basic protein 1 (PB1) subunit. The PB1 subunit is responsible for the termination of mRNA transcription.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Pol protein of the Influenza A Virus affects mRNA transcription termination.\n2. The Pol protein is involved in the replication and transcription of the viral genome.\n3. The Pol protein is responsible for terminating mRNA transcription.\n4. The Pol protein has a heterodimeric structure.\n5. The polymerase basic protein 1 (PB1) subunit of the Pol protein is responsible for the termination of mRNA transcription.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Pol protein of the Influenza A Virus affects mRNA transcription termination.",
      "The Pol protein is involved in the replication and transcription of the viral genome.",
      "The Pol protein is responsible for terminating mRNA transcription.",
      "The Pol protein has a heterodimeric structure.",
      "The polymerase basic protein 1 (PB1) subunit of the Pol protein is responsible for the termination of mRNA transcription."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The polymerase acidic (PA) protein of the Influenza A Virus, not the Pol protein, affects mRNA transcription termination.\n2. TRUE\n3. FALSE [correction]: It is the polymerase acidic (PA) protein of the Influenza A Virus that is responsible for the endonuclease activity involved in the \"cap-snatching\" mechanism, which is important for the initiation of mRNA synthesis, not termination.\n4. UNKNOWN\n5. FALSE [correction]: It is not the polymerase basic protein 1 (PB1) that is responsible for the termination of mRNA transcription, but rather it is the PA protein that plays a role in the initiation process through its endonuclease activity, and PB1 is the polymerase's catalytic subunit. The termination of mRNA transcription in influenza virus involves polyadenylation, which is not solely attributed to the PB1 subunit.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 4183,
    "user_query": "Is Tranexamic acid effective for intracerebral haemorrhage?",
    "yulan-chat-2-13b-fp16_response": "Tranexamic acid is a medication that is sometimes used to treat intracerebral hemorrhage (ICH), which is a type of stroke that occurs when blood vessels in the brain rupture and bleed into the surrounding tissue. Studies have shown that tranexamic acid can help reduce the risk of death and the severity of disability in people with ICH. However, the evidence for its effectiveness is not definitive and more research is needed to fully understand its role in the treatment of ICH. It is important to note that the decision to use tranexamic acid for ICH should be made by a qualified medical professional, taking into account the individual patient's medical history and other relevant factors.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tranexamic acid is used to treat intracerebral hemorrhage (ICH).\n2. Intracerebral hemorrhage is a type of stroke that occurs when blood vessels in the brain rupture.\n3. Studies have suggested that tranexamic acid can help reduce the risk of death in people with ICH.\n4. There is evidence that tranexamic acid might lessen the severity of disability in people with ICH.\n5. More research is necessary to fully understand the effectiveness of tranexamic acid in the treatment of ICH.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tranexamic acid is used to treat intracerebral hemorrhage (ICH).",
      "Intracerebral hemorrhage is a type of stroke that occurs when blood vessels in the brain rupture.",
      "Studies have suggested that tranexamic acid can help reduce the risk of death in people with ICH.",
      "There is evidence that tranexamic acid might lessen the severity of disability in people with ICH.",
      "More research is necessary to fully understand the effectiveness of tranexamic acid in the treatment of ICH."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Tranexamic acid is typically used to treat or prevent excessive bleeding but its use in treating intracerebral hemorrhage (ICH) is still under investigation and not a standard treatment.\n2. TRUE\n3. TRUE: Some studies have suggested that tranexamic acid may reduce the risk of death in people with acute ICH, but there is still a need for further research to confirm this.\n4. UNKNOWN: The effect of tranexamic acid on the severity of disability following ICH requires more evidence before a definitive statement can be made.\n5. TRUE: Ongoing research and clinical trials are necessary to clarify the role of tranexamic acid in the treatment of intracerebral hemorrhage.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4186,
    "user_query": "What is particular about the 3D structure of the inactive X chromosome?",
    "yulan-chat-2-13b-fp16_response": "The inactive X chromosome (Xi) undergoes a process called Imprinting, which is a mechanism that leads to the silencing of one of the two copies of an X chromosome in female mammals. This process results in the formation of a specialized 3D structure known as a Barr body.\nThe Barr body is a highly condensed and inactive form of the X chromosome that is localized to the nucleus of the cell. It is composed of a dense nucleoprotein complex that is formed through the interaction of the Xi chromosome with specific proteins, including the histone proteins and the non-coding RNA molecules.\nThe Barr body is important for the regulation of X-chromosome gene expression in female mammals, as it ensures that only one copy of the X chromosome is active, while the other copy is silenced. This mechanism helps to maintain the proper balance of gene expression and prevent the negative consequences of having two active X chromosomes in female cells.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The inactive X chromosome (Xi) undergoes a process called Imprinting in female mammals.\n2. As a result of Imprinting, one of the two X chromosomes is silenced in female mammals.\n3. The silenced X chromosome forms a specialized 3D structure known as a Barr body.\n4. The Barr body is a highly condensed, inactive form of the X chromosome located in the cell nucleus.\n5. The Barr body contains a dense nucleoprotein complex formed through interactions with specific proteins and non-coding RNA molecules.",
    "yulan-chat-2-13b-fp16_fact": [
      "The inactive X chromosome (Xi) undergoes a process called Imprinting in female mammals.",
      "As a result of Imprinting, one of the two X chromosomes is silenced in female mammals.",
      "The silenced X chromosome forms a specialized 3D structure known as a Barr body.",
      "The Barr body is a highly condensed, inactive form of the X chromosome located in the cell nucleus.",
      "The Barr body contains a dense nucleoprotein complex formed through interactions with specific proteins and non-coding RNA molecules."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The inactive X chromosome (Xi) undergoes a process called X-chromosome inactivation, not imprinting. Imprinting is a different epigenetic process that affects certain genes based on their parent of origin.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4187,
    "user_query": "Why mothers with a CYP2D6 ultrarapid metabolizer phenotype may expose their infants to risk of adverse events when taking codeine while breastfeeding?",
    "yulan-chat-2-13b-fp16_response": "Mothers with a CYP2D6 ultrarapid metabolizer phenotype are able to metabolize codeine more quickly than normal, which can result in higher levels of the active metabolite, morphine, in their breast milk. This can cause adverse effects in their breastfed infants, such as drowsiness, breathing difficulties, and even death in rare cases. As a result, these mothers are advised to avoid taking codeine while breastfeeding or to use alternative pain medications that are safe for breastfeeding.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mothers with a CYP2D6 ultrarapid metabolizer phenotype can metabolize codeine more quickly than normal.\n2. Higher levels of codeine's active metabolite, morphine, can be present in the breast milk of mothers who are CYP2D6 ultrarapid metabolizers.\n3. Infants breastfed by mothers who are CYP2D6 ultrarapid metabolizers and take codeine may experience adverse effects such as drowsiness and breathing difficulties.\n4. There have been rare cases of death in breastfed infants exposed to high levels of morphine due to the mother's CYP2D6 ultrarapid metabolizer phenotype and codeine use.\n5. Mothers who are CYP2D6 ultrarapid metabolizers are advised to avoid taking codeine while breastfeeding.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mothers with a CYP2D6 ultrarapid metabolizer phenotype can metabolize codeine more quickly than normal.",
      "Higher levels of codeine's active metabolite, morphine, can be present in the breast milk of mothers who are CYP2D6 ultrarapid metabolizers.",
      "Infants breastfed by mothers who are CYP2D6 ultrarapid metabolizers and take codeine may experience adverse effects such as drowsiness and breathing difficulties.",
      "There have been rare cases of death in breastfed infants exposed to high levels of morphine due to the mother's CYP2D6 ultrarapid metabolizer phenotype and codeine use.",
      "Mothers who are CYP2D6 ultrarapid metabolizers are advised to avoid taking codeine while breastfeeding."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4188,
    "user_query": "Which R package can infer protein-protein interactions via thermal proximity coaggregation (TPCA)?",
    "yulan-chat-2-13b-fp16_response": "The R package that can infer protein-protein interactions via thermal proximity coaggregation (TPCA) is called \"ProteinInteractome\". This package provides a range of tools for analyzing protein-protein interaction data, including methods for inferring interactions from co-immunoprecipitation experiments, yeast two-hybrid assays, and other types of experimental data. It also includes functions for visualizing and analyzing protein-protein interaction networks, as well as tools for predicting interactions based on sequence similarity and other features.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4189,
    "user_query": "What is the mechanisms of action of Evinacumab?",
    "yulan-chat-2-13b-fp16_response": "Evinacumab is an investigational drug being developed for the treatment of various diseases, including cancer and inflammatory disorders. It is a monoclonal antibody that targets a protein called Ephrin type-A receptor 2 (EphA2) which is overexpressed in certain types of cancer cells.\nThe mechanism of action of evinacumab is thought to involve blocking the signaling pathway that is mediated by EphA2, which can promote cancer cell growth, survival, and metastasis. By binding to EphA2 and inhibiting its activity, evinacumab may help to reduce the growth and spread of cancer cells.\nIn addition to its potential use in cancer treatment, evinacumab is also being studied for its potential to treat other conditions, such as inflammatory disorders. However, further research is needed to fully understand its mechanism of action and potential therapeutic applications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Evinacumab is an investigational drug.\n2. Evinacumab is being developed for the treatment of various diseases, including cancer and inflammatory disorders.\n3. Evinacumab is a monoclonal antibody that targets the protein Ephrin type-A receptor 2 (EphA2).\n4. EphA2 is overexpressed in certain types of cancer cells.\n5. Evinacumab's mechanism of action involves blocking the signaling pathway mediated by EphA2.",
    "yulan-chat-2-13b-fp16_fact": [
      "Evinacumab is an investigational drug.",
      "Evinacumab is being developed for the treatment of various diseases, including cancer and inflammatory disorders.",
      "Evinacumab is a monoclonal antibody that targets the protein Ephrin type-A receptor 2 (EphA2).",
      "EphA2 is overexpressed in certain types of cancer cells.",
      "Evinacumab's mechanism of action involves blocking the signaling pathway mediated by EphA2."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Evinacumab is no longer just investigational; it has been approved by the FDA for the treatment of homozygous familial hypercholesterolemia.\n2. FALSE [correction]: Evinacumab is developed specifically for the treatment of hyperlipidemia, particularly homozygous familial hypercholesterolemia, and not for various diseases including cancer and inflammatory disorders.\n3. FALSE [correction]: Evinacumab is a monoclonal antibody that targets angiopoietin-like 3 (ANGPTL3), not Ephrin type-A receptor 2 (EphA2).\n4. TRUE\n5. FALSE [correction]: Evinacumab's mechanism of action involves blocking the activity of angiopoietin-like 3 (ANGPTL3), not blocking the signaling pathway mediated by EphA2.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 4191,
    "user_query": "What year was the first successful human heart transplant performed?",
    "yulan-chat-2-13b-fp16_response": "The first successful human heart transplant was performed in 1967 by a team of surgeons led by Dr. Christiaan Barnard. The patient, a 54-year-old man named Louis Washkansky, lived for 18 days after the transplant before ultimately succumbing to other health complications.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The first successful human heart transplant was performed in 1967.\n2. The surgical team was led by Dr. Christiaan Barnard.\n3. The patient's name was Louis Washkansky.\n4. Louis Washkansky lived for 18 days after the heart transplant.",
    "yulan-chat-2-13b-fp16_fact": [
      "The first successful human heart transplant was performed in 1967.",
      "The surgical team was led by Dr. Christiaan Barnard.",
      "The patient's name was Louis Washkansky.",
      "Louis Washkansky lived for 18 days after the heart transplant."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4196,
    "user_query": "Which human tissue synthesize CRP?",
    "yulan-chat-2-13b-fp16_response": "Human tissues that synthesize C-reactive protein (CRP) include the liver, the spleen, and some immune cells such as macrophages and granulocytes.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The liver synthesizes C-reactive protein (CRP).\n2. The spleen is involved in the synthesis of C-reactive protein (CRP).\n3. Immune cells such as macrophages synthesize C-reactive protein (CRP).\n4. Granulocytes are involved in the synthesis of C-reactive protein (CRP).",
    "yulan-chat-2-13b-fp16_fact": [
      "The liver synthesizes C-reactive protein (CRP).",
      "The spleen is involved in the synthesis of C-reactive protein (CRP).",
      "Immune cells such as macrophages synthesize C-reactive protein (CRP).",
      "Granulocytes are involved in the synthesis of C-reactive protein (CRP)."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The spleen does not synthesize C-reactive protein (CRP); it is synthesized primarily in the liver.\n3. FALSE [correction]: While immune cells such as macrophages do not synthesize C-reactive protein (CRP), they release cytokines that can stimulate the liver to produce CRP.\n4. FALSE [correction]: Granulocytes are not involved in the synthesis of C-reactive protein (CRP); CRP is produced by the liver in response to factors released by macrophages and fat cells.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4197,
    "user_query": "What is the relationship between the X chromosome and a  neutrophil drumstick?",
    "yulan-chat-2-13b-fp16_response": "There is no direct relationship between the X chromosome and a neutrophil drumstick. The X chromosome is one of the two sex chromosomes in humans, and it plays a role in determining an individual's sex and some inherited traits. A neutrophil drumstick, on the other hand, is a specific type of blood cell that is an important part of the immune system. It is formed when a neutrophil, a type of white blood cell, is activated and develops a distinctive lobed shape. The X chromosome and neutrophil drumstick are two completely unrelated biological concepts.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The X chromosome is one of the two sex chromosomes in humans.\n2. The X chromosome plays a role in determining an individual's sex.\n3. A neutrophil drumstick is a specific type of blood cell.\n4. Neutrophil drumsticks are part of the immune system.\n5. Neutrophil drumsticks develop a distinctive lobed shape when a neutrophil is activated.",
    "yulan-chat-2-13b-fp16_fact": [
      "The X chromosome is one of the two sex chromosomes in humans.",
      "The X chromosome plays a role in determining an individual's sex.",
      "A neutrophil drumstick is a specific type of blood cell.",
      "Neutrophil drumsticks are part of the immune system.",
      "Neutrophil drumsticks develop a distinctive lobed shape when a neutrophil is activated."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: A neutrophil drumstick (also known as a Barr body) is not a type of blood cell but rather a small appendage on one of the lobes of the nucleus in neutrophils that is indicative of the inactive X chromosome in cells of females.\n4. UNKNOWN (While neutrophils are indeed part of the immune system, the statement specifically refers to \"neutrophil drumsticks,\" which, as corrected in the previous statement, are a manifestation of an inactive X chromosome and not a part of cells.)\n5. FALSE [correction]: Neutrophil drumsticks do not develop as a result of neutrophil activation. They are an indication of an inactive X chromosome and are present whether or not the neutrophil is activated. The lobed shape of neutrophils is a characteristic of their normal morphology, not specifically related to activation.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 4201,
    "user_query": "Which molecule is targeted by Teprotumumab?",
    "yulan-chat-2-13b-fp16_response": "Teprotumumab is a monoclonal antibody that targets insulin-like growth factor-1 receptor (IGF-1R). IGF-1R is a receptor for insulin-like growth factor 1 (IGF-1), which is a potent mitogenic and anabolic agent that plays an important role in cell growth and survival. Teprotumumab binds to IGF-1R and inhibits its activity, which has been shown to be effective in treating certain types of thyroid eye disease.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Teprotumumab is a monoclonal antibody.\n2. Teprotumumab targets the insulin-like growth factor-1 receptor (IGF-1R).\n3. The insulin-like growth factor-1 receptor (IGF-1R) is a receptor for insulin-like growth factor 1 (IGF-1).\n4. Insulin-like growth factor 1 (IGF-1) is a potent mitogenic and anabolic agent important for cell growth and survival.\n5. Teprotumumab has been shown to be effective in treating certain types of thyroid eye disease.",
    "yulan-chat-2-13b-fp16_fact": [
      "Teprotumumab is a monoclonal antibody.",
      "Teprotumumab targets the insulin-like growth factor-1 receptor (IGF-1R).",
      "The insulin-like growth factor-1 receptor (IGF-1R) is a receptor for insulin-like growth factor 1 (IGF-1).",
      "Insulin-like growth factor 1 (IGF-1) is a potent mitogenic and anabolic agent important for cell growth and survival.",
      "Teprotumumab has been shown to be effective in treating certain types of thyroid eye disease."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4204,
    "user_query": "What is the major sequence determinant for nucleosome positioning?",
    "yulan-chat-2-13b-fp16_response": "The major sequence determinant for nucleosome positioning is the distribution of nucleosome-forming sequences, which are short stretches of DNA that can form nucleosomes. These sequences are typically composed of a consensus sequence (such as the \"Grande\" sequence) and various flanking sequences that can influence the positioning of the nucleosome. The presence of these sequences and their specific arrangement within a DNA sequence can determine where nucleosomes are formed and how they are positioned.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4205,
    "user_query": "Which is the primary enzyme metabolizing esomeprazole?",
    "yulan-chat-2-13b-fp16_response": "Esomeprazole is primarily metabolized by the enzyme CYP2C19, which is found in the liver and other organs. This enzyme is responsible for converting esomeprazole into its active metabolite, esomeprazole sulphone. Other enzymes, such as CYP2C9, CYP2C13, and CYP3A4, can also metabolize esomeprazole to a lesser extent. The rate at which esomeprazole is metabolized can vary depending on the individual and their genetic makeup, as well as other factors such as the presence of other medications that can affect the activity of CYP2C19.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Esomeprazole is primarily metabolized by the enzyme CYP2C19.\n2. The enzyme CYP2C19 is found in the liver and other organs.\n3. CYP2C19 converts esomeprazole into esomeprazole sulphone.\n4. Other enzymes that can metabolize esomeprazole include CYP2C9, CYP2C13, and CYP3A4.\n5. The rate of esomeprazole metabolism can vary depending on an individual's genetic makeup.",
    "yulan-chat-2-13b-fp16_fact": [
      "Esomeprazole is primarily metabolized by the enzyme CYP2C19.",
      "The enzyme CYP2C19 is found in the liver and other organs.",
      "CYP2C19 converts esomeprazole into esomeprazole sulphone.",
      "Other enzymes that can metabolize esomeprazole include CYP2C9, CYP2C13, and CYP3A4.",
      "The rate of esomeprazole metabolism can vary depending on an individual's genetic makeup."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CYP2C19 converts esomeprazole into its hydroxy and desmethyl metabolites, not esomeprazole sulphone.\n4. FALSE [correction]: While CYP3A4 can metabolize esomeprazole, there is no enzyme identified as CYP2C13. CYP2C9 has a minor role in its metabolism.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "yulan-chat-2-13b-fp16_response": "Thiazovivin is a small molecule inhibitor of the protein kinase C (PKC) enzyme. PKC is a family of enzymes that play a role in various cellular processes, including cell growth, differentiation, and survival. Thiazovivin works by binding to and inhibiting the activity of PKC, which in turn leads to the inhibition of these cellular processes.\nThe mode of action of thiazovivin is thought to involve the inhibition of PKC-dependent signaling pathways that promote cell proliferation and survival. By inhibiting PKC, thiazovivin can block these signaling pathways and induce apoptosis (cell death) in cancer cells.\nThiazovivin has been shown to have anticancer activity in preclinical studies, and it is currently being investigated as a potential therapeutic agent for the treatment of various types of cancer. However, further research is needed to fully understand its mechanism of action and to determine its safety and efficacy as a cancer therapy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thiazovivin is an inhibitor of the protein kinase C (PKC) enzyme.\n2. Protein kinase C (PKC) is a family of enzymes that contributes to cell growth, differentiation, and survival.\n3. Thiazovivin binds to and inhibits the activity of PKC.\n4. Inhibition of PKC by thiazovivin can lead to cell apoptosis (cell death).\n5. Thiazovivin has been examined in preclinical studies for its anticancer activity.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thiazovivin is an inhibitor of the protein kinase C (PKC) enzyme.",
      "Protein kinase C (PKC) is a family of enzymes that contributes to cell growth, differentiation, and survival.",
      "Thiazovivin binds to and inhibits the activity of PKC.",
      "Inhibition of PKC by thiazovivin can lead to cell apoptosis (cell death).",
      "Thiazovivin has been examined in preclinical studies for its anticancer activity."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Thiazovivin is actually an inhibitor of Rho-associated protein kinase (ROCK), not protein kinase C (PKC).\n2. TRUE\n3. FALSE [correction]: Thiazovivin binds to and inhibits the activity of ROCK, not PKC.\n4. UNKNOWN (While inhibition of PKC can lead to cell apoptosis, the statement incorrectly identifies thiazovivin as a PKC inhibitor when it is a ROCK inhibitor; thus, without more context on the effects of ROCK inhibition specifically, the outcome on cell apoptosis remains unknown.)\n5. UNKNOWN (Without specific details on whether thiazovivin has been studied in this context or not, this statement's validity cannot be confirmed.)",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4216,
    "user_query": "Which methods infer 3D genome structure without proximity ligation?",
    "yulan-chat-2-13b-fp16_response": "There are several methods that can infer 3D genome structure without using proximity ligation. Here are a few examples:\n1. Single-molecule sequencing: This method involves sequencing individual DNA molecules and can be used to infer 3D genome structure by analyzing the spatial arrangement of sequencing reads.\n2. Hi-C: Hi-C is a method that uses formaldehyde crosslinking to fix chromatin structures and then performs DNA sequencing to infer 3D genome structure. While Hi-C typically uses proximity ligation, it can also be used without it by analyzing crosslinked chromatin fragments that are ligated with a non-specific ligase.\n3. Chromatin conformation capture (3C): 3C is a method that uses formaldehyde crosslinking to fix chromatin structures and then performs DNA sequencing to infer 3D genome structure. 3C can also be used without proximity ligation by analyzing crosslinked chromatin fragments that are ligated with a non-specific ligase.\n4. Genome-wide nucleosome position and genome-wide histone H3 lysine 56 trimethylation (genome-wide Nuc/H3K56me3): These methods use nucleosome-selective sequencing and histone modification analysis to infer 3D genome structure.\n5. Single-cell sequencing: This method involves sequencing individual cells and can be used to infer 3D genome structure by analyzing the spatial arrangement of sequencing reads at the single-cell level.\nIt's worth noting that while these methods can infer 3D genome structure without proximity ligation, they may have different strengths and weaknesses depending on the specific research question and experimental design.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Single-molecule sequencing can infer 3D genome structure by analyzing the spatial arrangement of sequencing reads.\n2. While Hi-C typically uses proximity ligation, it can also infer 3D genome structure without proximity ligation by analyzing crosslinked chromatin fragments with non-specific ligase.\n3. 3C can infer 3D genome structure without proximity ligation by analyzing crosslinked chromatin fragments with non-specific ligase.\n4. Genome-wide nucleosome position and genome-wide histone H3 lysine 56 trimethylation can be used to infer 3D genome structure.\n5. Single-cell sequencing can infer 3D genome structure at the single-cell level by analyzing spatial arrangement of sequencing reads.",
    "yulan-chat-2-13b-fp16_fact": [
      "Single-molecule sequencing can infer 3D genome structure by analyzing the spatial arrangement of sequencing reads.",
      "While Hi-C typically uses proximity ligation, it can also infer 3D genome structure without proximity ligation by analyzing crosslinked chromatin fragments with non-specific ligase.",
      "3C can infer 3D genome structure without proximity ligation by analyzing crosslinked chromatin fragments with non-specific ligase.",
      "Genome-wide nucleosome position and genome-wide histone H3 lysine 56 trimethylation can be used to infer 3D genome structure.",
      "Single-cell sequencing can infer 3D genome structure at the single-cell level by analyzing spatial arrangement of sequencing reads."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: While Hi-C typically uses proximity ligation to infer 3D genome structure, it does not infer this structure without proximity ligationthe technique relies on crosslinking chromatin fragments, digesting them with restriction enzymes, and then ligating the resulting fragments to preserve information on spatial proximity.\n3. FALSE [correction]: 3C (chromosome conformation capture) also requires proximity ligation to infer 3D genome structure. It analyzes the frequency at which different chromatin fragments are ligated together to provide information on their spatial proximity within the nucleus.\n4. UNKNOWN: While genome-wide nucleosome position and histone modifications like H3 lysine 56 trimethylation can provide information on chromatin state and gene regulation, they do not inherently provide information on 3D genome structure. Other techniques might be necessary to infer actual 3D structure.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4219,
    "user_query": "Can thiotepa be recommended for treatment of osteosarcoma?",
    "yulan-chat-2-13b-fp16_response": "Thiotepa is an alkylating agent that has been used in the treatment of various types of cancer, including osteosarcoma. However, its use in the treatment of osteosarcoma is not widely recommended due to limited evidence of its effectiveness and potential toxicity.\nWhile thiotepa has been used in some studies as a component of combination chemotherapy regimens for osteosarcoma, the overall evidence supporting its use in this context is limited and inconclusive. Additionally, thiotepa can cause significant side effects, including nausea, vomiting, hair loss, and bone marrow suppression, which can impact the quality of life for patients.\nTherefore, while thiotepa may be considered as an option for the treatment of osteosarcoma in some cases, it is generally not recommended as a standard treatment for this type of cancer. Other chemotherapy drugs, such as doxorubicin, ifosfamide, and carboplatin, are more commonly used in the treatment of osteosarcoma and have been shown to be effective in controlled clinical trials. The specific treatment approach for osteosarcoma will depend on various factors, including the stage and location of the tumor, as well as the patient's overall health and preferences. It is important to consult with a medical oncologist or other qualified healthcare provider for personalized treatment recommendations.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thiotepa is an alkylating agent used in the treatment of various types of cancer.\n2. Thiotepa's use in the treatment of osteosarcoma is not widely recommended due to limited evidence of effectiveness.\n3. Thiotepa can cause side effects such as nausea, vomiting, hair loss, and bone marrow suppression.\n4. Chemotherapy drugs such as doxorubicin, ifosfamide, and carboplatin are more commonly used in the treatment of osteosarcoma than thiotepa.\n5. The treatment approach for osteosarcoma depends on the stage and location of the tumor, as well as the patient's overall health and preferences.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thiotepa is an alkylating agent used in the treatment of various types of cancer.",
      "Thiotepa's use in the treatment of osteosarcoma is not widely recommended due to limited evidence of effectiveness.",
      "Thiotepa can cause side effects such as nausea, vomiting, hair loss, and bone marrow suppression.",
      "Chemotherapy drugs such as doxorubicin, ifosfamide, and carboplatin are more commonly used in the treatment of osteosarcoma than thiotepa.",
      "The treatment approach for osteosarcoma depends on the stage and location of the tumor, as well as the patient's overall health and preferences."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4223,
    "user_query": "Has the companion diagnostic HercepTest received FDA approval?",
    "yulan-chat-2-13b-fp16_response": "As of my knowledge cutoff date in September 2021, HercepTest was not approved by the FDA. However, it is important to note that regulatory statuses can change over time, so it is advisable to check the current status of the diagnostic test with the FDA or the manufacturer's website.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4224,
    "user_query": "Which R/Bioconductor package has been developed for visualizing differential amino acid group usage in proteomics?",
    "yulan-chat-2-13b-fp16_response": "The R/Bioconductor package that has been developed for visualizing differential amino acid group usage in proteomics is called \"proteomicsDAVG\".",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There is an R/Bioconductor package developed for visualizing differential amino acid group usage in proteomics.\n2. The package is called \"proteomicsDAVG\".",
    "yulan-chat-2-13b-fp16_fact": [
      "There is an R/Bioconductor package developed for visualizing differential amino acid group usage in proteomics.",
      "The package is called \"proteomicsDAVG\"."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: The R/Bioconductor package developed for visualizing differential amino acid group usage in proteomics is not known by the name \"proteomicsDAVG\". Without additional context or a known package with this exact name, the specific name of the package cannot be confirmed. Therefore, the exact name of the package remains UNKNOWN unless additional information is provided.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown"
    ]
  },
  {
    "id": 4226,
    "user_query": "Is phosphoenolpyruvate carboxykinase 1 (PCK1) the rate-limiting enzyme in gluconeogenesis?",
    "yulan-chat-2-13b-fp16_response": "Phosphoenolpyruvate carboxykinase 1 (PCK1) is an important enzyme in gluconeogenesis, which is the process of converting non-carbohydrate sources into glucose in the liver. However, whether PCK1 is the rate-limiting enzyme in gluconeogenesis is a matter of debate among researchers.\nSome studies suggest that PCK1 may be the rate-limiting enzyme in gluconeogenesis, as it is the first committed step in the process and regulates the flow of metabolites into the gluconeogenic pathway. Other studies, however, have suggested that other enzymes, such as fructose-1,6-bisphosphatase, may be the rate-limiting step in gluconeogenesis.\nOverall, while PCK1 is an important enzyme in gluconeogenesis, the exact rate-limiting enzyme may depend on the specific conditions and metabolic state of the organism.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Phosphoenolpyruvate carboxykinase 1 (PCK1) is an enzyme involved in the process of gluconeogenesis.\n2. Gluconeogenesis is the process of converting non-carbohydrate sources into glucose in the liver.\n3. There is debate among researchers regarding whether PCK1 is the rate-limiting enzyme in gluconeogenesis.\n4. Studies indicate that PCK1 might be the rate-limiting enzyme since it represents the first committed step in gluconeogenesis.\n5. Other studies suggest that fructose-1,6-bisphosphatase could be the rate-limiting step in gluconeogenesis.",
    "yulan-chat-2-13b-fp16_fact": [
      "Phosphoenolpyruvate carboxykinase 1 (PCK1) is an enzyme involved in the process of gluconeogenesis.",
      "Gluconeogenesis is the process of converting non-carbohydrate sources into glucose in the liver.",
      "There is debate among researchers regarding whether PCK1 is the rate-limiting enzyme in gluconeogenesis.",
      "Studies indicate that PCK1 might be the rate-limiting enzyme since it represents the first committed step in gluconeogenesis.",
      "Other studies suggest that fructose-1,6-bisphosphatase could be the rate-limiting step in gluconeogenesis."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Studies might indicate that PCK1 is important because it represents a key control point in gluconeogenesis, but it is not the first committed step. The first committed step of gluconeogenesis is actually catalyzed by the enzyme pyruvate carboxylase.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 4227,
    "user_query": "What conditions are diagnosed using the scratch collapse test?",
    "yulan-chat-2-13b-fp16_response": "The scratch collapse test is a diagnostic test used to evaluate the quality of eggshells. It is performed by tapping a hard-boiled egg on a flat surface and observing the behavior of the eggshell when it is scratched or punctured.\nThe test is used to determine whether the eggshell is strong and adherent, or weak and brittle. A strong and adherent eggshell will resist collapse when scratched or punctured, while a weak and brittle eggshell will collapse easily.\nThe scratch collapse test is used to diagnose conditions such as:\n1. Eggshell quality: The test is used to evaluate the quality of eggshells, which can be affected by factors such as the breed of chicken, feed quality, and age of the hen.\n2. Egg quality: The test can be used to evaluate the overall quality of eggs, which can be affected by factors such as the breed of chicken, feed quality, and age of the hen.\n3. Infection: The test can be used to diagnose infections such as salmonella, which can weaken the eggshell and make it more susceptible to collapse.\n4. Contamination: The test can be used to diagnose contamination of the egg, which can weaken the eggshell and make it more susceptible to collapse.\n5. Shell thickness: The test can be used to evaluate the thickness of the eggshell, which can be affected by factors such as the breed of chicken and feed quality.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The scratch collapse test is used to evaluate the quality of eggshells.\n2. The test is performed by tapping a hard-boiled egg on a flat surface and observing the behavior of the eggshell when it is scratched or punctured.\n3. A strong and adherent eggshell will resist collapse when scratched or punctured.\n4. The test can be used to diagnose infections in eggs, such as salmonella.\n5. The scratch collapse test can be used to evaluate the thickness of the eggshell.",
    "yulan-chat-2-13b-fp16_fact": [
      "The scratch collapse test is used to evaluate the quality of eggshells.",
      "The test is performed by tapping a hard-boiled egg on a flat surface and observing the behavior of the eggshell when it is scratched or punctured.",
      "A strong and adherent eggshell will resist collapse when scratched or punctured.",
      "The test can be used to diagnose infections in eggs, such as salmonella.",
      "The scratch collapse test can be used to evaluate the thickness of the eggshell."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: The scratch collapse test is not used to evaluate the quality of eggshells; it is a diagnostic test used to detect nerve compression or carpal tunnel syndrome.\n2. FALSE [correction]: The scratch collapse test involves scratching the skin near a suspect nerve and observing for a reflexive collapse or weakness in the muscle supplied by that nerve, not tapping a hard-boiled egg.\n3. FALSE [correction]: A strong and adherent eggshell has nothing to do with the scratch collapse test, which is related to nerve function, not eggshell quality.\n4. FALSE [correction]: The scratch collapse test is not used to diagnose infections in eggs; it is used in a medical context to assess nerve function.\n5. FALSE [correction]: The scratch collapse test has no application in evaluating the thickness of eggshells; it is a clinical test used in the diagnosis of nerve entrapment conditions.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4231,
    "user_query": "Which disease can be treated with Relugolix.",
    "yulan-chat-2-13b-fp16_response": "Relugolix is a drug that is being developed for the treatment of various conditions, including prostate cancer, breast cancer, and uterine fibroids. It works by blocking the action of hormones that can stimulate the growth of these tissues. In clinical trials, Relugolix has shown promise in reducing the size of prostate tumors and inhibiting the growth of breast cancer cells. It has also been shown to reduce the symptoms of uterine fibroids, which are noncancerous growths in the uterus. However, it is important to note that Relugolix is still in the development phase and has not yet been approved for use by regulatory agencies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Relugolix is being developed for the treatment of prostate cancer.\n2. Relugolix is being developed for the treatment of breast cancer.\n3. Relugolix is being developed for the treatment of uterine fibroids.\n4. In clinical trials, Relugolix has been shown to reduce the size of prostate tumors.\n5. In clinical trials, Relugolix has been shown to reduce symptoms of uterine fibroids.",
    "yulan-chat-2-13b-fp16_fact": [
      "Relugolix is being developed for the treatment of prostate cancer.",
      "Relugolix is being developed for the treatment of breast cancer.",
      "Relugolix is being developed for the treatment of uterine fibroids.",
      "In clinical trials, Relugolix has been shown to reduce the size of prostate tumors.",
      "In clinical trials, Relugolix has been shown to reduce symptoms of uterine fibroids."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4233,
    "user_query": "What 3 organs are the sphincter of Oddi associated with?",
    "yulan-chat-2-13b-fp16_response": "The sphincter of Oddi is a muscular ring that controls the opening and closing of the ductus choledochus, the ductus pancreaticus, and the common bile duct. These three ducts carry digestive enzymes and bile from the pancreas and liver, respectively, to the small intestine. The sphincter of Oddi plays a crucial role in regulating the flow of these digestive fluids into the small intestine.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The sphincter of Oddi is associated with the ductus choledochus.\n2. The sphincter of Oddi is associated with the ductus pancreaticus.\n3. The sphincter of Oddi is associated with the common bile duct.\n4. The sphincter of Oddi regulates the flow of digestive enzymes and bile into the small intestine.",
    "yulan-chat-2-13b-fp16_fact": [
      "The sphincter of Oddi is associated with the ductus choledochus.",
      "The sphincter of Oddi is associated with the ductus pancreaticus.",
      "The sphincter of Oddi is associated with the common bile duct.",
      "The sphincter of Oddi regulates the flow of digestive enzymes and bile into the small intestine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4245,
    "user_query": "why are eggs linked to cancer progression ?",
    "yulan-chat-2-13b-fp16_response": "Eggs are not directly linked to cancer progression. However, diets high in protein, including eggs, have been associated with an increased risk of certain types of cancer, such as breast, prostate, and colon cancer. This is because high protein intake can increase the production of growth hormones, which can stimulate the growth of cancer cells. Additionally, diets high in fat and cholesterol, both of which are found in eggs, have also been linked to an increased risk of cancer. However, it's important to note that a well-balanced diet that includes eggs in moderation is not likely to have a significant impact on cancer risk.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Diets high in protein have been associated with an increased risk of certain types of cancer including breast, prostate, and colon cancer.\n2. High protein intake can increase the production of growth hormones.\n3. Growth hormones can stimulate the growth of cancer cells.\n4. Diets high in fat and cholesterol have been linked to an increased risk of cancer.\n5. Eggs contain both fat and cholesterol.",
    "yulan-chat-2-13b-fp16_fact": [
      "Diets high in protein have been associated with an increased risk of certain types of cancer including breast, prostate, and colon cancer.",
      "High protein intake can increase the production of growth hormones.",
      "Growth hormones can stimulate the growth of cancer cells.",
      "Diets high in fat and cholesterol have been linked to an increased risk of cancer.",
      "Eggs contain both fat and cholesterol."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: The association between high-protein diets and cancer risk is complex and not definitively established. Some studies suggest that certain types of high-protein diets may be linked to an increased risk of certain cancers, while others do not find a significant association.\n2. TRUE: High protein intake can indeed increase the production of growth hormones like insulin-like growth factor 1 (IGF-1), which may have an impact on cancer risk.\n3. TRUE: Growth hormones, like IGF-1, can stimulate the growth of cancer cells. This is an area of ongoing research, and the relationship is complex.\n4. TRUE: Diets high in saturated fats and cholesterol have been linked to an increased risk of various types of cancer, including breast and colorectal cancer. However, the link is complex and influenced by many factors.\n5. TRUE: Eggs do contain both dietary fat and cholesterol, but they also provide important nutrients and their impact on health must be considered in the context of the overall diet.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4246,
    "user_query": "tarragon toxicity ?",
    "yulan-chat-2-13b-fp16_response": "Tarragon is generally considered safe when consumed in small amounts. However, ingesting large amounts of tarragon may cause toxicity and adverse effects.\nTarragon contains a compound called estragole, which is a known toxic substance. Ingestion of large amounts of tarragon or products containing tarragon oil can cause estragole toxicity.\nSymptoms of estragole toxicity may include nausea, vomiting, diarrhea, abdominal pain, and liver damage. In severe cases, it can even lead to coma and death.\nIt is important to use tarragon and tarragon-containing products in moderation and according to recommended dosages. If you experience any adverse effects after consuming tarragon, seek medical attention immediately.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Tarragon is generally considered safe when consumed in small amounts.\n2. Large amounts of tarragon can cause toxicity and adverse effects.\n3. Tarragon contains a toxic compound called estragole.\n4. Symptoms of estragole toxicity may include nausea, vomiting, diarrhea, abdominal pain, and liver damage.\n5. In severe cases, estragole toxicity can lead to coma and death.",
    "yulan-chat-2-13b-fp16_fact": [
      "Tarragon is generally considered safe when consumed in small amounts.",
      "Large amounts of tarragon can cause toxicity and adverse effects.",
      "Tarragon contains a toxic compound called estragole.",
      "Symptoms of estragole toxicity may include nausea, vomiting, diarrhea, abdominal pain, and liver damage.",
      "In severe cases, estragole toxicity can lead to coma and death."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4277,
    "user_query": "which parts of the mediterranean diet extended life ?",
    "yulan-chat-2-13b-fp16_response": "The Mediterranean diet has been associated with a number of health benefits, including an increased lifespan. The diet is characterized by a high intake of fruits, vegetables, whole grains, legumes, nuts, and healthy fats, such as olive oil, and a low intake of red meat and processed foods.\nResearch has shown that the Mediterranean diet may help to reduce the risk of chronic diseases, such as heart disease, stroke, and certain types of cancer, which are leading causes of death in many countries. The diet has also been linked to a lower risk of cognitive decline and dementia in older adults.\nIt's important to note that the Mediterranean diet is not a magic bullet for extending life, and there are many other factors that can impact lifespan, such as genetics, lifestyle, and access to healthcare. However, following a healthy diet like the Mediterranean diet can be an important part of a overall strategy for promoting health and well-being throughout life.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Mediterranean diet is high in fruits, vegetables, whole grains, legumes, nuts, and healthy fats like olive oil.\n2. The Mediterranean diet includes a low intake of red meat and processed foods.\n3. The Mediterranean diet may help to reduce the risk of chronic diseases such as heart disease, stroke, and certain types of cancer.\n4. The Mediterranean diet has been linked to a lower risk of cognitive decline and dementia in older adults.\n5. The health benefits of the Mediterranean diet are associated with increased lifespan.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Mediterranean diet is high in fruits, vegetables, whole grains, legumes, nuts, and healthy fats like olive oil.",
      "The Mediterranean diet includes a low intake of red meat and processed foods.",
      "The Mediterranean diet may help to reduce the risk of chronic diseases such as heart disease, stroke, and certain types of cancer.",
      "The Mediterranean diet has been linked to a lower risk of cognitive decline and dementia in older adults.",
      "The health benefits of the Mediterranean diet are associated with increased lifespan."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4278,
    "user_query": "predimed : does eating nuts prevent strokes ?",
    "yulan-chat-2-13b-fp16_response": "There is evidence to suggest that eating nuts may help to prevent strokes. Nuts are a good source of healthy fats, fiber, and various vitamins and minerals, and research has shown that they may help to lower the risk of developing cardiovascular disease, which is a leading cause of stroke.\nStudies have found that people who eat nuts regularly have a lower risk of developing cardiovascular disease than those who do not. Nuts have been shown to help lower levels of harmful LDL cholesterol, reduce inflammation, and improve blood pressure, all of which are risk factors for cardiovascular disease.\nIn addition, nuts are high in antioxidants, which can help to protect the body against the damage caused by free radicals. Free radicals are unstable molecules that can damage cells and contribute to the development of chronic diseases, including stroke.\nIt is important to note that nuts are high in calories, so it is important to eat them in moderation as part of a healthy diet. Additionally, it is always a good idea to speak with a healthcare provider before making any significant changes to your diet.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Consuming nuts may help to lower the risk of developing cardiovascular disease.\n2. Cardiovascular disease is a leading cause of stroke.\n3. Regular consumption of nuts is associated with a reduced risk of cardiovascular disease compared to those who do not eat nuts.\n4. Nuts can help lower levels of harmful LDL cholesterol and reduce inflammation.\n5. Nuts are high in antioxidants that may protect against cell damage caused by free radicals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Consuming nuts may help to lower the risk of developing cardiovascular disease.",
      "Cardiovascular disease is a leading cause of stroke.",
      "Regular consumption of nuts is associated with a reduced risk of cardiovascular disease compared to those who do not eat nuts.",
      "Nuts can help lower levels of harmful LDL cholesterol and reduce inflammation.",
      "Nuts are high in antioxidants that may protect against cell damage caused by free radicals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4285,
    "user_query": "why do vegan women have 5x fewer twins ?",
    "yulan-chat-2-13b-fp16_response": "There is no scientific evidence to support the claim that vegan women have five times fewer twins than non-vegan women. In fact, there is no clear evidence that diet has any significant effect on the likelihood of having twins. While it is true that some studies have found a slightly lower incidence of twins among vegan women compared to non-vegan women, the difference is not as large as five times. It is important to note that the incidence of twins is influenced by many factors, including genetics, age, and environmental factors, and it is not clear how diet fits into this picture.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There is no scientific evidence to support the claim that vegan women have five times fewer twins than non-vegan women.\n2. Some studies have found a slightly lower incidence of twins among vegan women compared to non-vegan women.\n3. The incidence of twins is influenced by many factors, including genetics, age, and environmental factors.\n4. It is not clear how diet affects the likelihood of having twins.",
    "yulan-chat-2-13b-fp16_fact": [
      "There is no scientific evidence to support the claim that vegan women have five times fewer twins than non-vegan women.",
      "Some studies have found a slightly lower incidence of twins among vegan women compared to non-vegan women.",
      "The incidence of twins is influenced by many factors, including genetics, age, and environmental factors.",
      "It is not clear how diet affects the likelihood of having twins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: There is scientific evidence suggesting that vegan women may have fewer twins, potentially attributed to lower levels of insulin-like growth factor (IGF) which is influenced by diet. However, the specific claim of \"five times fewer\" might be an overstatement without specific data to back that figure.\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4292,
    "user_query": "is there too much aluminum in tea ?",
    "yulan-chat-2-13b-fp16_response": "There is no definitive answer to whether there is too much aluminum in tea, as the amount of aluminum in tea can vary depending on a number of factors, such as the type of tea, the location and conditions in which it was grown, and the processing methods used.\nHowever, it is worth noting that tea is generally considered to be a safe and healthy beverage, and there is no evidence to suggest that the levels of aluminum found in tea pose a significant health risk to most people.\nThat being said, some studies have suggested that consuming high levels of aluminum over a long period of time may be linked to certain health problems, such as Alzheimer's disease and other forms of dementia. However, the evidence for this is not conclusive, and more research is needed to fully understand the potential health effects of aluminum in tea and other foods.\nIf you are concerned about the aluminum content of your tea, you may want to consider choosing teas that are grown and processed in ways that are known to reduce aluminum absorption, such as using filtered water, avoiding tea that is heavily fermented or processed, and choosing teas that are high in compounds that bind to aluminum and help to reduce its absorption.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The amount of aluminum in tea can vary based on factors like the type of tea, growth conditions, and processing methods.\n2. Tea is generally considered to be a safe and healthy beverage.\n3. There is no evidence suggesting that levels of aluminum found in tea pose a significant health risk to most people.\n4. Some studies have linked high levels of aluminum consumption over time with health issues such as Alzheimer's disease and other forms of dementia.\n5. Research regarding the health effects of aluminum in tea and other foods is not conclusive.",
    "yulan-chat-2-13b-fp16_fact": [
      "The amount of aluminum in tea can vary based on factors like the type of tea, growth conditions, and processing methods.",
      "Tea is generally considered to be a safe and healthy beverage.",
      "There is no evidence suggesting that levels of aluminum found in tea pose a significant health risk to most people.",
      "Some studies have linked high levels of aluminum consumption over time with health issues such as Alzheimer's disease and other forms of dementia.",
      "Research regarding the health effects of aluminum in tea and other foods is not conclusive."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4293,
    "user_query": "does meditation affect cellular aging ?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that meditation may have an impact on cellular aging. Studies have shown that meditation can reduce the levels of stress hormones in the body, which can help to slow down the process of cellular aging. Additionally, meditation has been shown to improve the function of the immune system, which can also help to slow down the process of cellular aging. However, more research is needed to fully understand the relationship between meditation and cellular aging.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Meditation may have an impact on cellular aging.\n2. Studies have shown that meditation can reduce the levels of stress hormones in the body.\n3. Meditation has been shown to improve the function of the immune system.\n4. The process of cellular aging may be slowed down by reducing stress hormone levels and improving immune function through meditation.\n5. More research is needed to fully understand the relationship between meditation and cellular aging.",
    "yulan-chat-2-13b-fp16_fact": [
      "Meditation may have an impact on cellular aging.",
      "Studies have shown that meditation can reduce the levels of stress hormones in the body.",
      "Meditation has been shown to improve the function of the immune system.",
      "The process of cellular aging may be slowed down by reducing stress hormone levels and improving immune function through meditation.",
      "More research is needed to fully understand the relationship between meditation and cellular aging."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4294,
    "user_query": "is gluten sensitivity real ?",
    "yulan-chat-2-13b-fp16_response": "Yes, gluten sensitivity is a real condition. It is a medical condition in which a person has a non-celiac response to gluten, a protein found in wheat, barley, and rye. This can cause a range of symptoms, including abdominal pain, bloating, diarrhea, and fatigue. However, it is important to note that gluten sensitivity is not the same as celiac disease, which is a serious autoimmune disorder that can cause damage to the small intestine if left untreated.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gluten sensitivity is a medical condition where a person has a non-celiac response to gluten.\n2. Gluten is a protein found in wheat, barley, and rye.\n3. Symptoms of gluten sensitivity can include abdominal pain, bloating, diarrhea, and fatigue.\n4. Gluten sensitivity is different from celiac disease.\n5. Celiac disease is a serious autoimmune disorder that can cause damage to the small intestine.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gluten sensitivity is a medical condition where a person has a non-celiac response to gluten.",
      "Gluten is a protein found in wheat, barley, and rye.",
      "Symptoms of gluten sensitivity can include abdominal pain, bloating, diarrhea, and fatigue.",
      "Gluten sensitivity is different from celiac disease.",
      "Celiac disease is a serious autoimmune disorder that can cause damage to the small intestine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4300,
    "user_query": "fruits , veggies , and longevity : how many minutes per mouthful ?",
    "yulan-chat-2-13b-fp16_response": "It's difficult to determine an exact number of minutes per mouthful for fruits and vegetables in relation to longevity, as there are many factors that can impact lifespan, including genetics, lifestyle, and overall health. However, research has shown that a diet rich in fruits and vegetables can have numerous health benefits, including reducing the risk of chronic diseases such as heart disease, cancer, and diabetes.\nEating a variety of fruits and vegetables can provide essential nutrients, fiber, and antioxidants that are important for maintaining good health. While it's difficult to quantify the exact amount of time that eating fruits and vegetables can add to your lifespan, making them a regular part of your diet can certainly have a positive impact on your overall health and well-being.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A diet rich in fruits and vegetables can reduce the risk of chronic diseases such as heart disease, cancer, and diabetes.\n2. Eating a variety of fruits and vegetables provides essential nutrients, fiber, and antioxidants.\n3. The consumption of fruits and vegetables is important for maintaining good health.",
    "yulan-chat-2-13b-fp16_fact": [
      "A diet rich in fruits and vegetables can reduce the risk of chronic diseases such as heart disease, cancer, and diabetes.",
      "Eating a variety of fruits and vegetables provides essential nutrients, fiber, and antioxidants.",
      "The consumption of fruits and vegetables is important for maintaining good health."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4310,
    "user_query": "should we take a multivitamin ?",
    "yulan-chat-2-13b-fp16_response": "Whether or not to take a multivitamin is a personal decision that depends on your individual needs and preferences. Some people may benefit from taking a multivitamin, particularly if they have a diet that is lacking in certain nutrients or if they have a medical condition that affects their ability to absorb nutrients from food. However, others may not need to take a multivitamin and may even experience negative health effects from taking certain types of supplements.\nIt's important to talk to your healthcare provider before starting to take any supplements, including multivitamins. They can help you determine if a multivitamin is right for you and recommend a specific product if necessary. It's also important to follow the recommended dosage on the supplement label and to be aware of any potential interactions with other medications you may be taking.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Taking a multivitamin can depend on individual nutritional deficiencies or medical conditions affecting nutrient absorption.\n2. Some individuals might not need to take a multivitamin.\n3. Healthcare providers can help determine if a multivitamin is appropriate for an individual.\n4. It is recommended to follow the dosage instructions on a supplement label.\n5. There may be potential interactions between multivitamins and other medications.",
    "yulan-chat-2-13b-fp16_fact": [
      "Taking a multivitamin can depend on individual nutritional deficiencies or medical conditions affecting nutrient absorption.",
      "Some individuals might not need to take a multivitamin.",
      "Healthcare providers can help determine if a multivitamin is appropriate for an individual.",
      "It is recommended to follow the dosage instructions on a supplement label.",
      "There may be potential interactions between multivitamins and other medications."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4315,
    "user_query": "canned beans or cooked beans ?",
    "yulan-chat-2-13b-fp16_response": "Canned beans and cooked beans can both be used in recipes, but there are some differences to consider.\nCanned beans are convenient and can be used in recipes without any additional preparation. They are also a good source of protein and fiber. However, canned beans are often packed in salted water, which can add unnecessary sodium to your diet. Some people also prefer to use dried beans and cook them themselves, as this allows them to control the amount of sodium and seasonings used.\nCooked beans, whether homemade or store-bought, are a healthy addition to many dishes. They are a good source of protein, fiber, and various vitamins and minerals. Cooked beans are also more versatile than canned beans, as they can be seasoned and used in a variety of dishes.\nUltimately, the choice between canned beans and cooked beans depends on personal preference and the specific recipe you are making.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Canned beans are convenient and require no additional preparation to be used in recipes.\n2. Canned beans are a good source of protein and fiber.\n3. Canned beans are often packed in salted water, which can add extra sodium to the diet.\n4. Cooked beans are a healthy addition to many dishes and are a good source of protein, fiber, and various vitamins and minerals.\n5. Cooked beans are considered more versatile than canned beans because they can be seasoned for use in different dishes.",
    "yulan-chat-2-13b-fp16_fact": [
      "Canned beans are convenient and require no additional preparation to be used in recipes.",
      "Canned beans are a good source of protein and fiber.",
      "Canned beans are often packed in salted water, which can add extra sodium to the diet.",
      "Cooked beans are a healthy addition to many dishes and are a good source of protein, fiber, and various vitamins and minerals.",
      "Cooked beans are considered more versatile than canned beans because they can be seasoned for use in different dishes."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Canned beans are convenient but often require rinsing before being used in recipes to remove excess sodium.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4316,
    "user_query": "how many poppy seeds are too many ?",
    "yulan-chat-2-13b-fp16_response": "It is difficult to say how many poppy seeds are too many, as it depends on the specific context and purpose of the poppy seeds. Poppy seeds are used in a variety of culinary and medicinal applications, and the appropriate amount can vary depending on the intended use.\nIn general, poppy seeds are considered safe to consume in small amounts, and are often used as a spice or in baked goods. However, consuming large amounts of poppy seeds or using poppy seed extracts or concentrates can be dangerous and may have negative effects on health.\nIt is important to be cautious when using poppy seeds and to follow recommended guidelines for their use. If you have any concerns about the use of poppy seeds, it is always a good idea to consult with a healthcare professional or qualified expert.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4326,
    "user_query": "which fruit fights cancer better ?",
    "yulan-chat-2-13b-fp16_response": "There is no single fruit that is considered to be the best at fighting cancer. Different fruits have different nutrients and compounds that may have potential anti-cancer properties. However, many fruits are rich in vitamins, minerals, and antioxidants, which can help to protect cells from damage that can lead to cancer. Some fruits that are often recommended for their potential anti-cancer properties include berries, citrus fruits, and cruciferous vegetables such as broccoli and cauliflower. It is important to eat a variety of fruits and vegetables as part of a healthy diet to ensure that you are getting a range of nutrients and beneficial compounds.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Different fruits have different nutrients and compounds that may have potential anti-cancer properties.\n2. Fruits are rich in vitamins, minerals, and antioxidants, which can help protect cells from damage that can lead to cancer.\n3. Berries and citrus fruits are often recommended for their potential anti-cancer properties.\n4. Cruciferous vegetables such as broccoli and cauliflower are often recommended for their potential anti-cancer properties.\n5. Eating a variety of fruits and vegetables is important for getting a range of nutrients and beneficial compounds.",
    "yulan-chat-2-13b-fp16_fact": [
      "Different fruits have different nutrients and compounds that may have potential anti-cancer properties.",
      "Fruits are rich in vitamins, minerals, and antioxidants, which can help protect cells from damage that can lead to cancer.",
      "Berries and citrus fruits are often recommended for their potential anti-cancer properties.",
      "Cruciferous vegetables such as broccoli and cauliflower are often recommended for their potential anti-cancer properties.",
      "Eating a variety of fruits and vegetables is important for getting a range of nutrients and beneficial compounds."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4333,
    "user_query": "can gargling prevent the common cold ?",
    "yulan-chat-2-13b-fp16_response": "Gargling with salt water can help relieve symptoms of a sore throat, which is a common symptom of the common cold. However, gargling alone is not enough to prevent the common cold. To prevent the common cold, it is important to practice good hygiene, such as washing your hands frequently and avoiding close contact with people who are sick.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gargling with salt water can help relieve symptoms of a sore throat.\n2. A sore throat is a common symptom of the common cold.\n3. Gargling alone is not sufficient to prevent the common cold.\n4. Washing hands frequently is recommended to help prevent the common cold.\n5. Avoiding close contact with sick people is advised as a preventative measure against the common cold.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gargling with salt water can help relieve symptoms of a sore throat.",
      "A sore throat is a common symptom of the common cold.",
      "Gargling alone is not sufficient to prevent the common cold.",
      "Washing hands frequently is recommended to help prevent the common cold.",
      "Avoiding close contact with sick people is advised as a preventative measure against the common cold."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4334,
    "user_query": "are cats or dogs more protective for children 's health ?",
    "yulan-chat-2-13b-fp16_response": "Both cats and dogs can be protective of children's health in different ways.\nDogs are often considered to be more protective of children because they are naturally more alert and responsive to their surroundings. They can be trained to recognize and respond to potential dangers, such as strangers approaching the house or potential hazards in the environment. Dogs can also provide a sense of security and comfort to children, which can help to reduce stress and anxiety.\nCats, on the other hand, may not be as overtly protective of children as dogs, but they can still provide health benefits. Studies have shown that exposure to pet allergens in the home can help to build immunity and reduce the risk of allergies and asthma in children. Additionally, cats are known for their calming presence and can help to reduce stress and anxiety in both children and adults.\nUltimately, the decision to get a pet for a child should be based on the individual needs and preferences of the family. It's important to consider factors such as the child's age, the family's lifestyle, and the type of pet that is best suited to the home.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dogs are naturally more alert and responsive to their surroundings than cats.\n2. Dogs can be trained to recognize and respond to potential dangers.\n3. Studies have shown that exposure to pet allergens in the home can help to build immunity and reduce the risk of allergies and asthma in children.\n4. Cats are known for their calming presence and can help to reduce stress and anxiety in both children and adults.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dogs are naturally more alert and responsive to their surroundings than cats.",
      "Dogs can be trained to recognize and respond to potential dangers.",
      "Studies have shown that exposure to pet allergens in the home can help to build immunity and reduce the risk of allergies and asthma in children.",
      "Cats are known for their calming presence and can help to reduce stress and anxiety in both children and adults."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: The statement about dogs being naturally more alert and responsive than cats is subjective and can vary based on individual animals and breed. Some dogs may be more alert due to breeding for certain traits, but it's not a universal truth applicable to all dogs and cats.\n2. TRUE: Dogs can indeed be trained to recognize and respond to potential dangers. This is evidenced by the use of working dogs in various fields such as police, military, and personal protection.\n3. TRUE: Studies have indicated that early exposure to pet allergens, particularly from dogs and cats, may lead to a reduced risk of developing allergies and asthma in children.\n4. TRUE: Cats are often recognized for their calming influence and their presence has been associated with a reduction in stress and anxiety in humans. This is supported by various studies on pet therapy and the psychological effects of pet ownership.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4342,
    "user_query": "do eden beans have too much iodine ?",
    "yulan-chat-2-13b-fp16_response": "Eden beans are a brand of canned beans that are known for their high quality and taste. They are made from a variety of beans, including navy beans, pinto beans, and black beans, and are canned in water or oil.\nIodine is an essential nutrient that is necessary for the proper functioning of the thyroid gland, which is responsible for regulating metabolism in the body. It is important to get enough iodine in your diet, but it is also important to avoid getting too much.\nIt is unlikely that Eden beans would have too much iodine, as the amount of iodine in foods is typically very low. However, it is always a good idea to check the label of any food product to see if it contains iodine, and to talk to your doctor if you have any concerns about your iodine intake.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4360,
    "user_query": "better than green tea ?",
    "yulan-chat-2-13b-fp16_response": "It is subjective to determine if matcha is better than green tea, as both have unique health benefits and flavor profiles. Matcha is a finely ground powder made from green tea leaves, while green tea is made from steeping whole tea leaves in hot water.\nMatcha is known to have a stronger flavor and contains more caffeine and antioxidants than green tea. It also has a higher concentration of L-theanine, an amino acid that promotes relaxation and may improve cognitive function.\nOn the other hand, green tea contains a variety of polyphenols and flavonoids that have been shown to have anti-inflammatory and anticancer properties. It also has a lighter flavor than matcha and can be enjoyed hot or iced.\nUltimately, the choice between matcha and green tea comes down to personal preference and individual needs. Both have health benefits and can be incorporated into a healthy diet.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Matcha is a finely ground powder made from green tea leaves.\n2. Green tea is made by steeping whole tea leaves in hot water.\n3. Matcha contains more caffeine and antioxidants than green tea.\n4. Matcha has a higher concentration of L-theanine compared to green tea.\n5. Green tea contains anti-inflammatory and anticancer properties.",
    "yulan-chat-2-13b-fp16_fact": [
      "Matcha is a finely ground powder made from green tea leaves.",
      "Green tea is made by steeping whole tea leaves in hot water.",
      "Matcha contains more caffeine and antioxidants than green tea.",
      "Matcha has a higher concentration of L-theanine compared to green tea.",
      "Green tea contains anti-inflammatory and anticancer properties."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4361,
    "user_query": "fast food : do you want fries with that lipitor ?",
    "yulan-chat-2-13b-fp16_response": "Fast food is typically known for its unhealthy and high-calorie menu items, so it would be unusual to see a promotion for fries and Lipitor, a medication used to lower cholesterol. It's important to maintain a healthy diet and exercise regularly to manage cholesterol levels, rather than relying on medication alone.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Fast food is typically associated with unhealthy and high-calorie menu items.\n2. Lipitor is a medication used to lower cholesterol.\n3. It is advised to maintain a healthy diet and exercise regularly to manage cholesterol levels.",
    "yulan-chat-2-13b-fp16_fact": [
      "Fast food is typically associated with unhealthy and high-calorie menu items.",
      "Lipitor is a medication used to lower cholesterol.",
      "It is advised to maintain a healthy diet and exercise regularly to manage cholesterol levels."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4375,
    "user_query": "are dates good for you ?",
    "yulan-chat-2-13b-fp16_response": "Dates are generally considered a healthy food option and can be a good choice as part of a balanced diet. They are a good source of fiber, vitamins, and minerals, including potassium, vitamin B6, and vitamin C.\nHowever, it's important to keep in mind that dates are also high in natural sugars, so they should be consumed in moderation as part of a balanced diet. Additionally, some people may be allergic to dates, so it's important to be aware of any potential allergic reactions before consuming them.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dates are a source of fiber.\n2. Dates contain potassium, vitamin B6, and vitamin C.\n3. Dates are high in natural sugars.\n4. Some people may be allergic to dates.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dates are a source of fiber.",
      "Dates contain potassium, vitamin B6, and vitamin C.",
      "Dates are high in natural sugars.",
      "Some people may be allergic to dates."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Dates contain potassium and vitamin B6, but they are not a significant source of vitamin C.\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4376,
    "user_query": "are chili peppers good for you ?",
    "yulan-chat-2-13b-fp16_response": "Yes, chili peppers can be good for you when consumed in moderation. They are a good source of vitamins A and C, as well as potassium and capsaicin, which has been shown to have potential health benefits such as reducing inflammation and improving digestion. However, consuming large amounts of chili peppers can cause digestive discomfort.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chili peppers are a good source of vitamins A and C.\n2. Chili peppers contain potassium.\n3. Capsaicin, found in chili peppers, has potential health benefits.\n4. Capsaicin has been shown to reduce inflammation.\n5. Capsaicin can improve digestion.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chili peppers are a good source of vitamins A and C.",
      "Chili peppers contain potassium.",
      "Capsaicin, found in chili peppers, has potential health benefits.",
      "Capsaicin has been shown to reduce inflammation.",
      "Capsaicin can improve digestion."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4383,
    "user_query": "can cholesterol be too low ?",
    "yulan-chat-2-13b-fp16_response": "Yes, cholesterol can be too low, and this condition is called hypocholesterolemia. While high cholesterol is a well-known risk factor for heart disease, low cholesterol levels can also have negative effects on the body.\nLow cholesterol levels can cause problems with the liver, hormone production, and nerve function. In rare cases, severe low cholesterol levels can lead to muscle weakness, fatigue, and even heart failure.\nHowever, it's important to note that most people don't need to worry about having low cholesterol levels. Low-density lipoprotein (LDL) cholesterol, the \"bad\" cholesterol, is more of a concern because it can build up in the arteries and lead to heart disease. A total cholesterol level below 150 mg/dL is generally considered low, but this may not be a problem for everyone.\nIf you're concerned about your cholesterol levels, it's important to speak with your doctor. They can help you determine what your cholesterol levels should be and what steps you can take to improve your overall health.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Low levels of cholesterol in the body can lead to a condition called hypocholesterolemia.\n2. Low cholesterol levels can cause problems with the liver, hormone production, and nerve function.\n3. Severe low cholesterol levels can lead to muscle weakness, fatigue, and even heart failure in rare cases.\n4. Low-density lipoprotein (LDL) cholesterol is often considered the \"bad\" cholesterol because it can accumulate in the arteries, leading to heart disease.\n5. A total cholesterol level below 150 mg/dL is commonly considered low.",
    "yulan-chat-2-13b-fp16_fact": [
      "Low levels of cholesterol in the body can lead to a condition called hypocholesterolemia.",
      "Low cholesterol levels can cause problems with the liver, hormone production, and nerve function.",
      "Severe low cholesterol levels can lead to muscle weakness, fatigue, and even heart failure in rare cases.",
      "Low-density lipoprotein (LDL) cholesterol is often considered the \"bad\" cholesterol because it can accumulate in the arteries, leading to heart disease.",
      "A total cholesterol level below 150 mg/dL is commonly considered low."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4385,
    "user_query": "how much pus is there in milk ?",
    "yulan-chat-2-13b-fp16_response": "There is typically very little pus in milk. Pus is a fluid that is formed as a result of an infection, and it is not a normal component of milk. If you are concerned about the quality or safety of your milk, it is always a good idea to check the expiration date and make sure that it has been stored properly. If you have any concerns about the appearance or consistency of your milk, you should not consume it and should contact your healthcare provider for advice.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4391,
    "user_query": "toxins in cooked potatoes ?",
    "yulan-chat-2-13b-fp16_response": "Cooked potatoes can contain toxins, specifically, solanine and chaconine. These toxins are naturally occurring in the potato plant and can accumulate in the tubers, especially in green areas where the plant may have been exposed to too much sunlight.\nSolanine is a glycoalkaloid toxin that is found in all parts of the potato plant, but is particularly concentrated in the green areas. It is a bitter, white, crystalline substance that can cause vomiting, diarrhea, and headaches if ingested in large amounts.\nChaconine is another glycoalkaloid toxin that is also found in potatoes. It is less toxic than solanine but can still cause digestive problems if consumed in large amounts.\nTo minimize the risk of toxicity, it is recommended to avoid eating green areas of potatoes and to cook potatoes thoroughly before consuming them. Boiling, baking, or frying potatoes can help to reduce the levels of toxins. It is also important to not store potatoes with other fruits and vegetables, as they can transfer toxins to other foods.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cooked potatoes can contain the toxins solanine and chaconine.\n2. Solanine is a glycoalkaloid toxin that is concentrated in the green areas of the potato plant.\n3. Ingesting large amounts of solanine can cause symptoms such as vomiting, diarrhea, and headaches.\n4. Chaconine is a glycoalkaloid toxin found in potatoes that is less toxic than solanine.\n5. To reduce the risk of toxicity, it is recommended to avoid eating green areas of potatoes and to cook potatoes thoroughly.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cooked potatoes can contain the toxins solanine and chaconine.",
      "Solanine is a glycoalkaloid toxin that is concentrated in the green areas of the potato plant.",
      "Ingesting large amounts of solanine can cause symptoms such as vomiting, diarrhea, and headaches.",
      "Chaconine is a glycoalkaloid toxin found in potatoes that is less toxic than solanine.",
      "To reduce the risk of toxicity, it is recommended to avoid eating green areas of potatoes and to cook potatoes thoroughly."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Chaconine is also a glycoalkaloid toxin found in potatoes, but it has not been definitively established whether it is less toxic than solanine.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4408,
    "user_query": "is chlorella good for you ?",
    "yulan-chat-2-13b-fp16_response": "Yes, chlorella is considered to be good for you. Chlorella is a type of single-celled freshwater algae that is often used as a dietary supplement. It is rich in nutrients, including protein, vitamins, and minerals, and is a good source of chlorophyll. Some people believe that chlorella may have health benefits, such as improving digestion, boosting the immune system, and detoxifying the body. However, more research is needed to confirm these potential benefits. It is important to talk to a healthcare provider before taking chlorella supplements, as they can interact with certain medications and may cause side effects in some people.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chlorella is a type of single-celled freshwater algae.\n2. Chlorella is often used as a dietary supplement.\n3. Chlorella is rich in nutrients such as protein, vitamins, and minerals.\n4. Chlorella is a source of chlorophyll.\n5. Chlorella supplements can potentially interact with certain medications.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chlorella is a type of single-celled freshwater algae.",
      "Chlorella is often used as a dietary supplement.",
      "Chlorella is rich in nutrients such as protein, vitamins, and minerals.",
      "Chlorella is a source of chlorophyll.",
      "Chlorella supplements can potentially interact with certain medications."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4420,
    "user_query": "what do eggs do to our arteries ?",
    "yulan-chat-2-13b-fp16_response": "Eggs have been shown to have a positive effect on cholesterol levels and may have a small impact on artery function. However, the overall impact of eggs on artery health is likely to be minimal when consumed as part of a balanced diet.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Eggs have been shown to have a positive effect on cholesterol levels.\n2. Eggs may have a small impact on artery function.\n3. The overall impact of eggs on artery health is likely minimal when consumed as part of a balanced diet.",
    "yulan-chat-2-13b-fp16_fact": [
      "Eggs have been shown to have a positive effect on cholesterol levels.",
      "Eggs may have a small impact on artery function.",
      "The overall impact of eggs on artery health is likely minimal when consumed as part of a balanced diet."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: The effect of eggs on cholesterol levels can vary; some studies suggest that they can raise levels of good HDL cholesterol, but their impact on LDL (bad) cholesterol varies among individuals.\n2. UNKNOWN: The impact of eggs on artery function can depend on various factors, including an individuals overall health and diet; research has shown conflicting results.\n3. UNKNOWN: The statement is too vague without specific research context or parameters. While some studies suggest that when eaten in moderation, eggs can be part of a healthy diet, the definitive overall impact on artery health can vary between individuals and depends on the rest of their diet and lifestyle.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4427,
    "user_query": "is msg bad for you ?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not sure what you are asking. \"msg\" could refer to many different things, and without more context, I cannot provide a specific answer.\nIn general, however, \"msg\" is not inherently bad for you. It could refer to a message or a communication, which are generally considered to be beneficial for human communication and interaction.\nIf you are asking about a specific product or substance that is labeled as \"msg,\" it is important to understand that the safety and potential health effects of any product or substance depend on a variety of factors, including the ingredients, the intended use, and the individual user's health status and sensitivities.\nTherefore, it is always a good idea to carefully read labels and instructions, and to consult with a healthcare professional if you have any concerns about a particular product or substance.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4431,
    "user_query": "why would eating fish increase diabetes risk ?",
    "yulan-chat-2-13b-fp16_response": "Eating fish does not necessarily increase the risk of diabetes. However, some types of fish may contain high levels of contaminants such as mercury, which can have negative effects on insulin sensitivity and blood sugar control. Additionally, consuming fish that are high in omega-3 fatty acids may increase the risk of bleeding, which could be a concern for people with diabetes who are at risk for complications. It is important to consume fish as part of a balanced diet and to choose fish that are low in contaminants and high in omega-3 fatty acids.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Some types of fish may contain high levels of contaminants such as mercury.\n2. High levels of contaminants like mercury in fish can negatively affect insulin sensitivity and blood sugar control.\n3. Consuming fish high in omega-3 fatty acids may increase the risk of bleeding.\n4. People with diabetes who are at risk for complications could be concerned about the increased risk of bleeding from consuming fish high in omega-3 fatty acids.",
    "yulan-chat-2-13b-fp16_fact": [
      "Some types of fish may contain high levels of contaminants such as mercury.",
      "High levels of contaminants like mercury in fish can negatively affect insulin sensitivity and blood sugar control.",
      "Consuming fish high in omega-3 fatty acids may increase the risk of bleeding.",
      "People with diabetes who are at risk for complications could be concerned about the increased risk of bleeding from consuming fish high in omega-3 fatty acids."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4440,
    "user_query": "should i stay away from soy if i have breast cancer ?",
    "yulan-chat-2-13b-fp16_response": "It is recommended that breast cancer survivors avoid consuming soy products in large quantities, as some studies have suggested that soy may increase the risk of recurrence. However, other studies have found no such link, and the American Cancer Society recommends that breast cancer survivors consume soy in moderation as part of a healthy diet. It is always best to consult with a healthcare professional for personalized advice.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Some studies have suggested that consuming soy in large quantities may increase the risk of breast cancer recurrence.\n2. Other studies have found no link between soy consumption and the risk of breast cancer recurrence.\n3. The American Cancer Society recommends that breast cancer survivors consume soy in moderation as part of a healthy diet.\n4. It is advised that individuals consult with a healthcare professional for personalized advice on soy consumption if they are breast cancer survivors.",
    "yulan-chat-2-13b-fp16_fact": [
      "Some studies have suggested that consuming soy in large quantities may increase the risk of breast cancer recurrence.",
      "Other studies have found no link between soy consumption and the risk of breast cancer recurrence.",
      "The American Cancer Society recommends that breast cancer survivors consume soy in moderation as part of a healthy diet.",
      "It is advised that individuals consult with a healthcare professional for personalized advice on soy consumption if they are breast cancer survivors."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4442,
    "user_query": "have you seen the very recent web blitz on heavy metals ( particularly thallium ) in cruciferous vegetables ( particularly kale ) ... ?",
    "yulan-chat-2-13b-fp16_response": "Yes, I am aware of the recent news articles and studies about the presence of heavy metals, including thallium, in cruciferous vegetables such as kale.\nThallium is a toxic heavy metal that can accumulate in the environment and in the human body. It is naturally occurring in soil and rock, and can also be released into the environment through human activities such as mining and smelting.\nStudies have found that some cruciferous vegetables, such as kale, can accumulate thallium from the soil in which they are grown. However, it is important to note that the levels of thallium found in these vegetables are generally low and are not considered a significant health risk for most people.\nIt is always a good idea to eat a varied diet and to choose foods that are grown in environments with low levels of contamination. However, it is not necessary to avoid cruciferous vegetables such as kale based on concerns about thallium contamination.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Thallium is a toxic heavy metal that can accumulate in the environment and the human body.\n2. Thallium is naturally occurring in soil and rock.\n3. Human activities such as mining and smelting can release thallium into the environment.\n4. Cruciferous vegetables like kale can accumulate thallium from the soil.\n5. The levels of thallium found in some cruciferous vegetables are generally low and not considered a significant health risk for most people.",
    "yulan-chat-2-13b-fp16_fact": [
      "Thallium is a toxic heavy metal that can accumulate in the environment and the human body.",
      "Thallium is naturally occurring in soil and rock.",
      "Human activities such as mining and smelting can release thallium into the environment.",
      "Cruciferous vegetables like kale can accumulate thallium from the soil.",
      "The levels of thallium found in some cruciferous vegetables are generally low and not considered a significant health risk for most people."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4444,
    "user_query": "might too many antioxidants cause cancer ?",
    "yulan-chat-2-13b-fp16_response": "No, having too many antioxidants does not cause cancer. In fact, antioxidants are important for maintaining good health and preventing cancer.\nAntioxidants are substances that protect cells from damage caused by free radicals, which are unstable molecules that can cause damage to cells and contribute to the development of cancer. By neutralizing free radicals, antioxidants can help prevent cancer and other diseases.\nHowever, it is important to note that excessive intake of certain antioxidants, such as beta-carotene, vitamin E, and vitamin A, may actually increase the risk of certain types of cancer. This is because high doses of these antioxidants can act as pro-oxidants, which means they generate free radicals that can cause damage to cells.\nIt is important to maintain a balanced diet and to get antioxidants from a variety of sources, rather than relying on supplements. Eating a diet rich in fruits, vegetables, and whole grains can provide a variety of antioxidants and other important nutrients that can help prevent cancer and other diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Antioxidants protect cells from damage caused by free radicals.\n2. Free radicals are unstable molecules that can contribute to the development of cancer.\n3. Excessive intake of certain antioxidants, such as beta-carotene, vitamin E, and vitamin A, may increase the risk of certain types of cancer.\n4. High doses of some antioxidants can act as pro-oxidants, generating free radicals that can damage cells.\n5. A diet rich in fruits, vegetables, and whole grains can provide a variety of antioxidants.",
    "yulan-chat-2-13b-fp16_fact": [
      "Antioxidants protect cells from damage caused by free radicals.",
      "Free radicals are unstable molecules that can contribute to the development of cancer.",
      "Excessive intake of certain antioxidants, such as beta-carotene, vitamin E, and vitamin A, may increase the risk of certain types of cancer.",
      "High doses of some antioxidants can act as pro-oxidants, generating free radicals that can damage cells.",
      "A diet rich in fruits, vegetables, and whole grains can provide a variety of antioxidants."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4449,
    "user_query": "what is the best way to get vitamin b12 ?",
    "yulan-chat-2-13b-fp16_response": "Vitamin B12 is an essential nutrient that is important for the proper functioning of the nervous system and the production of red blood cells. It is found primarily in animal products, such as meat, poultry, fish, and dairy products. Vegetarians and vegans may be at risk of vitamin B12 deficiency, as plant-based foods do not provide a reliable source of this vitamin.\nThe best way to get vitamin B12 is through dietary sources, such as meat, poultry, fish, and dairy products. If you are a vegetarian or vegan, you may want to consider taking a vitamin B12 supplement to ensure that you are getting enough of this important nutrient. Vitamin B12 supplements are available in a variety of forms, including tablets, capsules, and liquid drops. They can be found at most health food stores and pharmacies.\nIt is also important to note that some fortified foods, such as fortified plant-based milk and breakfast cereals, may provide a source of vitamin B12. However, it is important to check the nutrition label to confirm that the product is fortified with vitamin B12.\nIn summary, the best way to get vitamin B12 is through dietary sources, such as meat, poultry, fish, and dairy products, or through supplements. It is important to ensure that you are getting enough of this important nutrient to support the proper functioning of your body.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vitamin B12 is important for the proper functioning of the nervous system and the production of red blood cells.\n2. Animal products such as meat, poultry, fish, and dairy products are primary sources of vitamin B12.\n3. Vegetarians and vegans may be at risk of vitamin B12 deficiency due to the lack of this vitamin in plant-based foods.\n4. Vitamin B12 supplements are available in forms such as tablets, capsules, and liquid drops.\n5. Some fortified foods, like certain plant-based milks and breakfast cereals, can be sources of vitamin B12 if they are fortified with it.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vitamin B12 is important for the proper functioning of the nervous system and the production of red blood cells.",
      "Animal products such as meat, poultry, fish, and dairy products are primary sources of vitamin B12.",
      "Vegetarians and vegans may be at risk of vitamin B12 deficiency due to the lack of this vitamin in plant-based foods.",
      "Vitamin B12 supplements are available in forms such as tablets, capsules, and liquid drops.",
      "Some fortified foods, like certain plant-based milks and breakfast cereals, can be sources of vitamin B12 if they are fortified with it."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4451,
    "user_query": "might flax seeds ( ala ) increase prostate cancer risk ?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that high levels of alpha-linolenic acid (ALA), the omega-3 fatty acid found in flax seeds, may increase the risk of prostate cancer. However, the research on this topic is still inconclusive and more studies are needed to fully understand the relationship between ALA and prostate cancer risk. It is important to note that flax seeds are also rich in other nutrients that may have health benefits, and it is generally considered safe to consume them in moderation as part of a healthy diet.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alpha-linolenic acid (ALA) is an omega-3 fatty acid found in flax seeds.\n2. There is some evidence that high levels of ALA may increase the risk of prostate cancer.\n3. The research on the relationship between ALA and prostate cancer risk is inconclusive.\n4. More studies are needed to fully understand the relationship between ALA and prostate cancer risk.\n5. Flax seeds are considered safe to consume in moderation as part of a healthy diet.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alpha-linolenic acid (ALA) is an omega-3 fatty acid found in flax seeds.",
      "There is some evidence that high levels of ALA may increase the risk of prostate cancer.",
      "The research on the relationship between ALA and prostate cancer risk is inconclusive.",
      "More studies are needed to fully understand the relationship between ALA and prostate cancer risk.",
      "Flax seeds are considered safe to consume in moderation as part of a healthy diet."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4452,
    "user_query": "viral food poisoning from pesticides ?",
    "yulan-chat-2-13b-fp16_response": "Food poisoning caused by pesticides can occur when pesticides are used in a way that results in contamination of food. This can happen during the production, processing, or storage of food. Pesticides can also enter the food chain through the environment, such as through runoff from agricultural fields or through the presence of pesticides in the soil.\nWhen pesticides are ingested through contaminated food, they can cause a range of symptoms, including nausea, vomiting, diarrhea, abdominal pain, and headache. In severe cases, food poisoning from pesticides can lead to more serious health complications, such as organ damage or death.\nIt is important to follow proper food safety guidelines and to be aware of the potential risks associated with pesticide use in order to minimize the risk of food poisoning from pesticides. This includes washing fruits and vegetables thoroughly, cooking food thoroughly, and avoiding the consumption of food that has been contaminated with pesticides.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Food poisoning caused by pesticides can result from contamination during production, processing, or storage of food.\n2. Pesticides can enter the food chain through environmental pathways, such as agricultural runoff or presence in the soil.\n3. Symptoms of food poisoning caused by pesticides may include nausea, vomiting, diarrhea, abdominal pain, and headache.\n4. Severe cases of pesticide food poisoning can lead to organ damage or death.\n5. Following proper food safety guidelines can help minimize the risk of food poisoning from pesticides.",
    "yulan-chat-2-13b-fp16_fact": [
      "Food poisoning caused by pesticides can result from contamination during production, processing, or storage of food.",
      "Pesticides can enter the food chain through environmental pathways, such as agricultural runoff or presence in the soil.",
      "Symptoms of food poisoning caused by pesticides may include nausea, vomiting, diarrhea, abdominal pain, and headache.",
      "Severe cases of pesticide food poisoning can lead to organ damage or death.",
      "Following proper food safety guidelines can help minimize the risk of food poisoning from pesticides."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4455,
    "user_query": "are neurotoxins only present in blue-green algae ?",
    "yulan-chat-2-13b-fp16_response": "Neurotoxins can be found in a variety of sources, including certain types of bacteria, fungi, plants, and animals. Blue-green algae, also known as cyanobacteria, are known to produce neurotoxins, but they are not the only source of these toxins.\nFor example, some species of fish and shellfish, such as puffer fish and geoduck clams, can accumulate neurotoxins in their tissues from consuming toxic algae. Additionally, some species of snakes, such as the coral snake, produce neurotoxins as a defense mechanism.\nIn plants, the poisonous substances that can cause harm to humans and animals are often referred to as \"toxic\" rather than \"neurotoxic,\" but they can still affect the nervous system. Examples of plants that produce toxic substances include the poison ivy, oak, and sumac, as well as the manchineel tree.\nOverall, neurotoxins can be found in a wide range of sources, and it is important to be aware of the potential risks associated with different types of toxins.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Neurotoxins can be found in certain types of bacteria, fungi, plants, and animals.\n2. Blue-green algae, also known as cyanobacteria, produce neurotoxins.\n3. Puffer fish and geoduck clams can accumulate neurotoxins in their tissues from consuming toxic algae.\n4. Some species of snakes, like the coral snake, produce neurotoxins as a defense mechanism.\n5. Plants such as poison ivy, oak, sumac, and the manchineel tree produce substances that can affect the nervous system.",
    "yulan-chat-2-13b-fp16_fact": [
      "Neurotoxins can be found in certain types of bacteria, fungi, plants, and animals.",
      "Blue-green algae, also known as cyanobacteria, produce neurotoxins.",
      "Puffer fish and geoduck clams can accumulate neurotoxins in their tissues from consuming toxic algae.",
      "Some species of snakes, like the coral snake, produce neurotoxins as a defense mechanism.",
      "Plants such as poison ivy, oak, sumac, and the manchineel tree produce substances that can affect the nervous system."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Poison ivy, oak, and sumac produce urushiol, an oil that causes skin irritation, and the manchineel tree produces a milky sap that can cause skin blisters and irritation; however, these are not specifically neurotoxins that affect the nervous system.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4458,
    "user_query": "what about gurmar , jamun , bitter melon , and fenugreek ?",
    "yulan-chat-2-13b-fp16_response": "Gurmar, jamun, bitter melon, and fenugreek are all plants that have been used in traditional medicine for various purposes.\nGurmar, also known as Gymnema sylvestre, is a plant native to India and Africa. It has been used in Ayurvedic and Unani medicine to treat a variety of conditions, including diabetes, obesity, and liver disorders. Gurmar is thought to work by regulating blood sugar levels and reducing inflammation.\nJamun, also known as Syzygium cumini, is a fruit native to India and Southeast Asia. It has been used in Ayurvedic medicine to treat a variety of conditions, including diabetes, liver disorders, and digestive problems. Jamun is thought to have anti-inflammatory and antioxidant properties.\nBitter melon, also known as Momordica foetida, is a plant native to India and Africa. It has been used in traditional medicine to treat a variety of conditions, including diabetes, fever, and digestive problems. Bitter melon is thought to work by regulating blood sugar levels and reducing inflammation.\nFenugreek, also known as Trigonella foenum-graecum, is a plant native to the Mediterranean region. It has been used in traditional medicine to treat a variety of conditions, including diabetes, digestive problems, and arthritis. Fenugreek is thought to work by regulating blood sugar levels and reducing inflammation.\nIt is important to note that while these plants have a long history of use in traditional medicine, their efficacy and safety have not been extensively studied using modern scientific methods. It is always best to consult with a healthcare professional before using any herbal remedies.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gurmar, also known as Gymnema sylvestre, is claimed to be used in Ayurvedic and Unani medicine to treat conditions such as diabetes, obesity, and liver disorders.\n2. Jamun, also known as Syzygium cumini, is said to be used in Ayurvedic medicine and is thought to have anti-inflammatory and antioxidant properties.\n3. Bitter melon, also known as Momordica charantia, is suggested to be used in traditional medicine to treat conditions like diabetes, fever, and digestive problems.\n4. Fenugreek, also known as Trigonella foenum-graecum, is claimed to be used in traditional medicine to treat conditions like diabetes, digestive problems, and arthritis.\n5. The efficacy and safety of gurmar, jamun, bitter melon, and fenugreek have not been extensively studied using modern scientific methods.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gurmar, also known as Gymnema sylvestre, is claimed to be used in Ayurvedic and Unani medicine to treat conditions such as diabetes, obesity, and liver disorders.",
      "Jamun, also known as Syzygium cumini, is said to be used in Ayurvedic medicine and is thought to have anti-inflammatory and antioxidant properties.",
      "Bitter melon, also known as Momordica charantia, is suggested to be used in traditional medicine to treat conditions like diabetes, fever, and digestive problems.",
      "Fenugreek, also known as Trigonella foenum-graecum, is claimed to be used in traditional medicine to treat conditions like diabetes, digestive problems, and arthritis.",
      "The efficacy and safety of gurmar, jamun, bitter melon, and fenugreek have not been extensively studied using modern scientific methods."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4462,
    "user_query": "my skin is turning orange ( carotenoderma ) --too many carrots ?",
    "yulan-chat-2-13b-fp16_response": "Carotenoderma, also known as carotenemia, is a condition that causes a yellow or orange discoloration of the skin. It is usually caused by an accumulation of carotenoids, which are pigments found in certain foods and plants, in the skin. While eating a lot of carrots can contribute to this condition, it can also be caused by other factors such as medications, liver disease, or certain infections. If you are concerned about your skin color, it is best to speak with a doctor or dermatologist to determine the cause and appropriate treatment.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Carotenoderma, also known as carotenemia, is a condition that causes yellow or orange discoloration of the skin.\n2. Carotenoderma is usually caused by an accumulation of carotenoids in the skin.\n3. Carotenoids are pigments found in certain foods and plants.\n4. Eating a lot of carrots can contribute to the condition of carotenoderma.\n5. Factors such as medications, liver disease, or certain infections can also cause carotenoderma.",
    "yulan-chat-2-13b-fp16_fact": [
      "Carotenoderma, also known as carotenemia, is a condition that causes yellow or orange discoloration of the skin.",
      "Carotenoderma is usually caused by an accumulation of carotenoids in the skin.",
      "Carotenoids are pigments found in certain foods and plants.",
      "Eating a lot of carrots can contribute to the condition of carotenoderma.",
      "Factors such as medications, liver disease, or certain infections can also cause carotenoderma."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4463,
    "user_query": "does caffeine impair endothelial function in our arteries ?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that caffeine may impair endothelial function in the short term. Endothelial function refers to the ability of the endothelium, which is the lining of the blood vessels, to regulate blood flow, blood clotting, and other processes.\nStudies have shown that acute consumption of caffeine can cause a short-term decrease in endothelial function, which may increase the risk of cardiovascular disease. However, it is important to note that the effects of caffeine on endothelial function may vary depending on the individual and the amount of caffeine consumed.\nIt is also worth noting that long-term consumption of caffeine may have different effects on endothelial function compared to acute consumption. Some studies have suggested that chronic caffeine consumption may actually improve endothelial function, while others have found no significant effect.\nOverall, the evidence suggests that caffeine may impair endothelial function in the short term, but the long-term effects are less clear and may depend on individual factors such as caffeine intake and overall lifestyle. It is always a good idea to consult with a healthcare professional before making any changes to your diet or lifestyle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Some evidence suggests caffeine may impair endothelial function in the short term.\n2. Endothelial function involves the regulation of blood flow and blood clotting, among other processes.\n3. Acute consumption of caffeine can cause a decrease in endothelial function.\n4. Chronic caffeine consumption may have different effects on endothelial function compared to acute consumption.\n5. Long-term effects of caffeine on endothelial function may depend on individual factors including caffeine intake and overall lifestyle.",
    "yulan-chat-2-13b-fp16_fact": [
      "Some evidence suggests caffeine may impair endothelial function in the short term.",
      "Endothelial function involves the regulation of blood flow and blood clotting, among other processes.",
      "Acute consumption of caffeine can cause a decrease in endothelial function.",
      "Chronic caffeine consumption may have different effects on endothelial function compared to acute consumption.",
      "Long-term effects of caffeine on endothelial function may depend on individual factors including caffeine intake and overall lifestyle."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4464,
    "user_query": "what about the oxalic acid in beets ?",
    "yulan-chat-2-13b-fp16_response": "Yes, beets are also a good source of oxalates. In fact, beets are one of the richest dietary sources of oxalates, containing about 71 mg of oxalates per 100 grams of beets. However, it's important to note that the oxalates in beets are mostly in the form of calcium oxalate, which is less likely to cause problems for most people than the form found in spinach and rhubarb.\nIn addition to the oxalates, beets are also a good source of fiber, vitamin C, potassium, and other nutrients. Eating a variety of fruits and vegetables, including those that contain oxalates, can provide a range of health benefits and help ensure that you're getting all the nutrients your body needs.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Beets contain about 71 mg of oxalates per 100 grams.\n2. The oxalates in beets are mostly in the form of calcium oxalate.\n3. Beets are a good source of fiber.\n4. Beets are a good source of vitamin C.\n5. Beets are a good source of potassium.",
    "yulan-chat-2-13b-fp16_fact": [
      "Beets contain about 71 mg of oxalates per 100 grams.",
      "The oxalates in beets are mostly in the form of calcium oxalate.",
      "Beets are a good source of fiber.",
      "Beets are a good source of vitamin C.",
      "Beets are a good source of potassium."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4466,
    "user_query": "what is the healthiest potato ?",
    "yulan-chat-2-13b-fp16_response": "All potatoes are relatively healthy and nutritious. They are a good source of fiber, vitamin C, potassium, and other essential nutrients. However, the healthiest potato is one that is not heavily processed or fried, and is consumed as part of a balanced diet. It is also important to choose potatoes that are not treated with pesticides or other chemicals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Potatoes are a good source of fiber, vitamin C, and potassium.\n2. The healthiest way to consume potatoes is not heavily processed or fried.\n3. It is important to choose potatoes that are not treated with pesticides or other chemicals for a healthier option.",
    "yulan-chat-2-13b-fp16_fact": [
      "Potatoes are a good source of fiber, vitamin C, and potassium.",
      "The healthiest way to consume potatoes is not heavily processed or fried.",
      "It is important to choose potatoes that are not treated with pesticides or other chemicals for a healthier option."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4468,
    "user_query": "should we avoid canned tomatoes and non-organic root vegetables ?",
    "yulan-chat-2-13b-fp16_response": "Whether or not to avoid canned tomatoes and non-organic root vegetables ultimately depends on your personal preferences and priorities. Here are some factors to consider:\n1. Nutritional value: Canned tomatoes and root vegetables can be good sources of vitamins and minerals, but their nutritional value may be affected by the canning process and the use of pesticides and fertilizers in non-organic farming.\n2. Taste and quality: Some people prefer the taste and quality of fresh produce over canned or frozen options. If you prioritize taste and quality, you may want to choose fresh produce over canned or frozen options.\n3. Convenience and cost: Canned tomatoes and root vegetables can be more convenient and cost-effective than fresh produce, especially if you live in an area with a limited growing season or limited access to fresh produce.\n4. Environmental impact: Some people choose to avoid canned tomatoes and non-organic root vegetables because of the environmental impact of the canning process and the use of pesticides and fertilizers in non-organic farming.\nUltimately, the decision to avoid canned tomatoes and non-organic root vegetables is a personal one that depends on your individual priorities and values. If you are concerned about the nutritional value, taste, convenience, cost, or environmental impact of these foods, you may want to choose fresh or frozen options instead.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4470,
    "user_query": "sulfite sensitivity from sulphur dioxide in dried fruits ?",
    "yulan-chat-2-13b-fp16_response": "Yes, some people may be sensitive or allergic to sulfites, which are preservatives commonly used in dried fruits to prevent spoilage and discoloration. Sulfites can cause an allergic reaction, including symptoms such as hives, itching, swelling, and difficulty breathing in severe cases. If you are sensitive to sulfites, it is important to check the labels of dried fruits and other food products to avoid them. Some dried fruit brands may offer sulfite-free options, or you can try making your own dried fruits at home using natural methods of preservation.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Sulfites are preservatives commonly used in dried fruits.\n2. The purpose of sulfites in dried fruits is to prevent spoilage and discoloration.\n3. Sulfites can cause allergic reactions in some people.\n4. Symptoms of a sulfite allergy may include hives, itching, swelling, and difficulty breathing.\n5. Some dried fruit brands may offer sulfite-free options.",
    "yulan-chat-2-13b-fp16_fact": [
      "Sulfites are preservatives commonly used in dried fruits.",
      "The purpose of sulfites in dried fruits is to prevent spoilage and discoloration.",
      "Sulfites can cause allergic reactions in some people.",
      "Symptoms of a sulfite allergy may include hives, itching, swelling, and difficulty breathing.",
      "Some dried fruit brands may offer sulfite-free options."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4471,
    "user_query": "are multivitamins just a waste of money ?",
    "yulan-chat-2-13b-fp16_response": "Multivitamins are a type of dietary supplement that contain a mix of vitamins and minerals. While they may be beneficial for some people, it is not necessary for everyone to take a multivitamin. The body needs a balanced diet to function properly, and taking a multivitamin cannot replace the nutrients found in whole foods.\nMultivitamins may be useful for people who have a limited diet, such as vegetarians or vegans, or for those who have difficulty absorbing nutrients from food due to certain health conditions. However, for most people, a balanced diet that includes a variety of fruits, vegetables, whole grains, lean proteins, and healthy fats can provide all the necessary vitamins and minerals.\nIt is important to note that taking excessive amounts of certain vitamins and minerals can be harmful, and some supplements may interact with medications or have side effects. Therefore, it is recommended to consult a healthcare professional before taking any supplement, including a multivitamin.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Multivitamins are a type of dietary supplement that contain a mix of vitamins and minerals.\n2. Some people may benefit from taking multivitamins, such as vegetarians, vegans, or those with certain health conditions that affect nutrient absorption.\n3. A balanced diet consisting of fruits, vegetables, whole grains, lean proteins, and healthy fats can provide all necessary vitamins and minerals for most people.\n4. Taking excessive amounts of certain vitamins and minerals can be harmful.\n5. Some supplements can interact with medications or cause side effects.",
    "yulan-chat-2-13b-fp16_fact": [
      "Multivitamins are a type of dietary supplement that contain a mix of vitamins and minerals.",
      "Some people may benefit from taking multivitamins, such as vegetarians, vegans, or those with certain health conditions that affect nutrient absorption.",
      "A balanced diet consisting of fruits, vegetables, whole grains, lean proteins, and healthy fats can provide all necessary vitamins and minerals for most people.",
      "Taking excessive amounts of certain vitamins and minerals can be harmful.",
      "Some supplements can interact with medications or cause side effects."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4473,
    "user_query": "what are the best sources of vitamin k ?",
    "yulan-chat-2-13b-fp16_response": "Vitamin K is an essential nutrient that plays a crucial role in blood clotting and bone health. There are two forms of vitamin K: vitamin K1 (phylloquinone) and vitamin K2 (menaquinone). While both forms of vitamin K are important for health, vitamin K2 is considered the more biologically active form.\nHere are some of the best sources of vitamin K:\n1. Leafy green vegetables: Leafy greens like spinach, kale, collard greens, and Swiss chard are excellent sources of vitamin K1. These vegetables are also rich in other nutrients like vitamin C, vitamin A, and calcium.\n2. Broccoli: Broccoli is another great source of vitamin K1, as well as other important nutrients like vitamin C and folate.\n3. Liver: Liver is one of the best dietary sources of vitamin K2. It's also rich in other nutrients like vitamin A, vitamin D, and iron.\n4. Fermented foods: Fermented foods like natto, sauerkraut, and kimchi are excellent sources of vitamin K2. These foods are also rich in other beneficial bacteria that can improve gut health.\n5. Egg yolks: Egg yolks are a good source of both vitamin K1 and vitamin K2. They're also rich in other nutrients like protein and choline.\n6. Cheese: Certain types of cheese, such as Gouda and cheddar, are good sources of vitamin K2. They're also rich in other nutrients like calcium and protein.\nIt's important to note that vitamin K is fat-soluble, which means that it's best absorbed when consumed with a source of dietary fat. Therefore, it's a good idea to include healthy fats like avocado or olive oil in your meals that contain these vitamin K-rich foods.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vitamin K1 (phylloquinone) is found in high amounts in leafy green vegetables such as spinach, kale, collard greens, and Swiss chard.\n2. Broccoli is a good source of vitamin K1.\n3. Liver, particularly from animals, is one of the best dietary sources of vitamin K2.\n4. Fermented foods like natto, sauerkraut, and kimchi are rich sources of vitamin K2.\n5. Egg yolks provide a good source of both vitamin K1 and K2.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vitamin K1 (phylloquinone) is found in high amounts in leafy green vegetables such as spinach, kale, collard greens, and Swiss chard.",
      "Broccoli is a good source of vitamin K1.",
      "Liver, particularly from animals, is one of the best dietary sources of vitamin K2.",
      "Fermented foods like natto, sauerkraut, and kimchi are rich sources of vitamin K2.",
      "Egg yolks provide a good source of both vitamin K1 and K2."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Egg yolks provide a good source of vitamin K2, but they are not a significant source of vitamin K1.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4477,
    "user_query": "is raw milk healthy ?",
    "yulan-chat-2-13b-fp16_response": "Raw milk can be a healthy choice for some people, but it can also pose risks. Raw milk is unpasteurized, which means it hasn't been heat-treated to kill harmful bacteria. These bacteria can cause foodborne illnesses, such as E. coli and Salmonella.\nRaw milk can also contain harmful bacteria, such as Listeria monocytogenes, which can cause listeriosis, a serious infection that can be fatal for pregnant women and people with weakened immune systems.\nHowever, some people believe that raw milk has health benefits, such as higher nutrient content and better taste. If you choose to consume raw milk, it's important to do so with caution. Look for milk from a reputable source that follows strict safety protocols, such as regular testing for bacteria.\nIt's also important to note that raw milk is not regulated by the FDA, so the quality and safety can vary greatly from one source to another. If you're pregnant, have a weakened immune system, or are otherwise at high risk for foodborne illness, it's best to avoid raw milk altogether.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Raw milk is unpasteurized, meaning it hasn't been heat-treated to kill harmful bacteria.\n2. Consumption of raw milk can lead to foodborne illnesses caused by bacteria such as E. coli and Salmonella.\n3. Listeria monocytogenes, which can be found in raw milk, can cause a serious infection known as listeriosis.\n4. Listeriosis can be fatal for pregnant women and people with weakened immune systems.\n5. Raw milk is not regulated by the FDA.",
    "yulan-chat-2-13b-fp16_fact": [
      "Raw milk is unpasteurized, meaning it hasn't been heat-treated to kill harmful bacteria.",
      "Consumption of raw milk can lead to foodborne illnesses caused by bacteria such as E. coli and Salmonella.",
      "Listeria monocytogenes, which can be found in raw milk, can cause a serious infection known as listeriosis.",
      "Listeriosis can be fatal for pregnant women and people with weakened immune systems.",
      "Raw milk is not regulated by the FDA."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Raw milk regulation varies by state, but it is under the regulation of the FDA at the federal level. The FDA prohibits the interstate sale or distribution of raw milk. Some states allow the sale of raw milk with certain regulations, while others do not.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4479,
    "user_query": "is the new vitamin d3 spray a waste of money ?",
    "yulan-chat-2-13b-fp16_response": "It is not appropriate for me to say whether a specific product is a waste of money without more information. Vitamin D3 sprays can be a convenient way to get your daily dose of vitamin D, but it is important to make sure that the product you are using is high quality and contains the appropriate amount of vitamin D. It is also important to talk to your healthcare provider before starting to take any supplements, including vitamin D. They can help you determine if you have a deficiency and if a supplement is necessary.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vitamin D3 sprays can be a convenient way to obtain a daily dose of vitamin D.\n2. It is important for a product to be high quality and contain the appropriate amount of vitamin D.\n3. People should consult their healthcare provider before starting to take any supplements, including vitamin D.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vitamin D3 sprays can be a convenient way to obtain a daily dose of vitamin D.",
      "It is important for a product to be high quality and contain the appropriate amount of vitamin D.",
      "People should consult their healthcare provider before starting to take any supplements, including vitamin D."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4481,
    "user_query": "how can i preserve the anti-cancer effects of cooked garlic ?",
    "yulan-chat-2-13b-fp16_response": "Garlic has been shown to have potential anti-cancer properties due to its high content of organosulfur compounds, which have been found to have antioxidant and anti-inflammatory effects. Cooking garlic can affect the levels of these compounds, but there are ways to preserve its anti-cancer effects.\nOne way to preserve the anti-cancer effects of cooked garlic is to minimize the cooking time. When garlic is cooked for a long time at high temperatures, the levels of its active compounds can decrease. Therefore, cooking garlic for a short time at a lower temperature can help to preserve its anti-cancer properties.\nAnother way to preserve the anti-cancer effects of cooked garlic is to consume it with other foods that have anti-cancer properties. For example, combining cooked garlic with cruciferous vegetables like broccoli, cauliflower, and kale can help to enhance its anti-cancer effects.\nFinally, it's important to note that consuming garlic as part of a balanced diet that includes a variety of fruits, vegetables, and other healthy foods is key to promoting overall health and reducing the risk of cancer.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Garlic contains high content of organosulfur compounds, which may have anti-cancer properties.\n2. These organosulfur compounds in garlic have antioxidant and anti-inflammatory effects.\n3. Cooking garlic for a long time at high temperatures can decrease the levels of its active compounds.\n4. Consuming cooked garlic with cruciferous vegetables like broccoli, cauliflower, and kale may enhance its anti-cancer effects.\n5. Garlic is most beneficial as part of a balanced diet that includes a variety of fruits, vegetables, and other healthy foods for overall health and cancer risk reduction.",
    "yulan-chat-2-13b-fp16_fact": [
      "Garlic contains high content of organosulfur compounds, which may have anti-cancer properties.",
      "These organosulfur compounds in garlic have antioxidant and anti-inflammatory effects.",
      "Cooking garlic for a long time at high temperatures can decrease the levels of its active compounds.",
      "Consuming cooked garlic with cruciferous vegetables like broccoli, cauliflower, and kale may enhance its anti-cancer effects.",
      "Garlic is most beneficial as part of a balanced diet that includes a variety of fruits, vegetables, and other healthy foods for overall health and cancer risk reduction."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4482,
    "user_query": "given the  brain-eating amoeba  ( naegleria fowleri ) in tap water should i sterilize my neti pot water ?",
    "yulan-chat-2-13b-fp16_response": "Yes, it is recommended to sterilize the water used in a neti pot to avoid the risk of infection, including the rare but potentially deadly brain-eating amoeba Naegleria fowleri.\nTo sterilize the water, you can use a sterile saline solution or sterile water that has been boiled and cooled to body temperature. It is also important to clean and sterilize the neti pot itself regularly to prevent bacterial or fungal growth.\nIt is important to note that the risk of contracting Naegleria fowleri from a neti pot is low, but it is still a good idea to take precautions to avoid any potential infection.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. It is recommended to sterilize the water used in a neti pot to prevent infection.\n2. Sterilization methods include using sterile saline solutions or sterile water that has been boiled and cooled.\n3. The neti pot itself should be cleaned and sterilized regularly.\n4. The risk of contracting Naegleria fowleri from a neti pot is low.",
    "yulan-chat-2-13b-fp16_fact": [
      "It is recommended to sterilize the water used in a neti pot to prevent infection.",
      "Sterilization methods include using sterile saline solutions or sterile water that has been boiled and cooled.",
      "The neti pot itself should be cleaned and sterilized regularly.",
      "The risk of contracting Naegleria fowleri from a neti pot is low."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4483,
    "user_query": "does adding baking soda to soaking beans reduce gas ?",
    "yulan-chat-2-13b-fp16_response": "Yes, adding baking soda to the water when soaking beans can help reduce gas. Beans contain a natural sugar called oligosaccharides that can be difficult for the body to digest, leading to gas and bloating. Baking soda, also known as sodium bicarbonate, is an alkaline substance that can help neutralize the acidity in the beans and make them easier to digest. Adding 1-2 teaspoons of baking soda per cup of water to the soaking water can help reduce gas and bloating.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Adding baking soda to the water when soaking beans can help reduce gas.\n2. Beans contain a type of natural sugar called oligosaccharides.\n3. Oligosaccharides in beans can be difficult for the body to digest, leading to gas and bloating.\n4. Baking soda is an alkaline substance that can help neutralize the acidity in beans.\n5. Adding 1-2 teaspoons of baking soda per cup of water to the soaking beans can help make them easier to digest.",
    "yulan-chat-2-13b-fp16_fact": [
      "Adding baking soda to the water when soaking beans can help reduce gas.",
      "Beans contain a type of natural sugar called oligosaccharides.",
      "Oligosaccharides in beans can be difficult for the body to digest, leading to gas and bloating.",
      "Baking soda is an alkaline substance that can help neutralize the acidity in beans.",
      "Adding 1-2 teaspoons of baking soda per cup of water to the soaking beans can help make them easier to digest."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Baking soda does not neutralize acidity in beans; it helps to break down the oligosaccharides that can cause gas and bloating.\n5. UNKNOWN",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 4487,
    "user_query": "can vitamin d supplements help prevent respiratory infections ?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that vitamin D supplements may help prevent respiratory infections, particularly in people who are deficient in vitamin D. However, more research is needed to confirm these findings and to determine the optimal dosage and duration of vitamin D supplementation for preventing respiratory infections. It is also important to note that vitamin D supplements should not be used as a substitute for other measures, such as getting vaccinated and practicing good hygiene, to prevent respiratory infections.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There is evidence that suggests vitamin D supplements may help prevent respiratory infections.\n2. Vitamin D deficiency may be a factor in the prevention of respiratory infections.\n3. More research is needed to confirm the findings regarding vitamin D supplementation and the prevention of respiratory infections.\n4. Further research is necessary to determine the optimal dosage and duration of vitamin D supplementation for preventing respiratory infections.\n5. Vitamin D supplements should not be used as a substitute for vaccinations and good hygiene practices in the effort to prevent respiratory infections.",
    "yulan-chat-2-13b-fp16_fact": [
      "There is evidence that suggests vitamin D supplements may help prevent respiratory infections.",
      "Vitamin D deficiency may be a factor in the prevention of respiratory infections.",
      "More research is needed to confirm the findings regarding vitamin D supplementation and the prevention of respiratory infections.",
      "Further research is necessary to determine the optimal dosage and duration of vitamin D supplementation for preventing respiratory infections.",
      "Vitamin D supplements should not be used as a substitute for vaccinations and good hygiene practices in the effort to prevent respiratory infections."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4489,
    "user_query": "what about getting gas from beans ?",
    "yulan-chat-2-13b-fp16_response": "It is possible to extract methane gas from beans, but it is not a commercially viable or practical method for producing fuel. The process of extracting methane from beans involves breaking down the organic matter in the beans through a process called anaerobic digestion, which produces methane gas as a byproduct. However, this process is much less efficient and produces less gas compared to other methods of producing methane, such as using agricultural waste or manure. Additionally, the use of beans as a fuel source would require a significant amount of land and resources to produce enough beans to make a significant impact on fuel production.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Methane gas can be extracted from beans through a process called anaerobic digestion.\n2. Anaerobic digestion of beans leads to the production of methane gas as a byproduct.\n3. The process of extracting methane from beans is less efficient compared to other methods such as using agricultural waste or manure.\n4. Producing methane gas from beans is not a commercially viable or practical method for fuel production.\n5. A significant amount of land and resources would be required to grow enough beans to have a substantial impact on fuel production.",
    "yulan-chat-2-13b-fp16_fact": [
      "Methane gas can be extracted from beans through a process called anaerobic digestion.",
      "Anaerobic digestion of beans leads to the production of methane gas as a byproduct.",
      "The process of extracting methane from beans is less efficient compared to other methods such as using agricultural waste or manure.",
      "Producing methane gas from beans is not a commercially viable or practical method for fuel production.",
      "A significant amount of land and resources would be required to grow enough beans to have a substantial impact on fuel production."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nWhile the specifics of efficiency and commercial viability may vary and could be subject to ongoing research and technological improvements, at the time of the knowledge cutoff, it is generally accepted that directly using food crops like beans for biofuel production is less efficient and practical compared to other biomass sources such as agricultural waste or manure. Additionally, dedicating significant land and resources to grow crops solely for fuel production can have adverse effects on food supply and land use.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4493,
    "user_query": "where does the fat come from in a skinless chicken breast ?",
    "yulan-chat-2-13b-fp16_response": "The fat in a skinless chicken breast comes from the connective tissue and muscle fibers in the meat. Chickens, like all animals, have a layer of fat under their skin that helps to insulate and protect their organs. When a chicken is slaughtered, this fat can be removed from the skin and left on the breast, or it can be trimmed off to create a skinless breast. The fat that is left on the breast can be beneficial, as it adds flavor and tenderness to the meat. However, if you are trying to reduce your fat intake, it is best to remove as much of the fat as possible before cooking.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The fat in a skinless chicken breast originates from the connective tissue and muscle fibers within the meat.\n2. Chickens have a layer of fat under their skin that serves as insulation and protection for their organs.\n3. The fat under a chicken's skin can be removed when it is slaughtered.\n4. Fat can be left on the breast after skin removal or trimmed off to produce a skinless chicken breast.\n5. Remaining fat on the chicken breast can contribute to the flavor and tenderness of the meat.",
    "yulan-chat-2-13b-fp16_fact": [
      "The fat in a skinless chicken breast originates from the connective tissue and muscle fibers within the meat.",
      "Chickens have a layer of fat under their skin that serves as insulation and protection for their organs.",
      "The fat under a chicken's skin can be removed when it is slaughtered.",
      "Fat can be left on the breast after skin removal or trimmed off to produce a skinless chicken breast.",
      "Remaining fat on the chicken breast can contribute to the flavor and tenderness of the meat."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4494,
    "user_query": "what is the recommended child requirement for vitamin d ?",
    "yulan-chat-2-13b-fp16_response": "The recommended daily intake of vitamin D for children varies depending on their age and gender. According to the National Institutes of Health (NIH), the recommended dietary allowances (RDAs) for vitamin D are:\n* Infants (0-12 months): 400 IU per day\n* Children (1-13 years): 600 IU per day\n* Adolescents (14-18 years): 600-800 IU per day\nIt's important to note that these are the minimum recommended intakes and that some experts believe that higher intakes may be necessary for optimal health. Additionally, it's important to talk to a healthcare provider before giving a child any supplements, including vitamin D.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Infants from 0 to 12 months are recommended to have a daily vitamin D intake of 400 IU.\n2. Children aged 1 to 13 years are recommended to have a daily vitamin D intake of 600 IU.\n3. Adolescents aged 14 to 18 years are recommended to have a daily vitamin D intake of 600 to 800 IU.\n4. The extracted recommendations were made by the National Institutes of Health (NIH).\n5. Healthcare providers should be consulted before giving children vitamin D supplements.",
    "yulan-chat-2-13b-fp16_fact": [
      "Infants from 0 to 12 months are recommended to have a daily vitamin D intake of 400 IU.",
      "Children aged 1 to 13 years are recommended to have a daily vitamin D intake of 600 IU.",
      "Adolescents aged 14 to 18 years are recommended to have a daily vitamin D intake of 600 to 800 IU.",
      "The extracted recommendations were made by the National Institutes of Health (NIH).",
      "Healthcare providers should be consulted before giving children vitamin D supplements."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4495,
    "user_query": "what is the definition of a \" handful \" serving of nuts ?",
    "yulan-chat-2-13b-fp16_response": "A \"handful\" serving of nuts is typically defined as a portion that can fit comfortably in the palm of your hand. The exact amount can vary depending on the type of nut and the size of your hand, but a general rule of thumb is that a handful of nuts is about 1.5 ounces or 40-45 nuts. This is a serving size that is often used in nutrition guidelines and can help you control your portion sizes and maintain a healthy diet.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A \"handful\" serving of nuts is a portion that fits in the palm of one's hand.\n2. The amount in a \"handful\" serving may vary depending on nut type and hand size.\n3. A handful of nuts is approximately 1.5 ounces.\n4. A handful of nuts is estimated to be around 40-45 nuts.\n5. The \"handful\" serving size is used in nutrition guidelines for portion control.",
    "yulan-chat-2-13b-fp16_fact": [
      "A \"handful\" serving of nuts is a portion that fits in the palm of one's hand.",
      "The amount in a \"handful\" serving may vary depending on nut type and hand size.",
      "A handful of nuts is approximately 1.5 ounces.",
      "A handful of nuts is estimated to be around 40-45 nuts.",
      "The \"handful\" serving size is used in nutrition guidelines for portion control."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: A handful of nuts is approximately 1 ounce (28 grams), but the exact amount may vary depending on the size of one's hand and the type of nuts.\n4. FALSE [correction]: The amount of nuts in a handful can vary widely depending on the type of nut, as some nuts are much larger than others. It's not accurate to estimate a specific number without specifying the type of nuts.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 4511,
    "user_query": "can hot peppers ( capsaicin ) cause cancer ?",
    "yulan-chat-2-13b-fp16_response": "There is no evidence to suggest that consuming hot peppers or capsaicin, the active ingredient in hot peppers, causes cancer. In fact, some studies have suggested that capsaicin may have anti-cancer properties. However, it is important to note that consuming large amounts of hot peppers may cause irritation or burns to the mouth and throat.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There is no evidence that consuming hot peppers or capsaicin causes cancer.\n2. Some studies have suggested that capsaicin may have anti-cancer properties.\n3. Consuming large amounts of hot peppers may cause irritation or burns to the mouth and throat.",
    "yulan-chat-2-13b-fp16_fact": [
      "There is no evidence that consuming hot peppers or capsaicin causes cancer.",
      "Some studies have suggested that capsaicin may have anti-cancer properties.",
      "Consuming large amounts of hot peppers may cause irritation or burns to the mouth and throat."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4513,
    "user_query": "is thermography better than mammograms for early breast cancer detection ?",
    "yulan-chat-2-13b-fp16_response": "Thermography and mammography are both imaging techniques used for breast cancer screening, but they work in different ways and have different strengths and weaknesses.\nMammography is the standard method for breast cancer screening and is considered the gold standard for detecting breast cancer in its early stages. It uses low-energy X-rays to produce detailed images of the breast tissue. Mammography can detect small lumps or calcifications in the breast tissue that may be indicative of breast cancer.\nThermography, on the other hand, uses infrared technology to detect changes in body temperature that may indicate the presence of breast cancer. It does not use ionizing radiation like mammography, which is a potential advantage. However, thermography is not as effective as mammography in detecting breast cancer in its early stages.\nWhile thermography may be useful for detecting heat patterns that could indicate the presence of breast cancer, it is not a substitute for mammography. The American Cancer Society recommends that women at average risk for breast cancer should have a mammogram every year starting at age 40. Women with a higher risk for breast cancer may need to start screening at an earlier age or have more frequent mammograms.\nIn summary, while thermography may have some potential advantages over mammography, it is not considered a substitute for mammography for breast cancer screening. Mammography remains the most effective method for detecting breast cancer in its early stages.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Mammography is considered the gold standard for detecting breast cancer in its early stages.\n2. Mammography uses low-energy X-rays to produce detailed images of the breast tissue.\n3. Thermography uses infrared technology to detect changes in body temperature that could indicate breast cancer.\n4. Thermography is not as effective as mammography in detecting early-stage breast cancer.\n5. The American Cancer Society recommends that women at average risk for breast cancer should have a mammogram every year starting at age 40.",
    "yulan-chat-2-13b-fp16_fact": [
      "Mammography is considered the gold standard for detecting breast cancer in its early stages.",
      "Mammography uses low-energy X-rays to produce detailed images of the breast tissue.",
      "Thermography uses infrared technology to detect changes in body temperature that could indicate breast cancer.",
      "Thermography is not as effective as mammography in detecting early-stage breast cancer.",
      "The American Cancer Society recommends that women at average risk for breast cancer should have a mammogram every year starting at age 40."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The American Cancer Society recommends that women at average risk for breast cancer should have a mammogram every year starting at age 45, and can then switch to mammograms every other year starting at age 55. Women should also have the option to start annual screening as early as age 40 if they choose to do so. It is important to note that guidelines may change and can vary by organization, so it's always best to consult the latest guidelines or a healthcare professional.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4514,
    "user_query": "does  organic  chicken contain less arsenic ?",
    "yulan-chat-2-13b-fp16_response": "Yes, \"organic\" chicken is generally considered to contain less arsenic than conventionally raised chicken. This is because organic chickens are not given any antibiotics or growth hormones, and are instead raised in conditions that prioritize their health and well-being. As a result, they are less likely to be contaminated with harmful substances like arsenic. However, it's important to note that all chicken can potentially contain traces of arsenic, as it can be found in the feed and water that the chickens consume. To minimize your exposure to arsenic, it's recommended to choose chicken that has been raised without the use of antibiotics or growth hormones, and to cook it in a way that reduces the formation of harmful compounds.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. \"Organic\" chicken is generally considered to contain less arsenic than conventionally raised chicken.\n2. Organic chickens are not given any antibiotics or growth hormones.\n3. Organic chickens are raised in conditions that prioritize their health and well-being.\n4. All chicken can potentially contain traces of arsenic due to its presence in feed and water.\n5. It is recommended to choose chicken raised without the use of antibiotics or growth hormones to minimize exposure to arsenic.",
    "yulan-chat-2-13b-fp16_fact": [
      "\"Organic\" chicken is generally considered to contain less arsenic than conventionally raised chicken.",
      "Organic chickens are not given any antibiotics or growth hormones.",
      "Organic chickens are raised in conditions that prioritize their health and well-being.",
      "All chicken can potentially contain traces of arsenic due to its presence in feed and water.",
      "It is recommended to choose chicken raised without the use of antibiotics or growth hormones to minimize exposure to arsenic."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While choosing chicken raised without the use of antibiotics or growth hormones may address concerns about antibiotic resistance and hormone exposure, it does not specifically relate to arsenic exposure. To minimize exposure to arsenic, one should look for chickens raised on feed with low arsenic content or chickens that are specifically tested for low arsenic levels.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4515,
    "user_query": "are there any risks of excess vitamin b12 consumption ?",
    "yulan-chat-2-13b-fp16_response": "Yes, there are some risks associated with excessive consumption of vitamin B12. While it is generally considered safe to take high doses of vitamin B12, there are some potential risks to be aware of.\nOne of the main risks of excessive vitamin B12 consumption is the potential for adverse effects on the body. High doses of vitamin B12 can cause acne, rosacea, and other skin conditions, as well as high blood pressure, acne-like skin lesions, and even increased risk of heart disease.\nAdditionally, excessive vitamin B12 consumption can interfere with the body's ability to absorb other nutrients, such as iron and folate. This can lead to deficiencies in these nutrients and potentially cause health problems.\nIt's important to note that the risk of adverse effects from vitamin B12 is generally dose-dependent, meaning that the higher the dose, the greater the risk of side effects. It's generally recommended to consult with a healthcare provider before taking high doses of vitamin B12 to ensure that it is safe for you to do so.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. High doses of vitamin B12 can cause skin conditions such as acne and rosacea.\n2. Excessive consumption of vitamin B12 can lead to high blood pressure.\n3. There is an increased risk of heart disease associated with high doses of vitamin B12.\n4. Overconsumption of vitamin B12 can interfere with the absorption of other nutrients, including iron and folate.\n5. The risk of adverse effects from vitamin B12 consumption is dose-dependent.",
    "yulan-chat-2-13b-fp16_fact": [
      "High doses of vitamin B12 can cause skin conditions such as acne and rosacea.",
      "Excessive consumption of vitamin B12 can lead to high blood pressure.",
      "There is an increased risk of heart disease associated with high doses of vitamin B12.",
      "Overconsumption of vitamin B12 can interfere with the absorption of other nutrients, including iron and folate.",
      "The risk of adverse effects from vitamin B12 consumption is dose-dependent."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: While there are various health considerations associated with nutrient intake, there's no direct evidence that excessive consumption of vitamin B12 leads to high blood pressure.\n3. FALSE [correction]: There is no clear evidence that high doses of vitamin B12 increase the risk of heart disease. Some studies suggest the opposite, as B12 is essential for heart health, though elevated levels of B12 have been associated with an increased risk of some conditions in some studies.\n4. TRUE (However, this is generally a concern only in the case of significant imbalance or underlying health conditions).\n5. TRUE (The risk of adverse effects can be dose-dependent, but for vitamin B12, toxicity is quite rare due to its water-soluble nature, except in very specific circumstances or in individuals with certain health conditions).",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4516,
    "user_query": "how do you achieve a good omega 3 to omega 6 fatty acid ratio ?",
    "yulan-chat-2-13b-fp16_response": "Achieving a good omega-3 to omega-6 fatty acid ratio is important for maintaining good health, as these fatty acids play a crucial role in various bodily functions. The ideal ratio of omega-3 to omega-6 fatty acids is a matter of debate, but a generally accepted range is between 1:1 and 1:4.\nTo achieve a good omega-3 to omega-6 fatty acid ratio, you can follow these tips:\n1. Increase your intake of omega-3 rich foods: Foods rich in omega-3 fatty acids include fatty fish (such as salmon, mackerel, and sardines), flaxseeds, chia seeds, walnuts, and soybean oil.\n2. Decrease your intake of omega-6 rich foods: Foods rich in omega-6 fatty acids include vegetable oils (such as corn, safflower, and sunflower oil), nuts, and seeds. While these foods are not bad in and of themselves, it's important to consume them in moderation to maintain a healthy balance.\n3. Choose leaner cuts of meat: Choosing leaner cuts of meat, such as chicken breast or turkey breast, can help reduce your intake of omega-6 fatty acids.\n4. Avoid processed foods: Processed foods often contain high levels of omega-6 fatty acids, as they are used in the manufacturing process. Avoiding processed foods can help you maintain a healthier balance of omega-3 to omega-6 fatty acids.\n5. Consider supplementing with omega-3s: If you find it difficult to achieve a good balance through diet alone, you may want to consider supplementing with omega-3 fatty acids. However, it's important to talk to your healthcare provider before starting any supplements.\nRemember, achieving a good omega-3 to omega-6 fatty acid ratio is just one aspect of a healthy diet. It's also important to consume a variety of nutrient-dense foods and maintain a healthy lifestyle overall.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A generally accepted range for the ideal ratio of omega-3 to omega-6 fatty acids is between 1:1 and 1:4.\n2. Foods rich in omega-3 fatty acids include fatty fish like salmon, mackerel, and sardines, as well as flaxseeds, chia seeds, walnuts, and soybean oil.\n3. Foods high in omega-6 fatty acids include vegetable oils like corn, safflower, and sunflower oil, in addition to nuts and seeds.\n4. Leaner cuts of meat, such as chicken breast or turkey breast, have lower levels of omega-6 fatty acids.\n5. Processed foods often contain high levels of omega-6 fatty acids.",
    "yulan-chat-2-13b-fp16_fact": [
      "A generally accepted range for the ideal ratio of omega-3 to omega-6 fatty acids is between 1:1 and 1:4.",
      "Foods rich in omega-3 fatty acids include fatty fish like salmon, mackerel, and sardines, as well as flaxseeds, chia seeds, walnuts, and soybean oil.",
      "Foods high in omega-6 fatty acids include vegetable oils like corn, safflower, and sunflower oil, in addition to nuts and seeds.",
      "Leaner cuts of meat, such as chicken breast or turkey breast, have lower levels of omega-6 fatty acids.",
      "Processed foods often contain high levels of omega-6 fatty acids."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4518,
    "user_query": "how long to avoid fish before conception ?",
    "yulan-chat-2-13b-fp16_response": "It is recommended to avoid consuming fish that are high in mercury for at least two to three months before trying to conceive. Mercury is a toxic substance that can harm the developing fetus and negatively impact the health of the mother. Some of the fish that are high in mercury include tuna, swordfish, king mackerel, and shark. It is important to consult with a healthcare provider or a nutritionist for specific recommendations on which fish to avoid and which ones are safe to consume during pregnancy.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. It is recommended to avoid consuming fish high in mercury for at least two to three months before trying to conceive.\n2. Mercury is a toxic substance that can harm a developing fetus.\n3. High levels of mercury can negatively impact the health of the mother.\n4. Fish that are high in mercury include tuna, swordfish, king mackerel, and shark.",
    "yulan-chat-2-13b-fp16_fact": [
      "It is recommended to avoid consuming fish high in mercury for at least two to three months before trying to conceive.",
      "Mercury is a toxic substance that can harm a developing fetus.",
      "High levels of mercury can negatively impact the health of the mother.",
      "Fish that are high in mercury include tuna, swordfish, king mackerel, and shark."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4522,
    "user_query": "are canned beans as healthy as home cooked ?",
    "yulan-chat-2-13b-fp16_response": "Canned beans can be a convenient and nutritious option, but they may not be as healthy as home-cooked beans. This is because canned beans often contain added salt and/or sugar, and the canning process can reduce the content of some vitamins and minerals.\nHome-cooked beans, on the other hand, allow you to control the ingredients and seasonings, so you can avoid added salt and sugar and ensure that the beans are cooked with the right ratio of water to beans. Additionally, home-cooked beans retain more of their original nutrients compared to canned beans.\nHowever, canned beans can still be a good source of protein, fiber, and other nutrients, especially if you choose low-sodium and no-sugar-added options. It's also important to note that canned beans are a convenient and affordable option for those who don't have time or resources to cook beans from scratch.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Canned beans often contain added salt and/or sugar.\n2. The canning process can reduce the content of some vitamins and minerals in beans.\n3. Home-cooked beans allow for control over ingredients and seasonings.\n4. Home-cooked beans retain more of their original nutrients compared to canned beans.\n5. Canned beans can be a good source of protein, fiber, and other nutrients when low-sodium and no-sugar-added options are chosen.",
    "yulan-chat-2-13b-fp16_fact": [
      "Canned beans often contain added salt and/or sugar.",
      "The canning process can reduce the content of some vitamins and minerals in beans.",
      "Home-cooked beans allow for control over ingredients and seasonings.",
      "Home-cooked beans retain more of their original nutrients compared to canned beans.",
      "Canned beans can be a good source of protein, fiber, and other nutrients when low-sodium and no-sugar-added options are chosen."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4525,
    "user_query": "does animal protein cause osteoporosis ?",
    "yulan-chat-2-13b-fp16_response": "No, animal protein alone does not cause osteoporosis. Osteoporosis is a condition characterized by a loss of bone density and strength, leading to an increased risk of fractures. While consuming a diet high in animal protein may increase the risk of developing osteoporosis, it is not the sole cause.\nThere are several factors that can contribute to the development of osteoporosis, including:\n1. Hormonal imbalances: A decrease in estrogen levels in women and testosterone levels in men can lead to bone loss.\n2. Lack of physical activity: Weight-bearing exercise is essential for maintaining bone density.\n3. Poor nutrition: A diet deficient in calcium, vitamin D, and other essential nutrients can contribute to bone loss.\n4. Age: As we age, our bones naturally lose density.\n5. Medications: Certain medications, such as corticosteroids, can interfere with bone metabolism.\nWhile animal protein can provide essential amino acids that are important for bone health, it is not the only factor to consider. A balanced diet that includes adequate amounts of calcium, vitamin D, and other essential nutrients, as well as regular weight-bearing exercise, is important for maintaining strong bones and preventing osteoporosis.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Osteoporosis is characterized by a loss of bone density and strength, which increases the risk of fractures.\n2. A decrease in estrogen levels in women and testosterone levels in men can contribute to bone loss.\n3. Weight-bearing exercise is essential for maintaining bone density.\n4. A diet deficient in calcium, vitamin D, and other essential nutrients contributes to bone loss.\n5. Certain medications, such as corticosteroids, can interfere with bone metabolism.",
    "yulan-chat-2-13b-fp16_fact": [
      "Osteoporosis is characterized by a loss of bone density and strength, which increases the risk of fractures.",
      "A decrease in estrogen levels in women and testosterone levels in men can contribute to bone loss.",
      "Weight-bearing exercise is essential for maintaining bone density.",
      "A diet deficient in calcium, vitamin D, and other essential nutrients contributes to bone loss.",
      "Certain medications, such as corticosteroids, can interfere with bone metabolism."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4540,
    "user_query": "which parts of the mediterranean diet extended life ?",
    "yulan-chat-2-13b-fp16_response": "The Mediterranean diet has been associated with a number of health benefits, including an increased lifespan. The diet is characterized by a high intake of fruits, vegetables, whole grains, legumes, nuts, and healthy fats, such as olive oil, and a low intake of red meat and processed foods.\nResearch has shown that the Mediterranean diet may help to reduce the risk of chronic diseases, such as heart disease, stroke, and certain types of cancer, which are leading causes of death in many countries. The diet has also been linked to a lower risk of cognitive decline and dementia in older adults.\nIt's important to note that the Mediterranean diet is not a magic bullet for extending life, and there are many other factors that can impact lifespan, such as genetics, lifestyle, and access to healthcare. However, following a healthy diet like the Mediterranean diet can be an important part of a overall strategy for promoting health and well-being throughout life.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Mediterranean diet is rich in fruits, vegetables, whole grains, legumes, nuts, and healthy fats such as olive oil.\n2. The Mediterranean diet includes a low intake of red meat and processed foods.\n3. The Mediterranean diet may help to reduce the risk of chronic diseases like heart disease and stroke.\n4. The Mediterranean diet has been linked to a lower risk of certain types of cancer.\n5. The Mediterranean diet is associated with a lower risk of cognitive decline and dementia in older adults.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Mediterranean diet is rich in fruits, vegetables, whole grains, legumes, nuts, and healthy fats such as olive oil.",
      "The Mediterranean diet includes a low intake of red meat and processed foods.",
      "The Mediterranean diet may help to reduce the risk of chronic diseases like heart disease and stroke.",
      "The Mediterranean diet has been linked to a lower risk of certain types of cancer.",
      "The Mediterranean diet is associated with a lower risk of cognitive decline and dementia in older adults."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4541,
    "user_query": "predimed : does eating nuts prevent strokes ?",
    "yulan-chat-2-13b-fp16_response": "There is evidence to suggest that eating nuts may help to prevent strokes. Nuts are a good source of healthy fats, fiber, and various vitamins and minerals, and research has shown that they may help to lower the risk of developing cardiovascular disease, which is a leading cause of stroke.\nStudies have found that people who eat nuts regularly have a lower risk of developing cardiovascular disease than those who do not. Nuts have been shown to help lower levels of harmful LDL cholesterol, reduce inflammation, and improve blood pressure, all of which are risk factors for cardiovascular disease.\nIn addition, nuts are high in antioxidants, which can help to protect the body against the damage caused by free radicals. Free radicals are unstable molecules that can damage cells and contribute to the development of chronic diseases, including stroke.\nIt is important to note that nuts are high in calories, so it is important to eat them in moderation as part of a healthy diet. Additionally, it is always a good idea to speak with a healthcare provider before making any significant changes to your diet.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Nuts may help to lower the risk of developing cardiovascular disease.\n2. Regular consumption of nuts is associated with a lower risk of cardiovascular disease compared to those who do not eat nuts.\n3. Nuts can help lower levels of harmful LDL cholesterol.\n4. Nuts have properties that reduce inflammation and improve blood pressure.\n5. Nuts are high in antioxidants that protect against damage from free radicals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Nuts may help to lower the risk of developing cardiovascular disease.",
      "Regular consumption of nuts is associated with a lower risk of cardiovascular disease compared to those who do not eat nuts.",
      "Nuts can help lower levels of harmful LDL cholesterol.",
      "Nuts have properties that reduce inflammation and improve blood pressure.",
      "Nuts are high in antioxidants that protect against damage from free radicals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nNuts are generally recognized as a heart-healthy food when consumed in moderation as part of a balanced diet. They are indeed associated with lowering the risk of cardiovascular disease, reducing levels of LDL cholesterol, exhibiting anti-inflammatory properties, improving blood pressure, and they are a source of antioxidants.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4548,
    "user_query": "why do vegan women have 5x fewer twins ?",
    "yulan-chat-2-13b-fp16_response": "There is no scientific evidence to support the claim that vegan women have five times fewer twins than non-vegan women. In fact, there is no clear evidence that diet has any significant effect on the likelihood of having twins. While it is true that some studies have found a slightly lower incidence of twins among vegan women compared to non-vegan women, the difference is not as large as five times. It is important to note that the incidence of twins is influenced by many factors, including genetics, age, and environmental factors, and it is not clear how diet fits into this picture.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There is no scientific evidence to support the claim that vegan women have five times fewer twins than non-vegan women.\n2. Some studies have found a slightly lower incidence of twins among vegan women compared to non-vegan women.\n3. The incidence of twins is influenced by factors including genetics, age, and environmental factors.\n4. There is no clear evidence that diet has a significant effect on the likelihood of having twins.",
    "yulan-chat-2-13b-fp16_fact": [
      "There is no scientific evidence to support the claim that vegan women have five times fewer twins than non-vegan women.",
      "Some studies have found a slightly lower incidence of twins among vegan women compared to non-vegan women.",
      "The incidence of twins is influenced by factors including genetics, age, and environmental factors.",
      "There is no clear evidence that diet has a significant effect on the likelihood of having twins."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Some scientific evidence suggests that vegan women may have a lower incidence of twins, possibly due to lower levels of insulin-like growth factor (IGF) linked to animal protein consumption.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While there is no consensus on the extent of the effect, some evidence indicates that diet, along with genetics, age, and environmental factors, could influence the likelihood of having twins. For example, higher levels of dairy consumption have been correlated with increased rates of twin births, potentially attributable to the growth hormones found in animal products.",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4554,
    "user_query": "is there too much aluminum in tea ?",
    "yulan-chat-2-13b-fp16_response": "There is no definitive answer to whether there is too much aluminum in tea, as the amount of aluminum in tea can vary depending on a number of factors, such as the type of tea, the location and conditions in which it was grown, and the processing methods used.\nHowever, it is worth noting that tea is generally considered to be a safe and healthy beverage, and there is no evidence to suggest that the levels of aluminum found in tea pose a significant health risk to most people.\nThat being said, some studies have suggested that consuming high levels of aluminum over a long period of time may be linked to certain health problems, such as Alzheimer's disease and other forms of dementia. However, the evidence for this is not conclusive, and more research is needed to fully understand the potential health effects of aluminum in tea and other foods.\nIf you are concerned about the aluminum content of your tea, you may want to consider choosing teas that are grown and processed in ways that are known to reduce aluminum absorption, such as using filtered water, avoiding tea that is heavily fermented or processed, and choosing teas that are high in compounds that bind to aluminum and help to reduce its absorption.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The amount of aluminum in tea can vary based on factors including the type of tea, its growing conditions, and processing methods.\n2. Tea is generally considered a safe and healthy beverage.\n3. There is no evidence indicating that the levels of aluminum found in tea are a significant health risk to most people.\n4. Some studies have suggested a potential link between high levels of aluminum consumption over time and health issues such as Alzheimer's disease and other forms of dementia.\n5. Choosing teas grown and processed to reduce aluminum absorption and using filtered water can help decrease aluminum intake from tea.",
    "yulan-chat-2-13b-fp16_fact": [
      "The amount of aluminum in tea can vary based on factors including the type of tea, its growing conditions, and processing methods.",
      "Tea is generally considered a safe and healthy beverage.",
      "There is no evidence indicating that the levels of aluminum found in tea are a significant health risk to most people.",
      "Some studies have suggested a potential link between high levels of aluminum consumption over time and health issues such as Alzheimer's disease and other forms of dementia.",
      "Choosing teas grown and processed to reduce aluminum absorption and using filtered water can help decrease aluminum intake from tea."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE - The consensus among health authorities is that the aluminum levels in tea are generally not considered to be a significant health risk for most people.\n4. TRUE - While there is ongoing research and debate about the impact of aluminum on health, some studies have indeed suggested a potential link between high levels of aluminum consumption and neurological health issues.\n5. TRUE - Selecting teas known for lower aluminum levels and using filtered water may help reduce aluminum intake from tea.",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4555,
    "user_query": "does meditation affect cellular aging ?",
    "yulan-chat-2-13b-fp16_response": "There is some evidence to suggest that meditation may have an impact on cellular aging. Studies have shown that meditation can reduce the levels of stress hormones in the body, which can help to slow down the process of cellular aging. Additionally, meditation has been shown to improve the function of the immune system, which can also help to slow down the process of cellular aging. However, more research is needed to fully understand the relationship between meditation and cellular aging.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Studies have shown that meditation can reduce the levels of stress hormones in the body.\n2. Reduced stress hormone levels may help to slow down the process of cellular aging.\n3. Meditation has been shown to improve the function of the immune system.\n4. The improved immune system function can help to slow down cellular aging.\n5. More research is needed to fully understand the relationship between meditation and cellular aging.",
    "yulan-chat-2-13b-fp16_fact": [
      "Studies have shown that meditation can reduce the levels of stress hormones in the body.",
      "Reduced stress hormone levels may help to slow down the process of cellular aging.",
      "Meditation has been shown to improve the function of the immune system.",
      "The improved immune system function can help to slow down cellular aging.",
      "More research is needed to fully understand the relationship between meditation and cellular aging."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4556,
    "user_query": "is gluten sensitivity real ?",
    "yulan-chat-2-13b-fp16_response": "Yes, gluten sensitivity is a real condition. It is a medical condition in which a person has a non-celiac response to gluten, a protein found in wheat, barley, and rye. This can cause a range of symptoms, including abdominal pain, bloating, diarrhea, and fatigue. However, it is important to note that gluten sensitivity is not the same as celiac disease, which is a serious autoimmune disorder that can cause damage to the small intestine if left untreated.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gluten sensitivity is a medical condition characterized by a non-celiac response to gluten.\n2. Gluten is a protein found in wheat, barley, and rye.\n3. Symptoms of gluten sensitivity can include abdominal pain, bloating, diarrhea, and fatigue.\n4. Gluten sensitivity is different from celiac disease, which is an autoimmune disorder.\n5. Untreated celiac disease can cause damage to the small intestine.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gluten sensitivity is a medical condition characterized by a non-celiac response to gluten.",
      "Gluten is a protein found in wheat, barley, and rye.",
      "Symptoms of gluten sensitivity can include abdominal pain, bloating, diarrhea, and fatigue.",
      "Gluten sensitivity is different from celiac disease, which is an autoimmune disorder.",
      "Untreated celiac disease can cause damage to the small intestine."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4562,
    "user_query": "fruits , veggies , and longevity : how many minutes per mouthful ?",
    "yulan-chat-2-13b-fp16_response": "It's difficult to determine an exact number of minutes per mouthful for fruits and vegetables in relation to longevity, as there are many factors that can impact lifespan, including genetics, lifestyle, and overall health. However, research has shown that a diet rich in fruits and vegetables can have numerous health benefits, including reducing the risk of chronic diseases such as heart disease, cancer, and diabetes.\nEating a variety of fruits and vegetables can provide essential nutrients, fiber, and antioxidants that are important for maintaining good health. While it's difficult to quantify the exact amount of time that eating fruits and vegetables can add to your lifespan, making them a regular part of your diet can certainly have a positive impact on your overall health and well-being.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. A diet rich in fruits and vegetables can reduce the risk of chronic diseases such as heart disease, cancer, and diabetes.\n2. Fruits and vegetables provide essential nutrients, fiber, and antioxidants.\n3. Eating a variety of fruits and vegetables is important for maintaining good health.",
    "yulan-chat-2-13b-fp16_fact": [
      "A diet rich in fruits and vegetables can reduce the risk of chronic diseases such as heart disease, cancer, and diabetes.",
      "Fruits and vegetables provide essential nutrients, fiber, and antioxidants.",
      "Eating a variety of fruits and vegetables is important for maintaining good health."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4571,
    "user_query": "should we take a multivitamin ?",
    "yulan-chat-2-13b-fp16_response": "Whether or not to take a multivitamin is a personal decision that depends on your individual needs and preferences. Some people may benefit from taking a multivitamin, particularly if they have a diet that is lacking in certain nutrients or if they have a medical condition that affects their ability to absorb nutrients from food. However, others may not need to take a multivitamin and may even experience negative health effects from taking certain types of supplements.\nIt's important to talk to your healthcare provider before starting to take any supplements, including multivitamins. They can help you determine if a multivitamin is right for you and recommend a specific product if necessary. It's also important to follow the recommended dosage on the supplement label and to be aware of any potential interactions with other medications you may be taking.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4576,
    "user_query": "canned beans or cooked beans ?",
    "yulan-chat-2-13b-fp16_response": "Canned beans and cooked beans can both be used in recipes, but there are some differences to consider.\nCanned beans are convenient and can be used in recipes without any additional preparation. They are also a good source of protein and fiber. However, canned beans are often packed in salted water, which can add unnecessary sodium to your diet. Some people also prefer to use dried beans and cook them themselves, as this allows them to control the amount of sodium and seasonings used.\nCooked beans, whether homemade or store-bought, are a healthy addition to many dishes. They are a good source of protein, fiber, and various vitamins and minerals. Cooked beans are also more versatile than canned beans, as they can be seasoned and used in a variety of dishes.\nUltimately, the choice between canned beans and cooked beans depends on personal preference and the specific recipe you are making.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Canned beans can be used in recipes without any additional preparation.\n2. Canned beans are a good source of protein and fiber.\n3. Canned beans often contain added sodium due to being packed in salted water.\n4. Cooked beans are a healthy addition to many dishes and provide protein, fiber, and various vitamins and minerals.\n5. Cooked beans can be more versatile than canned beans because they can be seasoned differently.",
    "yulan-chat-2-13b-fp16_fact": [
      "Canned beans can be used in recipes without any additional preparation.",
      "Canned beans are a good source of protein and fiber.",
      "Canned beans often contain added sodium due to being packed in salted water.",
      "Cooked beans are a healthy addition to many dishes and provide protein, fiber, and various vitamins and minerals.",
      "Cooked beans can be more versatile than canned beans because they can be seasoned differently."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4577,
    "user_query": "how many poppy seeds are too many ?",
    "yulan-chat-2-13b-fp16_response": "It is difficult to say how many poppy seeds are too many, as it depends on the specific context and purpose of the poppy seeds. Poppy seeds are used in a variety of culinary and medicinal applications, and the appropriate amount can vary depending on the intended use.\nIn general, poppy seeds are considered safe to consume in small amounts, and are often used as a spice or in baked goods. However, consuming large amounts of poppy seeds or using poppy seed extracts or concentrates can be dangerous and may have negative effects on health.\nIt is important to be cautious when using poppy seeds and to follow recommended guidelines for their use. If you have any concerns about the use of poppy seeds, it is always a good idea to consult with a healthcare professional or qualified expert.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Poppy seeds are used in culinary and medicinal applications.\n2. Poppy seeds are considered safe to consume in small amounts.\n3. Poppy seeds are often used as a spice or in baked goods.\n4. Consuming large amounts of poppy seeds can be dangerous and may have negative effects on health.\n5. It is recommended to consult with a healthcare professional or qualified expert if there are concerns about the use of poppy seeds.",
    "yulan-chat-2-13b-fp16_fact": [
      "Poppy seeds are used in culinary and medicinal applications.",
      "Poppy seeds are considered safe to consume in small amounts.",
      "Poppy seeds are often used as a spice or in baked goods.",
      "Consuming large amounts of poppy seeds can be dangerous and may have negative effects on health.",
      "It is recommended to consult with a healthcare professional or qualified expert if there are concerns about the use of poppy seeds."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4584,
    "user_query": "which fruit fights cancer better ?",
    "yulan-chat-2-13b-fp16_response": "There is no single fruit that is considered to be the best at fighting cancer. Different fruits have different nutrients and compounds that may have potential anti-cancer properties. However, many fruits are rich in vitamins, minerals, and antioxidants, which can help to protect cells from damage that can lead to cancer. Some fruits that are often recommended for their potential anti-cancer properties include berries, citrus fruits, and cruciferous vegetables such as broccoli and cauliflower. It is important to eat a variety of fruits and vegetables as part of a healthy diet to ensure that you are getting a range of nutrients and beneficial compounds.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. There is no single fruit recognized as the best at fighting cancer.\n2. Different fruits contain various nutrients and compounds with potential anti-cancer properties.\n3. Fruits rich in vitamins, minerals, and antioxidants may help protect cells from damage that can lead to cancer.\n4. Berries and citrus fruits are recommended for their potential anti-cancer properties.\n5. Cruciferous vegetables like broccoli and cauliflower are also noted for potential anti-cancer properties.",
    "yulan-chat-2-13b-fp16_fact": [
      "There is no single fruit recognized as the best at fighting cancer.",
      "Different fruits contain various nutrients and compounds with potential anti-cancer properties.",
      "Fruits rich in vitamins, minerals, and antioxidants may help protect cells from damage that can lead to cancer.",
      "Berries and citrus fruits are recommended for their potential anti-cancer properties.",
      "Cruciferous vegetables like broccoli and cauliflower are also noted for potential anti-cancer properties."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4590,
    "user_query": "can gargling prevent the common cold ?",
    "yulan-chat-2-13b-fp16_response": "Gargling with salt water can help relieve symptoms of a sore throat, which is a common symptom of the common cold. However, gargling alone is not enough to prevent the common cold. To prevent the common cold, it is important to practice good hygiene, such as washing your hands frequently and avoiding close contact with people who are sick.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Gargling with salt water can help relieve symptoms of a sore throat.\n2. A sore throat is a common symptom of the common cold.\n3. Gargling alone cannot prevent the common cold.\n4. Practicing good hygiene can help prevent the common cold.\n5. Good hygiene practices to prevent the common cold include washing hands frequently and avoiding close contact with sick individuals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Gargling with salt water can help relieve symptoms of a sore throat.",
      "A sore throat is a common symptom of the common cold.",
      "Gargling alone cannot prevent the common cold.",
      "Practicing good hygiene can help prevent the common cold.",
      "Good hygiene practices to prevent the common cold include washing hands frequently and avoiding close contact with sick individuals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4591,
    "user_query": "are cats or dogs more protective for children 's health ?",
    "yulan-chat-2-13b-fp16_response": "Both cats and dogs can be protective of children's health in different ways.\nDogs are often considered to be more protective of children because they are naturally more alert and responsive to their surroundings. They can be trained to recognize and respond to potential dangers, such as strangers approaching the house or potential hazards in the environment. Dogs can also provide a sense of security and comfort to children, which can help to reduce stress and anxiety.\nCats, on the other hand, may not be as overtly protective of children as dogs, but they can still provide health benefits. Studies have shown that exposure to pet allergens in the home can help to build immunity and reduce the risk of allergies and asthma in children. Additionally, cats are known for their calming presence and can help to reduce stress and anxiety in both children and adults.\nUltimately, the decision to get a pet for a child should be based on the individual needs and preferences of the family. It's important to consider factors such as the child's age, the family's lifestyle, and the type of pet that is best suited to the home.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dogs are often considered to be more protective of children because they are naturally more alert and responsive.\n2. Dogs can be trained to recognize and respond to potential dangers, such as strangers approaching the house.\n3. Dogs can provide a sense of security and comfort to children that may help reduce stress and anxiety.\n4. Exposure to pet allergens from cats can help build immunity and reduce the risk of allergies and asthma in children.\n5. Cats are known for their calming presence, which can help reduce stress and anxiety.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dogs are often considered to be more protective of children because they are naturally more alert and responsive.",
      "Dogs can be trained to recognize and respond to potential dangers, such as strangers approaching the house.",
      "Dogs can provide a sense of security and comfort to children that may help reduce stress and anxiety.",
      "Exposure to pet allergens from cats can help build immunity and reduce the risk of allergies and asthma in children.",
      "Cats are known for their calming presence, which can help reduce stress and anxiety."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Exposure to pet allergens from dogs (not cats) at a very early age can sometimes help build immunity and reduce the risk of allergies and asthma in children.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4613,
    "user_query": "better than green tea ?",
    "yulan-chat-2-13b-fp16_response": "It is subjective to determine if matcha is better than green tea, as both have unique health benefits and flavor profiles. Matcha is a finely ground powder made from green tea leaves, while green tea is made from steeping whole tea leaves in hot water.\nMatcha is known to have a stronger flavor and contains more caffeine and antioxidants than green tea. It also has a higher concentration of L-theanine, an amino acid that promotes relaxation and may improve cognitive function.\nOn the other hand, green tea contains a variety of polyphenols and flavonoids that have been shown to have anti-inflammatory and anticancer properties. It also has a lighter flavor than matcha and can be enjoyed hot or iced.\nUltimately, the choice between matcha and green tea comes down to personal preference and individual needs. Both have health benefits and can be incorporated into a healthy diet.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Matcha is a finely ground powder made from green tea leaves.\n2. Green tea is made from steeping whole tea leaves in hot water.\n3. Matcha contains more caffeine and antioxidants than green tea.\n4. Matcha has a higher concentration of L-theanine compared to green tea.\n5. Green tea contains polyphenols and flavonoids with anti-inflammatory and anticancer properties.",
    "yulan-chat-2-13b-fp16_fact": [
      "Matcha is a finely ground powder made from green tea leaves.",
      "Green tea is made from steeping whole tea leaves in hot water.",
      "Matcha contains more caffeine and antioxidants than green tea.",
      "Matcha has a higher concentration of L-theanine compared to green tea.",
      "Green tea contains polyphenols and flavonoids with anti-inflammatory and anticancer properties."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4614,
    "user_query": "fast food : do you want fries with that lipitor ?",
    "yulan-chat-2-13b-fp16_response": "Fast food is typically known for its unhealthy and high-calorie menu items, so it would be unusual to see a promotion for fries and Lipitor, a medication used to lower cholesterol. It's important to maintain a healthy diet and exercise regularly to manage cholesterol levels, rather than relying on medication alone.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4628,
    "user_query": "are dates good for you ?",
    "yulan-chat-2-13b-fp16_response": "Dates are generally considered a healthy food option and can be a good choice as part of a balanced diet. They are a good source of fiber, vitamins, and minerals, including potassium, vitamin B6, and vitamin C.\nHowever, it's important to keep in mind that dates are also high in natural sugars, so they should be consumed in moderation as part of a balanced diet. Additionally, some people may be allergic to dates, so it's important to be aware of any potential allergic reactions before consuming them.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dates are considered a healthy food option.\n2. Dates are a good source of fiber.\n3. Dates contain potassium, vitamin B6, and vitamin C.\n4. Dates are high in natural sugars.\n5. Some people may be allergic to dates.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dates are considered a healthy food option.",
      "Dates are a good source of fiber.",
      "Dates contain potassium, vitamin B6, and vitamin C.",
      "Dates are high in natural sugars.",
      "Some people may be allergic to dates."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4629,
    "user_query": "are chili peppers good for you ?",
    "yulan-chat-2-13b-fp16_response": "Yes, chili peppers can be good for you when consumed in moderation. They are a good source of vitamins A and C, as well as potassium and capsaicin, which has been shown to have potential health benefits such as reducing inflammation and improving digestion. However, consuming large amounts of chili peppers can cause digestive discomfort.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chili peppers are a source of vitamins A and C.\n2. Chili peppers contain potassium.\n3. Capsaicin, found in chili peppers, has potential health benefits including reducing inflammation.\n4. Capsaicin is associated with improving digestion.\n5. Consuming large amounts of chili peppers can lead to digestive discomfort.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chili peppers are a source of vitamins A and C.",
      "Chili peppers contain potassium.",
      "Capsaicin, found in chili peppers, has potential health benefits including reducing inflammation.",
      "Capsaicin is associated with improving digestion.",
      "Consuming large amounts of chili peppers can lead to digestive discomfort."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4636,
    "user_query": "can cholesterol be too low ?",
    "yulan-chat-2-13b-fp16_response": "Yes, cholesterol can be too low, and this condition is called hypocholesterolemia. While high cholesterol is a well-known risk factor for heart disease, low cholesterol levels can also have negative effects on the body.\nLow cholesterol levels can cause problems with the liver, hormone production, and nerve function. In rare cases, severe low cholesterol levels can lead to muscle weakness, fatigue, and even heart failure.\nHowever, it's important to note that most people don't need to worry about having low cholesterol levels. Low-density lipoprotein (LDL) cholesterol, the \"bad\" cholesterol, is more of a concern because it can build up in the arteries and lead to heart disease. A total cholesterol level below 150 mg/dL is generally considered low, but this may not be a problem for everyone.\nIf you're concerned about your cholesterol levels, it's important to speak with your doctor. They can help you determine what your cholesterol levels should be and what steps you can take to improve your overall health.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Cholesterol can be too low, a condition known as hypocholesterolemia.\n2. Low cholesterol levels can negatively affect liver function.\n3. Low cholesterol levels can lead to issues with hormone production.\n4. Low cholesterol levels can impact nerve function.\n5. A total cholesterol level below 150 mg/dL is generally considered low.",
    "yulan-chat-2-13b-fp16_fact": [
      "Cholesterol can be too low, a condition known as hypocholesterolemia.",
      "Low cholesterol levels can negatively affect liver function.",
      "Low cholesterol levels can lead to issues with hormone production.",
      "Low cholesterol levels can impact nerve function.",
      "A total cholesterol level below 150 mg/dL is generally considered low."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Low cholesterol does not directly affect liver function; rather, the liver is typically the organ that manufactures cholesterol. Issues with liver function can affect cholesterol levels, not the other way around.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4643,
    "user_query": "toxins in cooked potatoes ?",
    "yulan-chat-2-13b-fp16_response": "Cooked potatoes can contain toxins, specifically, solanine and chaconine. These toxins are naturally occurring in the potato plant and can accumulate in the tubers, especially in green areas where the plant may have been exposed to too much sunlight.\nSolanine is a glycoalkaloid toxin that is found in all parts of the potato plant, but is particularly concentrated in the green areas. It is a bitter, white, crystalline substance that can cause vomiting, diarrhea, and headaches if ingested in large amounts.\nChaconine is another glycoalkaloid toxin that is also found in potatoes. It is less toxic than solanine but can still cause digestive problems if consumed in large amounts.\nTo minimize the risk of toxicity, it is recommended to avoid eating green areas of potatoes and to cook potatoes thoroughly before consuming them. Boiling, baking, or frying potatoes can help to reduce the levels of toxins. It is also important to not store potatoes with other fruits and vegetables, as they can transfer toxins to other foods.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Solanine and chaconine are toxins that can be found in cooked potatoes.\n2. Solanine and chaconine accumulate especially in the green areas of potatoes.\n3. Solanine is a glycoalkaloid toxin concentrated in the green areas of the potato plant.\n4. Chaconine is a glycoalkaloid toxin found in potatoes and is less toxic than solanine.\n5. To reduce toxin levels, it is recommended to avoid eating green areas of potatoes and to cook potatoes thoroughly.",
    "yulan-chat-2-13b-fp16_fact": [
      "Solanine and chaconine are toxins that can be found in cooked potatoes.",
      "Solanine and chaconine accumulate especially in the green areas of potatoes.",
      "Solanine is a glycoalkaloid toxin concentrated in the green areas of the potato plant.",
      "Chaconine is a glycoalkaloid toxin found in potatoes and is less toxic than solanine.",
      "To reduce toxin levels, it is recommended to avoid eating green areas of potatoes and to cook potatoes thoroughly."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Solanine and chaconine are toxins that can be found in potatoes, but cooking reduces their levels.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Chaconine is a glycoalkaloid toxin found in potatoes, but it is not necessarily less toxic than solanine; the toxicity of both compounds can vary and depend on several factors.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4660,
    "user_query": "is chlorella good for you ?",
    "yulan-chat-2-13b-fp16_response": "Yes, chlorella is considered to be good for you. Chlorella is a type of single-celled freshwater algae that is often used as a dietary supplement. It is rich in nutrients, including protein, vitamins, and minerals, and is a good source of chlorophyll. Some people believe that chlorella may have health benefits, such as improving digestion, boosting the immune system, and detoxifying the body. However, more research is needed to confirm these potential benefits. It is important to talk to a healthcare provider before taking chlorella supplements, as they can interact with certain medications and may cause side effects in some people.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Chlorella is a type of single-celled freshwater algae.\n2. Chlorella is used as a dietary supplement.\n3. Chlorella is rich in nutrients, including protein, vitamins, and minerals.\n4. Chlorella is a good source of chlorophyll.\n5. Taking chlorella can interact with certain medications.",
    "yulan-chat-2-13b-fp16_fact": [
      "Chlorella is a type of single-celled freshwater algae.",
      "Chlorella is used as a dietary supplement.",
      "Chlorella is rich in nutrients, including protein, vitamins, and minerals.",
      "Chlorella is a good source of chlorophyll.",
      "Taking chlorella can interact with certain medications."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4677,
    "user_query": "is msg bad for you ?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I'm not sure what you are asking. \"msg\" could refer to many different things, and without more context, I cannot provide a specific answer.\nIn general, however, \"msg\" is not inherently bad for you. It could refer to a message or a communication, which are generally considered to be beneficial for human communication and interaction.\nIf you are asking about a specific product or substance that is labeled as \"msg,\" it is important to understand that the safety and potential health effects of any product or substance depend on a variety of factors, including the ingredients, the intended use, and the individual user's health status and sensitivities.\nTherefore, it is always a good idea to carefully read labels and instructions, and to consult with a healthcare professional if you have any concerns about a particular product or substance.",
    "yulan-chat-2-13b-fp16_fact_raw": "NO FACTS",
    "yulan-chat-2-13b-fp16_fact": [],
    "yulan-chat-2-13b-fp16_judge": []
  },
  {
    "id": 4693,
    "user_query": "are organic foods safer ?",
    "yulan-chat-2-13b-fp16_response": "Organic foods are produced using farming practices that avoid the use of synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge. Some people believe that organic foods are safer to eat because they are free from these substances, which can be harmful to human health and the environment.\nHowever, it is important to note that there is no conclusive evidence that organic foods are inherently safer than conventionally grown foods. While organic farming practices may reduce exposure to certain chemicals, they do not necessarily make the food itself any safer to eat.\nAdditionally, some studies have suggested that organic foods may have higher levels of certain nutrients, such as antioxidants, compared to conventionally grown foods. However, the differences in nutrient levels are generally small and may not have a significant impact on human health.\nUltimately, the decision to choose organic foods is a personal one that depends on a variety of factors, including individual preferences, concerns about environmental impact, and beliefs about the health benefits of organic foods.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Organic foods are produced without the use of synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge.\n2. There is no conclusive evidence that organic foods are inherently safer than conventionally grown foods.\n3. Organic farming practices may reduce exposure to certain chemicals.\n4. Some studies suggest that organic foods may have higher levels of certain nutrients, such as antioxidants, compared to conventionally grown foods.\n5. The differences in nutrient levels between organic and conventionally grown foods are generally small.",
    "yulan-chat-2-13b-fp16_fact": [
      "Organic foods are produced without the use of synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge.",
      "There is no conclusive evidence that organic foods are inherently safer than conventionally grown foods.",
      "Organic farming practices may reduce exposure to certain chemicals.",
      "Some studies suggest that organic foods may have higher levels of certain nutrients, such as antioxidants, compared to conventionally grown foods.",
      "The differences in nutrient levels between organic and conventionally grown foods are generally small."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4696,
    "user_query": "do vegetarians get enough protein ?",
    "yulan-chat-2-13b-fp16_response": "Yes, vegetarians can get enough protein from a variety of plant-based sources. Some good sources of protein for vegetarians include beans, lentils, tofu, tempeh, nuts, seeds, and whole grains. It is important for vegetarians to include a variety of these protein sources in their diet to ensure that they are getting all of the essential amino acids that their body needs. In general, it is possible for vegetarians to get enough protein as long as they are consuming a balanced diet that includes a variety of plant-based protein sources.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vegetarians can get protein from plant-based sources.\n2. Beans, lentils, tofu, tempeh, nuts, seeds, and whole grains are good sources of protein for vegetarians.\n3. It is important for vegetarians to consume a variety of protein sources to get all essential amino acids.\n4. Vegetarians can get enough protein if they consume a balanced diet with a variety of plant-based protein sources.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vegetarians can get protein from plant-based sources.",
      "Beans, lentils, tofu, tempeh, nuts, seeds, and whole grains are good sources of protein for vegetarians.",
      "It is important for vegetarians to consume a variety of protein sources to get all essential amino acids.",
      "Vegetarians can get enough protein if they consume a balanced diet with a variety of plant-based protein sources."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4708,
    "user_query": "is dragon fruit good for you ?",
    "yulan-chat-2-13b-fp16_response": "Yes, dragon fruit is considered to be a healthy fruit. It is low in calories and high in fiber, vitamins, and antioxidants. It is a good source of vitamin C, vitamin B3, and potassium. It also contains a type of fiber called soluble fiber, which can help to lower cholesterol levels and improve digestive health. Additionally, dragon fruit has been shown to have anti-inflammatory and antioxidant properties, which may help to protect against chronic diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dragon fruit is low in calories.\n2. Dragon fruit is high in fiber.\n3. Dragon fruit is a good source of vitamin C, vitamin B3, and potassium.\n4. Dragon fruit contains soluble fiber, which can help to lower cholesterol levels and improve digestive health.\n5. Dragon fruit has anti-inflammatory and antioxidant properties.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dragon fruit is low in calories.",
      "Dragon fruit is high in fiber.",
      "Dragon fruit is a good source of vitamin C, vitamin B3, and potassium.",
      "Dragon fruit contains soluble fiber, which can help to lower cholesterol levels and improve digestive health.",
      "Dragon fruit has anti-inflammatory and antioxidant properties."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4713,
    "user_query": "is coconut milk good for you ?",
    "yulan-chat-2-13b-fp16_response": "Coconut milk can be a nutritious and healthy addition to your diet when consumed in moderation. It is a good source of healthy fats, fiber, and several essential vitamins and minerals, such as iron, potassium, and vitamin C.\nHowever, it is important to note that coconut milk is high in calories and saturated fat, which can be detrimental to your health if consumed in excess. It is also important to choose unsweetened and non-processed coconut milk to avoid added sugars and other unnecessary ingredients.\nOverall, coconut milk can be a healthy addition to a balanced diet when consumed in moderation and as part of a healthy lifestyle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Coconut milk is a source of healthy fats, fiber, iron, potassium, and vitamin C.\n2. Coconut milk is high in calories and saturated fat.\n3. Consumption of coconut milk in excess can be detrimental to your health.\n4. Unsweetened and non-processed coconut milk is preferable to avoid added sugars and unnecessary ingredients.\n5. Coconut milk can be a healthy addition to a balanced diet when consumed in moderation.",
    "yulan-chat-2-13b-fp16_fact": [
      "Coconut milk is a source of healthy fats, fiber, iron, potassium, and vitamin C.",
      "Coconut milk is high in calories and saturated fat.",
      "Consumption of coconut milk in excess can be detrimental to your health.",
      "Unsweetened and non-processed coconut milk is preferable to avoid added sugars and unnecessary ingredients.",
      "Coconut milk can be a healthy addition to a balanced diet when consumed in moderation."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Coconut milk is a source of healthy fats, fiber, iron, and potassium, but it is not a significant source of vitamin C.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4717,
    "user_query": "what do you think of dr. jenkins ' take on paleolithic diets ?",
    "yulan-chat-2-13b-fp16_response": "I'm sorry, but I am not able to browse the internet or access any information outside of my training data, so I am not able to provide an opinion on Dr. Jenkins' take on Paleolithic diets. However, I can tell you that the Paleolithic diet, also known as the \"caveman diet,\" is a diet based on the foods that people ate during the Paleolithic era, which is the period from about 2.5 million to 10,000 years ago. The diet focuses on eating whole, unprocessed foods that were available to people during this time, such as meat, fish, fruits, vegetables, and nuts. Some proponents of the diet believe that it can help people lose weight, improve their health, and reduce their risk of chronic diseases. However, there is some debate among experts about the healthfulness of the Paleolithic diet and whether it is a sustainable or balanced way of eating.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. The Paleolithic diet is also known as the \"caveman diet.\"\n2. The Paleolithic era covers the period from about 2.5 million to 10,000 years ago.\n3. The Paleolithic diet includes whole, unprocessed foods such as meat, fish, fruits, vegetables, and nuts.\n4. Proponents of the Paleolithic diet believe it can help with weight loss, health improvement, and reduction of chronic disease risk.\n5. There is some debate among experts regarding the healthfulness and sustainability of the Paleolithic diet.",
    "yulan-chat-2-13b-fp16_fact": [
      "The Paleolithic diet is also known as the \"caveman diet.\"",
      "The Paleolithic era covers the period from about 2.5 million to 10,000 years ago.",
      "The Paleolithic diet includes whole, unprocessed foods such as meat, fish, fruits, vegetables, and nuts.",
      "Proponents of the Paleolithic diet believe it can help with weight loss, health improvement, and reduction of chronic disease risk.",
      "There is some debate among experts regarding the healthfulness and sustainability of the Paleolithic diet."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4721,
    "user_query": "are krill oil supplements better than fish oil capsules ?",
    "yulan-chat-2-13b-fp16_response": "Krill oil and fish oil supplements both contain omega-3 fatty acids, which are important for heart health, brain function, and inflammation. However, there are some differences between the two that may make one more suitable for certain individuals.\nKrill oil is derived from Antarctic krill, which is a small shrimp-like creature. It contains a type of omega-3 fatty acid called EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in a more bioavailable form than fish oil. This means that the body is able to absorb and utilize the omega-3s from krill oil more easily than from fish oil.\nFish oil, on the other hand, is derived from the tissues of oily fish such as salmon, mackerel, and herring. It is a rich source of EPA and DHA, but it may not be as easily absorbed by the body as krill oil.\nIn terms of sustainability, krill oil is considered to be a more environmentally friendly option than fish oil, as krill are a more abundant and renewable resource than many fish species.\nUltimately, the choice between krill oil and fish oil supplements may depend on individual factors such as dietary restrictions, environmental concerns, and personal preferences. It is always best to consult with a healthcare professional before starting any new supplement regimen.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Krill oil contains omega-3 fatty acids EPA and DHA in a form that is more bioavailable than those in fish oil.\n2. Krill oil is derived from Antarctic krill, a small shrimp-like creature.\n3. Fish oil is derived from the tissues of oily fish such as salmon, mackerel, and herring.\n4. Krill oil is considered to be a more environmentally friendly option than fish oil in terms of sustainability.\n5. Krill are a more abundant and renewable resource compared to many fish species.",
    "yulan-chat-2-13b-fp16_fact": [
      "Krill oil contains omega-3 fatty acids EPA and DHA in a form that is more bioavailable than those in fish oil.",
      "Krill oil is derived from Antarctic krill, a small shrimp-like creature.",
      "Fish oil is derived from the tissues of oily fish such as salmon, mackerel, and herring.",
      "Krill oil is considered to be a more environmentally friendly option than fish oil in terms of sustainability.",
      "Krill are a more abundant and renewable resource compared to many fish species."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While krill oil is marketed as being more sustainable due to the abundant nature of krill, concerns about the ecological impacts of krill harvesting and the overall sustainability of both krill and fish oil production are complex and ongoing. Therefore, it is not definitively established that krill oil is more environmentally friendly than fish oil.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4729,
    "user_query": "are organic foods safer ?",
    "yulan-chat-2-13b-fp16_response": "Organic foods are produced using farming practices that avoid the use of synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge. Some people believe that organic foods are safer to eat because they are free from these substances, which can be harmful to human health and the environment.\nHowever, it is important to note that there is no conclusive evidence that organic foods are inherently safer than conventionally grown foods. While organic farming practices may reduce exposure to certain chemicals, they do not necessarily make the food itself any safer to eat.\nAdditionally, some studies have suggested that organic foods may have higher levels of certain nutrients, such as antioxidants, compared to conventionally grown foods. However, the differences in nutrient levels are generally small and may not have a significant impact on human health.\nUltimately, the decision to choose organic foods is a personal one that depends on a variety of factors, including individual preferences, concerns about environmental impact, and beliefs about the health benefits of organic foods.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Organic foods are produced avoiding synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge.\n2. There is no conclusive evidence that organic foods are inherently safer than conventionally grown foods.\n3. Organic farming practices may reduce exposure to certain chemicals compared to conventional farming practices.\n4. Some studies suggest that organic foods may have higher levels of certain nutrients, such as antioxidants. \n5. The differences in nutrient levels between organic and conventionally grown foods are generally small.",
    "yulan-chat-2-13b-fp16_fact": [
      "Organic foods are produced avoiding synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge.",
      "There is no conclusive evidence that organic foods are inherently safer than conventionally grown foods.",
      "Organic farming practices may reduce exposure to certain chemicals compared to conventional farming practices.",
      "Some studies suggest that organic foods may have higher levels of certain nutrients, such as antioxidants.",
      "The differences in nutrient levels between organic and conventionally grown foods are generally small."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4732,
    "user_query": "do vegetarians get enough protein ?",
    "yulan-chat-2-13b-fp16_response": "Yes, vegetarians can get enough protein from a variety of plant-based sources. Some good sources of protein for vegetarians include beans, lentils, tofu, tempeh, nuts, seeds, and whole grains. It is important for vegetarians to include a variety of these protein sources in their diet to ensure that they are getting all of the essential amino acids that their body needs. In general, it is possible for vegetarians to get enough protein as long as they are consuming a balanced diet that includes a variety of plant-based protein sources.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Vegetarians can get enough protein from plant-based sources.\n2. Beans, lentils, tofu, tempeh, nuts, seeds, and whole grains are good sources of protein for vegetarians.\n3. Consuming a variety of plant-based protein sources helps vegetarians get all the essential amino acids needed by the body.",
    "yulan-chat-2-13b-fp16_fact": [
      "Vegetarians can get enough protein from plant-based sources.",
      "Beans, lentils, tofu, tempeh, nuts, seeds, and whole grains are good sources of protein for vegetarians.",
      "Consuming a variety of plant-based protein sources helps vegetarians get all the essential amino acids needed by the body."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4743,
    "user_query": "is dragon fruit good for you ?",
    "yulan-chat-2-13b-fp16_response": "Yes, dragon fruit is considered to be a healthy fruit. It is low in calories and high in fiber, vitamins, and antioxidants. It is a good source of vitamin C, vitamin B3, and potassium. It also contains a type of fiber called soluble fiber, which can help to lower cholesterol levels and improve digestive health. Additionally, dragon fruit has been shown to have anti-inflammatory and antioxidant properties, which may help to protect against chronic diseases.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Dragon fruit is low in calories.\n2. Dragon fruit is high in fiber, vitamins, and antioxidants.\n3. Dragon fruit is a good source of vitamin C, vitamin B3, and potassium.\n4. Dragon fruit contains soluble fiber that can help to lower cholesterol levels and improve digestive health.\n5. Dragon fruit has anti-inflammatory and antioxidant properties that may help protect against chronic diseases.",
    "yulan-chat-2-13b-fp16_fact": [
      "Dragon fruit is low in calories.",
      "Dragon fruit is high in fiber, vitamins, and antioxidants.",
      "Dragon fruit is a good source of vitamin C, vitamin B3, and potassium.",
      "Dragon fruit contains soluble fiber that can help to lower cholesterol levels and improve digestive health.",
      "Dragon fruit has anti-inflammatory and antioxidant properties that may help protect against chronic diseases."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4746,
    "user_query": "is coconut milk good for you ?",
    "yulan-chat-2-13b-fp16_response": "Coconut milk can be a nutritious and healthy addition to your diet when consumed in moderation. It is a good source of healthy fats, fiber, and several essential vitamins and minerals, such as iron, potassium, and vitamin C.\nHowever, it is important to note that coconut milk is high in calories and saturated fat, which can be detrimental to your health if consumed in excess. It is also important to choose unsweetened and non-processed coconut milk to avoid added sugars and other unnecessary ingredients.\nOverall, coconut milk can be a healthy addition to a balanced diet when consumed in moderation and as part of a healthy lifestyle.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Coconut milk is a source of healthy fats and fiber.\n2. Coconut milk contains several essential vitamins and minerals, including iron, potassium, and vitamin C.\n3. Coconut milk is high in calories and saturated fat.\n4. Excessive consumption of coconut milk can be detrimental to health.\n5. It is advisable to choose unsweetened and non-processed coconut milk to avoid added sugars and other unnecessary ingredients.",
    "yulan-chat-2-13b-fp16_fact": [
      "Coconut milk is a source of healthy fats and fiber.",
      "Coconut milk contains several essential vitamins and minerals, including iron, potassium, and vitamin C.",
      "Coconut milk is high in calories and saturated fat.",
      "Excessive consumption of coconut milk can be detrimental to health.",
      "It is advisable to choose unsweetened and non-processed coconut milk to avoid added sugars and other unnecessary ingredients."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. FALSE [correction]: Coconut milk contains some essential vitamins and minerals, including iron and potassium, but it is not a significant source of vitamin C.\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4748,
    "user_query": "can we fight the blues with greens ?",
    "yulan-chat-2-13b-fp16_response": "Yes, consuming foods that are high in antioxidants, such as leafy greens, can help to combat the effects of stress and improve mood. However, it is important to note that a healthy diet alone may not be enough to treat clinical depression and other mental health conditions. It is always best to consult with a healthcare professional if you are experiencing symptoms of depression or other mental health conditions.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Leafy greens are high in antioxidants.\n2. Antioxidants can help to combat the effects of stress and improve mood.\n3. A healthy diet alone may not be sufficient to treat clinical depression and other mental health conditions.\n4. Consulting with a healthcare professional is recommended for symptoms of depression or other mental health conditions.",
    "yulan-chat-2-13b-fp16_fact": [
      "Leafy greens are high in antioxidants.",
      "Antioxidants can help to combat the effects of stress and improve mood.",
      "A healthy diet alone may not be sufficient to treat clinical depression and other mental health conditions.",
      "Consulting with a healthcare professional is recommended for symptoms of depression or other mental health conditions."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4759,
    "user_query": "should probiotics be taken before , during , or after meals ?",
    "yulan-chat-2-13b-fp16_response": "Probiotics should be taken after meals, preferably with a small amount of water. This allows the probiotics to reach the intestines, where they can have a beneficial effect on the gut microbiome. Taking probiotics before or during meals can reduce their effectiveness, as the stomach acid can kill off some of the beneficial bacteria before they reach the intestines.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Probiotics should be taken after meals.\n2. Probiotics are taken with a small amount of water.\n3. Probiotics can have a beneficial effect on the gut microbiome.\n4. Taking probiotics before or during meals can reduce their effectiveness.\n5. Stomach acid can kill some of the beneficial bacteria in probiotics if taken before they reach the intestines.",
    "yulan-chat-2-13b-fp16_fact": [
      "Probiotics should be taken after meals.",
      "Probiotics are taken with a small amount of water.",
      "Probiotics can have a beneficial effect on the gut microbiome.",
      "Taking probiotics before or during meals can reduce their effectiveness.",
      "Stomach acid can kill some of the beneficial bacteria in probiotics if taken before they reach the intestines."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. FALSE [correction]: Probiotics are often recommended to be taken before or during meals. The food can act as a buffer and ensure more probiotics reach the intestines.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Taking probiotics before or during meals can actually be more effective, as the food may protect the bacteria as they pass through the stomach.\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4764,
    "user_query": "are avocados bad for you ?",
    "yulan-chat-2-13b-fp16_response": "Avocados are a nutritious and healthy food that can be a part of a balanced diet. They are a good source of healthy fats, fiber, and various vitamins and minerals. However, like any food, avocados should be consumed in moderation as part of a balanced diet. Eating too much of any food, including avocados, can lead to weight gain and other health problems. It is also important to consider the potential for avocado allergies in some individuals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Avocados are a source of healthy fats.\n2. Avocados contain fiber.\n3. Avocados provide various vitamins and minerals.\n4. Consuming too much of any food, including avocados, can lead to weight gain and other health problems.\n5. Some individuals may have allergies to avocados.",
    "yulan-chat-2-13b-fp16_fact": [
      "Avocados are a source of healthy fats.",
      "Avocados contain fiber.",
      "Avocados provide various vitamins and minerals.",
      "Consuming too much of any food, including avocados, can lead to weight gain and other health problems.",
      "Some individuals may have allergies to avocados."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4776,
    "user_query": "in making water alkaline , how much baking soda is too much ?",
    "yulan-chat-2-13b-fp16_response": "It is generally safe to add small amounts of baking soda to water, but adding too much can make the water too alkaline and can be harmful. The recommended amount of baking soda to add to water to make it alkaline is typically around 1/2 teaspoon per gallon of water. Adding more than this can cause the pH of the water to become too high and can be harmful to plants and animals. It is important to use caution when making water alkaline and to test the pH of the water to ensure that it is within a safe range.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Adding small amounts of baking soda to water to make it alkaline is generally safe.\n2. The recommended amount of baking soda to add to water for alkalinity is about 1/2 teaspoon per gallon of water.\n3. Adding more than the recommended amount of baking soda can cause the pH of the water to become too high.\n4. Water that is too alkaline can be harmful to plants and animals.\n5. It is important to test the pH of the water to ensure it is within a safe range when making it alkaline.",
    "yulan-chat-2-13b-fp16_fact": [
      "Adding small amounts of baking soda to water to make it alkaline is generally safe.",
      "The recommended amount of baking soda to add to water for alkalinity is about 1/2 teaspoon per gallon of water.",
      "Adding more than the recommended amount of baking soda can cause the pH of the water to become too high.",
      "Water that is too alkaline can be harmful to plants and animals.",
      "It is important to test the pH of the water to ensure it is within a safe range when making it alkaline."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4779,
    "user_query": "isn 't regular cocoa powder healthier than alkali-processed \" dutched \" cocoa ?",
    "yulan-chat-2-13b-fp16_response": "It's difficult to say whether regular cocoa powder is healthier than alkali-processed \"dutched\" cocoa without more information about the specific products you are comparing.\nIn general, cocoa powder is a good source of antioxidants, flavonoids, and other beneficial compounds. However, the processing methods used to make cocoa powder can affect its nutritional content and potential health benefits.\nAlkali-processed \"dutched\" cocoa powder has been treated with a base (such as sodium hydroxide or potassium hydroxide) to neutralize its acidity and give it a milder flavor. This process can affect the flavonoid content of the cocoa powder, potentially reducing its health benefits.\nOn the other hand, regular cocoa powder is typically not alkali-treated and may retain more of its natural flavonoid content. However, it's important to note that the quality and sourcing of the cocoa beans used to make cocoa powder can also affect its nutritional content.\nUltimately, the healthiness of cocoa powder depends on a variety of factors, including the processing method, the quality of the cocoa beans, and the amount consumed. It's always a good idea to choose high-quality, unsweetened cocoa powder in moderation as part of a balanced diet.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Alkali-processed \"dutched\" cocoa powder is treated with a base to neutralize its acidity and modify its flavor.\n2. The process of alkali treatment can affect the flavonoid content of \"dutched\" cocoa powder.\n3. Regular cocoa powder is typically not alkali-treated.\n4. Regular cocoa powder may retain more of its natural flavonoid content compared to alkali-processed cocoa.\n5. The quality and sourcing of the cocoa beans can affect the nutritional content of cocoa powder.",
    "yulan-chat-2-13b-fp16_fact": [
      "Alkali-processed \"dutched\" cocoa powder is treated with a base to neutralize its acidity and modify its flavor.",
      "The process of alkali treatment can affect the flavonoid content of \"dutched\" cocoa powder.",
      "Regular cocoa powder is typically not alkali-treated.",
      "Regular cocoa powder may retain more of its natural flavonoid content compared to alkali-processed cocoa.",
      "The quality and sourcing of the cocoa beans can affect the nutritional content of cocoa powder."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4787,
    "user_query": "should probiotics be taken before , during , or after meals ?",
    "yulan-chat-2-13b-fp16_response": "Probiotics should be taken after meals, preferably with a small amount of water. This allows the probiotics to reach the intestines, where they can have a beneficial effect on the gut microbiome. Taking probiotics before or during meals can reduce their effectiveness, as the stomach acid can kill off some of the beneficial bacteria before they reach the intestines.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Probiotics should be taken after meals.\n2. Probiotics are more effective when they reach the intestines.\n3. Stomach acid can kill off some of the beneficial bacteria in probiotics if taken before or during meals.",
    "yulan-chat-2-13b-fp16_fact": [
      "Probiotics should be taken after meals.",
      "Probiotics are more effective when they reach the intestines.",
      "Stomach acid can kill off some of the beneficial bacteria in probiotics if taken before or during meals."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. UNKNOWN: There is no consensus on the best time to take probiotics; some sources suggest taking them on an empty stomach, while others recommend taking them with or after a meal when stomach acid levels are lower.\n2. TRUE: Probiotics are more effective when they reach the intestines because that is where they exert their beneficial effects on the gut flora.\n3. TRUE: Stomach acid can kill some of the beneficial bacteria in probiotics, which is why some recommendations suggest taking them with food, as food can buffer stomach acid and allow more bacteria to survive the journey to the intestines.",
    "yulan-chat-2-13b-fp16_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4792,
    "user_query": "are avocados bad for you ?",
    "yulan-chat-2-13b-fp16_response": "Avocados are a nutritious and healthy food that can be a part of a balanced diet. They are a good source of healthy fats, fiber, and various vitamins and minerals. However, like any food, avocados should be consumed in moderation as part of a balanced diet. Eating too much of any food, including avocados, can lead to weight gain and other health problems. It is also important to consider the potential for avocado allergies in some individuals.",
    "yulan-chat-2-13b-fp16_fact_raw": "1. Avocados are a source of healthy fats.\n2. Avocados contain fiber.\n3. Avocados provide various vitamins and minerals.\n4. Eating too much of any food, including avocados, can lead to weight gain and other health problems.\n5. Some individuals may have allergies to avocados.",
    "yulan-chat-2-13b-fp16_fact": [
      "Avocados are a source of healthy fats.",
      "Avocados contain fiber.",
      "Avocados provide various vitamins and minerals.",
      "Eating too much of any food, including avocados, can lead to weight gain and other health problems.",
      "Some individuals may have allergies to avocados."
    ],
    "yulan-chat-2-13b-fp16_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "yulan-chat-2-13b-fp16_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  }
]